sentenceId,word,offsetLeft,offsetRight,BIOtag
DDI-MedLine.d62.s0,Activation,0,9,O
DDI-MedLine.d62.s0,of,11,12,O
DDI-MedLine.d62.s0,an,14,15,O
DDI-MedLine.d62.s0,effector,17,24,O
DDI-MedLine.d62.s0,immediate-early,26,40,O
DDI-MedLine.d62.s0,gene,42,45,O
DDI-MedLine.d62.s0,arc,47,49,O
DDI-MedLine.d62.s0,by,51,52,O
DDI-MedLine.d62.s0,methamphetamine,54,68,B-drug
DDI-MedLine.d62.s0,.,69,69,O
DDI-MedLine.d62.s1,As,0,1,O
DDI-MedLine.d62.s1,immediate-early,3,17,O
DDI-MedLine.d62.s1,genes,19,23,O
DDI-MedLine.d62.s1,(,25,25,O
DDI-MedLine.d62.s1,IEGs,26,29,O
DDI-MedLine.d62.s1,),30,30,O
DDI-MedLine.d62.s1,are,32,34,O
DDI-MedLine.d62.s1,thought,36,42,O
DDI-MedLine.d62.s1,to,44,45,O
DDI-MedLine.d62.s1,play,47,50,O
DDI-MedLine.d62.s1,a,52,52,O
DDI-MedLine.d62.s1,critical,54,61,O
DDI-MedLine.d62.s1,role,63,66,O
DDI-MedLine.d62.s1,in,68,69,O
DDI-MedLine.d62.s1,mediating,71,79,O
DDI-MedLine.d62.s1,stimulus-induced,81,96,O
DDI-MedLine.d62.s1,neural,98,103,O
DDI-MedLine.d62.s1,plasticity,105,114,O
DDI-MedLine.d62.s1,",",115,115,O
DDI-MedLine.d62.s1,IEG,117,119,O
DDI-MedLine.d62.s1,response,121,128,O
DDI-MedLine.d62.s1,induced,130,136,O
DDI-MedLine.d62.s1,by,138,139,O
DDI-MedLine.d62.s1,methamphetamine,141,155,B-drug
DDI-MedLine.d62.s1,(,157,157,O
DDI-MedLine.d62.s1,METH,158,161,B-drug
DDI-MedLine.d62.s1,),162,162,O
DDI-MedLine.d62.s1,has,164,166,O
DDI-MedLine.d62.s1,been,168,171,O
DDI-MedLine.d62.s1,characterized,173,185,O
DDI-MedLine.d62.s1,to,187,188,O
DDI-MedLine.d62.s1,define,190,195,O
DDI-MedLine.d62.s1,the,197,199,O
DDI-MedLine.d62.s1,changes,201,207,O
DDI-MedLine.d62.s1,in,209,210,O
DDI-MedLine.d62.s1,gene,212,215,O
DDI-MedLine.d62.s1,expression,217,226,O
DDI-MedLine.d62.s1,that,228,231,O
DDI-MedLine.d62.s1,may,233,235,O
DDI-MedLine.d62.s1,underlie,237,244,O
DDI-MedLine.d62.s1,its,246,248,O
DDI-MedLine.d62.s1,long-lasting,250,261,O
DDI-MedLine.d62.s1,behavioral,263,272,O
DDI-MedLine.d62.s1,effects,274,280,O
DDI-MedLine.d62.s1,.,281,281,O
DDI-MedLine.d62.s2,Although,0,7,O
DDI-MedLine.d62.s2,activation,9,18,O
DDI-MedLine.d62.s2,of,20,21,O
DDI-MedLine.d62.s2,several,23,29,O
DDI-MedLine.d62.s2,transcription,31,43,O
DDI-MedLine.d62.s2,factor,45,50,O
DDI-MedLine.d62.s2,IEGs,52,55,O
DDI-MedLine.d62.s2,has,57,59,O
DDI-MedLine.d62.s2,been,61,64,O
DDI-MedLine.d62.s2,described,66,74,O
DDI-MedLine.d62.s2,",",75,75,O
DDI-MedLine.d62.s2,little,77,82,O
DDI-MedLine.d62.s2,is,84,85,O
DDI-MedLine.d62.s2,known,87,91,O
DDI-MedLine.d62.s2,about,93,97,O
DDI-MedLine.d62.s2,effector,99,106,O
DDI-MedLine.d62.s2,IEGs,108,111,O
DDI-MedLine.d62.s2,.,112,112,O
DDI-MedLine.d62.s3,Here,0,3,O
DDI-MedLine.d62.s3,",",4,4,O
DDI-MedLine.d62.s3,we,6,7,O
DDI-MedLine.d62.s3,have,9,12,O
DDI-MedLine.d62.s3,examined,14,21,O
DDI-MedLine.d62.s3,whether,23,29,O
DDI-MedLine.d62.s3,METH,31,34,B-drug
DDI-MedLine.d62.s3,administration,36,49,O
DDI-MedLine.d62.s3,affects,51,57,O
DDI-MedLine.d62.s3,expression,59,68,O
DDI-MedLine.d62.s3,of,70,71,O
DDI-MedLine.d62.s3,an,73,74,O
DDI-MedLine.d62.s3,effector,76,83,O
DDI-MedLine.d62.s3,IEG,85,87,O
DDI-MedLine.d62.s3,arc,89,91,O
DDI-MedLine.d62.s3,(,93,93,O
DDI-MedLine.d62.s3,activity-regulated,94,111,O
DDI-MedLine.d62.s3,",",112,112,O
DDI-MedLine.d62.s3,cytoskeleton-associated,114,136,O
DDI-MedLine.d62.s3,),137,137,O
DDI-MedLine.d62.s3,that,139,142,O
DDI-MedLine.d62.s3,encodes,144,150,O
DDI-MedLine.d62.s3,a,152,152,O
DDI-MedLine.d62.s3,protein,154,160,O
DDI-MedLine.d62.s3,with,162,165,O
DDI-MedLine.d62.s3,homology,167,174,O
DDI-MedLine.d62.s3,to,176,177,O
DDI-MedLine.d62.s3,spectrin,179,186,O
DDI-MedLine.d62.s3,.,187,187,O
DDI-MedLine.d62.s4,Using,0,4,O
DDI-MedLine.d62.s4,in,6,7,O
DDI-MedLine.d62.s4,situ,9,12,O
DDI-MedLine.d62.s4,hybridization,14,26,O
DDI-MedLine.d62.s4,",",27,27,O
DDI-MedLine.d62.s4,we,29,30,O
DDI-MedLine.d62.s4,observed,32,39,O
DDI-MedLine.d62.s4,that,41,44,O
DDI-MedLine.d62.s4,METH,46,49,B-drug
DDI-MedLine.d62.s4,caused,51,56,O
DDI-MedLine.d62.s4,a,58,58,O
DDI-MedLine.d62.s4,rapid,60,64,O
DDI-MedLine.d62.s4,and,66,68,O
DDI-MedLine.d62.s4,transient,70,78,O
DDI-MedLine.d62.s4,dose-dependent,80,93,O
DDI-MedLine.d62.s4,increase,95,102,O
DDI-MedLine.d62.s4,in,104,105,O
DDI-MedLine.d62.s4,arc,107,109,O
DDI-MedLine.d62.s4,mRNA,111,114,O
DDI-MedLine.d62.s4,level,116,120,O
DDI-MedLine.d62.s4,in,122,123,O
DDI-MedLine.d62.s4,the,125,127,O
DDI-MedLine.d62.s4,striatum,129,136,O
DDI-MedLine.d62.s4,and,138,140,O
DDI-MedLine.d62.s4,cortex,142,147,O
DDI-MedLine.d62.s4,that,149,152,O
DDI-MedLine.d62.s4,was,154,156,O
DDI-MedLine.d62.s4,abolished,158,166,O
DDI-MedLine.d62.s4,by,168,169,O
DDI-MedLine.d62.s4,pretreatment,171,182,O
DDI-MedLine.d62.s4,with,184,187,O
DDI-MedLine.d62.s4,the,189,191,O
DDI-MedLine.d62.s4,specific,193,200,O
DDI-MedLine.d62.s4,dopamine,202,209,O
DDI-MedLine.d62.s4,D1,211,212,O
DDI-MedLine.d62.s4,receptor,214,221,O
DDI-MedLine.d62.s4,antagonist,223,232,O
DDI-MedLine.d62.s4,SCH-23390,234,242,B-drug_n
DDI-MedLine.d62.s4,but,244,246,O
DDI-MedLine.d62.s4,not,248,250,O
DDI-MedLine.d62.s4,by,252,253,O
DDI-MedLine.d62.s4,an,255,256,O
DDI-MedLine.d62.s4,atypical,258,265,B-group
DDI-MedLine.d62.s4,neuroleptic,267,277,I-group
DDI-MedLine.d62.s4,clozapine,279,287,B-drug
DDI-MedLine.d62.s4,.,288,288,O
DDI-MedLine.d62.s5,METH,0,3,B-drug
DDI-MedLine.d62.s5,induced,5,11,O
DDI-MedLine.d62.s5,arc,13,15,O
DDI-MedLine.d62.s5,mRNA,17,20,O
DDI-MedLine.d62.s5,in,22,23,O
DDI-MedLine.d62.s5,layers,25,30,O
DDI-MedLine.d62.s5,IV,32,33,O
DDI-MedLine.d62.s5,and,35,37,O
DDI-MedLine.d62.s5,VI,39,40,O
DDI-MedLine.d62.s5,of,42,43,O
DDI-MedLine.d62.s5,the,45,47,O
DDI-MedLine.d62.s5,cortex,49,54,O
DDI-MedLine.d62.s5,which,56,60,O
DDI-MedLine.d62.s5,dopamine,62,69,O
DDI-MedLine.d62.s5,receptor,71,78,O
DDI-MedLine.d62.s5,are,80,82,O
DDI-MedLine.d62.s5,localized,84,92,O
DDI-MedLine.d62.s5,to,94,95,O
DDI-MedLine.d62.s5,.,96,96,O
DDI-MedLine.d62.s6,These,0,4,O
DDI-MedLine.d62.s6,results,6,12,O
DDI-MedLine.d62.s6,suggest,14,20,O
DDI-MedLine.d62.s6,that,22,25,O
DDI-MedLine.d62.s6,D1,27,28,O
DDI-MedLine.d62.s6,receptors,30,38,O
DDI-MedLine.d62.s6,are,40,42,O
DDI-MedLine.d62.s6,coupled,44,50,O
DDI-MedLine.d62.s6,to,52,53,O
DDI-MedLine.d62.s6,activation,55,64,O
DDI-MedLine.d62.s6,of,66,67,O
DDI-MedLine.d62.s6,arc,69,71,O
DDI-MedLine.d62.s6,gene,73,76,O
DDI-MedLine.d62.s6,",",77,77,O
DDI-MedLine.d62.s6,which,79,83,O
DDI-MedLine.d62.s6,may,85,87,O
DDI-MedLine.d62.s6,be,89,90,O
DDI-MedLine.d62.s6,involved,92,99,O
DDI-MedLine.d62.s6,in,101,102,O
DDI-MedLine.d62.s6,functional,104,113,O
DDI-MedLine.d62.s6,or,115,116,O
DDI-MedLine.d62.s6,structural,118,127,O
DDI-MedLine.d62.s6,alterations,129,139,O
DDI-MedLine.d62.s6,underlying,141,150,O
DDI-MedLine.d62.s6,neural,152,157,O
DDI-MedLine.d62.s6,plasticity,159,168,O
DDI-MedLine.d62.s6,triggered,170,178,O
DDI-MedLine.d62.s6,by,180,181,O
DDI-MedLine.d62.s6,METH,183,186,B-drug
DDI-MedLine.d62.s6,.,187,187,O
DDI-MedLine.d59.s0,A,0,0,O
DDI-MedLine.d59.s0,proposed,2,9,O
DDI-MedLine.d59.s0,mechanism,11,19,O
DDI-MedLine.d59.s0,for,21,23,O
DDI-MedLine.d59.s0,the,25,27,O
DDI-MedLine.d59.s0,potentiation,29,40,O
DDI-MedLine.d59.s0,of,42,43,O
DDI-MedLine.d59.s0,cAMP-mediated,45,57,O
DDI-MedLine.d59.s0,acid,59,62,O
DDI-MedLine.d59.s0,secretion,64,72,O
DDI-MedLine.d59.s0,by,74,75,O
DDI-MedLine.d59.s0,carbachol,77,85,B-drug
DDI-MedLine.d59.s0,.,86,86,O
DDI-MedLine.d59.s1,Acid,0,3,O
DDI-MedLine.d59.s1,secretion,5,13,O
DDI-MedLine.d59.s1,in,15,16,O
DDI-MedLine.d59.s1,isolated,18,25,O
DDI-MedLine.d59.s1,rabbit,27,32,O
DDI-MedLine.d59.s1,gastric,34,40,O
DDI-MedLine.d59.s1,glands,42,47,O
DDI-MedLine.d59.s1,was,49,51,O
DDI-MedLine.d59.s1,monitored,53,61,O
DDI-MedLine.d59.s1,by,63,64,O
DDI-MedLine.d59.s1,the,66,68,O
DDI-MedLine.d59.s1,accumulation,70,81,O
DDI-MedLine.d59.s1,of,83,84,O
DDI-MedLine.d59.s1,[,86,86,O
DDI-MedLine.d59.s1,(,87,87,O
DDI-MedLine.d59.s1,14,88,89,O
DDI-MedLine.d59.s1,),90,90,O
DDI-MedLine.d59.s1,C,91,91,O
DDI-MedLine.d59.s1,],92,92,O
DDI-MedLine.d59.s1,aminopyrine,93,103,B-drug
DDI-MedLine.d59.s1,.,104,104,O
DDI-MedLine.d59.s2,Stimulation,0,10,O
DDI-MedLine.d59.s2,of,12,13,O
DDI-MedLine.d59.s2,the,15,17,O
DDI-MedLine.d59.s2,glands,19,24,O
DDI-MedLine.d59.s2,with,26,29,O
DDI-MedLine.d59.s2,carbachol,31,39,B-drug
DDI-MedLine.d59.s2,synergistically,41,55,O
DDI-MedLine.d59.s2,augmented,57,65,O
DDI-MedLine.d59.s2,the,67,69,O
DDI-MedLine.d59.s2,response,71,78,O
DDI-MedLine.d59.s2,to,80,81,O
DDI-MedLine.d59.s2,dibutyryl,83,91,O
DDI-MedLine.d59.s2,cAMP,93,96,O
DDI-MedLine.d59.s2,.,97,97,O
DDI-MedLine.d59.s3,The,0,2,O
DDI-MedLine.d59.s3,augmentation,4,15,O
DDI-MedLine.d59.s3,persisted,17,25,O
DDI-MedLine.d59.s3,even,27,30,O
DDI-MedLine.d59.s3,after,32,36,O
DDI-MedLine.d59.s3,carbachol,38,46,B-drug
DDI-MedLine.d59.s3,was,48,50,O
DDI-MedLine.d59.s3,washed,52,57,O
DDI-MedLine.d59.s3,out,59,61,O
DDI-MedLine.d59.s3,and,63,65,O
DDI-MedLine.d59.s3,was,67,69,O
DDI-MedLine.d59.s3,resistant,71,79,O
DDI-MedLine.d59.s3,to,81,82,O
DDI-MedLine.d59.s3,chelated,84,91,O
DDI-MedLine.d59.s3,extracellular,93,105,O
DDI-MedLine.d59.s3,Ca,107,108,O
DDI-MedLine.d59.s3,(,109,109,O
DDI-MedLine.d59.s3,2+,110,111,O
DDI-MedLine.d59.s3,),112,112,O
DDI-MedLine.d59.s3,and,114,116,O
DDI-MedLine.d59.s3,to,118,119,O
DDI-MedLine.d59.s3,inhibitors,121,130,O
DDI-MedLine.d59.s3,of,132,133,O
DDI-MedLine.d59.s3,either,135,140,O
DDI-MedLine.d59.s3,protein,142,148,O
DDI-MedLine.d59.s3,kinase,150,155,O
DDI-MedLine.d59.s3,C,157,157,O
DDI-MedLine.d59.s3,or,159,160,O
DDI-MedLine.d59.s3,calmodulin,162,171,O
DDI-MedLine.d59.s3,kinase,173,178,O
DDI-MedLine.d59.s3,II,180,181,O
DDI-MedLine.d59.s3,.,182,182,O
DDI-MedLine.d59.s4,Cytochalasin,0,11,B-drug_n
DDI-MedLine.d59.s4,D,13,13,I-drug_n
DDI-MedLine.d59.s4,at,15,16,O
DDI-MedLine.d59.s4,10,18,19,O
DDI-MedLine.d59.s4,microM,21,26,O
DDI-MedLine.d59.s4,preferentially,28,41,O
DDI-MedLine.d59.s4,blocked,43,49,O
DDI-MedLine.d59.s4,the,51,53,O
DDI-MedLine.d59.s4,secretory,55,63,O
DDI-MedLine.d59.s4,effect,65,70,O
DDI-MedLine.d59.s4,of,72,73,O
DDI-MedLine.d59.s4,carbachol,75,83,B-drug
DDI-MedLine.d59.s4,and,85,87,O
DDI-MedLine.d59.s4,its,89,91,O
DDI-MedLine.d59.s4,synergism,93,101,O
DDI-MedLine.d59.s4,with,103,106,O
DDI-MedLine.d59.s4,cAMP,108,111,O
DDI-MedLine.d59.s4,",",112,112,O
DDI-MedLine.d59.s4,whereas,114,120,O
DDI-MedLine.d59.s4,it,122,123,O
DDI-MedLine.d59.s4,had,125,127,O
DDI-MedLine.d59.s4,no,129,130,O
DDI-MedLine.d59.s4,effect,132,137,O
DDI-MedLine.d59.s4,on,139,140,O
DDI-MedLine.d59.s4,histamine-,142,151,O
DDI-MedLine.d59.s4,or,153,154,O
DDI-MedLine.d59.s4,cAMP-stimulated,156,170,O
DDI-MedLine.d59.s4,acid,172,175,O
DDI-MedLine.d59.s4,secretion,177,185,O
DDI-MedLine.d59.s4,within,187,192,O
DDI-MedLine.d59.s4,15,194,195,O
DDI-MedLine.d59.s4,min,197,199,O
DDI-MedLine.d59.s4,.,200,200,O
DDI-MedLine.d59.s5,Cytochalasin,0,11,B-drug_n
DDI-MedLine.d59.s5,D,13,13,I-drug_n
DDI-MedLine.d59.s5,inhibited,15,23,O
DDI-MedLine.d59.s5,the,25,27,O
DDI-MedLine.d59.s5,carbachol-stimulated,29,48,O
DDI-MedLine.d59.s5,intracellular,50,62,O
DDI-MedLine.d59.s5,Ca,64,65,O
DDI-MedLine.d59.s5,(,66,66,O
DDI-MedLine.d59.s5,2+,67,68,O
DDI-MedLine.d59.s5,),69,69,O
DDI-MedLine.d59.s5,concentration,71,83,O
DDI-MedLine.d59.s5,(,85,85,O
DDI-MedLine.d59.s5,[,86,86,O
DDI-MedLine.d59.s5,Ca,87,88,O
DDI-MedLine.d59.s5,(,89,89,O
DDI-MedLine.d59.s5,2+,90,91,O
DDI-MedLine.d59.s5,),92,92,O
DDI-MedLine.d59.s5,],93,93,O
DDI-MedLine.d59.s5,(,94,94,O
DDI-MedLine.d59.s5,i,95,95,O
DDI-MedLine.d59.s5,),96,96,O
DDI-MedLine.d59.s5,),97,97,O
DDI-MedLine.d59.s5,increase,99,106,O
DDI-MedLine.d59.s5,due,108,110,O
DDI-MedLine.d59.s5,to,112,113,O
DDI-MedLine.d59.s5,release,115,121,O
DDI-MedLine.d59.s5,from,123,126,O
DDI-MedLine.d59.s5,the,128,130,O
DDI-MedLine.d59.s5,Ca,132,133,O
DDI-MedLine.d59.s5,(,134,134,O
DDI-MedLine.d59.s5,2+,135,136,O
DDI-MedLine.d59.s5,),137,137,O
DDI-MedLine.d59.s5,store,139,143,O
DDI-MedLine.d59.s5,.,144,144,O
DDI-MedLine.d59.s6,Treatment,0,8,O
DDI-MedLine.d59.s6,of,10,11,O
DDI-MedLine.d59.s6,the,13,15,O
DDI-MedLine.d59.s6,glands,17,22,O
DDI-MedLine.d59.s6,with,24,27,O
DDI-MedLine.d59.s6,cytochalasin,29,40,B-drug_n
DDI-MedLine.d59.s6,D,42,42,I-drug_n
DDI-MedLine.d59.s6,redistributed,44,56,O
DDI-MedLine.d59.s6,type,58,61,O
DDI-MedLine.d59.s6,3,63,63,O
DDI-MedLine.d59.s6,inositol,65,72,O
DDI-MedLine.d59.s6,"1,4,5-trisphosphate",74,92,O
DDI-MedLine.d59.s6,receptor,94,101,O
DDI-MedLine.d59.s6,(,103,103,O
DDI-MedLine.d59.s6,the,104,106,O
DDI-MedLine.d59.s6,major,108,112,O
DDI-MedLine.d59.s6,subtype,114,120,O
DDI-MedLine.d59.s6,in,122,123,O
DDI-MedLine.d59.s6,the,125,127,O
DDI-MedLine.d59.s6,parietal,129,136,O
DDI-MedLine.d59.s6,cell,138,141,O
DDI-MedLine.d59.s6,),142,142,O
DDI-MedLine.d59.s6,from,144,147,O
DDI-MedLine.d59.s6,the,149,151,O
DDI-MedLine.d59.s6,fraction,153,160,O
DDI-MedLine.d59.s6,containing,162,171,O
DDI-MedLine.d59.s6,membranes,173,181,O
DDI-MedLine.d59.s6,of,183,184,O
DDI-MedLine.d59.s6,large,186,190,O
DDI-MedLine.d59.s6,size,192,195,O
DDI-MedLine.d59.s6,to,197,198,O
DDI-MedLine.d59.s6,the,200,202,O
DDI-MedLine.d59.s6,microsomal,204,213,O
DDI-MedLine.d59.s6,fraction,215,222,O
DDI-MedLine.d59.s6,",",223,223,O
DDI-MedLine.d59.s6,suggesting,225,234,O
DDI-MedLine.d59.s6,a,236,236,O
DDI-MedLine.d59.s6,dissociation,238,249,O
DDI-MedLine.d59.s6,of,251,252,O
DDI-MedLine.d59.s6,the,254,256,O
DDI-MedLine.d59.s6,store,258,262,O
DDI-MedLine.d59.s6,from,264,267,O
DDI-MedLine.d59.s6,the,269,271,O
DDI-MedLine.d59.s6,plasma,273,278,O
DDI-MedLine.d59.s6,membrane,280,287,O
DDI-MedLine.d59.s6,.,288,288,O
DDI-MedLine.d59.s7,These,0,4,O
DDI-MedLine.d59.s7,findings,6,13,O
DDI-MedLine.d59.s7,suggest,15,21,O
DDI-MedLine.d59.s7,that,23,26,O
DDI-MedLine.d59.s7,intracellular,28,40,O
DDI-MedLine.d59.s7,Ca,42,43,O
DDI-MedLine.d59.s7,(,44,44,O
DDI-MedLine.d59.s7,2+,45,46,O
DDI-MedLine.d59.s7,),47,47,O
DDI-MedLine.d59.s7,release,49,55,O
DDI-MedLine.d59.s7,by,57,58,O
DDI-MedLine.d59.s7,cholinergic,60,70,O
DDI-MedLine.d59.s7,stimulation,72,82,O
DDI-MedLine.d59.s7,is,84,85,O
DDI-MedLine.d59.s7,critical,87,94,O
DDI-MedLine.d59.s7,for,96,98,O
DDI-MedLine.d59.s7,determining,100,110,O
DDI-MedLine.d59.s7,synergism,112,120,O
DDI-MedLine.d59.s7,with,122,125,O
DDI-MedLine.d59.s7,cAMP,127,130,O
DDI-MedLine.d59.s7,in,132,133,O
DDI-MedLine.d59.s7,parietal,135,142,O
DDI-MedLine.d59.s7,cell,144,147,O
DDI-MedLine.d59.s7,activation,149,158,O
DDI-MedLine.d59.s7,and,160,162,O
DDI-MedLine.d59.s7,that,164,167,O
DDI-MedLine.d59.s7,functional,169,178,O
DDI-MedLine.d59.s7,coupling,180,187,O
DDI-MedLine.d59.s7,between,189,195,O
DDI-MedLine.d59.s7,the,197,199,O
DDI-MedLine.d59.s7,Ca,201,202,O
DDI-MedLine.d59.s7,(,203,203,O
DDI-MedLine.d59.s7,2+,204,205,O
DDI-MedLine.d59.s7,),206,206,O
DDI-MedLine.d59.s7,store,208,212,O
DDI-MedLine.d59.s7,and,214,216,O
DDI-MedLine.d59.s7,the,218,220,O
DDI-MedLine.d59.s7,receptor,222,229,O
DDI-MedLine.d59.s7,is,231,232,O
DDI-MedLine.d59.s7,maintained,234,243,O
DDI-MedLine.d59.s7,by,245,246,O
DDI-MedLine.d59.s7,actin,248,252,O
DDI-MedLine.d59.s7,microfilaments,254,267,O
DDI-MedLine.d59.s7,.,268,268,O
DDI-MedLine.d47.s0,Activity,0,7,O
DDI-MedLine.d47.s0,of,9,10,O
DDI-MedLine.d47.s0,buforin,12,18,B-drug_n
DDI-MedLine.d47.s0,II,20,21,I-drug_n
DDI-MedLine.d47.s0,alone,23,27,O
DDI-MedLine.d47.s0,and,29,31,O
DDI-MedLine.d47.s0,in,33,34,O
DDI-MedLine.d47.s0,combination,36,46,O
DDI-MedLine.d47.s0,with,48,51,O
DDI-MedLine.d47.s0,azithromycin,53,64,B-drug
DDI-MedLine.d47.s0,and,66,68,O
DDI-MedLine.d47.s0,minocycline,70,80,B-drug
DDI-MedLine.d47.s0,against,82,88,O
DDI-MedLine.d47.s0,Cryptosporidium,90,104,O
DDI-MedLine.d47.s0,parvum,106,111,O
DDI-MedLine.d47.s0,in,113,114,O
DDI-MedLine.d47.s0,cell,116,119,O
DDI-MedLine.d47.s0,culture,121,127,O
DDI-MedLine.d47.s0,.,128,128,O
DDI-MedLine.d47.s1,The,0,2,O
DDI-MedLine.d47.s1,in,4,5,O
DDI-MedLine.d47.s1,vitro,7,11,O
DDI-MedLine.d47.s1,anti-cryptosporidial,13,32,O
DDI-MedLine.d47.s1,activity,34,41,O
DDI-MedLine.d47.s1,of,43,44,O
DDI-MedLine.d47.s1,buforin,46,52,B-drug_n
DDI-MedLine.d47.s1,II,54,55,I-drug_n
DDI-MedLine.d47.s1,alone,57,61,O
DDI-MedLine.d47.s1,and,63,65,O
DDI-MedLine.d47.s1,in,67,68,O
DDI-MedLine.d47.s1,combination,70,80,O
DDI-MedLine.d47.s1,with,82,85,O
DDI-MedLine.d47.s1,azithromycin,87,98,B-drug
DDI-MedLine.d47.s1,and,100,102,O
DDI-MedLine.d47.s1,minocycline,104,114,B-drug
DDI-MedLine.d47.s1,was,116,118,O
DDI-MedLine.d47.s1,investigated,120,131,O
DDI-MedLine.d47.s1,.,132,132,O
DDI-MedLine.d47.s2,Buforin,0,6,B-drug_n
DDI-MedLine.d47.s2,II,8,9,I-drug_n
DDI-MedLine.d47.s2,showed,11,16,O
DDI-MedLine.d47.s2,moderate,18,25,O
DDI-MedLine.d47.s2,activity,27,34,O
DDI-MedLine.d47.s2,",",35,35,O
DDI-MedLine.d47.s2,which,37,41,O
DDI-MedLine.d47.s2,increased,43,51,O
DDI-MedLine.d47.s2,with,53,56,O
DDI-MedLine.d47.s2,increasing,58,67,O
DDI-MedLine.d47.s2,concentration,69,81,O
DDI-MedLine.d47.s2,to,83,84,O
DDI-MedLine.d47.s2,55.7,86,89,O
DDI-MedLine.d47.s2,%,90,90,O
DDI-MedLine.d47.s2,suppression,92,102,O
DDI-MedLine.d47.s2,of,104,105,O
DDI-MedLine.d47.s2,growth,107,112,O
DDI-MedLine.d47.s2,at,114,115,O
DDI-MedLine.d47.s2,20,117,118,O
DDI-MedLine.d47.s2,microM,120,125,O
DDI-MedLine.d47.s2,.,126,126,O
DDI-MedLine.d47.s3,Moreover,0,7,O
DDI-MedLine.d47.s3,",",8,8,O
DDI-MedLine.d47.s3,its,10,12,O
DDI-MedLine.d47.s3,activity,14,21,O
DDI-MedLine.d47.s3,was,23,25,O
DDI-MedLine.d47.s3,enhanced,27,34,O
DDI-MedLine.d47.s3,when,36,39,O
DDI-MedLine.d47.s3,it,41,42,O
DDI-MedLine.d47.s3,was,44,46,O
DDI-MedLine.d47.s3,combined,48,55,O
DDI-MedLine.d47.s3,with,57,60,O
DDI-MedLine.d47.s3,either,62,67,O
DDI-MedLine.d47.s3,azithromycin,69,80,B-drug
DDI-MedLine.d47.s3,or,82,83,O
DDI-MedLine.d47.s3,minocycline,85,95,B-drug
DDI-MedLine.d47.s3,with,97,100,O
DDI-MedLine.d47.s3,90,102,103,O
DDI-MedLine.d47.s3,%,104,104,O
DDI-MedLine.d47.s3,parasite,106,113,O
DDI-MedLine.d47.s3,reduction,115,123,O
DDI-MedLine.d47.s3,at,125,126,O
DDI-MedLine.d47.s3,the,128,130,O
DDI-MedLine.d47.s3,highest,132,138,O
DDI-MedLine.d47.s3,concentration,140,152,O
DDI-MedLine.d47.s3,tested,154,159,O
DDI-MedLine.d47.s3,.,160,160,O
DDI-MedLine.d47.s4,Buforin,0,6,B-drug_n
DDI-MedLine.d47.s4,II,8,9,I-drug_n
DDI-MedLine.d47.s4,may,11,13,O
DDI-MedLine.d47.s4,be,15,16,O
DDI-MedLine.d47.s4,active,18,23,O
DDI-MedLine.d47.s4,in,25,26,O
DDI-MedLine.d47.s4,inhibiting,28,37,O
DDI-MedLine.d47.s4,Cryptosporidium,39,53,O
DDI-MedLine.d47.s4,parvum,55,60,O
DDI-MedLine.d47.s4,growth,62,67,O
DDI-MedLine.d47.s4,in,69,70,O
DDI-MedLine.d47.s4,vitro,72,76,O
DDI-MedLine.d47.s4,upon,78,81,O
DDI-MedLine.d47.s4,combination,83,93,O
DDI-MedLine.d47.s4,with,95,98,O
DDI-MedLine.d47.s4,either,100,105,O
DDI-MedLine.d47.s4,azithromycin,107,118,B-drug
DDI-MedLine.d47.s4,or,120,121,O
DDI-MedLine.d47.s4,minocycline,123,133,B-drug
DDI-MedLine.d47.s4,.,134,134,O
DDI-MedLine.d65.s0,Drug,0,3,O
DDI-MedLine.d65.s0,interactions,5,16,O
DDI-MedLine.d65.s0,:,17,17,O
DDI-MedLine.d65.s0,How,19,21,O
DDI-MedLine.d65.s0,to,23,24,O
DDI-MedLine.d65.s0,identify,26,33,O
DDI-MedLine.d65.s0,them,35,38,O
DDI-MedLine.d65.s0,.,39,39,O
DDI-MedLine.d65.s1,Interactions,0,11,O
DDI-MedLine.d65.s1,between,13,19,O
DDI-MedLine.d65.s1,theraputic,21,30,O
DDI-MedLine.d65.s1,agents,32,37,O
DDI-MedLine.d65.s1,have,39,42,O
DDI-MedLine.d65.s1,been,44,47,O
DDI-MedLine.d65.s1,recognized,49,58,O
DDI-MedLine.d65.s1,as,60,61,O
DDI-MedLine.d65.s1,increasingly,63,74,O
DDI-MedLine.d65.s1,important,76,84,O
DDI-MedLine.d65.s1,causes,86,91,O
DDI-MedLine.d65.s1,of,93,94,O
DDI-MedLine.d65.s1,drug,96,99,O
DDI-MedLine.d65.s1,at,101,102,O
DDI-MedLine.d65.s1,their,104,108,O
DDI-MedLine.d65.s1,usual,110,114,O
DDI-MedLine.d65.s1,recommended,116,126,O
DDI-MedLine.d65.s1,dose,128,131,O
DDI-MedLine.d65.s1,may,133,135,O
DDI-MedLine.d65.s1,",",136,136,O
DDI-MedLine.d65.s1,under,138,142,O
DDI-MedLine.d65.s1,certain,144,150,O
DDI-MedLine.d65.s1,conditions,152,161,O
DDI-MedLine.d65.s1,",",162,162,O
DDI-MedLine.d65.s1,produce,164,170,O
DDI-MedLine.d65.s1,toxicity,172,179,O
DDI-MedLine.d65.s1,of,181,182,O
DDI-MedLine.d65.s1,life-endangering,184,199,O
DDI-MedLine.d65.s1,proportions,201,211,O
DDI-MedLine.d65.s1,.,212,212,O
DDI-MedLine.d65.s2,While,0,4,O
DDI-MedLine.d65.s2,the,6,8,O
DDI-MedLine.d65.s2,recognition,10,20,O
DDI-MedLine.d65.s2,of,22,23,O
DDI-MedLine.d65.s2,drug,25,28,O
DDI-MedLine.d65.s2,toxicity,30,37,O
DDI-MedLine.d65.s2,resulting,39,47,O
DDI-MedLine.d65.s2,from,49,52,O
DDI-MedLine.d65.s2,interactions,54,65,O
DDI-MedLine.d65.s2,is,67,68,O
DDI-MedLine.d65.s2,of,70,71,O
DDI-MedLine.d65.s2,importance,73,82,O
DDI-MedLine.d65.s2,to,84,85,O
DDI-MedLine.d65.s2,all,87,89,O
DDI-MedLine.d65.s2,physciains,91,100,O
DDI-MedLine.d65.s2,",",101,101,O
DDI-MedLine.d65.s2,it,103,104,O
DDI-MedLine.d65.s2,is,106,107,O
DDI-MedLine.d65.s2,especially,109,118,O
DDI-MedLine.d65.s2,so,120,121,O
DDI-MedLine.d65.s2,for,123,125,O
DDI-MedLine.d65.s2,the,127,129,O
DDI-MedLine.d65.s2,clinician,131,139,O
DDI-MedLine.d65.s2,responsible,141,151,O
DDI-MedLine.d65.s2,for,153,155,O
DDI-MedLine.d65.s2,the,157,159,O
DDI-MedLine.d65.s2,welfare,161,167,O
DDI-MedLine.d65.s2,of,169,170,O
DDI-MedLine.d65.s2,those,172,176,O
DDI-MedLine.d65.s2,in,178,179,O
DDI-MedLine.d65.s2,the,181,183,O
DDI-MedLine.d65.s2,aerospace,185,193,O
DDI-MedLine.d65.s2,environment,195,205,O
DDI-MedLine.d65.s2,.,206,206,O
DDI-MedLine.d65.s3,This,0,3,O
DDI-MedLine.d65.s3,paper,5,9,O
DDI-MedLine.d65.s3,attempts,11,18,O
DDI-MedLine.d65.s3,to,20,21,O
DDI-MedLine.d65.s3,provide,23,29,O
DDI-MedLine.d65.s3,a,31,31,O
DDI-MedLine.d65.s3,basis,33,37,O
DDI-MedLine.d65.s3,for,39,41,O
DDI-MedLine.d65.s3,the,43,45,O
DDI-MedLine.d65.s3,understanding,47,59,O
DDI-MedLine.d65.s3,and,61,63,O
DDI-MedLine.d65.s3,identifications,65,79,O
DDI-MedLine.d65.s3,of,81,82,O
DDI-MedLine.d65.s3,important,84,92,O
DDI-MedLine.d65.s3,drug,94,97,O
DDI-MedLine.d65.s3,interactions,99,110,O
DDI-MedLine.d65.s3,.,111,111,O
DDI-MedLine.d65.s4,Guidelines,0,9,O
DDI-MedLine.d65.s4,are,11,13,O
DDI-MedLine.d65.s4,provided,15,22,O
DDI-MedLine.d65.s4,to,24,25,O
DDI-MedLine.d65.s4,assist,27,32,O
DDI-MedLine.d65.s4,the,34,36,O
DDI-MedLine.d65.s4,clinician,38,46,O
DDI-MedLine.d65.s4,in,48,49,O
DDI-MedLine.d65.s4,his,51,53,O
DDI-MedLine.d65.s4,logical,55,61,O
DDI-MedLine.d65.s4,approach,63,70,O
DDI-MedLine.d65.s4,to,72,73,O
DDI-MedLine.d65.s4,the,75,77,O
DDI-MedLine.d65.s4,identification,79,92,O
DDI-MedLine.d65.s4,of,94,95,O
DDI-MedLine.d65.s4,drug,97,100,O
DDI-MedLine.d65.s4,interactions,102,113,O
DDI-MedLine.d65.s4,when,115,118,O
DDI-MedLine.d65.s4,serious,120,126,O
DDI-MedLine.d65.s4,drug,128,131,O
DDI-MedLine.d65.s4,toxicity,133,140,O
DDI-MedLine.d65.s4,is,142,143,O
DDI-MedLine.d65.s4,encountered,145,155,O
DDI-MedLine.d65.s4,in,157,158,O
DDI-MedLine.d65.s4,a,160,160,O
DDI-MedLine.d65.s4,pateint,162,168,O
DDI-MedLine.d65.s4,.,169,169,O
DDI-MedLine.d65.s5,Only,0,3,O
DDI-MedLine.d65.s5,with,5,8,O
DDI-MedLine.d65.s5,knowledge,10,18,O
DDI-MedLine.d65.s5,of,20,21,O
DDI-MedLine.d65.s5,the,23,25,O
DDI-MedLine.d65.s5,interaction,27,37,O
DDI-MedLine.d65.s5,can,39,41,O
DDI-MedLine.d65.s5,the,43,45,O
DDI-MedLine.d65.s5,therapeutic,47,57,O
DDI-MedLine.d65.s5,regimen,59,65,O
DDI-MedLine.d65.s5,be,67,68,O
DDI-MedLine.d65.s5,altered,70,76,O
DDI-MedLine.d65.s5,so,78,79,O
DDI-MedLine.d65.s5,as,81,82,O
DDI-MedLine.d65.s5,to,84,85,O
DDI-MedLine.d65.s5,provide,87,93,O
DDI-MedLine.d65.s5,therapeutic,95,105,O
DDI-MedLine.d65.s5,levels,107,112,O
DDI-MedLine.d65.s5,of,114,115,O
DDI-MedLine.d65.s5,necessary,117,125,O
DDI-MedLine.d65.s5,drugs,127,131,O
DDI-MedLine.d65.s5,while,133,137,O
DDI-MedLine.d65.s5,avoiding,139,146,O
DDI-MedLine.d65.s5,toxicity,148,155,O
DDI-MedLine.d65.s5,.,156,156,O
DDI-MedLine.d74.s0,Responses,0,8,O
DDI-MedLine.d74.s0,to,10,11,O
DDI-MedLine.d74.s0,arginine,13,20,B-drug
DDI-MedLine.d74.s0,of,22,23,O
DDI-MedLine.d74.s0,the,25,27,O
DDI-MedLine.d74.s0,perfused,29,36,O
DDI-MedLine.d74.s0,pancreas,38,45,O
DDI-MedLine.d74.s0,of,47,48,O
DDI-MedLine.d74.s0,the,50,52,O
DDI-MedLine.d74.s0,genetically,54,64,O
DDI-MedLine.d74.s0,diabetic,66,73,O
DDI-MedLine.d74.s0,Chinese,75,81,O
DDI-MedLine.d74.s0,hamster,83,89,O
DDI-MedLine.d74.s0,.,90,90,O
DDI-MedLine.d74.s1,Nonketotic,0,9,O
DDI-MedLine.d74.s1,",",10,10,O
DDI-MedLine.d74.s1,genetically,12,22,O
DDI-MedLine.d74.s1,diabetic,24,31,O
DDI-MedLine.d74.s1,Cinese,33,38,O
DDI-MedLine.d74.s1,hamsters,40,47,O
DDI-MedLine.d74.s1,show,49,52,O
DDI-MedLine.d74.s1,subnormal,54,62,O
DDI-MedLine.d74.s1,pancreatic,64,73,O
DDI-MedLine.d74.s1,insulin,75,81,O
DDI-MedLine.d74.s1,release,83,89,O
DDI-MedLine.d74.s1,and,91,93,O
DDI-MedLine.d74.s1,impaired,95,102,O
DDI-MedLine.d74.s1,suppression,104,114,O
DDI-MedLine.d74.s1,of,116,117,O
DDI-MedLine.d74.s1,glucagon,119,126,O
DDI-MedLine.d74.s1,in,128,129,O
DDI-MedLine.d74.s1,response,131,138,O
DDI-MedLine.d74.s1,to,140,141,O
DDI-MedLine.d74.s1,glucose,143,149,O
DDI-MedLine.d74.s1,.,150,150,O
DDI-MedLine.d74.s2,To,0,1,O
DDI-MedLine.d74.s2,study,3,7,O
DDI-MedLine.d74.s2,the,9,11,O
DDI-MedLine.d74.s2,pancreatic,13,22,O
DDI-MedLine.d74.s2,effects,24,30,O
DDI-MedLine.d74.s2,of,32,33,O
DDI-MedLine.d74.s2,other,35,39,O
DDI-MedLine.d74.s2,agents,41,46,O
DDI-MedLine.d74.s2,",",47,47,O
DDI-MedLine.d74.s2,dynamic,49,55,O
DDI-MedLine.d74.s2,insulin,57,63,O
DDI-MedLine.d74.s2,and,65,67,O
DDI-MedLine.d74.s2,glucagon,69,76,O
DDI-MedLine.d74.s2,release,78,84,O
DDI-MedLine.d74.s2,was,86,88,O
DDI-MedLine.d74.s2,measured,90,97,O
DDI-MedLine.d74.s2,from,99,102,O
DDI-MedLine.d74.s2,the,104,106,O
DDI-MedLine.d74.s2,in,108,109,O
DDI-MedLine.d74.s2,vitro,111,115,O
DDI-MedLine.d74.s2,perfused,117,124,O
DDI-MedLine.d74.s2,pancreases,126,135,O
DDI-MedLine.d74.s2,of,137,138,O
DDI-MedLine.d74.s2,normal,140,145,O
DDI-MedLine.d74.s2,and,147,149,O
DDI-MedLine.d74.s2,diabetic,151,158,O
DDI-MedLine.d74.s2,Chinese,160,166,O
DDI-MedLine.d74.s2,hamsters,168,175,O
DDI-MedLine.d74.s2,in,177,178,O
DDI-MedLine.d74.s2,response,180,187,O
DDI-MedLine.d74.s2,to,189,190,O
DDI-MedLine.d74.s2,various,192,198,O
DDI-MedLine.d74.s2,combinations,200,211,O
DDI-MedLine.d74.s2,of,213,214,O
DDI-MedLine.d74.s2,arginine,216,223,B-drug
DDI-MedLine.d74.s2,(,225,225,O
DDI-MedLine.d74.s2,20mM,226,229,O
DDI-MedLine.d74.s2,),230,230,O
DDI-MedLine.d74.s2,",",231,231,O
DDI-MedLine.d74.s2,glucose,233,239,B-drug
DDI-MedLine.d74.s2,(,241,241,O
DDI-MedLine.d74.s2,100,242,244,O
DDI-MedLine.d74.s2,or,246,247,O
DDI-MedLine.d74.s2,150,249,251,O
DDI-MedLine.d74.s2,mg.,253,255,O
DDI-MedLine.d74.s2,per,257,259,O
DDI-MedLine.d74.s2,100,261,263,O
DDI-MedLine.d74.s2,ml,265,266,O
DDI-MedLine.d74.s2,.,267,267,O
DDI-MedLine.d74.s2,),268,268,O
DDI-MedLine.d74.s2,",",269,269,O
DDI-MedLine.d74.s2,and,271,273,O
DDI-MedLine.d74.s2,theophylline,275,286,B-drug
DDI-MedLine.d74.s2,(,288,288,O
DDI-MedLine.d74.s2,10,289,290,O
DDI-MedLine.d74.s2,mM,292,293,O
DDI-MedLine.d74.s2,),294,294,O
DDI-MedLine.d74.s2,.,295,295,O
DDI-MedLine.d74.s3,Theophylline,0,11,B-drug
DDI-MedLine.d74.s3,alone,13,17,O
DDI-MedLine.d74.s3,caused,19,24,O
DDI-MedLine.d74.s3,identical,26,34,O
DDI-MedLine.d74.s3,insulin,36,42,O
DDI-MedLine.d74.s3,and,44,46,O
DDI-MedLine.d74.s3,glucagon,48,55,O
DDI-MedLine.d74.s3,release,57,63,O
DDI-MedLine.d74.s3,in,65,66,O
DDI-MedLine.d74.s3,diabetics,68,76,O
DDI-MedLine.d74.s3,and,78,80,O
DDI-MedLine.d74.s3,normals,82,88,O
DDI-MedLine.d74.s3,.,89,89,O
DDI-MedLine.d74.s4,Glucose,0,6,B-drug
DDI-MedLine.d74.s4,",",7,7,O
DDI-MedLine.d74.s4,alone,9,13,O
DDI-MedLine.d74.s4,and,15,17,O
DDI-MedLine.d74.s4,in,19,20,O
DDI-MedLine.d74.s4,the,22,24,O
DDI-MedLine.d74.s4,presence,26,33,O
DDI-MedLine.d74.s4,of,35,36,O
DDI-MedLine.d74.s4,theophylline,38,49,B-drug
DDI-MedLine.d74.s4,",",50,50,O
DDI-MedLine.d74.s4,caused,52,57,O
DDI-MedLine.d74.s4,subnormal,59,67,O
DDI-MedLine.d74.s4,insulin,69,75,O
DDI-MedLine.d74.s4,release,77,83,O
DDI-MedLine.d74.s4,and,85,87,O
DDI-MedLine.d74.s4,less,89,92,O
DDI-MedLine.d74.s4,suppression,94,104,O
DDI-MedLine.d74.s4,of,106,107,O
DDI-MedLine.d74.s4,glucagon,109,116,O
DDI-MedLine.d74.s4,release,118,124,O
DDI-MedLine.d74.s4,in,126,127,O
DDI-MedLine.d74.s4,the,129,131,O
DDI-MedLine.d74.s4,diabectics,133,142,O
DDI-MedLine.d74.s4,than,144,147,O
DDI-MedLine.d74.s4,in,149,150,O
DDI-MedLine.d74.s4,the,152,154,O
DDI-MedLine.d74.s4,normals,156,162,O
DDI-MedLine.d74.s4,.,163,163,O
DDI-MedLine.d74.s5,Arginine,0,7,B-drug
DDI-MedLine.d74.s5,",",8,8,O
DDI-MedLine.d74.s5,in,10,11,O
DDI-MedLine.d74.s5,the,13,15,O
DDI-MedLine.d74.s5,presence,17,24,O
DDI-MedLine.d74.s5,of,26,27,O
DDI-MedLine.d74.s5,glucose,29,35,B-drug
DDI-MedLine.d74.s5,and,37,39,O
DDI-MedLine.d74.s5,theophylline,41,52,B-drug
DDI-MedLine.d74.s5,",",53,53,O
DDI-MedLine.d74.s5,caused,55,60,O
DDI-MedLine.d74.s5,excessive,62,70,O
DDI-MedLine.d74.s5,glucagon,72,79,O
DDI-MedLine.d74.s5,release,81,87,O
DDI-MedLine.d74.s5,but,89,91,O
DDI-MedLine.d74.s5,nearly,93,98,O
DDI-MedLine.d74.s5,normal,100,105,O
DDI-MedLine.d74.s5,insulin,107,113,O
DDI-MedLine.d74.s5,release,115,121,O
DDI-MedLine.d74.s5,in,123,124,O
DDI-MedLine.d74.s5,the,126,128,O
DDI-MedLine.d74.s5,diabetics,130,138,O
DDI-MedLine.d74.s5,.,139,139,O
DDI-MedLine.d74.s6,Arginine,0,7,B-drug
DDI-MedLine.d74.s6,",",8,8,O
DDI-MedLine.d74.s6,in,10,11,O
DDI-MedLine.d74.s6,the,13,15,O
DDI-MedLine.d74.s6,absence,17,23,O
DDI-MedLine.d74.s6,of,25,26,O
DDI-MedLine.d74.s6,glucose,28,34,B-drug
DDI-MedLine.d74.s6,or,36,37,O
DDI-MedLine.d74.s6,theophylline,39,50,B-drug
DDI-MedLine.d74.s6,",",51,51,O
DDI-MedLine.d74.s6,caused,53,58,O
DDI-MedLine.d74.s6,excessive,60,68,O
DDI-MedLine.d74.s6,glucagon,70,77,O
DDI-MedLine.d74.s6,release,79,85,O
DDI-MedLine.d74.s6,in,87,88,O
DDI-MedLine.d74.s6,the,90,92,O
DDI-MedLine.d74.s6,diabetics,94,102,O
DDI-MedLine.d74.s6,and,104,106,O
DDI-MedLine.d74.s6,undetectable,108,119,O
DDI-MedLine.d74.s6,insulin,121,127,O
DDI-MedLine.d74.s6,release,129,135,O
DDI-MedLine.d74.s6,in,137,138,O
DDI-MedLine.d74.s6,either,140,145,O
DDI-MedLine.d74.s6,diabetics,147,155,O
DDI-MedLine.d74.s6,or,157,158,O
DDI-MedLine.d74.s6,normals,160,166,O
DDI-MedLine.d74.s6,.,167,167,O
DDI-MedLine.d74.s7,Pancreatic,0,9,O
DDI-MedLine.d74.s7,content,11,17,O
DDI-MedLine.d74.s7,after,19,23,O
DDI-MedLine.d74.s7,perfusion,25,33,O
DDI-MedLine.d74.s7,did,35,37,O
DDI-MedLine.d74.s7,not,39,41,O
DDI-MedLine.d74.s7,correlate,43,51,O
DDI-MedLine.d74.s7,with,53,56,O
DDI-MedLine.d74.s7,release,58,64,O
DDI-MedLine.d74.s7,during,66,71,O
DDI-MedLine.d74.s7,perfusion,73,81,O
DDI-MedLine.d74.s7,.,82,82,O
DDI-MedLine.d74.s8,Infusion,0,7,O
DDI-MedLine.d74.s8,of,9,10,O
DDI-MedLine.d74.s8,arginine,12,19,B-drug
DDI-MedLine.d74.s8,alone,21,25,O
DDI-MedLine.d74.s8,markedly,27,34,O
DDI-MedLine.d74.s8,decreased,36,44,O
DDI-MedLine.d74.s8,the,46,48,O
DDI-MedLine.d74.s8,amount,50,55,O
DDI-MedLine.d74.s8,of,57,58,O
DDI-MedLine.d74.s8,extractable,60,70,O
DDI-MedLine.d74.s8,pancreatic,72,81,O
DDI-MedLine.d74.s8,insulin,83,89,O
DDI-MedLine.d74.s8,and,91,93,O
DDI-MedLine.d74.s8,glucagon,95,102,O
DDI-MedLine.d74.s8,.,103,103,O
DDI-MedLine.d74.s9,These,0,4,O
DDI-MedLine.d74.s9,results,6,12,O
DDI-MedLine.d74.s9,indicate,14,21,O
DDI-MedLine.d74.s9,that,23,26,O
DDI-MedLine.d74.s9,the,28,30,O
DDI-MedLine.d74.s9,pancreatic,32,41,O
DDI-MedLine.d74.s9,alpha,43,47,O
DDI-MedLine.d74.s9,cell,49,52,O
DDI-MedLine.d74.s9,of,54,55,O
DDI-MedLine.d74.s9,the,57,59,O
DDI-MedLine.d74.s9,diabetic,61,68,O
DDI-MedLine.d74.s9,Chinese,70,76,O
DDI-MedLine.d74.s9,hamster,78,84,O
DDI-MedLine.d74.s9,responds,86,93,O
DDI-MedLine.d74.s9,excessively,95,105,O
DDI-MedLine.d74.s9,to,107,108,O
DDI-MedLine.d74.s9,arginine,110,117,B-drug
DDI-MedLine.d74.s9,",",118,118,O
DDI-MedLine.d74.s9,as,120,121,O
DDI-MedLine.d74.s9,is,123,124,O
DDI-MedLine.d74.s9,seen,126,129,O
DDI-MedLine.d74.s9,in,131,132,O
DDI-MedLine.d74.s9,the,134,136,O
DDI-MedLine.d74.s9,human,138,142,O
DDI-MedLine.d74.s9,diabetic,144,151,O
DDI-MedLine.d74.s9,.,152,152,O
DDI-MedLine.d74.s10,This,0,3,O
DDI-MedLine.d74.s10,defect,5,10,O
DDI-MedLine.d74.s10,is,12,13,O
DDI-MedLine.d74.s10,not,15,17,O
DDI-MedLine.d74.s10,related,19,25,O
DDI-MedLine.d74.s10,to,27,28,O
DDI-MedLine.d74.s10,acute,30,34,O
DDI-MedLine.d74.s10,insulin,36,42,O
DDI-MedLine.d74.s10,release,44,50,O
DDI-MedLine.d74.s10,or,52,53,O
DDI-MedLine.d74.s10,the,55,57,O
DDI-MedLine.d74.s10,presence,59,66,O
DDI-MedLine.d74.s10,of,68,69,O
DDI-MedLine.d74.s10,glucose,71,77,B-drug
DDI-MedLine.d74.s10,.,78,78,O
DDI-MedLine.d74.s11,Further,0,6,O
DDI-MedLine.d74.s11,",",7,7,O
DDI-MedLine.d74.s11,these,9,13,O
DDI-MedLine.d74.s11,results,15,21,O
DDI-MedLine.d74.s11,confirm,23,29,O
DDI-MedLine.d74.s11,that,31,34,O
DDI-MedLine.d74.s11,the,36,38,O
DDI-MedLine.d74.s11,diabetic,40,47,O
DDI-MedLine.d74.s11,Chinese,49,55,O
DDI-MedLine.d74.s11,hamster,57,63,O
DDI-MedLine.d74.s11,'s,64,65,O
DDI-MedLine.d74.s11,alpha,67,71,O
DDI-MedLine.d74.s11,and,73,75,O
DDI-MedLine.d74.s11,beta,77,80,O
DDI-MedLine.d74.s11,cells,82,86,O
DDI-MedLine.d74.s11,respond,88,94,O
DDI-MedLine.d74.s11,normally,96,103,O
DDI-MedLine.d74.s11,to,105,106,O
DDI-MedLine.d74.s11,theophylline,108,119,B-drug
DDI-MedLine.d74.s11,",",120,120,O
DDI-MedLine.d74.s11,but,122,124,O
DDI-MedLine.d74.s11,are,126,128,O
DDI-MedLine.d74.s11,relatively,130,139,O
DDI-MedLine.d74.s11,insensitive,141,151,O
DDI-MedLine.d74.s11,to,153,154,O
DDI-MedLine.d74.s11,glucose,156,162,B-drug
DDI-MedLine.d74.s11,.,163,163,O
DDI-MedLine.d44.s0,Effects,0,6,O
DDI-MedLine.d44.s0,of,8,9,O
DDI-MedLine.d44.s0,etofibrate,11,20,B-drug
DDI-MedLine.d44.s0,upon,22,25,O
DDI-MedLine.d44.s0,the,27,29,O
DDI-MedLine.d44.s0,metabolism,31,40,O
DDI-MedLine.d44.s0,of,42,43,O
DDI-MedLine.d44.s0,chylomicron-like,45,60,O
DDI-MedLine.d44.s0,emulsions,62,70,O
DDI-MedLine.d44.s0,in,72,73,O
DDI-MedLine.d44.s0,patients,75,82,O
DDI-MedLine.d44.s0,with,84,87,O
DDI-MedLine.d44.s0,coronary,89,96,O
DDI-MedLine.d44.s0,artery,98,103,O
DDI-MedLine.d44.s0,disease,105,111,O
DDI-MedLine.d44.s0,.,112,112,O
DDI-MedLine.d44.s1,Slow,0,3,O
DDI-MedLine.d44.s1,chylomicron,5,15,O
DDI-MedLine.d44.s1,intravascular,17,29,O
DDI-MedLine.d44.s1,catabolism,31,40,O
DDI-MedLine.d44.s1,has,42,44,O
DDI-MedLine.d44.s1,been,46,49,O
DDI-MedLine.d44.s1,associated,51,60,O
DDI-MedLine.d44.s1,with,62,65,O
DDI-MedLine.d44.s1,coronary,67,74,O
DDI-MedLine.d44.s1,artery,76,81,O
DDI-MedLine.d44.s1,disease,83,89,O
DDI-MedLine.d44.s1,and,91,93,O
DDI-MedLine.d44.s1,screening,95,103,O
DDI-MedLine.d44.s1,for,105,107,O
DDI-MedLine.d44.s1,drugs,109,113,O
DDI-MedLine.d44.s1,that,115,118,O
DDI-MedLine.d44.s1,can,120,122,O
DDI-MedLine.d44.s1,speed-up,124,131,O
DDI-MedLine.d44.s1,this,133,136,O
DDI-MedLine.d44.s1,process,138,144,O
DDI-MedLine.d44.s1,can,146,148,O
DDI-MedLine.d44.s1,be,150,151,O
DDI-MedLine.d44.s1,important,153,161,O
DDI-MedLine.d44.s1,.,162,162,O
DDI-MedLine.d44.s2,In,0,1,O
DDI-MedLine.d44.s2,this,3,6,O
DDI-MedLine.d44.s2,study,8,12,O
DDI-MedLine.d44.s2,",",13,13,O
DDI-MedLine.d44.s2,the,15,17,O
DDI-MedLine.d44.s2,effects,19,25,O
DDI-MedLine.d44.s2,of,27,28,O
DDI-MedLine.d44.s2,etofibrate,30,39,B-drug
DDI-MedLine.d44.s2,upon,41,44,O
DDI-MedLine.d44.s2,chylomicron,46,56,O
DDI-MedLine.d44.s2,metabolism,58,67,O
DDI-MedLine.d44.s2,was,69,71,O
DDI-MedLine.d44.s2,tested,73,78,O
DDI-MedLine.d44.s2,by,80,81,O
DDI-MedLine.d44.s2,determination,83,95,O
DDI-MedLine.d44.s2,of,97,98,O
DDI-MedLine.d44.s2,the,100,102,O
DDI-MedLine.d44.s2,plasma,104,109,O
DDI-MedLine.d44.s2,kinetics,111,118,O
DDI-MedLine.d44.s2,of,120,121,O
DDI-MedLine.d44.s2,a,123,123,O
DDI-MedLine.d44.s2,chylomicron-like,125,140,O
DDI-MedLine.d44.s2,emulsion,142,149,O
DDI-MedLine.d44.s2,model,151,155,O
DDI-MedLine.d44.s2,in,157,158,O
DDI-MedLine.d44.s2,12,160,161,O
DDI-MedLine.d44.s2,patients,163,170,O
DDI-MedLine.d44.s2,with,172,175,O
DDI-MedLine.d44.s2,coronary,177,184,O
DDI-MedLine.d44.s2,artery,186,191,O
DDI-MedLine.d44.s2,disease,193,199,O
DDI-MedLine.d44.s2,",",200,200,O
DDI-MedLine.d44.s2,aged,202,205,O
DDI-MedLine.d44.s2,59+/-11,207,213,O
DDI-MedLine.d44.s2,years,215,219,O
DDI-MedLine.d44.s2,",",220,220,O
DDI-MedLine.d44.s2,(,222,222,O
DDI-MedLine.d44.s2,total,223,227,O
DDI-MedLine.d44.s2,cholesterol,229,239,O
DDI-MedLine.d44.s2,:,240,240,O
DDI-MedLine.d44.s2,240+/-41,242,249,O
DDI-MedLine.d44.s2,mg/dl,251,255,O
DDI-MedLine.d44.s2,;,256,256,O
DDI-MedLine.d44.s2,triglycerides,258,270,O
DDI-MedLine.d44.s2,:,271,271,O
DDI-MedLine.d44.s2,188+/-42,273,280,O
DDI-MedLine.d44.s2,mg/dl,282,286,O
DDI-MedLine.d44.s2,),287,287,O
DDI-MedLine.d44.s2,submitted,289,297,O
DDI-MedLine.d44.s2,to,299,300,O
DDI-MedLine.d44.s2,a,302,302,O
DDI-MedLine.d44.s2,randomized,304,313,O
DDI-MedLine.d44.s2,",",314,314,O
DDI-MedLine.d44.s2,crossover,316,324,O
DDI-MedLine.d44.s2,",",325,325,O
DDI-MedLine.d44.s2,double-blind,327,338,O
DDI-MedLine.d44.s2,",",339,339,O
DDI-MedLine.d44.s2,placebo-controlled,341,358,O
DDI-MedLine.d44.s2,study,360,364,O
DDI-MedLine.d44.s2,with,366,369,O
DDI-MedLine.d44.s2,administration,371,384,O
DDI-MedLine.d44.s2,of,386,387,O
DDI-MedLine.d44.s2,1,389,389,O
DDI-MedLine.d44.s2,g,391,391,O
DDI-MedLine.d44.s2,per,393,395,O
DDI-MedLine.d44.s2,day,397,399,O
DDI-MedLine.d44.s2,etofibrate,401,410,B-drug
DDI-MedLine.d44.s2,or,412,413,O
DDI-MedLine.d44.s2,placebo,415,421,O
DDI-MedLine.d44.s2,for,423,425,O
DDI-MedLine.d44.s2,1-month,427,433,O
DDI-MedLine.d44.s2,.,434,434,O
DDI-MedLine.d44.s3,A,0,0,O
DDI-MedLine.d44.s3,1-month,2,8,O
DDI-MedLine.d44.s3,washout,10,16,O
DDI-MedLine.d44.s3,period,18,23,O
DDI-MedLine.d44.s3,was,25,27,O
DDI-MedLine.d44.s3,inserted,29,36,O
DDI-MedLine.d44.s3,between,38,44,O
DDI-MedLine.d44.s3,the,46,48,O
DDI-MedLine.d44.s3,treatment,50,58,O
DDI-MedLine.d44.s3,periods,60,66,O
DDI-MedLine.d44.s3,.,67,67,O
DDI-MedLine.d44.s4,Patients,0,7,O
DDI-MedLine.d44.s4,were,9,12,O
DDI-MedLine.d44.s4,intravenously,14,26,O
DDI-MedLine.d44.s4,injected,28,35,O
DDI-MedLine.d44.s4,a,37,37,O
DDI-MedLine.d44.s4,chylomicron-like,39,54,O
DDI-MedLine.d44.s4,emulsion,56,63,O
DDI-MedLine.d44.s4,doubly,65,70,O
DDI-MedLine.d44.s4,labeled,72,78,O
DDI-MedLine.d44.s4,with,80,83,O
DDI-MedLine.d44.s4,14C-cholesteryl,85,99,O
DDI-MedLine.d44.s4,oleate,101,106,O
DDI-MedLine.d44.s4,and,108,110,O
DDI-MedLine.d44.s4,3H-triolein,112,122,O
DDI-MedLine.d44.s4,at,124,125,O
DDI-MedLine.d44.s4,baseline,127,134,O
DDI-MedLine.d44.s4,and,136,138,O
DDI-MedLine.d44.s4,after,140,144,O
DDI-MedLine.d44.s4,treatments,146,155,O
DDI-MedLine.d44.s4,.,156,156,O
DDI-MedLine.d44.s5,After,0,4,O
DDI-MedLine.d44.s5,etofibrate,6,15,B-drug
DDI-MedLine.d44.s5,treatment,17,25,O
DDI-MedLine.d44.s5,",",26,26,O
DDI-MedLine.d44.s5,there,28,32,O
DDI-MedLine.d44.s5,was,34,36,O
DDI-MedLine.d44.s5,decrease,38,45,O
DDI-MedLine.d44.s5,of,47,48,O
DDI-MedLine.d44.s5,total,50,54,O
DDI-MedLine.d44.s5,cholesterol,56,66,O
DDI-MedLine.d44.s5,and,68,70,O
DDI-MedLine.d44.s5,triglyceride,72,83,O
DDI-MedLine.d44.s5,plasma,85,90,O
DDI-MedLine.d44.s5,levels,92,97,O
DDI-MedLine.d44.s5,and,99,101,O
DDI-MedLine.d44.s5,a,103,103,O
DDI-MedLine.d44.s5,trend,105,109,O
DDI-MedLine.d44.s5,to,111,112,O
DDI-MedLine.d44.s5,increase,114,121,O
DDI-MedLine.d44.s5,high-density,123,134,O
DDI-MedLine.d44.s5,lipoprotein,136,146,O
DDI-MedLine.d44.s5,cholesterol,148,158,O
DDI-MedLine.d44.s5,plasma,160,165,O
DDI-MedLine.d44.s5,levels,167,172,O
DDI-MedLine.d44.s5,.,173,173,O
DDI-MedLine.d44.s6,Etofibrate,0,9,B-drug
DDI-MedLine.d44.s6,elicited,11,18,O
DDI-MedLine.d44.s6,62,20,21,O
DDI-MedLine.d44.s6,%,22,22,O
DDI-MedLine.d44.s6,enhancement,24,34,O
DDI-MedLine.d44.s6,of,36,37,O
DDI-MedLine.d44.s6,post-heparin,39,50,O
DDI-MedLine.d44.s6,lipolytic,52,60,O
DDI-MedLine.d44.s6,activity,62,69,O
DDI-MedLine.d44.s6,and,71,73,O
DDI-MedLine.d44.s6,100,75,77,O
DDI-MedLine.d44.s6,%,78,78,O
DDI-MedLine.d44.s6,increase,80,87,O
DDI-MedLine.d44.s6,of,89,90,O
DDI-MedLine.d44.s6,3H-triglyceride,92,106,O
DDI-MedLine.d44.s6,fractional,108,117,O
DDI-MedLine.d44.s6,clearance,119,127,O
DDI-MedLine.d44.s6,rate,129,132,O
DDI-MedLine.d44.s6,compared,134,141,O
DDI-MedLine.d44.s6,with,143,146,O
DDI-MedLine.d44.s6,placebo,148,154,O
DDI-MedLine.d44.s6,treatment,156,164,O
DDI-MedLine.d44.s6,.,165,165,O
DDI-MedLine.d44.s7,14C-cholesterol,0,14,O
DDI-MedLine.d44.s7,ester,16,20,O
DDI-MedLine.d44.s7,fractional,22,31,O
DDI-MedLine.d44.s7,clearance,33,41,O
DDI-MedLine.d44.s7,rate,43,46,O
DDI-MedLine.d44.s7,was,48,50,O
DDI-MedLine.d44.s7,260,52,54,O
DDI-MedLine.d44.s7,%,55,55,O
DDI-MedLine.d44.s7,greater,57,63,O
DDI-MedLine.d44.s7,after,65,69,O
DDI-MedLine.d44.s7,etofibrate,71,80,B-drug
DDI-MedLine.d44.s7,than,82,85,O
DDI-MedLine.d44.s7,after,87,91,O
DDI-MedLine.d44.s7,placebo,93,99,O
DDI-MedLine.d44.s7,.,100,100,O
DDI-MedLine.d44.s8,Therefore,0,8,O
DDI-MedLine.d44.s8,",",9,9,O
DDI-MedLine.d44.s8,a,11,11,O
DDI-MedLine.d44.s8,potent,13,18,O
DDI-MedLine.d44.s8,effect,20,25,O
DDI-MedLine.d44.s8,of,27,28,O
DDI-MedLine.d44.s8,etofibrate,30,39,B-drug
DDI-MedLine.d44.s8,on,41,42,O
DDI-MedLine.d44.s8,both,44,47,O
DDI-MedLine.d44.s8,chylomicron,49,59,O
DDI-MedLine.d44.s8,lipolysis,61,69,O
DDI-MedLine.d44.s8,and,71,73,O
DDI-MedLine.d44.s8,remnant,75,81,O
DDI-MedLine.d44.s8,removal,83,89,O
DDI-MedLine.d44.s8,was,91,93,O
DDI-MedLine.d44.s8,achieved,95,102,O
DDI-MedLine.d44.s8,",",103,103,O
DDI-MedLine.d44.s8,indicating,105,114,O
DDI-MedLine.d44.s8,that,116,119,O
DDI-MedLine.d44.s8,this,121,124,O
DDI-MedLine.d44.s8,drug,126,129,O
DDI-MedLine.d44.s8,can,131,133,O
DDI-MedLine.d44.s8,be,135,136,O
DDI-MedLine.d44.s8,used,138,141,O
DDI-MedLine.d44.s8,to,143,144,O
DDI-MedLine.d44.s8,improve,146,152,O
DDI-MedLine.d44.s8,this,154,157,O
DDI-MedLine.d44.s8,metabolism,159,168,O
DDI-MedLine.d44.s8,in,170,171,O
DDI-MedLine.d44.s8,future,173,178,O
DDI-MedLine.d44.s8,prospective,180,190,O
DDI-MedLine.d44.s8,studies,192,198,O
DDI-MedLine.d44.s8,.,199,199,O
DDI-MedLine.d86.s0,Pharmacokinetic,0,14,O
DDI-MedLine.d86.s0,interaction,16,26,O
DDI-MedLine.d86.s0,between,28,34,O
DDI-MedLine.d86.s0,single,36,41,O
DDI-MedLine.d86.s0,oral,43,46,O
DDI-MedLine.d86.s0,doses,48,52,O
DDI-MedLine.d86.s0,of,54,55,O
DDI-MedLine.d86.s0,diltiazem,57,65,B-drug
DDI-MedLine.d86.s0,and,67,69,O
DDI-MedLine.d86.s0,sirolimus,71,79,B-drug
DDI-MedLine.d86.s0,in,81,82,O
DDI-MedLine.d86.s0,healthy,84,90,O
DDI-MedLine.d86.s0,volunteers,92,101,O
DDI-MedLine.d86.s0,.,102,102,O
DDI-MedLine.d86.s1,AIM,0,2,O
DDI-MedLine.d86.s1,AND,4,6,O
DDI-MedLine.d86.s1,BACKGROUND,8,17,O
DDI-MedLine.d86.s1,:,18,18,O
DDI-MedLine.d86.s1,The,20,22,O
DDI-MedLine.d86.s1,pharmacokinetic,24,38,O
DDI-MedLine.d86.s1,interaction,40,50,O
DDI-MedLine.d86.s1,between,52,58,O
DDI-MedLine.d86.s1,sirolimus,60,68,B-drug
DDI-MedLine.d86.s1,",",69,69,O
DDI-MedLine.d86.s1,a,71,71,O
DDI-MedLine.d86.s1,macrolide,73,81,B-group
DDI-MedLine.d86.s1,immunosuppressant,83,99,I-group
DDI-MedLine.d86.s1,metabolized,101,111,O
DDI-MedLine.d86.s1,by,113,114,O
DDI-MedLine.d86.s1,CYP3A4,116,121,O
DDI-MedLine.d86.s1,",",122,122,O
DDI-MedLine.d86.s1,and,124,126,O
DDI-MedLine.d86.s1,the,128,130,O
DDI-MedLine.d86.s1,calcium,132,138,B-group
DDI-MedLine.d86.s1,channel,140,146,I-group
DDI-MedLine.d86.s1,blocker,148,154,I-group
DDI-MedLine.d86.s1,diltiazem,156,164,B-drug
DDI-MedLine.d86.s1,was,166,168,O
DDI-MedLine.d86.s1,studied,170,176,O
DDI-MedLine.d86.s1,in,178,179,O
DDI-MedLine.d86.s1,18,181,182,O
DDI-MedLine.d86.s1,healthy,184,190,O
DDI-MedLine.d86.s1,subjects,192,199,O
DDI-MedLine.d86.s1,.,200,200,O
DDI-MedLine.d86.s2,Several,0,6,O
DDI-MedLine.d86.s2,clinically,8,17,O
DDI-MedLine.d86.s2,important,19,27,O
DDI-MedLine.d86.s2,interactions,29,40,O
DDI-MedLine.d86.s2,have,42,45,O
DDI-MedLine.d86.s2,previously,47,56,O
DDI-MedLine.d86.s2,been,58,61,O
DDI-MedLine.d86.s2,reported,63,70,O
DDI-MedLine.d86.s2,for,72,74,O
DDI-MedLine.d86.s2,other,76,80,O
DDI-MedLine.d86.s2,immunosuppressive,82,98,B-group
DDI-MedLine.d86.s2,drugs,100,104,I-group
DDI-MedLine.d86.s2,that,106,109,O
DDI-MedLine.d86.s2,are,111,113,O
DDI-MedLine.d86.s2,metabolized,115,125,O
DDI-MedLine.d86.s2,by,127,128,O
DDI-MedLine.d86.s2,the,130,132,O
DDI-MedLine.d86.s2,same,134,137,O
DDI-MedLine.d86.s2,enzyme,139,144,O
DDI-MedLine.d86.s2,and,146,148,O
DDI-MedLine.d86.s2,for,150,152,O
DDI-MedLine.d86.s2,calcium,154,160,B-group
DDI-MedLine.d86.s2,antagonists,162,172,I-group
DDI-MedLine.d86.s2,.,173,173,O
DDI-MedLine.d86.s3,METHODS,0,6,O
DDI-MedLine.d86.s3,:,7,7,O
DDI-MedLine.d86.s3,Healthy,9,15,O
DDI-MedLine.d86.s3,subjects,17,24,O
DDI-MedLine.d86.s3,who,26,28,O
DDI-MedLine.d86.s3,were,30,33,O
DDI-MedLine.d86.s3,20,35,36,O
DDI-MedLine.d86.s3,to,38,39,O
DDI-MedLine.d86.s3,43,41,42,O
DDI-MedLine.d86.s3,years,44,48,O
DDI-MedLine.d86.s3,old,50,52,O
DDI-MedLine.d86.s3,participated,54,65,O
DDI-MedLine.d86.s3,in,67,68,O
DDI-MedLine.d86.s3,an,70,71,O
DDI-MedLine.d86.s3,open,73,76,O
DDI-MedLine.d86.s3,",",77,77,O
DDI-MedLine.d86.s3,three-period,79,90,O
DDI-MedLine.d86.s3,",",91,91,O
DDI-MedLine.d86.s3,randomized,93,102,O
DDI-MedLine.d86.s3,",",103,103,O
DDI-MedLine.d86.s3,crossover,105,113,O
DDI-MedLine.d86.s3,study,115,119,O
DDI-MedLine.d86.s3,of,121,122,O
DDI-MedLine.d86.s3,the,124,126,O
DDI-MedLine.d86.s3,pharmacokinetics,128,143,O
DDI-MedLine.d86.s3,of,145,146,O
DDI-MedLine.d86.s3,a,148,148,O
DDI-MedLine.d86.s3,single,150,155,O
DDI-MedLine.d86.s3,10-mg,157,161,O
DDI-MedLine.d86.s3,oral,163,166,O
DDI-MedLine.d86.s3,dose,168,171,O
DDI-MedLine.d86.s3,of,173,174,O
DDI-MedLine.d86.s3,sirolimus,176,184,B-drug
DDI-MedLine.d86.s3,",",185,185,O
DDI-MedLine.d86.s3,a,187,187,O
DDI-MedLine.d86.s3,single,189,194,O
DDI-MedLine.d86.s3,oral,196,199,O
DDI-MedLine.d86.s3,120-mg,201,206,O
DDI-MedLine.d86.s3,dose,208,211,O
DDI-MedLine.d86.s3,of,213,214,O
DDI-MedLine.d86.s3,diltiazem,216,224,B-drug
DDI-MedLine.d86.s3,",",225,225,O
DDI-MedLine.d86.s3,and,227,229,O
DDI-MedLine.d86.s3,the,231,233,O
DDI-MedLine.d86.s3,two,235,237,O
DDI-MedLine.d86.s3,drugs,239,243,O
DDI-MedLine.d86.s3,given,245,249,O
DDI-MedLine.d86.s3,together,251,258,O
DDI-MedLine.d86.s3,.,259,259,O
DDI-MedLine.d86.s4,The,0,2,O
DDI-MedLine.d86.s4,three,4,8,O
DDI-MedLine.d86.s4,study,10,14,O
DDI-MedLine.d86.s4,periods,16,22,O
DDI-MedLine.d86.s4,were,24,27,O
DDI-MedLine.d86.s4,separated,29,37,O
DDI-MedLine.d86.s4,by,39,40,O
DDI-MedLine.d86.s4,a,42,42,O
DDI-MedLine.d86.s4,21-day,44,49,O
DDI-MedLine.d86.s4,washout,51,57,O
DDI-MedLine.d86.s4,phase,59,63,O
DDI-MedLine.d86.s4,.,64,64,O
DDI-MedLine.d86.s5,RESULTS,0,6,O
DDI-MedLine.d86.s5,:,7,7,O
DDI-MedLine.d86.s5,The,9,11,O
DDI-MedLine.d86.s5,geometric,13,21,O
DDI-MedLine.d86.s5,mean,23,26,O
DDI-MedLine.d86.s5,(,28,28,O
DDI-MedLine.d86.s5,90,29,30,O
DDI-MedLine.d86.s5,%,31,31,O
DDI-MedLine.d86.s5,confidence,33,42,O
DDI-MedLine.d86.s5,interval,44,51,O
DDI-MedLine.d86.s5,),52,52,O
DDI-MedLine.d86.s5,whole,54,58,O
DDI-MedLine.d86.s5,blood,60,64,O
DDI-MedLine.d86.s5,sirolimus,66,74,B-drug
DDI-MedLine.d86.s5,area,76,79,O
DDI-MedLine.d86.s5,under,81,85,O
DDI-MedLine.d86.s5,the,87,89,O
DDI-MedLine.d86.s5,plasma,91,96,O
DDI-MedLine.d86.s5,concentration,98,110,O
DDI-MedLine.d86.s5,time-curve,112,121,O
DDI-MedLine.d86.s5,increased,123,131,O
DDI-MedLine.d86.s5,60,133,134,O
DDI-MedLine.d86.s5,%,135,135,O
DDI-MedLine.d86.s5,(,137,137,O
DDI-MedLine.d86.s5,35,138,139,O
DDI-MedLine.d86.s5,%,140,140,O
DDI-MedLine.d86.s5,-90,141,143,O
DDI-MedLine.d86.s5,%,144,144,O
DDI-MedLine.d86.s5,),145,145,O
DDI-MedLine.d86.s5,",",146,146,O
DDI-MedLine.d86.s5,from,148,151,O
DDI-MedLine.d86.s5,736,153,155,O
DDI-MedLine.d86.s5,to,157,158,O
DDI-MedLine.d86.s5,1178,160,163,O
DDI-MedLine.d86.s5,ng,165,166,O
DDI-MedLine.d86.s5,x,168,168,O
DDI-MedLine.d86.s5,h/mL,170,173,O
DDI-MedLine.d86.s5,",",174,174,O
DDI-MedLine.d86.s5,and,176,178,O
DDI-MedLine.d86.s5,maximum,180,186,O
DDI-MedLine.d86.s5,concentration,188,200,O
DDI-MedLine.d86.s5,increased,202,210,O
DDI-MedLine.d86.s5,43,212,213,O
DDI-MedLine.d86.s5,%,214,214,O
DDI-MedLine.d86.s5,(,216,216,O
DDI-MedLine.d86.s5,14,217,218,O
DDI-MedLine.d86.s5,%,219,219,O
DDI-MedLine.d86.s5,-81,220,222,O
DDI-MedLine.d86.s5,%,223,223,O
DDI-MedLine.d86.s5,),224,224,O
DDI-MedLine.d86.s5,",",225,225,O
DDI-MedLine.d86.s5,from,227,230,O
DDI-MedLine.d86.s5,67,232,233,O
DDI-MedLine.d86.s5,to,235,236,O
DDI-MedLine.d86.s5,96,238,239,O
DDI-MedLine.d86.s5,ng/mL,241,245,O
DDI-MedLine.d86.s5,",",246,246,O
DDI-MedLine.d86.s5,with,248,251,O
DDI-MedLine.d86.s5,diltiazem,253,261,B-drug
DDI-MedLine.d86.s5,coadministration,263,278,O
DDI-MedLine.d86.s5,",",279,279,O
DDI-MedLine.d86.s5,whereas,281,287,O
DDI-MedLine.d86.s5,the,289,291,O
DDI-MedLine.d86.s5,mean,293,296,O
DDI-MedLine.d86.s5,elimination,298,308,O
DDI-MedLine.d86.s5,half-life,310,318,O
DDI-MedLine.d86.s5,of,320,321,O
DDI-MedLine.d86.s5,sirolimus,323,331,B-drug
DDI-MedLine.d86.s5,decreased,333,341,O
DDI-MedLine.d86.s5,slightly,343,350,O
DDI-MedLine.d86.s5,",",351,351,O
DDI-MedLine.d86.s5,from,353,356,O
DDI-MedLine.d86.s5,79,358,359,O
DDI-MedLine.d86.s5,to,361,362,O
DDI-MedLine.d86.s5,67,364,365,O
DDI-MedLine.d86.s5,hours,367,371,O
DDI-MedLine.d86.s5,.,372,372,O
DDI-MedLine.d86.s6,Apparent,0,7,O
DDI-MedLine.d86.s6,oral,9,12,O
DDI-MedLine.d86.s6,clearance,14,22,O
DDI-MedLine.d86.s6,and,24,26,O
DDI-MedLine.d86.s6,volume,28,33,O
DDI-MedLine.d86.s6,of,35,36,O
DDI-MedLine.d86.s6,distribution,38,49,O
DDI-MedLine.d86.s6,of,51,52,O
DDI-MedLine.d86.s6,sirolimus,54,62,B-drug
DDI-MedLine.d86.s6,decreased,64,72,O
DDI-MedLine.d86.s6,with,74,77,O
DDI-MedLine.d86.s6,38,79,80,O
DDI-MedLine.d86.s6,%,81,81,O
DDI-MedLine.d86.s6,and,83,85,O
DDI-MedLine.d86.s6,45,87,88,O
DDI-MedLine.d86.s6,%,89,89,O
DDI-MedLine.d86.s6,",",90,90,O
DDI-MedLine.d86.s6,respectively,92,103,O
DDI-MedLine.d86.s6,",",104,104,O
DDI-MedLine.d86.s6,when,106,109,O
DDI-MedLine.d86.s6,sirolimus,111,119,B-drug
DDI-MedLine.d86.s6,was,121,123,O
DDI-MedLine.d86.s6,given,125,129,O
DDI-MedLine.d86.s6,with,131,134,O
DDI-MedLine.d86.s6,diltiazem,136,144,B-drug
DDI-MedLine.d86.s6,.,145,145,O
DDI-MedLine.d86.s7,The,0,2,O
DDI-MedLine.d86.s7,plasma,4,9,O
DDI-MedLine.d86.s7,maximum,11,17,O
DDI-MedLine.d86.s7,concentration,19,31,O
DDI-MedLine.d86.s7,and,33,35,O
DDI-MedLine.d86.s7,area,37,40,O
DDI-MedLine.d86.s7,under,42,46,O
DDI-MedLine.d86.s7,the,48,50,O
DDI-MedLine.d86.s7,plasma,52,57,O
DDI-MedLine.d86.s7,concentration-time,59,76,O
DDI-MedLine.d86.s7,curve,78,82,O
DDI-MedLine.d86.s7,of,84,85,O
DDI-MedLine.d86.s7,diltiazem,87,95,B-drug
DDI-MedLine.d86.s7,",",96,96,O
DDI-MedLine.d86.s7,desacetyldiltiazem,98,115,B-drug_n
DDI-MedLine.d86.s7,",",116,116,O
DDI-MedLine.d86.s7,and,118,120,O
DDI-MedLine.d86.s7,desmethyldiltiazem,122,139,B-drug_n
DDI-MedLine.d86.s7,were,141,144,O
DDI-MedLine.d86.s7,unchanged,146,154,O
DDI-MedLine.d86.s7,after,156,160,O
DDI-MedLine.d86.s7,coadministration,162,177,O
DDI-MedLine.d86.s7,of,179,180,O
DDI-MedLine.d86.s7,sirolimus,182,190,B-drug
DDI-MedLine.d86.s7,",",191,191,O
DDI-MedLine.d86.s7,and,193,195,O
DDI-MedLine.d86.s7,no,197,198,O
DDI-MedLine.d86.s7,potentiation,200,211,O
DDI-MedLine.d86.s7,of,213,214,O
DDI-MedLine.d86.s7,the,216,218,O
DDI-MedLine.d86.s7,effects,220,226,O
DDI-MedLine.d86.s7,of,228,229,O
DDI-MedLine.d86.s7,diltiazem,231,239,B-drug
DDI-MedLine.d86.s7,on,241,242,O
DDI-MedLine.d86.s7,diastolic,244,252,O
DDI-MedLine.d86.s7,or,254,255,O
DDI-MedLine.d86.s7,systolic,257,264,O
DDI-MedLine.d86.s7,blood,266,270,O
DDI-MedLine.d86.s7,pressure,272,279,O
DDI-MedLine.d86.s7,or,281,282,O
DDI-MedLine.d86.s7,on,284,285,O
DDI-MedLine.d86.s7,the,287,289,O
DDI-MedLine.d86.s7,electrocardiographic,291,310,O
DDI-MedLine.d86.s7,parameters,312,321,O
DDI-MedLine.d86.s7,was,323,325,O
DDI-MedLine.d86.s7,seen,327,330,O
DDI-MedLine.d86.s7,.,331,331,O
DDI-MedLine.d86.s8,CONCLUSIONS,0,10,O
DDI-MedLine.d86.s8,:,11,11,O
DDI-MedLine.d86.s8,Single-dose,13,23,O
DDI-MedLine.d86.s8,diltiazem,25,33,B-drug
DDI-MedLine.d86.s8,coadministration,35,50,O
DDI-MedLine.d86.s8,leads,52,56,O
DDI-MedLine.d86.s8,to,58,59,O
DDI-MedLine.d86.s8,higher,61,66,O
DDI-MedLine.d86.s8,sirolimus,68,76,B-drug
DDI-MedLine.d86.s8,exposure,78,85,O
DDI-MedLine.d86.s8,",",86,86,O
DDI-MedLine.d86.s8,presumably,88,97,O
DDI-MedLine.d86.s8,by,99,100,O
DDI-MedLine.d86.s8,inhibition,102,111,O
DDI-MedLine.d86.s8,of,113,114,O
DDI-MedLine.d86.s8,the,116,118,O
DDI-MedLine.d86.s8,first-pass,120,129,O
DDI-MedLine.d86.s8,metabolism,131,140,O
DDI-MedLine.d86.s8,of,142,143,O
DDI-MedLine.d86.s8,sirolimus,145,153,B-drug
DDI-MedLine.d86.s8,.,154,154,O
DDI-MedLine.d86.s9,Because,0,6,O
DDI-MedLine.d86.s9,of,8,9,O
DDI-MedLine.d86.s9,the,11,13,O
DDI-MedLine.d86.s9,pronounced,15,24,O
DDI-MedLine.d86.s9,intersubject,26,37,O
DDI-MedLine.d86.s9,variability,39,49,O
DDI-MedLine.d86.s9,in,51,52,O
DDI-MedLine.d86.s9,the,54,56,O
DDI-MedLine.d86.s9,extent,58,63,O
DDI-MedLine.d86.s9,of,65,66,O
DDI-MedLine.d86.s9,the,68,70,O
DDI-MedLine.d86.s9,sirolimus-diltiazem,72,90,O
DDI-MedLine.d86.s9,interaction,92,102,O
DDI-MedLine.d86.s9,",",103,103,O
DDI-MedLine.d86.s9,whole,105,109,O
DDI-MedLine.d86.s9,blood,111,115,O
DDI-MedLine.d86.s9,sirolimus,117,125,B-drug
DDI-MedLine.d86.s9,concentrations,127,140,O
DDI-MedLine.d86.s9,should,142,147,O
DDI-MedLine.d86.s9,be,149,150,O
DDI-MedLine.d86.s9,monitored,152,160,O
DDI-MedLine.d86.s9,closely,162,168,O
DDI-MedLine.d86.s9,in,170,171,O
DDI-MedLine.d86.s9,patients,173,180,O
DDI-MedLine.d86.s9,treated,182,188,O
DDI-MedLine.d86.s9,with,190,193,O
DDI-MedLine.d86.s9,the,195,197,O
DDI-MedLine.d86.s9,two,199,201,O
DDI-MedLine.d86.s9,drugs,203,207,O
DDI-MedLine.d86.s9,.,208,208,O
DDI-MedLine.d1.s0,[,0,0,O
DDI-MedLine.d1.s0,Drug,1,4,O
DDI-MedLine.d1.s0,treatment,6,14,O
DDI-MedLine.d1.s0,of,16,17,O
DDI-MedLine.d1.s0,erection,19,26,O
DDI-MedLine.d1.s0,disorders,28,36,O
DDI-MedLine.d1.s0,in,38,39,O
DDI-MedLine.d1.s0,patients,41,48,O
DDI-MedLine.d1.s0,with,50,53,O
DDI-MedLine.d1.s0,cardiovascular,55,68,O
DDI-MedLine.d1.s0,disease,70,76,O
DDI-MedLine.d1.s0,],77,77,O
DDI-MedLine.d1.s0,Erectile,79,86,O
DDI-MedLine.d1.s0,dysfunction,88,98,O
DDI-MedLine.d1.s0,is,100,101,O
DDI-MedLine.d1.s0,a,103,103,O
DDI-MedLine.d1.s0,frequent,105,112,O
DDI-MedLine.d1.s0,condition,114,122,O
DDI-MedLine.d1.s0,in,124,125,O
DDI-MedLine.d1.s0,cardiovascular,127,140,O
DDI-MedLine.d1.s0,patients,142,149,O
DDI-MedLine.d1.s0,.,150,150,O
DDI-MedLine.d1.s1,Since,0,4,O
DDI-MedLine.d1.s1,the,6,8,O
DDI-MedLine.d1.s1,arrival,10,16,O
DDI-MedLine.d1.s1,of,18,19,O
DDI-MedLine.d1.s1,oral,21,24,O
DDI-MedLine.d1.s1,erection-supporting,26,44,B-group
DDI-MedLine.d1.s1,medication,46,55,I-group
DDI-MedLine.d1.s1,",",56,56,O
DDI-MedLine.d1.s1,patients,58,65,O
DDI-MedLine.d1.s1,want,67,70,O
DDI-MedLine.d1.s1,to,72,73,O
DDI-MedLine.d1.s1,know,75,78,O
DDI-MedLine.d1.s1,how,80,82,O
DDI-MedLine.d1.s1,safe,84,87,O
DDI-MedLine.d1.s1,sexual,89,94,O
DDI-MedLine.d1.s1,activity,96,103,O
DDI-MedLine.d1.s1,is,105,106,O
DDI-MedLine.d1.s1,in,108,109,O
DDI-MedLine.d1.s1,cardiovascular,111,124,O
DDI-MedLine.d1.s1,disease,126,132,O
DDI-MedLine.d1.s1,in,134,135,O
DDI-MedLine.d1.s1,general,137,143,O
DDI-MedLine.d1.s1,and,145,147,O
DDI-MedLine.d1.s1,during,149,154,O
DDI-MedLine.d1.s1,use,156,158,O
DDI-MedLine.d1.s1,of,160,161,O
DDI-MedLine.d1.s1,erection-supporting,163,181,B-group
DDI-MedLine.d1.s1,medication,183,192,I-group
DDI-MedLine.d1.s1,in,194,195,O
DDI-MedLine.d1.s1,particular,197,206,O
DDI-MedLine.d1.s1,.,207,207,O
DDI-MedLine.d1.s2,Sexual,0,5,O
DDI-MedLine.d1.s2,intercourse,7,17,O
DDI-MedLine.d1.s2,with,19,22,O
DDI-MedLine.d1.s2,a,24,24,O
DDI-MedLine.d1.s2,steady,26,31,O
DDI-MedLine.d1.s2,partner,33,39,O
DDI-MedLine.d1.s2,causes,41,46,O
DDI-MedLine.d1.s2,no,48,49,O
DDI-MedLine.d1.s2,more,51,54,O
DDI-MedLine.d1.s2,cardiovascular,56,69,O
DDI-MedLine.d1.s2,risk,71,74,O
DDI-MedLine.d1.s2,than,76,79,O
DDI-MedLine.d1.s2,normal,81,86,O
DDI-MedLine.d1.s2,daily,88,92,O
DDI-MedLine.d1.s2,activities,94,103,O
DDI-MedLine.d1.s2,such,105,108,O
DDI-MedLine.d1.s2,as,110,111,O
DDI-MedLine.d1.s2,ironing,113,119,O
DDI-MedLine.d1.s2,",",120,120,O
DDI-MedLine.d1.s2,2,122,122,O
DDI-MedLine.d1.s2,kilometers,124,133,O
DDI-MedLine.d1.s2,of,135,136,O
DDI-MedLine.d1.s2,walking,138,144,O
DDI-MedLine.d1.s2,without,146,152,O
DDI-MedLine.d1.s2,climbing,154,161,O
DDI-MedLine.d1.s2,",",162,162,O
DDI-MedLine.d1.s2,paperhanging,164,175,O
DDI-MedLine.d1.s2,",",176,176,O
DDI-MedLine.d1.s2,playing,178,184,O
DDI-MedLine.d1.s2,golf,186,189,O
DDI-MedLine.d1.s2,or,191,192,O
DDI-MedLine.d1.s2,gardening,194,202,O
DDI-MedLine.d1.s2,.,203,203,O
DDI-MedLine.d1.s3,The,0,2,O
DDI-MedLine.d1.s3,relative,4,11,O
DDI-MedLine.d1.s3,risk,13,16,O
DDI-MedLine.d1.s3,of,18,19,O
DDI-MedLine.d1.s3,myocardial,21,30,O
DDI-MedLine.d1.s3,infarction,32,41,O
DDI-MedLine.d1.s3,during,43,48,O
DDI-MedLine.d1.s3,sexual,50,55,O
DDI-MedLine.d1.s3,activity,57,64,O
DDI-MedLine.d1.s3,is,66,67,O
DDI-MedLine.d1.s3,not,69,71,O
DDI-MedLine.d1.s3,significantly,73,85,O
DDI-MedLine.d1.s3,higher,87,92,O
DDI-MedLine.d1.s3,than,94,97,O
DDI-MedLine.d1.s3,for,99,101,O
DDI-MedLine.d1.s3,healthy,103,109,O
DDI-MedLine.d1.s3,persons,111,117,O
DDI-MedLine.d1.s3,.,118,118,O
DDI-MedLine.d1.s4,The,0,2,O
DDI-MedLine.d1.s4,incidence,4,12,O
DDI-MedLine.d1.s4,of,14,15,O
DDI-MedLine.d1.s4,cardiovascular,17,30,O
DDI-MedLine.d1.s4,morbidity,32,40,O
DDI-MedLine.d1.s4,and,42,44,O
DDI-MedLine.d1.s4,mortality,46,54,O
DDI-MedLine.d1.s4,is,56,57,O
DDI-MedLine.d1.s4,not,59,61,O
DDI-MedLine.d1.s4,higher,63,68,O
DDI-MedLine.d1.s4,among,70,74,O
DDI-MedLine.d1.s4,users,76,80,O
DDI-MedLine.d1.s4,of,82,83,O
DDI-MedLine.d1.s4,sildenafil,85,94,B-drug
DDI-MedLine.d1.s4,.,95,95,O
DDI-MedLine.d1.s5,Sildenafil,0,9,B-drug
DDI-MedLine.d1.s5,is,11,12,O
DDI-MedLine.d1.s5,contraindicated,14,28,O
DDI-MedLine.d1.s5,in,30,31,O
DDI-MedLine.d1.s5,patients,33,40,O
DDI-MedLine.d1.s5,using,42,46,O
DDI-MedLine.d1.s5,long-acting,48,58,B-group
DDI-MedLine.d1.s5,nitrates,60,67,I-group
DDI-MedLine.d1.s5,or,69,70,O
DDI-MedLine.d1.s5,who,72,74,O
DDI-MedLine.d1.s5,may,76,78,O
DDI-MedLine.d1.s5,need,80,83,O
DDI-MedLine.d1.s5,to,85,86,O
DDI-MedLine.d1.s5,use,88,90,O
DDI-MedLine.d1.s5,short-acting,92,103,B-group
DDI-MedLine.d1.s5,nitrates,105,112,I-group
DDI-MedLine.d1.s5,",",113,113,O
DDI-MedLine.d1.s5,because,115,121,O
DDI-MedLine.d1.s5,the,123,125,O
DDI-MedLine.d1.s5,combination,127,137,O
DDI-MedLine.d1.s5,may,139,141,O
DDI-MedLine.d1.s5,cause,143,147,O
DDI-MedLine.d1.s5,a,149,149,O
DDI-MedLine.d1.s5,sharp,151,155,O
DDI-MedLine.d1.s5,fall,157,160,O
DDI-MedLine.d1.s5,of,162,163,O
DDI-MedLine.d1.s5,the,165,167,O
DDI-MedLine.d1.s5,blood,169,173,O
DDI-MedLine.d1.s5,pressure,175,182,O
DDI-MedLine.d1.s5,.,183,183,O
DDI-MedLine.d1.s6,No,0,1,O
DDI-MedLine.d1.s6,interactions,3,14,O
DDI-MedLine.d1.s6,have,16,19,O
DDI-MedLine.d1.s6,been,21,24,O
DDI-MedLine.d1.s6,observed,26,33,O
DDI-MedLine.d1.s6,with,35,38,O
DDI-MedLine.d1.s6,beta-receptor,40,52,B-group
DDI-MedLine.d1.s6,blockers,54,61,I-group
DDI-MedLine.d1.s6,",",62,62,O
DDI-MedLine.d1.s6,calcium,64,70,B-group
DDI-MedLine.d1.s6,antagonists,72,82,I-group
DDI-MedLine.d1.s6,",",83,83,O
DDI-MedLine.d1.s6,thiazide,85,92,B-group
DDI-MedLine.d1.s6,and,94,96,O
DDI-MedLine.d1.s6,loop,98,101,B-group
DDI-MedLine.d1.s6,diuretics,103,111,I-group
DDI-MedLine.d1.s6,and,113,115,O
DDI-MedLine.d1.s6,ACE,117,119,B-group
DDI-MedLine.d1.s6,inhibitors,121,130,I-group
DDI-MedLine.d1.s6,.,131,131,O
DDI-MedLine.d1.s7,Before,0,5,O
DDI-MedLine.d1.s7,prescribing,7,17,O
DDI-MedLine.d1.s7,a,19,19,O
DDI-MedLine.d1.s7,symptomatic,21,31,O
DDI-MedLine.d1.s7,(,33,33,O
DDI-MedLine.d1.s7,pharmaceutical,34,47,O
DDI-MedLine.d1.s7,),48,48,O
DDI-MedLine.d1.s7,treatment,50,58,O
DDI-MedLine.d1.s7,for,60,62,O
DDI-MedLine.d1.s7,patients,64,71,O
DDI-MedLine.d1.s7,with,73,76,O
DDI-MedLine.d1.s7,an,78,79,O
DDI-MedLine.d1.s7,erection,81,88,O
DDI-MedLine.d1.s7,disorder,90,97,O
DDI-MedLine.d1.s7,",",98,98,O
DDI-MedLine.d1.s7,attention,100,108,O
DDI-MedLine.d1.s7,should,110,115,O
DDI-MedLine.d1.s7,be,117,118,O
DDI-MedLine.d1.s7,given,120,124,O
DDI-MedLine.d1.s7,tot,126,128,O
DDI-MedLine.d1.s7,the,130,132,O
DDI-MedLine.d1.s7,sexological,134,144,O
DDI-MedLine.d1.s7,",",145,145,O
DDI-MedLine.d1.s7,psychological,147,159,O
DDI-MedLine.d1.s7,and,161,163,O
DDI-MedLine.d1.s7,medical,165,171,O
DDI-MedLine.d1.s7,backgrounds,173,183,O
DDI-MedLine.d1.s7,of,185,186,O
DDI-MedLine.d1.s7,the,188,190,O
DDI-MedLine.d1.s7,disorder,192,199,O
DDI-MedLine.d1.s7,.,200,200,O
DDI-MedLine.d1.s8,Secondary,0,8,O
DDI-MedLine.d1.s8,prevention,10,19,O
DDI-MedLine.d1.s8,of,21,22,O
DDI-MedLine.d1.s8,atherosclerotic,24,38,O
DDI-MedLine.d1.s8,risk,40,43,O
DDI-MedLine.d1.s8,factors,45,51,O
DDI-MedLine.d1.s8,is,53,54,O
DDI-MedLine.d1.s8,also,56,59,O
DDI-MedLine.d1.s8,important,61,69,O
DDI-MedLine.d1.s8,:,70,70,O
DDI-MedLine.d1.s8,regulation,72,81,O
DDI-MedLine.d1.s8,of,83,84,O
DDI-MedLine.d1.s8,blood,86,90,O
DDI-MedLine.d1.s8,pressure,92,99,O
DDI-MedLine.d1.s8,and,101,103,O
DDI-MedLine.d1.s8,blood,105,109,O
DDI-MedLine.d1.s8,sugar,111,115,O
DDI-MedLine.d1.s8,level,117,121,O
DDI-MedLine.d1.s8,",",122,122,O
DDI-MedLine.d1.s8,hyperlipidaemia,124,138,O
DDI-MedLine.d1.s8,and,140,142,O
DDI-MedLine.d1.s8,obesity,144,150,O
DDI-MedLine.d1.s8,",",151,151,O
DDI-MedLine.d1.s8,as,153,154,O
DDI-MedLine.d1.s8,well,156,159,O
DDI-MedLine.d1.s8,as,161,162,O
DDI-MedLine.d1.s8,a,164,164,O
DDI-MedLine.d1.s8,change,166,171,O
DDI-MedLine.d1.s8,of,173,174,O
DDI-MedLine.d1.s8,lifestyle,176,184,O
DDI-MedLine.d1.s8,(,186,186,O
DDI-MedLine.d1.s8,giving,187,192,O
DDI-MedLine.d1.s8,up,194,195,O
DDI-MedLine.d1.s8,smoking,197,203,O
DDI-MedLine.d1.s8,",",204,204,O
DDI-MedLine.d1.s8,adapting,206,213,O
DDI-MedLine.d1.s8,of,215,216,O
DDI-MedLine.d1.s8,diet,218,221,O
DDI-MedLine.d1.s8,and,223,225,O
DDI-MedLine.d1.s8,more,227,230,O
DDI-MedLine.d1.s8,physical,232,239,O
DDI-MedLine.d1.s8,exertion,241,248,O
DDI-MedLine.d1.s8,),249,249,O
DDI-MedLine.d1.s8,.,250,250,O
DDI-MedLine.d1.s9,Patients,0,7,O
DDI-MedLine.d1.s9,with,9,12,O
DDI-MedLine.d1.s9,a,14,14,O
DDI-MedLine.d1.s9,very,16,19,O
DDI-MedLine.d1.s9,low,21,23,O
DDI-MedLine.d1.s9,cardiac,25,31,O
DDI-MedLine.d1.s9,capacity,33,40,O
DDI-MedLine.d1.s9,should,42,47,O
DDI-MedLine.d1.s9,be,49,50,O
DDI-MedLine.d1.s9,advised,52,58,O
DDI-MedLine.d1.s9,to,60,61,O
DDI-MedLine.d1.s9,refrain,63,69,O
DDI-MedLine.d1.s9,from,71,74,O
DDI-MedLine.d1.s9,treatment,76,84,O
DDI-MedLine.d1.s9,of,86,87,O
DDI-MedLine.d1.s9,the,89,91,O
DDI-MedLine.d1.s9,erection,93,100,O
DDI-MedLine.d1.s9,disorder,102,109,O
DDI-MedLine.d1.s9,.,110,110,O
DDI-MedLine.d132.s0,The,0,2,O
DDI-MedLine.d132.s0,emerging,4,11,O
DDI-MedLine.d132.s0,roles,13,17,O
DDI-MedLine.d132.s0,of,19,20,O
DDI-MedLine.d132.s0,non-nucleoside,22,35,B-group
DDI-MedLine.d132.s0,reverse,37,43,I-group
DDI-MedLine.d132.s0,transcriptase,45,57,I-group
DDI-MedLine.d132.s0,inhibitors,59,68,I-group
DDI-MedLine.d132.s0,in,70,71,O
DDI-MedLine.d132.s0,antiretroviral,73,86,B-group
DDI-MedLine.d132.s0,therapy,88,94,O
DDI-MedLine.d132.s0,.,95,95,O
DDI-MedLine.d132.s1,The,0,2,O
DDI-MedLine.d132.s1,availability,4,15,O
DDI-MedLine.d132.s1,of,17,18,O
DDI-MedLine.d132.s1,potent,20,25,O
DDI-MedLine.d132.s1,non-nucleoside,27,40,B-group
DDI-MedLine.d132.s1,reverse,42,48,I-group
DDI-MedLine.d132.s1,transcriptase,50,62,I-group
DDI-MedLine.d132.s1,inhibitor,64,72,I-group
DDI-MedLine.d132.s1,(,74,74,O
DDI-MedLine.d132.s1,NNRTI,75,79,B-group
DDI-MedLine.d132.s1,),80,80,O
DDI-MedLine.d132.s1,-based,81,86,O
DDI-MedLine.d132.s1,regimens,88,95,O
DDI-MedLine.d132.s1,for,97,99,O
DDI-MedLine.d132.s1,antiretroviral,101,114,B-group
DDI-MedLine.d132.s1,therapy,116,122,O
DDI-MedLine.d132.s1,and,124,126,O
DDI-MedLine.d132.s1,concerns,128,135,O
DDI-MedLine.d132.s1,regarding,137,145,O
DDI-MedLine.d132.s1,protease,147,154,B-group
DDI-MedLine.d132.s1,inhibitor,156,164,I-group
DDI-MedLine.d132.s1,(,166,166,O
DDI-MedLine.d132.s1,PI,167,168,B-group
DDI-MedLine.d132.s1,),169,169,O
DDI-MedLine.d132.s1,-related,170,177,O
DDI-MedLine.d132.s1,metabolic,179,187,O
DDI-MedLine.d132.s1,disturbances,189,200,O
DDI-MedLine.d132.s1,have,202,205,O
DDI-MedLine.d132.s1,led,207,209,O
DDI-MedLine.d132.s1,to,211,212,O
DDI-MedLine.d132.s1,significant,214,224,O
DDI-MedLine.d132.s1,shifts,226,231,O
DDI-MedLine.d132.s1,in,233,234,O
DDI-MedLine.d132.s1,treatment,236,244,O
DDI-MedLine.d132.s1,practices,246,254,O
DDI-MedLine.d132.s1,in,256,257,O
DDI-MedLine.d132.s1,HIV,259,261,O
DDI-MedLine.d132.s1,infection,263,271,O
DDI-MedLine.d132.s1,.,272,272,O
DDI-MedLine.d132.s2,NNRTI-based,0,10,O
DDI-MedLine.d132.s2,regimens,12,19,O
DDI-MedLine.d132.s2,may,21,23,O
DDI-MedLine.d132.s2,have,25,28,O
DDI-MedLine.d132.s2,several,30,36,O
DDI-MedLine.d132.s2,advantages,38,47,O
DDI-MedLine.d132.s2,over,49,52,O
DDI-MedLine.d132.s2,PI-based,54,61,O
DDI-MedLine.d132.s2,therapy,63,69,O
DDI-MedLine.d132.s2,for,71,73,O
DDI-MedLine.d132.s2,initial,75,81,O
DDI-MedLine.d132.s2,or,83,84,O
DDI-MedLine.d132.s2,prolonged,86,94,O
DDI-MedLine.d132.s2,therapy,96,102,O
DDI-MedLine.d132.s2,",",103,103,O
DDI-MedLine.d132.s2,including,105,113,O
DDI-MedLine.d132.s2,more,115,118,O
DDI-MedLine.d132.s2,convenient,120,129,O
DDI-MedLine.d132.s2,administration,131,144,O
DDI-MedLine.d132.s2,regimens,146,153,O
DDI-MedLine.d132.s2,",",154,154,O
DDI-MedLine.d132.s2,lower,156,160,O
DDI-MedLine.d132.s2,tablet,162,167,O
DDI-MedLine.d132.s2,volume,169,174,O
DDI-MedLine.d132.s2,",",175,175,O
DDI-MedLine.d132.s2,fewer,177,181,O
DDI-MedLine.d132.s2,drug,183,186,O
DDI-MedLine.d132.s2,interactions,188,199,O
DDI-MedLine.d132.s2,",",200,200,O
DDI-MedLine.d132.s2,and,202,204,O
DDI-MedLine.d132.s2,central,206,212,O
DDI-MedLine.d132.s2,nervous,214,220,O
DDI-MedLine.d132.s2,system,222,227,O
DDI-MedLine.d132.s2,penetration,229,239,O
DDI-MedLine.d132.s2,.,240,240,O
DDI-MedLine.d132.s3,No,0,1,O
DDI-MedLine.d132.s3,data,3,6,O
DDI-MedLine.d132.s3,from,8,11,O
DDI-MedLine.d132.s3,prospective,13,23,O
DDI-MedLine.d132.s3,clinical,25,32,O
DDI-MedLine.d132.s3,trials,34,39,O
DDI-MedLine.d132.s3,currently,41,49,O
DDI-MedLine.d132.s3,exist,51,55,O
DDI-MedLine.d132.s3,comparing,57,65,O
DDI-MedLine.d132.s3,the,67,69,O
DDI-MedLine.d132.s3,3,71,71,O
DDI-MedLine.d132.s3,approved,73,80,O
DDI-MedLine.d132.s3,agents,82,87,O
DDI-MedLine.d132.s3,(,89,89,O
DDI-MedLine.d132.s3,efavirenz,90,98,B-drug
DDI-MedLine.d132.s3,",",99,99,O
DDI-MedLine.d132.s3,nevirapine,101,110,B-drug
DDI-MedLine.d132.s3,or,112,113,O
DDI-MedLine.d132.s3,delavirdine,115,125,B-drug
DDI-MedLine.d132.s3,),126,126,O
DDI-MedLine.d132.s3,.,127,127,O
DDI-MedLine.d132.s4,Both,0,3,O
DDI-MedLine.d132.s4,efavirenz,5,13,B-drug
DDI-MedLine.d132.s4,and,15,17,O
DDI-MedLine.d132.s4,nevirapine,19,28,B-drug
DDI-MedLine.d132.s4,have,30,33,O
DDI-MedLine.d132.s4,been,35,38,O
DDI-MedLine.d132.s4,compared,40,47,O
DDI-MedLine.d132.s4,to,49,50,O
DDI-MedLine.d132.s4,triple,52,57,O
DDI-MedLine.d132.s4,therapy,59,65,O
DDI-MedLine.d132.s4,with,67,70,O
DDI-MedLine.d132.s4,the,72,74,O
DDI-MedLine.d132.s4,PI,76,77,B-group
DDI-MedLine.d132.s4,indinavir,79,87,B-drug
DDI-MedLine.d132.s4,over,89,92,O
DDI-MedLine.d132.s4,48,94,95,O
DDI-MedLine.d132.s4,weeks,97,101,O
DDI-MedLine.d132.s4,as,103,104,O
DDI-MedLine.d132.s4,initial,106,112,O
DDI-MedLine.d132.s4,therapy,114,120,O
DDI-MedLine.d132.s4,",",121,121,O
DDI-MedLine.d132.s4,with,123,126,O
DDI-MedLine.d132.s4,similar,128,134,O
DDI-MedLine.d132.s4,responses,136,144,O
DDI-MedLine.d132.s4,being,146,150,O
DDI-MedLine.d132.s4,observed,152,159,O
DDI-MedLine.d132.s4,with,161,164,O
DDI-MedLine.d132.s4,nevirapine,166,175,B-drug
DDI-MedLine.d132.s4,regimens,177,184,O
DDI-MedLine.d132.s4,and,186,188,O
DDI-MedLine.d132.s4,superiority,190,200,O
DDI-MedLine.d132.s4,observed,202,209,O
DDI-MedLine.d132.s4,with,211,214,O
DDI-MedLine.d132.s4,efavirenz,216,224,B-drug
DDI-MedLine.d132.s4,.,225,225,O
DDI-MedLine.d132.s5,A,0,0,O
DDI-MedLine.d132.s5,smaller,2,8,O
DDI-MedLine.d132.s5,24-week,10,16,O
DDI-MedLine.d132.s5,study,18,22,O
DDI-MedLine.d132.s5,has,24,26,O
DDI-MedLine.d132.s5,suggested,28,36,O
DDI-MedLine.d132.s5,nevirapine,38,47,B-drug
DDI-MedLine.d132.s5,may,49,51,O
DDI-MedLine.d132.s5,be,53,54,O
DDI-MedLine.d132.s5,superior,56,63,O
DDI-MedLine.d132.s5,to,65,66,O
DDI-MedLine.d132.s5,the,68,70,O
DDI-MedLine.d132.s5,PI,72,73,B-group
DDI-MedLine.d132.s5,nelfinavir,75,84,B-drug
DDI-MedLine.d132.s5,.,85,85,O
DDI-MedLine.d132.s6,Limited,0,6,O
DDI-MedLine.d132.s6,comparative,8,18,O
DDI-MedLine.d132.s6,data,20,23,O
DDI-MedLine.d132.s6,in,25,26,O
DDI-MedLine.d132.s6,patients,28,35,O
DDI-MedLine.d132.s6,with,37,40,O
DDI-MedLine.d132.s6,high,42,45,O
DDI-MedLine.d132.s6,viral,47,51,O
DDI-MedLine.d132.s6,loads,53,57,O
DDI-MedLine.d132.s6,treated,59,65,O
DDI-MedLine.d132.s6,with,67,70,O
DDI-MedLine.d132.s6,nevirapine-,72,82,O
DDI-MedLine.d132.s6,or,84,85,O
DDI-MedLine.d132.s6,delavirdine-based,87,103,O
DDI-MedLine.d132.s6,regimens,105,112,O
DDI-MedLine.d132.s6,currently,114,122,O
DDI-MedLine.d132.s6,exist,124,128,O
DDI-MedLine.d132.s6,.,129,129,O
DDI-MedLine.d132.s7,However,0,6,O
DDI-MedLine.d132.s7,",",7,7,O
DDI-MedLine.d132.s7,cohort,9,14,O
DDI-MedLine.d132.s7,data,16,19,O
DDI-MedLine.d132.s7,and,21,23,O
DDI-MedLine.d132.s7,selected,25,32,O
DDI-MedLine.d132.s7,patient,34,40,O
DDI-MedLine.d132.s7,data,42,45,O
DDI-MedLine.d132.s7,from,47,50,O
DDI-MedLine.d132.s7,clinical,52,59,O
DDI-MedLine.d132.s7,trials,61,66,O
DDI-MedLine.d132.s7,suggest,68,74,O
DDI-MedLine.d132.s7,comparable,76,85,O
DDI-MedLine.d132.s7,activity,87,94,O
DDI-MedLine.d132.s7,to,96,97,O
DDI-MedLine.d132.s7,PI-based,99,106,O
DDI-MedLine.d132.s7,regimens,108,115,O
DDI-MedLine.d132.s7,in,117,118,O
DDI-MedLine.d132.s7,these,120,124,O
DDI-MedLine.d132.s7,patients,126,133,O
DDI-MedLine.d132.s7,.,134,134,O
DDI-MedLine.d132.s8,The,0,2,O
DDI-MedLine.d132.s8,superiority,4,14,O
DDI-MedLine.d132.s8,of,16,17,O
DDI-MedLine.d132.s8,efavirenz,19,27,B-drug
DDI-MedLine.d132.s8,over,29,32,O
DDI-MedLine.d132.s8,indinavir-based,34,48,O
DDI-MedLine.d132.s8,regimens,50,57,O
DDI-MedLine.d132.s8,has,59,61,O
DDI-MedLine.d132.s8,been,63,66,O
DDI-MedLine.d132.s8,observed,68,75,O
DDI-MedLine.d132.s8,in,77,78,O
DDI-MedLine.d132.s8,comparative,80,90,O
DDI-MedLine.d132.s8,data,92,95,O
DDI-MedLine.d132.s8,in,97,98,O
DDI-MedLine.d132.s8,a,100,100,O
DDI-MedLine.d132.s8,subset,102,107,O
DDI-MedLine.d132.s8,of,109,110,O
DDI-MedLine.d132.s8,patients,112,119,O
DDI-MedLine.d132.s8,with,121,124,O
DDI-MedLine.d132.s8,high,126,129,O
DDI-MedLine.d132.s8,viral,131,135,O
DDI-MedLine.d132.s8,loads,137,141,O
DDI-MedLine.d132.s8,.,142,142,O
DDI-MedLine.d132.s9,In,0,1,O
DDI-MedLine.d132.s9,treatment-experienced,3,23,O
DDI-MedLine.d132.s9,patients,25,32,O
DDI-MedLine.d132.s9,",",33,33,O
DDI-MedLine.d132.s9,available,35,43,O
DDI-MedLine.d132.s9,uncontrolled,45,56,O
DDI-MedLine.d132.s9,data,58,61,O
DDI-MedLine.d132.s9,suggest,63,69,O
DDI-MedLine.d132.s9,these,71,75,O
DDI-MedLine.d132.s9,agents,77,82,O
DDI-MedLine.d132.s9,contribute,84,93,O
DDI-MedLine.d132.s9,to,95,96,O
DDI-MedLine.d132.s9,regimen,98,104,O
DDI-MedLine.d132.s9,efficacy,106,113,O
DDI-MedLine.d132.s9,in,115,116,O
DDI-MedLine.d132.s9,NNRTI-na,118,125,O
DDI-MedLine.d132.s9,ve,128,129,O
DDI-MedLine.d132.s9,",",130,130,O
DDI-MedLine.d132.s9,treatment-experienced,132,152,O
DDI-MedLine.d132.s9,patients,154,161,O
DDI-MedLine.d132.s9,.,162,162,O
DDI-MedLine.d132.s10,Efavirenz,0,8,B-drug
DDI-MedLine.d132.s10,has,10,12,O
DDI-MedLine.d132.s10,demonstrated,14,25,O
DDI-MedLine.d132.s10,superiority,27,37,O
DDI-MedLine.d132.s10,over,39,42,O
DDI-MedLine.d132.s10,nelfinavir,44,53,B-drug
DDI-MedLine.d132.s10,in,55,56,O
DDI-MedLine.d132.s10,nucleoside-experienced,58,79,O
DDI-MedLine.d132.s10,patients,81,88,O
DDI-MedLine.d132.s10,",",89,89,O
DDI-MedLine.d132.s10,although,91,98,O
DDI-MedLine.d132.s10,combining,100,108,O
DDI-MedLine.d132.s10,these,110,114,O
DDI-MedLine.d132.s10,2,116,116,O
DDI-MedLine.d132.s10,agents,118,123,O
DDI-MedLine.d132.s10,may,125,127,O
DDI-MedLine.d132.s10,represent,129,137,O
DDI-MedLine.d132.s10,the,139,141,O
DDI-MedLine.d132.s10,best,143,146,O
DDI-MedLine.d132.s10,approach,148,155,O
DDI-MedLine.d132.s10,in,157,158,O
DDI-MedLine.d132.s10,these,160,164,O
DDI-MedLine.d132.s10,circumstances,166,178,O
DDI-MedLine.d132.s10,.,179,179,O
DDI-MedLine.d132.s11,The,0,2,O
DDI-MedLine.d132.s11,tolerability,4,15,O
DDI-MedLine.d132.s11,of,17,18,O
DDI-MedLine.d132.s11,NNRTIs,20,25,B-group
DDI-MedLine.d132.s11,appears,27,33,O
DDI-MedLine.d132.s11,generally,35,43,O
DDI-MedLine.d132.s11,good,45,48,O
DDI-MedLine.d132.s11,with,50,53,O
DDI-MedLine.d132.s11,few,55,57,O
DDI-MedLine.d132.s11,individuals,59,69,O
DDI-MedLine.d132.s11,discontinuing,71,83,O
DDI-MedLine.d132.s11,in,85,86,O
DDI-MedLine.d132.s11,clinical,88,95,O
DDI-MedLine.d132.s11,studies,97,103,O
DDI-MedLine.d132.s11,as,105,106,O
DDI-MedLine.d132.s11,a,108,108,O
DDI-MedLine.d132.s11,result,110,115,O
DDI-MedLine.d132.s11,of,117,118,O
DDI-MedLine.d132.s11,adverse,120,126,O
DDI-MedLine.d132.s11,drug,128,131,O
DDI-MedLine.d132.s11,events,133,138,O
DDI-MedLine.d132.s11,.,139,139,O
DDI-MedLine.d132.s12,The,0,2,O
DDI-MedLine.d132.s12,majority,4,11,O
DDI-MedLine.d132.s12,of,13,14,O
DDI-MedLine.d132.s12,adverse,16,22,O
DDI-MedLine.d132.s12,events,24,29,O
DDI-MedLine.d132.s12,with,31,34,O
DDI-MedLine.d132.s12,NNRTIs,36,41,B-group
DDI-MedLine.d132.s12,occur,43,47,O
DDI-MedLine.d132.s12,within,49,54,O
DDI-MedLine.d132.s12,the,56,58,O
DDI-MedLine.d132.s12,first,60,64,O
DDI-MedLine.d132.s12,month,66,70,O
DDI-MedLine.d132.s12,",",71,71,O
DDI-MedLine.d132.s12,and,73,75,O
DDI-MedLine.d132.s12,are,77,79,O
DDI-MedLine.d132.s12,predictable,81,91,O
DDI-MedLine.d132.s12,and,93,95,O
DDI-MedLine.d132.s12,manageable,97,106,O
DDI-MedLine.d132.s12,without,108,114,O
DDI-MedLine.d132.s12,therapy,116,122,O
DDI-MedLine.d132.s12,interruption,124,135,O
DDI-MedLine.d132.s12,.,136,136,O
DDI-MedLine.d23.s0,The,0,2,O
DDI-MedLine.d23.s0,effects,4,10,O
DDI-MedLine.d23.s0,of,12,13,O
DDI-MedLine.d23.s0,ketamine,15,22,B-drug
DDI-MedLine.d23.s0,and,24,26,O
DDI-MedLine.d23.s0,of,28,29,O
DDI-MedLine.d23.s0,Innovar,31,37,B-brand
DDI-MedLine.d23.s0,anesthesia,39,48,O
DDI-MedLine.d23.s0,on,50,51,O
DDI-MedLine.d23.s0,digitalis,53,61,B-group
DDI-MedLine.d23.s0,tolerance,63,71,O
DDI-MedLine.d23.s0,in,73,74,O
DDI-MedLine.d23.s0,dogs,76,79,O
DDI-MedLine.d23.s0,.,80,80,O
DDI-MedLine.d23.s1,In,0,1,O
DDI-MedLine.d23.s1,a,3,3,O
DDI-MedLine.d23.s1,comparison,5,14,O
DDI-MedLine.d23.s1,of,16,17,O
DDI-MedLine.d23.s1,digitalis,19,27,B-group
DDI-MedLine.d23.s1,tolerance,29,37,O
DDI-MedLine.d23.s1,in,39,40,O
DDI-MedLine.d23.s1,dogs,42,45,O
DDI-MedLine.d23.s1,anesthetized,47,58,O
DDI-MedLine.d23.s1,with,60,63,O
DDI-MedLine.d23.s1,ketamine,65,72,B-drug
DDI-MedLine.d23.s1,",",73,73,O
DDI-MedLine.d23.s1,Innovar,75,81,B-brand
DDI-MedLine.d23.s1,Vet,83,85,I-brand
DDI-MedLine.d23.s1,",",86,86,O
DDI-MedLine.d23.s1,or,88,89,O
DDI-MedLine.d23.s1,pentobarbital,91,103,B-drug
DDI-MedLine.d23.s1,",",104,104,O
DDI-MedLine.d23.s1,the,106,108,O
DDI-MedLine.d23.s1,dosage,110,115,O
DDI-MedLine.d23.s1,of,117,118,O
DDI-MedLine.d23.s1,ouabain,120,126,B-drug
DDI-MedLine.d23.s1,needed,128,133,O
DDI-MedLine.d23.s1,to,135,136,O
DDI-MedLine.d23.s1,cause,138,142,O
DDI-MedLine.d23.s1,ventricular,144,154,O
DDI-MedLine.d23.s1,tachycardia,156,166,O
DDI-MedLine.d23.s1,was,168,170,O
DDI-MedLine.d23.s1,significantly,172,184,O
DDI-MedLine.d23.s1,higher,186,191,O
DDI-MedLine.d23.s1,",",192,192,O
DDI-MedLine.d23.s1,as,194,195,O
DDI-MedLine.d23.s1,was,197,199,O
DDI-MedLine.d23.s1,the,201,203,O
DDI-MedLine.d23.s1,LD50,205,208,O
DDI-MedLine.d23.s1,of,210,211,O
DDI-MedLine.d23.s1,ouabain,213,219,B-drug
DDI-MedLine.d23.s1,",",220,220,O
DDI-MedLine.d23.s1,with,222,225,O
DDI-MedLine.d23.s1,ketamine,227,234,B-drug
DDI-MedLine.d23.s1,or,236,237,O
DDI-MedLine.d23.s1,Innovar,239,245,B-brand
DDI-MedLine.d23.s1,than,247,250,O
DDI-MedLine.d23.s1,with,252,255,O
DDI-MedLine.d23.s1,pentobarbital,257,269,B-drug
DDI-MedLine.d23.s1,.,270,270,O
DDI-MedLine.d23.s2,Ventricular,0,10,O
DDI-MedLine.d23.s2,tachycardia,12,22,O
DDI-MedLine.d23.s2,induced,24,30,O
DDI-MedLine.d23.s2,by,32,33,O
DDI-MedLine.d23.s2,ouabain,35,41,B-drug
DDI-MedLine.d23.s2,was,43,45,O
DDI-MedLine.d23.s2,generally,47,55,O
DDI-MedLine.d23.s2,converted,57,65,O
DDI-MedLine.d23.s2,to,67,68,O
DDI-MedLine.d23.s2,sinus,70,74,O
DDI-MedLine.d23.s2,rhythm,76,81,O
DDI-MedLine.d23.s2,following,83,91,O
DDI-MedLine.d23.s2,administration,93,106,O
DDI-MedLine.d23.s2,of,108,109,O
DDI-MedLine.d23.s2,Innovar,111,117,B-brand
DDI-MedLine.d23.s2,",",118,118,O
DDI-MedLine.d23.s2,ketamine,120,127,B-drug
DDI-MedLine.d23.s2,",",128,128,O
DDI-MedLine.d23.s2,or,130,131,O
DDI-MedLine.d23.s2,droperidol,133,142,B-drug
DDI-MedLine.d23.s2,but,144,146,O
DDI-MedLine.d23.s2,not,148,150,O
DDI-MedLine.d23.s2,after,152,156,O
DDI-MedLine.d23.s2,administration,158,171,O
DDI-MedLine.d23.s2,of,173,174,O
DDI-MedLine.d23.s2,fentayl,176,182,B-drug
DDI-MedLine.d23.s2,alone,184,188,O
DDI-MedLine.d23.s2,or,190,191,O
DDI-MedLine.d23.s2,after,193,197,O
DDI-MedLine.d23.s2,pentobarbital,199,211,B-drug
DDI-MedLine.d23.s2,.,212,212,O
DDI-MedLine.d138.s0,Interaction,0,10,O
DDI-MedLine.d138.s0,between,12,18,O
DDI-MedLine.d138.s0,oxytocin,20,27,B-drug
DDI-MedLine.d138.s0,and,29,31,O
DDI-MedLine.d138.s0,antidiuretic,33,44,O
DDI-MedLine.d138.s0,hormone,46,52,O
DDI-MedLine.d138.s0,and,54,56,O
DDI-MedLine.d138.s0,its,58,60,O
DDI-MedLine.d138.s0,effect,62,67,O
DDI-MedLine.d138.s0,on,69,70,O
DDI-MedLine.d138.s0,the,72,74,O
DDI-MedLine.d138.s0,milk,76,79,O
DDI-MedLine.d138.s0,secretion,81,89,O
DDI-MedLine.d138.s0,by,91,92,O
DDI-MedLine.d138.s0,alveoli,94,100,O
DDI-MedLine.d138.s0,of,102,103,O
DDI-MedLine.d138.s0,the,105,107,O
DDI-MedLine.d138.s0,mammary,109,115,O
DDI-MedLine.d138.s0,gland,117,121,O
DDI-MedLine.d138.s0,of,123,124,O
DDI-MedLine.d138.s0,lactating,126,134,O
DDI-MedLine.d138.s0,rats,136,139,O
DDI-MedLine.d138.s0,.,140,140,O
DDI-MedLine.d138.s1,Interaction,0,10,O
DDI-MedLine.d138.s1,between,12,18,O
DDI-MedLine.d138.s1,exogenous,20,28,O
DDI-MedLine.d138.s1,and,30,32,O
DDI-MedLine.d138.s1,endogenous,34,43,O
DDI-MedLine.d138.s1,oxytocin,45,52,B-drug
DDI-MedLine.d138.s1,and,54,56,O
DDI-MedLine.d138.s1,vasopressin,58,68,O
DDI-MedLine.d138.s1,was,70,72,O
DDI-MedLine.d138.s1,found,74,78,O
DDI-MedLine.d138.s1,to,80,81,O
DDI-MedLine.d138.s1,affect,83,88,O
DDI-MedLine.d138.s1,the,90,92,O
DDI-MedLine.d138.s1,mechanism,94,102,O
DDI-MedLine.d138.s1,of,104,105,O
DDI-MedLine.d138.s1,milk,107,110,O
DDI-MedLine.d138.s1,ejection,112,119,O
DDI-MedLine.d138.s1,by,121,122,O
DDI-MedLine.d138.s1,the,124,126,O
DDI-MedLine.d138.s1,alveoli,128,134,O
DDI-MedLine.d138.s1,of,136,137,O
DDI-MedLine.d138.s1,the,139,141,O
DDI-MedLine.d138.s1,mammary,143,149,O
DDI-MedLine.d138.s1,gland,151,155,O
DDI-MedLine.d138.s1,in,157,158,O
DDI-MedLine.d138.s1,lactating,160,168,O
DDI-MedLine.d138.s1,rats,170,173,O
DDI-MedLine.d138.s1,.,174,174,O
DDI-MedLine.d138.s2,Inhibition,0,9,O
DDI-MedLine.d138.s2,and,11,13,O
DDI-MedLine.d138.s2,stimulation,15,25,O
DDI-MedLine.d138.s2,of,27,28,O
DDI-MedLine.d138.s2,the,30,32,O
DDI-MedLine.d138.s2,effect,34,39,O
DDI-MedLine.d138.s2,of,41,42,O
DDI-MedLine.d138.s2,oxytocin,44,51,B-drug
DDI-MedLine.d138.s2,on,53,54,O
DDI-MedLine.d138.s2,milk,56,59,O
DDI-MedLine.d138.s2,ejection,61,68,O
DDI-MedLine.d138.s2,by,70,71,O
DDI-MedLine.d138.s2,vasopressin,73,83,O
DDI-MedLine.d138.s2,was,85,87,O
DDI-MedLine.d138.s2,demonstrated,89,100,O
DDI-MedLine.d138.s2,.,101,101,O
DDI-MedLine.d138.s3,On,0,1,O
DDI-MedLine.d138.s3,the,3,5,O
DDI-MedLine.d138.s3,basis,7,11,O
DDI-MedLine.d138.s3,of,13,14,O
DDI-MedLine.d138.s3,the,16,18,O
DDI-MedLine.d138.s3,principles,20,29,O
DDI-MedLine.d138.s3,observed,31,38,O
DDI-MedLine.d138.s3,the,40,42,O
DDI-MedLine.d138.s3,concentrations,44,57,O
DDI-MedLine.d138.s3,fo,59,60,O
DDI-MedLine.d138.s3,these,62,66,O
DDI-MedLine.d138.s3,hormones,68,75,O
DDI-MedLine.d138.s3,were,77,80,O
DDI-MedLine.d138.s3,investigated,82,93,O
DDI-MedLine.d138.s3,in,95,96,O
DDI-MedLine.d138.s3,the,98,100,O
DDI-MedLine.d138.s3,plasma,102,107,O
DDI-MedLine.d138.s3,of,109,110,O
DDI-MedLine.d138.s3,dogs,112,115,O
DDI-MedLine.d138.s3,deprived,117,124,O
DDI-MedLine.d138.s3,of,126,127,O
DDI-MedLine.d138.s3,water,129,133,O
DDI-MedLine.d138.s3,for,135,137,O
DDI-MedLine.d138.s3,3,139,139,O
DDI-MedLine.d138.s3,days,141,144,O
DDI-MedLine.d138.s3,and,146,148,O
DDI-MedLine.d138.s3,then,150,153,O
DDI-MedLine.d138.s3,allowed,155,161,O
DDI-MedLine.d138.s3,to,163,164,O
DDI-MedLine.d138.s3,drink,166,170,O
DDI-MedLine.d138.s3,.,171,171,O
DDI-MedLine.d29.s0,Effect,0,5,O
DDI-MedLine.d29.s0,of,7,8,O
DDI-MedLine.d29.s0,probenecid,10,19,B-drug
DDI-MedLine.d29.s0,on,21,22,O
DDI-MedLine.d29.s0,the,24,26,O
DDI-MedLine.d29.s0,apparent,28,35,O
DDI-MedLine.d29.s0,volume,37,42,O
DDI-MedLine.d29.s0,of,44,45,O
DDI-MedLine.d29.s0,distribution,47,58,O
DDI-MedLine.d29.s0,and,60,62,O
DDI-MedLine.d29.s0,elimination,64,74,O
DDI-MedLine.d29.s0,of,76,77,O
DDI-MedLine.d29.s0,cloxacillin,79,89,B-drug
DDI-MedLine.d29.s0,.,90,90,O
DDI-MedLine.d29.s1,According,0,8,O
DDI-MedLine.d29.s1,to,10,11,O
DDI-MedLine.d29.s1,Gibaldi,13,19,O
DDI-MedLine.d29.s1,et,21,22,O
DDI-MedLine.d29.s1,al,24,25,O
DDI-MedLine.d29.s1,.,26,26,O
DDI-MedLine.d29.s2,(,0,0,O
DDI-MedLine.d29.s2,1968,1,4,O
DDI-MedLine.d29.s2,",",5,5,O
DDI-MedLine.d29.s2,1970,7,10,O
DDI-MedLine.d29.s2,),11,11,O
DDI-MedLine.d29.s2,",",12,12,O
DDI-MedLine.d29.s2,the,14,16,O
DDI-MedLine.d29.s2,higher,18,23,O
DDI-MedLine.d29.s2,serum,25,29,O
DDI-MedLine.d29.s2,concentrations,31,44,O
DDI-MedLine.d29.s2,of,46,47,O
DDI-MedLine.d29.s2,penicillins,49,59,B-group
DDI-MedLine.d29.s2,and,61,63,O
DDI-MedLine.d29.s2,cephaloridine,65,77,B-drug
DDI-MedLine.d29.s2,reached,79,85,O
DDI-MedLine.d29.s2,after,87,91,O
DDI-MedLine.d29.s2,administration,93,106,O
DDI-MedLine.d29.s2,of,108,109,O
DDI-MedLine.d29.s2,probenecid,111,120,B-drug
DDI-MedLine.d29.s2,are,122,124,O
DDI-MedLine.d29.s2,due,126,128,O
DDI-MedLine.d29.s2,not,130,132,O
DDI-MedLine.d29.s2,only,134,137,O
DDI-MedLine.d29.s2,to,139,140,O
DDI-MedLine.d29.s2,slower,142,147,O
DDI-MedLine.d29.s2,renal,149,153,O
DDI-MedLine.d29.s2,elimination,155,165,O
DDI-MedLine.d29.s2,but,167,169,O
DDI-MedLine.d29.s2,also,171,174,O
DDI-MedLine.d29.s2,to,176,177,O
DDI-MedLine.d29.s2,an,179,180,O
DDI-MedLine.d29.s2,altered,182,188,O
DDI-MedLine.d29.s2,distribution,190,201,O
DDI-MedLine.d29.s2,in,203,204,O
DDI-MedLine.d29.s2,the,206,208,O
DDI-MedLine.d29.s2,body,210,213,O
DDI-MedLine.d29.s2,.,214,214,O
DDI-MedLine.d29.s3,To,0,1,O
DDI-MedLine.d29.s3,determine,3,11,O
DDI-MedLine.d29.s3,whether,13,19,O
DDI-MedLine.d29.s3,probenecid,21,30,B-drug
DDI-MedLine.d29.s3,has,32,34,O
DDI-MedLine.d29.s3,a,36,36,O
DDI-MedLine.d29.s3,direct,38,43,O
DDI-MedLine.d29.s3,effect,45,50,O
DDI-MedLine.d29.s3,on,52,53,O
DDI-MedLine.d29.s3,the,55,57,O
DDI-MedLine.d29.s3,distribution,59,70,O
DDI-MedLine.d29.s3,of,72,73,O
DDI-MedLine.d29.s3,cloxacillin,75,85,B-drug
DDI-MedLine.d29.s3,",",86,86,O
DDI-MedLine.d29.s3,the,88,90,O
DDI-MedLine.d29.s3,elimination,92,102,O
DDI-MedLine.d29.s3,and,104,106,O
DDI-MedLine.d29.s3,distribution,108,119,O
DDI-MedLine.d29.s3,of,121,122,O
DDI-MedLine.d29.s3,cloxacillin,124,134,B-drug
DDI-MedLine.d29.s3,was,136,138,O
DDI-MedLine.d29.s3,studied,140,146,O
DDI-MedLine.d29.s3,in,148,149,O
DDI-MedLine.d29.s3,six,151,153,O
DDI-MedLine.d29.s3,patients,155,162,O
DDI-MedLine.d29.s3,",",163,163,O
DDI-MedLine.d29.s3,five,165,168,O
DDI-MedLine.d29.s3,lacking,170,176,O
DDI-MedLine.d29.s3,kidney,178,183,O
DDI-MedLine.d29.s3,function,185,192,O
DDI-MedLine.d29.s3,and,194,196,O
DDI-MedLine.d29.s3,one,198,200,O
DDI-MedLine.d29.s3,with,202,205,O
DDI-MedLine.d29.s3,a,207,207,O
DDI-MedLine.d29.s3,partially,209,217,O
DDI-MedLine.d29.s3,impaired,219,226,O
DDI-MedLine.d29.s3,renal,228,232,O
DDI-MedLine.d29.s3,function,234,241,O
DDI-MedLine.d29.s3,",",242,242,O
DDI-MedLine.d29.s3,in,244,245,O
DDI-MedLine.d29.s3,the,247,249,O
DDI-MedLine.d29.s3,presence,251,258,O
DDI-MedLine.d29.s3,or,260,261,O
DDI-MedLine.d29.s3,absence,263,269,O
DDI-MedLine.d29.s3,of,271,272,O
DDI-MedLine.d29.s3,probenecid,274,283,B-drug
DDI-MedLine.d29.s3,.,284,284,O
DDI-MedLine.d29.s4,No,0,1,O
DDI-MedLine.d29.s4,significant,3,13,O
DDI-MedLine.d29.s4,difference,15,24,O
DDI-MedLine.d29.s4,was,26,28,O
DDI-MedLine.d29.s4,found,30,34,O
DDI-MedLine.d29.s4,between,36,42,O
DDI-MedLine.d29.s4,the,44,46,O
DDI-MedLine.d29.s4,mean,48,51,O
DDI-MedLine.d29.s4,values,53,58,O
DDI-MedLine.d29.s4,of,60,61,O
DDI-MedLine.d29.s4,the,63,65,O
DDI-MedLine.d29.s4,volume,67,72,O
DDI-MedLine.d29.s4,of,74,75,O
DDI-MedLine.d29.s4,distribution,77,88,O
DDI-MedLine.d29.s4,of,90,91,O
DDI-MedLine.d29.s4,cloxacillin,93,103,B-drug
DDI-MedLine.d29.s4,with,105,108,O
DDI-MedLine.d29.s4,and,110,112,O
DDI-MedLine.d29.s4,without,114,120,O
DDI-MedLine.d29.s4,probenecid,122,131,B-drug
DDI-MedLine.d29.s4,(,133,133,O
DDI-MedLine.d29.s4,13.0,134,137,O
DDI-MedLine.d29.s4,and,139,141,O
DDI-MedLine.d29.s4,12.6,143,146,O
DDI-MedLine.d29.s4,liters,148,153,O
DDI-MedLine.d29.s4,",",154,154,O
DDI-MedLine.d29.s4,respectively,156,167,O
DDI-MedLine.d29.s4,),168,168,O
DDI-MedLine.d29.s4,.,169,169,O
DDI-MedLine.d29.s5,Thus,0,3,O
DDI-MedLine.d29.s5,",",4,4,O
DDI-MedLine.d29.s5,the,6,8,O
DDI-MedLine.d29.s5,hypothesis,10,19,O
DDI-MedLine.d29.s5,of,21,22,O
DDI-MedLine.d29.s5,Gibaldi,24,30,O
DDI-MedLine.d29.s5,et,32,33,O
DDI-MedLine.d29.s5,al,35,36,O
DDI-MedLine.d29.s5,.,37,37,O
DDI-MedLine.d29.s6,could,0,4,O
DDI-MedLine.d29.s6,not,6,8,O
DDI-MedLine.d29.s6,be,10,11,O
DDI-MedLine.d29.s6,confirmed,13,21,O
DDI-MedLine.d29.s6,for,23,25,O
DDI-MedLine.d29.s6,cloxacillin,27,37,B-drug
DDI-MedLine.d29.s6,in,39,40,O
DDI-MedLine.d29.s6,patients,42,49,O
DDI-MedLine.d29.s6,lacking,51,57,O
DDI-MedLine.d29.s6,kidney,59,64,O
DDI-MedLine.d29.s6,function,66,73,O
DDI-MedLine.d29.s6,.,74,74,O
DDI-MedLine.d29.s7,In,0,1,O
DDI-MedLine.d29.s7,spite,3,7,O
DDI-MedLine.d29.s7,of,9,10,O
DDI-MedLine.d29.s7,the,12,14,O
DDI-MedLine.d29.s7,absence,16,22,O
DDI-MedLine.d29.s7,of,24,25,O
DDI-MedLine.d29.s7,kidney,27,32,O
DDI-MedLine.d29.s7,function,34,41,O
DDI-MedLine.d29.s7,",",42,42,O
DDI-MedLine.d29.s7,the,44,46,O
DDI-MedLine.d29.s7,value,48,52,O
DDI-MedLine.d29.s7,of,54,55,O
DDI-MedLine.d29.s7,the,57,59,O
DDI-MedLine.d29.s7,elimination,61,71,O
DDI-MedLine.d29.s7,rate,73,76,O
DDI-MedLine.d29.s7,constant,78,85,O
DDI-MedLine.d29.s7,was,87,89,O
DDI-MedLine.d29.s7,significantly,91,103,O
DDI-MedLine.d29.s7,decreased,105,113,O
DDI-MedLine.d29.s7,in,115,116,O
DDI-MedLine.d29.s7,the,118,120,O
DDI-MedLine.d29.s7,presence,122,129,O
DDI-MedLine.d29.s7,of,131,132,O
DDI-MedLine.d29.s7,probenecid,134,143,B-drug
DDI-MedLine.d29.s7,(,145,145,O
DDI-MedLine.d29.s7,from,146,149,O
DDI-MedLine.d29.s7,0.326,151,155,O
DDI-MedLine.d29.s7,to,157,158,O
DDI-MedLine.d29.s7,0.263/h,160,166,O
DDI-MedLine.d29.s7,),167,167,O
DDI-MedLine.d29.s7,.,168,168,O
DDI-MedLine.d29.s8,This,0,3,O
DDI-MedLine.d29.s8,might,5,9,O
DDI-MedLine.d29.s8,be,11,12,O
DDI-MedLine.d29.s8,explained,14,22,O
DDI-MedLine.d29.s8,by,24,25,O
DDI-MedLine.d29.s8,a,27,27,O
DDI-MedLine.d29.s8,blockade,29,36,O
DDI-MedLine.d29.s8,by,38,39,O
DDI-MedLine.d29.s8,probenecid,41,50,B-drug
DDI-MedLine.d29.s8,of,52,53,O
DDI-MedLine.d29.s8,the,55,57,O
DDI-MedLine.d29.s8,elimination,59,69,O
DDI-MedLine.d29.s8,of,71,72,O
DDI-MedLine.d29.s8,cloxacillin,74,84,B-drug
DDI-MedLine.d29.s8,by,86,87,O
DDI-MedLine.d29.s8,the,89,91,O
DDI-MedLine.d29.s8,liver,93,97,O
DDI-MedLine.d29.s8,.,98,98,O
DDI-MedLine.d118.s0,Sirolimus,0,8,B-drug
DDI-MedLine.d118.s0,:,9,9,O
DDI-MedLine.d118.s0,mammalian,11,19,O
DDI-MedLine.d118.s0,target,21,26,O
DDI-MedLine.d118.s0,of,28,29,O
DDI-MedLine.d118.s0,rapamycin,31,39,B-drug
DDI-MedLine.d118.s0,inhibitor,41,49,O
DDI-MedLine.d118.s0,to,51,52,O
DDI-MedLine.d118.s0,prevent,54,60,O
DDI-MedLine.d118.s0,kidney,62,67,O
DDI-MedLine.d118.s0,rejection,69,77,O
DDI-MedLine.d118.s0,.,78,78,O
DDI-MedLine.d118.s1,Current,0,6,O
DDI-MedLine.d118.s1,immunosuppressive,8,24,O
DDI-MedLine.d118.s1,therapies,26,34,O
DDI-MedLine.d118.s1,are,36,38,O
DDI-MedLine.d118.s1,effective,40,48,O
DDI-MedLine.d118.s1,but,50,52,O
DDI-MedLine.d118.s1,can,54,56,O
DDI-MedLine.d118.s1,be,58,59,O
DDI-MedLine.d118.s1,associated,61,70,O
DDI-MedLine.d118.s1,with,72,75,O
DDI-MedLine.d118.s1,significant,77,87,O
DDI-MedLine.d118.s1,adverse,89,95,O
DDI-MedLine.d118.s1,reactions,97,105,O
DDI-MedLine.d118.s1,.,106,106,O
DDI-MedLine.d118.s2,Sirolimus,0,8,B-drug
DDI-MedLine.d118.s2,works,10,14,O
DDI-MedLine.d118.s2,differently,16,26,O
DDI-MedLine.d118.s2,from,28,31,O
DDI-MedLine.d118.s2,the,33,35,O
DDI-MedLine.d118.s2,immunosuppressants,37,54,B-group
DDI-MedLine.d118.s2,currently,56,64,O
DDI-MedLine.d118.s2,available,66,74,O
DDI-MedLine.d118.s2,",",75,75,O
DDI-MedLine.d118.s2,and,77,79,O
DDI-MedLine.d118.s2,except,81,86,O
DDI-MedLine.d118.s2,for,88,90,O
DDI-MedLine.d118.s2,increased,92,100,O
DDI-MedLine.d118.s2,lipid,102,106,O
DDI-MedLine.d118.s2,levels,108,113,O
DDI-MedLine.d118.s2,",",114,114,O
DDI-MedLine.d118.s2,the,116,118,O
DDI-MedLine.d118.s2,adverse,120,126,O
DDI-MedLine.d118.s2,reaction,128,135,O
DDI-MedLine.d118.s2,profile,137,143,O
DDI-MedLine.d118.s2,of,145,146,O
DDI-MedLine.d118.s2,sirolimus,148,156,B-drug
DDI-MedLine.d118.s2,does,158,161,O
DDI-MedLine.d118.s2,not,163,165,O
DDI-MedLine.d118.s2,appear,167,172,O
DDI-MedLine.d118.s2,to,174,175,O
DDI-MedLine.d118.s2,overlap,177,183,O
DDI-MedLine.d118.s2,to,185,186,O
DDI-MedLine.d118.s2,any,188,190,O
DDI-MedLine.d118.s2,great,192,196,O
DDI-MedLine.d118.s2,extent,198,203,O
DDI-MedLine.d118.s2,with,205,208,O
DDI-MedLine.d118.s2,that,210,213,O
DDI-MedLine.d118.s2,associated,215,224,O
DDI-MedLine.d118.s2,with,226,229,O
DDI-MedLine.d118.s2,cyclosporine,231,242,B-drug
DDI-MedLine.d118.s2,or,244,245,O
DDI-MedLine.d118.s2,tacrolimus,247,256,B-drug
DDI-MedLine.d118.s2,.,257,257,O
DDI-MedLine.d118.s3,While,0,4,O
DDI-MedLine.d118.s3,additional,6,15,O
DDI-MedLine.d118.s3,research,17,24,O
DDI-MedLine.d118.s3,is,26,27,O
DDI-MedLine.d118.s3,needed,29,34,O
DDI-MedLine.d118.s3,",",35,35,O
DDI-MedLine.d118.s3,the,37,39,O
DDI-MedLine.d118.s3,initial,41,47,O
DDI-MedLine.d118.s3,clinical,49,56,O
DDI-MedLine.d118.s3,data,58,61,O
DDI-MedLine.d118.s3,in,63,64,O
DDI-MedLine.d118.s3,kidney,66,71,O
DDI-MedLine.d118.s3,recipients,73,82,O
DDI-MedLine.d118.s3,suggest,84,90,O
DDI-MedLine.d118.s3,that,92,95,O
DDI-MedLine.d118.s3,sirolimus,97,105,B-drug
DDI-MedLine.d118.s3,",",106,106,O
DDI-MedLine.d118.s3,in,108,109,O
DDI-MedLine.d118.s3,combination,111,121,O
DDI-MedLine.d118.s3,with,123,126,O
DDI-MedLine.d118.s3,cyclosporine,128,139,B-drug
DDI-MedLine.d118.s3,or,141,142,O
DDI-MedLine.d118.s3,tacrolimus,144,153,B-drug
DDI-MedLine.d118.s3,",",154,154,O
DDI-MedLine.d118.s3,might,156,160,O
DDI-MedLine.d118.s3,have,162,165,O
DDI-MedLine.d118.s3,the,167,169,O
DDI-MedLine.d118.s3,potential,171,179,O
DDI-MedLine.d118.s3,to,181,182,O
DDI-MedLine.d118.s3,reduce,184,189,O
DDI-MedLine.d118.s3,the,191,193,O
DDI-MedLine.d118.s3,frequency,195,203,O
DDI-MedLine.d118.s3,of,205,206,O
DDI-MedLine.d118.s3,rejection,208,216,O
DDI-MedLine.d118.s3,episodes,218,225,O
DDI-MedLine.d118.s3,",",226,226,O
DDI-MedLine.d118.s3,permit,228,233,O
DDI-MedLine.d118.s3,reductions,235,244,O
DDI-MedLine.d118.s3,in,246,247,O
DDI-MedLine.d118.s3,cyclosporine,249,260,B-drug
DDI-MedLine.d118.s3,or,262,263,O
DDI-MedLine.d118.s3,tacrolimus,265,274,B-drug
DDI-MedLine.d118.s3,dosage,276,281,O
DDI-MedLine.d118.s3,",",282,282,O
DDI-MedLine.d118.s3,and,284,286,O
DDI-MedLine.d118.s3,permit,288,293,O
DDI-MedLine.d118.s3,steroid,295,301,O
DDI-MedLine.d118.s3,withdrawal,303,312,O
DDI-MedLine.d118.s3,(,314,314,O
DDI-MedLine.d118.s3,Kelly,315,319,O
DDI-MedLine.d118.s3,",",320,320,O
DDI-MedLine.d118.s3,1999,322,325,O
DDI-MedLine.d118.s3,),326,326,O
DDI-MedLine.d118.s3,.,327,327,O
DDI-MedLine.d185.s0,Effect,0,5,O
DDI-MedLine.d185.s0,of,7,8,O
DDI-MedLine.d185.s0,ketoconazole-mediated,10,30,O
DDI-MedLine.d185.s0,CYP3A4,32,37,O
DDI-MedLine.d185.s0,inhibition,39,48,O
DDI-MedLine.d185.s0,on,50,51,O
DDI-MedLine.d185.s0,clinical,53,60,O
DDI-MedLine.d185.s0,pharmacokinetics,62,77,O
DDI-MedLine.d185.s0,of,79,80,O
DDI-MedLine.d185.s0,panobinostat,82,93,B-drug
DDI-MedLine.d185.s0,(,95,95,O
DDI-MedLine.d185.s0,LBH589,96,101,B-drug
DDI-MedLine.d185.s0,),102,102,O
DDI-MedLine.d185.s0,",",103,103,O
DDI-MedLine.d185.s0,an,105,106,O
DDI-MedLine.d185.s0,orally,108,113,O
DDI-MedLine.d185.s0,active,115,120,O
DDI-MedLine.d185.s0,histone,122,128,B-group
DDI-MedLine.d185.s0,deacetylase,130,140,I-group
DDI-MedLine.d185.s0,inhibitor,142,150,I-group
DDI-MedLine.d185.s0,.,151,151,O
DDI-MedLine.d185.s1,Panobinostat,0,11,B-drug
DDI-MedLine.d185.s1,is,13,14,O
DDI-MedLine.d185.s1,partly,16,21,O
DDI-MedLine.d185.s1,metabolized,23,33,O
DDI-MedLine.d185.s1,by,35,36,O
DDI-MedLine.d185.s1,CYP3A4,38,43,O
DDI-MedLine.d185.s1,in,45,46,O
DDI-MedLine.d185.s1,vitro,48,52,O
DDI-MedLine.d185.s1,.,53,53,O
DDI-MedLine.d185.s2,This,0,3,O
DDI-MedLine.d185.s2,study,5,9,O
DDI-MedLine.d185.s2,evaluated,11,19,O
DDI-MedLine.d185.s2,the,21,23,O
DDI-MedLine.d185.s2,effect,25,30,O
DDI-MedLine.d185.s2,of,32,33,O
DDI-MedLine.d185.s2,a,35,35,O
DDI-MedLine.d185.s2,potent,37,42,O
DDI-MedLine.d185.s2,CYP3A,44,48,O
DDI-MedLine.d185.s2,inhibitor,50,58,O
DDI-MedLine.d185.s2,",",59,59,O
DDI-MedLine.d185.s2,ketoconazole,61,72,B-drug
DDI-MedLine.d185.s2,",",73,73,O
DDI-MedLine.d185.s2,on,75,76,O
DDI-MedLine.d185.s2,the,78,80,O
DDI-MedLine.d185.s2,pharmacokinetics,82,97,O
DDI-MedLine.d185.s2,and,99,101,O
DDI-MedLine.d185.s2,safety,103,108,O
DDI-MedLine.d185.s2,of,110,111,O
DDI-MedLine.d185.s2,panobinostat,113,124,B-drug
DDI-MedLine.d185.s2,.,125,125,O
DDI-MedLine.d185.s3,Patients,0,7,O
DDI-MedLine.d185.s3,received,9,16,O
DDI-MedLine.d185.s3,a,18,18,O
DDI-MedLine.d185.s3,single,20,25,O
DDI-MedLine.d185.s3,panobinostat,27,38,B-drug
DDI-MedLine.d185.s3,oral,40,43,O
DDI-MedLine.d185.s3,dose,45,48,O
DDI-MedLine.d185.s3,on,50,51,O
DDI-MedLine.d185.s3,day,53,55,O
DDI-MedLine.d185.s3,1,57,57,O
DDI-MedLine.d185.s3,",",58,58,O
DDI-MedLine.d185.s3,followed,60,67,O
DDI-MedLine.d185.s3,by,69,70,O
DDI-MedLine.d185.s3,4,72,72,O
DDI-MedLine.d185.s3,days,75,78,O
DDI-MedLine.d185.s3,wash-out,80,87,O
DDI-MedLine.d185.s3,period,89,94,O
DDI-MedLine.d185.s3,.,95,95,O
DDI-MedLine.d185.s4,On,0,1,O
DDI-MedLine.d185.s4,days,3,6,O
DDI-MedLine.d185.s4,5-9,8,10,O
DDI-MedLine.d185.s4,",",11,11,O
DDI-MedLine.d185.s4,ketoconazole,13,24,B-drug
DDI-MedLine.d185.s4,was,26,28,O
DDI-MedLine.d185.s4,administered,30,41,O
DDI-MedLine.d185.s4,.,42,42,O
DDI-MedLine.d185.s5,On,0,1,O
DDI-MedLine.d185.s5,day,3,5,O
DDI-MedLine.d185.s5,8,7,7,O
DDI-MedLine.d185.s5,",",8,8,O
DDI-MedLine.d185.s5,a,10,10,O
DDI-MedLine.d185.s5,single,12,17,O
DDI-MedLine.d185.s5,panobinostat,19,30,B-drug
DDI-MedLine.d185.s5,dose,32,35,O
DDI-MedLine.d185.s5,was,37,39,O
DDI-MedLine.d185.s5,co-administered,41,55,O
DDI-MedLine.d185.s5,with,57,60,O
DDI-MedLine.d185.s5,ketoconazole,62,73,B-drug
DDI-MedLine.d185.s5,.,74,74,O
DDI-MedLine.d185.s6,Panobinostat,0,11,B-drug
DDI-MedLine.d185.s6,was,13,15,O
DDI-MedLine.d185.s6,administered,17,28,O
DDI-MedLine.d185.s6,as,30,31,O
DDI-MedLine.d185.s6,single,33,38,O
DDI-MedLine.d185.s6,agent,40,44,O
DDI-MedLine.d185.s6,three,46,50,O
DDI-MedLine.d185.s6,times,52,56,O
DDI-MedLine.d185.s6,a,58,58,O
DDI-MedLine.d185.s6,week,60,63,O
DDI-MedLine.d185.s6,on,65,66,O
DDI-MedLine.d185.s6,day,68,70,O
DDI-MedLine.d185.s6,15,72,73,O
DDI-MedLine.d185.s6,and,75,77,O
DDI-MedLine.d185.s6,onward,79,84,O
DDI-MedLine.d185.s6,.,85,85,O
DDI-MedLine.d185.s7,In,0,1,O
DDI-MedLine.d185.s7,the,3,5,O
DDI-MedLine.d185.s7,presence,7,14,O
DDI-MedLine.d185.s7,of,16,17,O
DDI-MedLine.d185.s7,ketoconazole,19,30,B-drug
DDI-MedLine.d185.s7,",",31,31,O
DDI-MedLine.d185.s7,there,33,37,O
DDI-MedLine.d185.s7,was,39,41,O
DDI-MedLine.d185.s7,1.6-,43,46,O
DDI-MedLine.d185.s7,and,48,50,O
DDI-MedLine.d185.s7,1.8-fold,52,59,O
DDI-MedLine.d185.s7,increase,61,68,O
DDI-MedLine.d185.s7,in,70,71,O
DDI-MedLine.d185.s7,C,73,73,O
DDI-MedLine.d185.s7,(,75,75,O
DDI-MedLine.d185.s7,max,76,78,O
DDI-MedLine.d185.s7,),79,79,O
DDI-MedLine.d185.s7,and,81,83,O
DDI-MedLine.d185.s7,AUC,85,87,O
DDI-MedLine.d185.s7,of,89,90,O
DDI-MedLine.d185.s7,panobinostat,92,103,B-drug
DDI-MedLine.d185.s7,",",104,104,O
DDI-MedLine.d185.s7,respectively,106,117,O
DDI-MedLine.d185.s7,.,118,118,O
DDI-MedLine.d185.s8,No,0,1,O
DDI-MedLine.d185.s8,substantial,3,13,O
DDI-MedLine.d185.s8,change,15,20,O
DDI-MedLine.d185.s8,in,22,23,O
DDI-MedLine.d185.s8,T,25,25,O
DDI-MedLine.d185.s8,(,27,27,O
DDI-MedLine.d185.s8,max,28,30,O
DDI-MedLine.d185.s8,),31,31,O
DDI-MedLine.d185.s8,or,33,34,O
DDI-MedLine.d185.s8,half-life,36,44,O
DDI-MedLine.d185.s8,was,46,48,O
DDI-MedLine.d185.s8,observed,50,57,O
DDI-MedLine.d185.s8,.,58,58,O
DDI-MedLine.d185.s9,No,0,1,O
DDI-MedLine.d185.s9,difference,3,12,O
DDI-MedLine.d185.s9,in,14,15,O
DDI-MedLine.d185.s9,panobinostat-pharmacokinetics,17,45,O
DDI-MedLine.d185.s9,between,47,53,O
DDI-MedLine.d185.s9,patients,55,62,O
DDI-MedLine.d185.s9,carrying,64,71,O
DDI-MedLine.d185.s9,CYP3A5,73,78,O
DDI-MedLine.d185.s9,*,79,79,O
DDI-MedLine.d185.s9,1/,80,81,O
DDI-MedLine.d185.s9,*,82,82,O
DDI-MedLine.d185.s9,3,83,83,O
DDI-MedLine.d185.s9,and,85,87,O
DDI-MedLine.d185.s9,CYP3A5,89,94,O
DDI-MedLine.d185.s9,*,95,95,O
DDI-MedLine.d185.s9,3/,96,97,O
DDI-MedLine.d185.s9,*,98,98,O
DDI-MedLine.d185.s9,3,99,99,O
DDI-MedLine.d185.s9,alleles,101,107,O
DDI-MedLine.d185.s9,was,109,111,O
DDI-MedLine.d185.s9,observed,113,120,O
DDI-MedLine.d185.s9,.,121,121,O
DDI-MedLine.d185.s10,Most,0,3,O
DDI-MedLine.d185.s10,frequently,5,14,O
DDI-MedLine.d185.s10,reported,16,23,O
DDI-MedLine.d185.s10,adverse,25,31,O
DDI-MedLine.d185.s10,events,33,38,O
DDI-MedLine.d185.s10,were,40,43,O
DDI-MedLine.d185.s10,gastrointestinal,45,60,O
DDI-MedLine.d185.s10,related,62,68,O
DDI-MedLine.d185.s10,.,69,69,O
DDI-MedLine.d185.s11,Patients,0,7,O
DDI-MedLine.d185.s11,had,9,11,O
DDI-MedLine.d185.s11,asymptomatic,13,24,O
DDI-MedLine.d185.s11,hypophosphatemia,26,41,O
DDI-MedLine.d185.s11,(,43,43,O
DDI-MedLine.d185.s11,64,44,45,O
DDI-MedLine.d185.s11,%,46,46,O
DDI-MedLine.d185.s11,),47,47,O
DDI-MedLine.d185.s11,",",48,48,O
DDI-MedLine.d185.s11,and,50,52,O
DDI-MedLine.d185.s11,urine,54,58,O
DDI-MedLine.d185.s11,analysis,60,67,O
DDI-MedLine.d185.s11,suggested,69,77,O
DDI-MedLine.d185.s11,renal,79,83,O
DDI-MedLine.d185.s11,phosphate,85,93,O
DDI-MedLine.d185.s11,wasting,95,101,O
DDI-MedLine.d185.s11,.,102,102,O
DDI-MedLine.d185.s12,Co-administration,0,16,O
DDI-MedLine.d185.s12,of,18,19,O
DDI-MedLine.d185.s12,panobinostat,21,32,B-drug
DDI-MedLine.d185.s12,with,34,37,O
DDI-MedLine.d185.s12,CYP3A,39,43,O
DDI-MedLine.d185.s12,inhibitors,45,54,O
DDI-MedLine.d185.s12,is,56,57,O
DDI-MedLine.d185.s12,feasible,59,66,O
DDI-MedLine.d185.s12,as,68,69,O
DDI-MedLine.d185.s12,the,71,73,O
DDI-MedLine.d185.s12,observed,75,82,O
DDI-MedLine.d185.s12,increase,84,91,O
DDI-MedLine.d185.s12,in,93,94,O
DDI-MedLine.d185.s12,panobinostat,96,107,B-drug
DDI-MedLine.d185.s12,PK,109,110,O
DDI-MedLine.d185.s12,parameters,112,121,O
DDI-MedLine.d185.s12,was,123,125,O
DDI-MedLine.d185.s12,not,127,129,O
DDI-MedLine.d185.s12,considered,131,140,O
DDI-MedLine.d185.s12,clinically,142,151,O
DDI-MedLine.d185.s12,relevant,153,160,O
DDI-MedLine.d185.s12,.,161,161,O
DDI-MedLine.d185.s13,Considering,0,10,O
DDI-MedLine.d185.s13,the,12,14,O
DDI-MedLine.d185.s13,variability,16,26,O
DDI-MedLine.d185.s13,in,28,29,O
DDI-MedLine.d185.s13,exposure,31,38,O
DDI-MedLine.d185.s13,following,40,48,O
DDI-MedLine.d185.s13,enzyme,50,55,O
DDI-MedLine.d185.s13,inhibition,57,66,O
DDI-MedLine.d185.s13,and,68,70,O
DDI-MedLine.d185.s13,the,72,74,O
DDI-MedLine.d185.s13,fact,76,79,O
DDI-MedLine.d185.s13,that,81,84,O
DDI-MedLine.d185.s13,chronic,86,92,O
DDI-MedLine.d185.s13,dosing,94,99,O
DDI-MedLine.d185.s13,of,101,102,O
DDI-MedLine.d185.s13,panobinostat,104,115,B-drug
DDI-MedLine.d185.s13,was,117,119,O
DDI-MedLine.d185.s13,not,121,123,O
DDI-MedLine.d185.s13,studied,125,131,O
DDI-MedLine.d185.s13,with,133,136,O
DDI-MedLine.d185.s13,CYP3A,138,142,O
DDI-MedLine.d185.s13,inhibitors,144,153,O
DDI-MedLine.d185.s13,",",154,154,O
DDI-MedLine.d185.s13,close,156,160,O
DDI-MedLine.d185.s13,monitoring,162,171,O
DDI-MedLine.d185.s13,of,173,174,O
DDI-MedLine.d185.s13,panobinostat-related,176,195,O
DDI-MedLine.d185.s13,adverse,197,203,O
DDI-MedLine.d185.s13,events,205,210,O
DDI-MedLine.d185.s13,is,212,213,O
DDI-MedLine.d185.s13,necessary,215,223,O
DDI-MedLine.d185.s13,.,224,224,O
DDI-MedLine.d180.s0,Determinants,0,11,O
DDI-MedLine.d180.s0,of,13,14,O
DDI-MedLine.d180.s0,sensitivity,16,26,O
DDI-MedLine.d180.s0,to,28,29,O
DDI-MedLine.d180.s0,DZNep,31,35,B-drug_n
DDI-MedLine.d180.s0,induced,37,43,O
DDI-MedLine.d180.s0,apoptosis,45,53,O
DDI-MedLine.d180.s0,in,55,56,O
DDI-MedLine.d180.s0,multiple,58,65,O
DDI-MedLine.d180.s0,myeloma,67,73,O
DDI-MedLine.d180.s0,cells,75,79,O
DDI-MedLine.d180.s0,.,80,80,O
DDI-MedLine.d180.s1,The,0,2,O
DDI-MedLine.d180.s1,3-Deazaneplanocin,4,20,B-drug_n
DDI-MedLine.d180.s1,A,22,22,I-drug_n
DDI-MedLine.d180.s1,(,24,24,O
DDI-MedLine.d180.s1,DZNep,25,29,B-drug_n
DDI-MedLine.d180.s1,),30,30,O
DDI-MedLine.d180.s1,",",31,31,O
DDI-MedLine.d180.s1,one,33,35,O
DDI-MedLine.d180.s1,of,37,38,O
DDI-MedLine.d180.s1,S-adenosylhomocysteine,40,61,O
DDI-MedLine.d180.s1,(,63,63,O
DDI-MedLine.d180.s1,AdoHcy,64,69,O
DDI-MedLine.d180.s1,),70,70,O
DDI-MedLine.d180.s1,hydrolase,72,80,O
DDI-MedLine.d180.s1,inhibitors,82,91,O
DDI-MedLine.d180.s1,",",92,92,O
DDI-MedLine.d180.s1,has,94,96,O
DDI-MedLine.d180.s1,shown,98,102,O
DDI-MedLine.d180.s1,antitumor,104,112,O
DDI-MedLine.d180.s1,activities,114,123,O
DDI-MedLine.d180.s1,in,125,126,O
DDI-MedLine.d180.s1,a,128,128,O
DDI-MedLine.d180.s1,broad,130,134,O
DDI-MedLine.d180.s1,range,136,140,O
DDI-MedLine.d180.s1,of,142,143,O
DDI-MedLine.d180.s1,solid,145,149,O
DDI-MedLine.d180.s1,tumors,151,156,O
DDI-MedLine.d180.s1,and,158,160,O
DDI-MedLine.d180.s1,acute,162,166,O
DDI-MedLine.d180.s1,myeloid,168,174,O
DDI-MedLine.d180.s1,leukemia,176,183,O
DDI-MedLine.d180.s1,.,184,184,O
DDI-MedLine.d180.s2,Here,0,3,O
DDI-MedLine.d180.s2,",",4,4,O
DDI-MedLine.d180.s2,we,6,7,O
DDI-MedLine.d180.s2,examined,9,16,O
DDI-MedLine.d180.s2,its,18,20,O
DDI-MedLine.d180.s2,effects,22,28,O
DDI-MedLine.d180.s2,on,30,31,O
DDI-MedLine.d180.s2,multiple,33,40,O
DDI-MedLine.d180.s2,myeloma,42,48,O
DDI-MedLine.d180.s2,(,50,50,O
DDI-MedLine.d180.s2,MM,51,52,O
DDI-MedLine.d180.s2,),53,53,O
DDI-MedLine.d180.s2,cells,55,59,O
DDI-MedLine.d180.s2,and,61,63,O
DDI-MedLine.d180.s2,found,65,69,O
DDI-MedLine.d180.s2,that,71,74,O
DDI-MedLine.d180.s2,",",75,75,O
DDI-MedLine.d180.s2,at,77,78,O
DDI-MedLine.d180.s2,500,80,82,O
DDI-MedLine.d180.s2,nM,84,85,O
DDI-MedLine.d180.s2,",",86,86,O
DDI-MedLine.d180.s2,it,88,89,O
DDI-MedLine.d180.s2,potently,91,98,O
DDI-MedLine.d180.s2,inhibited,100,108,O
DDI-MedLine.d180.s2,growth,110,115,O
DDI-MedLine.d180.s2,and,117,119,O
DDI-MedLine.d180.s2,induced,121,127,O
DDI-MedLine.d180.s2,apoptosis,129,137,O
DDI-MedLine.d180.s2,in,139,140,O
DDI-MedLine.d180.s2,2,142,142,O
DDI-MedLine.d180.s2,of,144,145,O
DDI-MedLine.d180.s2,8,147,147,O
DDI-MedLine.d180.s2,MM,149,150,O
DDI-MedLine.d180.s2,cell,152,155,O
DDI-MedLine.d180.s2,lines,157,161,O
DDI-MedLine.d180.s2,.,162,162,O
DDI-MedLine.d180.s3,RNA,0,2,O
DDI-MedLine.d180.s3,from,4,7,O
DDI-MedLine.d180.s3,un-treated,9,18,O
DDI-MedLine.d180.s3,and,20,22,O
DDI-MedLine.d180.s3,DZNep,24,28,B-drug_n
DDI-MedLine.d180.s3,treated,30,36,O
DDI-MedLine.d180.s3,cells,38,42,O
DDI-MedLine.d180.s3,was,44,46,O
DDI-MedLine.d180.s3,profiled,48,55,O
DDI-MedLine.d180.s3,by,57,58,O
DDI-MedLine.d180.s3,Affymetrix,60,69,O
DDI-MedLine.d180.s3,HG-U133,71,77,O
DDI-MedLine.d180.s3,Plus,79,82,O
DDI-MedLine.d180.s3,2.0,84,86,O
DDI-MedLine.d180.s3,microarray,88,97,O
DDI-MedLine.d180.s3,and,99,101,O
DDI-MedLine.d180.s3,genes,103,107,O
DDI-MedLine.d180.s3,with,109,112,O
DDI-MedLine.d180.s3,a,114,114,O
DDI-MedLine.d180.s3,significant,116,126,O
DDI-MedLine.d180.s3,change,128,133,O
DDI-MedLine.d180.s3,in,135,136,O
DDI-MedLine.d180.s3,gene,138,141,O
DDI-MedLine.d180.s3,expression,143,152,O
DDI-MedLine.d180.s3,were,154,157,O
DDI-MedLine.d180.s3,determined,159,168,O
DDI-MedLine.d180.s3,by,170,171,O
DDI-MedLine.d180.s3,significance,173,184,O
DDI-MedLine.d180.s3,analysis,186,193,O
DDI-MedLine.d180.s3,of,195,196,O
DDI-MedLine.d180.s3,microarray,198,207,O
DDI-MedLine.d180.s3,(,209,209,O
DDI-MedLine.d180.s3,SAM,210,212,O
DDI-MedLine.d180.s3,),213,213,O
DDI-MedLine.d180.s3,testing,215,221,O
DDI-MedLine.d180.s3,.,222,222,O
DDI-MedLine.d180.s4,ALOX5,0,4,O
DDI-MedLine.d180.s4,was,6,8,O
DDI-MedLine.d180.s4,the,10,12,O
DDI-MedLine.d180.s4,most,14,17,O
DDI-MedLine.d180.s4,down-regulated,19,32,O
DDI-MedLine.d180.s4,gene,34,37,O
DDI-MedLine.d180.s4,(,39,39,O
DDI-MedLine.d180.s4,5.8-fold,40,47,O
DDI-MedLine.d180.s4,),48,48,O
DDI-MedLine.d180.s4,in,50,51,O
DDI-MedLine.d180.s4,sensitive,53,61,O
DDI-MedLine.d180.s4,cells,63,67,O
DDI-MedLine.d180.s4,and,69,71,O
DDI-MedLine.d180.s4,was,73,75,O
DDI-MedLine.d180.s4,expressed,77,85,O
DDI-MedLine.d180.s4,at,87,88,O
DDI-MedLine.d180.s4,low,90,92,O
DDI-MedLine.d180.s4,level,94,98,O
DDI-MedLine.d180.s4,in,100,101,O
DDI-MedLine.d180.s4,resistant,103,111,O
DDI-MedLine.d180.s4,cells,113,117,O
DDI-MedLine.d180.s4,.,118,118,O
DDI-MedLine.d180.s5,The,0,2,O
DDI-MedLine.d180.s5,results,4,10,O
DDI-MedLine.d180.s5,were,12,15,O
DDI-MedLine.d180.s5,corroborated,17,28,O
DDI-MedLine.d180.s5,by,30,31,O
DDI-MedLine.d180.s5,quantitative,33,44,O
DDI-MedLine.d180.s5,RT-PCR,46,51,O
DDI-MedLine.d180.s5,.,52,52,O
DDI-MedLine.d180.s6,Western-blot,0,11,O
DDI-MedLine.d180.s6,analysis,13,20,O
DDI-MedLine.d180.s6,indicated,22,30,O
DDI-MedLine.d180.s6,ALOX5,32,36,O
DDI-MedLine.d180.s6,was,38,40,O
DDI-MedLine.d180.s6,highly,42,47,O
DDI-MedLine.d180.s6,expressed,49,57,O
DDI-MedLine.d180.s6,only,59,62,O
DDI-MedLine.d180.s6,in,64,65,O
DDI-MedLine.d180.s6,sensitive,67,75,O
DDI-MedLine.d180.s6,cell,77,80,O
DDI-MedLine.d180.s6,line,82,85,O
DDI-MedLine.d180.s6,H929,87,90,O
DDI-MedLine.d180.s6,and,92,94,O
DDI-MedLine.d180.s6,greatly,96,102,O
DDI-MedLine.d180.s6,decreased,104,112,O
DDI-MedLine.d180.s6,upon,114,117,O
DDI-MedLine.d180.s6,DZNep,119,123,B-drug_n
DDI-MedLine.d180.s6,treatment,125,133,O
DDI-MedLine.d180.s6,.,134,134,O
DDI-MedLine.d180.s7,Ectopic,0,6,O
DDI-MedLine.d180.s7,expression,8,17,O
DDI-MedLine.d180.s7,of,19,20,O
DDI-MedLine.d180.s7,ALOX5,22,26,O
DDI-MedLine.d180.s7,reduced,28,34,O
DDI-MedLine.d180.s7,sensitivity,36,46,O
DDI-MedLine.d180.s7,to,48,49,O
DDI-MedLine.d180.s7,DZNep,51,55,B-drug_n
DDI-MedLine.d180.s7,in,57,58,O
DDI-MedLine.d180.s7,H929,60,63,O
DDI-MedLine.d180.s7,cells,65,69,O
DDI-MedLine.d180.s7,.,70,70,O
DDI-MedLine.d180.s8,Furthermore,0,10,O
DDI-MedLine.d180.s8,",",11,11,O
DDI-MedLine.d180.s8,down-regulation,13,27,O
DDI-MedLine.d180.s8,of,29,30,O
DDI-MedLine.d180.s8,ALOX5,32,36,O
DDI-MedLine.d180.s8,by,38,39,O
DDI-MedLine.d180.s8,RNA,41,43,O
DDI-MedLine.d180.s8,interference,45,56,O
DDI-MedLine.d180.s8,could,58,62,O
DDI-MedLine.d180.s8,also,64,67,O
DDI-MedLine.d180.s8,induce,69,74,O
DDI-MedLine.d180.s8,apoptosis,76,84,O
DDI-MedLine.d180.s8,in,86,87,O
DDI-MedLine.d180.s8,H929,89,92,O
DDI-MedLine.d180.s8,.,93,93,O
DDI-MedLine.d180.s9,Gene,0,3,O
DDI-MedLine.d180.s9,expression,5,14,O
DDI-MedLine.d180.s9,analysis,16,23,O
DDI-MedLine.d180.s9,on,25,26,O
DDI-MedLine.d180.s9,MM,28,29,O
DDI-MedLine.d180.s9,patient,31,37,O
DDI-MedLine.d180.s9,dataset,39,45,O
DDI-MedLine.d180.s9,indicated,47,55,O
DDI-MedLine.d180.s9,ALOX5,57,61,O
DDI-MedLine.d180.s9,expression,63,72,O
DDI-MedLine.d180.s9,was,74,76,O
DDI-MedLine.d180.s9,significantly,78,90,O
DDI-MedLine.d180.s9,higher,92,97,O
DDI-MedLine.d180.s9,in,99,100,O
DDI-MedLine.d180.s9,MM,102,103,O
DDI-MedLine.d180.s9,patients,105,112,O
DDI-MedLine.d180.s9,compared,114,121,O
DDI-MedLine.d180.s9,to,123,124,O
DDI-MedLine.d180.s9,normal,126,131,O
DDI-MedLine.d180.s9,plasma,133,138,O
DDI-MedLine.d180.s9,cells,140,144,O
DDI-MedLine.d180.s9,.,145,145,O
DDI-MedLine.d180.s10,We,0,1,O
DDI-MedLine.d180.s10,also,3,6,O
DDI-MedLine.d180.s10,found,8,12,O
DDI-MedLine.d180.s10,that,14,17,O
DDI-MedLine.d180.s10,Bcl-2,19,23,O
DDI-MedLine.d180.s10,was,25,27,O
DDI-MedLine.d180.s10,overexpressed,29,41,O
DDI-MedLine.d180.s10,in,43,44,O
DDI-MedLine.d180.s10,DZNep,46,50,B-drug_n
DDI-MedLine.d180.s10,insensitive,52,62,O
DDI-MedLine.d180.s10,cells,64,68,O
DDI-MedLine.d180.s10,",",69,69,O
DDI-MedLine.d180.s10,and,71,73,O
DDI-MedLine.d180.s10,cotreatment,75,85,O
DDI-MedLine.d180.s10,with,87,90,O
DDI-MedLine.d180.s10,DZNep,92,96,B-drug_n
DDI-MedLine.d180.s10,and,98,100,O
DDI-MedLine.d180.s10,ABT-737,102,108,B-drug_n
DDI-MedLine.d180.s10,",",109,109,O
DDI-MedLine.d180.s10,a,111,111,O
DDI-MedLine.d180.s10,Bcl-2,113,117,O
DDI-MedLine.d180.s10,family,119,124,O
DDI-MedLine.d180.s10,inhibitor,126,134,O
DDI-MedLine.d180.s10,",",135,135,O
DDI-MedLine.d180.s10,synergistically,137,151,O
DDI-MedLine.d180.s10,inhibited,153,161,O
DDI-MedLine.d180.s10,growth,163,168,O
DDI-MedLine.d180.s10,and,170,172,O
DDI-MedLine.d180.s10,induced,174,180,O
DDI-MedLine.d180.s10,apoptosis,182,190,O
DDI-MedLine.d180.s10,of,192,193,O
DDI-MedLine.d180.s10,DZNep,195,199,B-drug_n
DDI-MedLine.d180.s10,insensitive,201,211,O
DDI-MedLine.d180.s10,MM,213,214,O
DDI-MedLine.d180.s10,cells,216,220,O
DDI-MedLine.d180.s10,.,221,221,O
DDI-MedLine.d180.s11,Taken,0,4,O
DDI-MedLine.d180.s11,together,6,13,O
DDI-MedLine.d180.s11,",",14,14,O
DDI-MedLine.d180.s11,this,16,19,O
DDI-MedLine.d180.s11,study,21,25,O
DDI-MedLine.d180.s11,shows,27,31,O
DDI-MedLine.d180.s11,one,33,35,O
DDI-MedLine.d180.s11,of,37,38,O
DDI-MedLine.d180.s11,mechanisms,40,49,O
DDI-MedLine.d180.s11,of,51,52,O
DDI-MedLine.d180.s11,the,54,56,O
DDI-MedLine.d180.s11,DZNep,58,62,B-drug_n
DDI-MedLine.d180.s11,efficacy,64,71,O
DDI-MedLine.d180.s11,on,73,74,O
DDI-MedLine.d180.s11,MM,76,77,O
DDI-MedLine.d180.s11,correlates,79,88,O
DDI-MedLine.d180.s11,with,90,93,O
DDI-MedLine.d180.s11,its,95,97,O
DDI-MedLine.d180.s11,ability,99,105,O
DDI-MedLine.d180.s11,to,107,108,O
DDI-MedLine.d180.s11,down-regulate,110,122,O
DDI-MedLine.d180.s11,the,124,126,O
DDI-MedLine.d180.s11,ALOX5,128,132,O
DDI-MedLine.d180.s11,levels,134,139,O
DDI-MedLine.d180.s11,.,140,140,O
DDI-MedLine.d180.s12,In,0,1,O
DDI-MedLine.d180.s12,addition,3,10,O
DDI-MedLine.d180.s12,",",11,11,O
DDI-MedLine.d180.s12,DZNep,13,17,B-drug_n
DDI-MedLine.d180.s12,insensitivity,19,31,O
DDI-MedLine.d180.s12,might,33,37,O
DDI-MedLine.d180.s12,be,39,40,O
DDI-MedLine.d180.s12,associated,42,51,O
DDI-MedLine.d180.s12,with,53,56,O
DDI-MedLine.d180.s12,overexpression,58,71,O
DDI-MedLine.d180.s12,of,73,74,O
DDI-MedLine.d180.s12,Bcl-2,76,80,O
DDI-MedLine.d180.s12,",",81,81,O
DDI-MedLine.d180.s12,and,83,85,O
DDI-MedLine.d180.s12,the,87,89,O
DDI-MedLine.d180.s12,combination,91,101,O
DDI-MedLine.d180.s12,of,103,104,O
DDI-MedLine.d180.s12,ABT-737,106,112,B-drug_n
DDI-MedLine.d180.s12,and,114,116,O
DDI-MedLine.d180.s12,DZNep,118,122,B-drug_n
DDI-MedLine.d180.s12,could,124,128,O
DDI-MedLine.d180.s12,synergistically,130,144,O
DDI-MedLine.d180.s12,induced,146,152,O
DDI-MedLine.d180.s12,apoptosis,154,162,O
DDI-MedLine.d180.s12,.,163,163,O
DDI-MedLine.d180.s13,These,0,4,O
DDI-MedLine.d180.s13,results,6,12,O
DDI-MedLine.d180.s13,suggest,14,20,O
DDI-MedLine.d180.s13,that,22,25,O
DDI-MedLine.d180.s13,DZNep,27,31,B-drug_n
DDI-MedLine.d180.s13,may,33,35,O
DDI-MedLine.d180.s13,be,37,38,O
DDI-MedLine.d180.s13,exploited,40,48,O
DDI-MedLine.d180.s13,therapeutically,50,64,O
DDI-MedLine.d180.s13,for,66,68,O
DDI-MedLine.d180.s13,a,70,70,O
DDI-MedLine.d180.s13,subset,72,77,O
DDI-MedLine.d180.s13,of,79,80,O
DDI-MedLine.d180.s13,MM,82,83,O
DDI-MedLine.d180.s13,.,84,84,O
DDI-MedLine.d181.s0,Drug,0,3,O
DDI-MedLine.d181.s0,interaction,5,15,O
DDI-MedLine.d181.s0,of,17,18,O
DDI-MedLine.d181.s0,levothyroxine,20,32,B-drug
DDI-MedLine.d181.s0,with,34,37,O
DDI-MedLine.d181.s0,infant,39,44,O
DDI-MedLine.d181.s0,colic,46,50,O
DDI-MedLine.d181.s0,drops,52,56,O
DDI-MedLine.d181.s0,.,57,57,O
DDI-MedLine.d181.s1,Infacol,0,6,B-brand
DDI-MedLine.d181.s1,(,8,8,O
DDI-MedLine.d181.s1,Forest,9,14,O
DDI-MedLine.d181.s1,Laboratories,16,27,O
DDI-MedLine.d181.s1,UK,29,30,O
DDI-MedLine.d181.s1,",",31,31,O
DDI-MedLine.d181.s1,Kent,33,36,O
DDI-MedLine.d181.s1,",",37,37,O
DDI-MedLine.d181.s1,UK,39,40,O
DDI-MedLine.d181.s1,),41,41,O
DDI-MedLine.d181.s1,is,43,44,O
DDI-MedLine.d181.s1,a,46,46,O
DDI-MedLine.d181.s1,widely,48,53,O
DDI-MedLine.d181.s1,available,55,63,O
DDI-MedLine.d181.s1,over-the-counter,65,80,O
DDI-MedLine.d181.s1,preparation,82,92,O
DDI-MedLine.d181.s1,used,94,97,O
DDI-MedLine.d181.s1,to,99,100,O
DDI-MedLine.d181.s1,relieve,102,108,O
DDI-MedLine.d181.s1,colic,110,114,O
DDI-MedLine.d181.s1,symptoms,116,123,O
DDI-MedLine.d181.s1,in,125,126,O
DDI-MedLine.d181.s1,neonates,128,135,O
DDI-MedLine.d181.s1,and,137,139,O
DDI-MedLine.d181.s1,infants,141,147,O
DDI-MedLine.d181.s1,.,148,148,O
DDI-MedLine.d181.s2,The,0,2,O
DDI-MedLine.d181.s2,active,4,9,O
DDI-MedLine.d181.s2,ingredient,11,20,O
DDI-MedLine.d181.s2,is,22,23,O
DDI-MedLine.d181.s2,simeticone,25,34,B-drug
DDI-MedLine.d181.s2,.,35,35,O
DDI-MedLine.d181.s3,No,0,1,O
DDI-MedLine.d181.s3,drug,3,6,O
DDI-MedLine.d181.s3,interactions,8,19,O
DDI-MedLine.d181.s3,with,21,24,O
DDI-MedLine.d181.s3,simeticone,26,35,B-drug
DDI-MedLine.d181.s3,are,37,39,O
DDI-MedLine.d181.s3,documented,41,50,O
DDI-MedLine.d181.s3,in,52,53,O
DDI-MedLine.d181.s3,the,55,57,O
DDI-MedLine.d181.s3,current,59,65,O
DDI-MedLine.d181.s3,summary,67,73,O
DDI-MedLine.d181.s3,of,75,76,O
DDI-MedLine.d181.s3,product,78,84,O
DDI-MedLine.d181.s3,characteristics,86,100,O
DDI-MedLine.d181.s3,.,101,101,O
DDI-MedLine.d181.s4,The,0,2,O
DDI-MedLine.d181.s4,authors,4,10,O
DDI-MedLine.d181.s4,report,12,17,O
DDI-MedLine.d181.s4,the,19,21,O
DDI-MedLine.d181.s4,case,23,26,O
DDI-MedLine.d181.s4,of,28,29,O
DDI-MedLine.d181.s4,an,31,32,O
DDI-MedLine.d181.s4,infant,34,39,O
DDI-MedLine.d181.s4,with,41,44,O
DDI-MedLine.d181.s4,confirmed,46,54,O
DDI-MedLine.d181.s4,congenital,56,65,O
DDI-MedLine.d181.s4,hypothyroidism,67,80,O
DDI-MedLine.d181.s4,on,82,83,O
DDI-MedLine.d181.s4,levothyroxine,85,97,B-drug
DDI-MedLine.d181.s4,who,99,101,O
DDI-MedLine.d181.s4,experienced,103,113,O
DDI-MedLine.d181.s4,a,115,115,O
DDI-MedLine.d181.s4,possible,117,124,O
DDI-MedLine.d181.s4,drug,126,129,O
DDI-MedLine.d181.s4,interaction,131,141,O
DDI-MedLine.d181.s4,with,143,146,O
DDI-MedLine.d181.s4,simeticone,148,157,B-drug
DDI-MedLine.d181.s4,.,158,158,O
DDI-MedLine.d181.s5,Despite,0,6,O
DDI-MedLine.d181.s5,adequate,8,15,O
DDI-MedLine.d181.s5,levothyroxine,17,29,B-drug
DDI-MedLine.d181.s5,dosage,31,36,O
DDI-MedLine.d181.s5,",",37,37,O
DDI-MedLine.d181.s5,thyroid,39,45,O
DDI-MedLine.d181.s5,stimulating,47,57,O
DDI-MedLine.d181.s5,hormone,59,65,O
DDI-MedLine.d181.s5,(,67,67,O
DDI-MedLine.d181.s5,TSH,68,70,O
DDI-MedLine.d181.s5,),71,71,O
DDI-MedLine.d181.s5,was,73,75,O
DDI-MedLine.d181.s5,high,77,80,O
DDI-MedLine.d181.s5,",",81,81,O
DDI-MedLine.d181.s5,suggesting,83,92,O
DDI-MedLine.d181.s5,undertreatment,94,107,O
DDI-MedLine.d181.s5,.,108,108,O
DDI-MedLine.d181.s6,Questioning,0,10,O
DDI-MedLine.d181.s6,revealed,12,19,O
DDI-MedLine.d181.s6,the,21,23,O
DDI-MedLine.d181.s6,child,25,29,O
DDI-MedLine.d181.s6,was,31,33,O
DDI-MedLine.d181.s6,taking,35,40,O
DDI-MedLine.d181.s6,Infacol,42,48,B-brand
DDI-MedLine.d181.s6,drops,50,54,O
DDI-MedLine.d181.s6,before,56,61,O
DDI-MedLine.d181.s6,feeds,63,67,O
DDI-MedLine.d181.s6,while,69,73,O
DDI-MedLine.d181.s6,on,75,76,O
DDI-MedLine.d181.s6,levothyroxine,78,90,B-drug
DDI-MedLine.d181.s6,.,91,91,O
DDI-MedLine.d181.s7,The,0,2,O
DDI-MedLine.d181.s7,colic,4,8,O
DDI-MedLine.d181.s7,drops,10,14,O
DDI-MedLine.d181.s7,were,16,19,O
DDI-MedLine.d181.s7,immediately,21,31,O
DDI-MedLine.d181.s7,discontinued,33,44,O
DDI-MedLine.d181.s7,and,46,48,O
DDI-MedLine.d181.s7,TSH,50,52,O
DDI-MedLine.d181.s7,promptly,54,61,O
DDI-MedLine.d181.s7,normalised,63,72,O
DDI-MedLine.d181.s7,with,74,77,O
DDI-MedLine.d181.s7,a,79,79,O
DDI-MedLine.d181.s7,reduction,81,89,O
DDI-MedLine.d181.s7,in,91,92,O
DDI-MedLine.d181.s7,thyroxine,94,102,O
DDI-MedLine.d181.s7,requirement,104,114,O
DDI-MedLine.d181.s7,to,116,117,O
DDI-MedLine.d181.s7,an,119,120,O
DDI-MedLine.d181.s7,age,122,124,O
DDI-MedLine.d181.s7,appropriate,126,136,O
DDI-MedLine.d181.s7,dosage,138,143,O
DDI-MedLine.d181.s7,.,144,144,O
DDI-MedLine.d181.s8,Drug,0,3,O
DDI-MedLine.d181.s8,interaction,5,15,O
DDI-MedLine.d181.s8,of,17,18,O
DDI-MedLine.d181.s8,thyroxine,20,28,B-drug
DDI-MedLine.d181.s8,with,30,33,O
DDI-MedLine.d181.s8,simeticone,35,44,B-drug
DDI-MedLine.d181.s8,has,46,48,O
DDI-MedLine.d181.s8,not,50,52,O
DDI-MedLine.d181.s8,been,54,57,O
DDI-MedLine.d181.s8,reported,59,66,O
DDI-MedLine.d181.s8,previously,68,77,O
DDI-MedLine.d181.s8,and,79,81,O
DDI-MedLine.d181.s8,is,83,84,O
DDI-MedLine.d181.s8,not,86,88,O
DDI-MedLine.d181.s8,listed,90,95,O
DDI-MedLine.d181.s8,in,97,98,O
DDI-MedLine.d181.s8,the,100,102,O
DDI-MedLine.d181.s8,British,104,110,O
DDI-MedLine.d181.s8,National,112,119,O
DDI-MedLine.d181.s8,Formulary,121,129,O
DDI-MedLine.d181.s8,for,131,133,O
DDI-MedLine.d181.s8,Children,135,142,O
DDI-MedLine.d181.s8,.,143,143,O
DDI-MedLine.d181.s9,Clinicians,0,9,O
DDI-MedLine.d181.s9,and,11,13,O
DDI-MedLine.d181.s9,parents,15,21,O
DDI-MedLine.d181.s9,need,23,26,O
DDI-MedLine.d181.s9,to,28,29,O
DDI-MedLine.d181.s9,be,31,32,O
DDI-MedLine.d181.s9,aware,34,38,O
DDI-MedLine.d181.s9,of,40,41,O
DDI-MedLine.d181.s9,this,43,46,O
DDI-MedLine.d181.s9,interaction,48,58,O
DDI-MedLine.d181.s9,to,60,61,O
DDI-MedLine.d181.s9,avoid,63,67,O
DDI-MedLine.d181.s9,unnecessary,69,79,O
DDI-MedLine.d181.s9,undertreatment,81,94,O
DDI-MedLine.d181.s9,and,96,98,O
DDI-MedLine.d181.s9,prevent,100,106,O
DDI-MedLine.d181.s9,potential,108,116,O
DDI-MedLine.d181.s9,long-term,118,126,O
DDI-MedLine.d181.s9,neurological,128,139,O
DDI-MedLine.d181.s9,sequelae,141,148,O
DDI-MedLine.d181.s9,.,149,149,O
DDI-MedLine.d169.s0,Calcium,0,6,B-drug
DDI-MedLine.d169.s0,does,8,11,O
DDI-MedLine.d169.s0,not,13,15,O
DDI-MedLine.d169.s0,inhibit,17,23,O
DDI-MedLine.d169.s0,the,25,27,O
DDI-MedLine.d169.s0,absorption,29,38,O
DDI-MedLine.d169.s0,of,40,41,O
DDI-MedLine.d169.s0,5,43,43,O
DDI-MedLine.d169.s0,milligrams,45,54,O
DDI-MedLine.d169.s0,of,56,57,O
DDI-MedLine.d169.s0,nonheme,59,65,B-drug
DDI-MedLine.d169.s0,or,67,68,O
DDI-MedLine.d169.s0,heme,70,73,B-drug
DDI-MedLine.d169.s0,iron,75,78,I-drug
DDI-MedLine.d169.s0,at,80,81,O
DDI-MedLine.d169.s0,doses,83,87,O
DDI-MedLine.d169.s0,less,89,92,O
DDI-MedLine.d169.s0,than,94,97,O
DDI-MedLine.d169.s0,800,99,101,O
DDI-MedLine.d169.s0,milligrams,103,112,O
DDI-MedLine.d169.s0,in,114,115,O
DDI-MedLine.d169.s0,nonpregnant,117,127,O
DDI-MedLine.d169.s0,women,129,133,O
DDI-MedLine.d169.s0,.,134,134,O
DDI-MedLine.d169.s1,Calcium,0,6,B-drug
DDI-MedLine.d169.s1,is,8,9,O
DDI-MedLine.d169.s1,the,11,13,O
DDI-MedLine.d169.s1,only,15,18,O
DDI-MedLine.d169.s1,known,20,24,O
DDI-MedLine.d169.s1,component,26,34,O
DDI-MedLine.d169.s1,in,36,37,O
DDI-MedLine.d169.s1,the,39,41,O
DDI-MedLine.d169.s1,diet,43,46,O
DDI-MedLine.d169.s1,that,48,51,O
DDI-MedLine.d169.s1,may,53,55,O
DDI-MedLine.d169.s1,affect,57,62,O
DDI-MedLine.d169.s1,absorption,64,73,O
DDI-MedLine.d169.s1,of,75,76,O
DDI-MedLine.d169.s1,both,78,81,O
DDI-MedLine.d169.s1,nonheme,83,89,B-drug
DDI-MedLine.d169.s1,and,91,93,O
DDI-MedLine.d169.s1,heme,95,98,B-drug
DDI-MedLine.d169.s1,iron,100,103,I-drug
DDI-MedLine.d169.s1,.,104,104,O
DDI-MedLine.d169.s2,However,0,6,O
DDI-MedLine.d169.s2,",",7,7,O
DDI-MedLine.d169.s2,the,9,11,O
DDI-MedLine.d169.s2,evidence,13,20,O
DDI-MedLine.d169.s2,for,22,24,O
DDI-MedLine.d169.s2,a,26,26,O
DDI-MedLine.d169.s2,calcium,28,34,B-drug
DDI-MedLine.d169.s2,effect,36,41,O
DDI-MedLine.d169.s2,on,43,44,O
DDI-MedLine.d169.s2,iron,46,49,B-drug
DDI-MedLine.d169.s2,absorption,51,60,O
DDI-MedLine.d169.s2,mainly,62,67,O
DDI-MedLine.d169.s2,comes,69,73,O
DDI-MedLine.d169.s2,from,75,78,O
DDI-MedLine.d169.s2,studies,80,86,O
DDI-MedLine.d169.s2,that,88,91,O
DDI-MedLine.d169.s2,did,93,95,O
DDI-MedLine.d169.s2,not,97,99,O
DDI-MedLine.d169.s2,isolate,101,107,O
DDI-MedLine.d169.s2,the,109,111,O
DDI-MedLine.d169.s2,effect,113,118,O
DDI-MedLine.d169.s2,of,120,121,O
DDI-MedLine.d169.s2,calcium,123,129,B-drug
DDI-MedLine.d169.s2,from,131,134,O
DDI-MedLine.d169.s2,that,136,139,O
DDI-MedLine.d169.s2,of,141,142,O
DDI-MedLine.d169.s2,other,144,148,O
DDI-MedLine.d169.s2,dietary,150,156,O
DDI-MedLine.d169.s2,components,158,167,O
DDI-MedLine.d169.s2,",",168,168,O
DDI-MedLine.d169.s2,because,170,176,O
DDI-MedLine.d169.s2,it,178,179,O
DDI-MedLine.d169.s2,was,181,183,O
DDI-MedLine.d169.s2,detected,185,192,O
DDI-MedLine.d169.s2,in,194,195,O
DDI-MedLine.d169.s2,single-meal,197,207,O
DDI-MedLine.d169.s2,studies,209,215,O
DDI-MedLine.d169.s2,.,216,216,O
DDI-MedLine.d169.s3,Our,0,2,O
DDI-MedLine.d169.s3,objective,4,12,O
DDI-MedLine.d169.s3,was,14,16,O
DDI-MedLine.d169.s3,to,18,19,O
DDI-MedLine.d169.s3,establish,21,29,O
DDI-MedLine.d169.s3,potential,31,39,O
DDI-MedLine.d169.s3,effects,41,47,O
DDI-MedLine.d169.s3,of,49,50,O
DDI-MedLine.d169.s3,calcium,52,58,B-drug
DDI-MedLine.d169.s3,on,60,61,O
DDI-MedLine.d169.s3,absorption,63,72,O
DDI-MedLine.d169.s3,of,74,75,O
DDI-MedLine.d169.s3,nonheme,77,83,B-drug
DDI-MedLine.d169.s3,and,85,87,O
DDI-MedLine.d169.s3,heme,89,92,B-drug
DDI-MedLine.d169.s3,iron,94,97,I-drug
DDI-MedLine.d169.s3,and,99,101,O
DDI-MedLine.d169.s3,the,103,105,O
DDI-MedLine.d169.s3,dose,107,110,O
DDI-MedLine.d169.s3,response,112,119,O
DDI-MedLine.d169.s3,for,121,123,O
DDI-MedLine.d169.s3,this,125,128,O
DDI-MedLine.d169.s3,effect,130,135,O
DDI-MedLine.d169.s3,in,137,138,O
DDI-MedLine.d169.s3,the,140,142,O
DDI-MedLine.d169.s3,absence,144,150,O
DDI-MedLine.d169.s3,of,152,153,O
DDI-MedLine.d169.s3,a,155,155,O
DDI-MedLine.d169.s3,meal,157,160,O
DDI-MedLine.d169.s3,.,161,161,O
DDI-MedLine.d169.s4,Fifty-four,0,9,O
DDI-MedLine.d169.s4,healthy,11,17,O
DDI-MedLine.d169.s4,",",18,18,O
DDI-MedLine.d169.s4,nonpregnant,20,30,O
DDI-MedLine.d169.s4,women,32,36,O
DDI-MedLine.d169.s4,were,38,41,O
DDI-MedLine.d169.s4,selected,43,50,O
DDI-MedLine.d169.s4,to,52,53,O
DDI-MedLine.d169.s4,participate,55,65,O
DDI-MedLine.d169.s4,in,67,68,O
DDI-MedLine.d169.s4,4,70,70,O
DDI-MedLine.d169.s4,iron,72,75,B-drug
DDI-MedLine.d169.s4,absorption,77,86,O
DDI-MedLine.d169.s4,studies,88,94,O
DDI-MedLine.d169.s4,using,96,100,O
DDI-MedLine.d169.s4,iron,102,105,O
DDI-MedLine.d169.s4,radioactive,107,117,O
DDI-MedLine.d169.s4,tracers,119,125,O
DDI-MedLine.d169.s4,.,126,126,O
DDI-MedLine.d169.s5,We,0,1,O
DDI-MedLine.d169.s5,evaluated,3,11,O
DDI-MedLine.d169.s5,the,13,15,O
DDI-MedLine.d169.s5,effects,17,23,O
DDI-MedLine.d169.s5,of,25,26,O
DDI-MedLine.d169.s5,calcium,28,34,B-drug
DDI-MedLine.d169.s5,doses,36,40,O
DDI-MedLine.d169.s5,between,42,48,O
DDI-MedLine.d169.s5,200,50,52,O
DDI-MedLine.d169.s5,and,54,56,O
DDI-MedLine.d169.s5,1500,58,61,O
DDI-MedLine.d169.s5,mg,63,64,O
DDI-MedLine.d169.s5,on,66,67,O
DDI-MedLine.d169.s5,absorption,69,78,O
DDI-MedLine.d169.s5,of,80,81,O
DDI-MedLine.d169.s5,5,83,83,O
DDI-MedLine.d169.s5,mg,85,86,O
DDI-MedLine.d169.s5,nonheme,88,94,B-drug
DDI-MedLine.d169.s5,iron,96,99,I-drug
DDI-MedLine.d169.s5,(,101,101,O
DDI-MedLine.d169.s5,as,102,103,O
DDI-MedLine.d169.s5,ferrous,105,111,B-drug
DDI-MedLine.d169.s5,sulfate,113,119,I-drug
DDI-MedLine.d169.s5,),120,120,O
DDI-MedLine.d169.s5,.,121,121,O
DDI-MedLine.d169.s6,We,0,1,O
DDI-MedLine.d169.s6,also,3,6,O
DDI-MedLine.d169.s6,evaluated,8,16,O
DDI-MedLine.d169.s6,the,18,20,O
DDI-MedLine.d169.s6,effects,22,28,O
DDI-MedLine.d169.s6,of,30,31,O
DDI-MedLine.d169.s6,calcium,33,39,B-drug
DDI-MedLine.d169.s6,doses,41,45,O
DDI-MedLine.d169.s6,between,47,53,O
DDI-MedLine.d169.s6,200,55,57,O
DDI-MedLine.d169.s6,and,59,61,O
DDI-MedLine.d169.s6,800,63,65,O
DDI-MedLine.d169.s6,mg,67,68,O
DDI-MedLine.d169.s6,on,70,71,O
DDI-MedLine.d169.s6,absorption,73,82,O
DDI-MedLine.d169.s6,of,84,85,O
DDI-MedLine.d169.s6,5,87,87,O
DDI-MedLine.d169.s6,mg,89,90,O
DDI-MedLine.d169.s6,heme,92,95,B-drug
DDI-MedLine.d169.s6,iron,97,100,I-drug
DDI-MedLine.d169.s6,[,102,102,O
DDI-MedLine.d169.s6,as,103,104,O
DDI-MedLine.d169.s6,concentrated,106,117,O
DDI-MedLine.d169.s6,RBC,119,121,O
DDI-MedLine.d169.s6,(,123,123,O
DDI-MedLine.d169.s6,CRBC,124,127,O
DDI-MedLine.d169.s6,),128,128,O
DDI-MedLine.d169.s6,],129,129,O
DDI-MedLine.d169.s6,.,130,130,O
DDI-MedLine.d169.s7,Calcium,0,6,B-drug
DDI-MedLine.d169.s7,was,8,10,O
DDI-MedLine.d169.s7,administered,12,23,O
DDI-MedLine.d169.s7,as,25,26,O
DDI-MedLine.d169.s7,calcium,28,34,B-drug
DDI-MedLine.d169.s7,chloride,36,43,I-drug
DDI-MedLine.d169.s7,in,45,46,O
DDI-MedLine.d169.s7,all,48,50,O
DDI-MedLine.d169.s7,studies,52,58,O
DDI-MedLine.d169.s7,and,60,62,O
DDI-MedLine.d169.s7,minerals,64,71,B-group
DDI-MedLine.d169.s7,were,73,76,O
DDI-MedLine.d169.s7,ingested,78,85,O
DDI-MedLine.d169.s7,on,87,88,O
DDI-MedLine.d169.s7,an,90,91,O
DDI-MedLine.d169.s7,empty,93,97,O
DDI-MedLine.d169.s7,stomach,99,105,O
DDI-MedLine.d169.s7,.,106,106,O
DDI-MedLine.d169.s8,Calcium,0,6,B-drug
DDI-MedLine.d169.s8,doses,8,12,O
DDI-MedLine.d169.s8,1000,16,19,O
DDI-MedLine.d169.s8,mg,21,22,O
DDI-MedLine.d169.s8,diminished,24,33,O
DDI-MedLine.d169.s8,nonheme,35,41,B-drug
DDI-MedLine.d169.s8,iron,43,46,I-drug
DDI-MedLine.d169.s8,absorption,48,57,O
DDI-MedLine.d169.s8,by,59,60,O
DDI-MedLine.d169.s8,an,62,63,O
DDI-MedLine.d169.s8,average,65,71,O
DDI-MedLine.d169.s8,of,73,74,O
DDI-MedLine.d169.s8,49.6,76,79,O
DDI-MedLine.d169.s8,%,80,80,O
DDI-MedLine.d169.s8,.,81,81,O
DDI-MedLine.d169.s9,A,0,0,O
DDI-MedLine.d169.s9,calcium,2,8,B-drug
DDI-MedLine.d169.s9,dose,10,13,O
DDI-MedLine.d169.s9,of,15,16,O
DDI-MedLine.d169.s9,800,18,20,O
DDI-MedLine.d169.s9,mg,22,23,O
DDI-MedLine.d169.s9,diminished,25,34,O
DDI-MedLine.d169.s9,absorption,36,45,O
DDI-MedLine.d169.s9,of,47,48,O
DDI-MedLine.d169.s9,5,50,50,O
DDI-MedLine.d169.s9,mg,52,53,O
DDI-MedLine.d169.s9,heme,55,58,B-drug
DDI-MedLine.d169.s9,iron,60,63,I-drug
DDI-MedLine.d169.s9,by,65,66,O
DDI-MedLine.d169.s9,37.7,68,71,O
DDI-MedLine.d169.s9,%,72,72,O
DDI-MedLine.d169.s9,.,73,73,O
DDI-MedLine.d169.s10,In,0,1,O
DDI-MedLine.d169.s10,conclusion,3,12,O
DDI-MedLine.d169.s10,",",13,13,O
DDI-MedLine.d169.s10,we,15,16,O
DDI-MedLine.d169.s10,demonstrated,18,29,O
DDI-MedLine.d169.s10,an,31,32,O
DDI-MedLine.d169.s10,isolated,34,41,O
DDI-MedLine.d169.s10,effect,43,48,O
DDI-MedLine.d169.s10,of,50,51,O
DDI-MedLine.d169.s10,calcium,53,59,B-drug
DDI-MedLine.d169.s10,(,61,61,O
DDI-MedLine.d169.s10,as,62,63,O
DDI-MedLine.d169.s10,chloride,65,72,O
DDI-MedLine.d169.s10,),73,73,O
DDI-MedLine.d169.s10,on,75,76,O
DDI-MedLine.d169.s10,absorption,78,87,O
DDI-MedLine.d169.s10,of,89,90,O
DDI-MedLine.d169.s10,5,92,92,O
DDI-MedLine.d169.s10,mg,94,95,O
DDI-MedLine.d169.s10,of,97,98,O
DDI-MedLine.d169.s10,iron,100,103,O
DDI-MedLine.d169.s10,provided,105,112,O
DDI-MedLine.d169.s10,as,114,115,O
DDI-MedLine.d169.s10,nonheme,117,123,B-drug
DDI-MedLine.d169.s10,(,125,125,O
DDI-MedLine.d169.s10,as,126,127,O
DDI-MedLine.d169.s10,sulfate,129,135,O
DDI-MedLine.d169.s10,),136,136,O
DDI-MedLine.d169.s10,and,138,140,O
DDI-MedLine.d169.s10,heme,142,145,B-drug
DDI-MedLine.d169.s10,(,147,147,O
DDI-MedLine.d169.s10,as,148,149,O
DDI-MedLine.d169.s10,CRBC,151,154,O
DDI-MedLine.d169.s10,),155,155,O
DDI-MedLine.d169.s10,iron,157,160,O
DDI-MedLine.d169.s10,.,161,161,O
DDI-MedLine.d169.s11,This,0,3,O
DDI-MedLine.d169.s11,effect,5,10,O
DDI-MedLine.d169.s11,was,12,14,O
DDI-MedLine.d169.s11,observed,16,23,O
DDI-MedLine.d169.s11,at,25,26,O
DDI-MedLine.d169.s11,doses,28,32,O
DDI-MedLine.d169.s11,higher,34,39,O
DDI-MedLine.d169.s11,than,41,44,O
DDI-MedLine.d169.s11,previously,46,55,O
DDI-MedLine.d169.s11,reported,57,64,O
DDI-MedLine.d169.s11,from,66,69,O
DDI-MedLine.d169.s11,single-meal,71,81,O
DDI-MedLine.d169.s11,studies,83,89,O
DDI-MedLine.d169.s11,",",90,90,O
DDI-MedLine.d169.s11,starting,92,99,O
DDI-MedLine.d169.s11,at,101,102,O
DDI-MedLine.d169.s11,~800,104,107,O
DDI-MedLine.d169.s11,mg,109,110,O
DDI-MedLine.d169.s11,of,112,113,O
DDI-MedLine.d169.s11,calcium,115,121,B-drug
DDI-MedLine.d169.s11,.,122,122,O
DDI-MedLine.d179.s0,Synergistic,0,10,O
DDI-MedLine.d179.s0,interaction,12,22,O
DDI-MedLine.d179.s0,between,24,30,O
DDI-MedLine.d179.s0,sunitinib,32,40,B-drug
DDI-MedLine.d179.s0,and,42,44,O
DDI-MedLine.d179.s0,docetaxel,46,54,B-drug
DDI-MedLine.d179.s0,is,56,57,O
DDI-MedLine.d179.s0,sequence,59,66,O
DDI-MedLine.d179.s0,dependent,68,76,O
DDI-MedLine.d179.s0,in,78,79,O
DDI-MedLine.d179.s0,human,81,85,O
DDI-MedLine.d179.s0,non-small,87,95,O
DDI-MedLine.d179.s0,lung,97,100,O
DDI-MedLine.d179.s0,cancer,102,107,O
DDI-MedLine.d179.s0,with,109,112,O
DDI-MedLine.d179.s0,EGFR,114,117,O
DDI-MedLine.d179.s0,TKIs-resistant,119,132,O
DDI-MedLine.d179.s0,mutation,134,141,O
DDI-MedLine.d179.s0,.,142,142,O
DDI-MedLine.d179.s1,Previous,0,7,O
DDI-MedLine.d179.s1,studies,9,15,O
DDI-MedLine.d179.s1,have,17,20,O
DDI-MedLine.d179.s1,demonstrated,22,33,O
DDI-MedLine.d179.s1,that,35,38,O
DDI-MedLine.d179.s1,sunitinib,40,48,B-drug
DDI-MedLine.d179.s1,has,50,52,O
DDI-MedLine.d179.s1,the,54,56,O
DDI-MedLine.d179.s1,anti-tumor,58,67,O
DDI-MedLine.d179.s1,activity,69,76,O
DDI-MedLine.d179.s1,in,78,79,O
DDI-MedLine.d179.s1,human,81,85,O
DDI-MedLine.d179.s1,non-small,87,95,O
DDI-MedLine.d179.s1,cell,97,100,O
DDI-MedLine.d179.s1,lung,102,105,O
DDI-MedLine.d179.s1,cancer,107,112,O
DDI-MedLine.d179.s1,(,114,114,O
DDI-MedLine.d179.s1,NSCLC,115,119,O
DDI-MedLine.d179.s1,),120,120,O
DDI-MedLine.d179.s1,.,121,121,O
DDI-MedLine.d179.s2,This,0,3,O
DDI-MedLine.d179.s2,study,5,9,O
DDI-MedLine.d179.s2,was,11,13,O
DDI-MedLine.d179.s2,aimed,15,19,O
DDI-MedLine.d179.s2,to,21,22,O
DDI-MedLine.d179.s2,investigate,24,34,O
DDI-MedLine.d179.s2,the,36,38,O
DDI-MedLine.d179.s2,efficacy,40,47,O
DDI-MedLine.d179.s2,of,49,50,O
DDI-MedLine.d179.s2,single,52,57,O
DDI-MedLine.d179.s2,use,59,61,O
DDI-MedLine.d179.s2,of,63,64,O
DDI-MedLine.d179.s2,sunitinib,66,74,B-drug
DDI-MedLine.d179.s2,and,76,78,O
DDI-MedLine.d179.s2,that,80,83,O
DDI-MedLine.d179.s2,of,85,86,O
DDI-MedLine.d179.s2,concurrent,88,97,O
DDI-MedLine.d179.s2,or,99,100,O
DDI-MedLine.d179.s2,sequential,102,111,O
DDI-MedLine.d179.s2,administration,113,126,O
DDI-MedLine.d179.s2,of,128,129,O
DDI-MedLine.d179.s2,sunitinib,131,139,B-drug
DDI-MedLine.d179.s2,and,141,143,O
DDI-MedLine.d179.s2,docetaxel,145,153,B-drug
DDI-MedLine.d179.s2,in,155,156,O
DDI-MedLine.d179.s2,NSCLC,158,162,O
DDI-MedLine.d179.s2,cell,164,167,O
DDI-MedLine.d179.s2,lines,169,173,O
DDI-MedLine.d179.s2,that,175,178,O
DDI-MedLine.d179.s2,are,180,182,O
DDI-MedLine.d179.s2,resistant,184,192,O
DDI-MedLine.d179.s2,to,194,195,O
DDI-MedLine.d179.s2,EGFR,197,200,O
DDI-MedLine.d179.s2,TKIs,202,205,O
DDI-MedLine.d179.s2,.,206,206,O
DDI-MedLine.d179.s3,NSCLC,0,4,O
DDI-MedLine.d179.s3,cell,6,9,O
DDI-MedLine.d179.s3,lines,11,15,O
DDI-MedLine.d179.s3,with,17,20,O
DDI-MedLine.d179.s3,EGFR,22,25,O
DDI-MedLine.d179.s3,T790M,27,31,O
DDI-MedLine.d179.s3,mutation,33,40,O
DDI-MedLine.d179.s3,and,42,44,O
DDI-MedLine.d179.s3,K-ras,46,50,O
DDI-MedLine.d179.s3,mutation,52,59,O
DDI-MedLine.d179.s3,were,61,64,O
DDI-MedLine.d179.s3,exposed,66,72,O
DDI-MedLine.d179.s3,to,74,75,O
DDI-MedLine.d179.s3,either,77,82,O
DDI-MedLine.d179.s3,sunitinib,84,92,B-drug
DDI-MedLine.d179.s3,or,94,95,O
DDI-MedLine.d179.s3,docetaxel,97,105,B-drug
DDI-MedLine.d179.s3,or,107,108,O
DDI-MedLine.d179.s3,both,110,113,O
DDI-MedLine.d179.s3,based,115,119,O
DDI-MedLine.d179.s3,on,121,122,O
DDI-MedLine.d179.s3,various,124,130,O
DDI-MedLine.d179.s3,sequential,132,141,O
DDI-MedLine.d179.s3,administrations,143,157,O
DDI-MedLine.d179.s3,.,158,158,O
DDI-MedLine.d179.s4,After,0,4,O
DDI-MedLine.d179.s4,exposure,6,13,O
DDI-MedLine.d179.s4,",",14,14,O
DDI-MedLine.d179.s4,the,16,18,O
DDI-MedLine.d179.s4,cell,20,23,O
DDI-MedLine.d179.s4,viability,25,33,O
DDI-MedLine.d179.s4,was,35,37,O
DDI-MedLine.d179.s4,measured,39,46,O
DDI-MedLine.d179.s4,by,48,49,O
DDI-MedLine.d179.s4,MTT,51,53,O
DDI-MedLine.d179.s4,assay,55,59,O
DDI-MedLine.d179.s4,",",60,60,O
DDI-MedLine.d179.s4,cell,62,65,O
DDI-MedLine.d179.s4,cycle,67,71,O
DDI-MedLine.d179.s4,distribution,73,84,O
DDI-MedLine.d179.s4,was,86,88,O
DDI-MedLine.d179.s4,analyzed,90,97,O
DDI-MedLine.d179.s4,by,99,100,O
DDI-MedLine.d179.s4,flow,102,105,O
DDI-MedLine.d179.s4,cytometry,107,115,O
DDI-MedLine.d179.s4,",",116,116,O
DDI-MedLine.d179.s4,and,118,120,O
DDI-MedLine.d179.s4,alterations,122,132,O
DDI-MedLine.d179.s4,in,134,135,O
DDI-MedLine.d179.s4,signaling,137,145,O
DDI-MedLine.d179.s4,pathway,147,153,O
DDI-MedLine.d179.s4,were,155,158,O
DDI-MedLine.d179.s4,determined,160,169,O
DDI-MedLine.d179.s4,by,171,172,O
DDI-MedLine.d179.s4,immunoblotting,174,187,O
DDI-MedLine.d179.s4,.,188,188,O
DDI-MedLine.d179.s5,Sunitinib,0,8,B-drug
DDI-MedLine.d179.s5,exhibited,10,18,O
DDI-MedLine.d179.s5,dose-dependent,20,33,O
DDI-MedLine.d179.s5,growth,35,40,O
DDI-MedLine.d179.s5,inhibition,42,51,O
DDI-MedLine.d179.s5,in,53,54,O
DDI-MedLine.d179.s5,NSCLC,56,60,O
DDI-MedLine.d179.s5,cell,62,65,O
DDI-MedLine.d179.s5,lines,67,71,O
DDI-MedLine.d179.s5,and,73,75,O
DDI-MedLine.d179.s5,arrested,77,84,O
DDI-MedLine.d179.s5,cell,86,89,O
DDI-MedLine.d179.s5,cycle,91,95,O
DDI-MedLine.d179.s5,at,97,98,O
DDI-MedLine.d179.s5,G1,100,101,O
DDI-MedLine.d179.s5,phase,103,107,O
DDI-MedLine.d179.s5,",",108,108,O
DDI-MedLine.d179.s5,whereas,110,116,O
DDI-MedLine.d179.s5,docetaxel,118,126,B-drug
DDI-MedLine.d179.s5,arrested,128,135,O
DDI-MedLine.d179.s5,at,137,138,O
DDI-MedLine.d179.s5,S,140,140,O
DDI-MedLine.d179.s5,phase,142,146,O
DDI-MedLine.d179.s5,.,147,147,O
DDI-MedLine.d179.s6,Although,0,7,O
DDI-MedLine.d179.s6,single,9,14,O
DDI-MedLine.d179.s6,or,16,17,O
DDI-MedLine.d179.s6,concurrent,19,28,O
DDI-MedLine.d179.s6,use,30,32,O
DDI-MedLine.d179.s6,of,34,35,O
DDI-MedLine.d179.s6,sunitinib,37,45,B-drug
DDI-MedLine.d179.s6,and,47,49,O
DDI-MedLine.d179.s6,docetaxel,51,59,B-drug
DDI-MedLine.d179.s6,has,61,63,O
DDI-MedLine.d179.s6,some,65,68,O
DDI-MedLine.d179.s6,anti-proliferative,70,87,O
DDI-MedLine.d179.s6,effects,89,95,O
DDI-MedLine.d179.s6,",",96,96,O
DDI-MedLine.d179.s6,the,98,100,O
DDI-MedLine.d179.s6,sequential,102,111,O
DDI-MedLine.d179.s6,administrations,113,127,O
DDI-MedLine.d179.s6,of,129,130,O
DDI-MedLine.d179.s6,both,132,135,O
DDI-MedLine.d179.s6,drugs,137,141,O
DDI-MedLine.d179.s6,remarkably,143,152,O
DDI-MedLine.d179.s6,enhanced,154,161,O
DDI-MedLine.d179.s6,anti-tumor,163,172,O
DDI-MedLine.d179.s6,activity,174,181,O
DDI-MedLine.d179.s6,.,182,182,O
DDI-MedLine.d179.s7,When,0,3,O
DDI-MedLine.d179.s7,cells,5,9,O
DDI-MedLine.d179.s7,were,11,14,O
DDI-MedLine.d179.s7,exposed,16,22,O
DDI-MedLine.d179.s7,to,24,25,O
DDI-MedLine.d179.s7,docetaxel,27,35,B-drug
DDI-MedLine.d179.s7,followed,37,44,O
DDI-MedLine.d179.s7,by,46,47,O
DDI-MedLine.d179.s7,sunitinib,49,57,B-drug
DDI-MedLine.d179.s7,",",58,58,O
DDI-MedLine.d179.s7,synergism,60,68,O
DDI-MedLine.d179.s7,was,70,72,O
DDI-MedLine.d179.s7,observed,74,81,O
DDI-MedLine.d179.s7,.,82,82,O
DDI-MedLine.d179.s8,The,0,2,O
DDI-MedLine.d179.s8,molecular,4,12,O
DDI-MedLine.d179.s8,basis,14,18,O
DDI-MedLine.d179.s8,of,20,21,O
DDI-MedLine.d179.s8,this,23,26,O
DDI-MedLine.d179.s8,synergism,28,36,O
DDI-MedLine.d179.s8,is,38,39,O
DDI-MedLine.d179.s8,that,41,44,O
DDI-MedLine.d179.s8,the,46,48,O
DDI-MedLine.d179.s8,signaling,50,58,O
DDI-MedLine.d179.s8,pathways,60,67,O
DDI-MedLine.d179.s8,that,69,72,O
DDI-MedLine.d179.s8,were,74,77,O
DDI-MedLine.d179.s8,initially,79,87,O
DDI-MedLine.d179.s8,activated,89,97,O
DDI-MedLine.d179.s8,by,99,100,O
DDI-MedLine.d179.s8,docetaxel,102,110,B-drug
DDI-MedLine.d179.s8,exposure,112,119,O
DDI-MedLine.d179.s8,were,121,124,O
DDI-MedLine.d179.s8,efficiently,126,136,O
DDI-MedLine.d179.s8,suppressed,138,147,O
DDI-MedLine.d179.s8,by,149,150,O
DDI-MedLine.d179.s8,the,152,154,O
DDI-MedLine.d179.s8,subsequent,156,165,O
DDI-MedLine.d179.s8,exposure,167,174,O
DDI-MedLine.d179.s8,to,176,177,O
DDI-MedLine.d179.s8,sunitinib,179,187,B-drug
DDI-MedLine.d179.s8,.,188,188,O
DDI-MedLine.d179.s9,In,0,1,O
DDI-MedLine.d179.s9,contrast,3,10,O
DDI-MedLine.d179.s9,",",11,11,O
DDI-MedLine.d179.s9,the,13,15,O
DDI-MedLine.d179.s9,reverse,17,23,O
DDI-MedLine.d179.s9,of,25,26,O
DDI-MedLine.d179.s9,this,28,31,O
DDI-MedLine.d179.s9,sequential,33,42,O
DDI-MedLine.d179.s9,administration,44,57,O
DDI-MedLine.d179.s9,resulted,59,66,O
DDI-MedLine.d179.s9,in,68,69,O
DDI-MedLine.d179.s9,antagonism,71,80,O
DDI-MedLine.d179.s9,",",81,81,O
DDI-MedLine.d179.s9,which,83,87,O
DDI-MedLine.d179.s9,may,89,91,O
DDI-MedLine.d179.s9,be,93,94,O
DDI-MedLine.d179.s9,due,96,98,O
DDI-MedLine.d179.s9,to,100,101,O
DDI-MedLine.d179.s9,differential,103,114,O
DDI-MedLine.d179.s9,effects,116,122,O
DDI-MedLine.d179.s9,on,124,125,O
DDI-MedLine.d179.s9,cell,127,130,O
DDI-MedLine.d179.s9,cycle,132,136,O
DDI-MedLine.d179.s9,arrest,138,143,O
DDI-MedLine.d179.s9,.,144,144,O
DDI-MedLine.d179.s10,Sunitinib,0,8,B-drug
DDI-MedLine.d179.s10,as,10,11,O
DDI-MedLine.d179.s10,a,13,13,O
DDI-MedLine.d179.s10,single,15,20,O
DDI-MedLine.d179.s10,agent,22,26,O
DDI-MedLine.d179.s10,exhibits,28,35,O
DDI-MedLine.d179.s10,anti-proliferative,37,54,O
DDI-MedLine.d179.s10,effects,56,62,O
DDI-MedLine.d179.s10,in,64,65,O
DDI-MedLine.d179.s10,vitro,67,71,O
DDI-MedLine.d179.s10,in,73,74,O
DDI-MedLine.d179.s10,NSCLC,76,80,O
DDI-MedLine.d179.s10,cell,82,85,O
DDI-MedLine.d179.s10,lines,87,91,O
DDI-MedLine.d179.s10,with,93,96,O
DDI-MedLine.d179.s10,EGFR,98,101,O
DDI-MedLine.d179.s10,T790M,103,107,O
DDI-MedLine.d179.s10,and,109,111,O
DDI-MedLine.d179.s10,K-ras,113,117,O
DDI-MedLine.d179.s10,mutations,119,127,O
DDI-MedLine.d179.s10,but,129,131,O
DDI-MedLine.d179.s10,the,133,135,O
DDI-MedLine.d179.s10,sequential,137,146,O
DDI-MedLine.d179.s10,administration,148,161,O
DDI-MedLine.d179.s10,of,163,164,O
DDI-MedLine.d179.s10,docetaxel,166,174,B-drug
DDI-MedLine.d179.s10,followed,176,183,O
DDI-MedLine.d179.s10,by,185,186,O
DDI-MedLine.d179.s10,sunitinib,188,196,B-drug
DDI-MedLine.d179.s10,is,198,199,O
DDI-MedLine.d179.s10,superior,201,208,O
DDI-MedLine.d179.s10,to,210,211,O
DDI-MedLine.d179.s10,sunitinib,213,221,B-drug
DDI-MedLine.d179.s10,followed,223,230,O
DDI-MedLine.d179.s10,by,232,233,O
DDI-MedLine.d179.s10,docetaxel,235,243,B-drug
DDI-MedLine.d179.s10,and,245,247,O
DDI-MedLine.d179.s10,concurrent,249,258,O
DDI-MedLine.d179.s10,administration,260,273,O
DDI-MedLine.d179.s10,.,274,274,O
DDI-MedLine.d159.s0,Protective,0,9,O
DDI-MedLine.d159.s0,effect,11,16,O
DDI-MedLine.d159.s0,of,18,19,O
DDI-MedLine.d159.s0,acetyl-l-carnitine,21,38,B-drug
DDI-MedLine.d159.s0,and,40,42,O
DDI-MedLine.d159.s0,alpha,45,49,B-drug_n
DDI-MedLine.d159.s0,lipoic,51,56,I-drug_n
DDI-MedLine.d159.s0,acid,58,61,I-drug_n
DDI-MedLine.d159.s0,against,63,69,O
DDI-MedLine.d159.s0,the,71,73,O
DDI-MedLine.d159.s0,acute,75,79,O
DDI-MedLine.d159.s0,toxicity,81,88,O
DDI-MedLine.d159.s0,of,90,91,O
DDI-MedLine.d159.s0,diepoxybutane,93,105,O
DDI-MedLine.d159.s0,to,107,108,O
DDI-MedLine.d159.s0,human,110,114,O
DDI-MedLine.d159.s0,lymphocytes,116,126,O
DDI-MedLine.d159.s0,.,127,127,O
DDI-MedLine.d159.s1,The,0,2,O
DDI-MedLine.d159.s1,biotransformation,4,20,O
DDI-MedLine.d159.s1,and,22,24,O
DDI-MedLine.d159.s1,oxidative,26,34,O
DDI-MedLine.d159.s1,stress,36,41,O
DDI-MedLine.d159.s1,may,43,45,O
DDI-MedLine.d159.s1,contribute,47,56,O
DDI-MedLine.d159.s1,to,58,59,O
DDI-MedLine.d159.s1,"1,2:3,4-diepoxybutane",61,81,O
DDI-MedLine.d159.s1,(,83,83,O
DDI-MedLine.d159.s1,DEB,84,86,O
DDI-MedLine.d159.s1,),87,87,O
DDI-MedLine.d159.s1,-induced,88,95,O
DDI-MedLine.d159.s1,toxicity,97,104,O
DDI-MedLine.d159.s1,to,106,107,O
DDI-MedLine.d159.s1,human,109,113,O
DDI-MedLine.d159.s1,lymphocytes,115,125,O
DDI-MedLine.d159.s1,of,127,128,O
DDI-MedLine.d159.s1,Fanconi,130,136,O
DDI-MedLine.d159.s1,Anemia,138,143,O
DDI-MedLine.d159.s1,(,145,145,O
DDI-MedLine.d159.s1,FA,146,147,O
DDI-MedLine.d159.s1,),148,148,O
DDI-MedLine.d159.s1,patients,150,157,O
DDI-MedLine.d159.s1,.,158,158,O
DDI-MedLine.d159.s2,Thus,0,3,O
DDI-MedLine.d159.s2,",",4,4,O
DDI-MedLine.d159.s2,the,6,8,O
DDI-MedLine.d159.s2,identification,10,23,O
DDI-MedLine.d159.s2,of,25,26,O
DDI-MedLine.d159.s2,putative,28,35,O
DDI-MedLine.d159.s2,inhibitors,37,46,O
DDI-MedLine.d159.s2,of,48,49,O
DDI-MedLine.d159.s2,bioactivation,51,63,O
DDI-MedLine.d159.s2,",",64,64,O
DDI-MedLine.d159.s2,as,66,67,O
DDI-MedLine.d159.s2,well,69,72,O
DDI-MedLine.d159.s2,as,74,75,O
DDI-MedLine.d159.s2,the,77,79,O
DDI-MedLine.d159.s2,determination,81,93,O
DDI-MedLine.d159.s2,of,95,96,O
DDI-MedLine.d159.s2,the,98,100,O
DDI-MedLine.d159.s2,protective,102,111,O
DDI-MedLine.d159.s2,role,113,116,O
DDI-MedLine.d159.s2,of,118,119,O
DDI-MedLine.d159.s2,oxidant,121,127,O
DDI-MedLine.d159.s2,defenses,129,136,O
DDI-MedLine.d159.s2,",",137,137,O
DDI-MedLine.d159.s2,on,139,140,O
DDI-MedLine.d159.s2,DEB-induced,142,152,O
DDI-MedLine.d159.s2,toxicity,154,161,O
DDI-MedLine.d159.s2,",",162,162,O
DDI-MedLine.d159.s2,can,164,166,O
DDI-MedLine.d159.s2,help,168,171,O
DDI-MedLine.d159.s2,to,173,174,O
DDI-MedLine.d159.s2,understand,176,185,O
DDI-MedLine.d159.s2,what,187,190,O
DDI-MedLine.d159.s2,is,192,193,O
DDI-MedLine.d159.s2,failing,195,201,O
DDI-MedLine.d159.s2,in,203,204,O
DDI-MedLine.d159.s2,FA,206,207,O
DDI-MedLine.d159.s2,cells,209,213,O
DDI-MedLine.d159.s2,.,214,214,O
DDI-MedLine.d159.s3,In,0,1,O
DDI-MedLine.d159.s3,the,3,5,O
DDI-MedLine.d159.s3,present,7,13,O
DDI-MedLine.d159.s3,work,15,18,O
DDI-MedLine.d159.s3,we,20,21,O
DDI-MedLine.d159.s3,studied,23,29,O
DDI-MedLine.d159.s3,the,31,33,O
DDI-MedLine.d159.s3,contribution,35,46,O
DDI-MedLine.d159.s3,of,48,49,O
DDI-MedLine.d159.s3,several,51,57,O
DDI-MedLine.d159.s3,biochemical,59,69,O
DDI-MedLine.d159.s3,pathways,71,78,O
DDI-MedLine.d159.s3,for,80,82,O
DDI-MedLine.d159.s3,DEB-induced,84,94,O
DDI-MedLine.d159.s3,acute,96,100,O
DDI-MedLine.d159.s3,toxicity,102,109,O
DDI-MedLine.d159.s3,in,111,112,O
DDI-MedLine.d159.s3,human,114,118,O
DDI-MedLine.d159.s3,lymphocyte,120,129,O
DDI-MedLine.d159.s3,suspensions,131,141,O
DDI-MedLine.d159.s3,",",142,142,O
DDI-MedLine.d159.s3,by,144,145,O
DDI-MedLine.d159.s3,using,147,151,O
DDI-MedLine.d159.s3,inhibitors,153,162,O
DDI-MedLine.d159.s3,of,164,165,O
DDI-MedLine.d159.s3,epoxide,167,173,O
DDI-MedLine.d159.s3,hydrolases,175,184,O
DDI-MedLine.d159.s3,",",185,185,O
DDI-MedLine.d159.s3,inhibitors,187,196,O
DDI-MedLine.d159.s3,of,198,199,O
DDI-MedLine.d159.s3,protective,201,210,O
DDI-MedLine.d159.s3,enzymes,212,218,O
DDI-MedLine.d159.s3,as,220,221,O
DDI-MedLine.d159.s3,glutathione,223,233,O
DDI-MedLine.d159.s3,S-transferase,235,247,O
DDI-MedLine.d159.s3,and,249,251,O
DDI-MedLine.d159.s3,catalase,253,260,O
DDI-MedLine.d159.s3,",",261,261,O
DDI-MedLine.d159.s3,the,263,265,O
DDI-MedLine.d159.s3,depletion,267,275,O
DDI-MedLine.d159.s3,of,277,278,O
DDI-MedLine.d159.s3,glutathione,280,290,O
DDI-MedLine.d159.s3,(,292,292,O
DDI-MedLine.d159.s3,GSH,293,295,O
DDI-MedLine.d159.s3,),296,296,O
DDI-MedLine.d159.s3,",",297,297,O
DDI-MedLine.d159.s3,and,299,301,O
DDI-MedLine.d159.s3,the,303,305,O
DDI-MedLine.d159.s3,inhibition,307,316,O
DDI-MedLine.d159.s3,of,318,319,O
DDI-MedLine.d159.s3,protein,321,327,O
DDI-MedLine.d159.s3,synthesis,329,337,O
DDI-MedLine.d159.s3,;,338,338,O
DDI-MedLine.d159.s4,and,0,2,O
DDI-MedLine.d159.s4,a,4,4,O
DDI-MedLine.d159.s4,variety,6,12,O
DDI-MedLine.d159.s4,of,14,15,O
DDI-MedLine.d159.s4,putative,17,24,O
DDI-MedLine.d159.s4,protective,26,35,O
DDI-MedLine.d159.s4,compounds,37,45,O
DDI-MedLine.d159.s4,",",46,46,O
DDI-MedLine.d159.s4,including,48,56,O
DDI-MedLine.d159.s4,antioxidants,58,69,O
DDI-MedLine.d159.s4,",",70,70,O
DDI-MedLine.d159.s4,and,72,74,O
DDI-MedLine.d159.s4,mitochondrial,76,88,O
DDI-MedLine.d159.s4,protective,90,99,O
DDI-MedLine.d159.s4,agents,101,106,O
DDI-MedLine.d159.s4,.,107,107,O
DDI-MedLine.d159.s5,The,0,2,O
DDI-MedLine.d159.s5,present,4,10,O
DDI-MedLine.d159.s5,study,12,16,O
DDI-MedLine.d159.s5,reports,18,24,O
DDI-MedLine.d159.s5,two,26,28,O
DDI-MedLine.d159.s5,novel,30,34,O
DDI-MedLine.d159.s5,findings,36,43,O
DDI-MedLine.d159.s5,:,44,44,O
DDI-MedLine.d159.s5,(,46,46,O
DDI-MedLine.d159.s5,i,47,47,O
DDI-MedLine.d159.s5,),48,48,O
DDI-MedLine.d159.s5,it,50,51,O
DDI-MedLine.d159.s5,was,53,55,O
DDI-MedLine.d159.s5,clearly,57,63,O
DDI-MedLine.d159.s5,evidenced,65,73,O
DDI-MedLine.d159.s5,",",74,74,O
DDI-MedLine.d159.s5,for,76,78,O
DDI-MedLine.d159.s5,the,80,82,O
DDI-MedLine.d159.s5,first,84,88,O
DDI-MedLine.d159.s5,time,90,93,O
DDI-MedLine.d159.s5,",",94,94,O
DDI-MedLine.d159.s5,that,96,99,O
DDI-MedLine.d159.s5,the,101,103,O
DDI-MedLine.d159.s5,acute,105,109,O
DDI-MedLine.d159.s5,exposure,111,118,O
DDI-MedLine.d159.s5,of,120,121,O
DDI-MedLine.d159.s5,freshly,123,129,O
DDI-MedLine.d159.s5,isolated,131,138,O
DDI-MedLine.d159.s5,human,140,144,O
DDI-MedLine.d159.s5,lymphocytes,146,156,O
DDI-MedLine.d159.s5,to,158,159,O
DDI-MedLine.d159.s5,DEB,161,163,O
DDI-MedLine.d159.s5,results,165,171,O
DDI-MedLine.d159.s5,in,173,174,O
DDI-MedLine.d159.s5,severe,176,181,O
DDI-MedLine.d159.s5,GSH,183,185,O
DDI-MedLine.d159.s5,depletion,187,195,O
DDI-MedLine.d159.s5,and,197,199,O
DDI-MedLine.d159.s5,loss,201,204,O
DDI-MedLine.d159.s5,of,206,207,O
DDI-MedLine.d159.s5,ATP,209,211,O
DDI-MedLine.d159.s5,",",212,212,O
DDI-MedLine.d159.s5,followed,214,221,O
DDI-MedLine.d159.s5,by,223,224,O
DDI-MedLine.d159.s5,cell,226,229,O
DDI-MedLine.d159.s5,death,231,235,O
DDI-MedLine.d159.s5,;,236,236,O
DDI-MedLine.d159.s6,(,0,0,O
DDI-MedLine.d159.s6,ii,1,2,O
DDI-MedLine.d159.s6,),3,3,O
DDI-MedLine.d159.s6,acetyl-l-carnitine,5,22,B-drug
DDI-MedLine.d159.s6,elicits,24,30,O
DDI-MedLine.d159.s6,a,32,32,O
DDI-MedLine.d159.s6,significant,34,44,O
DDI-MedLine.d159.s6,protective,46,55,O
DDI-MedLine.d159.s6,effect,57,62,O
DDI-MedLine.d159.s6,on,64,65,O
DDI-MedLine.d159.s6,DEB,67,69,O
DDI-MedLine.d159.s6,induced,71,77,O
DDI-MedLine.d159.s6,toxicity,79,86,O
DDI-MedLine.d159.s6,",",87,87,O
DDI-MedLine.d159.s6,which,89,93,O
DDI-MedLine.d159.s6,was,95,97,O
DDI-MedLine.d159.s6,potentiated,99,109,O
DDI-MedLine.d159.s6,by,111,112,O
DDI-MedLine.d159.s6,alpha-lipoic,115,126,B-drug
DDI-MedLine.d159.s6,acid,128,131,I-drug
DDI-MedLine.d159.s6,.,132,132,O
DDI-MedLine.d159.s7,Collectively,0,11,O
DDI-MedLine.d159.s7,",",12,12,O
DDI-MedLine.d159.s7,these,14,18,O
DDI-MedLine.d159.s7,findings,20,27,O
DDI-MedLine.d159.s7,contribute,29,38,O
DDI-MedLine.d159.s7,to,40,41,O
DDI-MedLine.d159.s7,increase,43,50,O
DDI-MedLine.d159.s7,our,52,54,O
DDI-MedLine.d159.s7,knowledge,56,64,O
DDI-MedLine.d159.s7,of,66,67,O
DDI-MedLine.d159.s7,DEB-induce,69,78,O
DDI-MedLine.d159.s7,toxicity,80,87,O
DDI-MedLine.d159.s7,and,89,91,O
DDI-MedLine.d159.s7,will,93,96,O
DDI-MedLine.d159.s7,be,98,99,O
DDI-MedLine.d159.s7,very,101,104,O
DDI-MedLine.d159.s7,useful,106,111,O
DDI-MedLine.d159.s7,when,113,116,O
DDI-MedLine.d159.s7,applied,118,124,O
DDI-MedLine.d159.s7,in,126,127,O
DDI-MedLine.d159.s7,studies,129,135,O
DDI-MedLine.d159.s7,with,137,140,O
DDI-MedLine.d159.s7,lymphocytes,142,152,O
DDI-MedLine.d159.s7,from,154,157,O
DDI-MedLine.d159.s7,FA,159,160,O
DDI-MedLine.d159.s7,patients,162,169,O
DDI-MedLine.d159.s7,",",170,170,O
DDI-MedLine.d159.s7,in,172,173,O
DDI-MedLine.d159.s7,order,175,179,O
DDI-MedLine.d159.s7,to,181,182,O
DDI-MedLine.d159.s7,find,184,187,O
DDI-MedLine.d159.s7,out,189,191,O
DDI-MedLine.d159.s7,a,193,193,O
DDI-MedLine.d159.s7,protective,195,204,O
DDI-MedLine.d159.s7,agent,206,210,O
DDI-MedLine.d159.s7,against,212,218,O
DDI-MedLine.d159.s7,spontaneous,220,230,O
DDI-MedLine.d159.s7,and,232,234,O
DDI-MedLine.d159.s7,DEB-induced,236,246,O
DDI-MedLine.d159.s7,chromosome,248,257,O
DDI-MedLine.d159.s7,instability,259,269,O
DDI-MedLine.d159.s7,.,270,270,O
DDI-MedLine.d164.s0,Lapatinib,0,8,B-drug
DDI-MedLine.d164.s0,enhances,10,17,O
DDI-MedLine.d164.s0,herceptin-mediated,19,36,O
DDI-MedLine.d164.s0,antibody-dependent,38,55,O
DDI-MedLine.d164.s0,cellular,57,64,O
DDI-MedLine.d164.s0,cytotoxicity,66,77,O
DDI-MedLine.d164.s0,by,79,80,O
DDI-MedLine.d164.s0,up-regulation,82,94,O
DDI-MedLine.d164.s0,of,96,97,O
DDI-MedLine.d164.s0,cell,99,102,O
DDI-MedLine.d164.s0,surface,104,110,O
DDI-MedLine.d164.s0,HER2,112,115,O
DDI-MedLine.d164.s0,expression,117,126,O
DDI-MedLine.d164.s0,.,127,127,O
DDI-MedLine.d164.s1,Although,0,7,O
DDI-MedLine.d164.s1,it,9,10,O
DDI-MedLine.d164.s1,was,12,14,O
DDI-MedLine.d164.s1,previously,16,25,O
DDI-MedLine.d164.s1,reported,27,34,O
DDI-MedLine.d164.s1,that,36,39,O
DDI-MedLine.d164.s1,lapatinib,41,49,B-drug
DDI-MedLine.d164.s1,combined,51,58,O
DDI-MedLine.d164.s1,with,60,63,O
DDI-MedLine.d164.s1,Herceptin,65,73,B-brand
DDI-MedLine.d164.s1,improved,75,82,O
DDI-MedLine.d164.s1,the,84,86,O
DDI-MedLine.d164.s1,progression-free,88,103,O
DDI-MedLine.d164.s1,survival,105,112,O
DDI-MedLine.d164.s1,rate,114,117,O
DDI-MedLine.d164.s1,compared,119,126,O
DDI-MedLine.d164.s1,with,128,131,O
DDI-MedLine.d164.s1,lapatinib,133,141,B-drug
DDI-MedLine.d164.s1,alone,143,147,O
DDI-MedLine.d164.s1,for,149,151,O
DDI-MedLine.d164.s1,patients,153,160,O
DDI-MedLine.d164.s1,with,162,165,O
DDI-MedLine.d164.s1,Herceptin-refractory,167,186,O
DDI-MedLine.d164.s1,HER2-positive,188,200,O
DDI-MedLine.d164.s1,metastatic,202,211,O
DDI-MedLine.d164.s1,breast,213,218,O
DDI-MedLine.d164.s1,cancer,220,225,O
DDI-MedLine.d164.s1,",",226,226,O
DDI-MedLine.d164.s1,the,228,230,O
DDI-MedLine.d164.s1,mechanism,232,240,O
DDI-MedLine.d164.s1,is,242,243,O
DDI-MedLine.d164.s1,purported,245,253,O
DDI-MedLine.d164.s1,to,255,256,O
DDI-MedLine.d164.s1,be,258,259,O
DDI-MedLine.d164.s1,an,261,262,O
DDI-MedLine.d164.s1,antiproliferative,264,280,O
DDI-MedLine.d164.s1,effect,282,287,O
DDI-MedLine.d164.s1,relating,289,296,O
DDI-MedLine.d164.s1,to,298,299,O
DDI-MedLine.d164.s1,the,301,303,O
DDI-MedLine.d164.s1,synergism,305,313,O
DDI-MedLine.d164.s1,of,315,316,O
DDI-MedLine.d164.s1,these,318,322,O
DDI-MedLine.d164.s1,two,324,326,O
DDI-MedLine.d164.s1,agents,328,333,O
DDI-MedLine.d164.s1,.,334,334,O
DDI-MedLine.d164.s2,We,0,1,O
DDI-MedLine.d164.s2,evaluated,3,11,O
DDI-MedLine.d164.s2,how,13,15,O
DDI-MedLine.d164.s2,lapatinib,17,25,B-drug
DDI-MedLine.d164.s2,interacts,27,35,O
DDI-MedLine.d164.s2,with,37,40,O
DDI-MedLine.d164.s2,Herceptin,42,50,B-brand
DDI-MedLine.d164.s2,in,52,53,O
DDI-MedLine.d164.s2,HER2-positive,55,67,O
DDI-MedLine.d164.s2,breast,69,74,O
DDI-MedLine.d164.s2,cancer,76,81,O
DDI-MedLine.d164.s2,",",82,82,O
DDI-MedLine.d164.s2,with,84,87,O
DDI-MedLine.d164.s2,a,89,89,O
DDI-MedLine.d164.s2,particular,91,100,O
DDI-MedLine.d164.s2,focus,102,106,O
DDI-MedLine.d164.s2,on,108,109,O
DDI-MedLine.d164.s2,Herceptin-mediated,111,128,O
DDI-MedLine.d164.s2,antibody-dependent,130,147,O
DDI-MedLine.d164.s2,cellular,149,156,O
DDI-MedLine.d164.s2,cytotoxicity,158,169,O
DDI-MedLine.d164.s2,(,171,171,O
DDI-MedLine.d164.s2,ADCC,172,175,O
DDI-MedLine.d164.s2,),176,176,O
DDI-MedLine.d164.s2,.,177,177,O
DDI-MedLine.d164.s3,In,0,1,O
DDI-MedLine.d164.s3,an,3,4,O
DDI-MedLine.d164.s3,in,6,7,O
DDI-MedLine.d164.s3,vitro,9,13,O
DDI-MedLine.d164.s3,assay,15,19,O
DDI-MedLine.d164.s3,",",20,20,O
DDI-MedLine.d164.s3,lapatinib,22,30,B-drug
DDI-MedLine.d164.s3,induced,32,38,O
DDI-MedLine.d164.s3,HER2,40,43,O
DDI-MedLine.d164.s3,expression,45,54,O
DDI-MedLine.d164.s3,at,56,57,O
DDI-MedLine.d164.s3,the,59,61,O
DDI-MedLine.d164.s3,cell,63,66,O
DDI-MedLine.d164.s3,surface,68,74,O
DDI-MedLine.d164.s3,of,76,77,O
DDI-MedLine.d164.s3,HER2-positive,79,91,O
DDI-MedLine.d164.s3,breast,93,98,O
DDI-MedLine.d164.s3,cancer,100,105,O
DDI-MedLine.d164.s3,cell,107,110,O
DDI-MedLine.d164.s3,lines,112,116,O
DDI-MedLine.d164.s3,",",117,117,O
DDI-MedLine.d164.s3,leading,119,125,O
DDI-MedLine.d164.s3,to,127,128,O
DDI-MedLine.d164.s3,the,130,132,O
DDI-MedLine.d164.s3,enhancement,134,144,O
DDI-MedLine.d164.s3,of,146,147,O
DDI-MedLine.d164.s3,Herceptin-mediated,149,166,O
DDI-MedLine.d164.s3,ADCC,168,171,O
DDI-MedLine.d164.s3,.,172,172,O
DDI-MedLine.d164.s4,Furthermore,0,10,O
DDI-MedLine.d164.s4,",",11,11,O
DDI-MedLine.d164.s4,we,13,14,O
DDI-MedLine.d164.s4,present,16,22,O
DDI-MedLine.d164.s4,a,24,24,O
DDI-MedLine.d164.s4,case,26,29,O
DDI-MedLine.d164.s4,report,31,36,O
DDI-MedLine.d164.s4,in,38,39,O
DDI-MedLine.d164.s4,which,41,45,O
DDI-MedLine.d164.s4,a,47,47,O
DDI-MedLine.d164.s4,second,49,54,O
DDI-MedLine.d164.s4,Herceptin,56,64,B-brand
DDI-MedLine.d164.s4,treatment,66,74,O
DDI-MedLine.d164.s4,following,76,84,O
DDI-MedLine.d164.s4,lapatinib,86,94,B-drug
DDI-MedLine.d164.s4,resulted,96,103,O
DDI-MedLine.d164.s4,in,105,106,O
DDI-MedLine.d164.s4,the,108,110,O
DDI-MedLine.d164.s4,marked,112,117,O
DDI-MedLine.d164.s4,shrinkage,119,127,O
DDI-MedLine.d164.s4,of,129,130,O
DDI-MedLine.d164.s4,multiple,132,139,O
DDI-MedLine.d164.s4,metastatic,141,150,O
DDI-MedLine.d164.s4,tumors,152,157,O
DDI-MedLine.d164.s4,in,159,160,O
DDI-MedLine.d164.s4,HER2-positive,162,174,O
DDI-MedLine.d164.s4,breast,176,181,O
DDI-MedLine.d164.s4,cancer,183,188,O
DDI-MedLine.d164.s4,.,189,189,O
DDI-MedLine.d164.s5,Lapatinib,0,8,B-drug
DDI-MedLine.d164.s5,may,10,12,O
DDI-MedLine.d164.s5,have,14,17,O
DDI-MedLine.d164.s5,the,19,21,O
DDI-MedLine.d164.s5,potential,23,31,O
DDI-MedLine.d164.s5,to,33,34,O
DDI-MedLine.d164.s5,convert,36,42,O
DDI-MedLine.d164.s5,Herceptin-refractory,44,63,O
DDI-MedLine.d164.s5,to,65,66,O
DDI-MedLine.d164.s5,Herceptin-sensitive,68,86,O
DDI-MedLine.d164.s5,tumors,88,93,O
DDI-MedLine.d164.s5,in,95,96,O
DDI-MedLine.d164.s5,HER2-positive,98,110,O
DDI-MedLine.d164.s5,breast,112,117,O
DDI-MedLine.d164.s5,cancer,119,124,O
DDI-MedLine.d164.s5,by,126,127,O
DDI-MedLine.d164.s5,up-regulation,129,141,O
DDI-MedLine.d164.s5,of,143,144,O
DDI-MedLine.d164.s5,the,146,148,O
DDI-MedLine.d164.s5,cell,150,153,O
DDI-MedLine.d164.s5,surface,155,161,O
DDI-MedLine.d164.s5,expression,163,172,O
DDI-MedLine.d164.s5,of,174,175,O
DDI-MedLine.d164.s5,HER2,177,180,O
DDI-MedLine.d164.s5,.,181,181,O
DDI-MedLine.d193.s0,Ticagrelor,0,9,B-drug
DDI-MedLine.d193.s0,(,11,11,O
DDI-MedLine.d193.s0,Brilinta,12,19,B-brand
DDI-MedLine.d193.s0,),20,20,O
DDI-MedLine.d193.s0,--,21,22,O
DDI-MedLine.d193.s0,better,23,28,O
DDI-MedLine.d193.s0,than,30,33,O
DDI-MedLine.d193.s0,clopidogrel,35,45,B-drug
DDI-MedLine.d193.s0,(,47,47,O
DDI-MedLine.d193.s0,Plavix,48,53,B-brand
DDI-MedLine.d193.s0,),54,54,O
DDI-MedLine.d193.s1,The,0,2,O
DDI-MedLine.d193.s1,FDA,4,6,O
DDI-MedLine.d193.s1,has,8,10,O
DDI-MedLine.d193.s1,approved,12,19,O
DDI-MedLine.d193.s1,ticagrelor,21,30,B-drug
DDI-MedLine.d193.s1,(,32,32,O
DDI-MedLine.d193.s1,Brilinta-AstraZeneca,33,52,O
DDI-MedLine.d193.s1,),53,53,O
DDI-MedLine.d193.s1,",",54,54,O
DDI-MedLine.d193.s1,an,56,57,O
DDI-MedLine.d193.s1,oral,59,62,O
DDI-MedLine.d193.s1,antiplatelet,64,75,B-group
DDI-MedLine.d193.s1,drug,77,80,I-group
DDI-MedLine.d193.s1,",",81,81,O
DDI-MedLine.d193.s1,for,83,85,O
DDI-MedLine.d193.s1,use,87,89,O
DDI-MedLine.d193.s1,with,91,94,O
DDI-MedLine.d193.s1,low-dose,96,103,O
DDI-MedLine.d193.s1,aspirin,105,111,B-brand
DDI-MedLine.d193.s1,to,113,114,O
DDI-MedLine.d193.s1,reduce,116,121,O
DDI-MedLine.d193.s1,the,123,125,O
DDI-MedLine.d193.s1,rate,127,130,O
DDI-MedLine.d193.s1,of,132,133,O
DDI-MedLine.d193.s1,thrombotic,135,144,O
DDI-MedLine.d193.s1,cardiovascular,146,159,O
DDI-MedLine.d193.s1,events,161,166,O
DDI-MedLine.d193.s1,in,168,169,O
DDI-MedLine.d193.s1,patients,171,178,O
DDI-MedLine.d193.s1,with,180,183,O
DDI-MedLine.d193.s1,acute,185,189,O
DDI-MedLine.d193.s1,coronary,191,198,O
DDI-MedLine.d193.s1,syndrome,200,207,O
DDI-MedLine.d193.s1,(,209,209,O
DDI-MedLine.d193.s1,ACS,210,212,O
DDI-MedLine.d193.s1,),213,213,O
DDI-MedLine.d193.s1,.,214,214,O
DDI-MedLine.d193.s2,It,0,1,O
DDI-MedLine.d193.s2,will,3,6,O
DDI-MedLine.d193.s2,compete,8,14,O
DDI-MedLine.d193.s2,with,16,19,O
DDI-MedLine.d193.s2,clopidogrel,21,31,B-drug
DDI-MedLine.d193.s2,(,33,33,O
DDI-MedLine.d193.s2,Plavix,34,39,B-brand
DDI-MedLine.d193.s2,),40,40,O
DDI-MedLine.d193.s2,and,42,44,O
DDI-MedLine.d193.s2,prasugrel,46,54,B-drug
DDI-MedLine.d193.s2,(,56,56,O
DDI-MedLine.d193.s2,Effient,57,63,B-brand
DDI-MedLine.d193.s2,),64,64,O
DDI-MedLine.d193.s2,for,66,68,O
DDI-MedLine.d193.s2,such,70,73,O
DDI-MedLine.d193.s2,use,75,77,O
DDI-MedLine.d193.s2,.,78,78,O
DDI-MedLine.d193.s3,Clopidogrel,0,10,B-drug
DDI-MedLine.d193.s3,is,12,13,O
DDI-MedLine.d193.s3,expected,15,22,O
DDI-MedLine.d193.s3,to,24,25,O
DDI-MedLine.d193.s3,become,27,32,O
DDI-MedLine.d193.s3,available,34,42,O
DDI-MedLine.d193.s3,generically,44,54,O
DDI-MedLine.d193.s3,in,56,57,O
DDI-MedLine.d193.s3,the,59,61,O
DDI-MedLine.d193.s3,US,63,64,O
DDI-MedLine.d193.s3,within,66,71,O
DDI-MedLine.d193.s3,the,73,75,O
DDI-MedLine.d193.s3,next,77,80,O
DDI-MedLine.d193.s3,few,82,84,O
DDI-MedLine.d193.s3,months,86,91,O
DDI-MedLine.d193.s3,.,92,92,O
DDI-MedLine.d43.s0,Tumor,0,4,O
DDI-MedLine.d43.s0,phenotype,6,14,O
DDI-MedLine.d43.s0,and,16,18,O
DDI-MedLine.d43.s0,susceptibility,20,33,O
DDI-MedLine.d43.s0,to,35,36,O
DDI-MedLine.d43.s0,progression,38,48,O
DDI-MedLine.d43.s0,as,50,51,O
DDI-MedLine.d43.s0,an,53,54,O
DDI-MedLine.d43.s0,expression,56,65,O
DDI-MedLine.d43.s0,of,67,68,O
DDI-MedLine.d43.s0,subpopulations,70,83,O
DDI-MedLine.d43.s0,of,85,86,O
DDI-MedLine.d43.s0,initiated,88,96,O
DDI-MedLine.d43.s0,murine,98,103,O
DDI-MedLine.d43.s0,cells,105,109,O
DDI-MedLine.d43.s0,.,110,110,O
DDI-MedLine.d43.s1,Currently,0,8,O
DDI-MedLine.d43.s1,",",9,9,O
DDI-MedLine.d43.s1,it,11,12,O
DDI-MedLine.d43.s1,is,14,15,O
DDI-MedLine.d43.s1,conceived,17,25,O
DDI-MedLine.d43.s1,that,27,30,O
DDI-MedLine.d43.s1,a,32,32,O
DDI-MedLine.d43.s1,number,34,39,O
DDI-MedLine.d43.s1,of,41,42,O
DDI-MedLine.d43.s1,events,44,49,O
DDI-MedLine.d43.s1,",",50,50,O
DDI-MedLine.d43.s1,or,52,53,O
DDI-MedLine.d43.s1,hits,55,58,O
DDI-MedLine.d43.s1,",",59,59,O
DDI-MedLine.d43.s1,are,61,63,O
DDI-MedLine.d43.s1,required,65,72,O
DDI-MedLine.d43.s1,for,74,76,O
DDI-MedLine.d43.s1,the,78,80,O
DDI-MedLine.d43.s1,induction,82,90,O
DDI-MedLine.d43.s1,of,92,93,O
DDI-MedLine.d43.s1,tumors,95,100,O
DDI-MedLine.d43.s1,by,102,103,O
DDI-MedLine.d43.s1,chemical,105,112,O
DDI-MedLine.d43.s1,agents,114,119,O
DDI-MedLine.d43.s1,.,120,120,O
DDI-MedLine.d43.s2,The,0,2,O
DDI-MedLine.d43.s2,first,4,8,O
DDI-MedLine.d43.s2,phase,10,14,O
DDI-MedLine.d43.s2,of,16,17,O
DDI-MedLine.d43.s2,this,19,22,O
DDI-MedLine.d43.s2,sequence,24,31,O
DDI-MedLine.d43.s2,",",32,32,O
DDI-MedLine.d43.s2,initiation,34,43,O
DDI-MedLine.d43.s2,",",44,44,O
DDI-MedLine.d43.s2,is,46,47,O
DDI-MedLine.d43.s2,considered,49,58,O
DDI-MedLine.d43.s2,to,60,61,O
DDI-MedLine.d43.s2,result,63,68,O
DDI-MedLine.d43.s2,from,70,73,O
DDI-MedLine.d43.s2,at,75,76,O
DDI-MedLine.d43.s2,least,78,82,O
DDI-MedLine.d43.s2,one,84,86,O
DDI-MedLine.d43.s2,event,88,92,O
DDI-MedLine.d43.s2,in,94,95,O
DDI-MedLine.d43.s2,the,97,99,O
DDI-MedLine.d43.s2,genetic,101,107,O
DDI-MedLine.d43.s2,apparatus,109,117,O
DDI-MedLine.d43.s2,.,118,118,O
DDI-MedLine.d43.s3,Analyses,0,7,O
DDI-MedLine.d43.s3,of,9,10,O
DDI-MedLine.d43.s3,this,12,15,O
DDI-MedLine.d43.s3,sequence,17,24,O
DDI-MedLine.d43.s3,",",25,25,O
DDI-MedLine.d43.s3,however,27,33,O
DDI-MedLine.d43.s3,",",34,34,O
DDI-MedLine.d43.s3,usually,36,42,O
DDI-MedLine.d43.s3,give,44,47,O
DDI-MedLine.d43.s3,little,49,54,O
DDI-MedLine.d43.s3,consideration,56,68,O
DDI-MedLine.d43.s3,to,70,71,O
DDI-MedLine.d43.s3,the,73,75,O
DDI-MedLine.d43.s3,nature,77,82,O
DDI-MedLine.d43.s3,of,84,85,O
DDI-MedLine.d43.s3,the,87,89,O
DDI-MedLine.d43.s3,target,91,96,O
DDI-MedLine.d43.s3,cell,98,101,O
DDI-MedLine.d43.s3,or,103,104,O
DDI-MedLine.d43.s3,to,106,107,O
DDI-MedLine.d43.s3,the,109,111,O
DDI-MedLine.d43.s3,characteristics,113,127,O
DDI-MedLine.d43.s3,of,129,130,O
DDI-MedLine.d43.s3,the,132,134,O
DDI-MedLine.d43.s3,resultant,136,144,O
DDI-MedLine.d43.s3,tumors,146,151,O
DDI-MedLine.d43.s3,.,152,152,O
DDI-MedLine.d43.s4,Vesselinovitch,0,13,O
DDI-MedLine.d43.s4,et,15,16,O
DDI-MedLine.d43.s4,al,18,19,O
DDI-MedLine.d43.s4,.,20,20,O
DDI-MedLine.d43.s5,(,0,0,O
DDI-MedLine.d43.s5,Cancer,1,6,O
DDI-MedLine.d43.s5,Res.,8,11,O
DDI-MedLine.d43.s5,",",12,12,O
DDI-MedLine.d43.s5,38,14,15,O
DDI-MedLine.d43.s5,:,16,16,O
DDI-MedLine.d43.s5,2003-2010,18,26,O
DDI-MedLine.d43.s5,",",27,27,O
DDI-MedLine.d43.s5,1978,29,32,O
DDI-MedLine.d43.s5,),33,33,O
DDI-MedLine.d43.s5,have,35,38,O
DDI-MedLine.d43.s5,reported,40,47,O
DDI-MedLine.d43.s5,that,49,52,O
DDI-MedLine.d43.s5,a,54,54,O
DDI-MedLine.d43.s5,single,56,61,O
DDI-MedLine.d43.s5,",",62,62,O
DDI-MedLine.d43.s5,small,64,68,O
DDI-MedLine.d43.s5,pulse,70,74,O
DDI-MedLine.d43.s5,of,76,77,O
DDI-MedLine.d43.s5,carcinogen,79,88,O
DDI-MedLine.d43.s5,can,90,92,O
DDI-MedLine.d43.s5,induce,94,99,O
DDI-MedLine.d43.s5,early,101,105,O
DDI-MedLine.d43.s5,and,107,109,O
DDI-MedLine.d43.s5,numerous,111,118,O
DDI-MedLine.d43.s5,liver,120,124,O
DDI-MedLine.d43.s5,tumors,126,131,O
DDI-MedLine.d43.s5,when,133,136,O
DDI-MedLine.d43.s5,administered,138,149,O
DDI-MedLine.d43.s5,neonatally,151,160,O
DDI-MedLine.d43.s5,to,162,163,O
DDI-MedLine.d43.s5,mice,165,168,O
DDI-MedLine.d43.s5,with,170,173,O
DDI-MedLine.d43.s5,a,175,175,O
DDI-MedLine.d43.s5,genetic,177,183,O
DDI-MedLine.d43.s5,predisposition,185,198,O
DDI-MedLine.d43.s5,to,200,201,O
DDI-MedLine.d43.s5,hepatotumorigenesis,203,221,O
DDI-MedLine.d43.s5,.,222,222,O
DDI-MedLine.d43.s6,In,0,1,O
DDI-MedLine.d43.s6,the,3,5,O
DDI-MedLine.d43.s6,current,7,13,O
DDI-MedLine.d43.s6,study,15,19,O
DDI-MedLine.d43.s6,",",20,20,O
DDI-MedLine.d43.s6,the,22,24,O
DDI-MedLine.d43.s6,nonpredisposed,26,39,O
DDI-MedLine.d43.s6,strain,41,46,O
DDI-MedLine.d43.s6,C57BL/6N,48,55,O
DDI-MedLine.d43.s6,was,57,59,O
DDI-MedLine.d43.s6,also,61,64,O
DDI-MedLine.d43.s6,shown,66,70,O
DDI-MedLine.d43.s6,to,72,73,O
DDI-MedLine.d43.s6,be,75,76,O
DDI-MedLine.d43.s6,highly,78,83,O
DDI-MedLine.d43.s6,susceptible,85,95,O
DDI-MedLine.d43.s6,to,97,98,O
DDI-MedLine.d43.s6,diethylnitrosamine,100,117,O
DDI-MedLine.d43.s6,during,119,124,O
DDI-MedLine.d43.s6,the,126,128,O
DDI-MedLine.d43.s6,neonatal,130,137,O
DDI-MedLine.d43.s6,period,139,144,O
DDI-MedLine.d43.s6,.,145,145,O
DDI-MedLine.d43.s7,C57BL/6N,0,7,O
DDI-MedLine.d43.s7,demonstrated,9,20,O
DDI-MedLine.d43.s7,large,22,26,O
DDI-MedLine.d43.s7,numbers,28,34,O
DDI-MedLine.d43.s7,of,36,37,O
DDI-MedLine.d43.s7,two,39,41,O
DDI-MedLine.d43.s7,of,43,44,O
DDI-MedLine.d43.s7,the,46,48,O
DDI-MedLine.d43.s7,three,50,54,O
DDI-MedLine.d43.s7,types,56,60,O
DDI-MedLine.d43.s7,of,62,63,O
DDI-MedLine.d43.s7,liver,65,69,O
DDI-MedLine.d43.s7,tumors,71,76,O
DDI-MedLine.d43.s7,seen,78,81,O
DDI-MedLine.d43.s7,in,83,84,O
DDI-MedLine.d43.s7,livers,86,91,O
DDI-MedLine.d43.s7,of,93,94,O
DDI-MedLine.d43.s7,genetically,96,106,O
DDI-MedLine.d43.s7,predisposed,108,118,O
DDI-MedLine.d43.s7,mice,120,123,O
DDI-MedLine.d43.s7,",",124,124,O
DDI-MedLine.d43.s7,one,126,128,O
DDI-MedLine.d43.s7,of,130,131,O
DDI-MedLine.d43.s7,which,133,137,O
DDI-MedLine.d43.s7,required,139,146,O
DDI-MedLine.d43.s7,the,148,150,O
DDI-MedLine.d43.s7,additional,152,161,O
DDI-MedLine.d43.s7,stimulus,163,170,O
DDI-MedLine.d43.s7,of,172,173,O
DDI-MedLine.d43.s7,dietary,175,181,O
DDI-MedLine.d43.s7,phenobarbital,183,195,B-drug
DDI-MedLine.d43.s7,for,197,199,O
DDI-MedLine.d43.s7,growth,201,206,O
DDI-MedLine.d43.s7,.,207,207,O
DDI-MedLine.d43.s8,Tumors,0,5,O
DDI-MedLine.d43.s8,of,7,8,O
DDI-MedLine.d43.s8,more,10,13,O
DDI-MedLine.d43.s8,malignant,15,23,O
DDI-MedLine.d43.s8,phenotype,25,33,O
DDI-MedLine.d43.s8,were,35,38,O
DDI-MedLine.d43.s8,demonstrated,40,51,O
DDI-MedLine.d43.s8,only,53,56,O
DDI-MedLine.d43.s8,in,58,59,O
DDI-MedLine.d43.s8,genetically,61,71,O
DDI-MedLine.d43.s8,predisposed,73,83,O
DDI-MedLine.d43.s8,mice,85,88,O
DDI-MedLine.d43.s8,(,90,90,O
DDI-MedLine.d43.s8,C57BL/6N,91,98,O
DDI-MedLine.d43.s8,X,100,100,O
DDI-MedLine.d43.s8,C3H/HeN,102,108,O
DDI-MedLine.d43.s8,F1,110,111,O
DDI-MedLine.d43.s8,),112,112,O
DDI-MedLine.d43.s8,that,114,117,O
DDI-MedLine.d43.s8,received,119,126,O
DDI-MedLine.d43.s8,one,128,130,O
DDI-MedLine.d43.s8,dose,132,135,O
DDI-MedLine.d43.s8,of,137,138,O
DDI-MedLine.d43.s8,carcinogen,140,149,O
DDI-MedLine.d43.s8,.,150,150,O
DDI-MedLine.d43.s9,These,0,4,O
DDI-MedLine.d43.s9,findings,6,13,O
DDI-MedLine.d43.s9,suggest,15,21,O
DDI-MedLine.d43.s9,that,23,26,O
DDI-MedLine.d43.s9,the,28,30,O
DDI-MedLine.d43.s9,phenotype,32,40,O
DDI-MedLine.d43.s9,of,42,43,O
DDI-MedLine.d43.s9,a,45,45,O
DDI-MedLine.d43.s9,tumor,47,51,O
DDI-MedLine.d43.s9,that,53,56,O
DDI-MedLine.d43.s9,results,58,64,O
DDI-MedLine.d43.s9,from,66,69,O
DDI-MedLine.d43.s9,a,71,71,O
DDI-MedLine.d43.s9,pulse,73,77,O
DDI-MedLine.d43.s9,of,79,80,O
DDI-MedLine.d43.s9,a,82,82,O
DDI-MedLine.d43.s9,chemical,84,91,O
DDI-MedLine.d43.s9,carcinogen,93,102,O
DDI-MedLine.d43.s9,may,104,106,O
DDI-MedLine.d43.s9,depend,108,113,O
DDI-MedLine.d43.s9,upon,115,118,O
DDI-MedLine.d43.s9,the,120,122,O
DDI-MedLine.d43.s9,target,124,129,O
DDI-MedLine.d43.s9,cell,131,134,O
DDI-MedLine.d43.s9,.,135,135,O
DDI-MedLine.d43.s10,The,0,2,O
DDI-MedLine.d43.s10,initiated,4,12,O
DDI-MedLine.d43.s10,cells,14,18,O
DDI-MedLine.d43.s10,that,20,23,O
DDI-MedLine.d43.s10,result,25,30,O
DDI-MedLine.d43.s10,from,32,35,O
DDI-MedLine.d43.s10,this,37,40,O
DDI-MedLine.d43.s10,hit,42,44,O
DDI-MedLine.d43.s10,may,46,48,O
DDI-MedLine.d43.s10,vary,50,53,O
DDI-MedLine.d43.s10,from,55,58,O
DDI-MedLine.d43.s10,those,60,64,O
DDI-MedLine.d43.s10,that,66,69,O
DDI-MedLine.d43.s10,demonstrate,71,81,O
DDI-MedLine.d43.s10,very,83,86,O
DDI-MedLine.d43.s10,little,88,93,O
DDI-MedLine.d43.s10,progression,95,105,O
DDI-MedLine.d43.s10,in,107,108,O
DDI-MedLine.d43.s10,cell,110,113,O
DDI-MedLine.d43.s10,type,115,118,O
DDI-MedLine.d43.s10,and,120,122,O
DDI-MedLine.d43.s10,may,124,126,O
DDI-MedLine.d43.s10,or,128,129,O
DDI-MedLine.d43.s10,may,131,133,O
DDI-MedLine.d43.s10,not,135,137,O
DDI-MedLine.d43.s10,require,139,145,O
DDI-MedLine.d43.s10,exogenous,147,155,O
DDI-MedLine.d43.s10,enhancement,157,167,O
DDI-MedLine.d43.s10,of,169,170,O
DDI-MedLine.d43.s10,growth,172,177,O
DDI-MedLine.d43.s10,to,179,180,O
DDI-MedLine.d43.s10,those,182,186,O
DDI-MedLine.d43.s10,that,188,191,O
DDI-MedLine.d43.s10,can,193,195,O
DDI-MedLine.d43.s10,progress,197,204,O
DDI-MedLine.d43.s10,very,206,209,O
DDI-MedLine.d43.s10,rapidly,211,217,O
DDI-MedLine.d43.s10,to,219,220,O
DDI-MedLine.d43.s10,fully,222,226,O
DDI-MedLine.d43.s10,malignant,228,236,O
DDI-MedLine.d43.s10,behavior,238,245,O
DDI-MedLine.d43.s10,.,246,246,O
DDI-MedLine.d43.s11,The,0,2,O
DDI-MedLine.d43.s11,latter,4,9,O
DDI-MedLine.d43.s11,might,11,15,O
DDI-MedLine.d43.s11,arise,17,21,O
DDI-MedLine.d43.s11,from,23,26,O
DDI-MedLine.d43.s11,a,28,28,O
DDI-MedLine.d43.s11,hit,30,32,O
DDI-MedLine.d43.s11,in,34,35,O
DDI-MedLine.d43.s11,a,37,37,O
DDI-MedLine.d43.s11,genetically,39,49,O
DDI-MedLine.d43.s11,initiated,51,59,O
DDI-MedLine.d43.s11,cell,61,64,O
DDI-MedLine.d43.s11,",",65,65,O
DDI-MedLine.d43.s11,the,67,69,O
DDI-MedLine.d43.s11,result,71,76,O
DDI-MedLine.d43.s11,of,78,79,O
DDI-MedLine.d43.s11,which,81,85,O
DDI-MedLine.d43.s11,is,87,88,O
DDI-MedLine.d43.s11,a,90,90,O
DDI-MedLine.d43.s11,more,92,95,O
DDI-MedLine.d43.s11,rapid,97,101,O
DDI-MedLine.d43.s11,progression,103,113,O
DDI-MedLine.d43.s11,in,115,116,O
DDI-MedLine.d43.s11,tumor,118,122,O
DDI-MedLine.d43.s11,type,124,127,O
DDI-MedLine.d43.s11,.,128,128,O
DDI-MedLine.d100.s0,Influence,0,8,O
DDI-MedLine.d100.s0,of,10,11,O
DDI-MedLine.d100.s0,calcium-channel,13,27,B-group
DDI-MedLine.d100.s0,blockers,29,36,I-group
DDI-MedLine.d100.s0,on,38,39,O
DDI-MedLine.d100.s0,platelet,41,48,O
DDI-MedLine.d100.s0,function,50,57,O
DDI-MedLine.d100.s0,and,59,61,O
DDI-MedLine.d100.s0,arachidonic,63,73,O
DDI-MedLine.d100.s0,acid,75,78,O
DDI-MedLine.d100.s0,metabolism,80,89,O
DDI-MedLine.d100.s0,.,90,90,O
DDI-MedLine.d100.s1,Available,0,8,O
DDI-MedLine.d100.s1,data,10,13,O
DDI-MedLine.d100.s1,indicate,15,22,O
DDI-MedLine.d100.s1,that,24,27,O
DDI-MedLine.d100.s1,platelet,29,36,O
DDI-MedLine.d100.s1,function,38,45,O
DDI-MedLine.d100.s1,and,47,49,O
DDI-MedLine.d100.s1,arachidonic,51,61,O
DDI-MedLine.d100.s1,acid,63,66,O
DDI-MedLine.d100.s1,metabolism,68,77,O
DDI-MedLine.d100.s1,are,79,81,O
DDI-MedLine.d100.s1,important,83,91,O
DDI-MedLine.d100.s1,factors,93,99,O
DDI-MedLine.d100.s1,in,101,102,O
DDI-MedLine.d100.s1,hemostasis,104,113,O
DDI-MedLine.d100.s1,and,115,117,O
DDI-MedLine.d100.s1,regulation,119,128,O
DDI-MedLine.d100.s1,of,130,131,O
DDI-MedLine.d100.s1,vascular,133,140,O
DDI-MedLine.d100.s1,tone,142,145,O
DDI-MedLine.d100.s1,.,146,146,O
DDI-MedLine.d100.s2,Plasma,0,5,O
DDI-MedLine.d100.s2,membrane,7,14,O
DDI-MedLine.d100.s2,and,16,18,O
DDI-MedLine.d100.s2,intracellular,20,32,O
DDI-MedLine.d100.s2,mobilization,34,45,O
DDI-MedLine.d100.s2,of,47,48,O
DDI-MedLine.d100.s2,calcium,50,56,O
DDI-MedLine.d100.s2,ions,58,61,O
DDI-MedLine.d100.s2,are,63,65,O
DDI-MedLine.d100.s2,intimately,67,76,O
DDI-MedLine.d100.s2,related,78,84,O
DDI-MedLine.d100.s2,to,86,87,O
DDI-MedLine.d100.s2,platelet,89,96,O
DDI-MedLine.d100.s2,activation,98,107,O
DDI-MedLine.d100.s2,and,109,111,O
DDI-MedLine.d100.s2,release,113,119,O
DDI-MedLine.d100.s2,of,121,122,O
DDI-MedLine.d100.s2,platelet,124,131,O
DDI-MedLine.d100.s2,contents,133,140,O
DDI-MedLine.d100.s2,.,141,141,O
DDI-MedLine.d100.s3,Release,0,6,O
DDI-MedLine.d100.s3,of,8,9,O
DDI-MedLine.d100.s3,arachidonic,11,21,O
DDI-MedLine.d100.s3,acid,23,26,O
DDI-MedLine.d100.s3,from,28,31,O
DDI-MedLine.d100.s3,membrane,33,40,O
DDI-MedLine.d100.s3,phospholipids,42,54,O
DDI-MedLine.d100.s3,as,56,57,O
DDI-MedLine.d100.s3,well,59,62,O
DDI-MedLine.d100.s3,as,64,65,O
DDI-MedLine.d100.s3,subsequent,67,76,O
DDI-MedLine.d100.s3,synthesis,78,86,O
DDI-MedLine.d100.s3,and,88,90,O
DDI-MedLine.d100.s3,release,92,98,O
DDI-MedLine.d100.s3,of,100,101,O
DDI-MedLine.d100.s3,vasoconstrictor,103,117,O
DDI-MedLine.d100.s3,thromboxane,119,129,O
DDI-MedLine.d100.s3,A2,131,132,O
DDI-MedLine.d100.s3,are,134,136,O
DDI-MedLine.d100.s3,also,138,141,O
DDI-MedLine.d100.s3,regulated,143,151,O
DDI-MedLine.d100.s3,by,153,154,O
DDI-MedLine.d100.s3,movement,156,163,O
DDI-MedLine.d100.s3,of,165,166,O
DDI-MedLine.d100.s3,calcium,168,174,O
DDI-MedLine.d100.s3,ions,176,179,O
DDI-MedLine.d100.s3,.,180,180,O
DDI-MedLine.d100.s4,Adenosine,0,8,O
DDI-MedLine.d100.s4,3':5'-cyclic,10,21,O
DDI-MedLine.d100.s4,phosphate,23,31,O
DDI-MedLine.d100.s4,in,33,34,O
DDI-MedLine.d100.s4,turn,36,39,O
DDI-MedLine.d100.s4,controls,41,48,O
DDI-MedLine.d100.s4,levels,50,55,O
DDI-MedLine.d100.s4,of,57,58,O
DDI-MedLine.d100.s4,free,60,63,O
DDI-MedLine.d100.s4,calcium,65,71,O
DDI-MedLine.d100.s4,ions,73,76,O
DDI-MedLine.d100.s4,in,78,79,O
DDI-MedLine.d100.s4,platelets,81,89,O
DDI-MedLine.d100.s4,and,91,93,O
DDI-MedLine.d100.s4,regulates,95,103,O
DDI-MedLine.d100.s4,calcium-dependent,105,121,O
DDI-MedLine.d100.s4,reactions,123,131,O
DDI-MedLine.d100.s4,.,132,132,O
DDI-MedLine.d100.s5,Slow-channel,0,11,B-group
DDI-MedLine.d100.s5,calcium,13,19,I-group
DDI-MedLine.d100.s5,blockers,21,28,I-group
DDI-MedLine.d100.s5,",",29,29,O
DDI-MedLine.d100.s5,such,31,34,O
DDI-MedLine.d100.s5,as,36,37,O
DDI-MedLine.d100.s5,verapamil,39,47,B-drug
DDI-MedLine.d100.s5,",",48,48,O
DDI-MedLine.d100.s5,diltiazem,50,58,B-drug
DDI-MedLine.d100.s5,and,60,62,O
DDI-MedLine.d100.s5,nifedipine,64,73,B-drug
DDI-MedLine.d100.s5,",",74,74,O
DDI-MedLine.d100.s5,inhibit,76,82,O
DDI-MedLine.d100.s5,platelet,84,91,O
DDI-MedLine.d100.s5,activation,93,102,O
DDI-MedLine.d100.s5,in,104,105,O
DDI-MedLine.d100.s5,vitro,107,111,O
DDI-MedLine.d100.s5,",",112,112,O
DDI-MedLine.d100.s5,and,114,116,O
DDI-MedLine.d100.s5,decrease,118,125,O
DDI-MedLine.d100.s5,platelet,127,134,O
DDI-MedLine.d100.s5,adhesion,136,143,O
DDI-MedLine.d100.s5,intravascularly,145,159,O
DDI-MedLine.d100.s5,.,160,160,O
DDI-MedLine.d100.s6,These,0,4,O
DDI-MedLine.d100.s6,agents,6,11,O
DDI-MedLine.d100.s6,have,13,16,O
DDI-MedLine.d100.s6,also,18,21,O
DDI-MedLine.d100.s6,been,23,26,O
DDI-MedLine.d100.s6,shown,28,32,O
DDI-MedLine.d100.s6,to,34,35,O
DDI-MedLine.d100.s6,decrease,37,44,O
DDI-MedLine.d100.s6,platelet,46,53,O
DDI-MedLine.d100.s6,nucleotide,55,64,O
DDI-MedLine.d100.s6,release,66,72,O
DDI-MedLine.d100.s6,and,74,76,O
DDI-MedLine.d100.s6,thromboxane,78,88,O
DDI-MedLine.d100.s6,A2,90,91,O
DDI-MedLine.d100.s6,generation,93,102,O
DDI-MedLine.d100.s6,.,103,103,O
DDI-MedLine.d100.s7,Some,0,3,O
DDI-MedLine.d100.s7,preliminary,5,15,O
DDI-MedLine.d100.s7,data,17,20,O
DDI-MedLine.d100.s7,suggest,22,28,O
DDI-MedLine.d100.s7,that,30,33,O
DDI-MedLine.d100.s7,calcium,35,41,B-group
DDI-MedLine.d100.s7,blockers,43,50,I-group
DDI-MedLine.d100.s7,also,52,55,O
DDI-MedLine.d100.s7,increase,57,64,O
DDI-MedLine.d100.s7,generation,66,75,O
DDI-MedLine.d100.s7,of,77,78,O
DDI-MedLine.d100.s7,vasodilator,80,90,O
DDI-MedLine.d100.s7,and,92,94,O
DDI-MedLine.d100.s7,platelet,96,103,O
DDI-MedLine.d100.s7,antiaggregant,105,117,O
DDI-MedLine.d100.s7,prostacyclin,119,130,O
DDI-MedLine.d100.s7,",",131,131,O
DDI-MedLine.d100.s7,which,133,137,O
DDI-MedLine.d100.s7,could,139,143,O
DDI-MedLine.d100.s7,contribute,145,154,O
DDI-MedLine.d100.s7,to,156,157,O
DDI-MedLine.d100.s7,decrease,159,166,O
DDI-MedLine.d100.s7,in,168,169,O
DDI-MedLine.d100.s7,platelet,171,178,O
DDI-MedLine.d100.s7,function,180,187,O
DDI-MedLine.d100.s7,.,188,188,O
DDI-MedLine.d100.s8,These,0,4,O
DDI-MedLine.d100.s8,effects,6,12,O
DDI-MedLine.d100.s8,of,14,15,O
DDI-MedLine.d100.s8,calcium,17,23,B-group
DDI-MedLine.d100.s8,blockers,25,32,I-group
DDI-MedLine.d100.s8,on,34,35,O
DDI-MedLine.d100.s8,platelet,37,44,O
DDI-MedLine.d100.s8,function,46,53,O
DDI-MedLine.d100.s8,and,55,57,O
DDI-MedLine.d100.s8,arachidonic,59,69,O
DDI-MedLine.d100.s8,acid,71,74,O
DDI-MedLine.d100.s8,metabolism,76,85,O
DDI-MedLine.d100.s8,could,87,91,O
DDI-MedLine.d100.s8,contribute,93,102,O
DDI-MedLine.d100.s8,in,104,105,O
DDI-MedLine.d100.s8,part,107,110,O
DDI-MedLine.d100.s8,to,112,113,O
DDI-MedLine.d100.s8,their,115,119,O
DDI-MedLine.d100.s8,efficacy,121,128,O
DDI-MedLine.d100.s8,in,130,131,O
DDI-MedLine.d100.s8,patients,133,140,O
DDI-MedLine.d100.s8,with,142,145,O
DDI-MedLine.d100.s8,ischemic,147,154,O
DDI-MedLine.d100.s8,heart,156,160,O
DDI-MedLine.d100.s8,disease,162,168,O
DDI-MedLine.d100.s8,.,169,169,O
DDI-MedLine.d73.s0,Neurochemical,0,12,O
DDI-MedLine.d73.s0,and,14,16,O
DDI-MedLine.d73.s0,functional,18,27,O
DDI-MedLine.d73.s0,consequences,29,40,O
DDI-MedLine.d73.s0,following,42,50,O
DDI-MedLine.d73.s0,"1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine",52,95,B-drug_n
DDI-MedLine.d73.s0,(,97,97,O
DDI-MedLine.d73.s0,MPTP,98,101,B-drug_n
DDI-MedLine.d73.s0,),102,102,O
DDI-MedLine.d73.s0,and,104,106,O
DDI-MedLine.d73.s0,methamphetamine,108,122,B-drug
DDI-MedLine.d73.s0,.,123,123,O
DDI-MedLine.d73.s1,The,0,2,O
DDI-MedLine.d73.s1,neurochemical,4,16,O
DDI-MedLine.d73.s1,and,18,20,O
DDI-MedLine.d73.s1,functional,22,31,O
DDI-MedLine.d73.s1,consequences,33,44,O
DDI-MedLine.d73.s1,following,46,54,O
DDI-MedLine.d73.s1,MPTP,56,59,B-drug_n
DDI-MedLine.d73.s1,administration,61,74,O
DDI-MedLine.d73.s1,to,76,77,O
DDI-MedLine.d73.s1,the,79,81,O
DDI-MedLine.d73.s1,rat,83,85,O
DDI-MedLine.d73.s1,were,87,90,O
DDI-MedLine.d73.s1,evaluated,92,100,O
DDI-MedLine.d73.s1,and,102,104,O
DDI-MedLine.d73.s1,compared,106,113,O
DDI-MedLine.d73.s1,to,115,116,O
DDI-MedLine.d73.s1,similar,118,124,O
DDI-MedLine.d73.s1,effects,126,132,O
DDI-MedLine.d73.s1,following,134,142,O
DDI-MedLine.d73.s1,methamphetamine,144,158,B-drug
DDI-MedLine.d73.s1,administration,160,173,O
DDI-MedLine.d73.s1,.,174,174,O
DDI-MedLine.d73.s2,It,0,1,O
DDI-MedLine.d73.s2,was,3,5,O
DDI-MedLine.d73.s2,observed,7,14,O
DDI-MedLine.d73.s2,that,16,19,O
DDI-MedLine.d73.s2,MPTP,21,24,B-drug_n
DDI-MedLine.d73.s2,induced,26,32,O
DDI-MedLine.d73.s2,long,34,37,O
DDI-MedLine.d73.s2,lasting,39,45,O
DDI-MedLine.d73.s2,depletions,47,56,O
DDI-MedLine.d73.s2,of,58,59,O
DDI-MedLine.d73.s2,striatal,61,68,O
DDI-MedLine.d73.s2,dopamine,70,77,O
DDI-MedLine.d73.s2,concentrations,79,92,O
DDI-MedLine.d73.s2,and,94,96,O
DDI-MedLine.d73.s2,this,98,101,O
DDI-MedLine.d73.s2,neurotoxic,103,112,O
DDI-MedLine.d73.s2,effect,114,119,O
DDI-MedLine.d73.s2,could,121,125,O
DDI-MedLine.d73.s2,be,127,128,O
DDI-MedLine.d73.s2,prevented,130,138,O
DDI-MedLine.d73.s2,by,140,141,O
DDI-MedLine.d73.s2,pargyline,143,151,B-drug
DDI-MedLine.d73.s2,pretreatment,153,164,O
DDI-MedLine.d73.s2,.,165,165,O
DDI-MedLine.d73.s3,The,0,2,O
DDI-MedLine.d73.s3,MPTP-induced,4,15,O
DDI-MedLine.d73.s3,neuronal,17,24,O
DDI-MedLine.d73.s3,damage,26,31,O
DDI-MedLine.d73.s3,produced,33,40,O
DDI-MedLine.d73.s3,a,42,42,O
DDI-MedLine.d73.s3,tolerance,44,52,O
DDI-MedLine.d73.s3,to,54,55,O
DDI-MedLine.d73.s3,the,57,59,O
DDI-MedLine.d73.s3,disruptive,61,70,O
DDI-MedLine.d73.s3,effects,72,78,O
DDI-MedLine.d73.s3,of,80,81,O
DDI-MedLine.d73.s3,amphetamine,83,93,B-drug
DDI-MedLine.d73.s3,and,95,97,O
DDI-MedLine.d73.s3,a,99,99,O
DDI-MedLine.d73.s3,supersensitivity,101,116,O
DDI-MedLine.d73.s3,to,118,119,O
DDI-MedLine.d73.s3,the,121,123,O
DDI-MedLine.d73.s3,disruptive,125,134,O
DDI-MedLine.d73.s3,effects,136,142,O
DDI-MedLine.d73.s3,of,144,145,O
DDI-MedLine.d73.s3,apomorphine,147,157,B-drug
DDI-MedLine.d73.s3,in,159,160,O
DDI-MedLine.d73.s3,rats,162,165,O
DDI-MedLine.d73.s3,responding,167,176,O
DDI-MedLine.d73.s3,in,178,179,O
DDI-MedLine.d73.s3,a,181,181,O
DDI-MedLine.d73.s3,schedule,183,190,O
DDI-MedLine.d73.s3,controlled,192,201,O
DDI-MedLine.d73.s3,paradigm,203,210,O
DDI-MedLine.d73.s3,.,211,211,O
DDI-MedLine.d73.s4,Methamphetamine,0,14,B-drug
DDI-MedLine.d73.s4,",",15,15,O
DDI-MedLine.d73.s4,like,17,20,O
DDI-MedLine.d73.s4,MPTP,22,25,B-drug_n
DDI-MedLine.d73.s4,",",26,26,O
DDI-MedLine.d73.s4,produced,28,35,O
DDI-MedLine.d73.s4,depletions,37,46,O
DDI-MedLine.d73.s4,of,48,49,O
DDI-MedLine.d73.s4,striatal,51,58,O
DDI-MedLine.d73.s4,dopamine,60,67,O
DDI-MedLine.d73.s4,but,69,71,O
DDI-MedLine.d73.s4,these,73,77,O
DDI-MedLine.d73.s4,actions,79,85,O
DDI-MedLine.d73.s4,were,87,90,O
DDI-MedLine.d73.s4,potentiated,92,102,O
DDI-MedLine.d73.s4,by,104,105,O
DDI-MedLine.d73.s4,pargyline,107,115,B-drug
DDI-MedLine.d73.s4,pretreatment,117,128,O
DDI-MedLine.d73.s4,.,129,129,O
DDI-MedLine.d73.s5,These,0,4,O
DDI-MedLine.d73.s5,observations,6,17,O
DDI-MedLine.d73.s5,are,19,21,O
DDI-MedLine.d73.s5,discussed,23,31,O
DDI-MedLine.d73.s5,in,33,34,O
DDI-MedLine.d73.s5,reference,36,44,O
DDI-MedLine.d73.s5,to,46,47,O
DDI-MedLine.d73.s5,possible,49,56,O
DDI-MedLine.d73.s5,deleterious,58,68,O
DDI-MedLine.d73.s5,effects,70,76,O
DDI-MedLine.d73.s5,following,78,86,O
DDI-MedLine.d73.s5,the,88,90,O
DDI-MedLine.d73.s5,administration,92,105,O
DDI-MedLine.d73.s5,of,107,108,O
DDI-MedLine.d73.s5,pargyline,110,118,B-drug
DDI-MedLine.d73.s5,to,120,121,O
DDI-MedLine.d73.s5,patients,123,130,O
DDI-MedLine.d73.s5,with,132,135,O
DDI-MedLine.d73.s5,Parkinson,137,145,O
DDI-MedLine.d73.s5,'s,146,147,O
DDI-MedLine.d73.s5,Disease,149,155,O
DDI-MedLine.d73.s5,.,156,156,O
DDI-MedLine.d31.s0,Cancer,0,5,O
DDI-MedLine.d31.s0,in,7,8,O
DDI-MedLine.d31.s0,the,10,12,O
DDI-MedLine.d31.s0,elderly,14,20,O
DDI-MedLine.d31.s0,:,21,21,O
DDI-MedLine.d31.s0,basic,23,27,O
DDI-MedLine.d31.s0,science,29,35,O
DDI-MedLine.d31.s0,and,37,39,O
DDI-MedLine.d31.s0,clinical,41,48,O
DDI-MedLine.d31.s0,aspects,50,56,O
DDI-MedLine.d31.s0,.,57,57,O
DDI-MedLine.d31.s1,The,0,2,O
DDI-MedLine.d31.s1,incidence,4,12,O
DDI-MedLine.d31.s1,of,14,15,O
DDI-MedLine.d31.s1,cancer,17,22,O
DDI-MedLine.d31.s1,increases,24,32,O
DDI-MedLine.d31.s1,progressively,34,46,O
DDI-MedLine.d31.s1,with,48,51,O
DDI-MedLine.d31.s1,age,53,55,O
DDI-MedLine.d31.s1,.,56,56,O
DDI-MedLine.d31.s2,Rearrangements,0,13,O
DDI-MedLine.d31.s2,of,15,16,O
DDI-MedLine.d31.s2,genomes,18,24,O
DDI-MedLine.d31.s2,have,26,29,O
DDI-MedLine.d31.s2,been,31,34,O
DDI-MedLine.d31.s2,found,36,40,O
DDI-MedLine.d31.s2,to,42,43,O
DDI-MedLine.d31.s2,accompany,45,53,O
DDI-MedLine.d31.s2,cellular,55,62,O
DDI-MedLine.d31.s2,aging,64,68,O
DDI-MedLine.d31.s2,.,69,69,O
DDI-MedLine.d31.s3,These,0,4,O
DDI-MedLine.d31.s3,factors,6,12,O
DDI-MedLine.d31.s3,",",13,13,O
DDI-MedLine.d31.s3,in,15,16,O
DDI-MedLine.d31.s3,concert,18,24,O
DDI-MedLine.d31.s3,with,26,29,O
DDI-MedLine.d31.s3,age-dependent,31,43,O
DDI-MedLine.d31.s3,alterations,45,55,O
DDI-MedLine.d31.s3,in,57,58,O
DDI-MedLine.d31.s3,immune,60,65,O
DDI-MedLine.d31.s3,function,67,74,O
DDI-MedLine.d31.s3,and,76,78,O
DDI-MedLine.d31.s3,host,80,83,O
DDI-MedLine.d31.s3,defense,85,91,O
DDI-MedLine.d31.s3,",",92,92,O
DDI-MedLine.d31.s3,may,94,96,O
DDI-MedLine.d31.s3,help,98,101,O
DDI-MedLine.d31.s3,to,103,104,O
DDI-MedLine.d31.s3,explain,106,112,O
DDI-MedLine.d31.s3,the,114,116,O
DDI-MedLine.d31.s3,increased,118,126,O
DDI-MedLine.d31.s3,risk,128,131,O
DDI-MedLine.d31.s3,of,133,134,O
DDI-MedLine.d31.s3,malignant,136,144,O
DDI-MedLine.d31.s3,disease,146,152,O
DDI-MedLine.d31.s3,in,154,155,O
DDI-MedLine.d31.s3,aged,157,160,O
DDI-MedLine.d31.s3,persons,162,168,O
DDI-MedLine.d31.s3,.,169,169,O
DDI-MedLine.d31.s4,The,0,2,O
DDI-MedLine.d31.s4,clinical,4,11,O
DDI-MedLine.d31.s4,presentation,13,24,O
DDI-MedLine.d31.s4,and,26,28,O
DDI-MedLine.d31.s4,natural,30,36,O
DDI-MedLine.d31.s4,history,38,44,O
DDI-MedLine.d31.s4,of,46,47,O
DDI-MedLine.d31.s4,neoplasia,49,57,O
DDI-MedLine.d31.s4,are,59,61,O
DDI-MedLine.d31.s4,also,63,66,O
DDI-MedLine.d31.s4,affected,68,75,O
DDI-MedLine.d31.s4,by,77,78,O
DDI-MedLine.d31.s4,aging,80,84,O
DDI-MedLine.d31.s4,.,85,85,O
DDI-MedLine.d31.s5,This,0,3,O
DDI-MedLine.d31.s5,conference,5,14,O
DDI-MedLine.d31.s5,reviews,16,22,O
DDI-MedLine.d31.s5,recent,24,29,O
DDI-MedLine.d31.s5,developments,31,42,O
DDI-MedLine.d31.s5,in,44,45,O
DDI-MedLine.d31.s5,these,47,51,O
DDI-MedLine.d31.s5,areas,53,57,O
DDI-MedLine.d31.s5,",",58,58,O
DDI-MedLine.d31.s5,examines,60,67,O
DDI-MedLine.d31.s5,the,69,71,O
DDI-MedLine.d31.s5,effects,73,79,O
DDI-MedLine.d31.s5,of,81,82,O
DDI-MedLine.d31.s5,drug,84,87,O
DDI-MedLine.d31.s5,use,89,91,O
DDI-MedLine.d31.s5,in,93,94,O
DDI-MedLine.d31.s5,the,96,98,O
DDI-MedLine.d31.s5,elderly,100,106,O
DDI-MedLine.d31.s5,and,108,110,O
DDI-MedLine.d31.s5,implications,112,123,O
DDI-MedLine.d31.s5,for,125,127,O
DDI-MedLine.d31.s5,management,129,138,O
DDI-MedLine.d31.s5,",",139,139,O
DDI-MedLine.d31.s5,and,141,143,O
DDI-MedLine.d31.s5,discusses,145,153,O
DDI-MedLine.d31.s5,current,155,161,O
DDI-MedLine.d31.s5,information,163,173,O
DDI-MedLine.d31.s5,on,175,176,O
DDI-MedLine.d31.s5,how,178,180,O
DDI-MedLine.d31.s5,age,182,184,O
DDI-MedLine.d31.s5,may,186,188,O
DDI-MedLine.d31.s5,influence,190,198,O
DDI-MedLine.d31.s5,the,200,202,O
DDI-MedLine.d31.s5,response,204,211,O
DDI-MedLine.d31.s5,of,213,214,O
DDI-MedLine.d31.s5,cancer,216,221,O
DDI-MedLine.d31.s5,to,223,224,O
DDI-MedLine.d31.s5,therapy,226,232,O
DDI-MedLine.d31.s5,.,233,233,O
DDI-DrugBank.d449.s0,Co-administration,0,16,O
DDI-DrugBank.d449.s0,with,18,21,O
DDI-DrugBank.d449.s0,antifungal,23,32,B-group
DDI-DrugBank.d449.s0,agents,34,39,I-group
DDI-DrugBank.d449.s0,such,41,44,O
DDI-DrugBank.d449.s0,as,46,47,O
DDI-DrugBank.d449.s0,ketoconazole,49,60,B-drug
DDI-DrugBank.d449.s0,or,62,63,O
DDI-DrugBank.d449.s0,itraconazole,65,76,B-drug
DDI-DrugBank.d449.s0,is,78,79,O
DDI-DrugBank.d449.s0,not,81,83,O
DDI-DrugBank.d449.s0,recommended,85,95,O
DDI-DrugBank.d449.s0,.,96,96,O
DDI-DrugBank.d449.s1,Nafazodone,0,9,B-drug
DDI-DrugBank.d449.s1,",",10,10,O
DDI-DrugBank.d449.s1,fluvoxamine,12,22,B-drug
DDI-DrugBank.d449.s1,",",23,23,O
DDI-DrugBank.d449.s1,cimetidine,25,34,B-drug
DDI-DrugBank.d449.s1,(,36,36,O
DDI-DrugBank.d449.s1,consider,37,44,O
DDI-DrugBank.d449.s1,Xanax,46,50,B-brand
DDI-DrugBank.d449.s1,dose,52,55,O
DDI-DrugBank.d449.s1,reduction,57,65,O
DDI-DrugBank.d449.s1,),66,66,O
DDI-DrugBank.d449.s1,.,67,67,O
DDI-DrugBank.d449.s2,Fluoxetine,0,9,B-drug
DDI-DrugBank.d449.s2,",",10,10,O
DDI-DrugBank.d449.s2,OCs,12,14,B-group
DDI-DrugBank.d449.s2,",",15,15,O
DDI-DrugBank.d449.s2,sertraline,17,26,B-drug
DDI-DrugBank.d449.s2,",",27,27,O
DDI-DrugBank.d449.s2,diltiazem,29,37,B-drug
DDI-DrugBank.d449.s2,",",38,38,O
DDI-DrugBank.d449.s2,macrolide,40,48,B-group
DDI-DrugBank.d449.s2,antibiotics,50,60,I-group
DDI-DrugBank.d449.s2,(,62,62,O
DDI-DrugBank.d449.s2,exercise,63,70,O
DDI-DrugBank.d449.s2,caution,72,78,O
DDI-DrugBank.d449.s2,),79,79,O
DDI-DrugBank.d449.s2,.,80,80,O
DDI-DrugBank.d8.s0,Both,0,3,O
DDI-DrugBank.d8.s0,the,5,7,O
DDI-DrugBank.d8.s0,magnitude,9,17,O
DDI-DrugBank.d8.s0,and,19,21,O
DDI-DrugBank.d8.s0,duration,23,30,O
DDI-DrugBank.d8.s0,of,32,33,O
DDI-DrugBank.d8.s0,central,35,41,O
DDI-DrugBank.d8.s0,nervous,43,49,O
DDI-DrugBank.d8.s0,system,51,56,O
DDI-DrugBank.d8.s0,and,58,60,O
DDI-DrugBank.d8.s0,cardiovascular,62,75,O
DDI-DrugBank.d8.s0,effects,77,83,O
DDI-DrugBank.d8.s0,may,85,87,O
DDI-DrugBank.d8.s0,be,89,90,O
DDI-DrugBank.d8.s0,enhanced,92,99,O
DDI-DrugBank.d8.s0,when,101,104,O
DDI-DrugBank.d8.s0,ALFENTA,106,112,B-brand
DDI-DrugBank.d8.s0,is,114,115,O
DDI-DrugBank.d8.s0,administered,117,128,O
DDI-DrugBank.d8.s0,in,130,131,O
DDI-DrugBank.d8.s0,combination,133,143,O
DDI-DrugBank.d8.s0,with,145,148,O
DDI-DrugBank.d8.s0,other,150,154,O
DDI-DrugBank.d8.s0,CNS,156,158,B-group
DDI-DrugBank.d8.s0,depressants,160,170,I-group
DDI-DrugBank.d8.s0,such,172,175,O
DDI-DrugBank.d8.s0,as,177,178,O
DDI-DrugBank.d8.s0,barbiturates,180,191,B-group
DDI-DrugBank.d8.s0,",",192,192,O
DDI-DrugBank.d8.s0,tranquilizers,194,206,B-group
DDI-DrugBank.d8.s0,",",207,207,O
DDI-DrugBank.d8.s0,opioids,209,215,B-group
DDI-DrugBank.d8.s0,",",216,216,O
DDI-DrugBank.d8.s0,or,218,219,O
DDI-DrugBank.d8.s0,inhalation,221,230,O
DDI-DrugBank.d8.s0,general,232,238,O
DDI-DrugBank.d8.s0,anesthetics,240,250,B-group
DDI-DrugBank.d8.s0,.,251,251,O
DDI-DrugBank.d8.s1,Postoperative,0,12,O
DDI-DrugBank.d8.s1,respiratory,14,24,O
DDI-DrugBank.d8.s1,depression,26,35,O
DDI-DrugBank.d8.s1,may,37,39,O
DDI-DrugBank.d8.s1,be,41,42,O
DDI-DrugBank.d8.s1,enhanced,44,51,O
DDI-DrugBank.d8.s1,or,53,54,O
DDI-DrugBank.d8.s1,prolonged,56,64,O
DDI-DrugBank.d8.s1,by,66,67,O
DDI-DrugBank.d8.s1,these,69,73,O
DDI-DrugBank.d8.s1,agents,75,80,O
DDI-DrugBank.d8.s1,.,81,81,O
DDI-DrugBank.d8.s2,In,0,1,O
DDI-DrugBank.d8.s2,such,3,6,O
DDI-DrugBank.d8.s2,cases,8,12,O
DDI-DrugBank.d8.s2,of,14,15,O
DDI-DrugBank.d8.s2,combined,17,24,O
DDI-DrugBank.d8.s2,treatment,26,34,O
DDI-DrugBank.d8.s2,",",35,35,O
DDI-DrugBank.d8.s2,the,37,39,O
DDI-DrugBank.d8.s2,dose,41,44,O
DDI-DrugBank.d8.s2,of,46,47,O
DDI-DrugBank.d8.s2,one,49,51,O
DDI-DrugBank.d8.s2,or,53,54,O
DDI-DrugBank.d8.s2,both,56,59,O
DDI-DrugBank.d8.s2,agents,61,66,O
DDI-DrugBank.d8.s2,should,68,73,O
DDI-DrugBank.d8.s2,be,75,76,O
DDI-DrugBank.d8.s2,reduced,78,84,O
DDI-DrugBank.d8.s2,.,85,85,O
DDI-DrugBank.d8.s3,Limited,0,6,O
DDI-DrugBank.d8.s3,clinical,8,15,O
DDI-DrugBank.d8.s3,experience,17,26,O
DDI-DrugBank.d8.s3,indicates,28,36,O
DDI-DrugBank.d8.s3,that,38,41,O
DDI-DrugBank.d8.s3,requirements,43,54,O
DDI-DrugBank.d8.s3,for,56,58,O
DDI-DrugBank.d8.s3,volatile,60,67,B-group
DDI-DrugBank.d8.s3,inhalation,69,78,I-group
DDI-DrugBank.d8.s3,anesthetics,80,90,I-group
DDI-DrugBank.d8.s3,are,92,94,O
DDI-DrugBank.d8.s3,reduced,96,102,O
DDI-DrugBank.d8.s3,by,104,105,O
DDI-DrugBank.d8.s3,30,107,108,O
DDI-DrugBank.d8.s3,to,110,111,O
DDI-DrugBank.d8.s3,50,113,114,O
DDI-DrugBank.d8.s3,%,115,115,O
DDI-DrugBank.d8.s3,for,117,119,O
DDI-DrugBank.d8.s3,the,121,123,O
DDI-DrugBank.d8.s3,first,125,129,O
DDI-DrugBank.d8.s3,sixty,131,135,O
DDI-DrugBank.d8.s3,(,137,137,O
DDI-DrugBank.d8.s3,60,138,139,O
DDI-DrugBank.d8.s3,),140,140,O
DDI-DrugBank.d8.s3,minutes,142,148,O
DDI-DrugBank.d8.s3,following,150,158,O
DDI-DrugBank.d8.s3,ALFENTA,160,166,B-brand
DDI-DrugBank.d8.s3,induction,168,176,O
DDI-DrugBank.d8.s3,The,178,180,O
DDI-DrugBank.d8.s3,concomitant,182,192,O
DDI-DrugBank.d8.s3,use,194,196,O
DDI-DrugBank.d8.s3,of,198,199,O
DDI-DrugBank.d8.s3,erythromycin,201,212,B-drug
DDI-DrugBank.d8.s3,with,214,217,O
DDI-DrugBank.d8.s3,ALFENTA,219,225,B-brand
DDI-DrugBank.d8.s3,can,227,229,O
DDI-DrugBank.d8.s3,significantly,231,243,O
DDI-DrugBank.d8.s3,inhibit,245,251,O
DDI-DrugBank.d8.s3,ALFENTA,253,259,B-brand
DDI-DrugBank.d8.s3,clearance,261,269,O
DDI-DrugBank.d8.s3,and,271,273,O
DDI-DrugBank.d8.s3,may,275,277,O
DDI-DrugBank.d8.s3,increase,279,286,O
DDI-DrugBank.d8.s3,the,288,290,O
DDI-DrugBank.d8.s3,risk,292,295,O
DDI-DrugBank.d8.s3,of,297,298,O
DDI-DrugBank.d8.s3,prolonged,300,308,O
DDI-DrugBank.d8.s3,or,310,311,O
DDI-DrugBank.d8.s3,delayed,313,319,O
DDI-DrugBank.d8.s3,respiratory,321,331,O
DDI-DrugBank.d8.s3,depression,333,342,O
DDI-DrugBank.d8.s3,.,343,343,O
DDI-DrugBank.d8.s4,Cimetidine,0,9,B-drug
DDI-DrugBank.d8.s4,reduces,11,17,O
DDI-DrugBank.d8.s4,the,19,21,O
DDI-DrugBank.d8.s4,clearance,23,31,O
DDI-DrugBank.d8.s4,of,33,34,O
DDI-DrugBank.d8.s4,ALFENTA,36,42,B-brand
DDI-DrugBank.d8.s4,.,43,43,O
DDI-DrugBank.d8.s5,Therefore,0,8,O
DDI-DrugBank.d8.s5,smaller,10,16,O
DDI-DrugBank.d8.s5,ALFENTA,18,24,B-brand
DDI-DrugBank.d8.s5,doses,26,30,O
DDI-DrugBank.d8.s5,will,32,35,O
DDI-DrugBank.d8.s5,be,37,38,O
DDI-DrugBank.d8.s5,required,40,47,O
DDI-DrugBank.d8.s5,with,49,52,O
DDI-DrugBank.d8.s5,prolonged,54,62,O
DDI-DrugBank.d8.s5,administration,64,77,O
DDI-DrugBank.d8.s5,and,79,81,O
DDI-DrugBank.d8.s5,the,83,85,O
DDI-DrugBank.d8.s5,duration,87,94,O
DDI-DrugBank.d8.s5,of,96,97,O
DDI-DrugBank.d8.s5,action,99,104,O
DDI-DrugBank.d8.s5,of,106,107,O
DDI-DrugBank.d8.s5,ALFENTA,109,115,B-brand
DDI-DrugBank.d8.s5,my,117,118,O
DDI-DrugBank.d8.s5,be,120,121,O
DDI-DrugBank.d8.s5,extended,123,130,O
DDI-DrugBank.d8.s5,.,131,131,O
DDI-DrugBank.d8.s6,Perioperative,0,12,O
DDI-DrugBank.d8.s6,administration,14,27,O
DDI-DrugBank.d8.s6,of,29,30,O
DDI-DrugBank.d8.s6,drugs,32,36,O
DDI-DrugBank.d8.s6,affecting,38,46,O
DDI-DrugBank.d8.s6,hepatic,48,54,O
DDI-DrugBank.d8.s6,blood,56,60,O
DDI-DrugBank.d8.s6,flow,62,65,O
DDI-DrugBank.d8.s6,or,67,68,O
DDI-DrugBank.d8.s6,enzyme,70,75,O
DDI-DrugBank.d8.s6,function,77,84,O
DDI-DrugBank.d8.s6,may,86,88,O
DDI-DrugBank.d8.s6,reduce,90,95,O
DDI-DrugBank.d8.s6,plasma,97,102,O
DDI-DrugBank.d8.s6,clearance,104,112,O
DDI-DrugBank.d8.s6,and,114,116,O
DDI-DrugBank.d8.s6,prolong,118,124,O
DDI-DrugBank.d8.s6,recovery,126,133,O
DDI-DrugBank.d8.s6,.,134,134,O
DDI-DrugBank.d416.s0,Renal,0,4,O
DDI-DrugBank.d416.s0,clearance,6,14,O
DDI-DrugBank.d416.s0,measurements,16,27,O
DDI-DrugBank.d416.s0,of,29,30,O
DDI-DrugBank.d416.s0,PAH,32,34,B-drug
DDI-DrugBank.d416.s0,can,36,38,O
DDI-DrugBank.d416.s0,not,39,41,O
DDI-DrugBank.d416.s0,be,43,44,O
DDI-DrugBank.d416.s0,made,46,49,O
DDI-DrugBank.d416.s0,with,51,54,O
DDI-DrugBank.d416.s0,any,56,58,O
DDI-DrugBank.d416.s0,significant,60,70,O
DDI-DrugBank.d416.s0,accuracy,72,79,O
DDI-DrugBank.d416.s0,in,81,82,O
DDI-DrugBank.d416.s0,patients,84,91,O
DDI-DrugBank.d416.s0,receiving,93,101,O
DDI-DrugBank.d416.s0,sulfonamides,103,114,B-group
DDI-DrugBank.d416.s0,",",115,115,O
DDI-DrugBank.d416.s0,procaine,117,124,B-drug
DDI-DrugBank.d416.s0,",",125,125,O
DDI-DrugBank.d416.s0,or,127,128,O
DDI-DrugBank.d416.s0,thiazolesulfone,130,144,B-drug
DDI-DrugBank.d416.s0,.,145,145,O
DDI-DrugBank.d416.s1,These,0,4,O
DDI-DrugBank.d416.s1,compounds,6,14,O
DDI-DrugBank.d416.s1,interfere,16,24,O
DDI-DrugBank.d416.s1,with,26,29,O
DDI-DrugBank.d416.s1,chemical,31,38,O
DDI-DrugBank.d416.s1,color,40,44,O
DDI-DrugBank.d416.s1,development,46,56,O
DDI-DrugBank.d416.s1,essential,58,66,O
DDI-DrugBank.d416.s1,to,68,69,O
DDI-DrugBank.d416.s1,the,71,73,O
DDI-DrugBank.d416.s1,analytical,75,84,O
DDI-DrugBank.d416.s1,procedures,86,95,O
DDI-DrugBank.d416.s1,.,96,96,O
DDI-DrugBank.d416.s2,Probenecid,0,9,B-drug
DDI-DrugBank.d416.s2,depresses,11,19,O
DDI-DrugBank.d416.s2,tubular,21,27,O
DDI-DrugBank.d416.s2,secretion,29,37,O
DDI-DrugBank.d416.s2,of,39,40,O
DDI-DrugBank.d416.s2,certain,42,48,O
DDI-DrugBank.d416.s2,weak,50,53,O
DDI-DrugBank.d416.s2,acids,55,59,O
DDI-DrugBank.d416.s2,such,61,64,O
DDI-DrugBank.d416.s2,as,66,67,O
DDI-DrugBank.d416.s2,PAH,69,71,B-drug
DDI-DrugBank.d416.s2,.,72,72,O
DDI-DrugBank.d416.s3,Therefore,0,8,O
DDI-DrugBank.d416.s3,",",9,9,O
DDI-DrugBank.d416.s3,patients,11,18,O
DDI-DrugBank.d416.s3,receiving,20,28,O
DDI-DrugBank.d416.s3,probenecid,30,39,B-drug
DDI-DrugBank.d416.s3,will,41,44,O
DDI-DrugBank.d416.s3,have,46,49,O
DDI-DrugBank.d416.s3,erroneously,51,61,O
DDI-DrugBank.d416.s3,low,63,65,O
DDI-DrugBank.d416.s3,ERPF,67,70,O
DDI-DrugBank.d416.s3,and,72,74,O
DDI-DrugBank.d416.s3,Tm,76,77,O
DDI-DrugBank.d416.s3,PAH,79,81,B-drug
DDI-DrugBank.d416.s3,values,83,88,O
DDI-DrugBank.d416.s3,.,89,89,O
DDI-DrugBank.d22.s0,Aminosalicylic,0,13,B-drug
DDI-DrugBank.d22.s0,acid,15,18,I-drug
DDI-DrugBank.d22.s0,may,20,22,O
DDI-DrugBank.d22.s0,decrease,24,31,O
DDI-DrugBank.d22.s0,the,33,35,O
DDI-DrugBank.d22.s0,amount,37,42,O
DDI-DrugBank.d22.s0,of,44,45,O
DDI-DrugBank.d22.s0,digoxin,47,53,B-drug
DDI-DrugBank.d22.s0,(,55,55,O
DDI-DrugBank.d22.s0,Lanoxin,56,62,B-brand
DDI-DrugBank.d22.s0,",",63,63,O
DDI-DrugBank.d22.s0,Lanoxicaps,65,74,B-drug
DDI-DrugBank.d22.s0,),75,75,O
DDI-DrugBank.d22.s0,that,77,80,O
DDI-DrugBank.d22.s0,gets,82,85,O
DDI-DrugBank.d22.s0,absorbed,87,94,O
DDI-DrugBank.d22.s0,into,96,99,O
DDI-DrugBank.d22.s0,your,101,104,O
DDI-DrugBank.d22.s0,body,106,109,O
DDI-DrugBank.d22.s0,.,110,110,O
DDI-DrugBank.d22.s1,In,0,1,O
DDI-DrugBank.d22.s1,the,3,5,O
DDI-DrugBank.d22.s1,case,7,10,O
DDI-DrugBank.d22.s1,that,12,15,O
DDI-DrugBank.d22.s1,you,17,19,O
DDI-DrugBank.d22.s1,are,21,23,O
DDI-DrugBank.d22.s1,taking,25,30,O
DDI-DrugBank.d22.s1,digoxin,32,38,B-drug
DDI-DrugBank.d22.s1,while,40,44,O
DDI-DrugBank.d22.s1,taking,46,51,O
DDI-DrugBank.d22.s1,aminosalicylic,53,66,B-drug
DDI-DrugBank.d22.s1,acid,68,71,I-drug
DDI-DrugBank.d22.s1,",",72,72,O
DDI-DrugBank.d22.s1,higher,74,79,O
DDI-DrugBank.d22.s1,doses,81,85,O
DDI-DrugBank.d22.s1,of,87,88,O
DDI-DrugBank.d22.s1,digoxin,90,96,B-drug
DDI-DrugBank.d22.s1,may,98,100,O
DDI-DrugBank.d22.s1,be,102,103,O
DDI-DrugBank.d22.s1,needed,105,110,O
DDI-DrugBank.d22.s1,.,111,111,O
DDI-DrugBank.d22.s2,Aminosalicylic,0,13,B-drug
DDI-DrugBank.d22.s2,acid,15,18,I-drug
DDI-DrugBank.d22.s2,may,20,22,O
DDI-DrugBank.d22.s2,also,24,27,O
DDI-DrugBank.d22.s2,decrease,29,36,O
DDI-DrugBank.d22.s2,the,38,40,O
DDI-DrugBank.d22.s2,absorption,42,51,O
DDI-DrugBank.d22.s2,of,53,54,O
DDI-DrugBank.d22.s2,vitamin,56,62,B-drug
DDI-DrugBank.d22.s2,B12,64,66,I-drug
DDI-DrugBank.d22.s2,",",67,67,O
DDI-DrugBank.d22.s2,which,69,73,O
DDI-DrugBank.d22.s2,can,75,77,O
DDI-DrugBank.d22.s2,lead,79,82,O
DDI-DrugBank.d22.s2,to,84,85,O
DDI-DrugBank.d22.s2,a,87,87,O
DDI-DrugBank.d22.s2,deficiency,89,98,O
DDI-DrugBank.d22.s2,.,99,99,O
DDI-DrugBank.d22.s3,Therefore,0,8,O
DDI-DrugBank.d22.s3,you,10,12,O
DDI-DrugBank.d22.s3,may,14,16,O
DDI-DrugBank.d22.s3,need,18,21,O
DDI-DrugBank.d22.s3,to,23,24,O
DDI-DrugBank.d22.s3,take,26,29,O
DDI-DrugBank.d22.s3,a,31,31,O
DDI-DrugBank.d22.s3,vitamin,33,39,B-drug
DDI-DrugBank.d22.s3,B12,41,43,I-drug
DDI-DrugBank.d22.s3,supplement,45,54,O
DDI-DrugBank.d22.s3,while,56,60,O
DDI-DrugBank.d22.s3,taking,62,67,O
DDI-DrugBank.d22.s3,aminosalicylic,69,82,B-drug
DDI-DrugBank.d22.s3,acid,84,87,I-drug
DDI-DrugBank.d22.s3,.,88,88,O
DDI-DrugBank.d318.s0,When,0,3,O
DDI-DrugBank.d318.s0,administered,5,16,O
DDI-DrugBank.d318.s0,concurrently,18,29,O
DDI-DrugBank.d318.s0,",",30,30,O
DDI-DrugBank.d318.s0,the,32,34,O
DDI-DrugBank.d318.s0,following,36,44,O
DDI-DrugBank.d318.s0,drugs,46,50,O
DDI-DrugBank.d318.s0,may,52,54,O
DDI-DrugBank.d318.s0,interact,56,63,O
DDI-DrugBank.d318.s0,with,65,68,O
DDI-DrugBank.d318.s0,amphotericin,70,81,B-drug
DDI-DrugBank.d318.s0,B,83,83,I-drug
DDI-DrugBank.d318.s0,:,84,84,O
DDI-DrugBank.d318.s0,Antineoplastic,86,99,B-group
DDI-DrugBank.d318.s0,agents,101,106,I-group
DDI-DrugBank.d318.s0,:,107,107,O
DDI-DrugBank.d318.s0,may,109,111,O
DDI-DrugBank.d318.s0,enhance,113,119,O
DDI-DrugBank.d318.s0,the,121,123,O
DDI-DrugBank.d318.s0,potential,125,133,O
DDI-DrugBank.d318.s0,for,135,137,O
DDI-DrugBank.d318.s0,renal,139,143,O
DDI-DrugBank.d318.s0,toxicity,145,152,O
DDI-DrugBank.d318.s0,",",153,153,O
DDI-DrugBank.d318.s0,bronchospasm,155,166,O
DDI-DrugBank.d318.s0,and,168,170,O
DDI-DrugBank.d318.s0,hypotension,172,182,O
DDI-DrugBank.d318.s0,.,183,183,O
DDI-DrugBank.d318.s1,Antineoplastic,0,13,B-group
DDI-DrugBank.d318.s1,agents,15,20,I-group
DDI-DrugBank.d318.s1,(,22,22,O
DDI-DrugBank.d318.s1,e.,23,24,O
DDI-DrugBank.d318.s1,g.,26,27,O
DDI-DrugBank.d318.s1,",",28,28,O
DDI-DrugBank.d318.s1,nitrogen,30,37,B-drug
DDI-DrugBank.d318.s1,mustard,39,45,I-drug
DDI-DrugBank.d318.s1,",",46,46,O
DDI-DrugBank.d318.s1,etc,48,50,O
DDI-DrugBank.d318.s1,.,51,51,O
DDI-DrugBank.d318.s1,),52,52,O
DDI-DrugBank.d318.s1,should,54,59,O
DDI-DrugBank.d318.s1,be,61,62,O
DDI-DrugBank.d318.s1,given,64,68,O
DDI-DrugBank.d318.s1,concomitantly,70,82,O
DDI-DrugBank.d318.s1,only,84,87,O
DDI-DrugBank.d318.s1,with,89,92,O
DDI-DrugBank.d318.s1,great,94,98,O
DDI-DrugBank.d318.s1,caution,100,106,O
DDI-DrugBank.d318.s1,.,107,107,O
DDI-DrugBank.d318.s2,Corticosteroids,0,14,B-group
DDI-DrugBank.d318.s2,and,16,18,O
DDI-DrugBank.d318.s2,Corticotropin,20,32,B-drug
DDI-DrugBank.d318.s2,(,34,34,O
DDI-DrugBank.d318.s2,ACTH,35,38,B-group
DDI-DrugBank.d318.s2,),39,39,O
DDI-DrugBank.d318.s2,:,40,40,O
DDI-DrugBank.d318.s2,may,42,44,O
DDI-DrugBank.d318.s2,potentiate,46,55,O
DDI-DrugBank.d318.s2,amphotericin,57,68,B-drug
DDI-DrugBank.d318.s2,B-,70,71,O
DDI-DrugBank.d318.s2,induced,73,79,O
DDI-DrugBank.d318.s2,hypokalemia,81,91,O
DDI-DrugBank.d318.s2,which,93,97,O
DDI-DrugBank.d318.s2,may,99,101,O
DDI-DrugBank.d318.s2,predispose,103,112,O
DDI-DrugBank.d318.s2,the,114,116,O
DDI-DrugBank.d318.s2,patient,118,124,O
DDI-DrugBank.d318.s2,to,126,127,O
DDI-DrugBank.d318.s2,cardiac,129,135,O
DDI-DrugBank.d318.s2,dysfunction,137,147,O
DDI-DrugBank.d318.s2,.,148,148,O
DDI-DrugBank.d318.s3,Avoid,0,4,O
DDI-DrugBank.d318.s3,concomitant,6,16,O
DDI-DrugBank.d318.s3,use,18,20,O
DDI-DrugBank.d318.s3,unless,22,27,O
DDI-DrugBank.d318.s3,necessary,29,37,O
DDI-DrugBank.d318.s3,to,39,40,O
DDI-DrugBank.d318.s3,control,42,48,O
DDI-DrugBank.d318.s3,side,50,53,O
DDI-DrugBank.d318.s3,effects,55,61,O
DDI-DrugBank.d318.s3,of,63,64,O
DDI-DrugBank.d318.s3,amphotericin,66,77,B-drug
DDI-DrugBank.d318.s3,B,79,79,I-drug
DDI-DrugBank.d318.s3,.,80,80,O
DDI-DrugBank.d318.s4,If,0,1,O
DDI-DrugBank.d318.s4,used,3,6,O
DDI-DrugBank.d318.s4,concomitantly,8,20,O
DDI-DrugBank.d318.s4,",",21,21,O
DDI-DrugBank.d318.s4,closely,23,29,O
DDI-DrugBank.d318.s4,monitor,31,37,O
DDI-DrugBank.d318.s4,serum,39,43,O
DDI-DrugBank.d318.s4,electrolytes,45,56,O
DDI-DrugBank.d318.s4,and,58,60,O
DDI-DrugBank.d318.s4,cardiac,62,68,O
DDI-DrugBank.d318.s4,function,70,77,O
DDI-DrugBank.d318.s4,.,78,78,O
DDI-DrugBank.d318.s5,Digitalis,0,8,B-group
DDI-DrugBank.d318.s5,glycosides,10,19,I-group
DDI-DrugBank.d318.s5,:,20,20,O
DDI-DrugBank.d318.s5,amphotericin,22,33,B-drug
DDI-DrugBank.d318.s5,B-induced,35,43,O
DDI-DrugBank.d318.s5,hypokalemia,45,55,O
DDI-DrugBank.d318.s5,may,57,59,O
DDI-DrugBank.d318.s5,potentiate,61,70,O
DDI-DrugBank.d318.s5,digitalis,72,80,B-group
DDI-DrugBank.d318.s5,toxicity,82,89,O
DDI-DrugBank.d318.s5,.,90,90,O
DDI-DrugBank.d318.s6,Serum,0,4,O
DDI-DrugBank.d318.s6,potassium,6,14,O
DDI-DrugBank.d318.s6,levels,16,21,O
DDI-DrugBank.d318.s6,and,23,25,O
DDI-DrugBank.d318.s6,cardiac,27,33,O
DDI-DrugBank.d318.s6,function,35,42,O
DDI-DrugBank.d318.s6,should,44,49,O
DDI-DrugBank.d318.s6,be,51,52,O
DDI-DrugBank.d318.s6,closely,54,60,O
DDI-DrugBank.d318.s6,monitored,62,70,O
DDI-DrugBank.d318.s6,and,72,74,O
DDI-DrugBank.d318.s6,any,76,78,O
DDI-DrugBank.d318.s6,deficit,80,86,O
DDI-DrugBank.d318.s6,promptly,88,95,O
DDI-DrugBank.d318.s6,corrected,97,105,O
DDI-DrugBank.d318.s6,.,106,106,O
DDI-DrugBank.d318.s7,Flucytosine,0,10,B-drug
DDI-DrugBank.d318.s7,:,11,11,O
DDI-DrugBank.d318.s7,while,13,17,O
DDI-DrugBank.d318.s7,a,19,19,O
DDI-DrugBank.d318.s7,synergistic,21,31,O
DDI-DrugBank.d318.s7,relationship,33,44,O
DDI-DrugBank.d318.s7,with,46,49,O
DDI-DrugBank.d318.s7,amphotericin,51,62,B-drug
DDI-DrugBank.d318.s7,B,64,64,I-drug
DDI-DrugBank.d318.s7,has,66,68,O
DDI-DrugBank.d318.s7,been,70,73,O
DDI-DrugBank.d318.s7,reported,75,82,O
DDI-DrugBank.d318.s7,",",83,83,O
DDI-DrugBank.d318.s7,concomitant,85,95,O
DDI-DrugBank.d318.s7,use,97,99,O
DDI-DrugBank.d318.s7,may,101,103,O
DDI-DrugBank.d318.s7,increase,105,112,O
DDI-DrugBank.d318.s7,the,114,116,O
DDI-DrugBank.d318.s7,toxicity,118,125,O
DDI-DrugBank.d318.s7,of,127,128,O
DDI-DrugBank.d318.s7,flucytosine,130,140,B-drug
DDI-DrugBank.d318.s7,by,142,143,O
DDI-DrugBank.d318.s7,possibly,145,152,O
DDI-DrugBank.d318.s7,increasing,154,163,O
DDI-DrugBank.d318.s7,its,165,167,O
DDI-DrugBank.d318.s7,cellular,169,176,O
DDI-DrugBank.d318.s7,uptake,178,183,O
DDI-DrugBank.d318.s7,and/or,185,190,O
DDI-DrugBank.d318.s7,impairing,192,200,O
DDI-DrugBank.d318.s7,its,202,204,O
DDI-DrugBank.d318.s7,renal,206,210,O
DDI-DrugBank.d318.s7,excretion,212,220,O
DDI-DrugBank.d318.s7,.,221,221,O
DDI-DrugBank.d318.s8,Imidazoles,0,9,B-group
DDI-DrugBank.d318.s8,(,11,11,O
DDI-DrugBank.d318.s8,e.,12,13,O
DDI-DrugBank.d318.s8,g.,15,16,O
DDI-DrugBank.d318.s8,",",17,17,O
DDI-DrugBank.d318.s8,ketoconazole,19,30,B-drug
DDI-DrugBank.d318.s8,",",31,31,O
DDI-DrugBank.d318.s8,miconazole,33,42,B-drug
DDI-DrugBank.d318.s8,",",43,43,O
DDI-DrugBank.d318.s8,clotrimazole,45,56,B-drug
DDI-DrugBank.d318.s8,",",57,57,O
DDI-DrugBank.d318.s8,fluconazole,59,69,B-drug
DDI-DrugBank.d318.s8,",",70,70,O
DDI-DrugBank.d318.s8,etc,72,74,O
DDI-DrugBank.d318.s8,.,75,75,O
DDI-DrugBank.d318.s8,),76,76,O
DDI-DrugBank.d318.s8,:,77,77,O
DDI-DrugBank.d318.s8,in,79,80,O
DDI-DrugBank.d318.s8,vitro,82,86,O
DDI-DrugBank.d318.s8,and,88,90,O
DDI-DrugBank.d318.s8,animal,92,97,O
DDI-DrugBank.d318.s8,studies,99,105,O
DDI-DrugBank.d318.s8,with,107,110,O
DDI-DrugBank.d318.s8,the,112,114,O
DDI-DrugBank.d318.s8,combination,116,126,O
DDI-DrugBank.d318.s8,of,128,129,O
DDI-DrugBank.d318.s8,amphotericin,131,142,B-drug
DDI-DrugBank.d318.s8,B,144,144,I-drug
DDI-DrugBank.d318.s8,and,146,148,O
DDI-DrugBank.d318.s8,imidazoles,150,159,B-group
DDI-DrugBank.d318.s8,suggest,161,167,O
DDI-DrugBank.d318.s8,that,169,172,O
DDI-DrugBank.d318.s8,imidazoles,174,183,B-group
DDI-DrugBank.d318.s8,may,185,187,O
DDI-DrugBank.d318.s8,induce,189,194,O
DDI-DrugBank.d318.s8,fungal,196,201,O
DDI-DrugBank.d318.s8,resistance,203,212,O
DDI-DrugBank.d318.s8,to,214,215,O
DDI-DrugBank.d318.s8,amphotericin,217,228,B-drug
DDI-DrugBank.d318.s8,B,230,230,I-drug
DDI-DrugBank.d318.s8,.,231,231,O
DDI-DrugBank.d318.s9,Combination,0,10,O
DDI-DrugBank.d318.s9,therapy,12,18,O
DDI-DrugBank.d318.s9,should,20,25,O
DDI-DrugBank.d318.s9,be,27,28,O
DDI-DrugBank.d318.s9,administered,30,41,O
DDI-DrugBank.d318.s9,with,43,46,O
DDI-DrugBank.d318.s9,caution,48,54,O
DDI-DrugBank.d318.s9,",",55,55,O
DDI-DrugBank.d318.s9,especially,57,66,O
DDI-DrugBank.d318.s9,in,68,69,O
DDI-DrugBank.d318.s9,immunocompromised,71,87,O
DDI-DrugBank.d318.s9,patients,89,96,O
DDI-DrugBank.d318.s9,.,97,97,O
DDI-DrugBank.d318.s10,Other,0,4,O
DDI-DrugBank.d318.s10,nephrotoxic,6,16,O
DDI-DrugBank.d318.s10,medications,18,28,O
DDI-DrugBank.d318.s10,:,29,29,O
DDI-DrugBank.d318.s10,agents,31,36,O
DDI-DrugBank.d318.s10,such,38,41,O
DDI-DrugBank.d318.s10,as,43,44,O
DDI-DrugBank.d318.s10,aminoglycosides,46,60,B-group
DDI-DrugBank.d318.s10,",",61,61,O
DDI-DrugBank.d318.s10,cyclosporine,63,74,B-drug
DDI-DrugBank.d318.s10,",",75,75,O
DDI-DrugBank.d318.s10,and,77,79,O
DDI-DrugBank.d318.s10,pentamidine,81,91,B-drug
DDI-DrugBank.d318.s10,may,93,95,O
DDI-DrugBank.d318.s10,enhance,97,103,O
DDI-DrugBank.d318.s10,the,105,107,O
DDI-DrugBank.d318.s10,potential,109,117,O
DDI-DrugBank.d318.s10,for,119,121,O
DDI-DrugBank.d318.s10,drug-induced,123,134,O
DDI-DrugBank.d318.s10,renal,136,140,O
DDI-DrugBank.d318.s10,toxicity,142,149,O
DDI-DrugBank.d318.s10,",",150,150,O
DDI-DrugBank.d318.s10,and,152,154,O
DDI-DrugBank.d318.s10,should,156,161,O
DDI-DrugBank.d318.s10,be,163,164,O
DDI-DrugBank.d318.s10,used,166,169,O
DDI-DrugBank.d318.s10,concomitantly,171,183,O
DDI-DrugBank.d318.s10,only,185,188,O
DDI-DrugBank.d318.s10,with,190,193,O
DDI-DrugBank.d318.s10,great,195,199,O
DDI-DrugBank.d318.s10,caution,201,207,O
DDI-DrugBank.d318.s10,.,208,208,O
DDI-DrugBank.d318.s11,Intensive,0,8,O
DDI-DrugBank.d318.s11,monitoring,10,19,O
DDI-DrugBank.d318.s11,of,21,22,O
DDI-DrugBank.d318.s11,renal,24,28,O
DDI-DrugBank.d318.s11,function,30,37,O
DDI-DrugBank.d318.s11,is,39,40,O
DDI-DrugBank.d318.s11,recommended,42,52,O
DDI-DrugBank.d318.s11,in,54,55,O
DDI-DrugBank.d318.s11,patients,57,64,O
DDI-DrugBank.d318.s11,requiring,66,74,O
DDI-DrugBank.d318.s11,any,76,78,O
DDI-DrugBank.d318.s11,combination,80,90,O
DDI-DrugBank.d318.s11,of,92,93,O
DDI-DrugBank.d318.s11,nephrotoxic,95,105,O
DDI-DrugBank.d318.s11,medications,107,117,O
DDI-DrugBank.d318.s11,.,119,119,O
DDI-DrugBank.d318.s12,Skeletal,0,7,B-group
DDI-DrugBank.d318.s12,muscle,9,14,I-group
DDI-DrugBank.d318.s12,relaxants,16,24,I-group
DDI-DrugBank.d318.s12,:,25,25,O
DDI-DrugBank.d318.s12,amphotericin,27,38,B-drug
DDI-DrugBank.d318.s12,B-induced,40,48,O
DDI-DrugBank.d318.s12,hypokalemia,50,60,O
DDI-DrugBank.d318.s12,may,62,64,O
DDI-DrugBank.d318.s12,enhance,66,72,O
DDI-DrugBank.d318.s12,the,74,76,O
DDI-DrugBank.d318.s12,curariform,78,87,O
DDI-DrugBank.d318.s12,effect,89,94,O
DDI-DrugBank.d318.s12,of,96,97,O
DDI-DrugBank.d318.s12,skeletal,99,106,B-group
DDI-DrugBank.d318.s12,muscle,108,113,I-group
DDI-DrugBank.d318.s12,relaxants,115,123,I-group
DDI-DrugBank.d318.s12,(,125,125,O
DDI-DrugBank.d318.s12,e.g.,126,129,O
DDI-DrugBank.d318.s12,",",130,130,O
DDI-DrugBank.d318.s12,tubocurarine,132,143,B-drug
DDI-DrugBank.d318.s12,),144,144,O
DDI-DrugBank.d318.s12,.,145,145,O
DDI-DrugBank.d318.s13,Serum,0,4,O
DDI-DrugBank.d318.s13,potassium,6,14,O
DDI-DrugBank.d318.s13,levels,16,21,O
DDI-DrugBank.d318.s13,should,23,28,O
DDI-DrugBank.d318.s13,be,30,31,O
DDI-DrugBank.d318.s13,monitored,33,41,O
DDI-DrugBank.d318.s13,and,43,45,O
DDI-DrugBank.d318.s13,deficiencies,47,58,O
DDI-DrugBank.d318.s13,corrected,60,68,O
DDI-DrugBank.d318.s13,.,69,69,O
DDI-DrugBank.d318.s14,Leukocyte,0,8,B-drug_n
DDI-DrugBank.d318.s14,transfusions,10,21,I-drug_n
DDI-DrugBank.d318.s14,:,22,22,O
DDI-DrugBank.d318.s14,acute,24,28,O
DDI-DrugBank.d318.s14,pulmonary,30,38,O
DDI-DrugBank.d318.s14,toxicity,40,47,O
DDI-DrugBank.d318.s14,has,49,51,O
DDI-DrugBank.d318.s14,been,53,56,O
DDI-DrugBank.d318.s14,reported,58,65,O
DDI-DrugBank.d318.s14,in,67,68,O
DDI-DrugBank.d318.s14,patients,70,77,O
DDI-DrugBank.d318.s14,receiving,79,87,O
DDI-DrugBank.d318.s14,intravenous,89,99,O
DDI-DrugBank.d318.s14,amphotericin,101,112,B-drug
DDI-DrugBank.d318.s14,B,114,114,I-drug
DDI-DrugBank.d318.s14,and,116,118,O
DDI-DrugBank.d318.s14,leukocyte,120,128,B-drug_n
DDI-DrugBank.d318.s14,transfusions,130,141,I-drug_n
DDI-DrugBank.d318.s14,.,142,142,O
DDI-DrugBank.d357.s0,5HT3,0,3,B-group
DDI-DrugBank.d357.s0,Antagonists,5,15,I-group
DDI-DrugBank.d357.s0,:,16,16,O
DDI-DrugBank.d357.s0,Based,18,22,O
DDI-DrugBank.d357.s0,on,24,25,O
DDI-DrugBank.d357.s0,reports,27,33,O
DDI-DrugBank.d357.s0,of,35,36,O
DDI-DrugBank.d357.s0,profound,38,45,O
DDI-DrugBank.d357.s0,hypotension,47,57,O
DDI-DrugBank.d357.s0,and,59,61,O
DDI-DrugBank.d357.s0,loss,63,66,O
DDI-DrugBank.d357.s0,of,68,69,O
DDI-DrugBank.d357.s0,consciousness,71,83,O
DDI-DrugBank.d357.s0,when,85,88,O
DDI-DrugBank.d357.s0,apomorphine,90,100,B-drug
DDI-DrugBank.d357.s0,was,102,104,O
DDI-DrugBank.d357.s0,administered,106,117,O
DDI-DrugBank.d357.s0,with,119,122,O
DDI-DrugBank.d357.s0,ondansetron,124,134,B-drug
DDI-DrugBank.d357.s0,",",135,135,O
DDI-DrugBank.d357.s0,the,137,139,O
DDI-DrugBank.d357.s0,concomitant,141,151,O
DDI-DrugBank.d357.s0,use,153,155,O
DDI-DrugBank.d357.s0,of,157,158,O
DDI-DrugBank.d357.s0,apomorphine,160,170,B-drug
DDI-DrugBank.d357.s0,with,172,175,O
DDI-DrugBank.d357.s0,drugs,177,181,O
DDI-DrugBank.d357.s0,of,183,184,O
DDI-DrugBank.d357.s0,the,186,188,O
DDI-DrugBank.d357.s0,5HT3,190,193,B-group
DDI-DrugBank.d357.s0,antagonist,195,204,I-group
DDI-DrugBank.d357.s0,class,206,210,I-group
DDI-DrugBank.d357.s0,(,212,212,O
DDI-DrugBank.d357.s0,including,213,221,O
DDI-DrugBank.d357.s0,",",222,222,O
DDI-DrugBank.d357.s0,for,224,226,O
DDI-DrugBank.d357.s0,example,228,234,O
DDI-DrugBank.d357.s0,",",235,235,O
DDI-DrugBank.d357.s0,ondansetron,237,247,B-drug
DDI-DrugBank.d357.s0,",",248,248,O
DDI-DrugBank.d357.s0,granisetron,250,260,B-drug
DDI-DrugBank.d357.s0,",",261,261,O
DDI-DrugBank.d357.s0,dolasetron,263,272,B-drug
DDI-DrugBank.d357.s0,",",273,273,O
DDI-DrugBank.d357.s0,palonosetron,275,286,B-drug
DDI-DrugBank.d357.s0,",",287,287,O
DDI-DrugBank.d357.s0,and,289,291,O
DDI-DrugBank.d357.s0,alosetron,293,301,B-drug
DDI-DrugBank.d357.s0,),302,302,O
DDI-DrugBank.d357.s0,is,304,305,O
DDI-DrugBank.d357.s0,contraindicated,307,321,O
DDI-DrugBank.d357.s0,.,323,323,O
DDI-DrugBank.d357.s1,Antihypertensive,0,15,B-group
DDI-DrugBank.d357.s1,Medications,17,27,I-group
DDI-DrugBank.d357.s1,and,29,31,O
DDI-DrugBank.d357.s1,Vasodilators,33,44,B-group
DDI-DrugBank.d357.s1,:,45,45,O
DDI-DrugBank.d357.s1,The,47,49,O
DDI-DrugBank.d357.s1,following,51,59,O
DDI-DrugBank.d357.s1,adverse,61,67,O
DDI-DrugBank.d357.s1,events,69,74,O
DDI-DrugBank.d357.s1,were,76,79,O
DDI-DrugBank.d357.s1,experienced,81,91,O
DDI-DrugBank.d357.s1,more,93,96,O
DDI-DrugBank.d357.s1,commonly,98,105,O
DDI-DrugBank.d357.s1,in,107,108,O
DDI-DrugBank.d357.s1,patients,110,117,O
DDI-DrugBank.d357.s1,receiving,119,127,O
DDI-DrugBank.d357.s1,concomitant,129,139,O
DDI-DrugBank.d357.s1,antihypertensive,141,156,B-group
DDI-DrugBank.d357.s1,medications,158,168,I-group
DDI-DrugBank.d357.s1,or,170,171,O
DDI-DrugBank.d357.s1,vasodilators,173,184,B-group
DDI-DrugBank.d357.s1,(,186,186,O
DDI-DrugBank.d357.s1,n,187,187,O
DDI-DrugBank.d357.s1,=,189,189,O
DDI-DrugBank.d357.s1,94,191,192,O
DDI-DrugBank.d357.s1,),193,193,O
DDI-DrugBank.d357.s1,compared,195,202,O
DDI-DrugBank.d357.s1,to,204,205,O
DDI-DrugBank.d357.s1,patients,207,214,O
DDI-DrugBank.d357.s1,not,216,218,O
DDI-DrugBank.d357.s1,receiving,220,228,O
DDI-DrugBank.d357.s1,these,230,234,O
DDI-DrugBank.d357.s1,concomitant,236,246,O
DDI-DrugBank.d357.s1,drugs,248,252,O
DDI-DrugBank.d357.s1,(,254,254,O
DDI-DrugBank.d357.s1,n,255,255,O
DDI-DrugBank.d357.s1,=,257,257,O
DDI-DrugBank.d357.s1,456,259,261,O
DDI-DrugBank.d357.s1,),262,262,O
DDI-DrugBank.d357.s1,:,263,263,O
DDI-DrugBank.d357.s1,hypotension,265,275,O
DDI-DrugBank.d357.s1,10,277,278,O
DDI-DrugBank.d357.s1,%,279,279,O
DDI-DrugBank.d357.s1,vs,281,282,O
DDI-DrugBank.d357.s1,4,284,284,O
DDI-DrugBank.d357.s1,%,285,285,O
DDI-DrugBank.d357.s1,",",286,286,O
DDI-DrugBank.d357.s1,myocardial,288,297,O
DDI-DrugBank.d357.s1,infarction,299,308,O
DDI-DrugBank.d357.s1,3,310,310,O
DDI-DrugBank.d357.s1,%,311,311,O
DDI-DrugBank.d357.s1,vs,313,314,O
DDI-DrugBank.d357.s1,1,316,316,O
DDI-DrugBank.d357.s1,%,317,317,O
DDI-DrugBank.d357.s1,",",318,318,O
DDI-DrugBank.d357.s1,serious,320,326,O
DDI-DrugBank.d357.s1,pneumonia,328,336,O
DDI-DrugBank.d357.s1,5,338,338,O
DDI-DrugBank.d357.s1,%,339,339,O
DDI-DrugBank.d357.s1,vs,341,342,O
DDI-DrugBank.d357.s1,3,344,344,O
DDI-DrugBank.d357.s1,%,345,345,O
DDI-DrugBank.d357.s1,",",346,346,O
DDI-DrugBank.d357.s1,serious,348,354,O
DDI-DrugBank.d357.s1,falls,356,360,O
DDI-DrugBank.d357.s1,9,362,362,O
DDI-DrugBank.d357.s1,%,363,363,O
DDI-DrugBank.d357.s1,vs,365,366,O
DDI-DrugBank.d357.s1,3,368,368,O
DDI-DrugBank.d357.s1,%,369,369,O
DDI-DrugBank.d357.s1,",",370,370,O
DDI-DrugBank.d357.s1,and,372,374,O
DDI-DrugBank.d357.s1,bone,376,379,O
DDI-DrugBank.d357.s1,and,381,383,O
DDI-DrugBank.d357.s1,joint,385,389,O
DDI-DrugBank.d357.s1,injuries,391,398,O
DDI-DrugBank.d357.s1,6,400,400,O
DDI-DrugBank.d357.s1,%,401,401,O
DDI-DrugBank.d357.s1,vs,403,404,O
DDI-DrugBank.d357.s1,2,406,406,O
DDI-DrugBank.d357.s1,%,407,407,O
DDI-DrugBank.d357.s1,.,408,408,O
DDI-DrugBank.d357.s2,The,0,2,O
DDI-DrugBank.d357.s2,mechanism,4,12,O
DDI-DrugBank.d357.s2,underlying,14,23,O
DDI-DrugBank.d357.s2,many,25,28,O
DDI-DrugBank.d357.s2,of,30,31,O
DDI-DrugBank.d357.s2,these,33,37,O
DDI-DrugBank.d357.s2,events,39,44,O
DDI-DrugBank.d357.s2,is,46,47,O
DDI-DrugBank.d357.s2,unknown,49,55,O
DDI-DrugBank.d357.s2,",",56,56,O
DDI-DrugBank.d357.s2,but,58,60,O
DDI-DrugBank.d357.s2,may,62,64,O
DDI-DrugBank.d357.s2,represent,66,74,O
DDI-DrugBank.d357.s2,increased,76,84,O
DDI-DrugBank.d357.s2,hypotension,86,96,O
DDI-DrugBank.d357.s2,.,98,98,O
DDI-DrugBank.d357.s3,Dopamine,0,7,B-group
DDI-DrugBank.d357.s3,Antagonists,9,19,I-group
DDI-DrugBank.d357.s3,:,20,20,O
DDI-DrugBank.d357.s3,Since,22,26,O
DDI-DrugBank.d357.s3,apomorphine,28,38,B-drug
DDI-DrugBank.d357.s3,is,40,41,O
DDI-DrugBank.d357.s3,a,43,43,O
DDI-DrugBank.d357.s3,dopamine,45,52,B-group
DDI-DrugBank.d357.s3,agonist,54,60,I-group
DDI-DrugBank.d357.s3,",",61,61,O
DDI-DrugBank.d357.s3,it,63,64,O
DDI-DrugBank.d357.s3,is,66,67,O
DDI-DrugBank.d357.s3,possible,69,76,O
DDI-DrugBank.d357.s3,that,78,81,O
DDI-DrugBank.d357.s3,dopamine,83,90,B-group
DDI-DrugBank.d357.s3,antagonists,92,102,I-group
DDI-DrugBank.d357.s3,",",103,103,O
DDI-DrugBank.d357.s3,such,105,108,O
DDI-DrugBank.d357.s3,as,110,111,O
DDI-DrugBank.d357.s3,the,113,115,O
DDI-DrugBank.d357.s3,neuroleptics,117,128,B-group
DDI-DrugBank.d357.s3,(,130,130,O
DDI-DrugBank.d357.s3,phenothiazines,131,144,B-group
DDI-DrugBank.d357.s3,",",145,145,O
DDI-DrugBank.d357.s3,butyrophenones,147,160,B-group
DDI-DrugBank.d357.s3,",",161,161,O
DDI-DrugBank.d357.s3,thioxanthenes,163,175,B-group
DDI-DrugBank.d357.s3,),176,176,O
DDI-DrugBank.d357.s3,or,178,179,O
DDI-DrugBank.d357.s3,metoclopramide,181,194,B-drug
DDI-DrugBank.d357.s3,",",195,195,O
DDI-DrugBank.d357.s3,may,197,199,O
DDI-DrugBank.d357.s3,diminish,201,208,O
DDI-DrugBank.d357.s3,the,210,212,O
DDI-DrugBank.d357.s3,effectiveness,214,226,O
DDI-DrugBank.d357.s3,of,228,229,O
DDI-DrugBank.d357.s3,APOKYN,231,236,B-brand
DDI-DrugBank.d357.s3,.,237,237,O
DDI-DrugBank.d357.s4,Patients,0,7,O
DDI-DrugBank.d357.s4,with,9,12,O
DDI-DrugBank.d357.s4,major,14,18,O
DDI-DrugBank.d357.s4,psychotic,20,28,O
DDI-DrugBank.d357.s4,disorders,30,38,O
DDI-DrugBank.d357.s4,",",39,39,O
DDI-DrugBank.d357.s4,treated,41,47,O
DDI-DrugBank.d357.s4,with,49,52,O
DDI-DrugBank.d357.s4,neuroleptics,54,65,B-group
DDI-DrugBank.d357.s4,",",66,66,O
DDI-DrugBank.d357.s4,should,68,73,O
DDI-DrugBank.d357.s4,be,75,76,O
DDI-DrugBank.d357.s4,treated,78,84,O
DDI-DrugBank.d357.s4,with,86,89,O
DDI-DrugBank.d357.s4,dopamine,91,98,B-group
DDI-DrugBank.d357.s4,agonists,100,107,I-group
DDI-DrugBank.d357.s4,only,109,112,O
DDI-DrugBank.d357.s4,if,114,115,O
DDI-DrugBank.d357.s4,the,117,119,O
DDI-DrugBank.d357.s4,potential,121,129,O
DDI-DrugBank.d357.s4,benefits,131,138,O
DDI-DrugBank.d357.s4,outweigh,140,147,O
DDI-DrugBank.d357.s4,the,149,151,O
DDI-DrugBank.d357.s4,risks,153,157,O
DDI-DrugBank.d357.s4,.,158,158,O
DDI-DrugBank.d357.s5,Drugs,0,4,O
DDI-DrugBank.d357.s5,Prolonging,6,15,O
DDI-DrugBank.d357.s5,the,17,19,O
DDI-DrugBank.d357.s5,QT/QTc,21,26,O
DDI-DrugBank.d357.s5,Interval,28,35,O
DDI-DrugBank.d357.s5,Caution,37,43,O
DDI-DrugBank.d357.s5,should,45,50,O
DDI-DrugBank.d357.s5,be,52,53,O
DDI-DrugBank.d357.s5,exercised,55,63,O
DDI-DrugBank.d357.s5,when,65,68,O
DDI-DrugBank.d357.s5,prescribing,70,80,O
DDI-DrugBank.d357.s5,apomorphine,82,92,B-drug
DDI-DrugBank.d357.s5,concomitantly,94,106,O
DDI-DrugBank.d357.s5,with,108,111,O
DDI-DrugBank.d357.s5,drugs,113,117,O
DDI-DrugBank.d357.s5,that,119,122,O
DDI-DrugBank.d357.s5,prolong,124,130,O
DDI-DrugBank.d357.s5,the,132,134,O
DDI-DrugBank.d357.s5,QT/QTc,136,141,O
DDI-DrugBank.d357.s5,interval,143,150,O
DDI-DrugBank.d357.s5,.,151,151,O
DDI-DrugBank.d357.s6,Drug/Laboratory,0,14,O
DDI-DrugBank.d357.s6,Test,16,19,O
DDI-DrugBank.d357.s6,Interactions,21,32,O
DDI-DrugBank.d357.s6,There,34,38,O
DDI-DrugBank.d357.s6,are,40,42,O
DDI-DrugBank.d357.s6,no,44,45,O
DDI-DrugBank.d357.s6,known,47,51,O
DDI-DrugBank.d357.s6,interactions,53,64,O
DDI-DrugBank.d357.s6,between,66,72,O
DDI-DrugBank.d357.s6,APOKYN,74,79,B-brand
DDI-DrugBank.d357.s6,and,81,83,O
DDI-DrugBank.d357.s6,laboratory,85,94,O
DDI-DrugBank.d357.s6,tests,96,100,O
DDI-DrugBank.d357.s6,.,101,101,O
DDI-DrugBank.d253.s0,Beta-adrenergic,0,14,B-group
DDI-DrugBank.d253.s0,blocking,16,23,I-group
DDI-DrugBank.d253.s0,agents,25,30,I-group
DDI-DrugBank.d253.s0,:,31,31,O
DDI-DrugBank.d253.s0,concurrent,33,42,O
DDI-DrugBank.d253.s0,use,44,46,O
DDI-DrugBank.d253.s0,may,48,50,O
DDI-DrugBank.d253.s0,blunt,52,56,O
DDI-DrugBank.d253.s0,the,58,60,O
DDI-DrugBank.d253.s0,response,62,69,O
DDI-DrugBank.d253.s0,to,71,72,O
DDI-DrugBank.d253.s0,arbutamine,74,83,B-drug
DDI-DrugBank.d253.s0,.,84,84,O
DDI-DrugBank.d253.s1,Beta-adrenergic,0,14,B-group
DDI-DrugBank.d253.s1,blocking,16,23,I-group
DDI-DrugBank.d253.s1,agents,25,30,I-group
DDI-DrugBank.d253.s1,should,32,37,O
DDI-DrugBank.d253.s1,be,39,40,O
DDI-DrugBank.d253.s1,withdrawn,42,50,O
DDI-DrugBank.d253.s1,at,52,53,O
DDI-DrugBank.d253.s1,least,55,59,O
DDI-DrugBank.d253.s1,48,61,62,O
DDI-DrugBank.d253.s1,hours,64,68,O
DDI-DrugBank.d253.s1,before,70,75,O
DDI-DrugBank.d253.s1,conducting,77,86,O
DDI-DrugBank.d253.s1,an,88,89,O
DDI-DrugBank.d253.s1,arbutamine-mediated,91,109,O
DDI-DrugBank.d253.s1,stress,111,116,O
DDI-DrugBank.d253.s1,test,118,121,O
DDI-DrugBank.d253.s1,.,122,122,O
DDI-DrugBank.d253.s2,Antiarrhythmic,0,13,B-drug
DDI-DrugBank.d253.s2,agents,15,20,I-drug
DDI-DrugBank.d253.s2,",",21,21,I-drug
DDI-DrugBank.d253.s2,class,23,27,I-drug
DDI-DrugBank.d253.s2,I,29,29,I-drug
DDI-DrugBank.d253.s2,(,31,31,O
DDI-DrugBank.d253.s2,such,32,35,O
DDI-DrugBank.d253.s2,as,37,38,O
DDI-DrugBank.d253.s2,flecainide,40,49,B-drug
DDI-DrugBank.d253.s2,",",50,50,O
DDI-DrugBank.d253.s2,lidocaine,52,60,B-drug
DDI-DrugBank.d253.s2,",",61,61,O
DDI-DrugBank.d253.s2,or,63,64,O
DDI-DrugBank.d253.s2,quinidine,66,74,B-drug
DDI-DrugBank.d253.s2,),75,75,O
DDI-DrugBank.d253.s2,:,76,76,O
DDI-DrugBank.d253.s2,concurrent,78,87,O
DDI-DrugBank.d253.s2,use,89,91,O
DDI-DrugBank.d253.s2,with,93,96,O
DDI-DrugBank.d253.s2,arbutamine,98,107,B-drug
DDI-DrugBank.d253.s2,may,109,111,O
DDI-DrugBank.d253.s2,have,113,116,O
DDI-DrugBank.d253.s2,a,118,118,O
DDI-DrugBank.d253.s2,proarrhythmic,120,132,O
DDI-DrugBank.d253.s2,effect,134,139,O
DDI-DrugBank.d253.s2,.,140,140,O
DDI-DrugBank.d253.s3,Antidepressants,0,14,B-group
DDI-DrugBank.d253.s3,(,16,16,O
DDI-DrugBank.d253.s3,tricyclic,17,25,B-group
DDI-DrugBank.d253.s3,),26,26,O
DDI-DrugBank.d253.s3,",",27,27,O
DDI-DrugBank.d253.s3,atropine,29,36,B-drug
DDI-DrugBank.d253.s3,or,38,39,O
DDI-DrugBank.d253.s3,other,41,45,O
DDI-DrugBank.d253.s3,anticholinergic,47,61,B-group
DDI-DrugBank.d253.s3,agents,63,68,I-group
DDI-DrugBank.d253.s3,",",69,69,O
DDI-DrugBank.d253.s3,or,71,72,O
DDI-DrugBank.d253.s3,digitalis,74,82,B-group
DDI-DrugBank.d253.s3,glycosides,84,93,I-group
DDI-DrugBank.d253.s3,:,94,94,O
DDI-DrugBank.d253.s3,concurrent,96,105,O
DDI-DrugBank.d253.s3,use,107,109,O
DDI-DrugBank.d253.s3,with,111,114,O
DDI-DrugBank.d253.s3,arbutamine,116,125,B-drug
DDI-DrugBank.d253.s3,may,127,129,O
DDI-DrugBank.d253.s3,produce,131,137,O
DDI-DrugBank.d253.s3,additive,139,146,O
DDI-DrugBank.d253.s3,inotropic,148,156,O
DDI-DrugBank.d253.s3,and/or,158,163,O
DDI-DrugBank.d253.s3,chronotropic,165,176,O
DDI-DrugBank.d253.s3,effects,178,184,O
DDI-DrugBank.d253.s3,.,185,185,O
DDI-DrugBank.d105.s0,Anticoagulants,0,13,B-group
DDI-DrugBank.d105.s0,including,15,23,O
DDI-DrugBank.d105.s0,coumarin,25,32,O
DDI-DrugBank.d105.s0,derivatives,34,44,O
DDI-DrugBank.d105.s0,",",45,45,O
DDI-DrugBank.d105.s0,indandione,47,56,O
DDI-DrugBank.d105.s0,derivatives,58,68,O
DDI-DrugBank.d105.s0,",",69,69,O
DDI-DrugBank.d105.s0,and,71,73,O
DDI-DrugBank.d105.s0,platelet,75,82,B-group
DDI-DrugBank.d105.s0,aggregation,84,94,I-group
DDI-DrugBank.d105.s0,inhibitors,96,105,I-group
DDI-DrugBank.d105.s0,such,107,110,O
DDI-DrugBank.d105.s0,as,112,113,O
DDI-DrugBank.d105.s0,nonsteroidal,115,126,B-group
DDI-DrugBank.d105.s0,anti-inflammatory,128,144,I-group
DDI-DrugBank.d105.s0,drugs,146,150,I-group
DDI-DrugBank.d105.s0,(,152,152,O
DDI-DrugBank.d105.s0,NSAIDs,153,158,B-group
DDI-DrugBank.d105.s0,),159,159,O
DDI-DrugBank.d105.s0,",",160,160,O
DDI-DrugBank.d105.s0,and,162,164,O
DDI-DrugBank.d105.s0,aspirin,166,172,B-brand
DDI-DrugBank.d105.s0,may,174,176,O
DDI-DrugBank.d105.s0,increase,178,185,O
DDI-DrugBank.d105.s0,the,187,189,O
DDI-DrugBank.d105.s0,risk,191,194,O
DDI-DrugBank.d105.s0,of,196,197,O
DDI-DrugBank.d105.s0,bleeding,199,206,O
DDI-DrugBank.d105.s0,when,208,211,O
DDI-DrugBank.d105.s0,administered,213,224,O
DDI-DrugBank.d105.s0,concomitantly,226,238,O
DDI-DrugBank.d105.s0,with,240,243,O
DDI-DrugBank.d105.s0,ardeparin,245,253,B-drug
DDI-DrugBank.d105.s0,.,254,254,O
DDI-DrugBank.d509.s0,Drug-Drug,0,8,O
DDI-DrugBank.d509.s0,Interactions,10,21,O
DDI-DrugBank.d509.s0,Given,23,27,O
DDI-DrugBank.d509.s0,the,29,31,O
DDI-DrugBank.d509.s0,primary,33,39,O
DDI-DrugBank.d509.s0,CNS,41,43,O
DDI-DrugBank.d509.s0,effects,45,51,O
DDI-DrugBank.d509.s0,of,53,54,O
DDI-DrugBank.d509.s0,aripiprazole,56,67,B-drug
DDI-DrugBank.d509.s0,",",68,68,O
DDI-DrugBank.d509.s0,caution,70,76,O
DDI-DrugBank.d509.s0,should,78,83,O
DDI-DrugBank.d509.s0,be,85,86,O
DDI-DrugBank.d509.s0,used,88,91,O
DDI-DrugBank.d509.s0,when,93,96,O
DDI-DrugBank.d509.s0,ABILIFY,98,104,B-brand
DDI-DrugBank.d509.s0,is,106,107,O
DDI-DrugBank.d509.s0,taken,109,113,O
DDI-DrugBank.d509.s0,in,115,116,O
DDI-DrugBank.d509.s0,combination,118,128,O
DDI-DrugBank.d509.s0,with,130,133,O
DDI-DrugBank.d509.s0,other,135,139,O
DDI-DrugBank.d509.s0,centrally,141,149,B-group
DDI-DrugBank.d509.s0,acting,151,156,I-group
DDI-DrugBank.d509.s0,drugs,158,162,I-group
DDI-DrugBank.d509.s0,and,164,166,O
DDI-DrugBank.d509.s0,alcohol,168,174,B-drug
DDI-DrugBank.d509.s0,.,175,175,O
DDI-DrugBank.d509.s1,Due,0,2,O
DDI-DrugBank.d509.s1,to,4,5,O
DDI-DrugBank.d509.s1,its,7,9,O
DDI-DrugBank.d509.s2,1-,0,1,O
DDI-DrugBank.d509.s2,adrenergic,3,12,O
DDI-DrugBank.d509.s2,receptor,14,21,O
DDI-DrugBank.d509.s2,antagonism,23,32,O
DDI-DrugBank.d509.s2,",",33,33,O
DDI-DrugBank.d509.s2,aripiprazole,35,46,B-drug
DDI-DrugBank.d509.s2,has,48,50,O
DDI-DrugBank.d509.s2,the,52,54,O
DDI-DrugBank.d509.s2,potential,56,64,O
DDI-DrugBank.d509.s2,to,66,67,O
DDI-DrugBank.d509.s2,enhance,69,75,O
DDI-DrugBank.d509.s2,the,77,79,O
DDI-DrugBank.d509.s2,effect,81,86,O
DDI-DrugBank.d509.s2,of,88,89,O
DDI-DrugBank.d509.s2,certain,91,97,O
DDI-DrugBank.d509.s2,antihypertensive,99,114,B-group
DDI-DrugBank.d509.s2,agents,116,121,I-group
DDI-DrugBank.d509.s2,.,122,122,O
DDI-DrugBank.d509.s3,Potential,0,8,O
DDI-DrugBank.d509.s3,for,10,12,O
DDI-DrugBank.d509.s3,Other,14,18,O
DDI-DrugBank.d509.s3,Drugs,20,24,O
DDI-DrugBank.d509.s3,to,26,27,O
DDI-DrugBank.d509.s3,Affect,29,34,O
DDI-DrugBank.d509.s3,ABILIFY,36,42,B-brand
DDI-DrugBank.d509.s3,Aripiprazole,44,55,B-brand
DDI-DrugBank.d509.s3,is,57,58,O
DDI-DrugBank.d509.s3,not,60,62,O
DDI-DrugBank.d509.s3,a,64,64,O
DDI-DrugBank.d509.s3,substrate,66,74,O
DDI-DrugBank.d509.s3,of,76,77,O
DDI-DrugBank.d509.s3,CYP1A1,79,84,O
DDI-DrugBank.d509.s3,",",85,85,O
DDI-DrugBank.d509.s3,CYP1A2,87,92,O
DDI-DrugBank.d509.s3,",",93,93,O
DDI-DrugBank.d509.s3,CYP2A6,95,100,O
DDI-DrugBank.d509.s3,",",101,101,O
DDI-DrugBank.d509.s3,CYP2B6,103,108,O
DDI-DrugBank.d509.s3,",",109,109,O
DDI-DrugBank.d509.s3,CYP2C8,111,116,O
DDI-DrugBank.d509.s3,",",117,117,O
DDI-DrugBank.d509.s3,CYP2C9,119,124,O
DDI-DrugBank.d509.s3,",",125,125,O
DDI-DrugBank.d509.s3,CYP2C19,127,133,O
DDI-DrugBank.d509.s3,",",134,134,O
DDI-DrugBank.d509.s3,or,136,137,O
DDI-DrugBank.d509.s3,CYP2E1,139,144,O
DDI-DrugBank.d509.s3,enzymes,146,152,O
DDI-DrugBank.d509.s3,.,153,153,O
DDI-DrugBank.d509.s4,Aripiprazole,0,11,B-drug
DDI-DrugBank.d509.s4,also,13,16,O
DDI-DrugBank.d509.s4,does,18,21,O
DDI-DrugBank.d509.s4,not,23,25,O
DDI-DrugBank.d509.s4,undergo,27,33,O
DDI-DrugBank.d509.s4,direct,35,40,O
DDI-DrugBank.d509.s4,glucuronidation,42,56,O
DDI-DrugBank.d509.s4,.,57,57,O
DDI-DrugBank.d509.s5,This,0,3,O
DDI-DrugBank.d509.s5,suggests,5,12,O
DDI-DrugBank.d509.s5,that,14,17,O
DDI-DrugBank.d509.s5,an,19,20,O
DDI-DrugBank.d509.s5,interaction,22,32,O
DDI-DrugBank.d509.s5,of,34,35,O
DDI-DrugBank.d509.s5,aripiprazole,37,48,B-drug
DDI-DrugBank.d509.s5,with,50,53,O
DDI-DrugBank.d509.s5,inhibitors,55,64,O
DDI-DrugBank.d509.s5,or,66,67,O
DDI-DrugBank.d509.s5,inducers,69,76,O
DDI-DrugBank.d509.s5,of,78,79,O
DDI-DrugBank.d509.s5,these,81,85,O
DDI-DrugBank.d509.s5,enzymes,87,93,O
DDI-DrugBank.d509.s5,",",94,94,O
DDI-DrugBank.d509.s5,or,96,97,O
DDI-DrugBank.d509.s5,other,99,103,O
DDI-DrugBank.d509.s5,factors,105,111,O
DDI-DrugBank.d509.s5,",",112,112,O
DDI-DrugBank.d509.s5,like,114,117,O
DDI-DrugBank.d509.s5,smoking,119,125,O
DDI-DrugBank.d509.s5,",",126,126,O
DDI-DrugBank.d509.s5,is,128,129,O
DDI-DrugBank.d509.s5,unlikely,131,138,O
DDI-DrugBank.d509.s5,.,139,139,O
DDI-DrugBank.d509.s6,Both,0,3,O
DDI-DrugBank.d509.s6,CYP3A4,5,10,O
DDI-DrugBank.d509.s6,and,12,14,O
DDI-DrugBank.d509.s6,CYP2D6,16,21,O
DDI-DrugBank.d509.s6,are,23,25,O
DDI-DrugBank.d509.s6,responsible,27,37,O
DDI-DrugBank.d509.s6,for,39,41,O
DDI-DrugBank.d509.s6,aripiprazole,43,54,B-drug
DDI-DrugBank.d509.s6,metabolism,56,65,O
DDI-DrugBank.d509.s6,.,66,66,O
DDI-DrugBank.d509.s7,Agents,0,5,O
DDI-DrugBank.d509.s7,that,7,10,O
DDI-DrugBank.d509.s7,induce,12,17,O
DDI-DrugBank.d509.s7,CYP3A4,19,24,O
DDI-DrugBank.d509.s7,(,26,26,O
DDI-DrugBank.d509.s7,eg,27,28,O
DDI-DrugBank.d509.s7,",",29,29,O
DDI-DrugBank.d509.s7,carbamazepine,31,43,B-drug
DDI-DrugBank.d509.s7,),44,44,O
DDI-DrugBank.d509.s7,could,46,50,O
DDI-DrugBank.d509.s7,cause,52,56,O
DDI-DrugBank.d509.s7,an,58,59,O
DDI-DrugBank.d509.s7,increase,61,68,O
DDI-DrugBank.d509.s7,in,70,71,O
DDI-DrugBank.d509.s7,aripiprazole,73,84,B-drug
DDI-DrugBank.d509.s7,clearance,86,94,O
DDI-DrugBank.d509.s7,and,96,98,O
DDI-DrugBank.d509.s7,lower,100,104,O
DDI-DrugBank.d509.s7,blood,106,110,O
DDI-DrugBank.d509.s7,levels,112,117,O
DDI-DrugBank.d509.s7,.,118,118,O
DDI-DrugBank.d509.s8,Inhibitors,0,9,O
DDI-DrugBank.d509.s8,of,11,12,O
DDI-DrugBank.d509.s8,CYP3A4,14,19,O
DDI-DrugBank.d509.s8,(,21,21,O
DDI-DrugBank.d509.s8,eg,22,23,O
DDI-DrugBank.d509.s8,",",24,24,O
DDI-DrugBank.d509.s8,ketoconazole,26,37,B-drug
DDI-DrugBank.d509.s8,),38,38,O
DDI-DrugBank.d509.s8,or,40,41,O
DDI-DrugBank.d509.s8,CYP2D6,43,48,O
DDI-DrugBank.d509.s8,(,50,50,O
DDI-DrugBank.d509.s8,eg,51,52,O
DDI-DrugBank.d509.s8,",",53,53,O
DDI-DrugBank.d509.s8,quinidine,55,63,B-drug
DDI-DrugBank.d509.s8,",",64,64,O
DDI-DrugBank.d509.s8,fluoxetine,66,75,B-drug
DDI-DrugBank.d509.s8,",",76,76,O
DDI-DrugBank.d509.s8,or,78,79,O
DDI-DrugBank.d509.s8,paroxetine,81,90,B-drug
DDI-DrugBank.d509.s8,),91,91,O
DDI-DrugBank.d509.s8,can,93,95,O
DDI-DrugBank.d509.s8,inhibit,97,103,O
DDI-DrugBank.d509.s8,aripiprazole,105,116,B-drug
DDI-DrugBank.d509.s8,elimination,118,128,O
DDI-DrugBank.d509.s8,and,130,132,O
DDI-DrugBank.d509.s8,cause,134,138,O
DDI-DrugBank.d509.s8,increased,140,148,O
DDI-DrugBank.d509.s8,blood,150,154,O
DDI-DrugBank.d509.s8,levels,156,161,O
DDI-DrugBank.d509.s8,.,162,162,O
DDI-DrugBank.d509.s9,Ketoconazole,0,11,B-drug
DDI-DrugBank.d509.s9,:,12,12,O
DDI-DrugBank.d509.s9,Coadministration,14,29,O
DDI-DrugBank.d509.s9,of,31,32,O
DDI-DrugBank.d509.s9,ketoconazole,34,45,B-drug
DDI-DrugBank.d509.s9,(,47,47,O
DDI-DrugBank.d509.s9,200,48,50,O
DDI-DrugBank.d509.s9,mg/day,52,57,O
DDI-DrugBank.d509.s9,for,59,61,O
DDI-DrugBank.d509.s9,14,63,64,O
DDI-DrugBank.d509.s9,days,66,69,O
DDI-DrugBank.d509.s9,),70,70,O
DDI-DrugBank.d509.s9,with,72,75,O
DDI-DrugBank.d509.s9,a,77,77,O
DDI-DrugBank.d509.s9,15-mg,79,83,O
DDI-DrugBank.d509.s9,single,85,90,O
DDI-DrugBank.d509.s9,dose,92,95,O
DDI-DrugBank.d509.s9,of,97,98,O
DDI-DrugBank.d509.s9,aripiprazole,100,111,B-drug
DDI-DrugBank.d509.s9,increased,113,121,O
DDI-DrugBank.d509.s9,the,123,125,O
DDI-DrugBank.d509.s9,AUC,127,129,O
DDI-DrugBank.d509.s9,of,131,132,O
DDI-DrugBank.d509.s9,aripiprazole,134,145,B-drug
DDI-DrugBank.d509.s9,and,147,149,O
DDI-DrugBank.d509.s9,its,151,153,O
DDI-DrugBank.d509.s9,active,155,160,O
DDI-DrugBank.d509.s9,metabolite,162,171,O
DDI-DrugBank.d509.s9,by,173,174,O
DDI-DrugBank.d509.s9,63,176,177,O
DDI-DrugBank.d509.s9,%,178,178,O
DDI-DrugBank.d509.s9,and,180,182,O
DDI-DrugBank.d509.s9,77,184,185,O
DDI-DrugBank.d509.s9,%,186,186,O
DDI-DrugBank.d509.s9,",",187,187,O
DDI-DrugBank.d509.s9,respectively,189,200,O
DDI-DrugBank.d509.s9,.,201,201,O
DDI-DrugBank.d509.s10,The,0,2,O
DDI-DrugBank.d509.s10,effect,4,9,O
DDI-DrugBank.d509.s10,of,11,12,O
DDI-DrugBank.d509.s10,a,14,14,O
DDI-DrugBank.d509.s10,higher,16,21,O
DDI-DrugBank.d509.s10,ketoconazole,23,34,B-drug
DDI-DrugBank.d509.s10,dose,36,39,O
DDI-DrugBank.d509.s10,(,41,41,O
DDI-DrugBank.d509.s10,400,42,44,O
DDI-DrugBank.d509.s10,mg/day,46,51,O
DDI-DrugBank.d509.s10,),52,52,O
DDI-DrugBank.d509.s10,has,54,56,O
DDI-DrugBank.d509.s10,not,58,60,O
DDI-DrugBank.d509.s10,been,62,65,O
DDI-DrugBank.d509.s10,studied,67,73,O
DDI-DrugBank.d509.s10,.,74,74,O
DDI-DrugBank.d509.s11,When,0,3,O
DDI-DrugBank.d509.s11,concomitant,5,15,O
DDI-DrugBank.d509.s11,administration,17,30,O
DDI-DrugBank.d509.s11,of,32,33,O
DDI-DrugBank.d509.s11,ketoconazole,35,46,B-drug
DDI-DrugBank.d509.s11,with,48,51,O
DDI-DrugBank.d509.s11,aripiprazole,53,64,B-drug
DDI-DrugBank.d509.s11,occurs,66,71,O
DDI-DrugBank.d509.s11,",",72,72,O
DDI-DrugBank.d509.s11,aripiprazole,74,85,B-drug
DDI-DrugBank.d509.s11,dose,87,90,O
DDI-DrugBank.d509.s11,should,92,97,O
DDI-DrugBank.d509.s11,be,99,100,O
DDI-DrugBank.d509.s11,reduced,102,108,O
DDI-DrugBank.d509.s11,to,110,111,O
DDI-DrugBank.d509.s11,one-half,113,120,O
DDI-DrugBank.d509.s11,of,122,123,O
DDI-DrugBank.d509.s11,its,125,127,O
DDI-DrugBank.d509.s11,normal,129,134,O
DDI-DrugBank.d509.s11,dose,136,139,O
DDI-DrugBank.d509.s11,.,140,140,O
DDI-DrugBank.d509.s12,Other,0,4,O
DDI-DrugBank.d509.s12,strong,6,11,O
DDI-DrugBank.d509.s12,inhibitors,13,22,O
DDI-DrugBank.d509.s12,of,24,25,O
DDI-DrugBank.d509.s12,CYP3A4,27,32,O
DDI-DrugBank.d509.s12,(,34,34,O
DDI-DrugBank.d509.s12,itraconazole,35,46,B-drug
DDI-DrugBank.d509.s12,),47,47,O
DDI-DrugBank.d509.s12,would,49,53,O
DDI-DrugBank.d509.s12,be,55,56,O
DDI-DrugBank.d509.s12,expected,58,65,O
DDI-DrugBank.d509.s12,to,67,68,O
DDI-DrugBank.d509.s12,have,70,73,O
DDI-DrugBank.d509.s12,similar,75,81,O
DDI-DrugBank.d509.s12,effects,83,89,O
DDI-DrugBank.d509.s12,and,91,93,O
DDI-DrugBank.d509.s12,need,95,98,O
DDI-DrugBank.d509.s12,similar,100,106,O
DDI-DrugBank.d509.s12,dose,108,111,O
DDI-DrugBank.d509.s12,reductions,113,122,O
DDI-DrugBank.d509.s12,;,123,123,O
DDI-DrugBank.d509.s13,weaker,0,5,O
DDI-DrugBank.d509.s13,inhibitors,7,16,O
DDI-DrugBank.d509.s13,(,18,18,O
DDI-DrugBank.d509.s13,erythromycin,19,30,B-drug
DDI-DrugBank.d509.s13,",",31,31,O
DDI-DrugBank.d509.s13,grapefruit,33,42,O
DDI-DrugBank.d509.s13,juice,44,48,O
DDI-DrugBank.d509.s13,),49,49,O
DDI-DrugBank.d509.s13,have,51,54,O
DDI-DrugBank.d509.s13,not,56,58,O
DDI-DrugBank.d509.s13,been,60,63,O
DDI-DrugBank.d509.s13,studied,65,71,O
DDI-DrugBank.d509.s13,.,72,72,O
DDI-DrugBank.d509.s14,When,0,3,O
DDI-DrugBank.d509.s14,the,5,7,O
DDI-DrugBank.d509.s14,CYP3A4,9,14,O
DDI-DrugBank.d509.s14,inhibitor,16,24,O
DDI-DrugBank.d509.s14,is,26,27,O
DDI-DrugBank.d509.s14,withdrawn,29,37,O
DDI-DrugBank.d509.s14,from,39,42,O
DDI-DrugBank.d509.s14,the,44,46,O
DDI-DrugBank.d509.s14,combination,48,58,O
DDI-DrugBank.d509.s14,therapy,60,66,O
DDI-DrugBank.d509.s14,",",67,67,O
DDI-DrugBank.d509.s14,aripiprazole,69,80,B-drug
DDI-DrugBank.d509.s14,dose,82,85,O
DDI-DrugBank.d509.s14,should,87,92,O
DDI-DrugBank.d509.s14,then,94,97,O
DDI-DrugBank.d509.s14,be,99,100,O
DDI-DrugBank.d509.s14,increased,102,110,O
DDI-DrugBank.d509.s14,.,111,111,O
DDI-DrugBank.d509.s15,Quinidine,0,8,B-drug
DDI-DrugBank.d509.s15,:,9,9,O
DDI-DrugBank.d509.s15,Coadministration,11,26,O
DDI-DrugBank.d509.s15,of,28,29,O
DDI-DrugBank.d509.s15,a,31,31,O
DDI-DrugBank.d509.s15,10-mg,33,37,O
DDI-DrugBank.d509.s15,single,39,44,O
DDI-DrugBank.d509.s15,dose,46,49,O
DDI-DrugBank.d509.s15,of,51,52,O
DDI-DrugBank.d509.s15,aripiprazole,54,65,B-drug
DDI-DrugBank.d509.s15,with,67,70,O
DDI-DrugBank.d509.s15,quinidine,72,80,B-drug
DDI-DrugBank.d509.s15,(,82,82,O
DDI-DrugBank.d509.s15,166,83,85,O
DDI-DrugBank.d509.s15,mg/day,87,92,O
DDI-DrugBank.d509.s15,for,94,96,O
DDI-DrugBank.d509.s15,13,98,99,O
DDI-DrugBank.d509.s15,days,101,104,O
DDI-DrugBank.d509.s15,),105,105,O
DDI-DrugBank.d509.s15,",",106,106,O
DDI-DrugBank.d509.s15,a,108,108,O
DDI-DrugBank.d509.s15,potent,110,115,O
DDI-DrugBank.d509.s15,inhibitor,117,125,O
DDI-DrugBank.d509.s15,of,127,128,O
DDI-DrugBank.d509.s15,CYP2D6,130,135,O
DDI-DrugBank.d509.s15,",",136,136,O
DDI-DrugBank.d509.s15,increased,138,146,O
DDI-DrugBank.d509.s15,the,148,150,O
DDI-DrugBank.d509.s15,AUC,152,154,O
DDI-DrugBank.d509.s15,of,156,157,O
DDI-DrugBank.d509.s15,aripiprazole,159,170,B-drug
DDI-DrugBank.d509.s15,by,172,173,O
DDI-DrugBank.d509.s15,112,175,177,O
DDI-DrugBank.d509.s15,%,178,178,O
DDI-DrugBank.d509.s15,but,180,182,O
DDI-DrugBank.d509.s15,decreased,184,192,O
DDI-DrugBank.d509.s15,the,194,196,O
DDI-DrugBank.d509.s15,AUC,198,200,O
DDI-DrugBank.d509.s15,of,202,203,O
DDI-DrugBank.d509.s15,its,205,207,O
DDI-DrugBank.d509.s15,active,209,214,O
DDI-DrugBank.d509.s15,metabolite,216,225,O
DDI-DrugBank.d509.s15,",",226,226,O
DDI-DrugBank.d509.s15,dehydroaripiprazole,228,246,B-drug_n
DDI-DrugBank.d509.s15,",",247,247,O
DDI-DrugBank.d509.s15,by,249,250,O
DDI-DrugBank.d509.s15,35,252,253,O
DDI-DrugBank.d509.s15,%,254,254,O
DDI-DrugBank.d509.s15,.,255,255,O
DDI-DrugBank.d509.s16,Aripiprazole,0,11,B-drug
DDI-DrugBank.d509.s16,dose,13,16,O
DDI-DrugBank.d509.s16,should,18,23,O
DDI-DrugBank.d509.s16,be,25,26,O
DDI-DrugBank.d509.s16,reduced,28,34,O
DDI-DrugBank.d509.s16,to,36,37,O
DDI-DrugBank.d509.s16,one-half,39,46,O
DDI-DrugBank.d509.s16,of,48,49,O
DDI-DrugBank.d509.s16,its,51,53,O
DDI-DrugBank.d509.s16,normal,55,60,O
DDI-DrugBank.d509.s16,dose,62,65,O
DDI-DrugBank.d509.s16,when,67,70,O
DDI-DrugBank.d509.s16,concomitant,72,82,O
DDI-DrugBank.d509.s16,administration,84,97,O
DDI-DrugBank.d509.s16,of,99,100,O
DDI-DrugBank.d509.s16,quinidine,102,110,B-drug
DDI-DrugBank.d509.s16,with,112,115,O
DDI-DrugBank.d509.s16,aripiprazole,117,128,B-drug
DDI-DrugBank.d509.s16,occurs,130,135,O
DDI-DrugBank.d509.s16,.,136,136,O
DDI-DrugBank.d509.s17,Other,0,4,O
DDI-DrugBank.d509.s17,significant,6,16,O
DDI-DrugBank.d509.s17,inhibitors,18,27,O
DDI-DrugBank.d509.s17,of,29,30,O
DDI-DrugBank.d509.s17,CYP2D6,32,37,O
DDI-DrugBank.d509.s17,",",38,38,O
DDI-DrugBank.d509.s17,such,40,43,O
DDI-DrugBank.d509.s17,as,45,46,O
DDI-DrugBank.d509.s17,fluoxetine,48,57,B-drug
DDI-DrugBank.d509.s17,or,59,60,O
DDI-DrugBank.d509.s17,paroxetine,62,71,B-drug
DDI-DrugBank.d509.s17,",",72,72,O
DDI-DrugBank.d509.s17,would,74,78,O
DDI-DrugBank.d509.s17,be,80,81,O
DDI-DrugBank.d509.s17,expected,83,90,O
DDI-DrugBank.d509.s17,to,92,93,O
DDI-DrugBank.d509.s17,have,95,98,O
DDI-DrugBank.d509.s17,similar,100,106,O
DDI-DrugBank.d509.s17,effects,108,114,O
DDI-DrugBank.d509.s17,and,116,118,O
DDI-DrugBank.d509.s17,",",119,119,O
DDI-DrugBank.d509.s17,therefore,121,129,O
DDI-DrugBank.d509.s17,",",130,130,O
DDI-DrugBank.d509.s17,should,132,137,O
DDI-DrugBank.d509.s17,be,139,140,O
DDI-DrugBank.d509.s17,accompanied,142,152,O
DDI-DrugBank.d509.s17,by,154,155,O
DDI-DrugBank.d509.s17,similar,157,163,O
DDI-DrugBank.d509.s17,dose,165,168,O
DDI-DrugBank.d509.s17,reductions,170,179,O
DDI-DrugBank.d509.s17,.,180,180,O
DDI-DrugBank.d509.s18,When,0,3,O
DDI-DrugBank.d509.s18,the,5,7,O
DDI-DrugBank.d509.s18,CYP2D6,9,14,O
DDI-DrugBank.d509.s18,inhibitor,16,24,O
DDI-DrugBank.d509.s18,is,26,27,O
DDI-DrugBank.d509.s18,withdrawn,29,37,O
DDI-DrugBank.d509.s18,from,39,42,O
DDI-DrugBank.d509.s18,the,44,46,O
DDI-DrugBank.d509.s18,combination,48,58,O
DDI-DrugBank.d509.s18,therapy,60,66,O
DDI-DrugBank.d509.s18,",",67,67,O
DDI-DrugBank.d509.s18,aripiprazole,69,80,B-drug
DDI-DrugBank.d509.s18,dose,82,85,O
DDI-DrugBank.d509.s18,should,87,92,O
DDI-DrugBank.d509.s18,then,94,97,O
DDI-DrugBank.d509.s18,be,99,100,O
DDI-DrugBank.d509.s18,increased,102,110,O
DDI-DrugBank.d509.s18,.,111,111,O
DDI-DrugBank.d509.s19,Carbamazepine,0,12,B-drug
DDI-DrugBank.d509.s19,:,13,13,O
DDI-DrugBank.d509.s19,Coadministration,15,30,O
DDI-DrugBank.d509.s19,of,32,33,O
DDI-DrugBank.d509.s19,carbamazepine,35,47,B-drug
DDI-DrugBank.d509.s19,(,49,49,O
DDI-DrugBank.d509.s19,200,50,52,O
DDI-DrugBank.d509.s19,mg,54,55,O
DDI-DrugBank.d509.s19,BID,57,59,O
DDI-DrugBank.d509.s19,),60,60,O
DDI-DrugBank.d509.s19,",",61,61,O
DDI-DrugBank.d509.s19,a,63,63,O
DDI-DrugBank.d509.s19,potent,65,70,O
DDI-DrugBank.d509.s19,CYP3A4,72,77,O
DDI-DrugBank.d509.s19,inducer,79,85,O
DDI-DrugBank.d509.s19,",",86,86,O
DDI-DrugBank.d509.s19,with,88,91,O
DDI-DrugBank.d509.s19,aripiprazole,93,104,B-drug
DDI-DrugBank.d509.s19,(,106,106,O
DDI-DrugBank.d509.s19,30,107,108,O
DDI-DrugBank.d509.s19,mg,110,111,O
DDI-DrugBank.d509.s19,QD,113,114,O
DDI-DrugBank.d509.s19,),115,115,O
DDI-DrugBank.d509.s19,resulted,117,124,O
DDI-DrugBank.d509.s19,in,126,127,O
DDI-DrugBank.d509.s19,an,129,130,O
DDI-DrugBank.d509.s19,approximate,132,142,O
DDI-DrugBank.d509.s19,70,144,145,O
DDI-DrugBank.d509.s19,%,146,146,O
DDI-DrugBank.d509.s19,decrease,148,155,O
DDI-DrugBank.d509.s19,in,157,158,O
DDI-DrugBank.d509.s19,Cmax,160,163,O
DDI-DrugBank.d509.s19,and,165,167,O
DDI-DrugBank.d509.s19,AUC,169,171,O
DDI-DrugBank.d509.s19,values,173,178,O
DDI-DrugBank.d509.s19,of,180,181,O
DDI-DrugBank.d509.s19,both,183,186,O
DDI-DrugBank.d509.s19,aripiprazole,188,199,B-drug
DDI-DrugBank.d509.s19,and,201,203,O
DDI-DrugBank.d509.s19,its,205,207,O
DDI-DrugBank.d509.s19,active,209,214,O
DDI-DrugBank.d509.s19,metabolite,216,225,O
DDI-DrugBank.d509.s19,",",226,226,O
DDI-DrugBank.d509.s19,dehydro-aripiprazole,228,247,B-drug_n
DDI-DrugBank.d509.s19,.,248,248,O
DDI-DrugBank.d509.s20,When,0,3,O
DDI-DrugBank.d509.s20,carbamazepine,5,17,B-drug
DDI-DrugBank.d509.s20,is,19,20,O
DDI-DrugBank.d509.s20,added,22,26,O
DDI-DrugBank.d509.s20,to,28,29,O
DDI-DrugBank.d509.s20,aripiprazole,31,42,B-drug
DDI-DrugBank.d509.s20,therapy,44,50,O
DDI-DrugBank.d509.s20,",",51,51,O
DDI-DrugBank.d509.s20,aripiprazole,53,64,B-drug
DDI-DrugBank.d509.s20,dose,66,69,O
DDI-DrugBank.d509.s20,should,71,76,O
DDI-DrugBank.d509.s20,be,78,79,O
DDI-DrugBank.d509.s20,doubled,81,87,O
DDI-DrugBank.d509.s20,.,88,88,O
DDI-DrugBank.d509.s21,Additional,0,9,O
DDI-DrugBank.d509.s21,dose,11,14,O
DDI-DrugBank.d509.s21,increases,16,24,O
DDI-DrugBank.d509.s21,should,26,31,O
DDI-DrugBank.d509.s21,be,33,34,O
DDI-DrugBank.d509.s21,based,36,40,O
DDI-DrugBank.d509.s21,on,42,43,O
DDI-DrugBank.d509.s21,clinical,45,52,O
DDI-DrugBank.d509.s21,evaluation,54,63,O
DDI-DrugBank.d509.s21,.,64,64,O
DDI-DrugBank.d509.s22,When,0,3,O
DDI-DrugBank.d509.s22,carbamazepine,5,17,B-drug
DDI-DrugBank.d509.s22,is,19,20,O
DDI-DrugBank.d509.s22,withdrawn,22,30,O
DDI-DrugBank.d509.s22,from,32,35,O
DDI-DrugBank.d509.s22,the,37,39,O
DDI-DrugBank.d509.s22,combination,41,51,O
DDI-DrugBank.d509.s22,therapy,53,59,O
DDI-DrugBank.d509.s22,",",60,60,O
DDI-DrugBank.d509.s22,aripiprazole,62,73,B-drug
DDI-DrugBank.d509.s22,dose,75,78,O
DDI-DrugBank.d509.s22,should,80,85,O
DDI-DrugBank.d509.s22,then,87,90,O
DDI-DrugBank.d509.s22,be,92,93,O
DDI-DrugBank.d509.s22,reduced,95,101,O
DDI-DrugBank.d509.s22,.,102,102,O
DDI-DrugBank.d509.s23,No,0,1,O
DDI-DrugBank.d509.s23,clinically,3,12,O
DDI-DrugBank.d509.s23,significant,14,24,O
DDI-DrugBank.d509.s23,effect,26,31,O
DDI-DrugBank.d509.s23,of,33,34,O
DDI-DrugBank.d509.s23,famotidine,36,45,B-drug
DDI-DrugBank.d509.s23,",",46,46,O
DDI-DrugBank.d509.s23,valproate,48,56,B-drug
DDI-DrugBank.d509.s23,",",57,57,O
DDI-DrugBank.d509.s23,or,59,60,O
DDI-DrugBank.d509.s23,lithium,62,68,B-drug
DDI-DrugBank.d509.s23,was,70,72,O
DDI-DrugBank.d509.s23,seen,74,77,O
DDI-DrugBank.d509.s23,on,79,80,O
DDI-DrugBank.d509.s23,the,82,84,O
DDI-DrugBank.d509.s23,pharmacokinetics,86,101,O
DDI-DrugBank.d509.s23,of,103,104,O
DDI-DrugBank.d509.s23,aripiprazole,106,117,B-drug
DDI-DrugBank.d509.s23,(,119,119,O
DDI-DrugBank.d509.s23,see,120,122,O
DDI-DrugBank.d509.s23,CLINICAL,124,131,O
DDI-DrugBank.d509.s23,PHARMACOLOGY,133,144,O
DDI-DrugBank.d509.s23,:,145,145,O
DDI-DrugBank.d509.s23,Drug-,147,151,O
DDI-DrugBank.d509.s23,Drug,153,156,O
DDI-DrugBank.d509.s23,Interactions,158,169,O
DDI-DrugBank.d509.s23,),170,170,O
DDI-DrugBank.d509.s23,.,171,171,O
DDI-DrugBank.d509.s24,Potential,0,8,O
DDI-DrugBank.d509.s24,for,10,12,O
DDI-DrugBank.d509.s24,ABILIFY,14,20,B-brand
DDI-DrugBank.d509.s24,to,22,23,O
DDI-DrugBank.d509.s24,Affect,25,30,O
DDI-DrugBank.d509.s24,Other,32,36,O
DDI-DrugBank.d509.s24,Drugs,38,42,O
DDI-DrugBank.d509.s24,Aripiprazole,44,55,B-drug
DDI-DrugBank.d509.s24,is,57,58,O
DDI-DrugBank.d509.s24,unlikely,60,67,O
DDI-DrugBank.d509.s24,to,69,70,O
DDI-DrugBank.d509.s24,cause,72,76,O
DDI-DrugBank.d509.s24,clinically,78,87,O
DDI-DrugBank.d509.s24,important,89,97,O
DDI-DrugBank.d509.s24,pharmacokinetic,99,113,O
DDI-DrugBank.d509.s24,interactions,115,126,O
DDI-DrugBank.d509.s24,with,128,131,O
DDI-DrugBank.d509.s24,drugs,133,137,O
DDI-DrugBank.d509.s24,metabolized,139,149,O
DDI-DrugBank.d509.s24,by,151,152,O
DDI-DrugBank.d509.s24,cytochrome,154,163,O
DDI-DrugBank.d509.s24,P450,165,168,O
DDI-DrugBank.d509.s24,enzymes,170,176,O
DDI-DrugBank.d509.s24,.,177,177,O
DDI-DrugBank.d509.s25,In,0,1,O
DDI-DrugBank.d509.s25,in,3,4,O
DDI-DrugBank.d509.s25,vivo,6,9,O
DDI-DrugBank.d509.s25,studies,11,17,O
DDI-DrugBank.d509.s25,",",18,18,O
DDI-DrugBank.d509.s25,10-,20,22,O
DDI-DrugBank.d509.s25,to,24,25,O
DDI-DrugBank.d509.s25,30-mg/day,27,35,O
DDI-DrugBank.d509.s25,doses,37,41,O
DDI-DrugBank.d509.s25,of,43,44,O
DDI-DrugBank.d509.s25,aripiprazole,46,57,B-drug
DDI-DrugBank.d509.s25,had,59,61,O
DDI-DrugBank.d509.s25,no,63,64,O
DDI-DrugBank.d509.s25,significant,66,76,O
DDI-DrugBank.d509.s25,effect,78,83,O
DDI-DrugBank.d509.s25,on,85,86,O
DDI-DrugBank.d509.s25,metabolism,88,97,O
DDI-DrugBank.d509.s25,by,99,100,O
DDI-DrugBank.d509.s25,CYP2D6,102,107,O
DDI-DrugBank.d509.s25,(,109,109,O
DDI-DrugBank.d509.s25,dextromethorphan,110,125,B-drug
DDI-DrugBank.d509.s25,),126,126,O
DDI-DrugBank.d509.s25,",",127,127,O
DDI-DrugBank.d509.s25,CYP2C9,129,134,O
DDI-DrugBank.d509.s25,(,136,136,O
DDI-DrugBank.d509.s25,warfarin,137,144,B-drug
DDI-DrugBank.d509.s25,),145,145,O
DDI-DrugBank.d509.s25,",",146,146,O
DDI-DrugBank.d509.s25,CYP2C19,148,154,O
DDI-DrugBank.d509.s25,(,156,156,O
DDI-DrugBank.d509.s25,omeprazole,157,166,B-drug
DDI-DrugBank.d509.s25,",",167,167,O
DDI-DrugBank.d509.s25,warfarin,169,176,B-drug
DDI-DrugBank.d509.s25,),177,177,O
DDI-DrugBank.d509.s25,",",178,178,O
DDI-DrugBank.d509.s25,and,180,182,O
DDI-DrugBank.d509.s25,CYP3A4,184,189,O
DDI-DrugBank.d509.s25,(,191,191,O
DDI-DrugBank.d509.s25,dextromethorphan,192,207,B-drug
DDI-DrugBank.d509.s25,),208,208,O
DDI-DrugBank.d509.s25,substrates,210,219,O
DDI-DrugBank.d509.s25,.,220,220,O
DDI-DrugBank.d509.s26,Additionally,0,11,O
DDI-DrugBank.d509.s26,",",12,12,O
DDI-DrugBank.d509.s26,aripiprazole,14,25,B-drug
DDI-DrugBank.d509.s26,and,27,29,O
DDI-DrugBank.d509.s26,dehydroaripiprazole,31,49,B-drug_n
DDI-DrugBank.d509.s26,did,51,53,O
DDI-DrugBank.d509.s26,not,55,57,O
DDI-DrugBank.d509.s26,show,59,62,O
DDI-DrugBank.d509.s26,potential,64,72,O
DDI-DrugBank.d509.s26,for,74,76,O
DDI-DrugBank.d509.s26,altering,78,85,O
DDI-DrugBank.d509.s26,CYP1A2-mediated,87,101,O
DDI-DrugBank.d509.s26,metabolism,103,112,O
DDI-DrugBank.d509.s26,in,114,115,O
DDI-DrugBank.d509.s26,vitro,117,121,O
DDI-DrugBank.d509.s26,.,122,122,O
DDI-DrugBank.d509.s27,Alcohol,0,6,B-drug
DDI-DrugBank.d509.s27,:,7,7,O
DDI-DrugBank.d509.s27,There,9,13,O
DDI-DrugBank.d509.s27,was,15,17,O
DDI-DrugBank.d509.s27,no,19,20,O
DDI-DrugBank.d509.s27,significant,22,32,O
DDI-DrugBank.d509.s27,difference,34,43,O
DDI-DrugBank.d509.s27,between,45,51,O
DDI-DrugBank.d509.s27,aripiprazole,53,64,B-drug
DDI-DrugBank.d509.s27,coadministered,66,79,O
DDI-DrugBank.d509.s27,with,81,84,O
DDI-DrugBank.d509.s27,ethanol,86,92,B-drug
DDI-DrugBank.d509.s27,and,94,96,O
DDI-DrugBank.d509.s27,placebo,98,104,O
DDI-DrugBank.d509.s27,coadministered,106,119,O
DDI-DrugBank.d509.s27,with,121,124,O
DDI-DrugBank.d509.s27,ethanol,126,132,B-drug
DDI-DrugBank.d509.s27,on,134,135,O
DDI-DrugBank.d509.s27,performance,137,147,O
DDI-DrugBank.d509.s27,of,149,150,O
DDI-DrugBank.d509.s27,gross,152,156,O
DDI-DrugBank.d509.s27,motor,158,162,O
DDI-DrugBank.d509.s27,skills,164,169,O
DDI-DrugBank.d509.s27,or,171,172,O
DDI-DrugBank.d509.s27,stimulus,174,181,O
DDI-DrugBank.d509.s27,response,183,190,O
DDI-DrugBank.d509.s27,in,192,193,O
DDI-DrugBank.d509.s27,healthy,195,201,O
DDI-DrugBank.d509.s27,subjects,203,210,O
DDI-DrugBank.d509.s27,.,211,211,O
DDI-DrugBank.d509.s28,As,0,1,O
DDI-DrugBank.d509.s28,with,3,6,O
DDI-DrugBank.d509.s28,most,8,11,O
DDI-DrugBank.d509.s28,psychoactive,13,24,O
DDI-DrugBank.d509.s28,medications,26,36,O
DDI-DrugBank.d509.s28,",",37,37,O
DDI-DrugBank.d509.s28,patients,39,46,O
DDI-DrugBank.d509.s28,should,48,53,O
DDI-DrugBank.d509.s28,be,55,56,O
DDI-DrugBank.d509.s28,advised,58,64,O
DDI-DrugBank.d509.s28,to,66,67,O
DDI-DrugBank.d509.s28,avoid,69,73,O
DDI-DrugBank.d509.s28,alcohol,75,81,B-drug
DDI-DrugBank.d509.s28,while,83,87,O
DDI-DrugBank.d509.s28,taking,89,94,O
DDI-DrugBank.d509.s28,ABILIFY,96,102,B-brand
DDI-DrugBank.d509.s29,.,0,0,O
DDI-DrugBank.d109.s0,Ketoconazole/Itraconazole,0,24,O
DDI-DrugBank.d109.s0,",",25,25,O
DDI-DrugBank.d109.s0,Macrolides,27,36,B-group
DDI-DrugBank.d109.s0,",",37,37,O
DDI-DrugBank.d109.s0,Including,39,47,O
DDI-DrugBank.d109.s0,Erythromycin,49,60,B-drug
DDI-DrugBank.d73.s0,Catecholamine-depleting,0,22,O
DDI-DrugBank.d73.s0,drugs,24,28,O
DDI-DrugBank.d73.s0,(,30,30,O
DDI-DrugBank.d73.s0,eg,31,32,O
DDI-DrugBank.d73.s0,",",33,33,O
DDI-DrugBank.d73.s0,reserpine,35,43,B-drug
DDI-DrugBank.d73.s0,),44,44,O
DDI-DrugBank.d73.s0,may,46,48,O
DDI-DrugBank.d73.s0,have,50,53,O
DDI-DrugBank.d73.s0,an,55,56,O
DDI-DrugBank.d73.s0,additive,58,65,O
DDI-DrugBank.d73.s0,effect,67,72,O
DDI-DrugBank.d73.s0,when,74,77,O
DDI-DrugBank.d73.s0,given,79,83,O
DDI-DrugBank.d73.s0,with,85,88,O
DDI-DrugBank.d73.s0,beta-blocking,90,102,B-group
DDI-DrugBank.d73.s0,agents,104,109,I-group
DDI-DrugBank.d73.s0,.,110,110,O
DDI-DrugBank.d73.s1,Patients,0,7,O
DDI-DrugBank.d73.s1,treated,9,15,O
DDI-DrugBank.d73.s1,with,17,20,O
DDI-DrugBank.d73.s1,TENORMIN,22,29,B-brand
DDI-DrugBank.d73.s1,plus,31,34,O
DDI-DrugBank.d73.s1,a,36,36,O
DDI-DrugBank.d73.s1,catecholamine,38,50,O
DDI-DrugBank.d73.s1,depletor,52,59,O
DDI-DrugBank.d73.s1,should,61,66,O
DDI-DrugBank.d73.s1,therefore,68,76,O
DDI-DrugBank.d73.s1,be,78,79,O
DDI-DrugBank.d73.s1,closely,81,87,O
DDI-DrugBank.d73.s1,observed,89,96,O
DDI-DrugBank.d73.s1,for,98,100,O
DDI-DrugBank.d73.s1,evidence,102,109,O
DDI-DrugBank.d73.s1,of,111,112,O
DDI-DrugBank.d73.s1,hypotension,114,124,O
DDI-DrugBank.d73.s1,and/or,126,131,O
DDI-DrugBank.d73.s1,marked,133,138,O
DDI-DrugBank.d73.s1,bradycardia,140,150,O
DDI-DrugBank.d73.s1,which,152,156,O
DDI-DrugBank.d73.s1,may,158,160,O
DDI-DrugBank.d73.s1,produce,162,168,O
DDI-DrugBank.d73.s1,vertigo,170,176,O
DDI-DrugBank.d73.s1,",",177,177,O
DDI-DrugBank.d73.s1,syncope,179,185,O
DDI-DrugBank.d73.s1,",",186,186,O
DDI-DrugBank.d73.s1,or,188,189,O
DDI-DrugBank.d73.s1,postural,191,198,O
DDI-DrugBank.d73.s1,hypotension,200,210,O
DDI-DrugBank.d73.s1,.,211,211,O
DDI-DrugBank.d73.s2,Calcium,0,6,B-group
DDI-DrugBank.d73.s2,channel,8,14,I-group
DDI-DrugBank.d73.s2,blockers,16,23,I-group
DDI-DrugBank.d73.s2,may,25,27,O
DDI-DrugBank.d73.s2,also,29,32,O
DDI-DrugBank.d73.s2,have,34,37,O
DDI-DrugBank.d73.s2,an,39,40,O
DDI-DrugBank.d73.s2,additive,42,49,O
DDI-DrugBank.d73.s2,effect,51,56,O
DDI-DrugBank.d73.s2,when,58,61,O
DDI-DrugBank.d73.s2,given,63,67,O
DDI-DrugBank.d73.s2,with,69,72,O
DDI-DrugBank.d73.s2,TENORMIN,74,81,B-brand
DDI-DrugBank.d73.s2,.,83,83,O
DDI-DrugBank.d73.s3,Beta,0,3,B-group
DDI-DrugBank.d73.s3,blockers,5,12,I-group
DDI-DrugBank.d73.s3,may,14,16,O
DDI-DrugBank.d73.s3,exacerbate,18,27,O
DDI-DrugBank.d73.s3,the,29,31,O
DDI-DrugBank.d73.s3,rebound,33,39,O
DDI-DrugBank.d73.s3,hypertension,41,52,O
DDI-DrugBank.d73.s3,which,54,58,O
DDI-DrugBank.d73.s3,can,60,62,O
DDI-DrugBank.d73.s3,follow,64,69,O
DDI-DrugBank.d73.s3,the,71,73,O
DDI-DrugBank.d73.s3,withdrawal,75,84,O
DDI-DrugBank.d73.s3,of,86,87,O
DDI-DrugBank.d73.s3,clonidine,89,97,B-drug
DDI-DrugBank.d73.s3,.,98,98,O
DDI-DrugBank.d73.s4,If,0,1,O
DDI-DrugBank.d73.s4,the,3,5,O
DDI-DrugBank.d73.s4,two,7,9,O
DDI-DrugBank.d73.s4,drugs,11,15,O
DDI-DrugBank.d73.s4,are,17,19,O
DDI-DrugBank.d73.s4,coadministered,21,34,O
DDI-DrugBank.d73.s4,",",35,35,O
DDI-DrugBank.d73.s4,the,37,39,O
DDI-DrugBank.d73.s4,beta,41,44,B-group
DDI-DrugBank.d73.s4,blocker,46,52,I-group
DDI-DrugBank.d73.s4,should,54,59,O
DDI-DrugBank.d73.s4,be,61,62,O
DDI-DrugBank.d73.s4,withdrawn,64,72,O
DDI-DrugBank.d73.s4,several,74,80,O
DDI-DrugBank.d73.s4,days,82,85,O
DDI-DrugBank.d73.s4,before,87,92,O
DDI-DrugBank.d73.s4,the,94,96,O
DDI-DrugBank.d73.s4,gradual,98,104,O
DDI-DrugBank.d73.s4,withdrawal,106,115,O
DDI-DrugBank.d73.s4,of,117,118,O
DDI-DrugBank.d73.s4,clonidine,120,128,B-drug
DDI-DrugBank.d73.s4,.,129,129,O
DDI-DrugBank.d73.s5,If,0,1,O
DDI-DrugBank.d73.s5,replacing,3,11,O
DDI-DrugBank.d73.s5,clonidine,13,21,B-drug
DDI-DrugBank.d73.s5,by,23,24,O
DDI-DrugBank.d73.s5,beta-blocker,26,37,B-group
DDI-DrugBank.d73.s5,therapy,39,45,O
DDI-DrugBank.d73.s5,",",46,46,O
DDI-DrugBank.d73.s5,the,48,50,O
DDI-DrugBank.d73.s5,introduction,52,63,O
DDI-DrugBank.d73.s5,of,65,66,O
DDI-DrugBank.d73.s5,beta,68,71,B-group
DDI-DrugBank.d73.s5,blockers,73,80,I-group
DDI-DrugBank.d73.s5,should,82,87,O
DDI-DrugBank.d73.s5,be,89,90,O
DDI-DrugBank.d73.s5,delayed,92,98,O
DDI-DrugBank.d73.s5,for,100,102,O
DDI-DrugBank.d73.s5,several,104,110,O
DDI-DrugBank.d73.s5,days,112,115,O
DDI-DrugBank.d73.s5,after,117,121,O
DDI-DrugBank.d73.s5,clonidine,123,131,B-drug
DDI-DrugBank.d73.s5,administration,133,146,O
DDI-DrugBank.d73.s5,has,148,150,O
DDI-DrugBank.d73.s5,stopped,152,158,O
DDI-DrugBank.d73.s5,.,159,159,O
DDI-DrugBank.d73.s6,Concomitant,0,10,O
DDI-DrugBank.d73.s6,use,12,14,O
DDI-DrugBank.d73.s6,of,16,17,O
DDI-DrugBank.d73.s6,prostaglandin,19,31,O
DDI-DrugBank.d73.s6,synthase,33,40,O
DDI-DrugBank.d73.s6,inhibiting,42,51,O
DDI-DrugBank.d73.s6,drugs,53,57,O
DDI-DrugBank.d73.s6,",",58,58,O
DDI-DrugBank.d73.s6,eg,60,61,O
DDI-DrugBank.d73.s6,",",62,62,O
DDI-DrugBank.d73.s6,indomethacin,64,75,B-drug
DDI-DrugBank.d73.s6,",",76,76,O
DDI-DrugBank.d73.s6,may,78,80,O
DDI-DrugBank.d73.s6,decrease,82,89,O
DDI-DrugBank.d73.s6,the,91,93,O
DDI-DrugBank.d73.s6,hypotensive,95,105,O
DDI-DrugBank.d73.s6,effects,107,113,O
DDI-DrugBank.d73.s6,of,115,116,O
DDI-DrugBank.d73.s6,beta,118,121,B-group
DDI-DrugBank.d73.s6,blockers,123,130,I-group
DDI-DrugBank.d73.s6,.,131,131,O
DDI-DrugBank.d73.s7,Information,0,10,O
DDI-DrugBank.d73.s7,on,12,13,O
DDI-DrugBank.d73.s7,concurrent,15,24,O
DDI-DrugBank.d73.s7,usage,26,30,O
DDI-DrugBank.d73.s7,of,32,33,O
DDI-DrugBank.d73.s7,atenolol,35,42,B-drug
DDI-DrugBank.d73.s7,and,44,46,O
DDI-DrugBank.d73.s7,aspirin,48,54,B-brand
DDI-DrugBank.d73.s7,is,56,57,O
DDI-DrugBank.d73.s7,limited,59,65,O
DDI-DrugBank.d73.s7,.,66,66,O
DDI-DrugBank.d73.s8,Data,0,3,O
DDI-DrugBank.d73.s8,from,5,8,O
DDI-DrugBank.d73.s8,several,10,16,O
DDI-DrugBank.d73.s8,studies,18,24,O
DDI-DrugBank.d73.s8,",",25,25,O
DDI-DrugBank.d73.s8,ie,27,28,O
DDI-DrugBank.d73.s8,",",29,29,O
DDI-DrugBank.d73.s8,TIMI-II,31,37,O
DDI-DrugBank.d73.s8,",",38,38,O
DDI-DrugBank.d73.s8,ISIS-2,40,45,O
DDI-DrugBank.d73.s8,",",46,46,O
DDI-DrugBank.d73.s8,currently,48,56,O
DDI-DrugBank.d73.s8,do,58,59,O
DDI-DrugBank.d73.s8,not,61,63,O
DDI-DrugBank.d73.s8,suggest,65,71,O
DDI-DrugBank.d73.s8,any,73,75,O
DDI-DrugBank.d73.s8,clinical,77,84,O
DDI-DrugBank.d73.s8,interaction,86,96,O
DDI-DrugBank.d73.s8,between,98,104,O
DDI-DrugBank.d73.s8,aspirin,106,112,B-brand
DDI-DrugBank.d73.s8,and,114,116,O
DDI-DrugBank.d73.s8,beta,118,121,B-group
DDI-DrugBank.d73.s8,blockers,123,130,I-group
DDI-DrugBank.d73.s8,in,132,133,O
DDI-DrugBank.d73.s8,the,135,137,O
DDI-DrugBank.d73.s8,acute,139,143,O
DDI-DrugBank.d73.s8,myocardial,145,154,O
DDI-DrugBank.d73.s8,infarction,156,165,O
DDI-DrugBank.d73.s8,setting,167,173,O
DDI-DrugBank.d73.s8,.,174,174,O
DDI-DrugBank.d73.s9,While,0,4,O
DDI-DrugBank.d73.s9,taking,6,11,O
DDI-DrugBank.d73.s9,beta,13,16,B-group
DDI-DrugBank.d73.s9,blockers,18,25,I-group
DDI-DrugBank.d73.s9,",",26,26,O
DDI-DrugBank.d73.s9,patients,28,35,O
DDI-DrugBank.d73.s9,with,37,40,O
DDI-DrugBank.d73.s9,a,42,42,O
DDI-DrugBank.d73.s9,history,44,50,O
DDI-DrugBank.d73.s9,of,52,53,O
DDI-DrugBank.d73.s9,anaphylactic,55,66,O
DDI-DrugBank.d73.s9,reaction,68,75,O
DDI-DrugBank.d73.s9,to,77,78,O
DDI-DrugBank.d73.s9,a,80,80,O
DDI-DrugBank.d73.s9,variety,82,88,O
DDI-DrugBank.d73.s9,of,90,91,O
DDI-DrugBank.d73.s9,allergens,93,101,O
DDI-DrugBank.d73.s9,may,103,105,O
DDI-DrugBank.d73.s9,have,107,110,O
DDI-DrugBank.d73.s9,a,112,112,O
DDI-DrugBank.d73.s9,more,114,117,O
DDI-DrugBank.d73.s9,severe,119,124,O
DDI-DrugBank.d73.s9,reaction,126,133,O
DDI-DrugBank.d73.s9,on,135,136,O
DDI-DrugBank.d73.s9,repeated,138,145,O
DDI-DrugBank.d73.s9,challenge,147,155,O
DDI-DrugBank.d73.s9,",",156,156,O
DDI-DrugBank.d73.s9,either,158,163,O
DDI-DrugBank.d73.s9,accidental,165,174,O
DDI-DrugBank.d73.s9,",",175,175,O
DDI-DrugBank.d73.s9,diagnostic,177,186,O
DDI-DrugBank.d73.s9,or,188,189,O
DDI-DrugBank.d73.s9,therapeutic,191,201,O
DDI-DrugBank.d73.s9,.,202,202,O
DDI-DrugBank.d73.s10,Such,0,3,O
DDI-DrugBank.d73.s10,patients,5,12,O
DDI-DrugBank.d73.s10,may,14,16,O
DDI-DrugBank.d73.s10,be,18,19,O
DDI-DrugBank.d73.s10,unresponsive,21,32,O
DDI-DrugBank.d73.s10,to,34,35,O
DDI-DrugBank.d73.s10,the,37,39,O
DDI-DrugBank.d73.s10,usual,41,45,O
DDI-DrugBank.d73.s10,doses,47,51,O
DDI-DrugBank.d73.s10,of,53,54,O
DDI-DrugBank.d73.s10,epinephrine,56,66,B-drug
DDI-DrugBank.d73.s10,used,68,71,O
DDI-DrugBank.d73.s10,to,73,74,O
DDI-DrugBank.d73.s10,treat,76,80,O
DDI-DrugBank.d73.s10,the,82,84,O
DDI-DrugBank.d73.s10,allergic,86,93,O
DDI-DrugBank.d73.s10,reaction,95,102,O
DDI-DrugBank.d73.s10,.,103,103,O
DDI-DrugBank.d383.s0,No,0,1,O
DDI-DrugBank.d383.s0,information,3,13,O
DDI-DrugBank.d383.s0,provided,15,22,O
DDI-DrugBank.d489.s0,The,0,2,O
DDI-DrugBank.d489.s0,following,4,12,O
DDI-DrugBank.d489.s0,drugs,14,18,O
DDI-DrugBank.d489.s0,have,20,23,O
DDI-DrugBank.d489.s0,been,25,28,O
DDI-DrugBank.d489.s0,coadministered,30,43,O
DDI-DrugBank.d489.s0,with,45,48,O
DDI-DrugBank.d489.s0,Kerlone,50,56,B-brand
DDI-DrugBank.d489.s0,and,58,60,O
DDI-DrugBank.d489.s0,have,62,65,O
DDI-DrugBank.d489.s0,not,67,69,O
DDI-DrugBank.d489.s0,altered,71,77,O
DDI-DrugBank.d489.s0,its,79,81,O
DDI-DrugBank.d489.s0,pharmacokinetics,83,98,O
DDI-DrugBank.d489.s0,:,99,99,O
DDI-DrugBank.d489.s0,cimetidine,101,110,B-drug
DDI-DrugBank.d489.s0,",",111,111,O
DDI-DrugBank.d489.s0,nifedipine,113,122,B-drug
DDI-DrugBank.d489.s0,",",123,123,O
DDI-DrugBank.d489.s0,chlorthalidone,125,138,B-drug
DDI-DrugBank.d489.s0,",",139,139,O
DDI-DrugBank.d489.s0,and,141,143,O
DDI-DrugBank.d489.s0,hydrochlorothiazide,145,163,B-drug
DDI-DrugBank.d489.s0,.,164,164,O
DDI-DrugBank.d489.s1,Concomitant,0,10,O
DDI-DrugBank.d489.s1,administration,12,25,O
DDI-DrugBank.d489.s1,of,27,28,O
DDI-DrugBank.d489.s1,Kerlone,30,36,B-brand
DDI-DrugBank.d489.s1,with,38,41,O
DDI-DrugBank.d489.s1,the,43,45,O
DDI-DrugBank.d489.s1,oral,47,50,O
DDI-DrugBank.d489.s1,anticoagulant,52,64,B-group
DDI-DrugBank.d489.s1,warfarin,66,73,B-drug
DDI-DrugBank.d489.s1,has,75,77,O
DDI-DrugBank.d489.s1,been,79,82,O
DDI-DrugBank.d489.s1,shown,84,88,O
DDI-DrugBank.d489.s1,not,90,92,O
DDI-DrugBank.d489.s1,to,94,95,O
DDI-DrugBank.d489.s1,potentiate,97,106,O
DDI-DrugBank.d489.s1,the,108,110,O
DDI-DrugBank.d489.s1,anticoagulant,112,124,O
DDI-DrugBank.d489.s1,effect,126,131,O
DDI-DrugBank.d489.s1,of,133,134,O
DDI-DrugBank.d489.s1,warfarin,136,143,B-drug
DDI-DrugBank.d489.s1,.,144,144,O
DDI-DrugBank.d489.s2,Catecholamine-depleting,0,22,O
DDI-DrugBank.d489.s2,drugs,24,28,O
DDI-DrugBank.d489.s2,(,30,30,O
DDI-DrugBank.d489.s2,e.g.,31,34,O
DDI-DrugBank.d489.s2,",",35,35,O
DDI-DrugBank.d489.s2,reserpine,37,45,B-drug
DDI-DrugBank.d489.s2,),46,46,O
DDI-DrugBank.d489.s2,may,48,50,O
DDI-DrugBank.d489.s2,have,52,55,O
DDI-DrugBank.d489.s2,an,57,58,O
DDI-DrugBank.d489.s2,additive,60,67,O
DDI-DrugBank.d489.s2,effect,69,74,O
DDI-DrugBank.d489.s2,when,76,79,O
DDI-DrugBank.d489.s2,given,81,85,O
DDI-DrugBank.d489.s2,with,87,90,O
DDI-DrugBank.d489.s2,beta-blocking,92,104,B-drug
DDI-DrugBank.d489.s2,agents,106,111,O
DDI-DrugBank.d489.s2,.,112,112,O
DDI-DrugBank.d489.s3,Patients,0,7,O
DDI-DrugBank.d489.s3,treated,9,15,O
DDI-DrugBank.d489.s3,with,17,20,O
DDI-DrugBank.d489.s3,a,22,22,O
DDI-DrugBank.d489.s3,beta-adrenergic,24,38,B-group
DDI-DrugBank.d489.s3,receptor,40,47,I-group
DDI-DrugBank.d489.s3,blocking,49,56,I-group
DDI-DrugBank.d489.s3,agent,58,62,I-group
DDI-DrugBank.d489.s3,plus,64,67,O
DDI-DrugBank.d489.s3,a,69,69,O
DDI-DrugBank.d489.s3,catecholamine,71,83,O
DDI-DrugBank.d489.s3,depletor,85,92,O
DDI-DrugBank.d489.s3,should,94,99,O
DDI-DrugBank.d489.s3,therefore,101,109,O
DDI-DrugBank.d489.s3,be,111,112,O
DDI-DrugBank.d489.s3,closely,114,120,O
DDI-DrugBank.d489.s3,observed,122,129,O
DDI-DrugBank.d489.s3,for,131,133,O
DDI-DrugBank.d489.s3,evidence,135,142,O
DDI-DrugBank.d489.s3,of,144,145,O
DDI-DrugBank.d489.s3,hypotension,147,157,O
DDI-DrugBank.d489.s3,or,159,160,O
DDI-DrugBank.d489.s3,marked,162,167,O
DDI-DrugBank.d489.s3,bradycardia,169,179,O
DDI-DrugBank.d489.s3,",",180,180,O
DDI-DrugBank.d489.s3,which,182,186,O
DDI-DrugBank.d489.s3,may,188,190,O
DDI-DrugBank.d489.s3,produce,192,198,O
DDI-DrugBank.d489.s3,vertigo,200,206,O
DDI-DrugBank.d489.s3,",",207,207,O
DDI-DrugBank.d489.s3,syncope,209,215,O
DDI-DrugBank.d489.s3,",",216,216,O
DDI-DrugBank.d489.s3,or,218,219,O
DDI-DrugBank.d489.s3,postural,221,228,O
DDI-DrugBank.d489.s3,hypotension,230,240,O
DDI-DrugBank.d489.s3,.,241,241,O
DDI-DrugBank.d489.s4,Should,0,5,O
DDI-DrugBank.d489.s4,it,7,8,O
DDI-DrugBank.d489.s4,be,10,11,O
DDI-DrugBank.d489.s4,decided,13,19,O
DDI-DrugBank.d489.s4,to,21,22,O
DDI-DrugBank.d489.s4,discontinue,24,34,O
DDI-DrugBank.d489.s4,therapy,36,42,O
DDI-DrugBank.d489.s4,in,44,45,O
DDI-DrugBank.d489.s4,patients,47,54,O
DDI-DrugBank.d489.s4,receiving,56,64,O
DDI-DrugBank.d489.s4,beta-blockers,66,78,B-group
DDI-DrugBank.d489.s4,and,80,82,O
DDI-DrugBank.d489.s4,clonidine,84,92,B-drug
DDI-DrugBank.d489.s4,concurrently,94,105,O
DDI-DrugBank.d489.s4,",",106,106,O
DDI-DrugBank.d489.s4,the,108,110,O
DDI-DrugBank.d489.s4,beta-blocker,112,123,B-group
DDI-DrugBank.d489.s4,should,125,130,O
DDI-DrugBank.d489.s4,be,132,133,O
DDI-DrugBank.d489.s4,discontinued,135,146,O
DDI-DrugBank.d489.s4,slowly,148,153,O
DDI-DrugBank.d489.s4,over,155,158,O
DDI-DrugBank.d489.s4,several,160,166,O
DDI-DrugBank.d489.s4,days,168,171,O
DDI-DrugBank.d489.s4,before,173,178,O
DDI-DrugBank.d489.s4,the,180,182,O
DDI-DrugBank.d489.s4,gradual,184,190,O
DDI-DrugBank.d489.s4,withdrawal,192,201,O
DDI-DrugBank.d489.s4,of,203,204,O
DDI-DrugBank.d489.s4,clonidine,206,214,B-drug
DDI-DrugBank.d489.s4,.,215,215,O
DDI-DrugBank.d489.s5,Literature,0,9,O
DDI-DrugBank.d489.s5,reports,11,17,O
DDI-DrugBank.d489.s5,suggest,19,25,O
DDI-DrugBank.d489.s5,that,27,30,O
DDI-DrugBank.d489.s5,oral,32,35,O
DDI-DrugBank.d489.s5,calcium,37,43,B-group
DDI-DrugBank.d489.s5,antagonists,45,55,I-group
DDI-DrugBank.d489.s5,may,57,59,O
DDI-DrugBank.d489.s5,be,61,62,O
DDI-DrugBank.d489.s5,used,64,67,O
DDI-DrugBank.d489.s5,in,69,70,O
DDI-DrugBank.d489.s5,combination,72,82,O
DDI-DrugBank.d489.s5,with,84,87,O
DDI-DrugBank.d489.s5,beta-adrenergic,89,103,B-group
DDI-DrugBank.d489.s5,blocking,105,112,I-group
DDI-DrugBank.d489.s5,agents,114,119,I-group
DDI-DrugBank.d489.s5,when,121,124,O
DDI-DrugBank.d489.s5,heart,126,130,O
DDI-DrugBank.d489.s5,function,132,139,O
DDI-DrugBank.d489.s5,is,141,142,O
DDI-DrugBank.d489.s5,normal,144,149,O
DDI-DrugBank.d489.s5,",",150,150,O
DDI-DrugBank.d489.s5,but,152,154,O
DDI-DrugBank.d489.s5,should,156,161,O
DDI-DrugBank.d489.s5,be,163,164,O
DDI-DrugBank.d489.s5,avoided,166,172,O
DDI-DrugBank.d489.s5,in,174,175,O
DDI-DrugBank.d489.s5,patients,177,184,O
DDI-DrugBank.d489.s5,with,186,189,O
DDI-DrugBank.d489.s5,impaired,191,198,O
DDI-DrugBank.d489.s5,cardiac,200,206,O
DDI-DrugBank.d489.s5,function,208,215,O
DDI-DrugBank.d489.s5,.,216,216,O
DDI-DrugBank.d489.s6,Hypotension,0,10,O
DDI-DrugBank.d489.s6,",",11,11,O
DDI-DrugBank.d489.s6,AV,13,14,O
DDI-DrugBank.d489.s6,conduction,16,25,O
DDI-DrugBank.d489.s6,disturbances,27,38,O
DDI-DrugBank.d489.s6,",",39,39,O
DDI-DrugBank.d489.s6,and,41,43,O
DDI-DrugBank.d489.s6,left,45,48,O
DDI-DrugBank.d489.s6,ventricular,50,60,O
DDI-DrugBank.d489.s6,failure,62,68,O
DDI-DrugBank.d489.s6,have,70,73,O
DDI-DrugBank.d489.s6,been,75,78,O
DDI-DrugBank.d489.s6,reported,80,87,O
DDI-DrugBank.d489.s6,in,89,90,O
DDI-DrugBank.d489.s6,some,92,95,O
DDI-DrugBank.d489.s6,patients,97,104,O
DDI-DrugBank.d489.s6,receiving,106,114,O
DDI-DrugBank.d489.s6,beta-adrenergic,116,130,B-group
DDI-DrugBank.d489.s6,blocking,132,139,I-group
DDI-DrugBank.d489.s6,agents,141,146,I-group
DDI-DrugBank.d489.s6,when,148,151,O
DDI-DrugBank.d489.s6,an,153,154,O
DDI-DrugBank.d489.s6,oral,156,159,O
DDI-DrugBank.d489.s6,calcium,161,167,B-group
DDI-DrugBank.d489.s6,antagonist,169,178,I-group
DDI-DrugBank.d489.s6,was,180,182,O
DDI-DrugBank.d489.s6,added,184,188,O
DDI-DrugBank.d489.s6,to,190,191,O
DDI-DrugBank.d489.s6,the,193,195,O
DDI-DrugBank.d489.s6,treatment,197,205,O
DDI-DrugBank.d489.s6,regimen,207,213,O
DDI-DrugBank.d489.s6,.,214,214,O
DDI-DrugBank.d489.s7,Hypotension,0,10,O
DDI-DrugBank.d489.s7,was,12,14,O
DDI-DrugBank.d489.s7,more,16,19,O
DDI-DrugBank.d489.s7,likely,21,26,O
DDI-DrugBank.d489.s7,to,28,29,O
DDI-DrugBank.d489.s7,occur,31,35,O
DDI-DrugBank.d489.s7,if,37,38,O
DDI-DrugBank.d489.s7,the,40,42,O
DDI-DrugBank.d489.s7,calcium,44,50,B-group
DDI-DrugBank.d489.s7,antagonist,52,61,I-group
DDI-DrugBank.d489.s7,were,63,66,O
DDI-DrugBank.d489.s7,a,68,68,O
DDI-DrugBank.d489.s7,dihydropyridine,70,84,B-group
DDI-DrugBank.d489.s7,derivative,86,95,I-group
DDI-DrugBank.d489.s7,",",96,96,O
DDI-DrugBank.d489.s7,e.g.,98,101,O
DDI-DrugBank.d489.s7,",",102,102,O
DDI-DrugBank.d489.s7,nifedipine,104,113,B-drug
DDI-DrugBank.d489.s7,",",114,114,O
DDI-DrugBank.d489.s7,while,116,120,O
DDI-DrugBank.d489.s7,left,122,125,O
DDI-DrugBank.d489.s7,ventricular,127,137,O
DDI-DrugBank.d489.s7,failure,139,145,O
DDI-DrugBank.d489.s7,and,147,149,O
DDI-DrugBank.d489.s7,AV,151,152,O
DDI-DrugBank.d489.s7,conduction,154,163,O
DDI-DrugBank.d489.s7,disturbances,165,176,O
DDI-DrugBank.d489.s7,",",177,177,O
DDI-DrugBank.d489.s7,including,179,187,O
DDI-DrugBank.d489.s7,complete,189,196,O
DDI-DrugBank.d489.s7,heart,198,202,O
DDI-DrugBank.d489.s7,block,204,208,O
DDI-DrugBank.d489.s7,",",209,209,O
DDI-DrugBank.d489.s7,were,211,214,O
DDI-DrugBank.d489.s7,more,216,219,O
DDI-DrugBank.d489.s7,likely,221,226,O
DDI-DrugBank.d489.s7,to,228,229,O
DDI-DrugBank.d489.s7,occur,231,235,O
DDI-DrugBank.d489.s7,with,237,240,O
DDI-DrugBank.d489.s7,either,242,247,O
DDI-DrugBank.d489.s7,verapamil,249,257,B-drug
DDI-DrugBank.d489.s7,or,259,260,O
DDI-DrugBank.d489.s7,diltiazem,262,270,B-drug
DDI-DrugBank.d489.s7,.,271,271,O
DDI-DrugBank.d489.s8,Risk,0,3,O
DDI-DrugBank.d489.s8,of,5,6,O
DDI-DrugBank.d489.s8,Anaphylactic,8,19,O
DDI-DrugBank.d489.s8,Reaction,21,28,O
DDI-DrugBank.d489.s8,:,29,29,O
DDI-DrugBank.d489.s8,Although,31,38,O
DDI-DrugBank.d489.s8,it,40,41,O
DDI-DrugBank.d489.s8,is,43,44,O
DDI-DrugBank.d489.s8,known,46,50,O
DDI-DrugBank.d489.s8,that,52,55,O
DDI-DrugBank.d489.s8,patients,57,64,O
DDI-DrugBank.d489.s8,on,66,67,O
DDI-DrugBank.d489.s8,beta-blockers,69,81,B-group
DDI-DrugBank.d489.s8,may,83,85,O
DDI-DrugBank.d489.s8,be,87,88,O
DDI-DrugBank.d489.s8,refractory,90,99,O
DDI-DrugBank.d489.s8,to,101,102,O
DDI-DrugBank.d489.s8,epinephrine,104,114,B-drug
DDI-DrugBank.d489.s8,in,116,117,O
DDI-DrugBank.d489.s8,the,119,121,O
DDI-DrugBank.d489.s8,treatment,123,131,O
DDI-DrugBank.d489.s8,of,133,134,O
DDI-DrugBank.d489.s8,anaphylactic,136,147,O
DDI-DrugBank.d489.s8,shock,149,153,O
DDI-DrugBank.d489.s8,",",154,154,O
DDI-DrugBank.d489.s8,beta-blockers,156,168,B-group
DDI-DrugBank.d489.s8,can,170,172,O
DDI-DrugBank.d489.s8,",",173,173,O
DDI-DrugBank.d489.s8,in,175,176,O
DDI-DrugBank.d489.s8,addition,178,185,O
DDI-DrugBank.d489.s8,",",186,186,O
DDI-DrugBank.d489.s8,interfere,188,196,O
DDI-DrugBank.d489.s8,with,198,201,O
DDI-DrugBank.d489.s8,the,203,205,O
DDI-DrugBank.d489.s8,modulation,207,216,O
DDI-DrugBank.d489.s8,of,218,219,O
DDI-DrugBank.d489.s8,allergic,221,228,O
DDI-DrugBank.d489.s8,reaction,230,237,O
DDI-DrugBank.d489.s8,and,239,241,O
DDI-DrugBank.d489.s8,lead,243,246,O
DDI-DrugBank.d489.s8,to,248,249,O
DDI-DrugBank.d489.s8,an,251,252,O
DDI-DrugBank.d489.s8,increased,254,262,O
DDI-DrugBank.d489.s8,severity,264,271,O
DDI-DrugBank.d489.s8,and/or,273,278,O
DDI-DrugBank.d489.s8,frequency,280,288,O
DDI-DrugBank.d489.s8,of,290,291,O
DDI-DrugBank.d489.s8,attacks,293,299,O
DDI-DrugBank.d489.s8,.,300,300,O
DDI-DrugBank.d489.s9,Severe,0,5,O
DDI-DrugBank.d489.s9,allergic,7,14,O
DDI-DrugBank.d489.s9,reactions,16,24,O
DDI-DrugBank.d489.s9,including,26,34,O
DDI-DrugBank.d489.s9,anaphylaxis,36,46,O
DDI-DrugBank.d489.s9,have,48,51,O
DDI-DrugBank.d489.s9,been,53,56,O
DDI-DrugBank.d489.s9,reported,58,65,O
DDI-DrugBank.d489.s9,in,67,68,O
DDI-DrugBank.d489.s9,patients,70,77,O
DDI-DrugBank.d489.s9,exposed,79,85,O
DDI-DrugBank.d489.s9,to,87,88,O
DDI-DrugBank.d489.s9,a,90,90,O
DDI-DrugBank.d489.s9,variety,92,98,O
DDI-DrugBank.d489.s9,of,100,101,O
DDI-DrugBank.d489.s9,allergens,103,111,O
DDI-DrugBank.d489.s9,either,113,118,O
DDI-DrugBank.d489.s9,by,120,121,O
DDI-DrugBank.d489.s9,repeated,123,130,O
DDI-DrugBank.d489.s9,challenge,132,140,O
DDI-DrugBank.d489.s9,",",141,141,O
DDI-DrugBank.d489.s9,or,143,144,O
DDI-DrugBank.d489.s9,accidental,146,155,O
DDI-DrugBank.d489.s9,contact,157,163,O
DDI-DrugBank.d489.s9,",",164,164,O
DDI-DrugBank.d489.s9,and,166,168,O
DDI-DrugBank.d489.s9,with,170,173,O
DDI-DrugBank.d489.s9,diagnostic,175,184,O
DDI-DrugBank.d489.s9,or,186,187,O
DDI-DrugBank.d489.s9,therapeutic,189,199,O
DDI-DrugBank.d489.s9,agents,201,206,O
DDI-DrugBank.d489.s9,while,208,212,O
DDI-DrugBank.d489.s9,receiving,214,222,O
DDI-DrugBank.d489.s9,beta-blockers,224,236,B-group
DDI-DrugBank.d489.s9,.,237,237,O
DDI-DrugBank.d489.s10,Such,0,3,O
DDI-DrugBank.d489.s10,patients,5,12,O
DDI-DrugBank.d489.s10,may,14,16,O
DDI-DrugBank.d489.s10,be,18,19,O
DDI-DrugBank.d489.s10,unresponsive,21,32,O
DDI-DrugBank.d489.s10,to,34,35,O
DDI-DrugBank.d489.s10,the,37,39,O
DDI-DrugBank.d489.s10,usual,41,45,O
DDI-DrugBank.d489.s10,doses,47,51,O
DDI-DrugBank.d489.s10,of,53,54,O
DDI-DrugBank.d489.s10,epinephrine,56,66,B-drug
DDI-DrugBank.d489.s10,used,68,71,O
DDI-DrugBank.d489.s10,to,73,74,O
DDI-DrugBank.d489.s10,treat,76,80,O
DDI-DrugBank.d489.s10,allergic,82,89,O
DDI-DrugBank.d489.s10,reaction,91,98,O
DDI-DrugBank.d489.s10,.,99,99,O
DDI-DrugBank.d497.s0,AZOPT,0,4,B-brand
DDI-DrugBank.d497.s0,(,6,6,O
DDI-DrugBank.d497.s0,brinzolamide,7,18,B-drug
DDI-DrugBank.d497.s0,ophthalmic,20,29,O
DDI-DrugBank.d497.s0,suspension,31,40,O
DDI-DrugBank.d497.s0,),41,41,O
DDI-DrugBank.d497.s0,1,43,43,O
DDI-DrugBank.d497.s0,%,44,44,O
DDI-DrugBank.d497.s0,contains,46,53,O
DDI-DrugBank.d497.s0,a,55,55,O
DDI-DrugBank.d497.s0,carbonic,57,64,B-group
DDI-DrugBank.d497.s0,anhydrase,66,74,I-group
DDI-DrugBank.d497.s0,inhibitor,76,84,I-group
DDI-DrugBank.d497.s0,.,85,85,O
DDI-DrugBank.d497.s1,Acid-base,0,8,O
DDI-DrugBank.d497.s1,and,10,12,O
DDI-DrugBank.d497.s1,electrolyte,14,24,O
DDI-DrugBank.d497.s1,alterations,26,36,O
DDI-DrugBank.d497.s1,were,38,41,O
DDI-DrugBank.d497.s1,not,43,45,O
DDI-DrugBank.d497.s1,reported,47,54,O
DDI-DrugBank.d497.s1,in,56,57,O
DDI-DrugBank.d497.s1,the,59,61,O
DDI-DrugBank.d497.s1,clinical,63,70,O
DDI-DrugBank.d497.s1,trials,72,77,O
DDI-DrugBank.d497.s1,with,79,82,O
DDI-DrugBank.d497.s1,brinzolamide,84,95,B-drug
DDI-DrugBank.d497.s1,.,96,96,O
DDI-DrugBank.d497.s2,However,0,6,O
DDI-DrugBank.d497.s2,",",7,7,O
DDI-DrugBank.d497.s2,in,9,10,O
DDI-DrugBank.d497.s2,patients,12,19,O
DDI-DrugBank.d497.s2,treated,21,27,O
DDI-DrugBank.d497.s2,with,29,32,O
DDI-DrugBank.d497.s2,oral,34,37,O
DDI-DrugBank.d497.s2,carbonic,39,46,B-group
DDI-DrugBank.d497.s2,anhydrase,48,56,I-group
DDI-DrugBank.d497.s2,inhibitors,58,67,I-group
DDI-DrugBank.d497.s2,",",68,68,O
DDI-DrugBank.d497.s2,rare,70,73,O
DDI-DrugBank.d497.s2,instances,75,83,O
DDI-DrugBank.d497.s2,of,85,86,O
DDI-DrugBank.d497.s2,drug,88,91,O
DDI-DrugBank.d497.s2,interactions,93,104,O
DDI-DrugBank.d497.s2,have,106,109,O
DDI-DrugBank.d497.s2,occurred,111,118,O
DDI-DrugBank.d497.s2,with,120,123,O
DDI-DrugBank.d497.s2,high-dose,125,133,O
DDI-DrugBank.d497.s2,salicylate,135,144,B-drug
DDI-DrugBank.d497.s2,therapy,146,152,O
DDI-DrugBank.d497.s2,.,153,153,O
DDI-DrugBank.d497.s3,Therefore,0,8,O
DDI-DrugBank.d497.s3,",",9,9,O
DDI-DrugBank.d497.s3,the,11,13,O
DDI-DrugBank.d497.s3,potential,15,23,O
DDI-DrugBank.d497.s3,for,25,27,O
DDI-DrugBank.d497.s3,such,29,32,O
DDI-DrugBank.d497.s3,drug,34,37,O
DDI-DrugBank.d497.s3,interaction,39,49,O
DDI-DrugBank.d497.s3,should,51,56,O
DDI-DrugBank.d497.s3,be,58,59,O
DDI-DrugBank.d497.s3,considered,61,70,O
DDI-DrugBank.d497.s3,in,72,73,O
DDI-DrugBank.d497.s3,patients,75,82,O
DDI-DrugBank.d497.s3,receiving,84,92,O
DDI-DrugBank.d497.s3,AZOPT,94,98,B-brand
DDI-DrugBank.d497.s3,(,100,100,O
DDI-DrugBank.d497.s3,brinzolamide,101,112,B-drug
DDI-DrugBank.d497.s3,ophthalmic,114,123,O
DDI-DrugBank.d497.s3,suspension,125,134,O
DDI-DrugBank.d497.s3,),135,135,O
DDI-DrugBank.d497.s3,1,137,137,O
DDI-DrugBank.d497.s3,%,138,138,O
DDI-DrugBank.d497.s3,.,139,139,O
DDI-DrugBank.d153.s0,The,0,2,O
DDI-DrugBank.d153.s0,administration,4,17,O
DDI-DrugBank.d153.s0,of,19,20,O
DDI-DrugBank.d153.s0,local,22,26,O
DDI-DrugBank.d153.s0,anesthetic,28,37,B-group
DDI-DrugBank.d153.s0,solutions,39,47,I-group
DDI-DrugBank.d153.s0,containing,49,58,O
DDI-DrugBank.d153.s0,epinephrine,60,70,B-drug
DDI-DrugBank.d153.s0,or,72,73,O
DDI-DrugBank.d153.s0,norepinephrine,75,88,B-drug
DDI-DrugBank.d153.s0,to,90,91,O
DDI-DrugBank.d153.s0,patients,93,100,O
DDI-DrugBank.d153.s0,receiving,102,110,O
DDI-DrugBank.d153.s0,monoamine,112,120,B-group
DDI-DrugBank.d153.s0,oxidase,122,128,I-group
DDI-DrugBank.d153.s0,inhibitors,130,139,I-group
DDI-DrugBank.d153.s0,or,141,142,O
DDI-DrugBank.d153.s0,tricyclic,144,152,B-group
DDI-DrugBank.d153.s0,antidepressants,154,168,I-group
DDI-DrugBank.d153.s0,may,170,172,O
DDI-DrugBank.d153.s0,produce,174,180,O
DDI-DrugBank.d153.s0,severe,182,187,O
DDI-DrugBank.d153.s0,",",188,188,O
DDI-DrugBank.d153.s0,prolonged,190,198,O
DDI-DrugBank.d153.s0,hypertension,200,211,O
DDI-DrugBank.d153.s0,.,212,212,O
DDI-DrugBank.d153.s1,Concurrent,0,9,O
DDI-DrugBank.d153.s1,use,11,13,O
DDI-DrugBank.d153.s1,of,15,16,O
DDI-DrugBank.d153.s1,these,18,22,O
DDI-DrugBank.d153.s1,agents,24,29,O
DDI-DrugBank.d153.s1,should,31,36,O
DDI-DrugBank.d153.s1,generally,38,46,O
DDI-DrugBank.d153.s1,be,48,49,O
DDI-DrugBank.d153.s1,avoided,51,57,O
DDI-DrugBank.d153.s1,.,58,58,O
DDI-DrugBank.d153.s2,In,0,1,O
DDI-DrugBank.d153.s2,situations,3,12,O
DDI-DrugBank.d153.s2,in,14,15,O
DDI-DrugBank.d153.s2,which,17,21,O
DDI-DrugBank.d153.s2,concurrent,23,32,O
DDI-DrugBank.d153.s2,therapy,34,40,O
DDI-DrugBank.d153.s2,is,42,43,O
DDI-DrugBank.d153.s2,necessary,45,53,O
DDI-DrugBank.d153.s2,",",54,54,O
DDI-DrugBank.d153.s2,careful,56,62,O
DDI-DrugBank.d153.s2,patient,64,70,O
DDI-DrugBank.d153.s2,monitoring,72,81,O
DDI-DrugBank.d153.s2,is,83,84,O
DDI-DrugBank.d153.s2,essential,86,94,O
DDI-DrugBank.d153.s2,.,95,95,O
DDI-DrugBank.d153.s3,Concurrent,0,9,O
DDI-DrugBank.d153.s3,administration,11,24,O
DDI-DrugBank.d153.s3,of,26,27,O
DDI-DrugBank.d153.s3,vasopressor,29,39,B-group
DDI-DrugBank.d153.s3,drugs,41,45,I-group
DDI-DrugBank.d153.s3,and,47,49,O
DDI-DrugBank.d153.s3,of,51,52,O
DDI-DrugBank.d153.s3,ergot-type,54,63,B-group
DDI-DrugBank.d153.s3,oxytocic,65,72,I-group
DDI-DrugBank.d153.s3,drugs,74,78,I-group
DDI-DrugBank.d153.s3,may,80,82,O
DDI-DrugBank.d153.s3,cause,84,88,O
DDI-DrugBank.d153.s3,severe,90,95,O
DDI-DrugBank.d153.s3,",",96,96,O
DDI-DrugBank.d153.s3,persistent,98,107,O
DDI-DrugBank.d153.s3,hypertension,109,120,O
DDI-DrugBank.d153.s3,or,122,123,O
DDI-DrugBank.d153.s3,cerebrovascular,125,139,O
DDI-DrugBank.d153.s3,accidents,141,149,O
DDI-DrugBank.d153.s3,.,150,150,O
DDI-DrugBank.d153.s4,Phenothiazines,0,13,B-group
DDI-DrugBank.d153.s4,and,15,17,O
DDI-DrugBank.d153.s4,butyrophenones,19,32,B-group
DDI-DrugBank.d153.s4,may,34,36,O
DDI-DrugBank.d153.s4,reduce,38,43,O
DDI-DrugBank.d153.s4,or,45,46,O
DDI-DrugBank.d153.s4,reverse,48,54,O
DDI-DrugBank.d153.s4,the,56,58,O
DDI-DrugBank.d153.s4,pressor,60,66,O
DDI-DrugBank.d153.s4,effect,68,73,O
DDI-DrugBank.d153.s4,of,75,76,O
DDI-DrugBank.d153.s4,epinephrine,78,88,B-drug
DDI-DrugBank.d153.s4,.,89,89,O
DDI-DrugBank.d213.s0,Iodine,0,5,B-drug
DDI-DrugBank.d213.s0,or,7,8,O
DDI-DrugBank.d213.s0,iodine,10,15,B-drug
DDI-DrugBank.d213.s0,excess,17,22,O
DDI-DrugBank.d213.s0,may,24,26,O
DDI-DrugBank.d213.s0,decrease,28,35,O
DDI-DrugBank.d213.s0,the,37,39,O
DDI-DrugBank.d213.s0,effect,41,46,O
DDI-DrugBank.d213.s0,of,48,49,O
DDI-DrugBank.d213.s0,Carbimazole,51,61,B-drug
DDI-DrugBank.d213.s0,",",62,62,O
DDI-DrugBank.d213.s0,and,64,66,O
DDI-DrugBank.d213.s0,an,68,69,O
DDI-DrugBank.d213.s0,iodine,71,76,B-drug
DDI-DrugBank.d213.s0,deficiency,78,87,O
DDI-DrugBank.d213.s0,can,89,91,O
DDI-DrugBank.d213.s0,increase,93,100,O
DDI-DrugBank.d213.s0,the,102,104,O
DDI-DrugBank.d213.s0,effect,106,111,O
DDI-DrugBank.d213.s0,of,113,114,O
DDI-DrugBank.d213.s0,Carbimazole,116,126,B-drug
DDI-DrugBank.d213.s0,.,127,127,O
DDI-DrugBank.d213.s1,Serum,0,4,O
DDI-DrugBank.d213.s1,concentration,6,18,O
DDI-DrugBank.d213.s1,of,20,21,O
DDI-DrugBank.d213.s1,digoxin,23,29,B-drug
DDI-DrugBank.d213.s1,and,31,33,O
DDI-DrugBank.d213.s1,digitoxin,35,43,B-drug
DDI-DrugBank.d213.s1,may,45,47,O
DDI-DrugBank.d213.s1,increase,49,56,O
DDI-DrugBank.d213.s1,when,58,61,O
DDI-DrugBank.d213.s1,patients,63,70,O
DDI-DrugBank.d213.s1,take,72,75,O
DDI-DrugBank.d213.s1,antithyroid,77,87,B-group
DDI-DrugBank.d213.s1,agents,89,94,I-group
DDI-DrugBank.d213.s1,.,95,95,O
DDI-DrugBank.d213.s2,A,0,0,O
DDI-DrugBank.d213.s2,decrease,2,9,O
DDI-DrugBank.d213.s2,of,11,12,O
DDI-DrugBank.d213.s2,the,14,16,O
DDI-DrugBank.d213.s2,dosage,18,23,O
DDI-DrugBank.d213.s2,may,25,27,O
DDI-DrugBank.d213.s2,be,29,30,O
DDI-DrugBank.d213.s2,necessary,32,40,O
DDI-DrugBank.d213.s2,when,42,45,O
DDI-DrugBank.d213.s2,patient,47,53,O
DDI-DrugBank.d213.s2,becomes,55,61,O
DDI-DrugBank.d213.s2,euthyroid,63,71,O
DDI-DrugBank.d213.s2,.,72,72,O
DDI-DrugBank.d213.s3,Antithyroid,0,10,B-group
DDI-DrugBank.d213.s3,agents,12,17,I-group
DDI-DrugBank.d213.s3,may,19,21,O
DDI-DrugBank.d213.s3,decrease,23,30,O
DDI-DrugBank.d213.s3,thyroidal,32,40,O
DDI-DrugBank.d213.s3,uptake,42,47,O
DDI-DrugBank.d213.s3,of,49,50,O
DDI-DrugBank.d213.s3,sodium,52,57,B-drug
DDI-DrugBank.d213.s3,iodide,59,64,I-drug
DDI-DrugBank.d213.s3,I131,66,69,I-drug
DDI-DrugBank.d213.s3,",",70,70,O
DDI-DrugBank.d213.s3,a,72,72,O
DDI-DrugBank.d213.s3,rebound,74,80,O
DDI-DrugBank.d213.s3,in,82,83,O
DDI-DrugBank.d213.s3,uptake,85,90,O
DDI-DrugBank.d213.s3,may,92,94,O
DDI-DrugBank.d213.s3,occur,96,100,O
DDI-DrugBank.d213.s3,up,102,103,O
DDI-DrugBank.d213.s3,to,105,106,O
DDI-DrugBank.d213.s3,5,108,108,O
DDI-DrugBank.d213.s3,days,110,113,O
DDI-DrugBank.d213.s3,after,115,119,O
DDI-DrugBank.d213.s3,sudden,121,126,O
DDI-DrugBank.d213.s3,withdrawal,128,137,O
DDI-DrugBank.d213.s3,of,139,140,O
DDI-DrugBank.d213.s3,Carbimazole,142,152,B-drug
DDI-DrugBank.d213.s3,.,153,153,O
DDI-DrugBank.d213.s4,Patients,0,7,O
DDI-DrugBank.d213.s4,response,9,16,O
DDI-DrugBank.d213.s4,to,18,19,O
DDI-DrugBank.d213.s4,oral,21,24,O
DDI-DrugBank.d213.s4,anticoagulants,26,39,B-group
DDI-DrugBank.d213.s4,may,41,43,O
DDI-DrugBank.d213.s4,be,45,46,O
DDI-DrugBank.d213.s4,affected,48,55,O
DDI-DrugBank.d213.s4,by,57,58,O
DDI-DrugBank.d213.s4,his/her,60,66,O
DDI-DrugBank.d213.s4,thyroid,68,74,O
DDI-DrugBank.d213.s4,and,76,78,O
DDI-DrugBank.d213.s4,metabolic,80,88,O
DDI-DrugBank.d213.s4,status,90,95,O
DDI-DrugBank.d213.s4,.,96,96,O
DDI-DrugBank.d213.s5,An,0,1,O
DDI-DrugBank.d213.s5,evaluation,3,12,O
DDI-DrugBank.d213.s5,of,14,15,O
DDI-DrugBank.d213.s5,prothrombin,17,27,O
DDI-DrugBank.d213.s5,time,29,32,O
DDI-DrugBank.d213.s5,and,34,36,O
DDI-DrugBank.d213.s5,an,38,39,O
DDI-DrugBank.d213.s5,adjustment,41,50,O
DDI-DrugBank.d213.s5,of,52,53,O
DDI-DrugBank.d213.s5,anticoagulant,55,67,B-group
DDI-DrugBank.d213.s5,dosage,69,74,O
DDI-DrugBank.d213.s5,are,76,78,O
DDI-DrugBank.d213.s5,recommended,80,90,O
DDI-DrugBank.d520.s0,The,0,2,O
DDI-DrugBank.d520.s0,renal,4,8,O
DDI-DrugBank.d520.s0,effects,10,16,O
DDI-DrugBank.d520.s0,of,18,19,O
DDI-DrugBank.d520.s0,nephrotoxic,21,31,O
DDI-DrugBank.d520.s0,compounds,33,41,O
DDI-DrugBank.d520.s0,may,43,45,O
DDI-DrugBank.d520.s0,be,47,48,O
DDI-DrugBank.d520.s0,potentiated,50,60,O
DDI-DrugBank.d520.s0,by,62,63,O
DDI-DrugBank.d520.s0,Carboplatin,65,75,B-drug
DDI-DrugBank.d520.s0,.,76,76,O
DDI-DrugBank.d269.s0,Inhibitors,0,9,O
DDI-DrugBank.d269.s0,of,11,12,O
DDI-DrugBank.d269.s0,CYP2D6,14,19,O
DDI-DrugBank.d269.s0,;,20,20,O
DDI-DrugBank.d269.s1,poor,0,3,O
DDI-DrugBank.d269.s1,metabolizers,5,16,O
DDI-DrugBank.d269.s1,of,18,19,O
DDI-DrugBank.d269.s1,debrisoquin,21,31,B-drug
DDI-DrugBank.d269.s1,:,32,32,O
DDI-DrugBank.d269.s1,Interactions,34,45,O
DDI-DrugBank.d269.s1,of,47,48,O
DDI-DrugBank.d269.s1,carvedilol,50,59,B-drug
DDI-DrugBank.d269.s1,with,61,64,O
DDI-DrugBank.d269.s1,strong,66,71,O
DDI-DrugBank.d269.s1,inhibitors,73,82,O
DDI-DrugBank.d269.s1,of,84,85,O
DDI-DrugBank.d269.s1,CYP2D6,87,92,O
DDI-DrugBank.d269.s1,(,94,94,O
DDI-DrugBank.d269.s1,such,95,98,O
DDI-DrugBank.d269.s1,as,100,101,O
DDI-DrugBank.d269.s1,quinidine,103,111,B-drug
DDI-DrugBank.d269.s1,",",112,112,O
DDI-DrugBank.d269.s1,fluoxetine,114,123,B-drug
DDI-DrugBank.d269.s1,",",124,124,O
DDI-DrugBank.d269.s1,paroxetine,126,135,B-drug
DDI-DrugBank.d269.s1,",",136,136,O
DDI-DrugBank.d269.s1,and,138,140,O
DDI-DrugBank.d269.s1,propafenone,142,152,B-drug
DDI-DrugBank.d269.s1,),153,153,O
DDI-DrugBank.d269.s1,have,155,158,O
DDI-DrugBank.d269.s1,not,160,162,O
DDI-DrugBank.d269.s1,been,164,167,O
DDI-DrugBank.d269.s1,studied,169,175,O
DDI-DrugBank.d269.s1,",",176,176,O
DDI-DrugBank.d269.s1,but,178,180,O
DDI-DrugBank.d269.s1,these,182,186,O
DDI-DrugBank.d269.s1,drugs,188,192,O
DDI-DrugBank.d269.s1,would,194,198,O
DDI-DrugBank.d269.s1,be,200,201,O
DDI-DrugBank.d269.s1,expected,203,210,O
DDI-DrugBank.d269.s1,to,212,213,O
DDI-DrugBank.d269.s1,increase,215,222,O
DDI-DrugBank.d269.s1,blood,224,228,O
DDI-DrugBank.d269.s1,levels,230,235,O
DDI-DrugBank.d269.s1,of,237,238,O
DDI-DrugBank.d269.s1,the,240,242,O
DDI-DrugBank.d269.s1,R,244,244,O
DDI-DrugBank.d269.s1,(,245,245,O
DDI-DrugBank.d269.s1,+,246,246,O
DDI-DrugBank.d269.s1,),247,247,O
DDI-DrugBank.d269.s1,enantiomer,249,258,O
DDI-DrugBank.d269.s1,of,260,261,O
DDI-DrugBank.d269.s1,carvedilol,263,272,B-drug
DDI-DrugBank.d269.s1,.,274,274,O
DDI-DrugBank.d269.s2,Retrospective,0,12,O
DDI-DrugBank.d269.s2,analysis,14,21,O
DDI-DrugBank.d269.s2,of,23,24,O
DDI-DrugBank.d269.s2,side,26,29,O
DDI-DrugBank.d269.s2,effects,31,37,O
DDI-DrugBank.d269.s2,in,39,40,O
DDI-DrugBank.d269.s2,clinical,42,49,O
DDI-DrugBank.d269.s2,trials,51,56,O
DDI-DrugBank.d269.s2,showed,58,63,O
DDI-DrugBank.d269.s2,that,65,68,O
DDI-DrugBank.d269.s2,poor,70,73,O
DDI-DrugBank.d269.s2,2D6,75,77,O
DDI-DrugBank.d269.s2,metabolizers,79,90,O
DDI-DrugBank.d269.s2,had,92,94,O
DDI-DrugBank.d269.s2,a,96,96,O
DDI-DrugBank.d269.s2,higher,98,103,O
DDI-DrugBank.d269.s2,rate,105,108,O
DDI-DrugBank.d269.s2,of,110,111,O
DDI-DrugBank.d269.s2,dizziness,113,121,O
DDI-DrugBank.d269.s2,during,123,128,O
DDI-DrugBank.d269.s2,up-titration,130,141,O
DDI-DrugBank.d269.s2,",",142,142,O
DDI-DrugBank.d269.s2,presumably,144,153,O
DDI-DrugBank.d269.s2,resulting,155,163,O
DDI-DrugBank.d269.s2,from,165,168,O
DDI-DrugBank.d269.s2,vasodilating,170,181,O
DDI-DrugBank.d269.s2,effects,183,189,O
DDI-DrugBank.d269.s2,of,191,192,O
DDI-DrugBank.d269.s2,the,194,196,O
DDI-DrugBank.d269.s2,higher,198,203,O
DDI-DrugBank.d269.s2,concentrations,205,218,O
DDI-DrugBank.d269.s2,of,220,221,O
DDI-DrugBank.d269.s2,the,223,225,O
DDI-DrugBank.d269.s2,a-blocking,227,236,O
DDI-DrugBank.d269.s2,R,238,238,O
DDI-DrugBank.d269.s2,(,239,239,O
DDI-DrugBank.d269.s2,+,240,240,O
DDI-DrugBank.d269.s2,),241,241,O
DDI-DrugBank.d269.s2,enantiomer,243,252,O
DDI-DrugBank.d269.s2,.,253,253,O
DDI-DrugBank.d269.s3,Catecholamine-depleting,0,22,O
DDI-DrugBank.d269.s3,Agents,24,29,O
DDI-DrugBank.d269.s3,:,30,30,O
DDI-DrugBank.d269.s3,Patients,32,39,O
DDI-DrugBank.d269.s3,taking,41,46,O
DDI-DrugBank.d269.s3,both,48,51,O
DDI-DrugBank.d269.s3,agents,53,58,B-group
DDI-DrugBank.d269.s3,with,60,63,I-group
DDI-DrugBank.d269.s3,b-blocking,65,74,I-group
DDI-DrugBank.d269.s3,properties,76,85,I-group
DDI-DrugBank.d269.s3,and,87,89,O
DDI-DrugBank.d269.s3,a,91,91,O
DDI-DrugBank.d269.s3,drug,93,96,O
DDI-DrugBank.d269.s3,that,98,101,O
DDI-DrugBank.d269.s3,can,103,105,O
DDI-DrugBank.d269.s3,deplete,107,113,O
DDI-DrugBank.d269.s3,catecholamines,115,128,O
DDI-DrugBank.d269.s3,(,130,130,O
DDI-DrugBank.d269.s3,e.g.,131,134,O
DDI-DrugBank.d269.s3,",",135,135,O
DDI-DrugBank.d269.s3,reserpine,137,145,B-drug
DDI-DrugBank.d269.s3,and,147,149,O
DDI-DrugBank.d269.s3,monoamine,151,159,B-group
DDI-DrugBank.d269.s3,oxidase,161,167,I-group
DDI-DrugBank.d269.s3,inhibitors,169,178,I-group
DDI-DrugBank.d269.s3,),179,179,O
DDI-DrugBank.d269.s3,should,181,186,O
DDI-DrugBank.d269.s3,be,188,189,O
DDI-DrugBank.d269.s3,observed,191,198,O
DDI-DrugBank.d269.s3,closely,200,206,O
DDI-DrugBank.d269.s3,for,208,210,O
DDI-DrugBank.d269.s3,signs,212,216,O
DDI-DrugBank.d269.s3,of,218,219,O
DDI-DrugBank.d269.s3,hypotension,221,231,O
DDI-DrugBank.d269.s3,and/or,233,238,O
DDI-DrugBank.d269.s3,severe,240,245,O
DDI-DrugBank.d269.s3,bradycardia,247,257,O
DDI-DrugBank.d269.s3,.,258,258,O
DDI-DrugBank.d269.s4,Clonidine,0,8,B-drug
DDI-DrugBank.d269.s4,:,9,9,O
DDI-DrugBank.d269.s4,Concomitant,11,21,O
DDI-DrugBank.d269.s4,administration,23,36,O
DDI-DrugBank.d269.s4,of,38,39,O
DDI-DrugBank.d269.s4,clonidine,41,49,B-drug
DDI-DrugBank.d269.s4,with,51,54,O
DDI-DrugBank.d269.s4,agents,56,61,B-group
DDI-DrugBank.d269.s4,with,63,66,I-group
DDI-DrugBank.d269.s4,b-blocking,68,77,I-group
DDI-DrugBank.d269.s4,properties,79,88,I-group
DDI-DrugBank.d269.s4,may,90,92,O
DDI-DrugBank.d269.s4,potentiate,94,103,O
DDI-DrugBank.d269.s4,blood-pressure-,105,119,O
DDI-DrugBank.d269.s4,and,121,123,O
DDI-DrugBank.d269.s4,heart-rate-lowering,125,143,O
DDI-DrugBank.d269.s4,effects,145,151,O
DDI-DrugBank.d269.s4,.,152,152,O
DDI-DrugBank.d269.s5,When,0,3,O
DDI-DrugBank.d269.s5,concomitant,5,15,O
DDI-DrugBank.d269.s5,treatment,17,25,O
DDI-DrugBank.d269.s5,with,27,30,O
DDI-DrugBank.d269.s5,agents,32,37,B-group
DDI-DrugBank.d269.s5,with,39,42,I-group
DDI-DrugBank.d269.s5,b-blocking,44,53,I-group
DDI-DrugBank.d269.s5,properties,55,64,I-group
DDI-DrugBank.d269.s5,and,66,68,O
DDI-DrugBank.d269.s5,clonidine,70,78,B-drug
DDI-DrugBank.d269.s5,is,80,81,O
DDI-DrugBank.d269.s5,to,83,84,O
DDI-DrugBank.d269.s5,be,86,87,O
DDI-DrugBank.d269.s5,terminated,89,98,O
DDI-DrugBank.d269.s5,",",99,99,O
DDI-DrugBank.d269.s5,the,101,103,O
DDI-DrugBank.d269.s5,b-blocking,105,114,B-group
DDI-DrugBank.d269.s5,agent,116,120,I-group
DDI-DrugBank.d269.s5,should,122,127,O
DDI-DrugBank.d269.s5,be,129,130,O
DDI-DrugBank.d269.s5,discontinued,132,143,O
DDI-DrugBank.d269.s5,first,145,149,O
DDI-DrugBank.d269.s5,.,150,150,O
DDI-DrugBank.d269.s6,Clonidine,0,8,B-drug
DDI-DrugBank.d269.s6,therapy,10,16,O
DDI-DrugBank.d269.s6,can,18,20,O
DDI-DrugBank.d269.s6,then,22,25,O
DDI-DrugBank.d269.s6,be,27,28,O
DDI-DrugBank.d269.s6,discontinued,30,41,O
DDI-DrugBank.d269.s6,several,43,49,O
DDI-DrugBank.d269.s6,days,51,54,O
DDI-DrugBank.d269.s6,later,56,60,O
DDI-DrugBank.d269.s6,by,62,63,O
DDI-DrugBank.d269.s6,gradually,65,73,O
DDI-DrugBank.d269.s6,decreasing,75,84,O
DDI-DrugBank.d269.s6,the,86,88,O
DDI-DrugBank.d269.s6,dosage,90,95,O
DDI-DrugBank.d269.s6,.,96,96,O
DDI-DrugBank.d269.s7,Cyclosporine,0,11,B-drug
DDI-DrugBank.d269.s7,:,12,12,O
DDI-DrugBank.d269.s7,Modest,14,19,O
DDI-DrugBank.d269.s7,increases,21,29,O
DDI-DrugBank.d269.s7,in,31,32,O
DDI-DrugBank.d269.s7,mean,34,37,O
DDI-DrugBank.d269.s7,trough,39,44,O
DDI-DrugBank.d269.s7,cyclosporine,46,57,B-drug
DDI-DrugBank.d269.s7,concentrations,59,72,O
DDI-DrugBank.d269.s7,were,74,77,O
DDI-DrugBank.d269.s7,observed,79,86,O
DDI-DrugBank.d269.s7,following,88,96,O
DDI-DrugBank.d269.s7,initiation,98,107,O
DDI-DrugBank.d269.s7,of,109,110,O
DDI-DrugBank.d269.s7,carvedilol,112,121,B-drug
DDI-DrugBank.d269.s7,treatment,123,131,O
DDI-DrugBank.d269.s7,in,133,134,O
DDI-DrugBank.d269.s7,21,136,137,O
DDI-DrugBank.d269.s7,renal,139,143,O
DDI-DrugBank.d269.s7,transplant,145,154,O
DDI-DrugBank.d269.s7,patients,156,163,O
DDI-DrugBank.d269.s7,suffering,165,173,O
DDI-DrugBank.d269.s7,from,175,178,O
DDI-DrugBank.d269.s7,chronic,180,186,O
DDI-DrugBank.d269.s7,vascular,188,195,O
DDI-DrugBank.d269.s7,rejection,197,205,O
DDI-DrugBank.d269.s7,.,206,206,O
DDI-DrugBank.d269.s8,In,0,1,O
DDI-DrugBank.d269.s8,about,3,7,O
DDI-DrugBank.d269.s8,30,9,10,O
DDI-DrugBank.d269.s8,%,11,11,O
DDI-DrugBank.d269.s8,of,13,14,O
DDI-DrugBank.d269.s8,patients,16,23,O
DDI-DrugBank.d269.s8,",",24,24,O
DDI-DrugBank.d269.s8,the,26,28,O
DDI-DrugBank.d269.s8,dose,30,33,O
DDI-DrugBank.d269.s8,of,35,36,O
DDI-DrugBank.d269.s8,cyclosporine,38,49,B-drug
DDI-DrugBank.d269.s8,had,51,53,O
DDI-DrugBank.d269.s8,to,55,56,O
DDI-DrugBank.d269.s8,be,58,59,O
DDI-DrugBank.d269.s8,reduced,61,67,O
DDI-DrugBank.d269.s8,in,69,70,O
DDI-DrugBank.d269.s8,order,72,76,O
DDI-DrugBank.d269.s8,to,78,79,O
DDI-DrugBank.d269.s8,maintain,81,88,O
DDI-DrugBank.d269.s8,cyclosporine,90,101,B-drug
DDI-DrugBank.d269.s8,concentrations,103,116,O
DDI-DrugBank.d269.s8,within,118,123,O
DDI-DrugBank.d269.s8,the,125,127,O
DDI-DrugBank.d269.s8,therapeutic,129,139,O
DDI-DrugBank.d269.s8,range,141,145,O
DDI-DrugBank.d269.s8,",",146,146,O
DDI-DrugBank.d269.s8,while,148,152,O
DDI-DrugBank.d269.s8,in,154,155,O
DDI-DrugBank.d269.s8,the,157,159,O
DDI-DrugBank.d269.s8,remainder,161,169,O
DDI-DrugBank.d269.s8,no,171,172,O
DDI-DrugBank.d269.s8,adjustment,174,183,O
DDI-DrugBank.d269.s8,was,185,187,O
DDI-DrugBank.d269.s8,needed,189,194,O
DDI-DrugBank.d269.s8,.,195,195,O
DDI-DrugBank.d269.s9,On,0,1,O
DDI-DrugBank.d269.s9,the,3,5,O
DDI-DrugBank.d269.s9,average,7,13,O
DDI-DrugBank.d269.s9,for,15,17,O
DDI-DrugBank.d269.s9,the,19,21,O
DDI-DrugBank.d269.s9,group,23,27,O
DDI-DrugBank.d269.s9,",",28,28,O
DDI-DrugBank.d269.s9,the,30,32,O
DDI-DrugBank.d269.s9,dose,34,37,O
DDI-DrugBank.d269.s9,of,39,40,O
DDI-DrugBank.d269.s9,cyclosporine,42,53,B-drug
DDI-DrugBank.d269.s9,was,55,57,O
DDI-DrugBank.d269.s9,reduced,59,65,O
DDI-DrugBank.d269.s9,about,67,71,O
DDI-DrugBank.d269.s9,20,73,74,O
DDI-DrugBank.d269.s9,%,75,75,O
DDI-DrugBank.d269.s9,in,77,78,O
DDI-DrugBank.d269.s9,these,80,84,O
DDI-DrugBank.d269.s9,patients,86,93,O
DDI-DrugBank.d269.s9,.,94,94,O
DDI-DrugBank.d269.s10,Due,0,2,O
DDI-DrugBank.d269.s10,to,4,5,O
DDI-DrugBank.d269.s10,wide,7,10,O
DDI-DrugBank.d269.s10,interindividual,12,26,O
DDI-DrugBank.d269.s10,variability,28,38,O
DDI-DrugBank.d269.s10,in,40,41,O
DDI-DrugBank.d269.s10,the,43,45,O
DDI-DrugBank.d269.s10,dose,47,50,O
DDI-DrugBank.d269.s10,adjustment,52,61,O
DDI-DrugBank.d269.s10,required,63,70,O
DDI-DrugBank.d269.s10,",",71,71,O
DDI-DrugBank.d269.s10,it,73,74,O
DDI-DrugBank.d269.s10,is,76,77,O
DDI-DrugBank.d269.s10,recommended,79,89,O
DDI-DrugBank.d269.s10,that,91,94,O
DDI-DrugBank.d269.s10,cyclosporine,96,107,B-drug
DDI-DrugBank.d269.s10,concentrations,109,122,O
DDI-DrugBank.d269.s10,be,124,125,O
DDI-DrugBank.d269.s10,monitored,127,135,O
DDI-DrugBank.d269.s10,closely,137,143,O
DDI-DrugBank.d269.s10,after,145,149,O
DDI-DrugBank.d269.s10,initiation,151,160,O
DDI-DrugBank.d269.s10,of,162,163,O
DDI-DrugBank.d269.s10,carvedilol,165,174,B-drug
DDI-DrugBank.d269.s10,therapy,176,182,O
DDI-DrugBank.d269.s10,and,184,186,O
DDI-DrugBank.d269.s10,that,188,191,O
DDI-DrugBank.d269.s10,the,193,195,O
DDI-DrugBank.d269.s10,dose,197,200,O
DDI-DrugBank.d269.s10,of,202,203,O
DDI-DrugBank.d269.s10,cyclosporine,205,216,B-drug
DDI-DrugBank.d269.s10,be,218,219,O
DDI-DrugBank.d269.s10,adjusted,221,228,O
DDI-DrugBank.d269.s10,as,230,231,O
DDI-DrugBank.d269.s10,appropriate,233,243,O
DDI-DrugBank.d269.s10,.,244,244,O
DDI-DrugBank.d269.s11,Digoxin,0,6,B-drug
DDI-DrugBank.d269.s11,:,7,7,O
DDI-DrugBank.d269.s11,Digoxin,9,15,B-drug
DDI-DrugBank.d269.s11,concentrations,17,30,O
DDI-DrugBank.d269.s11,are,32,34,O
DDI-DrugBank.d269.s11,increased,36,44,O
DDI-DrugBank.d269.s11,by,46,47,O
DDI-DrugBank.d269.s11,about,49,53,O
DDI-DrugBank.d269.s11,15,55,56,O
DDI-DrugBank.d269.s11,%,57,57,O
DDI-DrugBank.d269.s11,when,59,62,O
DDI-DrugBank.d269.s11,digoxin,64,70,B-drug
DDI-DrugBank.d269.s11,and,72,74,O
DDI-DrugBank.d269.s11,carvedilol,76,85,B-drug
DDI-DrugBank.d269.s11,are,87,89,O
DDI-DrugBank.d269.s11,administered,91,102,O
DDI-DrugBank.d269.s11,concomitantly,104,116,O
DDI-DrugBank.d269.s11,.,117,117,O
DDI-DrugBank.d269.s12,Both,0,3,O
DDI-DrugBank.d269.s12,digoxin,5,11,B-drug
DDI-DrugBank.d269.s12,and,13,15,O
DDI-DrugBank.d269.s12,COREG,17,21,B-brand
DDI-DrugBank.d269.s12,slow,23,26,O
DDI-DrugBank.d269.s12,AV,28,29,O
DDI-DrugBank.d269.s12,conduction,31,40,O
DDI-DrugBank.d269.s12,.,41,41,O
DDI-DrugBank.d269.s13,Therefore,0,8,O
DDI-DrugBank.d269.s13,",",9,9,O
DDI-DrugBank.d269.s13,increased,11,19,O
DDI-DrugBank.d269.s13,monitoring,21,30,O
DDI-DrugBank.d269.s13,of,32,33,O
DDI-DrugBank.d269.s13,digoxin,35,41,B-drug
DDI-DrugBank.d269.s13,is,43,44,O
DDI-DrugBank.d269.s13,recommended,46,56,O
DDI-DrugBank.d269.s13,when,58,61,O
DDI-DrugBank.d269.s13,initiating,63,72,O
DDI-DrugBank.d269.s13,",",73,73,O
DDI-DrugBank.d269.s13,adjusting,75,83,O
DDI-DrugBank.d269.s13,",",84,84,O
DDI-DrugBank.d269.s13,or,86,87,O
DDI-DrugBank.d269.s13,discontinuing,89,101,O
DDI-DrugBank.d269.s13,COREG,103,107,B-brand
DDI-DrugBank.d269.s13,.,108,108,O
DDI-DrugBank.d269.s14,Inducers,0,7,O
DDI-DrugBank.d269.s14,and,9,11,O
DDI-DrugBank.d269.s14,Inhibitors,13,22,O
DDI-DrugBank.d269.s14,of,24,25,O
DDI-DrugBank.d269.s14,Hepatic,27,33,O
DDI-DrugBank.d269.s14,Metabolism,35,44,O
DDI-DrugBank.d269.s14,:,45,45,O
DDI-DrugBank.d269.s14,Rifampin,47,54,B-drug
DDI-DrugBank.d269.s14,reduced,56,62,O
DDI-DrugBank.d269.s14,plasma,64,69,O
DDI-DrugBank.d269.s14,concentrations,71,84,O
DDI-DrugBank.d269.s14,of,86,87,O
DDI-DrugBank.d269.s14,carvedilol,89,98,B-drug
DDI-DrugBank.d269.s14,by,100,101,O
DDI-DrugBank.d269.s14,about,103,107,O
DDI-DrugBank.d269.s14,70,109,110,O
DDI-DrugBank.d269.s14,%,111,111,O
DDI-DrugBank.d269.s14,.,112,112,O
DDI-DrugBank.d269.s15,Cimetidine,0,9,B-drug
DDI-DrugBank.d269.s15,increased,11,19,O
DDI-DrugBank.d269.s15,AUC,21,23,O
DDI-DrugBank.d269.s15,by,25,26,O
DDI-DrugBank.d269.s15,about,28,32,O
DDI-DrugBank.d269.s15,30,34,35,O
DDI-DrugBank.d269.s15,%,36,36,O
DDI-DrugBank.d269.s15,but,38,40,O
DDI-DrugBank.d269.s15,caused,42,47,O
DDI-DrugBank.d269.s15,no,49,50,O
DDI-DrugBank.d269.s15,change,52,57,O
DDI-DrugBank.d269.s15,in,59,60,O
DDI-DrugBank.d269.s15,Cmax,62,65,O
DDI-DrugBank.d269.s15,.,66,66,O
DDI-DrugBank.d269.s16,Calcium,0,6,B-group
DDI-DrugBank.d269.s16,Channel,8,14,I-group
DDI-DrugBank.d269.s16,Blockers,16,23,I-group
DDI-DrugBank.d269.s16,:,24,24,O
DDI-DrugBank.d269.s16,Isolated,26,33,O
DDI-DrugBank.d269.s16,cases,35,39,O
DDI-DrugBank.d269.s16,of,41,42,O
DDI-DrugBank.d269.s16,conduction,44,53,O
DDI-DrugBank.d269.s16,disturbance,55,65,O
DDI-DrugBank.d269.s16,(,67,67,O
DDI-DrugBank.d269.s16,rarely,68,73,O
DDI-DrugBank.d269.s16,with,75,78,O
DDI-DrugBank.d269.s16,hemodynamic,80,90,O
DDI-DrugBank.d269.s16,compromise,92,101,O
DDI-DrugBank.d269.s16,),102,102,O
DDI-DrugBank.d269.s16,have,104,107,O
DDI-DrugBank.d269.s16,been,109,112,O
DDI-DrugBank.d269.s16,observed,114,121,O
DDI-DrugBank.d269.s16,when,123,126,O
DDI-DrugBank.d269.s16,COREG,128,132,B-brand
DDI-DrugBank.d269.s16,is,134,135,O
DDI-DrugBank.d269.s16,co-administered,137,151,O
DDI-DrugBank.d269.s16,with,153,156,O
DDI-DrugBank.d269.s16,diltiazem,158,166,B-drug
DDI-DrugBank.d269.s16,.,167,167,O
DDI-DrugBank.d269.s17,As,0,1,O
DDI-DrugBank.d269.s17,with,3,6,O
DDI-DrugBank.d269.s17,other,8,12,O
DDI-DrugBank.d269.s17,agents,14,19,B-group
DDI-DrugBank.d269.s17,with,21,24,I-group
DDI-DrugBank.d269.s17,b-blocking,26,35,I-group
DDI-DrugBank.d269.s17,properties,37,46,I-group
DDI-DrugBank.d269.s17,",",47,47,O
DDI-DrugBank.d269.s17,if,49,50,O
DDI-DrugBank.d269.s17,COREG,52,56,B-brand
DDI-DrugBank.d269.s17,is,58,59,O
DDI-DrugBank.d269.s17,to,61,62,O
DDI-DrugBank.d269.s17,be,64,65,O
DDI-DrugBank.d269.s17,administered,67,78,O
DDI-DrugBank.d269.s17,orally,80,85,O
DDI-DrugBank.d269.s17,with,87,90,O
DDI-DrugBank.d269.s17,calcium,92,98,B-group
DDI-DrugBank.d269.s17,channel,100,106,I-group
DDI-DrugBank.d269.s17,blockers,108,115,I-group
DDI-DrugBank.d269.s17,of,117,118,O
DDI-DrugBank.d269.s17,the,120,122,O
DDI-DrugBank.d269.s17,verapamil,124,132,B-drug
DDI-DrugBank.d269.s17,or,134,135,O
DDI-DrugBank.d269.s17,diltiazem,137,145,B-drug
DDI-DrugBank.d269.s17,type,147,150,O
DDI-DrugBank.d269.s17,",",151,151,O
DDI-DrugBank.d269.s17,it,153,154,O
DDI-DrugBank.d269.s17,is,156,157,O
DDI-DrugBank.d269.s17,recommended,159,169,O
DDI-DrugBank.d269.s17,that,171,174,O
DDI-DrugBank.d269.s17,ECG,176,178,O
DDI-DrugBank.d269.s17,and,180,182,O
DDI-DrugBank.d269.s17,blood,184,188,O
DDI-DrugBank.d269.s17,pressure,190,197,O
DDI-DrugBank.d269.s17,be,199,200,O
DDI-DrugBank.d269.s17,monitored,202,210,O
DDI-DrugBank.d269.s17,.,211,211,O
DDI-DrugBank.d269.s18,Insulin,0,6,B-drug
DDI-DrugBank.d269.s18,or,8,9,O
DDI-DrugBank.d269.s18,Oral,11,14,O
DDI-DrugBank.d269.s18,Hypoglycemics,16,28,B-group
DDI-DrugBank.d269.s18,:,29,29,O
DDI-DrugBank.d269.s18,Agents,31,36,B-group
DDI-DrugBank.d269.s18,with,38,41,I-group
DDI-DrugBank.d269.s18,b-blocking,43,52,I-group
DDI-DrugBank.d269.s18,properties,54,63,I-group
DDI-DrugBank.d269.s18,may,65,67,O
DDI-DrugBank.d269.s18,enhance,69,75,O
DDI-DrugBank.d269.s18,the,77,79,O
DDI-DrugBank.d269.s18,blood-sugar-reducing,81,100,O
DDI-DrugBank.d269.s18,effect,102,107,O
DDI-DrugBank.d269.s18,of,109,110,O
DDI-DrugBank.d269.s18,insulin,112,118,B-drug
DDI-DrugBank.d269.s18,and,120,122,O
DDI-DrugBank.d269.s18,oral,124,127,O
DDI-DrugBank.d269.s18,hypoglycemics,129,141,B-group
DDI-DrugBank.d269.s18,.,142,142,O
DDI-DrugBank.d269.s19,Therefore,0,8,O
DDI-DrugBank.d269.s19,",",9,9,O
DDI-DrugBank.d269.s19,in,11,12,O
DDI-DrugBank.d269.s19,patients,14,21,O
DDI-DrugBank.d269.s19,taking,23,28,O
DDI-DrugBank.d269.s19,insulin,30,36,B-drug
DDI-DrugBank.d269.s19,or,38,39,O
DDI-DrugBank.d269.s19,oral,41,44,O
DDI-DrugBank.d269.s19,hypoglycemics,46,58,B-group
DDI-DrugBank.d269.s19,",",59,59,O
DDI-DrugBank.d269.s19,regular,61,67,O
DDI-DrugBank.d269.s19,monitoring,69,78,O
DDI-DrugBank.d269.s19,of,80,81,O
DDI-DrugBank.d269.s19,blood,83,87,O
DDI-DrugBank.d269.s19,glucose,89,95,O
DDI-DrugBank.d269.s19,is,97,98,O
DDI-DrugBank.d269.s19,recommended,100,110,O
DDI-DrugBank.d269.s19,.,111,111,O
DDI-DrugBank.d339.s0,Carbamazepine,0,12,B-drug
DDI-DrugBank.d339.s0,:,13,13,O
DDI-DrugBank.d339.s0,Elevated,15,22,O
DDI-DrugBank.d339.s0,carbamazepine,24,36,B-drug
DDI-DrugBank.d339.s0,levels,38,43,O
DDI-DrugBank.d339.s0,have,45,48,O
DDI-DrugBank.d339.s0,been,50,53,O
DDI-DrugBank.d339.s0,reported,55,62,O
DDI-DrugBank.d339.s0,in,64,65,O
DDI-DrugBank.d339.s0,postmarketing,67,79,O
DDI-DrugBank.d339.s0,experience,81,90,O
DDI-DrugBank.d339.s0,when,92,95,O
DDI-DrugBank.d339.s0,SUPRAX,97,102,B-brand
DDI-DrugBank.d339.s0,is,104,105,O
DDI-DrugBank.d339.s0,administered,107,118,O
DDI-DrugBank.d339.s0,concomitantly,120,132,O
DDI-DrugBank.d339.s0,.,133,133,O
DDI-DrugBank.d339.s1,Drug,0,3,O
DDI-DrugBank.d339.s1,monitoring,5,14,O
DDI-DrugBank.d339.s1,may,16,18,O
DDI-DrugBank.d339.s1,be,20,21,O
DDI-DrugBank.d339.s1,of,23,24,O
DDI-DrugBank.d339.s1,assistance,26,35,O
DDI-DrugBank.d339.s1,in,37,38,O
DDI-DrugBank.d339.s1,detecting,40,48,O
DDI-DrugBank.d339.s1,alterations,50,60,O
DDI-DrugBank.d339.s1,in,62,63,O
DDI-DrugBank.d339.s1,carbamazepine,65,77,B-drug
DDI-DrugBank.d339.s1,plasma,79,84,O
DDI-DrugBank.d339.s1,concentrations,86,99,O
DDI-DrugBank.d339.s1,.,100,100,O
DDI-DrugBank.d339.s2,Warfarin,0,7,B-drug
DDI-DrugBank.d339.s2,and,9,11,O
DDI-DrugBank.d339.s2,Anticoagulants,13,26,B-group
DDI-DrugBank.d339.s2,:,27,27,O
DDI-DrugBank.d339.s2,Increased,29,37,O
DDI-DrugBank.d339.s2,prothrombin,39,49,O
DDI-DrugBank.d339.s2,time,51,54,O
DDI-DrugBank.d339.s2,",",55,55,O
DDI-DrugBank.d339.s2,with,57,60,O
DDI-DrugBank.d339.s2,or,62,63,O
DDI-DrugBank.d339.s2,without,65,71,O
DDI-DrugBank.d339.s2,clinical,73,80,O
DDI-DrugBank.d339.s2,bleeding,82,89,O
DDI-DrugBank.d339.s2,",",90,90,O
DDI-DrugBank.d339.s2,has,92,94,O
DDI-DrugBank.d339.s2,been,96,99,O
DDI-DrugBank.d339.s2,reported,101,108,O
DDI-DrugBank.d339.s2,when,110,113,O
DDI-DrugBank.d339.s2,cefixime,115,122,B-drug
DDI-DrugBank.d339.s2,is,124,125,O
DDI-DrugBank.d339.s2,administered,127,138,O
DDI-DrugBank.d339.s2,concomitantly,140,152,O
DDI-DrugBank.d339.s2,.,153,153,O
DDI-DrugBank.d339.s3,Drug/Laboratory,0,14,O
DDI-DrugBank.d339.s3,Test,16,19,O
DDI-DrugBank.d339.s3,Interactions,21,32,O
DDI-DrugBank.d339.s3,A,34,34,O
DDI-DrugBank.d339.s3,false-positive,36,49,O
DDI-DrugBank.d339.s3,reaction,51,58,O
DDI-DrugBank.d339.s3,for,60,62,O
DDI-DrugBank.d339.s3,ketones,64,70,O
DDI-DrugBank.d339.s3,in,72,73,O
DDI-DrugBank.d339.s3,the,75,77,O
DDI-DrugBank.d339.s3,urine,79,83,O
DDI-DrugBank.d339.s3,may,85,87,O
DDI-DrugBank.d339.s3,occur,89,93,O
DDI-DrugBank.d339.s3,with,95,98,O
DDI-DrugBank.d339.s3,tests,100,104,O
DDI-DrugBank.d339.s3,using,106,110,O
DDI-DrugBank.d339.s3,nitroprusside,112,124,B-drug
DDI-DrugBank.d339.s3,but,126,128,O
DDI-DrugBank.d339.s3,not,130,132,O
DDI-DrugBank.d339.s3,with,134,137,O
DDI-DrugBank.d339.s3,those,139,143,O
DDI-DrugBank.d339.s3,using,145,149,O
DDI-DrugBank.d339.s3,nitroferricyanide,151,167,B-drug
DDI-DrugBank.d339.s3,.,168,168,O
DDI-DrugBank.d339.s4,The,0,2,O
DDI-DrugBank.d339.s4,administration,4,17,O
DDI-DrugBank.d339.s4,of,19,20,O
DDI-DrugBank.d339.s4,SUPRAX,22,27,B-brand
DDI-DrugBank.d339.s4,may,29,31,O
DDI-DrugBank.d339.s4,result,33,38,O
DDI-DrugBank.d339.s4,in,40,41,O
DDI-DrugBank.d339.s4,a,43,43,O
DDI-DrugBank.d339.s4,false-positive,45,58,O
DDI-DrugBank.d339.s4,reaction,60,67,O
DDI-DrugBank.d339.s4,for,69,71,O
DDI-DrugBank.d339.s4,glucose,73,79,O
DDI-DrugBank.d339.s4,in,81,82,O
DDI-DrugBank.d339.s4,the,84,86,O
DDI-DrugBank.d339.s4,urine,88,92,O
DDI-DrugBank.d339.s4,using,94,98,O
DDI-DrugBank.d339.s4,Clinitest,100,108,O
DDI-DrugBank.d339.s4,*,110,110,O
DDI-DrugBank.d339.s4,*,111,111,O
DDI-DrugBank.d339.s4,",",112,112,O
DDI-DrugBank.d339.s4,Benedict,114,121,O
DDI-DrugBank.d339.s4,s,123,123,O
DDI-DrugBank.d339.s4,solution,125,132,O
DDI-DrugBank.d339.s4,",",133,133,O
DDI-DrugBank.d339.s4,or,135,136,O
DDI-DrugBank.d339.s4,Fehling,138,144,O
DDI-DrugBank.d339.s4,s,146,146,O
DDI-DrugBank.d339.s4,solution,148,155,O
DDI-DrugBank.d339.s4,.,156,156,O
DDI-DrugBank.d339.s5,It,0,1,O
DDI-DrugBank.d339.s5,is,3,4,O
DDI-DrugBank.d339.s5,recommended,6,16,O
DDI-DrugBank.d339.s5,that,18,21,O
DDI-DrugBank.d339.s5,glucose,23,29,O
DDI-DrugBank.d339.s5,tests,31,35,O
DDI-DrugBank.d339.s5,based,37,41,O
DDI-DrugBank.d339.s5,on,43,44,O
DDI-DrugBank.d339.s5,enzymatic,46,54,O
DDI-DrugBank.d339.s5,glucose,56,62,O
DDI-DrugBank.d339.s5,oxidase,64,70,O
DDI-DrugBank.d339.s5,reactions,72,80,O
DDI-DrugBank.d339.s5,(,82,82,O
DDI-DrugBank.d339.s5,such,83,86,O
DDI-DrugBank.d339.s5,as,88,89,O
DDI-DrugBank.d339.s5,Clinistix,91,99,O
DDI-DrugBank.d339.s5,*,101,101,O
DDI-DrugBank.d339.s5,*,102,102,O
DDI-DrugBank.d339.s5,or,104,105,O
DDI-DrugBank.d339.s5,Tes-Tape,107,114,O
DDI-DrugBank.d339.s5,*,116,116,O
DDI-DrugBank.d339.s5,*,117,117,O
DDI-DrugBank.d339.s5,),118,118,O
DDI-DrugBank.d339.s5,be,120,121,O
DDI-DrugBank.d339.s5,used,123,126,O
DDI-DrugBank.d339.s5,.,127,127,O
DDI-DrugBank.d339.s6,A,0,0,O
DDI-DrugBank.d339.s6,false-positive,2,15,O
DDI-DrugBank.d339.s6,direct,17,22,O
DDI-DrugBank.d339.s6,Coombs,24,29,O
DDI-DrugBank.d339.s6,test,31,34,O
DDI-DrugBank.d339.s6,has,36,38,O
DDI-DrugBank.d339.s6,been,40,43,O
DDI-DrugBank.d339.s6,reported,45,52,O
DDI-DrugBank.d339.s6,during,54,59,O
DDI-DrugBank.d339.s6,treatment,61,69,O
DDI-DrugBank.d339.s6,with,71,74,O
DDI-DrugBank.d339.s6,other,76,80,O
DDI-DrugBank.d339.s6,cephalosporin,82,94,B-group
DDI-DrugBank.d339.s6,antibiotics,96,106,I-group
DDI-DrugBank.d339.s6,;,107,107,O
DDI-DrugBank.d339.s7,therefore,0,8,O
DDI-DrugBank.d339.s7,",",9,9,O
DDI-DrugBank.d339.s7,it,11,12,O
DDI-DrugBank.d339.s7,should,14,19,O
DDI-DrugBank.d339.s7,be,21,22,O
DDI-DrugBank.d339.s7,recognized,24,33,O
DDI-DrugBank.d339.s7,that,35,38,O
DDI-DrugBank.d339.s7,a,40,40,O
DDI-DrugBank.d339.s7,positive,42,49,O
DDI-DrugBank.d339.s7,Coombs,51,56,O
DDI-DrugBank.d339.s7,test,58,61,O
DDI-DrugBank.d339.s7,may,63,65,O
DDI-DrugBank.d339.s7,be,67,68,O
DDI-DrugBank.d339.s7,due,70,72,O
DDI-DrugBank.d339.s7,to,74,75,O
DDI-DrugBank.d339.s7,the,77,79,O
DDI-DrugBank.d339.s7,drug,81,84,O
DDI-DrugBank.d339.s7,.,85,85,O
DDI-DrugBank.d172.s0,General,0,6,O
DDI-DrugBank.d172.s0,:,7,7,O
DDI-DrugBank.d172.s0,Significant,9,19,O
DDI-DrugBank.d172.s0,interactions,21,32,O
DDI-DrugBank.d172.s0,may,34,36,O
DDI-DrugBank.d172.s0,occur,38,42,O
DDI-DrugBank.d172.s0,when,44,47,O
DDI-DrugBank.d172.s0,celecoxib,49,57,B-drug
DDI-DrugBank.d172.s0,is,59,60,O
DDI-DrugBank.d172.s0,administered,62,73,O
DDI-DrugBank.d172.s0,together,75,82,O
DDI-DrugBank.d172.s0,with,84,87,O
DDI-DrugBank.d172.s0,drugs,89,93,O
DDI-DrugBank.d172.s0,that,95,98,O
DDI-DrugBank.d172.s0,inhibit,100,106,O
DDI-DrugBank.d172.s0,P450,108,111,O
DDI-DrugBank.d172.s0,2C9,113,115,O
DDI-DrugBank.d172.s0,.,116,116,O
DDI-DrugBank.d172.s1,Celecoxib,0,8,B-drug
DDI-DrugBank.d172.s1,metabolism,10,19,O
DDI-DrugBank.d172.s1,is,21,22,O
DDI-DrugBank.d172.s1,predominantly,24,36,O
DDI-DrugBank.d172.s1,mediated,38,45,O
DDI-DrugBank.d172.s1,via,47,49,O
DDI-DrugBank.d172.s1,cytochrome,51,60,O
DDI-DrugBank.d172.s1,P450,62,65,O
DDI-DrugBank.d172.s1,2C9,67,69,O
DDI-DrugBank.d172.s1,in,71,72,O
DDI-DrugBank.d172.s1,the,74,76,O
DDI-DrugBank.d172.s1,liver,78,82,O
DDI-DrugBank.d172.s1,.,83,83,O
DDI-DrugBank.d172.s2,Co-administration,0,16,O
DDI-DrugBank.d172.s2,of,18,19,O
DDI-DrugBank.d172.s2,celecoxib,21,29,B-drug
DDI-DrugBank.d172.s2,with,31,34,O
DDI-DrugBank.d172.s2,drugs,36,40,O
DDI-DrugBank.d172.s2,that,42,45,O
DDI-DrugBank.d172.s2,are,47,49,O
DDI-DrugBank.d172.s2,known,51,55,O
DDI-DrugBank.d172.s2,to,57,58,O
DDI-DrugBank.d172.s2,inhibit,60,66,O
DDI-DrugBank.d172.s2,2C9,68,70,O
DDI-DrugBank.d172.s2,should,72,77,O
DDI-DrugBank.d172.s2,be,79,80,O
DDI-DrugBank.d172.s2,done,82,85,O
DDI-DrugBank.d172.s2,with,87,90,O
DDI-DrugBank.d172.s2,caution,92,98,O
DDI-DrugBank.d172.s2,.,99,99,O
DDI-DrugBank.d172.s3,In,0,1,O
DDI-DrugBank.d172.s3,vitro,3,7,O
DDI-DrugBank.d172.s3,studies,9,15,O
DDI-DrugBank.d172.s3,indicate,17,24,O
DDI-DrugBank.d172.s3,that,26,29,O
DDI-DrugBank.d172.s3,celecoxib,31,39,B-drug
DDI-DrugBank.d172.s3,is,41,42,O
DDI-DrugBank.d172.s3,not,44,46,O
DDI-DrugBank.d172.s3,an,48,49,O
DDI-DrugBank.d172.s3,inhibitor,51,59,O
DDI-DrugBank.d172.s3,of,61,62,O
DDI-DrugBank.d172.s3,cytochrome,64,73,O
DDI-DrugBank.d172.s3,P450,75,78,O
DDI-DrugBank.d172.s3,2C9,80,82,O
DDI-DrugBank.d172.s3,",",83,83,O
DDI-DrugBank.d172.s3,2C19,85,88,O
DDI-DrugBank.d172.s3,or,90,91,O
DDI-DrugBank.d172.s3,3A4,93,95,O
DDI-DrugBank.d172.s3,.,96,96,O
DDI-DrugBank.d172.s4,In,0,1,O
DDI-DrugBank.d172.s4,vitro,3,7,O
DDI-DrugBank.d172.s4,studies,9,15,O
DDI-DrugBank.d172.s4,also,17,20,O
DDI-DrugBank.d172.s4,indicate,22,29,O
DDI-DrugBank.d172.s4,that,31,34,O
DDI-DrugBank.d172.s4,celecoxib,36,44,B-drug
DDI-DrugBank.d172.s4,",",45,45,O
DDI-DrugBank.d172.s4,although,47,54,O
DDI-DrugBank.d172.s4,not,56,58,O
DDI-DrugBank.d172.s4,a,60,60,O
DDI-DrugBank.d172.s4,substrate,62,70,O
DDI-DrugBank.d172.s4,",",71,71,O
DDI-DrugBank.d172.s4,is,73,74,O
DDI-DrugBank.d172.s4,an,76,77,O
DDI-DrugBank.d172.s4,inhibitor,79,87,O
DDI-DrugBank.d172.s4,of,89,90,O
DDI-DrugBank.d172.s4,cytochrome,92,101,O
DDI-DrugBank.d172.s4,P450,103,106,O
DDI-DrugBank.d172.s4,2D6,108,110,O
DDI-DrugBank.d172.s4,.,111,111,O
DDI-DrugBank.d172.s5,Therefore,0,8,O
DDI-DrugBank.d172.s5,",",9,9,O
DDI-DrugBank.d172.s5,there,11,15,O
DDI-DrugBank.d172.s5,is,17,18,O
DDI-DrugBank.d172.s5,a,20,20,O
DDI-DrugBank.d172.s5,potential,22,30,O
DDI-DrugBank.d172.s5,for,32,34,O
DDI-DrugBank.d172.s5,an,36,37,O
DDI-DrugBank.d172.s5,in,39,40,O
DDI-DrugBank.d172.s5,vivo,42,45,O
DDI-DrugBank.d172.s5,drug,47,50,O
DDI-DrugBank.d172.s5,interaction,52,62,O
DDI-DrugBank.d172.s5,with,64,67,O
DDI-DrugBank.d172.s5,drugs,69,73,O
DDI-DrugBank.d172.s5,that,75,78,O
DDI-DrugBank.d172.s5,are,80,82,O
DDI-DrugBank.d172.s5,metabolized,84,94,O
DDI-DrugBank.d172.s5,by,96,97,O
DDI-DrugBank.d172.s5,P450,99,102,O
DDI-DrugBank.d172.s5,2D6,104,106,O
DDI-DrugBank.d172.s5,.,107,107,O
DDI-DrugBank.d172.s6,Clinical,0,7,O
DDI-DrugBank.d172.s6,studies,9,15,O
DDI-DrugBank.d172.s6,with,17,20,O
DDI-DrugBank.d172.s6,celecoxib,22,30,B-drug
DDI-DrugBank.d172.s6,have,32,35,O
DDI-DrugBank.d172.s6,identified,37,46,O
DDI-DrugBank.d172.s6,potentially,48,58,O
DDI-DrugBank.d172.s6,significant,60,70,O
DDI-DrugBank.d172.s6,interactions,72,83,O
DDI-DrugBank.d172.s6,with,85,88,O
DDI-DrugBank.d172.s6,fluconazole,90,100,B-drug
DDI-DrugBank.d172.s6,and,102,104,O
DDI-DrugBank.d172.s6,lithium,106,112,B-drug
DDI-DrugBank.d172.s6,.,113,113,O
DDI-DrugBank.d172.s7,Experience,0,9,O
DDI-DrugBank.d172.s7,with,11,14,O
DDI-DrugBank.d172.s7,nonsteroidal,16,27,B-group
DDI-DrugBank.d172.s7,anti-inflammatory,29,45,I-group
DDI-DrugBank.d172.s7,drugs,47,51,I-group
DDI-DrugBank.d172.s7,(,53,53,O
DDI-DrugBank.d172.s7,NSAIDs,54,59,B-group
DDI-DrugBank.d172.s7,),60,60,O
DDI-DrugBank.d172.s7,suggests,62,69,O
DDI-DrugBank.d172.s7,the,71,73,O
DDI-DrugBank.d172.s7,potential,75,83,O
DDI-DrugBank.d172.s7,for,85,87,O
DDI-DrugBank.d172.s7,interactions,89,100,O
DDI-DrugBank.d172.s7,with,102,105,O
DDI-DrugBank.d172.s7,furosemide,107,116,B-drug
DDI-DrugBank.d172.s7,and,118,120,O
DDI-DrugBank.d172.s7,ACE,122,124,B-group
DDI-DrugBank.d172.s7,inhibitors,126,135,I-group
DDI-DrugBank.d172.s7,.,136,136,O
DDI-DrugBank.d172.s8,The,0,2,O
DDI-DrugBank.d172.s8,effects,4,10,O
DDI-DrugBank.d172.s8,celecoxib,12,20,B-drug
DDI-DrugBank.d172.s8,on,22,23,O
DDI-DrugBank.d172.s8,the,25,27,O
DDI-DrugBank.d172.s8,pharmacokinetics,29,44,O
DDI-DrugBank.d172.s8,and/or,46,51,O
DDI-DrugBank.d172.s8,pharmacodynamics,53,68,O
DDI-DrugBank.d172.s8,of,70,71,O
DDI-DrugBank.d172.s8,glyburide,73,81,B-drug
DDI-DrugBank.d172.s8,",",82,82,O
DDI-DrugBank.d172.s8,ketoconazole,84,95,B-drug
DDI-DrugBank.d172.s8,",",96,96,O
DDI-DrugBank.d172.s8,methotrexate,98,109,B-drug
DDI-DrugBank.d172.s8,",",110,110,O
DDI-DrugBank.d172.s8,phenytoin,112,120,B-drug
DDI-DrugBank.d172.s8,",",121,121,O
DDI-DrugBank.d172.s8,tolbutamide,123,133,B-drug
DDI-DrugBank.d172.s8,",",134,134,O
DDI-DrugBank.d172.s8,and,136,138,O
DDI-DrugBank.d172.s8,warfarin,140,147,B-drug
DDI-DrugBank.d172.s8,have,149,152,O
DDI-DrugBank.d172.s8,been,154,157,O
DDI-DrugBank.d172.s8,studied,159,165,O
DDI-DrugBank.d172.s8,in,167,168,O
DDI-DrugBank.d172.s8,vivo,170,173,O
DDI-DrugBank.d172.s8,and,175,177,O
DDI-DrugBank.d172.s8,clinically,179,188,O
DDI-DrugBank.d172.s8,important,190,198,O
DDI-DrugBank.d172.s8,interactions,200,211,O
DDI-DrugBank.d172.s8,have,213,216,O
DDI-DrugBank.d172.s8,not,218,220,O
DDI-DrugBank.d172.s8,been,222,225,O
DDI-DrugBank.d172.s8,found,227,231,O
DDI-DrugBank.d172.s8,.,232,232,O
DDI-DrugBank.d172.s9,ACE,0,2,B-group
DDI-DrugBank.d172.s9,inhibitors,4,13,I-group
DDI-DrugBank.d172.s9,:,14,14,O
DDI-DrugBank.d172.s9,Reports,16,22,O
DDI-DrugBank.d172.s9,suggest,24,30,O
DDI-DrugBank.d172.s9,that,32,35,O
DDI-DrugBank.d172.s9,NSAIDs,37,42,B-group
DDI-DrugBank.d172.s9,may,44,46,O
DDI-DrugBank.d172.s9,diminish,48,55,O
DDI-DrugBank.d172.s9,the,57,59,O
DDI-DrugBank.d172.s9,antihypertensive,61,76,O
DDI-DrugBank.d172.s9,effect,78,83,O
DDI-DrugBank.d172.s9,of,85,86,O
DDI-DrugBank.d172.s9,Angiotensin,88,98,B-group
DDI-DrugBank.d172.s9,Converting,100,109,I-group
DDI-DrugBank.d172.s9,Enzyme,111,116,I-group
DDI-DrugBank.d172.s9,(,118,118,I-group
DDI-DrugBank.d172.s9,ACE,119,121,I-group
DDI-DrugBank.d172.s9,),122,122,I-group
DDI-DrugBank.d172.s9,inhibitors,124,133,I-group
DDI-DrugBank.d172.s9,.,134,134,O
DDI-DrugBank.d172.s10,This,0,3,O
DDI-DrugBank.d172.s10,interaction,5,15,O
DDI-DrugBank.d172.s10,should,17,22,O
DDI-DrugBank.d172.s10,be,24,25,O
DDI-DrugBank.d172.s10,given,27,31,O
DDI-DrugBank.d172.s10,consideration,33,45,O
DDI-DrugBank.d172.s10,in,47,48,O
DDI-DrugBank.d172.s10,patients,50,57,O
DDI-DrugBank.d172.s10,taking,59,64,O
DDI-DrugBank.d172.s10,CELEBREX,66,73,B-brand
DDI-DrugBank.d172.s10,concomitantly,75,87,O
DDI-DrugBank.d172.s10,with,89,92,O
DDI-DrugBank.d172.s10,ACE-inhibitors,94,107,B-group
DDI-DrugBank.d172.s10,.,108,108,O
DDI-DrugBank.d172.s11,Furosemide,0,9,B-drug
DDI-DrugBank.d172.s11,:,10,10,O
DDI-DrugBank.d172.s11,Clinical,12,19,O
DDI-DrugBank.d172.s11,studies,21,27,O
DDI-DrugBank.d172.s11,",",28,28,O
DDI-DrugBank.d172.s11,as,30,31,O
DDI-DrugBank.d172.s11,well,33,36,O
DDI-DrugBank.d172.s11,as,38,39,O
DDI-DrugBank.d172.s11,post,41,44,O
DDI-DrugBank.d172.s11,marketing,46,54,O
DDI-DrugBank.d172.s11,observations,56,67,O
DDI-DrugBank.d172.s11,",",68,68,O
DDI-DrugBank.d172.s11,have,70,73,O
DDI-DrugBank.d172.s11,shown,75,79,O
DDI-DrugBank.d172.s11,that,81,84,O
DDI-DrugBank.d172.s11,NSAIDs,86,91,B-group
DDI-DrugBank.d172.s11,can,93,95,O
DDI-DrugBank.d172.s11,reduce,97,102,O
DDI-DrugBank.d172.s11,the,104,106,O
DDI-DrugBank.d172.s11,natriuretic,108,118,O
DDI-DrugBank.d172.s11,effect,120,125,O
DDI-DrugBank.d172.s11,of,127,128,O
DDI-DrugBank.d172.s11,furosemide,130,139,B-drug
DDI-DrugBank.d172.s11,and,141,143,O
DDI-DrugBank.d172.s11,thiazides,145,153,B-group
DDI-DrugBank.d172.s11,in,155,156,O
DDI-DrugBank.d172.s11,some,158,161,O
DDI-DrugBank.d172.s11,patients,163,170,O
DDI-DrugBank.d172.s11,.,171,171,O
DDI-DrugBank.d172.s12,This,0,3,O
DDI-DrugBank.d172.s12,response,5,12,O
DDI-DrugBank.d172.s12,has,14,16,O
DDI-DrugBank.d172.s12,been,18,21,O
DDI-DrugBank.d172.s12,attributed,23,32,O
DDI-DrugBank.d172.s12,to,34,35,O
DDI-DrugBank.d172.s12,inhibition,37,46,O
DDI-DrugBank.d172.s12,of,48,49,O
DDI-DrugBank.d172.s12,renal,51,55,O
DDI-DrugBank.d172.s12,prostaglandin,57,69,O
DDI-DrugBank.d172.s12,synthesis,71,79,O
DDI-DrugBank.d172.s12,.,80,80,O
DDI-DrugBank.d172.s13,Aspirin,0,6,B-brand
DDI-DrugBank.d172.s13,:,7,7,O
DDI-DrugBank.d172.s13,CELEBREX,9,16,B-brand
DDI-DrugBank.d172.s13,can,18,20,O
DDI-DrugBank.d172.s13,be,22,23,O
DDI-DrugBank.d172.s13,used,25,28,O
DDI-DrugBank.d172.s13,with,30,33,O
DDI-DrugBank.d172.s13,low,35,37,O
DDI-DrugBank.d172.s13,dose,39,42,O
DDI-DrugBank.d172.s13,aspirin,44,50,B-brand
DDI-DrugBank.d172.s13,.,51,51,O
DDI-DrugBank.d172.s14,However,0,6,O
DDI-DrugBank.d172.s14,",",7,7,O
DDI-DrugBank.d172.s14,concomitant,9,19,O
DDI-DrugBank.d172.s14,administration,21,34,O
DDI-DrugBank.d172.s14,of,36,37,O
DDI-DrugBank.d172.s14,aspirin,39,45,B-brand
DDI-DrugBank.d172.s14,with,47,50,O
DDI-DrugBank.d172.s14,CELEBREX,52,59,B-brand
DDI-DrugBank.d172.s14,may,61,63,O
DDI-DrugBank.d172.s14,result,65,70,O
DDI-DrugBank.d172.s14,in,72,73,O
DDI-DrugBank.d172.s14,an,75,76,O
DDI-DrugBank.d172.s14,increased,78,86,O
DDI-DrugBank.d172.s14,rate,88,91,O
DDI-DrugBank.d172.s14,of,93,94,O
DDI-DrugBank.d172.s14,GI,96,97,O
DDI-DrugBank.d172.s14,ulceration,99,108,O
DDI-DrugBank.d172.s14,or,110,111,O
DDI-DrugBank.d172.s14,other,113,117,O
DDI-DrugBank.d172.s14,complications,119,131,O
DDI-DrugBank.d172.s14,",",132,132,O
DDI-DrugBank.d172.s14,compared,134,141,O
DDI-DrugBank.d172.s14,to,143,144,O
DDI-DrugBank.d172.s14,use,146,148,O
DDI-DrugBank.d172.s14,of,150,151,O
DDI-DrugBank.d172.s14,CELEBREX,153,160,B-brand
DDI-DrugBank.d172.s14,alone,162,166,O
DDI-DrugBank.d172.s14,.,167,167,O
DDI-DrugBank.d172.s15,Because,0,6,O
DDI-DrugBank.d172.s15,of,8,9,O
DDI-DrugBank.d172.s15,its,11,13,O
DDI-DrugBank.d172.s15,lack,15,18,O
DDI-DrugBank.d172.s15,of,20,21,O
DDI-DrugBank.d172.s15,platelet,23,30,O
DDI-DrugBank.d172.s15,effects,32,38,O
DDI-DrugBank.d172.s15,",",39,39,O
DDI-DrugBank.d172.s15,CELEBREX,41,48,B-brand
DDI-DrugBank.d172.s15,is,50,51,O
DDI-DrugBank.d172.s15,not,53,55,O
DDI-DrugBank.d172.s15,a,57,57,O
DDI-DrugBank.d172.s15,substitute,59,68,O
DDI-DrugBank.d172.s15,for,70,72,O
DDI-DrugBank.d172.s15,aspirin,74,80,B-brand
DDI-DrugBank.d172.s15,for,82,84,O
DDI-DrugBank.d172.s15,cardiovascular,86,99,O
DDI-DrugBank.d172.s15,prophylaxis,101,111,O
DDI-DrugBank.d172.s15,.,112,112,O
DDI-DrugBank.d172.s16,Fluconazole,0,10,B-drug
DDI-DrugBank.d172.s16,:,11,11,O
DDI-DrugBank.d172.s16,Concomitant,13,23,O
DDI-DrugBank.d172.s16,administration,25,38,O
DDI-DrugBank.d172.s16,of,40,41,O
DDI-DrugBank.d172.s16,fluconazole,43,53,B-drug
DDI-DrugBank.d172.s16,at,55,56,O
DDI-DrugBank.d172.s16,200,58,60,O
DDI-DrugBank.d172.s16,mg,62,63,O
DDI-DrugBank.d172.s16,QD,65,66,O
DDI-DrugBank.d172.s16,resulted,68,75,O
DDI-DrugBank.d172.s16,in,77,78,O
DDI-DrugBank.d172.s16,a,80,80,O
DDI-DrugBank.d172.s16,two-fold,82,89,O
DDI-DrugBank.d172.s16,increase,91,98,O
DDI-DrugBank.d172.s16,in,100,101,O
DDI-DrugBank.d172.s16,celecoxib,103,111,B-drug
DDI-DrugBank.d172.s16,plasma,113,118,O
DDI-DrugBank.d172.s16,concentration,120,132,O
DDI-DrugBank.d172.s16,.,133,133,O
DDI-DrugBank.d172.s17,This,0,3,O
DDI-DrugBank.d172.s17,increase,5,12,O
DDI-DrugBank.d172.s17,is,14,15,O
DDI-DrugBank.d172.s17,due,17,19,O
DDI-DrugBank.d172.s17,to,21,22,O
DDI-DrugBank.d172.s17,the,24,26,O
DDI-DrugBank.d172.s17,inhibition,28,37,O
DDI-DrugBank.d172.s17,of,39,40,O
DDI-DrugBank.d172.s17,celecoxib,42,50,B-drug
DDI-DrugBank.d172.s17,metabolism,52,61,O
DDI-DrugBank.d172.s17,via,63,65,O
DDI-DrugBank.d172.s17,P450,67,70,O
DDI-DrugBank.d172.s17,2C9,72,74,O
DDI-DrugBank.d172.s17,by,76,77,O
DDI-DrugBank.d172.s17,fluconazole,79,89,B-drug
DDI-DrugBank.d172.s17,(,91,91,O
DDI-DrugBank.d172.s17,see,92,94,O
DDI-DrugBank.d172.s17,CLINICAL,96,103,O
DDI-DrugBank.d172.s17,PHARMACOLOGY,105,116,O
DDI-DrugBank.d172.s17,-,118,118,O
DDI-DrugBank.d172.s17,Pharmacokinetics,120,135,O
DDI-DrugBank.d172.s17,:,136,136,O
DDI-DrugBank.d172.s17,Metabolism,138,147,O
DDI-DrugBank.d172.s17,),148,148,O
DDI-DrugBank.d172.s17,.,149,149,O
DDI-DrugBank.d172.s18,CELEBREX,0,7,B-brand
DDI-DrugBank.d172.s18,should,9,14,O
DDI-DrugBank.d172.s18,be,16,17,O
DDI-DrugBank.d172.s18,introduced,19,28,O
DDI-DrugBank.d172.s18,at,30,31,O
DDI-DrugBank.d172.s18,the,33,35,O
DDI-DrugBank.d172.s18,lowest,37,42,O
DDI-DrugBank.d172.s18,recommended,44,54,O
DDI-DrugBank.d172.s18,dose,56,59,O
DDI-DrugBank.d172.s18,in,61,62,O
DDI-DrugBank.d172.s18,patients,64,71,O
DDI-DrugBank.d172.s18,receiving,73,81,O
DDI-DrugBank.d172.s18,fluconazole,83,93,B-drug
DDI-DrugBank.d172.s18,.,94,94,O
DDI-DrugBank.d172.s19,Lithium,0,6,B-drug
DDI-DrugBank.d172.s19,:,7,7,O
DDI-DrugBank.d172.s19,In,9,10,O
DDI-DrugBank.d172.s19,a,12,12,O
DDI-DrugBank.d172.s19,study,14,18,O
DDI-DrugBank.d172.s19,conducted,20,28,O
DDI-DrugBank.d172.s19,in,30,31,O
DDI-DrugBank.d172.s19,healthy,33,39,O
DDI-DrugBank.d172.s19,subjects,41,48,O
DDI-DrugBank.d172.s19,",",49,49,O
DDI-DrugBank.d172.s19,mean,51,54,O
DDI-DrugBank.d172.s19,steady-state,56,67,O
DDI-DrugBank.d172.s19,lithium,69,75,B-drug
DDI-DrugBank.d172.s19,plasma,77,82,O
DDI-DrugBank.d172.s19,levels,84,89,O
DDI-DrugBank.d172.s19,increased,91,99,O
DDI-DrugBank.d172.s19,approximately,101,113,O
DDI-DrugBank.d172.s19,17,115,116,O
DDI-DrugBank.d172.s19,%,117,117,O
DDI-DrugBank.d172.s19,in,119,120,O
DDI-DrugBank.d172.s19,subjects,122,129,O
DDI-DrugBank.d172.s19,receiving,131,139,O
DDI-DrugBank.d172.s19,lithium,141,147,B-drug
DDI-DrugBank.d172.s19,450,149,151,O
DDI-DrugBank.d172.s19,mg,153,154,O
DDI-DrugBank.d172.s19,BID,156,158,O
DDI-DrugBank.d172.s19,with,160,163,O
DDI-DrugBank.d172.s19,CELEBREX,165,172,B-brand
DDI-DrugBank.d172.s19,200,174,176,O
DDI-DrugBank.d172.s19,mg,178,179,O
DDI-DrugBank.d172.s19,BID,181,183,O
DDI-DrugBank.d172.s19,as,185,186,O
DDI-DrugBank.d172.s19,compared,188,195,O
DDI-DrugBank.d172.s19,to,197,198,O
DDI-DrugBank.d172.s19,subjects,200,207,O
DDI-DrugBank.d172.s19,receiving,209,217,O
DDI-DrugBank.d172.s19,lithium,219,225,B-drug
DDI-DrugBank.d172.s19,alone,227,231,O
DDI-DrugBank.d172.s19,.,232,232,O
DDI-DrugBank.d172.s20,Patients,0,7,O
DDI-DrugBank.d172.s20,on,9,10,O
DDI-DrugBank.d172.s20,lithium,12,18,B-drug
DDI-DrugBank.d172.s20,treatment,20,28,O
DDI-DrugBank.d172.s20,should,30,35,O
DDI-DrugBank.d172.s20,be,37,38,O
DDI-DrugBank.d172.s20,closely,40,46,O
DDI-DrugBank.d172.s20,monitored,48,56,O
DDI-DrugBank.d172.s20,when,58,61,O
DDI-DrugBank.d172.s20,CELEBREX,63,70,B-brand
DDI-DrugBank.d172.s20,is,72,73,O
DDI-DrugBank.d172.s20,introduced,75,84,O
DDI-DrugBank.d172.s20,or,86,87,O
DDI-DrugBank.d172.s20,withdrawn,89,97,O
DDI-DrugBank.d172.s20,.,98,98,O
DDI-DrugBank.d172.s21,Methotrexate,0,11,B-drug
DDI-DrugBank.d172.s21,:,12,12,O
DDI-DrugBank.d172.s21,In,14,15,O
DDI-DrugBank.d172.s21,an,17,18,O
DDI-DrugBank.d172.s21,interaction,20,30,O
DDI-DrugBank.d172.s21,study,32,36,O
DDI-DrugBank.d172.s21,of,38,39,O
DDI-DrugBank.d172.s21,rheumatoid,41,50,O
DDI-DrugBank.d172.s21,arthritis,52,60,O
DDI-DrugBank.d172.s21,patients,62,69,O
DDI-DrugBank.d172.s21,taking,71,76,O
DDI-DrugBank.d172.s21,methotrexate,78,89,B-drug
DDI-DrugBank.d172.s21,",",90,90,O
DDI-DrugBank.d172.s21,CELEBREX,92,99,B-brand
DDI-DrugBank.d172.s21,did,101,103,O
DDI-DrugBank.d172.s21,not,105,107,O
DDI-DrugBank.d172.s21,have,109,112,O
DDI-DrugBank.d172.s21,a,114,114,O
DDI-DrugBank.d172.s21,significant,116,126,O
DDI-DrugBank.d172.s21,effect,128,133,O
DDI-DrugBank.d172.s21,on,135,136,O
DDI-DrugBank.d172.s21,the,138,140,O
DDI-DrugBank.d172.s21,pharmacokinetics,142,157,O
DDI-DrugBank.d172.s21,of,159,160,O
DDI-DrugBank.d172.s21,methotrexate,162,173,B-drug
DDI-DrugBank.d172.s21,.,174,174,O
DDI-DrugBank.d172.s22,Warfarin,0,7,B-drug
DDI-DrugBank.d172.s22,:,8,8,O
DDI-DrugBank.d172.s22,The,10,12,O
DDI-DrugBank.d172.s22,effect,14,19,O
DDI-DrugBank.d172.s22,of,21,22,O
DDI-DrugBank.d172.s22,celecoxib,24,32,B-drug
DDI-DrugBank.d172.s22,on,34,35,O
DDI-DrugBank.d172.s22,the,37,39,O
DDI-DrugBank.d172.s22,anti-coagulant,41,54,O
DDI-DrugBank.d172.s22,effect,56,61,O
DDI-DrugBank.d172.s22,of,63,64,O
DDI-DrugBank.d172.s22,warfarin,66,73,B-drug
DDI-DrugBank.d172.s22,was,75,77,O
DDI-DrugBank.d172.s22,studied,79,85,O
DDI-DrugBank.d172.s22,in,87,88,O
DDI-DrugBank.d172.s22,a,90,90,O
DDI-DrugBank.d172.s22,group,92,96,O
DDI-DrugBank.d172.s22,of,98,99,O
DDI-DrugBank.d172.s22,healthy,101,107,O
DDI-DrugBank.d172.s22,subjects,109,116,O
DDI-DrugBank.d172.s22,receiving,118,126,O
DDI-DrugBank.d172.s22,daily,128,132,O
DDI-DrugBank.d172.s22,doses,134,138,O
DDI-DrugBank.d172.s22,of,140,141,O
DDI-DrugBank.d172.s22,2-5,143,145,O
DDI-DrugBank.d172.s22,mg,147,148,O
DDI-DrugBank.d172.s22,of,150,151,O
DDI-DrugBank.d172.s22,warfarin,153,160,B-drug
DDI-DrugBank.d172.s22,.,161,161,O
DDI-DrugBank.d172.s23,In,0,1,O
DDI-DrugBank.d172.s23,these,3,7,O
DDI-DrugBank.d172.s23,subjects,9,16,O
DDI-DrugBank.d172.s23,",",17,17,O
DDI-DrugBank.d172.s23,celecoxib,19,27,B-drug
DDI-DrugBank.d172.s23,did,29,31,O
DDI-DrugBank.d172.s23,not,33,35,O
DDI-DrugBank.d172.s23,alter,37,41,O
DDI-DrugBank.d172.s23,the,43,45,O
DDI-DrugBank.d172.s23,anticoagulant,47,59,O
DDI-DrugBank.d172.s23,effect,61,66,O
DDI-DrugBank.d172.s23,of,68,69,O
DDI-DrugBank.d172.s23,warfarin,71,78,B-drug
DDI-DrugBank.d172.s23,as,80,81,O
DDI-DrugBank.d172.s23,determined,83,92,O
DDI-DrugBank.d172.s23,by,94,95,O
DDI-DrugBank.d172.s23,prothrombin,97,107,O
DDI-DrugBank.d172.s23,time,109,112,O
DDI-DrugBank.d172.s23,.,113,113,O
DDI-DrugBank.d172.s24,However,0,6,O
DDI-DrugBank.d172.s24,",",7,7,O
DDI-DrugBank.d172.s24,caution,9,15,O
DDI-DrugBank.d172.s24,should,17,22,O
DDI-DrugBank.d172.s24,be,24,25,O
DDI-DrugBank.d172.s24,used,27,30,O
DDI-DrugBank.d172.s24,when,32,35,O
DDI-DrugBank.d172.s24,administering,37,49,O
DDI-DrugBank.d172.s24,CELEBREX,51,58,B-brand
DDI-DrugBank.d172.s24,with,60,63,O
DDI-DrugBank.d172.s24,warfarin,65,72,B-drug
DDI-DrugBank.d172.s24,since,74,78,O
DDI-DrugBank.d172.s24,these,80,84,O
DDI-DrugBank.d172.s24,patients,86,93,O
DDI-DrugBank.d172.s24,are,95,97,O
DDI-DrugBank.d172.s24,at,99,100,O
DDI-DrugBank.d172.s24,increased,102,110,O
DDI-DrugBank.d172.s24,risk,112,115,O
DDI-DrugBank.d172.s24,of,117,118,O
DDI-DrugBank.d172.s24,bleeding,120,127,O
DDI-DrugBank.d172.s24,complications,129,141,O
DDI-DrugBank.d172.s24,.,142,142,O
DDI-DrugBank.d141.s0,Immunosuppressive,0,16,B-group
DDI-DrugBank.d141.s0,Drugs,18,22,I-group
DDI-DrugBank.d141.s0,",",23,23,O
DDI-DrugBank.d141.s0,Fibric,25,30,B-group
DDI-DrugBank.d141.s0,Acid,32,35,I-group
DDI-DrugBank.d141.s0,Derivatives,37,47,I-group
DDI-DrugBank.d141.s0,",",48,48,O
DDI-DrugBank.d141.s0,Niacin,50,55,B-drug
DDI-DrugBank.d141.s0,(,57,57,O
DDI-DrugBank.d141.s0,Nicotinic,58,66,B-drug
DDI-DrugBank.d141.s0,Acid,68,71,I-drug
DDI-DrugBank.d141.s0,",",72,72,O
DDI-DrugBank.d141.s0,Erythromycin,74,85,B-drug
DDI-DrugBank.d141.s0,",",86,86,O
DDI-DrugBank.d141.s0,Azole,88,92,B-group
DDI-DrugBank.d141.s0,Antifungals,94,104,I-group
DDI-DrugBank.d141.s0,:,105,105,O
DDI-DrugBank.d141.s0,Skeletal,107,114,O
DDI-DrugBank.d141.s0,Muscle,116,121,O
DDI-DrugBank.d141.s0,.,122,122,O
DDI-DrugBank.d141.s1,ANTACID,0,6,B-group
DDI-DrugBank.d141.s1,(,8,8,O
DDI-DrugBank.d141.s1,Magnesium-Aluminum,9,26,B-drug
DDI-DrugBank.d141.s1,Hydroxide,28,36,I-drug
DDI-DrugBank.d141.s1,),37,37,O
DDI-DrugBank.d141.s1,:,38,38,O
DDI-DrugBank.d141.s1,Cerivastatin,40,51,B-drug
DDI-DrugBank.d141.s1,plasma,53,58,O
DDI-DrugBank.d141.s1,concentrations,60,73,O
DDI-DrugBank.d141.s1,were,75,78,O
DDI-DrugBank.d141.s1,not,80,82,O
DDI-DrugBank.d141.s1,affected,84,91,O
DDI-DrugBank.d141.s1,by,93,94,O
DDI-DrugBank.d141.s1,co-administration,96,112,O
DDI-DrugBank.d141.s1,of,114,115,O
DDI-DrugBank.d141.s1,antacid,117,123,B-group
DDI-DrugBank.d141.s1,.,124,124,O
DDI-DrugBank.d141.s2,CIMETlDINE,0,9,B-drug
DDI-DrugBank.d141.s2,:,10,10,O
DDI-DrugBank.d141.s2,Cerivastatin,12,23,B-drug
DDI-DrugBank.d141.s2,plasma,25,30,O
DDI-DrugBank.d141.s2,concentrations,32,45,O
DDI-DrugBank.d141.s2,were,47,50,O
DDI-DrugBank.d141.s2,not,52,54,O
DDI-DrugBank.d141.s2,affected,56,63,O
DDI-DrugBank.d141.s2,by,65,66,O
DDI-DrugBank.d141.s2,co-administration,68,84,O
DDI-DrugBank.d141.s2,of,86,87,O
DDI-DrugBank.d141.s2,cimetidine,89,98,B-drug
DDI-DrugBank.d141.s2,.,99,99,O
DDI-DrugBank.d141.s3,CHOLESTYRAMINE,0,13,B-drug
DDI-DrugBank.d141.s3,:,14,14,O
DDI-DrugBank.d141.s3,The,16,18,O
DDI-DrugBank.d141.s3,influence,20,28,O
DDI-DrugBank.d141.s3,of,30,31,O
DDI-DrugBank.d141.s3,the,33,35,O
DDI-DrugBank.d141.s3,bile-acidsequestering,37,57,O
DDI-DrugBank.d141.s3,agent,59,63,O
DDI-DrugBank.d141.s3,cholestyramine,65,78,B-drug
DDI-DrugBank.d141.s3,on,80,81,O
DDI-DrugBank.d141.s3,the,83,85,O
DDI-DrugBank.d141.s3,pharmacokinetits,87,102,O
DDI-DrugBank.d141.s3,of,104,105,O
DDI-DrugBank.d141.s3,cerivastatin,107,118,B-drug
DDI-DrugBank.d141.s3,sodium,120,125,I-drug
DDI-DrugBank.d141.s3,was,127,129,O
DDI-DrugBank.d141.s3,evaluated,131,139,O
DDI-DrugBank.d141.s3,in,141,142,O
DDI-DrugBank.d141.s3,12,144,145,O
DDI-DrugBank.d141.s3,healthy,147,153,O
DDI-DrugBank.d141.s3,males,155,159,O
DDI-DrugBank.d141.s3,in,161,162,O
DDI-DrugBank.d141.s3,2,164,164,O
DDI-DrugBank.d141.s3,separate,166,173,O
DDI-DrugBank.d141.s3,randomized,175,184,O
DDI-DrugBank.d141.s3,crossover,186,194,O
DDI-DrugBank.d141.s3,studies,196,202,O
DDI-DrugBank.d141.s3,.,203,203,O
DDI-DrugBank.d141.s4,In,0,1,O
DDI-DrugBank.d141.s4,the,3,5,O
DDI-DrugBank.d141.s4,first,7,11,O
DDI-DrugBank.d141.s4,study,13,17,O
DDI-DrugBank.d141.s4,",",18,18,O
DDI-DrugBank.d141.s4,concomitant,20,30,O
DDI-DrugBank.d141.s4,administration,32,45,O
DDI-DrugBank.d141.s4,of,47,48,O
DDI-DrugBank.d141.s4,0.2,50,52,O
DDI-DrugBank.d141.s4,mg,54,55,O
DDI-DrugBank.d141.s4,cerivastatin,57,68,B-drug
DDI-DrugBank.d141.s4,sodium,70,75,I-drug
DDI-DrugBank.d141.s4,and,77,79,O
DDI-DrugBank.d141.s4,12,81,82,O
DDI-DrugBank.d141.s4,g,84,84,O
DDI-DrugBank.d141.s4,cholestyramine,86,99,B-drug
DDI-DrugBank.d141.s4,resulted,101,108,O
DDI-DrugBank.d141.s4,in,110,111,O
DDI-DrugBank.d141.s4,decreases,113,121,O
DDI-DrugBank.d141.s4,of,123,124,O
DDI-DrugBank.d141.s4,more,126,129,O
DDI-DrugBank.d141.s4,than,131,134,O
DDI-DrugBank.d141.s4,22,136,137,O
DDI-DrugBank.d141.s4,%,138,138,O
DDI-DrugBank.d141.s4,for,140,142,O
DDI-DrugBank.d141.s4,AUC,144,146,O
DDI-DrugBank.d141.s4,and,148,150,O
DDI-DrugBank.d141.s4,40,152,153,O
DDI-DrugBank.d141.s4,%,154,154,O
DDI-DrugBank.d141.s4,for,156,158,O
DDI-DrugBank.d141.s4,Cmax,160,163,O
DDI-DrugBank.d141.s4,when,165,168,O
DDI-DrugBank.d141.s4,compared,170,177,O
DDI-DrugBank.d141.s4,to,179,180,O
DDI-DrugBank.d141.s4,dosing,182,187,O
DDI-DrugBank.d141.s4,cerivastatin,189,200,B-drug
DDI-DrugBank.d141.s4,sodium,202,207,I-drug
DDI-DrugBank.d141.s4,alone,209,213,O
DDI-DrugBank.d141.s4,.,214,214,O
DDI-DrugBank.d141.s5,However,0,6,O
DDI-DrugBank.d141.s5,",",7,7,O
DDI-DrugBank.d141.s5,in,9,10,O
DDI-DrugBank.d141.s5,the,12,14,O
DDI-DrugBank.d141.s5,second,16,21,O
DDI-DrugBank.d141.s5,study,23,27,O
DDI-DrugBank.d141.s5,",",28,28,O
DDI-DrugBank.d141.s5,administration,30,43,O
DDI-DrugBank.d141.s5,of,45,46,O
DDI-DrugBank.d141.s5,12,48,49,O
DDI-DrugBank.d141.s5,g,51,51,O
DDI-DrugBank.d141.s5,cholestyramine,53,66,B-drug
DDI-DrugBank.d141.s5,1,68,68,O
DDI-DrugBank.d141.s5,hour,70,73,O
DDI-DrugBank.d141.s5,before,75,80,O
DDI-DrugBank.d141.s5,the,82,84,O
DDI-DrugBank.d141.s5,evening,86,92,O
DDI-DrugBank.d141.s5,meal,94,97,O
DDI-DrugBank.d141.s5,and,99,101,O
DDI-DrugBank.d141.s5,0.3,103,105,O
DDI-DrugBank.d141.s5,mg,107,108,O
DDI-DrugBank.d141.s5,cerivastatin,110,121,B-drug
DDI-DrugBank.d141.s5,sodium,123,128,I-drug
DDI-DrugBank.d141.s5,approximately,130,142,O
DDI-DrugBank.d141.s5,4,144,144,O
DDI-DrugBank.d141.s5,hours,146,150,O
DDI-DrugBank.d141.s5,after,152,156,O
DDI-DrugBank.d141.s5,the,158,160,O
DDI-DrugBank.d141.s5,same,162,165,O
DDI-DrugBank.d141.s5,evening,167,173,O
DDI-DrugBank.d141.s5,meal,175,178,O
DDI-DrugBank.d141.s5,resulted,180,187,O
DDI-DrugBank.d141.s5,in,189,190,O
DDI-DrugBank.d141.s5,a,192,192,O
DDI-DrugBank.d141.s5,decrease,194,201,O
DDI-DrugBank.d141.s5,in,203,204,O
DDI-DrugBank.d141.s5,the,206,208,O
DDI-DrugBank.d141.s5,cerivastatin,210,221,B-drug
DDI-DrugBank.d141.s5,AUC,223,225,O
DDI-DrugBank.d141.s5,of,227,228,O
DDI-DrugBank.d141.s5,less,230,233,O
DDI-DrugBank.d141.s5,than,235,238,O
DDI-DrugBank.d141.s5,8,240,240,O
DDI-DrugBank.d141.s5,%,241,241,O
DDI-DrugBank.d141.s5,",",242,242,O
DDI-DrugBank.d141.s5,and,244,246,O
DDI-DrugBank.d141.s5,a,248,248,O
DDI-DrugBank.d141.s5,decrease,250,257,O
DDI-DrugBank.d141.s5,in,259,260,O
DDI-DrugBank.d141.s5,Cmax,262,265,O
DDI-DrugBank.d141.s5,of,267,268,O
DDI-DrugBank.d141.s5,about,270,274,O
DDI-DrugBank.d141.s5,30,276,277,O
DDI-DrugBank.d141.s5,%,278,278,O
DDI-DrugBank.d141.s5,when,280,283,O
DDI-DrugBank.d141.s5,compared,285,292,O
DDI-DrugBank.d141.s5,to,294,295,O
DDI-DrugBank.d141.s5,dosing,297,302,O
DDI-DrugBank.d141.s5,cerivastatin,304,315,B-drug
DDI-DrugBank.d141.s5,sodium,317,322,I-drug
DDI-DrugBank.d141.s5,alone,324,328,O
DDI-DrugBank.d141.s5,.,329,329,O
DDI-DrugBank.d141.s6,Therefore,0,8,O
DDI-DrugBank.d141.s6,",",9,9,O
DDI-DrugBank.d141.s6,it,11,12,O
DDI-DrugBank.d141.s6,would,14,18,O
DDI-DrugBank.d141.s6,be,20,21,O
DDI-DrugBank.d141.s6,expected,23,30,O
DDI-DrugBank.d141.s6,that,32,35,O
DDI-DrugBank.d141.s6,a,37,37,O
DDI-DrugBank.d141.s6,dosing,39,44,O
DDI-DrugBank.d141.s6,schedule,46,53,O
DDI-DrugBank.d141.s6,of,55,56,O
DDI-DrugBank.d141.s6,cerivastatin,58,69,B-drug
DDI-DrugBank.d141.s6,sodium,71,76,I-drug
DDI-DrugBank.d141.s6,given,78,82,O
DDI-DrugBank.d141.s6,at,84,85,O
DDI-DrugBank.d141.s6,bedtime,87,93,O
DDI-DrugBank.d141.s6,and,95,97,O
DDI-DrugBank.d141.s6,cholestyramine,99,112,B-drug
DDI-DrugBank.d141.s6,given,114,118,O
DDI-DrugBank.d141.s6,before,120,125,O
DDI-DrugBank.d141.s6,the,127,129,O
DDI-DrugBank.d141.s6,evening,131,137,O
DDI-DrugBank.d141.s6,meal,139,142,O
DDI-DrugBank.d141.s6,would,144,148,O
DDI-DrugBank.d141.s6,not,150,152,O
DDI-DrugBank.d141.s6,result,154,159,O
DDI-DrugBank.d141.s6,in,161,162,O
DDI-DrugBank.d141.s6,a,164,164,O
DDI-DrugBank.d141.s6,significant,166,176,O
DDI-DrugBank.d141.s6,decrease,178,185,O
DDI-DrugBank.d141.s6,in,187,188,O
DDI-DrugBank.d141.s6,the,190,192,O
DDI-DrugBank.d141.s6,clinical,194,201,O
DDI-DrugBank.d141.s6,effect,203,208,O
DDI-DrugBank.d141.s6,of,210,211,O
DDI-DrugBank.d141.s6,cerivastatin,213,224,B-drug
DDI-DrugBank.d141.s6,sodium,226,231,I-drug
DDI-DrugBank.d141.s6,.,232,232,O
DDI-DrugBank.d141.s7,DIGOXIN,0,6,B-drug
DDI-DrugBank.d141.s7,:,7,7,O
DDI-DrugBank.d141.s7,Plasma,9,14,O
DDI-DrugBank.d141.s7,digoxin,16,22,B-drug
DDI-DrugBank.d141.s7,levels,24,29,O
DDI-DrugBank.d141.s7,and,31,33,O
DDI-DrugBank.d141.s7,digoxin,35,41,B-drug
DDI-DrugBank.d141.s7,clearance,43,51,O
DDI-DrugBank.d141.s7,at,53,54,O
DDI-DrugBank.d141.s7,steady-state,56,67,O
DDI-DrugBank.d141.s7,were,69,72,O
DDI-DrugBank.d141.s7,not,74,76,O
DDI-DrugBank.d141.s7,affected,78,85,O
DDI-DrugBank.d141.s7,by,87,88,O
DDI-DrugBank.d141.s7,co-administration,90,106,O
DDI-DrugBank.d141.s7,of,108,109,O
DDI-DrugBank.d141.s7,0.2,111,113,O
DDI-DrugBank.d141.s7,mg,115,116,O
DDI-DrugBank.d141.s7,cerivastatin,118,129,B-drug
DDI-DrugBank.d141.s7,sodium,131,136,I-drug
DDI-DrugBank.d141.s7,.,137,137,O
DDI-DrugBank.d141.s8,Cerivastatin,0,11,B-drug
DDI-DrugBank.d141.s8,plasma,13,18,O
DDI-DrugBank.d141.s8,concentrations,20,33,O
DDI-DrugBank.d141.s8,were,35,38,O
DDI-DrugBank.d141.s8,also,40,43,O
DDI-DrugBank.d141.s8,not,45,47,O
DDI-DrugBank.d141.s8,affected,49,56,O
DDI-DrugBank.d141.s8,by,58,59,O
DDI-DrugBank.d141.s8,co-administration,61,77,O
DDI-DrugBank.d141.s8,of,79,80,O
DDI-DrugBank.d141.s8,digoxin,82,88,B-drug
DDI-DrugBank.d141.s8,.,89,89,O
DDI-DrugBank.d141.s9,WARFARIN,0,7,B-drug
DDI-DrugBank.d141.s9,:,8,8,O
DDI-DrugBank.d141.s9,Co-,10,12,O
DDI-DrugBank.d141.s9,administration,14,27,O
DDI-DrugBank.d141.s9,of,29,30,O
DDI-DrugBank.d141.s9,warfarin,32,39,B-drug
DDI-DrugBank.d141.s9,and,41,43,O
DDI-DrugBank.d141.s9,cerivastatin,45,56,B-drug
DDI-DrugBank.d141.s9,to,58,59,O
DDI-DrugBank.d141.s9,healthy,61,67,O
DDI-DrugBank.d141.s9,volunteers,69,78,O
DDI-DrugBank.d141.s9,did,80,82,O
DDI-DrugBank.d141.s9,not,84,86,O
DDI-DrugBank.d141.s9,result,88,93,O
DDI-DrugBank.d141.s9,in,95,96,O
DDI-DrugBank.d141.s9,any,98,100,O
DDI-DrugBank.d141.s9,changes,102,108,O
DDI-DrugBank.d141.s9,in,110,111,O
DDI-DrugBank.d141.s9,prothrombin,113,123,O
DDI-DrugBank.d141.s9,time,125,128,O
DDI-DrugBank.d141.s9,or,130,131,O
DDI-DrugBank.d141.s9,clotting,133,140,O
DDI-DrugBank.d141.s9,factor,142,147,O
DDI-DrugBank.d141.s9,VII,149,151,O
DDI-DrugBank.d141.s9,when,153,156,O
DDI-DrugBank.d141.s9,compared,158,165,O
DDI-DrugBank.d141.s9,to,167,168,O
DDI-DrugBank.d141.s9,co-administration,170,186,O
DDI-DrugBank.d141.s9,of,188,189,O
DDI-DrugBank.d141.s9,warfarin,191,198,B-drug
DDI-DrugBank.d141.s9,and,200,202,O
DDI-DrugBank.d141.s9,placebo,204,210,O
DDI-DrugBank.d141.s9,.,211,211,O
DDI-DrugBank.d141.s10,The,0,2,O
DDI-DrugBank.d141.s10,AUC,4,6,O
DDI-DrugBank.d141.s10,and,8,10,O
DDI-DrugBank.d141.s10,Cmax,12,15,O
DDI-DrugBank.d141.s10,of,17,18,O
DDI-DrugBank.d141.s10,both,20,23,O
DDI-DrugBank.d141.s10,the,25,27,O
DDI-DrugBank.d141.s10,(,29,29,O
DDI-DrugBank.d141.s10,R,30,30,O
DDI-DrugBank.d141.s10,),31,31,O
DDI-DrugBank.d141.s10,and,33,35,O
DDI-DrugBank.d141.s10,(,37,37,O
DDI-DrugBank.d141.s10,S,38,38,O
DDI-DrugBank.d141.s10,),39,39,O
DDI-DrugBank.d141.s10,isomers,41,47,O
DDI-DrugBank.d141.s10,of,49,50,O
DDI-DrugBank.d141.s10,warfarin,52,59,B-drug
DDI-DrugBank.d141.s10,were,61,64,O
DDI-DrugBank.d141.s10,unaffected,66,75,O
DDI-DrugBank.d141.s10,by,77,78,O
DDI-DrugBank.d141.s10,concurrent,80,89,O
DDI-DrugBank.d141.s10,dosing,91,96,O
DDI-DrugBank.d141.s10,of,98,99,O
DDI-DrugBank.d141.s10,0.3,101,103,O
DDI-DrugBank.d141.s10,mg,105,106,O
DDI-DrugBank.d141.s10,cerivastatin,108,119,B-drug
DDI-DrugBank.d141.s10,sodium,121,126,I-drug
DDI-DrugBank.d141.s10,.,127,127,O
DDI-DrugBank.d141.s11,Co-administration,0,16,O
DDI-DrugBank.d141.s11,of,18,19,O
DDI-DrugBank.d141.s11,warfarin,21,28,B-drug
DDI-DrugBank.d141.s11,and,30,32,O
DDI-DrugBank.d141.s11,cerivastatin,34,45,B-drug
DDI-DrugBank.d141.s11,did,47,49,O
DDI-DrugBank.d141.s11,not,51,53,O
DDI-DrugBank.d141.s11,alter,55,59,O
DDI-DrugBank.d141.s11,the,61,63,O
DDI-DrugBank.d141.s11,pharmacokinetics,65,80,O
DDI-DrugBank.d141.s11,of,82,83,O
DDI-DrugBank.d141.s11,cerivastatin,85,96,B-drug
DDI-DrugBank.d141.s11,sodium,98,103,I-drug
DDI-DrugBank.d141.s11,.,104,104,O
DDI-DrugBank.d141.s12,ERYTHROMYCIN,0,11,B-drug
DDI-DrugBank.d141.s12,:,12,12,O
DDI-DrugBank.d141.s12,In,14,15,O
DDI-DrugBank.d141.s12,hypercholesterolemic,17,36,O
DDI-DrugBank.d141.s12,patients,38,45,O
DDI-DrugBank.d141.s12,",",46,46,O
DDI-DrugBank.d141.s12,steady-state,48,59,O
DDI-DrugBank.d141.s12,cerivastatin,61,72,B-drug
DDI-DrugBank.d141.s12,AUC,74,76,O
DDI-DrugBank.d141.s12,and,78,80,O
DDI-DrugBank.d141.s12,Cmax,82,85,O
DDI-DrugBank.d141.s12,increased,87,95,O
DDI-DrugBank.d141.s12,approximately,97,109,O
DDI-DrugBank.d141.s12,50,111,112,O
DDI-DrugBank.d141.s12,%,113,113,O
DDI-DrugBank.d141.s12,and,115,117,O
DDI-DrugBank.d141.s12,24,119,120,O
DDI-DrugBank.d141.s12,%,121,121,O
DDI-DrugBank.d141.s12,respectively,123,134,O
DDI-DrugBank.d141.s12,after,136,140,O
DDI-DrugBank.d141.s12,10,142,143,O
DDI-DrugBank.d141.s12,days,145,148,O
DDI-DrugBank.d141.s12,with,150,153,O
DDI-DrugBank.d141.s12,co-administration,155,171,O
DDI-DrugBank.d141.s12,of,173,174,O
DDI-DrugBank.d141.s12,erythromycin,176,187,B-drug
DDI-DrugBank.d141.s12,",",188,188,O
DDI-DrugBank.d141.s12,a,190,190,O
DDI-DrugBank.d141.s12,known,192,196,O
DDI-DrugBank.d141.s12,inhibitor,198,206,O
DDI-DrugBank.d141.s12,of,208,209,O
DDI-DrugBank.d141.s12,cytochrome,211,220,O
DDI-DrugBank.d141.s12,P450,222,225,O
DDI-DrugBank.d141.s12,3A4,227,229,O
DDI-DrugBank.d141.s12,.,230,230,O
DDI-DrugBank.d141.s13,OTHER,0,4,O
DDI-DrugBank.d141.s13,CONCOMITANT,6,16,O
DDI-DrugBank.d141.s13,THERAPY,18,24,O
DDI-DrugBank.d141.s13,:,25,25,O
DDI-DrugBank.d141.s13,Although,27,34,O
DDI-DrugBank.d141.s13,specific,36,43,O
DDI-DrugBank.d141.s13,interaction,45,55,O
DDI-DrugBank.d141.s13,studies,57,63,O
DDI-DrugBank.d141.s13,were,65,68,O
DDI-DrugBank.d141.s13,not,70,72,O
DDI-DrugBank.d141.s13,performed,74,82,O
DDI-DrugBank.d141.s13,",",83,83,O
DDI-DrugBank.d141.s13,in,85,86,O
DDI-DrugBank.d141.s13,clinical,88,95,O
DDI-DrugBank.d141.s13,studies,97,103,O
DDI-DrugBank.d141.s13,",",104,104,O
DDI-DrugBank.d141.s13,cerivastatin,106,117,B-drug
DDI-DrugBank.d141.s13,sodium,119,124,I-drug
DDI-DrugBank.d141.s13,was,126,128,O
DDI-DrugBank.d141.s13,used,130,133,O
DDI-DrugBank.d141.s13,concomitantly,135,147,O
DDI-DrugBank.d141.s13,with,149,152,O
DDI-DrugBank.d141.s13,angiotensin-,154,165,B-group
DDI-DrugBank.d141.s13,converting,167,176,I-group
DDI-DrugBank.d141.s13,enzyme,178,183,I-group
DDI-DrugBank.d141.s13,(,185,185,I-group
DDI-DrugBank.d141.s13,ACE,186,188,I-group
DDI-DrugBank.d141.s13,),189,189,I-group
DDI-DrugBank.d141.s13,inhibitors,191,200,I-group
DDI-DrugBank.d141.s13,",",201,201,O
DDI-DrugBank.d141.s13,betablockers,203,214,B-group
DDI-DrugBank.d141.s13,",",215,215,O
DDI-DrugBank.d141.s13,calcium-channel,217,231,B-group
DDI-DrugBank.d141.s13,blockers,233,240,I-group
DDI-DrugBank.d141.s13,",",241,241,O
DDI-DrugBank.d141.s13,diuretics,243,251,B-group
DDI-DrugBank.d141.s13,",",252,252,O
DDI-DrugBank.d141.s13,and,254,256,O
DDI-DrugBank.d141.s13,nonsteroidal,258,269,B-group
DDI-DrugBank.d141.s13,anti-inflammatory,271,287,I-group
DDI-DrugBank.d141.s13,drugs,289,293,I-group
DDI-DrugBank.d141.s13,(,295,295,O
DDI-DrugBank.d141.s13,NSAIDs,296,301,B-group
DDI-DrugBank.d141.s13,),302,302,O
DDI-DrugBank.d141.s13,without,304,310,O
DDI-DrugBank.d141.s13,evidence,312,319,O
DDI-DrugBank.d141.s13,of,321,322,O
DDI-DrugBank.d141.s13,clinically,324,333,O
DDI-DrugBank.d141.s13,significant,335,345,O
DDI-DrugBank.d141.s13,adverse,347,353,O
DDI-DrugBank.d141.s13,interactions,355,366,O
DDI-DrugBank.d141.s13,.,367,367,O
DDI-DrugBank.d287.s0,Cevimeline,0,9,B-drug
DDI-DrugBank.d287.s0,should,11,16,O
DDI-DrugBank.d287.s0,be,18,19,O
DDI-DrugBank.d287.s0,administered,21,32,O
DDI-DrugBank.d287.s0,with,34,37,O
DDI-DrugBank.d287.s0,caution,39,45,O
DDI-DrugBank.d287.s0,to,47,48,O
DDI-DrugBank.d287.s0,patients,50,57,O
DDI-DrugBank.d287.s0,taking,59,64,O
DDI-DrugBank.d287.s0,beta,66,69,B-group
DDI-DrugBank.d287.s0,adrenergic,71,80,I-group
DDI-DrugBank.d287.s0,antagonists,82,92,I-group
DDI-DrugBank.d287.s0,",",93,93,O
DDI-DrugBank.d287.s0,because,95,101,O
DDI-DrugBank.d287.s0,of,103,104,O
DDI-DrugBank.d287.s0,the,106,108,O
DDI-DrugBank.d287.s0,possibility,110,120,O
DDI-DrugBank.d287.s0,of,122,123,O
DDI-DrugBank.d287.s0,conduction,125,134,O
DDI-DrugBank.d287.s0,disturbances,136,147,O
DDI-DrugBank.d287.s0,.,148,148,O
DDI-DrugBank.d287.s1,Drugs,0,4,O
DDI-DrugBank.d287.s1,with,6,9,O
DDI-DrugBank.d287.s1,parasympathomimetic,11,29,O
DDI-DrugBank.d287.s1,effects,31,37,O
DDI-DrugBank.d287.s1,administered,39,50,O
DDI-DrugBank.d287.s1,concurrently,52,63,O
DDI-DrugBank.d287.s1,with,65,68,O
DDI-DrugBank.d287.s1,cevimeline,70,79,B-drug
DDI-DrugBank.d287.s1,can,81,83,O
DDI-DrugBank.d287.s1,be,85,86,O
DDI-DrugBank.d287.s1,expected,88,95,O
DDI-DrugBank.d287.s1,to,97,98,O
DDI-DrugBank.d287.s1,have,100,103,O
DDI-DrugBank.d287.s1,additive,105,112,O
DDI-DrugBank.d287.s1,effects,114,120,O
DDI-DrugBank.d287.s1,.,121,121,O
DDI-DrugBank.d287.s2,Cevimeline,0,9,B-drug
DDI-DrugBank.d287.s2,might,11,15,O
DDI-DrugBank.d287.s2,interfere,17,25,O
DDI-DrugBank.d287.s2,with,27,30,O
DDI-DrugBank.d287.s2,desirable,32,40,O
DDI-DrugBank.d287.s2,antimuscarinic,42,55,O
DDI-DrugBank.d287.s2,effects,57,63,O
DDI-DrugBank.d287.s2,of,65,66,O
DDI-DrugBank.d287.s2,drugs,68,72,O
DDI-DrugBank.d287.s2,used,74,77,O
DDI-DrugBank.d287.s2,concomitantly,79,91,O
DDI-DrugBank.d287.s2,.,92,92,O
DDI-DrugBank.d287.s3,Drugs,0,4,O
DDI-DrugBank.d287.s3,which,6,10,O
DDI-DrugBank.d287.s3,inhibit,12,18,O
DDI-DrugBank.d287.s3,CYP2D6,20,25,O
DDI-DrugBank.d287.s3,and,27,29,O
DDI-DrugBank.d287.s3,CYP3A3/4,31,38,O
DDI-DrugBank.d287.s3,also,40,43,O
DDI-DrugBank.d287.s3,inhibit,45,51,O
DDI-DrugBank.d287.s3,the,53,55,O
DDI-DrugBank.d287.s3,metabolism,57,66,O
DDI-DrugBank.d287.s3,of,68,69,O
DDI-DrugBank.d287.s3,cevimeline,71,80,B-drug
DDI-DrugBank.d287.s3,.,81,81,O
DDI-DrugBank.d287.s4,Cevimeline,0,9,B-drug
DDI-DrugBank.d287.s4,should,11,16,O
DDI-DrugBank.d287.s4,be,18,19,O
DDI-DrugBank.d287.s4,used,21,24,O
DDI-DrugBank.d287.s4,with,26,29,O
DDI-DrugBank.d287.s4,caution,31,37,O
DDI-DrugBank.d287.s4,in,39,40,O
DDI-DrugBank.d287.s4,individuals,42,52,O
DDI-DrugBank.d287.s4,known,54,58,O
DDI-DrugBank.d287.s4,or,60,61,O
DDI-DrugBank.d287.s4,suspected,63,71,O
DDI-DrugBank.d287.s4,to,73,74,O
DDI-DrugBank.d287.s4,be,76,77,O
DDI-DrugBank.d287.s4,deficient,79,87,O
DDI-DrugBank.d287.s4,in,89,90,O
DDI-DrugBank.d287.s4,CYP2D6,92,97,O
DDI-DrugBank.d287.s4,activity,99,106,O
DDI-DrugBank.d287.s4,",",107,107,O
DDI-DrugBank.d287.s4,based,109,113,O
DDI-DrugBank.d287.s4,on,115,116,O
DDI-DrugBank.d287.s4,previous,118,125,O
DDI-DrugBank.d287.s4,experience,127,136,O
DDI-DrugBank.d287.s4,",",137,137,O
DDI-DrugBank.d287.s4,as,139,140,O
DDI-DrugBank.d287.s4,they,142,145,O
DDI-DrugBank.d287.s4,may,147,149,O
DDI-DrugBank.d287.s4,be,151,152,O
DDI-DrugBank.d287.s4,at,154,155,O
DDI-DrugBank.d287.s4,a,157,157,O
DDI-DrugBank.d287.s4,higher,159,164,O
DDI-DrugBank.d287.s4,risk,166,169,O
DDI-DrugBank.d287.s4,of,171,172,O
DDI-DrugBank.d287.s4,adverse,174,180,O
DDI-DrugBank.d287.s4,events,182,187,O
DDI-DrugBank.d287.s4,.,188,188,O
DDI-DrugBank.d287.s5,In,0,1,O
DDI-DrugBank.d287.s5,an,3,4,O
DDI-DrugBank.d287.s5,in,6,7,O
DDI-DrugBank.d287.s5,vitro,9,13,O
DDI-DrugBank.d287.s5,study,15,19,O
DDI-DrugBank.d287.s5,",",20,20,O
DDI-DrugBank.d287.s5,cytochrome,22,31,O
DDI-DrugBank.d287.s5,P450,33,36,O
DDI-DrugBank.d287.s5,isozymes,38,45,O
DDI-DrugBank.d287.s5,1A2,47,49,O
DDI-DrugBank.d287.s5,",",50,50,O
DDI-DrugBank.d287.s5,2A6,52,54,O
DDI-DrugBank.d287.s5,",",55,55,O
DDI-DrugBank.d287.s5,2C9,57,59,O
DDI-DrugBank.d287.s5,",",60,60,O
DDI-DrugBank.d287.s5,2C19,62,65,O
DDI-DrugBank.d287.s5,",",66,66,O
DDI-DrugBank.d287.s5,2D6,68,70,O
DDI-DrugBank.d287.s5,",",71,71,O
DDI-DrugBank.d287.s5,2E1,73,75,O
DDI-DrugBank.d287.s5,",",76,76,O
DDI-DrugBank.d287.s5,and,78,80,O
DDI-DrugBank.d287.s5,3A4,82,84,O
DDI-DrugBank.d287.s5,were,86,89,O
DDI-DrugBank.d287.s5,not,91,93,O
DDI-DrugBank.d287.s5,inhibited,95,103,O
DDI-DrugBank.d287.s5,by,105,106,O
DDI-DrugBank.d287.s5,exposure,108,115,O
DDI-DrugBank.d287.s5,to,117,118,O
DDI-DrugBank.d287.s5,cevimeline,120,129,B-drug
DDI-DrugBank.d287.s5,.,130,130,O
DDI-DrugBank.d255.s0,There,0,4,O
DDI-DrugBank.d255.s0,are,6,8,O
DDI-DrugBank.d255.s0,no,10,11,O
DDI-DrugBank.d255.s0,known,13,17,O
DDI-DrugBank.d255.s0,drug/drug,19,27,O
DDI-DrugBank.d255.s0,interactions,29,40,O
DDI-DrugBank.d255.s0,with,42,45,O
DDI-DrugBank.d255.s0,chlorambucil,47,58,B-drug
DDI-DrugBank.d255.s0,.,59,59,O
DDI-DrugBank.d110.s0,The,0,2,O
DDI-DrugBank.d110.s0,administration,4,17,O
DDI-DrugBank.d110.s0,of,19,20,O
DDI-DrugBank.d110.s0,local,22,26,O
DDI-DrugBank.d110.s0,anesthetic,28,37,B-group
DDI-DrugBank.d110.s0,solutions,39,47,I-group
DDI-DrugBank.d110.s0,containing,49,58,O
DDI-DrugBank.d110.s0,epinephrine,60,70,B-drug
DDI-DrugBank.d110.s0,or,72,73,O
DDI-DrugBank.d110.s0,norepinephrine,75,88,B-drug
DDI-DrugBank.d110.s0,to,90,91,O
DDI-DrugBank.d110.s0,patients,93,100,O
DDI-DrugBank.d110.s0,receiving,102,110,O
DDI-DrugBank.d110.s0,monoamine,112,120,B-group
DDI-DrugBank.d110.s0,oxidase,122,128,I-group
DDI-DrugBank.d110.s0,inhibitors,130,139,I-group
DDI-DrugBank.d110.s0,",",140,140,O
DDI-DrugBank.d110.s0,tricyclic,142,150,B-group
DDI-DrugBank.d110.s0,antidepressants,152,166,I-group
DDI-DrugBank.d110.s0,or,168,169,O
DDI-DrugBank.d110.s0,phenothiazines,171,184,B-group
DDI-DrugBank.d110.s0,may,186,188,O
DDI-DrugBank.d110.s0,produce,190,196,O
DDI-DrugBank.d110.s0,severe,198,203,O
DDI-DrugBank.d110.s0,",",204,204,O
DDI-DrugBank.d110.s0,prolonged,206,214,O
DDI-DrugBank.d110.s0,hypotension,216,226,O
DDI-DrugBank.d110.s0,or,228,229,O
DDI-DrugBank.d110.s0,hypertension,231,242,O
DDI-DrugBank.d110.s0,.,243,243,O
DDI-DrugBank.d110.s1,Concurrent,0,9,O
DDI-DrugBank.d110.s1,use,11,13,O
DDI-DrugBank.d110.s1,of,15,16,O
DDI-DrugBank.d110.s1,these,18,22,O
DDI-DrugBank.d110.s1,agents,24,29,O
DDI-DrugBank.d110.s1,should,31,36,O
DDI-DrugBank.d110.s1,generally,38,46,O
DDI-DrugBank.d110.s1,be,48,49,O
DDI-DrugBank.d110.s1,avoided,51,57,O
DDI-DrugBank.d110.s1,.,58,58,O
DDI-DrugBank.d110.s2,In,0,1,O
DDI-DrugBank.d110.s2,situations,3,12,O
DDI-DrugBank.d110.s2,when,14,17,O
DDI-DrugBank.d110.s2,concurrent,19,28,O
DDI-DrugBank.d110.s2,therapy,30,36,O
DDI-DrugBank.d110.s2,is,38,39,O
DDI-DrugBank.d110.s2,necessary,41,49,O
DDI-DrugBank.d110.s2,",",50,50,O
DDI-DrugBank.d110.s2,careful,52,58,O
DDI-DrugBank.d110.s2,patient,60,66,O
DDI-DrugBank.d110.s2,monitoring,68,77,O
DDI-DrugBank.d110.s2,is,79,80,O
DDI-DrugBank.d110.s2,essential,82,90,O
DDI-DrugBank.d110.s2,.,91,91,O
DDI-DrugBank.d110.s3,Concurrent,0,9,O
DDI-DrugBank.d110.s3,administration,11,24,O
DDI-DrugBank.d110.s3,of,26,27,O
DDI-DrugBank.d110.s3,vasopressor,29,39,B-group
DDI-DrugBank.d110.s3,drugs,41,45,I-group
DDI-DrugBank.d110.s3,(,47,47,O
DDI-DrugBank.d110.s3,for,48,50,O
DDI-DrugBank.d110.s3,the,52,54,O
DDI-DrugBank.d110.s3,treatment,56,64,O
DDI-DrugBank.d110.s3,of,66,67,O
DDI-DrugBank.d110.s3,hypotension,69,79,O
DDI-DrugBank.d110.s3,related,81,87,O
DDI-DrugBank.d110.s3,to,89,90,O
DDI-DrugBank.d110.s3,obstetric,92,100,O
DDI-DrugBank.d110.s3,blocks,102,107,O
DDI-DrugBank.d110.s3,),108,108,O
DDI-DrugBank.d110.s3,and,110,112,O
DDI-DrugBank.d110.s3,ergot-type,114,123,B-group
DDI-DrugBank.d110.s3,oxytocic,125,132,I-group
DDI-DrugBank.d110.s3,drugs,134,138,I-group
DDI-DrugBank.d110.s3,may,140,142,O
DDI-DrugBank.d110.s3,cause,144,148,O
DDI-DrugBank.d110.s3,severe,150,155,O
DDI-DrugBank.d110.s3,",",156,156,O
DDI-DrugBank.d110.s3,persistent,158,167,O
DDI-DrugBank.d110.s3,hypertension,169,180,O
DDI-DrugBank.d110.s3,or,182,183,O
DDI-DrugBank.d110.s3,cerebrovascular,185,199,O
DDI-DrugBank.d110.s3,accidents,201,209,O
DDI-DrugBank.d110.s3,.,210,210,O
DDI-DrugBank.d110.s4,The,0,2,O
DDI-DrugBank.d110.s4,para-aminobenzoic,4,20,O
DDI-DrugBank.d110.s4,acid,22,25,O
DDI-DrugBank.d110.s4,metabolite,27,36,O
DDI-DrugBank.d110.s4,of,38,39,O
DDI-DrugBank.d110.s4,chloroprocaine,41,54,O
DDI-DrugBank.d110.s4,inhibits,56,63,O
DDI-DrugBank.d110.s4,the,65,67,O
DDI-DrugBank.d110.s4,action,69,74,O
DDI-DrugBank.d110.s4,of,76,77,O
DDI-DrugBank.d110.s4,sulfonamides,79,90,B-group
DDI-DrugBank.d110.s4,.,91,91,O
DDI-DrugBank.d110.s5,Therefore,0,8,O
DDI-DrugBank.d110.s5,",",9,9,O
DDI-DrugBank.d110.s5,chloroprocaine,11,24,B-drug
DDI-DrugBank.d110.s5,should,26,31,O
DDI-DrugBank.d110.s5,not,33,35,O
DDI-DrugBank.d110.s5,be,37,38,O
DDI-DrugBank.d110.s5,used,40,43,O
DDI-DrugBank.d110.s5,in,45,46,O
DDI-DrugBank.d110.s5,any,48,50,O
DDI-DrugBank.d110.s5,condition,52,60,O
DDI-DrugBank.d110.s5,in,62,63,O
DDI-DrugBank.d110.s5,which,65,69,O
DDI-DrugBank.d110.s5,a,71,71,O
DDI-DrugBank.d110.s5,sulfonamide,73,83,B-group
DDI-DrugBank.d110.s5,drug,85,88,I-group
DDI-DrugBank.d110.s5,is,90,91,O
DDI-DrugBank.d110.s5,being,93,97,O
DDI-DrugBank.d110.s5,employed,99,106,O
DDI-DrugBank.d110.s5,.,107,107,O
DDI-DrugBank.d429.s0,Antacids,0,7,B-group
DDI-DrugBank.d429.s0,and,9,11,O
DDI-DrugBank.d429.s0,kaolin,13,18,B-drug
DDI-DrugBank.d429.s0,:,19,19,O
DDI-DrugBank.d429.s0,Antacids,21,28,B-group
DDI-DrugBank.d429.s0,and,30,32,O
DDI-DrugBank.d429.s0,kaolin,34,39,B-drug
DDI-DrugBank.d429.s0,can,41,43,O
DDI-DrugBank.d429.s0,reduce,45,50,O
DDI-DrugBank.d429.s0,absorption,52,61,O
DDI-DrugBank.d429.s0,of,63,64,O
DDI-DrugBank.d429.s0,chloroquine,66,76,B-drug
DDI-DrugBank.d429.s0,;,77,77,O
DDI-DrugBank.d429.s1,an,0,1,O
DDI-DrugBank.d429.s1,interval,3,10,O
DDI-DrugBank.d429.s1,of,12,13,O
DDI-DrugBank.d429.s1,at,15,16,O
DDI-DrugBank.d429.s1,least,18,22,O
DDI-DrugBank.d429.s1,4,24,24,O
DDI-DrugBank.d429.s1,hours,26,30,O
DDI-DrugBank.d429.s1,between,32,38,O
DDI-DrugBank.d429.s1,intake,40,45,O
DDI-DrugBank.d429.s1,of,47,48,O
DDI-DrugBank.d429.s1,these,50,54,O
DDI-DrugBank.d429.s1,agents,56,61,O
DDI-DrugBank.d429.s1,and,63,65,O
DDI-DrugBank.d429.s1,chloroquine,67,77,B-drug
DDI-DrugBank.d429.s1,should,79,84,O
DDI-DrugBank.d429.s1,be,86,87,O
DDI-DrugBank.d429.s1,observed,89,96,O
DDI-DrugBank.d429.s1,.,97,97,O
DDI-DrugBank.d429.s2,Cimetidine,0,9,B-drug
DDI-DrugBank.d429.s2,:,10,10,O
DDI-DrugBank.d429.s2,Cimetidine,12,21,B-drug
DDI-DrugBank.d429.s2,can,23,25,O
DDI-DrugBank.d429.s2,inhibit,27,33,O
DDI-DrugBank.d429.s2,the,35,37,O
DDI-DrugBank.d429.s2,metabolism,39,48,O
DDI-DrugBank.d429.s2,of,50,51,O
DDI-DrugBank.d429.s2,chloroquine,53,63,B-drug
DDI-DrugBank.d429.s2,",",64,64,O
DDI-DrugBank.d429.s2,increasing,66,75,O
DDI-DrugBank.d429.s2,its,77,79,O
DDI-DrugBank.d429.s2,plasma,81,86,O
DDI-DrugBank.d429.s2,level,88,92,O
DDI-DrugBank.d429.s2,.,93,93,O
DDI-DrugBank.d429.s3,Concomitant,0,10,O
DDI-DrugBank.d429.s3,use,12,14,O
DDI-DrugBank.d429.s3,of,16,17,O
DDI-DrugBank.d429.s3,cimetidine,19,28,B-drug
DDI-DrugBank.d429.s3,should,30,35,O
DDI-DrugBank.d429.s3,be,37,38,O
DDI-DrugBank.d429.s3,avoided,40,46,O
DDI-DrugBank.d429.s3,.,47,47,O
DDI-DrugBank.d429.s4,Ampicillin,0,9,B-drug
DDI-DrugBank.d429.s4,:,10,10,O
DDI-DrugBank.d429.s4,In,12,13,O
DDI-DrugBank.d429.s4,a,15,15,O
DDI-DrugBank.d429.s4,study,17,21,O
DDI-DrugBank.d429.s4,of,23,24,O
DDI-DrugBank.d429.s4,healthy,26,32,O
DDI-DrugBank.d429.s4,volunteers,34,43,O
DDI-DrugBank.d429.s4,",",44,44,O
DDI-DrugBank.d429.s4,chloroquine,46,56,B-drug
DDI-DrugBank.d429.s4,significantly,58,70,O
DDI-DrugBank.d429.s4,reduced,72,78,O
DDI-DrugBank.d429.s4,the,80,82,O
DDI-DrugBank.d429.s4,bioavailability,84,98,O
DDI-DrugBank.d429.s4,of,100,101,O
DDI-DrugBank.d429.s4,ampicillin,103,112,B-drug
DDI-DrugBank.d429.s4,.,113,113,O
DDI-DrugBank.d429.s5,An,0,1,O
DDI-DrugBank.d429.s5,interval,3,10,O
DDI-DrugBank.d429.s5,of,12,13,O
DDI-DrugBank.d429.s5,at,15,16,O
DDI-DrugBank.d429.s5,least,18,22,O
DDI-DrugBank.d429.s5,two,24,26,O
DDI-DrugBank.d429.s5,hours,28,32,O
DDI-DrugBank.d429.s5,between,34,40,O
DDI-DrugBank.d429.s5,intake,42,47,O
DDI-DrugBank.d429.s5,of,49,50,O
DDI-DrugBank.d429.s5,this,52,55,O
DDI-DrugBank.d429.s5,agent,57,61,O
DDI-DrugBank.d429.s5,and,63,65,O
DDI-DrugBank.d429.s5,chloroquine,67,77,B-drug
DDI-DrugBank.d429.s5,should,79,84,O
DDI-DrugBank.d429.s5,be,86,87,O
DDI-DrugBank.d429.s5,observed,89,96,O
DDI-DrugBank.d429.s5,.,97,97,O
DDI-DrugBank.d429.s6,Cyclosporin,0,10,B-drug
DDI-DrugBank.d429.s6,:,11,11,O
DDI-DrugBank.d429.s6,After,13,17,O
DDI-DrugBank.d429.s6,introduction,19,30,O
DDI-DrugBank.d429.s6,of,32,33,O
DDI-DrugBank.d429.s6,chloroquine,35,45,B-drug
DDI-DrugBank.d429.s6,(,47,47,O
DDI-DrugBank.d429.s6,oral,48,51,O
DDI-DrugBank.d429.s6,form,53,56,O
DDI-DrugBank.d429.s6,),57,57,O
DDI-DrugBank.d429.s6,",",58,58,O
DDI-DrugBank.d429.s6,a,60,60,O
DDI-DrugBank.d429.s6,sudden,62,67,O
DDI-DrugBank.d429.s6,increase,69,76,O
DDI-DrugBank.d429.s6,in,78,79,O
DDI-DrugBank.d429.s6,serum,81,85,O
DDI-DrugBank.d429.s6,cyclosporin,87,97,B-drug
DDI-DrugBank.d429.s6,level,99,103,O
DDI-DrugBank.d429.s6,has,105,107,O
DDI-DrugBank.d429.s6,been,109,112,O
DDI-DrugBank.d429.s6,reported,114,121,O
DDI-DrugBank.d429.s6,.,122,122,O
DDI-DrugBank.d429.s7,Therefore,0,8,O
DDI-DrugBank.d429.s7,",",9,9,O
DDI-DrugBank.d429.s7,close,11,15,O
DDI-DrugBank.d429.s7,monitoring,17,26,O
DDI-DrugBank.d429.s7,of,28,29,O
DDI-DrugBank.d429.s7,serum,31,35,O
DDI-DrugBank.d429.s7,cyclosporin,37,47,B-drug
DDI-DrugBank.d429.s7,level,49,53,O
DDI-DrugBank.d429.s7,is,55,56,O
DDI-DrugBank.d429.s7,recommended,58,68,O
DDI-DrugBank.d429.s7,and,70,72,O
DDI-DrugBank.d429.s7,",",73,73,O
DDI-DrugBank.d429.s7,if,75,76,O
DDI-DrugBank.d429.s7,necessary,78,86,O
DDI-DrugBank.d429.s7,",",87,87,O
DDI-DrugBank.d429.s7,chloroquine,89,99,B-drug
DDI-DrugBank.d429.s7,should,101,106,O
DDI-DrugBank.d429.s7,be,108,109,O
DDI-DrugBank.d429.s7,discontinued,111,122,O
DDI-DrugBank.d429.s7,.,123,123,O
DDI-DrugBank.d446.s0,Chlorotrianisene,0,15,B-drug
DDI-DrugBank.d446.s0,may,17,19,O
DDI-DrugBank.d446.s0,interact,21,28,O
DDI-DrugBank.d446.s0,with,30,33,O
DDI-DrugBank.d446.s0,antidepressants,35,49,B-group
DDI-DrugBank.d446.s0,",",50,50,O
DDI-DrugBank.d446.s0,aspirin,52,58,B-brand
DDI-DrugBank.d446.s0,",",59,59,O
DDI-DrugBank.d446.s0,barbiturates,61,72,B-group
DDI-DrugBank.d446.s0,",",73,73,O
DDI-DrugBank.d446.s0,bromocriptine,75,87,B-drug
DDI-DrugBank.d446.s0,",",88,88,O
DDI-DrugBank.d446.s0,calcium,90,96,B-drug
DDI-DrugBank.d446.s0,supplements,98,108,O
DDI-DrugBank.d446.s0,",",109,109,O
DDI-DrugBank.d446.s0,corticosteroids,111,125,B-group
DDI-DrugBank.d446.s0,",",126,126,O
DDI-DrugBank.d446.s0,corticotropin,128,140,B-drug
DDI-DrugBank.d446.s0,",",141,141,O
DDI-DrugBank.d446.s0,cyclosporine,143,154,B-drug
DDI-DrugBank.d446.s0,",",155,155,O
DDI-DrugBank.d446.s0,dantrolene,157,166,B-drug
DDI-DrugBank.d446.s0,",",167,167,O
DDI-DrugBank.d446.s0,nicotine,169,176,B-drug
DDI-DrugBank.d446.s0,",",177,177,O
DDI-DrugBank.d446.s0,somatropin,179,188,B-drug
DDI-DrugBank.d446.s0,",",189,189,O
DDI-DrugBank.d446.s0,tamoxifen,191,199,B-drug
DDI-DrugBank.d446.s0,",",200,200,O
DDI-DrugBank.d446.s0,and,202,204,O
DDI-DrugBank.d446.s0,warfarin,206,213,B-drug
DDI-DrugBank.d446.s0,.,214,214,O
DDI-DrugBank.d245.s0,The,0,2,O
DDI-DrugBank.d245.s0,hypoglycemic,4,15,O
DDI-DrugBank.d245.s0,action,17,22,O
DDI-DrugBank.d245.s0,of,24,25,O
DDI-DrugBank.d245.s0,sulfonylurea,27,38,B-group
DDI-DrugBank.d245.s0,may,40,42,O
DDI-DrugBank.d245.s0,be,44,45,O
DDI-DrugBank.d245.s0,potentiated,47,57,O
DDI-DrugBank.d245.s0,by,59,60,O
DDI-DrugBank.d245.s0,certain,62,68,O
DDI-DrugBank.d245.s0,drugs,70,74,O
DDI-DrugBank.d245.s0,including,76,84,O
DDI-DrugBank.d245.s0,nonsteroidal,86,97,B-group
DDI-DrugBank.d245.s0,anti-inflammatory,99,115,I-group
DDI-DrugBank.d245.s0,agents,117,122,I-group
DDI-DrugBank.d245.s0,and,124,126,O
DDI-DrugBank.d245.s0,other,128,132,O
DDI-DrugBank.d245.s0,drugs,134,138,O
DDI-DrugBank.d245.s0,that,140,143,O
DDI-DrugBank.d245.s0,are,145,147,O
DDI-DrugBank.d245.s0,highly,149,154,O
DDI-DrugBank.d245.s0,protein,156,162,O
DDI-DrugBank.d245.s0,bound,164,168,O
DDI-DrugBank.d245.s0,",",169,169,O
DDI-DrugBank.d245.s0,salicylates,171,181,B-group
DDI-DrugBank.d245.s0,",",182,182,O
DDI-DrugBank.d245.s0,sulfonamides,184,195,B-group
DDI-DrugBank.d245.s0,",",196,196,O
DDI-DrugBank.d245.s0,chloramphenicol,198,212,B-drug
DDI-DrugBank.d245.s0,",",213,213,O
DDI-DrugBank.d245.s0,probenecid,215,224,B-drug
DDI-DrugBank.d245.s0,",",225,225,O
DDI-DrugBank.d245.s0,coumarins,227,235,B-group
DDI-DrugBank.d245.s0,",",236,236,O
DDI-DrugBank.d245.s0,monoamine,238,246,B-group
DDI-DrugBank.d245.s0,oxidase,248,254,I-group
DDI-DrugBank.d245.s0,inhibitors,256,265,I-group
DDI-DrugBank.d245.s0,",",266,266,O
DDI-DrugBank.d245.s0,and,268,270,O
DDI-DrugBank.d245.s0,beta,272,275,B-group
DDI-DrugBank.d245.s0,adrenergic,277,286,I-group
DDI-DrugBank.d245.s0,blocking,288,295,I-group
DDI-DrugBank.d245.s0,agents,297,302,I-group
DDI-DrugBank.d245.s0,.,303,303,O
DDI-DrugBank.d245.s1,When,0,3,O
DDI-DrugBank.d245.s1,such,5,8,O
DDI-DrugBank.d245.s1,drugs,10,14,O
DDI-DrugBank.d245.s1,are,16,18,O
DDI-DrugBank.d245.s1,administered,20,31,O
DDI-DrugBank.d245.s1,to,33,34,O
DDI-DrugBank.d245.s1,a,36,36,O
DDI-DrugBank.d245.s1,patient,38,44,O
DDI-DrugBank.d245.s1,receiving,46,54,O
DDI-DrugBank.d245.s1,DIABINESE,56,64,B-brand
DDI-DrugBank.d245.s1,",",65,65,O
DDI-DrugBank.d245.s1,the,67,69,O
DDI-DrugBank.d245.s1,patient,71,77,O
DDI-DrugBank.d245.s1,should,79,84,O
DDI-DrugBank.d245.s1,be,86,87,O
DDI-DrugBank.d245.s1,observed,89,96,O
DDI-DrugBank.d245.s1,closely,98,104,O
DDI-DrugBank.d245.s1,for,106,108,O
DDI-DrugBank.d245.s1,hypoglycemia,110,121,O
DDI-DrugBank.d245.s1,.,122,122,O
DDI-DrugBank.d245.s2,When,0,3,O
DDI-DrugBank.d245.s2,such,5,8,O
DDI-DrugBank.d245.s2,drugs,10,14,O
DDI-DrugBank.d245.s2,are,16,18,O
DDI-DrugBank.d245.s2,withdrawn,20,28,O
DDI-DrugBank.d245.s2,from,30,33,O
DDI-DrugBank.d245.s2,a,35,35,O
DDI-DrugBank.d245.s2,patient,37,43,O
DDI-DrugBank.d245.s2,receiving,45,53,O
DDI-DrugBank.d245.s2,DIABINESE,55,63,B-brand
DDI-DrugBank.d245.s2,",",64,64,O
DDI-DrugBank.d245.s2,the,66,68,O
DDI-DrugBank.d245.s2,patient,70,76,O
DDI-DrugBank.d245.s2,should,78,83,O
DDI-DrugBank.d245.s2,be,85,86,O
DDI-DrugBank.d245.s2,observed,88,95,O
DDI-DrugBank.d245.s2,closely,97,103,O
DDI-DrugBank.d245.s2,for,105,107,O
DDI-DrugBank.d245.s2,loss,109,112,O
DDI-DrugBank.d245.s2,of,114,115,O
DDI-DrugBank.d245.s2,control,117,123,O
DDI-DrugBank.d245.s2,.,124,124,O
DDI-DrugBank.d245.s3,Certain,0,6,O
DDI-DrugBank.d245.s3,drugs,8,12,O
DDI-DrugBank.d245.s3,tend,14,17,O
DDI-DrugBank.d245.s3,to,19,20,O
DDI-DrugBank.d245.s3,produce,22,28,O
DDI-DrugBank.d245.s3,hyperglycemia,30,42,O
DDI-DrugBank.d245.s3,and,44,46,O
DDI-DrugBank.d245.s3,may,48,50,O
DDI-DrugBank.d245.s3,lead,52,55,O
DDI-DrugBank.d245.s3,to,57,58,O
DDI-DrugBank.d245.s3,loss,60,63,O
DDI-DrugBank.d245.s3,of,65,66,O
DDI-DrugBank.d245.s3,control,68,74,O
DDI-DrugBank.d245.s3,.,75,75,O
DDI-DrugBank.d245.s4,These,0,4,O
DDI-DrugBank.d245.s4,drugs,6,10,O
DDI-DrugBank.d245.s4,include,12,18,O
DDI-DrugBank.d245.s4,the,20,22,O
DDI-DrugBank.d245.s4,thiazides,24,32,B-group
DDI-DrugBank.d245.s4,and,34,36,O
DDI-DrugBank.d245.s4,other,38,42,O
DDI-DrugBank.d245.s4,diuretics,44,52,B-group
DDI-DrugBank.d245.s4,",",53,53,O
DDI-DrugBank.d245.s4,corticosteroids,55,69,B-group
DDI-DrugBank.d245.s4,",",70,70,O
DDI-DrugBank.d245.s4,phenothiazines,72,85,B-group
DDI-DrugBank.d245.s4,",",86,86,O
DDI-DrugBank.d245.s4,thyroid,88,94,O
DDI-DrugBank.d245.s4,products,96,103,O
DDI-DrugBank.d245.s4,",",104,104,O
DDI-DrugBank.d245.s4,estrogens,106,114,B-group
DDI-DrugBank.d245.s4,",",115,115,O
DDI-DrugBank.d245.s4,oral,117,120,O
DDI-DrugBank.d245.s4,contraceptives,122,135,B-group
DDI-DrugBank.d245.s4,",",136,136,O
DDI-DrugBank.d245.s4,phenytoin,138,146,B-drug
DDI-DrugBank.d245.s4,",",147,147,O
DDI-DrugBank.d245.s4,nicotinic,149,157,B-drug
DDI-DrugBank.d245.s4,acid,159,162,I-drug
DDI-DrugBank.d245.s4,",",163,163,O
DDI-DrugBank.d245.s4,sympathomimetics,165,180,B-group
DDI-DrugBank.d245.s4,",",181,181,O
DDI-DrugBank.d245.s4,calcium,183,189,B-group
DDI-DrugBank.d245.s4,channel,191,197,I-group
DDI-DrugBank.d245.s4,blocking,199,206,I-group
DDI-DrugBank.d245.s4,drugs,208,212,I-group
DDI-DrugBank.d245.s4,",",213,213,O
DDI-DrugBank.d245.s4,and,215,217,O
DDI-DrugBank.d245.s4,isoniazid,219,227,B-drug
DDI-DrugBank.d245.s4,.,228,228,O
DDI-DrugBank.d245.s5,When,0,3,O
DDI-DrugBank.d245.s5,such,5,8,O
DDI-DrugBank.d245.s5,drugs,10,14,O
DDI-DrugBank.d245.s5,are,16,18,O
DDI-DrugBank.d245.s5,administered,20,31,O
DDI-DrugBank.d245.s5,to,33,34,O
DDI-DrugBank.d245.s5,a,36,36,O
DDI-DrugBank.d245.s5,patient,38,44,O
DDI-DrugBank.d245.s5,receiving,46,54,O
DDI-DrugBank.d245.s5,DIABINESE,56,64,B-brand
DDI-DrugBank.d245.s5,",",65,65,O
DDI-DrugBank.d245.s5,the,67,69,O
DDI-DrugBank.d245.s5,patient,71,77,O
DDI-DrugBank.d245.s5,should,79,84,O
DDI-DrugBank.d245.s5,be,86,87,O
DDI-DrugBank.d245.s5,closely,89,95,O
DDI-DrugBank.d245.s5,observed,97,104,O
DDI-DrugBank.d245.s5,for,106,108,O
DDI-DrugBank.d245.s5,loss,110,113,O
DDI-DrugBank.d245.s5,of,115,116,O
DDI-DrugBank.d245.s5,control,118,124,O
DDI-DrugBank.d245.s5,.,125,125,O
DDI-DrugBank.d245.s6,When,0,3,O
DDI-DrugBank.d245.s6,such,5,8,O
DDI-DrugBank.d245.s6,drugs,10,14,O
DDI-DrugBank.d245.s6,are,16,18,O
DDI-DrugBank.d245.s6,withdrawn,20,28,O
DDI-DrugBank.d245.s6,from,30,33,O
DDI-DrugBank.d245.s6,a,35,35,O
DDI-DrugBank.d245.s6,patient,37,43,O
DDI-DrugBank.d245.s6,receiving,45,53,O
DDI-DrugBank.d245.s6,DIABINESE,55,63,B-brand
DDI-DrugBank.d245.s6,",",64,64,O
DDI-DrugBank.d245.s6,the,66,68,O
DDI-DrugBank.d245.s6,patient,70,76,O
DDI-DrugBank.d245.s6,should,78,83,O
DDI-DrugBank.d245.s6,be,85,86,O
DDI-DrugBank.d245.s6,observed,88,95,O
DDI-DrugBank.d245.s6,closely,97,103,O
DDI-DrugBank.d245.s6,for,105,107,O
DDI-DrugBank.d245.s6,hypoglycemia,109,120,O
DDI-DrugBank.d245.s6,.,121,121,O
DDI-DrugBank.d245.s7,Since,0,4,O
DDI-DrugBank.d245.s7,animal,6,11,O
DDI-DrugBank.d245.s7,studies,13,19,O
DDI-DrugBank.d245.s7,suggest,21,27,O
DDI-DrugBank.d245.s7,that,29,32,O
DDI-DrugBank.d245.s7,the,34,36,O
DDI-DrugBank.d245.s7,action,38,43,O
DDI-DrugBank.d245.s7,of,45,46,O
DDI-DrugBank.d245.s7,barbiturates,48,59,B-group
DDI-DrugBank.d245.s7,may,61,63,O
DDI-DrugBank.d245.s7,be,65,66,O
DDI-DrugBank.d245.s7,prolonged,68,76,O
DDI-DrugBank.d245.s7,by,78,79,O
DDI-DrugBank.d245.s7,therapy,81,87,O
DDI-DrugBank.d245.s7,with,89,92,O
DDI-DrugBank.d245.s7,chlorpropamide,94,107,B-drug
DDI-DrugBank.d245.s7,",",108,108,O
DDI-DrugBank.d245.s7,barbiturates,110,121,B-group
DDI-DrugBank.d245.s7,should,123,128,O
DDI-DrugBank.d245.s7,be,130,131,O
DDI-DrugBank.d245.s7,employed,133,140,O
DDI-DrugBank.d245.s7,with,142,145,O
DDI-DrugBank.d245.s7,caution,147,153,O
DDI-DrugBank.d245.s7,.,154,154,O
DDI-DrugBank.d245.s8,In,0,1,O
DDI-DrugBank.d245.s8,some,3,6,O
DDI-DrugBank.d245.s8,patients,8,15,O
DDI-DrugBank.d245.s8,",",16,16,O
DDI-DrugBank.d245.s8,a,18,18,O
DDI-DrugBank.d245.s8,disulfiram-like,20,34,O
DDI-DrugBank.d245.s8,reaction,36,43,O
DDI-DrugBank.d245.s8,may,45,47,O
DDI-DrugBank.d245.s8,be,49,50,O
DDI-DrugBank.d245.s8,produced,52,59,O
DDI-DrugBank.d245.s8,by,61,62,O
DDI-DrugBank.d245.s8,the,64,66,O
DDI-DrugBank.d245.s8,ingestion,68,76,O
DDI-DrugBank.d245.s8,of,78,79,O
DDI-DrugBank.d245.s8,alcohol,81,87,B-drug
DDI-DrugBank.d245.s8,.,88,88,O
DDI-DrugBank.d245.s9,A,0,0,O
DDI-DrugBank.d245.s9,potential,2,10,O
DDI-DrugBank.d245.s9,interaction,12,22,O
DDI-DrugBank.d245.s9,between,24,30,O
DDI-DrugBank.d245.s9,oral,32,35,O
DDI-DrugBank.d245.s9,miconazole,37,46,B-drug
DDI-DrugBank.d245.s9,and,48,50,O
DDI-DrugBank.d245.s9,oral,52,55,O
DDI-DrugBank.d245.s9,hypoglycemic,57,68,B-group
DDI-DrugBank.d245.s9,agents,70,75,I-group
DDI-DrugBank.d245.s9,leading,77,83,O
DDI-DrugBank.d245.s9,to,85,86,O
DDI-DrugBank.d245.s9,severe,88,93,O
DDI-DrugBank.d245.s9,hypoglycemia,95,106,O
DDI-DrugBank.d245.s9,has,108,110,O
DDI-DrugBank.d245.s9,been,112,115,O
DDI-DrugBank.d245.s9,reported,117,124,O
DDI-DrugBank.d245.s9,.,125,125,O
DDI-DrugBank.d245.s10,Whether,0,6,O
DDI-DrugBank.d245.s10,this,8,11,O
DDI-DrugBank.d245.s10,interaction,13,23,O
DDI-DrugBank.d245.s10,also,25,28,O
DDI-DrugBank.d245.s10,occurs,30,35,O
DDI-DrugBank.d245.s10,with,37,40,O
DDI-DrugBank.d245.s10,the,42,44,O
DDI-DrugBank.d245.s10,intravenous,46,56,O
DDI-DrugBank.d245.s10,",",57,57,O
DDI-DrugBank.d245.s10,topical,59,65,O
DDI-DrugBank.d245.s10,",",66,66,O
DDI-DrugBank.d245.s10,or,68,69,O
DDI-DrugBank.d245.s10,vaginal,71,77,O
DDI-DrugBank.d245.s10,preparations,79,90,O
DDI-DrugBank.d245.s10,of,92,93,O
DDI-DrugBank.d245.s10,miconazole,95,104,B-drug
DDI-DrugBank.d245.s10,is,106,107,O
DDI-DrugBank.d245.s10,not,109,111,O
DDI-DrugBank.d245.s10,known,113,117,O
DDI-DrugBank.d245.s10,.,118,118,O
DDI-DrugBank.d171.s0,Tagamet,0,6,B-brand
DDI-DrugBank.d171.s0,",",7,7,O
DDI-DrugBank.d171.s0,apparently,9,18,O
DDI-DrugBank.d171.s0,through,20,26,O
DDI-DrugBank.d171.s0,an,28,29,O
DDI-DrugBank.d171.s0,effect,31,36,O
DDI-DrugBank.d171.s0,on,38,39,O
DDI-DrugBank.d171.s0,certain,41,47,O
DDI-DrugBank.d171.s0,microsomal,49,58,O
DDI-DrugBank.d171.s0,enzyme,60,65,O
DDI-DrugBank.d171.s0,systems,67,73,O
DDI-DrugBank.d171.s0,",",74,74,O
DDI-DrugBank.d171.s0,has,76,78,O
DDI-DrugBank.d171.s0,been,80,83,O
DDI-DrugBank.d171.s0,reported,85,92,O
DDI-DrugBank.d171.s0,to,94,95,O
DDI-DrugBank.d171.s0,reduce,97,102,O
DDI-DrugBank.d171.s0,the,104,106,O
DDI-DrugBank.d171.s0,hepatic,108,114,O
DDI-DrugBank.d171.s0,metabolism,116,125,O
DDI-DrugBank.d171.s0,of,127,128,O
DDI-DrugBank.d171.s0,warfarin-type,130,142,B-group
DDI-DrugBank.d171.s0,anticoagulants,144,157,I-group
DDI-DrugBank.d171.s0,",",158,158,O
DDI-DrugBank.d171.s0,phenytoin,160,168,B-drug
DDI-DrugBank.d171.s0,",",169,169,O
DDI-DrugBank.d171.s0,propranolol,171,181,B-drug
DDI-DrugBank.d171.s0,",",182,182,O
DDI-DrugBank.d171.s0,nifedipine,184,193,B-drug
DDI-DrugBank.d171.s0,",",194,194,O
DDI-DrugBank.d171.s0,chlordiazepoxide,196,211,B-drug
DDI-DrugBank.d171.s0,",",212,212,O
DDI-DrugBank.d171.s0,diazepam,214,221,B-drug
DDI-DrugBank.d171.s0,",",222,222,O
DDI-DrugBank.d171.s0,certain,224,230,O
DDI-DrugBank.d171.s0,tricyclic,232,240,B-group
DDI-DrugBank.d171.s0,antidepressants,242,256,I-group
DDI-DrugBank.d171.s0,",",257,257,O
DDI-DrugBank.d171.s0,lidocaine,259,267,B-drug
DDI-DrugBank.d171.s0,",",268,268,O
DDI-DrugBank.d171.s0,theophylline,270,281,B-drug
DDI-DrugBank.d171.s0,and,283,285,O
DDI-DrugBank.d171.s0,metronidazole,287,299,B-drug
DDI-DrugBank.d171.s0,",",300,300,O
DDI-DrugBank.d171.s0,thereby,302,308,O
DDI-DrugBank.d171.s0,delaying,310,317,O
DDI-DrugBank.d171.s0,elimination,319,329,O
DDI-DrugBank.d171.s0,and,331,333,O
DDI-DrugBank.d171.s0,increasing,335,344,O
DDI-DrugBank.d171.s0,blood,346,350,O
DDI-DrugBank.d171.s0,levels,352,357,O
DDI-DrugBank.d171.s0,of,359,360,O
DDI-DrugBank.d171.s0,these,362,366,O
DDI-DrugBank.d171.s0,drugs,368,372,O
DDI-DrugBank.d171.s0,.,373,373,O
DDI-DrugBank.d171.s1,Clinically,0,9,O
DDI-DrugBank.d171.s1,significant,11,21,O
DDI-DrugBank.d171.s1,effects,23,29,O
DDI-DrugBank.d171.s1,have,31,34,O
DDI-DrugBank.d171.s1,been,36,39,O
DDI-DrugBank.d171.s1,reported,41,48,O
DDI-DrugBank.d171.s1,with,50,53,O
DDI-DrugBank.d171.s1,the,55,57,O
DDI-DrugBank.d171.s1,warfarin,59,66,B-group
DDI-DrugBank.d171.s1,anticoagulants,68,81,I-group
DDI-DrugBank.d171.s1,;,82,82,O
DDI-DrugBank.d171.s2,therefore,0,8,O
DDI-DrugBank.d171.s2,",",9,9,O
DDI-DrugBank.d171.s2,close,11,15,O
DDI-DrugBank.d171.s2,monitoring,17,26,O
DDI-DrugBank.d171.s2,of,28,29,O
DDI-DrugBank.d171.s2,prothrombin,31,41,O
DDI-DrugBank.d171.s2,time,43,46,O
DDI-DrugBank.d171.s2,is,48,49,O
DDI-DrugBank.d171.s2,recommended,51,61,O
DDI-DrugBank.d171.s2,",",62,62,O
DDI-DrugBank.d171.s2,and,64,66,O
DDI-DrugBank.d171.s2,adjustment,68,77,O
DDI-DrugBank.d171.s2,of,79,80,O
DDI-DrugBank.d171.s2,the,82,84,O
DDI-DrugBank.d171.s2,anticoagulant,86,98,B-group
DDI-DrugBank.d171.s2,dose,100,103,O
DDI-DrugBank.d171.s2,may,105,107,O
DDI-DrugBank.d171.s2,be,109,110,O
DDI-DrugBank.d171.s2,necessary,112,120,O
DDI-DrugBank.d171.s2,when,122,125,O
DDI-DrugBank.d171.s2,Tagamet,127,133,B-brand
DDI-DrugBank.d171.s2,is,135,136,O
DDI-DrugBank.d171.s2,administered,138,149,O
DDI-DrugBank.d171.s2,concomitantly,151,163,O
DDI-DrugBank.d171.s2,.,164,164,O
DDI-DrugBank.d171.s3,Interaction,0,10,O
DDI-DrugBank.d171.s3,with,12,15,O
DDI-DrugBank.d171.s3,phenytoin,17,25,B-drug
DDI-DrugBank.d171.s3,",",26,26,O
DDI-DrugBank.d171.s3,lidocaine,28,36,B-drug
DDI-DrugBank.d171.s3,and,38,40,O
DDI-DrugBank.d171.s3,theophylline,42,53,B-drug
DDI-DrugBank.d171.s3,has,55,57,O
DDI-DrugBank.d171.s3,also,59,62,O
DDI-DrugBank.d171.s3,been,64,67,O
DDI-DrugBank.d171.s3,reported,69,76,O
DDI-DrugBank.d171.s3,to,78,79,O
DDI-DrugBank.d171.s3,produce,81,87,O
DDI-DrugBank.d171.s3,adverse,89,95,O
DDI-DrugBank.d171.s3,clinical,97,104,O
DDI-DrugBank.d171.s3,effects,106,112,O
DDI-DrugBank.d171.s3,.,113,113,O
DDI-DrugBank.d171.s4,However,0,6,O
DDI-DrugBank.d171.s4,",",7,7,O
DDI-DrugBank.d171.s4,a,9,9,O
DDI-DrugBank.d171.s4,crossover,11,19,O
DDI-DrugBank.d171.s4,study,21,25,O
DDI-DrugBank.d171.s4,in,27,28,O
DDI-DrugBank.d171.s4,healthy,30,36,O
DDI-DrugBank.d171.s4,subjects,38,45,O
DDI-DrugBank.d171.s4,receiving,47,55,O
DDI-DrugBank.d171.s4,either,57,62,O
DDI-DrugBank.d171.s4,Tagamet,64,70,B-brand
DDI-DrugBank.d171.s4,300,72,74,O
DDI-DrugBank.d171.s4,mg,76,77,O
DDI-DrugBank.d171.s4,q.i.d,79,83,O
DDI-DrugBank.d171.s4,.,84,84,O
DDI-DrugBank.d171.s4,or,86,87,O
DDI-DrugBank.d171.s4,800,89,91,O
DDI-DrugBank.d171.s4,mg,93,94,O
DDI-DrugBank.d171.s4,h.s,96,98,O
DDI-DrugBank.d171.s4,.,99,99,O
DDI-DrugBank.d171.s4,concomitantly,101,113,O
DDI-DrugBank.d171.s4,with,115,118,O
DDI-DrugBank.d171.s4,a,120,120,O
DDI-DrugBank.d171.s4,300,122,124,O
DDI-DrugBank.d171.s4,mg,126,127,O
DDI-DrugBank.d171.s4,b.i.d,129,133,O
DDI-DrugBank.d171.s4,.,134,134,O
DDI-DrugBank.d171.s4,dosage,136,141,O
DDI-DrugBank.d171.s4,of,143,144,O
DDI-DrugBank.d171.s4,theophylline,146,157,B-drug
DDI-DrugBank.d171.s4,(,159,159,O
DDI-DrugBank.d171.s4,Theo-Dur,160,167,B-brand
DDI-DrugBank.d171.s4,",",169,169,O
DDI-DrugBank.d171.s4,Key,171,173,O
DDI-DrugBank.d171.s4,Pharmaceuticals,175,189,O
DDI-DrugBank.d171.s4,",",190,190,O
DDI-DrugBank.d171.s4,Inc.,192,195,O
DDI-DrugBank.d171.s4,),196,196,O
DDI-DrugBank.d171.s4,demonstrated,198,209,O
DDI-DrugBank.d171.s4,less,211,214,O
DDI-DrugBank.d171.s4,alteration,216,225,O
DDI-DrugBank.d171.s4,in,227,228,O
DDI-DrugBank.d171.s4,steady-state,230,241,O
DDI-DrugBank.d171.s4,theophylline,243,254,B-drug
DDI-DrugBank.d171.s4,peak,256,259,O
DDI-DrugBank.d171.s4,serum,261,265,O
DDI-DrugBank.d171.s4,levels,267,272,O
DDI-DrugBank.d171.s4,with,274,277,O
DDI-DrugBank.d171.s4,the,279,281,O
DDI-DrugBank.d171.s4,800,283,285,O
DDI-DrugBank.d171.s4,mg,287,288,O
DDI-DrugBank.d171.s4,h.s,290,292,O
DDI-DrugBank.d171.s4,.,293,293,O
DDI-DrugBank.d171.s4,regimen,295,301,O
DDI-DrugBank.d171.s4,",",302,302,O
DDI-DrugBank.d171.s4,particularly,304,315,O
DDI-DrugBank.d171.s4,in,317,318,O
DDI-DrugBank.d171.s4,subjects,320,327,O
DDI-DrugBank.d171.s4,aged,329,332,O
DDI-DrugBank.d171.s4,54,334,335,O
DDI-DrugBank.d171.s4,years,337,341,O
DDI-DrugBank.d171.s4,and,343,345,O
DDI-DrugBank.d171.s4,older,347,351,O
DDI-DrugBank.d171.s4,.,352,352,O
DDI-DrugBank.d171.s5,Data,0,3,O
DDI-DrugBank.d171.s5,beyond,5,10,O
DDI-DrugBank.d171.s5,10,12,13,O
DDI-DrugBank.d171.s5,days,15,18,O
DDI-DrugBank.d171.s5,are,20,22,O
DDI-DrugBank.d171.s5,not,24,26,O
DDI-DrugBank.d171.s5,available,28,36,O
DDI-DrugBank.d171.s5,.,37,37,O
DDI-DrugBank.d171.s6,(,0,0,O
DDI-DrugBank.d171.s6,Note,1,4,O
DDI-DrugBank.d171.s6,:,5,5,O
DDI-DrugBank.d171.s6,All,7,9,O
DDI-DrugBank.d171.s6,patients,11,18,O
DDI-DrugBank.d171.s6,receiving,20,28,O
DDI-DrugBank.d171.s6,theophylline,30,41,B-drug
DDI-DrugBank.d171.s6,should,43,48,O
DDI-DrugBank.d171.s6,be,50,51,O
DDI-DrugBank.d171.s6,monitored,53,61,O
DDI-DrugBank.d171.s6,appropriately,63,75,O
DDI-DrugBank.d171.s6,",",76,76,O
DDI-DrugBank.d171.s6,regardless,78,87,O
DDI-DrugBank.d171.s6,of,89,90,O
DDI-DrugBank.d171.s6,concomitant,92,102,O
DDI-DrugBank.d171.s6,drug,104,107,O
DDI-DrugBank.d171.s6,therapy,109,115,O
DDI-DrugBank.d171.s6,.,116,116,O
DDI-DrugBank.d171.s6,),117,117,O
DDI-DrugBank.d171.s7,Dosage,0,5,O
DDI-DrugBank.d171.s7,of,7,8,O
DDI-DrugBank.d171.s7,the,10,12,O
DDI-DrugBank.d171.s7,drugs,14,18,O
DDI-DrugBank.d171.s7,mentioned,20,28,O
DDI-DrugBank.d171.s7,above,30,34,O
DDI-DrugBank.d171.s7,and,36,38,O
DDI-DrugBank.d171.s7,other,40,44,O
DDI-DrugBank.d171.s7,similarly,46,54,O
DDI-DrugBank.d171.s7,metabolized,56,66,O
DDI-DrugBank.d171.s7,drugs,68,72,O
DDI-DrugBank.d171.s7,",",73,73,O
DDI-DrugBank.d171.s7,particularly,75,86,O
DDI-DrugBank.d171.s7,those,88,92,O
DDI-DrugBank.d171.s7,of,94,95,O
DDI-DrugBank.d171.s7,low,97,99,O
DDI-DrugBank.d171.s7,therapeutic,101,111,O
DDI-DrugBank.d171.s7,ratio,113,117,O
DDI-DrugBank.d171.s7,or,119,120,O
DDI-DrugBank.d171.s7,in,122,123,O
DDI-DrugBank.d171.s7,patients,125,132,O
DDI-DrugBank.d171.s7,with,134,137,O
DDI-DrugBank.d171.s7,renal,139,143,O
DDI-DrugBank.d171.s7,and/or,145,150,O
DDI-DrugBank.d171.s7,hepatic,152,158,O
DDI-DrugBank.d171.s7,impairment,160,169,O
DDI-DrugBank.d171.s7,",",170,170,O
DDI-DrugBank.d171.s7,may,172,174,O
DDI-DrugBank.d171.s7,require,176,182,O
DDI-DrugBank.d171.s7,adjustment,184,193,O
DDI-DrugBank.d171.s7,when,195,198,O
DDI-DrugBank.d171.s7,starting,200,207,O
DDI-DrugBank.d171.s7,or,209,210,O
DDI-DrugBank.d171.s7,stopping,212,219,O
DDI-DrugBank.d171.s7,concomitantly,221,233,O
DDI-DrugBank.d171.s7,administered,235,246,O
DDI-DrugBank.d171.s7,Tagamet,248,254,B-brand
DDI-DrugBank.d171.s7,to,256,257,O
DDI-DrugBank.d171.s7,maintain,259,266,O
DDI-DrugBank.d171.s7,optimum,268,274,O
DDI-DrugBank.d171.s7,therapeutic,276,286,O
DDI-DrugBank.d171.s7,blood,288,292,O
DDI-DrugBank.d171.s7,levels,294,299,O
DDI-DrugBank.d171.s7,.,300,300,O
DDI-DrugBank.d171.s8,Alteration,0,9,O
DDI-DrugBank.d171.s8,of,11,12,O
DDI-DrugBank.d171.s8,pH,14,15,O
DDI-DrugBank.d171.s8,may,17,19,O
DDI-DrugBank.d171.s8,affect,21,26,O
DDI-DrugBank.d171.s8,absorption,28,37,O
DDI-DrugBank.d171.s8,of,39,40,O
DDI-DrugBank.d171.s8,certain,42,48,O
DDI-DrugBank.d171.s8,drugs,50,54,O
DDI-DrugBank.d171.s8,(,56,56,O
DDI-DrugBank.d171.s8,e.g.,57,60,O
DDI-DrugBank.d171.s8,",",61,61,O
DDI-DrugBank.d171.s8,ketoconazole,63,74,B-drug
DDI-DrugBank.d171.s8,),75,75,O
DDI-DrugBank.d171.s8,.,76,76,O
DDI-DrugBank.d171.s9,If,0,1,O
DDI-DrugBank.d171.s9,these,3,7,O
DDI-DrugBank.d171.s9,products,9,16,O
DDI-DrugBank.d171.s9,are,18,20,O
DDI-DrugBank.d171.s9,needed,22,27,O
DDI-DrugBank.d171.s9,",",28,28,O
DDI-DrugBank.d171.s9,they,30,33,O
DDI-DrugBank.d171.s9,should,35,40,O
DDI-DrugBank.d171.s9,be,42,43,O
DDI-DrugBank.d171.s9,given,45,49,O
DDI-DrugBank.d171.s9,at,51,52,O
DDI-DrugBank.d171.s9,least,54,58,O
DDI-DrugBank.d171.s9,2,60,60,O
DDI-DrugBank.d171.s9,hours,62,66,O
DDI-DrugBank.d171.s9,before,68,73,O
DDI-DrugBank.d171.s9,cimetidine,75,84,B-drug
DDI-DrugBank.d171.s9,administration,86,99,O
DDI-DrugBank.d171.s9,.,100,100,O
DDI-DrugBank.d171.s10,Additional,0,9,O
DDI-DrugBank.d171.s10,clinical,11,18,O
DDI-DrugBank.d171.s10,experience,20,29,O
DDI-DrugBank.d171.s10,may,31,33,O
DDI-DrugBank.d171.s10,reveal,35,40,O
DDI-DrugBank.d171.s10,other,42,46,O
DDI-DrugBank.d171.s10,drugs,48,52,O
DDI-DrugBank.d171.s10,affected,54,61,O
DDI-DrugBank.d171.s10,by,63,64,O
DDI-DrugBank.d171.s10,the,66,68,O
DDI-DrugBank.d171.s10,concomitant,70,80,O
DDI-DrugBank.d171.s10,administration,82,95,O
DDI-DrugBank.d171.s10,of,97,98,O
DDI-DrugBank.d171.s10,Tagamet,100,106,B-brand
DDI-DrugBank.d171.s10,.,107,107,O
DDI-DrugBank.d237.s0,Cisapride,0,8,B-drug
DDI-DrugBank.d237.s0,is,10,11,O
DDI-DrugBank.d237.s0,metabolized,13,23,O
DDI-DrugBank.d237.s0,mainly,25,30,O
DDI-DrugBank.d237.s0,via,32,34,O
DDI-DrugBank.d237.s0,the,36,38,O
DDI-DrugBank.d237.s0,cytochrome,40,49,O
DDI-DrugBank.d237.s0,P450,51,54,O
DDI-DrugBank.d237.s0,3A4,56,58,O
DDI-DrugBank.d237.s0,enzyme,60,65,O
DDI-DrugBank.d237.s0,.,66,66,O
DDI-DrugBank.d237.s1,In,0,1,O
DDI-DrugBank.d237.s1,some,3,6,O
DDI-DrugBank.d237.s1,cases,8,12,O
DDI-DrugBank.d237.s1,where,14,18,O
DDI-DrugBank.d237.s1,serious,20,26,O
DDI-DrugBank.d237.s1,ventricular,28,38,O
DDI-DrugBank.d237.s1,arrhythmias,40,50,O
DDI-DrugBank.d237.s1,",",51,51,O
DDI-DrugBank.d237.s1,QT,53,54,O
DDI-DrugBank.d237.s1,prolongation,56,67,O
DDI-DrugBank.d237.s1,",",68,68,O
DDI-DrugBank.d237.s1,and,70,72,O
DDI-DrugBank.d237.s1,torsades,74,81,O
DDI-DrugBank.d237.s1,de,83,84,O
DDI-DrugBank.d237.s1,pointes,86,92,O
DDI-DrugBank.d237.s1,have,94,97,O
DDI-DrugBank.d237.s1,occurred,99,106,O
DDI-DrugBank.d237.s1,when,108,111,O
DDI-DrugBank.d237.s1,cisapride,113,121,B-drug
DDI-DrugBank.d237.s1,was,123,125,O
DDI-DrugBank.d237.s1,taken,127,131,O
DDI-DrugBank.d237.s1,in,133,134,O
DDI-DrugBank.d237.s1,conjunction,136,146,O
DDI-DrugBank.d237.s1,with,148,151,O
DDI-DrugBank.d237.s1,one,153,155,O
DDI-DrugBank.d237.s1,of,157,158,O
DDI-DrugBank.d237.s1,the,160,162,O
DDI-DrugBank.d237.s1,cytochrome,164,173,O
DDI-DrugBank.d237.s1,P450,175,178,O
DDI-DrugBank.d237.s1,3A4,180,182,O
DDI-DrugBank.d237.s1,inhibitors,184,193,O
DDI-DrugBank.d237.s1,",",194,194,O
DDI-DrugBank.d237.s1,elevated,196,203,O
DDI-DrugBank.d237.s1,blood,205,209,O
DDI-DrugBank.d237.s1,cisapride,211,219,B-drug
DDI-DrugBank.d237.s1,levels,221,226,O
DDI-DrugBank.d237.s1,were,228,231,O
DDI-DrugBank.d237.s1,noted,233,237,O
DDI-DrugBank.d237.s1,at,239,240,O
DDI-DrugBank.d237.s1,the,242,244,O
DDI-DrugBank.d237.s1,time,246,249,O
DDI-DrugBank.d237.s1,of,251,252,O
DDI-DrugBank.d237.s1,the,254,256,O
DDI-DrugBank.d237.s1,QT,258,259,O
DDI-DrugBank.d237.s1,prolongation,261,272,O
DDI-DrugBank.d237.s1,.,273,273,O
DDI-DrugBank.d237.s2,Antibiotics,0,10,B-group
DDI-DrugBank.d237.s2,:,11,11,O
DDI-DrugBank.d237.s2,In,13,14,O
DDI-DrugBank.d237.s2,vitro,16,20,O
DDI-DrugBank.d237.s2,and/or,22,27,O
DDI-DrugBank.d237.s2,in,29,30,O
DDI-DrugBank.d237.s2,vivo,32,35,O
DDI-DrugBank.d237.s2,data,37,40,O
DDI-DrugBank.d237.s2,show,42,45,O
DDI-DrugBank.d237.s2,that,47,50,O
DDI-DrugBank.d237.s2,clarithromycin,52,65,B-drug
DDI-DrugBank.d237.s2,",",66,66,O
DDI-DrugBank.d237.s2,erythromycin,68,79,B-drug
DDI-DrugBank.d237.s2,",",80,80,O
DDI-DrugBank.d237.s2,and,82,84,O
DDI-DrugBank.d237.s2,troleandomycin,86,99,B-drug
DDI-DrugBank.d237.s2,markedly,101,108,O
DDI-DrugBank.d237.s2,inhibit,110,116,O
DDI-DrugBank.d237.s2,the,118,120,O
DDI-DrugBank.d237.s2,metabolism,122,131,O
DDI-DrugBank.d237.s2,of,133,134,O
DDI-DrugBank.d237.s2,cisapride,136,144,B-drug
DDI-DrugBank.d237.s2,",",145,145,O
DDI-DrugBank.d237.s2,which,147,151,O
DDI-DrugBank.d237.s2,can,153,155,O
DDI-DrugBank.d237.s2,result,157,162,O
DDI-DrugBank.d237.s2,in,164,165,O
DDI-DrugBank.d237.s2,an,167,168,O
DDI-DrugBank.d237.s2,increase,170,177,O
DDI-DrugBank.d237.s2,in,179,180,O
DDI-DrugBank.d237.s2,plasma,182,187,O
DDI-DrugBank.d237.s2,cisapride,189,197,B-drug
DDI-DrugBank.d237.s2,levels,199,204,O
DDI-DrugBank.d237.s2,and,206,208,O
DDI-DrugBank.d237.s2,prolongation,210,221,O
DDI-DrugBank.d237.s2,of,223,224,O
DDI-DrugBank.d237.s2,the,226,228,O
DDI-DrugBank.d237.s2,QT,230,231,O
DDI-DrugBank.d237.s2,interval,233,240,O
DDI-DrugBank.d237.s2,on,242,243,O
DDI-DrugBank.d237.s2,the,245,247,O
DDI-DrugBank.d237.s2,ECG,249,251,O
DDI-DrugBank.d237.s2,.,252,252,O
DDI-DrugBank.d237.s3,Anticholinergics,0,15,B-group
DDI-DrugBank.d237.s3,:,16,16,O
DDI-DrugBank.d237.s3,Concurrent,18,27,O
DDI-DrugBank.d237.s3,administration,29,42,O
DDI-DrugBank.d237.s3,of,44,45,O
DDI-DrugBank.d237.s3,certain,47,53,O
DDI-DrugBank.d237.s3,anticholinergic,55,69,B-group
DDI-DrugBank.d237.s3,compounds,71,79,I-group
DDI-DrugBank.d237.s3,",",80,80,O
DDI-DrugBank.d237.s3,such,82,85,O
DDI-DrugBank.d237.s3,as,87,88,O
DDI-DrugBank.d237.s3,belladonna,90,99,B-group
DDI-DrugBank.d237.s3,alkaloids,101,109,I-group
DDI-DrugBank.d237.s3,and,111,113,O
DDI-DrugBank.d237.s3,dicyclomine,115,125,B-drug
DDI-DrugBank.d237.s3,",",126,126,O
DDI-DrugBank.d237.s3,would,128,132,O
DDI-DrugBank.d237.s3,be,134,135,O
DDI-DrugBank.d237.s3,expected,137,144,O
DDI-DrugBank.d237.s3,to,146,147,O
DDI-DrugBank.d237.s3,compromise,149,158,O
DDI-DrugBank.d237.s3,the,160,162,O
DDI-DrugBank.d237.s3,beneficial,164,173,O
DDI-DrugBank.d237.s3,effects,175,181,O
DDI-DrugBank.d237.s3,of,183,184,O
DDI-DrugBank.d237.s3,cisapride,186,194,B-drug
DDI-DrugBank.d237.s3,.,195,195,O
DDI-DrugBank.d237.s4,Anticoagulants,0,13,B-group
DDI-DrugBank.d237.s4,(,15,15,O
DDI-DrugBank.d237.s4,Oral,16,19,O
DDI-DrugBank.d237.s4,),20,20,O
DDI-DrugBank.d237.s4,:,21,21,O
DDI-DrugBank.d237.s4,In,23,24,O
DDI-DrugBank.d237.s4,patients,26,33,O
DDI-DrugBank.d237.s4,receiving,35,43,O
DDI-DrugBank.d237.s4,oral,45,48,O
DDI-DrugBank.d237.s4,anticoagulants,50,63,B-group
DDI-DrugBank.d237.s4,",",64,64,O
DDI-DrugBank.d237.s4,the,66,68,O
DDI-DrugBank.d237.s4,coagulation,70,80,O
DDI-DrugBank.d237.s4,times,82,86,O
DDI-DrugBank.d237.s4,were,88,91,O
DDI-DrugBank.d237.s4,increased,93,101,O
DDI-DrugBank.d237.s4,in,103,104,O
DDI-DrugBank.d237.s4,some,106,109,O
DDI-DrugBank.d237.s4,cases,111,115,O
DDI-DrugBank.d237.s4,.,116,116,O
DDI-DrugBank.d237.s5,It,0,1,O
DDI-DrugBank.d237.s5,is,3,4,O
DDI-DrugBank.d237.s5,advisable,6,14,O
DDI-DrugBank.d237.s5,to,16,17,O
DDI-DrugBank.d237.s5,check,19,23,O
DDI-DrugBank.d237.s5,coagulation,25,35,O
DDI-DrugBank.d237.s5,time,37,40,O
DDI-DrugBank.d237.s5,within,42,47,O
DDI-DrugBank.d237.s5,the,49,51,O
DDI-DrugBank.d237.s5,first,53,57,O
DDI-DrugBank.d237.s5,few,59,61,O
DDI-DrugBank.d237.s5,days,63,66,O
DDI-DrugBank.d237.s5,after,68,72,O
DDI-DrugBank.d237.s5,the,74,76,O
DDI-DrugBank.d237.s5,start,78,82,O
DDI-DrugBank.d237.s5,and,84,86,O
DDI-DrugBank.d237.s5,discontinuation,88,102,O
DDI-DrugBank.d237.s5,of,104,105,O
DDI-DrugBank.d237.s5,cisapride,107,115,B-drug
DDI-DrugBank.d237.s5,therapy,117,123,O
DDI-DrugBank.d237.s5,",",124,124,O
DDI-DrugBank.d237.s5,with,126,129,O
DDI-DrugBank.d237.s5,an,131,132,O
DDI-DrugBank.d237.s5,appropriate,134,144,O
DDI-DrugBank.d237.s5,adjustment,146,155,O
DDI-DrugBank.d237.s5,of,157,158,O
DDI-DrugBank.d237.s5,the,160,162,O
DDI-DrugBank.d237.s5,anticoagulant,164,176,B-group
DDI-DrugBank.d237.s5,dose,178,181,O
DDI-DrugBank.d237.s5,",",182,182,O
DDI-DrugBank.d237.s5,if,184,185,O
DDI-DrugBank.d237.s5,necessary,187,195,O
DDI-DrugBank.d237.s5,.,196,196,O
DDI-DrugBank.d237.s6,Antidepressants,0,14,B-group
DDI-DrugBank.d237.s6,:,15,15,O
DDI-DrugBank.d237.s6,In,17,18,O
DDI-DrugBank.d237.s6,vitro,20,24,O
DDI-DrugBank.d237.s6,data,26,29,O
DDI-DrugBank.d237.s6,indicate,31,38,O
DDI-DrugBank.d237.s6,that,40,43,O
DDI-DrugBank.d237.s6,nefazodone,45,54,B-drug
DDI-DrugBank.d237.s6,inhibits,56,63,O
DDI-DrugBank.d237.s6,the,65,67,O
DDI-DrugBank.d237.s6,metabolism,69,78,O
DDI-DrugBank.d237.s6,of,80,81,O
DDI-DrugBank.d237.s6,cisapride,83,91,B-drug
DDI-DrugBank.d237.s6,",",92,92,O
DDI-DrugBank.d237.s6,which,94,98,O
DDI-DrugBank.d237.s6,can,100,102,O
DDI-DrugBank.d237.s6,result,104,109,O
DDI-DrugBank.d237.s6,in,111,112,O
DDI-DrugBank.d237.s6,an,114,115,O
DDI-DrugBank.d237.s6,increase,117,124,O
DDI-DrugBank.d237.s6,in,126,127,O
DDI-DrugBank.d237.s6,plasma,129,134,O
DDI-DrugBank.d237.s6,cisapride,136,144,B-drug
DDI-DrugBank.d237.s6,levels,146,151,O
DDI-DrugBank.d237.s6,and,153,155,O
DDI-DrugBank.d237.s6,prolongation,157,168,O
DDI-DrugBank.d237.s6,of,170,171,O
DDI-DrugBank.d237.s6,the,173,175,O
DDI-DrugBank.d237.s6,QT,177,178,O
DDI-DrugBank.d237.s6,interval,180,187,O
DDI-DrugBank.d237.s6,on,189,190,O
DDI-DrugBank.d237.s6,the,192,194,O
DDI-DrugBank.d237.s6,ECG,196,198,O
DDI-DrugBank.d237.s6,.,199,199,O
DDI-DrugBank.d237.s7,Antifungals,0,10,B-group
DDI-DrugBank.d237.s7,:,11,11,O
DDI-DrugBank.d237.s7,In,13,14,O
DDI-DrugBank.d237.s7,vitro,16,20,O
DDI-DrugBank.d237.s7,and/or,22,27,O
DDI-DrugBank.d237.s7,in,29,30,O
DDI-DrugBank.d237.s7,vivo,32,35,O
DDI-DrugBank.d237.s7,data,37,40,O
DDI-DrugBank.d237.s7,indicate,42,49,O
DDI-DrugBank.d237.s7,that,51,54,O
DDI-DrugBank.d237.s7,fluconazole,56,66,B-drug
DDI-DrugBank.d237.s7,",",67,67,O
DDI-DrugBank.d237.s7,itraconazole,69,80,B-drug
DDI-DrugBank.d237.s7,",",81,81,O
DDI-DrugBank.d237.s7,and,83,85,O
DDI-DrugBank.d237.s7,oral,87,90,O
DDI-DrugBank.d237.s7,ketoconazole,92,103,B-drug
DDI-DrugBank.d237.s7,markedly,105,112,O
DDI-DrugBank.d237.s7,inhibit,114,120,O
DDI-DrugBank.d237.s7,the,122,124,O
DDI-DrugBank.d237.s7,metabolism,126,135,O
DDI-DrugBank.d237.s7,of,137,138,O
DDI-DrugBank.d237.s7,cisapride,140,148,B-drug
DDI-DrugBank.d237.s7,",",149,149,O
DDI-DrugBank.d237.s7,which,151,155,O
DDI-DrugBank.d237.s7,can,157,159,O
DDI-DrugBank.d237.s7,result,161,166,O
DDI-DrugBank.d237.s7,in,168,169,O
DDI-DrugBank.d237.s7,an,171,172,O
DDI-DrugBank.d237.s7,increase,174,181,O
DDI-DrugBank.d237.s7,in,183,184,O
DDI-DrugBank.d237.s7,plasma,186,191,O
DDI-DrugBank.d237.s7,cisapride,193,201,B-drug
DDI-DrugBank.d237.s7,levels,203,208,O
DDI-DrugBank.d237.s7,and,210,212,O
DDI-DrugBank.d237.s7,prolongation,214,225,O
DDI-DrugBank.d237.s7,of,227,228,O
DDI-DrugBank.d237.s7,the,230,232,O
DDI-DrugBank.d237.s7,QT,234,235,O
DDI-DrugBank.d237.s7,interval,237,244,O
DDI-DrugBank.d237.s7,on,246,247,O
DDI-DrugBank.d237.s7,the,249,251,O
DDI-DrugBank.d237.s7,ECG,253,255,O
DDI-DrugBank.d237.s7,.,256,256,O
DDI-DrugBank.d237.s8,Human,0,4,O
DDI-DrugBank.d237.s8,pharmacokinetic,6,20,O
DDI-DrugBank.d237.s8,data,22,25,O
DDI-DrugBank.d237.s8,indicate,27,34,O
DDI-DrugBank.d237.s8,that,36,39,O
DDI-DrugBank.d237.s8,oral,41,44,O
DDI-DrugBank.d237.s8,ketoconazole,46,57,B-drug
DDI-DrugBank.d237.s8,markedly,59,66,O
DDI-DrugBank.d237.s8,inhibits,68,75,O
DDI-DrugBank.d237.s8,the,77,79,O
DDI-DrugBank.d237.s8,metabolism,81,90,O
DDI-DrugBank.d237.s8,of,92,93,O
DDI-DrugBank.d237.s8,cisapride,95,103,B-drug
DDI-DrugBank.d237.s8,",",104,104,O
DDI-DrugBank.d237.s8,resulting,106,114,O
DDI-DrugBank.d237.s8,in,116,117,O
DDI-DrugBank.d237.s8,a,119,119,O
DDI-DrugBank.d237.s8,mean,121,124,O
DDI-DrugBank.d237.s8,eight-fold,126,135,O
DDI-DrugBank.d237.s8,increase,137,144,O
DDI-DrugBank.d237.s8,in,146,147,O
DDI-DrugBank.d237.s8,AUC,149,151,O
DDI-DrugBank.d237.s8,of,153,154,O
DDI-DrugBank.d237.s8,cisapride,156,164,B-drug
DDI-DrugBank.d237.s8,.,165,165,O
DDI-DrugBank.d237.s9,A,0,0,O
DDI-DrugBank.d237.s9,study,2,6,O
DDI-DrugBank.d237.s9,in,8,9,O
DDI-DrugBank.d237.s9,14,11,12,O
DDI-DrugBank.d237.s9,normal,14,19,O
DDI-DrugBank.d237.s9,male,21,24,O
DDI-DrugBank.d237.s9,and,26,28,O
DDI-DrugBank.d237.s9,female,30,35,O
DDI-DrugBank.d237.s9,volunteers,37,46,O
DDI-DrugBank.d237.s9,suggests,48,55,O
DDI-DrugBank.d237.s9,that,57,60,O
DDI-DrugBank.d237.s9,coadministration,62,77,O
DDI-DrugBank.d237.s9,of,79,80,O
DDI-DrugBank.d237.s9,cisapride,82,90,B-drug
DDI-DrugBank.d237.s9,and,92,94,O
DDI-DrugBank.d237.s9,ketoconazole,96,107,B-drug
DDI-DrugBank.d237.s9,can,109,111,O
DDI-DrugBank.d237.s9,result,113,118,O
DDI-DrugBank.d237.s9,in,120,121,O
DDI-DrugBank.d237.s9,prolongation,123,134,O
DDI-DrugBank.d237.s9,of,136,137,O
DDI-DrugBank.d237.s9,the,139,141,O
DDI-DrugBank.d237.s9,QT,143,144,O
DDI-DrugBank.d237.s9,interval,146,153,O
DDI-DrugBank.d237.s9,on,155,156,O
DDI-DrugBank.d237.s9,the,158,160,O
DDI-DrugBank.d237.s9,ECG,162,164,O
DDI-DrugBank.d237.s9,.,165,165,O
DDI-DrugBank.d237.s10,H2,0,1,B-group
DDI-DrugBank.d237.s10,Receptor,3,10,I-group
DDI-DrugBank.d237.s10,Antagonists,12,22,I-group
DDI-DrugBank.d237.s10,:,23,23,O
DDI-DrugBank.d237.s10,Cimetidine,25,34,B-drug
DDI-DrugBank.d237.s10,coadministration,36,51,O
DDI-DrugBank.d237.s10,leads,53,57,O
DDI-DrugBank.d237.s10,to,59,60,O
DDI-DrugBank.d237.s10,an,62,63,O
DDI-DrugBank.d237.s10,increased,65,73,O
DDI-DrugBank.d237.s10,peak,75,78,O
DDI-DrugBank.d237.s10,plasma,80,85,O
DDI-DrugBank.d237.s10,concentration,87,99,O
DDI-DrugBank.d237.s10,and,101,103,O
DDI-DrugBank.d237.s10,AUC,105,107,O
DDI-DrugBank.d237.s10,of,109,110,O
DDI-DrugBank.d237.s10,cisapride,112,120,B-drug
DDI-DrugBank.d237.s10,",",121,121,O
DDI-DrugBank.d237.s10,there,123,127,O
DDI-DrugBank.d237.s10,is,129,130,O
DDI-DrugBank.d237.s10,no,132,133,O
DDI-DrugBank.d237.s10,effect,135,140,O
DDI-DrugBank.d237.s10,on,142,143,O
DDI-DrugBank.d237.s10,cisapride,145,153,B-drug
DDI-DrugBank.d237.s10,absorption,155,164,O
DDI-DrugBank.d237.s10,when,166,169,O
DDI-DrugBank.d237.s10,it,171,172,O
DDI-DrugBank.d237.s10,is,174,175,O
DDI-DrugBank.d237.s10,coadministered,177,190,O
DDI-DrugBank.d237.s10,with,192,195,O
DDI-DrugBank.d237.s10,ranitidine,197,206,B-drug
DDI-DrugBank.d237.s10,.,207,207,O
DDI-DrugBank.d237.s11,The,0,2,O
DDI-DrugBank.d237.s11,gastrointestinal,4,19,O
DDI-DrugBank.d237.s11,absorption,21,30,O
DDI-DrugBank.d237.s11,of,32,33,O
DDI-DrugBank.d237.s11,cimetidine,35,44,B-drug
DDI-DrugBank.d237.s11,and,46,48,O
DDI-DrugBank.d237.s11,ranitidine,50,59,B-drug
DDI-DrugBank.d237.s11,is,61,62,O
DDI-DrugBank.d237.s11,accelerated,64,74,O
DDI-DrugBank.d237.s11,when,76,79,O
DDI-DrugBank.d237.s11,they,81,84,O
DDI-DrugBank.d237.s11,are,86,88,O
DDI-DrugBank.d237.s11,coadministered,90,103,O
DDI-DrugBank.d237.s11,with,105,108,O
DDI-DrugBank.d237.s11,cisapride,110,118,B-drug
DDI-DrugBank.d237.s11,.,119,119,O
DDI-DrugBank.d237.s12,Protease,0,7,B-group
DDI-DrugBank.d237.s12,Inhibitors,9,18,I-group
DDI-DrugBank.d237.s12,:,19,19,O
DDI-DrugBank.d237.s12,In,21,22,O
DDI-DrugBank.d237.s12,vitro,24,28,O
DDI-DrugBank.d237.s12,data,30,33,O
DDI-DrugBank.d237.s12,indicate,35,42,O
DDI-DrugBank.d237.s12,that,44,47,O
DDI-DrugBank.d237.s12,indinavir,49,57,B-drug
DDI-DrugBank.d237.s12,and,59,61,O
DDI-DrugBank.d237.s12,ritonavir,63,71,B-drug
DDI-DrugBank.d237.s12,markedly,73,80,O
DDI-DrugBank.d237.s12,inhibit,82,88,O
DDI-DrugBank.d237.s12,the,90,92,O
DDI-DrugBank.d237.s12,metabolism,94,103,O
DDI-DrugBank.d237.s12,of,105,106,O
DDI-DrugBank.d237.s12,cisapride,108,116,B-drug
DDI-DrugBank.d237.s12,which,118,122,O
DDI-DrugBank.d237.s12,can,124,126,O
DDI-DrugBank.d237.s12,result,128,133,O
DDI-DrugBank.d237.s12,in,135,136,O
DDI-DrugBank.d237.s12,an,138,139,O
DDI-DrugBank.d237.s12,increase,141,148,O
DDI-DrugBank.d237.s12,in,150,151,O
DDI-DrugBank.d237.s12,plasma,153,158,O
DDI-DrugBank.d237.s12,cisapride,160,168,B-drug
DDI-DrugBank.d237.s12,levels,170,175,O
DDI-DrugBank.d237.s12,and,177,179,O
DDI-DrugBank.d237.s12,prolongation,181,192,O
DDI-DrugBank.d237.s12,of,194,195,O
DDI-DrugBank.d237.s12,the,197,199,O
DDI-DrugBank.d237.s12,QT,201,202,O
DDI-DrugBank.d237.s12,interval,204,211,O
DDI-DrugBank.d237.s12,on,213,214,O
DDI-DrugBank.d237.s12,the,216,218,O
DDI-DrugBank.d237.s12,ECG,220,222,O
DDI-DrugBank.d237.s12,.,223,223,O
DDI-DrugBank.d237.s13,Other,0,4,O
DDI-DrugBank.d237.s13,:,5,5,O
DDI-DrugBank.d237.s13,Coadministration,7,22,O
DDI-DrugBank.d237.s13,of,24,25,O
DDI-DrugBank.d237.s13,grapefruit,27,36,O
DDI-DrugBank.d237.s13,juice,38,42,O
DDI-DrugBank.d237.s13,with,44,47,O
DDI-DrugBank.d237.s13,cisapride,49,57,B-drug
DDI-DrugBank.d237.s13,increases,59,67,O
DDI-DrugBank.d237.s13,the,69,71,O
DDI-DrugBank.d237.s13,bioavailability,73,87,O
DDI-DrugBank.d237.s13,of,89,90,O
DDI-DrugBank.d237.s13,cisapride,92,100,B-drug
DDI-DrugBank.d237.s13,and,102,104,O
DDI-DrugBank.d237.s13,concomitant,106,116,O
DDI-DrugBank.d237.s13,use,118,120,O
DDI-DrugBank.d237.s13,should,122,127,O
DDI-DrugBank.d237.s13,be,129,130,O
DDI-DrugBank.d237.s13,avoided,132,138,O
DDI-DrugBank.d237.s13,.,139,139,O
DDI-DrugBank.d237.s14,Cisapride,0,8,B-drug
DDI-DrugBank.d237.s14,should,10,15,O
DDI-DrugBank.d237.s14,not,17,19,O
DDI-DrugBank.d237.s14,be,21,22,O
DDI-DrugBank.d237.s14,used,24,27,O
DDI-DrugBank.d237.s14,concomitantly,29,41,O
DDI-DrugBank.d237.s14,with,43,46,O
DDI-DrugBank.d237.s14,other,48,52,O
DDI-DrugBank.d237.s14,drugs,54,58,O
DDI-DrugBank.d237.s14,known,60,64,O
DDI-DrugBank.d237.s14,to,66,67,O
DDI-DrugBank.d237.s14,prolong,69,75,O
DDI-DrugBank.d237.s14,the,77,79,O
DDI-DrugBank.d237.s14,QT,81,82,O
DDI-DrugBank.d237.s14,interval,84,91,O
DDI-DrugBank.d237.s14,:,92,92,O
DDI-DrugBank.d237.s14,certain,94,100,O
DDI-DrugBank.d237.s14,antiarrhythmics,102,116,B-group
DDI-DrugBank.d237.s14,",",117,117,O
DDI-DrugBank.d237.s14,including,119,127,O
DDI-DrugBank.d237.s14,those,129,133,O
DDI-DrugBank.d237.s14,of,135,136,O
DDI-DrugBank.d237.s14,Class,138,142,O
DDI-DrugBank.d237.s14,IA,144,145,O
DDI-DrugBank.d237.s14,(,147,147,O
DDI-DrugBank.d237.s14,such,148,151,O
DDI-DrugBank.d237.s14,as,153,154,O
DDI-DrugBank.d237.s14,quinidine,156,164,B-drug
DDI-DrugBank.d237.s14,and,166,168,O
DDI-DrugBank.d237.s14,procainamide,170,181,B-drug
DDI-DrugBank.d237.s14,),182,182,O
DDI-DrugBank.d237.s14,and,184,186,O
DDI-DrugBank.d237.s14,Class,188,192,O
DDI-DrugBank.d237.s14,III,194,196,O
DDI-DrugBank.d237.s14,(,198,198,O
DDI-DrugBank.d237.s14,such,199,202,O
DDI-DrugBank.d237.s14,as,204,205,O
DDI-DrugBank.d237.s14,sotalol,207,213,B-drug
DDI-DrugBank.d237.s14,),214,214,O
DDI-DrugBank.d237.s14,;,215,215,O
DDI-DrugBank.d237.s15,tricyclic,0,8,B-group
DDI-DrugBank.d237.s15,antidepressants,10,24,I-group
DDI-DrugBank.d237.s15,(,26,26,O
DDI-DrugBank.d237.s15,such,27,30,O
DDI-DrugBank.d237.s15,as,32,33,O
DDI-DrugBank.d237.s15,amitriptyline,35,47,B-drug
DDI-DrugBank.d237.s15,),48,48,O
DDI-DrugBank.d237.s15,;,49,49,O
DDI-DrugBank.d237.s16,certain,0,6,O
DDI-DrugBank.d237.s16,tetracyclic,8,18,B-group
DDI-DrugBank.d237.s16,antidepressants,20,34,I-group
DDI-DrugBank.d237.s16,(,36,36,O
DDI-DrugBank.d237.s16,such,37,40,O
DDI-DrugBank.d237.s16,as,42,43,O
DDI-DrugBank.d237.s16,maprotiline,45,55,B-drug
DDI-DrugBank.d237.s16,),56,56,O
DDI-DrugBank.d237.s16,;,57,57,O
DDI-DrugBank.d237.s17,certain,0,6,O
DDI-DrugBank.d237.s17,antipsychotic,8,20,B-group
DDI-DrugBank.d237.s17,medications,22,32,I-group
DDI-DrugBank.d237.s17,(,34,34,O
DDI-DrugBank.d237.s17,such,35,38,O
DDI-DrugBank.d237.s17,as,40,41,O
DDI-DrugBank.d237.s17,sertindole,43,52,B-drug
DDI-DrugBank.d237.s17,),53,53,O
DDI-DrugBank.d237.s17,;,54,54,O
DDI-DrugBank.d237.s18,astemizole,0,9,B-drug
DDI-DrugBank.d237.s18,",",10,10,O
DDI-DrugBank.d237.s18,bepridil,12,19,B-drug
DDI-DrugBank.d237.s18,",",20,20,O
DDI-DrugBank.d237.s18,sparfloxacin,22,33,B-drug
DDI-DrugBank.d237.s18,",",34,34,O
DDI-DrugBank.d237.s18,and,36,38,O
DDI-DrugBank.d237.s18,terodiline,40,49,B-drug
DDI-DrugBank.d237.s18,.,50,50,O
DDI-DrugBank.d237.s19,The,0,2,O
DDI-DrugBank.d237.s19,preceding,4,12,O
DDI-DrugBank.d237.s19,lists,14,18,O
DDI-DrugBank.d237.s19,of,20,21,O
DDI-DrugBank.d237.s19,drugs,23,27,O
DDI-DrugBank.d237.s19,are,29,31,O
DDI-DrugBank.d237.s19,not,33,35,O
DDI-DrugBank.d237.s19,comprehensive,37,49,O
DDI-DrugBank.d237.s19,.,50,50,O
DDI-DrugBank.d237.s20,The,0,2,O
DDI-DrugBank.d237.s20,acceleration,4,15,O
DDI-DrugBank.d237.s20,of,17,18,O
DDI-DrugBank.d237.s20,gastric,20,26,O
DDI-DrugBank.d237.s20,emptying,28,35,O
DDI-DrugBank.d237.s20,by,37,38,O
DDI-DrugBank.d237.s20,cisapride,40,48,B-drug
DDI-DrugBank.d237.s20,could,50,54,O
DDI-DrugBank.d237.s20,affect,56,61,O
DDI-DrugBank.d237.s20,the,63,65,O
DDI-DrugBank.d237.s20,rate,67,70,O
DDI-DrugBank.d237.s20,of,72,73,O
DDI-DrugBank.d237.s20,absorption,75,84,O
DDI-DrugBank.d237.s20,of,86,87,O
DDI-DrugBank.d237.s20,other,89,93,O
DDI-DrugBank.d237.s20,drugs,95,99,O
DDI-DrugBank.d237.s20,.,100,100,O
DDI-DrugBank.d237.s21,Patients,0,7,O
DDI-DrugBank.d237.s21,receiving,9,17,O
DDI-DrugBank.d237.s21,narrow,19,24,O
DDI-DrugBank.d237.s21,therapeutic,26,36,O
DDI-DrugBank.d237.s21,ratio,38,42,O
DDI-DrugBank.d237.s21,drugs,44,48,O
DDI-DrugBank.d237.s21,or,50,51,O
DDI-DrugBank.d237.s21,other,53,57,O
DDI-DrugBank.d237.s21,drugs,59,63,O
DDI-DrugBank.d237.s21,that,65,68,O
DDI-DrugBank.d237.s21,require,70,76,O
DDI-DrugBank.d237.s21,careful,78,84,O
DDI-DrugBank.d237.s21,titration,86,94,O
DDI-DrugBank.d237.s21,should,96,101,O
DDI-DrugBank.d237.s21,be,103,104,O
DDI-DrugBank.d237.s21,followed,106,113,O
DDI-DrugBank.d237.s21,closely,115,121,O
DDI-DrugBank.d237.s21,;,122,122,O
DDI-DrugBank.d237.s22,if,0,1,O
DDI-DrugBank.d237.s22,plasma,3,8,O
DDI-DrugBank.d237.s22,levels,10,15,O
DDI-DrugBank.d237.s22,are,17,19,O
DDI-DrugBank.d237.s22,being,21,25,O
DDI-DrugBank.d237.s22,monitored,27,35,O
DDI-DrugBank.d237.s22,",",36,36,O
DDI-DrugBank.d237.s22,they,38,41,O
DDI-DrugBank.d237.s22,should,43,48,O
DDI-DrugBank.d237.s22,be,50,51,O
DDI-DrugBank.d237.s22,reassessed,53,62,O
DDI-DrugBank.d237.s22,.,63,63,O
DDI-DrugBank.d464.s0,Codeine,0,6,B-drug
DDI-DrugBank.d464.s0,in,8,9,O
DDI-DrugBank.d464.s0,combination,11,21,O
DDI-DrugBank.d464.s0,with,23,26,O
DDI-DrugBank.d464.s0,other,28,32,O
DDI-DrugBank.d464.s0,narcotic,34,41,B-group
DDI-DrugBank.d464.s0,analgesics,43,52,I-group
DDI-DrugBank.d464.s0,",",53,53,O
DDI-DrugBank.d464.s0,general,55,61,O
DDI-DrugBank.d464.s0,anesthetics,63,73,B-group
DDI-DrugBank.d464.s0,",",74,74,O
DDI-DrugBank.d464.s0,phenothiazines,76,89,B-group
DDI-DrugBank.d464.s0,",",90,90,O
DDI-DrugBank.d464.s0,tranquilizers,92,104,B-group
DDI-DrugBank.d464.s0,",",105,105,O
DDI-DrugBank.d464.s0,sedative-hypnotics,107,124,B-group
DDI-DrugBank.d464.s0,",",125,125,O
DDI-DrugBank.d464.s0,or,127,128,O
DDI-DrugBank.d464.s0,other,130,134,O
DDI-DrugBank.d464.s0,CNS,136,138,B-group
DDI-DrugBank.d464.s0,depressants,140,150,I-group
DDI-DrugBank.d464.s0,(,152,152,O
DDI-DrugBank.d464.s0,including,153,161,O
DDI-DrugBank.d464.s0,alcohol,163,169,B-drug
DDI-DrugBank.d464.s0,),170,170,O
DDI-DrugBank.d464.s0,has,172,174,O
DDI-DrugBank.d464.s0,additive,176,183,O
DDI-DrugBank.d464.s0,depressant,185,194,O
DDI-DrugBank.d464.s0,effects,196,202,O
DDI-DrugBank.d464.s0,.,203,203,O
DDI-DrugBank.d464.s1,When,0,3,O
DDI-DrugBank.d464.s1,s.c,5,7,O
DDI-DrugBank.d464.s1,.,8,8,O
DDI-DrugBank.d464.s2,combination,0,10,O
DDI-DrugBank.d464.s2,therapy,12,18,O
DDI-DrugBank.d464.s2,is,20,21,O
DDI-DrugBank.d464.s2,contemplated,23,34,O
DDI-DrugBank.d464.s2,",",35,35,O
DDI-DrugBank.d464.s2,the,37,39,O
DDI-DrugBank.d464.s2,dosage,41,46,O
DDI-DrugBank.d464.s2,of,48,49,O
DDI-DrugBank.d464.s2,one,51,53,O
DDI-DrugBank.d464.s2,or,55,56,O
DDI-DrugBank.d464.s2,both,58,61,O
DDI-DrugBank.d464.s2,agents,63,68,O
DDI-DrugBank.d464.s2,should,70,75,O
DDI-DrugBank.d464.s2,be,77,78,O
DDI-DrugBank.d464.s2,reduced,80,86,O
DDI-DrugBank.d464.s2,.,87,87,O
DDI-DrugBank.d250.s0,Certain,0,6,O
DDI-DrugBank.d250.s0,other,8,12,O
DDI-DrugBank.d250.s0,antibiotics,14,24,B-group
DDI-DrugBank.d250.s0,(,26,26,O
DDI-DrugBank.d250.s0,aminoglycosides,27,41,B-group
DDI-DrugBank.d250.s0,and,43,45,O
DDI-DrugBank.d250.s0,polymyxin,47,55,B-group
DDI-DrugBank.d250.s0,),56,56,O
DDI-DrugBank.d250.s0,have,58,61,O
DDI-DrugBank.d250.s0,also,63,66,O
DDI-DrugBank.d250.s0,been,68,71,O
DDI-DrugBank.d250.s0,reported,73,80,O
DDI-DrugBank.d250.s0,to,82,83,O
DDI-DrugBank.d250.s0,interfere,85,93,O
DDI-DrugBank.d250.s0,with,95,98,O
DDI-DrugBank.d250.s0,the,100,102,O
DDI-DrugBank.d250.s0,nerve,104,108,O
DDI-DrugBank.d250.s0,transmission,110,121,O
DDI-DrugBank.d250.s0,at,123,124,O
DDI-DrugBank.d250.s0,the,126,128,O
DDI-DrugBank.d250.s0,neuromuscular,130,142,O
DDI-DrugBank.d250.s0,junction,144,151,O
DDI-DrugBank.d250.s0,.,152,152,O
DDI-DrugBank.d250.s1,Based,0,4,O
DDI-DrugBank.d250.s1,on,6,7,O
DDI-DrugBank.d250.s1,this,9,12,O
DDI-DrugBank.d250.s1,reported,14,21,O
DDI-DrugBank.d250.s1,activity,23,30,O
DDI-DrugBank.d250.s1,",",31,31,O
DDI-DrugBank.d250.s1,they,33,36,O
DDI-DrugBank.d250.s1,should,38,43,O
DDI-DrugBank.d250.s1,not,45,47,O
DDI-DrugBank.d250.s1,be,49,50,O
DDI-DrugBank.d250.s1,given,52,56,O
DDI-DrugBank.d250.s1,concomitantly,58,70,O
DDI-DrugBank.d250.s1,with,72,75,O
DDI-DrugBank.d250.s1,Coly-Mycin,77,86,B-brand
DDI-DrugBank.d250.s1,M,88,88,I-brand
DDI-DrugBank.d250.s1,Parenteral,90,99,O
DDI-DrugBank.d250.s1,except,101,106,O
DDI-DrugBank.d250.s1,with,108,111,O
DDI-DrugBank.d250.s1,the,113,115,O
DDI-DrugBank.d250.s1,greatest,117,124,O
DDI-DrugBank.d250.s1,caution,126,132,O
DDI-DrugBank.d250.s1,.,133,133,O
DDI-DrugBank.d250.s2,Curariform,0,9,B-brand
DDI-DrugBank.d250.s2,muscle,11,16,I-brand
DDI-DrugBank.d250.s2,relaxants,18,26,I-brand
DDI-DrugBank.d250.s2,(,28,28,O
DDI-DrugBank.d250.s2,eg,29,30,O
DDI-DrugBank.d250.s2,",",31,31,O
DDI-DrugBank.d250.s2,tubocurarine,33,44,B-drug
DDI-DrugBank.d250.s2,),45,45,O
DDI-DrugBank.d250.s2,and,47,49,O
DDI-DrugBank.d250.s2,other,51,55,O
DDI-DrugBank.d250.s2,drugs,57,61,O
DDI-DrugBank.d250.s2,",",62,62,O
DDI-DrugBank.d250.s2,including,64,72,O
DDI-DrugBank.d250.s2,ether,74,78,O
DDI-DrugBank.d250.s2,",",79,79,O
DDI-DrugBank.d250.s2,succinylcholine,81,95,B-drug
DDI-DrugBank.d250.s2,",",96,96,O
DDI-DrugBank.d250.s2,gallamine,98,106,B-drug
DDI-DrugBank.d250.s2,",",107,107,O
DDI-DrugBank.d250.s2,decamethonium,109,121,B-drug
DDI-DrugBank.d250.s2,and,123,125,O
DDI-DrugBank.d250.s2,sodium,127,132,B-drug
DDI-DrugBank.d250.s2,citrate,134,140,I-drug
DDI-DrugBank.d250.s2,",",141,141,O
DDI-DrugBank.d250.s2,potentiate,143,152,O
DDI-DrugBank.d250.s2,the,154,156,O
DDI-DrugBank.d250.s2,neuromuscular,158,170,O
DDI-DrugBank.d250.s2,blocking,172,179,O
DDI-DrugBank.d250.s2,effect,181,186,O
DDI-DrugBank.d250.s2,and,188,190,O
DDI-DrugBank.d250.s2,should,192,197,O
DDI-DrugBank.d250.s2,be,199,200,O
DDI-DrugBank.d250.s2,used,202,205,O
DDI-DrugBank.d250.s2,with,207,210,O
DDI-DrugBank.d250.s2,extreme,212,218,O
DDI-DrugBank.d250.s2,caution,220,226,O
DDI-DrugBank.d250.s2,in,228,229,O
DDI-DrugBank.d250.s2,patients,231,238,O
DDI-DrugBank.d250.s2,being,240,244,O
DDI-DrugBank.d250.s2,treated,246,252,O
DDI-DrugBank.d250.s2,with,254,257,O
DDI-DrugBank.d250.s2,Coly-Mycin,259,268,B-brand
DDI-DrugBank.d250.s2,M,270,270,I-brand
DDI-DrugBank.d250.s2,Parenteral,272,281,O
DDI-DrugBank.d250.s2,.,282,282,O
DDI-DrugBank.d250.s3,Sodium,0,5,B-drug
DDI-DrugBank.d250.s3,cephalothin,7,17,I-drug
DDI-DrugBank.d250.s3,may,19,21,O
DDI-DrugBank.d250.s3,enhance,23,29,O
DDI-DrugBank.d250.s3,the,31,33,O
DDI-DrugBank.d250.s3,nephrotoxicity,35,48,O
DDI-DrugBank.d250.s3,of,50,51,O
DDI-DrugBank.d250.s3,Coly-Mycin,53,62,B-brand
DDI-DrugBank.d250.s3,M,64,64,I-brand
DDI-DrugBank.d250.s3,Parenteral,66,75,O
DDI-DrugBank.d250.s3,.,76,76,O
DDI-DrugBank.d250.s4,The,0,2,O
DDI-DrugBank.d250.s4,concomitant,4,14,O
DDI-DrugBank.d250.s4,use,16,18,O
DDI-DrugBank.d250.s4,of,20,21,O
DDI-DrugBank.d250.s4,sodium,23,28,B-drug
DDI-DrugBank.d250.s4,cephalothin,30,40,I-drug
DDI-DrugBank.d250.s4,and,42,44,O
DDI-DrugBank.d250.s4,Coly-Mycin,46,55,B-brand
DDI-DrugBank.d250.s4,M,57,57,I-brand
DDI-DrugBank.d250.s4,Parenteral,59,68,O
DDI-DrugBank.d250.s4,should,70,75,O
DDI-DrugBank.d250.s4,be,77,78,O
DDI-DrugBank.d250.s4,avoided,80,86,O
DDI-DrugBank.d250.s4,.,87,87,O
DDI-DrugBank.d317.s0,DRUG/LABORATORY,0,14,O
DDI-DrugBank.d317.s0,TEST,16,19,O
DDI-DrugBank.d317.s0,INTERACTIONS,21,32,O
DDI-DrugBank.d317.s0,1,34,34,O
DDI-DrugBank.d317.s0,.,35,35,O
DDI-DrugBank.d317.s1,Accelerated,0,10,O
DDI-DrugBank.d317.s1,prothrombin,12,22,O
DDI-DrugBank.d317.s1,time,24,27,O
DDI-DrugBank.d317.s1,",",28,28,O
DDI-DrugBank.d317.s1,partial,30,36,O
DDI-DrugBank.d317.s1,thromboplastin,38,51,O
DDI-DrugBank.d317.s1,time,53,56,O
DDI-DrugBank.d317.s1,",",57,57,O
DDI-DrugBank.d317.s1,and,59,61,O
DDI-DrugBank.d317.s1,platelet,63,70,O
DDI-DrugBank.d317.s1,aggregation,72,82,O
DDI-DrugBank.d317.s1,time,84,87,O
DDI-DrugBank.d317.s1,;,88,88,O
DDI-DrugBank.d317.s2,increased,0,8,O
DDI-DrugBank.d317.s2,platelet,10,17,O
DDI-DrugBank.d317.s2,count,19,23,O
DDI-DrugBank.d317.s2,;,24,24,O
DDI-DrugBank.d317.s3,increased,0,8,O
DDI-DrugBank.d317.s3,factors,10,16,O
DDI-DrugBank.d317.s3,II,18,19,O
DDI-DrugBank.d317.s3,",",20,20,O
DDI-DrugBank.d317.s3,VII,22,24,O
DDI-DrugBank.d317.s3,antigen,26,32,O
DDI-DrugBank.d317.s3,",",33,33,O
DDI-DrugBank.d317.s3,VIII,35,38,O
DDI-DrugBank.d317.s3,antigen,40,46,O
DDI-DrugBank.d317.s3,",",47,47,O
DDI-DrugBank.d317.s3,VIII,49,52,O
DDI-DrugBank.d317.s3,coagulant,54,62,O
DDI-DrugBank.d317.s3,activity,64,71,O
DDI-DrugBank.d317.s3,",",72,72,O
DDI-DrugBank.d317.s3,IX,74,75,O
DDI-DrugBank.d317.s3,",",76,76,O
DDI-DrugBank.d317.s3,X,78,78,O
DDI-DrugBank.d317.s3,",",79,79,O
DDI-DrugBank.d317.s3,XII,81,83,O
DDI-DrugBank.d317.s3,",",84,84,O
DDI-DrugBank.d317.s3,VII-X,86,90,O
DDI-DrugBank.d317.s3,complex,92,98,O
DDI-DrugBank.d317.s3,",",99,99,O
DDI-DrugBank.d317.s3,II-VII-X,101,108,O
DDI-DrugBank.d317.s3,complex,110,116,O
DDI-DrugBank.d317.s3,",",117,117,O
DDI-DrugBank.d317.s3,and,119,121,O
DDI-DrugBank.d317.s3,beta-thromboglobulin,123,142,O
DDI-DrugBank.d317.s3,;,143,143,O
DDI-DrugBank.d317.s4,decreased,0,8,O
DDI-DrugBank.d317.s4,levels,10,15,O
DDI-DrugBank.d317.s4,of,17,18,O
DDI-DrugBank.d317.s4,anti-factor,20,30,O
DDI-DrugBank.d317.s4,Xa,32,33,O
DDI-DrugBank.d317.s4,and,35,37,O
DDI-DrugBank.d317.s4,antithrombin,39,50,B-drug
DDI-DrugBank.d317.s4,III,52,54,I-drug
DDI-DrugBank.d317.s4,",",55,55,O
DDI-DrugBank.d317.s4,decreased,57,65,O
DDI-DrugBank.d317.s4,antithrombin,67,78,B-drug
DDI-DrugBank.d317.s4,III,80,82,I-drug
DDI-DrugBank.d317.s4,activity,84,91,O
DDI-DrugBank.d317.s4,;,92,92,O
DDI-DrugBank.d317.s5,increased,0,8,O
DDI-DrugBank.d317.s5,levels,10,15,O
DDI-DrugBank.d317.s5,of,17,18,O
DDI-DrugBank.d317.s5,fibrinogen,20,29,B-drug
DDI-DrugBank.d317.s5,and,31,33,O
DDI-DrugBank.d317.s5,fibrinogen,35,44,B-drug
DDI-DrugBank.d317.s5,activity,46,53,O
DDI-DrugBank.d317.s5,;,54,54,O
DDI-DrugBank.d317.s6,increased,0,8,O
DDI-DrugBank.d317.s6,plasminogen,10,20,O
DDI-DrugBank.d317.s6,antigen,22,28,O
DDI-DrugBank.d317.s6,and,30,32,O
DDI-DrugBank.d317.s6,activity,34,41,O
DDI-DrugBank.d317.s6,.,42,42,O
DDI-DrugBank.d317.s7,2,0,0,O
DDI-DrugBank.d317.s7,.,1,1,O
DDI-DrugBank.d317.s8,Increased,0,8,O
DDI-DrugBank.d317.s8,thyroid-binding,10,24,O
DDI-DrugBank.d317.s8,globulin,26,33,O
DDI-DrugBank.d317.s8,(,35,35,O
DDI-DrugBank.d317.s8,TBG,36,38,O
DDI-DrugBank.d317.s8,),39,39,O
DDI-DrugBank.d317.s8,levels,41,46,O
DDI-DrugBank.d317.s8,leading,48,54,O
DDI-DrugBank.d317.s8,to,56,57,O
DDI-DrugBank.d317.s8,increased,59,67,O
DDI-DrugBank.d317.s8,circulating,69,79,O
DDI-DrugBank.d317.s8,total,81,85,O
DDI-DrugBank.d317.s8,thyroid,87,93,O
DDI-DrugBank.d317.s8,hormone,95,101,O
DDI-DrugBank.d317.s8,levels,103,108,O
DDI-DrugBank.d317.s8,as,110,111,O
DDI-DrugBank.d317.s8,measured,113,120,O
DDI-DrugBank.d317.s8,by,122,123,O
DDI-DrugBank.d317.s8,protein-bound,125,137,O
DDI-DrugBank.d317.s8,iodine,139,144,B-drug
DDI-DrugBank.d317.s8,(,146,146,O
DDI-DrugBank.d317.s8,PBI,147,149,O
DDI-DrugBank.d317.s8,),150,150,O
DDI-DrugBank.d317.s8,",",151,151,O
DDI-DrugBank.d317.s8,T4,153,154,O
DDI-DrugBank.d317.s8,levels,156,161,O
DDI-DrugBank.d317.s8,(,163,163,O
DDI-DrugBank.d317.s8,by,164,165,O
DDI-DrugBank.d317.s8,column,167,172,O
DDI-DrugBank.d317.s8,or,174,175,O
DDI-DrugBank.d317.s8,by,177,178,O
DDI-DrugBank.d317.s8,radioimmunoassay,180,195,O
DDI-DrugBank.d317.s8,),196,196,O
DDI-DrugBank.d317.s8,or,198,199,O
DDI-DrugBank.d317.s8,T3,201,202,O
DDI-DrugBank.d317.s8,levels,204,209,O
DDI-DrugBank.d317.s8,by,211,212,O
DDI-DrugBank.d317.s8,radioimmunoassay,214,229,O
DDI-DrugBank.d317.s8,.,230,230,O
DDI-DrugBank.d317.s9,T3,0,1,O
DDI-DrugBank.d317.s9,resin,3,7,O
DDI-DrugBank.d317.s9,uptake,9,14,O
DDI-DrugBank.d317.s9,is,16,17,O
DDI-DrugBank.d317.s9,decreased,19,27,O
DDI-DrugBank.d317.s9,",",28,28,O
DDI-DrugBank.d317.s9,reflecting,30,39,O
DDI-DrugBank.d317.s9,the,41,43,O
DDI-DrugBank.d317.s9,elevated,45,52,O
DDI-DrugBank.d317.s9,TBG,54,56,O
DDI-DrugBank.d317.s9,.,57,57,O
DDI-DrugBank.d317.s10,Free,0,3,O
DDI-DrugBank.d317.s10,T4,5,6,O
DDI-DrugBank.d317.s10,and,8,10,O
DDI-DrugBank.d317.s10,free,12,15,O
DDI-DrugBank.d317.s10,T3,17,18,O
DDI-DrugBank.d317.s10,concentrations,20,33,O
DDI-DrugBank.d317.s10,are,35,37,O
DDI-DrugBank.d317.s10,unaltered,39,47,O
DDI-DrugBank.d317.s10,.,48,48,O
DDI-DrugBank.d317.s11,Patients,0,7,O
DDI-DrugBank.d317.s11,on,9,10,O
DDI-DrugBank.d317.s11,thyroid,12,18,O
DDI-DrugBank.d317.s11,replacement,20,30,O
DDI-DrugBank.d317.s11,therapy,32,38,O
DDI-DrugBank.d317.s11,may,40,42,O
DDI-DrugBank.d317.s11,require,44,50,O
DDI-DrugBank.d317.s11,higher,52,57,O
DDI-DrugBank.d317.s11,doses,59,63,O
DDI-DrugBank.d317.s11,of,65,66,O
DDI-DrugBank.d317.s11,thyroid,68,74,B-group
DDI-DrugBank.d317.s11,hormone,76,82,I-group
DDI-DrugBank.d317.s11,.,83,83,O
DDI-DrugBank.d317.s12,3,0,0,O
DDI-DrugBank.d317.s12,.,1,1,O
DDI-DrugBank.d317.s13,Other,0,4,O
DDI-DrugBank.d317.s13,binding,6,12,O
DDI-DrugBank.d317.s13,proteins,14,21,O
DDI-DrugBank.d317.s13,may,23,25,O
DDI-DrugBank.d317.s13,be,27,28,O
DDI-DrugBank.d317.s13,elevated,30,37,O
DDI-DrugBank.d317.s13,in,39,40,O
DDI-DrugBank.d317.s13,serum,42,46,O
DDI-DrugBank.d317.s13,",",47,47,O
DDI-DrugBank.d317.s13,(,49,49,O
DDI-DrugBank.d317.s13,i.e.,50,53,O
DDI-DrugBank.d317.s13,",",54,54,O
DDI-DrugBank.d317.s13,corticosteroid,56,69,O
DDI-DrugBank.d317.s13,binding,71,77,O
DDI-DrugBank.d317.s13,globulin,79,86,O
DDI-DrugBank.d317.s13,(,88,88,O
DDI-DrugBank.d317.s13,CBG,89,91,O
DDI-DrugBank.d317.s13,),92,92,O
DDI-DrugBank.d317.s13,",",93,93,O
DDI-DrugBank.d317.s13,sex,95,97,O
DDI-DrugBank.d317.s13,hormone,99,105,O
DDI-DrugBank.d317.s13,binding,107,113,O
DDI-DrugBank.d317.s13,globulin,115,122,O
DDI-DrugBank.d317.s13,(,124,124,O
DDI-DrugBank.d317.s13,SHBG,125,128,O
DDI-DrugBank.d317.s13,),129,129,O
DDI-DrugBank.d317.s13,),130,130,O
DDI-DrugBank.d317.s13,leading,132,138,O
DDI-DrugBank.d317.s13,to,140,141,O
DDI-DrugBank.d317.s13,increased,143,151,O
DDI-DrugBank.d317.s13,total,153,157,O
DDI-DrugBank.d317.s13,circulating,159,169,O
DDI-DrugBank.d317.s13,corticosteroids,171,185,B-group
DDI-DrugBank.d317.s13,and,187,189,O
DDI-DrugBank.d317.s13,sex,191,193,B-group
DDI-DrugBank.d317.s13,steroids,195,202,I-group
DDI-DrugBank.d317.s13,",",203,203,O
DDI-DrugBank.d317.s13,respectively,205,216,O
DDI-DrugBank.d317.s13,.,217,217,O
DDI-DrugBank.d317.s14,Free,0,3,O
DDI-DrugBank.d317.s14,hormone,5,11,O
DDI-DrugBank.d317.s14,concentrations,13,26,O
DDI-DrugBank.d317.s14,may,28,30,O
DDI-DrugBank.d317.s14,be,32,33,O
DDI-DrugBank.d317.s14,decreased,35,43,O
DDI-DrugBank.d317.s14,.,44,44,O
DDI-DrugBank.d317.s15,Other,0,4,O
DDI-DrugBank.d317.s15,plasma,6,11,O
DDI-DrugBank.d317.s15,proteins,13,20,O
DDI-DrugBank.d317.s15,may,22,24,O
DDI-DrugBank.d317.s15,be,26,27,O
DDI-DrugBank.d317.s15,increased,29,37,O
DDI-DrugBank.d317.s15,(,39,39,O
DDI-DrugBank.d317.s15,angiotensinogen/renin,40,60,O
DDI-DrugBank.d317.s15,substrate,62,70,O
DDI-DrugBank.d317.s15,",",71,71,O
DDI-DrugBank.d317.s15,alpha-1-antitrypsin,73,91,O
DDI-DrugBank.d317.s15,",",92,92,O
DDI-DrugBank.d317.s15,ceruloplasmin,94,106,O
DDI-DrugBank.d317.s15,),107,107,O
DDI-DrugBank.d317.s15,.,108,108,O
DDI-DrugBank.d317.s16,4,0,0,O
DDI-DrugBank.d317.s16,.,1,1,O
DDI-DrugBank.d317.s17,Increased,0,8,O
DDI-DrugBank.d317.s17,plasma,10,15,O
DDI-DrugBank.d317.s17,HDL,17,19,O
DDI-DrugBank.d317.s17,and,21,23,O
DDI-DrugBank.d317.s17,HDL2,25,28,O
DDI-DrugBank.d317.s17,cholesterol,30,40,O
DDI-DrugBank.d317.s17,subfraction,42,52,O
DDI-DrugBank.d317.s17,concentrations,54,67,O
DDI-DrugBank.d317.s17,",",68,68,O
DDI-DrugBank.d317.s17,reduced,70,76,O
DDI-DrugBank.d317.s17,LDL,78,80,O
DDI-DrugBank.d317.s17,cholesterol,82,92,O
DDI-DrugBank.d317.s17,concentration,94,106,O
DDI-DrugBank.d317.s17,",",107,107,O
DDI-DrugBank.d317.s17,increased,109,117,O
DDI-DrugBank.d317.s17,triglyceride,119,130,O
DDI-DrugBank.d317.s17,levels,132,137,O
DDI-DrugBank.d317.s17,.,138,138,O
DDI-DrugBank.d317.s18,5,0,0,O
DDI-DrugBank.d317.s18,.,1,1,O
DDI-DrugBank.d317.s19,Impaired,0,7,O
DDI-DrugBank.d317.s19,glucose,9,15,O
DDI-DrugBank.d317.s19,tolerance,17,25,O
DDI-DrugBank.d317.s19,.,26,26,O
DDI-DrugBank.d317.s20,6,0,0,O
DDI-DrugBank.d317.s20,.,1,1,O
DDI-DrugBank.d317.s21,Reduced,0,6,O
DDI-DrugBank.d317.s21,response,8,15,O
DDI-DrugBank.d317.s21,to,17,18,O
DDI-DrugBank.d317.s21,metyrapone,20,29,O
DDI-DrugBank.d317.s21,test,31,34,O
DDI-DrugBank.d317.s21,.,35,35,O
DDI-DrugBank.d439.s0,Corticotropin,0,12,B-drug
DDI-DrugBank.d439.s0,may,14,16,O
DDI-DrugBank.d439.s0,accentuate,18,27,O
DDI-DrugBank.d439.s0,the,29,31,O
DDI-DrugBank.d439.s0,electrolyte,33,43,O
DDI-DrugBank.d439.s0,loss,45,48,O
DDI-DrugBank.d439.s0,associated,50,59,O
DDI-DrugBank.d439.s0,with,61,64,O
DDI-DrugBank.d439.s0,diuretic,66,73,B-group
DDI-DrugBank.d439.s0,therapy,75,81,O
DDI-DrugBank.d439.s0,.,82,82,O
DDI-DrugBank.d101.s0,Steady,0,5,O
DDI-DrugBank.d101.s0,state,7,11,O
DDI-DrugBank.d101.s0,plasma,13,18,O
DDI-DrugBank.d101.s0,digitoxin,20,28,B-drug
DDI-DrugBank.d101.s0,concentrations,30,43,O
DDI-DrugBank.d101.s0,did,45,47,O
DDI-DrugBank.d101.s0,not,49,51,O
DDI-DrugBank.d101.s0,appear,53,58,O
DDI-DrugBank.d101.s0,to,60,61,O
DDI-DrugBank.d101.s0,change,63,68,O
DDI-DrugBank.d101.s0,.,69,69,O
DDI-DrugBank.d101.s1,Therefore,0,8,O
DDI-DrugBank.d101.s1,",",9,9,O
DDI-DrugBank.d101.s1,monitoring,11,20,O
DDI-DrugBank.d101.s1,of,22,23,O
DDI-DrugBank.d101.s1,plasma,25,30,O
DDI-DrugBank.d101.s1,digoxin,32,38,B-drug
DDI-DrugBank.d101.s1,levels,40,45,O
DDI-DrugBank.d101.s1,may,47,49,O
DDI-DrugBank.d101.s1,be,51,52,O
DDI-DrugBank.d101.s1,indicated,54,62,O
DDI-DrugBank.d101.s1,in,64,65,O
DDI-DrugBank.d101.s1,patients,67,74,O
DDI-DrugBank.d101.s1,receiving,76,84,O
DDI-DrugBank.d101.s1,similar,86,92,O
DDI-DrugBank.d101.s1,combination,94,104,O
DDI-DrugBank.d101.s1,chemotherapy,106,117,O
DDI-DrugBank.d101.s1,regimens,119,126,O
DDI-DrugBank.d101.s1,.,127,127,O
DDI-DrugBank.d101.s2,The,0,2,O
DDI-DrugBank.d101.s2,utilization,4,14,O
DDI-DrugBank.d101.s2,of,16,17,O
DDI-DrugBank.d101.s2,digitoxin,19,27,B-drug
DDI-DrugBank.d101.s2,for,29,31,O
DDI-DrugBank.d101.s2,such,33,36,O
DDI-DrugBank.d101.s2,patients,38,45,O
DDI-DrugBank.d101.s2,may,47,49,O
DDI-DrugBank.d101.s2,be,51,52,O
DDI-DrugBank.d101.s2,considered,54,63,O
DDI-DrugBank.d101.s2,as,65,66,O
DDI-DrugBank.d101.s2,an,68,69,O
DDI-DrugBank.d101.s2,alternative,71,81,O
DDI-DrugBank.d101.s2,.,82,82,O
DDI-DrugBank.d101.s3,Also,0,3,O
DDI-DrugBank.d101.s3,flucytosine,5,15,B-drug
DDI-DrugBank.d101.s3,.,16,16,O
DDI-DrugBank.d185.s0,A,0,0,O
DDI-DrugBank.d185.s0,drug-drug,2,10,O
DDI-DrugBank.d185.s0,interaction,12,22,O
DDI-DrugBank.d185.s0,study,24,28,O
DDI-DrugBank.d185.s0,evaluated,30,38,O
DDI-DrugBank.d185.s0,the,40,42,O
DDI-DrugBank.d185.s0,effect,44,49,O
DDI-DrugBank.d185.s0,of,51,52,O
DDI-DrugBank.d185.s0,the,54,56,O
DDI-DrugBank.d185.s0,use,58,60,O
DDI-DrugBank.d185.s0,of,62,63,O
DDI-DrugBank.d185.s0,ACZONE,65,70,B-brand
DDI-DrugBank.d185.s0,Gel,72,74,O
DDI-DrugBank.d185.s0,",",75,75,O
DDI-DrugBank.d185.s0,5,77,77,O
DDI-DrugBank.d185.s0,%,78,78,O
DDI-DrugBank.d185.s0,",",79,79,O
DDI-DrugBank.d185.s0,in,81,82,O
DDI-DrugBank.d185.s0,combination,84,94,O
DDI-DrugBank.d185.s0,with,96,99,O
DDI-DrugBank.d185.s0,double,101,106,O
DDI-DrugBank.d185.s0,strength,108,115,O
DDI-DrugBank.d185.s0,(,117,117,O
DDI-DrugBank.d185.s0,160,118,120,O
DDI-DrugBank.d185.s0,mg/800,122,127,O
DDI-DrugBank.d185.s0,mg,129,130,O
DDI-DrugBank.d185.s0,),131,131,O
DDI-DrugBank.d185.s0,trimethoprim/sulfamethoxazole,133,161,O
DDI-DrugBank.d185.s0,(,163,163,O
DDI-DrugBank.d185.s0,TMP/SMX,164,170,O
DDI-DrugBank.d185.s0,),171,171,O
DDI-DrugBank.d185.s0,.,172,172,O
DDI-DrugBank.d185.s1,During,0,5,O
DDI-DrugBank.d185.s1,co-administration,7,23,O
DDI-DrugBank.d185.s1,",",24,24,O
DDI-DrugBank.d185.s1,systemic,26,33,O
DDI-DrugBank.d185.s1,levels,35,40,O
DDI-DrugBank.d185.s1,of,42,43,O
DDI-DrugBank.d185.s1,TMP,45,47,B-drug
DDI-DrugBank.d185.s1,and,49,51,O
DDI-DrugBank.d185.s1,SMX,53,55,B-drug
DDI-DrugBank.d185.s1,were,57,60,O
DDI-DrugBank.d185.s1,essentially,62,72,O
DDI-DrugBank.d185.s1,unchanged,74,82,O
DDI-DrugBank.d185.s1,.,83,83,O
DDI-DrugBank.d185.s2,Notably,0,6,O
DDI-DrugBank.d185.s2,",",7,7,O
DDI-DrugBank.d185.s2,systemic,9,16,O
DDI-DrugBank.d185.s2,exposure,18,25,O
DDI-DrugBank.d185.s2,(,27,27,O
DDI-DrugBank.d185.s2,AUC0-12,28,34,O
DDI-DrugBank.d185.s2,),35,35,O
DDI-DrugBank.d185.s2,of,37,38,O
DDI-DrugBank.d185.s2,dapsone,40,46,B-drug_n
DDI-DrugBank.d185.s2,hydroxylamine,48,60,I-drug_n
DDI-DrugBank.d185.s2,(,62,62,O
DDI-DrugBank.d185.s2,DHA,63,65,B-drug_n
DDI-DrugBank.d185.s2,),66,66,O
DDI-DrugBank.d185.s2,was,68,70,O
DDI-DrugBank.d185.s2,more,72,75,O
DDI-DrugBank.d185.s2,than,77,80,O
DDI-DrugBank.d185.s2,doubled,82,88,O
DDI-DrugBank.d185.s2,in,90,91,O
DDI-DrugBank.d185.s2,the,93,95,O
DDI-DrugBank.d185.s2,presence,97,104,O
DDI-DrugBank.d185.s2,of,106,107,O
DDI-DrugBank.d185.s2,TMP/SMX,109,115,O
DDI-DrugBank.d185.s2,.,116,116,O
DDI-DrugBank.d185.s3,Exposure,0,7,O
DDI-DrugBank.d185.s3,from,9,12,O
DDI-DrugBank.d185.s3,the,14,16,O
DDI-DrugBank.d185.s3,proposed,18,25,O
DDI-DrugBank.d185.s3,topical,27,33,O
DDI-DrugBank.d185.s3,dose,35,38,O
DDI-DrugBank.d185.s3,is,40,41,O
DDI-DrugBank.d185.s3,about,43,47,O
DDI-DrugBank.d185.s3,1,49,49,O
DDI-DrugBank.d185.s3,%,50,50,O
DDI-DrugBank.d185.s3,of,52,53,O
DDI-DrugBank.d185.s3,that,55,58,O
DDI-DrugBank.d185.s3,from,60,63,O
DDI-DrugBank.d185.s3,the,65,67,O
DDI-DrugBank.d185.s3,100,69,71,O
DDI-DrugBank.d185.s3,mg,73,74,O
DDI-DrugBank.d185.s3,oral,76,79,O
DDI-DrugBank.d185.s3,dose,81,84,O
DDI-DrugBank.d185.s3,",",85,85,O
DDI-DrugBank.d185.s3,even,87,90,O
DDI-DrugBank.d185.s3,when,92,95,O
DDI-DrugBank.d185.s3,co-administered,97,111,O
DDI-DrugBank.d185.s3,with,113,116,O
DDI-DrugBank.d185.s3,TMP/SMX,118,124,O
DDI-DrugBank.d185.s3,.,125,125,O
DDI-DrugBank.d185.s4,Certain,0,6,O
DDI-DrugBank.d185.s4,concomitant,8,18,O
DDI-DrugBank.d185.s4,medications,20,30,O
DDI-DrugBank.d185.s4,(,32,32,O
DDI-DrugBank.d185.s4,such,33,36,O
DDI-DrugBank.d185.s4,as,38,39,O
DDI-DrugBank.d185.s4,rifampin,41,48,B-drug
DDI-DrugBank.d185.s4,",",49,49,O
DDI-DrugBank.d185.s4,anticonvulsants,51,65,B-group
DDI-DrugBank.d185.s4,",",66,66,O
DDI-DrugBank.d185.s4,St,68,69,O
DDI-DrugBank.d185.s4,.,70,70,O
DDI-DrugBank.d185.s5,John,0,3,O
DDI-DrugBank.d185.s5,s,5,5,O
DDI-DrugBank.d185.s5,wort,7,10,O
DDI-DrugBank.d185.s5,),11,11,O
DDI-DrugBank.d185.s5,may,13,15,O
DDI-DrugBank.d185.s5,increase,17,24,O
DDI-DrugBank.d185.s5,the,26,28,O
DDI-DrugBank.d185.s5,formation,30,38,O
DDI-DrugBank.d185.s5,of,40,41,O
DDI-DrugBank.d185.s5,dapsone,43,49,B-drug_n
DDI-DrugBank.d185.s5,hydroxylamine,51,63,I-drug_n
DDI-DrugBank.d185.s5,",",64,64,O
DDI-DrugBank.d185.s5,a,66,66,O
DDI-DrugBank.d185.s5,metabolite,68,77,O
DDI-DrugBank.d185.s5,of,79,80,O
DDI-DrugBank.d185.s5,dapsone,82,88,B-drug
DDI-DrugBank.d185.s5,associated,90,99,O
DDI-DrugBank.d185.s5,with,101,104,O
DDI-DrugBank.d185.s5,hemolysis,106,114,O
DDI-DrugBank.d185.s5,.,115,115,O
DDI-DrugBank.d185.s6,With,0,3,O
DDI-DrugBank.d185.s6,oral,5,8,O
DDI-DrugBank.d185.s6,dapsone,10,16,B-drug
DDI-DrugBank.d185.s6,treatment,18,26,O
DDI-DrugBank.d185.s6,",",27,27,O
DDI-DrugBank.d185.s6,folic,29,33,B-group
DDI-DrugBank.d185.s6,acid,35,38,I-group
DDI-DrugBank.d185.s6,antagonists,40,50,I-group
DDI-DrugBank.d185.s6,such,52,55,O
DDI-DrugBank.d185.s6,as,57,58,O
DDI-DrugBank.d185.s6,pyrimethamine,60,72,B-drug
DDI-DrugBank.d185.s6,have,74,77,O
DDI-DrugBank.d185.s6,been,79,82,O
DDI-DrugBank.d185.s6,noted,84,88,O
DDI-DrugBank.d185.s6,to,90,91,O
DDI-DrugBank.d185.s6,possibly,93,100,O
DDI-DrugBank.d185.s6,increase,102,109,O
DDI-DrugBank.d185.s6,the,111,113,O
DDI-DrugBank.d185.s6,likelihood,115,124,O
DDI-DrugBank.d185.s6,of,126,127,O
DDI-DrugBank.d185.s6,hematologic,129,139,O
DDI-DrugBank.d185.s6,reactions,141,149,O
DDI-DrugBank.d185.s7,.,0,0,O
DDI-DrugBank.d69.s0,Use,0,2,O
DDI-DrugBank.d69.s0,of,4,5,O
DDI-DrugBank.d69.s0,Cerubidine,7,16,B-brand
DDI-DrugBank.d69.s0,in,18,19,O
DDI-DrugBank.d69.s0,a,21,21,O
DDI-DrugBank.d69.s0,patient,23,29,O
DDI-DrugBank.d69.s0,who,31,33,O
DDI-DrugBank.d69.s0,has,35,37,O
DDI-DrugBank.d69.s0,previously,39,48,O
DDI-DrugBank.d69.s0,received,50,57,O
DDI-DrugBank.d69.s0,doxorubicin,59,69,B-drug
DDI-DrugBank.d69.s0,increases,71,79,O
DDI-DrugBank.d69.s0,the,81,83,O
DDI-DrugBank.d69.s0,risk,85,88,O
DDI-DrugBank.d69.s0,of,90,91,O
DDI-DrugBank.d69.s0,cardiotoxicity,93,106,O
DDI-DrugBank.d69.s0,.,107,107,O
DDI-DrugBank.d69.s1,Cerubidine,0,9,B-brand
DDI-DrugBank.d69.s1,should,11,16,O
DDI-DrugBank.d69.s1,not,18,20,O
DDI-DrugBank.d69.s1,be,22,23,O
DDI-DrugBank.d69.s1,used,25,28,O
DDI-DrugBank.d69.s1,in,30,31,O
DDI-DrugBank.d69.s1,patients,33,40,O
DDI-DrugBank.d69.s1,who,42,44,O
DDI-DrugBank.d69.s1,have,46,49,O
DDI-DrugBank.d69.s1,previously,51,60,O
DDI-DrugBank.d69.s1,received,62,69,O
DDI-DrugBank.d69.s1,the,71,73,O
DDI-DrugBank.d69.s1,recommended,75,85,O
DDI-DrugBank.d69.s1,maximum,87,93,O
DDI-DrugBank.d69.s1,cumulative,95,104,O
DDI-DrugBank.d69.s1,doses,106,110,O
DDI-DrugBank.d69.s1,of,112,113,O
DDI-DrugBank.d69.s1,doxorubicin,115,125,B-drug
DDI-DrugBank.d69.s1,or,127,128,O
DDI-DrugBank.d69.s1,Cerubidine,130,139,B-brand
DDI-DrugBank.d69.s1,.,140,140,O
DDI-DrugBank.d69.s2,Cyclophosphamide,0,15,B-drug
DDI-DrugBank.d69.s2,used,17,20,O
DDI-DrugBank.d69.s2,concurrently,22,33,O
DDI-DrugBank.d69.s2,with,35,38,O
DDI-DrugBank.d69.s2,Cerubidine,40,49,B-brand
DDI-DrugBank.d69.s2,may,51,53,O
DDI-DrugBank.d69.s2,also,55,58,O
DDI-DrugBank.d69.s2,result,60,65,O
DDI-DrugBank.d69.s2,in,67,68,O
DDI-DrugBank.d69.s2,increased,70,78,O
DDI-DrugBank.d69.s2,cardiotoxicity,80,93,O
DDI-DrugBank.d69.s2,.,94,94,O
DDI-DrugBank.d69.s3,Dosage,0,5,O
DDI-DrugBank.d69.s3,reduction,7,15,O
DDI-DrugBank.d69.s3,of,17,18,O
DDI-DrugBank.d69.s3,Cerubidine,20,29,B-brand
DDI-DrugBank.d69.s3,may,31,33,O
DDI-DrugBank.d69.s3,be,35,36,O
DDI-DrugBank.d69.s3,required,38,45,O
DDI-DrugBank.d69.s3,when,47,50,O
DDI-DrugBank.d69.s3,used,52,55,O
DDI-DrugBank.d69.s3,concurrently,57,68,O
DDI-DrugBank.d69.s3,with,70,73,O
DDI-DrugBank.d69.s3,other,75,79,O
DDI-DrugBank.d69.s3,myelosuppressive,81,96,O
DDI-DrugBank.d69.s3,agents,98,103,O
DDI-DrugBank.d69.s3,.,104,104,O
DDI-DrugBank.d69.s4,Hepatotoxic,0,10,O
DDI-DrugBank.d69.s4,medications,12,22,O
DDI-DrugBank.d69.s4,",",23,23,O
DDI-DrugBank.d69.s4,such,25,28,O
DDI-DrugBank.d69.s4,as,30,31,O
DDI-DrugBank.d69.s4,high-dose,33,41,O
DDI-DrugBank.d69.s4,methotrexate,43,54,B-drug
DDI-DrugBank.d69.s4,",",55,55,O
DDI-DrugBank.d69.s4,may,57,59,O
DDI-DrugBank.d69.s4,impair,61,66,O
DDI-DrugBank.d69.s4,liver,68,72,O
DDI-DrugBank.d69.s4,function,74,81,O
DDI-DrugBank.d69.s4,and,83,85,O
DDI-DrugBank.d69.s4,increase,87,94,O
DDI-DrugBank.d69.s4,the,96,98,O
DDI-DrugBank.d69.s4,risk,100,103,O
DDI-DrugBank.d69.s4,of,105,106,O
DDI-DrugBank.d69.s4,toxicity,108,115,O
DDI-DrugBank.d69.s4,.,116,116,O
DDI-DrugBank.d197.s0,General,0,6,O
DDI-DrugBank.d197.s0,In,8,9,O
DDI-DrugBank.d197.s0,vitro,11,15,O
DDI-DrugBank.d197.s0,studies,17,23,O
DDI-DrugBank.d197.s0,in,25,26,O
DDI-DrugBank.d197.s0,human,28,32,O
DDI-DrugBank.d197.s0,liver,34,38,O
DDI-DrugBank.d197.s0,microsomes,40,49,O
DDI-DrugBank.d197.s0,demonstrated,51,62,O
DDI-DrugBank.d197.s0,no,64,65,O
DDI-DrugBank.d197.s0,evidence,67,74,O
DDI-DrugBank.d197.s0,of,76,77,O
DDI-DrugBank.d197.s0,cytochrome,79,88,O
DDI-DrugBank.d197.s0,P450-mediated,90,102,O
DDI-DrugBank.d197.s0,drug,104,107,O
DDI-DrugBank.d197.s0,interactions,109,120,O
DDI-DrugBank.d197.s0,that,122,125,O
DDI-DrugBank.d197.s0,are,127,129,O
DDI-DrugBank.d197.s0,likely,131,136,O
DDI-DrugBank.d197.s0,to,138,139,O
DDI-DrugBank.d197.s0,be,141,142,O
DDI-DrugBank.d197.s0,of,144,145,O
DDI-DrugBank.d197.s0,clinical,147,154,O
DDI-DrugBank.d197.s0,relevance,156,164,O
DDI-DrugBank.d197.s0,.,165,165,O
DDI-DrugBank.d197.s1,Anesthetics/Sedatives/Hypnotics/Opioids,0,38,O
DDI-DrugBank.d197.s1,:,39,39,O
DDI-DrugBank.d197.s1,Co-administration,41,57,O
DDI-DrugBank.d197.s1,of,59,60,O
DDI-DrugBank.d197.s1,PRECEDEX,62,69,B-brand
DDI-DrugBank.d197.s1,with,71,74,O
DDI-DrugBank.d197.s1,anesthetics,76,86,B-group
DDI-DrugBank.d197.s1,",",87,87,O
DDI-DrugBank.d197.s1,sedatives,89,97,B-group
DDI-DrugBank.d197.s1,",",98,98,O
DDI-DrugBank.d197.s1,hypnotics,100,108,B-group
DDI-DrugBank.d197.s1,",",109,109,O
DDI-DrugBank.d197.s1,and,111,113,O
DDI-DrugBank.d197.s1,opioids,115,121,B-group
DDI-DrugBank.d197.s1,is,123,124,O
DDI-DrugBank.d197.s1,likely,126,131,O
DDI-DrugBank.d197.s1,to,133,134,O
DDI-DrugBank.d197.s1,lead,136,139,O
DDI-DrugBank.d197.s1,to,141,142,O
DDI-DrugBank.d197.s1,an,144,145,O
DDI-DrugBank.d197.s1,enhancement,147,157,O
DDI-DrugBank.d197.s1,of,159,160,O
DDI-DrugBank.d197.s1,effects,162,168,O
DDI-DrugBank.d197.s1,.,169,169,O
DDI-DrugBank.d197.s2,Specific,0,7,O
DDI-DrugBank.d197.s2,studies,9,15,O
DDI-DrugBank.d197.s2,have,17,20,O
DDI-DrugBank.d197.s2,confirmed,22,30,O
DDI-DrugBank.d197.s2,these,32,36,O
DDI-DrugBank.d197.s2,effects,38,44,O
DDI-DrugBank.d197.s2,with,46,49,O
DDI-DrugBank.d197.s2,sevoflurane,51,61,B-drug
DDI-DrugBank.d197.s2,",",62,62,O
DDI-DrugBank.d197.s2,isoflurane,64,73,B-drug
DDI-DrugBank.d197.s2,",",74,74,O
DDI-DrugBank.d197.s2,propofol,76,83,B-drug
DDI-DrugBank.d197.s2,",",84,84,O
DDI-DrugBank.d197.s2,alfentanil,86,95,B-drug
DDI-DrugBank.d197.s2,",",96,96,O
DDI-DrugBank.d197.s2,and,98,100,O
DDI-DrugBank.d197.s2,midazolam,102,110,B-drug
DDI-DrugBank.d197.s2,.,111,111,O
DDI-DrugBank.d197.s3,No,0,1,O
DDI-DrugBank.d197.s3,pharmacokinetic,3,17,O
DDI-DrugBank.d197.s3,interactions,19,30,O
DDI-DrugBank.d197.s3,between,32,38,O
DDI-DrugBank.d197.s3,dexmedetomidine,40,54,B-drug
DDI-DrugBank.d197.s3,and,56,58,O
DDI-DrugBank.d197.s3,isoflurane,60,69,B-drug
DDI-DrugBank.d197.s3,",",70,70,O
DDI-DrugBank.d197.s3,propofol,72,79,B-drug
DDI-DrugBank.d197.s3,",",80,80,O
DDI-DrugBank.d197.s3,alfentanil,82,91,B-drug
DDI-DrugBank.d197.s3,",",92,92,O
DDI-DrugBank.d197.s3,and,94,96,O
DDI-DrugBank.d197.s3,midazolam,98,106,B-drug
DDI-DrugBank.d197.s3,have,108,111,O
DDI-DrugBank.d197.s3,been,113,116,O
DDI-DrugBank.d197.s3,demonstrated,118,129,O
DDI-DrugBank.d197.s3,.,130,130,O
DDI-DrugBank.d197.s4,However,0,6,O
DDI-DrugBank.d197.s4,",",7,7,O
DDI-DrugBank.d197.s4,due,9,11,O
DDI-DrugBank.d197.s4,to,13,14,O
DDI-DrugBank.d197.s4,possible,16,23,O
DDI-DrugBank.d197.s4,pharmacodynamic,25,39,O
DDI-DrugBank.d197.s4,interactions,41,52,O
DDI-DrugBank.d197.s4,",",53,53,O
DDI-DrugBank.d197.s4,when,55,58,O
DDI-DrugBank.d197.s4,co-administered,60,74,O
DDI-DrugBank.d197.s4,with,76,79,O
DDI-DrugBank.d197.s4,PRECEDEX,81,88,B-brand
DDI-DrugBank.d197.s4,",",89,89,O
DDI-DrugBank.d197.s4,a,91,91,O
DDI-DrugBank.d197.s4,reduction,93,101,O
DDI-DrugBank.d197.s4,in,103,104,O
DDI-DrugBank.d197.s4,dosage,106,111,O
DDI-DrugBank.d197.s4,of,113,114,O
DDI-DrugBank.d197.s4,PRECEDEX,116,123,B-brand
DDI-DrugBank.d197.s4,on,125,126,O
DDI-DrugBank.d197.s4,the,128,130,O
DDI-DrugBank.d197.s4,concomitant,132,142,O
DDI-DrugBank.d197.s4,anesthetic,144,153,B-group
DDI-DrugBank.d197.s4,",",154,154,O
DDI-DrugBank.d197.s4,sedative,156,163,B-group
DDI-DrugBank.d197.s4,",",164,164,O
DDI-DrugBank.d197.s4,hypnotic,166,173,B-group
DDI-DrugBank.d197.s4,or,175,176,O
DDI-DrugBank.d197.s4,opioid,178,183,B-group
DDI-DrugBank.d197.s4,may,185,187,O
DDI-DrugBank.d197.s4,be,189,190,O
DDI-DrugBank.d197.s4,required,192,199,O
DDI-DrugBank.d197.s4,.,200,200,O
DDI-DrugBank.d197.s5,Neuromuscular,0,12,B-group
DDI-DrugBank.d197.s5,Blockers,14,21,I-group
DDI-DrugBank.d197.s5,:,22,22,O
DDI-DrugBank.d197.s5,In,24,25,O
DDI-DrugBank.d197.s5,one,27,29,O
DDI-DrugBank.d197.s5,study,31,35,O
DDI-DrugBank.d197.s5,of,37,38,O
DDI-DrugBank.d197.s5,10,40,41,O
DDI-DrugBank.d197.s5,healthy,43,49,O
DDI-DrugBank.d197.s5,volunteers,51,60,O
DDI-DrugBank.d197.s5,",",61,61,O
DDI-DrugBank.d197.s5,administration,63,76,O
DDI-DrugBank.d197.s5,of,78,79,O
DDI-DrugBank.d197.s5,PRECEDEX,81,88,B-brand
DDI-DrugBank.d197.s5,for,90,92,O
DDI-DrugBank.d197.s5,45,94,95,O
DDI-DrugBank.d197.s5,minutes,97,103,O
DDI-DrugBank.d197.s5,at,105,106,O
DDI-DrugBank.d197.s5,a,108,108,O
DDI-DrugBank.d197.s5,plasma,110,115,O
DDI-DrugBank.d197.s5,concentration,117,129,O
DDI-DrugBank.d197.s5,of,131,132,O
DDI-DrugBank.d197.s5,1,134,134,O
DDI-DrugBank.d197.s5,(,136,136,O
DDI-DrugBank.d197.s5,one,137,139,O
DDI-DrugBank.d197.s5,),140,140,O
DDI-DrugBank.d197.s5,ng/mL,142,146,O
DDI-DrugBank.d197.s5,resulted,148,155,O
DDI-DrugBank.d197.s5,in,157,158,O
DDI-DrugBank.d197.s5,no,160,161,O
DDI-DrugBank.d197.s5,clinically,163,172,O
DDI-DrugBank.d197.s5,meaningful,174,183,O
DDI-DrugBank.d197.s5,increases,185,193,O
DDI-DrugBank.d197.s5,in,195,196,O
DDI-DrugBank.d197.s5,the,198,200,O
DDI-DrugBank.d197.s5,magnitude,202,210,O
DDI-DrugBank.d197.s5,or,212,213,O
DDI-DrugBank.d197.s5,neuromuscular,215,227,O
DDI-DrugBank.d197.s5,blockade,229,236,O
DDI-DrugBank.d197.s5,associated,238,247,O
DDI-DrugBank.d197.s5,with,249,252,O
DDI-DrugBank.d197.s5,rocuronium,254,263,B-drug
DDI-DrugBank.d197.s5,administration,265,278,O
DDI-DrugBank.d197.s5,.,279,279,O
DDI-DrugBank.d181.s0,Oxytocin,0,7,B-drug
DDI-DrugBank.d181.s0,or,9,10,O
DDI-DrugBank.d181.s0,other,12,16,O
DDI-DrugBank.d181.s0,oxytocics,18,26,B-group
DDI-DrugBank.d181.s0,(,28,28,O
DDI-DrugBank.d181.s0,concurrent,29,38,O
DDI-DrugBank.d181.s0,use,40,42,O
DDI-DrugBank.d181.s0,with,44,47,O
DDI-DrugBank.d181.s0,dinoprost,49,57,B-drug
DDI-DrugBank.d181.s0,may,59,61,O
DDI-DrugBank.d181.s0,result,63,68,O
DDI-DrugBank.d181.s0,in,70,71,O
DDI-DrugBank.d181.s0,uterine,73,79,O
DDI-DrugBank.d181.s0,hypertonus,81,90,O
DDI-DrugBank.d181.s0,",",91,91,O
DDI-DrugBank.d181.s0,possibly,93,100,O
DDI-DrugBank.d181.s0,causing,102,108,O
DDI-DrugBank.d181.s0,uterine,110,116,O
DDI-DrugBank.d181.s0,rupture,118,124,O
DDI-DrugBank.d181.s0,or,126,127,O
DDI-DrugBank.d181.s0,cervical,129,136,O
DDI-DrugBank.d181.s0,laceration,138,147,O
DDI-DrugBank.d181.s0,",",148,148,O
DDI-DrugBank.d181.s0,especially,150,159,O
DDI-DrugBank.d181.s0,in,161,162,O
DDI-DrugBank.d181.s0,the,164,166,O
DDI-DrugBank.d181.s0,absence,168,174,O
DDI-DrugBank.d181.s0,of,176,177,O
DDI-DrugBank.d181.s0,adequate,179,186,O
DDI-DrugBank.d181.s0,cervical,188,195,O
DDI-DrugBank.d181.s0,dilatation,197,206,O
DDI-DrugBank.d181.s0,;,207,207,O
DDI-DrugBank.d181.s1,although,0,7,O
DDI-DrugBank.d181.s1,combinations,9,20,O
DDI-DrugBank.d181.s1,are,22,24,O
DDI-DrugBank.d181.s1,sometimes,26,34,O
DDI-DrugBank.d181.s1,used,36,39,O
DDI-DrugBank.d181.s1,for,41,43,O
DDI-DrugBank.d181.s1,therapeutic,45,55,O
DDI-DrugBank.d181.s1,advantage,57,65,O
DDI-DrugBank.d181.s1,",",66,66,O
DDI-DrugBank.d181.s1,when,68,71,O
DDI-DrugBank.d181.s1,used,73,76,O
DDI-DrugBank.d181.s1,concurrently,78,89,O
DDI-DrugBank.d181.s1,",",90,90,O
DDI-DrugBank.d181.s1,patient,92,98,O
DDI-DrugBank.d181.s1,should,100,105,O
DDI-DrugBank.d181.s1,be,107,108,O
DDI-DrugBank.d181.s1,closely,110,116,O
DDI-DrugBank.d181.s1,monitored,118,126,O
DDI-DrugBank.d181.s1,.,127,127,O
DDI-DrugBank.d168.s0,This,0,3,O
DDI-DrugBank.d168.s0,drug,5,8,O
DDI-DrugBank.d168.s0,may,10,12,O
DDI-DrugBank.d168.s0,interact,14,21,O
DDI-DrugBank.d168.s0,with,23,26,O
DDI-DrugBank.d168.s0,alcohol,28,34,B-drug
DDI-DrugBank.d168.s0,or,36,37,O
DDI-DrugBank.d168.s0,other,39,43,O
DDI-DrugBank.d168.s0,CNS,45,47,B-group
DDI-DrugBank.d168.s0,depressants,49,59,I-group
DDI-DrugBank.d168.s0,(,61,61,O
DDI-DrugBank.d168.s0,may,62,64,O
DDI-DrugBank.d168.s0,potentiate,66,75,O
DDI-DrugBank.d168.s0,the,77,79,O
DDI-DrugBank.d168.s0,CNS,81,83,O
DDI-DrugBank.d168.s0,depressant,85,94,O
DDI-DrugBank.d168.s0,effects,96,102,O
DDI-DrugBank.d168.s0,of,104,105,O
DDI-DrugBank.d168.s0,either,107,112,O
DDI-DrugBank.d168.s0,these,114,118,O
DDI-DrugBank.d168.s0,medications,120,130,O
DDI-DrugBank.d168.s0,or,132,133,O
DDI-DrugBank.d168.s0,antihistamines,135,148,B-group
DDI-DrugBank.d168.s0,),149,149,O
DDI-DrugBank.d168.s0,",",150,150,O
DDI-DrugBank.d168.s0,anticholinergics,152,167,B-group
DDI-DrugBank.d168.s0,or,169,170,O
DDI-DrugBank.d168.s0,other,172,176,O
DDI-DrugBank.d168.s0,medications,178,188,O
DDI-DrugBank.d168.s0,with,190,193,O
DDI-DrugBank.d168.s0,anticholinergic,195,209,O
DDI-DrugBank.d168.s0,activity,211,218,O
DDI-DrugBank.d168.s0,(,220,220,O
DDI-DrugBank.d168.s0,anticholinergic,221,235,O
DDI-DrugBank.d168.s0,effects,237,243,O
DDI-DrugBank.d168.s0,may,245,247,O
DDI-DrugBank.d168.s0,be,249,250,O
DDI-DrugBank.d168.s0,potentiated,252,262,O
DDI-DrugBank.d168.s0,when,264,267,O
DDI-DrugBank.d168.s0,these,269,273,O
DDI-DrugBank.d168.s0,medications,275,285,O
DDI-DrugBank.d168.s0,are,287,289,O
DDI-DrugBank.d168.s0,used,291,294,O
DDI-DrugBank.d168.s0,concurrently,296,307,O
DDI-DrugBank.d168.s0,with,309,312,O
DDI-DrugBank.d168.s0,antihistamines,314,327,B-group
DDI-DrugBank.d168.s0,),328,328,O
DDI-DrugBank.d168.s0,",",329,329,O
DDI-DrugBank.d168.s0,and,331,333,O
DDI-DrugBank.d168.s0,monoamine,335,343,B-group
DDI-DrugBank.d168.s0,oxidase,345,351,I-group
DDI-DrugBank.d168.s0,(,353,353,I-group
DDI-DrugBank.d168.s0,MAO,354,356,I-group
DDI-DrugBank.d168.s0,),357,357,I-group
DDI-DrugBank.d168.s0,inhibitors,359,368,I-group
DDI-DrugBank.d168.s0,(,370,370,O
DDI-DrugBank.d168.s0,concurrent,371,380,O
DDI-DrugBank.d168.s0,use,382,384,O
DDI-DrugBank.d168.s0,with,386,389,O
DDI-DrugBank.d168.s0,antihistamines,391,404,B-drug
DDI-DrugBank.d168.s0,may,406,408,O
DDI-DrugBank.d168.s0,prolong,410,416,O
DDI-DrugBank.d168.s0,and,418,420,O
DDI-DrugBank.d168.s0,intensify,422,430,O
DDI-DrugBank.d168.s0,the,432,434,O
DDI-DrugBank.d168.s0,anticholinergic,436,450,O
DDI-DrugBank.d168.s0,and,452,454,O
DDI-DrugBank.d168.s0,CNS,456,458,O
DDI-DrugBank.d168.s0,depressant,460,469,O
DDI-DrugBank.d168.s0,effects,471,477,O
DDI-DrugBank.d168.s0,of,479,480,O
DDI-DrugBank.d168.s0,antihistamines,482,495,B-drug
DDI-DrugBank.d168.s0,),496,496,O
DDI-DrugBank.d168.s0,.,497,497,O
DDI-DrugBank.d19.s0,Disulfiram,0,9,B-drug
DDI-DrugBank.d19.s0,appears,11,17,O
DDI-DrugBank.d19.s0,to,19,20,O
DDI-DrugBank.d19.s0,decrease,22,29,O
DDI-DrugBank.d19.s0,the,31,33,O
DDI-DrugBank.d19.s0,rate,35,38,O
DDI-DrugBank.d19.s0,at,40,41,O
DDI-DrugBank.d19.s0,which,43,47,O
DDI-DrugBank.d19.s0,certain,49,55,O
DDI-DrugBank.d19.s0,drugs,57,61,O
DDI-DrugBank.d19.s0,are,63,65,O
DDI-DrugBank.d19.s0,metabolized,67,77,O
DDI-DrugBank.d19.s0,and,79,81,O
DDI-DrugBank.d19.s0,therefore,83,91,O
DDI-DrugBank.d19.s0,may,93,95,O
DDI-DrugBank.d19.s0,increase,97,104,O
DDI-DrugBank.d19.s0,the,106,108,O
DDI-DrugBank.d19.s0,blood,110,114,O
DDI-DrugBank.d19.s0,levels,116,121,O
DDI-DrugBank.d19.s0,and,123,125,O
DDI-DrugBank.d19.s0,the,127,129,O
DDI-DrugBank.d19.s0,possibility,131,141,O
DDI-DrugBank.d19.s0,of,143,144,O
DDI-DrugBank.d19.s0,clinical,146,153,O
DDI-DrugBank.d19.s0,toxicity,155,162,O
DDI-DrugBank.d19.s0,of,164,165,O
DDI-DrugBank.d19.s0,drugs,167,171,O
DDI-DrugBank.d19.s0,given,173,177,O
DDI-DrugBank.d19.s0,concomitantly,179,191,O
DDI-DrugBank.d19.s0,.,192,192,O
DDI-DrugBank.d19.s1,DISULFIRAM,0,9,B-drug
DDI-DrugBank.d19.s1,SHOULD,11,16,O
DDI-DrugBank.d19.s1,BE,18,19,O
DDI-DrugBank.d19.s1,USED,21,24,O
DDI-DrugBank.d19.s1,WITH,26,29,O
DDI-DrugBank.d19.s1,CAUTION,31,37,O
DDI-DrugBank.d19.s1,IN,39,40,O
DDI-DrugBank.d19.s1,THOSE,42,46,O
DDI-DrugBank.d19.s1,PATIENTS,48,55,O
DDI-DrugBank.d19.s1,REVEIVING,57,65,O
DDI-DrugBank.d19.s1,PHENYTOIN,67,75,B-drug
DDI-DrugBank.d19.s1,AND,77,79,O
DDI-DrugBank.d19.s1,ITS,81,83,O
DDI-DrugBank.d19.s1,CONGENERS,85,93,O
DDI-DrugBank.d19.s1,.,94,94,O
DDI-DrugBank.d19.s2,SINCE,0,4,O
DDI-DrugBank.d19.s2,THE,6,8,O
DDI-DrugBank.d19.s2,CONCOMITANT,10,20,O
DDI-DrugBank.d19.s2,ADMINISTRATION,22,35,O
DDI-DrugBank.d19.s2,OF,37,38,O
DDI-DrugBank.d19.s2,THESE,40,44,O
DDI-DrugBank.d19.s2,TWO,46,48,O
DDI-DrugBank.d19.s2,DRUGS,50,54,O
DDI-DrugBank.d19.s2,CAN,56,58,O
DDI-DrugBank.d19.s2,LEAD,60,63,O
DDI-DrugBank.d19.s2,TO,65,66,O
DDI-DrugBank.d19.s2,PHENYTOIN,68,76,B-drug
DDI-DrugBank.d19.s2,INTOXICATION,78,89,O
DDI-DrugBank.d19.s2,",",90,90,O
DDI-DrugBank.d19.s2,PRIOR,92,96,O
DDI-DrugBank.d19.s2,TO,98,99,O
DDI-DrugBank.d19.s2,ADMINISTERING,101,113,O
DDI-DrugBank.d19.s2,DISULFIRAM,115,124,B-drug
DDI-DrugBank.d19.s2,TO,126,127,O
DDI-DrugBank.d19.s2,A,129,129,O
DDI-DrugBank.d19.s2,PATIENT,131,137,O
DDI-DrugBank.d19.s2,ON,139,140,O
DDI-DrugBank.d19.s2,PHENYTOIN,142,150,B-drug
DDI-DrugBank.d19.s2,THERAPY,152,158,O
DDI-DrugBank.d19.s2,",",159,159,O
DDI-DrugBank.d19.s2,A,161,161,O
DDI-DrugBank.d19.s2,BASELINE,163,170,O
DDI-DrugBank.d19.s2,PHENYTOIN,172,180,B-drug
DDI-DrugBank.d19.s2,SERUM,182,186,O
DDI-DrugBank.d19.s2,LEVEL,188,192,O
DDI-DrugBank.d19.s2,SHOULD,194,199,O
DDI-DrugBank.d19.s2,BE,201,202,O
DDI-DrugBank.d19.s2,OBTAINED,204,211,O
DDI-DrugBank.d19.s2,.,212,212,O
DDI-DrugBank.d19.s3,SUBSEQUENT,0,9,O
DDI-DrugBank.d19.s3,TO,11,12,O
DDI-DrugBank.d19.s3,INITIATION,14,23,O
DDI-DrugBank.d19.s3,OF,25,26,O
DDI-DrugBank.d19.s3,DISULFIRAM,28,37,B-drug
DDI-DrugBank.d19.s3,THERAPY,39,45,O
DDI-DrugBank.d19.s3,.,46,46,O
DDI-DrugBank.d19.s4,SERUM,0,4,O
DDI-DrugBank.d19.s4,LEVELS,6,11,O
DDI-DrugBank.d19.s4,OF,13,14,O
DDI-DrugBank.d19.s4,PHENYTOIN,16,24,B-drug
DDI-DrugBank.d19.s4,SHOULD,26,31,O
DDI-DrugBank.d19.s4,BE,33,34,O
DDI-DrugBank.d19.s4,DETERMINED,36,45,O
DDI-DrugBank.d19.s4,ON,47,48,O
DDI-DrugBank.d19.s4,DIFFERENT,50,58,O
DDI-DrugBank.d19.s4,DAYS,60,63,O
DDI-DrugBank.d19.s4,FOR,65,67,O
DDI-DrugBank.d19.s4,EVIDENCE,69,76,O
DDI-DrugBank.d19.s4,OF,78,79,O
DDI-DrugBank.d19.s4,AN,81,82,O
DDI-DrugBank.d19.s4,INCREASE,84,91,O
DDI-DrugBank.d19.s4,OR,93,94,O
DDI-DrugBank.d19.s4,FOR,96,98,O
DDI-DrugBank.d19.s4,A,100,100,O
DDI-DrugBank.d19.s4,CONTINUING,102,111,O
DDI-DrugBank.d19.s4,RISE,113,116,O
DDI-DrugBank.d19.s4,IN,118,119,O
DDI-DrugBank.d19.s4,LEVELS,121,126,O
DDI-DrugBank.d19.s4,.,127,127,O
DDI-DrugBank.d19.s5,INCREASED,0,8,O
DDI-DrugBank.d19.s5,PHENYTOIN,10,18,B-drug
DDI-DrugBank.d19.s5,LEVELS,20,25,O
DDI-DrugBank.d19.s5,SHOULD,27,32,O
DDI-DrugBank.d19.s5,BE,34,35,O
DDI-DrugBank.d19.s5,TREATED,37,43,O
DDI-DrugBank.d19.s5,WITH,45,48,O
DDI-DrugBank.d19.s5,APPROPRIATE,50,60,O
DDI-DrugBank.d19.s5,DOSAGE,62,67,O
DDI-DrugBank.d19.s5,ADJUSTMENT,69,78,O
DDI-DrugBank.d19.s5,.,79,79,O
DDI-DrugBank.d19.s6,It,0,1,O
DDI-DrugBank.d19.s6,may,3,5,O
DDI-DrugBank.d19.s6,be,7,8,O
DDI-DrugBank.d19.s6,necessary,10,18,O
DDI-DrugBank.d19.s6,to,20,21,O
DDI-DrugBank.d19.s6,adjust,23,28,O
DDI-DrugBank.d19.s6,the,30,32,O
DDI-DrugBank.d19.s6,dosage,34,39,O
DDI-DrugBank.d19.s6,of,41,42,O
DDI-DrugBank.d19.s6,oral,44,47,O
DDI-DrugBank.d19.s6,anticoagulants,49,62,B-group
DDI-DrugBank.d19.s6,upon,64,67,O
DDI-DrugBank.d19.s6,beginning,69,77,O
DDI-DrugBank.d19.s6,or,79,80,O
DDI-DrugBank.d19.s6,stopping,82,89,O
DDI-DrugBank.d19.s6,disulfiram,91,100,B-drug
DDI-DrugBank.d19.s6,.,101,101,O
DDI-DrugBank.d19.s6,since,103,107,O
DDI-DrugBank.d19.s6,disulfiram,109,118,B-drug
DDI-DrugBank.d19.s6,may,120,122,O
DDI-DrugBank.d19.s6,prolong,124,130,O
DDI-DrugBank.d19.s6,prothrombin,132,142,O
DDI-DrugBank.d19.s6,time,144,147,O
DDI-DrugBank.d19.s6,.,148,148,O
DDI-DrugBank.d19.s7,Patients,0,7,O
DDI-DrugBank.d19.s7,taking,9,14,O
DDI-DrugBank.d19.s7,isoniazid,16,24,B-drug
DDI-DrugBank.d19.s7,when,26,29,O
DDI-DrugBank.d19.s7,disulfiram,31,40,B-drug
DDI-DrugBank.d19.s7,is,42,43,O
DDI-DrugBank.d19.s7,given,45,49,O
DDI-DrugBank.d19.s7,should,51,56,O
DDI-DrugBank.d19.s7,be,58,59,O
DDI-DrugBank.d19.s7,observed,61,68,O
DDI-DrugBank.d19.s7,for,70,72,O
DDI-DrugBank.d19.s7,the,74,76,O
DDI-DrugBank.d19.s7,appearance,78,87,O
DDI-DrugBank.d19.s7,of,89,90,O
DDI-DrugBank.d19.s7,unsteady,92,99,O
DDI-DrugBank.d19.s7,gait,101,104,O
DDI-DrugBank.d19.s7,or,106,107,O
DDI-DrugBank.d19.s7,marked,109,114,O
DDI-DrugBank.d19.s7,changes,116,122,O
DDI-DrugBank.d19.s7,in,124,125,O
DDI-DrugBank.d19.s7,mental,127,132,O
DDI-DrugBank.d19.s7,status,134,139,O
DDI-DrugBank.d19.s7,;,140,140,O
DDI-DrugBank.d19.s8,the,0,2,O
DDI-DrugBank.d19.s8,disulfiram,4,13,B-drug
DDI-DrugBank.d19.s8,should,15,20,O
DDI-DrugBank.d19.s8,be,22,23,O
DDI-DrugBank.d19.s8,discontinued,25,36,O
DDI-DrugBank.d19.s8,if,38,39,O
DDI-DrugBank.d19.s8,such,41,44,O
DDI-DrugBank.d19.s8,signs,46,50,O
DDI-DrugBank.d19.s8,appear,52,57,O
DDI-DrugBank.d19.s8,.,58,58,O
DDI-DrugBank.d19.s9,In,0,1,O
DDI-DrugBank.d19.s9,rats,3,6,O
DDI-DrugBank.d19.s9,",",7,7,O
DDI-DrugBank.d19.s9,simultaneous,9,20,O
DDI-DrugBank.d19.s9,ingestion,22,30,O
DDI-DrugBank.d19.s9,of,32,33,O
DDI-DrugBank.d19.s9,disulfiram,35,44,B-drug
DDI-DrugBank.d19.s9,and,46,48,O
DDI-DrugBank.d19.s9,nitrite,50,56,B-drug
DDI-DrugBank.d19.s9,in,58,59,O
DDI-DrugBank.d19.s9,the,61,63,O
DDI-DrugBank.d19.s9,diet,65,68,O
DDI-DrugBank.d19.s9,for,70,72,O
DDI-DrugBank.d19.s9,78,74,75,O
DDI-DrugBank.d19.s9,weeks,77,81,O
DDI-DrugBank.d19.s9,has,83,85,O
DDI-DrugBank.d19.s9,been,87,90,O
DDI-DrugBank.d19.s9,reported,92,99,O
DDI-DrugBank.d19.s9,to,101,102,O
DDI-DrugBank.d19.s9,cause,104,108,O
DDI-DrugBank.d19.s9,tumors,110,115,O
DDI-DrugBank.d19.s9,",",116,116,O
DDI-DrugBank.d19.s9,and,118,120,O
DDI-DrugBank.d19.s9,it,122,123,O
DDI-DrugBank.d19.s9,has,125,127,O
DDI-DrugBank.d19.s9,been,129,132,O
DDI-DrugBank.d19.s9,suggested,134,142,O
DDI-DrugBank.d19.s9,that,144,147,O
DDI-DrugBank.d19.s9,disulfiram,149,158,B-drug
DDI-DrugBank.d19.s9,may,160,162,O
DDI-DrugBank.d19.s9,react,164,168,O
DDI-DrugBank.d19.s9,with,170,173,O
DDI-DrugBank.d19.s9,nitrites,175,182,B-group
DDI-DrugBank.d19.s9,in,184,185,O
DDI-DrugBank.d19.s9,the,187,189,O
DDI-DrugBank.d19.s9,rat,191,193,O
DDI-DrugBank.d19.s9,stomach,195,201,O
DDI-DrugBank.d19.s9,to,203,204,O
DDI-DrugBank.d19.s9,form,206,209,O
DDI-DrugBank.d19.s9,a,211,211,O
DDI-DrugBank.d19.s9,nitrosamine,213,223,O
DDI-DrugBank.d19.s9,",",224,224,O
DDI-DrugBank.d19.s9,which,226,230,O
DDI-DrugBank.d19.s9,is,232,233,O
DDI-DrugBank.d19.s9,tumorigenic,235,245,O
DDI-DrugBank.d19.s9,.,246,246,O
DDI-DrugBank.d19.s10,Disulfiram,0,9,B-drug
DDI-DrugBank.d19.s10,alone,11,15,O
DDI-DrugBank.d19.s10,in,17,18,O
DDI-DrugBank.d19.s10,the,20,22,O
DDI-DrugBank.d19.s10,rat,24,26,O
DDI-DrugBank.d19.s10,s,28,28,O
DDI-DrugBank.d19.s10,diet,30,33,O
DDI-DrugBank.d19.s10,did,35,37,O
DDI-DrugBank.d19.s10,not,39,41,O
DDI-DrugBank.d19.s10,lead,43,46,O
DDI-DrugBank.d19.s10,to,48,49,O
DDI-DrugBank.d19.s10,such,51,54,O
DDI-DrugBank.d19.s10,tumors,56,61,O
DDI-DrugBank.d19.s10,.,62,62,O
DDI-DrugBank.d19.s11,The,0,2,O
DDI-DrugBank.d19.s11,relevance,4,12,O
DDI-DrugBank.d19.s11,of,14,15,O
DDI-DrugBank.d19.s11,this,17,20,O
DDI-DrugBank.d19.s11,finding,22,28,O
DDI-DrugBank.d19.s11,to,30,31,O
DDI-DrugBank.d19.s11,humans,33,38,O
DDI-DrugBank.d19.s11,is,40,41,O
DDI-DrugBank.d19.s11,not,43,45,O
DDI-DrugBank.d19.s11,known,47,51,O
DDI-DrugBank.d19.s11,at,53,54,O
DDI-DrugBank.d19.s11,this,56,59,O
DDI-DrugBank.d19.s11,time,61,64,O
DDI-DrugBank.d19.s11,.,65,65,O
DDI-DrugBank.d371.s0,There,0,4,O
DDI-DrugBank.d371.s0,have,6,9,O
DDI-DrugBank.d371.s0,been,11,14,O
DDI-DrugBank.d371.s0,no,16,17,O
DDI-DrugBank.d371.s0,formal,19,24,O
DDI-DrugBank.d371.s0,clinical,26,33,O
DDI-DrugBank.d371.s0,studies,35,41,O
DDI-DrugBank.d371.s0,to,43,44,O
DDI-DrugBank.d371.s0,evaluate,46,53,O
DDI-DrugBank.d371.s0,the,55,57,O
DDI-DrugBank.d371.s0,drug,59,62,O
DDI-DrugBank.d371.s0,interactions,64,75,O
DDI-DrugBank.d371.s0,of,77,78,O
DDI-DrugBank.d371.s0,TAXOTERE,80,87,B-brand
DDI-DrugBank.d371.s0,with,89,92,O
DDI-DrugBank.d371.s0,other,94,98,O
DDI-DrugBank.d371.s0,medications,100,110,O
DDI-DrugBank.d371.s0,.,111,111,O
DDI-DrugBank.d371.s1,In,0,1,O
DDI-DrugBank.d371.s1,vitro,3,7,O
DDI-DrugBank.d371.s1,studies,9,15,O
DDI-DrugBank.d371.s1,have,17,20,O
DDI-DrugBank.d371.s1,shown,22,26,O
DDI-DrugBank.d371.s1,that,28,31,O
DDI-DrugBank.d371.s1,the,33,35,O
DDI-DrugBank.d371.s1,metabolism,37,46,O
DDI-DrugBank.d371.s1,of,48,49,O
DDI-DrugBank.d371.s1,docetaxel,51,59,B-drug
DDI-DrugBank.d371.s1,may,61,63,O
DDI-DrugBank.d371.s1,be,65,66,O
DDI-DrugBank.d371.s1,modified,68,75,O
DDI-DrugBank.d371.s1,by,77,78,O
DDI-DrugBank.d371.s1,the,80,82,O
DDI-DrugBank.d371.s1,concomitant,84,94,O
DDI-DrugBank.d371.s1,administration,96,109,O
DDI-DrugBank.d371.s1,of,111,112,O
DDI-DrugBank.d371.s1,compounds,114,122,O
DDI-DrugBank.d371.s1,that,124,127,O
DDI-DrugBank.d371.s1,induce,129,134,O
DDI-DrugBank.d371.s1,",",135,135,O
DDI-DrugBank.d371.s1,inhibit,137,143,O
DDI-DrugBank.d371.s1,",",144,144,O
DDI-DrugBank.d371.s1,or,146,147,O
DDI-DrugBank.d371.s1,are,149,151,O
DDI-DrugBank.d371.s1,metabolized,153,163,O
DDI-DrugBank.d371.s1,by,165,166,O
DDI-DrugBank.d371.s1,cytochrome,168,177,O
DDI-DrugBank.d371.s1,P450,179,182,O
DDI-DrugBank.d371.s1,3A4,184,186,O
DDI-DrugBank.d371.s1,",",187,187,O
DDI-DrugBank.d371.s1,such,189,192,O
DDI-DrugBank.d371.s1,as,194,195,O
DDI-DrugBank.d371.s1,cyclosporine,197,208,B-drug
DDI-DrugBank.d371.s1,",",209,209,O
DDI-DrugBank.d371.s1,terfenadine,211,221,B-drug
DDI-DrugBank.d371.s1,",",222,222,O
DDI-DrugBank.d371.s1,ketoconazole,224,235,B-drug
DDI-DrugBank.d371.s1,",",236,236,O
DDI-DrugBank.d371.s1,erythromycin,238,249,B-drug
DDI-DrugBank.d371.s1,",",250,250,O
DDI-DrugBank.d371.s1,and,252,254,O
DDI-DrugBank.d371.s1,troleandomycin,256,269,B-drug
DDI-DrugBank.d371.s1,.,270,270,O
DDI-DrugBank.d371.s2,Caution,0,6,O
DDI-DrugBank.d371.s2,should,8,13,O
DDI-DrugBank.d371.s2,be,15,16,O
DDI-DrugBank.d371.s2,exercised,18,26,O
DDI-DrugBank.d371.s2,with,28,31,O
DDI-DrugBank.d371.s2,these,33,37,O
DDI-DrugBank.d371.s2,drugs,39,43,O
DDI-DrugBank.d371.s2,when,45,48,O
DDI-DrugBank.d371.s2,treating,50,57,O
DDI-DrugBank.d371.s2,patients,59,66,O
DDI-DrugBank.d371.s2,receiving,68,76,O
DDI-DrugBank.d371.s2,TAXOTERE,78,85,B-brand
DDI-DrugBank.d371.s2,as,87,88,O
DDI-DrugBank.d371.s2,there,90,94,O
DDI-DrugBank.d371.s2,is,96,97,O
DDI-DrugBank.d371.s2,a,99,99,O
DDI-DrugBank.d371.s2,potential,101,109,O
DDI-DrugBank.d371.s2,for,111,113,O
DDI-DrugBank.d371.s2,a,115,115,O
DDI-DrugBank.d371.s2,significant,117,127,O
DDI-DrugBank.d371.s2,interaction,129,139,O
DDI-DrugBank.d371.s2,.,140,140,O
DDI-DrugBank.d367.s0,Most,0,3,O
DDI-DrugBank.d367.s0,(,5,5,O
DDI-DrugBank.d367.s0,98,6,7,O
DDI-DrugBank.d367.s0,%,8,8,O
DDI-DrugBank.d367.s0,),9,9,O
DDI-DrugBank.d367.s0,of,11,12,O
DDI-DrugBank.d367.s0,plasma,14,19,O
DDI-DrugBank.d367.s0,doxazosin,21,29,B-drug
DDI-DrugBank.d367.s0,is,31,32,O
DDI-DrugBank.d367.s0,protein,34,40,O
DDI-DrugBank.d367.s0,bound,42,46,O
DDI-DrugBank.d367.s0,.,47,47,O
DDI-DrugBank.d367.s1,In,0,1,O
DDI-DrugBank.d367.s1,vitro,3,7,O
DDI-DrugBank.d367.s1,data,9,12,O
DDI-DrugBank.d367.s1,in,14,15,O
DDI-DrugBank.d367.s1,human,17,21,O
DDI-DrugBank.d367.s1,plasma,23,28,O
DDI-DrugBank.d367.s1,indicate,30,37,O
DDI-DrugBank.d367.s1,that,39,42,O
DDI-DrugBank.d367.s1,doxazosin,44,52,B-drug
DDI-DrugBank.d367.s1,mesylate,54,61,I-drug
DDI-DrugBank.d367.s1,has,63,65,O
DDI-DrugBank.d367.s1,no,67,68,O
DDI-DrugBank.d367.s1,effect,70,75,O
DDI-DrugBank.d367.s1,on,77,78,O
DDI-DrugBank.d367.s1,protein,80,86,O
DDI-DrugBank.d367.s1,binding,88,94,O
DDI-DrugBank.d367.s1,of,96,97,O
DDI-DrugBank.d367.s1,digoxin,99,105,B-drug
DDI-DrugBank.d367.s1,",",106,106,O
DDI-DrugBank.d367.s1,warfarin,108,115,B-drug
DDI-DrugBank.d367.s1,",",116,116,O
DDI-DrugBank.d367.s1,phenytoin,118,126,B-drug
DDI-DrugBank.d367.s1,or,128,129,O
DDI-DrugBank.d367.s1,indomethacin,131,142,B-drug
DDI-DrugBank.d367.s1,.,143,143,O
DDI-DrugBank.d367.s2,There,0,4,O
DDI-DrugBank.d367.s2,is,6,7,O
DDI-DrugBank.d367.s2,no,9,10,O
DDI-DrugBank.d367.s2,information,12,22,O
DDI-DrugBank.d367.s2,on,24,25,O
DDI-DrugBank.d367.s2,the,27,29,O
DDI-DrugBank.d367.s2,effect,31,36,O
DDI-DrugBank.d367.s2,of,38,39,O
DDI-DrugBank.d367.s2,other,41,45,O
DDI-DrugBank.d367.s2,highly,47,52,O
DDI-DrugBank.d367.s2,plasma,54,59,O
DDI-DrugBank.d367.s2,protein,61,67,O
DDI-DrugBank.d367.s2,bound,69,73,O
DDI-DrugBank.d367.s2,drugs,75,79,O
DDI-DrugBank.d367.s2,on,81,82,O
DDI-DrugBank.d367.s2,doxazosin,84,92,B-drug
DDI-DrugBank.d367.s2,binding,94,100,O
DDI-DrugBank.d367.s2,.,101,101,O
DDI-DrugBank.d367.s3,Doxazosin,0,8,B-drug
DDI-DrugBank.d367.s3,mesylate,10,17,I-drug
DDI-DrugBank.d367.s3,has,19,21,O
DDI-DrugBank.d367.s3,been,23,26,O
DDI-DrugBank.d367.s3,administered,28,39,O
DDI-DrugBank.d367.s3,without,41,47,O
DDI-DrugBank.d367.s3,any,49,51,O
DDI-DrugBank.d367.s3,evidence,53,60,O
DDI-DrugBank.d367.s3,of,62,63,O
DDI-DrugBank.d367.s3,an,65,66,O
DDI-DrugBank.d367.s3,adverse,68,74,O
DDI-DrugBank.d367.s3,drug,76,79,O
DDI-DrugBank.d367.s3,interaction,81,91,O
DDI-DrugBank.d367.s3,to,93,94,O
DDI-DrugBank.d367.s3,patients,96,103,O
DDI-DrugBank.d367.s3,receiving,105,113,O
DDI-DrugBank.d367.s3,thiazide,115,122,B-group
DDI-DrugBank.d367.s3,diuretics,124,132,I-group
DDI-DrugBank.d367.s3,",",133,133,O
DDI-DrugBank.d367.s3,beta-blocking,135,147,B-group
DDI-DrugBank.d367.s3,agents,149,154,I-group
DDI-DrugBank.d367.s3,",",155,155,O
DDI-DrugBank.d367.s3,and,157,159,O
DDI-DrugBank.d367.s3,nonsteroidal,161,172,B-group
DDI-DrugBank.d367.s3,anti-inflammatory,174,190,I-group
DDI-DrugBank.d367.s3,drugs,192,196,I-group
DDI-DrugBank.d367.s3,.,197,197,O
DDI-DrugBank.d367.s4,In,0,1,O
DDI-DrugBank.d367.s4,a,3,3,O
DDI-DrugBank.d367.s4,placebo-controlled,5,22,O
DDI-DrugBank.d367.s4,trial,24,28,O
DDI-DrugBank.d367.s4,in,30,31,O
DDI-DrugBank.d367.s4,normal,33,38,O
DDI-DrugBank.d367.s4,volunteers,40,49,O
DDI-DrugBank.d367.s4,",",50,50,O
DDI-DrugBank.d367.s4,the,52,54,O
DDI-DrugBank.d367.s4,administration,56,69,O
DDI-DrugBank.d367.s4,of,71,72,O
DDI-DrugBank.d367.s4,a,74,74,O
DDI-DrugBank.d367.s4,single,76,81,O
DDI-DrugBank.d367.s4,1,83,83,O
DDI-DrugBank.d367.s4,mg,85,86,O
DDI-DrugBank.d367.s4,dose,88,91,O
DDI-DrugBank.d367.s4,of,93,94,O
DDI-DrugBank.d367.s4,doxazosin,96,104,B-drug
DDI-DrugBank.d367.s4,on,106,107,O
DDI-DrugBank.d367.s4,day,109,111,O
DDI-DrugBank.d367.s4,1,113,113,O
DDI-DrugBank.d367.s4,of,115,116,O
DDI-DrugBank.d367.s4,a,118,118,O
DDI-DrugBank.d367.s4,four-day,120,127,O
DDI-DrugBank.d367.s4,regimen,129,135,O
DDI-DrugBank.d367.s4,of,137,138,O
DDI-DrugBank.d367.s4,oral,140,143,O
DDI-DrugBank.d367.s4,cimetidine,145,154,B-drug
DDI-DrugBank.d367.s4,(,156,156,O
DDI-DrugBank.d367.s4,400,157,159,O
DDI-DrugBank.d367.s4,mg,161,162,O
DDI-DrugBank.d367.s4,twice,164,168,O
DDI-DrugBank.d367.s4,daily,170,174,O
DDI-DrugBank.d367.s4,),175,175,O
DDI-DrugBank.d367.s4,resulted,177,184,O
DDI-DrugBank.d367.s4,in,186,187,O
DDI-DrugBank.d367.s4,a,189,189,O
DDI-DrugBank.d367.s4,10,191,192,O
DDI-DrugBank.d367.s4,%,193,193,O
DDI-DrugBank.d367.s4,increase,195,202,O
DDI-DrugBank.d367.s4,in,204,205,O
DDI-DrugBank.d367.s4,mean,207,210,O
DDI-DrugBank.d367.s4,AUC,212,214,O
DDI-DrugBank.d367.s4,of,216,217,O
DDI-DrugBank.d367.s4,doxazosin,219,227,B-drug
DDI-DrugBank.d367.s4,(,229,229,O
DDI-DrugBank.d367.s4,p=0.006,230,236,O
DDI-DrugBank.d367.s4,),237,237,O
DDI-DrugBank.d367.s4,",",238,238,O
DDI-DrugBank.d367.s4,and,240,242,O
DDI-DrugBank.d367.s4,a,244,244,O
DDI-DrugBank.d367.s4,slight,246,251,O
DDI-DrugBank.d367.s4,but,253,255,O
DDI-DrugBank.d367.s4,not,257,259,O
DDI-DrugBank.d367.s4,statistically,261,273,O
DDI-DrugBank.d367.s4,significant,275,285,O
DDI-DrugBank.d367.s4,increase,287,294,O
DDI-DrugBank.d367.s4,in,296,297,O
DDI-DrugBank.d367.s4,mean,299,302,O
DDI-DrugBank.d367.s4,Cmax,304,307,O
DDI-DrugBank.d367.s4,and,309,311,O
DDI-DrugBank.d367.s4,mean,313,316,O
DDI-DrugBank.d367.s4,half-life,318,326,O
DDI-DrugBank.d367.s4,of,328,329,O
DDI-DrugBank.d367.s4,doxazosin,331,339,B-drug
DDI-DrugBank.d367.s4,.,340,340,O
DDI-DrugBank.d367.s5,The,0,2,O
DDI-DrugBank.d367.s5,clinical,4,11,O
DDI-DrugBank.d367.s5,significance,13,24,O
DDI-DrugBank.d367.s5,of,26,27,O
DDI-DrugBank.d367.s5,this,29,32,O
DDI-DrugBank.d367.s5,increase,34,41,O
DDI-DrugBank.d367.s5,in,43,44,O
DDI-DrugBank.d367.s5,doxazosin,46,54,B-drug
DDI-DrugBank.d367.s5,AUC,56,58,O
DDI-DrugBank.d367.s5,is,60,61,O
DDI-DrugBank.d367.s5,unknown,63,69,O
DDI-DrugBank.d367.s5,.,70,70,O
DDI-DrugBank.d367.s6,In,0,1,O
DDI-DrugBank.d367.s6,clinical,3,10,O
DDI-DrugBank.d367.s6,trials,12,17,O
DDI-DrugBank.d367.s6,",",18,18,O
DDI-DrugBank.d367.s6,doxazosin,20,28,B-drug
DDI-DrugBank.d367.s6,mesylate,30,37,I-drug
DDI-DrugBank.d367.s6,tablets,39,45,O
DDI-DrugBank.d367.s6,have,47,50,O
DDI-DrugBank.d367.s6,been,52,55,O
DDI-DrugBank.d367.s6,administered,57,68,O
DDI-DrugBank.d367.s6,to,70,71,O
DDI-DrugBank.d367.s6,patients,73,80,O
DDI-DrugBank.d367.s6,on,82,83,O
DDI-DrugBank.d367.s6,a,85,85,O
DDI-DrugBank.d367.s6,variety,87,93,O
DDI-DrugBank.d367.s6,of,95,96,O
DDI-DrugBank.d367.s6,concomitant,98,108,O
DDI-DrugBank.d367.s6,medications,110,120,O
DDI-DrugBank.d367.s6,;,121,121,O
DDI-DrugBank.d367.s7,while,0,4,O
DDI-DrugBank.d367.s7,no,6,7,O
DDI-DrugBank.d367.s7,formal,9,14,O
DDI-DrugBank.d367.s7,interaction,16,26,O
DDI-DrugBank.d367.s7,studies,28,34,O
DDI-DrugBank.d367.s7,have,36,39,O
DDI-DrugBank.d367.s7,been,41,44,O
DDI-DrugBank.d367.s7,conducted,46,54,O
DDI-DrugBank.d367.s7,",",55,55,O
DDI-DrugBank.d367.s7,no,57,58,O
DDI-DrugBank.d367.s7,interactions,60,71,O
DDI-DrugBank.d367.s7,were,73,76,O
DDI-DrugBank.d367.s7,observed,78,85,O
DDI-DrugBank.d367.s7,.,86,86,O
DDI-DrugBank.d367.s8,Doxazosin,0,8,B-drug
DDI-DrugBank.d367.s8,mesylate,10,17,I-drug
DDI-DrugBank.d367.s8,tablets,19,25,O
DDI-DrugBank.d367.s8,have,27,30,O
DDI-DrugBank.d367.s8,been,32,35,O
DDI-DrugBank.d367.s8,used,37,40,O
DDI-DrugBank.d367.s8,with,42,45,O
DDI-DrugBank.d367.s8,the,47,49,O
DDI-DrugBank.d367.s8,following,51,59,O
DDI-DrugBank.d367.s8,drugs,61,65,O
DDI-DrugBank.d367.s8,or,67,68,O
DDI-DrugBank.d367.s8,drug,70,73,O
DDI-DrugBank.d367.s8,classes,75,81,O
DDI-DrugBank.d367.s8,:,82,82,O
DDI-DrugBank.d367.s8,1,84,84,O
DDI-DrugBank.d367.s8,.,85,85,O
DDI-DrugBank.d367.s9,Analgesic/anti-inflammatory,0,26,O
DDI-DrugBank.d367.s9,(,28,28,O
DDI-DrugBank.d367.s9,e.g.,29,32,O
DDI-DrugBank.d367.s9,",",33,33,O
DDI-DrugBank.d367.s9,acetaminophen,35,47,B-drug
DDI-DrugBank.d367.s9,",",48,48,O
DDI-DrugBank.d367.s9,aspirin,50,56,B-brand
DDI-DrugBank.d367.s9,",",57,57,O
DDI-DrugBank.d367.s9,codeine,59,65,B-drug
DDI-DrugBank.d367.s9,and,67,69,O
DDI-DrugBank.d367.s9,codeine,71,77,B-drug
DDI-DrugBank.d367.s9,combinations,79,90,O
DDI-DrugBank.d367.s9,",",91,91,O
DDI-DrugBank.d367.s9,ibuprofen,93,101,B-drug
DDI-DrugBank.d367.s9,",",102,102,O
DDI-DrugBank.d367.s9,indomethacin,104,115,B-drug
DDI-DrugBank.d367.s9,),116,116,O
DDI-DrugBank.d367.s9,.,117,117,O
DDI-DrugBank.d367.s10,2,0,0,O
DDI-DrugBank.d367.s10,.,1,1,O
DDI-DrugBank.d367.s11,Antibiotics,0,10,B-group
DDI-DrugBank.d367.s11,(,12,12,O
DDI-DrugBank.d367.s11,e.g.,13,16,O
DDI-DrugBank.d367.s11,",",17,17,O
DDI-DrugBank.d367.s11,erythromycin,19,30,B-drug
DDI-DrugBank.d367.s11,",",31,31,O
DDI-DrugBank.d367.s11,trimethoprim,33,44,B-drug
DDI-DrugBank.d367.s11,and,46,48,O
DDI-DrugBank.d367.s11,sulfamethoxazole,50,65,B-drug
DDI-DrugBank.d367.s11,",",66,66,O
DDI-DrugBank.d367.s11,amoxicillin,68,78,B-drug
DDI-DrugBank.d367.s11,),79,79,O
DDI-DrugBank.d367.s11,.,80,80,O
DDI-DrugBank.d367.s12,3,0,0,O
DDI-DrugBank.d367.s12,.,1,1,O
DDI-DrugBank.d367.s13,Antihistamines,0,13,B-group
DDI-DrugBank.d367.s13,(,15,15,O
DDI-DrugBank.d367.s13,e.g.,16,19,O
DDI-DrugBank.d367.s13,",",20,20,O
DDI-DrugBank.d367.s13,chlorpheniramine,22,37,B-group
DDI-DrugBank.d367.s13,),38,38,O
DDI-DrugBank.d367.s13,.,39,39,O
DDI-DrugBank.d367.s14,4,0,0,O
DDI-DrugBank.d367.s14,.,1,1,O
DDI-DrugBank.d367.s15,Cardiovascular,0,13,O
DDI-DrugBank.d367.s15,agents,15,20,O
DDI-DrugBank.d367.s15,(,22,22,O
DDI-DrugBank.d367.s15,e.g.,23,26,O
DDI-DrugBank.d367.s15,",",27,27,O
DDI-DrugBank.d367.s15,atenolol,29,36,B-drug
DDI-DrugBank.d367.s15,",",37,37,O
DDI-DrugBank.d367.s15,hydrochlorothiazide,39,57,B-drug
DDI-DrugBank.d367.s15,",",58,58,O
DDI-DrugBank.d367.s15,propranolol,60,70,B-drug
DDI-DrugBank.d367.s15,),71,71,O
DDI-DrugBank.d367.s15,.,72,72,O
DDI-DrugBank.d367.s16,5,0,0,O
DDI-DrugBank.d367.s16,.,1,1,O
DDI-DrugBank.d367.s17,Corticosteroids,0,14,B-group
DDI-DrugBank.d367.s17,.,15,15,O
DDI-DrugBank.d367.s18,6,0,0,O
DDI-DrugBank.d367.s18,.,1,1,O
DDI-DrugBank.d367.s19,Gastrointestinal,0,15,O
DDI-DrugBank.d367.s19,agents,17,22,O
DDI-DrugBank.d367.s19,(,24,24,O
DDI-DrugBank.d367.s19,e.g.,25,28,O
DDI-DrugBank.d367.s19,",",29,29,O
DDI-DrugBank.d367.s19,antacids,31,38,B-group
DDI-DrugBank.d367.s19,),39,39,O
DDI-DrugBank.d367.s19,.,40,40,O
DDI-DrugBank.d367.s20,7,0,0,O
DDI-DrugBank.d367.s20,.,1,1,O
DDI-DrugBank.d367.s21,Hypoglycemics,0,12,B-group
DDI-DrugBank.d367.s21,and,14,16,O
DDI-DrugBank.d367.s21,endocrine,18,26,O
DDI-DrugBank.d367.s21,drugs,28,32,O
DDI-DrugBank.d367.s21,.,33,33,O
DDI-DrugBank.d367.s22,8,0,0,O
DDI-DrugBank.d367.s22,.,1,1,O
DDI-DrugBank.d367.s23,Sedatives,0,8,B-group
DDI-DrugBank.d367.s23,and,10,12,O
DDI-DrugBank.d367.s23,tranquilizers,14,26,B-group
DDI-DrugBank.d367.s23,(,28,28,O
DDI-DrugBank.d367.s23,e.g.,29,32,O
DDI-DrugBank.d367.s23,",",33,33,O
DDI-DrugBank.d367.s23,diazepam,35,42,B-drug
DDI-DrugBank.d367.s23,),43,43,O
DDI-DrugBank.d367.s23,.,44,44,O
DDI-DrugBank.d367.s24,9,0,0,O
DDI-DrugBank.d367.s24,.,1,1,O
DDI-DrugBank.d367.s25,Cold,0,3,O
DDI-DrugBank.d367.s25,and,5,7,O
DDI-DrugBank.d367.s25,flu,9,11,O
DDI-DrugBank.d367.s25,remedies,13,20,O
DDI-DrugBank.d367.s25,.,21,21,O
DDI-DrugBank.d223.s0,Drugs,0,4,O
DDI-DrugBank.d223.s0,Metabolized,6,16,O
DDI-DrugBank.d223.s0,by,18,19,O
DDI-DrugBank.d223.s0,P450,21,24,O
DDI-DrugBank.d223.s0,2D6,26,28,O
DDI-DrugBank.d223.s0,:,29,29,O
DDI-DrugBank.d223.s0,The,31,33,O
DDI-DrugBank.d223.s0,biochemical,35,45,O
DDI-DrugBank.d223.s0,activity,47,54,O
DDI-DrugBank.d223.s0,of,56,57,O
DDI-DrugBank.d223.s0,the,59,61,O
DDI-DrugBank.d223.s0,drug,63,66,O
DDI-DrugBank.d223.s0,metabolizing,68,79,O
DDI-DrugBank.d223.s0,isozyme,81,87,O
DDI-DrugBank.d223.s0,cytochrome,89,98,O
DDI-DrugBank.d223.s0,P450,100,103,O
DDI-DrugBank.d223.s0,2D6,105,107,O
DDI-DrugBank.d223.s0,(,109,109,O
DDI-DrugBank.d223.s0,debrisoquin,110,120,O
DDI-DrugBank.d223.s0,hydroxylase,122,132,O
DDI-DrugBank.d223.s0,),133,133,O
DDI-DrugBank.d223.s0,is,135,136,O
DDI-DrugBank.d223.s0,reduced,138,144,O
DDI-DrugBank.d223.s0,in,146,147,O
DDI-DrugBank.d223.s0,a,149,149,O
DDI-DrugBank.d223.s0,subset,151,156,O
DDI-DrugBank.d223.s0,of,158,159,O
DDI-DrugBank.d223.s0,the,161,163,O
DDI-DrugBank.d223.s0,Caucasian,165,173,O
DDI-DrugBank.d223.s0,population,175,184,O
DDI-DrugBank.d223.s0,(,186,186,O
DDI-DrugBank.d223.s0,about,187,191,O
DDI-DrugBank.d223.s0,7-10,193,196,O
DDI-DrugBank.d223.s0,%,197,197,O
DDI-DrugBank.d223.s0,of,199,200,O
DDI-DrugBank.d223.s0,Caucasians,202,211,O
DDI-DrugBank.d223.s0,are,213,215,O
DDI-DrugBank.d223.s0,so-called,217,225,O
DDI-DrugBank.d223.s0,poor,227,230,O
DDI-DrugBank.d223.s0,metabolizers,232,243,O
DDI-DrugBank.d223.s0,),244,244,O
DDI-DrugBank.d223.s0,;,245,245,O
DDI-DrugBank.d223.s1,reliable,0,7,O
DDI-DrugBank.d223.s1,estimates,9,17,O
DDI-DrugBank.d223.s1,of,19,20,O
DDI-DrugBank.d223.s1,the,22,24,O
DDI-DrugBank.d223.s1,prevalence,26,35,O
DDI-DrugBank.d223.s1,of,37,38,O
DDI-DrugBank.d223.s1,reduced,40,46,O
DDI-DrugBank.d223.s1,P450,48,51,O
DDI-DrugBank.d223.s1,2D6,53,55,O
DDI-DrugBank.d223.s1,isozyme,57,63,O
DDI-DrugBank.d223.s1,activity,65,72,O
DDI-DrugBank.d223.s1,among,74,78,O
DDI-DrugBank.d223.s1,Asian,80,84,O
DDI-DrugBank.d223.s1,",",85,85,O
DDI-DrugBank.d223.s1,African,87,93,O
DDI-DrugBank.d223.s1,and,95,97,O
DDI-DrugBank.d223.s1,other,99,103,O
DDI-DrugBank.d223.s1,populations,105,115,O
DDI-DrugBank.d223.s1,are,117,119,O
DDI-DrugBank.d223.s1,not,121,123,O
DDI-DrugBank.d223.s1,yet,125,127,O
DDI-DrugBank.d223.s1,available,129,137,O
DDI-DrugBank.d223.s1,.,138,138,O
DDI-DrugBank.d223.s2,Poor,0,3,O
DDI-DrugBank.d223.s2,metabolizers,5,16,O
DDI-DrugBank.d223.s2,have,18,21,O
DDI-DrugBank.d223.s2,higher,23,28,O
DDI-DrugBank.d223.s2,than,30,33,O
DDI-DrugBank.d223.s2,expected,35,42,O
DDI-DrugBank.d223.s2,plasma,44,49,O
DDI-DrugBank.d223.s2,concentrations,51,64,O
DDI-DrugBank.d223.s2,of,66,67,O
DDI-DrugBank.d223.s2,tricyclic,69,77,B-group
DDI-DrugBank.d223.s2,antidepressants,79,93,I-group
DDI-DrugBank.d223.s2,(,95,95,O
DDI-DrugBank.d223.s2,TCAs,96,99,B-group
DDI-DrugBank.d223.s2,),100,100,O
DDI-DrugBank.d223.s2,when,102,105,O
DDI-DrugBank.d223.s2,given,107,111,O
DDI-DrugBank.d223.s2,usual,113,117,O
DDI-DrugBank.d223.s2,doses,119,123,O
DDI-DrugBank.d223.s2,.,124,124,O
DDI-DrugBank.d223.s3,Depending,0,8,O
DDI-DrugBank.d223.s3,on,10,11,O
DDI-DrugBank.d223.s3,the,13,15,O
DDI-DrugBank.d223.s3,fraction,17,24,O
DDI-DrugBank.d223.s3,of,26,27,O
DDI-DrugBank.d223.s3,drug,29,32,O
DDI-DrugBank.d223.s3,metabolized,34,44,O
DDI-DrugBank.d223.s3,by,46,47,O
DDI-DrugBank.d223.s3,P450,49,52,O
DDI-DrugBank.d223.s3,2D6,54,56,O
DDI-DrugBank.d223.s3,",",57,57,O
DDI-DrugBank.d223.s3,the,59,61,O
DDI-DrugBank.d223.s3,increase,63,70,O
DDI-DrugBank.d223.s3,in,72,73,O
DDI-DrugBank.d223.s3,plasma,75,80,O
DDI-DrugBank.d223.s3,concentration,82,94,O
DDI-DrugBank.d223.s3,may,96,98,O
DDI-DrugBank.d223.s3,be,100,101,O
DDI-DrugBank.d223.s3,small,103,107,O
DDI-DrugBank.d223.s3,",",108,108,O
DDI-DrugBank.d223.s3,or,110,111,O
DDI-DrugBank.d223.s3,quite,113,117,O
DDI-DrugBank.d223.s3,large,119,123,O
DDI-DrugBank.d223.s3,(,125,125,O
DDI-DrugBank.d223.s3,8-fold,126,131,O
DDI-DrugBank.d223.s3,increase,133,140,O
DDI-DrugBank.d223.s3,in,142,143,O
DDI-DrugBank.d223.s3,plasma,145,150,O
DDI-DrugBank.d223.s3,AUC,152,154,O
DDI-DrugBank.d223.s3,of,156,157,O
DDI-DrugBank.d223.s3,the,159,161,O
DDI-DrugBank.d223.s3,TCA,163,165,O
DDI-DrugBank.d223.s3,),166,166,O
DDI-DrugBank.d223.s3,.,167,167,O
DDI-DrugBank.d223.s4,In,0,1,O
DDI-DrugBank.d223.s4,addition,3,10,O
DDI-DrugBank.d223.s4,",",11,11,O
DDI-DrugBank.d223.s4,certain,13,19,O
DDI-DrugBank.d223.s4,drugs,21,25,O
DDI-DrugBank.d223.s4,inhibit,27,33,O
DDI-DrugBank.d223.s4,the,35,37,O
DDI-DrugBank.d223.s4,activity,39,46,O
DDI-DrugBank.d223.s4,of,48,49,O
DDI-DrugBank.d223.s4,this,51,54,O
DDI-DrugBank.d223.s4,isozyme,56,62,O
DDI-DrugBank.d223.s4,and,64,66,O
DDI-DrugBank.d223.s4,make,68,71,O
DDI-DrugBank.d223.s4,normal,73,78,O
DDI-DrugBank.d223.s4,metabolizers,80,91,O
DDI-DrugBank.d223.s4,resemble,93,100,O
DDI-DrugBank.d223.s4,poor,102,105,O
DDI-DrugBank.d223.s4,metabolizers,107,118,O
DDI-DrugBank.d223.s4,.,119,119,O
DDI-DrugBank.d223.s5,An,0,1,O
DDI-DrugBank.d223.s5,individual,3,12,O
DDI-DrugBank.d223.s5,who,14,16,O
DDI-DrugBank.d223.s5,is,18,19,O
DDI-DrugBank.d223.s5,stable,21,26,O
DDI-DrugBank.d223.s5,on,28,29,O
DDI-DrugBank.d223.s5,a,31,31,O
DDI-DrugBank.d223.s5,given,33,37,O
DDI-DrugBank.d223.s5,dose,39,42,O
DDI-DrugBank.d223.s5,of,44,45,O
DDI-DrugBank.d223.s5,TCA,47,49,B-group
DDI-DrugBank.d223.s5,may,51,53,O
DDI-DrugBank.d223.s5,become,55,60,O
DDI-DrugBank.d223.s5,abruptly,62,69,O
DDI-DrugBank.d223.s5,toxic,71,75,O
DDI-DrugBank.d223.s5,when,77,80,O
DDI-DrugBank.d223.s5,given,82,86,O
DDI-DrugBank.d223.s5,one,88,90,O
DDI-DrugBank.d223.s5,of,92,93,O
DDI-DrugBank.d223.s5,these,95,99,O
DDI-DrugBank.d223.s5,inhibiting,101,110,O
DDI-DrugBank.d223.s5,drugs,112,116,O
DDI-DrugBank.d223.s5,as,118,119,O
DDI-DrugBank.d223.s5,concomitant,121,131,O
DDI-DrugBank.d223.s5,therapy,133,139,O
DDI-DrugBank.d223.s5,.,140,140,O
DDI-DrugBank.d223.s6,The,0,2,O
DDI-DrugBank.d223.s6,drugs,4,8,O
DDI-DrugBank.d223.s6,that,10,13,O
DDI-DrugBank.d223.s6,inhibit,15,21,O
DDI-DrugBank.d223.s6,cytochrome,23,32,O
DDI-DrugBank.d223.s6,P450,34,37,O
DDI-DrugBank.d223.s6,2D6,39,41,O
DDI-DrugBank.d223.s6,include,43,49,O
DDI-DrugBank.d223.s6,some,51,54,O
DDI-DrugBank.d223.s6,that,56,59,O
DDI-DrugBank.d223.s6,are,61,63,O
DDI-DrugBank.d223.s6,not,65,67,O
DDI-DrugBank.d223.s6,metabolized,69,79,O
DDI-DrugBank.d223.s6,by,81,82,O
DDI-DrugBank.d223.s6,the,84,86,O
DDI-DrugBank.d223.s6,enzyme,88,93,O
DDI-DrugBank.d223.s6,(,95,95,O
DDI-DrugBank.d223.s6,quinidine,96,104,B-drug
DDI-DrugBank.d223.s6,;,105,105,O
DDI-DrugBank.d223.s7,cimetidine,0,9,B-drug
DDI-DrugBank.d223.s7,),10,10,O
DDI-DrugBank.d223.s7,and,12,14,O
DDI-DrugBank.d223.s7,many,16,19,O
DDI-DrugBank.d223.s7,that,21,24,O
DDI-DrugBank.d223.s7,are,26,28,O
DDI-DrugBank.d223.s7,substrates,30,39,O
DDI-DrugBank.d223.s7,for,41,43,O
DDI-DrugBank.d223.s7,P450,45,48,O
DDI-DrugBank.d223.s7,2D6,50,52,O
DDI-DrugBank.d223.s7,(,54,54,O
DDI-DrugBank.d223.s7,many,55,58,O
DDI-DrugBank.d223.s7,other,60,64,O
DDI-DrugBank.d223.s7,antidepressants,66,80,B-group
DDI-DrugBank.d223.s7,",",81,81,O
DDI-DrugBank.d223.s7,phenothiazines,83,96,B-group
DDI-DrugBank.d223.s7,",",97,97,O
DDI-DrugBank.d223.s7,and,99,101,O
DDI-DrugBank.d223.s7,the,103,105,O
DDI-DrugBank.d223.s7,Type,107,110,B-group
DDI-DrugBank.d223.s7,1C,112,113,I-group
DDI-DrugBank.d223.s7,antiarrhythmics,115,129,I-group
DDI-DrugBank.d223.s7,propafenone,131,141,B-drug
DDI-DrugBank.d223.s7,and,143,145,O
DDI-DrugBank.d223.s7,flecainide,147,156,B-drug
DDI-DrugBank.d223.s7,),157,157,O
DDI-DrugBank.d223.s7,.,158,158,O
DDI-DrugBank.d223.s8,While,0,4,O
DDI-DrugBank.d223.s8,all,6,8,O
DDI-DrugBank.d223.s8,the,10,12,O
DDI-DrugBank.d223.s8,selective,14,22,B-group
DDI-DrugBank.d223.s8,serotonin,24,32,I-group
DDI-DrugBank.d223.s8,reuptake,34,41,I-group
DDI-DrugBank.d223.s8,inhibitors,43,52,I-group
DDI-DrugBank.d223.s8,(,54,54,O
DDI-DrugBank.d223.s8,SSRIs,55,59,B-group
DDI-DrugBank.d223.s8,),60,60,O
DDI-DrugBank.d223.s8,",",61,61,O
DDI-DrugBank.d223.s8,e.g.,63,66,O
DDI-DrugBank.d223.s8,",",67,67,O
DDI-DrugBank.d223.s8,citalopram,69,78,B-drug
DDI-DrugBank.d223.s8,",",79,79,O
DDI-DrugBank.d223.s8,escitalopram,81,92,B-drug
DDI-DrugBank.d223.s8,",",93,93,O
DDI-DrugBank.d223.s8,fluoxetine,95,104,B-drug
DDI-DrugBank.d223.s8,",",105,105,O
DDI-DrugBank.d223.s8,sertraline,107,116,B-drug
DDI-DrugBank.d223.s8,",",117,117,O
DDI-DrugBank.d223.s8,and,119,121,O
DDI-DrugBank.d223.s8,paroxetine,123,132,B-drug
DDI-DrugBank.d223.s8,",",133,133,O
DDI-DrugBank.d223.s8,inhibit,135,141,O
DDI-DrugBank.d223.s8,P450,143,146,O
DDI-DrugBank.d223.s8,2D6,148,150,O
DDI-DrugBank.d223.s8,",",151,151,O
DDI-DrugBank.d223.s8,they,153,156,O
DDI-DrugBank.d223.s8,may,158,160,O
DDI-DrugBank.d223.s8,vary,162,165,O
DDI-DrugBank.d223.s8,in,167,168,O
DDI-DrugBank.d223.s8,the,170,172,O
DDI-DrugBank.d223.s8,extent,174,179,O
DDI-DrugBank.d223.s8,of,181,182,O
DDI-DrugBank.d223.s8,inhibition,184,193,O
DDI-DrugBank.d223.s8,.,194,194,O
DDI-DrugBank.d223.s9,The,0,2,O
DDI-DrugBank.d223.s9,extent,4,9,O
DDI-DrugBank.d223.s9,to,11,12,O
DDI-DrugBank.d223.s9,which,14,18,O
DDI-DrugBank.d223.s9,SSRI-TCA,20,27,O
DDI-DrugBank.d223.s9,interactions,29,40,O
DDI-DrugBank.d223.s9,may,42,44,O
DDI-DrugBank.d223.s9,pose,46,49,O
DDI-DrugBank.d223.s9,clinical,51,58,O
DDI-DrugBank.d223.s9,problems,60,67,O
DDI-DrugBank.d223.s9,will,69,72,O
DDI-DrugBank.d223.s9,depend,74,79,O
DDI-DrugBank.d223.s9,on,81,82,O
DDI-DrugBank.d223.s9,the,84,86,O
DDI-DrugBank.d223.s9,degree,88,93,O
DDI-DrugBank.d223.s9,of,95,96,O
DDI-DrugBank.d223.s9,inhibition,98,107,O
DDI-DrugBank.d223.s9,and,109,111,O
DDI-DrugBank.d223.s9,the,113,115,O
DDI-DrugBank.d223.s9,pharmacokinetics,117,132,O
DDI-DrugBank.d223.s9,of,134,135,O
DDI-DrugBank.d223.s9,the,137,139,O
DDI-DrugBank.d223.s9,SSRI,141,144,B-group
DDI-DrugBank.d223.s9,involved,146,153,O
DDI-DrugBank.d223.s9,.,154,154,O
DDI-DrugBank.d223.s10,Nevertheless,0,11,O
DDI-DrugBank.d223.s10,",",12,12,O
DDI-DrugBank.d223.s10,caution,14,20,O
DDI-DrugBank.d223.s10,is,22,23,O
DDI-DrugBank.d223.s10,indicated,25,33,O
DDI-DrugBank.d223.s10,in,35,36,O
DDI-DrugBank.d223.s10,the,38,40,O
DDI-DrugBank.d223.s10,co-administration,42,58,O
DDI-DrugBank.d223.s10,of,60,61,O
DDI-DrugBank.d223.s10,TCAs,63,66,B-group
DDI-DrugBank.d223.s10,with,68,71,O
DDI-DrugBank.d223.s10,any,73,75,O
DDI-DrugBank.d223.s10,of,77,78,O
DDI-DrugBank.d223.s10,the,80,82,O
DDI-DrugBank.d223.s10,SSRIs,84,88,B-group
DDI-DrugBank.d223.s10,and,90,92,O
DDI-DrugBank.d223.s10,also,94,97,O
DDI-DrugBank.d223.s10,in,99,100,O
DDI-DrugBank.d223.s10,switching,102,110,O
DDI-DrugBank.d223.s10,from,112,115,O
DDI-DrugBank.d223.s10,one,117,119,O
DDI-DrugBank.d223.s10,class,121,125,O
DDI-DrugBank.d223.s10,to,127,128,O
DDI-DrugBank.d223.s10,the,130,132,O
DDI-DrugBank.d223.s10,other,134,138,O
DDI-DrugBank.d223.s10,.,139,139,O
DDI-DrugBank.d223.s11,Of,0,1,O
DDI-DrugBank.d223.s11,particular,3,12,O
DDI-DrugBank.d223.s11,importance,14,23,O
DDI-DrugBank.d223.s11,",",24,24,O
DDI-DrugBank.d223.s11,sufficient,26,35,O
DDI-DrugBank.d223.s11,time,37,40,O
DDI-DrugBank.d223.s11,must,42,45,O
DDI-DrugBank.d223.s11,elapse,47,52,O
DDI-DrugBank.d223.s11,before,54,59,O
DDI-DrugBank.d223.s11,initiating,61,70,O
DDI-DrugBank.d223.s11,TCA,72,74,O
DDI-DrugBank.d223.s11,treatment,76,84,O
DDI-DrugBank.d223.s11,in,86,87,O
DDI-DrugBank.d223.s11,a,89,89,O
DDI-DrugBank.d223.s11,patient,91,97,O
DDI-DrugBank.d223.s11,being,99,103,O
DDI-DrugBank.d223.s11,withdrawn,105,113,O
DDI-DrugBank.d223.s11,from,115,118,O
DDI-DrugBank.d223.s11,fluoxetine,120,129,B-drug
DDI-DrugBank.d223.s11,",",130,130,O
DDI-DrugBank.d223.s11,given,132,136,O
DDI-DrugBank.d223.s11,the,138,140,O
DDI-DrugBank.d223.s11,long,142,145,O
DDI-DrugBank.d223.s11,half-life,147,155,O
DDI-DrugBank.d223.s11,of,157,158,O
DDI-DrugBank.d223.s11,the,160,162,O
DDI-DrugBank.d223.s11,parent,164,169,O
DDI-DrugBank.d223.s11,and,171,173,O
DDI-DrugBank.d223.s11,active,175,180,O
DDI-DrugBank.d223.s11,metabolite,182,191,O
DDI-DrugBank.d223.s11,(,193,193,O
DDI-DrugBank.d223.s11,at,194,195,O
DDI-DrugBank.d223.s11,least,197,201,O
DDI-DrugBank.d223.s11,5,203,203,O
DDI-DrugBank.d223.s11,weeks,205,209,O
DDI-DrugBank.d223.s11,may,211,213,O
DDI-DrugBank.d223.s11,be,215,216,O
DDI-DrugBank.d223.s11,necessary,218,226,O
DDI-DrugBank.d223.s11,),227,227,O
DDI-DrugBank.d223.s11,.,228,228,O
DDI-DrugBank.d223.s12,Concomitant,0,10,O
DDI-DrugBank.d223.s12,use,12,14,O
DDI-DrugBank.d223.s12,of,16,17,O
DDI-DrugBank.d223.s12,tricyclic,19,27,B-group
DDI-DrugBank.d223.s12,antidepressants,29,43,I-group
DDI-DrugBank.d223.s12,with,45,48,O
DDI-DrugBank.d223.s12,drugs,50,54,O
DDI-DrugBank.d223.s12,that,56,59,O
DDI-DrugBank.d223.s12,can,61,63,O
DDI-DrugBank.d223.s12,inhibit,65,71,O
DDI-DrugBank.d223.s12,cytochrome,73,82,O
DDI-DrugBank.d223.s12,P450,84,87,O
DDI-DrugBank.d223.s12,2D6,89,91,O
DDI-DrugBank.d223.s12,may,93,95,O
DDI-DrugBank.d223.s12,require,97,103,O
DDI-DrugBank.d223.s12,lower,105,109,O
DDI-DrugBank.d223.s12,doses,111,115,O
DDI-DrugBank.d223.s12,than,117,120,O
DDI-DrugBank.d223.s12,usually,122,128,O
DDI-DrugBank.d223.s12,prescribed,130,139,O
DDI-DrugBank.d223.s12,for,141,143,O
DDI-DrugBank.d223.s12,either,145,150,O
DDI-DrugBank.d223.s12,the,152,154,O
DDI-DrugBank.d223.s12,tricyclic,156,164,B-group
DDI-DrugBank.d223.s12,antidepressant,166,179,I-group
DDI-DrugBank.d223.s12,or,181,182,O
DDI-DrugBank.d223.s12,the,184,186,O
DDI-DrugBank.d223.s12,other,188,192,O
DDI-DrugBank.d223.s12,drug,194,197,O
DDI-DrugBank.d223.s12,.,198,198,O
DDI-DrugBank.d223.s13,Furthermore,0,10,O
DDI-DrugBank.d223.s13,",",11,11,O
DDI-DrugBank.d223.s13,whenever,13,20,O
DDI-DrugBank.d223.s13,one,22,24,O
DDI-DrugBank.d223.s13,of,26,27,O
DDI-DrugBank.d223.s13,these,29,33,O
DDI-DrugBank.d223.s13,other,35,39,O
DDI-DrugBank.d223.s13,drugs,41,45,O
DDI-DrugBank.d223.s13,is,47,48,O
DDI-DrugBank.d223.s13,withdrawn,50,58,O
DDI-DrugBank.d223.s13,from,60,63,O
DDI-DrugBank.d223.s13,co-therapy,65,74,O
DDI-DrugBank.d223.s13,",",75,75,O
DDI-DrugBank.d223.s13,an,77,78,O
DDI-DrugBank.d223.s13,increased,80,88,O
DDI-DrugBank.d223.s13,dose,90,93,O
DDI-DrugBank.d223.s13,of,95,96,O
DDI-DrugBank.d223.s13,tricyclic,98,106,B-group
DDI-DrugBank.d223.s13,antidepressant,108,121,I-group
DDI-DrugBank.d223.s13,may,123,125,O
DDI-DrugBank.d223.s13,be,127,128,O
DDI-DrugBank.d223.s13,required,130,137,O
DDI-DrugBank.d223.s13,.,138,138,O
DDI-DrugBank.d223.s14,It,0,1,O
DDI-DrugBank.d223.s14,is,3,4,O
DDI-DrugBank.d223.s14,desirable,6,14,O
DDI-DrugBank.d223.s14,to,16,17,O
DDI-DrugBank.d223.s14,monitor,19,25,O
DDI-DrugBank.d223.s14,TCA,27,29,B-group
DDI-DrugBank.d223.s14,plasma,31,36,O
DDI-DrugBank.d223.s14,levels,38,43,O
DDI-DrugBank.d223.s14,whenever,45,52,O
DDI-DrugBank.d223.s14,a,54,54,O
DDI-DrugBank.d223.s14,TCA,56,58,B-group
DDI-DrugBank.d223.s14,is,60,61,O
DDI-DrugBank.d223.s14,going,63,67,O
DDI-DrugBank.d223.s14,to,69,70,O
DDI-DrugBank.d223.s14,be,72,73,O
DDI-DrugBank.d223.s14,co-administered,75,89,O
DDI-DrugBank.d223.s14,with,91,94,O
DDI-DrugBank.d223.s14,another,96,102,O
DDI-DrugBank.d223.s14,drug,104,107,O
DDI-DrugBank.d223.s14,known,109,113,O
DDI-DrugBank.d223.s14,to,115,116,O
DDI-DrugBank.d223.s14,be,118,119,O
DDI-DrugBank.d223.s14,an,121,122,O
DDI-DrugBank.d223.s14,inhibitor,124,132,O
DDI-DrugBank.d223.s14,of,134,135,O
DDI-DrugBank.d223.s14,P450,137,140,O
DDI-DrugBank.d223.s14,2D6,142,144,O
DDI-DrugBank.d223.s14,.,145,145,O
DDI-DrugBank.d223.s15,Doxepin,0,6,B-drug
DDI-DrugBank.d223.s15,is,8,9,O
DDI-DrugBank.d223.s15,primarily,11,19,O
DDI-DrugBank.d223.s15,metabolized,21,31,O
DDI-DrugBank.d223.s15,by,33,34,O
DDI-DrugBank.d223.s15,CYP2D6,36,41,O
DDI-DrugBank.d223.s15,(,43,43,O
DDI-DrugBank.d223.s15,with,44,47,O
DDI-DrugBank.d223.s15,CYP1A2,49,54,O
DDI-DrugBank.d223.s15,and,57,59,O
DDI-DrugBank.d223.s15,CYP3A4,62,67,O
DDI-DrugBank.d223.s15,as,69,70,O
DDI-DrugBank.d223.s15,minor,72,76,O
DDI-DrugBank.d223.s15,pathways,78,85,O
DDI-DrugBank.d223.s15,),86,86,O
DDI-DrugBank.d223.s15,.,87,87,O
DDI-DrugBank.d223.s16,Inhibitors,0,9,O
DDI-DrugBank.d223.s16,or,11,12,O
DDI-DrugBank.d223.s16,substrates,14,23,O
DDI-DrugBank.d223.s16,of,25,26,O
DDI-DrugBank.d223.s16,CYP2D6,28,33,O
DDI-DrugBank.d223.s16,(,35,35,O
DDI-DrugBank.d223.s16,i.e.,36,39,O
DDI-DrugBank.d223.s16,",",40,40,O
DDI-DrugBank.d223.s16,quinidine,42,50,B-drug
DDI-DrugBank.d223.s16,",",51,51,O
DDI-DrugBank.d223.s16,selective,53,61,B-group
DDI-DrugBank.d223.s16,serotonin,63,71,I-group
DDI-DrugBank.d223.s16,reuptake,73,80,I-group
DDI-DrugBank.d223.s16,inhibitors,82,91,I-group
DDI-DrugBank.d223.s16,[,93,93,O
DDI-DrugBank.d223.s16,SSRIs,94,98,B-group
DDI-DrugBank.d223.s16,],99,99,O
DDI-DrugBank.d223.s16,),100,100,O
DDI-DrugBank.d223.s16,may,102,104,O
DDI-DrugBank.d223.s16,increase,106,113,O
DDI-DrugBank.d223.s16,the,115,117,O
DDI-DrugBank.d223.s16,plasma,119,124,O
DDI-DrugBank.d223.s16,concentration,126,138,O
DDI-DrugBank.d223.s16,of,140,141,O
DDI-DrugBank.d223.s16,doxepin,143,149,B-drug
DDI-DrugBank.d223.s16,when,151,154,O
DDI-DrugBank.d223.s16,administered,156,167,O
DDI-DrugBank.d223.s16,concomitantly,169,181,O
DDI-DrugBank.d223.s16,.,182,182,O
DDI-DrugBank.d223.s17,The,0,2,O
DDI-DrugBank.d223.s17,extent,4,9,O
DDI-DrugBank.d223.s17,of,11,12,O
DDI-DrugBank.d223.s17,interaction,14,24,O
DDI-DrugBank.d223.s17,depends,26,32,O
DDI-DrugBank.d223.s17,on,34,35,O
DDI-DrugBank.d223.s17,the,37,39,O
DDI-DrugBank.d223.s17,variability,41,51,O
DDI-DrugBank.d223.s17,of,53,54,O
DDI-DrugBank.d223.s17,effect,56,61,O
DDI-DrugBank.d223.s17,on,63,64,O
DDI-DrugBank.d223.s17,CYP2D6,66,71,O
DDI-DrugBank.d223.s17,.,72,72,O
DDI-DrugBank.d223.s18,The,0,2,O
DDI-DrugBank.d223.s18,clinical,4,11,O
DDI-DrugBank.d223.s18,significance,13,24,O
DDI-DrugBank.d223.s18,of,26,27,O
DDI-DrugBank.d223.s18,this,29,32,O
DDI-DrugBank.d223.s18,interaction,34,44,O
DDI-DrugBank.d223.s18,with,46,49,O
DDI-DrugBank.d223.s18,doxepin,51,57,B-drug
DDI-DrugBank.d223.s18,has,59,61,O
DDI-DrugBank.d223.s18,not,63,65,O
DDI-DrugBank.d223.s18,been,67,70,O
DDI-DrugBank.d223.s18,systematically,72,85,O
DDI-DrugBank.d223.s18,evaluated,87,95,O
DDI-DrugBank.d223.s18,.,96,96,O
DDI-DrugBank.d223.s19,MAO,0,2,B-group
DDI-DrugBank.d223.s19,Inhibitors,4,13,I-group
DDI-DrugBank.d223.s19,:,14,14,O
DDI-DrugBank.d223.s19,Serious,16,22,O
DDI-DrugBank.d223.s19,side,24,27,O
DDI-DrugBank.d223.s19,effects,29,35,O
DDI-DrugBank.d223.s19,and,37,39,O
DDI-DrugBank.d223.s19,even,41,44,O
DDI-DrugBank.d223.s19,death,46,50,O
DDI-DrugBank.d223.s19,have,52,55,O
DDI-DrugBank.d223.s19,been,57,60,O
DDI-DrugBank.d223.s19,reported,62,69,O
DDI-DrugBank.d223.s19,following,71,79,O
DDI-DrugBank.d223.s19,the,81,83,O
DDI-DrugBank.d223.s19,concomitant,85,95,O
DDI-DrugBank.d223.s19,use,97,99,O
DDI-DrugBank.d223.s19,of,101,102,O
DDI-DrugBank.d223.s19,certain,104,110,O
DDI-DrugBank.d223.s19,drugs,112,116,O
DDI-DrugBank.d223.s19,with,118,121,O
DDI-DrugBank.d223.s19,MAO,123,125,B-group
DDI-DrugBank.d223.s19,inhibitors,127,136,I-group
DDI-DrugBank.d223.s19,.,137,137,O
DDI-DrugBank.d223.s20,Therefore,0,8,O
DDI-DrugBank.d223.s20,",",9,9,O
DDI-DrugBank.d223.s20,MAO,11,13,B-group
DDI-DrugBank.d223.s20,inhibitors,15,24,I-group
DDI-DrugBank.d223.s20,should,26,31,O
DDI-DrugBank.d223.s20,be,33,34,O
DDI-DrugBank.d223.s20,discontinued,36,47,O
DDI-DrugBank.d223.s20,at,49,50,O
DDI-DrugBank.d223.s20,least,52,56,O
DDI-DrugBank.d223.s20,two,58,60,O
DDI-DrugBank.d223.s20,weeks,62,66,O
DDI-DrugBank.d223.s20,prior,68,72,O
DDI-DrugBank.d223.s20,to,74,75,O
DDI-DrugBank.d223.s20,the,77,79,O
DDI-DrugBank.d223.s20,cautious,81,88,O
DDI-DrugBank.d223.s20,initiation,90,99,O
DDI-DrugBank.d223.s20,of,101,102,O
DDI-DrugBank.d223.s20,therapy,104,110,O
DDI-DrugBank.d223.s20,with,112,115,O
DDI-DrugBank.d223.s20,SINEQUAN,117,124,B-brand
DDI-DrugBank.d223.s20,.,125,125,O
DDI-DrugBank.d223.s21,The,0,2,O
DDI-DrugBank.d223.s21,exact,4,8,O
DDI-DrugBank.d223.s21,length,10,15,O
DDI-DrugBank.d223.s21,of,17,18,O
DDI-DrugBank.d223.s21,time,20,23,O
DDI-DrugBank.d223.s21,may,25,27,O
DDI-DrugBank.d223.s21,vary,29,32,O
DDI-DrugBank.d223.s21,and,34,36,O
DDI-DrugBank.d223.s21,is,38,39,O
DDI-DrugBank.d223.s21,dependent,41,49,O
DDI-DrugBank.d223.s21,upon,51,54,O
DDI-DrugBank.d223.s21,the,56,58,O
DDI-DrugBank.d223.s21,particular,60,69,O
DDI-DrugBank.d223.s21,MAO,71,73,B-group
DDI-DrugBank.d223.s21,inhibitor,75,83,I-group
DDI-DrugBank.d223.s21,being,85,89,O
DDI-DrugBank.d223.s21,used,91,94,O
DDI-DrugBank.d223.s21,",",95,95,O
DDI-DrugBank.d223.s21,the,97,99,O
DDI-DrugBank.d223.s21,length,101,106,O
DDI-DrugBank.d223.s21,of,108,109,O
DDI-DrugBank.d223.s21,time,111,114,O
DDI-DrugBank.d223.s21,it,116,117,O
DDI-DrugBank.d223.s21,has,119,121,O
DDI-DrugBank.d223.s21,been,123,126,O
DDI-DrugBank.d223.s21,administered,128,139,O
DDI-DrugBank.d223.s21,",",140,140,O
DDI-DrugBank.d223.s21,and,142,144,O
DDI-DrugBank.d223.s21,the,146,148,O
DDI-DrugBank.d223.s21,dosage,150,155,O
DDI-DrugBank.d223.s21,involved,157,164,O
DDI-DrugBank.d223.s21,.,165,165,O
DDI-DrugBank.d223.s22,Cimetidine,0,9,B-drug
DDI-DrugBank.d223.s22,:,10,10,O
DDI-DrugBank.d223.s22,Cimetidine,12,21,B-drug
DDI-DrugBank.d223.s22,has,23,25,O
DDI-DrugBank.d223.s22,been,27,30,O
DDI-DrugBank.d223.s22,reported,32,39,O
DDI-DrugBank.d223.s22,to,41,42,O
DDI-DrugBank.d223.s22,produce,44,50,O
DDI-DrugBank.d223.s22,clinically,52,61,O
DDI-DrugBank.d223.s22,significant,63,73,O
DDI-DrugBank.d223.s22,fluctuations,75,86,O
DDI-DrugBank.d223.s22,in,88,89,O
DDI-DrugBank.d223.s22,steady-state,91,102,O
DDI-DrugBank.d223.s22,serum,104,108,O
DDI-DrugBank.d223.s22,concentrations,110,123,O
DDI-DrugBank.d223.s22,of,125,126,O
DDI-DrugBank.d223.s22,various,128,134,O
DDI-DrugBank.d223.s22,tricyclic,136,144,B-group
DDI-DrugBank.d223.s22,antidepressants,146,160,I-group
DDI-DrugBank.d223.s22,.,161,161,O
DDI-DrugBank.d223.s23,Serious,0,6,O
DDI-DrugBank.d223.s23,anticholinergic,8,22,O
DDI-DrugBank.d223.s23,symptoms,24,31,O
DDI-DrugBank.d223.s23,(,33,33,O
DDI-DrugBank.d223.s23,i.e.,34,37,O
DDI-DrugBank.d223.s23,",",38,38,O
DDI-DrugBank.d223.s23,severe,40,45,O
DDI-DrugBank.d223.s23,dry,47,49,O
DDI-DrugBank.d223.s23,mouth,51,55,O
DDI-DrugBank.d223.s23,",",56,56,O
DDI-DrugBank.d223.s23,urinary,58,64,O
DDI-DrugBank.d223.s23,retention,66,74,O
DDI-DrugBank.d223.s23,and,76,78,O
DDI-DrugBank.d223.s23,blurred,80,86,O
DDI-DrugBank.d223.s23,vision,88,93,O
DDI-DrugBank.d223.s23,),94,94,O
DDI-DrugBank.d223.s23,have,96,99,O
DDI-DrugBank.d223.s23,been,101,104,O
DDI-DrugBank.d223.s23,associated,106,115,O
DDI-DrugBank.d223.s23,with,117,120,O
DDI-DrugBank.d223.s23,elevations,122,131,O
DDI-DrugBank.d223.s23,in,133,134,O
DDI-DrugBank.d223.s23,the,136,138,O
DDI-DrugBank.d223.s23,serum,140,144,O
DDI-DrugBank.d223.s23,levels,146,151,O
DDI-DrugBank.d223.s23,of,153,154,O
DDI-DrugBank.d223.s23,tricyclic,156,164,B-group
DDI-DrugBank.d223.s23,antidepressant,166,179,I-group
DDI-DrugBank.d223.s23,when,181,184,O
DDI-DrugBank.d223.s23,cimetidine,186,195,B-drug
DDI-DrugBank.d223.s23,therapy,197,203,O
DDI-DrugBank.d223.s23,is,205,206,O
DDI-DrugBank.d223.s23,initiated,208,216,O
DDI-DrugBank.d223.s23,.,217,217,O
DDI-DrugBank.d223.s24,Additionally,0,11,O
DDI-DrugBank.d223.s24,",",12,12,O
DDI-DrugBank.d223.s24,higher,14,19,O
DDI-DrugBank.d223.s24,than,21,24,O
DDI-DrugBank.d223.s24,expected,26,33,O
DDI-DrugBank.d223.s24,tricyclic,35,43,B-group
DDI-DrugBank.d223.s24,antidepressant,45,58,I-group
DDI-DrugBank.d223.s24,levels,60,65,O
DDI-DrugBank.d223.s24,have,67,70,O
DDI-DrugBank.d223.s24,been,72,75,O
DDI-DrugBank.d223.s24,observed,77,84,O
DDI-DrugBank.d223.s24,when,86,89,O
DDI-DrugBank.d223.s24,they,91,94,O
DDI-DrugBank.d223.s24,are,96,98,O
DDI-DrugBank.d223.s24,begun,100,104,O
DDI-DrugBank.d223.s24,in,106,107,O
DDI-DrugBank.d223.s24,patients,109,116,O
DDI-DrugBank.d223.s24,already,118,124,O
DDI-DrugBank.d223.s24,taking,126,131,O
DDI-DrugBank.d223.s24,cimetidine,133,142,B-drug
DDI-DrugBank.d223.s24,.,143,143,O
DDI-DrugBank.d223.s25,In,0,1,O
DDI-DrugBank.d223.s25,patients,3,10,O
DDI-DrugBank.d223.s25,who,12,14,O
DDI-DrugBank.d223.s25,have,16,19,O
DDI-DrugBank.d223.s25,been,21,24,O
DDI-DrugBank.d223.s25,reported,26,33,O
DDI-DrugBank.d223.s25,to,35,36,O
DDI-DrugBank.d223.s25,be,38,39,O
DDI-DrugBank.d223.s25,well,41,44,O
DDI-DrugBank.d223.s25,controlled,46,55,O
DDI-DrugBank.d223.s25,on,57,58,O
DDI-DrugBank.d223.s25,tricyclic,60,68,B-group
DDI-DrugBank.d223.s25,antidepressants,70,84,I-group
DDI-DrugBank.d223.s25,receiving,86,94,O
DDI-DrugBank.d223.s25,concurrent,96,105,O
DDI-DrugBank.d223.s25,cimetidine,107,116,B-drug
DDI-DrugBank.d223.s25,therapy,118,124,O
DDI-DrugBank.d223.s25,",",125,125,O
DDI-DrugBank.d223.s25,discontinuation,127,141,O
DDI-DrugBank.d223.s25,of,143,144,O
DDI-DrugBank.d223.s25,cimetidine,146,155,B-drug
DDI-DrugBank.d223.s25,has,157,159,O
DDI-DrugBank.d223.s25,been,161,164,O
DDI-DrugBank.d223.s25,reported,166,173,O
DDI-DrugBank.d223.s25,to,175,176,O
DDI-DrugBank.d223.s25,decrease,178,185,O
DDI-DrugBank.d223.s25,established,187,197,O
DDI-DrugBank.d223.s25,steady-state,199,210,O
DDI-DrugBank.d223.s25,serum,212,216,O
DDI-DrugBank.d223.s25,tricyclic,218,226,B-group
DDI-DrugBank.d223.s25,antidepressant,228,241,I-group
DDI-DrugBank.d223.s25,levels,243,248,O
DDI-DrugBank.d223.s25,and,250,252,O
DDI-DrugBank.d223.s25,compromise,254,263,O
DDI-DrugBank.d223.s25,their,265,269,O
DDI-DrugBank.d223.s25,therapeutic,271,281,O
DDI-DrugBank.d223.s25,effects,283,289,O
DDI-DrugBank.d223.s25,.,290,290,O
DDI-DrugBank.d223.s26,Alcohol,0,6,B-drug
DDI-DrugBank.d223.s26,:,7,7,O
DDI-DrugBank.d223.s26,It,9,10,O
DDI-DrugBank.d223.s26,should,12,17,O
DDI-DrugBank.d223.s26,be,19,20,O
DDI-DrugBank.d223.s26,borne,22,26,O
DDI-DrugBank.d223.s26,in,28,29,O
DDI-DrugBank.d223.s26,mind,31,34,O
DDI-DrugBank.d223.s26,that,36,39,O
DDI-DrugBank.d223.s26,alcohol,41,47,B-drug
DDI-DrugBank.d223.s26,ingestion,49,57,O
DDI-DrugBank.d223.s26,may,59,61,O
DDI-DrugBank.d223.s26,increase,63,70,O
DDI-DrugBank.d223.s26,the,72,74,O
DDI-DrugBank.d223.s26,danger,76,81,O
DDI-DrugBank.d223.s26,inherent,83,90,O
DDI-DrugBank.d223.s26,in,92,93,O
DDI-DrugBank.d223.s26,any,95,97,O
DDI-DrugBank.d223.s26,intentional,99,109,O
DDI-DrugBank.d223.s26,or,111,112,O
DDI-DrugBank.d223.s26,unintentional,114,126,O
DDI-DrugBank.d223.s26,SINEQUAN,128,135,B-brand
DDI-DrugBank.d223.s26,overdosage,137,146,O
DDI-DrugBank.d223.s26,.,147,147,O
DDI-DrugBank.d223.s27,This,0,3,O
DDI-DrugBank.d223.s27,is,5,6,O
DDI-DrugBank.d223.s27,especially,8,17,O
DDI-DrugBank.d223.s27,important,19,27,O
DDI-DrugBank.d223.s27,in,29,30,O
DDI-DrugBank.d223.s27,patients,32,39,O
DDI-DrugBank.d223.s27,who,41,43,O
DDI-DrugBank.d223.s27,may,45,47,O
DDI-DrugBank.d223.s27,use,49,51,O
DDI-DrugBank.d223.s27,alcohol,53,59,B-drug
DDI-DrugBank.d223.s27,excessively,61,71,O
DDI-DrugBank.d223.s27,.,72,72,O
DDI-DrugBank.d223.s28,Tolazamide,0,9,B-drug
DDI-DrugBank.d223.s28,:,10,10,O
DDI-DrugBank.d223.s28,A,12,12,O
DDI-DrugBank.d223.s28,case,14,17,O
DDI-DrugBank.d223.s28,of,19,20,O
DDI-DrugBank.d223.s28,severe,22,27,O
DDI-DrugBank.d223.s28,hypoglycemia,29,40,O
DDI-DrugBank.d223.s28,has,42,44,O
DDI-DrugBank.d223.s28,been,46,49,O
DDI-DrugBank.d223.s28,reported,51,58,O
DDI-DrugBank.d223.s28,in,60,61,O
DDI-DrugBank.d223.s28,a,63,63,O
DDI-DrugBank.d223.s28,type,65,68,O
DDI-DrugBank.d223.s28,II,70,71,O
DDI-DrugBank.d223.s28,diabetic,73,80,O
DDI-DrugBank.d223.s28,patient,82,88,O
DDI-DrugBank.d223.s28,maintained,90,99,O
DDI-DrugBank.d223.s28,on,101,102,O
DDI-DrugBank.d223.s28,tolazamide,104,113,B-drug
DDI-DrugBank.d223.s28,(,115,115,O
DDI-DrugBank.d223.s28,1,116,116,O
DDI-DrugBank.d223.s28,gm/day,118,123,O
DDI-DrugBank.d223.s28,),124,124,O
DDI-DrugBank.d223.s28,11,126,127,O
DDI-DrugBank.d223.s28,days,129,132,O
DDI-DrugBank.d223.s28,after,134,138,O
DDI-DrugBank.d223.s28,the,140,142,O
DDI-DrugBank.d223.s28,addition,144,151,O
DDI-DrugBank.d223.s28,of,153,154,O
DDI-DrugBank.d223.s28,doxepin,156,162,B-drug
DDI-DrugBank.d223.s28,(,164,164,O
DDI-DrugBank.d223.s28,75,165,166,O
DDI-DrugBank.d223.s28,mg/day,168,173,O
DDI-DrugBank.d223.s28,),174,174,O
DDI-DrugBank.d223.s28,.,175,175,O
DDI-DrugBank.d44.s0,No,0,1,O
DDI-DrugBank.d44.s0,formal,3,8,O
DDI-DrugBank.d44.s0,drug,10,13,O
DDI-DrugBank.d44.s0,interaction,15,25,O
DDI-DrugBank.d44.s0,studies,27,33,O
DDI-DrugBank.d44.s0,have,35,38,O
DDI-DrugBank.d44.s0,been,40,43,O
DDI-DrugBank.d44.s0,performed,45,53,O
DDI-DrugBank.d44.s0,with,55,58,O
DDI-DrugBank.d44.s0,RAPTIVA,60,66,B-brand
DDI-DrugBank.d44.s0,.,67,67,O
DDI-DrugBank.d44.s1,RAPTIVA,0,6,B-brand
DDI-DrugBank.d44.s1,should,8,13,O
DDI-DrugBank.d44.s1,not,15,17,O
DDI-DrugBank.d44.s1,be,19,20,O
DDI-DrugBank.d44.s1,used,22,25,O
DDI-DrugBank.d44.s1,with,27,30,O
DDI-DrugBank.d44.s1,other,32,36,O
DDI-DrugBank.d44.s1,immunosuppressive,38,54,B-group
DDI-DrugBank.d44.s1,drugs,56,60,I-group
DDI-DrugBank.d44.s1,.,61,61,O
DDI-DrugBank.d44.s2,Acellular,0,8,B-group
DDI-DrugBank.d44.s2,",",9,9,O
DDI-DrugBank.d44.s2,live,11,14,B-group
DDI-DrugBank.d44.s2,and,16,18,O
DDI-DrugBank.d44.s2,live-attenuated,20,34,B-group
DDI-DrugBank.d44.s2,vaccines,36,43,I-group
DDI-DrugBank.d44.s2,should,45,50,O
DDI-DrugBank.d44.s2,not,52,54,O
DDI-DrugBank.d44.s2,be,56,57,O
DDI-DrugBank.d44.s2,administered,59,70,O
DDI-DrugBank.d44.s2,during,72,77,O
DDI-DrugBank.d44.s2,RAPTIVA,79,85,B-brand
DDI-DrugBank.d44.s2,treatment,87,95,O
DDI-DrugBank.d44.s2,.,96,96,O
DDI-DrugBank.d44.s3,Drug/Laboratory,0,14,O
DDI-DrugBank.d44.s3,Test,16,19,O
DDI-DrugBank.d44.s3,Interactions,21,32,O
DDI-DrugBank.d44.s3,Increases,34,42,O
DDI-DrugBank.d44.s3,in,44,45,O
DDI-DrugBank.d44.s3,lymphocyte,47,56,O
DDI-DrugBank.d44.s3,counts,58,63,O
DDI-DrugBank.d44.s3,related,65,71,O
DDI-DrugBank.d44.s3,to,73,74,O
DDI-DrugBank.d44.s3,the,76,78,O
DDI-DrugBank.d44.s3,pharmacologic,80,92,O
DDI-DrugBank.d44.s3,mechanism,94,102,O
DDI-DrugBank.d44.s3,of,104,105,O
DDI-DrugBank.d44.s3,action,107,112,O
DDI-DrugBank.d44.s3,are,114,116,O
DDI-DrugBank.d44.s3,frequently,118,127,O
DDI-DrugBank.d44.s3,observed,129,136,O
DDI-DrugBank.d44.s3,during,138,143,O
DDI-DrugBank.d44.s3,RAPTIVA,145,151,B-brand
DDI-DrugBank.d44.s3,treatment,153,161,O
DDI-DrugBank.d44.s3,.,162,162,O
DDI-DrugBank.d531.s0,Efavirenz,0,8,B-drug
DDI-DrugBank.d531.s0,has,10,12,O
DDI-DrugBank.d531.s0,been,14,17,O
DDI-DrugBank.d531.s0,shown,19,23,O
DDI-DrugBank.d531.s0,in,25,26,O
DDI-DrugBank.d531.s0,vivo,28,31,O
DDI-DrugBank.d531.s0,to,33,34,O
DDI-DrugBank.d531.s0,induce,36,41,O
DDI-DrugBank.d531.s0,CYP3A4,43,48,O
DDI-DrugBank.d531.s0,.,49,49,O
DDI-DrugBank.d531.s1,Other,0,4,O
DDI-DrugBank.d531.s1,compounds,6,14,O
DDI-DrugBank.d531.s1,that,16,19,O
DDI-DrugBank.d531.s1,are,21,23,O
DDI-DrugBank.d531.s1,substrates,25,34,O
DDI-DrugBank.d531.s1,of,36,37,O
DDI-DrugBank.d531.s1,CYP3A4,39,44,O
DDI-DrugBank.d531.s1,may,46,48,O
DDI-DrugBank.d531.s1,have,50,53,O
DDI-DrugBank.d531.s1,decreased,55,63,O
DDI-DrugBank.d531.s1,plasma,65,70,O
DDI-DrugBank.d531.s1,concentrations,72,85,O
DDI-DrugBank.d531.s1,when,87,90,O
DDI-DrugBank.d531.s1,coadministered,92,105,O
DDI-DrugBank.d531.s1,with,107,110,O
DDI-DrugBank.d531.s1,SUSTIVA,112,118,B-brand
DDI-DrugBank.d531.s1,(,120,120,O
DDI-DrugBank.d531.s1,efavirenz,121,129,B-drug
DDI-DrugBank.d531.s1,),130,130,O
DDI-DrugBank.d531.s1,.,131,131,O
DDI-DrugBank.d531.s2,In,0,1,O
DDI-DrugBank.d531.s2,vitro,3,7,O
DDI-DrugBank.d531.s2,studies,9,15,O
DDI-DrugBank.d531.s2,have,17,20,O
DDI-DrugBank.d531.s2,demonstrated,22,33,O
DDI-DrugBank.d531.s2,that,35,38,O
DDI-DrugBank.d531.s2,efavirenz,40,48,B-drug
DDI-DrugBank.d531.s2,inhibits,50,57,O
DDI-DrugBank.d531.s2,2C9,59,61,O
DDI-DrugBank.d531.s2,",",62,62,O
DDI-DrugBank.d531.s2,2C19,64,67,O
DDI-DrugBank.d531.s2,",",68,68,O
DDI-DrugBank.d531.s2,and,70,72,O
DDI-DrugBank.d531.s2,3A4,74,76,O
DDI-DrugBank.d531.s2,isozymes,78,85,O
DDI-DrugBank.d531.s2,in,87,88,O
DDI-DrugBank.d531.s2,the,90,92,O
DDI-DrugBank.d531.s2,range,94,98,O
DDI-DrugBank.d531.s2,of,100,101,O
DDI-DrugBank.d531.s2,observed,103,110,O
DDI-DrugBank.d531.s2,efavirenz,112,120,B-drug
DDI-DrugBank.d531.s2,plasma,122,127,O
DDI-DrugBank.d531.s2,concentrations,129,142,O
DDI-DrugBank.d531.s2,.,143,143,O
DDI-DrugBank.d531.s3,Coadministration,0,15,O
DDI-DrugBank.d531.s3,of,17,18,O
DDI-DrugBank.d531.s3,efavirenz,20,28,B-drug
DDI-DrugBank.d531.s3,with,30,33,O
DDI-DrugBank.d531.s3,drugs,35,39,O
DDI-DrugBank.d531.s3,primarily,41,49,O
DDI-DrugBank.d531.s3,metabolized,51,61,O
DDI-DrugBank.d531.s3,by,63,64,O
DDI-DrugBank.d531.s3,these,66,70,O
DDI-DrugBank.d531.s3,isozymes,72,79,O
DDI-DrugBank.d531.s3,may,81,83,O
DDI-DrugBank.d531.s3,result,85,90,O
DDI-DrugBank.d531.s3,in,92,93,O
DDI-DrugBank.d531.s3,altered,95,101,O
DDI-DrugBank.d531.s3,plasma,103,108,O
DDI-DrugBank.d531.s3,concentrations,110,123,O
DDI-DrugBank.d531.s3,of,125,126,O
DDI-DrugBank.d531.s3,the,128,130,O
DDI-DrugBank.d531.s3,coadministered,132,145,O
DDI-DrugBank.d531.s3,drug,147,150,O
DDI-DrugBank.d531.s3,.,151,151,O
DDI-DrugBank.d531.s4,Therefore,0,8,O
DDI-DrugBank.d531.s4,",",9,9,O
DDI-DrugBank.d531.s4,appropriate,11,21,O
DDI-DrugBank.d531.s4,dose,23,26,O
DDI-DrugBank.d531.s4,adjustments,28,38,O
DDI-DrugBank.d531.s4,may,40,42,O
DDI-DrugBank.d531.s4,be,44,45,O
DDI-DrugBank.d531.s4,necessary,47,55,O
DDI-DrugBank.d531.s4,for,57,59,O
DDI-DrugBank.d531.s4,these,61,65,O
DDI-DrugBank.d531.s4,drugs,67,71,O
DDI-DrugBank.d531.s4,.,72,72,O
DDI-DrugBank.d531.s5,Drugs,0,4,O
DDI-DrugBank.d531.s5,which,6,10,O
DDI-DrugBank.d531.s5,induce,12,17,O
DDI-DrugBank.d531.s5,CYP3A4,19,24,O
DDI-DrugBank.d531.s5,activity,26,33,O
DDI-DrugBank.d531.s5,(,35,35,O
DDI-DrugBank.d531.s5,eg,36,37,O
DDI-DrugBank.d531.s5,",",38,38,O
DDI-DrugBank.d531.s5,phenobarbital,40,52,B-drug
DDI-DrugBank.d531.s5,",",53,53,O
DDI-DrugBank.d531.s5,rifampin,55,62,B-drug
DDI-DrugBank.d531.s5,",",63,63,O
DDI-DrugBank.d531.s5,rifabutin,65,73,B-drug
DDI-DrugBank.d531.s5,),74,74,O
DDI-DrugBank.d531.s5,would,76,80,O
DDI-DrugBank.d531.s5,be,82,83,O
DDI-DrugBank.d531.s5,expected,85,92,O
DDI-DrugBank.d531.s5,to,94,95,O
DDI-DrugBank.d531.s5,increase,97,104,O
DDI-DrugBank.d531.s5,the,106,108,O
DDI-DrugBank.d531.s5,clearance,110,118,O
DDI-DrugBank.d531.s5,of,120,121,O
DDI-DrugBank.d531.s5,efavirenz,123,131,B-drug
DDI-DrugBank.d531.s5,resulting,133,141,O
DDI-DrugBank.d531.s5,in,143,144,O
DDI-DrugBank.d531.s5,lowered,146,152,O
DDI-DrugBank.d531.s5,plasma,154,159,O
DDI-DrugBank.d531.s5,concentrations,161,174,O
DDI-DrugBank.d531.s5,.,175,175,O
DDI-DrugBank.d531.s6,Drug,0,3,O
DDI-DrugBank.d531.s6,interactions,5,16,O
DDI-DrugBank.d531.s6,with,18,21,O
DDI-DrugBank.d531.s6,SUSTIVA,23,29,B-brand
DDI-DrugBank.d531.s6,are,31,33,O
DDI-DrugBank.d531.s6,summarized,35,44,O
DDI-DrugBank.d531.s6,in,46,47,O
DDI-DrugBank.d531.s6,Table,49,53,O
DDI-DrugBank.d531.s6,5,55,55,O
DDI-DrugBank.d531.s6,.,56,56,O
DDI-DrugBank.d531.s7,Table,0,4,O
DDI-DrugBank.d531.s7,5a,6,7,O
DDI-DrugBank.d531.s7,:,8,8,O
DDI-DrugBank.d531.s7,Drugs,10,14,O
DDI-DrugBank.d531.s7,That,16,19,O
DDI-DrugBank.d531.s7,Should,21,26,O
DDI-DrugBank.d531.s7,Not,28,30,O
DDI-DrugBank.d531.s7,Be,32,33,O
DDI-DrugBank.d531.s7,Coadministered,35,48,O
DDI-DrugBank.d531.s7,With,50,53,O
DDI-DrugBank.d531.s7,SUSTIVA,55,61,B-brand
DDI-DrugBank.d531.s8,Drug,0,3,O
DDI-DrugBank.d531.s8,Class,5,9,O
DDI-DrugBank.d531.s9,Drugs,0,4,O
DDI-DrugBank.d531.s9,Within,6,11,O
DDI-DrugBank.d531.s9,Class,13,17,O
DDI-DrugBank.d531.s9,Not,19,21,O
DDI-DrugBank.d531.s9,To,23,24,O
DDI-DrugBank.d531.s9,Be,26,27,O
DDI-DrugBank.d531.s9,Coadministered,29,42,O
DDI-DrugBank.d531.s9,With,44,47,O
DDI-DrugBank.d531.s9,SUSTIVA,49,55,B-brand
DDI-DrugBank.d531.s10,Antihistamines,0,13,B-group
DDI-DrugBank.d531.s10,:,14,14,O
DDI-DrugBank.d531.s10,Benzodiazepines,16,30,B-group
DDI-DrugBank.d531.s10,GI,32,33,O
DDI-DrugBank.d531.s10,Motility,35,42,O
DDI-DrugBank.d531.s10,Agents,44,49,O
DDI-DrugBank.d531.s10,Anti-Migraine,51,63,B-group
DDI-DrugBank.d531.s10,Antifungal,65,74,B-group
DDI-DrugBank.d531.s11,astemizole,0,9,B-drug
DDI-DrugBank.d531.s11,midazolam,11,19,B-drug
DDI-DrugBank.d531.s11,",",20,20,O
DDI-DrugBank.d531.s11,triazolam,22,30,B-drug
DDI-DrugBank.d531.s11,cisapride,32,40,B-drug
DDI-DrugBank.d531.s11,ergot,42,46,O
DDI-DrugBank.d531.s11,derivatives,48,58,O
DDI-DrugBank.d531.s11,voriconazole,60,71,B-drug
DDI-DrugBank.d531.s12,Established,0,10,O
DDI-DrugBank.d531.s12,Drug,12,15,O
DDI-DrugBank.d531.s12,Interactions,17,28,O
DDI-DrugBank.d531.s14,Drug,0,3,O
DDI-DrugBank.d531.s14,Name,5,8,O
DDI-DrugBank.d531.s15,Effect,0,5,O
DDI-DrugBank.d531.s16,Clinical,0,7,O
DDI-DrugBank.d531.s16,Comment,9,15,O
DDI-DrugBank.d531.s17,Atazanavir,0,9,B-drug
DDI-DrugBank.d531.s18,atazanavir,0,9,B-drug
DDI-DrugBank.d531.s19,When,0,3,O
DDI-DrugBank.d531.s19,coadministered,5,18,O
DDI-DrugBank.d531.s19,with,20,23,O
DDI-DrugBank.d531.s19,SUSTIVA,25,31,B-brand
DDI-DrugBank.d531.s19,in,33,34,O
DDI-DrugBank.d531.s19,treatment-naive,36,50,O
DDI-DrugBank.d531.s19,patients,52,59,O
DDI-DrugBank.d531.s19,",",60,60,O
DDI-DrugBank.d531.s19,the,62,64,O
DDI-DrugBank.d531.s19,recommended,66,76,O
DDI-DrugBank.d531.s19,dose,78,81,O
DDI-DrugBank.d531.s19,of,83,84,O
DDI-DrugBank.d531.s19,atazanavir,86,95,B-drug
DDI-DrugBank.d531.s19,is,97,98,O
DDI-DrugBank.d531.s19,300,100,102,O
DDI-DrugBank.d531.s19,mg,104,105,O
DDI-DrugBank.d531.s19,with,107,110,O
DDI-DrugBank.d531.s19,ritonavir,112,120,B-drug
DDI-DrugBank.d531.s19,100,122,124,O
DDI-DrugBank.d531.s19,mg,126,127,O
DDI-DrugBank.d531.s19,and,129,131,O
DDI-DrugBank.d531.s19,SUSTIVA,133,139,B-brand
DDI-DrugBank.d531.s19,600,141,143,O
DDI-DrugBank.d531.s19,mg,145,146,O
DDI-DrugBank.d531.s19,(,148,148,O
DDI-DrugBank.d531.s19,all,149,151,O
DDI-DrugBank.d531.s19,once,153,156,O
DDI-DrugBank.d531.s19,daily,158,162,O
DDI-DrugBank.d531.s19,),163,163,O
DDI-DrugBank.d531.s19,.,164,164,O
DDI-DrugBank.d531.s20,Dosing,0,5,O
DDI-DrugBank.d531.s20,recommendations,7,21,O
DDI-DrugBank.d531.s20,for,23,25,O
DDI-DrugBank.d531.s20,SUSTIVA,27,33,B-brand
DDI-DrugBank.d531.s20,and,35,37,O
DDI-DrugBank.d531.s20,atazanavir,39,48,B-drug
DDI-DrugBank.d531.s20,in,50,51,O
DDI-DrugBank.d531.s20,treatment-experienced,53,73,O
DDI-DrugBank.d531.s20,patients,75,82,O
DDI-DrugBank.d531.s20,have,84,87,O
DDI-DrugBank.d531.s20,not,89,91,O
DDI-DrugBank.d531.s20,been,93,96,O
DDI-DrugBank.d531.s20,established,98,108,O
DDI-DrugBank.d531.s20,.,109,109,O
DDI-DrugBank.d531.s21,Established,0,10,O
DDI-DrugBank.d531.s21,Drug,12,15,O
DDI-DrugBank.d531.s21,Interactions,17,28,O
DDI-DrugBank.d531.s21,(,30,30,O
DDI-DrugBank.d531.s21,continued,31,39,O
DDI-DrugBank.d531.s21,),40,40,O
DDI-DrugBank.d531.s22,Drug,0,3,O
DDI-DrugBank.d531.s22,Name,5,8,O
DDI-DrugBank.d531.s23,Effect,0,5,O
DDI-DrugBank.d531.s24,Clinical,0,7,O
DDI-DrugBank.d531.s24,Comment,9,15,O
DDI-DrugBank.d531.s25,Clarithromycin,0,13,B-drug
DDI-DrugBank.d531.s26,clarithromycin,0,13,B-drug
DDI-DrugBank.d531.s26,concentration,15,27,O
DDI-DrugBank.d531.s27,Plasma,0,5,O
DDI-DrugBank.d531.s27,concentrations,7,20,O
DDI-DrugBank.d531.s27,decreased,22,30,O
DDI-DrugBank.d531.s27,by,32,33,O
DDI-DrugBank.d531.s27,SUSTIVA,35,41,B-brand
DDI-DrugBank.d531.s27,;,42,42,O
DDI-DrugBank.d531.s28,clinical,0,7,O
DDI-DrugBank.d531.s28,significance,9,20,O
DDI-DrugBank.d531.s28,unknown,22,28,O
DDI-DrugBank.d531.s28,.,29,29,O
DDI-DrugBank.d531.s29,In,0,1,O
DDI-DrugBank.d531.s29,uninfected,3,12,O
DDI-DrugBank.d531.s29,volunteers,14,23,O
DDI-DrugBank.d531.s29,",",24,24,O
DDI-DrugBank.d531.s29,46,26,27,O
DDI-DrugBank.d531.s29,%,28,28,O
DDI-DrugBank.d531.s29,developed,30,38,O
DDI-DrugBank.d531.s29,rash,40,43,O
DDI-DrugBank.d531.s29,while,45,49,O
DDI-DrugBank.d531.s29,receiving,51,59,O
DDI-DrugBank.d531.s29,SUSTIVA,61,67,B-brand
DDI-DrugBank.d531.s29,and,69,71,O
DDI-DrugBank.d531.s29,clarithromycin,73,86,B-drug
DDI-DrugBank.d531.s29,.,87,87,O
DDI-DrugBank.d531.s30,No,0,1,O
DDI-DrugBank.d531.s30,dose,3,6,O
DDI-DrugBank.d531.s30,adjustment,8,17,O
DDI-DrugBank.d531.s30,of,19,20,O
DDI-DrugBank.d531.s30,SUSTIVA,22,28,B-brand
DDI-DrugBank.d531.s30,is,30,31,O
DDI-DrugBank.d531.s30,recommended,33,43,O
DDI-DrugBank.d531.s30,when,45,48,O
DDI-DrugBank.d531.s30,given,50,54,O
DDI-DrugBank.d531.s30,with,56,59,O
DDI-DrugBank.d531.s30,clarithromycin,61,74,B-drug
DDI-DrugBank.d531.s30,.,75,75,O
DDI-DrugBank.d531.s31,Alternatives,0,11,O
DDI-DrugBank.d531.s31,to,13,14,O
DDI-DrugBank.d531.s31,clarithromycin,16,29,B-drug
DDI-DrugBank.d531.s31,",",30,30,O
DDI-DrugBank.d531.s31,such,32,35,O
DDI-DrugBank.d531.s31,as,37,38,O
DDI-DrugBank.d531.s31,azithromycin,40,51,B-drug
DDI-DrugBank.d531.s31,",",52,52,O
DDI-DrugBank.d531.s31,should,54,59,O
DDI-DrugBank.d531.s31,be,61,62,O
DDI-DrugBank.d531.s31,considered,64,73,O
DDI-DrugBank.d531.s31,.,74,74,O
DDI-DrugBank.d531.s32,Other,0,4,O
DDI-DrugBank.d531.s32,macrolide,6,14,B-group
DDI-DrugBank.d531.s32,antibiotics,16,26,I-group
DDI-DrugBank.d531.s32,",",27,27,O
DDI-DrugBank.d531.s32,such,29,32,O
DDI-DrugBank.d531.s32,as,34,35,O
DDI-DrugBank.d531.s32,erythromycin,37,48,B-drug
DDI-DrugBank.d531.s32,",",49,49,O
DDI-DrugBank.d531.s32,have,51,54,O
DDI-DrugBank.d531.s32,not,56,58,O
DDI-DrugBank.d531.s32,been,60,63,O
DDI-DrugBank.d531.s32,studied,65,71,O
DDI-DrugBank.d531.s32,in,73,74,O
DDI-DrugBank.d531.s32,combination,76,86,O
DDI-DrugBank.d531.s32,with,88,91,O
DDI-DrugBank.d531.s32,SUSTIVA,93,99,B-brand
DDI-DrugBank.d531.s32,.,100,100,O
DDI-DrugBank.d531.s34,14-OH,0,4,O
DDI-DrugBank.d531.s34,metabolite,6,15,O
DDI-DrugBank.d531.s34,concentration,17,29,O
DDI-DrugBank.d531.s35,Indinavir,0,8,B-drug
DDI-DrugBank.d531.s36,indinavir,0,8,B-drug
DDI-DrugBank.d531.s36,concentration,10,22,O
DDI-DrugBank.d531.s37,The,0,2,O
DDI-DrugBank.d531.s37,optimal,4,10,O
DDI-DrugBank.d531.s37,dose,12,15,O
DDI-DrugBank.d531.s37,of,17,18,O
DDI-DrugBank.d531.s37,indinavir,20,28,B-drug
DDI-DrugBank.d531.s37,",",29,29,O
DDI-DrugBank.d531.s37,when,31,34,O
DDI-DrugBank.d531.s37,given,36,40,O
DDI-DrugBank.d531.s37,in,42,43,O
DDI-DrugBank.d531.s37,combination,45,55,O
DDI-DrugBank.d531.s37,with,57,60,O
DDI-DrugBank.d531.s37,SUSTIVA,62,68,B-brand
DDI-DrugBank.d531.s37,",",69,69,O
DDI-DrugBank.d531.s37,is,71,72,O
DDI-DrugBank.d531.s37,not,74,76,O
DDI-DrugBank.d531.s37,known,78,82,O
DDI-DrugBank.d531.s37,.,83,83,O
DDI-DrugBank.d531.s38,Increasing,0,9,O
DDI-DrugBank.d531.s38,the,11,13,O
DDI-DrugBank.d531.s38,indinavir,15,23,B-drug
DDI-DrugBank.d531.s38,dose,25,28,O
DDI-DrugBank.d531.s38,to,30,31,O
DDI-DrugBank.d531.s38,1000,33,36,O
DDI-DrugBank.d531.s38,mg,38,39,O
DDI-DrugBank.d531.s38,every,41,45,O
DDI-DrugBank.d531.s38,8,47,47,O
DDI-DrugBank.d531.s38,hours,49,53,O
DDI-DrugBank.d531.s38,does,55,58,O
DDI-DrugBank.d531.s38,not,60,62,O
DDI-DrugBank.d531.s38,compensate,64,73,O
DDI-DrugBank.d531.s38,for,75,77,O
DDI-DrugBank.d531.s38,the,79,81,O
DDI-DrugBank.d531.s38,increased,83,91,O
DDI-DrugBank.d531.s38,indinavir,93,101,B-drug
DDI-DrugBank.d531.s38,metabolism,103,112,O
DDI-DrugBank.d531.s38,due,114,116,O
DDI-DrugBank.d531.s38,to,118,119,O
DDI-DrugBank.d531.s38,SUSTIVA,121,127,B-brand
DDI-DrugBank.d531.s38,.,128,128,O
DDI-DrugBank.d531.s39,When,0,3,O
DDI-DrugBank.d531.s39,indinavir,5,13,B-drug
DDI-DrugBank.d531.s39,at,15,16,O
DDI-DrugBank.d531.s39,an,18,19,O
DDI-DrugBank.d531.s39,increased,21,29,O
DDI-DrugBank.d531.s39,dose,31,34,O
DDI-DrugBank.d531.s39,(,36,36,O
DDI-DrugBank.d531.s39,1000,37,40,O
DDI-DrugBank.d531.s39,mg,42,43,O
DDI-DrugBank.d531.s39,every,45,49,O
DDI-DrugBank.d531.s39,8,51,51,O
DDI-DrugBank.d531.s39,hours,53,57,O
DDI-DrugBank.d531.s39,),58,58,O
DDI-DrugBank.d531.s39,was,60,62,O
DDI-DrugBank.d531.s39,given,64,68,O
DDI-DrugBank.d531.s39,with,70,73,O
DDI-DrugBank.d531.s39,SUSTIVA,75,81,B-brand
DDI-DrugBank.d531.s39,(,83,83,O
DDI-DrugBank.d531.s39,600,84,86,O
DDI-DrugBank.d531.s39,mg,88,89,O
DDI-DrugBank.d531.s39,once,91,94,O
DDI-DrugBank.d531.s39,daily,96,100,O
DDI-DrugBank.d531.s39,),101,101,O
DDI-DrugBank.d531.s39,",",102,102,O
DDI-DrugBank.d531.s39,the,104,106,O
DDI-DrugBank.d531.s39,indinavir,108,116,B-drug
DDI-DrugBank.d531.s39,AUC,118,120,O
DDI-DrugBank.d531.s39,and,122,124,O
DDI-DrugBank.d531.s39,Cmin,126,129,O
DDI-DrugBank.d531.s39,were,131,134,O
DDI-DrugBank.d531.s39,decreased,136,144,O
DDI-DrugBank.d531.s39,on,146,147,O
DDI-DrugBank.d531.s39,average,149,155,O
DDI-DrugBank.d531.s39,by,157,158,O
DDI-DrugBank.d531.s39,33-46,160,164,O
DDI-DrugBank.d531.s39,%,165,165,O
DDI-DrugBank.d531.s39,and,167,169,O
DDI-DrugBank.d531.s39,39-57,171,175,O
DDI-DrugBank.d531.s39,%,176,176,O
DDI-DrugBank.d531.s39,",",177,177,O
DDI-DrugBank.d531.s39,respectively,179,190,O
DDI-DrugBank.d531.s39,",",191,191,O
DDI-DrugBank.d531.s39,compared,193,200,O
DDI-DrugBank.d531.s39,to,202,203,O
DDI-DrugBank.d531.s39,when,205,208,O
DDI-DrugBank.d531.s39,indinavir,210,218,B-drug
DDI-DrugBank.d531.s39,(,220,220,O
DDI-DrugBank.d531.s39,800,221,223,O
DDI-DrugBank.d531.s39,mg,225,226,O
DDI-DrugBank.d531.s39,every,228,232,O
DDI-DrugBank.d531.s39,8,234,234,O
DDI-DrugBank.d531.s39,hours,236,240,O
DDI-DrugBank.d531.s39,),241,241,O
DDI-DrugBank.d531.s39,was,243,245,O
DDI-DrugBank.d531.s39,given,247,251,O
DDI-DrugBank.d531.s39,alone,253,257,O
DDI-DrugBank.d531.s39,.,258,258,O
DDI-DrugBank.d531.s40,Lopinavir/ritonavir,0,18,O
DDI-DrugBank.d531.s41,lopinavir,0,8,B-drug
DDI-DrugBank.d531.s41,concentration,10,22,O
DDI-DrugBank.d531.s42,A,0,0,O
DDI-DrugBank.d531.s42,dose,2,5,O
DDI-DrugBank.d531.s42,increase,7,14,O
DDI-DrugBank.d531.s42,of,16,17,O
DDI-DrugBank.d531.s42,lopinavir/ritonavir,19,37,O
DDI-DrugBank.d531.s42,to,39,40,O
DDI-DrugBank.d531.s42,533/133,42,48,O
DDI-DrugBank.d531.s42,mg,50,51,O
DDI-DrugBank.d531.s42,(,53,53,O
DDI-DrugBank.d531.s42,4,54,54,O
DDI-DrugBank.d531.s42,capsules,56,63,O
DDI-DrugBank.d531.s42,or,65,66,O
DDI-DrugBank.d531.s42,6.5,68,70,O
DDI-DrugBank.d531.s42,mL,72,73,O
DDI-DrugBank.d531.s42,),74,74,O
DDI-DrugBank.d531.s42,twice,76,80,O
DDI-DrugBank.d531.s42,daily,82,86,O
DDI-DrugBank.d531.s42,taken,88,92,O
DDI-DrugBank.d531.s42,with,94,97,O
DDI-DrugBank.d531.s42,food,99,102,O
DDI-DrugBank.d531.s42,is,104,105,O
DDI-DrugBank.d531.s42,recommended,107,117,O
DDI-DrugBank.d531.s42,when,119,122,O
DDI-DrugBank.d531.s42,used,124,127,O
DDI-DrugBank.d531.s42,in,129,130,O
DDI-DrugBank.d531.s42,combination,132,142,O
DDI-DrugBank.d531.s42,with,144,147,O
DDI-DrugBank.d531.s42,SUSTIVA,149,155,B-brand
DDI-DrugBank.d531.s42,.,156,156,O
DDI-DrugBank.d531.s43,Methadone,0,8,B-drug
DDI-DrugBank.d531.s44,methadone,0,8,B-drug
DDI-DrugBank.d531.s44,concentration,10,22,O
DDI-DrugBank.d531.s45,Coadministration,0,15,O
DDI-DrugBank.d531.s45,in,17,18,O
DDI-DrugBank.d531.s45,HIV-infected,20,31,O
DDI-DrugBank.d531.s45,individuals,33,43,O
DDI-DrugBank.d531.s45,with,45,48,O
DDI-DrugBank.d531.s45,a,50,50,O
DDI-DrugBank.d531.s45,history,52,58,O
DDI-DrugBank.d531.s45,of,60,61,O
DDI-DrugBank.d531.s45,injection,63,71,O
DDI-DrugBank.d531.s45,drug,73,76,O
DDI-DrugBank.d531.s45,use,78,80,O
DDI-DrugBank.d531.s45,resulted,82,89,O
DDI-DrugBank.d531.s45,in,91,92,O
DDI-DrugBank.d531.s45,decreased,94,102,O
DDI-DrugBank.d531.s45,plasma,104,109,O
DDI-DrugBank.d531.s45,levels,111,116,O
DDI-DrugBank.d531.s45,of,118,119,O
DDI-DrugBank.d531.s45,methadone,121,129,B-drug
DDI-DrugBank.d531.s45,and,131,133,O
DDI-DrugBank.d531.s45,signs,135,139,O
DDI-DrugBank.d531.s45,of,141,142,O
DDI-DrugBank.d531.s45,opiate,144,149,B-group
DDI-DrugBank.d531.s45,withdrawal,151,160,O
DDI-DrugBank.d531.s45,.,161,161,O
DDI-DrugBank.d531.s46,Methadone,0,8,B-drug
DDI-DrugBank.d531.s46,dose,10,13,O
DDI-DrugBank.d531.s46,was,15,17,O
DDI-DrugBank.d531.s46,increased,19,27,O
DDI-DrugBank.d531.s46,by,29,30,O
DDI-DrugBank.d531.s46,a,32,32,O
DDI-DrugBank.d531.s46,mean,34,37,O
DDI-DrugBank.d531.s46,of,39,40,O
DDI-DrugBank.d531.s46,22,42,43,O
DDI-DrugBank.d531.s46,%,44,44,O
DDI-DrugBank.d531.s46,to,46,47,O
DDI-DrugBank.d531.s46,alleviate,49,57,O
DDI-DrugBank.d531.s46,withdrawal,59,68,O
DDI-DrugBank.d531.s46,symptoms,70,77,O
DDI-DrugBank.d531.s46,.,78,78,O
DDI-DrugBank.d531.s47,Patients,0,7,O
DDI-DrugBank.d531.s47,should,9,14,O
DDI-DrugBank.d531.s47,be,16,17,O
DDI-DrugBank.d531.s47,monitored,19,27,O
DDI-DrugBank.d531.s47,for,29,31,O
DDI-DrugBank.d531.s47,signs,33,37,O
DDI-DrugBank.d531.s47,of,39,40,O
DDI-DrugBank.d531.s47,withdrawal,42,51,O
DDI-DrugBank.d531.s47,and,53,55,O
DDI-DrugBank.d531.s47,their,57,61,O
DDI-DrugBank.d531.s47,methadone,63,71,B-drug
DDI-DrugBank.d531.s47,dose,73,76,O
DDI-DrugBank.d531.s47,increased,78,86,O
DDI-DrugBank.d531.s47,as,88,89,O
DDI-DrugBank.d531.s47,required,91,98,O
DDI-DrugBank.d531.s47,to,100,101,O
DDI-DrugBank.d531.s47,alleviate,103,111,O
DDI-DrugBank.d531.s47,withdrawal,113,122,O
DDI-DrugBank.d531.s47,symptoms,124,131,O
DDI-DrugBank.d531.s47,.,132,132,O
DDI-DrugBank.d531.s48,Ethinyl,0,6,B-drug
DDI-DrugBank.d531.s48,estradiol,8,16,I-drug
DDI-DrugBank.d531.s49,ethinyl,0,6,B-drug
DDI-DrugBank.d531.s49,estradiol,8,16,I-drug
DDI-DrugBank.d531.s49,concentration,18,30,O
DDI-DrugBank.d531.s50,Plasma,0,5,O
DDI-DrugBank.d531.s50,concentrations,7,20,O
DDI-DrugBank.d531.s50,increased,22,30,O
DDI-DrugBank.d531.s50,by,32,33,O
DDI-DrugBank.d531.s50,SUSTIVA,35,41,B-brand
DDI-DrugBank.d531.s50,(,43,43,O
DDI-DrugBank.d531.s50,efavirenz,44,52,B-drug
DDI-DrugBank.d531.s50,),53,53,O
DDI-DrugBank.d531.s50,;,54,54,O
DDI-DrugBank.d531.s51,clinical,0,7,O
DDI-DrugBank.d531.s51,significance,9,20,O
DDI-DrugBank.d531.s51,unknown,22,28,O
DDI-DrugBank.d531.s51,.,29,29,O
DDI-DrugBank.d531.s52,Because,0,6,O
DDI-DrugBank.d531.s52,the,8,10,O
DDI-DrugBank.d531.s52,potential,12,20,O
DDI-DrugBank.d531.s52,interaction,22,32,O
DDI-DrugBank.d531.s52,of,34,35,O
DDI-DrugBank.d531.s52,efavirenz,37,45,B-drug
DDI-DrugBank.d531.s52,with,47,50,O
DDI-DrugBank.d531.s52,oral,52,55,O
DDI-DrugBank.d531.s52,contraceptives,57,70,B-group
DDI-DrugBank.d531.s52,has,72,74,O
DDI-DrugBank.d531.s52,not,76,78,O
DDI-DrugBank.d531.s52,been,80,83,O
DDI-DrugBank.d531.s52,fully,85,89,O
DDI-DrugBank.d531.s52,characterized,91,103,O
DDI-DrugBank.d531.s52,",",104,104,O
DDI-DrugBank.d531.s52,a,106,106,O
DDI-DrugBank.d531.s52,reliable,108,115,O
DDI-DrugBank.d531.s52,method,117,122,O
DDI-DrugBank.d531.s52,of,124,125,O
DDI-DrugBank.d531.s52,barrier,127,133,O
DDI-DrugBank.d531.s52,contraception,135,147,O
DDI-DrugBank.d531.s52,should,149,154,O
DDI-DrugBank.d531.s52,be,156,157,O
DDI-DrugBank.d531.s52,used,159,162,O
DDI-DrugBank.d531.s52,in,164,165,O
DDI-DrugBank.d531.s52,addition,167,174,O
DDI-DrugBank.d531.s52,to,176,177,O
DDI-DrugBank.d531.s52,oral,179,182,O
DDI-DrugBank.d531.s52,contraceptives,184,197,B-group
DDI-DrugBank.d531.s52,.,198,198,O
DDI-DrugBank.d531.s53,Rifabutin,0,8,B-drug
DDI-DrugBank.d531.s54,rifabutin,0,8,B-drug
DDI-DrugBank.d531.s54,concentration,10,22,O
DDI-DrugBank.d531.s55,Increase,0,7,O
DDI-DrugBank.d531.s55,daily,9,13,O
DDI-DrugBank.d531.s55,dose,15,18,O
DDI-DrugBank.d531.s55,of,20,21,O
DDI-DrugBank.d531.s55,rifabutin,23,31,B-drug
DDI-DrugBank.d531.s55,by,33,34,O
DDI-DrugBank.d531.s55,50,36,37,O
DDI-DrugBank.d531.s55,%,38,38,O
DDI-DrugBank.d531.s55,.,39,39,O
DDI-DrugBank.d531.s56,Consider,0,7,O
DDI-DrugBank.d531.s56,doubling,9,16,O
DDI-DrugBank.d531.s56,the,18,20,O
DDI-DrugBank.d531.s56,rifabutin,22,30,B-drug
DDI-DrugBank.d531.s56,dose,32,35,O
DDI-DrugBank.d531.s56,in,37,38,O
DDI-DrugBank.d531.s56,regimens,40,47,O
DDI-DrugBank.d531.s56,where,49,53,O
DDI-DrugBank.d531.s56,rifabutin,55,63,B-drug
DDI-DrugBank.d531.s56,is,65,66,O
DDI-DrugBank.d531.s56,given,68,72,O
DDI-DrugBank.d531.s56,2,74,74,O
DDI-DrugBank.d531.s56,or,76,77,O
DDI-DrugBank.d531.s56,3,79,79,O
DDI-DrugBank.d531.s56,times,81,85,O
DDI-DrugBank.d531.s56,a,87,87,O
DDI-DrugBank.d531.s56,week,89,92,O
DDI-DrugBank.d531.s56,.,93,93,O
DDI-DrugBank.d531.s57,Rifampin,0,7,B-drug
DDI-DrugBank.d531.s58,efavirenz,0,8,B-drug
DDI-DrugBank.d531.s58,concentration,10,22,O
DDI-DrugBank.d531.s59,Clinical,0,7,O
DDI-DrugBank.d531.s59,significance,9,20,O
DDI-DrugBank.d531.s59,of,22,23,O
DDI-DrugBank.d531.s59,reduced,25,31,O
DDI-DrugBank.d531.s59,efavirenz,33,41,B-drug
DDI-DrugBank.d531.s59,concentrations,43,56,O
DDI-DrugBank.d531.s59,unknown,58,64,O
DDI-DrugBank.d531.s59,.,65,65,O
DDI-DrugBank.d531.s60,Ritonavir,0,8,B-drug
DDI-DrugBank.d531.s61,ritonavir,0,8,B-drug
DDI-DrugBank.d531.s61,concentration,10,22,O
DDI-DrugBank.d531.s62,Combination,0,10,O
DDI-DrugBank.d531.s62,was,12,14,O
DDI-DrugBank.d531.s62,associated,16,25,O
DDI-DrugBank.d531.s62,with,27,30,O
DDI-DrugBank.d531.s62,a,32,32,O
DDI-DrugBank.d531.s62,higher,34,39,O
DDI-DrugBank.d531.s62,frequency,41,49,O
DDI-DrugBank.d531.s62,of,51,52,O
DDI-DrugBank.d531.s62,adverse,54,60,O
DDI-DrugBank.d531.s62,clinical,62,69,O
DDI-DrugBank.d531.s62,experiences,71,81,O
DDI-DrugBank.d531.s62,(,83,83,O
DDI-DrugBank.d531.s62,eg,84,85,O
DDI-DrugBank.d531.s62,",",86,86,O
DDI-DrugBank.d531.s62,dizziness,88,96,O
DDI-DrugBank.d531.s62,",",97,97,O
DDI-DrugBank.d531.s62,nausea,99,104,O
DDI-DrugBank.d531.s62,",",105,105,O
DDI-DrugBank.d531.s62,paresthesia,107,117,O
DDI-DrugBank.d531.s62,),118,118,O
DDI-DrugBank.d531.s62,and,120,122,O
DDI-DrugBank.d531.s62,laboratory,124,133,O
DDI-DrugBank.d531.s62,abnormalities,135,147,O
DDI-DrugBank.d531.s62,(,149,149,O
DDI-DrugBank.d531.s62,elevated,150,157,O
DDI-DrugBank.d531.s62,liver,159,163,O
DDI-DrugBank.d531.s62,enzymes,165,171,O
DDI-DrugBank.d531.s62,),172,172,O
DDI-DrugBank.d531.s62,.,173,173,O
DDI-DrugBank.d531.s63,Monitoring,0,9,O
DDI-DrugBank.d531.s63,of,11,12,O
DDI-DrugBank.d531.s63,liver,14,18,O
DDI-DrugBank.d531.s63,enzymes,20,26,O
DDI-DrugBank.d531.s63,is,28,29,O
DDI-DrugBank.d531.s63,recommended,31,41,O
DDI-DrugBank.d531.s63,when,43,46,O
DDI-DrugBank.d531.s63,SUSTIVA,48,54,B-brand
DDI-DrugBank.d531.s63,is,56,57,O
DDI-DrugBank.d531.s63,used,59,62,O
DDI-DrugBank.d531.s63,in,64,65,O
DDI-DrugBank.d531.s63,combination,67,77,O
DDI-DrugBank.d531.s63,with,79,82,O
DDI-DrugBank.d531.s63,ritonavir,84,92,B-drug
DDI-DrugBank.d531.s63,.,93,93,O
DDI-DrugBank.d531.s64,efavirenz,0,8,B-drug
DDI-DrugBank.d531.s64,concentration,10,22,O
DDI-DrugBank.d531.s65,Saquinavir,0,9,B-drug
DDI-DrugBank.d531.s66,saquinavir,0,9,B-drug
DDI-DrugBank.d531.s66,concentration,11,23,O
DDI-DrugBank.d531.s67,Should,0,5,O
DDI-DrugBank.d531.s67,not,7,9,O
DDI-DrugBank.d531.s67,be,11,12,O
DDI-DrugBank.d531.s67,used,14,17,O
DDI-DrugBank.d531.s67,as,19,20,O
DDI-DrugBank.d531.s67,sole,22,25,O
DDI-DrugBank.d531.s67,protease,27,34,B-group
DDI-DrugBank.d531.s67,inhibitor,36,44,I-group
DDI-DrugBank.d531.s67,in,46,47,O
DDI-DrugBank.d531.s67,combination,49,59,O
DDI-DrugBank.d531.s67,with,61,64,O
DDI-DrugBank.d531.s67,SUSTIVA,66,72,B-brand
DDI-DrugBank.d531.s67,.,73,73,O
DDI-DrugBank.d531.s68,Sertraline,0,9,B-drug
DDI-DrugBank.d531.s69,sertraline,0,9,B-drug
DDI-DrugBank.d531.s69,concentration,11,23,O
DDI-DrugBank.d531.s70,Increases,0,8,O
DDI-DrugBank.d531.s70,in,10,11,O
DDI-DrugBank.d531.s70,sertraline,13,22,B-drug
DDI-DrugBank.d531.s70,dose,24,27,O
DDI-DrugBank.d531.s70,should,29,34,O
DDI-DrugBank.d531.s70,be,36,37,O
DDI-DrugBank.d531.s70,guided,39,44,O
DDI-DrugBank.d531.s70,by,46,47,O
DDI-DrugBank.d531.s70,clinical,49,56,O
DDI-DrugBank.d531.s70,response,58,65,O
DDI-DrugBank.d531.s70,.,66,66,O
DDI-DrugBank.d531.s71,Other,0,4,O
DDI-DrugBank.d531.s71,Potentially,6,16,O
DDI-DrugBank.d531.s71,Clinically,18,27,O
DDI-DrugBank.d531.s71,Significant,29,39,O
DDI-DrugBank.d531.s71,Drug,41,44,O
DDI-DrugBank.d531.s71,or,46,47,O
DDI-DrugBank.d531.s71,Herbal,49,54,O
DDI-DrugBank.d531.s71,Product,56,62,O
DDI-DrugBank.d531.s71,Interactions,64,75,O
DDI-DrugBank.d531.s71,With,77,80,O
DDI-DrugBank.d531.s71,SUSTIVAb,82,89,O
DDI-DrugBank.d531.s72,Anticoagulants,0,13,B-group
DDI-DrugBank.d531.s72,:,14,14,O
DDI-DrugBank.d531.s72,Warfarin,16,23,B-drug
DDI-DrugBank.d531.s73,Plasma,0,5,O
DDI-DrugBank.d531.s73,concentrations,7,20,O
DDI-DrugBank.d531.s73,and,22,24,O
DDI-DrugBank.d531.s73,effects,26,32,O
DDI-DrugBank.d531.s73,potentially,34,44,O
DDI-DrugBank.d531.s73,increased,46,54,O
DDI-DrugBank.d531.s73,or,56,57,O
DDI-DrugBank.d531.s73,decreased,59,67,O
DDI-DrugBank.d531.s73,by,69,70,O
DDI-DrugBank.d531.s73,SUSTIVA,72,78,B-brand
DDI-DrugBank.d531.s73,.,79,79,O
DDI-DrugBank.d531.s74,Anticonvulsants,0,14,B-group
DDI-DrugBank.d531.s74,:,15,15,O
DDI-DrugBank.d531.s74,Phenytoin,17,25,B-drug
DDI-DrugBank.d531.s74,Phenobarbital,27,39,B-drug
DDI-DrugBank.d531.s74,Carbamazepine,41,53,B-drug
DDI-DrugBank.d531.s75,Potential,0,8,O
DDI-DrugBank.d531.s75,for,10,12,O
DDI-DrugBank.d531.s75,reduction,14,22,O
DDI-DrugBank.d531.s75,in,24,25,O
DDI-DrugBank.d531.s75,anticonvulsant,27,40,B-group
DDI-DrugBank.d531.s75,and/or,42,47,O
DDI-DrugBank.d531.s75,efavirenz,49,57,B-drug
DDI-DrugBank.d531.s75,plasma,59,64,O
DDI-DrugBank.d531.s75,levels,66,71,O
DDI-DrugBank.d531.s75,;,72,72,O
DDI-DrugBank.d531.s76,periodic,0,7,O
DDI-DrugBank.d531.s76,monitoring,9,18,O
DDI-DrugBank.d531.s76,of,20,21,O
DDI-DrugBank.d531.s76,anticonvulsant,23,36,B-group
DDI-DrugBank.d531.s76,plasma,38,43,O
DDI-DrugBank.d531.s76,levels,45,50,O
DDI-DrugBank.d531.s76,should,52,57,O
DDI-DrugBank.d531.s76,be,59,60,O
DDI-DrugBank.d531.s76,conducted,62,70,O
DDI-DrugBank.d531.s76,.,71,71,O
DDI-DrugBank.d531.s77,Antifungals,0,10,B-group
DDI-DrugBank.d531.s77,:,11,11,O
DDI-DrugBank.d531.s77,Itraconazole,13,24,B-drug
DDI-DrugBank.d531.s77,Ketoconazole,26,37,B-drug
DDI-DrugBank.d531.s78,Drug,0,3,O
DDI-DrugBank.d531.s78,interaction,5,15,O
DDI-DrugBank.d531.s78,studies,17,23,O
DDI-DrugBank.d531.s78,with,25,28,O
DDI-DrugBank.d531.s78,SUSTIVA,30,36,B-brand
DDI-DrugBank.d531.s78,and,38,40,O
DDI-DrugBank.d531.s78,these,42,46,O
DDI-DrugBank.d531.s78,imidazole,48,56,B-group
DDI-DrugBank.d531.s78,and,58,60,O
DDI-DrugBank.d531.s78,triazole,62,69,B-group
DDI-DrugBank.d531.s78,antifungals,71,81,I-group
DDI-DrugBank.d531.s78,have,83,86,O
DDI-DrugBank.d531.s78,not,88,90,O
DDI-DrugBank.d531.s78,been,92,95,O
DDI-DrugBank.d531.s78,conducted,97,105,O
DDI-DrugBank.d531.s78,.,106,106,O
DDI-DrugBank.d531.s79,SUSTIVA,0,6,B-brand
DDI-DrugBank.d531.s79,has,8,10,O
DDI-DrugBank.d531.s79,the,12,14,O
DDI-DrugBank.d531.s79,potential,16,24,O
DDI-DrugBank.d531.s79,to,26,27,O
DDI-DrugBank.d531.s79,decrease,29,36,O
DDI-DrugBank.d531.s79,plasma,38,43,O
DDI-DrugBank.d531.s79,concentrations,45,58,O
DDI-DrugBank.d531.s79,of,60,61,O
DDI-DrugBank.d531.s79,itraconazole,63,74,B-drug
DDI-DrugBank.d531.s79,and,76,78,O
DDI-DrugBank.d531.s79,ketoconazole,80,91,B-drug
DDI-DrugBank.d531.s79,.,92,92,O
DDI-DrugBank.d531.s80,Anti-HIV,0,7,B-group
DDI-DrugBank.d531.s80,protease,9,16,I-group
DDI-DrugBank.d531.s80,inhibitors,18,27,I-group
DDI-DrugBank.d531.s80,:,28,28,O
DDI-DrugBank.d531.s80,Saquinavir/ritonavir,30,49,O
DDI-DrugBank.d531.s80,combination,51,61,O
DDI-DrugBank.d531.s81,No,0,1,O
DDI-DrugBank.d531.s81,pharmacokinetic,3,17,O
DDI-DrugBank.d531.s81,data,19,22,O
DDI-DrugBank.d531.s81,are,24,26,O
DDI-DrugBank.d531.s81,available,28,36,O
DDI-DrugBank.d531.s81,.,37,37,O
DDI-DrugBank.d531.s82,Amprenavir,0,9,B-drug
DDI-DrugBank.d531.s83,SUSTIVAhas,0,9,O
DDI-DrugBank.d531.s83,the,11,13,O
DDI-DrugBank.d531.s83,potential,15,23,O
DDI-DrugBank.d531.s83,to,25,26,O
DDI-DrugBank.d531.s83,decrease,28,35,O
DDI-DrugBank.d531.s83,serum,37,41,O
DDI-DrugBank.d531.s83,concentrations,43,56,O
DDI-DrugBank.d531.s83,of,58,59,O
DDI-DrugBank.d531.s83,amprenavir,61,70,B-drug
DDI-DrugBank.d531.s83,.,71,71,O
DDI-DrugBank.d531.s84,Non-nucleoside,0,13,B-group
DDI-DrugBank.d531.s84,reverse,15,21,I-group
DDI-DrugBank.d531.s84,transcriptase,23,35,I-group
DDI-DrugBank.d531.s84,inhibitors,37,46,I-group
DDI-DrugBank.d531.s85,No,0,1,O
DDI-DrugBank.d531.s85,studies,3,9,O
DDI-DrugBank.d531.s85,have,11,14,O
DDI-DrugBank.d531.s85,been,16,19,O
DDI-DrugBank.d531.s85,performed,21,29,O
DDI-DrugBank.d531.s85,with,31,34,O
DDI-DrugBank.d531.s85,other,36,40,O
DDI-DrugBank.d531.s85,NNRTIs,42,47,B-group
DDI-DrugBank.d531.s85,.,48,48,O
DDI-DrugBank.d531.s86,St.,0,2,O
DDI-DrugBank.d531.s86,John,4,7,O
DDI-DrugBank.d531.s86,s,9,9,O
DDI-DrugBank.d531.s86,wort,11,14,O
DDI-DrugBank.d531.s86,(,16,16,O
DDI-DrugBank.d531.s86,Hypericum,17,25,O
DDI-DrugBank.d531.s86,perforatum,27,36,O
DDI-DrugBank.d531.s86,),37,37,O
DDI-DrugBank.d531.s87,Expected,0,7,O
DDI-DrugBank.d531.s87,to,9,10,O
DDI-DrugBank.d531.s87,substantially,12,24,O
DDI-DrugBank.d531.s87,decrease,26,33,O
DDI-DrugBank.d531.s87,plasma,35,40,O
DDI-DrugBank.d531.s87,levels,42,47,O
DDI-DrugBank.d531.s87,of,49,50,O
DDI-DrugBank.d531.s87,efavirenz,52,60,B-drug
DDI-DrugBank.d531.s87,;,61,61,O
DDI-DrugBank.d531.s87,has,62,64,O
DDI-DrugBank.d531.s87,not,66,68,O
DDI-DrugBank.d531.s87,been,70,73,O
DDI-DrugBank.d531.s87,studied,75,81,O
DDI-DrugBank.d531.s87,in,83,84,O
DDI-DrugBank.d531.s87,combination,86,96,O
DDI-DrugBank.d531.s87,with,98,101,O
DDI-DrugBank.d531.s87,SUSTIVA,103,109,B-brand
DDI-DrugBank.d531.s87,.,110,110,O
DDI-DrugBank.d531.s88,a,0,0,O
DDI-DrugBank.d531.s88,See,2,4,O
DDI-DrugBank.d531.s88,Tables,6,11,O
DDI-DrugBank.d531.s88,1,13,13,O
DDI-DrugBank.d531.s88,and,15,17,O
DDI-DrugBank.d531.s88,2,19,19,O
DDI-DrugBank.d531.s88,.,20,20,O
DDI-DrugBank.d531.s89,b,0,0,O
DDI-DrugBank.d531.s89,This,2,5,O
DDI-DrugBank.d531.s89,table,7,11,O
DDI-DrugBank.d531.s89,is,13,14,O
DDI-DrugBank.d531.s89,not,16,18,O
DDI-DrugBank.d531.s89,all-inclusive,20,32,O
DDI-DrugBank.d531.s89,.,33,33,O
DDI-DrugBank.d531.s90,Other,0,4,O
DDI-DrugBank.d531.s90,Drugs,6,10,O
DDI-DrugBank.d531.s90,:,11,11,O
DDI-DrugBank.d531.s90,Based,13,17,O
DDI-DrugBank.d531.s90,on,19,20,O
DDI-DrugBank.d531.s90,the,22,24,O
DDI-DrugBank.d531.s90,results,26,32,O
DDI-DrugBank.d531.s90,of,34,35,O
DDI-DrugBank.d531.s90,drug,37,40,O
DDI-DrugBank.d531.s90,interaction,42,52,O
DDI-DrugBank.d531.s90,studies,54,60,O
DDI-DrugBank.d531.s90,",",61,61,O
DDI-DrugBank.d531.s90,no,63,64,O
DDI-DrugBank.d531.s90,dosage,66,71,O
DDI-DrugBank.d531.s90,adjustment,73,82,O
DDI-DrugBank.d531.s90,is,84,85,O
DDI-DrugBank.d531.s90,recommended,87,97,O
DDI-DrugBank.d531.s90,when,99,102,O
DDI-DrugBank.d531.s90,SUSTIVA,104,110,B-brand
DDI-DrugBank.d531.s90,(,112,112,O
DDI-DrugBank.d531.s90,efavirenz,113,121,B-drug
DDI-DrugBank.d531.s90,),122,122,O
DDI-DrugBank.d531.s90,is,124,125,O
DDI-DrugBank.d531.s90,given,127,131,O
DDI-DrugBank.d531.s90,with,133,136,O
DDI-DrugBank.d531.s90,the,138,140,O
DDI-DrugBank.d531.s90,following,142,150,O
DDI-DrugBank.d531.s90,:,151,151,O
DDI-DrugBank.d531.s90,aluminum/magnesium,153,170,B-group
DDI-DrugBank.d531.s90,hydroxide,172,180,I-group
DDI-DrugBank.d531.s90,antacids,182,189,I-group
DDI-DrugBank.d531.s90,",",190,190,O
DDI-DrugBank.d531.s90,azithromycin,192,203,B-drug
DDI-DrugBank.d531.s90,",",204,204,O
DDI-DrugBank.d531.s90,cetirizine,206,215,B-drug
DDI-DrugBank.d531.s90,",",216,216,O
DDI-DrugBank.d531.s90,famotidine,218,227,B-drug
DDI-DrugBank.d531.s90,",",228,228,O
DDI-DrugBank.d531.s90,fluconazole,230,240,B-drug
DDI-DrugBank.d531.s90,",",241,241,O
DDI-DrugBank.d531.s90,lamivudine,243,252,B-drug
DDI-DrugBank.d531.s90,",",253,253,O
DDI-DrugBank.d531.s90,lorazepam,255,263,B-drug
DDI-DrugBank.d531.s90,",",264,264,O
DDI-DrugBank.d531.s90,nelfinavir,266,275,B-drug
DDI-DrugBank.d531.s90,",",276,276,O
DDI-DrugBank.d531.s90,paroxetine,278,287,B-drug
DDI-DrugBank.d531.s90,",",288,288,O
DDI-DrugBank.d531.s90,and,290,292,O
DDI-DrugBank.d531.s90,zidovudine,294,303,B-drug
DDI-DrugBank.d531.s90,.,304,304,O
DDI-DrugBank.d531.s91,Specific,0,7,O
DDI-DrugBank.d531.s91,drug,9,12,O
DDI-DrugBank.d531.s91,interaction,14,24,O
DDI-DrugBank.d531.s91,studies,26,32,O
DDI-DrugBank.d531.s91,have,34,37,O
DDI-DrugBank.d531.s91,not,39,41,O
DDI-DrugBank.d531.s91,been,43,46,O
DDI-DrugBank.d531.s91,performed,48,56,O
DDI-DrugBank.d531.s91,with,58,61,O
DDI-DrugBank.d531.s91,SUSTIVA,63,69,B-brand
DDI-DrugBank.d531.s91,and,71,73,O
DDI-DrugBank.d531.s91,NRTIs,75,79,B-group
DDI-DrugBank.d531.s91,other,81,85,O
DDI-DrugBank.d531.s91,than,87,90,O
DDI-DrugBank.d531.s91,lamivudine,92,101,B-drug
DDI-DrugBank.d531.s91,and,103,105,O
DDI-DrugBank.d531.s91,zidovudine,107,116,B-drug
DDI-DrugBank.d531.s91,.,117,117,O
DDI-DrugBank.d531.s92,Clinically,0,9,O
DDI-DrugBank.d531.s92,significant,11,21,O
DDI-DrugBank.d531.s92,interactions,23,34,O
DDI-DrugBank.d531.s92,would,36,40,O
DDI-DrugBank.d531.s92,not,42,44,O
DDI-DrugBank.d531.s92,be,46,47,O
DDI-DrugBank.d531.s92,expected,49,56,O
DDI-DrugBank.d531.s92,since,58,62,O
DDI-DrugBank.d531.s92,the,64,66,O
DDI-DrugBank.d531.s92,NRTIs,68,72,B-group
DDI-DrugBank.d531.s92,are,74,76,O
DDI-DrugBank.d531.s92,metabolized,78,88,O
DDI-DrugBank.d531.s92,via,90,92,O
DDI-DrugBank.d531.s92,a,94,94,O
DDI-DrugBank.d531.s92,different,96,104,O
DDI-DrugBank.d531.s92,route,106,110,O
DDI-DrugBank.d531.s92,than,112,115,O
DDI-DrugBank.d531.s92,efavirenz,117,125,B-drug
DDI-DrugBank.d531.s92,and,127,129,O
DDI-DrugBank.d531.s92,would,131,135,O
DDI-DrugBank.d531.s92,be,137,138,O
DDI-DrugBank.d531.s92,unlikely,140,147,O
DDI-DrugBank.d531.s92,to,149,150,O
DDI-DrugBank.d531.s92,compete,152,158,O
DDI-DrugBank.d531.s92,for,160,162,O
DDI-DrugBank.d531.s92,the,164,166,O
DDI-DrugBank.d531.s92,same,168,171,O
DDI-DrugBank.d531.s92,metabolic,173,181,O
DDI-DrugBank.d531.s92,enzymes,183,189,O
DDI-DrugBank.d531.s92,and,191,193,O
DDI-DrugBank.d531.s92,elimination,195,205,O
DDI-DrugBank.d531.s92,pathways,207,214,O
DDI-DrugBank.d531.s92,.,215,215,O
DDI-DrugBank.d107.s0,Hypotension,0,10,O
DDI-DrugBank.d107.s0,:,11,11,O
DDI-DrugBank.d107.s0,Patients,13,20,O
DDI-DrugBank.d107.s0,on,22,23,O
DDI-DrugBank.d107.s0,Diuretic,25,32,O
DDI-DrugBank.d107.s0,Therapy,34,40,O
DDI-DrugBank.d107.s0,:,41,41,O
DDI-DrugBank.d107.s0,Patients,43,50,O
DDI-DrugBank.d107.s0,on,52,53,O
DDI-DrugBank.d107.s0,diuretics,55,63,B-drug
DDI-DrugBank.d107.s0,and,65,67,O
DDI-DrugBank.d107.s0,especially,69,78,O
DDI-DrugBank.d107.s0,those,80,84,O
DDI-DrugBank.d107.s0,in,86,87,O
DDI-DrugBank.d107.s0,whom,89,92,O
DDI-DrugBank.d107.s0,diuretic,94,101,O
DDI-DrugBank.d107.s0,therapy,103,109,O
DDI-DrugBank.d107.s0,was,111,113,O
DDI-DrugBank.d107.s0,recently,115,122,O
DDI-DrugBank.d107.s0,instituted,124,133,O
DDI-DrugBank.d107.s0,",",134,134,O
DDI-DrugBank.d107.s0,may,136,138,O
DDI-DrugBank.d107.s0,occasionally,140,151,O
DDI-DrugBank.d107.s0,experience,153,162,O
DDI-DrugBank.d107.s0,an,164,165,O
DDI-DrugBank.d107.s0,excessive,167,175,O
DDI-DrugBank.d107.s0,reduction,177,185,O
DDI-DrugBank.d107.s0,of,187,188,O
DDI-DrugBank.d107.s0,blood,190,194,O
DDI-DrugBank.d107.s0,pressure,196,203,O
DDI-DrugBank.d107.s0,after,205,209,O
DDI-DrugBank.d107.s0,initiation,211,220,O
DDI-DrugBank.d107.s0,of,222,223,O
DDI-DrugBank.d107.s0,therapy,225,231,O
DDI-DrugBank.d107.s0,with,233,236,O
DDI-DrugBank.d107.s0,enalapril,238,246,B-drug
DDI-DrugBank.d107.s0,or,248,249,O
DDI-DrugBank.d107.s0,enalaprilat,251,261,B-drug
DDI-DrugBank.d107.s0,.,262,262,O
DDI-DrugBank.d107.s1,The,0,2,O
DDI-DrugBank.d107.s1,possibility,4,14,O
DDI-DrugBank.d107.s1,of,16,17,O
DDI-DrugBank.d107.s1,hypotensive,19,29,O
DDI-DrugBank.d107.s1,effects,31,37,O
DDI-DrugBank.d107.s1,with,39,42,O
DDI-DrugBank.d107.s1,enalapril,44,52,B-drug
DDI-DrugBank.d107.s1,or,54,55,O
DDI-DrugBank.d107.s1,enalaprilat,57,67,B-drug
DDI-DrugBank.d107.s1,can,69,71,O
DDI-DrugBank.d107.s1,be,73,74,O
DDI-DrugBank.d107.s1,minimized,76,84,O
DDI-DrugBank.d107.s1,by,86,87,O
DDI-DrugBank.d107.s1,either,89,94,O
DDI-DrugBank.d107.s1,discontinuing,96,108,O
DDI-DrugBank.d107.s1,the,110,112,O
DDI-DrugBank.d107.s1,diuretic,114,121,B-drug
DDI-DrugBank.d107.s1,or,123,124,O
DDI-DrugBank.d107.s1,increasing,126,135,O
DDI-DrugBank.d107.s1,the,137,139,O
DDI-DrugBank.d107.s1,salt,141,144,O
DDI-DrugBank.d107.s1,intake,146,151,O
DDI-DrugBank.d107.s1,prior,153,157,O
DDI-DrugBank.d107.s1,to,159,160,O
DDI-DrugBank.d107.s1,initiation,162,171,O
DDI-DrugBank.d107.s1,of,173,174,O
DDI-DrugBank.d107.s1,treatment,176,184,O
DDI-DrugBank.d107.s1,with,186,189,O
DDI-DrugBank.d107.s1,enalapril,191,199,B-drug
DDI-DrugBank.d107.s1,or,201,202,O
DDI-DrugBank.d107.s1,enalaprilat,204,214,B-drug
DDI-DrugBank.d107.s1,.,215,215,O
DDI-DrugBank.d107.s2,If,0,1,O
DDI-DrugBank.d107.s2,it,3,4,O
DDI-DrugBank.d107.s2,is,6,7,O
DDI-DrugBank.d107.s2,necessary,9,17,O
DDI-DrugBank.d107.s2,to,19,20,O
DDI-DrugBank.d107.s2,continue,22,29,O
DDI-DrugBank.d107.s2,the,31,33,O
DDI-DrugBank.d107.s2,diuretic,35,42,B-group
DDI-DrugBank.d107.s2,",",43,43,O
DDI-DrugBank.d107.s2,provide,45,51,O
DDI-DrugBank.d107.s2,close,53,57,O
DDI-DrugBank.d107.s2,medical,59,65,O
DDI-DrugBank.d107.s2,supervision,67,77,O
DDI-DrugBank.d107.s2,after,79,83,O
DDI-DrugBank.d107.s2,the,85,87,O
DDI-DrugBank.d107.s2,initial,89,95,O
DDI-DrugBank.d107.s2,dose,97,100,O
DDI-DrugBank.d107.s2,for,102,104,O
DDI-DrugBank.d107.s2,at,106,107,O
DDI-DrugBank.d107.s2,least,109,113,O
DDI-DrugBank.d107.s2,two,115,117,O
DDI-DrugBank.d107.s2,hours,119,123,O
DDI-DrugBank.d107.s2,and,125,127,O
DDI-DrugBank.d107.s2,until,129,133,O
DDI-DrugBank.d107.s2,blood,135,139,O
DDI-DrugBank.d107.s2,pressure,141,148,O
DDI-DrugBank.d107.s2,has,150,152,O
DDI-DrugBank.d107.s2,stabilized,154,163,O
DDI-DrugBank.d107.s2,for,165,167,O
DDI-DrugBank.d107.s2,at,169,170,O
DDI-DrugBank.d107.s2,least,172,176,O
DDI-DrugBank.d107.s2,an,178,179,O
DDI-DrugBank.d107.s2,additional,181,190,O
DDI-DrugBank.d107.s2,hour,192,195,O
DDI-DrugBank.d107.s2,..,196,197,O
DDI-DrugBank.d107.s3,Agents,0,5,O
DDI-DrugBank.d107.s3,Causing,7,13,O
DDI-DrugBank.d107.s3,Renin,15,19,O
DDI-DrugBank.d107.s3,Release,21,27,O
DDI-DrugBank.d107.s3,:,28,28,O
DDI-DrugBank.d107.s3,The,30,32,O
DDI-DrugBank.d107.s3,antihypertensive,34,49,O
DDI-DrugBank.d107.s3,effect,51,56,O
DDI-DrugBank.d107.s3,of,58,59,O
DDI-DrugBank.d107.s3,enalapril,61,69,B-drug
DDI-DrugBank.d107.s3,and,71,73,O
DDI-DrugBank.d107.s3,enalapril,75,83,B-drug
DDI-DrugBank.d107.s3,IV,85,86,O
DDI-DrugBank.d107.s3,is,88,89,O
DDI-DrugBank.d107.s3,augmented,91,99,O
DDI-DrugBank.d107.s3,by,101,102,O
DDI-DrugBank.d107.s3,antihypertensive,104,119,B-group
DDI-DrugBank.d107.s3,agents,121,126,I-group
DDI-DrugBank.d107.s3,that,128,131,O
DDI-DrugBank.d107.s3,cause,133,137,O
DDI-DrugBank.d107.s3,renin,139,143,O
DDI-DrugBank.d107.s3,release,145,151,O
DDI-DrugBank.d107.s3,(,153,153,O
DDI-DrugBank.d107.s3,e.g.,154,157,O
DDI-DrugBank.d107.s3,",",158,158,O
DDI-DrugBank.d107.s3,diuretics,160,168,B-group
DDI-DrugBank.d107.s3,),169,169,O
DDI-DrugBank.d107.s3,.,170,170,O
DDI-DrugBank.d107.s4,Non-steroidal,0,12,B-group
DDI-DrugBank.d107.s4,Anti-inflammatory,14,30,I-group
DDI-DrugBank.d107.s4,Agents,32,37,I-group
DDI-DrugBank.d107.s4,:,38,38,O
DDI-DrugBank.d107.s4,In,40,41,O
DDI-DrugBank.d107.s4,some,43,46,O
DDI-DrugBank.d107.s4,patients,48,55,O
DDI-DrugBank.d107.s4,with,57,60,O
DDI-DrugBank.d107.s4,compromised,62,72,O
DDI-DrugBank.d107.s4,renal,74,78,O
DDI-DrugBank.d107.s4,function,80,87,O
DDI-DrugBank.d107.s4,who,89,91,O
DDI-DrugBank.d107.s4,are,93,95,O
DDI-DrugBank.d107.s4,being,97,101,O
DDI-DrugBank.d107.s4,treated,103,109,O
DDI-DrugBank.d107.s4,with,111,114,O
DDI-DrugBank.d107.s4,nonsteroidal,116,127,B-group
DDI-DrugBank.d107.s4,anti-inflammatory,129,145,I-group
DDI-DrugBank.d107.s4,drugs,147,151,I-group
DDI-DrugBank.d107.s4,",",152,152,O
DDI-DrugBank.d107.s4,the,154,156,O
DDI-DrugBank.d107.s4,co-administration,158,174,O
DDI-DrugBank.d107.s4,of,176,177,O
DDI-DrugBank.d107.s4,enalapril,179,187,B-drug
DDI-DrugBank.d107.s4,may,189,191,O
DDI-DrugBank.d107.s4,result,193,198,O
DDI-DrugBank.d107.s4,in,200,201,O
DDI-DrugBank.d107.s4,a,203,203,O
DDI-DrugBank.d107.s4,further,205,211,O
DDI-DrugBank.d107.s4,deterioration,213,225,O
DDI-DrugBank.d107.s4,of,227,228,O
DDI-DrugBank.d107.s4,renal,230,234,O
DDI-DrugBank.d107.s4,function,236,243,O
DDI-DrugBank.d107.s4,.,244,244,O
DDI-DrugBank.d107.s5,These,0,4,O
DDI-DrugBank.d107.s5,effects,6,12,O
DDI-DrugBank.d107.s5,are,14,16,O
DDI-DrugBank.d107.s5,usually,18,24,O
DDI-DrugBank.d107.s5,reversible,26,35,O
DDI-DrugBank.d107.s5,.,36,36,O
DDI-DrugBank.d107.s6,In,0,1,O
DDI-DrugBank.d107.s6,a,3,3,O
DDI-DrugBank.d107.s6,clinical,5,12,O
DDI-DrugBank.d107.s6,pharmacology,14,25,O
DDI-DrugBank.d107.s6,study,27,31,O
DDI-DrugBank.d107.s6,",",32,32,O
DDI-DrugBank.d107.s6,indomethacin,34,45,B-drug
DDI-DrugBank.d107.s6,or,47,48,O
DDI-DrugBank.d107.s6,sulindac,50,57,B-drug
DDI-DrugBank.d107.s6,was,59,61,O
DDI-DrugBank.d107.s6,administered,63,74,O
DDI-DrugBank.d107.s6,to,76,77,O
DDI-DrugBank.d107.s6,hypertensive,79,90,O
DDI-DrugBank.d107.s6,patients,92,99,O
DDI-DrugBank.d107.s6,receiving,101,109,O
DDI-DrugBank.d107.s6,VASOTEC,111,117,B-brand
DDI-DrugBank.d107.s6,.,118,118,O
DDI-DrugBank.d107.s7,In,0,1,O
DDI-DrugBank.d107.s7,this,3,6,O
DDI-DrugBank.d107.s7,study,8,12,O
DDI-DrugBank.d107.s7,there,14,18,O
DDI-DrugBank.d107.s7,was,20,22,O
DDI-DrugBank.d107.s7,no,24,25,O
DDI-DrugBank.d107.s7,evidence,27,34,O
DDI-DrugBank.d107.s7,of,36,37,O
DDI-DrugBank.d107.s7,a,39,39,O
DDI-DrugBank.d107.s7,blunting,41,48,O
DDI-DrugBank.d107.s7,of,50,51,O
DDI-DrugBank.d107.s7,the,53,55,O
DDI-DrugBank.d107.s7,antihypertensive,57,72,O
DDI-DrugBank.d107.s7,action,74,79,O
DDI-DrugBank.d107.s7,of,81,82,O
DDI-DrugBank.d107.s7,VASOTEC,84,90,B-brand
DDI-DrugBank.d107.s7,.,91,91,O
DDI-DrugBank.d107.s8,However,0,6,O
DDI-DrugBank.d107.s8,",",7,7,O
DDI-DrugBank.d107.s8,reports,9,15,O
DDI-DrugBank.d107.s8,suggest,17,23,O
DDI-DrugBank.d107.s8,that,25,28,O
DDI-DrugBank.d107.s8,NSAIDs,30,35,B-group
DDI-DrugBank.d107.s8,may,37,39,O
DDI-DrugBank.d107.s8,diminish,41,48,O
DDI-DrugBank.d107.s8,the,50,52,O
DDI-DrugBank.d107.s8,antihypertensive,54,69,O
DDI-DrugBank.d107.s8,effect,71,76,O
DDI-DrugBank.d107.s8,of,78,79,O
DDI-DrugBank.d107.s8,ACE,81,83,B-group
DDI-DrugBank.d107.s8,inhibitors,85,94,I-group
DDI-DrugBank.d107.s8,.,95,95,O
DDI-DrugBank.d107.s9,This,0,3,O
DDI-DrugBank.d107.s9,interaction,5,15,O
DDI-DrugBank.d107.s9,should,17,22,O
DDI-DrugBank.d107.s9,be,24,25,O
DDI-DrugBank.d107.s9,given,27,31,O
DDI-DrugBank.d107.s9,consideration,33,45,O
DDI-DrugBank.d107.s9,in,47,48,O
DDI-DrugBank.d107.s9,patients,50,57,O
DDI-DrugBank.d107.s9,taking,59,64,O
DDI-DrugBank.d107.s9,NSAIDs,66,71,B-group
DDI-DrugBank.d107.s9,concomitantly,73,85,O
DDI-DrugBank.d107.s9,with,87,90,O
DDI-DrugBank.d107.s9,ACE,92,94,B-group
DDI-DrugBank.d107.s9,inhibitors,96,105,I-group
DDI-DrugBank.d107.s9,.,106,106,O
DDI-DrugBank.d107.s10,Other,0,4,O
DDI-DrugBank.d107.s10,Cardiovascular,6,19,O
DDI-DrugBank.d107.s10,Agents,21,26,O
DDI-DrugBank.d107.s10,:,27,27,O
DDI-DrugBank.d107.s10,Enalapril,29,37,B-drug
DDI-DrugBank.d107.s10,and,39,41,O
DDI-DrugBank.d107.s10,enalapril,43,51,B-drug
DDI-DrugBank.d107.s10,IV,53,54,O
DDI-DrugBank.d107.s10,have,56,59,O
DDI-DrugBank.d107.s10,been,61,64,O
DDI-DrugBank.d107.s10,used,66,69,O
DDI-DrugBank.d107.s10,concomitantly,71,83,O
DDI-DrugBank.d107.s10,with,85,88,O
DDI-DrugBank.d107.s10,beta,90,93,B-group
DDI-DrugBank.d107.s10,adrenergic-blocking,95,113,I-group
DDI-DrugBank.d107.s10,agents,115,120,I-group
DDI-DrugBank.d107.s10,",",121,121,O
DDI-DrugBank.d107.s10,methyldopa,123,132,B-drug
DDI-DrugBank.d107.s10,",",133,133,O
DDI-DrugBank.d107.s10,nitrates,135,142,B-group
DDI-DrugBank.d107.s10,",",143,143,O
DDI-DrugBank.d107.s10,calcium-blocking,145,160,B-group
DDI-DrugBank.d107.s10,agents,162,167,I-group
DDI-DrugBank.d107.s10,",",168,168,O
DDI-DrugBank.d107.s10,hydralazine,170,180,B-drug
DDI-DrugBank.d107.s10,",",181,181,O
DDI-DrugBank.d107.s10,prazosin,183,190,B-drug
DDI-DrugBank.d107.s10,and,192,194,O
DDI-DrugBank.d107.s10,digoxin,196,202,B-drug
DDI-DrugBank.d107.s10,without,204,210,O
DDI-DrugBank.d107.s10,evidence,212,219,O
DDI-DrugBank.d107.s10,of,221,222,O
DDI-DrugBank.d107.s10,clinically,224,233,O
DDI-DrugBank.d107.s10,significant,235,245,O
DDI-DrugBank.d107.s10,adverse,247,253,O
DDI-DrugBank.d107.s10,interactions,255,266,O
DDI-DrugBank.d107.s10,.,267,267,O
DDI-DrugBank.d107.s11,Enalapril,0,8,B-drug
DDI-DrugBank.d107.s11,IV,10,11,O
DDI-DrugBank.d107.s11,has,13,15,O
DDI-DrugBank.d107.s11,been,17,20,O
DDI-DrugBank.d107.s11,used,22,25,O
DDI-DrugBank.d107.s11,concomitantly,27,39,O
DDI-DrugBank.d107.s11,with,41,44,O
DDI-DrugBank.d107.s11,digitalis,46,54,B-group
DDI-DrugBank.d107.s11,without,56,62,O
DDI-DrugBank.d107.s11,evidence,64,71,O
DDI-DrugBank.d107.s11,of,73,74,O
DDI-DrugBank.d107.s11,clinically,76,85,O
DDI-DrugBank.d107.s11,significant,87,97,O
DDI-DrugBank.d107.s11,adverse,99,105,O
DDI-DrugBank.d107.s11,reactions,107,115,O
DDI-DrugBank.d107.s11,.,116,116,O
DDI-DrugBank.d107.s12,Agents,0,5,O
DDI-DrugBank.d107.s12,Increasing,7,16,O
DDI-DrugBank.d107.s12,Serum,18,22,O
DDI-DrugBank.d107.s12,Potassium,24,32,O
DDI-DrugBank.d107.s12,:,33,33,O
DDI-DrugBank.d107.s12,Enalapril,35,43,B-drug
DDI-DrugBank.d107.s12,and,45,47,O
DDI-DrugBank.d107.s12,enalapril,49,57,B-drug
DDI-DrugBank.d107.s12,IV,59,60,O
DDI-DrugBank.d107.s12,attenuate,62,70,O
DDI-DrugBank.d107.s12,potassium,72,80,O
DDI-DrugBank.d107.s12,loss,82,85,O
DDI-DrugBank.d107.s12,caused,87,92,O
DDI-DrugBank.d107.s12,by,94,95,O
DDI-DrugBank.d107.s12,thiazide-type,97,109,B-group
DDI-DrugBank.d107.s12,diuretics,111,119,I-group
DDI-DrugBank.d107.s12,.,120,120,O
DDI-DrugBank.d107.s13,Potassium-sparing,0,16,B-group
DDI-DrugBank.d107.s13,diuretics,18,26,I-group
DDI-DrugBank.d107.s13,(,28,28,O
DDI-DrugBank.d107.s13,e.g.,29,32,O
DDI-DrugBank.d107.s13,",",33,33,O
DDI-DrugBank.d107.s13,spironolactone,35,48,B-drug
DDI-DrugBank.d107.s13,",",49,49,O
DDI-DrugBank.d107.s13,triamterene,51,61,B-drug
DDI-DrugBank.d107.s13,",",62,62,O
DDI-DrugBank.d107.s13,or,64,65,O
DDI-DrugBank.d107.s13,amiloride,67,75,B-drug
DDI-DrugBank.d107.s13,),76,76,O
DDI-DrugBank.d107.s13,",",77,77,O
DDI-DrugBank.d107.s13,potassium,79,87,B-drug
DDI-DrugBank.d107.s13,supplements,89,99,O
DDI-DrugBank.d107.s13,",",100,100,O
DDI-DrugBank.d107.s13,or,102,103,O
DDI-DrugBank.d107.s13,potassium-containing,105,124,O
DDI-DrugBank.d107.s13,salt,126,129,O
DDI-DrugBank.d107.s13,substitutes,131,141,O
DDI-DrugBank.d107.s13,may,143,145,O
DDI-DrugBank.d107.s13,lead,147,150,O
DDI-DrugBank.d107.s13,to,152,153,O
DDI-DrugBank.d107.s13,significant,155,165,O
DDI-DrugBank.d107.s13,increases,167,175,O
DDI-DrugBank.d107.s13,in,177,178,O
DDI-DrugBank.d107.s13,serum,180,184,O
DDI-DrugBank.d107.s13,potassium,186,194,O
DDI-DrugBank.d107.s13,.,195,195,O
DDI-DrugBank.d107.s14,Therefore,0,8,O
DDI-DrugBank.d107.s14,",",9,9,O
DDI-DrugBank.d107.s14,if,11,12,O
DDI-DrugBank.d107.s14,concomitant,14,24,O
DDI-DrugBank.d107.s14,use,26,28,O
DDI-DrugBank.d107.s14,of,30,31,O
DDI-DrugBank.d107.s14,these,33,37,O
DDI-DrugBank.d107.s14,agents,39,44,O
DDI-DrugBank.d107.s14,is,46,47,O
DDI-DrugBank.d107.s14,indicated,49,57,O
DDI-DrugBank.d107.s14,because,59,65,O
DDI-DrugBank.d107.s14,of,67,68,O
DDI-DrugBank.d107.s14,demonstrated,70,81,O
DDI-DrugBank.d107.s14,hypokalemia,83,93,O
DDI-DrugBank.d107.s14,",",94,94,O
DDI-DrugBank.d107.s14,they,96,99,O
DDI-DrugBank.d107.s14,should,101,106,O
DDI-DrugBank.d107.s14,be,108,109,O
DDI-DrugBank.d107.s14,used,111,114,O
DDI-DrugBank.d107.s14,with,116,119,O
DDI-DrugBank.d107.s14,caution,121,127,O
DDI-DrugBank.d107.s14,and,129,131,O
DDI-DrugBank.d107.s14,with,133,136,O
DDI-DrugBank.d107.s14,frequent,138,145,O
DDI-DrugBank.d107.s14,monitoring,147,156,O
DDI-DrugBank.d107.s14,of,158,159,O
DDI-DrugBank.d107.s14,serum,161,165,O
DDI-DrugBank.d107.s14,potassium,167,175,O
DDI-DrugBank.d107.s14,.,176,176,O
DDI-DrugBank.d107.s15,Potassium,0,8,O
DDI-DrugBank.d107.s15,sparing,10,16,O
DDI-DrugBank.d107.s15,agents,18,23,O
DDI-DrugBank.d107.s15,should,25,30,O
DDI-DrugBank.d107.s15,generally,32,40,O
DDI-DrugBank.d107.s15,not,42,44,O
DDI-DrugBank.d107.s15,be,46,47,O
DDI-DrugBank.d107.s15,used,49,52,O
DDI-DrugBank.d107.s15,in,54,55,O
DDI-DrugBank.d107.s15,patients,57,64,O
DDI-DrugBank.d107.s15,with,66,69,O
DDI-DrugBank.d107.s15,heart,71,75,O
DDI-DrugBank.d107.s15,failure,77,83,O
DDI-DrugBank.d107.s15,receiving,85,93,O
DDI-DrugBank.d107.s15,enalapril,95,103,B-drug
DDI-DrugBank.d107.s15,.,104,104,O
DDI-DrugBank.d107.s16,Lithium,0,6,B-drug
DDI-DrugBank.d107.s16,:,7,7,O
DDI-DrugBank.d107.s16,Lithium,9,15,B-drug
DDI-DrugBank.d107.s16,toxicity,17,24,O
DDI-DrugBank.d107.s16,has,26,28,O
DDI-DrugBank.d107.s16,been,30,33,O
DDI-DrugBank.d107.s16,reported,35,42,O
DDI-DrugBank.d107.s16,in,44,45,O
DDI-DrugBank.d107.s16,patients,47,54,O
DDI-DrugBank.d107.s16,receiving,56,64,O
DDI-DrugBank.d107.s16,lithium,66,72,B-drug
DDI-DrugBank.d107.s16,concomitantly,74,86,O
DDI-DrugBank.d107.s16,with,88,91,O
DDI-DrugBank.d107.s16,drugs,93,97,O
DDI-DrugBank.d107.s16,which,99,103,O
DDI-DrugBank.d107.s16,cause,105,109,O
DDI-DrugBank.d107.s16,elimination,111,121,O
DDI-DrugBank.d107.s16,of,123,124,O
DDI-DrugBank.d107.s16,sodium,126,131,O
DDI-DrugBank.d107.s16,",",132,132,O
DDI-DrugBank.d107.s16,including,134,142,O
DDI-DrugBank.d107.s16,ACE,144,146,B-group
DDI-DrugBank.d107.s16,inhibitors,148,157,I-group
DDI-DrugBank.d107.s16,.,158,158,O
DDI-DrugBank.d107.s17,It,0,1,O
DDI-DrugBank.d107.s17,is,3,4,O
DDI-DrugBank.d107.s17,recommended,6,16,O
DDI-DrugBank.d107.s17,that,18,21,O
DDI-DrugBank.d107.s17,serum,23,27,O
DDI-DrugBank.d107.s17,lithium,29,35,B-drug
DDI-DrugBank.d107.s17,levels,37,42,O
DDI-DrugBank.d107.s17,be,44,45,O
DDI-DrugBank.d107.s17,monitored,47,55,O
DDI-DrugBank.d107.s17,frequently,57,66,O
DDI-DrugBank.d107.s17,if,68,69,O
DDI-DrugBank.d107.s17,enalapril,71,79,B-drug
DDI-DrugBank.d107.s17,is,81,82,O
DDI-DrugBank.d107.s17,administered,84,95,O
DDI-DrugBank.d107.s17,concomitantly,97,109,O
DDI-DrugBank.d107.s17,with,111,114,O
DDI-DrugBank.d107.s17,lithium,116,122,B-drug
DDI-DrugBank.d107.s17,.,123,123,O
DDI-DrugBank.d395.s0,Bismuth,0,6,B-drug
DDI-DrugBank.d395.s0,:,7,7,O
DDI-DrugBank.d395.s0,Bismuth,9,15,B-drug
DDI-DrugBank.d395.s0,subsalicylate,17,29,I-drug
DDI-DrugBank.d395.s0,",",30,30,O
DDI-DrugBank.d395.s0,given,32,36,O
DDI-DrugBank.d395.s0,concomitantly,38,50,O
DDI-DrugBank.d395.s0,with,52,55,O
DDI-DrugBank.d395.s0,enoxacin,57,64,B-drug
DDI-DrugBank.d395.s0,or,66,67,O
DDI-DrugBank.d395.s0,60,69,70,O
DDI-DrugBank.d395.s0,minutes,72,78,O
DDI-DrugBank.d395.s0,following,80,88,O
DDI-DrugBank.d395.s0,enoxacin,90,97,B-drug
DDI-DrugBank.d395.s0,administration,99,112,O
DDI-DrugBank.d395.s0,",",113,113,O
DDI-DrugBank.d395.s0,decreased,115,123,O
DDI-DrugBank.d395.s0,enoxacin,125,132,B-drug
DDI-DrugBank.d395.s0,bioavailability,134,148,O
DDI-DrugBank.d395.s0,by,150,151,O
DDI-DrugBank.d395.s0,approximately,153,165,O
DDI-DrugBank.d395.s0,25,167,168,O
DDI-DrugBank.d395.s0,%,169,169,O
DDI-DrugBank.d395.s0,.,170,170,O
DDI-DrugBank.d395.s1,Thus,0,3,O
DDI-DrugBank.d395.s1,",",4,4,O
DDI-DrugBank.d395.s1,concomitant,6,16,O
DDI-DrugBank.d395.s1,administration,18,31,O
DDI-DrugBank.d395.s1,of,33,34,O
DDI-DrugBank.d395.s1,enoxacin,36,43,B-drug
DDI-DrugBank.d395.s1,and,45,47,O
DDI-DrugBank.d395.s1,bismuth,49,55,B-drug
DDI-DrugBank.d395.s1,subsalicylate,57,69,I-drug
DDI-DrugBank.d395.s1,should,71,76,O
DDI-DrugBank.d395.s1,be,78,79,O
DDI-DrugBank.d395.s1,avoided,81,87,O
DDI-DrugBank.d395.s1,.,88,88,O
DDI-DrugBank.d395.s2,Caffeine,0,7,B-drug
DDI-DrugBank.d395.s2,:,8,8,O
DDI-DrugBank.d395.s2,Enoxacin,10,17,B-drug
DDI-DrugBank.d395.s2,is,19,20,O
DDI-DrugBank.d395.s2,a,22,22,O
DDI-DrugBank.d395.s2,potent,24,29,O
DDI-DrugBank.d395.s2,inhibitor,31,39,O
DDI-DrugBank.d395.s2,of,41,42,O
DDI-DrugBank.d395.s2,the,44,46,O
DDI-DrugBank.d395.s2,cytochrome,48,57,O
DDI-DrugBank.d395.s2,P-450,59,63,O
DDI-DrugBank.d395.s2,isozymes,65,72,O
DDI-DrugBank.d395.s2,responsible,74,84,O
DDI-DrugBank.d395.s2,for,86,88,O
DDI-DrugBank.d395.s2,the,90,92,O
DDI-DrugBank.d395.s2,metabolism,94,103,O
DDI-DrugBank.d395.s2,of,105,106,O
DDI-DrugBank.d395.s2,methylxanthines,108,122,B-group
DDI-DrugBank.d395.s2,.,123,123,O
DDI-DrugBank.d395.s3,In,0,1,O
DDI-DrugBank.d395.s3,a,3,3,O
DDI-DrugBank.d395.s3,multiple-dose,5,17,O
DDI-DrugBank.d395.s3,study,19,23,O
DDI-DrugBank.d395.s3,",",24,24,O
DDI-DrugBank.d395.s3,enoxacin,26,33,B-drug
DDI-DrugBank.d395.s3,caused,35,40,O
DDI-DrugBank.d395.s3,a,42,42,O
DDI-DrugBank.d395.s3,dose-related,44,55,O
DDI-DrugBank.d395.s3,increase,57,64,O
DDI-DrugBank.d395.s3,in,66,67,O
DDI-DrugBank.d395.s3,the,69,71,O
DDI-DrugBank.d395.s3,mean,73,76,O
DDI-DrugBank.d395.s3,elimination,78,88,O
DDI-DrugBank.d395.s3,half-life,90,98,O
DDI-DrugBank.d395.s3,of,100,101,O
DDI-DrugBank.d395.s3,caffeine,103,110,B-drug
DDI-DrugBank.d395.s3,",",111,111,O
DDI-DrugBank.d395.s3,thereby,113,119,O
DDI-DrugBank.d395.s3,decreasing,121,130,O
DDI-DrugBank.d395.s3,the,132,134,O
DDI-DrugBank.d395.s3,clearance,136,144,O
DDI-DrugBank.d395.s3,of,146,147,O
DDI-DrugBank.d395.s3,caffeine,149,156,B-drug
DDI-DrugBank.d395.s3,by,158,159,O
DDI-DrugBank.d395.s3,up,161,162,O
DDI-DrugBank.d395.s3,to,164,165,O
DDI-DrugBank.d395.s3,80,167,168,O
DDI-DrugBank.d395.s3,%,169,169,O
DDI-DrugBank.d395.s3,and,171,173,O
DDI-DrugBank.d395.s3,leading,175,181,O
DDI-DrugBank.d395.s3,to,183,184,O
DDI-DrugBank.d395.s3,a,186,186,O
DDI-DrugBank.d395.s3,five-fold,188,196,O
DDI-DrugBank.d395.s3,increase,198,205,O
DDI-DrugBank.d395.s3,in,207,208,O
DDI-DrugBank.d395.s3,the,210,212,O
DDI-DrugBank.d395.s3,AUC,214,216,O
DDI-DrugBank.d395.s3,and,218,220,O
DDI-DrugBank.d395.s3,the,222,224,O
DDI-DrugBank.d395.s3,half-life,226,234,O
DDI-DrugBank.d395.s3,of,236,237,O
DDI-DrugBank.d395.s3,caffeine,239,246,B-drug
DDI-DrugBank.d395.s3,.,247,247,O
DDI-DrugBank.d395.s4,Trough,0,5,O
DDI-DrugBank.d395.s4,plasma,7,12,O
DDI-DrugBank.d395.s4,enoxacin,14,21,B-drug
DDI-DrugBank.d395.s4,levels,23,28,O
DDI-DrugBank.d395.s4,were,30,33,O
DDI-DrugBank.d395.s4,also,35,38,O
DDI-DrugBank.d395.s4,20,40,41,O
DDI-DrugBank.d395.s4,%,42,42,O
DDI-DrugBank.d395.s4,higher,44,49,O
DDI-DrugBank.d395.s4,when,51,54,O
DDI-DrugBank.d395.s4,caffeine,56,63,B-drug
DDI-DrugBank.d395.s4,and,65,67,O
DDI-DrugBank.d395.s4,enoxacin,69,76,B-drug
DDI-DrugBank.d395.s4,were,78,81,O
DDI-DrugBank.d395.s4,administered,83,94,O
DDI-DrugBank.d395.s4,concomitantly,96,108,O
DDI-DrugBank.d395.s4,.,109,109,O
DDI-DrugBank.d395.s5,Caffeine-related,0,15,O
DDI-DrugBank.d395.s5,adverse,17,23,O
DDI-DrugBank.d395.s5,effects,25,31,O
DDI-DrugBank.d395.s5,have,33,36,O
DDI-DrugBank.d395.s5,occurred,38,45,O
DDI-DrugBank.d395.s5,in,47,48,O
DDI-DrugBank.d395.s5,patients,50,57,O
DDI-DrugBank.d395.s5,consuming,59,67,O
DDI-DrugBank.d395.s5,caffeine,69,76,B-drug
DDI-DrugBank.d395.s5,while,78,82,O
DDI-DrugBank.d395.s5,on,84,85,O
DDI-DrugBank.d395.s5,therapy,87,93,O
DDI-DrugBank.d395.s5,with,95,98,O
DDI-DrugBank.d395.s5,enoxacin,100,107,B-drug
DDI-DrugBank.d395.s5,.,108,108,O
DDI-DrugBank.d395.s6,Cyclosporine,0,11,B-drug
DDI-DrugBank.d395.s6,:,12,12,O
DDI-DrugBank.d395.s6,Elevated,14,21,O
DDI-DrugBank.d395.s6,serum,23,27,O
DDI-DrugBank.d395.s6,levels,29,34,O
DDI-DrugBank.d395.s6,of,36,37,O
DDI-DrugBank.d395.s6,cyclosporine,39,50,B-drug
DDI-DrugBank.d395.s6,have,52,55,O
DDI-DrugBank.d395.s6,been,57,60,O
DDI-DrugBank.d395.s6,reported,62,69,O
DDI-DrugBank.d395.s6,with,71,74,O
DDI-DrugBank.d395.s6,concomitant,76,86,O
DDI-DrugBank.d395.s6,use,88,90,O
DDI-DrugBank.d395.s6,of,92,93,O
DDI-DrugBank.d395.s6,cyclosporine,95,106,B-drug
DDI-DrugBank.d395.s6,with,108,111,O
DDI-DrugBank.d395.s6,other,113,117,O
DDI-DrugBank.d395.s6,members,119,125,O
DDI-DrugBank.d395.s6,of,127,128,O
DDI-DrugBank.d395.s6,the,130,132,O
DDI-DrugBank.d395.s6,quinolone,134,142,B-group
DDI-DrugBank.d395.s6,class,144,148,I-group
DDI-DrugBank.d395.s6,.,149,149,O
DDI-DrugBank.d395.s7,Digoxin,0,6,B-drug
DDI-DrugBank.d395.s7,:,7,7,O
DDI-DrugBank.d395.s7,Enoxacin,9,16,B-drug
DDI-DrugBank.d395.s7,may,18,20,O
DDI-DrugBank.d395.s7,raise,22,26,O
DDI-DrugBank.d395.s7,serum,28,32,O
DDI-DrugBank.d395.s7,digoxin,34,40,B-drug
DDI-DrugBank.d395.s7,levels,42,47,O
DDI-DrugBank.d395.s7,in,49,50,O
DDI-DrugBank.d395.s7,some,52,55,O
DDI-DrugBank.d395.s7,individuals,57,67,O
DDI-DrugBank.d395.s7,.,68,68,O
DDI-DrugBank.d395.s8,If,0,1,O
DDI-DrugBank.d395.s8,signs,3,7,O
DDI-DrugBank.d395.s8,and,9,11,O
DDI-DrugBank.d395.s8,symptoms,13,20,O
DDI-DrugBank.d395.s8,suggestive,22,31,O
DDI-DrugBank.d395.s8,of,33,34,O
DDI-DrugBank.d395.s8,digoxin,36,42,B-drug
DDI-DrugBank.d395.s8,toxicity,44,51,O
DDI-DrugBank.d395.s8,occur,53,57,O
DDI-DrugBank.d395.s8,when,59,62,O
DDI-DrugBank.d395.s8,enoxacin,64,71,B-drug
DDI-DrugBank.d395.s8,and,73,75,O
DDI-DrugBank.d395.s8,digoxin,77,83,B-drug
DDI-DrugBank.d395.s8,are,85,87,O
DDI-DrugBank.d395.s8,given,89,93,O
DDI-DrugBank.d395.s8,concomitantly,95,107,O
DDI-DrugBank.d395.s8,",",108,108,O
DDI-DrugBank.d395.s8,physicians,110,119,O
DDI-DrugBank.d395.s8,are,121,123,O
DDI-DrugBank.d395.s8,advised,125,131,O
DDI-DrugBank.d395.s8,to,133,134,O
DDI-DrugBank.d395.s8,obtain,136,141,O
DDI-DrugBank.d395.s8,serum,143,147,O
DDI-DrugBank.d395.s8,digoxin,149,155,B-drug
DDI-DrugBank.d395.s8,levels,157,162,O
DDI-DrugBank.d395.s8,and,164,166,O
DDI-DrugBank.d395.s8,adjust,168,173,O
DDI-DrugBank.d395.s8,digoxin,175,181,B-drug
DDI-DrugBank.d395.s8,doses,183,187,O
DDI-DrugBank.d395.s8,appropriately,189,201,O
DDI-DrugBank.d395.s8,.,202,202,O
DDI-DrugBank.d395.s9,Non-steroidal,0,12,B-group
DDI-DrugBank.d395.s9,anti-inflammatory,14,30,I-group
DDI-DrugBank.d395.s9,agents,32,37,I-group
DDI-DrugBank.d395.s9,:,38,38,O
DDI-DrugBank.d395.s9,Seizures,40,47,O
DDI-DrugBank.d395.s9,have,49,52,O
DDI-DrugBank.d395.s9,been,54,57,O
DDI-DrugBank.d395.s9,reported,59,66,O
DDI-DrugBank.d395.s9,in,68,69,O
DDI-DrugBank.d395.s9,patients,71,78,O
DDI-DrugBank.d395.s9,taking,80,85,O
DDI-DrugBank.d395.s9,enoxacin,87,94,B-drug
DDI-DrugBank.d395.s9,concomitantly,96,108,O
DDI-DrugBank.d395.s9,with,110,113,O
DDI-DrugBank.d395.s9,the,115,117,O
DDI-DrugBank.d395.s9,nonsteroidal,119,130,B-group
DDI-DrugBank.d395.s9,anti-inflammatory,132,148,I-group
DDI-DrugBank.d395.s9,drug,150,153,I-group
DDI-DrugBank.d395.s9,fenbufen,155,162,B-drug
DDI-DrugBank.d395.s9,.,163,163,O
DDI-DrugBank.d395.s10,Animal,0,5,O
DDI-DrugBank.d395.s10,studies,7,13,O
DDI-DrugBank.d395.s10,also,15,18,O
DDI-DrugBank.d395.s10,suggest,20,26,O
DDI-DrugBank.d395.s10,an,28,29,O
DDI-DrugBank.d395.s10,increased,31,39,O
DDI-DrugBank.d395.s10,potential,41,49,O
DDI-DrugBank.d395.s10,for,51,53,O
DDI-DrugBank.d395.s10,seizures,55,62,O
DDI-DrugBank.d395.s10,when,64,67,O
DDI-DrugBank.d395.s10,these,69,73,O
DDI-DrugBank.d395.s10,two,75,77,O
DDI-DrugBank.d395.s10,drugs,79,83,O
DDI-DrugBank.d395.s10,are,85,87,O
DDI-DrugBank.d395.s10,given,89,93,O
DDI-DrugBank.d395.s10,concomitantly,95,107,O
DDI-DrugBank.d395.s10,.,108,108,O
DDI-DrugBank.d395.s11,Fenbufen,0,7,B-drug
DDI-DrugBank.d395.s11,is,9,10,O
DDI-DrugBank.d395.s11,not,12,14,O
DDI-DrugBank.d395.s11,approved,16,23,O
DDI-DrugBank.d395.s11,in,25,26,O
DDI-DrugBank.d395.s11,the,28,30,O
DDI-DrugBank.d395.s11,United,32,37,O
DDI-DrugBank.d395.s11,States,39,44,O
DDI-DrugBank.d395.s11,at,46,47,O
DDI-DrugBank.d395.s11,this,49,52,O
DDI-DrugBank.d395.s11,time,54,57,O
DDI-DrugBank.d395.s11,.,58,58,O
DDI-DrugBank.d395.s12,Sucralfate,0,9,B-drug
DDI-DrugBank.d395.s12,and,11,13,O
DDI-DrugBank.d395.s12,antacids,15,22,B-group
DDI-DrugBank.d395.s12,:,23,23,O
DDI-DrugBank.d395.s12,Quinolones,25,34,B-group
DDI-DrugBank.d395.s12,form,36,39,O
DDI-DrugBank.d395.s12,chelates,41,48,O
DDI-DrugBank.d395.s12,with,50,53,O
DDI-DrugBank.d395.s12,metal,55,59,O
DDI-DrugBank.d395.s12,cations,61,67,O
DDI-DrugBank.d395.s12,.,68,68,O
DDI-DrugBank.d395.s13,Therefore,0,8,O
DDI-DrugBank.d395.s13,",",9,9,O
DDI-DrugBank.d395.s13,administration,11,24,O
DDI-DrugBank.d395.s13,of,26,27,O
DDI-DrugBank.d395.s13,quinolones,29,38,B-group
DDI-DrugBank.d395.s13,with,40,43,O
DDI-DrugBank.d395.s13,antacids,45,52,B-group
DDI-DrugBank.d395.s13,containing,54,63,O
DDI-DrugBank.d395.s13,calcium,65,71,B-drug
DDI-DrugBank.d395.s13,",",72,72,O
DDI-DrugBank.d395.s13,magnesium,74,82,B-drug
DDI-DrugBank.d395.s13,",",83,83,O
DDI-DrugBank.d395.s13,or,85,86,O
DDI-DrugBank.d395.s13,aluminum,88,95,B-drug
DDI-DrugBank.d395.s13,;,96,96,O
DDI-DrugBank.d395.s14,with,0,3,O
DDI-DrugBank.d395.s14,sucralfate,5,14,B-drug
DDI-DrugBank.d395.s14,;,15,15,O
DDI-DrugBank.d395.s15,with,0,3,O
DDI-DrugBank.d395.s15,divalent,5,12,O
DDI-DrugBank.d395.s15,or,14,15,O
DDI-DrugBank.d395.s15,trivalent,17,25,O
DDI-DrugBank.d395.s15,cations,27,33,O
DDI-DrugBank.d395.s15,such,35,38,O
DDI-DrugBank.d395.s15,as,40,41,O
DDI-DrugBank.d395.s15,iron,43,46,B-drug
DDI-DrugBank.d395.s15,;,47,47,O
DDI-DrugBank.d395.s16,or,0,1,O
DDI-DrugBank.d395.s16,with,3,6,O
DDI-DrugBank.d395.s16,multivitamins,8,20,B-group
DDI-DrugBank.d395.s16,containing,22,31,O
DDI-DrugBank.d395.s16,zinc,33,36,B-drug
DDI-DrugBank.d395.s16,may,38,40,O
DDI-DrugBank.d395.s16,substantially,42,54,O
DDI-DrugBank.d395.s16,interfere,56,64,O
DDI-DrugBank.d395.s16,with,66,69,O
DDI-DrugBank.d395.s16,drug,71,74,O
DDI-DrugBank.d395.s16,absorption,76,85,O
DDI-DrugBank.d395.s16,and,87,89,O
DDI-DrugBank.d395.s16,result,91,96,O
DDI-DrugBank.d395.s16,in,98,99,O
DDI-DrugBank.d395.s16,insufficient,101,112,O
DDI-DrugBank.d395.s16,plasma,114,119,O
DDI-DrugBank.d395.s16,and,121,123,O
DDI-DrugBank.d395.s16,tissue,125,130,O
DDI-DrugBank.d395.s16,quinolone,132,140,B-group
DDI-DrugBank.d395.s16,concentrations,142,155,O
DDI-DrugBank.d395.s16,.,156,156,O
DDI-DrugBank.d395.s17,Antacids,0,7,B-group
DDI-DrugBank.d395.s17,containing,9,18,O
DDI-DrugBank.d395.s17,aluminum,20,27,B-drug
DDI-DrugBank.d395.s17,hydroxide,29,37,I-drug
DDI-DrugBank.d395.s17,and,39,41,O
DDI-DrugBank.d395.s17,magnesium,43,51,B-drug
DDI-DrugBank.d395.s17,hydroxide,53,61,I-drug
DDI-DrugBank.d395.s17,reduce,63,68,O
DDI-DrugBank.d395.s17,the,70,72,O
DDI-DrugBank.d395.s17,oral,74,77,O
DDI-DrugBank.d395.s17,absorption,79,88,O
DDI-DrugBank.d395.s17,of,90,91,O
DDI-DrugBank.d395.s17,enoxacin,93,100,B-drug
DDI-DrugBank.d395.s17,by,102,103,O
DDI-DrugBank.d395.s17,75,105,106,O
DDI-DrugBank.d395.s17,%,107,107,O
DDI-DrugBank.d395.s17,.,108,108,O
DDI-DrugBank.d395.s18,The,0,2,O
DDI-DrugBank.d395.s18,oral,4,7,O
DDI-DrugBank.d395.s18,bioavailability,9,23,O
DDI-DrugBank.d395.s18,of,25,26,O
DDI-DrugBank.d395.s18,enoxacin,28,35,B-drug
DDI-DrugBank.d395.s18,is,37,38,O
DDI-DrugBank.d395.s18,reduced,40,46,O
DDI-DrugBank.d395.s18,by,48,49,O
DDI-DrugBank.d395.s18,60,51,52,O
DDI-DrugBank.d395.s18,%,53,53,O
DDI-DrugBank.d395.s18,with,55,58,O
DDI-DrugBank.d395.s18,coadministration,60,75,O
DDI-DrugBank.d395.s18,of,77,78,O
DDI-DrugBank.d395.s18,ranitidine,80,89,B-drug
DDI-DrugBank.d395.s18,.,90,90,O
DDI-DrugBank.d395.s19,These,0,4,O
DDI-DrugBank.d395.s19,agents,6,11,O
DDI-DrugBank.d395.s19,should,13,18,O
DDI-DrugBank.d395.s19,not,20,22,O
DDI-DrugBank.d395.s19,be,24,25,O
DDI-DrugBank.d395.s19,taken,27,31,O
DDI-DrugBank.d395.s19,for,33,35,O
DDI-DrugBank.d395.s19,8,37,37,O
DDI-DrugBank.d395.s19,hours,39,43,O
DDI-DrugBank.d395.s19,before,45,50,O
DDI-DrugBank.d395.s19,or,52,53,O
DDI-DrugBank.d395.s19,for,55,57,O
DDI-DrugBank.d395.s19,2,59,59,O
DDI-DrugBank.d395.s19,hours,61,65,O
DDI-DrugBank.d395.s19,after,67,71,O
DDI-DrugBank.d395.s19,enoxacin,73,80,B-drug
DDI-DrugBank.d395.s19,administration,82,95,O
DDI-DrugBank.d395.s19,.,96,96,O
DDI-DrugBank.d395.s20,Theophylline,0,11,B-drug
DDI-DrugBank.d395.s20,:,12,12,O
DDI-DrugBank.d395.s20,Enoxacin,14,21,B-drug
DDI-DrugBank.d395.s20,is,23,24,O
DDI-DrugBank.d395.s20,a,26,26,O
DDI-DrugBank.d395.s20,potent,28,33,O
DDI-DrugBank.d395.s20,inhibitor,35,43,O
DDI-DrugBank.d395.s20,of,45,46,O
DDI-DrugBank.d395.s20,the,48,50,O
DDI-DrugBank.d395.s20,cytochrome,52,61,O
DDI-DrugBank.d395.s20,P-450,63,67,O
DDI-DrugBank.d395.s20,isozymes,69,76,O
DDI-DrugBank.d395.s20,responsible,78,88,O
DDI-DrugBank.d395.s20,for,90,92,O
DDI-DrugBank.d395.s20,the,94,96,O
DDI-DrugBank.d395.s20,metabolism,98,107,O
DDI-DrugBank.d395.s20,of,109,110,O
DDI-DrugBank.d395.s20,methylxanthines,112,126,B-group
DDI-DrugBank.d395.s20,.,127,127,O
DDI-DrugBank.d395.s21,Enoxacin,0,7,B-drug
DDI-DrugBank.d395.s21,interferes,9,18,O
DDI-DrugBank.d395.s21,with,20,23,O
DDI-DrugBank.d395.s21,the,25,27,O
DDI-DrugBank.d395.s21,metabolism,29,38,O
DDI-DrugBank.d395.s21,of,40,41,O
DDI-DrugBank.d395.s21,theophylline,43,54,B-drug
DDI-DrugBank.d395.s21,resulting,56,64,O
DDI-DrugBank.d395.s21,in,66,67,O
DDI-DrugBank.d395.s21,a,69,69,O
DDI-DrugBank.d395.s21,42,71,72,O
DDI-DrugBank.d395.s21,%,73,73,O
DDI-DrugBank.d395.s21,to,75,76,O
DDI-DrugBank.d395.s21,74,78,79,O
DDI-DrugBank.d395.s21,%,80,80,O
DDI-DrugBank.d395.s21,dose-related,82,93,O
DDI-DrugBank.d395.s21,decrease,95,102,O
DDI-DrugBank.d395.s21,in,104,105,O
DDI-DrugBank.d395.s21,theophylline,107,118,B-drug
DDI-DrugBank.d395.s21,clearance,120,128,O
DDI-DrugBank.d395.s21,and,130,132,O
DDI-DrugBank.d395.s21,a,134,134,O
DDI-DrugBank.d395.s21,subsequent,136,145,O
DDI-DrugBank.d395.s21,260,147,149,O
DDI-DrugBank.d395.s21,%,150,150,O
DDI-DrugBank.d395.s21,to,152,153,O
DDI-DrugBank.d395.s21,350,155,157,O
DDI-DrugBank.d395.s21,%,158,158,O
DDI-DrugBank.d395.s21,increase,160,167,O
DDI-DrugBank.d395.s21,in,169,170,O
DDI-DrugBank.d395.s21,serum,172,176,O
DDI-DrugBank.d395.s21,theophylline,178,189,O
DDI-DrugBank.d395.s21,levels,191,196,O
DDI-DrugBank.d395.s21,.,197,197,O
DDI-DrugBank.d395.s22,Theophylline-related,0,19,O
DDI-DrugBank.d395.s22,adverse,21,27,O
DDI-DrugBank.d395.s22,effects,29,35,O
DDI-DrugBank.d395.s22,have,37,40,O
DDI-DrugBank.d395.s22,occurred,42,49,O
DDI-DrugBank.d395.s22,in,51,52,O
DDI-DrugBank.d395.s22,patients,54,61,O
DDI-DrugBank.d395.s22,when,63,66,O
DDI-DrugBank.d395.s22,theophylline,68,79,B-drug
DDI-DrugBank.d395.s22,and,81,83,O
DDI-DrugBank.d395.s22,enoxacin,85,92,B-drug
DDI-DrugBank.d395.s22,were,94,97,O
DDI-DrugBank.d395.s22,coadministered,99,112,O
DDI-DrugBank.d395.s22,.,113,113,O
DDI-DrugBank.d395.s23,Warfarin,0,7,B-drug
DDI-DrugBank.d395.s23,:,8,8,O
DDI-DrugBank.d395.s23,Quinolones,10,19,B-group
DDI-DrugBank.d395.s23,",",20,20,O
DDI-DrugBank.d395.s23,including,22,30,O
DDI-DrugBank.d395.s23,enoxacin,32,39,B-drug
DDI-DrugBank.d395.s23,",",40,40,O
DDI-DrugBank.d395.s23,decrease,42,49,O
DDI-DrugBank.d395.s23,the,51,53,O
DDI-DrugBank.d395.s23,clearance,55,63,O
DDI-DrugBank.d395.s23,of,65,66,O
DDI-DrugBank.d395.s23,R-warfarin,68,77,B-drug
DDI-DrugBank.d395.s23,",",78,78,O
DDI-DrugBank.d395.s23,the,80,82,O
DDI-DrugBank.d395.s23,less,84,87,O
DDI-DrugBank.d395.s23,active,89,94,O
DDI-DrugBank.d395.s23,isomer,96,101,O
DDI-DrugBank.d395.s23,of,103,104,O
DDI-DrugBank.d395.s23,racemic,106,112,O
DDI-DrugBank.d395.s23,warfarin,114,121,B-drug
DDI-DrugBank.d395.s23,.,122,122,O
DDI-DrugBank.d395.s24,Enoxacin,0,7,B-drug
DDI-DrugBank.d395.s24,does,9,12,O
DDI-DrugBank.d395.s24,not,14,16,O
DDI-DrugBank.d395.s24,affect,18,23,O
DDI-DrugBank.d395.s24,the,25,27,O
DDI-DrugBank.d395.s24,clearance,29,37,O
DDI-DrugBank.d395.s24,of,39,40,O
DDI-DrugBank.d395.s24,the,42,44,O
DDI-DrugBank.d395.s24,active,46,51,O
DDI-DrugBank.d395.s24,S-isomer,53,60,O
DDI-DrugBank.d395.s24,",",61,61,O
DDI-DrugBank.d395.s24,and,63,65,O
DDI-DrugBank.d395.s24,changes,67,73,O
DDI-DrugBank.d395.s24,in,75,76,O
DDI-DrugBank.d395.s24,clotting,78,85,O
DDI-DrugBank.d395.s24,time,87,90,O
DDI-DrugBank.d395.s24,have,92,95,O
DDI-DrugBank.d395.s24,not,97,99,O
DDI-DrugBank.d395.s24,been,101,104,O
DDI-DrugBank.d395.s24,observed,106,113,O
DDI-DrugBank.d395.s24,when,115,118,O
DDI-DrugBank.d395.s24,enoxacin,120,127,B-drug
DDI-DrugBank.d395.s24,and,129,131,O
DDI-DrugBank.d395.s24,warfarin,133,140,B-drug
DDI-DrugBank.d395.s24,were,142,145,O
DDI-DrugBank.d395.s24,coadministered,147,160,O
DDI-DrugBank.d395.s24,.,161,161,O
DDI-DrugBank.d395.s25,Nevertheless,0,11,O
DDI-DrugBank.d395.s25,",",12,12,O
DDI-DrugBank.d395.s25,the,14,16,O
DDI-DrugBank.d395.s25,prothrombin,18,28,O
DDI-DrugBank.d395.s25,time,30,33,O
DDI-DrugBank.d395.s25,or,35,36,O
DDI-DrugBank.d395.s25,other,38,42,O
DDI-DrugBank.d395.s25,suitable,44,51,O
DDI-DrugBank.d395.s25,coagulation,53,63,O
DDI-DrugBank.d395.s25,test,65,68,O
DDI-DrugBank.d395.s25,should,70,75,O
DDI-DrugBank.d395.s25,be,77,78,O
DDI-DrugBank.d395.s25,monitored,80,88,O
DDI-DrugBank.d395.s25,when,90,93,O
DDI-DrugBank.d395.s25,warfarin,95,102,B-drug
DDI-DrugBank.d395.s25,or,104,105,O
DDI-DrugBank.d395.s25,its,107,109,O
DDI-DrugBank.d395.s25,derivatives,111,121,O
DDI-DrugBank.d395.s25,and,123,125,O
DDI-DrugBank.d395.s25,enoxacin,127,134,B-drug
DDI-DrugBank.d395.s25,are,136,138,O
DDI-DrugBank.d395.s25,given,140,144,O
DDI-DrugBank.d395.s25,concomitantly,146,158,O
DDI-DrugBank.d395.s25,.,159,159,O
DDI-DrugBank.d241.s0,Additional,0,9,O
DDI-DrugBank.d241.s0,reductions,11,20,O
DDI-DrugBank.d241.s0,in,22,23,O
DDI-DrugBank.d241.s0,blood,25,29,O
DDI-DrugBank.d241.s0,pressure,31,38,O
DDI-DrugBank.d241.s0,may,40,42,O
DDI-DrugBank.d241.s0,occur,44,48,O
DDI-DrugBank.d241.s0,when,50,53,O
DDI-DrugBank.d241.s0,FLOLAN,55,60,B-brand
DDI-DrugBank.d241.s0,is,62,63,O
DDI-DrugBank.d241.s0,administered,65,76,O
DDI-DrugBank.d241.s0,with,78,81,O
DDI-DrugBank.d241.s0,diuretics,83,91,B-group
DDI-DrugBank.d241.s0,",",92,92,O
DDI-DrugBank.d241.s0,antihypertensive,94,109,B-group
DDI-DrugBank.d241.s0,agents,111,116,I-group
DDI-DrugBank.d241.s0,",",117,117,O
DDI-DrugBank.d241.s0,or,119,120,O
DDI-DrugBank.d241.s0,other,122,126,O
DDI-DrugBank.d241.s0,vasodilators,128,139,B-group
DDI-DrugBank.d241.s0,.,140,140,O
DDI-DrugBank.d241.s1,When,0,3,O
DDI-DrugBank.d241.s1,other,5,9,O
DDI-DrugBank.d241.s1,antiplatelet,11,22,B-group
DDI-DrugBank.d241.s1,agents,24,29,I-group
DDI-DrugBank.d241.s1,or,31,32,O
DDI-DrugBank.d241.s1,anticoagulants,34,47,B-group
DDI-DrugBank.d241.s1,are,49,51,O
DDI-DrugBank.d241.s1,used,53,56,O
DDI-DrugBank.d241.s1,concomitantly,58,70,O
DDI-DrugBank.d241.s1,",",71,71,O
DDI-DrugBank.d241.s1,there,73,77,O
DDI-DrugBank.d241.s1,is,79,80,O
DDI-DrugBank.d241.s1,the,82,84,O
DDI-DrugBank.d241.s1,potential,86,94,O
DDI-DrugBank.d241.s1,for,96,98,O
DDI-DrugBank.d241.s1,FLOLAN,100,105,B-brand
DDI-DrugBank.d241.s1,to,107,108,O
DDI-DrugBank.d241.s1,increase,110,117,O
DDI-DrugBank.d241.s1,the,119,121,O
DDI-DrugBank.d241.s1,risk,123,126,O
DDI-DrugBank.d241.s1,of,128,129,O
DDI-DrugBank.d241.s1,bleeding,131,138,O
DDI-DrugBank.d241.s1,.,139,139,O
DDI-DrugBank.d241.s2,However,0,6,O
DDI-DrugBank.d241.s2,",",7,7,O
DDI-DrugBank.d241.s2,patients,9,16,O
DDI-DrugBank.d241.s2,receiving,18,26,O
DDI-DrugBank.d241.s2,infusions,28,36,O
DDI-DrugBank.d241.s2,of,38,39,O
DDI-DrugBank.d241.s2,FLOLAN,41,46,B-brand
DDI-DrugBank.d241.s2,in,48,49,O
DDI-DrugBank.d241.s2,clinical,51,58,O
DDI-DrugBank.d241.s2,trials,60,65,O
DDI-DrugBank.d241.s2,were,67,70,O
DDI-DrugBank.d241.s2,maintained,72,81,O
DDI-DrugBank.d241.s2,on,83,84,O
DDI-DrugBank.d241.s2,anticoagulants,86,99,B-group
DDI-DrugBank.d241.s2,without,101,107,O
DDI-DrugBank.d241.s2,evidence,109,116,O
DDI-DrugBank.d241.s2,of,118,119,O
DDI-DrugBank.d241.s2,increased,121,129,O
DDI-DrugBank.d241.s2,bleeding,131,138,O
DDI-DrugBank.d241.s2,.,139,139,O
DDI-DrugBank.d241.s3,In,0,1,O
DDI-DrugBank.d241.s3,clinical,3,10,O
DDI-DrugBank.d241.s3,trials,12,17,O
DDI-DrugBank.d241.s3,",",18,18,O
DDI-DrugBank.d241.s3,FLOLAN,20,25,B-brand
DDI-DrugBank.d241.s3,was,27,29,O
DDI-DrugBank.d241.s3,used,31,34,O
DDI-DrugBank.d241.s3,with,36,39,O
DDI-DrugBank.d241.s3,digoxin,41,47,B-drug
DDI-DrugBank.d241.s3,",",48,48,O
DDI-DrugBank.d241.s3,diuretics,50,58,B-group
DDI-DrugBank.d241.s3,",",59,59,O
DDI-DrugBank.d241.s3,anticoagulants,61,74,B-group
DDI-DrugBank.d241.s3,",",75,75,O
DDI-DrugBank.d241.s3,oral,77,80,O
DDI-DrugBank.d241.s3,vasodilators,82,93,B-group
DDI-DrugBank.d241.s3,",",94,94,O
DDI-DrugBank.d241.s3,and,96,98,O
DDI-DrugBank.d241.s3,supplemental,100,111,O
DDI-DrugBank.d241.s3,oxygen.In,113,121,O
DDI-DrugBank.d241.s3,a,123,123,O
DDI-DrugBank.d241.s3,pharmacokinetic,125,139,O
DDI-DrugBank.d241.s3,substudy,141,148,O
DDI-DrugBank.d241.s3,in,150,151,O
DDI-DrugBank.d241.s3,patients,153,160,O
DDI-DrugBank.d241.s3,with,162,165,O
DDI-DrugBank.d241.s3,congestive,167,176,O
DDI-DrugBank.d241.s3,heart,178,182,O
DDI-DrugBank.d241.s3,failure,184,190,O
DDI-DrugBank.d241.s3,receiving,192,200,O
DDI-DrugBank.d241.s3,furosemide,202,211,B-drug
DDI-DrugBank.d241.s3,or,213,214,O
DDI-DrugBank.d241.s3,digoxin,216,222,B-drug
DDI-DrugBank.d241.s3,in,224,225,O
DDI-DrugBank.d241.s3,whom,227,230,O
DDI-DrugBank.d241.s3,therapy,232,238,O
DDI-DrugBank.d241.s3,with,240,243,O
DDI-DrugBank.d241.s3,FLOLAN,245,250,B-brand
DDI-DrugBank.d241.s3,was,252,254,O
DDI-DrugBank.d241.s3,initiated,256,264,O
DDI-DrugBank.d241.s3,",",265,265,O
DDI-DrugBank.d241.s3,apparent,267,274,O
DDI-DrugBank.d241.s3,oral,276,279,O
DDI-DrugBank.d241.s3,clearance,281,289,O
DDI-DrugBank.d241.s3,values,291,296,O
DDI-DrugBank.d241.s3,for,298,300,O
DDI-DrugBank.d241.s3,furosemide,302,311,B-drug
DDI-DrugBank.d241.s3,(,313,313,O
DDI-DrugBank.d241.s3,n,314,314,O
DDI-DrugBank.d241.s3,=,316,316,O
DDI-DrugBank.d241.s3,23,318,319,O
DDI-DrugBank.d241.s3,),320,320,O
DDI-DrugBank.d241.s3,and,322,324,O
DDI-DrugBank.d241.s3,digoxin,326,332,B-drug
DDI-DrugBank.d241.s3,(,334,334,O
DDI-DrugBank.d241.s3,n,335,335,O
DDI-DrugBank.d241.s3,=,337,337,O
DDI-DrugBank.d241.s3,30,339,340,O
DDI-DrugBank.d241.s3,),341,341,O
DDI-DrugBank.d241.s3,were,343,346,O
DDI-DrugBank.d241.s3,decreased,348,356,O
DDI-DrugBank.d241.s3,by,358,359,O
DDI-DrugBank.d241.s3,13,361,362,O
DDI-DrugBank.d241.s3,%,363,363,O
DDI-DrugBank.d241.s3,and,365,367,O
DDI-DrugBank.d241.s3,15,369,370,O
DDI-DrugBank.d241.s3,%,371,371,O
DDI-DrugBank.d241.s3,",",372,372,O
DDI-DrugBank.d241.s3,respectively,374,385,O
DDI-DrugBank.d241.s3,",",386,386,O
DDI-DrugBank.d241.s3,on,388,389,O
DDI-DrugBank.d241.s3,the,391,393,O
DDI-DrugBank.d241.s3,second,395,400,O
DDI-DrugBank.d241.s3,day,402,404,O
DDI-DrugBank.d241.s3,of,406,407,O
DDI-DrugBank.d241.s3,therapy,409,415,O
DDI-DrugBank.d241.s3,and,417,419,O
DDI-DrugBank.d241.s3,had,421,423,O
DDI-DrugBank.d241.s3,returned,425,432,O
DDI-DrugBank.d241.s3,to,434,435,O
DDI-DrugBank.d241.s3,baseline,437,444,O
DDI-DrugBank.d241.s3,values,446,451,O
DDI-DrugBank.d241.s3,by,453,454,O
DDI-DrugBank.d241.s3,day,456,458,O
DDI-DrugBank.d241.s3,87,460,461,O
DDI-DrugBank.d241.s3,.,462,462,O
DDI-DrugBank.d241.s4,The,0,2,O
DDI-DrugBank.d241.s4,change,4,9,O
DDI-DrugBank.d241.s4,in,11,12,O
DDI-DrugBank.d241.s4,furosemide,14,23,B-drug
DDI-DrugBank.d241.s4,clearance,25,33,O
DDI-DrugBank.d241.s4,value,35,39,O
DDI-DrugBank.d241.s4,is,41,42,O
DDI-DrugBank.d241.s4,not,44,46,O
DDI-DrugBank.d241.s4,likely,48,53,O
DDI-DrugBank.d241.s4,to,55,56,O
DDI-DrugBank.d241.s4,be,58,59,O
DDI-DrugBank.d241.s4,clinically,61,70,O
DDI-DrugBank.d241.s4,significant,72,82,O
DDI-DrugBank.d241.s4,.,83,83,O
DDI-DrugBank.d241.s5,However,0,6,O
DDI-DrugBank.d241.s5,",",7,7,O
DDI-DrugBank.d241.s5,patients,9,16,O
DDI-DrugBank.d241.s5,on,18,19,O
DDI-DrugBank.d241.s5,digoxin,21,27,B-drug
DDI-DrugBank.d241.s5,may,29,31,O
DDI-DrugBank.d241.s5,show,33,36,O
DDI-DrugBank.d241.s5,elevations,38,47,O
DDI-DrugBank.d241.s5,of,49,50,O
DDI-DrugBank.d241.s5,digoxin,52,58,B-drug
DDI-DrugBank.d241.s5,concentrations,60,73,O
DDI-DrugBank.d241.s5,after,75,79,O
DDI-DrugBank.d241.s5,initiation,81,90,O
DDI-DrugBank.d241.s5,of,92,93,O
DDI-DrugBank.d241.s5,therapy,95,101,O
DDI-DrugBank.d241.s5,with,103,106,O
DDI-DrugBank.d241.s5,FLOLAN,108,113,B-brand
DDI-DrugBank.d241.s5,",",114,114,O
DDI-DrugBank.d241.s5,which,116,120,O
DDI-DrugBank.d241.s5,may,122,124,O
DDI-DrugBank.d241.s5,be,126,127,O
DDI-DrugBank.d241.s5,clinically,129,138,O
DDI-DrugBank.d241.s5,significant,140,150,O
DDI-DrugBank.d241.s5,in,152,153,O
DDI-DrugBank.d241.s5,patients,155,162,O
DDI-DrugBank.d241.s5,prone,164,168,O
DDI-DrugBank.d241.s5,to,170,171,O
DDI-DrugBank.d241.s5,digoxin,173,179,B-drug
DDI-DrugBank.d241.s5,toxicity,181,188,O
DDI-DrugBank.d241.s5,.,189,189,O
DDI-DrugBank.d525.s0,Eprosartan,0,9,B-drug
DDI-DrugBank.d525.s0,has,11,13,O
DDI-DrugBank.d525.s0,been,15,18,O
DDI-DrugBank.d525.s0,shown,20,24,O
DDI-DrugBank.d525.s0,to,26,27,O
DDI-DrugBank.d525.s0,have,29,32,O
DDI-DrugBank.d525.s0,no,34,35,O
DDI-DrugBank.d525.s0,effect,37,42,O
DDI-DrugBank.d525.s0,on,44,45,O
DDI-DrugBank.d525.s0,the,47,49,O
DDI-DrugBank.d525.s0,pharmacokinetics,51,66,O
DDI-DrugBank.d525.s0,of,68,69,O
DDI-DrugBank.d525.s0,digoxin,71,77,B-drug
DDI-DrugBank.d525.s0,and,79,81,O
DDI-DrugBank.d525.s0,the,83,85,O
DDI-DrugBank.d525.s0,pharmacodynamics,87,102,O
DDI-DrugBank.d525.s0,of,104,105,O
DDI-DrugBank.d525.s0,warfarin,107,114,B-drug
DDI-DrugBank.d525.s0,and,116,118,O
DDI-DrugBank.d525.s0,glyburide,120,128,B-drug
DDI-DrugBank.d525.s0,.,129,129,O
DDI-DrugBank.d525.s1,Thus,0,3,O
DDI-DrugBank.d525.s1,no,5,6,O
DDI-DrugBank.d525.s1,dosing,8,13,O
DDI-DrugBank.d525.s1,adjustments,15,25,O
DDI-DrugBank.d525.s1,are,27,29,O
DDI-DrugBank.d525.s1,necessary,31,39,O
DDI-DrugBank.d525.s1,during,41,46,O
DDI-DrugBank.d525.s1,concomitant,48,58,O
DDI-DrugBank.d525.s1,use,60,62,O
DDI-DrugBank.d525.s1,with,64,67,O
DDI-DrugBank.d525.s1,these,69,73,O
DDI-DrugBank.d525.s1,agents,75,80,O
DDI-DrugBank.d525.s1,.,81,81,O
DDI-DrugBank.d525.s2,Because,0,6,O
DDI-DrugBank.d525.s2,eprosartan,8,17,B-drug
DDI-DrugBank.d525.s2,is,19,20,O
DDI-DrugBank.d525.s2,not,22,24,O
DDI-DrugBank.d525.s2,metabolized,26,36,O
DDI-DrugBank.d525.s2,by,38,39,O
DDI-DrugBank.d525.s2,the,41,43,O
DDI-DrugBank.d525.s2,cytochrome,45,54,O
DDI-DrugBank.d525.s2,P450,56,59,O
DDI-DrugBank.d525.s2,system,61,66,O
DDI-DrugBank.d525.s2,",",67,67,O
DDI-DrugBank.d525.s2,inhibitors,69,78,O
DDI-DrugBank.d525.s2,of,80,81,O
DDI-DrugBank.d525.s2,CYP450,83,88,O
DDI-DrugBank.d525.s2,enzyme,90,95,O
DDI-DrugBank.d525.s2,would,97,101,O
DDI-DrugBank.d525.s2,not,103,105,O
DDI-DrugBank.d525.s2,be,107,108,O
DDI-DrugBank.d525.s2,expected,110,117,O
DDI-DrugBank.d525.s2,to,119,120,O
DDI-DrugBank.d525.s2,affect,122,127,O
DDI-DrugBank.d525.s2,its,129,131,O
DDI-DrugBank.d525.s2,metabolism,133,142,O
DDI-DrugBank.d525.s2,",",143,143,O
DDI-DrugBank.d525.s2,and,145,147,O
DDI-DrugBank.d525.s2,ketoconazole,149,160,B-drug
DDI-DrugBank.d525.s2,and,162,164,O
DDI-DrugBank.d525.s2,fluconazole,166,176,B-drug
DDI-DrugBank.d525.s2,",",177,177,O
DDI-DrugBank.d525.s2,potent,179,184,O
DDI-DrugBank.d525.s2,inhibitors,186,195,O
DDI-DrugBank.d525.s2,of,197,198,O
DDI-DrugBank.d525.s2,CYP3A,200,204,O
DDI-DrugBank.d525.s2,and,206,208,O
DDI-DrugBank.d525.s2,2C9,210,212,O
DDI-DrugBank.d525.s2,",",213,213,O
DDI-DrugBank.d525.s2,respectively,215,226,O
DDI-DrugBank.d525.s2,",",227,227,O
DDI-DrugBank.d525.s2,have,229,232,O
DDI-DrugBank.d525.s2,been,234,237,O
DDI-DrugBank.d525.s2,shown,239,243,O
DDI-DrugBank.d525.s2,to,245,246,O
DDI-DrugBank.d525.s2,have,248,251,O
DDI-DrugBank.d525.s2,no,253,254,O
DDI-DrugBank.d525.s2,effect,256,261,O
DDI-DrugBank.d525.s2,on,263,264,O
DDI-DrugBank.d525.s2,eprosartan,266,275,B-drug
DDI-DrugBank.d525.s2,pharmacokinetics,277,292,O
DDI-DrugBank.d525.s2,.,293,293,O
DDI-DrugBank.d525.s3,Ranitidine,0,9,B-drug
DDI-DrugBank.d525.s3,also,11,14,O
DDI-DrugBank.d525.s3,has,16,18,O
DDI-DrugBank.d525.s3,no,20,21,O
DDI-DrugBank.d525.s3,effect,23,28,O
DDI-DrugBank.d525.s3,on,30,31,O
DDI-DrugBank.d525.s3,eprosartan,33,42,B-drug
DDI-DrugBank.d525.s3,pharmacokinetics,44,59,O
DDI-DrugBank.d525.s3,.,60,60,O
DDI-DrugBank.d525.s4,Eprosartan,0,9,B-drug
DDI-DrugBank.d525.s4,(,11,11,O
DDI-DrugBank.d525.s4,up,12,13,O
DDI-DrugBank.d525.s4,to,15,16,O
DDI-DrugBank.d525.s4,400,18,20,O
DDI-DrugBank.d525.s4,mg,22,23,O
DDI-DrugBank.d525.s4,b.i.d,25,29,O
DDI-DrugBank.d525.s4,.,30,30,O
DDI-DrugBank.d525.s4,or,32,33,O
DDI-DrugBank.d525.s4,800,35,37,O
DDI-DrugBank.d525.s4,mg,39,40,O
DDI-DrugBank.d525.s4,q.d,42,44,O
DDI-DrugBank.d525.s4,.,45,45,O
DDI-DrugBank.d525.s4,),46,46,O
DDI-DrugBank.d525.s4,doses,48,52,O
DDI-DrugBank.d525.s4,have,54,57,O
DDI-DrugBank.d525.s4,been,59,62,O
DDI-DrugBank.d525.s4,safely,64,69,O
DDI-DrugBank.d525.s4,used,71,74,O
DDI-DrugBank.d525.s4,concomitantly,76,88,O
DDI-DrugBank.d525.s4,with,90,93,O
DDI-DrugBank.d525.s4,a,95,95,O
DDI-DrugBank.d525.s4,thiazide,97,104,B-group
DDI-DrugBank.d525.s4,diuretic,106,113,I-group
DDI-DrugBank.d525.s4,(,115,115,O
DDI-DrugBank.d525.s4,hydrochlorothiazide,116,134,B-drug
DDI-DrugBank.d525.s4,),135,135,O
DDI-DrugBank.d525.s4,.,136,136,O
DDI-DrugBank.d525.s5,Eprosartan,0,9,B-drug
DDI-DrugBank.d525.s5,doses,11,15,O
DDI-DrugBank.d525.s5,of,17,18,O
DDI-DrugBank.d525.s5,up,20,21,O
DDI-DrugBank.d525.s5,to,23,24,O
DDI-DrugBank.d525.s5,300,26,28,O
DDI-DrugBank.d525.s5,mg,30,31,O
DDI-DrugBank.d525.s5,b.i.d,33,37,O
DDI-DrugBank.d525.s5,.,38,38,O
DDI-DrugBank.d525.s5,have,40,43,O
DDI-DrugBank.d525.s5,been,45,48,O
DDI-DrugBank.d525.s5,safely,50,55,O
DDI-DrugBank.d525.s5,used,57,60,O
DDI-DrugBank.d525.s5,concomitantly,62,74,O
DDI-DrugBank.d525.s5,with,76,79,O
DDI-DrugBank.d525.s5,sustained-release,81,97,O
DDI-DrugBank.d525.s5,calcium,99,105,B-group
DDI-DrugBank.d525.s5,channel,107,113,I-group
DDI-DrugBank.d525.s5,blockers,115,122,I-group
DDI-DrugBank.d525.s5,(,124,124,O
DDI-DrugBank.d525.s5,sustained-release,125,141,O
DDI-DrugBank.d525.s5,nifedipine,143,152,B-drug
DDI-DrugBank.d525.s5,),153,153,O
DDI-DrugBank.d525.s5,with,155,158,O
DDI-DrugBank.d525.s5,no,160,161,O
DDI-DrugBank.d525.s5,clinically,163,172,O
DDI-DrugBank.d525.s5,significant,174,184,O
DDI-DrugBank.d525.s5,adverse,186,192,O
DDI-DrugBank.d525.s5,interactions,194,205,O
DDI-DrugBank.d525.s5,.,206,206,O
DDI-DrugBank.d278.s0,Enoxaparin,0,9,B-drug
DDI-DrugBank.d278.s0,dosed,11,15,O
DDI-DrugBank.d278.s0,as,17,18,O
DDI-DrugBank.d278.s0,a,20,20,O
DDI-DrugBank.d278.s0,1.0,22,24,O
DDI-DrugBank.d278.s0,mg/kg,26,30,O
DDI-DrugBank.d278.s0,subcutaneous,32,43,O
DDI-DrugBank.d278.s0,injection,45,53,O
DDI-DrugBank.d278.s0,q12h,55,58,O
DDI-DrugBank.d278.s0,for,60,62,O
DDI-DrugBank.d278.s0,four,64,67,O
DDI-DrugBank.d278.s0,doses,69,73,O
DDI-DrugBank.d278.s0,did,75,77,O
DDI-DrugBank.d278.s0,not,79,81,O
DDI-DrugBank.d278.s0,alter,83,87,O
DDI-DrugBank.d278.s0,the,89,91,O
DDI-DrugBank.d278.s0,pharmacokinetics,93,108,O
DDI-DrugBank.d278.s0,of,110,111,O
DDI-DrugBank.d278.s0,eptifibatide,113,124,B-drug
DDI-DrugBank.d278.s0,or,126,127,O
DDI-DrugBank.d278.s0,the,129,131,O
DDI-DrugBank.d278.s0,level,133,137,O
DDI-DrugBank.d278.s0,of,139,140,O
DDI-DrugBank.d278.s0,platelet,142,149,O
DDI-DrugBank.d278.s0,aggregation,151,161,O
DDI-DrugBank.d278.s0,in,163,164,O
DDI-DrugBank.d278.s0,healthy,166,172,O
DDI-DrugBank.d278.s0,adults,174,179,O
DDI-DrugBank.d278.s0,.,180,180,O
DDI-DrugBank.d152.s0,Certain,0,6,O
DDI-DrugBank.d152.s0,endocrine,8,16,O
DDI-DrugBank.d152.s0,and,18,20,O
DDI-DrugBank.d152.s0,liver,22,26,O
DDI-DrugBank.d152.s0,function,28,35,O
DDI-DrugBank.d152.s0,tests,37,41,O
DDI-DrugBank.d152.s0,may,43,45,O
DDI-DrugBank.d152.s0,be,47,48,O
DDI-DrugBank.d152.s0,affected,50,57,O
DDI-DrugBank.d152.s0,by,59,60,O
DDI-DrugBank.d152.s0,estrogen-containing,62,80,O
DDI-DrugBank.d152.s0,oral,82,85,O
DDI-DrugBank.d152.s0,contraceptives,87,100,B-group
DDI-DrugBank.d152.s0,.,101,101,O
DDI-DrugBank.d152.s1,The,0,2,O
DDI-DrugBank.d152.s1,following,4,12,O
DDI-DrugBank.d152.s1,similar,14,20,O
DDI-DrugBank.d152.s1,changes,22,28,O
DDI-DrugBank.d152.s1,may,30,32,O
DDI-DrugBank.d152.s1,be,34,35,O
DDI-DrugBank.d152.s1,expected,37,44,O
DDI-DrugBank.d152.s1,with,46,49,O
DDI-DrugBank.d152.s1,larger,51,56,O
DDI-DrugBank.d152.s1,doses,58,62,O
DDI-DrugBank.d152.s1,of,64,65,O
DDI-DrugBank.d152.s1,estrogen,67,74,B-group
DDI-DrugBank.d152.s1,:,75,75,O
DDI-DrugBank.d152.s1,Increased,77,85,O
DDI-DrugBank.d152.s1,sulfobromophthalein,87,105,O
DDI-DrugBank.d152.s1,retention,107,115,O
DDI-DrugBank.d152.s1,;,116,116,O
DDI-DrugBank.d152.s2,increased,0,8,O
DDI-DrugBank.d152.s2,prothrombin,10,20,O
DDI-DrugBank.d152.s2,and,22,24,O
DDI-DrugBank.d152.s2,factors,26,32,O
DDI-DrugBank.d152.s2,VII,34,36,O
DDI-DrugBank.d152.s2,",",37,37,O
DDI-DrugBank.d152.s2,VIII,39,42,O
DDI-DrugBank.d152.s2,",",43,43,O
DDI-DrugBank.d152.s2,IX,45,46,O
DDI-DrugBank.d152.s2,",",47,47,O
DDI-DrugBank.d152.s2,and,49,51,O
DDI-DrugBank.d152.s2,X,53,53,O
DDI-DrugBank.d152.s2,;,54,54,O
DDI-DrugBank.d152.s3,decreased,0,8,O
DDI-DrugBank.d152.s3,antithrombin,10,21,O
DDI-DrugBank.d152.s3,3,23,23,O
DDI-DrugBank.d152.s3,;,24,24,O
DDI-DrugBank.d152.s4,increased,0,8,O
DDI-DrugBank.d152.s4,norepinephrine-induced,10,31,O
DDI-DrugBank.d152.s4,platel,33,38,O
DDI-DrugBank.d152.s4,et,40,41,O
DDI-DrugBank.d152.s4,aggregation,43,53,O
DDI-DrugBank.d152.s4,;,54,54,O
DDI-DrugBank.d152.s5,increased,0,8,O
DDI-DrugBank.d152.s5,thyroid,10,16,O
DDI-DrugBank.d152.s5,binding,18,24,O
DDI-DrugBank.d152.s5,globulin,26,33,O
DDI-DrugBank.d152.s5,(,35,35,O
DDI-DrugBank.d152.s5,TBG,36,38,O
DDI-DrugBank.d152.s5,),39,39,O
DDI-DrugBank.d152.s5,leading,41,47,O
DDI-DrugBank.d152.s5,to,49,50,O
DDI-DrugBank.d152.s5,increased,52,60,O
DDI-DrugBank.d152.s5,circulating,62,72,O
DDI-DrugBank.d152.s5,total,74,78,O
DDI-DrugBank.d152.s5,thyroid,80,86,O
DDI-DrugBank.d152.s5,hormone,88,94,O
DDI-DrugBank.d152.s5,",",95,95,O
DDI-DrugBank.d152.s5,as,97,98,O
DDI-DrugBank.d152.s5,measured,100,107,O
DDI-DrugBank.d152.s5,by,109,110,O
DDI-DrugBank.d152.s5,PBI,112,114,O
DDI-DrugBank.d152.s5,",",115,115,O
DDI-DrugBank.d152.s5,T4,117,118,O
DDI-DrugBank.d152.s5,by,120,121,O
DDI-DrugBank.d152.s5,column,123,128,O
DDI-DrugBank.d152.s5,",",129,129,O
DDI-DrugBank.d152.s5,or,131,132,O
DDI-DrugBank.d152.s5,T4,134,135,O
DDI-DrugBank.d152.s5,by,137,138,O
DDI-DrugBank.d152.s5,radioimmunoassay,140,155,O
DDI-DrugBank.d152.s5,.,156,156,O
DDI-DrugBank.d152.s6,Free,0,3,O
DDI-DrugBank.d152.s6,T3,5,6,O
DDI-DrugBank.d152.s6,resin,8,12,O
DDI-DrugBank.d152.s6,uptake,14,19,O
DDI-DrugBank.d152.s6,is,21,22,O
DDI-DrugBank.d152.s6,decreased,24,32,O
DDI-DrugBank.d152.s6,",",33,33,O
DDI-DrugBank.d152.s6,reflecting,35,44,O
DDI-DrugBank.d152.s6,the,46,48,O
DDI-DrugBank.d152.s6,elevated,50,57,O
DDI-DrugBank.d152.s6,TBG,59,61,O
DDI-DrugBank.d152.s6,;,62,62,O
DDI-DrugBank.d152.s7,free,0,3,O
DDI-DrugBank.d152.s7,T4,5,6,O
DDI-DrugBank.d152.s7,concentration,8,20,O
DDI-DrugBank.d152.s7,is,22,23,O
DDI-DrugBank.d152.s7,unaltered,25,33,O
DDI-DrugBank.d152.s7,:,34,34,O
DDI-DrugBank.d152.s7,impaired,36,43,O
DDI-DrugBank.d152.s7,glucose,45,51,O
DDI-DrugBank.d152.s7,tolerance,53,61,O
DDI-DrugBank.d152.s7,;,62,62,O
DDI-DrugBank.d152.s8,decreased,0,8,O
DDI-DrugBank.d152.s8,pregnanediol,10,21,O
DDI-DrugBank.d152.s8,excretion,23,31,O
DDI-DrugBank.d152.s8,;,32,32,O
DDI-DrugBank.d152.s9,reduced,0,6,O
DDI-DrugBank.d152.s9,response,8,15,O
DDI-DrugBank.d152.s9,to,17,18,O
DDI-DrugBank.d152.s9,metyrapone,20,29,O
DDI-DrugBank.d152.s9,test,31,34,O
DDI-DrugBank.d152.s9,;,35,35,O
DDI-DrugBank.d152.s10,reduced,0,6,O
DDI-DrugBank.d152.s10,serum,8,12,O
DDI-DrugBank.d152.s10,folate,14,19,O
DDI-DrugBank.d152.s10,concentration,21,33,O
DDI-DrugBank.d152.s10,;,34,34,O
DDI-DrugBank.d152.s11,increased,0,8,O
DDI-DrugBank.d152.s11,serum,10,14,O
DDI-DrugBank.d152.s11,triglyceride,16,27,O
DDI-DrugBank.d152.s11,and,29,31,O
DDI-DrugBank.d152.s11,phospholipid,33,44,O
DDI-DrugBank.d152.s11,concentration,46,58,O
DDI-DrugBank.d152.s11,.,59,59,O
DDI-DrugBank.d359.s0,PEGANONE,0,7,B-brand
DDI-DrugBank.d359.s0,used,9,12,O
DDI-DrugBank.d359.s0,in,14,15,O
DDI-DrugBank.d359.s0,combination,17,27,O
DDI-DrugBank.d359.s0,with,29,32,O
DDI-DrugBank.d359.s0,other,34,38,O
DDI-DrugBank.d359.s0,drugs,40,44,O
DDI-DrugBank.d359.s0,known,46,50,O
DDI-DrugBank.d359.s0,to,52,53,O
DDI-DrugBank.d359.s0,adversely,55,63,O
DDI-DrugBank.d359.s0,affect,65,70,O
DDI-DrugBank.d359.s0,the,72,74,O
DDI-DrugBank.d359.s0,hematopoietic,76,88,O
DDI-DrugBank.d359.s0,system,90,95,O
DDI-DrugBank.d359.s0,should,97,102,O
DDI-DrugBank.d359.s0,be,104,105,O
DDI-DrugBank.d359.s0,avoided,107,113,O
DDI-DrugBank.d359.s0,if,115,116,O
DDI-DrugBank.d359.s0,possible,118,125,O
DDI-DrugBank.d359.s0,.,126,126,O
DDI-DrugBank.d359.s1,Considerable,0,11,O
DDI-DrugBank.d359.s1,caution,13,19,O
DDI-DrugBank.d359.s1,should,21,26,O
DDI-DrugBank.d359.s1,be,28,29,O
DDI-DrugBank.d359.s1,exercised,31,39,O
DDI-DrugBank.d359.s1,if,41,42,O
DDI-DrugBank.d359.s1,PEGANONE,44,51,B-brand
DDI-DrugBank.d359.s1,is,53,54,O
DDI-DrugBank.d359.s1,administered,56,67,O
DDI-DrugBank.d359.s1,concurrently,69,80,O
DDI-DrugBank.d359.s1,with,82,85,O
DDI-DrugBank.d359.s1,Phenurone,87,95,B-brand
DDI-DrugBank.d359.s1,(,97,97,O
DDI-DrugBank.d359.s1,phenacemide,98,108,B-drug
DDI-DrugBank.d359.s1,),109,109,O
DDI-DrugBank.d359.s1,since,111,115,O
DDI-DrugBank.d359.s1,paranoid,117,124,O
DDI-DrugBank.d359.s1,symptoms,126,133,O
DDI-DrugBank.d359.s1,have,135,138,O
DDI-DrugBank.d359.s1,been,140,143,O
DDI-DrugBank.d359.s1,reported,145,152,O
DDI-DrugBank.d359.s1,during,154,159,O
DDI-DrugBank.d359.s1,therapy,161,167,O
DDI-DrugBank.d359.s1,with,169,172,O
DDI-DrugBank.d359.s1,this,174,177,O
DDI-DrugBank.d359.s1,combination,179,189,O
DDI-DrugBank.d359.s1,.,190,190,O
DDI-DrugBank.d359.s2,A,0,0,O
DDI-DrugBank.d359.s2,two-way,2,8,O
DDI-DrugBank.d359.s2,interaction,10,20,O
DDI-DrugBank.d359.s2,between,22,28,O
DDI-DrugBank.d359.s2,the,30,32,O
DDI-DrugBank.d359.s2,hydantoin,34,42,B-group
DDI-DrugBank.d359.s2,antiepileptic,44,56,I-group
DDI-DrugBank.d359.s2,",",57,57,O
DDI-DrugBank.d359.s2,phenytoin,59,67,B-drug
DDI-DrugBank.d359.s2,",",68,68,O
DDI-DrugBank.d359.s2,and,70,72,O
DDI-DrugBank.d359.s2,the,74,76,O
DDI-DrugBank.d359.s2,coumarin,78,85,B-group
DDI-DrugBank.d359.s2,anticoagulants,87,100,I-group
DDI-DrugBank.d359.s2,has,102,104,O
DDI-DrugBank.d359.s2,been,106,109,O
DDI-DrugBank.d359.s2,suggested,111,119,O
DDI-DrugBank.d359.s2,.,120,120,O
DDI-DrugBank.d359.s3,Presumably,0,9,O
DDI-DrugBank.d359.s3,",",10,10,O
DDI-DrugBank.d359.s3,phenytoin,12,20,B-drug
DDI-DrugBank.d359.s3,acts,22,25,O
DDI-DrugBank.d359.s3,as,27,28,O
DDI-DrugBank.d359.s3,a,30,30,O
DDI-DrugBank.d359.s3,stimulator,32,41,O
DDI-DrugBank.d359.s3,of,43,44,O
DDI-DrugBank.d359.s3,coumarin,46,53,B-group
DDI-DrugBank.d359.s3,metabolism,55,64,O
DDI-DrugBank.d359.s3,and,66,68,O
DDI-DrugBank.d359.s3,has,70,72,O
DDI-DrugBank.d359.s3,been,74,77,O
DDI-DrugBank.d359.s3,reported,79,86,O
DDI-DrugBank.d359.s3,to,88,89,O
DDI-DrugBank.d359.s3,cause,91,95,O
DDI-DrugBank.d359.s3,decreased,97,105,O
DDI-DrugBank.d359.s3,serum,107,111,O
DDI-DrugBank.d359.s3,levels,113,118,O
DDI-DrugBank.d359.s3,of,120,121,O
DDI-DrugBank.d359.s3,the,123,125,O
DDI-DrugBank.d359.s3,coumarin,127,134,B-group
DDI-DrugBank.d359.s3,anticoagulants,136,149,I-group
DDI-DrugBank.d359.s3,and,151,153,O
DDI-DrugBank.d359.s3,increased,155,163,O
DDI-DrugBank.d359.s3,prothrombin-proconvertin,165,188,O
DDI-DrugBank.d359.s3,concentrations,190,203,O
DDI-DrugBank.d359.s3,.,204,204,O
DDI-DrugBank.d359.s4,Conversely,0,9,O
DDI-DrugBank.d359.s4,",",10,10,O
DDI-DrugBank.d359.s4,the,12,14,O
DDI-DrugBank.d359.s4,coumarin,16,23,B-group
DDI-DrugBank.d359.s4,anticoagulants,25,38,I-group
DDI-DrugBank.d359.s4,have,40,43,O
DDI-DrugBank.d359.s4,been,45,48,O
DDI-DrugBank.d359.s4,reported,50,57,O
DDI-DrugBank.d359.s4,to,59,60,O
DDI-DrugBank.d359.s4,increase,62,69,O
DDI-DrugBank.d359.s4,the,71,73,O
DDI-DrugBank.d359.s4,serum,75,79,O
DDI-DrugBank.d359.s4,levels,81,86,O
DDI-DrugBank.d359.s4,and,88,90,O
DDI-DrugBank.d359.s4,prolong,92,98,O
DDI-DrugBank.d359.s4,the,100,102,O
DDI-DrugBank.d359.s4,serum,104,108,O
DDI-DrugBank.d359.s4,half-life,110,118,O
DDI-DrugBank.d359.s4,of,120,121,O
DDI-DrugBank.d359.s4,phenytoin,123,131,B-drug
DDI-DrugBank.d359.s4,by,133,134,O
DDI-DrugBank.d359.s4,inhibiting,136,145,O
DDI-DrugBank.d359.s4,its,147,149,O
DDI-DrugBank.d359.s4,metabolism,151,160,O
DDI-DrugBank.d359.s4,.,161,161,O
DDI-DrugBank.d359.s5,Although,0,7,O
DDI-DrugBank.d359.s5,there,9,13,O
DDI-DrugBank.d359.s5,is,15,16,O
DDI-DrugBank.d359.s5,no,18,19,O
DDI-DrugBank.d359.s5,documentation,21,33,O
DDI-DrugBank.d359.s5,of,35,36,O
DDI-DrugBank.d359.s5,such,38,41,O
DDI-DrugBank.d359.s5,",",42,42,O
DDI-DrugBank.d359.s5,a,44,44,O
DDI-DrugBank.d359.s5,similar,46,52,O
DDI-DrugBank.d359.s5,interaction,54,64,O
DDI-DrugBank.d359.s5,between,66,72,O
DDI-DrugBank.d359.s5,ethotoin,74,81,B-drug
DDI-DrugBank.d359.s5,and,83,85,O
DDI-DrugBank.d359.s5,the,87,89,O
DDI-DrugBank.d359.s5,coumarin,91,98,B-group
DDI-DrugBank.d359.s5,anticoagulants,100,113,I-group
DDI-DrugBank.d359.s5,may,115,117,O
DDI-DrugBank.d359.s5,occur,119,123,O
DDI-DrugBank.d359.s5,.,124,124,O
DDI-DrugBank.d359.s6,Caution,0,6,O
DDI-DrugBank.d359.s6,is,8,9,O
DDI-DrugBank.d359.s6,therefore,11,19,O
DDI-DrugBank.d359.s6,advised,21,27,O
DDI-DrugBank.d359.s6,when,29,32,O
DDI-DrugBank.d359.s6,administering,34,46,O
DDI-DrugBank.d359.s6,PEGANONE,48,55,B-brand
DDI-DrugBank.d359.s6,to,57,58,O
DDI-DrugBank.d359.s6,patients,60,67,O
DDI-DrugBank.d359.s6,receiving,69,77,O
DDI-DrugBank.d359.s6,coumarin,79,86,B-group
DDI-DrugBank.d359.s6,anticoagulants,88,101,I-group
DDI-DrugBank.d359.s6,.,102,102,O
DDI-DrugBank.d219.s0,ACE-inhibitors,0,13,B-group
DDI-DrugBank.d219.s0,Reports,15,21,O
DDI-DrugBank.d219.s0,suggest,23,29,O
DDI-DrugBank.d219.s0,that,31,34,O
DDI-DrugBank.d219.s0,NSAIDs,36,41,B-group
DDI-DrugBank.d219.s0,may,43,45,O
DDI-DrugBank.d219.s0,diminish,47,54,O
DDI-DrugBank.d219.s0,the,56,58,O
DDI-DrugBank.d219.s0,antihypertensive,60,75,O
DDI-DrugBank.d219.s0,effect,77,82,O
DDI-DrugBank.d219.s0,of,84,85,O
DDI-DrugBank.d219.s0,ACE-inhibitors,87,100,B-group
DDI-DrugBank.d219.s0,.,101,101,O
DDI-DrugBank.d219.s1,This,0,3,O
DDI-DrugBank.d219.s1,interaction,5,15,O
DDI-DrugBank.d219.s1,should,17,22,O
DDI-DrugBank.d219.s1,be,24,25,O
DDI-DrugBank.d219.s1,given,27,31,O
DDI-DrugBank.d219.s1,consideration,33,45,O
DDI-DrugBank.d219.s1,in,47,48,O
DDI-DrugBank.d219.s1,patients,50,57,O
DDI-DrugBank.d219.s1,taking,59,64,O
DDI-DrugBank.d219.s1,NSAIDs,66,71,B-group
DDI-DrugBank.d219.s1,concomitantly,73,85,O
DDI-DrugBank.d219.s1,with,87,90,O
DDI-DrugBank.d219.s1,ACE-inhibitors,92,105,B-group
DDI-DrugBank.d219.s1,.,106,106,O
DDI-DrugBank.d219.s2,Antacids,0,7,B-group
DDI-DrugBank.d219.s2,:,8,8,O
DDI-DrugBank.d219.s2,The,10,12,O
DDI-DrugBank.d219.s2,concomitant,14,24,O
DDI-DrugBank.d219.s2,administration,26,39,O
DDI-DrugBank.d219.s2,of,41,42,O
DDI-DrugBank.d219.s2,antacids,44,51,B-group
DDI-DrugBank.d219.s2,has,53,55,O
DDI-DrugBank.d219.s2,no,57,58,O
DDI-DrugBank.d219.s2,apparent,60,67,O
DDI-DrugBank.d219.s2,effect,69,74,O
DDI-DrugBank.d219.s2,on,76,77,O
DDI-DrugBank.d219.s2,the,79,81,O
DDI-DrugBank.d219.s2,extent,83,88,O
DDI-DrugBank.d219.s2,of,90,91,O
DDI-DrugBank.d219.s2,absorption,93,102,O
DDI-DrugBank.d219.s2,of,104,105,O
DDI-DrugBank.d219.s2,Lodine,107,112,B-brand
DDI-DrugBank.d219.s2,.,113,113,O
DDI-DrugBank.d219.s3,However,0,6,O
DDI-DrugBank.d219.s3,",",7,7,O
DDI-DrugBank.d219.s3,antacids,9,16,B-group
DDI-DrugBank.d219.s3,can,18,20,O
DDI-DrugBank.d219.s3,decrease,22,29,O
DDI-DrugBank.d219.s3,the,31,33,O
DDI-DrugBank.d219.s3,peak,35,38,O
DDI-DrugBank.d219.s3,concentration,40,52,O
DDI-DrugBank.d219.s3,reached,54,60,O
DDI-DrugBank.d219.s3,by,62,63,O
DDI-DrugBank.d219.s3,15,65,66,O
DDI-DrugBank.d219.s3,%,67,67,O
DDI-DrugBank.d219.s3,to,69,70,O
DDI-DrugBank.d219.s3,20,72,73,O
DDI-DrugBank.d219.s3,%,74,74,O
DDI-DrugBank.d219.s3,but,76,78,O
DDI-DrugBank.d219.s3,have,80,83,O
DDI-DrugBank.d219.s3,no,85,86,O
DDI-DrugBank.d219.s3,detectable,88,97,O
DDI-DrugBank.d219.s3,effect,99,104,O
DDI-DrugBank.d219.s3,on,106,107,O
DDI-DrugBank.d219.s3,the,109,111,O
DDI-DrugBank.d219.s3,time-to-peak,113,124,O
DDI-DrugBank.d219.s3,.,125,125,O
DDI-DrugBank.d219.s4,Aspirin,0,6,B-brand
DDI-DrugBank.d219.s4,:,7,7,O
DDI-DrugBank.d219.s4,When,9,12,O
DDI-DrugBank.d219.s4,Lodine,14,19,B-brand
DDI-DrugBank.d219.s4,is,21,22,O
DDI-DrugBank.d219.s4,administered,24,35,O
DDI-DrugBank.d219.s4,with,37,40,O
DDI-DrugBank.d219.s4,aspirin,42,48,B-brand
DDI-DrugBank.d219.s4,",",49,49,O
DDI-DrugBank.d219.s4,its,51,53,O
DDI-DrugBank.d219.s4,protein,55,61,O
DDI-DrugBank.d219.s4,binding,63,69,O
DDI-DrugBank.d219.s4,is,71,72,O
DDI-DrugBank.d219.s4,reduced,74,80,O
DDI-DrugBank.d219.s4,",",81,81,O
DDI-DrugBank.d219.s4,although,83,90,O
DDI-DrugBank.d219.s4,the,92,94,O
DDI-DrugBank.d219.s4,clearance,96,104,O
DDI-DrugBank.d219.s4,of,106,107,O
DDI-DrugBank.d219.s4,free,109,112,O
DDI-DrugBank.d219.s4,etodolac,114,121,B-drug
DDI-DrugBank.d219.s4,is,123,124,O
DDI-DrugBank.d219.s4,not,126,128,O
DDI-DrugBank.d219.s4,altered,130,136,O
DDI-DrugBank.d219.s4,.,137,137,O
DDI-DrugBank.d219.s5,The,0,2,O
DDI-DrugBank.d219.s5,clinical,4,11,O
DDI-DrugBank.d219.s5,significance,13,24,O
DDI-DrugBank.d219.s5,of,26,27,O
DDI-DrugBank.d219.s5,this,29,32,O
DDI-DrugBank.d219.s5,interaction,34,44,O
DDI-DrugBank.d219.s5,is,46,47,O
DDI-DrugBank.d219.s5,not,49,51,O
DDI-DrugBank.d219.s5,known,53,57,O
DDI-DrugBank.d219.s5,;,58,58,O
DDI-DrugBank.d219.s6,however,0,6,O
DDI-DrugBank.d219.s6,",",7,7,O
DDI-DrugBank.d219.s6,as,9,10,O
DDI-DrugBank.d219.s6,with,12,15,O
DDI-DrugBank.d219.s6,other,17,21,O
DDI-DrugBank.d219.s6,NSAIDs,23,28,B-group
DDI-DrugBank.d219.s6,",",29,29,O
DDI-DrugBank.d219.s6,concomitant,31,41,O
DDI-DrugBank.d219.s6,administration,43,56,O
DDI-DrugBank.d219.s6,of,58,59,O
DDI-DrugBank.d219.s6,Lodine,61,66,B-brand
DDI-DrugBank.d219.s6,and,68,70,O
DDI-DrugBank.d219.s6,aspirin,72,78,B-brand
DDI-DrugBank.d219.s6,is,80,81,O
DDI-DrugBank.d219.s6,not,83,85,O
DDI-DrugBank.d219.s6,generally,87,95,O
DDI-DrugBank.d219.s6,recommended,97,107,O
DDI-DrugBank.d219.s6,because,109,115,O
DDI-DrugBank.d219.s6,of,117,118,O
DDI-DrugBank.d219.s6,the,120,122,O
DDI-DrugBank.d219.s6,potential,124,132,O
DDI-DrugBank.d219.s6,of,134,135,O
DDI-DrugBank.d219.s6,increased,137,145,O
DDI-DrugBank.d219.s6,adverse,147,153,O
DDI-DrugBank.d219.s6,effects,155,161,O
DDI-DrugBank.d219.s6,.,162,162,O
DDI-DrugBank.d219.s7,Cyclosporine,0,11,O
DDI-DrugBank.d219.s7,",",12,12,O
DDI-DrugBank.d219.s7,Digoxin,14,20,O
DDI-DrugBank.d219.s7,",",21,21,O
DDI-DrugBank.d219.s7,Methotrexate,23,34,O
DDI-DrugBank.d219.s7,Lodine,36,41,B-brand
DDI-DrugBank.d219.s7,",",42,42,O
DDI-DrugBank.d219.s7,like,44,47,O
DDI-DrugBank.d219.s7,other,49,53,O
DDI-DrugBank.d219.s7,NSAIDs,55,60,B-group
DDI-DrugBank.d219.s7,",",61,61,O
DDI-DrugBank.d219.s7,through,63,69,O
DDI-DrugBank.d219.s7,effects,71,77,O
DDI-DrugBank.d219.s7,on,79,80,O
DDI-DrugBank.d219.s7,renal,82,86,O
DDI-DrugBank.d219.s7,prostaglandins,88,101,O
DDI-DrugBank.d219.s7,",",102,102,O
DDI-DrugBank.d219.s7,may,104,106,O
DDI-DrugBank.d219.s7,cause,108,112,O
DDI-DrugBank.d219.s7,changes,114,120,O
DDI-DrugBank.d219.s7,in,122,123,O
DDI-DrugBank.d219.s7,the,125,127,O
DDI-DrugBank.d219.s7,elimination,129,139,O
DDI-DrugBank.d219.s7,of,141,142,O
DDI-DrugBank.d219.s7,these,144,148,O
DDI-DrugBank.d219.s7,drugs,150,154,O
DDI-DrugBank.d219.s7,leading,156,162,O
DDI-DrugBank.d219.s7,to,164,165,O
DDI-DrugBank.d219.s7,elevated,167,174,O
DDI-DrugBank.d219.s7,serum,176,180,O
DDI-DrugBank.d219.s7,levels,182,187,O
DDI-DrugBank.d219.s7,of,189,190,O
DDI-DrugBank.d219.s7,cyclosporine,192,203,B-drug
DDI-DrugBank.d219.s7,",",204,204,O
DDI-DrugBank.d219.s7,digoxin,206,212,B-drug
DDI-DrugBank.d219.s7,",",213,213,O
DDI-DrugBank.d219.s7,methotrexate,215,226,B-drug
DDI-DrugBank.d219.s7,",",227,227,O
DDI-DrugBank.d219.s7,and,229,231,O
DDI-DrugBank.d219.s7,increased,233,241,O
DDI-DrugBank.d219.s7,toxicity,243,250,O
DDI-DrugBank.d219.s7,.,251,251,O
DDI-DrugBank.d219.s8,Nephrotoxicity,0,13,O
DDI-DrugBank.d219.s8,associated,15,24,O
DDI-DrugBank.d219.s8,with,26,29,O
DDI-DrugBank.d219.s8,cyclosporine,31,42,B-drug
DDI-DrugBank.d219.s8,may,44,46,O
DDI-DrugBank.d219.s8,also,48,51,O
DDI-DrugBank.d219.s8,be,53,54,O
DDI-DrugBank.d219.s8,enhanced,56,63,O
DDI-DrugBank.d219.s8,.,64,64,O
DDI-DrugBank.d219.s9,Patients,0,7,O
DDI-DrugBank.d219.s9,receiving,9,17,O
DDI-DrugBank.d219.s9,these,19,23,O
DDI-DrugBank.d219.s9,drugs,25,29,O
DDI-DrugBank.d219.s9,who,31,33,O
DDI-DrugBank.d219.s9,are,35,37,O
DDI-DrugBank.d219.s9,given,39,43,O
DDI-DrugBank.d219.s9,Lodine,45,50,B-brand
DDI-DrugBank.d219.s9,",",51,51,O
DDI-DrugBank.d219.s9,or,53,54,O
DDI-DrugBank.d219.s9,any,56,58,O
DDI-DrugBank.d219.s9,other,60,64,O
DDI-DrugBank.d219.s9,NSAID,66,70,B-group
DDI-DrugBank.d219.s9,",",71,71,O
DDI-DrugBank.d219.s9,and,73,75,O
DDI-DrugBank.d219.s9,particularly,77,88,O
DDI-DrugBank.d219.s9,those,90,94,O
DDI-DrugBank.d219.s9,patients,96,103,O
DDI-DrugBank.d219.s9,with,105,108,O
DDI-DrugBank.d219.s9,altered,110,116,O
DDI-DrugBank.d219.s9,renal,118,122,O
DDI-DrugBank.d219.s9,function,124,131,O
DDI-DrugBank.d219.s9,",",132,132,O
DDI-DrugBank.d219.s9,should,134,139,O
DDI-DrugBank.d219.s9,be,141,142,O
DDI-DrugBank.d219.s9,observed,144,151,O
DDI-DrugBank.d219.s9,for,153,155,O
DDI-DrugBank.d219.s9,the,157,159,O
DDI-DrugBank.d219.s9,development,161,171,O
DDI-DrugBank.d219.s9,of,173,174,O
DDI-DrugBank.d219.s9,the,176,178,O
DDI-DrugBank.d219.s9,specific,180,187,O
DDI-DrugBank.d219.s9,toxicities,189,198,O
DDI-DrugBank.d219.s9,of,200,201,O
DDI-DrugBank.d219.s9,these,203,207,O
DDI-DrugBank.d219.s9,drugs,209,213,O
DDI-DrugBank.d219.s9,.,214,214,O
DDI-DrugBank.d219.s10,Diuretics,0,8,B-group
DDI-DrugBank.d219.s10,:,9,9,O
DDI-DrugBank.d219.s10,Etodolac,11,18,O
DDI-DrugBank.d219.s10,has,20,22,O
DDI-DrugBank.d219.s10,no,24,25,O
DDI-DrugBank.d219.s10,apparent,27,34,O
DDI-DrugBank.d219.s10,pharmacokinetic,36,50,O
DDI-DrugBank.d219.s10,interaction,52,62,O
DDI-DrugBank.d219.s10,when,64,67,O
DDI-DrugBank.d219.s10,administered,69,80,O
DDI-DrugBank.d219.s10,with,82,85,O
DDI-DrugBank.d219.s10,furosemide,87,96,B-drug
DDI-DrugBank.d219.s10,or,98,99,O
DDI-DrugBank.d219.s10,hydrochlorothiazide,101,119,B-drug
DDI-DrugBank.d219.s10,.,120,120,O
DDI-DrugBank.d219.s11,Nevertheless,0,11,O
DDI-DrugBank.d219.s11,",",12,12,O
DDI-DrugBank.d219.s11,clinical,14,21,O
DDI-DrugBank.d219.s11,studies,23,29,O
DDI-DrugBank.d219.s11,",",30,30,O
DDI-DrugBank.d219.s11,as,32,33,O
DDI-DrugBank.d219.s11,well,35,38,O
DDI-DrugBank.d219.s11,as,40,41,O
DDI-DrugBank.d219.s11,postmarketing,43,55,O
DDI-DrugBank.d219.s11,observations,57,68,O
DDI-DrugBank.d219.s11,have,70,73,O
DDI-DrugBank.d219.s11,shown,75,79,O
DDI-DrugBank.d219.s11,that,81,84,O
DDI-DrugBank.d219.s11,Lodine,86,91,B-brand
DDI-DrugBank.d219.s11,can,93,95,O
DDI-DrugBank.d219.s11,reduce,97,102,O
DDI-DrugBank.d219.s11,the,104,106,O
DDI-DrugBank.d219.s11,natriuretic,108,118,O
DDI-DrugBank.d219.s11,effect,120,125,O
DDI-DrugBank.d219.s11,of,127,128,O
DDI-DrugBank.d219.s11,furosemide,130,139,B-drug
DDI-DrugBank.d219.s11,and,141,143,O
DDI-DrugBank.d219.s11,thiazides,145,153,B-group
DDI-DrugBank.d219.s11,in,155,156,O
DDI-DrugBank.d219.s11,some,158,161,O
DDI-DrugBank.d219.s11,patients,163,170,O
DDI-DrugBank.d219.s11,.,171,171,O
DDI-DrugBank.d219.s12,This,0,3,O
DDI-DrugBank.d219.s12,response,5,12,O
DDI-DrugBank.d219.s12,has,14,16,O
DDI-DrugBank.d219.s12,been,18,21,O
DDI-DrugBank.d219.s12,attributed,23,32,O
DDI-DrugBank.d219.s12,to,34,35,O
DDI-DrugBank.d219.s12,inhibition,37,46,O
DDI-DrugBank.d219.s12,of,48,49,O
DDI-DrugBank.d219.s12,renal,51,55,O
DDI-DrugBank.d219.s12,prostaglandin,57,69,O
DDI-DrugBank.d219.s12,synthesis,71,79,O
DDI-DrugBank.d219.s12,.,80,80,O
DDI-DrugBank.d219.s13,During,0,5,O
DDI-DrugBank.d219.s13,concomitant,7,17,O
DDI-DrugBank.d219.s13,therapy,19,25,O
DDI-DrugBank.d219.s13,with,27,30,O
DDI-DrugBank.d219.s13,NSAIDs,32,37,B-group
DDI-DrugBank.d219.s13,",",38,38,O
DDI-DrugBank.d219.s13,the,40,42,O
DDI-DrugBank.d219.s13,patient,44,50,O
DDI-DrugBank.d219.s13,should,52,57,O
DDI-DrugBank.d219.s13,be,59,60,O
DDI-DrugBank.d219.s13,observed,62,69,O
DDI-DrugBank.d219.s13,closely,71,77,O
DDI-DrugBank.d219.s13,for,79,81,O
DDI-DrugBank.d219.s13,signs,83,87,O
DDI-DrugBank.d219.s13,of,89,90,O
DDI-DrugBank.d219.s13,renal,92,96,O
DDI-DrugBank.d219.s13,failure,98,104,O
DDI-DrugBank.d219.s13,",",105,105,O
DDI-DrugBank.d219.s13,as,107,108,O
DDI-DrugBank.d219.s13,well,110,113,O
DDI-DrugBank.d219.s13,as,115,116,O
DDI-DrugBank.d219.s13,to,118,119,O
DDI-DrugBank.d219.s13,assure,121,126,O
DDI-DrugBank.d219.s13,diuretic,128,135,O
DDI-DrugBank.d219.s13,efficacy,137,144,O
DDI-DrugBank.d219.s13,.,145,145,O
DDI-DrugBank.d219.s14,Glyburide,0,8,B-drug
DDI-DrugBank.d219.s14,:,9,9,O
DDI-DrugBank.d219.s14,Etodolac,11,18,B-drug
DDI-DrugBank.d219.s14,has,20,22,O
DDI-DrugBank.d219.s14,no,24,25,O
DDI-DrugBank.d219.s14,apparent,27,34,O
DDI-DrugBank.d219.s14,pharmacokinetic,36,50,O
DDI-DrugBank.d219.s14,interaction,52,62,O
DDI-DrugBank.d219.s14,when,64,67,O
DDI-DrugBank.d219.s14,administered,69,80,O
DDI-DrugBank.d219.s14,with,82,85,O
DDI-DrugBank.d219.s14,glyburide,87,95,B-drug
DDI-DrugBank.d219.s14,.,96,96,O
DDI-DrugBank.d219.s15,Lithium,0,6,B-drug
DDI-DrugBank.d219.s15,:,7,7,O
DDI-DrugBank.d219.s15,NSAIDs,9,14,B-group
DDI-DrugBank.d219.s15,have,16,19,O
DDI-DrugBank.d219.s15,produced,21,28,O
DDI-DrugBank.d219.s15,an,30,31,O
DDI-DrugBank.d219.s15,elevation,33,41,O
DDI-DrugBank.d219.s15,of,43,44,O
DDI-DrugBank.d219.s15,plasma,46,51,O
DDI-DrugBank.d219.s15,lithium,53,59,B-drug
DDI-DrugBank.d219.s15,levels,61,66,O
DDI-DrugBank.d219.s15,and,68,70,O
DDI-DrugBank.d219.s15,a,72,72,O
DDI-DrugBank.d219.s15,reduction,74,82,O
DDI-DrugBank.d219.s15,in,84,85,O
DDI-DrugBank.d219.s15,renal,87,91,O
DDI-DrugBank.d219.s15,lithium,93,99,B-drug
DDI-DrugBank.d219.s15,clearance,101,109,O
DDI-DrugBank.d219.s15,.,110,110,O
DDI-DrugBank.d219.s16,The,0,2,O
DDI-DrugBank.d219.s16,mean,4,7,O
DDI-DrugBank.d219.s16,minimum,9,15,O
DDI-DrugBank.d219.s16,lithium,17,23,B-drug
DDI-DrugBank.d219.s16,concentration,25,37,O
DDI-DrugBank.d219.s16,increased,39,47,O
DDI-DrugBank.d219.s16,15,49,50,O
DDI-DrugBank.d219.s16,%,51,51,O
DDI-DrugBank.d219.s16,and,53,55,O
DDI-DrugBank.d219.s16,the,57,59,O
DDI-DrugBank.d219.s16,renal,61,65,O
DDI-DrugBank.d219.s16,clearance,67,75,O
DDI-DrugBank.d219.s16,was,77,79,O
DDI-DrugBank.d219.s16,decreased,81,89,O
DDI-DrugBank.d219.s16,by,91,92,O
DDI-DrugBank.d219.s16,approximately,94,106,O
DDI-DrugBank.d219.s16,20,108,109,O
DDI-DrugBank.d219.s16,%,110,110,O
DDI-DrugBank.d219.s16,.,111,111,O
DDI-DrugBank.d219.s17,These,0,4,O
DDI-DrugBank.d219.s17,effects,6,12,O
DDI-DrugBank.d219.s17,have,14,17,O
DDI-DrugBank.d219.s17,been,19,22,O
DDI-DrugBank.d219.s17,attributed,24,33,O
DDI-DrugBank.d219.s17,to,35,36,O
DDI-DrugBank.d219.s17,inhibition,38,47,O
DDI-DrugBank.d219.s17,of,49,50,O
DDI-DrugBank.d219.s17,renal,52,56,O
DDI-DrugBank.d219.s17,prostaglandin,58,70,O
DDI-DrugBank.d219.s17,synthesis,72,80,O
DDI-DrugBank.d219.s17,by,82,83,O
DDI-DrugBank.d219.s17,the,85,87,O
DDI-DrugBank.d219.s17,NSAID,89,93,B-group
DDI-DrugBank.d219.s17,.,94,94,O
DDI-DrugBank.d219.s18,Thus,0,3,O
DDI-DrugBank.d219.s18,",",4,4,O
DDI-DrugBank.d219.s18,when,6,9,O
DDI-DrugBank.d219.s18,NSAIDs,11,16,B-group
DDI-DrugBank.d219.s18,and,18,20,O
DDI-DrugBank.d219.s18,lithium,22,28,B-drug
DDI-DrugBank.d219.s18,are,30,32,O
DDI-DrugBank.d219.s18,administered,34,45,O
DDI-DrugBank.d219.s18,concurrently,47,58,O
DDI-DrugBank.d219.s18,",",59,59,O
DDI-DrugBank.d219.s18,subjects,61,68,O
DDI-DrugBank.d219.s18,should,70,75,O
DDI-DrugBank.d219.s18,be,77,78,O
DDI-DrugBank.d219.s18,observed,80,87,O
DDI-DrugBank.d219.s18,carefully,89,97,O
DDI-DrugBank.d219.s18,for,99,101,O
DDI-DrugBank.d219.s18,signs,103,107,O
DDI-DrugBank.d219.s18,of,109,110,O
DDI-DrugBank.d219.s18,lithium,112,118,B-drug
DDI-DrugBank.d219.s18,toxicity,120,127,O
DDI-DrugBank.d219.s18,.,128,128,O
DDI-DrugBank.d219.s19,Phenylbutazone,0,13,B-drug
DDI-DrugBank.d219.s19,:,14,14,O
DDI-DrugBank.d219.s19,Phenylbutazone,16,29,B-drug
DDI-DrugBank.d219.s19,causes,31,36,O
DDI-DrugBank.d219.s19,increase,38,45,O
DDI-DrugBank.d219.s19,(,47,47,O
DDI-DrugBank.d219.s19,by,48,49,O
DDI-DrugBank.d219.s19,about,51,55,O
DDI-DrugBank.d219.s19,80,57,58,O
DDI-DrugBank.d219.s19,%,59,59,O
DDI-DrugBank.d219.s19,),60,60,O
DDI-DrugBank.d219.s19,in,62,63,O
DDI-DrugBank.d219.s19,the,65,67,O
DDI-DrugBank.d219.s19,free,69,72,O
DDI-DrugBank.d219.s19,fraction,74,81,O
DDI-DrugBank.d219.s19,of,83,84,O
DDI-DrugBank.d219.s19,etodolac,86,93,B-drug
DDI-DrugBank.d219.s19,.,94,94,O
DDI-DrugBank.d219.s20,Although,0,7,O
DDI-DrugBank.d219.s20,in,9,10,O
DDI-DrugBank.d219.s20,vivo,12,15,O
DDI-DrugBank.d219.s20,studies,17,23,O
DDI-DrugBank.d219.s20,have,25,28,O
DDI-DrugBank.d219.s20,not,30,32,O
DDI-DrugBank.d219.s20,been,34,37,O
DDI-DrugBank.d219.s20,done,39,42,O
DDI-DrugBank.d219.s20,to,44,45,O
DDI-DrugBank.d219.s20,see,47,49,O
DDI-DrugBank.d219.s20,if,51,52,O
DDI-DrugBank.d219.s20,etodolac,54,61,B-drug
DDI-DrugBank.d219.s20,clearance,63,71,O
DDI-DrugBank.d219.s20,is,73,74,O
DDI-DrugBank.d219.s20,changed,76,82,O
DDI-DrugBank.d219.s20,by,84,85,O
DDI-DrugBank.d219.s20,coadministration,87,102,O
DDI-DrugBank.d219.s20,of,104,105,O
DDI-DrugBank.d219.s20,phenylbutazone,107,120,B-drug
DDI-DrugBank.d219.s20,",",121,121,O
DDI-DrugBank.d219.s20,it,123,124,O
DDI-DrugBank.d219.s20,is,126,127,O
DDI-DrugBank.d219.s20,not,129,131,O
DDI-DrugBank.d219.s20,recommended,133,143,O
DDI-DrugBank.d219.s20,that,145,148,O
DDI-DrugBank.d219.s20,they,150,153,O
DDI-DrugBank.d219.s20,be,155,156,O
DDI-DrugBank.d219.s20,coadministered,158,171,O
DDI-DrugBank.d219.s20,.,172,172,O
DDI-DrugBank.d219.s21,Phenytoin,0,8,B-drug
DDI-DrugBank.d219.s21,:,9,9,O
DDI-DrugBank.d219.s21,Etodolac,11,18,B-drug
DDI-DrugBank.d219.s21,has,20,22,O
DDI-DrugBank.d219.s21,no,24,25,O
DDI-DrugBank.d219.s21,apparent,27,34,O
DDI-DrugBank.d219.s21,pharmacokinetic,36,50,O
DDI-DrugBank.d219.s21,interaction,52,62,O
DDI-DrugBank.d219.s21,when,64,67,O
DDI-DrugBank.d219.s21,administered,69,80,O
DDI-DrugBank.d219.s21,with,82,85,O
DDI-DrugBank.d219.s21,phenytoin,87,95,B-drug
DDI-DrugBank.d219.s21,.,96,96,O
DDI-DrugBank.d219.s22,Warfarin,0,7,B-drug
DDI-DrugBank.d219.s22,:,8,8,O
DDI-DrugBank.d219.s22,The,10,12,O
DDI-DrugBank.d219.s22,effects,14,20,O
DDI-DrugBank.d219.s22,of,22,23,O
DDI-DrugBank.d219.s22,warfarin,25,32,B-drug
DDI-DrugBank.d219.s22,and,34,36,O
DDI-DrugBank.d219.s22,NSAIDs,38,43,B-group
DDI-DrugBank.d219.s22,on,45,46,O
DDI-DrugBank.d219.s22,GI,48,49,O
DDI-DrugBank.d219.s22,bleeding,51,58,O
DDI-DrugBank.d219.s22,are,60,62,O
DDI-DrugBank.d219.s22,synergistic,64,74,O
DDI-DrugBank.d219.s22,",",75,75,O
DDI-DrugBank.d219.s22,such,77,80,O
DDI-DrugBank.d219.s22,that,82,85,O
DDI-DrugBank.d219.s22,users,87,91,O
DDI-DrugBank.d219.s22,of,93,94,O
DDI-DrugBank.d219.s22,both,96,99,O
DDI-DrugBank.d219.s22,drugs,101,105,O
DDI-DrugBank.d219.s22,together,107,114,O
DDI-DrugBank.d219.s22,have,116,119,O
DDI-DrugBank.d219.s22,a,121,121,O
DDI-DrugBank.d219.s22,risk,123,126,O
DDI-DrugBank.d219.s22,of,128,129,O
DDI-DrugBank.d219.s22,serious,131,137,O
DDI-DrugBank.d219.s22,GI,139,140,O
DDI-DrugBank.d219.s22,bleeding,142,149,O
DDI-DrugBank.d219.s22,higher,151,156,O
DDI-DrugBank.d219.s22,than,158,161,O
DDI-DrugBank.d219.s22,that,163,166,O
DDI-DrugBank.d219.s22,of,168,169,O
DDI-DrugBank.d219.s22,users,171,175,O
DDI-DrugBank.d219.s22,of,177,178,O
DDI-DrugBank.d219.s22,either,180,185,O
DDI-DrugBank.d219.s22,drug,187,190,O
DDI-DrugBank.d219.s22,alone,192,196,O
DDI-DrugBank.d219.s22,.,197,197,O
DDI-DrugBank.d219.s23,Short-term,0,9,O
DDI-DrugBank.d219.s23,pharmacokinetic,11,25,O
DDI-DrugBank.d219.s23,studies,27,33,O
DDI-DrugBank.d219.s23,have,35,38,O
DDI-DrugBank.d219.s23,demonstrated,40,51,O
DDI-DrugBank.d219.s23,that,53,56,O
DDI-DrugBank.d219.s23,concomitant,58,68,O
DDI-DrugBank.d219.s23,administration,70,83,O
DDI-DrugBank.d219.s23,of,85,86,O
DDI-DrugBank.d219.s23,warfarin,88,95,B-drug
DDI-DrugBank.d219.s23,and,97,99,O
DDI-DrugBank.d219.s23,Lodine,101,106,B-brand
DDI-DrugBank.d219.s23,(,109,109,O
DDI-DrugBank.d219.s23,etodolac,110,117,B-drug
DDI-DrugBank.d219.s23,capsules,119,126,O
DDI-DrugBank.d219.s23,and,128,130,O
DDI-DrugBank.d219.s23,tablets,132,138,O
DDI-DrugBank.d219.s23,),139,139,O
DDI-DrugBank.d219.s23,results,141,147,O
DDI-DrugBank.d219.s23,in,149,150,O
DDI-DrugBank.d219.s23,reduced,152,158,O
DDI-DrugBank.d219.s23,protein,160,166,O
DDI-DrugBank.d219.s23,binding,168,174,O
DDI-DrugBank.d219.s23,of,176,177,O
DDI-DrugBank.d219.s23,warfarin,179,186,B-drug
DDI-DrugBank.d219.s23,",",187,187,O
DDI-DrugBank.d219.s23,but,189,191,O
DDI-DrugBank.d219.s23,there,193,197,O
DDI-DrugBank.d219.s23,was,199,201,O
DDI-DrugBank.d219.s23,no,203,204,O
DDI-DrugBank.d219.s23,change,206,211,O
DDI-DrugBank.d219.s23,in,213,214,O
DDI-DrugBank.d219.s23,the,216,218,O
DDI-DrugBank.d219.s23,clearance,220,228,O
DDI-DrugBank.d219.s23,of,230,231,O
DDI-DrugBank.d219.s23,free,233,236,O
DDI-DrugBank.d219.s23,warfarin,238,245,B-drug
DDI-DrugBank.d219.s23,.,246,246,O
DDI-DrugBank.d219.s24,There,0,4,O
DDI-DrugBank.d219.s24,was,6,8,O
DDI-DrugBank.d219.s24,no,10,11,O
DDI-DrugBank.d219.s24,significant,13,23,O
DDI-DrugBank.d219.s24,difference,25,34,O
DDI-DrugBank.d219.s24,in,36,37,O
DDI-DrugBank.d219.s24,the,39,41,O
DDI-DrugBank.d219.s24,pharmacodynamic,43,57,O
DDI-DrugBank.d219.s24,effect,59,64,O
DDI-DrugBank.d219.s24,of,66,67,O
DDI-DrugBank.d219.s24,warfarin,69,76,B-drug
DDI-DrugBank.d219.s24,administered,78,89,O
DDI-DrugBank.d219.s24,alone,91,95,O
DDI-DrugBank.d219.s24,and,97,99,O
DDI-DrugBank.d219.s24,warfarin,101,108,B-drug
DDI-DrugBank.d219.s24,administered,110,121,O
DDI-DrugBank.d219.s24,with,123,126,O
DDI-DrugBank.d219.s24,Lodine,128,133,B-brand
DDI-DrugBank.d219.s24,as,135,136,O
DDI-DrugBank.d219.s24,measured,138,145,O
DDI-DrugBank.d219.s24,by,147,148,O
DDI-DrugBank.d219.s24,prothrombin,150,160,O
DDI-DrugBank.d219.s24,time,162,165,O
DDI-DrugBank.d219.s24,.,166,166,O
DDI-DrugBank.d219.s25,Thus,0,3,O
DDI-DrugBank.d219.s25,",",4,4,O
DDI-DrugBank.d219.s25,concomitant,6,16,O
DDI-DrugBank.d219.s25,therapy,18,24,O
DDI-DrugBank.d219.s25,with,26,29,O
DDI-DrugBank.d219.s25,warfarin,31,38,B-drug
DDI-DrugBank.d219.s25,and,40,42,O
DDI-DrugBank.d219.s25,Lodine,44,49,B-brand
DDI-DrugBank.d219.s25,should,51,56,O
DDI-DrugBank.d219.s25,not,58,60,O
DDI-DrugBank.d219.s25,require,62,68,O
DDI-DrugBank.d219.s25,dosage,70,75,O
DDI-DrugBank.d219.s25,adjustment,77,86,O
DDI-DrugBank.d219.s25,of,88,89,O
DDI-DrugBank.d219.s25,either,91,96,O
DDI-DrugBank.d219.s25,drug,98,101,O
DDI-DrugBank.d219.s25,.,102,102,O
DDI-DrugBank.d219.s26,However,0,6,O
DDI-DrugBank.d219.s26,",",7,7,O
DDI-DrugBank.d219.s26,caution,9,15,O
DDI-DrugBank.d219.s26,should,17,22,O
DDI-DrugBank.d219.s26,be,24,25,O
DDI-DrugBank.d219.s26,exercised,27,35,O
DDI-DrugBank.d219.s26,because,37,43,O
DDI-DrugBank.d219.s26,there,45,49,O
DDI-DrugBank.d219.s26,have,51,54,O
DDI-DrugBank.d219.s26,been,56,59,O
DDI-DrugBank.d219.s26,a,61,61,O
DDI-DrugBank.d219.s26,few,63,65,O
DDI-DrugBank.d219.s26,spontaneous,67,77,O
DDI-DrugBank.d219.s26,reports,79,85,O
DDI-DrugBank.d219.s26,of,87,88,O
DDI-DrugBank.d219.s26,prolonged,90,98,O
DDI-DrugBank.d219.s26,prothrombin,100,110,O
DDI-DrugBank.d219.s26,times,112,116,O
DDI-DrugBank.d219.s26,",",117,117,O
DDI-DrugBank.d219.s26,with,119,122,O
DDI-DrugBank.d219.s26,or,124,125,O
DDI-DrugBank.d219.s26,without,127,133,O
DDI-DrugBank.d219.s26,bleeding,135,142,O
DDI-DrugBank.d219.s26,",",143,143,O
DDI-DrugBank.d219.s26,in,145,146,O
DDI-DrugBank.d219.s26,etodolac-treated,148,163,O
DDI-DrugBank.d219.s26,patients,165,172,O
DDI-DrugBank.d219.s26,receiving,174,182,O
DDI-DrugBank.d219.s26,concomitant,184,194,O
DDI-DrugBank.d219.s26,warfarin,196,203,B-drug
DDI-DrugBank.d219.s26,therapy,205,211,O
DDI-DrugBank.d219.s26,.,212,212,O
DDI-DrugBank.d219.s27,Drug/Laboratory,0,14,O
DDI-DrugBank.d219.s27,Test,16,19,O
DDI-DrugBank.d219.s27,Interactions,21,32,O
DDI-DrugBank.d219.s27,The,34,36,O
DDI-DrugBank.d219.s27,urine,38,42,O
DDI-DrugBank.d219.s27,of,44,45,O
DDI-DrugBank.d219.s27,patients,47,54,O
DDI-DrugBank.d219.s27,who,56,58,O
DDI-DrugBank.d219.s27,take,60,63,O
DDI-DrugBank.d219.s27,Lodine,65,70,B-brand
DDI-DrugBank.d219.s27,can,72,74,O
DDI-DrugBank.d219.s27,give,76,79,O
DDI-DrugBank.d219.s27,a,81,81,O
DDI-DrugBank.d219.s27,false-positive,83,96,O
DDI-DrugBank.d219.s27,reaction,98,105,O
DDI-DrugBank.d219.s27,for,107,109,O
DDI-DrugBank.d219.s27,urinary,111,117,O
DDI-DrugBank.d219.s27,bilirubin,119,127,O
DDI-DrugBank.d219.s27,(,129,129,O
DDI-DrugBank.d219.s27,urobilin,130,137,O
DDI-DrugBank.d219.s27,),138,138,O
DDI-DrugBank.d219.s27,due,140,142,O
DDI-DrugBank.d219.s27,to,144,145,O
DDI-DrugBank.d219.s27,the,147,149,O
DDI-DrugBank.d219.s27,presence,151,158,O
DDI-DrugBank.d219.s27,of,160,161,O
DDI-DrugBank.d219.s27,phenolic,163,170,O
DDI-DrugBank.d219.s27,metabolites,172,182,O
DDI-DrugBank.d219.s27,of,184,185,O
DDI-DrugBank.d219.s27,etodolac,187,194,B-drug
DDI-DrugBank.d219.s27,.,195,195,O
DDI-DrugBank.d219.s28,Diagnostic,0,9,O
DDI-DrugBank.d219.s28,dip-stick,11,19,O
DDI-DrugBank.d219.s28,methodology,21,31,O
DDI-DrugBank.d219.s28,",",32,32,O
DDI-DrugBank.d219.s28,used,34,37,O
DDI-DrugBank.d219.s28,to,39,40,O
DDI-DrugBank.d219.s28,detect,42,47,O
DDI-DrugBank.d219.s28,ketone,49,54,O
DDI-DrugBank.d219.s28,bodies,56,61,O
DDI-DrugBank.d219.s28,in,63,64,O
DDI-DrugBank.d219.s28,urine,66,70,O
DDI-DrugBank.d219.s28,",",71,71,O
DDI-DrugBank.d219.s28,has,73,75,O
DDI-DrugBank.d219.s28,resulted,77,84,O
DDI-DrugBank.d219.s28,in,86,87,O
DDI-DrugBank.d219.s28,false-positive,89,102,O
DDI-DrugBank.d219.s28,findings,104,111,O
DDI-DrugBank.d219.s28,in,113,114,O
DDI-DrugBank.d219.s28,some,116,119,O
DDI-DrugBank.d219.s28,patients,121,128,O
DDI-DrugBank.d219.s28,treated,130,136,O
DDI-DrugBank.d219.s28,with,138,141,O
DDI-DrugBank.d219.s28,Lodine,143,148,B-brand
DDI-DrugBank.d219.s28,.,149,149,O
DDI-DrugBank.d219.s29,Generally,0,8,O
DDI-DrugBank.d219.s29,",",9,9,O
DDI-DrugBank.d219.s29,this,11,14,O
DDI-DrugBank.d219.s29,phenomenon,16,25,O
DDI-DrugBank.d219.s29,has,27,29,O
DDI-DrugBank.d219.s29,not,31,33,O
DDI-DrugBank.d219.s29,been,35,38,O
DDI-DrugBank.d219.s29,associated,40,49,O
DDI-DrugBank.d219.s29,with,51,54,O
DDI-DrugBank.d219.s29,other,56,60,O
DDI-DrugBank.d219.s29,clinically,62,71,O
DDI-DrugBank.d219.s29,significant,73,83,O
DDI-DrugBank.d219.s29,events,85,90,O
DDI-DrugBank.d219.s29,.,91,91,O
DDI-DrugBank.d219.s30,No,0,1,O
DDI-DrugBank.d219.s30,dose,3,6,O
DDI-DrugBank.d219.s30,relationship,8,19,O
DDI-DrugBank.d219.s30,has,21,23,O
DDI-DrugBank.d219.s30,been,25,28,O
DDI-DrugBank.d219.s30,observed,30,37,O
DDI-DrugBank.d219.s30,.,38,38,O
DDI-DrugBank.d219.s31,Lodine,0,5,B-brand
DDI-DrugBank.d219.s31,treatment,7,15,O
DDI-DrugBank.d219.s31,is,17,18,O
DDI-DrugBank.d219.s31,associated,20,29,O
DDI-DrugBank.d219.s31,with,31,34,O
DDI-DrugBank.d219.s31,a,36,36,O
DDI-DrugBank.d219.s31,small,38,42,O
DDI-DrugBank.d219.s31,decrease,44,51,O
DDI-DrugBank.d219.s31,in,53,54,O
DDI-DrugBank.d219.s31,serum,56,60,O
DDI-DrugBank.d219.s31,uric,62,65,O
DDI-DrugBank.d219.s31,acid,67,70,O
DDI-DrugBank.d219.s31,levels,72,77,O
DDI-DrugBank.d219.s31,.,78,78,O
DDI-DrugBank.d219.s32,In,0,1,O
DDI-DrugBank.d219.s32,clinical,3,10,O
DDI-DrugBank.d219.s32,trials,12,17,O
DDI-DrugBank.d219.s32,",",18,18,O
DDI-DrugBank.d219.s32,mean,20,23,O
DDI-DrugBank.d219.s32,decreases,25,33,O
DDI-DrugBank.d219.s32,of,35,36,O
DDI-DrugBank.d219.s32,1,38,38,O
DDI-DrugBank.d219.s32,to,40,41,O
DDI-DrugBank.d219.s32,2,43,43,O
DDI-DrugBank.d219.s32,mg/dL,45,49,O
DDI-DrugBank.d219.s32,were,51,54,O
DDI-DrugBank.d219.s32,observed,56,63,O
DDI-DrugBank.d219.s32,in,65,66,O
DDI-DrugBank.d219.s32,arthritic,68,76,O
DDI-DrugBank.d219.s32,patients,78,85,O
DDI-DrugBank.d219.s32,receiving,87,95,O
DDI-DrugBank.d219.s32,etodolac,97,104,B-drug
DDI-DrugBank.d219.s32,(,106,106,O
DDI-DrugBank.d219.s32,600,107,109,O
DDI-DrugBank.d219.s32,mg,111,112,O
DDI-DrugBank.d219.s32,to,114,115,O
DDI-DrugBank.d219.s32,1000,117,120,O
DDI-DrugBank.d219.s32,mg/day,122,127,O
DDI-DrugBank.d219.s32,),128,128,O
DDI-DrugBank.d219.s32,after,130,134,O
DDI-DrugBank.d219.s32,4,136,136,O
DDI-DrugBank.d219.s32,weeks,138,142,O
DDI-DrugBank.d219.s32,of,144,145,O
DDI-DrugBank.d219.s32,therapy,147,153,O
DDI-DrugBank.d219.s32,.,154,154,O
DDI-DrugBank.d219.s33,These,0,4,O
DDI-DrugBank.d219.s33,levels,6,11,O
DDI-DrugBank.d219.s33,then,13,16,O
DDI-DrugBank.d219.s33,remained,18,25,O
DDI-DrugBank.d219.s33,stable,27,32,O
DDI-DrugBank.d219.s33,for,34,36,O
DDI-DrugBank.d219.s33,up,38,39,O
DDI-DrugBank.d219.s33,to,41,42,O
DDI-DrugBank.d219.s33,1,44,44,O
DDI-DrugBank.d219.s33,year,46,49,O
DDI-DrugBank.d219.s33,of,51,52,O
DDI-DrugBank.d219.s33,therapy,54,60,O
DDI-DrugBank.d219.s33,.,61,61,O
DDI-DrugBank.d104.s0,Fenfluramine,0,11,B-drug
DDI-DrugBank.d104.s0,may,13,15,O
DDI-DrugBank.d104.s0,increase,17,24,O
DDI-DrugBank.d104.s0,slightly,26,33,O
DDI-DrugBank.d104.s0,the,35,37,O
DDI-DrugBank.d104.s0,effect,39,44,O
DDI-DrugBank.d104.s0,of,46,47,O
DDI-DrugBank.d104.s0,antihypertensive,49,64,B-group
DDI-DrugBank.d104.s0,drugs,66,70,I-group
DDI-DrugBank.d104.s0,",",71,71,O
DDI-DrugBank.d104.s0,e.g.,73,76,O
DDI-DrugBank.d104.s0,",",77,77,O
DDI-DrugBank.d104.s0,guanethidine,79,90,B-drug
DDI-DrugBank.d104.s0,",",91,91,O
DDI-DrugBank.d104.s0,methyldopa,93,102,B-drug
DDI-DrugBank.d104.s0,",",103,103,O
DDI-DrugBank.d104.s0,reserpine,105,113,B-drug
DDI-DrugBank.d104.s0,.,114,114,O
DDI-DrugBank.d104.s1,Other,0,4,O
DDI-DrugBank.d104.s1,CNS,6,8,B-group
DDI-DrugBank.d104.s1,depressant,10,19,I-group
DDI-DrugBank.d104.s1,drugs,21,25,I-group
DDI-DrugBank.d104.s1,should,27,32,O
DDI-DrugBank.d104.s1,be,34,35,O
DDI-DrugBank.d104.s1,used,37,40,O
DDI-DrugBank.d104.s1,with,42,45,O
DDI-DrugBank.d104.s1,caution,47,53,O
DDI-DrugBank.d104.s1,in,55,56,O
DDI-DrugBank.d104.s1,patients,58,65,O
DDI-DrugBank.d104.s1,taking,67,72,O
DDI-DrugBank.d104.s1,fenfluramine,74,85,B-drug
DDI-DrugBank.d104.s1,",",86,86,O
DDI-DrugBank.d104.s1,since,88,92,O
DDI-DrugBank.d104.s1,the,94,96,O
DDI-DrugBank.d104.s1,effects,98,104,O
DDI-DrugBank.d104.s1,may,106,108,O
DDI-DrugBank.d104.s1,be,110,111,O
DDI-DrugBank.d104.s1,additive,113,120,O
DDI-DrugBank.d104.s1,.,121,121,O
DDI-DrugBank.d546.s0,Drug,0,3,O
DDI-DrugBank.d546.s0,Interactions,5,16,O
DDI-DrugBank.d546.s0,with,18,21,O
DDI-DrugBank.d546.s0,Beta-Blockers,23,35,B-group
DDI-DrugBank.d546.s0,:,36,36,O
DDI-DrugBank.d546.s0,Concomitant,38,48,O
DDI-DrugBank.d546.s0,use,50,52,O
DDI-DrugBank.d546.s0,of,54,55,O
DDI-DrugBank.d546.s0,fenoldopam,57,66,B-drug
DDI-DrugBank.d546.s0,with,68,71,O
DDI-DrugBank.d546.s0,beta-blockers,73,85,B-group
DDI-DrugBank.d546.s0,should,87,92,O
DDI-DrugBank.d546.s0,be,94,95,O
DDI-DrugBank.d546.s0,avoided,97,103,O
DDI-DrugBank.d546.s0,.,104,104,O
DDI-DrugBank.d546.s1,If,0,1,O
DDI-DrugBank.d546.s1,the,3,5,O
DDI-DrugBank.d546.s1,drugs,7,11,O
DDI-DrugBank.d546.s1,are,13,15,O
DDI-DrugBank.d546.s1,used,17,20,O
DDI-DrugBank.d546.s1,together,22,29,O
DDI-DrugBank.d546.s1,",",30,30,O
DDI-DrugBank.d546.s1,caution,32,38,O
DDI-DrugBank.d546.s1,should,40,45,O
DDI-DrugBank.d546.s1,be,47,48,O
DDI-DrugBank.d546.s1,exercised,50,58,O
DDI-DrugBank.d546.s1,because,60,66,O
DDI-DrugBank.d546.s1,unexpected,68,77,O
DDI-DrugBank.d546.s1,hypotension,79,89,O
DDI-DrugBank.d546.s1,could,91,95,O
DDI-DrugBank.d546.s1,result,97,102,O
DDI-DrugBank.d546.s1,from,104,107,O
DDI-DrugBank.d546.s1,beta-blocker,109,120,O
DDI-DrugBank.d546.s1,inhibition,122,131,O
DDI-DrugBank.d546.s1,of,133,134,O
DDI-DrugBank.d546.s1,the,136,138,O
DDI-DrugBank.d546.s1,sympathetic,140,150,O
DDI-DrugBank.d546.s1,reflex,152,157,O
DDI-DrugBank.d546.s1,response,159,166,O
DDI-DrugBank.d546.s1,to,168,169,O
DDI-DrugBank.d546.s1,fenoldopam,171,180,B-drug
DDI-DrugBank.d546.s1,.,181,181,O
DDI-DrugBank.d546.s2,Drug,0,3,O
DDI-DrugBank.d546.s2,Interactions,5,16,O
DDI-DrugBank.d546.s2,",",17,17,O
DDI-DrugBank.d546.s2,General,19,25,O
DDI-DrugBank.d546.s2,:,26,26,O
DDI-DrugBank.d546.s2,Although,28,35,O
DDI-DrugBank.d546.s2,there,37,41,O
DDI-DrugBank.d546.s2,have,43,46,O
DDI-DrugBank.d546.s2,been,48,51,O
DDI-DrugBank.d546.s2,no,53,54,O
DDI-DrugBank.d546.s2,formal,56,61,O
DDI-DrugBank.d546.s2,interaction,63,73,O
DDI-DrugBank.d546.s2,studies,75,81,O
DDI-DrugBank.d546.s2,",",82,82,O
DDI-DrugBank.d546.s2,intravenous,84,94,O
DDI-DrugBank.d546.s2,fenoldopam,96,105,B-drug
DDI-DrugBank.d546.s2,has,107,109,O
DDI-DrugBank.d546.s2,been,111,114,O
DDI-DrugBank.d546.s2,administered,116,127,O
DDI-DrugBank.d546.s2,safely,129,134,O
DDI-DrugBank.d546.s2,with,136,139,O
DDI-DrugBank.d546.s2,drugs,141,145,O
DDI-DrugBank.d546.s2,such,147,150,O
DDI-DrugBank.d546.s2,as,152,153,O
DDI-DrugBank.d546.s2,digitalis,155,163,B-group
DDI-DrugBank.d546.s2,and,165,167,O
DDI-DrugBank.d546.s2,sublingual,169,178,O
DDI-DrugBank.d546.s2,nitroglycerin,180,192,B-drug
DDI-DrugBank.d546.s2,.,193,193,O
DDI-DrugBank.d546.s3,There,0,4,O
DDI-DrugBank.d546.s3,is,6,7,O
DDI-DrugBank.d546.s3,limited,9,15,O
DDI-DrugBank.d546.s3,experience,17,26,O
DDI-DrugBank.d546.s3,with,28,31,O
DDI-DrugBank.d546.s3,concomitant,33,43,O
DDI-DrugBank.d546.s3,antihypertensive,45,60,B-group
DDI-DrugBank.d546.s3,agents,62,67,I-group
DDI-DrugBank.d546.s3,such,69,72,O
DDI-DrugBank.d546.s3,as,74,75,O
DDI-DrugBank.d546.s3,alpha-blockers,77,90,B-group
DDI-DrugBank.d546.s3,",",91,91,O
DDI-DrugBank.d546.s3,calcium,93,99,B-group
DDI-DrugBank.d546.s3,channel-blockers,101,116,I-group
DDI-DrugBank.d546.s3,",",117,117,O
DDI-DrugBank.d546.s3,ACE,119,121,B-group
DDI-DrugBank.d546.s3,inhibitors,123,132,I-group
DDI-DrugBank.d546.s3,",",133,133,O
DDI-DrugBank.d546.s3,and,135,137,O
DDI-DrugBank.d546.s3,diuretics,139,147,B-group
DDI-DrugBank.d546.s3,(,149,149,O
DDI-DrugBank.d546.s3,both,150,153,O
DDI-DrugBank.d546.s3,thiazide-like,155,167,O
DDI-DrugBank.d546.s3,and,169,171,O
DDI-DrugBank.d546.s3,loop,173,176,O
DDI-DrugBank.d546.s3,),177,177,O
DDI-DrugBank.d546.s3,.,178,178,O
DDI-DrugBank.d776.s0,Clinically,0,9,O
DDI-DrugBank.d776.s0,or,11,12,O
DDI-DrugBank.d776.s0,potentially,14,24,O
DDI-DrugBank.d776.s0,significant,26,36,O
DDI-DrugBank.d776.s0,drug,38,41,O
DDI-DrugBank.d776.s0,interactions,43,54,O
DDI-DrugBank.d776.s0,between,56,62,O
DDI-DrugBank.d776.s0,DIFLUCAN,64,71,B-brand
DDI-DrugBank.d776.s0,and,73,75,O
DDI-DrugBank.d776.s0,the,77,79,O
DDI-DrugBank.d776.s0,following,81,89,O
DDI-DrugBank.d776.s0,agents/classes,91,104,O
DDI-DrugBank.d776.s0,have,106,109,O
DDI-DrugBank.d776.s0,been,111,114,O
DDI-DrugBank.d776.s0,observed,116,123,O
DDI-DrugBank.d776.s0,.,124,124,O
DDI-DrugBank.d776.s1,These,0,4,O
DDI-DrugBank.d776.s1,are,6,8,O
DDI-DrugBank.d776.s1,described,10,18,O
DDI-DrugBank.d776.s1,in,20,21,O
DDI-DrugBank.d776.s1,greater,23,29,O
DDI-DrugBank.d776.s1,detail,31,36,O
DDI-DrugBank.d776.s1,below,38,42,O
DDI-DrugBank.d776.s1,:,43,43,O
DDI-DrugBank.d776.s1,DIFLUCAN,45,52,B-brand
DDI-DrugBank.d776.s1,and,54,56,O
DDI-DrugBank.d776.s1,the,58,60,O
DDI-DrugBank.d776.s1,following,62,70,O
DDI-DrugBank.d776.s1,agents/classes,72,85,O
DDI-DrugBank.d776.s1,have,87,90,O
DDI-DrugBank.d776.s1,been,92,95,O
DDI-DrugBank.d776.s1,observed,97,104,O
DDI-DrugBank.d776.s1,.,105,105,O
DDI-DrugBank.d776.s2,These,0,4,O
DDI-DrugBank.d776.s2,are,6,8,O
DDI-DrugBank.d776.s2,described,10,18,O
DDI-DrugBank.d776.s2,in,20,21,O
DDI-DrugBank.d776.s2,greater,23,29,O
DDI-DrugBank.d776.s2,detail,31,36,O
DDI-DrugBank.d776.s2,below,38,42,O
DDI-DrugBank.d776.s2,:,43,43,O
DDI-DrugBank.d776.s2,Oral,46,49,O
DDI-DrugBank.d776.s2,hypoglycemics,51,63,B-group
DDI-DrugBank.d776.s2,",",64,64,O
DDI-DrugBank.d776.s2,Coumarin-type,66,78,B-group
DDI-DrugBank.d776.s2,anticoagulants,80,93,I-group
DDI-DrugBank.d776.s2,",",94,94,O
DDI-DrugBank.d776.s2,Phenytoin,96,104,B-drug
DDI-DrugBank.d776.s2,",",105,105,O
DDI-DrugBank.d776.s2,Cyclosporine,107,118,B-drug
DDI-DrugBank.d776.s2,",",119,119,O
DDI-DrugBank.d776.s2,Rifampin,121,128,B-drug
DDI-DrugBank.d776.s2,",",129,129,O
DDI-DrugBank.d776.s2,Theophylline,131,142,B-drug
DDI-DrugBank.d776.s2,",",143,143,O
DDI-DrugBank.d776.s2,Terfenadine,145,155,B-drug
DDI-DrugBank.d776.s2,",",156,156,O
DDI-DrugBank.d776.s2,Cisapride,158,166,B-drug
DDI-DrugBank.d776.s2,",",167,167,O
DDI-DrugBank.d776.s2,Astemizole,169,178,B-drug
DDI-DrugBank.d776.s2,",",179,179,O
DDI-DrugBank.d776.s2,Rifabutin,181,189,B-drug
DDI-DrugBank.d776.s2,",",190,190,O
DDI-DrugBank.d776.s2,Tacrolimus,192,201,B-drug
DDI-DrugBank.d776.s2,",",202,202,O
DDI-DrugBank.d776.s2,Short-acting,204,215,B-group
DDI-DrugBank.d776.s2,benzodiazepines,217,231,I-group
DDI-DrugBank.d776.s2,",",232,232,O
DDI-DrugBank.d776.s2,Oral,235,238,O
DDI-DrugBank.d776.s2,hypoglycemics,240,252,B-group
DDI-DrugBank.d776.s2,:,253,253,O
DDI-DrugBank.d776.s2,Clinically,255,264,O
DDI-DrugBank.d776.s2,significant,266,276,O
DDI-DrugBank.d776.s2,hypoglycemia,278,289,O
DDI-DrugBank.d776.s2,may,291,293,O
DDI-DrugBank.d776.s2,be,295,296,O
DDI-DrugBank.d776.s2,precipitated,298,309,O
DDI-DrugBank.d776.s2,by,311,312,O
DDI-DrugBank.d776.s2,the,314,316,O
DDI-DrugBank.d776.s2,use,318,320,O
DDI-DrugBank.d776.s2,of,322,323,O
DDI-DrugBank.d776.s2,DIFLUCAN,325,332,B-brand
DDI-DrugBank.d776.s2,with,334,337,O
DDI-DrugBank.d776.s2,oral,339,342,O
DDI-DrugBank.d776.s2,hypoglycemic,344,355,B-group
DDI-DrugBank.d776.s2,agents,357,362,I-group
DDI-DrugBank.d776.s2,;,363,363,O
DDI-DrugBank.d776.s3,one,0,2,O
DDI-DrugBank.d776.s3,fatality,4,11,O
DDI-DrugBank.d776.s3,has,13,15,O
DDI-DrugBank.d776.s3,been,17,20,O
DDI-DrugBank.d776.s3,reported,22,29,O
DDI-DrugBank.d776.s3,from,31,34,O
DDI-DrugBank.d776.s3,hypoglycemia,36,47,O
DDI-DrugBank.d776.s3,in,49,50,O
DDI-DrugBank.d776.s3,association,52,62,O
DDI-DrugBank.d776.s3,with,64,67,O
DDI-DrugBank.d776.s3,combined,69,76,O
DDI-DrugBank.d776.s3,DIFLUCAN,78,85,B-brand
DDI-DrugBank.d776.s3,and,87,89,O
DDI-DrugBank.d776.s3,glyburide,91,99,B-drug
DDI-DrugBank.d776.s3,use,101,103,O
DDI-DrugBank.d776.s3,.,104,104,O
DDI-DrugBank.d776.s4,DIFLUCAN,0,7,B-brand
DDI-DrugBank.d776.s4,reduces,9,15,O
DDI-DrugBank.d776.s4,the,17,19,O
DDI-DrugBank.d776.s4,metabolism,21,30,O
DDI-DrugBank.d776.s4,of,32,33,O
DDI-DrugBank.d776.s4,tolbutamide,35,45,B-drug
DDI-DrugBank.d776.s4,",",46,46,O
DDI-DrugBank.d776.s4,glyburide,48,56,B-drug
DDI-DrugBank.d776.s4,",",57,57,O
DDI-DrugBank.d776.s4,and,59,61,O
DDI-DrugBank.d776.s4,glipizide,63,71,B-drug
DDI-DrugBank.d776.s4,and,73,75,O
DDI-DrugBank.d776.s4,increases,77,85,O
DDI-DrugBank.d776.s4,the,87,89,O
DDI-DrugBank.d776.s4,plasma,91,96,O
DDI-DrugBank.d776.s4,concentration,98,110,O
DDI-DrugBank.d776.s4,of,112,113,O
DDI-DrugBank.d776.s4,these,115,119,O
DDI-DrugBank.d776.s4,agents,121,126,O
DDI-DrugBank.d776.s4,.,127,127,O
DDI-DrugBank.d776.s5,When,0,3,O
DDI-DrugBank.d776.s5,DIFLUCAN,5,12,B-brand
DDI-DrugBank.d776.s5,is,14,15,O
DDI-DrugBank.d776.s5,used,17,20,O
DDI-DrugBank.d776.s5,concomitantly,22,34,O
DDI-DrugBank.d776.s5,with,36,39,O
DDI-DrugBank.d776.s5,these,41,45,O
DDI-DrugBank.d776.s5,or,47,48,O
DDI-DrugBank.d776.s5,other,50,54,O
DDI-DrugBank.d776.s5,sulfonylurea,56,67,B-group
DDI-DrugBank.d776.s5,oral,69,72,I-group
DDI-DrugBank.d776.s5,hypoglycemic,74,85,I-group
DDI-DrugBank.d776.s5,agents,87,92,I-group
DDI-DrugBank.d776.s5,",",93,93,O
DDI-DrugBank.d776.s5,blood,95,99,O
DDI-DrugBank.d776.s5,glucose,101,107,O
DDI-DrugBank.d776.s5,concentrations,109,122,O
DDI-DrugBank.d776.s5,should,124,129,O
DDI-DrugBank.d776.s5,be,131,132,O
DDI-DrugBank.d776.s5,carefully,134,142,O
DDI-DrugBank.d776.s5,monitored,144,152,O
DDI-DrugBank.d776.s5,and,154,156,O
DDI-DrugBank.d776.s5,the,158,160,O
DDI-DrugBank.d776.s5,dose,162,165,O
DDI-DrugBank.d776.s5,of,167,168,O
DDI-DrugBank.d776.s5,the,170,172,O
DDI-DrugBank.d776.s5,sulfonylurea,174,185,B-group
DDI-DrugBank.d776.s5,should,187,192,O
DDI-DrugBank.d776.s5,be,194,195,O
DDI-DrugBank.d776.s5,adjusted,197,204,O
DDI-DrugBank.d776.s5,as,206,207,O
DDI-DrugBank.d776.s5,necessary,209,217,O
DDI-DrugBank.d776.s5,.,218,218,O
DDI-DrugBank.d776.s6,Coumarin-type,0,12,B-group
DDI-DrugBank.d776.s6,anticoagulants,14,27,I-group
DDI-DrugBank.d776.s6,:,28,28,O
DDI-DrugBank.d776.s6,Prothrombin,30,40,O
DDI-DrugBank.d776.s6,time,42,45,O
DDI-DrugBank.d776.s6,may,47,49,O
DDI-DrugBank.d776.s6,be,51,52,O
DDI-DrugBank.d776.s6,increased,54,62,O
DDI-DrugBank.d776.s6,in,64,65,O
DDI-DrugBank.d776.s6,patients,67,74,O
DDI-DrugBank.d776.s6,receiving,76,84,O
DDI-DrugBank.d776.s6,concomitant,86,96,O
DDI-DrugBank.d776.s6,DIFLUCAN,98,105,B-brand
DDI-DrugBank.d776.s6,and,107,109,O
DDI-DrugBank.d776.s6,coumarin-type,111,123,B-group
DDI-DrugBank.d776.s6,anticoagulants,125,138,I-group
DDI-DrugBank.d776.s6,.,139,139,O
DDI-DrugBank.d776.s7,In,0,1,O
DDI-DrugBank.d776.s7,post-marketing,3,16,O
DDI-DrugBank.d776.s7,experience,18,27,O
DDI-DrugBank.d776.s7,",",28,28,O
DDI-DrugBank.d776.s7,as,30,31,O
DDI-DrugBank.d776.s7,with,33,36,O
DDI-DrugBank.d776.s7,other,38,42,O
DDI-DrugBank.d776.s7,azole,44,48,B-group
DDI-DrugBank.d776.s7,antifungals,50,60,I-group
DDI-DrugBank.d776.s7,",",61,61,O
DDI-DrugBank.d776.s7,bleeding,63,70,O
DDI-DrugBank.d776.s7,events,72,77,O
DDI-DrugBank.d776.s7,(,79,79,O
DDI-DrugBank.d776.s7,bruising,80,87,O
DDI-DrugBank.d776.s7,",",88,88,O
DDI-DrugBank.d776.s7,epistaxis,90,98,O
DDI-DrugBank.d776.s7,",",99,99,O
DDI-DrugBank.d776.s7,gastrointestinal,101,116,O
DDI-DrugBank.d776.s7,bleeding,118,125,O
DDI-DrugBank.d776.s7,",",126,126,O
DDI-DrugBank.d776.s7,hematuria,128,136,O
DDI-DrugBank.d776.s7,",",137,137,O
DDI-DrugBank.d776.s7,and,139,141,O
DDI-DrugBank.d776.s7,melena,143,148,O
DDI-DrugBank.d776.s7,),149,149,O
DDI-DrugBank.d776.s7,have,151,154,O
DDI-DrugBank.d776.s7,been,156,159,O
DDI-DrugBank.d776.s7,reported,161,168,O
DDI-DrugBank.d776.s7,in,170,171,O
DDI-DrugBank.d776.s7,association,173,183,O
DDI-DrugBank.d776.s7,with,185,188,O
DDI-DrugBank.d776.s7,increases,190,198,O
DDI-DrugBank.d776.s7,in,200,201,O
DDI-DrugBank.d776.s7,prothrombin,203,213,O
DDI-DrugBank.d776.s7,time,215,218,O
DDI-DrugBank.d776.s7,in,220,221,O
DDI-DrugBank.d776.s7,patients,223,230,O
DDI-DrugBank.d776.s7,receiving,232,240,O
DDI-DrugBank.d776.s7,fluconazole,242,252,B-drug
DDI-DrugBank.d776.s7,concurrently,254,265,O
DDI-DrugBank.d776.s7,with,267,270,O
DDI-DrugBank.d776.s7,warfarin,272,279,B-drug
DDI-DrugBank.d776.s7,.,280,280,O
DDI-DrugBank.d776.s8,Careful,0,6,O
DDI-DrugBank.d776.s8,monitoring,8,17,O
DDI-DrugBank.d776.s8,of,19,20,O
DDI-DrugBank.d776.s8,prothrombin,22,32,O
DDI-DrugBank.d776.s8,time,34,37,O
DDI-DrugBank.d776.s8,in,39,40,O
DDI-DrugBank.d776.s8,patients,42,49,O
DDI-DrugBank.d776.s8,receiving,51,59,O
DDI-DrugBank.d776.s8,DIFLUCAN,61,68,B-brand
DDI-DrugBank.d776.s8,and,70,72,O
DDI-DrugBank.d776.s8,coumarin-type,74,86,B-group
DDI-DrugBank.d776.s8,anticoagulants,88,101,I-group
DDI-DrugBank.d776.s8,is,103,104,O
DDI-DrugBank.d776.s8,recommended,106,116,O
DDI-DrugBank.d776.s8,.,117,117,O
DDI-DrugBank.d776.s9,(,0,0,O
DDI-DrugBank.d776.s9,See,1,3,O
DDI-DrugBank.d776.s9,<,5,5,O
DDI-DrugBank.d776.s9,a,6,6,O
DDI-DrugBank.d776.s9,href=,8,12,O
DDI-DrugBank.d776.s9,``,-1,0,O
DDI-DrugBank.d776.s9,flucon_cp.htm,15,27,O
DDI-DrugBank.d776.s9,#,28,28,O
DDI-DrugBank.d776.s9,CP,29,30,O
DDI-DrugBank.d776.s9,'',-1,0,O
DDI-DrugBank.d776.s9,>,32,32,O
DDI-DrugBank.d776.s9,CLINICAL,33,40,O
DDI-DrugBank.d776.s9,PHARMACOLOGY,42,53,O
DDI-DrugBank.d776.s9,:,54,54,O
DDI-DrugBank.d776.s9,Drug,56,59,O
DDI-DrugBank.d776.s9,Interaction,61,71,O
DDI-DrugBank.d776.s9,Studies,73,79,O
DDI-DrugBank.d776.s9,.,80,80,O
DDI-DrugBank.d776.s9,),81,81,O
DDI-DrugBank.d776.s10,Phenytoin,0,8,B-drug
DDI-DrugBank.d776.s10,:,9,9,O
DDI-DrugBank.d776.s10,DIFLUCAN,11,18,B-brand
DDI-DrugBank.d776.s10,increases,20,28,O
DDI-DrugBank.d776.s10,the,30,32,O
DDI-DrugBank.d776.s10,plasma,34,39,O
DDI-DrugBank.d776.s10,concentrations,41,54,O
DDI-DrugBank.d776.s10,of,56,57,O
DDI-DrugBank.d776.s10,phenytoin,59,67,B-drug
DDI-DrugBank.d776.s10,.,68,68,O
DDI-DrugBank.d776.s11,Careful,0,6,O
DDI-DrugBank.d776.s11,monitoring,8,17,O
DDI-DrugBank.d776.s11,of,19,20,O
DDI-DrugBank.d776.s11,phenytoin,22,30,B-drug
DDI-DrugBank.d776.s11,concentrations,32,45,O
DDI-DrugBank.d776.s11,in,47,48,O
DDI-DrugBank.d776.s11,patients,50,57,O
DDI-DrugBank.d776.s11,receiving,59,67,O
DDI-DrugBank.d776.s11,DIFLUCAN,69,76,B-brand
DDI-DrugBank.d776.s11,and,78,80,O
DDI-DrugBank.d776.s11,phenytoin,82,90,B-drug
DDI-DrugBank.d776.s11,is,92,93,O
DDI-DrugBank.d776.s11,recommended,95,105,O
DDI-DrugBank.d776.s11,.,106,106,O
DDI-DrugBank.d776.s12,(,0,0,O
DDI-DrugBank.d776.s12,See,1,3,O
DDI-DrugBank.d776.s12,<,5,5,O
DDI-DrugBank.d776.s12,a,6,6,O
DDI-DrugBank.d776.s12,href=,8,12,O
DDI-DrugBank.d776.s12,``,-1,0,O
DDI-DrugBank.d776.s12,flucon_cp.htm,15,27,O
DDI-DrugBank.d776.s12,#,28,28,O
DDI-DrugBank.d776.s12,CP,29,30,O
DDI-DrugBank.d776.s12,'',-1,0,O
DDI-DrugBank.d776.s12,>,32,32,O
DDI-DrugBank.d776.s12,CLINICAL,33,40,O
DDI-DrugBank.d776.s12,PHARMACOLOGY,42,53,O
DDI-DrugBank.d776.s12,:,54,54,O
DDI-DrugBank.d776.s12,Drug,56,59,O
DDI-DrugBank.d776.s12,Interaction,61,71,O
DDI-DrugBank.d776.s12,Studies,73,79,O
DDI-DrugBank.d776.s12,.,80,80,O
DDI-DrugBank.d776.s12,),81,81,O
DDI-DrugBank.d776.s13,Cyclosporine,0,11,B-drug
DDI-DrugBank.d776.s13,:,12,12,O
DDI-DrugBank.d776.s13,DIFLUCAN,14,21,B-brand
DDI-DrugBank.d776.s13,may,23,25,O
DDI-DrugBank.d776.s13,significantly,27,39,O
DDI-DrugBank.d776.s13,increase,41,48,O
DDI-DrugBank.d776.s13,cyclosporine,50,61,B-drug
DDI-DrugBank.d776.s13,levels,63,68,O
DDI-DrugBank.d776.s13,in,70,71,O
DDI-DrugBank.d776.s13,renal,73,77,O
DDI-DrugBank.d776.s13,transplant,79,88,O
DDI-DrugBank.d776.s13,patients,90,97,O
DDI-DrugBank.d776.s13,with,99,102,O
DDI-DrugBank.d776.s13,or,104,105,O
DDI-DrugBank.d776.s13,without,107,113,O
DDI-DrugBank.d776.s13,renal,115,119,O
DDI-DrugBank.d776.s13,impairment,121,130,O
DDI-DrugBank.d776.s13,.,131,131,O
DDI-DrugBank.d776.s14,Careful,0,6,O
DDI-DrugBank.d776.s14,monitoring,8,17,O
DDI-DrugBank.d776.s14,of,19,20,O
DDI-DrugBank.d776.s14,cyclosporine,22,33,B-drug
DDI-DrugBank.d776.s14,concentrations,35,48,O
DDI-DrugBank.d776.s14,and,50,52,O
DDI-DrugBank.d776.s14,serum,54,58,O
DDI-DrugBank.d776.s14,creatinine,60,69,O
DDI-DrugBank.d776.s14,is,71,72,O
DDI-DrugBank.d776.s14,recommended,74,84,O
DDI-DrugBank.d776.s14,in,86,87,O
DDI-DrugBank.d776.s14,patients,89,96,O
DDI-DrugBank.d776.s14,receiving,98,106,O
DDI-DrugBank.d776.s14,DIFLUCAN,108,115,B-brand
DDI-DrugBank.d776.s14,and,117,119,O
DDI-DrugBank.d776.s14,cyclosporine,121,132,B-drug
DDI-DrugBank.d776.s14,.,133,133,O
DDI-DrugBank.d776.s15,(,0,0,O
DDI-DrugBank.d776.s15,See,1,3,O
DDI-DrugBank.d776.s15,CLINICAL,5,12,O
DDI-DrugBank.d776.s15,PHARMACOLOGY,14,25,O
DDI-DrugBank.d776.s15,:,26,26,O
DDI-DrugBank.d776.s15,Drug,28,31,O
DDI-DrugBank.d776.s15,Interaction,33,43,O
DDI-DrugBank.d776.s15,Studies,45,51,O
DDI-DrugBank.d776.s15,.,52,52,O
DDI-DrugBank.d776.s15,),53,53,O
DDI-DrugBank.d776.s16,Rifampin,0,7,B-drug
DDI-DrugBank.d776.s16,:,8,8,O
DDI-DrugBank.d776.s16,Rifampin,10,17,B-drug
DDI-DrugBank.d776.s16,enhances,19,26,O
DDI-DrugBank.d776.s16,the,28,30,O
DDI-DrugBank.d776.s16,metabolism,32,41,O
DDI-DrugBank.d776.s16,of,43,44,O
DDI-DrugBank.d776.s16,concurrently,46,57,O
DDI-DrugBank.d776.s16,administered,59,70,O
DDI-DrugBank.d776.s16,DIFLUCAN,72,79,B-brand
DDI-DrugBank.d776.s16,.,80,80,O
DDI-DrugBank.d776.s17,Depending,0,8,O
DDI-DrugBank.d776.s17,on,10,11,O
DDI-DrugBank.d776.s17,clinical,13,20,O
DDI-DrugBank.d776.s17,circumstances,22,34,O
DDI-DrugBank.d776.s17,",",35,35,O
DDI-DrugBank.d776.s17,consideration,37,49,O
DDI-DrugBank.d776.s17,should,51,56,O
DDI-DrugBank.d776.s17,be,58,59,O
DDI-DrugBank.d776.s17,given,61,65,O
DDI-DrugBank.d776.s17,to,67,68,O
DDI-DrugBank.d776.s17,increasing,70,79,O
DDI-DrugBank.d776.s17,the,81,83,O
DDI-DrugBank.d776.s17,dose,85,88,O
DDI-DrugBank.d776.s17,of,90,91,O
DDI-DrugBank.d776.s17,DIFLUCAN,93,100,B-brand
DDI-DrugBank.d776.s17,when,102,105,O
DDI-DrugBank.d776.s17,it,107,108,O
DDI-DrugBank.d776.s17,is,110,111,O
DDI-DrugBank.d776.s17,administered,113,124,O
DDI-DrugBank.d776.s17,with,126,129,O
DDI-DrugBank.d776.s17,rifampin,131,138,B-drug
DDI-DrugBank.d776.s17,.,139,139,O
DDI-DrugBank.d776.s18,Theophylline,0,11,B-drug
DDI-DrugBank.d776.s18,:,12,12,O
DDI-DrugBank.d776.s18,DIFLUCAN,14,21,B-brand
DDI-DrugBank.d776.s18,increases,23,31,O
DDI-DrugBank.d776.s18,the,33,35,O
DDI-DrugBank.d776.s18,serum,37,41,O
DDI-DrugBank.d776.s18,concentrations,43,56,O
DDI-DrugBank.d776.s18,of,58,59,O
DDI-DrugBank.d776.s18,theophylline,61,72,B-drug
DDI-DrugBank.d776.s18,.,73,73,O
DDI-DrugBank.d776.s19,Careful,0,6,O
DDI-DrugBank.d776.s19,monitoring,8,17,O
DDI-DrugBank.d776.s19,of,19,20,O
DDI-DrugBank.d776.s19,serum,22,26,O
DDI-DrugBank.d776.s19,theophylline,28,39,B-drug
DDI-DrugBank.d776.s19,concentrations,41,54,O
DDI-DrugBank.d776.s19,in,56,57,O
DDI-DrugBank.d776.s19,patients,59,66,O
DDI-DrugBank.d776.s19,receiving,68,76,O
DDI-DrugBank.d776.s19,DIFLUCAN,78,85,B-brand
DDI-DrugBank.d776.s19,and,87,89,O
DDI-DrugBank.d776.s19,theophylline,91,102,B-drug
DDI-DrugBank.d776.s19,is,104,105,O
DDI-DrugBank.d776.s19,recommended,107,117,O
DDI-DrugBank.d776.s19,.,118,118,O
DDI-DrugBank.d776.s20,Terfenadine,0,10,B-drug
DDI-DrugBank.d776.s20,:,11,11,O
DDI-DrugBank.d776.s20,Because,13,19,O
DDI-DrugBank.d776.s20,of,21,22,O
DDI-DrugBank.d776.s20,the,24,26,O
DDI-DrugBank.d776.s20,occurrence,28,37,O
DDI-DrugBank.d776.s20,of,39,40,O
DDI-DrugBank.d776.s20,serious,42,48,O
DDI-DrugBank.d776.s20,cardiac,50,56,O
DDI-DrugBank.d776.s20,dysrhythmias,58,69,O
DDI-DrugBank.d776.s20,secondary,71,79,O
DDI-DrugBank.d776.s20,to,81,82,O
DDI-DrugBank.d776.s20,prolongation,84,95,O
DDI-DrugBank.d776.s20,of,97,98,O
DDI-DrugBank.d776.s20,the,100,102,O
DDI-DrugBank.d776.s20,QTc,104,106,O
DDI-DrugBank.d776.s20,interval,108,115,O
DDI-DrugBank.d776.s20,in,117,118,O
DDI-DrugBank.d776.s20,patients,120,127,O
DDI-DrugBank.d776.s20,receiving,129,137,O
DDI-DrugBank.d776.s20,azole,139,143,B-group
DDI-DrugBank.d776.s20,antifungals,145,155,I-group
DDI-DrugBank.d776.s20,in,157,158,O
DDI-DrugBank.d776.s20,conjunction,160,170,O
DDI-DrugBank.d776.s20,with,172,175,O
DDI-DrugBank.d776.s20,terfenadine,177,187,B-drug
DDI-DrugBank.d776.s20,",",188,188,O
DDI-DrugBank.d776.s20,interaction,190,200,O
DDI-DrugBank.d776.s20,studies,202,208,O
DDI-DrugBank.d776.s20,have,210,213,O
DDI-DrugBank.d776.s20,been,215,218,O
DDI-DrugBank.d776.s20,performed,220,228,O
DDI-DrugBank.d776.s20,.,229,229,O
DDI-DrugBank.d776.s21,One,0,2,O
DDI-DrugBank.d776.s21,study,4,8,O
DDI-DrugBank.d776.s21,at,10,11,O
DDI-DrugBank.d776.s21,a,13,13,O
DDI-DrugBank.d776.s21,200-mg,15,20,O
DDI-DrugBank.d776.s21,daily,22,26,O
DDI-DrugBank.d776.s21,dose,28,31,O
DDI-DrugBank.d776.s21,of,33,34,O
DDI-DrugBank.d776.s21,fluconazole,36,46,B-drug
DDI-DrugBank.d776.s21,failed,48,53,O
DDI-DrugBank.d776.s21,to,55,56,O
DDI-DrugBank.d776.s21,demonstrate,58,68,O
DDI-DrugBank.d776.s21,a,70,70,O
DDI-DrugBank.d776.s21,prolongation,72,83,O
DDI-DrugBank.d776.s21,in,85,86,O
DDI-DrugBank.d776.s21,QTc,88,90,O
DDI-DrugBank.d776.s21,interval,92,99,O
DDI-DrugBank.d776.s21,.,100,100,O
DDI-DrugBank.d776.s22,Another,0,6,O
DDI-DrugBank.d776.s22,study,8,12,O
DDI-DrugBank.d776.s22,at,14,15,O
DDI-DrugBank.d776.s22,a,17,17,O
DDI-DrugBank.d776.s22,400-mg,19,24,O
DDI-DrugBank.d776.s22,and,26,28,O
DDI-DrugBank.d776.s22,800-mg,30,35,O
DDI-DrugBank.d776.s22,daily,37,41,O
DDI-DrugBank.d776.s22,dose,43,46,O
DDI-DrugBank.d776.s22,of,48,49,O
DDI-DrugBank.d776.s22,fluconazole,51,61,B-drug
DDI-DrugBank.d776.s22,demonstrated,63,74,O
DDI-DrugBank.d776.s22,that,76,79,O
DDI-DrugBank.d776.s22,DIFLUCAN,81,88,B-brand
DDI-DrugBank.d776.s22,taken,90,94,O
DDI-DrugBank.d776.s22,in,96,97,O
DDI-DrugBank.d776.s22,doses,99,103,O
DDI-DrugBank.d776.s22,of,105,106,O
DDI-DrugBank.d776.s22,400,108,110,O
DDI-DrugBank.d776.s22,mg,112,113,O
DDI-DrugBank.d776.s22,per,115,117,O
DDI-DrugBank.d776.s22,day,119,121,O
DDI-DrugBank.d776.s22,or,123,124,O
DDI-DrugBank.d776.s22,greater,126,132,O
DDI-DrugBank.d776.s22,significantly,134,146,O
DDI-DrugBank.d776.s22,increases,148,156,O
DDI-DrugBank.d776.s22,plasma,158,163,O
DDI-DrugBank.d776.s22,levels,165,170,O
DDI-DrugBank.d776.s22,of,172,173,O
DDI-DrugBank.d776.s22,terfenadine,175,185,B-drug
DDI-DrugBank.d776.s22,when,187,190,O
DDI-DrugBank.d776.s22,taken,192,196,O
DDI-DrugBank.d776.s22,concomitantly,198,210,O
DDI-DrugBank.d776.s22,.,211,211,O
DDI-DrugBank.d776.s23,The,0,2,O
DDI-DrugBank.d776.s23,combined,4,11,O
DDI-DrugBank.d776.s23,use,13,15,O
DDI-DrugBank.d776.s23,of,17,18,O
DDI-DrugBank.d776.s23,fluconazole,20,30,B-drug
DDI-DrugBank.d776.s23,at,32,33,O
DDI-DrugBank.d776.s23,doses,35,39,O
DDI-DrugBank.d776.s23,of,41,42,O
DDI-DrugBank.d776.s23,400,44,46,O
DDI-DrugBank.d776.s23,mg,48,49,O
DDI-DrugBank.d776.s23,or,51,52,O
DDI-DrugBank.d776.s23,greater,54,60,O
DDI-DrugBank.d776.s23,with,62,65,O
DDI-DrugBank.d776.s23,terfenadine,67,77,B-drug
DDI-DrugBank.d776.s23,is,79,80,O
DDI-DrugBank.d776.s23,contraindicated,82,96,O
DDI-DrugBank.d776.s23,.,97,97,O
DDI-DrugBank.d776.s24,The,0,2,O
DDI-DrugBank.d776.s24,coadministration,4,19,O
DDI-DrugBank.d776.s24,of,21,22,O
DDI-DrugBank.d776.s24,fluconazole,24,34,B-drug
DDI-DrugBank.d776.s24,at,36,37,O
DDI-DrugBank.d776.s24,doses,39,43,O
DDI-DrugBank.d776.s24,lower,45,49,O
DDI-DrugBank.d776.s24,than,51,54,O
DDI-DrugBank.d776.s24,400,56,58,O
DDI-DrugBank.d776.s24,mg/day,60,65,O
DDI-DrugBank.d776.s24,with,67,70,O
DDI-DrugBank.d776.s24,terfenadine,72,82,B-drug
DDI-DrugBank.d776.s24,should,84,89,O
DDI-DrugBank.d776.s24,be,91,92,O
DDI-DrugBank.d776.s24,carefully,94,102,O
DDI-DrugBank.d776.s24,monitored,104,112,O
DDI-DrugBank.d776.s24,.,113,113,O
DDI-DrugBank.d776.s25,Cisapride,0,8,B-drug
DDI-DrugBank.d776.s25,:,9,9,O
DDI-DrugBank.d776.s25,There,11,15,O
DDI-DrugBank.d776.s25,have,17,20,O
DDI-DrugBank.d776.s25,been,22,25,O
DDI-DrugBank.d776.s25,reports,27,33,O
DDI-DrugBank.d776.s25,of,35,36,O
DDI-DrugBank.d776.s25,cardiac,38,44,O
DDI-DrugBank.d776.s25,events,46,51,O
DDI-DrugBank.d776.s25,",",52,52,O
DDI-DrugBank.d776.s25,including,54,62,O
DDI-DrugBank.d776.s25,torsade,64,70,O
DDI-DrugBank.d776.s25,de,72,73,O
DDI-DrugBank.d776.s25,pointes,75,81,O
DDI-DrugBank.d776.s25,in,83,84,O
DDI-DrugBank.d776.s25,patients,86,93,O
DDI-DrugBank.d776.s25,to,95,96,O
DDI-DrugBank.d776.s25,whom,98,101,O
DDI-DrugBank.d776.s25,fluconazole,103,113,B-drug
DDI-DrugBank.d776.s25,and,115,117,O
DDI-DrugBank.d776.s25,cisapride,119,127,B-drug
DDI-DrugBank.d776.s25,were,129,132,O
DDI-DrugBank.d776.s25,coadministered,134,147,O
DDI-DrugBank.d776.s25,.,148,148,O
DDI-DrugBank.d776.s26,A,0,0,O
DDI-DrugBank.d776.s26,controlled,2,11,O
DDI-DrugBank.d776.s26,study,13,17,O
DDI-DrugBank.d776.s26,found,19,23,O
DDI-DrugBank.d776.s26,that,25,28,O
DDI-DrugBank.d776.s26,concomitant,30,40,O
DDI-DrugBank.d776.s26,fluconazole,42,52,B-drug
DDI-DrugBank.d776.s26,200,54,56,O
DDI-DrugBank.d776.s26,mg,58,59,O
DDI-DrugBank.d776.s26,once,61,64,O
DDI-DrugBank.d776.s26,daily,66,70,O
DDI-DrugBank.d776.s26,and,72,74,O
DDI-DrugBank.d776.s26,cisapride,76,84,B-drug
DDI-DrugBank.d776.s26,20,86,87,O
DDI-DrugBank.d776.s26,mg,89,90,O
DDI-DrugBank.d776.s26,four,92,95,O
DDI-DrugBank.d776.s26,times,97,101,O
DDI-DrugBank.d776.s26,a,103,103,O
DDI-DrugBank.d776.s26,day,105,107,O
DDI-DrugBank.d776.s26,yielded,109,115,O
DDI-DrugBank.d776.s26,a,117,117,O
DDI-DrugBank.d776.s26,significant,119,129,O
DDI-DrugBank.d776.s26,increase,131,138,O
DDI-DrugBank.d776.s26,in,140,141,O
DDI-DrugBank.d776.s26,cisapride,143,151,B-drug
DDI-DrugBank.d776.s26,plasma,153,158,O
DDI-DrugBank.d776.s26,levels,160,165,O
DDI-DrugBank.d776.s26,and,167,169,O
DDI-DrugBank.d776.s26,prolongation,171,182,O
DDI-DrugBank.d776.s26,of,184,185,O
DDI-DrugBank.d776.s26,QTc,187,189,O
DDI-DrugBank.d776.s26,interval,191,198,O
DDI-DrugBank.d776.s26,.,199,199,O
DDI-DrugBank.d776.s27,The,0,2,O
DDI-DrugBank.d776.s27,combined,4,11,O
DDI-DrugBank.d776.s27,use,13,15,O
DDI-DrugBank.d776.s27,of,17,18,O
DDI-DrugBank.d776.s27,fluconazole,20,30,B-drug
DDI-DrugBank.d776.s27,with,32,35,O
DDI-DrugBank.d776.s27,cisapride,37,45,B-drug
DDI-DrugBank.d776.s27,is,47,48,O
DDI-DrugBank.d776.s27,contraindicated,50,64,O
DDI-DrugBank.d776.s27,.,65,65,O
DDI-DrugBank.d776.s28,Astemizole,0,9,B-drug
DDI-DrugBank.d776.s28,:,10,10,O
DDI-DrugBank.d776.s28,The,12,14,O
DDI-DrugBank.d776.s28,use,16,18,O
DDI-DrugBank.d776.s28,of,20,21,O
DDI-DrugBank.d776.s28,fluconazole,23,33,B-drug
DDI-DrugBank.d776.s28,in,35,36,O
DDI-DrugBank.d776.s28,patients,38,45,O
DDI-DrugBank.d776.s28,concurrently,47,58,O
DDI-DrugBank.d776.s28,taking,60,65,O
DDI-DrugBank.d776.s28,astemizole,67,76,B-drug
DDI-DrugBank.d776.s28,or,78,79,O
DDI-DrugBank.d776.s28,other,81,85,O
DDI-DrugBank.d776.s28,drugs,87,91,O
DDI-DrugBank.d776.s28,metabolized,93,103,O
DDI-DrugBank.d776.s28,by,105,106,O
DDI-DrugBank.d776.s28,the,108,110,O
DDI-DrugBank.d776.s28,cytochrome,112,121,O
DDI-DrugBank.d776.s28,P450,123,126,O
DDI-DrugBank.d776.s28,system,128,133,O
DDI-DrugBank.d776.s28,may,135,137,O
DDI-DrugBank.d776.s28,be,139,140,O
DDI-DrugBank.d776.s28,associated,142,151,O
DDI-DrugBank.d776.s28,with,153,156,O
DDI-DrugBank.d776.s28,elevations,158,167,O
DDI-DrugBank.d776.s28,in,169,170,O
DDI-DrugBank.d776.s28,serum,172,176,O
DDI-DrugBank.d776.s28,levels,178,183,O
DDI-DrugBank.d776.s28,of,185,186,O
DDI-DrugBank.d776.s28,these,188,192,O
DDI-DrugBank.d776.s28,drugs,194,198,O
DDI-DrugBank.d776.s28,.,199,199,O
DDI-DrugBank.d776.s29,In,0,1,O
DDI-DrugBank.d776.s29,the,3,5,O
DDI-DrugBank.d776.s29,absence,7,13,O
DDI-DrugBank.d776.s29,of,15,16,O
DDI-DrugBank.d776.s29,definitive,18,27,O
DDI-DrugBank.d776.s29,information,29,39,O
DDI-DrugBank.d776.s29,",",40,40,O
DDI-DrugBank.d776.s29,caution,42,48,O
DDI-DrugBank.d776.s29,should,50,55,O
DDI-DrugBank.d776.s29,be,57,58,O
DDI-DrugBank.d776.s29,used,60,63,O
DDI-DrugBank.d776.s29,when,65,68,O
DDI-DrugBank.d776.s29,coadministering,70,84,O
DDI-DrugBank.d776.s29,fluconazole,86,96,B-drug
DDI-DrugBank.d776.s29,.,97,97,O
DDI-DrugBank.d776.s30,Patients,0,7,O
DDI-DrugBank.d776.s30,should,9,14,O
DDI-DrugBank.d776.s30,be,16,17,O
DDI-DrugBank.d776.s30,carefully,19,27,O
DDI-DrugBank.d776.s30,monitored,29,37,O
DDI-DrugBank.d776.s30,.,38,38,O
DDI-DrugBank.d776.s31,Rifabutin,0,8,B-drug
DDI-DrugBank.d776.s31,:,9,9,O
DDI-DrugBank.d776.s31,There,11,15,O
DDI-DrugBank.d776.s31,have,17,20,O
DDI-DrugBank.d776.s31,been,22,25,O
DDI-DrugBank.d776.s31,reports,27,33,O
DDI-DrugBank.d776.s31,of,35,36,O
DDI-DrugBank.d776.s31,uveitis,38,44,O
DDI-DrugBank.d776.s31,in,46,47,O
DDI-DrugBank.d776.s31,patients,49,56,O
DDI-DrugBank.d776.s31,to,58,59,O
DDI-DrugBank.d776.s31,whom,61,64,O
DDI-DrugBank.d776.s31,fluconazole,66,76,B-drug
DDI-DrugBank.d776.s31,and,78,80,O
DDI-DrugBank.d776.s31,rifabutin,82,90,B-drug
DDI-DrugBank.d776.s31,were,92,95,O
DDI-DrugBank.d776.s31,coadministered,97,110,O
DDI-DrugBank.d776.s31,.,111,111,O
DDI-DrugBank.d776.s32,Patients,0,7,O
DDI-DrugBank.d776.s32,receiving,9,17,O
DDI-DrugBank.d776.s32,rifabutin,19,27,B-drug
DDI-DrugBank.d776.s32,and,29,31,O
DDI-DrugBank.d776.s32,fluconazole,33,43,B-drug
DDI-DrugBank.d776.s32,concomitantly,45,57,O
DDI-DrugBank.d776.s32,should,59,64,O
DDI-DrugBank.d776.s32,be,66,67,O
DDI-DrugBank.d776.s32,carefully,69,77,O
DDI-DrugBank.d776.s32,monitored,79,87,O
DDI-DrugBank.d776.s32,.,88,88,O
DDI-DrugBank.d776.s33,Tacrolimus,0,9,B-drug
DDI-DrugBank.d776.s33,:,10,10,O
DDI-DrugBank.d776.s33,There,12,16,O
DDI-DrugBank.d776.s33,have,18,21,O
DDI-DrugBank.d776.s33,been,23,26,O
DDI-DrugBank.d776.s33,reports,28,34,O
DDI-DrugBank.d776.s33,of,36,37,O
DDI-DrugBank.d776.s33,nephrotoxicity,39,52,O
DDI-DrugBank.d776.s33,in,54,55,O
DDI-DrugBank.d776.s33,patients,57,64,O
DDI-DrugBank.d776.s33,to,66,67,O
DDI-DrugBank.d776.s33,whom,69,72,O
DDI-DrugBank.d776.s33,fluconazole,74,84,B-drug
DDI-DrugBank.d776.s33,and,86,88,O
DDI-DrugBank.d776.s33,tacrolimus,90,99,B-drug
DDI-DrugBank.d776.s33,were,101,104,O
DDI-DrugBank.d776.s33,coadministered,106,119,O
DDI-DrugBank.d776.s33,.,120,120,O
DDI-DrugBank.d776.s34,Patients,0,7,O
DDI-DrugBank.d776.s34,receiving,9,17,O
DDI-DrugBank.d776.s34,tacrolimus,19,28,B-drug
DDI-DrugBank.d776.s34,and,30,32,O
DDI-DrugBank.d776.s34,fluconazole,34,44,B-drug
DDI-DrugBank.d776.s34,concomitantly,46,58,O
DDI-DrugBank.d776.s34,should,60,65,O
DDI-DrugBank.d776.s34,be,67,68,O
DDI-DrugBank.d776.s34,carefully,70,78,O
DDI-DrugBank.d776.s34,monitored,80,88,O
DDI-DrugBank.d776.s34,.,89,89,O
DDI-DrugBank.d776.s35,Short-acting,0,11,B-group
DDI-DrugBank.d776.s35,Benzodiazepines,13,27,I-group
DDI-DrugBank.d776.s35,:,28,28,O
DDI-DrugBank.d776.s35,Following,30,38,O
DDI-DrugBank.d776.s35,oral,40,43,O
DDI-DrugBank.d776.s35,administration,45,58,O
DDI-DrugBank.d776.s35,of,60,61,O
DDI-DrugBank.d776.s35,midazolam,63,71,B-drug
DDI-DrugBank.d776.s35,",",72,72,O
DDI-DrugBank.d776.s35,fluconazole,74,84,B-drug
DDI-DrugBank.d776.s35,resulted,86,93,O
DDI-DrugBank.d776.s35,in,95,96,O
DDI-DrugBank.d776.s35,substantial,98,108,O
DDI-DrugBank.d776.s35,increases,110,118,O
DDI-DrugBank.d776.s35,in,120,121,O
DDI-DrugBank.d776.s35,midazolam,123,131,B-drug
DDI-DrugBank.d776.s35,concentrations,133,146,O
DDI-DrugBank.d776.s35,and,148,150,O
DDI-DrugBank.d776.s35,psychomotor,152,162,O
DDI-DrugBank.d776.s35,effects,164,170,O
DDI-DrugBank.d776.s35,.,171,171,O
DDI-DrugBank.d776.s36,This,0,3,O
DDI-DrugBank.d776.s36,effect,5,10,O
DDI-DrugBank.d776.s36,on,12,13,O
DDI-DrugBank.d776.s36,midazolam,15,23,B-drug
DDI-DrugBank.d776.s36,appears,25,31,O
DDI-DrugBank.d776.s36,to,33,34,O
DDI-DrugBank.d776.s36,be,36,37,O
DDI-DrugBank.d776.s36,more,39,42,O
DDI-DrugBank.d776.s36,pronounced,44,53,O
DDI-DrugBank.d776.s36,following,55,63,O
DDI-DrugBank.d776.s36,oral,65,68,O
DDI-DrugBank.d776.s36,administration,70,83,O
DDI-DrugBank.d776.s36,of,85,86,O
DDI-DrugBank.d776.s36,fluconazole,88,98,B-drug
DDI-DrugBank.d776.s36,than,100,103,O
DDI-DrugBank.d776.s36,with,105,108,O
DDI-DrugBank.d776.s36,fluconazole,110,120,B-drug
DDI-DrugBank.d776.s36,administered,122,133,O
DDI-DrugBank.d776.s36,intravenously,135,147,O
DDI-DrugBank.d776.s36,.,148,148,O
DDI-DrugBank.d776.s37,If,0,1,O
DDI-DrugBank.d776.s37,short-acting,3,14,B-group
DDI-DrugBank.d776.s37,benzodiazepines,16,30,I-group
DDI-DrugBank.d776.s37,",",31,31,O
DDI-DrugBank.d776.s37,which,33,37,O
DDI-DrugBank.d776.s37,are,39,41,O
DDI-DrugBank.d776.s37,metabolized,43,53,O
DDI-DrugBank.d776.s37,by,55,56,O
DDI-DrugBank.d776.s37,the,58,60,O
DDI-DrugBank.d776.s37,cytochrome,62,71,O
DDI-DrugBank.d776.s37,P450,73,76,O
DDI-DrugBank.d776.s37,system,78,83,O
DDI-DrugBank.d776.s37,",",84,84,O
DDI-DrugBank.d776.s37,are,86,88,O
DDI-DrugBank.d776.s37,concomitantly,90,102,O
DDI-DrugBank.d776.s37,administered,104,115,O
DDI-DrugBank.d776.s37,with,117,120,O
DDI-DrugBank.d776.s37,fluconazole,122,132,B-drug
DDI-DrugBank.d776.s37,",",133,133,O
DDI-DrugBank.d776.s37,consideration,135,147,O
DDI-DrugBank.d776.s37,should,149,154,O
DDI-DrugBank.d776.s37,be,156,157,O
DDI-DrugBank.d776.s37,given,159,163,O
DDI-DrugBank.d776.s37,to,165,166,O
DDI-DrugBank.d776.s37,decreasing,168,177,O
DDI-DrugBank.d776.s37,the,179,181,O
DDI-DrugBank.d776.s37,benzodiazepine,183,196,B-group
DDI-DrugBank.d776.s37,dosage,198,203,O
DDI-DrugBank.d776.s37,",",204,204,O
DDI-DrugBank.d776.s37,and,206,208,O
DDI-DrugBank.d776.s37,the,210,212,O
DDI-DrugBank.d776.s37,patients,214,221,O
DDI-DrugBank.d776.s37,should,223,228,O
DDI-DrugBank.d776.s37,be,230,231,O
DDI-DrugBank.d776.s37,appropriately,233,245,O
DDI-DrugBank.d776.s37,monitored,247,255,O
DDI-DrugBank.d776.s37,.,256,256,O
DDI-DrugBank.d776.s38,Fluconazole,0,10,B-drug
DDI-DrugBank.d776.s38,tablets,12,18,O
DDI-DrugBank.d776.s38,coadministered,20,33,O
DDI-DrugBank.d776.s38,with,35,38,O
DDI-DrugBank.d776.s38,ethinyl,40,46,B-drug
DDI-DrugBank.d776.s38,estradiol-,48,57,O
DDI-DrugBank.d776.s38,and,59,61,O
DDI-DrugBank.d776.s38,levonorgestrel-containing,63,87,O
DDI-DrugBank.d776.s38,oral,89,92,O
DDI-DrugBank.d776.s38,contraceptives,94,107,B-group
DDI-DrugBank.d776.s38,produced,109,116,O
DDI-DrugBank.d776.s38,an,118,119,O
DDI-DrugBank.d776.s38,overall,121,127,O
DDI-DrugBank.d776.s38,mean,129,132,O
DDI-DrugBank.d776.s38,increase,134,141,O
DDI-DrugBank.d776.s38,in,143,144,O
DDI-DrugBank.d776.s38,ethinyl,146,152,B-drug
DDI-DrugBank.d776.s38,estradiol,154,162,I-drug
DDI-DrugBank.d776.s38,and,164,166,O
DDI-DrugBank.d776.s38,levonorgestrel,168,181,B-drug
DDI-DrugBank.d776.s38,levels,183,188,O
DDI-DrugBank.d776.s38,;,189,189,O
DDI-DrugBank.d776.s39,however,0,6,O
DDI-DrugBank.d776.s39,",",7,7,O
DDI-DrugBank.d776.s39,in,9,10,O
DDI-DrugBank.d776.s39,some,12,15,O
DDI-DrugBank.d776.s39,patients,17,24,O
DDI-DrugBank.d776.s39,there,26,30,O
DDI-DrugBank.d776.s39,were,32,35,O
DDI-DrugBank.d776.s39,decreases,37,45,O
DDI-DrugBank.d776.s39,up,47,48,O
DDI-DrugBank.d776.s39,to,50,51,O
DDI-DrugBank.d776.s39,47,53,54,O
DDI-DrugBank.d776.s39,%,55,55,O
DDI-DrugBank.d776.s39,and,57,59,O
DDI-DrugBank.d776.s39,33,61,62,O
DDI-DrugBank.d776.s39,%,63,63,O
DDI-DrugBank.d776.s39,of,65,66,O
DDI-DrugBank.d776.s39,ethinyl,68,74,B-drug
DDI-DrugBank.d776.s39,estradiol,76,84,I-drug
DDI-DrugBank.d776.s39,and,86,88,O
DDI-DrugBank.d776.s39,levonorgestrel,90,103,B-drug
DDI-DrugBank.d776.s39,levels,105,110,O
DDI-DrugBank.d776.s39,.,111,111,O
DDI-DrugBank.d776.s40,The,0,2,O
DDI-DrugBank.d776.s40,data,4,7,O
DDI-DrugBank.d776.s40,presently,9,17,O
DDI-DrugBank.d776.s40,available,19,27,O
DDI-DrugBank.d776.s40,indicate,29,36,O
DDI-DrugBank.d776.s40,that,38,41,O
DDI-DrugBank.d776.s40,the,43,45,O
DDI-DrugBank.d776.s40,decreases,47,55,O
DDI-DrugBank.d776.s40,in,57,58,O
DDI-DrugBank.d776.s40,some,60,63,O
DDI-DrugBank.d776.s40,individual,65,74,O
DDI-DrugBank.d776.s40,ethinyl,76,82,B-drug
DDI-DrugBank.d776.s40,estradiol,84,92,I-drug
DDI-DrugBank.d776.s40,and,94,96,O
DDI-DrugBank.d776.s40,levonorgestrel,98,111,B-drug
DDI-DrugBank.d776.s40,AUC,113,115,O
DDI-DrugBank.d776.s40,values,117,122,O
DDI-DrugBank.d776.s40,with,124,127,O
DDI-DrugBank.d776.s40,fluconazole,129,139,B-drug
DDI-DrugBank.d776.s40,treatment,141,149,O
DDI-DrugBank.d776.s40,are,151,153,O
DDI-DrugBank.d776.s40,likely,155,160,O
DDI-DrugBank.d776.s40,the,162,164,O
DDI-DrugBank.d776.s40,result,166,171,O
DDI-DrugBank.d776.s40,of,173,174,O
DDI-DrugBank.d776.s40,random,176,181,O
DDI-DrugBank.d776.s40,variation,183,191,O
DDI-DrugBank.d776.s40,.,192,192,O
DDI-DrugBank.d776.s41,While,0,4,O
DDI-DrugBank.d776.s41,there,6,10,O
DDI-DrugBank.d776.s41,is,12,13,O
DDI-DrugBank.d776.s41,evidence,15,22,O
DDI-DrugBank.d776.s41,that,24,27,O
DDI-DrugBank.d776.s41,fluconazole,29,39,B-drug
DDI-DrugBank.d776.s41,can,41,43,O
DDI-DrugBank.d776.s41,inhibit,45,51,O
DDI-DrugBank.d776.s41,the,53,55,O
DDI-DrugBank.d776.s41,metabolism,57,66,O
DDI-DrugBank.d776.s41,of,68,69,O
DDI-DrugBank.d776.s41,ethinyl,71,77,B-drug
DDI-DrugBank.d776.s41,estradiol,79,87,I-drug
DDI-DrugBank.d776.s41,and,89,91,O
DDI-DrugBank.d776.s41,levonorgestrel,93,106,B-drug
DDI-DrugBank.d776.s41,",",107,107,O
DDI-DrugBank.d776.s41,there,109,113,O
DDI-DrugBank.d776.s41,is,115,116,O
DDI-DrugBank.d776.s41,no,118,119,O
DDI-DrugBank.d776.s41,evidence,121,128,O
DDI-DrugBank.d776.s41,that,130,133,O
DDI-DrugBank.d776.s41,fluconazole,135,145,B-drug
DDI-DrugBank.d776.s41,is,147,148,O
DDI-DrugBank.d776.s41,a,150,150,O
DDI-DrugBank.d776.s41,net,152,154,O
DDI-DrugBank.d776.s41,inducer,156,162,O
DDI-DrugBank.d776.s41,of,164,165,O
DDI-DrugBank.d776.s41,ethinyl,167,173,B-drug
DDI-DrugBank.d776.s41,estradiol,175,183,I-drug
DDI-DrugBank.d776.s41,or,185,186,O
DDI-DrugBank.d776.s41,levonorgestrel,188,201,B-drug
DDI-DrugBank.d776.s41,metabolism,203,212,O
DDI-DrugBank.d776.s41,.,213,213,O
DDI-DrugBank.d776.s42,The,0,2,O
DDI-DrugBank.d776.s42,clinical,4,11,O
DDI-DrugBank.d776.s42,significance,13,24,O
DDI-DrugBank.d776.s42,of,26,27,O
DDI-DrugBank.d776.s42,these,29,33,O
DDI-DrugBank.d776.s42,effects,35,41,O
DDI-DrugBank.d776.s42,is,43,44,O
DDI-DrugBank.d776.s42,presently,46,54,O
DDI-DrugBank.d776.s42,unknown,56,62,O
DDI-DrugBank.d776.s42,.,63,63,O
DDI-DrugBank.d776.s43,Physicians,0,9,O
DDI-DrugBank.d776.s43,should,11,16,O
DDI-DrugBank.d776.s43,be,18,19,O
DDI-DrugBank.d776.s43,aware,21,25,O
DDI-DrugBank.d776.s43,that,27,30,O
DDI-DrugBank.d776.s43,interaction,32,42,O
DDI-DrugBank.d776.s43,studies,44,50,O
DDI-DrugBank.d776.s43,with,52,55,O
DDI-DrugBank.d776.s43,medications,57,67,O
DDI-DrugBank.d776.s43,other,69,73,O
DDI-DrugBank.d776.s43,than,75,78,O
DDI-DrugBank.d776.s43,those,80,84,O
DDI-DrugBank.d776.s43,listed,86,91,O
DDI-DrugBank.d776.s43,in,93,94,O
DDI-DrugBank.d776.s43,the,96,98,O
DDI-DrugBank.d776.s43,<,100,100,O
DDI-DrugBank.d776.s43,a,101,101,O
DDI-DrugBank.d776.s43,href=,103,107,O
DDI-DrugBank.d776.s43,``,-1,0,O
DDI-DrugBank.d776.s43,flucon_cp.htm,110,122,O
DDI-DrugBank.d776.s43,#,123,123,O
DDI-DrugBank.d776.s43,CP,124,125,O
DDI-DrugBank.d776.s43,'',-1,0,O
DDI-DrugBank.d776.s43,>,127,127,O
DDI-DrugBank.d776.s43,CLINICAL,128,135,O
DDI-DrugBank.d776.s43,PHARMACOLOGY,137,148,O
DDI-DrugBank.d776.s43,section,150,156,O
DDI-DrugBank.d776.s43,have,158,161,O
DDI-DrugBank.d776.s43,not,163,165,O
DDI-DrugBank.d776.s43,been,167,170,O
DDI-DrugBank.d776.s43,conducted,172,180,O
DDI-DrugBank.d776.s43,",",181,181,O
DDI-DrugBank.d776.s43,but,183,185,O
DDI-DrugBank.d776.s43,such,187,190,O
DDI-DrugBank.d776.s43,interactions,192,203,O
DDI-DrugBank.d776.s43,may,205,207,O
DDI-DrugBank.d776.s43,occur,209,213,O
DDI-DrugBank.d776.s43,.,214,214,O
DDI-DrugBank.d78.s0,Antacids,0,7,B-group
DDI-DrugBank.d78.s0,",",8,8,O
DDI-DrugBank.d78.s0,Sucralfate,10,19,B-drug
DDI-DrugBank.d78.s0,",",20,20,O
DDI-DrugBank.d78.s0,Metal,22,26,O
DDI-DrugBank.d78.s0,Cations,28,34,O
DDI-DrugBank.d78.s0,",",35,35,O
DDI-DrugBank.d78.s0,Multivitamins,37,49,B-group
DDI-DrugBank.d78.s0,Quinolones,51,60,B-group
DDI-DrugBank.d78.s0,form,62,65,O
DDI-DrugBank.d78.s0,chelates,67,74,O
DDI-DrugBank.d78.s0,with,76,79,O
DDI-DrugBank.d78.s0,alkaline,81,88,O
DDI-DrugBank.d78.s0,earth,90,94,O
DDI-DrugBank.d78.s0,and,96,98,O
DDI-DrugBank.d78.s0,transition,100,109,O
DDI-DrugBank.d78.s0,metal,111,115,O
DDI-DrugBank.d78.s0,cations,117,123,O
DDI-DrugBank.d78.s0,.,124,124,O
DDI-DrugBank.d78.s1,Administration,0,13,O
DDI-DrugBank.d78.s1,of,15,16,O
DDI-DrugBank.d78.s1,quinolones,18,27,B-group
DDI-DrugBank.d78.s1,with,29,32,O
DDI-DrugBank.d78.s1,antacids,34,41,B-group
DDI-DrugBank.d78.s1,containing,43,52,O
DDI-DrugBank.d78.s1,aluminum,54,61,B-drug
DDI-DrugBank.d78.s1,",",62,62,O
DDI-DrugBank.d78.s1,magnesium,64,72,B-drug
DDI-DrugBank.d78.s1,",",73,73,O
DDI-DrugBank.d78.s1,or,75,76,O
DDI-DrugBank.d78.s1,calcium,78,84,B-drug
DDI-DrugBank.d78.s1,",",85,85,O
DDI-DrugBank.d78.s1,with,87,90,O
DDI-DrugBank.d78.s1,sucralfate,92,101,B-drug
DDI-DrugBank.d78.s1,",",102,102,O
DDI-DrugBank.d78.s1,with,104,107,O
DDI-DrugBank.d78.s1,metal,109,113,O
DDI-DrugBank.d78.s1,cations,115,121,O
DDI-DrugBank.d78.s1,such,123,126,O
DDI-DrugBank.d78.s1,as,128,129,O
DDI-DrugBank.d78.s1,iron,131,134,B-drug
DDI-DrugBank.d78.s1,",",135,135,O
DDI-DrugBank.d78.s1,or,137,138,O
DDI-DrugBank.d78.s1,with,140,143,O
DDI-DrugBank.d78.s1,multivitamins,145,157,B-group
DDI-DrugBank.d78.s1,containing,159,168,O
DDI-DrugBank.d78.s1,iron,170,173,B-drug
DDI-DrugBank.d78.s1,or,175,176,O
DDI-DrugBank.d78.s1,zinc,178,181,B-drug
DDI-DrugBank.d78.s1,",",182,182,O
DDI-DrugBank.d78.s1,or,184,185,O
DDI-DrugBank.d78.s1,with,187,190,O
DDI-DrugBank.d78.s1,formulations,192,203,O
DDI-DrugBank.d78.s1,containing,205,214,O
DDI-DrugBank.d78.s1,divalent,216,223,O
DDI-DrugBank.d78.s1,and,225,227,O
DDI-DrugBank.d78.s1,trivalent,229,237,O
DDI-DrugBank.d78.s1,cations,239,245,O
DDI-DrugBank.d78.s1,such,247,250,O
DDI-DrugBank.d78.s1,as,252,253,O
DDI-DrugBank.d78.s1,VIDEX,255,259,B-brand
DDI-DrugBank.d78.s1,(,261,261,O
DDI-DrugBank.d78.s1,didanosine,262,271,B-drug
DDI-DrugBank.d78.s1,),272,272,O
DDI-DrugBank.d78.s1,chewable/buffered,274,290,O
DDI-DrugBank.d78.s1,tablets,292,298,O
DDI-DrugBank.d78.s1,or,300,301,O
DDI-DrugBank.d78.s1,the,303,305,O
DDI-DrugBank.d78.s1,pediatric,307,315,O
DDI-DrugBank.d78.s1,powder,317,322,O
DDI-DrugBank.d78.s1,for,324,326,O
DDI-DrugBank.d78.s1,oral,328,331,O
DDI-DrugBank.d78.s1,solution,333,340,O
DDI-DrugBank.d78.s1,",",341,341,O
DDI-DrugBank.d78.s1,may,343,345,O
DDI-DrugBank.d78.s1,substantially,347,359,O
DDI-DrugBank.d78.s1,interfere,361,369,O
DDI-DrugBank.d78.s1,with,371,374,O
DDI-DrugBank.d78.s1,the,376,378,O
DDI-DrugBank.d78.s1,absorption,380,389,O
DDI-DrugBank.d78.s1,of,391,392,O
DDI-DrugBank.d78.s1,quinolones,394,403,B-group
DDI-DrugBank.d78.s1,",",404,404,O
DDI-DrugBank.d78.s1,resulting,406,414,O
DDI-DrugBank.d78.s1,in,416,417,O
DDI-DrugBank.d78.s1,systemic,419,426,O
DDI-DrugBank.d78.s1,concentrations,428,441,O
DDI-DrugBank.d78.s1,considerably,443,454,O
DDI-DrugBank.d78.s1,lower,456,460,O
DDI-DrugBank.d78.s1,than,462,465,O
DDI-DrugBank.d78.s1,desired,467,473,O
DDI-DrugBank.d78.s1,.,474,474,O
DDI-DrugBank.d78.s2,These,0,4,O
DDI-DrugBank.d78.s2,agents,6,11,O
DDI-DrugBank.d78.s2,should,13,18,O
DDI-DrugBank.d78.s2,not,20,22,O
DDI-DrugBank.d78.s2,be,24,25,O
DDI-DrugBank.d78.s2,taken,27,31,O
DDI-DrugBank.d78.s2,within,33,38,O
DDI-DrugBank.d78.s2,4,40,40,O
DDI-DrugBank.d78.s2,hours,42,46,O
DDI-DrugBank.d78.s2,before,48,53,O
DDI-DrugBank.d78.s2,or,55,56,O
DDI-DrugBank.d78.s2,4,58,58,O
DDI-DrugBank.d78.s2,hours,60,64,O
DDI-DrugBank.d78.s2,after,66,70,O
DDI-DrugBank.d78.s2,grepafloxacin,72,84,B-drug
DDI-DrugBank.d78.s2,administration,86,99,O
DDI-DrugBank.d78.s2,.,100,100,O
DDI-DrugBank.d78.s3,Caffeine,0,7,B-drug
DDI-DrugBank.d78.s3,Theobromine,9,19,B-drug
DDI-DrugBank.d78.s3,Grepafloxacin,21,33,B-drug
DDI-DrugBank.d78.s3,",",34,34,O
DDI-DrugBank.d78.s3,like,36,39,O
DDI-DrugBank.d78.s3,other,41,45,O
DDI-DrugBank.d78.s3,quinolones,47,56,B-group
DDI-DrugBank.d78.s3,",",57,57,O
DDI-DrugBank.d78.s3,may,59,61,O
DDI-DrugBank.d78.s3,inhibit,63,69,O
DDI-DrugBank.d78.s3,the,71,73,O
DDI-DrugBank.d78.s3,metabolism,75,84,O
DDI-DrugBank.d78.s3,of,86,87,O
DDI-DrugBank.d78.s3,caffeine,89,96,B-drug
DDI-DrugBank.d78.s3,and,98,100,O
DDI-DrugBank.d78.s3,theobromine,102,112,B-drug
DDI-DrugBank.d78.s3,.,113,113,O
DDI-DrugBank.d78.s4,These,0,4,O
DDI-DrugBank.d78.s4,stimulants,6,15,O
DDI-DrugBank.d78.s4,are,17,19,O
DDI-DrugBank.d78.s4,commonly,21,28,O
DDI-DrugBank.d78.s4,found,30,34,O
DDI-DrugBank.d78.s4,in,36,37,O
DDI-DrugBank.d78.s4,coffee,39,44,O
DDI-DrugBank.d78.s4,and,46,48,O
DDI-DrugBank.d78.s4,tea,50,52,O
DDI-DrugBank.d78.s4,",",53,53,O
DDI-DrugBank.d78.s4,respectively,55,66,O
DDI-DrugBank.d78.s4,.,67,67,O
DDI-DrugBank.d78.s5,In,0,1,O
DDI-DrugBank.d78.s5,some,3,6,O
DDI-DrugBank.d78.s5,patients,8,15,O
DDI-DrugBank.d78.s5,",",16,16,O
DDI-DrugBank.d78.s5,this,18,21,O
DDI-DrugBank.d78.s5,may,23,25,O
DDI-DrugBank.d78.s5,lead,27,30,O
DDI-DrugBank.d78.s5,to,32,33,O
DDI-DrugBank.d78.s5,reduced,35,41,O
DDI-DrugBank.d78.s5,clearance,43,51,O
DDI-DrugBank.d78.s5,",",52,52,O
DDI-DrugBank.d78.s5,prolongation,54,65,O
DDI-DrugBank.d78.s5,of,67,68,O
DDI-DrugBank.d78.s5,plasma,70,75,O
DDI-DrugBank.d78.s5,half-life,77,85,O
DDI-DrugBank.d78.s5,",",86,86,O
DDI-DrugBank.d78.s5,and,88,90,O
DDI-DrugBank.d78.s5,enhanced,92,99,O
DDI-DrugBank.d78.s5,effects,101,107,O
DDI-DrugBank.d78.s5,of,109,110,O
DDI-DrugBank.d78.s5,caffeine,112,119,B-drug
DDI-DrugBank.d78.s5,and,121,123,O
DDI-DrugBank.d78.s5,theobromine,125,135,B-drug
DDI-DrugBank.d78.s5,.,136,136,O
DDI-DrugBank.d78.s6,Theophylline,0,11,B-drug
DDI-DrugBank.d78.s6,:,12,12,O
DDI-DrugBank.d78.s6,Grepafloxacin,14,26,B-drug
DDI-DrugBank.d78.s6,is,28,29,O
DDI-DrugBank.d78.s6,a,31,31,O
DDI-DrugBank.d78.s6,competitive,33,43,O
DDI-DrugBank.d78.s6,inhibitor,45,53,O
DDI-DrugBank.d78.s6,of,55,56,O
DDI-DrugBank.d78.s6,the,58,60,O
DDI-DrugBank.d78.s6,metabolism,62,71,O
DDI-DrugBank.d78.s6,of,73,74,O
DDI-DrugBank.d78.s6,theophylline,76,87,B-drug
DDI-DrugBank.d78.s6,.,88,88,O
DDI-DrugBank.d78.s7,Serum,0,4,O
DDI-DrugBank.d78.s7,theophylline,6,17,B-drug
DDI-DrugBank.d78.s7,concentrations,19,32,O
DDI-DrugBank.d78.s7,increase,34,41,O
DDI-DrugBank.d78.s7,when,43,46,O
DDI-DrugBank.d78.s7,grepafloxacin,48,60,B-drug
DDI-DrugBank.d78.s7,is,62,63,O
DDI-DrugBank.d78.s7,initiated,65,73,O
DDI-DrugBank.d78.s7,in,75,76,O
DDI-DrugBank.d78.s7,a,78,78,O
DDI-DrugBank.d78.s7,patient,80,86,O
DDI-DrugBank.d78.s7,maintained,88,97,O
DDI-DrugBank.d78.s7,on,99,100,O
DDI-DrugBank.d78.s7,theophylline,102,113,B-drug
DDI-DrugBank.d78.s7,.,114,114,O
DDI-DrugBank.d78.s8,When,0,3,O
DDI-DrugBank.d78.s8,initiating,5,14,O
DDI-DrugBank.d78.s8,a,16,16,O
DDI-DrugBank.d78.s8,multi-day,18,26,O
DDI-DrugBank.d78.s8,course,28,33,O
DDI-DrugBank.d78.s8,of,35,36,O
DDI-DrugBank.d78.s8,grepafloxacin,38,50,B-drug
DDI-DrugBank.d78.s8,in,52,53,O
DDI-DrugBank.d78.s8,a,55,55,O
DDI-DrugBank.d78.s8,patient,57,63,O
DDI-DrugBank.d78.s8,maintained,65,74,O
DDI-DrugBank.d78.s8,on,76,77,O
DDI-DrugBank.d78.s8,theophylline,79,90,B-drug
DDI-DrugBank.d78.s8,",",91,91,O
DDI-DrugBank.d78.s8,the,93,95,O
DDI-DrugBank.d78.s8,theophylline,97,108,B-drug
DDI-DrugBank.d78.s8,maintenance,110,120,O
DDI-DrugBank.d78.s8,dose,122,125,O
DDI-DrugBank.d78.s8,should,127,132,O
DDI-DrugBank.d78.s8,be,134,135,O
DDI-DrugBank.d78.s8,halved,137,142,O
DDI-DrugBank.d78.s8,for,144,146,O
DDI-DrugBank.d78.s8,the,148,150,O
DDI-DrugBank.d78.s8,period,152,157,O
DDI-DrugBank.d78.s8,of,159,160,O
DDI-DrugBank.d78.s8,concurrent,162,171,O
DDI-DrugBank.d78.s8,use,173,175,O
DDI-DrugBank.d78.s8,of,177,178,O
DDI-DrugBank.d78.s8,grepafloxacin,180,192,B-drug
DDI-DrugBank.d78.s8,and,194,196,O
DDI-DrugBank.d78.s8,monitoring,198,207,O
DDI-DrugBank.d78.s8,of,209,210,O
DDI-DrugBank.d78.s8,serum,212,216,O
DDI-DrugBank.d78.s8,theophylline,218,229,B-drug
DDI-DrugBank.d78.s8,concentrations,231,244,O
DDI-DrugBank.d78.s8,should,246,251,O
DDI-DrugBank.d78.s8,be,253,254,O
DDI-DrugBank.d78.s8,initiated,256,264,O
DDI-DrugBank.d78.s8,as,266,267,O
DDI-DrugBank.d78.s8,a,269,269,O
DDI-DrugBank.d78.s8,guide,271,275,O
DDI-DrugBank.d78.s8,to,277,278,O
DDI-DrugBank.d78.s8,further,280,286,O
DDI-DrugBank.d78.s8,dosage,288,293,O
DDI-DrugBank.d78.s8,adjustments,295,305,O
DDI-DrugBank.d78.s8,.,306,306,O
DDI-DrugBank.d78.s9,Warfarin,0,7,B-drug
DDI-DrugBank.d78.s9,:,8,8,O
DDI-DrugBank.d78.s9,In,10,11,O
DDI-DrugBank.d78.s9,subjects,13,20,O
DDI-DrugBank.d78.s9,receiving,22,30,O
DDI-DrugBank.d78.s9,warfarin,32,39,B-drug
DDI-DrugBank.d78.s9,",",40,40,O
DDI-DrugBank.d78.s9,no,42,43,O
DDI-DrugBank.d78.s9,significant,45,55,O
DDI-DrugBank.d78.s9,change,57,62,O
DDI-DrugBank.d78.s9,in,64,65,O
DDI-DrugBank.d78.s9,clotting,67,74,O
DDI-DrugBank.d78.s9,time,76,79,O
DDI-DrugBank.d78.s9,was,81,83,O
DDI-DrugBank.d78.s9,observed,85,92,O
DDI-DrugBank.d78.s9,when,94,97,O
DDI-DrugBank.d78.s9,grepafloxacin,99,111,B-drug
DDI-DrugBank.d78.s9,was,113,115,O
DDI-DrugBank.d78.s9,coadministered,117,130,O
DDI-DrugBank.d78.s9,.,131,131,O
DDI-DrugBank.d78.s10,However,0,6,O
DDI-DrugBank.d78.s10,",",7,7,O
DDI-DrugBank.d78.s10,because,9,15,O
DDI-DrugBank.d78.s10,some,17,20,O
DDI-DrugBank.d78.s10,quinolones,22,31,B-group
DDI-DrugBank.d78.s10,have,33,36,O
DDI-DrugBank.d78.s10,been,38,41,O
DDI-DrugBank.d78.s10,reported,43,50,O
DDI-DrugBank.d78.s10,to,52,53,O
DDI-DrugBank.d78.s10,enhance,55,61,O
DDI-DrugBank.d78.s10,the,63,65,O
DDI-DrugBank.d78.s10,effects,67,73,O
DDI-DrugBank.d78.s10,of,75,76,O
DDI-DrugBank.d78.s10,warfarin,78,85,B-drug
DDI-DrugBank.d78.s10,or,87,88,O
DDI-DrugBank.d78.s10,its,90,92,O
DDI-DrugBank.d78.s10,derivatives,94,104,O
DDI-DrugBank.d78.s10,",",105,105,O
DDI-DrugBank.d78.s10,prothrombin,107,117,O
DDI-DrugBank.d78.s10,time,119,122,O
DDI-DrugBank.d78.s10,or,124,125,O
DDI-DrugBank.d78.s10,other,127,131,O
DDI-DrugBank.d78.s10,suitable,133,140,O
DDI-DrugBank.d78.s10,anticoagulation,142,156,O
DDI-DrugBank.d78.s10,test,158,161,O
DDI-DrugBank.d78.s10,should,163,168,O
DDI-DrugBank.d78.s10,be,170,171,O
DDI-DrugBank.d78.s10,monitored,173,181,O
DDI-DrugBank.d78.s10,closely,183,189,O
DDI-DrugBank.d78.s10,if,191,192,O
DDI-DrugBank.d78.s10,a,194,194,O
DDI-DrugBank.d78.s10,quinolone,196,204,B-group
DDI-DrugBank.d78.s10,antimicrobial,206,218,I-group
DDI-DrugBank.d78.s10,is,220,221,O
DDI-DrugBank.d78.s10,administered,223,234,O
DDI-DrugBank.d78.s10,with,236,239,O
DDI-DrugBank.d78.s10,warfarin,241,248,B-drug
DDI-DrugBank.d78.s10,or,250,251,O
DDI-DrugBank.d78.s10,its,253,255,O
DDI-DrugBank.d78.s10,derivatives,257,267,O
DDI-DrugBank.d78.s10,.,268,268,O
DDI-DrugBank.d78.s11,Drugs,0,4,O
DDI-DrugBank.d78.s11,Metabolized,6,16,O
DDI-DrugBank.d78.s11,by,18,19,O
DDI-DrugBank.d78.s11,Cytochrome,21,30,O
DDI-DrugBank.d78.s11,P450,32,35,O
DDI-DrugBank.d78.s11,Enzymes,37,43,O
DDI-DrugBank.d78.s11,The,45,47,O
DDI-DrugBank.d78.s11,drug,49,52,O
DDI-DrugBank.d78.s11,interaction,54,64,O
DDI-DrugBank.d78.s11,study,66,70,O
DDI-DrugBank.d78.s11,evaluating,72,81,O
DDI-DrugBank.d78.s11,the,83,85,O
DDI-DrugBank.d78.s11,effect,87,92,O
DDI-DrugBank.d78.s11,of,94,95,O
DDI-DrugBank.d78.s11,grepafloxacin,97,109,B-drug
DDI-DrugBank.d78.s11,on,111,112,O
DDI-DrugBank.d78.s11,theophylline,114,125,B-drug
DDI-DrugBank.d78.s11,indicates,127,135,O
DDI-DrugBank.d78.s11,that,137,140,O
DDI-DrugBank.d78.s11,grepafloxacin,142,154,B-drug
DDI-DrugBank.d78.s11,inhibits,156,163,O
DDI-DrugBank.d78.s11,theophylline,165,176,B-drug
DDI-DrugBank.d78.s11,metabolism,178,187,O
DDI-DrugBank.d78.s11,",",188,188,O
DDI-DrugBank.d78.s11,which,190,194,O
DDI-DrugBank.d78.s11,is,196,197,O
DDI-DrugBank.d78.s11,mediated,199,206,O
DDI-DrugBank.d78.s11,by,208,209,O
DDI-DrugBank.d78.s11,CYP1A2,211,216,O
DDI-DrugBank.d78.s11,.,217,217,O
DDI-DrugBank.d78.s12,While,0,4,O
DDI-DrugBank.d78.s12,no,6,7,O
DDI-DrugBank.d78.s12,clinical,9,16,O
DDI-DrugBank.d78.s12,studies,18,24,O
DDI-DrugBank.d78.s12,have,26,29,O
DDI-DrugBank.d78.s12,been,31,34,O
DDI-DrugBank.d78.s12,conducted,36,44,O
DDI-DrugBank.d78.s12,to,46,47,O
DDI-DrugBank.d78.s12,evaluate,49,56,O
DDI-DrugBank.d78.s12,the,58,60,O
DDI-DrugBank.d78.s12,effect,62,67,O
DDI-DrugBank.d78.s12,of,69,70,O
DDI-DrugBank.d78.s12,grepafloxacin,72,84,B-drug
DDI-DrugBank.d78.s12,on,86,87,O
DDI-DrugBank.d78.s12,the,89,91,O
DDI-DrugBank.d78.s12,metabolism,93,102,O
DDI-DrugBank.d78.s12,of,104,105,O
DDI-DrugBank.d78.s12,C.P.A,107,111,O
DDI-DrugBank.d78.s12,.,112,112,O
DDI-DrugBank.d78.s13,substrates,0,9,O
DDI-DrugBank.d78.s13,",",10,10,O
DDI-DrugBank.d78.s13,in,12,13,O
DDI-DrugBank.d78.s13,vitro,15,19,O
DDI-DrugBank.d78.s13,data,21,24,O
DDI-DrugBank.d78.s13,suggest,26,32,O
DDI-DrugBank.d78.s13,similar,34,40,O
DDI-DrugBank.d78.s13,effects,42,48,O
DDI-DrugBank.d78.s13,of,50,51,O
DDI-DrugBank.d78.s13,grepafloxacin,53,65,B-drug
DDI-DrugBank.d78.s13,in,67,68,O
DDI-DrugBank.d78.s13,CYP3A4,70,75,O
DDI-DrugBank.d78.s13,mediated,77,84,O
DDI-DrugBank.d78.s13,metabolism,86,95,O
DDI-DrugBank.d78.s13,and,97,99,O
DDI-DrugBank.d78.s13,theophylline,101,112,B-drug
DDI-DrugBank.d78.s13,metabolism,114,123,O
DDI-DrugBank.d78.s13,.,124,124,O
DDI-DrugBank.d78.s14,In,0,1,O
DDI-DrugBank.d78.s14,addition,3,10,O
DDI-DrugBank.d78.s14,",",11,11,O
DDI-DrugBank.d78.s14,other,13,17,O
DDI-DrugBank.d78.s14,quinolones,19,28,B-group
DDI-DrugBank.d78.s14,have,30,33,O
DDI-DrugBank.d78.s14,been,35,38,O
DDI-DrugBank.d78.s14,reported,40,47,O
DDI-DrugBank.d78.s14,to,49,50,O
DDI-DrugBank.d78.s14,decrease,52,59,O
DDI-DrugBank.d78.s14,the,61,63,O
DDI-DrugBank.d78.s14,CYP3A4-mediated,65,79,O
DDI-DrugBank.d78.s14,metabolism,81,90,O
DDI-DrugBank.d78.s14,of,92,93,O
DDI-DrugBank.d78.s14,cyclosporine,95,106,B-drug
DDI-DrugBank.d78.s14,.,107,107,O
DDI-DrugBank.d78.s15,Other,0,4,O
DDI-DrugBank.d78.s15,drugs,6,10,O
DDI-DrugBank.d78.s15,metabolized,12,22,O
DDI-DrugBank.d78.s15,by,24,25,O
DDI-DrugBank.d78.s15,C.P.A,27,31,O
DDI-DrugBank.d78.s15,.,32,32,O
DDI-DrugBank.d78.s16,include,0,6,O
DDI-DrugBank.d78.s16,terfenadine,8,18,B-drug
DDI-DrugBank.d78.s16,",",19,19,O
DDI-DrugBank.d78.s16,astemizole,21,30,B-drug
DDI-DrugBank.d78.s16,",",31,31,O
DDI-DrugBank.d78.s16,cisapride,33,41,B-drug
DDI-DrugBank.d78.s16,",",42,42,O
DDI-DrugBank.d78.s16,midazolam,44,52,B-drug
DDI-DrugBank.d78.s16,",",53,53,O
DDI-DrugBank.d78.s16,and,55,57,O
DDI-DrugBank.d78.s16,triazolam,59,67,B-drug
DDI-DrugBank.d78.s16,.,68,68,O
DDI-DrugBank.d78.s17,The,0,2,O
DDI-DrugBank.d78.s17,clinical,4,11,O
DDI-DrugBank.d78.s17,relevance,13,21,O
DDI-DrugBank.d78.s17,of,23,24,O
DDI-DrugBank.d78.s17,the,26,28,O
DDI-DrugBank.d78.s17,potential,30,38,O
DDI-DrugBank.d78.s17,effect,40,45,O
DDI-DrugBank.d78.s17,of,47,48,O
DDI-DrugBank.d78.s17,grepafloxacin,50,62,B-drug
DDI-DrugBank.d78.s17,on,64,65,O
DDI-DrugBank.d78.s17,the,67,69,O
DDI-DrugBank.d78.s17,metabolism,71,80,O
DDI-DrugBank.d78.s17,of,82,83,O
DDI-DrugBank.d78.s17,C.P.A,85,89,O
DDI-DrugBank.d78.s17,.,90,90,O
DDI-DrugBank.d78.s17,substrates,92,101,O
DDI-DrugBank.d78.s17,is,103,104,O
DDI-DrugBank.d78.s17,not,106,108,O
DDI-DrugBank.d78.s17,known,110,114,O
DDI-DrugBank.d78.s17,.,115,115,O
DDI-DrugBank.d78.s18,Patients,0,7,O
DDI-DrugBank.d78.s18,receiving,9,17,O
DDI-DrugBank.d78.s18,concurrent,19,28,O
DDI-DrugBank.d78.s18,administration,30,43,O
DDI-DrugBank.d78.s18,of,45,46,O
DDI-DrugBank.d78.s18,substrates,48,57,O
DDI-DrugBank.d78.s18,of,59,60,O
DDI-DrugBank.d78.s18,C.P.A,62,66,O
DDI-DrugBank.d78.s18,.,67,67,O
DDI-DrugBank.d78.s18,were,69,72,O
DDI-DrugBank.d78.s18,not,74,76,O
DDI-DrugBank.d78.s18,excluded,78,85,O
DDI-DrugBank.d78.s18,from,87,90,O
DDI-DrugBank.d78.s18,clinical,92,99,O
DDI-DrugBank.d78.s18,trials,101,106,O
DDI-DrugBank.d78.s18,of,108,109,O
DDI-DrugBank.d78.s18,grepafloxacin,111,123,B-drug
DDI-DrugBank.d78.s18,.,124,124,O
DDI-DrugBank.d78.s19,Nonsteroidal,0,11,B-group
DDI-DrugBank.d78.s19,Anti-inflammatory,13,29,I-group
DDI-DrugBank.d78.s19,Drugs,31,35,I-group
DDI-DrugBank.d78.s19,(,37,37,O
DDI-DrugBank.d78.s19,NSAIDs,38,43,B-group
DDI-DrugBank.d78.s19,),44,44,O
DDI-DrugBank.d78.s19,:,45,45,O
DDI-DrugBank.d78.s19,The,47,49,O
DDI-DrugBank.d78.s19,concomitant,51,61,O
DDI-DrugBank.d78.s19,administration,63,76,O
DDI-DrugBank.d78.s19,of,78,79,O
DDI-DrugBank.d78.s19,a,81,81,O
DDI-DrugBank.d78.s19,nonsteroidal,83,94,B-group
DDI-DrugBank.d78.s19,anti,96,99,I-group
DDI-DrugBank.d78.s19,inflammatory,101,112,I-group
DDI-DrugBank.d78.s19,drug,114,117,I-group
DDI-DrugBank.d78.s19,with,119,122,O
DDI-DrugBank.d78.s19,a,124,124,O
DDI-DrugBank.d78.s19,quinolone,126,134,B-group
DDI-DrugBank.d78.s19,may,136,138,O
DDI-DrugBank.d78.s19,increase,140,147,O
DDI-DrugBank.d78.s19,the,149,151,O
DDI-DrugBank.d78.s19,risks,153,157,O
DDI-DrugBank.d78.s19,of,159,160,O
DDI-DrugBank.d78.s19,CNS,162,164,O
DDI-DrugBank.d78.s19,stimulation,166,176,O
DDI-DrugBank.d78.s19,and,178,180,O
DDI-DrugBank.d78.s19,convulsions,182,192,O
DDI-DrugBank.d78.s19,.,193,193,O
DDI-DrugBank.d78.s20,Antidiabetic,0,11,B-group
DDI-DrugBank.d78.s20,Agents,13,18,I-group
DDI-DrugBank.d78.s20,:,19,19,O
DDI-DrugBank.d78.s20,Disturbances,21,32,O
DDI-DrugBank.d78.s20,of,34,35,O
DDI-DrugBank.d78.s20,blood,37,41,O
DDI-DrugBank.d78.s20,glucose,43,49,O
DDI-DrugBank.d78.s20,",",50,50,O
DDI-DrugBank.d78.s20,including,52,60,O
DDI-DrugBank.d78.s20,hyperglycemia,62,74,O
DDI-DrugBank.d78.s20,and,76,78,O
DDI-DrugBank.d78.s20,hypoglycemia,80,91,O
DDI-DrugBank.d78.s20,",",92,92,O
DDI-DrugBank.d78.s20,have,94,97,O
DDI-DrugBank.d78.s20,been,99,102,O
DDI-DrugBank.d78.s20,reported,104,111,O
DDI-DrugBank.d78.s20,in,113,114,O
DDI-DrugBank.d78.s20,patients,116,123,O
DDI-DrugBank.d78.s20,treated,125,131,O
DDI-DrugBank.d78.s20,concomitantly,133,145,O
DDI-DrugBank.d78.s20,with,147,150,O
DDI-DrugBank.d78.s20,quinolones,152,161,B-group
DDI-DrugBank.d78.s20,and,163,165,O
DDI-DrugBank.d78.s20,an,167,168,O
DDI-DrugBank.d78.s20,antidiabetic,170,181,B-group
DDI-DrugBank.d78.s20,agent,183,187,I-group
DDI-DrugBank.d78.s20,.,188,188,O
DDI-DrugBank.d78.s21,Therefore,0,8,O
DDI-DrugBank.d78.s21,",",9,9,O
DDI-DrugBank.d78.s21,careful,11,17,O
DDI-DrugBank.d78.s21,monitoring,19,28,O
DDI-DrugBank.d78.s21,of,30,31,O
DDI-DrugBank.d78.s21,blood,33,37,O
DDI-DrugBank.d78.s21,glucose,39,45,O
DDI-DrugBank.d78.s21,is,47,48,O
DDI-DrugBank.d78.s21,recommended,50,60,O
DDI-DrugBank.d78.s21,when,62,65,O
DDI-DrugBank.d78.s21,these,67,71,O
DDI-DrugBank.d78.s21,agents,73,78,O
DDI-DrugBank.d78.s21,are,80,82,O
DDI-DrugBank.d78.s21,coadministered,84,97,O
DDI-DrugBank.d78.s21,.,98,98,O
DDI-DrugBank.d302.s0,http,0,3,O
DDI-DrugBank.d302.s0,:,4,4,O
DDI-DrugBank.d302.s0,//www.rxlist.com/cgi/generic3/guanethidine_od.htm,5,53,O
DDI-DrugBank.d186.s0,An,0,1,O
DDI-DrugBank.d186.s0,encephalopathic,3,17,O
DDI-DrugBank.d186.s0,syndrome,19,26,O
DDI-DrugBank.d186.s0,(,28,28,O
DDI-DrugBank.d186.s0,characterized,29,41,O
DDI-DrugBank.d186.s0,by,43,44,O
DDI-DrugBank.d186.s0,weakness,46,53,O
DDI-DrugBank.d186.s0,",",54,54,O
DDI-DrugBank.d186.s0,lethargy,56,63,O
DDI-DrugBank.d186.s0,",",64,64,O
DDI-DrugBank.d186.s0,fever,66,70,O
DDI-DrugBank.d186.s0,",",71,71,O
DDI-DrugBank.d186.s0,tremulousness,73,85,O
DDI-DrugBank.d186.s0,and,87,89,O
DDI-DrugBank.d186.s0,confusion,91,99,O
DDI-DrugBank.d186.s0,",",100,100,O
DDI-DrugBank.d186.s0,extrapyramidal,102,115,O
DDI-DrugBank.d186.s0,symptoms,117,124,O
DDI-DrugBank.d186.s0,",",125,125,O
DDI-DrugBank.d186.s0,leukocytosis,127,138,O
DDI-DrugBank.d186.s0,",",139,139,O
DDI-DrugBank.d186.s0,elevated,141,148,O
DDI-DrugBank.d186.s0,serum,150,154,O
DDI-DrugBank.d186.s0,enzymes,156,162,O
DDI-DrugBank.d186.s0,",",163,163,O
DDI-DrugBank.d186.s0,BUN,165,167,O
DDI-DrugBank.d186.s0,",",168,168,O
DDI-DrugBank.d186.s0,and,170,172,O
DDI-DrugBank.d186.s0,FBS,174,176,O
DDI-DrugBank.d186.s0,),177,177,O
DDI-DrugBank.d186.s0,followed,179,186,O
DDI-DrugBank.d186.s0,by,188,189,O
DDI-DrugBank.d186.s0,irreversible,191,202,O
DDI-DrugBank.d186.s0,brain,204,208,O
DDI-DrugBank.d186.s0,damage,210,215,O
DDI-DrugBank.d186.s0,has,217,219,O
DDI-DrugBank.d186.s0,occurred,221,228,O
DDI-DrugBank.d186.s0,in,230,231,O
DDI-DrugBank.d186.s0,a,233,233,O
DDI-DrugBank.d186.s0,few,235,237,O
DDI-DrugBank.d186.s0,patients,239,246,O
DDI-DrugBank.d186.s0,treated,248,254,O
DDI-DrugBank.d186.s0,with,256,259,O
DDI-DrugBank.d186.s0,lithium,261,267,B-drug
DDI-DrugBank.d186.s0,plus,269,272,O
DDI-DrugBank.d186.s0,HALDOL,274,279,B-brand
DDI-DrugBank.d186.s0,.,280,280,O
DDI-DrugBank.d186.s1,A,0,0,O
DDI-DrugBank.d186.s1,causal,2,7,O
DDI-DrugBank.d186.s1,relationship,9,20,O
DDI-DrugBank.d186.s1,between,22,28,O
DDI-DrugBank.d186.s1,these,30,34,O
DDI-DrugBank.d186.s1,events,36,41,O
DDI-DrugBank.d186.s1,and,43,45,O
DDI-DrugBank.d186.s1,the,47,49,O
DDI-DrugBank.d186.s1,concomitant,51,61,O
DDI-DrugBank.d186.s1,administration,63,76,O
DDI-DrugBank.d186.s1,of,78,79,O
DDI-DrugBank.d186.s1,lithium,81,87,B-drug
DDI-DrugBank.d186.s1,and,89,91,O
DDI-DrugBank.d186.s1,HALDOL,93,98,B-brand
DDI-DrugBank.d186.s1,has,100,102,O
DDI-DrugBank.d186.s1,not,104,106,O
DDI-DrugBank.d186.s1,been,108,111,O
DDI-DrugBank.d186.s1,established,113,123,O
DDI-DrugBank.d186.s1,;,124,124,O
DDI-DrugBank.d186.s2,however,0,6,O
DDI-DrugBank.d186.s2,",",7,7,O
DDI-DrugBank.d186.s2,patients,9,16,O
DDI-DrugBank.d186.s2,receiving,18,26,O
DDI-DrugBank.d186.s2,such,28,31,O
DDI-DrugBank.d186.s2,combined,33,40,O
DDI-DrugBank.d186.s2,therapy,42,48,O
DDI-DrugBank.d186.s2,should,50,55,O
DDI-DrugBank.d186.s2,be,57,58,O
DDI-DrugBank.d186.s2,monitored,60,68,O
DDI-DrugBank.d186.s2,closely,70,76,O
DDI-DrugBank.d186.s2,for,78,80,O
DDI-DrugBank.d186.s2,early,82,86,O
DDI-DrugBank.d186.s2,evidence,88,95,O
DDI-DrugBank.d186.s2,of,97,98,O
DDI-DrugBank.d186.s2,neurological,100,111,O
DDI-DrugBank.d186.s2,toxicity,113,120,O
DDI-DrugBank.d186.s2,and,122,124,O
DDI-DrugBank.d186.s2,treatment,126,134,O
DDI-DrugBank.d186.s2,discontinued,136,147,O
DDI-DrugBank.d186.s2,promptly,149,156,O
DDI-DrugBank.d186.s2,if,158,159,O
DDI-DrugBank.d186.s2,such,161,164,O
DDI-DrugBank.d186.s2,signs,166,170,O
DDI-DrugBank.d186.s2,appear,172,177,O
DDI-DrugBank.d186.s2,.,178,178,O
DDI-DrugBank.d186.s3,As,0,1,O
DDI-DrugBank.d186.s3,with,3,6,O
DDI-DrugBank.d186.s3,other,8,12,O
DDI-DrugBank.d186.s3,antipsychotic,14,26,B-group
DDI-DrugBank.d186.s3,agents,28,33,I-group
DDI-DrugBank.d186.s3,",",34,34,O
DDI-DrugBank.d186.s3,it,36,37,O
DDI-DrugBank.d186.s3,should,39,44,O
DDI-DrugBank.d186.s3,be,46,47,O
DDI-DrugBank.d186.s3,noted,49,53,O
DDI-DrugBank.d186.s3,that,55,58,O
DDI-DrugBank.d186.s3,HALDOL,60,65,B-brand
DDI-DrugBank.d186.s3,may,67,69,O
DDI-DrugBank.d186.s3,be,71,72,O
DDI-DrugBank.d186.s3,capable,74,80,O
DDI-DrugBank.d186.s3,of,82,83,O
DDI-DrugBank.d186.s3,potentiating,85,96,O
DDI-DrugBank.d186.s3,CNS,98,100,B-group
DDI-DrugBank.d186.s3,depressants,102,112,I-group
DDI-DrugBank.d186.s3,such,114,117,O
DDI-DrugBank.d186.s3,as,119,120,O
DDI-DrugBank.d186.s3,anesthetics,122,132,B-group
DDI-DrugBank.d186.s3,",",133,133,O
DDI-DrugBank.d186.s3,opiates,135,141,B-group
DDI-DrugBank.d186.s3,",",142,142,O
DDI-DrugBank.d186.s3,and,144,146,O
DDI-DrugBank.d186.s3,alcohol,148,154,B-drug
DDI-DrugBank.d186.s3,.,155,155,O
DDI-DrugBank.d186.s4,In,0,1,O
DDI-DrugBank.d186.s4,a,3,3,O
DDI-DrugBank.d186.s4,study,5,9,O
DDI-DrugBank.d186.s4,of,11,12,O
DDI-DrugBank.d186.s4,12,14,15,O
DDI-DrugBank.d186.s4,schizophrenic,17,29,O
DDI-DrugBank.d186.s4,patients,31,38,O
DDI-DrugBank.d186.s4,coadministered,40,53,O
DDI-DrugBank.d186.s4,oral,55,58,O
DDI-DrugBank.d186.s4,haloperidol,60,70,B-drug
DDI-DrugBank.d186.s4,and,72,74,O
DDI-DrugBank.d186.s4,rifampin,76,83,B-drug
DDI-DrugBank.d186.s4,",",84,84,O
DDI-DrugBank.d186.s4,plasma,86,91,O
DDI-DrugBank.d186.s4,haloperidol,93,103,B-drug
DDI-DrugBank.d186.s4,levels,105,110,O
DDI-DrugBank.d186.s4,were,112,115,O
DDI-DrugBank.d186.s4,decreased,117,125,O
DDI-DrugBank.d186.s4,by,127,128,O
DDI-DrugBank.d186.s4,a,130,130,O
DDI-DrugBank.d186.s4,mean,132,135,O
DDI-DrugBank.d186.s4,of,137,138,O
DDI-DrugBank.d186.s4,70,140,141,O
DDI-DrugBank.d186.s4,%,142,142,O
DDI-DrugBank.d186.s4,and,144,146,O
DDI-DrugBank.d186.s4,mean,148,151,O
DDI-DrugBank.d186.s4,scores,153,158,O
DDI-DrugBank.d186.s4,on,160,161,O
DDI-DrugBank.d186.s4,the,163,165,O
DDI-DrugBank.d186.s4,Brief,167,171,O
DDI-DrugBank.d186.s4,Psychiatric,173,183,O
DDI-DrugBank.d186.s4,Rating,185,190,O
DDI-DrugBank.d186.s4,Scale,192,196,O
DDI-DrugBank.d186.s4,were,198,201,O
DDI-DrugBank.d186.s4,increased,203,211,O
DDI-DrugBank.d186.s4,from,213,216,O
DDI-DrugBank.d186.s4,baseline,218,225,O
DDI-DrugBank.d186.s4,.,226,226,O
DDI-DrugBank.d186.s5,In,0,1,O
DDI-DrugBank.d186.s5,5,3,3,O
DDI-DrugBank.d186.s5,other,5,9,O
DDI-DrugBank.d186.s5,schizophrenic,11,23,O
DDI-DrugBank.d186.s5,patients,25,32,O
DDI-DrugBank.d186.s5,treated,34,40,O
DDI-DrugBank.d186.s5,with,42,45,O
DDI-DrugBank.d186.s5,oral,47,50,O
DDI-DrugBank.d186.s5,haloperidol,52,62,B-drug
DDI-DrugBank.d186.s5,and,64,66,O
DDI-DrugBank.d186.s5,rifampin,68,75,B-drug
DDI-DrugBank.d186.s5,",",76,76,O
DDI-DrugBank.d186.s5,discontinuation,78,92,O
DDI-DrugBank.d186.s5,of,94,95,O
DDI-DrugBank.d186.s5,rifampin,97,104,B-drug
DDI-DrugBank.d186.s5,produced,106,113,O
DDI-DrugBank.d186.s5,a,115,115,O
DDI-DrugBank.d186.s5,mean,117,120,O
DDI-DrugBank.d186.s5,3.3-fold,122,129,O
DDI-DrugBank.d186.s5,increase,131,138,O
DDI-DrugBank.d186.s5,in,140,141,O
DDI-DrugBank.d186.s5,haloperidol,143,153,B-drug
DDI-DrugBank.d186.s5,concentrations,155,168,O
DDI-DrugBank.d186.s5,.,169,169,O
DDI-DrugBank.d186.s6,Thus,0,3,O
DDI-DrugBank.d186.s6,",",4,4,O
DDI-DrugBank.d186.s6,careful,6,12,O
DDI-DrugBank.d186.s6,monitoring,14,23,O
DDI-DrugBank.d186.s6,of,25,26,O
DDI-DrugBank.d186.s6,clinical,28,35,O
DDI-DrugBank.d186.s6,status,37,42,O
DDI-DrugBank.d186.s6,is,44,45,O
DDI-DrugBank.d186.s6,warranted,47,55,O
DDI-DrugBank.d186.s6,when,57,60,O
DDI-DrugBank.d186.s6,rifampin,62,69,B-drug
DDI-DrugBank.d186.s6,is,71,72,O
DDI-DrugBank.d186.s6,administered,74,85,O
DDI-DrugBank.d186.s6,or,87,88,O
DDI-DrugBank.d186.s6,discontinued,90,101,O
DDI-DrugBank.d186.s6,in,103,104,O
DDI-DrugBank.d186.s6,haloperidol-treated,106,124,O
DDI-DrugBank.d186.s6,patients,126,133,O
DDI-DrugBank.d186.s6,.,134,134,O
DDI-DrugBank.d514.s0,Opioids,0,6,B-group
DDI-DrugBank.d514.s0,are,8,10,O
DDI-DrugBank.d514.s0,strong,12,17,O
DDI-DrugBank.d514.s0,central,19,25,B-group
DDI-DrugBank.d514.s0,nervous,27,33,I-group
DDI-DrugBank.d514.s0,system,35,40,I-group
DDI-DrugBank.d514.s0,depressants,42,52,I-group
DDI-DrugBank.d514.s0,",",53,53,O
DDI-DrugBank.d514.s0,but,55,57,O
DDI-DrugBank.d514.s0,regular,59,65,O
DDI-DrugBank.d514.s0,users,67,71,O
DDI-DrugBank.d514.s0,develop,73,79,O
DDI-DrugBank.d514.s0,physiological,81,93,O
DDI-DrugBank.d514.s0,tolerance,95,103,O
DDI-DrugBank.d514.s0,allowing,105,112,O
DDI-DrugBank.d514.s0,gradually,114,122,O
DDI-DrugBank.d514.s0,increased,124,132,O
DDI-DrugBank.d514.s0,dosages,134,140,O
DDI-DrugBank.d514.s0,.,141,141,O
DDI-DrugBank.d514.s1,In,0,1,O
DDI-DrugBank.d514.s1,combination,3,13,O
DDI-DrugBank.d514.s1,with,15,18,O
DDI-DrugBank.d514.s1,other,20,24,O
DDI-DrugBank.d514.s1,central,26,32,B-group
DDI-DrugBank.d514.s1,nervous,34,40,I-group
DDI-DrugBank.d514.s1,system,42,47,I-group
DDI-DrugBank.d514.s1,depressants,49,59,I-group
DDI-DrugBank.d514.s1,",",60,60,O
DDI-DrugBank.d514.s1,heroin,62,67,B-drug_n
DDI-DrugBank.d514.s1,may,69,71,O
DDI-DrugBank.d514.s1,still,73,77,O
DDI-DrugBank.d514.s1,kill,79,82,O
DDI-DrugBank.d514.s1,even,84,87,O
DDI-DrugBank.d514.s1,experienced,89,99,O
DDI-DrugBank.d514.s1,users,101,105,O
DDI-DrugBank.d514.s1,",",106,106,O
DDI-DrugBank.d514.s1,particularly,108,119,O
DDI-DrugBank.d514.s1,if,121,122,O
DDI-DrugBank.d514.s1,their,124,128,O
DDI-DrugBank.d514.s1,tolerance,130,138,O
DDI-DrugBank.d514.s1,to,140,141,O
DDI-DrugBank.d514.s1,the,143,145,O
DDI-DrugBank.d514.s1,drug,147,150,O
DDI-DrugBank.d514.s1,has,152,154,O
DDI-DrugBank.d514.s1,reduced,156,162,O
DDI-DrugBank.d514.s1,or,164,165,O
DDI-DrugBank.d514.s1,the,167,169,O
DDI-DrugBank.d514.s1,strength,171,178,O
DDI-DrugBank.d514.s1,of,180,181,O
DDI-DrugBank.d514.s1,their,183,187,O
DDI-DrugBank.d514.s1,usual,189,193,O
DDI-DrugBank.d514.s1,dose,195,198,O
DDI-DrugBank.d514.s1,has,200,202,O
DDI-DrugBank.d514.s1,increased,204,212,O
DDI-DrugBank.d514.s1,.,213,213,O
DDI-DrugBank.d514.s2,Toxicology,0,9,O
DDI-DrugBank.d514.s2,studies,11,17,O
DDI-DrugBank.d514.s2,of,19,20,O
DDI-DrugBank.d514.s2,heroin-related,22,35,O
DDI-DrugBank.d514.s2,deaths,37,42,O
DDI-DrugBank.d514.s2,reveal,44,49,O
DDI-DrugBank.d514.s2,frequent,51,58,O
DDI-DrugBank.d514.s2,involvement,60,70,O
DDI-DrugBank.d514.s2,of,72,73,O
DDI-DrugBank.d514.s2,other,75,79,O
DDI-DrugBank.d514.s2,central,81,87,B-group
DDI-DrugBank.d514.s2,nervous,89,95,I-group
DDI-DrugBank.d514.s2,system,97,102,I-group
DDI-DrugBank.d514.s2,depressants,104,114,I-group
DDI-DrugBank.d514.s2,",",115,115,O
DDI-DrugBank.d514.s2,including,117,125,O
DDI-DrugBank.d514.s2,alcohol,127,133,B-drug
DDI-DrugBank.d514.s2,",",134,134,O
DDI-DrugBank.d514.s2,benzodiazepines,136,150,B-group
DDI-DrugBank.d514.s2,such,152,155,O
DDI-DrugBank.d514.s2,as,157,158,O
DDI-DrugBank.d514.s2,diazepam,160,167,B-drug
DDI-DrugBank.d514.s2,(,169,169,O
DDI-DrugBank.d514.s2,Valium,170,175,B-brand
DDI-DrugBank.d514.s2,),176,176,O
DDI-DrugBank.d514.s2,",",177,177,O
DDI-DrugBank.d514.s2,and,179,181,O
DDI-DrugBank.d514.s2,",",182,182,O
DDI-DrugBank.d514.s2,to,184,185,O
DDI-DrugBank.d514.s2,a,187,187,O
DDI-DrugBank.d514.s2,rising,189,194,O
DDI-DrugBank.d514.s2,degree,196,201,O
DDI-DrugBank.d514.s2,",",202,202,O
DDI-DrugBank.d514.s2,methadone,204,212,B-drug
DDI-DrugBank.d514.s2,.,213,213,O
DDI-DrugBank.d514.s3,Ironically,0,9,O
DDI-DrugBank.d514.s3,",",10,10,O
DDI-DrugBank.d514.s3,benzodiazepines,12,26,B-group
DDI-DrugBank.d514.s3,are,28,30,O
DDI-DrugBank.d514.s3,often,32,36,O
DDI-DrugBank.d514.s3,used,38,41,O
DDI-DrugBank.d514.s3,in,43,44,O
DDI-DrugBank.d514.s3,the,46,48,O
DDI-DrugBank.d514.s3,treatment,50,58,O
DDI-DrugBank.d514.s3,of,60,61,O
DDI-DrugBank.d514.s3,heroin,63,68,B-drug
DDI-DrugBank.d514.s3,addiction,70,78,O
DDI-DrugBank.d514.s3,while,80,84,O
DDI-DrugBank.d514.s3,they,86,89,O
DDI-DrugBank.d514.s3,cause,91,95,O
DDI-DrugBank.d514.s3,much,97,100,O
DDI-DrugBank.d514.s3,more,102,105,O
DDI-DrugBank.d514.s3,severe,107,112,O
DDI-DrugBank.d514.s3,withdrawal,114,123,O
DDI-DrugBank.d514.s3,symptoms,125,132,O
DDI-DrugBank.d514.s3,.,133,133,O
DDI-DrugBank.d514.s4,Cocaine,0,6,B-drug
DDI-DrugBank.d514.s4,sometimes,8,16,O
DDI-DrugBank.d514.s4,proves,18,23,O
DDI-DrugBank.d514.s4,to,25,26,O
DDI-DrugBank.d514.s4,be,28,29,O
DDI-DrugBank.d514.s4,fatal,31,35,O
DDI-DrugBank.d514.s4,when,37,40,O
DDI-DrugBank.d514.s4,used,42,45,O
DDI-DrugBank.d514.s4,in,47,48,O
DDI-DrugBank.d514.s4,combination,50,60,O
DDI-DrugBank.d514.s4,with,62,65,O
DDI-DrugBank.d514.s4,heroin,67,72,B-drug_n
DDI-DrugBank.d514.s4,.,73,73,O
DDI-DrugBank.d17.s0,Anticoagulants,0,13,B-group
DDI-DrugBank.d17.s0,",",14,14,O
DDI-DrugBank.d17.s0,oral,16,19,O
DDI-DrugBank.d17.s1,(,0,0,O
DDI-DrugBank.d17.s1,Effects,1,7,O
DDI-DrugBank.d17.s1,may,9,11,O
DDI-DrugBank.d17.s1,be,13,14,O
DDI-DrugBank.d17.s1,decreased,16,24,O
DDI-DrugBank.d17.s1,when,26,29,O
DDI-DrugBank.d17.s1,used,31,34,O
DDI-DrugBank.d17.s1,concurrently,36,47,O
DDI-DrugBank.d17.s1,with,49,52,O
DDI-DrugBank.d17.s1,thiazide,54,61,B-group
DDI-DrugBank.d17.s1,diuretics,63,71,I-group
DDI-DrugBank.d17.s1,;,72,72,O
DDI-DrugBank.d17.s2,dosage,0,5,O
DDI-DrugBank.d17.s2,adjustments,7,17,O
DDI-DrugBank.d17.s2,may,19,21,O
DDI-DrugBank.d17.s2,be,23,24,O
DDI-DrugBank.d17.s2,necessary,26,34,O
DDI-DrugBank.d17.s2,.,35,35,O
DDI-DrugBank.d17.s2,),36,36,O
DDI-DrugBank.d17.s3,Antigout,0,7,B-group
DDI-DrugBank.d17.s3,medications,9,19,I-group
DDI-DrugBank.d17.s4,(,0,0,O
DDI-DrugBank.d17.s4,Thiazide,1,8,B-group
DDI-DrugBank.d17.s4,diuretics,10,18,I-group
DDI-DrugBank.d17.s4,may,20,22,O
DDI-DrugBank.d17.s4,raise,24,28,O
DDI-DrugBank.d17.s4,the,30,32,O
DDI-DrugBank.d17.s4,level,34,38,O
DDI-DrugBank.d17.s4,of,40,41,O
DDI-DrugBank.d17.s4,blood,43,47,O
DDI-DrugBank.d17.s4,uric,49,52,O
DDI-DrugBank.d17.s4,acid,54,57,O
DDI-DrugBank.d17.s4,;,58,58,O
DDI-DrugBank.d17.s5,dosage,0,5,O
DDI-DrugBank.d17.s5,adjustment,7,16,O
DDI-DrugBank.d17.s5,of,18,19,O
DDI-DrugBank.d17.s5,antigout,21,28,B-group
DDI-DrugBank.d17.s5,medications,30,40,I-group
DDI-DrugBank.d17.s5,may,42,44,O
DDI-DrugBank.d17.s5,be,46,47,O
DDI-DrugBank.d17.s5,necessary,49,57,O
DDI-DrugBank.d17.s5,to,59,60,O
DDI-DrugBank.d17.s5,control,62,68,O
DDI-DrugBank.d17.s5,hyperuricemia,70,82,O
DDI-DrugBank.d17.s5,and,84,86,O
DDI-DrugBank.d17.s5,gout,88,91,O
DDI-DrugBank.d17.s5,.,92,92,O
DDI-DrugBank.d17.s5,),93,93,O
DDI-DrugBank.d17.s6,Antihypertensive,0,15,B-group
DDI-DrugBank.d17.s6,medications,17,27,I-group
DDI-DrugBank.d17.s6,",",28,28,O
DDI-DrugBank.d17.s6,other,30,34,O
DDI-DrugBank.d17.s6,",",35,35,O
DDI-DrugBank.d17.s6,especially,37,46,O
DDI-DrugBank.d17.s6,diazoxide,48,56,B-drug
DDI-DrugBank.d17.s6,",",57,57,O
DDI-DrugBank.d17.s6,or,59,60,O
DDI-DrugBank.d17.s6,preanesthetic,62,74,O
DDI-DrugBank.d17.s6,and,76,78,O
DDI-DrugBank.d17.s6,anesthetic,80,89,O
DDI-DrugBank.d17.s6,agents,91,96,O
DDI-DrugBank.d17.s6,used,98,101,O
DDI-DrugBank.d17.s6,in,103,104,O
DDI-DrugBank.d17.s6,surgery,106,112,O
DDI-DrugBank.d17.s6,or,114,115,O
DDI-DrugBank.d17.s6,skeletal-muscle,117,131,B-group
DDI-DrugBank.d17.s6,relaxants,133,141,I-group
DDI-DrugBank.d17.s6,",",142,142,O
DDI-DrugBank.d17.s6,nondepolarizing,144,158,O
DDI-DrugBank.d17.s6,",",159,159,O
DDI-DrugBank.d17.s6,used,161,164,O
DDI-DrugBank.d17.s6,in,166,167,O
DDI-DrugBank.d17.s6,surgery,169,175,O
DDI-DrugBank.d17.s7,(,0,0,O
DDI-DrugBank.d17.s7,Effects,1,7,O
DDI-DrugBank.d17.s7,may,9,11,O
DDI-DrugBank.d17.s7,be,13,14,O
DDI-DrugBank.d17.s7,potentiated,16,26,O
DDI-DrugBank.d17.s7,when,28,31,O
DDI-DrugBank.d17.s7,used,33,36,O
DDI-DrugBank.d17.s7,concurrently,38,49,O
DDI-DrugBank.d17.s7,with,51,54,O
DDI-DrugBank.d17.s7,thiazide,56,63,B-group
DDI-DrugBank.d17.s7,diuretics,65,73,I-group
DDI-DrugBank.d17.s7,;,74,74,O
DDI-DrugBank.d17.s8,dosage,0,5,O
DDI-DrugBank.d17.s8,adjustments,7,17,O
DDI-DrugBank.d17.s8,may,19,21,O
DDI-DrugBank.d17.s8,be,23,24,O
DDI-DrugBank.d17.s8,necessary,26,34,O
DDI-DrugBank.d17.s8,.,35,35,O
DDI-DrugBank.d17.s8,),36,36,O
DDI-DrugBank.d17.s9,Amphotericin,0,11,B-drug
DDI-DrugBank.d17.s9,B,13,13,I-drug
DDI-DrugBank.d17.s9,or,15,16,O
DDI-DrugBank.d17.s9,Corticosteroids,18,32,B-group
DDI-DrugBank.d17.s9,or,34,35,O
DDI-DrugBank.d17.s9,Corticotropin,37,49,B-drug
DDI-DrugBank.d17.s9,(,51,51,O
DDI-DrugBank.d17.s9,ACTH,52,55,B-drug
DDI-DrugBank.d17.s9,),56,56,O
DDI-DrugBank.d17.s10,(,0,0,O
DDI-DrugBank.d17.s10,Concurrent,1,10,O
DDI-DrugBank.d17.s10,use,12,14,O
DDI-DrugBank.d17.s10,with,16,19,O
DDI-DrugBank.d17.s10,thiazide,21,28,B-group
DDI-DrugBank.d17.s10,diuretics,30,38,I-group
DDI-DrugBank.d17.s10,may,40,42,O
DDI-DrugBank.d17.s10,intensify,44,52,O
DDI-DrugBank.d17.s10,electrolyte,54,64,O
DDI-DrugBank.d17.s10,imbalance,66,74,O
DDI-DrugBank.d17.s10,",",75,75,O
DDI-DrugBank.d17.s10,particularly,77,88,O
DDI-DrugBank.d17.s10,hypokalemia,90,100,O
DDI-DrugBank.d17.s10,.,101,101,O
DDI-DrugBank.d17.s10,),102,102,O
DDI-DrugBank.d17.s11,Cardiac,0,6,B-group
DDI-DrugBank.d17.s11,glycosides,8,17,I-group
DDI-DrugBank.d17.s12,(,0,0,O
DDI-DrugBank.d17.s12,Concurrent,1,10,O
DDI-DrugBank.d17.s12,use,12,14,O
DDI-DrugBank.d17.s12,with,16,19,O
DDI-DrugBank.d17.s12,thiazide,21,28,B-group
DDI-DrugBank.d17.s12,diuretics,30,38,I-group
DDI-DrugBank.d17.s12,may,40,42,O
DDI-DrugBank.d17.s12,enhance,44,50,O
DDI-DrugBank.d17.s12,the,52,54,O
DDI-DrugBank.d17.s12,possibility,56,66,O
DDI-DrugBank.d17.s12,of,68,69,O
DDI-DrugBank.d17.s12,digitalis,71,79,B-group
DDI-DrugBank.d17.s12,toxicity,81,88,O
DDI-DrugBank.d17.s12,associated,90,99,O
DDI-DrugBank.d17.s12,with,101,104,O
DDI-DrugBank.d17.s12,hypokalemia,106,116,O
DDI-DrugBank.d17.s12,.,117,117,O
DDI-DrugBank.d17.s12,),118,118,O
DDI-DrugBank.d17.s13,Colestipol,0,9,B-drug
DDI-DrugBank.d17.s14,(,0,0,O
DDI-DrugBank.d17.s14,May,1,3,O
DDI-DrugBank.d17.s14,inhibit,5,11,O
DDI-DrugBank.d17.s14,gastrointestinal,13,28,O
DDI-DrugBank.d17.s14,absorption,30,39,O
DDI-DrugBank.d17.s14,of,41,42,O
DDI-DrugBank.d17.s14,the,44,46,O
DDI-DrugBank.d17.s14,thiazide,48,55,B-group
DDI-DrugBank.d17.s14,diuretics,57,65,I-group
DDI-DrugBank.d17.s14,;,66,66,O
DDI-DrugBank.d17.s15,administration,0,13,O
DDI-DrugBank.d17.s15,1,15,15,O
DDI-DrugBank.d17.s15,hour,17,20,O
DDI-DrugBank.d17.s15,before,22,27,O
DDI-DrugBank.d17.s15,or,29,30,O
DDI-DrugBank.d17.s15,4,32,32,O
DDI-DrugBank.d17.s15,hours,34,38,O
DDI-DrugBank.d17.s15,after,40,44,O
DDI-DrugBank.d17.s15,colestipol,46,55,B-drug
DDI-DrugBank.d17.s15,is,57,58,O
DDI-DrugBank.d17.s15,recommended,60,70,O
DDI-DrugBank.d17.s15,.,71,71,O
DDI-DrugBank.d17.s15,),72,72,O
DDI-DrugBank.d17.s16,Hypoglycemics,0,12,B-group
DDI-DrugBank.d17.s17,(,0,0,O
DDI-DrugBank.d17.s17,Thiazide,1,8,B-group
DDI-DrugBank.d17.s17,diuretics,10,18,I-group
DDI-DrugBank.d17.s17,may,20,22,O
DDI-DrugBank.d17.s17,raise,24,28,O
DDI-DrugBank.d17.s17,blood,30,34,O
DDI-DrugBank.d17.s17,glucose,36,42,O
DDI-DrugBank.d17.s17,levels,44,49,O
DDI-DrugBank.d17.s17,;,50,50,O
DDI-DrugBank.d17.s18,for,0,2,O
DDI-DrugBank.d17.s18,adult-onset,4,14,O
DDI-DrugBank.d17.s18,diabetics,16,24,O
DDI-DrugBank.d17.s18,",",25,25,O
DDI-DrugBank.d17.s18,dosage,27,32,O
DDI-DrugBank.d17.s18,adjustment,34,43,O
DDI-DrugBank.d17.s18,of,45,46,O
DDI-DrugBank.d17.s18,hypoglycemic,48,59,B-group
DDI-DrugBank.d17.s18,medications,61,71,I-group
DDI-DrugBank.d17.s18,may,73,75,O
DDI-DrugBank.d17.s18,be,77,78,O
DDI-DrugBank.d17.s18,necessary,80,88,O
DDI-DrugBank.d17.s18,during,90,95,O
DDI-DrugBank.d17.s18,and,97,99,O
DDI-DrugBank.d17.s18,after,101,105,O
DDI-DrugBank.d17.s18,thiazide,107,114,B-group
DDI-DrugBank.d17.s18,diuretic,116,123,I-group
DDI-DrugBank.d17.s18,therapy,125,131,O
DDI-DrugBank.d17.s18,;,132,132,O
DDI-DrugBank.d17.s19,insulin,0,6,B-drug
DDI-DrugBank.d17.s19,requirements,8,19,O
DDI-DrugBank.d17.s19,may,21,23,O
DDI-DrugBank.d17.s19,be,25,26,O
DDI-DrugBank.d17.s19,increased,28,36,O
DDI-DrugBank.d17.s19,",",37,37,O
DDI-DrugBank.d17.s19,decreased,39,47,O
DDI-DrugBank.d17.s19,",",48,48,O
DDI-DrugBank.d17.s19,or,50,51,O
DDI-DrugBank.d17.s19,unchanged,53,61,O
DDI-DrugBank.d17.s19,.,62,62,O
DDI-DrugBank.d17.s19,),63,63,O
DDI-DrugBank.d17.s20,Lithium,0,6,B-drug
DDI-DrugBank.d17.s20,salts,8,12,O
DDI-DrugBank.d17.s21,(,0,0,O
DDI-DrugBank.d17.s21,Concurrent,1,10,O
DDI-DrugBank.d17.s21,use,12,14,O
DDI-DrugBank.d17.s21,with,16,19,O
DDI-DrugBank.d17.s21,thiazide,21,28,B-group
DDI-DrugBank.d17.s21,diuretics,30,38,I-group
DDI-DrugBank.d17.s21,is,40,41,O
DDI-DrugBank.d17.s21,not,43,45,O
DDI-DrugBank.d17.s21,recommended,47,57,O
DDI-DrugBank.d17.s21,",",58,58,O
DDI-DrugBank.d17.s21,as,60,61,O
DDI-DrugBank.d17.s21,they,63,66,O
DDI-DrugBank.d17.s21,may,68,70,O
DDI-DrugBank.d17.s21,provoke,72,78,O
DDI-DrugBank.d17.s21,lithium,80,86,B-drug
DDI-DrugBank.d17.s21,toxicity,88,95,O
DDI-DrugBank.d17.s21,because,97,103,O
DDI-DrugBank.d17.s21,of,105,106,O
DDI-DrugBank.d17.s21,reduced,108,114,O
DDI-DrugBank.d17.s21,renal,116,120,O
DDI-DrugBank.d17.s21,clearance,122,130,O
DDI-DrugBank.d17.s21,.,131,131,O
DDI-DrugBank.d17.s21,),132,132,O
DDI-DrugBank.d17.s22,Methenamine,0,10,B-drug
DDI-DrugBank.d17.s23,(,0,0,O
DDI-DrugBank.d17.s23,Effectiveness,1,13,O
DDI-DrugBank.d17.s23,may,15,17,O
DDI-DrugBank.d17.s23,be,19,20,O
DDI-DrugBank.d17.s23,decreased,22,30,O
DDI-DrugBank.d17.s23,when,32,35,O
DDI-DrugBank.d17.s23,used,37,40,O
DDI-DrugBank.d17.s23,concurrently,42,53,O
DDI-DrugBank.d17.s23,with,55,58,O
DDI-DrugBank.d17.s23,thiazide,60,67,B-group
DDI-DrugBank.d17.s23,diuretics,69,77,I-group
DDI-DrugBank.d17.s23,because,79,85,O
DDI-DrugBank.d17.s23,of,87,88,O
DDI-DrugBank.d17.s23,alkalinization,90,103,O
DDI-DrugBank.d17.s23,of,105,106,O
DDI-DrugBank.d17.s23,the,108,110,O
DDI-DrugBank.d17.s23,urine,112,116,O
DDI-DrugBank.d17.s23,.,117,117,O
DDI-DrugBank.d17.s23,),118,118,O
DDI-DrugBank.d17.s24,Nonsteroidal,0,11,B-group
DDI-DrugBank.d17.s24,anti-inflammatory,13,29,I-group
DDI-DrugBank.d17.s24,agents,31,36,I-group
DDI-DrugBank.d17.s25,(,0,0,O
DDI-DrugBank.d17.s25,In,1,2,O
DDI-DrugBank.d17.s25,some,4,7,O
DDI-DrugBank.d17.s25,patients,9,16,O
DDI-DrugBank.d17.s25,",",17,17,O
DDI-DrugBank.d17.s25,the,19,21,O
DDI-DrugBank.d17.s25,steroidal,23,31,B-group
DDI-DrugBank.d17.s25,anti-inflammatory,33,49,I-group
DDI-DrugBank.d17.s25,agent,51,55,I-group
DDI-DrugBank.d17.s25,can,57,59,O
DDI-DrugBank.d17.s25,reduce,61,66,O
DDI-DrugBank.d17.s25,the,68,70,O
DDI-DrugBank.d17.s25,diuretic,72,79,O
DDI-DrugBank.d17.s25,",",80,80,O
DDI-DrugBank.d17.s25,natriuretic,82,92,O
DDI-DrugBank.d17.s25,",",93,93,O
DDI-DrugBank.d17.s25,and,95,97,O
DDI-DrugBank.d17.s25,antihypertensive,99,114,O
DDI-DrugBank.d17.s25,effects,116,122,O
DDI-DrugBank.d17.s25,of,124,125,O
DDI-DrugBank.d17.s25,loop,127,130,B-group
DDI-DrugBank.d17.s25,",",131,131,O
DDI-DrugBank.d17.s25,potassium,133,141,B-group
DDI-DrugBank.d17.s25,sparing,143,149,I-group
DDI-DrugBank.d17.s25,",",150,150,O
DDI-DrugBank.d17.s25,and,152,154,O
DDI-DrugBank.d17.s25,thiazide,156,163,B-group
DDI-DrugBank.d17.s25,diuretics,165,173,I-group
DDI-DrugBank.d17.s25,.,174,174,O
DDI-DrugBank.d17.s26,Therefore,0,8,O
DDI-DrugBank.d17.s26,",",9,9,O
DDI-DrugBank.d17.s26,when,11,14,O
DDI-DrugBank.d17.s26,hydroflumethiazide,16,33,B-drug
DDI-DrugBank.d17.s26,and,35,37,O
DDI-DrugBank.d17.s26,nonsteroidal,39,50,B-group
DDI-DrugBank.d17.s26,anti-inflammatory,52,68,I-group
DDI-DrugBank.d17.s26,agents,70,75,I-group
DDI-DrugBank.d17.s26,are,77,79,O
DDI-DrugBank.d17.s26,used,81,84,O
DDI-DrugBank.d17.s26,concomitantly,86,98,O
DDI-DrugBank.d17.s26,",",99,99,O
DDI-DrugBank.d17.s26,the,101,103,O
DDI-DrugBank.d17.s26,patient,105,111,O
DDI-DrugBank.d17.s26,should,113,118,O
DDI-DrugBank.d17.s26,be,120,121,O
DDI-DrugBank.d17.s26,observed,123,130,O
DDI-DrugBank.d17.s26,closely,132,138,O
DDI-DrugBank.d17.s26,to,140,141,O
DDI-DrugBank.d17.s26,determine,143,151,O
DDI-DrugBank.d17.s26,if,153,154,O
DDI-DrugBank.d17.s26,the,156,158,O
DDI-DrugBank.d17.s26,desired,160,166,O
DDI-DrugBank.d17.s26,effect,168,173,O
DDI-DrugBank.d17.s26,of,175,176,O
DDI-DrugBank.d17.s26,the,178,180,O
DDI-DrugBank.d17.s26,diuretic,182,189,B-group
DDI-DrugBank.d17.s26,is,191,192,O
DDI-DrugBank.d17.s26,obtained,194,201,O
DDI-DrugBank.d17.s26,.,202,202,O
DDI-DrugBank.d17.s26,),203,203,O
DDI-DrugBank.d17.s27,Norepinephrine,0,13,B-drug
DDI-DrugBank.d17.s28,(,0,0,O
DDI-DrugBank.d17.s28,Thiazides,1,9,B-group
DDI-DrugBank.d17.s28,may,11,13,O
DDI-DrugBank.d17.s28,decrease,15,22,O
DDI-DrugBank.d17.s28,arterial,24,31,O
DDI-DrugBank.d17.s28,responsiveness,33,46,O
DDI-DrugBank.d17.s28,to,48,49,O
DDI-DrugBank.d17.s28,norepinephrine,51,64,B-drug
DDI-DrugBank.d17.s28,.,65,65,O
DDI-DrugBank.d17.s29,This,0,3,O
DDI-DrugBank.d17.s29,diminution,5,14,O
DDI-DrugBank.d17.s29,is,16,17,O
DDI-DrugBank.d17.s29,not,19,21,O
DDI-DrugBank.d17.s29,sufficient,23,32,O
DDI-DrugBank.d17.s29,to,34,35,O
DDI-DrugBank.d17.s29,preclude,37,44,O
DDI-DrugBank.d17.s29,effectiveness,46,58,O
DDI-DrugBank.d17.s29,of,60,61,O
DDI-DrugBank.d17.s29,the,63,65,O
DDI-DrugBank.d17.s29,pressor,67,73,O
DDI-DrugBank.d17.s29,agent,75,79,O
DDI-DrugBank.d17.s29,for,81,83,O
DDI-DrugBank.d17.s29,therapeutic,85,95,O
DDI-DrugBank.d17.s29,use,97,99,O
DDI-DrugBank.d17.s29,.,100,100,O
DDI-DrugBank.d17.s29,),101,101,O
DDI-DrugBank.d17.s30,Tubocurarine,0,11,B-drug
DDI-DrugBank.d17.s31,(,0,0,O
DDI-DrugBank.d17.s31,Thiazide,1,8,B-group
DDI-DrugBank.d17.s31,drugs,10,14,I-group
DDI-DrugBank.d17.s31,may,16,18,O
DDI-DrugBank.d17.s31,increase,20,27,O
DDI-DrugBank.d17.s31,the,29,31,O
DDI-DrugBank.d17.s31,responsiveness,33,46,O
DDI-DrugBank.d17.s31,to,48,49,O
DDI-DrugBank.d17.s31,tubocurarine,51,62,B-drug
DDI-DrugBank.d17.s31,.,63,63,O
DDI-DrugBank.d17.s31,),64,64,O
DDI-DrugBank.d17.s32,DIAGNOSTIC,0,9,O
DDI-DrugBank.d17.s32,INTERFERENCE,11,22,O
DDI-DrugBank.d17.s32,With,24,27,O
DDI-DrugBank.d17.s32,expected,29,36,O
DDI-DrugBank.d17.s32,physiologic,38,48,O
DDI-DrugBank.d17.s32,effects,50,56,O
DDI-DrugBank.d17.s32,:,57,57,O
DDI-DrugBank.d17.s32,Blood,59,63,O
DDI-DrugBank.d17.s32,and,65,67,O
DDI-DrugBank.d17.s32,urine,69,73,O
DDI-DrugBank.d17.s32,glucose,75,81,O
DDI-DrugBank.d17.s32,levels,83,88,O
DDI-DrugBank.d17.s32,(,90,90,O
DDI-DrugBank.d17.s32,usually,91,97,O
DDI-DrugBank.d17.s32,only,99,102,O
DDI-DrugBank.d17.s32,in,104,105,O
DDI-DrugBank.d17.s32,patients,107,114,O
DDI-DrugBank.d17.s32,with,116,119,O
DDI-DrugBank.d17.s32,a,121,121,O
DDI-DrugBank.d17.s32,predisposition,123,136,O
DDI-DrugBank.d17.s32,for,138,140,O
DDI-DrugBank.d17.s32,glucose,142,148,O
DDI-DrugBank.d17.s32,intolerance,150,160,O
DDI-DrugBank.d17.s32,),161,161,O
DDI-DrugBank.d17.s32,and,163,165,O
DDI-DrugBank.d17.s32,Serum,167,171,O
DDI-DrugBank.d17.s32,bilirubin,173,181,O
DDI-DrugBank.d17.s32,levels,183,188,O
DDI-DrugBank.d17.s32,(,190,190,O
DDI-DrugBank.d17.s32,by,191,192,O
DDI-DrugBank.d17.s32,displacement,194,205,O
DDI-DrugBank.d17.s32,from,207,210,O
DDI-DrugBank.d17.s32,albumin,212,218,O
DDI-DrugBank.d17.s32,binding,220,226,O
DDI-DrugBank.d17.s32,),227,227,O
DDI-DrugBank.d17.s32,and,229,231,O
DDI-DrugBank.d17.s32,Serum,233,237,O
DDI-DrugBank.d17.s32,calcium,239,245,O
DDI-DrugBank.d17.s32,levels,247,252,O
DDI-DrugBank.d17.s32,(,254,254,O
DDI-DrugBank.d17.s32,thiazide,255,262,B-group
DDI-DrugBank.d17.s32,diuretics,264,272,I-group
DDI-DrugBank.d17.s32,should,274,279,O
DDI-DrugBank.d17.s32,be,281,282,O
DDI-DrugBank.d17.s32,discontinued,284,295,O
DDI-DrugBank.d17.s32,before,297,302,O
DDI-DrugBank.d17.s32,parathyroid-function,304,323,O
DDI-DrugBank.d17.s32,tests,325,329,O
DDI-DrugBank.d17.s32,are,331,333,O
DDI-DrugBank.d17.s32,carried,335,341,O
DDI-DrugBank.d17.s32,out,343,345,O
DDI-DrugBank.d17.s32,),346,346,O
DDI-DrugBank.d17.s32,and,348,350,O
DDI-DrugBank.d17.s32,Serum,352,356,O
DDI-DrugBank.d17.s32,uric,358,361,O
DDI-DrugBank.d17.s32,acid,363,366,O
DDI-DrugBank.d17.s32,levels,368,373,O
DDI-DrugBank.d17.s32,(,375,375,O
DDI-DrugBank.d17.s32,may,376,378,O
DDI-DrugBank.d17.s32,be,380,381,O
DDI-DrugBank.d17.s32,increased,383,391,O
DDI-DrugBank.d17.s32,),392,392,O
DDI-DrugBank.d17.s32,Serum,394,398,O
DDI-DrugBank.d17.s32,magnesium,400,408,O
DDI-DrugBank.d17.s32,",",409,409,O
DDI-DrugBank.d17.s32,potassium,411,419,O
DDI-DrugBank.d17.s32,",",420,420,O
DDI-DrugBank.d17.s32,and,422,424,O
DDI-DrugBank.d17.s32,sodium,426,431,O
DDI-DrugBank.d17.s32,levels,433,438,O
DDI-DrugBank.d17.s32,(,440,440,O
DDI-DrugBank.d17.s32,may,441,443,O
DDI-DrugBank.d17.s32,be,445,446,O
DDI-DrugBank.d17.s32,decreased,448,456,O
DDI-DrugBank.d17.s32,;,457,457,O
DDI-DrugBank.d17.s33,serum,0,4,O
DDI-DrugBank.d17.s33,magnesium,6,14,O
DDI-DrugBank.d17.s33,levels,16,21,O
DDI-DrugBank.d17.s33,may,23,25,O
DDI-DrugBank.d17.s33,increase,27,34,O
DDI-DrugBank.d17.s33,in,36,37,O
DDI-DrugBank.d17.s33,uremic,39,44,O
DDI-DrugBank.d17.s33,patients,46,53,O
DDI-DrugBank.d17.s33,),54,54,O
DDI-DrugBank.d17.s33,Serum,56,60,O
DDI-DrugBank.d17.s33,protein-bound,62,74,O
DDI-DrugBank.d17.s33,iodine,76,81,O
DDI-DrugBank.d17.s33,(,83,83,O
DDI-DrugBank.d17.s33,PBI,84,86,O
DDI-DrugBank.d17.s33,),87,87,O
DDI-DrugBank.d17.s33,levels,89,94,O
DDI-DrugBank.d17.s33,(,96,96,O
DDI-DrugBank.d17.s33,may,97,99,O
DDI-DrugBank.d17.s33,be,101,102,O
DDI-DrugBank.d17.s33,decreased,104,112,O
DDI-DrugBank.d17.s33,),113,113,O
DDI-DrugBank.d17.s33,Thiazides,115,123,B-group
DDI-DrugBank.d17.s33,should,125,130,O
DDI-DrugBank.d17.s33,be,132,133,O
DDI-DrugBank.d17.s33,discontinued,135,146,O
DDI-DrugBank.d17.s33,before,148,153,O
DDI-DrugBank.d17.s33,carrying,155,162,O
DDI-DrugBank.d17.s33,out,164,166,O
DDI-DrugBank.d17.s33,tests,168,172,O
DDI-DrugBank.d17.s33,for,174,176,O
DDI-DrugBank.d17.s33,parathyroid,178,188,O
DDI-DrugBank.d17.s33,function,190,197,O
DDI-DrugBank.d17.s33,.,198,198,O
DDI-DrugBank.d418.s0,No,0,1,O
DDI-DrugBank.d418.s0,formal,3,8,O
DDI-DrugBank.d418.s0,drug,10,13,O
DDI-DrugBank.d418.s0,interaction,15,25,O
DDI-DrugBank.d418.s0,studies,27,33,O
DDI-DrugBank.d418.s0,have,35,38,O
DDI-DrugBank.d418.s0,been,40,43,O
DDI-DrugBank.d418.s0,conducted,45,53,O
DDI-DrugBank.d418.s0,with,55,58,O
DDI-DrugBank.d418.s0,Cyanokit,60,67,B-brand
DDI-DrugBank.d418.s0,.,68,68,O
DDI-DrugBank.d308.s0,THE,0,2,O
DDI-DrugBank.d308.s0,POTENTIATING,4,15,O
DDI-DrugBank.d308.s0,ACTION,17,22,O
DDI-DrugBank.d308.s0,OF,24,25,O
DDI-DrugBank.d308.s0,HYDROXYZINE,27,37,B-drug
DDI-DrugBank.d308.s0,MUST,39,42,O
DDI-DrugBank.d308.s0,BE,44,45,O
DDI-DrugBank.d308.s0,CONSIDERED,47,56,O
DDI-DrugBank.d308.s0,WHEN,58,61,O
DDI-DrugBank.d308.s0,THE,63,65,O
DDI-DrugBank.d308.s0,DRUG,67,70,O
DDI-DrugBank.d308.s0,IS,72,73,O
DDI-DrugBank.d308.s0,USED,75,78,O
DDI-DrugBank.d308.s0,IN,80,81,O
DDI-DrugBank.d308.s0,CONJUNCTION,83,93,O
DDI-DrugBank.d308.s0,WITH,95,98,O
DDI-DrugBank.d308.s0,CENTRAL,100,106,B-group
DDI-DrugBank.d308.s0,NERVOUS,108,114,I-group
DDI-DrugBank.d308.s0,SYSTEM,116,121,I-group
DDI-DrugBank.d308.s0,DEPRESSANTS,123,133,I-group
DDI-DrugBank.d308.s0,SUCH,135,138,O
DDI-DrugBank.d308.s0,AS,140,141,O
DDI-DrugBank.d308.s0,NARCOTICS,143,151,B-group
DDI-DrugBank.d308.s0,",",152,152,O
DDI-DrugBank.d308.s0,NON-NARCOTIC,154,165,B-group
DDI-DrugBank.d308.s0,ANALGESICS,167,176,I-group
DDI-DrugBank.d308.s0,AND,178,180,O
DDI-DrugBank.d308.s0,BARBITURATES,182,193,B-group
DDI-DrugBank.d308.s0,.,194,194,O
DDI-DrugBank.d308.s1,Therefore,0,8,O
DDI-DrugBank.d308.s1,when,10,13,O
DDI-DrugBank.d308.s1,central,15,21,B-group
DDI-DrugBank.d308.s1,nervous,23,29,I-group
DDI-DrugBank.d308.s1,system,31,36,I-group
DDI-DrugBank.d308.s1,depressants,38,48,I-group
DDI-DrugBank.d308.s1,are,50,52,O
DDI-DrugBank.d308.s1,administered,54,65,O
DDI-DrugBank.d308.s1,concomitantly,67,79,O
DDI-DrugBank.d308.s1,with,81,84,O
DDI-DrugBank.d308.s1,hydroxyzine,86,96,B-drug
DDI-DrugBank.d308.s1,their,98,102,O
DDI-DrugBank.d308.s1,dosage,104,109,O
DDI-DrugBank.d308.s1,should,111,116,O
DDI-DrugBank.d308.s1,be,118,119,O
DDI-DrugBank.d308.s1,reduced,121,127,O
DDI-DrugBank.d308.s1,.,128,128,O
DDI-DrugBank.d308.s2,Since,0,4,O
DDI-DrugBank.d308.s2,drowsiness,6,15,O
DDI-DrugBank.d308.s2,may,17,19,O
DDI-DrugBank.d308.s2,occur,21,25,O
DDI-DrugBank.d308.s2,with,27,30,O
DDI-DrugBank.d308.s2,use,32,34,O
DDI-DrugBank.d308.s2,of,36,37,O
DDI-DrugBank.d308.s2,this,39,42,O
DDI-DrugBank.d308.s2,drug,44,47,O
DDI-DrugBank.d308.s2,",",48,48,O
DDI-DrugBank.d308.s2,patients,50,57,O
DDI-DrugBank.d308.s2,should,59,64,O
DDI-DrugBank.d308.s2,be,66,67,O
DDI-DrugBank.d308.s2,warned,69,74,O
DDI-DrugBank.d308.s2,of,76,77,O
DDI-DrugBank.d308.s2,this,79,82,O
DDI-DrugBank.d308.s2,possibility,84,94,O
DDI-DrugBank.d308.s2,and,96,98,O
DDI-DrugBank.d308.s2,cautioned,100,108,O
DDI-DrugBank.d308.s2,against,110,116,O
DDI-DrugBank.d308.s2,driving,118,124,O
DDI-DrugBank.d308.s2,a,126,126,O
DDI-DrugBank.d308.s2,car,128,130,O
DDI-DrugBank.d308.s2,or,132,133,O
DDI-DrugBank.d308.s2,operating,135,143,O
DDI-DrugBank.d308.s2,dangerous,145,153,O
DDI-DrugBank.d308.s2,machinery,155,163,O
DDI-DrugBank.d308.s2,while,165,169,O
DDI-DrugBank.d308.s2,taking,171,176,O
DDI-DrugBank.d308.s2,Atarax,178,183,B-brand
DDI-DrugBank.d308.s2,.,184,184,O
DDI-DrugBank.d308.s3,Patients,0,7,O
DDI-DrugBank.d308.s3,should,9,14,O
DDI-DrugBank.d308.s3,be,16,17,O
DDI-DrugBank.d308.s3,advised,19,25,O
DDI-DrugBank.d308.s3,against,27,33,O
DDI-DrugBank.d308.s3,the,35,37,O
DDI-DrugBank.d308.s3,simultaneous,39,50,O
DDI-DrugBank.d308.s3,use,52,54,O
DDI-DrugBank.d308.s3,of,56,57,O
DDI-DrugBank.d308.s3,other,59,63,O
DDI-DrugBank.d308.s3,CNS,65,67,B-group
DDI-DrugBank.d308.s3,depressant,69,78,I-group
DDI-DrugBank.d308.s3,drugs,80,84,I-group
DDI-DrugBank.d308.s3,",",85,85,O
DDI-DrugBank.d308.s3,and,87,89,O
DDI-DrugBank.d308.s3,cautioned,91,99,O
DDI-DrugBank.d308.s3,that,101,104,O
DDI-DrugBank.d308.s3,the,106,108,O
DDI-DrugBank.d308.s3,effect,110,115,O
DDI-DrugBank.d308.s3,of,117,118,O
DDI-DrugBank.d308.s3,alcohol,120,126,B-drug
DDI-DrugBank.d308.s3,may,128,130,O
DDI-DrugBank.d308.s3,be,132,133,O
DDI-DrugBank.d308.s3,increased,135,143,O
DDI-DrugBank.d308.s3,.,144,144,O
DDI-DrugBank.d515.s0,The,0,2,O
DDI-DrugBank.d515.s0,physician,4,12,O
DDI-DrugBank.d515.s0,should,14,19,O
DDI-DrugBank.d515.s0,be,21,22,O
DDI-DrugBank.d515.s0,alert,24,28,O
DDI-DrugBank.d515.s0,for,30,32,O
DDI-DrugBank.d515.s0,possible,34,41,O
DDI-DrugBank.d515.s0,combined,43,50,O
DDI-DrugBank.d515.s0,drug,52,55,O
DDI-DrugBank.d515.s0,actions,57,63,O
DDI-DrugBank.d515.s0,",",64,64,O
DDI-DrugBank.d515.s0,desirable,66,74,O
DDI-DrugBank.d515.s0,or,76,77,O
DDI-DrugBank.d515.s0,undesirable,79,89,O
DDI-DrugBank.d515.s0,",",90,90,O
DDI-DrugBank.d515.s0,involving,92,100,O
DDI-DrugBank.d515.s0,ifosfamide,102,111,B-drug
DDI-DrugBank.d515.s0,even,113,116,O
DDI-DrugBank.d515.s0,though,118,123,O
DDI-DrugBank.d515.s0,ifosfamide,125,134,B-drug
DDI-DrugBank.d515.s0,has,136,138,O
DDI-DrugBank.d515.s0,been,140,143,O
DDI-DrugBank.d515.s0,used,145,148,O
DDI-DrugBank.d515.s0,successfully,150,161,O
DDI-DrugBank.d515.s0,concurrently,163,174,O
DDI-DrugBank.d515.s0,with,176,179,O
DDI-DrugBank.d515.s0,other,181,185,O
DDI-DrugBank.d515.s0,drugs,187,191,O
DDI-DrugBank.d515.s0,",",192,192,O
DDI-DrugBank.d515.s0,including,194,202,O
DDI-DrugBank.d515.s0,other,204,208,O
DDI-DrugBank.d515.s0,cytotoxic,210,218,O
DDI-DrugBank.d515.s0,drugs,220,224,O
DDI-DrugBank.d515.s0,.,225,225,O
DDI-DrugBank.d549.s0,In,0,1,O
DDI-DrugBank.d549.s0,studies,3,9,O
DDI-DrugBank.d549.s0,in,11,12,O
DDI-DrugBank.d549.s0,normal,14,19,O
DDI-DrugBank.d549.s0,volunteers,21,30,O
DDI-DrugBank.d549.s0,",",31,31,O
DDI-DrugBank.d549.s0,there,33,37,O
DDI-DrugBank.d549.s0,was,39,41,O
DDI-DrugBank.d549.s0,no,43,44,O
DDI-DrugBank.d549.s0,pharmacodynamic,46,60,O
DDI-DrugBank.d549.s0,interaction,62,72,O
DDI-DrugBank.d549.s0,between,74,80,O
DDI-DrugBank.d549.s0,intravenous,82,92,O
DDI-DrugBank.d549.s0,iloprost,94,101,B-drug
DDI-DrugBank.d549.s0,and,103,105,O
DDI-DrugBank.d549.s0,either,107,112,O
DDI-DrugBank.d549.s0,nifedipine,114,123,B-drug
DDI-DrugBank.d549.s0,",",124,124,O
DDI-DrugBank.d549.s0,diltiazem,126,134,B-drug
DDI-DrugBank.d549.s0,",",135,135,O
DDI-DrugBank.d549.s0,or,137,138,O
DDI-DrugBank.d549.s0,captopril,140,148,B-drug
DDI-DrugBank.d549.s0,.,149,149,O
DDI-DrugBank.d549.s1,However,0,6,O
DDI-DrugBank.d549.s1,",",7,7,O
DDI-DrugBank.d549.s1,iloprost,9,16,B-drug
DDI-DrugBank.d549.s1,has,18,20,O
DDI-DrugBank.d549.s1,the,22,24,O
DDI-DrugBank.d549.s1,potential,26,34,O
DDI-DrugBank.d549.s1,to,36,37,O
DDI-DrugBank.d549.s1,increase,39,46,O
DDI-DrugBank.d549.s1,the,48,50,O
DDI-DrugBank.d549.s1,hypotensive,52,62,O
DDI-DrugBank.d549.s1,effect,64,69,O
DDI-DrugBank.d549.s1,of,71,72,O
DDI-DrugBank.d549.s1,vasodilators,74,85,B-group
DDI-DrugBank.d549.s1,and,87,89,O
DDI-DrugBank.d549.s1,antihypertensive,91,106,B-group
DDI-DrugBank.d549.s1,agents,108,113,I-group
DDI-DrugBank.d549.s1,.,114,114,O
DDI-DrugBank.d549.s2,Since,0,4,O
DDI-DrugBank.d549.s2,iloprost,6,13,B-drug
DDI-DrugBank.d549.s2,inhibits,15,22,O
DDI-DrugBank.d549.s2,platelet,24,31,O
DDI-DrugBank.d549.s2,function,33,40,O
DDI-DrugBank.d549.s2,",",41,41,O
DDI-DrugBank.d549.s2,there,43,47,O
DDI-DrugBank.d549.s2,is,49,50,O
DDI-DrugBank.d549.s2,a,52,52,O
DDI-DrugBank.d549.s2,potential,54,62,O
DDI-DrugBank.d549.s2,for,64,66,O
DDI-DrugBank.d549.s2,increased,68,76,O
DDI-DrugBank.d549.s2,risk,78,81,O
DDI-DrugBank.d549.s2,of,83,84,O
DDI-DrugBank.d549.s2,bleeding,86,93,O
DDI-DrugBank.d549.s2,",",94,94,O
DDI-DrugBank.d549.s2,particularly,96,107,O
DDI-DrugBank.d549.s2,in,109,110,O
DDI-DrugBank.d549.s2,patients,112,119,O
DDI-DrugBank.d549.s2,maintained,121,130,O
DDI-DrugBank.d549.s2,on,132,133,O
DDI-DrugBank.d549.s2,anticoagulants,135,148,B-group
DDI-DrugBank.d549.s2,.,149,149,O
DDI-DrugBank.d549.s3,During,0,5,O
DDI-DrugBank.d549.s3,clinical,7,14,O
DDI-DrugBank.d549.s3,trials,16,21,O
DDI-DrugBank.d549.s3,",",22,22,O
DDI-DrugBank.d549.s3,iloprost,24,31,B-drug
DDI-DrugBank.d549.s3,was,33,35,O
DDI-DrugBank.d549.s3,used,37,40,O
DDI-DrugBank.d549.s3,concurrently,42,53,O
DDI-DrugBank.d549.s3,with,55,58,O
DDI-DrugBank.d549.s3,anticoagulants,60,73,B-group
DDI-DrugBank.d549.s3,",",74,74,O
DDI-DrugBank.d549.s3,diuretics,76,84,B-group
DDI-DrugBank.d549.s3,",",85,85,O
DDI-DrugBank.d549.s3,cardiac,87,93,B-group
DDI-DrugBank.d549.s3,glycosides,95,104,I-group
DDI-DrugBank.d549.s3,",",105,105,O
DDI-DrugBank.d549.s3,calcium,107,113,B-group
DDI-DrugBank.d549.s3,channel,115,121,I-group
DDI-DrugBank.d549.s3,blockers,123,130,I-group
DDI-DrugBank.d549.s3,",",131,131,O
DDI-DrugBank.d549.s3,analgesics,133,142,B-group
DDI-DrugBank.d549.s3,",",143,143,O
DDI-DrugBank.d549.s3,antipyretics,145,156,B-group
DDI-DrugBank.d549.s3,",",157,157,O
DDI-DrugBank.d549.s3,nonsteroidal,159,170,B-group
DDI-DrugBank.d549.s3,antiinflammatories,172,189,I-group
DDI-DrugBank.d549.s3,",",190,190,O
DDI-DrugBank.d549.s3,corticosteroids,192,206,B-group
DDI-DrugBank.d549.s3,",",207,207,O
DDI-DrugBank.d549.s3,and,209,211,O
DDI-DrugBank.d549.s3,other,213,217,O
DDI-DrugBank.d549.s3,medications,219,229,O
DDI-DrugBank.d549.s3,.,230,230,O
DDI-DrugBank.d549.s4,Intravenous,0,10,O
DDI-DrugBank.d549.s4,infusion,12,19,O
DDI-DrugBank.d549.s4,of,21,22,O
DDI-DrugBank.d549.s4,iloprost,24,31,B-drug
DDI-DrugBank.d549.s4,had,33,35,O
DDI-DrugBank.d549.s4,no,37,38,O
DDI-DrugBank.d549.s4,effect,40,45,O
DDI-DrugBank.d549.s4,on,47,48,O
DDI-DrugBank.d549.s4,the,50,52,O
DDI-DrugBank.d549.s4,pharmacokinetics,54,69,O
DDI-DrugBank.d549.s4,of,71,72,O
DDI-DrugBank.d549.s4,digoxin,74,80,B-drug
DDI-DrugBank.d549.s4,.,81,81,O
DDI-DrugBank.d549.s5,Acetylsalicylic,0,14,B-drug
DDI-DrugBank.d549.s5,acid,16,19,I-drug
DDI-DrugBank.d549.s5,did,21,23,O
DDI-DrugBank.d549.s5,not,25,27,O
DDI-DrugBank.d549.s5,alter,29,33,O
DDI-DrugBank.d549.s5,the,35,37,O
DDI-DrugBank.d549.s5,clearance,39,47,O
DDI-DrugBank.d549.s5,(,49,49,O
DDI-DrugBank.d549.s5,pharmacokinetics,50,65,O
DDI-DrugBank.d549.s5,),66,66,O
DDI-DrugBank.d549.s5,of,68,69,O
DDI-DrugBank.d549.s5,iloprost,71,78,B-drug
DDI-DrugBank.d549.s5,.,79,79,O
DDI-DrugBank.d549.s6,Although,0,7,O
DDI-DrugBank.d549.s6,clinical,9,16,O
DDI-DrugBank.d549.s6,studies,18,24,O
DDI-DrugBank.d549.s6,have,26,29,O
DDI-DrugBank.d549.s6,not,31,33,O
DDI-DrugBank.d549.s6,been,35,38,O
DDI-DrugBank.d549.s6,conducted,40,48,O
DDI-DrugBank.d549.s6,",",49,49,O
DDI-DrugBank.d549.s6,in,51,52,O
DDI-DrugBank.d549.s6,vitro,54,58,O
DDI-DrugBank.d549.s6,studies,60,66,O
DDI-DrugBank.d549.s6,of,68,69,O
DDI-DrugBank.d549.s6,iloprost,71,78,B-drug
DDI-DrugBank.d549.s6,indicate,80,87,O
DDI-DrugBank.d549.s6,that,89,92,O
DDI-DrugBank.d549.s6,no,94,95,O
DDI-DrugBank.d549.s6,relevant,97,104,O
DDI-DrugBank.d549.s6,inhibition,106,115,O
DDI-DrugBank.d549.s6,of,117,118,O
DDI-DrugBank.d549.s6,cytochrome,120,129,O
DDI-DrugBank.d549.s6,P450,131,134,O
DDI-DrugBank.d549.s6,drug,136,139,O
DDI-DrugBank.d549.s6,metabolism,141,150,O
DDI-DrugBank.d549.s6,would,152,156,O
DDI-DrugBank.d549.s6,be,158,159,O
DDI-DrugBank.d549.s6,expected,161,168,O
DDI-DrugBank.d549.s6,.,169,169,O
DDI-DrugBank.d97.s0,Indinavir,0,8,B-drug
DDI-DrugBank.d97.s0,is,10,11,O
DDI-DrugBank.d97.s0,an,13,14,O
DDI-DrugBank.d97.s0,inhibitor,16,24,O
DDI-DrugBank.d97.s0,of,26,27,O
DDI-DrugBank.d97.s0,the,29,31,O
DDI-DrugBank.d97.s0,cytochrome,33,42,O
DDI-DrugBank.d97.s0,P450,44,47,O
DDI-DrugBank.d97.s0,isoform,49,55,O
DDI-DrugBank.d97.s0,CYP3A4,57,62,O
DDI-DrugBank.d97.s0,.,63,63,O
DDI-DrugBank.d97.s1,Coadministration,0,15,O
DDI-DrugBank.d97.s1,of,17,18,O
DDI-DrugBank.d97.s1,CRIXIVAN,20,27,B-brand
DDI-DrugBank.d97.s1,and,29,31,O
DDI-DrugBank.d97.s1,drugs,33,37,O
DDI-DrugBank.d97.s1,primarily,39,47,O
DDI-DrugBank.d97.s1,metabolized,49,59,O
DDI-DrugBank.d97.s1,by,61,62,O
DDI-DrugBank.d97.s1,CYP3A4,64,69,O
DDI-DrugBank.d97.s1,may,71,73,O
DDI-DrugBank.d97.s1,result,75,80,O
DDI-DrugBank.d97.s1,in,82,83,O
DDI-DrugBank.d97.s1,increased,85,93,O
DDI-DrugBank.d97.s1,plasma,95,100,O
DDI-DrugBank.d97.s1,concentrations,102,115,O
DDI-DrugBank.d97.s1,of,117,118,O
DDI-DrugBank.d97.s1,the,120,122,O
DDI-DrugBank.d97.s1,other,124,128,O
DDI-DrugBank.d97.s1,drug,130,133,O
DDI-DrugBank.d97.s1,",",134,134,O
DDI-DrugBank.d97.s1,which,136,140,O
DDI-DrugBank.d97.s1,could,142,146,O
DDI-DrugBank.d97.s1,increase,148,155,O
DDI-DrugBank.d97.s1,or,157,158,O
DDI-DrugBank.d97.s1,prolong,160,166,O
DDI-DrugBank.d97.s1,its,168,170,O
DDI-DrugBank.d97.s1,therapeutic,172,182,O
DDI-DrugBank.d97.s1,and,184,186,O
DDI-DrugBank.d97.s1,adverse,188,194,O
DDI-DrugBank.d97.s1,effects,196,202,O
DDI-DrugBank.d97.s1,.,203,203,O
DDI-DrugBank.d97.s2,Indinavir,0,8,B-drug
DDI-DrugBank.d97.s2,is,10,11,O
DDI-DrugBank.d97.s2,metabolized,13,23,O
DDI-DrugBank.d97.s2,by,25,26,O
DDI-DrugBank.d97.s2,CYP3A4,28,33,O
DDI-DrugBank.d97.s2,.,34,34,O
DDI-DrugBank.d97.s3,Drugs,0,4,O
DDI-DrugBank.d97.s3,that,6,9,O
DDI-DrugBank.d97.s3,induce,11,16,O
DDI-DrugBank.d97.s3,CYP3A4,18,23,O
DDI-DrugBank.d97.s3,activity,25,32,O
DDI-DrugBank.d97.s3,would,34,38,O
DDI-DrugBank.d97.s3,be,40,41,O
DDI-DrugBank.d97.s3,expected,43,50,O
DDI-DrugBank.d97.s3,to,52,53,O
DDI-DrugBank.d97.s3,increase,55,62,O
DDI-DrugBank.d97.s3,the,64,66,O
DDI-DrugBank.d97.s3,clearance,68,76,O
DDI-DrugBank.d97.s3,of,78,79,O
DDI-DrugBank.d97.s3,indinavir,81,89,B-drug
DDI-DrugBank.d97.s3,",",90,90,O
DDI-DrugBank.d97.s3,resulting,92,100,O
DDI-DrugBank.d97.s3,in,102,103,O
DDI-DrugBank.d97.s3,lowered,105,111,O
DDI-DrugBank.d97.s3,plasma,113,118,O
DDI-DrugBank.d97.s3,concentrations,120,133,O
DDI-DrugBank.d97.s3,of,135,136,O
DDI-DrugBank.d97.s3,indinavir,138,146,B-drug
DDI-DrugBank.d97.s3,.,147,147,O
DDI-DrugBank.d97.s4,Coadministration,0,15,O
DDI-DrugBank.d97.s4,of,17,18,O
DDI-DrugBank.d97.s4,CRIXIVAN,20,27,B-brand
DDI-DrugBank.d97.s4,and,29,31,O
DDI-DrugBank.d97.s4,other,33,37,O
DDI-DrugBank.d97.s4,drugs,39,43,O
DDI-DrugBank.d97.s4,that,45,48,O
DDI-DrugBank.d97.s4,inhibit,50,56,O
DDI-DrugBank.d97.s4,CYP3A4,58,63,O
DDI-DrugBank.d97.s4,may,65,67,O
DDI-DrugBank.d97.s4,decrease,69,76,O
DDI-DrugBank.d97.s4,the,78,80,O
DDI-DrugBank.d97.s4,clearance,82,90,O
DDI-DrugBank.d97.s4,of,92,93,O
DDI-DrugBank.d97.s4,indinavir,95,103,B-drug
DDI-DrugBank.d97.s4,and,105,107,O
DDI-DrugBank.d97.s4,may,109,111,O
DDI-DrugBank.d97.s4,result,113,118,O
DDI-DrugBank.d97.s4,in,120,121,O
DDI-DrugBank.d97.s4,increased,123,131,O
DDI-DrugBank.d97.s4,plasma,133,138,O
DDI-DrugBank.d97.s4,concentrations,140,153,O
DDI-DrugBank.d97.s4,of,155,156,O
DDI-DrugBank.d97.s4,indinavir,158,166,B-drug
DDI-DrugBank.d97.s4,.,167,167,O
DDI-DrugBank.d97.s5,Table,0,4,O
DDI-DrugBank.d97.s5,8,6,6,O
DDI-DrugBank.d97.s6,Drugs,0,4,O
DDI-DrugBank.d97.s6,That,6,9,O
DDI-DrugBank.d97.s6,Should,11,16,O
DDI-DrugBank.d97.s6,Not,18,20,O
DDI-DrugBank.d97.s6,Be,22,23,O
DDI-DrugBank.d97.s6,Coadministered,25,38,O
DDI-DrugBank.d97.s6,with,40,43,O
DDI-DrugBank.d97.s6,CRIXIVAN,45,52,B-brand
DDI-DrugBank.d97.s7,Drug,0,3,O
DDI-DrugBank.d97.s7,Class,5,9,O
DDI-DrugBank.d97.s7,:,10,10,O
DDI-DrugBank.d97.s7,Drug,12,15,O
DDI-DrugBank.d97.s7,Name,17,20,O
DDI-DrugBank.d97.s7,Clinical,22,29,O
DDI-DrugBank.d97.s7,Comment,31,37,O
DDI-DrugBank.d97.s8,Antiarrhythmics,0,14,B-group
DDI-DrugBank.d97.s8,:,15,15,O
DDI-DrugBank.d97.s8,amiodarone,17,26,B-drug
DDI-DrugBank.d97.s9,CONTRAINDICATED,0,14,O
DDI-DrugBank.d97.s9,due,16,18,O
DDI-DrugBank.d97.s9,to,20,21,O
DDI-DrugBank.d97.s9,potential,23,31,O
DDI-DrugBank.d97.s9,for,33,35,O
DDI-DrugBank.d97.s9,serious,37,43,O
DDI-DrugBank.d97.s9,and/or,45,50,O
DDI-DrugBank.d97.s9,life-threatening,52,67,O
DDI-DrugBank.d97.s9,reactions,69,77,O
DDI-DrugBank.d97.s9,such,79,82,O
DDI-DrugBank.d97.s9,as,84,85,O
DDI-DrugBank.d97.s9,cardiac,87,93,O
DDI-DrugBank.d97.s9,arrhythmias,95,105,O
DDI-DrugBank.d97.s9,.,106,106,O
DDI-DrugBank.d97.s10,Ergot,0,4,O
DDI-DrugBank.d97.s10,derivatives,6,16,O
DDI-DrugBank.d97.s10,:,17,17,O
DDI-DrugBank.d97.s10,dihydroergotamine,19,35,B-drug
DDI-DrugBank.d97.s10,",",36,36,O
DDI-DrugBank.d97.s10,ergonovine,38,47,B-drug
DDI-DrugBank.d97.s10,",",48,48,O
DDI-DrugBank.d97.s10,ergotamine,50,59,B-drug
DDI-DrugBank.d97.s10,",",60,60,O
DDI-DrugBank.d97.s10,methylergonovine,62,77,B-drug
DDI-DrugBank.d97.s11,CONTRAINDICATED,0,14,O
DDI-DrugBank.d97.s11,due,16,18,O
DDI-DrugBank.d97.s11,to,20,21,O
DDI-DrugBank.d97.s11,potential,23,31,O
DDI-DrugBank.d97.s11,for,33,35,O
DDI-DrugBank.d97.s11,serious,37,43,O
DDI-DrugBank.d97.s11,and/or,45,50,O
DDI-DrugBank.d97.s11,life-threatening,52,67,O
DDI-DrugBank.d97.s11,reactions,69,77,O
DDI-DrugBank.d97.s11,such,79,82,O
DDI-DrugBank.d97.s11,as,84,85,O
DDI-DrugBank.d97.s11,acute,87,91,O
DDI-DrugBank.d97.s11,ergot,93,97,O
DDI-DrugBank.d97.s11,toxicity,99,106,O
DDI-DrugBank.d97.s11,characterized,108,120,O
DDI-DrugBank.d97.s11,by,122,123,O
DDI-DrugBank.d97.s11,peripheral,125,134,O
DDI-DrugBank.d97.s11,vasospasm,136,144,O
DDI-DrugBank.d97.s11,and,146,148,O
DDI-DrugBank.d97.s11,ischemia,150,157,O
DDI-DrugBank.d97.s11,of,159,160,O
DDI-DrugBank.d97.s11,the,162,164,O
DDI-DrugBank.d97.s11,extremities,166,176,O
DDI-DrugBank.d97.s11,and,178,180,O
DDI-DrugBank.d97.s11,other,182,186,O
DDI-DrugBank.d97.s11,tissues,188,194,O
DDI-DrugBank.d97.s11,.,195,195,O
DDI-DrugBank.d97.s12,Sedative/hypnotics,0,17,O
DDI-DrugBank.d97.s12,:,18,18,O
DDI-DrugBank.d97.s12,midazolam,20,28,B-drug
DDI-DrugBank.d97.s12,",",29,29,O
DDI-DrugBank.d97.s12,triazolam,31,39,B-drug
DDI-DrugBank.d97.s13,CONTRAINDICATED,0,14,O
DDI-DrugBank.d97.s13,due,16,18,O
DDI-DrugBank.d97.s13,to,20,21,O
DDI-DrugBank.d97.s13,potential,23,31,O
DDI-DrugBank.d97.s13,for,33,35,O
DDI-DrugBank.d97.s13,serious,37,43,O
DDI-DrugBank.d97.s13,and/or,45,50,O
DDI-DrugBank.d97.s13,life-threatening,52,67,O
DDI-DrugBank.d97.s13,reactions,69,77,O
DDI-DrugBank.d97.s13,such,79,82,O
DDI-DrugBank.d97.s13,as,84,85,O
DDI-DrugBank.d97.s13,prolonged,87,95,O
DDI-DrugBank.d97.s13,or,97,98,O
DDI-DrugBank.d97.s13,increased,100,108,O
DDI-DrugBank.d97.s13,sedation,110,117,O
DDI-DrugBank.d97.s13,or,119,120,O
DDI-DrugBank.d97.s13,respiratory,122,132,O
DDI-DrugBank.d97.s13,depression,134,143,O
DDI-DrugBank.d97.s13,.,144,144,O
DDI-DrugBank.d97.s14,GI,0,1,O
DDI-DrugBank.d97.s14,motility,3,10,O
DDI-DrugBank.d97.s14,agents,12,17,O
DDI-DrugBank.d97.s14,:,18,18,O
DDI-DrugBank.d97.s14,cisapride,20,28,B-drug
DDI-DrugBank.d97.s15,CONTRAINDICATED,0,14,O
DDI-DrugBank.d97.s15,due,16,18,O
DDI-DrugBank.d97.s15,to,20,21,O
DDI-DrugBank.d97.s15,potential,23,31,O
DDI-DrugBank.d97.s15,for,33,35,O
DDI-DrugBank.d97.s15,serious,37,43,O
DDI-DrugBank.d97.s15,and/or,45,50,O
DDI-DrugBank.d97.s15,life-threatening,52,67,O
DDI-DrugBank.d97.s15,reactions,69,77,O
DDI-DrugBank.d97.s15,such,79,82,O
DDI-DrugBank.d97.s15,as,84,85,O
DDI-DrugBank.d97.s15,cardiac,87,93,O
DDI-DrugBank.d97.s15,arrhythmias,95,105,O
DDI-DrugBank.d97.s15,.,106,106,O
DDI-DrugBank.d97.s16,Neuroleptic,0,10,B-group
DDI-DrugBank.d97.s16,:,11,11,O
DDI-DrugBank.d97.s16,pimozide,13,20,B-drug
DDI-DrugBank.d97.s17,CONTRAINDICATED,0,14,O
DDI-DrugBank.d97.s17,due,16,18,O
DDI-DrugBank.d97.s17,to,20,21,O
DDI-DrugBank.d97.s17,potential,23,31,O
DDI-DrugBank.d97.s17,for,33,35,O
DDI-DrugBank.d97.s17,serious,37,43,O
DDI-DrugBank.d97.s17,and/or,45,50,O
DDI-DrugBank.d97.s17,life-threatening,52,67,O
DDI-DrugBank.d97.s17,reactions,69,77,O
DDI-DrugBank.d97.s17,such,79,82,O
DDI-DrugBank.d97.s17,as,84,85,O
DDI-DrugBank.d97.s17,cardiac,87,93,O
DDI-DrugBank.d97.s17,arrhythmias,95,105,O
DDI-DrugBank.d97.s17,.,106,106,O
DDI-DrugBank.d97.s18,Herbal,0,5,O
DDI-DrugBank.d97.s18,products,7,14,O
DDI-DrugBank.d97.s18,:,15,15,O
DDI-DrugBank.d97.s18,St.,17,19,O
DDI-DrugBank.d97.s18,John,21,24,O
DDI-DrugBank.d97.s18,s,26,26,O
DDI-DrugBank.d97.s18,wort,28,31,O
DDI-DrugBank.d97.s18,(,33,33,O
DDI-DrugBank.d97.s18,Hypericum,34,42,O
DDI-DrugBank.d97.s18,perforatum,44,53,O
DDI-DrugBank.d97.s18,),54,54,O
DDI-DrugBank.d97.s19,May,0,2,O
DDI-DrugBank.d97.s19,lead,4,7,O
DDI-DrugBank.d97.s19,to,9,10,O
DDI-DrugBank.d97.s19,loss,12,15,O
DDI-DrugBank.d97.s19,of,17,18,O
DDI-DrugBank.d97.s19,virologic,20,28,O
DDI-DrugBank.d97.s19,response,30,37,O
DDI-DrugBank.d97.s19,and,39,41,O
DDI-DrugBank.d97.s19,possible,43,50,O
DDI-DrugBank.d97.s19,resistance,52,61,O
DDI-DrugBank.d97.s19,to,63,64,O
DDI-DrugBank.d97.s19,CRIXIVAN,66,73,B-brand
DDI-DrugBank.d97.s19,or,75,76,O
DDI-DrugBank.d97.s19,to,78,79,O
DDI-DrugBank.d97.s19,the,81,83,O
DDI-DrugBank.d97.s19,class,85,89,O
DDI-DrugBank.d97.s19,of,91,92,O
DDI-DrugBank.d97.s19,protease,94,101,B-group
DDI-DrugBank.d97.s19,inhibitors,103,112,I-group
DDI-DrugBank.d97.s19,.,113,113,O
DDI-DrugBank.d97.s20,Antimycobacterial,0,16,B-group
DDI-DrugBank.d97.s20,:,17,17,O
DDI-DrugBank.d97.s20,rifampin,19,26,B-drug
DDI-DrugBank.d97.s21,May,0,2,O
DDI-DrugBank.d97.s21,lead,4,7,O
DDI-DrugBank.d97.s21,to,9,10,O
DDI-DrugBank.d97.s21,loss,12,15,O
DDI-DrugBank.d97.s21,of,17,18,O
DDI-DrugBank.d97.s21,virologic,20,28,O
DDI-DrugBank.d97.s21,response,30,37,O
DDI-DrugBank.d97.s21,and,39,41,O
DDI-DrugBank.d97.s21,possible,43,50,O
DDI-DrugBank.d97.s21,resistance,52,61,O
DDI-DrugBank.d97.s21,to,63,64,O
DDI-DrugBank.d97.s21,CRIXIVAN,66,73,B-brand
DDI-DrugBank.d97.s21,or,75,76,O
DDI-DrugBank.d97.s21,to,78,79,O
DDI-DrugBank.d97.s21,the,81,83,O
DDI-DrugBank.d97.s21,class,85,89,O
DDI-DrugBank.d97.s21,of,91,92,O
DDI-DrugBank.d97.s21,protease,94,101,B-group
DDI-DrugBank.d97.s21,inhibitors,103,112,I-group
DDI-DrugBank.d97.s21,or,114,115,O
DDI-DrugBank.d97.s21,other,117,121,O
DDI-DrugBank.d97.s21,coadministered,123,136,O
DDI-DrugBank.d97.s21,antiretroviral,138,151,B-group
DDI-DrugBank.d97.s21,agents,153,158,I-group
DDI-DrugBank.d97.s21,.,159,159,O
DDI-DrugBank.d97.s22,HMG-CoA,0,6,B-group
DDI-DrugBank.d97.s22,Reductase,8,16,I-group
DDI-DrugBank.d97.s22,inhibitors,18,27,I-group
DDI-DrugBank.d97.s22,:,28,28,O
DDI-DrugBank.d97.s22,lovastatin,30,39,B-drug
DDI-DrugBank.d97.s22,",",40,40,O
DDI-DrugBank.d97.s22,simvastatin,42,52,B-drug
DDI-DrugBank.d97.s23,Potential,0,8,O
DDI-DrugBank.d97.s23,for,10,12,O
DDI-DrugBank.d97.s23,serious,14,20,O
DDI-DrugBank.d97.s23,reactions,22,30,O
DDI-DrugBank.d97.s23,such,32,35,O
DDI-DrugBank.d97.s23,as,37,38,O
DDI-DrugBank.d97.s23,risk,40,43,O
DDI-DrugBank.d97.s23,of,45,46,O
DDI-DrugBank.d97.s23,myopathy,48,55,O
DDI-DrugBank.d97.s23,including,57,65,O
DDI-DrugBank.d97.s23,rhabdomyolysis,67,80,O
DDI-DrugBank.d97.s23,.,81,81,O
DDI-DrugBank.d97.s24,Protease,0,7,B-group
DDI-DrugBank.d97.s24,inhibitor,9,17,I-group
DDI-DrugBank.d97.s24,:,18,18,O
DDI-DrugBank.d97.s24,atazanavir,20,29,B-drug
DDI-DrugBank.d97.s25,Both,0,3,O
DDI-DrugBank.d97.s25,CRIXIVAN,5,12,B-brand
DDI-DrugBank.d97.s25,and,14,16,O
DDI-DrugBank.d97.s25,atazanavir,18,27,B-drug
DDI-DrugBank.d97.s25,are,29,31,O
DDI-DrugBank.d97.s25,associated,33,42,O
DDI-DrugBank.d97.s25,with,44,47,O
DDI-DrugBank.d97.s25,indirect,49,56,O
DDI-DrugBank.d97.s25,(,58,58,O
DDI-DrugBank.d97.s25,unconjugated,59,70,O
DDI-DrugBank.d97.s25,),71,71,O
DDI-DrugBank.d97.s25,hyperbilirubinemia,73,90,O
DDI-DrugBank.d97.s25,.,91,91,O
DDI-DrugBank.d97.s26,Combinations,0,11,O
DDI-DrugBank.d97.s26,of,13,14,O
DDI-DrugBank.d97.s26,these,16,20,O
DDI-DrugBank.d97.s26,drugs,22,26,O
DDI-DrugBank.d97.s26,have,28,31,O
DDI-DrugBank.d97.s26,not,33,35,O
DDI-DrugBank.d97.s26,been,37,40,O
DDI-DrugBank.d97.s26,studied,42,48,O
DDI-DrugBank.d97.s26,and,50,52,O
DDI-DrugBank.d97.s26,coadministration,54,69,O
DDI-DrugBank.d97.s26,of,71,72,O
DDI-DrugBank.d97.s26,CRIXIVAN,74,81,B-brand
DDI-DrugBank.d97.s26,and,83,85,O
DDI-DrugBank.d97.s26,atazanavir,87,96,B-drug
DDI-DrugBank.d97.s26,is,98,99,O
DDI-DrugBank.d97.s26,not,101,103,O
DDI-DrugBank.d97.s26,recommended,105,115,O
DDI-DrugBank.d97.s26,.,116,116,O
DDI-DrugBank.d97.s27,Table,0,4,O
DDI-DrugBank.d97.s27,9,6,6,O
DDI-DrugBank.d97.s28,Established,0,10,O
DDI-DrugBank.d97.s28,and,12,14,O
DDI-DrugBank.d97.s28,Other,16,20,O
DDI-DrugBank.d97.s28,Potentially,22,32,O
DDI-DrugBank.d97.s28,Significant,34,44,O
DDI-DrugBank.d97.s28,Drug,46,49,O
DDI-DrugBank.d97.s28,Interactions,51,62,O
DDI-DrugBank.d97.s28,:,63,63,O
DDI-DrugBank.d97.s28,Alteration,65,74,O
DDI-DrugBank.d97.s28,in,76,77,O
DDI-DrugBank.d97.s28,Dose,79,82,O
DDI-DrugBank.d97.s28,or,84,85,O
DDI-DrugBank.d97.s28,Regimen,87,93,O
DDI-DrugBank.d97.s28,May,95,97,O
DDI-DrugBank.d97.s28,Be,99,100,O
DDI-DrugBank.d97.s28,Recommended,102,112,O
DDI-DrugBank.d97.s28,Based,114,118,O
DDI-DrugBank.d97.s28,on,120,121,O
DDI-DrugBank.d97.s28,Drug,123,126,O
DDI-DrugBank.d97.s28,Interaction,128,138,O
DDI-DrugBank.d97.s28,Studies,140,146,O
DDI-DrugBank.d97.s28,or,148,149,O
DDI-DrugBank.d97.s28,Predicted,151,159,O
DDI-DrugBank.d97.s28,Interaction,161,171,O
DDI-DrugBank.d97.s29,Drug,0,3,O
DDI-DrugBank.d97.s29,Name,5,8,O
DDI-DrugBank.d97.s30,Effect,0,5,O
DDI-DrugBank.d97.s31,Clinical,0,7,O
DDI-DrugBank.d97.s31,Comment,9,15,O
DDI-DrugBank.d97.s32,HIV,0,2,B-group
DDI-DrugBank.d97.s32,Antiviral,4,12,I-group
DDI-DrugBank.d97.s32,Agents,14,19,I-group
DDI-DrugBank.d97.s33,Delavirdine,0,10,B-drug
DDI-DrugBank.d97.s34,indinavir,0,8,B-drug
DDI-DrugBank.d97.s34,concentration,10,22,O
DDI-DrugBank.d97.s35,Dose,0,3,O
DDI-DrugBank.d97.s35,reduction,5,13,O
DDI-DrugBank.d97.s35,of,15,16,O
DDI-DrugBank.d97.s35,CRIXIVAN,18,25,B-brand
DDI-DrugBank.d97.s35,to,27,28,O
DDI-DrugBank.d97.s35,600,30,32,O
DDI-DrugBank.d97.s35,mg,34,35,O
DDI-DrugBank.d97.s35,every,37,41,O
DDI-DrugBank.d97.s35,8,43,43,O
DDI-DrugBank.d97.s35,hours,45,49,O
DDI-DrugBank.d97.s35,should,51,56,O
DDI-DrugBank.d97.s35,be,58,59,O
DDI-DrugBank.d97.s35,considered,61,70,O
DDI-DrugBank.d97.s35,when,72,75,O
DDI-DrugBank.d97.s35,taking,77,82,O
DDI-DrugBank.d97.s35,delavirdine,84,94,B-drug
DDI-DrugBank.d97.s35,400,96,98,O
DDI-DrugBank.d97.s35,mg,100,101,O
DDI-DrugBank.d97.s35,three,103,107,O
DDI-DrugBank.d97.s35,times,109,113,O
DDI-DrugBank.d97.s35,a,115,115,O
DDI-DrugBank.d97.s35,day,117,119,O
DDI-DrugBank.d97.s35,.,120,120,O
DDI-DrugBank.d97.s36,Didanosine,0,9,B-drug
DDI-DrugBank.d97.s37,Indinavir,0,8,B-drug
DDI-DrugBank.d97.s37,and,10,12,O
DDI-DrugBank.d97.s37,didanosine,14,23,B-drug
DDI-DrugBank.d97.s37,formulations,25,36,O
DDI-DrugBank.d97.s37,containing,38,47,O
DDI-DrugBank.d97.s37,buffer,49,54,O
DDI-DrugBank.d97.s37,should,56,61,O
DDI-DrugBank.d97.s37,be,63,64,O
DDI-DrugBank.d97.s37,administered,66,77,O
DDI-DrugBank.d97.s37,at,79,80,O
DDI-DrugBank.d97.s37,least,82,86,O
DDI-DrugBank.d97.s37,one,88,90,O
DDI-DrugBank.d97.s37,hour,92,95,O
DDI-DrugBank.d97.s37,apart,97,101,O
DDI-DrugBank.d97.s37,on,103,104,O
DDI-DrugBank.d97.s37,an,106,107,O
DDI-DrugBank.d97.s37,empty,109,113,O
DDI-DrugBank.d97.s37,stomach,115,121,O
DDI-DrugBank.d97.s37,.,122,122,O
DDI-DrugBank.d97.s38,Efavirenz,0,8,B-drug
DDI-DrugBank.d97.s39,indinavir,0,8,B-drug
DDI-DrugBank.d97.s39,concentration,10,22,O
DDI-DrugBank.d97.s40,The,0,2,O
DDI-DrugBank.d97.s40,optimal,4,10,O
DDI-DrugBank.d97.s40,dose,12,15,O
DDI-DrugBank.d97.s40,of,17,18,O
DDI-DrugBank.d97.s40,indinavir,20,28,B-drug
DDI-DrugBank.d97.s40,",",29,29,O
DDI-DrugBank.d97.s40,when,31,34,O
DDI-DrugBank.d97.s40,given,36,40,O
DDI-DrugBank.d97.s40,in,42,43,O
DDI-DrugBank.d97.s40,combination,45,55,O
DDI-DrugBank.d97.s40,with,57,60,O
DDI-DrugBank.d97.s40,efavirenz,62,70,B-drug
DDI-DrugBank.d97.s40,",",71,71,O
DDI-DrugBank.d97.s40,is,73,74,O
DDI-DrugBank.d97.s40,not,76,78,O
DDI-DrugBank.d97.s40,known,80,84,O
DDI-DrugBank.d97.s40,.,85,85,O
DDI-DrugBank.d97.s41,Increasing,0,9,O
DDI-DrugBank.d97.s41,the,11,13,O
DDI-DrugBank.d97.s41,indinavir,15,23,B-drug
DDI-DrugBank.d97.s41,dose,25,28,O
DDI-DrugBank.d97.s41,to,30,31,O
DDI-DrugBank.d97.s41,1000,33,36,O
DDI-DrugBank.d97.s41,mg,38,39,O
DDI-DrugBank.d97.s41,every,41,45,O
DDI-DrugBank.d97.s41,8,47,47,O
DDI-DrugBank.d97.s41,hours,49,53,O
DDI-DrugBank.d97.s41,does,55,58,O
DDI-DrugBank.d97.s41,not,60,62,O
DDI-DrugBank.d97.s41,compensate,64,73,O
DDI-DrugBank.d97.s41,for,75,77,O
DDI-DrugBank.d97.s41,the,79,81,O
DDI-DrugBank.d97.s41,increased,83,91,O
DDI-DrugBank.d97.s41,indinavir,93,101,B-drug
DDI-DrugBank.d97.s41,metabolism,103,112,O
DDI-DrugBank.d97.s41,due,114,116,O
DDI-DrugBank.d97.s41,to,118,119,O
DDI-DrugBank.d97.s41,efavirenz,121,129,B-drug
DDI-DrugBank.d97.s41,.,130,130,O
DDI-DrugBank.d97.s42,Nelfinavir,0,9,B-drug
DDI-DrugBank.d97.s43,indinavir,0,8,B-drug
DDI-DrugBank.d97.s43,concentration,10,22,O
DDI-DrugBank.d97.s44,The,0,2,O
DDI-DrugBank.d97.s44,appropriate,4,14,O
DDI-DrugBank.d97.s44,doses,16,20,O
DDI-DrugBank.d97.s44,for,22,24,O
DDI-DrugBank.d97.s44,this,26,29,O
DDI-DrugBank.d97.s44,combination,31,41,O
DDI-DrugBank.d97.s44,",",42,42,O
DDI-DrugBank.d97.s44,with,44,47,O
DDI-DrugBank.d97.s44,respect,49,55,O
DDI-DrugBank.d97.s44,to,57,58,O
DDI-DrugBank.d97.s44,efficacy,60,67,O
DDI-DrugBank.d97.s44,and,69,71,O
DDI-DrugBank.d97.s44,safety,73,78,O
DDI-DrugBank.d97.s44,",",79,79,O
DDI-DrugBank.d97.s44,have,81,84,O
DDI-DrugBank.d97.s44,not,86,88,O
DDI-DrugBank.d97.s44,been,90,93,O
DDI-DrugBank.d97.s44,established,95,105,O
DDI-DrugBank.d97.s44,.,106,106,O
DDI-DrugBank.d97.s45,Nevirapine,0,9,B-drug
DDI-DrugBank.d97.s46,indinavir,0,8,B-drug
DDI-DrugBank.d97.s46,concentration,10,22,O
DDI-DrugBank.d97.s47,Indinavir,0,8,B-drug
DDI-DrugBank.d97.s47,concentrations,10,23,O
DDI-DrugBank.d97.s47,may,25,27,O
DDI-DrugBank.d97.s47,be,29,30,O
DDI-DrugBank.d97.s47,decreased,32,40,O
DDI-DrugBank.d97.s47,in,42,43,O
DDI-DrugBank.d97.s47,the,45,47,O
DDI-DrugBank.d97.s47,presence,49,56,O
DDI-DrugBank.d97.s47,of,58,59,O
DDI-DrugBank.d97.s47,nevirapine,61,70,B-drug
DDI-DrugBank.d97.s47,.,71,71,O
DDI-DrugBank.d97.s48,The,0,2,O
DDI-DrugBank.d97.s48,appropriate,4,14,O
DDI-DrugBank.d97.s48,doses,16,20,O
DDI-DrugBank.d97.s48,for,22,24,O
DDI-DrugBank.d97.s48,this,26,29,O
DDI-DrugBank.d97.s48,combination,31,41,O
DDI-DrugBank.d97.s48,",",42,42,O
DDI-DrugBank.d97.s48,with,44,47,O
DDI-DrugBank.d97.s48,respect,49,55,O
DDI-DrugBank.d97.s48,to,57,58,O
DDI-DrugBank.d97.s48,efficacy,60,67,O
DDI-DrugBank.d97.s48,and,69,71,O
DDI-DrugBank.d97.s48,safety,73,78,O
DDI-DrugBank.d97.s48,",",79,79,O
DDI-DrugBank.d97.s48,have,81,84,O
DDI-DrugBank.d97.s48,not,86,88,O
DDI-DrugBank.d97.s48,been,90,93,O
DDI-DrugBank.d97.s48,established,95,105,O
DDI-DrugBank.d97.s48,.,106,106,O
DDI-DrugBank.d97.s49,Ritonavir,0,8,B-drug
DDI-DrugBank.d97.s50,indinavir,0,8,B-drug
DDI-DrugBank.d97.s50,concentration,10,22,O
DDI-DrugBank.d97.s50,ritonavir,26,34,B-drug
DDI-DrugBank.d97.s50,concentration,36,48,O
DDI-DrugBank.d97.s51,The,0,2,O
DDI-DrugBank.d97.s51,appropriate,4,14,O
DDI-DrugBank.d97.s51,doses,16,20,O
DDI-DrugBank.d97.s51,for,22,24,O
DDI-DrugBank.d97.s51,this,26,29,O
DDI-DrugBank.d97.s51,combination,31,41,O
DDI-DrugBank.d97.s51,",",42,42,O
DDI-DrugBank.d97.s51,with,44,47,O
DDI-DrugBank.d97.s51,respect,49,55,O
DDI-DrugBank.d97.s51,to,57,58,O
DDI-DrugBank.d97.s51,efficacy,60,67,O
DDI-DrugBank.d97.s51,and,69,71,O
DDI-DrugBank.d97.s51,safety,73,78,O
DDI-DrugBank.d97.s51,",",79,79,O
DDI-DrugBank.d97.s51,have,81,84,O
DDI-DrugBank.d97.s51,not,86,88,O
DDI-DrugBank.d97.s51,been,90,93,O
DDI-DrugBank.d97.s51,established,95,105,O
DDI-DrugBank.d97.s51,.,106,106,O
DDI-DrugBank.d97.s52,Preliminary,0,10,O
DDI-DrugBank.d97.s52,clinical,12,19,O
DDI-DrugBank.d97.s52,data,21,24,O
DDI-DrugBank.d97.s52,suggest,26,32,O
DDI-DrugBank.d97.s52,that,34,37,O
DDI-DrugBank.d97.s52,the,39,41,O
DDI-DrugBank.d97.s52,incidence,43,51,O
DDI-DrugBank.d97.s52,of,53,54,O
DDI-DrugBank.d97.s52,nephrolithiasis,56,70,O
DDI-DrugBank.d97.s52,is,72,73,O
DDI-DrugBank.d97.s52,higher,75,80,O
DDI-DrugBank.d97.s52,in,82,83,O
DDI-DrugBank.d97.s52,patients,85,92,O
DDI-DrugBank.d97.s52,receiving,94,102,O
DDI-DrugBank.d97.s52,indinavir,104,112,B-drug
DDI-DrugBank.d97.s52,in,114,115,O
DDI-DrugBank.d97.s52,combination,117,127,O
DDI-DrugBank.d97.s52,with,129,132,O
DDI-DrugBank.d97.s52,ritonavir,134,142,B-drug
DDI-DrugBank.d97.s52,than,144,147,O
DDI-DrugBank.d97.s52,those,149,153,O
DDI-DrugBank.d97.s52,receiving,155,163,O
DDI-DrugBank.d97.s52,CRIXIVAN,165,172,B-brand
DDI-DrugBank.d97.s52,800,174,176,O
DDI-DrugBank.d97.s52,mg,178,179,O
DDI-DrugBank.d97.s52,q8h,181,183,O
DDI-DrugBank.d97.s52,.,184,184,O
DDI-DrugBank.d97.s53,Saquinavir,0,9,B-drug
DDI-DrugBank.d97.s54,saquinavir,0,9,B-drug
DDI-DrugBank.d97.s54,concentration,11,23,O
DDI-DrugBank.d97.s55,The,0,2,O
DDI-DrugBank.d97.s55,appropriate,4,14,O
DDI-DrugBank.d97.s55,doses,16,20,O
DDI-DrugBank.d97.s55,for,22,24,O
DDI-DrugBank.d97.s55,this,26,29,O
DDI-DrugBank.d97.s55,combination,31,41,O
DDI-DrugBank.d97.s55,",",42,42,O
DDI-DrugBank.d97.s55,with,44,47,O
DDI-DrugBank.d97.s55,respect,49,55,O
DDI-DrugBank.d97.s55,to,57,58,O
DDI-DrugBank.d97.s55,efficacy,60,67,O
DDI-DrugBank.d97.s55,and,69,71,O
DDI-DrugBank.d97.s55,safety,73,78,O
DDI-DrugBank.d97.s55,",",79,79,O
DDI-DrugBank.d97.s55,have,81,84,O
DDI-DrugBank.d97.s55,not,86,88,O
DDI-DrugBank.d97.s55,been,90,93,O
DDI-DrugBank.d97.s55,established,95,105,O
DDI-DrugBank.d97.s55,.,106,106,O
DDI-DrugBank.d97.s56,Other,0,4,O
DDI-DrugBank.d97.s56,Agents,6,11,O
DDI-DrugBank.d97.s57,Antiarrhythmics,0,14,B-group
DDI-DrugBank.d97.s57,:,15,15,O
DDI-DrugBank.d97.s57,bepridil,17,24,B-drug
DDI-DrugBank.d97.s57,",",25,25,O
DDI-DrugBank.d97.s57,lidocaine,27,35,B-drug
DDI-DrugBank.d97.s57,(,37,37,O
DDI-DrugBank.d97.s57,systemic,38,45,O
DDI-DrugBank.d97.s57,),46,46,O
DDI-DrugBank.d97.s57,and,48,50,O
DDI-DrugBank.d97.s57,quinidine,52,60,B-drug
DDI-DrugBank.d97.s58,antiarrhythmic,0,13,B-group
DDI-DrugBank.d97.s58,agents,15,20,I-group
DDI-DrugBank.d97.s58,concentration,22,34,O
DDI-DrugBank.d97.s59,Caution,0,6,O
DDI-DrugBank.d97.s59,is,8,9,O
DDI-DrugBank.d97.s59,warranted,11,19,O
DDI-DrugBank.d97.s59,and,21,23,O
DDI-DrugBank.d97.s59,therapeutic,25,35,O
DDI-DrugBank.d97.s59,concentration,37,49,O
DDI-DrugBank.d97.s59,monitoring,51,60,O
DDI-DrugBank.d97.s59,is,62,63,O
DDI-DrugBank.d97.s59,recommended,65,75,O
DDI-DrugBank.d97.s59,for,77,79,O
DDI-DrugBank.d97.s59,antiarrhythmics,81,95,B-group
DDI-DrugBank.d97.s59,when,97,100,O
DDI-DrugBank.d97.s59,coadministered,102,115,O
DDI-DrugBank.d97.s59,with,117,120,O
DDI-DrugBank.d97.s59,CRIXIVAN,122,129,B-brand
DDI-DrugBank.d97.s59,.,130,130,O
DDI-DrugBank.d97.s60,Anticonvulsants,0,14,B-group
DDI-DrugBank.d97.s60,:,15,15,O
DDI-DrugBank.d97.s60,carbamazepine,17,29,B-drug
DDI-DrugBank.d97.s60,",",30,30,O
DDI-DrugBank.d97.s60,phenobarbital,32,44,B-drug
DDI-DrugBank.d97.s60,",",45,45,O
DDI-DrugBank.d97.s60,phenytoin,47,55,B-drug
DDI-DrugBank.d97.s61,indinavir,0,8,B-drug
DDI-DrugBank.d97.s61,concentration,10,22,O
DDI-DrugBank.d97.s62,Use,0,2,O
DDI-DrugBank.d97.s62,with,4,7,O
DDI-DrugBank.d97.s62,caution,9,15,O
DDI-DrugBank.d97.s62,.,16,16,O
DDI-DrugBank.d97.s63,CRIXIVAN,0,7,B-brand
DDI-DrugBank.d97.s63,may,9,11,O
DDI-DrugBank.d97.s63,not,13,15,O
DDI-DrugBank.d97.s63,be,17,18,O
DDI-DrugBank.d97.s63,effective,20,28,O
DDI-DrugBank.d97.s63,due,30,32,O
DDI-DrugBank.d97.s63,to,34,35,O
DDI-DrugBank.d97.s63,decreased,37,45,O
DDI-DrugBank.d97.s63,indinavir,47,55,B-drug
DDI-DrugBank.d97.s63,concentrations,57,70,O
DDI-DrugBank.d97.s63,in,72,73,O
DDI-DrugBank.d97.s63,patients,75,82,O
DDI-DrugBank.d97.s63,taking,84,89,O
DDI-DrugBank.d97.s63,these,91,95,O
DDI-DrugBank.d97.s63,agents,97,102,O
DDI-DrugBank.d97.s63,concomitantly,104,116,O
DDI-DrugBank.d97.s63,.,117,117,O
DDI-DrugBank.d97.s64,Calcium,0,6,B-group
DDI-DrugBank.d97.s64,Channel,8,14,I-group
DDI-DrugBank.d97.s64,Blockers,16,23,I-group
DDI-DrugBank.d97.s64,",",24,24,O
DDI-DrugBank.d97.s64,Dihydropyridine,26,40,B-group
DDI-DrugBank.d97.s64,:,41,41,O
DDI-DrugBank.d97.s64,e.g.,43,46,O
DDI-DrugBank.d97.s64,",",47,47,O
DDI-DrugBank.d97.s64,felodipine,49,58,B-drug
DDI-DrugBank.d97.s64,",",59,59,O
DDI-DrugBank.d97.s64,nifedipine,61,70,B-drug
DDI-DrugBank.d97.s64,",",71,71,O
DDI-DrugBank.d97.s64,nicardipine,73,83,B-drug
DDI-DrugBank.d97.s65,dihydropyridine,0,14,B-group
DDI-DrugBank.d97.s65,calcium,16,22,I-group
DDI-DrugBank.d97.s65,channel,24,30,I-group
DDI-DrugBank.d97.s65,blockers,32,39,I-group
DDI-DrugBank.d97.s65,concentration,41,53,O
DDI-DrugBank.d97.s66,Caution,0,6,O
DDI-DrugBank.d97.s66,is,8,9,O
DDI-DrugBank.d97.s66,warranted,11,19,O
DDI-DrugBank.d97.s66,and,21,23,O
DDI-DrugBank.d97.s66,clinical,25,32,O
DDI-DrugBank.d97.s66,monitoring,34,43,O
DDI-DrugBank.d97.s66,of,45,46,O
DDI-DrugBank.d97.s66,patients,48,55,O
DDI-DrugBank.d97.s66,is,57,58,O
DDI-DrugBank.d97.s66,recommended,60,70,O
DDI-DrugBank.d97.s66,.,71,71,O
DDI-DrugBank.d97.s67,Clarithromycin,0,13,B-drug
DDI-DrugBank.d97.s68,clarithromycin,0,13,B-drug
DDI-DrugBank.d97.s68,concentration,15,27,O
DDI-DrugBank.d97.s68,indinavir,31,39,B-drug
DDI-DrugBank.d97.s68,concentration,41,53,O
DDI-DrugBank.d97.s69,The,0,2,O
DDI-DrugBank.d97.s69,appropriate,4,14,O
DDI-DrugBank.d97.s69,doses,16,20,O
DDI-DrugBank.d97.s69,for,22,24,O
DDI-DrugBank.d97.s69,this,26,29,O
DDI-DrugBank.d97.s69,combination,31,41,O
DDI-DrugBank.d97.s69,",",42,42,O
DDI-DrugBank.d97.s69,with,44,47,O
DDI-DrugBank.d97.s69,respect,49,55,O
DDI-DrugBank.d97.s69,to,57,58,O
DDI-DrugBank.d97.s69,efficacy,60,67,O
DDI-DrugBank.d97.s69,and,69,71,O
DDI-DrugBank.d97.s69,safety,73,78,O
DDI-DrugBank.d97.s69,",",79,79,O
DDI-DrugBank.d97.s69,have,81,84,O
DDI-DrugBank.d97.s69,not,86,88,O
DDI-DrugBank.d97.s69,been,90,93,O
DDI-DrugBank.d97.s69,established,95,105,O
DDI-DrugBank.d97.s69,.,106,106,O
DDI-DrugBank.d97.s70,HMG-CoA,0,6,B-group
DDI-DrugBank.d97.s70,Reductase,8,16,I-group
DDI-DrugBank.d97.s70,Inhibitor,18,26,I-group
DDI-DrugBank.d97.s70,:,27,27,O
DDI-DrugBank.d97.s70,atorvastatin,29,40,B-drug
DDI-DrugBank.d97.s71,atorvastatin,0,11,B-drug
DDI-DrugBank.d97.s71,concentration,13,25,O
DDI-DrugBank.d97.s72,Use,0,2,O
DDI-DrugBank.d97.s72,lowest,4,9,O
DDI-DrugBank.d97.s72,possible,11,18,O
DDI-DrugBank.d97.s72,dose,20,23,O
DDI-DrugBank.d97.s72,of,25,26,O
DDI-DrugBank.d97.s72,atorvastatin,28,39,B-drug
DDI-DrugBank.d97.s72,with,41,44,O
DDI-DrugBank.d97.s72,careful,46,52,O
DDI-DrugBank.d97.s72,monitoring,54,63,O
DDI-DrugBank.d97.s72,",",64,64,O
DDI-DrugBank.d97.s72,or,66,67,O
DDI-DrugBank.d97.s72,consider,69,76,O
DDI-DrugBank.d97.s72,HMG-CoA,78,84,B-group
DDI-DrugBank.d97.s72,reductase,86,94,I-group
DDI-DrugBank.d97.s72,inhibitors,96,105,I-group
DDI-DrugBank.d97.s72,that,107,110,O
DDI-DrugBank.d97.s72,are,112,114,O
DDI-DrugBank.d97.s72,not,116,118,O
DDI-DrugBank.d97.s72,primarily,120,128,O
DDI-DrugBank.d97.s72,metabolized,130,140,O
DDI-DrugBank.d97.s72,by,142,143,O
DDI-DrugBank.d97.s72,CYP3A4,145,150,O
DDI-DrugBank.d97.s72,",",151,151,O
DDI-DrugBank.d97.s72,such,153,156,O
DDI-DrugBank.d97.s72,as,158,159,O
DDI-DrugBank.d97.s72,pravastatin,161,171,B-drug
DDI-DrugBank.d97.s72,",",172,172,O
DDI-DrugBank.d97.s72,fluvastatin,174,184,B-drug
DDI-DrugBank.d97.s72,",",185,185,O
DDI-DrugBank.d97.s72,or,187,188,O
DDI-DrugBank.d97.s72,rosuvastatin,190,201,B-drug
DDI-DrugBank.d97.s72,in,203,204,O
DDI-DrugBank.d97.s72,combination,206,216,O
DDI-DrugBank.d97.s72,with,218,221,O
DDI-DrugBank.d97.s72,CRIXIVAN,223,230,B-brand
DDI-DrugBank.d97.s72,.,231,231,O
DDI-DrugBank.d97.s73,Immunosuppressants,0,17,B-group
DDI-DrugBank.d97.s73,:,18,18,O
DDI-DrugBank.d97.s73,cyclosporine,20,31,B-drug
DDI-DrugBank.d97.s73,",",32,32,O
DDI-DrugBank.d97.s73,tacrolimus,34,43,B-drug
DDI-DrugBank.d97.s73,",",44,44,O
DDI-DrugBank.d97.s73,sirolimus,46,54,B-drug
DDI-DrugBank.d97.s74,immunosuppressant,0,16,B-group
DDI-DrugBank.d97.s74,agents,18,23,I-group
DDI-DrugBank.d97.s74,concentration,25,37,O
DDI-DrugBank.d97.s75,Plasma,0,5,O
DDI-DrugBank.d97.s75,concentrations,7,20,O
DDI-DrugBank.d97.s75,may,22,24,O
DDI-DrugBank.d97.s75,be,26,27,O
DDI-DrugBank.d97.s75,increased,29,37,O
DDI-DrugBank.d97.s75,by,39,40,O
DDI-DrugBank.d97.s75,CRIXIVAN,42,49,B-brand
DDI-DrugBank.d97.s75,.,50,50,O
DDI-DrugBank.d97.s76,Itraconazole,0,11,B-drug
DDI-DrugBank.d97.s77,indinavir,0,8,B-drug
DDI-DrugBank.d97.s77,concentration,10,22,O
DDI-DrugBank.d97.s78,Dose,0,3,O
DDI-DrugBank.d97.s78,reduction,5,13,O
DDI-DrugBank.d97.s78,of,15,16,O
DDI-DrugBank.d97.s78,CRIXIVAN,18,25,B-brand
DDI-DrugBank.d97.s78,to,27,28,O
DDI-DrugBank.d97.s78,600,30,32,O
DDI-DrugBank.d97.s78,mg,34,35,O
DDI-DrugBank.d97.s78,every,37,41,O
DDI-DrugBank.d97.s78,8,43,43,O
DDI-DrugBank.d97.s78,hours,45,49,O
DDI-DrugBank.d97.s78,is,51,52,O
DDI-DrugBank.d97.s78,recommended,54,64,O
DDI-DrugBank.d97.s78,when,66,69,O
DDI-DrugBank.d97.s78,administering,71,83,O
DDI-DrugBank.d97.s78,itraconazole,85,96,B-drug
DDI-DrugBank.d97.s78,concurrently,98,109,O
DDI-DrugBank.d97.s78,.,110,110,O
DDI-DrugBank.d97.s79,Ketoconazole,0,11,B-drug
DDI-DrugBank.d97.s80,indinavir,0,8,B-drug
DDI-DrugBank.d97.s80,concentration,10,22,O
DDI-DrugBank.d97.s81,Dose,0,3,O
DDI-DrugBank.d97.s81,reduction,5,13,O
DDI-DrugBank.d97.s81,of,15,16,O
DDI-DrugBank.d97.s81,CRIXIVAN,18,25,B-brand
DDI-DrugBank.d97.s81,to,27,28,O
DDI-DrugBank.d97.s81,600,30,32,O
DDI-DrugBank.d97.s81,mg,34,35,O
DDI-DrugBank.d97.s81,every,37,41,O
DDI-DrugBank.d97.s81,8,43,43,O
DDI-DrugBank.d97.s81,hours,45,49,O
DDI-DrugBank.d97.s81,should,51,56,O
DDI-DrugBank.d97.s81,be,58,59,O
DDI-DrugBank.d97.s81,considered,61,70,O
DDI-DrugBank.d97.s81,.,71,71,O
DDI-DrugBank.d97.s82,Rifabutin,0,8,B-drug
DDI-DrugBank.d97.s83,indinavir,0,8,B-drug
DDI-DrugBank.d97.s83,concentration,10,22,O
DDI-DrugBank.d97.s83,rifabutin,26,34,B-drug
DDI-DrugBank.d97.s83,concentration,36,48,O
DDI-DrugBank.d97.s84,Dose,0,3,O
DDI-DrugBank.d97.s84,reduction,5,13,O
DDI-DrugBank.d97.s84,of,15,16,O
DDI-DrugBank.d97.s84,rifabutin,18,26,B-drug
DDI-DrugBank.d97.s84,to,28,29,O
DDI-DrugBank.d97.s84,half,31,34,O
DDI-DrugBank.d97.s84,the,36,38,O
DDI-DrugBank.d97.s84,standard,40,47,O
DDI-DrugBank.d97.s84,dose,49,52,O
DDI-DrugBank.d97.s84,and,54,56,O
DDI-DrugBank.d97.s84,a,58,58,O
DDI-DrugBank.d97.s84,dose,60,63,O
DDI-DrugBank.d97.s84,increase,65,72,O
DDI-DrugBank.d97.s84,of,74,75,O
DDI-DrugBank.d97.s84,CRIXIVAN,77,84,B-brand
DDI-DrugBank.d97.s84,to,86,87,O
DDI-DrugBank.d97.s84,1000,89,92,O
DDI-DrugBank.d97.s84,mg,94,95,O
DDI-DrugBank.d97.s84,(,97,97,O
DDI-DrugBank.d97.s84,three,98,102,O
DDI-DrugBank.d97.s84,333-mg,104,109,O
DDI-DrugBank.d97.s84,capsules,111,118,O
DDI-DrugBank.d97.s84,),119,119,O
DDI-DrugBank.d97.s84,every,121,125,O
DDI-DrugBank.d97.s84,8,127,127,O
DDI-DrugBank.d97.s84,hours,129,133,O
DDI-DrugBank.d97.s84,are,135,137,O
DDI-DrugBank.d97.s84,recommended,139,149,O
DDI-DrugBank.d97.s84,when,151,154,O
DDI-DrugBank.d97.s84,rifabutin,156,164,B-drug
DDI-DrugBank.d97.s84,and,166,168,O
DDI-DrugBank.d97.s84,CRIXIVAN,170,177,B-brand
DDI-DrugBank.d97.s84,are,179,181,O
DDI-DrugBank.d97.s84,coadministered,183,196,O
DDI-DrugBank.d97.s84,.,197,197,O
DDI-DrugBank.d97.s85,Sildenafil,0,9,B-drug
DDI-DrugBank.d97.s86,sildenafil,0,9,B-drug
DDI-DrugBank.d97.s86,concentration,11,23,O
DDI-DrugBank.d97.s87,Sildenafil,0,9,B-drug
DDI-DrugBank.d97.s87,dose,11,14,O
DDI-DrugBank.d97.s87,should,16,21,O
DDI-DrugBank.d97.s87,not,23,25,O
DDI-DrugBank.d97.s87,exceed,27,32,O
DDI-DrugBank.d97.s87,a,34,34,O
DDI-DrugBank.d97.s87,maximum,36,42,O
DDI-DrugBank.d97.s87,of,44,45,O
DDI-DrugBank.d97.s87,25,47,48,O
DDI-DrugBank.d97.s87,mg,50,51,O
DDI-DrugBank.d97.s87,in,53,54,O
DDI-DrugBank.d97.s87,a,56,56,O
DDI-DrugBank.d97.s87,48-,58,60,O
DDI-DrugBank.d97.s87,hour,62,65,O
DDI-DrugBank.d97.s87,period,67,72,O
DDI-DrugBank.d97.s87,in,74,75,O
DDI-DrugBank.d97.s87,patients,77,84,O
DDI-DrugBank.d97.s87,receiving,86,94,O
DDI-DrugBank.d97.s87,concomitant,96,106,O
DDI-DrugBank.d97.s87,indinavir,108,116,B-drug
DDI-DrugBank.d97.s87,therapy,118,124,O
DDI-DrugBank.d97.s87,.,125,125,O
DDI-DrugBank.d97.s88,Tadalafil,0,8,B-drug
DDI-DrugBank.d97.s89,tadalafil,0,8,B-drug
DDI-DrugBank.d97.s89,concentration,10,22,O
DDI-DrugBank.d97.s90,Tadalafil,0,8,B-drug
DDI-DrugBank.d97.s90,dose,10,13,O
DDI-DrugBank.d97.s90,should,15,20,O
DDI-DrugBank.d97.s90,not,22,24,O
DDI-DrugBank.d97.s90,exceed,26,31,O
DDI-DrugBank.d97.s90,a,33,33,O
DDI-DrugBank.d97.s90,maximum,35,41,O
DDI-DrugBank.d97.s90,of,43,44,O
DDI-DrugBank.d97.s90,10,46,47,O
DDI-DrugBank.d97.s90,mg,49,50,O
DDI-DrugBank.d97.s90,in,52,53,O
DDI-DrugBank.d97.s90,a,55,55,O
DDI-DrugBank.d97.s90,72-,57,59,O
DDI-DrugBank.d97.s90,hour,61,64,O
DDI-DrugBank.d97.s90,period,66,71,O
DDI-DrugBank.d97.s90,in,73,74,O
DDI-DrugBank.d97.s90,patients,76,83,O
DDI-DrugBank.d97.s90,receiving,85,93,O
DDI-DrugBank.d97.s90,concomitant,95,105,O
DDI-DrugBank.d97.s90,indinavir,107,115,B-drug
DDI-DrugBank.d97.s90,therapy,117,123,O
DDI-DrugBank.d97.s90,.,124,124,O
DDI-DrugBank.d97.s91,Vardenafil,0,9,B-drug
DDI-DrugBank.d97.s92,vardenafil,0,9,B-drug
DDI-DrugBank.d97.s92,concentration,11,23,O
DDI-DrugBank.d97.s93,Vardenafil,0,9,B-drug
DDI-DrugBank.d97.s93,dose,11,14,O
DDI-DrugBank.d97.s93,should,16,21,O
DDI-DrugBank.d97.s93,not,23,25,O
DDI-DrugBank.d97.s93,exceed,27,32,O
DDI-DrugBank.d97.s93,a,34,34,O
DDI-DrugBank.d97.s93,maximum,36,42,O
DDI-DrugBank.d97.s93,of,44,45,O
DDI-DrugBank.d97.s93,2.5,47,49,O
DDI-DrugBank.d97.s93,mg,51,52,O
DDI-DrugBank.d97.s93,in,54,55,O
DDI-DrugBank.d97.s93,a,57,57,O
DDI-DrugBank.d97.s93,24-hour,59,65,O
DDI-DrugBank.d97.s93,period,67,72,O
DDI-DrugBank.d97.s93,in,74,75,O
DDI-DrugBank.d97.s93,patients,77,84,O
DDI-DrugBank.d97.s93,receiving,86,94,O
DDI-DrugBank.d97.s93,concomitant,96,106,O
DDI-DrugBank.d97.s93,indinavir,108,116,B-drug
DDI-DrugBank.d97.s93,therapy,118,124,O
DDI-DrugBank.d97.s93,.,125,125,O
DDI-DrugBank.d97.s94,Note,0,3,O
DDI-DrugBank.d97.s94,:,4,4,O
DDI-DrugBank.d97.s95,=,0,0,O
DDI-DrugBank.d97.s95,increase,2,9,O
DDI-DrugBank.d97.s95,;,10,10,O
DDI-DrugBank.d97.s96,=,0,0,O
DDI-DrugBank.d97.s96,decrease,2,9,O
DDI-DrugBank.d433.s0,No,0,1,O
DDI-DrugBank.d433.s0,formal,3,8,O
DDI-DrugBank.d433.s0,drug,10,13,O
DDI-DrugBank.d433.s0,interaction,15,25,O
DDI-DrugBank.d433.s0,studies,27,33,O
DDI-DrugBank.d433.s0,have,35,38,O
DDI-DrugBank.d433.s0,been,40,43,O
DDI-DrugBank.d433.s0,conducted,45,53,O
DDI-DrugBank.d433.s0,with,55,58,O
DDI-DrugBank.d433.s0,Rebif,60,64,B-brand
DDI-DrugBank.d433.s0,.,66,66,O
DDI-DrugBank.d433.s1,Due,0,2,O
DDI-DrugBank.d433.s1,to,4,5,O
DDI-DrugBank.d433.s1,its,7,9,O
DDI-DrugBank.d433.s1,potential,11,19,O
DDI-DrugBank.d433.s1,to,21,22,O
DDI-DrugBank.d433.s1,cause,24,28,O
DDI-DrugBank.d433.s1,neutropenia,30,40,O
DDI-DrugBank.d433.s1,and,42,44,O
DDI-DrugBank.d433.s1,lymphopenia,46,56,O
DDI-DrugBank.d433.s1,",",57,57,O
DDI-DrugBank.d433.s1,proper,59,64,O
DDI-DrugBank.d433.s1,monitoring,66,75,O
DDI-DrugBank.d433.s1,of,77,78,O
DDI-DrugBank.d433.s1,patients,80,87,O
DDI-DrugBank.d433.s1,is,89,90,O
DDI-DrugBank.d433.s1,required,92,99,O
DDI-DrugBank.d433.s1,if,101,102,O
DDI-DrugBank.d433.s1,Rebif,104,108,B-brand
DDI-DrugBank.d433.s1,is,111,112,O
DDI-DrugBank.d433.s1,given,114,118,O
DDI-DrugBank.d433.s1,in,120,121,O
DDI-DrugBank.d433.s1,combination,123,133,O
DDI-DrugBank.d433.s1,with,135,138,O
DDI-DrugBank.d433.s1,myelosuppressive,140,155,O
DDI-DrugBank.d433.s1,agents,157,162,O
DDI-DrugBank.d433.s1,.,163,163,O
DDI-DrugBank.d433.s2,Also,0,3,O
DDI-DrugBank.d433.s2,",",4,4,O
DDI-DrugBank.d433.s2,the,6,8,O
DDI-DrugBank.d433.s2,potential,10,18,O
DDI-DrugBank.d433.s2,for,20,22,O
DDI-DrugBank.d433.s2,hepatic,24,30,O
DDI-DrugBank.d433.s2,injury,32,37,O
DDI-DrugBank.d433.s2,should,39,44,O
DDI-DrugBank.d433.s2,be,46,47,O
DDI-DrugBank.d433.s2,considered,49,58,O
DDI-DrugBank.d433.s2,when,60,63,O
DDI-DrugBank.d433.s2,Rebif,65,69,B-brand
DDI-DrugBank.d433.s2,is,72,73,O
DDI-DrugBank.d433.s2,used,75,78,O
DDI-DrugBank.d433.s2,in,80,81,O
DDI-DrugBank.d433.s2,combination,83,93,O
DDI-DrugBank.d433.s2,with,95,98,O
DDI-DrugBank.d433.s2,other,100,104,O
DDI-DrugBank.d433.s2,products,106,113,O
DDI-DrugBank.d433.s2,associated,115,124,O
DDI-DrugBank.d433.s2,with,126,129,O
DDI-DrugBank.d433.s2,hepatic,131,137,O
DDI-DrugBank.d433.s2,injury,139,144,O
DDI-DrugBank.d433.s2,",",145,145,O
DDI-DrugBank.d433.s2,or,147,148,O
DDI-DrugBank.d433.s2,when,150,153,O
DDI-DrugBank.d433.s2,new,155,157,O
DDI-DrugBank.d433.s2,agents,159,164,O
DDI-DrugBank.d433.s2,are,166,168,O
DDI-DrugBank.d433.s2,added,170,174,O
DDI-DrugBank.d433.s2,to,176,177,O
DDI-DrugBank.d433.s2,the,179,181,O
DDI-DrugBank.d433.s2,regimen,183,189,O
DDI-DrugBank.d433.s2,of,191,192,O
DDI-DrugBank.d433.s2,patients,194,201,O
DDI-DrugBank.d433.s2,already,203,209,O
DDI-DrugBank.d433.s2,on,211,212,O
DDI-DrugBank.d433.s2,Rebif,214,218,B-brand
DDI-DrugBank.d433.s2,.,220,220,O
DDI-DrugBank.d227.s0,Isoflurane,0,9,B-drug
DDI-DrugBank.d227.s0,potentiates,11,21,O
DDI-DrugBank.d227.s0,the,23,25,O
DDI-DrugBank.d227.s0,muscle,27,32,O
DDI-DrugBank.d227.s0,relaxant,34,41,O
DDI-DrugBank.d227.s0,effect,43,48,O
DDI-DrugBank.d227.s0,of,50,51,O
DDI-DrugBank.d227.s0,all,53,55,O
DDI-DrugBank.d227.s0,muscle,57,62,B-group
DDI-DrugBank.d227.s0,relaxants,64,72,I-group
DDI-DrugBank.d227.s0,",",73,73,O
DDI-DrugBank.d227.s0,most,75,78,O
DDI-DrugBank.d227.s0,notably,80,86,O
DDI-DrugBank.d227.s0,nondepolarizing,88,102,B-group
DDI-DrugBank.d227.s0,muscle,104,109,I-group
DDI-DrugBank.d227.s0,relaxants,111,119,I-group
DDI-DrugBank.d227.s0,",",120,120,O
DDI-DrugBank.d227.s0,and,122,124,O
DDI-DrugBank.d227.s0,MAC,126,128,O
DDI-DrugBank.d227.s0,(,130,130,O
DDI-DrugBank.d227.s0,minimum,131,137,O
DDI-DrugBank.d227.s0,alveolar,139,146,O
DDI-DrugBank.d227.s0,concentration,148,160,O
DDI-DrugBank.d227.s0,),161,161,O
DDI-DrugBank.d227.s0,is,163,164,O
DDI-DrugBank.d227.s0,reduced,166,172,O
DDI-DrugBank.d227.s0,by,174,175,O
DDI-DrugBank.d227.s0,concomitant,177,187,O
DDI-DrugBank.d227.s0,administration,189,202,O
DDI-DrugBank.d227.s0,of,204,205,O
DDI-DrugBank.d227.s0,N,207,207,O
DDI-DrugBank.d227.s0,2O,209,210,O
DDI-DrugBank.d227.s0,.,211,211,O
DDI-DrugBank.d227.s1,See,0,2,O
DDI-DrugBank.d227.s1,CLINICAL,4,11,O
DDI-DrugBank.d227.s1,PHARMACOLOGY,13,24,O
DDI-DrugBank.d227.s1,.,25,25,O
DDI-DrugBank.d465.s0,The,0,2,O
DDI-DrugBank.d465.s0,vasodilating,4,15,O
DDI-DrugBank.d465.s0,effects,17,23,O
DDI-DrugBank.d465.s0,of,25,26,O
DDI-DrugBank.d465.s0,isosorbide,28,37,B-drug
DDI-DrugBank.d465.s0,dinitrate,39,47,I-drug
DDI-DrugBank.d465.s0,may,49,51,O
DDI-DrugBank.d465.s0,be,53,54,O
DDI-DrugBank.d465.s0,additive,56,63,O
DDI-DrugBank.d465.s0,with,65,68,O
DDI-DrugBank.d465.s0,those,70,74,O
DDI-DrugBank.d465.s0,of,76,77,O
DDI-DrugBank.d465.s0,other,79,83,O
DDI-DrugBank.d465.s0,vasodilators,85,96,B-group
DDI-DrugBank.d465.s0,.,97,97,O
DDI-DrugBank.d465.s1,Alcohol,0,6,B-drug
DDI-DrugBank.d465.s1,",",7,7,O
DDI-DrugBank.d465.s1,in,9,10,O
DDI-DrugBank.d465.s1,particular,12,21,O
DDI-DrugBank.d465.s1,",",22,22,O
DDI-DrugBank.d465.s1,has,24,26,O
DDI-DrugBank.d465.s1,been,28,31,O
DDI-DrugBank.d465.s1,found,33,37,O
DDI-DrugBank.d465.s1,to,39,40,O
DDI-DrugBank.d465.s1,exhibit,42,48,O
DDI-DrugBank.d465.s1,additive,50,57,O
DDI-DrugBank.d465.s1,effects,59,65,O
DDI-DrugBank.d465.s1,of,67,68,O
DDI-DrugBank.d465.s1,this,70,73,O
DDI-DrugBank.d465.s1,variety,75,81,O
DDI-DrugBank.d465.s1,.,82,82,O
DDI-DrugBank.d163.s0,Vitamin,0,6,B-group
DDI-DrugBank.d163.s0,A,8,8,I-group
DDI-DrugBank.d163.s0,:,9,9,O
DDI-DrugBank.d163.s0,Because,11,17,O
DDI-DrugBank.d163.s0,of,19,20,O
DDI-DrugBank.d163.s0,the,22,24,O
DDI-DrugBank.d163.s0,relationship,26,37,O
DDI-DrugBank.d163.s0,of,39,40,O
DDI-DrugBank.d163.s0,Accutane,42,49,B-brand
DDI-DrugBank.d163.s0,to,51,52,O
DDI-DrugBank.d163.s0,vitamin,54,60,B-group
DDI-DrugBank.d163.s0,A,62,62,I-group
DDI-DrugBank.d163.s0,",",63,63,O
DDI-DrugBank.d163.s0,patients,65,72,O
DDI-DrugBank.d163.s0,should,74,79,O
DDI-DrugBank.d163.s0,be,81,82,O
DDI-DrugBank.d163.s0,advised,84,90,O
DDI-DrugBank.d163.s0,against,92,98,O
DDI-DrugBank.d163.s0,taking,100,105,O
DDI-DrugBank.d163.s0,vitamin,107,113,B-group
DDI-DrugBank.d163.s0,supplements,115,125,I-group
DDI-DrugBank.d163.s0,containing,127,136,O
DDI-DrugBank.d163.s0,vitamin,138,144,B-group
DDI-DrugBank.d163.s0,A,146,146,I-group
DDI-DrugBank.d163.s0,to,148,149,O
DDI-DrugBank.d163.s0,avoid,151,155,O
DDI-DrugBank.d163.s0,additive,157,164,O
DDI-DrugBank.d163.s0,toxic,166,170,O
DDI-DrugBank.d163.s0,effects,172,178,O
DDI-DrugBank.d163.s1,.,0,0,O
DDI-DrugBank.d163.s2,Tetracyclines,0,12,B-group
DDI-DrugBank.d163.s2,:,13,13,O
DDI-DrugBank.d163.s2,Concomitant,15,25,O
DDI-DrugBank.d163.s2,treatment,27,35,O
DDI-DrugBank.d163.s2,with,37,40,O
DDI-DrugBank.d163.s2,Accutane,42,49,B-brand
DDI-DrugBank.d163.s2,and,51,53,O
DDI-DrugBank.d163.s2,tetracyclines,55,67,B-group
DDI-DrugBank.d163.s2,should,69,74,O
DDI-DrugBank.d163.s2,be,76,77,O
DDI-DrugBank.d163.s2,avoided,79,85,O
DDI-DrugBank.d163.s2,because,87,93,O
DDI-DrugBank.d163.s2,Accutane,95,102,B-brand
DDI-DrugBank.d163.s2,use,104,106,O
DDI-DrugBank.d163.s2,has,108,110,O
DDI-DrugBank.d163.s2,been,112,115,O
DDI-DrugBank.d163.s2,associated,117,126,O
DDI-DrugBank.d163.s2,with,128,131,O
DDI-DrugBank.d163.s2,a,133,133,O
DDI-DrugBank.d163.s2,number,135,140,O
DDI-DrugBank.d163.s2,of,142,143,O
DDI-DrugBank.d163.s2,cases,145,149,O
DDI-DrugBank.d163.s2,of,151,152,O
DDI-DrugBank.d163.s2,pseudotumor,154,164,O
DDI-DrugBank.d163.s2,cerebri,166,172,O
DDI-DrugBank.d163.s2,(,174,174,O
DDI-DrugBank.d163.s2,benign,175,180,O
DDI-DrugBank.d163.s2,intracranial,182,193,O
DDI-DrugBank.d163.s2,hypertension,195,206,O
DDI-DrugBank.d163.s2,),207,207,O
DDI-DrugBank.d163.s2,",",208,208,O
DDI-DrugBank.d163.s2,some,210,213,O
DDI-DrugBank.d163.s2,of,215,216,O
DDI-DrugBank.d163.s2,which,218,222,O
DDI-DrugBank.d163.s2,involved,224,231,O
DDI-DrugBank.d163.s2,concomitant,233,243,O
DDI-DrugBank.d163.s2,use,245,247,O
DDI-DrugBank.d163.s2,of,249,250,O
DDI-DrugBank.d163.s2,tetracyclines,252,264,B-group
DDI-DrugBank.d163.s3,.,0,0,O
DDI-DrugBank.d163.s4,Micro-dosed,0,10,O
DDI-DrugBank.d163.s4,Progesterone,12,23,B-drug
DDI-DrugBank.d163.s4,Preparations,25,36,O
DDI-DrugBank.d163.s4,:,37,37,O
DDI-DrugBank.d163.s4,Micro-dosed,39,49,O
DDI-DrugBank.d163.s4,progesterone,51,62,B-drug
DDI-DrugBank.d163.s4,preparations,64,75,O
DDI-DrugBank.d163.s4,(,77,77,O
DDI-DrugBank.d163.s4,minipills,78,86,O
DDI-DrugBank.d163.s4,that,88,91,O
DDI-DrugBank.d163.s4,do,93,94,O
DDI-DrugBank.d163.s4,not,96,98,O
DDI-DrugBank.d163.s4,contain,100,106,O
DDI-DrugBank.d163.s4,an,108,109,O
DDI-DrugBank.d163.s4,estrogen,111,118,B-group
DDI-DrugBank.d163.s4,),119,119,O
DDI-DrugBank.d163.s4,may,121,123,O
DDI-DrugBank.d163.s4,be,125,126,O
DDI-DrugBank.d163.s4,an,128,129,O
DDI-DrugBank.d163.s4,inadequate,131,140,O
DDI-DrugBank.d163.s4,method,142,147,O
DDI-DrugBank.d163.s4,of,149,150,O
DDI-DrugBank.d163.s4,contraception,152,164,O
DDI-DrugBank.d163.s4,during,166,171,O
DDI-DrugBank.d163.s4,Accutane,173,180,B-brand
DDI-DrugBank.d163.s4,therapy,182,188,O
DDI-DrugBank.d163.s4,.,189,189,O
DDI-DrugBank.d163.s5,Although,0,7,O
DDI-DrugBank.d163.s5,other,9,13,O
DDI-DrugBank.d163.s5,hormonal,15,22,B-group
DDI-DrugBank.d163.s5,contraceptives,24,37,I-group
DDI-DrugBank.d163.s5,are,39,41,O
DDI-DrugBank.d163.s5,highly,43,48,O
DDI-DrugBank.d163.s5,effective,50,58,O
DDI-DrugBank.d163.s5,",",59,59,O
DDI-DrugBank.d163.s5,there,61,65,O
DDI-DrugBank.d163.s5,have,67,70,O
DDI-DrugBank.d163.s5,been,72,75,O
DDI-DrugBank.d163.s5,reports,77,83,O
DDI-DrugBank.d163.s5,of,85,86,O
DDI-DrugBank.d163.s5,pregnancy,88,96,O
DDI-DrugBank.d163.s5,from,98,101,O
DDI-DrugBank.d163.s5,women,103,107,O
DDI-DrugBank.d163.s5,who,109,111,O
DDI-DrugBank.d163.s5,have,113,116,O
DDI-DrugBank.d163.s5,used,118,121,O
DDI-DrugBank.d163.s5,combined,123,130,B-group
DDI-DrugBank.d163.s5,oral,132,135,I-group
DDI-DrugBank.d163.s5,contraceptives,137,150,I-group
DDI-DrugBank.d163.s5,",",151,151,O
DDI-DrugBank.d163.s5,as,153,154,O
DDI-DrugBank.d163.s5,well,156,159,O
DDI-DrugBank.d163.s5,as,161,162,O
DDI-DrugBank.d163.s5,topical/injectable/implantable/insertable,164,204,O
DDI-DrugBank.d163.s5,hormonal,206,213,O
DDI-DrugBank.d163.s5,birth,215,219,O
DDI-DrugBank.d163.s5,control,221,227,O
DDI-DrugBank.d163.s5,products,229,236,O
DDI-DrugBank.d163.s5,.,237,237,O
DDI-DrugBank.d163.s6,These,0,4,O
DDI-DrugBank.d163.s6,reports,6,12,O
DDI-DrugBank.d163.s6,are,14,16,O
DDI-DrugBank.d163.s6,more,18,21,O
DDI-DrugBank.d163.s6,frequent,23,30,O
DDI-DrugBank.d163.s6,for,32,34,O
DDI-DrugBank.d163.s6,women,36,40,O
DDI-DrugBank.d163.s6,who,42,44,O
DDI-DrugBank.d163.s6,use,46,48,O
DDI-DrugBank.d163.s6,only,50,53,O
DDI-DrugBank.d163.s6,a,55,55,O
DDI-DrugBank.d163.s6,single,57,62,O
DDI-DrugBank.d163.s6,method,64,69,O
DDI-DrugBank.d163.s6,of,71,72,O
DDI-DrugBank.d163.s6,contraception,74,86,O
DDI-DrugBank.d163.s6,.,87,87,O
DDI-DrugBank.d163.s7,It,0,1,O
DDI-DrugBank.d163.s7,is,3,4,O
DDI-DrugBank.d163.s7,not,6,8,O
DDI-DrugBank.d163.s7,known,10,14,O
DDI-DrugBank.d163.s7,if,16,17,O
DDI-DrugBank.d163.s7,hormonal,19,26,B-group
DDI-DrugBank.d163.s7,contraceptives,28,41,I-group
DDI-DrugBank.d163.s7,differ,43,48,O
DDI-DrugBank.d163.s7,in,50,51,O
DDI-DrugBank.d163.s7,their,53,57,O
DDI-DrugBank.d163.s7,effectiveness,59,71,O
DDI-DrugBank.d163.s7,when,73,76,O
DDI-DrugBank.d163.s7,used,78,81,O
DDI-DrugBank.d163.s7,with,83,86,O
DDI-DrugBank.d163.s7,Accutane,88,95,B-brand
DDI-DrugBank.d163.s7,.,96,96,O
DDI-DrugBank.d163.s8,Therefore,0,8,O
DDI-DrugBank.d163.s8,",",9,9,O
DDI-DrugBank.d163.s8,it,11,12,O
DDI-DrugBank.d163.s8,is,14,15,O
DDI-DrugBank.d163.s8,critically,17,26,O
DDI-DrugBank.d163.s8,important,28,36,O
DDI-DrugBank.d163.s8,for,38,40,O
DDI-DrugBank.d163.s8,women,42,46,O
DDI-DrugBank.d163.s8,of,48,49,O
DDI-DrugBank.d163.s8,childbearing,51,62,O
DDI-DrugBank.d163.s8,potential,64,72,O
DDI-DrugBank.d163.s8,to,74,75,O
DDI-DrugBank.d163.s8,select,77,82,O
DDI-DrugBank.d163.s8,and,84,86,O
DDI-DrugBank.d163.s8,commit,88,93,O
DDI-DrugBank.d163.s8,to,95,96,O
DDI-DrugBank.d163.s8,use,98,100,O
DDI-DrugBank.d163.s8,2,102,102,O
DDI-DrugBank.d163.s8,forms,104,108,O
DDI-DrugBank.d163.s8,of,110,111,O
DDI-DrugBank.d163.s8,effective,113,121,O
DDI-DrugBank.d163.s8,contraception,123,135,O
DDI-DrugBank.d163.s8,simultaneously,137,150,O
DDI-DrugBank.d163.s8,",",151,151,O
DDI-DrugBank.d163.s8,at,153,154,O
DDI-DrugBank.d163.s8,least,156,160,O
DDI-DrugBank.d163.s8,1,162,162,O
DDI-DrugBank.d163.s8,of,164,165,O
DDI-DrugBank.d163.s8,which,167,171,O
DDI-DrugBank.d163.s8,must,173,176,O
DDI-DrugBank.d163.s8,be,178,179,O
DDI-DrugBank.d163.s8,a,181,181,O
DDI-DrugBank.d163.s8,primary,183,189,O
DDI-DrugBank.d163.s8,form,191,194,O
DDI-DrugBank.d163.s8,",",195,195,O
DDI-DrugBank.d163.s8,unless,197,202,O
DDI-DrugBank.d163.s8,absolute,204,211,O
DDI-DrugBank.d163.s8,abstinence,213,222,O
DDI-DrugBank.d163.s8,is,224,225,O
DDI-DrugBank.d163.s8,the,227,229,O
DDI-DrugBank.d163.s8,chosen,231,236,O
DDI-DrugBank.d163.s8,method,238,243,O
DDI-DrugBank.d163.s8,",",244,244,O
DDI-DrugBank.d163.s8,or,246,247,O
DDI-DrugBank.d163.s8,the,249,251,O
DDI-DrugBank.d163.s8,patient,253,259,O
DDI-DrugBank.d163.s8,has,261,263,O
DDI-DrugBank.d163.s8,undergone,265,273,O
DDI-DrugBank.d163.s8,a,275,275,O
DDI-DrugBank.d163.s8,hysterectomy,277,288,O
DDI-DrugBank.d163.s9,.,0,0,O
DDI-DrugBank.d163.s10,Phenytoin,0,8,B-drug
DDI-DrugBank.d163.s10,:,9,9,O
DDI-DrugBank.d163.s10,Accutane,11,18,B-brand
DDI-DrugBank.d163.s10,has,20,22,O
DDI-DrugBank.d163.s10,not,24,26,O
DDI-DrugBank.d163.s10,been,28,31,O
DDI-DrugBank.d163.s10,shown,33,37,O
DDI-DrugBank.d163.s10,to,39,40,O
DDI-DrugBank.d163.s10,alter,42,46,O
DDI-DrugBank.d163.s10,the,48,50,O
DDI-DrugBank.d163.s10,pharmacokinetics,52,67,O
DDI-DrugBank.d163.s10,of,69,70,O
DDI-DrugBank.d163.s10,phenytoin,72,80,B-drug
DDI-DrugBank.d163.s10,in,82,83,O
DDI-DrugBank.d163.s10,a,85,85,O
DDI-DrugBank.d163.s10,study,87,91,O
DDI-DrugBank.d163.s10,in,93,94,O
DDI-DrugBank.d163.s10,seven,96,100,O
DDI-DrugBank.d163.s10,healthy,102,108,O
DDI-DrugBank.d163.s10,volunteers,110,119,O
DDI-DrugBank.d163.s10,.,120,120,O
DDI-DrugBank.d163.s11,These,0,4,O
DDI-DrugBank.d163.s11,results,6,12,O
DDI-DrugBank.d163.s11,are,14,16,O
DDI-DrugBank.d163.s11,consistent,18,27,O
DDI-DrugBank.d163.s11,with,29,32,O
DDI-DrugBank.d163.s11,the,34,36,O
DDI-DrugBank.d163.s11,in,38,39,O
DDI-DrugBank.d163.s11,vitro,41,45,O
DDI-DrugBank.d163.s11,finding,47,53,O
DDI-DrugBank.d163.s11,that,55,58,O
DDI-DrugBank.d163.s11,neither,60,66,O
DDI-DrugBank.d163.s11,isotretinoin,68,79,B-drug
DDI-DrugBank.d163.s11,nor,81,83,O
DDI-DrugBank.d163.s11,its,85,87,O
DDI-DrugBank.d163.s11,metabolites,89,99,O
DDI-DrugBank.d163.s11,induce,101,106,O
DDI-DrugBank.d163.s11,or,108,109,O
DDI-DrugBank.d163.s11,inhibit,111,117,O
DDI-DrugBank.d163.s11,the,119,121,O
DDI-DrugBank.d163.s11,activity,123,130,O
DDI-DrugBank.d163.s11,of,132,133,O
DDI-DrugBank.d163.s11,the,135,137,O
DDI-DrugBank.d163.s11,CYP,139,141,O
DDI-DrugBank.d163.s11,2C9,143,145,O
DDI-DrugBank.d163.s11,human,147,151,O
DDI-DrugBank.d163.s11,hepatic,153,159,O
DDI-DrugBank.d163.s11,P450,161,164,O
DDI-DrugBank.d163.s11,enzyme,166,171,O
DDI-DrugBank.d163.s11,.,172,172,O
DDI-DrugBank.d163.s12,Phenytoin,0,8,B-drug
DDI-DrugBank.d163.s12,is,10,11,O
DDI-DrugBank.d163.s12,known,13,17,O
DDI-DrugBank.d163.s12,to,19,20,O
DDI-DrugBank.d163.s12,cause,22,26,O
DDI-DrugBank.d163.s12,osteomalacia,28,39,O
DDI-DrugBank.d163.s12,.,40,40,O
DDI-DrugBank.d163.s13,No,0,1,O
DDI-DrugBank.d163.s13,formal,3,8,O
DDI-DrugBank.d163.s13,clinical,10,17,O
DDI-DrugBank.d163.s13,studies,19,25,O
DDI-DrugBank.d163.s13,have,27,30,O
DDI-DrugBank.d163.s13,been,32,35,O
DDI-DrugBank.d163.s13,conducted,37,45,O
DDI-DrugBank.d163.s13,to,47,48,O
DDI-DrugBank.d163.s13,assess,50,55,O
DDI-DrugBank.d163.s13,if,57,58,O
DDI-DrugBank.d163.s13,there,60,64,O
DDI-DrugBank.d163.s13,is,66,67,O
DDI-DrugBank.d163.s13,an,69,70,O
DDI-DrugBank.d163.s13,interactive,72,82,O
DDI-DrugBank.d163.s13,effect,84,89,O
DDI-DrugBank.d163.s13,on,91,92,O
DDI-DrugBank.d163.s13,bone,94,97,O
DDI-DrugBank.d163.s13,loss,99,102,O
DDI-DrugBank.d163.s13,between,104,110,O
DDI-DrugBank.d163.s13,phenytoin,112,120,B-drug
DDI-DrugBank.d163.s13,and,122,124,O
DDI-DrugBank.d163.s13,Accutane,126,133,B-brand
DDI-DrugBank.d163.s13,.,134,134,O
DDI-DrugBank.d163.s14,Therefore,0,8,O
DDI-DrugBank.d163.s14,",",9,9,O
DDI-DrugBank.d163.s14,caution,11,17,O
DDI-DrugBank.d163.s14,should,19,24,O
DDI-DrugBank.d163.s14,be,26,27,O
DDI-DrugBank.d163.s14,exercised,29,37,O
DDI-DrugBank.d163.s14,when,39,42,O
DDI-DrugBank.d163.s14,using,44,48,O
DDI-DrugBank.d163.s14,these,50,54,O
DDI-DrugBank.d163.s14,drugs,56,60,O
DDI-DrugBank.d163.s14,together,62,69,O
DDI-DrugBank.d163.s15,.,0,0,O
DDI-DrugBank.d163.s16,Systemic,0,7,B-group
DDI-DrugBank.d163.s16,Corticosteroids,9,23,I-group
DDI-DrugBank.d163.s16,:,24,24,O
DDI-DrugBank.d163.s16,Systemic,26,33,B-group
DDI-DrugBank.d163.s16,corticosteroids,35,49,I-group
DDI-DrugBank.d163.s16,are,51,53,O
DDI-DrugBank.d163.s16,known,55,59,O
DDI-DrugBank.d163.s16,to,61,62,O
DDI-DrugBank.d163.s16,cause,64,68,O
DDI-DrugBank.d163.s16,osteoporosis,70,81,O
DDI-DrugBank.d163.s16,.,82,82,O
DDI-DrugBank.d163.s17,No,0,1,O
DDI-DrugBank.d163.s17,formal,3,8,O
DDI-DrugBank.d163.s17,clinical,10,17,O
DDI-DrugBank.d163.s17,studies,19,25,O
DDI-DrugBank.d163.s17,have,27,30,O
DDI-DrugBank.d163.s17,been,32,35,O
DDI-DrugBank.d163.s17,conducted,37,45,O
DDI-DrugBank.d163.s17,to,47,48,O
DDI-DrugBank.d163.s17,assess,50,55,O
DDI-DrugBank.d163.s17,if,57,58,O
DDI-DrugBank.d163.s17,there,60,64,O
DDI-DrugBank.d163.s17,is,66,67,O
DDI-DrugBank.d163.s17,an,69,70,O
DDI-DrugBank.d163.s17,interactive,72,82,O
DDI-DrugBank.d163.s17,effect,84,89,O
DDI-DrugBank.d163.s17,on,91,92,O
DDI-DrugBank.d163.s17,bone,94,97,O
DDI-DrugBank.d163.s17,loss,99,102,O
DDI-DrugBank.d163.s17,between,104,110,O
DDI-DrugBank.d163.s17,systemic,112,119,B-group
DDI-DrugBank.d163.s17,corticosteroids,121,135,I-group
DDI-DrugBank.d163.s17,and,137,139,O
DDI-DrugBank.d163.s17,Accutane,141,148,B-brand
DDI-DrugBank.d163.s17,.,149,149,O
DDI-DrugBank.d163.s18,Therefore,0,8,O
DDI-DrugBank.d163.s18,",",9,9,O
DDI-DrugBank.d163.s18,caution,11,17,O
DDI-DrugBank.d163.s18,should,19,24,O
DDI-DrugBank.d163.s18,be,26,27,O
DDI-DrugBank.d163.s18,exercised,29,37,O
DDI-DrugBank.d163.s18,when,39,42,O
DDI-DrugBank.d163.s18,using,44,48,O
DDI-DrugBank.d163.s18,these,50,54,O
DDI-DrugBank.d163.s18,drugs,56,60,O
DDI-DrugBank.d163.s18,together,62,69,O
DDI-DrugBank.d163.s18,.,70,70,O
DDI-DrugBank.d163.s19,Prescribers,0,10,O
DDI-DrugBank.d163.s19,are,12,14,O
DDI-DrugBank.d163.s19,advised,16,22,O
DDI-DrugBank.d163.s19,to,24,25,O
DDI-DrugBank.d163.s19,consult,27,33,O
DDI-DrugBank.d163.s19,the,35,37,O
DDI-DrugBank.d163.s19,package,39,45,O
DDI-DrugBank.d163.s19,insert,47,52,O
DDI-DrugBank.d163.s19,of,54,55,O
DDI-DrugBank.d163.s19,medication,57,66,O
DDI-DrugBank.d163.s19,administered,68,79,O
DDI-DrugBank.d163.s19,concomitantly,81,93,O
DDI-DrugBank.d163.s19,with,95,98,O
DDI-DrugBank.d163.s19,hormonal,100,107,B-group
DDI-DrugBank.d163.s19,contraceptives,109,122,I-group
DDI-DrugBank.d163.s19,",",123,123,O
DDI-DrugBank.d163.s19,since,125,129,O
DDI-DrugBank.d163.s19,some,131,134,O
DDI-DrugBank.d163.s19,medications,136,146,O
DDI-DrugBank.d163.s19,may,148,150,O
DDI-DrugBank.d163.s19,decrease,152,159,O
DDI-DrugBank.d163.s19,the,161,163,O
DDI-DrugBank.d163.s19,effectiveness,165,177,O
DDI-DrugBank.d163.s19,of,179,180,O
DDI-DrugBank.d163.s19,these,182,186,O
DDI-DrugBank.d163.s19,birth,188,192,O
DDI-DrugBank.d163.s19,control,194,200,O
DDI-DrugBank.d163.s19,products,202,209,O
DDI-DrugBank.d163.s19,.,210,210,O
DDI-DrugBank.d163.s20,Accutane,0,7,B-brand
DDI-DrugBank.d163.s20,use,9,11,O
DDI-DrugBank.d163.s20,is,13,14,O
DDI-DrugBank.d163.s20,associated,16,25,O
DDI-DrugBank.d163.s20,with,27,30,O
DDI-DrugBank.d163.s20,depression,32,41,O
DDI-DrugBank.d163.s20,in,43,44,O
DDI-DrugBank.d163.s20,some,46,49,O
DDI-DrugBank.d163.s20,patients,51,58,O
DDI-DrugBank.d163.s20,.,59,59,O
DDI-DrugBank.d163.s21,Pregnancies,0,10,O
DDI-DrugBank.d163.s21,have,12,15,O
DDI-DrugBank.d163.s21,been,17,20,O
DDI-DrugBank.d163.s21,reported,22,29,O
DDI-DrugBank.d163.s21,by,31,32,O
DDI-DrugBank.d163.s21,users,34,38,O
DDI-DrugBank.d163.s21,of,40,41,O
DDI-DrugBank.d163.s21,combined,43,50,B-group
DDI-DrugBank.d163.s21,hormonal,52,59,I-group
DDI-DrugBank.d163.s21,contraceptives,61,74,I-group
DDI-DrugBank.d163.s21,who,76,78,O
DDI-DrugBank.d163.s21,also,80,83,O
DDI-DrugBank.d163.s21,used,85,88,O
DDI-DrugBank.d163.s21,some,90,93,O
DDI-DrugBank.d163.s21,form,95,98,O
DDI-DrugBank.d163.s21,of,100,101,O
DDI-DrugBank.d163.s21,St.,103,105,O
DDI-DrugBank.d163.s21,Johns,107,111,O
DDI-DrugBank.d163.s21,Wort,113,116,O
DDI-DrugBank.d163.s21,.,117,117,O
DDI-DrugBank.d163.s22,Laboratory,0,9,O
DDI-DrugBank.d163.s22,Tests,11,15,O
DDI-DrugBank.d163.s22,Pregnancy,17,25,O
DDI-DrugBank.d163.s22,Test,27,30,O
DDI-DrugBank.d163.s22,Female,32,37,O
DDI-DrugBank.d163.s22,patients,39,46,O
DDI-DrugBank.d163.s22,of,48,49,O
DDI-DrugBank.d163.s22,childbearing,51,62,O
DDI-DrugBank.d163.s22,potential,64,72,O
DDI-DrugBank.d163.s22,must,74,77,O
DDI-DrugBank.d163.s22,have,79,82,O
DDI-DrugBank.d163.s22,negative,84,91,O
DDI-DrugBank.d163.s22,results,93,99,O
DDI-DrugBank.d163.s22,from,101,104,O
DDI-DrugBank.d163.s22,2,106,106,O
DDI-DrugBank.d163.s22,urine,108,112,O
DDI-DrugBank.d163.s22,or,114,115,O
DDI-DrugBank.d163.s22,serum,117,121,O
DDI-DrugBank.d163.s22,pregnancy,123,131,O
DDI-DrugBank.d163.s22,tests,133,137,O
DDI-DrugBank.d163.s22,with,139,142,O
DDI-DrugBank.d163.s22,a,144,144,O
DDI-DrugBank.d163.s22,sensitivity,146,156,O
DDI-DrugBank.d163.s22,of,158,159,O
DDI-DrugBank.d163.s22,at,161,162,O
DDI-DrugBank.d163.s22,least,164,168,O
DDI-DrugBank.d163.s22,25,170,171,O
DDI-DrugBank.d163.s22,mIU/mL,173,178,O
DDI-DrugBank.d163.s22,before,180,185,O
DDI-DrugBank.d163.s22,receiving,187,195,O
DDI-DrugBank.d163.s22,the,197,199,O
DDI-DrugBank.d163.s22,initial,201,207,O
DDI-DrugBank.d163.s22,Accutane,209,216,B-brand
DDI-DrugBank.d163.s22,prescription,218,229,O
DDI-DrugBank.d163.s22,.,230,230,O
DDI-DrugBank.d163.s23,The,0,2,O
DDI-DrugBank.d163.s23,first,4,8,O
DDI-DrugBank.d163.s23,test,10,13,O
DDI-DrugBank.d163.s23,is,15,16,O
DDI-DrugBank.d163.s23,obtained,18,25,O
DDI-DrugBank.d163.s23,by,27,28,O
DDI-DrugBank.d163.s23,the,30,32,O
DDI-DrugBank.d163.s23,prescriber,34,43,O
DDI-DrugBank.d163.s23,when,45,48,O
DDI-DrugBank.d163.s23,the,50,52,O
DDI-DrugBank.d163.s23,decision,54,61,O
DDI-DrugBank.d163.s23,is,63,64,O
DDI-DrugBank.d163.s23,made,66,69,O
DDI-DrugBank.d163.s23,to,71,72,O
DDI-DrugBank.d163.s23,pursue,74,79,O
DDI-DrugBank.d163.s23,qualification,81,93,O
DDI-DrugBank.d163.s23,of,95,96,O
DDI-DrugBank.d163.s23,the,98,100,O
DDI-DrugBank.d163.s23,patient,102,108,O
DDI-DrugBank.d163.s23,for,110,112,O
DDI-DrugBank.d163.s23,Accutane,114,121,B-brand
DDI-DrugBank.d163.s23,(,123,123,O
DDI-DrugBank.d163.s23,a,124,124,O
DDI-DrugBank.d163.s23,screening,126,134,O
DDI-DrugBank.d163.s23,test,136,139,O
DDI-DrugBank.d163.s23,),140,140,O
DDI-DrugBank.d163.s23,.,141,141,O
DDI-DrugBank.d163.s24,The,0,2,O
DDI-DrugBank.d163.s24,second,4,9,O
DDI-DrugBank.d163.s24,pregnancy,11,19,O
DDI-DrugBank.d163.s24,test,21,24,O
DDI-DrugBank.d163.s24,(,26,26,O
DDI-DrugBank.d163.s24,a,27,27,O
DDI-DrugBank.d163.s24,confirmation,29,40,O
DDI-DrugBank.d163.s24,test,42,45,O
DDI-DrugBank.d163.s24,),46,46,O
DDI-DrugBank.d163.s24,should,48,53,O
DDI-DrugBank.d163.s24,be,55,56,O
DDI-DrugBank.d163.s24,done,58,61,O
DDI-DrugBank.d163.s24,during,63,68,O
DDI-DrugBank.d163.s24,the,70,72,O
DDI-DrugBank.d163.s24,first,74,78,O
DDI-DrugBank.d163.s24,5,80,80,O
DDI-DrugBank.d163.s24,days,82,85,O
DDI-DrugBank.d163.s24,of,87,88,O
DDI-DrugBank.d163.s24,the,90,92,O
DDI-DrugBank.d163.s24,menstrual,94,102,O
DDI-DrugBank.d163.s24,period,104,109,O
DDI-DrugBank.d163.s24,immediately,111,121,O
DDI-DrugBank.d163.s24,preceding,123,131,O
DDI-DrugBank.d163.s24,the,133,135,O
DDI-DrugBank.d163.s24,beginning,137,145,O
DDI-DrugBank.d163.s24,of,147,148,O
DDI-DrugBank.d163.s24,Accutane,150,157,B-brand
DDI-DrugBank.d163.s24,therapy,159,165,O
DDI-DrugBank.d163.s24,.,166,166,O
DDI-DrugBank.d163.s25,For,0,2,O
DDI-DrugBank.d163.s25,patients,4,11,O
DDI-DrugBank.d163.s25,with,13,16,O
DDI-DrugBank.d163.s25,amenorrhea,18,27,O
DDI-DrugBank.d163.s25,",",28,28,O
DDI-DrugBank.d163.s25,the,30,32,O
DDI-DrugBank.d163.s25,second,34,39,O
DDI-DrugBank.d163.s25,test,41,44,O
DDI-DrugBank.d163.s25,should,46,51,O
DDI-DrugBank.d163.s25,be,53,54,O
DDI-DrugBank.d163.s25,done,56,59,O
DDI-DrugBank.d163.s25,at,61,62,O
DDI-DrugBank.d163.s25,least,64,68,O
DDI-DrugBank.d163.s25,11,70,71,O
DDI-DrugBank.d163.s25,days,73,76,O
DDI-DrugBank.d163.s25,after,78,82,O
DDI-DrugBank.d163.s25,the,84,86,O
DDI-DrugBank.d163.s25,last,88,91,O
DDI-DrugBank.d163.s25,act,93,95,O
DDI-DrugBank.d163.s25,of,97,98,O
DDI-DrugBank.d163.s25,unprotected,100,110,O
DDI-DrugBank.d163.s25,sexual,112,117,O
DDI-DrugBank.d163.s25,intercourse,119,129,O
DDI-DrugBank.d163.s25,(,131,131,O
DDI-DrugBank.d163.s25,without,132,138,O
DDI-DrugBank.d163.s25,using,140,144,O
DDI-DrugBank.d163.s25,2,146,146,O
DDI-DrugBank.d163.s25,effective,148,156,O
DDI-DrugBank.d163.s25,forms,158,162,O
DDI-DrugBank.d163.s25,of,164,165,O
DDI-DrugBank.d163.s25,contraception,167,179,O
DDI-DrugBank.d163.s25,),180,180,O
DDI-DrugBank.d163.s25,.,181,181,O
DDI-DrugBank.d163.s26,Each,0,3,O
DDI-DrugBank.d163.s26,month,5,9,O
DDI-DrugBank.d163.s26,of,11,12,O
DDI-DrugBank.d163.s26,therapy,14,20,O
DDI-DrugBank.d163.s26,",",21,21,O
DDI-DrugBank.d163.s26,the,23,25,O
DDI-DrugBank.d163.s26,patient,27,33,O
DDI-DrugBank.d163.s26,must,35,38,O
DDI-DrugBank.d163.s26,have,40,43,O
DDI-DrugBank.d163.s26,a,45,45,O
DDI-DrugBank.d163.s26,negative,47,54,O
DDI-DrugBank.d163.s26,result,56,61,O
DDI-DrugBank.d163.s26,from,63,66,O
DDI-DrugBank.d163.s26,a,68,68,O
DDI-DrugBank.d163.s26,urine,70,74,O
DDI-DrugBank.d163.s26,or,76,77,O
DDI-DrugBank.d163.s26,serum,79,83,O
DDI-DrugBank.d163.s26,pregnancy,85,93,O
DDI-DrugBank.d163.s26,test,95,98,O
DDI-DrugBank.d163.s26,.,99,99,O
DDI-DrugBank.d163.s27,A,0,0,O
DDI-DrugBank.d163.s27,pregnancy,2,10,O
DDI-DrugBank.d163.s27,test,12,15,O
DDI-DrugBank.d163.s27,must,17,20,O
DDI-DrugBank.d163.s27,be,22,23,O
DDI-DrugBank.d163.s27,repeated,25,32,O
DDI-DrugBank.d163.s27,each,34,37,O
DDI-DrugBank.d163.s27,month,39,43,O
DDI-DrugBank.d163.s27,prior,45,49,O
DDI-DrugBank.d163.s27,to,51,52,O
DDI-DrugBank.d163.s27,the,54,56,O
DDI-DrugBank.d163.s27,female,58,63,O
DDI-DrugBank.d163.s27,patient,65,71,O
DDI-DrugBank.d163.s27,receiving,73,81,O
DDI-DrugBank.d163.s27,each,83,86,O
DDI-DrugBank.d163.s27,prescription,88,99,O
DDI-DrugBank.d163.s28,.,0,0,O
DDI-DrugBank.d163.s29,Lipids,0,5,O
DDI-DrugBank.d163.s29,:,6,6,O
DDI-DrugBank.d163.s29,Pretreatment,8,19,O
DDI-DrugBank.d163.s29,and,21,23,O
DDI-DrugBank.d163.s29,follow-up,25,33,O
DDI-DrugBank.d163.s29,blood,35,39,O
DDI-DrugBank.d163.s29,lipids,41,46,O
DDI-DrugBank.d163.s29,should,48,53,O
DDI-DrugBank.d163.s29,be,55,56,O
DDI-DrugBank.d163.s29,obtained,58,65,O
DDI-DrugBank.d163.s29,under,67,71,O
DDI-DrugBank.d163.s29,fasting,73,79,O
DDI-DrugBank.d163.s29,conditions,81,90,O
DDI-DrugBank.d163.s29,.,91,91,O
DDI-DrugBank.d163.s30,After,0,4,O
DDI-DrugBank.d163.s30,consumption,6,16,O
DDI-DrugBank.d163.s30,of,18,19,O
DDI-DrugBank.d163.s30,alcohol,21,27,B-drug
DDI-DrugBank.d163.s30,",",28,28,O
DDI-DrugBank.d163.s30,at,30,31,O
DDI-DrugBank.d163.s30,least,33,37,O
DDI-DrugBank.d163.s30,36,39,40,O
DDI-DrugBank.d163.s30,hours,42,46,O
DDI-DrugBank.d163.s30,should,48,53,O
DDI-DrugBank.d163.s30,elapse,55,60,O
DDI-DrugBank.d163.s30,before,62,67,O
DDI-DrugBank.d163.s30,these,69,73,O
DDI-DrugBank.d163.s30,determinations,75,88,O
DDI-DrugBank.d163.s30,are,90,92,O
DDI-DrugBank.d163.s30,made,94,97,O
DDI-DrugBank.d163.s30,.,98,98,O
DDI-DrugBank.d163.s31,It,0,1,O
DDI-DrugBank.d163.s31,is,3,4,O
DDI-DrugBank.d163.s31,recommended,6,16,O
DDI-DrugBank.d163.s31,that,18,21,O
DDI-DrugBank.d163.s31,these,23,27,O
DDI-DrugBank.d163.s31,tests,29,33,O
DDI-DrugBank.d163.s31,be,35,36,O
DDI-DrugBank.d163.s31,performed,38,46,O
DDI-DrugBank.d163.s31,at,48,49,O
DDI-DrugBank.d163.s31,weekly,51,56,O
DDI-DrugBank.d163.s31,or,58,59,O
DDI-DrugBank.d163.s31,biweekly,61,68,O
DDI-DrugBank.d163.s31,intervals,70,78,O
DDI-DrugBank.d163.s31,until,80,84,O
DDI-DrugBank.d163.s31,the,86,88,O
DDI-DrugBank.d163.s31,lipid,90,94,O
DDI-DrugBank.d163.s31,response,96,103,O
DDI-DrugBank.d163.s31,to,105,106,O
DDI-DrugBank.d163.s31,Accutane,108,115,B-brand
DDI-DrugBank.d163.s31,is,117,118,O
DDI-DrugBank.d163.s31,established,120,130,O
DDI-DrugBank.d163.s31,.,131,131,O
DDI-DrugBank.d163.s32,The,0,2,O
DDI-DrugBank.d163.s32,incidence,4,12,O
DDI-DrugBank.d163.s32,of,14,15,O
DDI-DrugBank.d163.s32,hypertriglyceridemia,17,36,O
DDI-DrugBank.d163.s32,is,38,39,O
DDI-DrugBank.d163.s32,1,41,41,O
DDI-DrugBank.d163.s32,patient,43,49,O
DDI-DrugBank.d163.s32,in,51,52,O
DDI-DrugBank.d163.s32,4,54,54,O
DDI-DrugBank.d163.s32,on,56,57,O
DDI-DrugBank.d163.s32,Accutane,59,66,B-brand
DDI-DrugBank.d163.s32,therapy,68,74,O
DDI-DrugBank.d163.s33,.,0,0,O
DDI-DrugBank.d163.s34,Liver,0,4,O
DDI-DrugBank.d163.s34,Function,6,13,O
DDI-DrugBank.d163.s34,Tests,15,19,O
DDI-DrugBank.d163.s34,:,20,20,O
DDI-DrugBank.d163.s34,Since,22,26,O
DDI-DrugBank.d163.s34,elevations,28,37,O
DDI-DrugBank.d163.s34,of,39,40,O
DDI-DrugBank.d163.s34,liver,42,46,O
DDI-DrugBank.d163.s34,enzymes,48,54,O
DDI-DrugBank.d163.s34,have,56,59,O
DDI-DrugBank.d163.s34,been,61,64,O
DDI-DrugBank.d163.s34,observed,66,73,O
DDI-DrugBank.d163.s34,during,75,80,O
DDI-DrugBank.d163.s34,clinical,82,89,O
DDI-DrugBank.d163.s34,trials,91,96,O
DDI-DrugBank.d163.s34,",",97,97,O
DDI-DrugBank.d163.s34,and,99,101,O
DDI-DrugBank.d163.s34,hepatitis,103,111,O
DDI-DrugBank.d163.s34,has,113,115,O
DDI-DrugBank.d163.s34,been,117,120,O
DDI-DrugBank.d163.s34,reported,122,129,O
DDI-DrugBank.d163.s34,",",130,130,O
DDI-DrugBank.d163.s34,pretreatment,132,143,O
DDI-DrugBank.d163.s34,and,145,147,O
DDI-DrugBank.d163.s34,follow-up,149,157,O
DDI-DrugBank.d163.s34,liver,159,163,O
DDI-DrugBank.d163.s34,function,165,172,O
DDI-DrugBank.d163.s34,tests,174,178,O
DDI-DrugBank.d163.s34,should,180,185,O
DDI-DrugBank.d163.s34,be,187,188,O
DDI-DrugBank.d163.s34,performed,190,198,O
DDI-DrugBank.d163.s34,at,200,201,O
DDI-DrugBank.d163.s34,weekly,203,208,O
DDI-DrugBank.d163.s34,or,210,211,O
DDI-DrugBank.d163.s34,biweekly,213,220,O
DDI-DrugBank.d163.s34,intervals,222,230,O
DDI-DrugBank.d163.s34,until,232,236,O
DDI-DrugBank.d163.s34,the,238,240,O
DDI-DrugBank.d163.s34,response,242,249,O
DDI-DrugBank.d163.s34,to,251,252,O
DDI-DrugBank.d163.s34,Accutane,254,261,B-brand
DDI-DrugBank.d163.s34,has,263,265,O
DDI-DrugBank.d163.s34,been,267,270,O
DDI-DrugBank.d163.s34,established,272,282,O
DDI-DrugBank.d163.s35,.,0,0,O
DDI-DrugBank.d163.s36,Glucose,0,6,O
DDI-DrugBank.d163.s36,:,7,7,O
DDI-DrugBank.d163.s36,Some,9,12,O
DDI-DrugBank.d163.s36,patients,14,21,O
DDI-DrugBank.d163.s36,receiving,23,31,O
DDI-DrugBank.d163.s36,Accutane,33,40,B-brand
DDI-DrugBank.d163.s36,have,42,45,O
DDI-DrugBank.d163.s36,experienced,47,57,O
DDI-DrugBank.d163.s36,problems,59,66,O
DDI-DrugBank.d163.s36,in,68,69,O
DDI-DrugBank.d163.s36,the,71,73,O
DDI-DrugBank.d163.s36,control,75,81,O
DDI-DrugBank.d163.s36,of,83,84,O
DDI-DrugBank.d163.s36,their,86,90,O
DDI-DrugBank.d163.s36,blood,92,96,O
DDI-DrugBank.d163.s36,sugar,98,102,O
DDI-DrugBank.d163.s36,.,103,103,O
DDI-DrugBank.d163.s37,In,0,1,O
DDI-DrugBank.d163.s37,addition,3,10,O
DDI-DrugBank.d163.s37,",",11,11,O
DDI-DrugBank.d163.s37,new,13,15,O
DDI-DrugBank.d163.s37,cases,17,21,O
DDI-DrugBank.d163.s37,of,23,24,O
DDI-DrugBank.d163.s37,diabetes,26,33,O
DDI-DrugBank.d163.s37,have,35,38,O
DDI-DrugBank.d163.s37,been,40,43,O
DDI-DrugBank.d163.s37,diagnosed,45,53,O
DDI-DrugBank.d163.s37,during,55,60,O
DDI-DrugBank.d163.s37,Accutane,62,69,B-brand
DDI-DrugBank.d163.s37,therapy,71,77,O
DDI-DrugBank.d163.s37,",",78,78,O
DDI-DrugBank.d163.s37,although,80,87,O
DDI-DrugBank.d163.s37,no,89,90,O
DDI-DrugBank.d163.s37,causal,92,97,O
DDI-DrugBank.d163.s37,relationship,99,110,O
DDI-DrugBank.d163.s37,has,112,114,O
DDI-DrugBank.d163.s37,been,116,119,O
DDI-DrugBank.d163.s37,established,121,131,O
DDI-DrugBank.d163.s38,.,0,0,O
DDI-DrugBank.d163.s39,CPK,0,2,O
DDI-DrugBank.d163.s39,:,3,3,O
DDI-DrugBank.d163.s39,Some,5,8,O
DDI-DrugBank.d163.s39,patients,10,17,O
DDI-DrugBank.d163.s39,undergoing,19,28,O
DDI-DrugBank.d163.s39,vigorous,30,37,O
DDI-DrugBank.d163.s39,physical,39,46,O
DDI-DrugBank.d163.s39,activity,48,55,O
DDI-DrugBank.d163.s39,while,57,61,O
DDI-DrugBank.d163.s39,on,63,64,O
DDI-DrugBank.d163.s39,Accutane,66,73,B-brand
DDI-DrugBank.d163.s39,therapy,75,81,O
DDI-DrugBank.d163.s39,have,83,86,O
DDI-DrugBank.d163.s39,experienced,88,98,O
DDI-DrugBank.d163.s39,elevated,100,107,O
DDI-DrugBank.d163.s39,CPK,109,111,O
DDI-DrugBank.d163.s39,levels,113,118,O
DDI-DrugBank.d163.s39,;,119,119,O
DDI-DrugBank.d163.s40,however,0,6,O
DDI-DrugBank.d163.s40,",",7,7,O
DDI-DrugBank.d163.s40,the,9,11,O
DDI-DrugBank.d163.s40,clinical,13,20,O
DDI-DrugBank.d163.s40,significance,22,33,O
DDI-DrugBank.d163.s40,is,35,36,O
DDI-DrugBank.d163.s40,unknown,38,44,O
DDI-DrugBank.d163.s40,.,45,45,O
DDI-DrugBank.d163.s41,There,0,4,O
DDI-DrugBank.d163.s41,have,6,9,O
DDI-DrugBank.d163.s41,been,11,14,O
DDI-DrugBank.d163.s41,rare,16,19,O
DDI-DrugBank.d163.s41,postmarketing,21,33,O
DDI-DrugBank.d163.s41,reports,35,41,O
DDI-DrugBank.d163.s41,of,43,44,O
DDI-DrugBank.d163.s41,rhabdomyolysis,46,59,O
DDI-DrugBank.d163.s41,",",60,60,O
DDI-DrugBank.d163.s41,some,62,65,O
DDI-DrugBank.d163.s41,associated,67,76,O
DDI-DrugBank.d163.s41,with,78,81,O
DDI-DrugBank.d163.s41,strenuous,83,91,O
DDI-DrugBank.d163.s41,physical,93,100,O
DDI-DrugBank.d163.s41,activity,102,109,O
DDI-DrugBank.d163.s41,.,110,110,O
DDI-DrugBank.d163.s42,In,0,1,O
DDI-DrugBank.d163.s42,a,3,3,O
DDI-DrugBank.d163.s42,clinical,5,12,O
DDI-DrugBank.d163.s42,trial,14,18,O
DDI-DrugBank.d163.s42,of,20,21,O
DDI-DrugBank.d163.s42,217,23,25,O
DDI-DrugBank.d163.s42,pediatric,27,35,O
DDI-DrugBank.d163.s42,patients,37,44,O
DDI-DrugBank.d163.s42,(,46,46,O
DDI-DrugBank.d163.s42,12,47,48,O
DDI-DrugBank.d163.s42,to,50,51,O
DDI-DrugBank.d163.s42,17,53,54,O
DDI-DrugBank.d163.s42,years,56,60,O
DDI-DrugBank.d163.s42,),61,61,O
DDI-DrugBank.d163.s42,with,63,66,O
DDI-DrugBank.d163.s42,severe,68,73,O
DDI-DrugBank.d163.s42,recalcitrant,75,86,O
DDI-DrugBank.d163.s42,nodular,88,94,O
DDI-DrugBank.d163.s42,acne,96,99,O
DDI-DrugBank.d163.s42,",",100,100,O
DDI-DrugBank.d163.s42,transient,102,110,O
DDI-DrugBank.d163.s42,elevations,112,121,O
DDI-DrugBank.d163.s42,in,123,124,O
DDI-DrugBank.d163.s42,CPK,126,128,O
DDI-DrugBank.d163.s42,were,130,133,O
DDI-DrugBank.d163.s42,observed,135,142,O
DDI-DrugBank.d163.s42,in,144,145,O
DDI-DrugBank.d163.s42,12,147,148,O
DDI-DrugBank.d163.s42,%,149,149,O
DDI-DrugBank.d163.s42,of,151,152,O
DDI-DrugBank.d163.s42,patients,154,161,O
DDI-DrugBank.d163.s42,",",162,162,O
DDI-DrugBank.d163.s42,including,164,172,O
DDI-DrugBank.d163.s42,those,174,178,O
DDI-DrugBank.d163.s42,undergoing,180,189,O
DDI-DrugBank.d163.s42,strenuous,191,199,O
DDI-DrugBank.d163.s42,physical,201,208,O
DDI-DrugBank.d163.s42,activity,210,217,O
DDI-DrugBank.d163.s42,in,219,220,O
DDI-DrugBank.d163.s42,association,222,232,O
DDI-DrugBank.d163.s42,with,234,237,O
DDI-DrugBank.d163.s42,reported,239,246,O
DDI-DrugBank.d163.s42,musculoskeletal,248,262,O
DDI-DrugBank.d163.s42,adverse,264,270,O
DDI-DrugBank.d163.s42,events,272,277,O
DDI-DrugBank.d163.s42,such,279,282,O
DDI-DrugBank.d163.s42,as,284,285,O
DDI-DrugBank.d163.s42,back,287,290,O
DDI-DrugBank.d163.s42,pain,292,295,O
DDI-DrugBank.d163.s42,",",296,296,O
DDI-DrugBank.d163.s42,arthralgia,298,307,O
DDI-DrugBank.d163.s42,",",308,308,O
DDI-DrugBank.d163.s42,limb,310,313,O
DDI-DrugBank.d163.s42,injury,315,320,O
DDI-DrugBank.d163.s42,",",321,321,O
DDI-DrugBank.d163.s42,or,323,324,O
DDI-DrugBank.d163.s42,muscle,326,331,O
DDI-DrugBank.d163.s42,sprain,333,338,O
DDI-DrugBank.d163.s42,.,339,339,O
DDI-DrugBank.d163.s43,In,0,1,O
DDI-DrugBank.d163.s43,these,3,7,O
DDI-DrugBank.d163.s43,patients,9,16,O
DDI-DrugBank.d163.s43,",",17,17,O
DDI-DrugBank.d163.s43,approximately,19,31,O
DDI-DrugBank.d163.s43,half,33,36,O
DDI-DrugBank.d163.s43,of,38,39,O
DDI-DrugBank.d163.s43,the,41,43,O
DDI-DrugBank.d163.s43,CPK,45,47,O
DDI-DrugBank.d163.s43,elevations,49,58,O
DDI-DrugBank.d163.s43,returned,60,67,O
DDI-DrugBank.d163.s43,to,69,70,O
DDI-DrugBank.d163.s43,normal,72,77,O
DDI-DrugBank.d163.s43,within,79,84,O
DDI-DrugBank.d163.s43,2,86,86,O
DDI-DrugBank.d163.s43,weeks,88,92,O
DDI-DrugBank.d163.s43,and,94,96,O
DDI-DrugBank.d163.s43,half,98,101,O
DDI-DrugBank.d163.s43,returned,103,110,O
DDI-DrugBank.d163.s43,to,112,113,O
DDI-DrugBank.d163.s43,normal,115,120,O
DDI-DrugBank.d163.s43,within,122,127,O
DDI-DrugBank.d163.s43,4,129,129,O
DDI-DrugBank.d163.s43,weeks,131,135,O
DDI-DrugBank.d163.s43,.,136,136,O
DDI-DrugBank.d163.s44,No,0,1,O
DDI-DrugBank.d163.s44,cases,3,7,O
DDI-DrugBank.d163.s44,of,9,10,O
DDI-DrugBank.d163.s44,rhabdomyolysis,12,25,O
DDI-DrugBank.d163.s44,were,27,30,O
DDI-DrugBank.d163.s44,reported,32,39,O
DDI-DrugBank.d163.s44,in,41,42,O
DDI-DrugBank.d163.s44,this,44,47,O
DDI-DrugBank.d163.s44,trial,49,53,O
DDI-DrugBank.d163.s44,.,54,54,O
DDI-DrugBank.d81.s0,Nitroglycerin,0,12,B-drug
DDI-DrugBank.d81.s0,:,13,13,O
DDI-DrugBank.d81.s0,DynaCirc,15,22,B-brand
DDI-DrugBank.d81.s0,(,25,25,O
DDI-DrugBank.d81.s0,isradipine,26,35,B-drug
DDI-DrugBank.d81.s0,),36,36,O
DDI-DrugBank.d81.s0,has,38,40,O
DDI-DrugBank.d81.s0,been,42,45,O
DDI-DrugBank.d81.s0,safely,47,52,O
DDI-DrugBank.d81.s0,coadministered,54,67,O
DDI-DrugBank.d81.s0,with,69,72,O
DDI-DrugBank.d81.s0,nitroglycerin,74,86,B-drug
DDI-DrugBank.d81.s0,.,87,87,O
DDI-DrugBank.d81.s1,Hydrochlorothiazide,0,18,B-drug
DDI-DrugBank.d81.s1,:,19,19,O
DDI-DrugBank.d81.s1,A,21,21,O
DDI-DrugBank.d81.s1,study,23,27,O
DDI-DrugBank.d81.s1,in,29,30,O
DDI-DrugBank.d81.s1,normal,32,37,O
DDI-DrugBank.d81.s1,healthy,39,45,O
DDI-DrugBank.d81.s1,volunteers,47,56,O
DDI-DrugBank.d81.s1,has,58,60,O
DDI-DrugBank.d81.s1,shown,62,66,O
DDI-DrugBank.d81.s1,that,68,71,O
DDI-DrugBank.d81.s1,concomitant,73,83,O
DDI-DrugBank.d81.s1,administration,85,98,O
DDI-DrugBank.d81.s1,of,100,101,O
DDI-DrugBank.d81.s1,DynaCirc,103,110,B-brand
DDI-DrugBank.d81.s1,(,113,113,O
DDI-DrugBank.d81.s1,isradipine,114,123,B-drug
DDI-DrugBank.d81.s1,),124,124,O
DDI-DrugBank.d81.s1,and,126,128,O
DDI-DrugBank.d81.s1,hydrochlorothiazide,130,148,B-drug
DDI-DrugBank.d81.s1,does,150,153,O
DDI-DrugBank.d81.s1,not,155,157,O
DDI-DrugBank.d81.s1,result,159,164,O
DDI-DrugBank.d81.s1,in,166,167,O
DDI-DrugBank.d81.s1,altered,169,175,O
DDI-DrugBank.d81.s1,pharmacoktnetics,177,192,O
DDI-DrugBank.d81.s1,of,194,195,O
DDI-DrugBank.d81.s1,either,197,202,O
DDI-DrugBank.d81.s1,drug,204,207,O
DDI-DrugBank.d81.s1,.,208,208,O
DDI-DrugBank.d81.s2,In,0,1,O
DDI-DrugBank.d81.s2,a,3,3,O
DDI-DrugBank.d81.s2,study,5,9,O
DDI-DrugBank.d81.s2,in,11,12,O
DDI-DrugBank.d81.s2,hypertensive,14,25,O
DDI-DrugBank.d81.s2,patients,27,34,O
DDI-DrugBank.d81.s2,",",35,35,O
DDI-DrugBank.d81.s2,addition,37,44,O
DDI-DrugBank.d81.s2,of,46,47,O
DDI-DrugBank.d81.s2,isradipine,49,58,B-drug
DDI-DrugBank.d81.s2,to,60,61,O
DDI-DrugBank.d81.s2,existing,63,70,O
DDI-DrugBank.d81.s2,hydrochlorothiazide,72,90,B-drug
DDI-DrugBank.d81.s2,therapy,92,98,O
DDI-DrugBank.d81.s2,did,100,102,O
DDI-DrugBank.d81.s2,not,104,106,O
DDI-DrugBank.d81.s2,result,108,113,O
DDI-DrugBank.d81.s2,in,115,116,O
DDI-DrugBank.d81.s2,any,118,120,O
DDI-DrugBank.d81.s2,unexpected,122,131,O
DDI-DrugBank.d81.s2,adverse,133,139,O
DDI-DrugBank.d81.s2,effects,141,147,O
DDI-DrugBank.d81.s2,",",148,148,O
DDI-DrugBank.d81.s2,and,150,152,O
DDI-DrugBank.d81.s2,isradipine,154,163,B-drug
DDI-DrugBank.d81.s2,had,165,167,O
DDI-DrugBank.d81.s2,an,169,170,O
DDI-DrugBank.d81.s2,additional,172,181,O
DDI-DrugBank.d81.s2,antihypertensive,183,198,O
DDI-DrugBank.d81.s2,effect,200,205,O
DDI-DrugBank.d81.s2,.,206,206,O
DDI-DrugBank.d81.s3,Propranolol,0,10,B-drug
DDI-DrugBank.d81.s3,:,11,11,O
DDI-DrugBank.d81.s3,In,13,14,O
DDI-DrugBank.d81.s3,a,16,16,O
DDI-DrugBank.d81.s3,single,18,23,O
DDI-DrugBank.d81.s3,dose,25,28,O
DDI-DrugBank.d81.s3,study,30,34,O
DDI-DrugBank.d81.s3,in,36,37,O
DDI-DrugBank.d81.s3,normal,39,44,O
DDI-DrugBank.d81.s3,volunteers,46,55,O
DDI-DrugBank.d81.s3,",",56,56,O
DDI-DrugBank.d81.s3,coadministration,58,73,O
DDI-DrugBank.d81.s3,of,75,76,O
DDI-DrugBank.d81.s3,propranolol,78,88,B-drug
DDI-DrugBank.d81.s3,had,90,92,O
DDI-DrugBank.d81.s3,a,94,94,O
DDI-DrugBank.d81.s3,small,96,100,O
DDI-DrugBank.d81.s3,effect,102,107,O
DDI-DrugBank.d81.s3,on,109,110,O
DDI-DrugBank.d81.s3,the,112,114,O
DDI-DrugBank.d81.s3,rate,116,119,O
DDI-DrugBank.d81.s3,but,121,123,O
DDI-DrugBank.d81.s3,no,125,126,O
DDI-DrugBank.d81.s3,effect,128,133,O
DDI-DrugBank.d81.s3,on,135,136,O
DDI-DrugBank.d81.s3,the,138,140,O
DDI-DrugBank.d81.s3,extent,142,147,O
DDI-DrugBank.d81.s3,of,149,150,O
DDI-DrugBank.d81.s3,isradipine,152,161,B-drug
DDI-DrugBank.d81.s3,bioavailability,163,177,O
DDI-DrugBank.d81.s3,.,178,178,O
DDI-DrugBank.d81.s4,Significant,0,10,O
DDI-DrugBank.d81.s4,increases,12,20,O
DDI-DrugBank.d81.s4,In,22,23,O
DDI-DrugBank.d81.s4,AUC,25,27,O
DDI-DrugBank.d81.s4,(,29,29,O
DDI-DrugBank.d81.s4,27,30,31,O
DDI-DrugBank.d81.s4,%,32,32,O
DDI-DrugBank.d81.s4,),33,33,O
DDI-DrugBank.d81.s4,and,35,37,O
DDI-DrugBank.d81.s4,Cmax,39,42,O
DDI-DrugBank.d81.s4,(,44,44,O
DDI-DrugBank.d81.s4,58,45,46,O
DDI-DrugBank.d81.s4,%,47,47,O
DDI-DrugBank.d81.s4,),48,48,O
DDI-DrugBank.d81.s4,and,50,52,O
DDI-DrugBank.d81.s4,decreases,54,62,O
DDI-DrugBank.d81.s4,in,64,65,O
DDI-DrugBank.d81.s4,tmax,67,70,O
DDI-DrugBank.d81.s4,(,72,72,O
DDI-DrugBank.d81.s4,23,73,74,O
DDI-DrugBank.d81.s4,%,75,75,O
DDI-DrugBank.d81.s4,),76,76,O
DDI-DrugBank.d81.s4,of,78,79,O
DDI-DrugBank.d81.s4,propranolol,81,91,B-drug
DDI-DrugBank.d81.s4,were,93,96,O
DDI-DrugBank.d81.s4,noted,98,102,O
DDI-DrugBank.d81.s4,in,104,105,O
DDI-DrugBank.d81.s4,this,107,110,O
DDI-DrugBank.d81.s4,study,112,116,O
DDI-DrugBank.d81.s4,.,117,117,O
DDI-DrugBank.d81.s5,However,0,6,O
DDI-DrugBank.d81.s5,",",7,7,O
DDI-DrugBank.d81.s5,concomitant,9,19,O
DDI-DrugBank.d81.s5,administration,21,34,O
DDI-DrugBank.d81.s5,of,36,37,O
DDI-DrugBank.d81.s5,5,39,39,O
DDI-DrugBank.d81.s5,mg,41,42,O
DDI-DrugBank.d81.s5,b.i.d,44,48,O
DDI-DrugBank.d81.s5,.,49,49,O
DDI-DrugBank.d81.s5,isradipine,51,60,B-drug
DDI-DrugBank.d81.s5,and,62,64,O
DDI-DrugBank.d81.s5,40,66,67,O
DDI-DrugBank.d81.s5,mg,69,70,O
DDI-DrugBank.d81.s5,b.i.d,72,76,O
DDI-DrugBank.d81.s5,.,77,77,O
DDI-DrugBank.d81.s6,propranolol,0,10,B-drug
DDI-DrugBank.d81.s6,to,12,13,O
DDI-DrugBank.d81.s6,healthy,15,21,O
DDI-DrugBank.d81.s6,volunteers,23,32,O
DDI-DrugBank.d81.s6,under,34,38,O
DDI-DrugBank.d81.s6,steady-state,40,51,O
DDI-DrugBank.d81.s6,conditions,53,62,O
DDI-DrugBank.d81.s6,had,64,66,O
DDI-DrugBank.d81.s6,no,68,69,O
DDI-DrugBank.d81.s6,relevant,71,78,O
DDI-DrugBank.d81.s6,effect,80,85,O
DDI-DrugBank.d81.s6,on,87,88,O
DDI-DrugBank.d81.s6,either,90,95,O
DDI-DrugBank.d81.s6,drug,97,100,O
DDI-DrugBank.d81.s6,s,102,102,O
DDI-DrugBank.d81.s6,bioavailability,104,118,O
DDI-DrugBank.d81.s6,",",119,119,O
DDI-DrugBank.d81.s6,AUC,121,123,O
DDI-DrugBank.d81.s6,and,125,127,O
DDI-DrugBank.d81.s6,Cmax,129,132,O
DDI-DrugBank.d81.s6,",",133,133,O
DDI-DrugBank.d81.s6,differences,135,145,O
DDI-DrugBank.d81.s6,were,147,150,O
DDI-DrugBank.d81.s6,20,153,154,O
DDI-DrugBank.d81.s6,%,155,155,O
DDI-DrugBank.d81.s6,between,157,163,O
DDI-DrugBank.d81.s6,isradipine,165,174,B-drug
DDI-DrugBank.d81.s6,given,176,180,O
DDI-DrugBank.d81.s6,singly,182,187,O
DDI-DrugBank.d81.s6,and,189,191,O
DDI-DrugBank.d81.s6,in,193,194,O
DDI-DrugBank.d81.s6,combination,196,206,O
DDI-DrugBank.d81.s6,with,208,211,O
DDI-DrugBank.d81.s6,propranolol,213,223,B-drug
DDI-DrugBank.d81.s6,",",224,224,O
DDI-DrugBank.d81.s6,and,226,228,O
DDI-DrugBank.d81.s6,between,230,236,O
DDI-DrugBank.d81.s6,propranolol,238,248,B-drug
DDI-DrugBank.d81.s6,given,250,254,O
DDI-DrugBank.d81.s6,singly,256,261,O
DDI-DrugBank.d81.s6,and,263,265,O
DDI-DrugBank.d81.s6,in,267,268,O
DDI-DrugBank.d81.s6,combination,270,280,O
DDI-DrugBank.d81.s6,with,282,285,O
DDI-DrugBank.d81.s6,isradipine,287,296,B-drug
DDI-DrugBank.d81.s6,.,297,297,O
DDI-DrugBank.d81.s7,Cimetidine,0,9,B-drug
DDI-DrugBank.d81.s7,:,10,10,O
DDI-DrugBank.d81.s7,In,12,13,O
DDI-DrugBank.d81.s7,a,15,15,O
DDI-DrugBank.d81.s7,study,17,21,O
DDI-DrugBank.d81.s7,in,23,24,O
DDI-DrugBank.d81.s7,healthy,26,32,O
DDI-DrugBank.d81.s7,volunteers,34,43,O
DDI-DrugBank.d81.s7,",",44,44,O
DDI-DrugBank.d81.s7,a,46,46,O
DDI-DrugBank.d81.s7,one-week,48,55,O
DDI-DrugBank.d81.s7,course,57,62,O
DDI-DrugBank.d81.s7,of,64,65,O
DDI-DrugBank.d81.s7,cimetidine,67,76,B-drug
DDI-DrugBank.d81.s7,at,78,79,O
DDI-DrugBank.d81.s7,400,81,83,O
DDI-DrugBank.d81.s7,mg,85,86,O
DDI-DrugBank.d81.s7,b.i.d,88,92,O
DDI-DrugBank.d81.s7,.,93,93,O
DDI-DrugBank.d81.s7,with,95,98,O
DDI-DrugBank.d81.s7,a,100,100,O
DDI-DrugBank.d81.s7,single,102,107,O
DDI-DrugBank.d81.s7,5,109,109,O
DDI-DrugBank.d81.s7,mg,111,112,O
DDI-DrugBank.d81.s7,dose,114,117,O
DDI-DrugBank.d81.s7,of,119,120,O
DDI-DrugBank.d81.s7,isradipine,122,131,B-drug
DDI-DrugBank.d81.s7,on,133,134,O
DDI-DrugBank.d81.s7,the,136,138,O
DDI-DrugBank.d81.s7,sixth,140,144,O
DDI-DrugBank.d81.s7,day,146,148,O
DDI-DrugBank.d81.s7,showed,150,155,O
DDI-DrugBank.d81.s7,an,157,158,O
DDI-DrugBank.d81.s7,increase,160,167,O
DDI-DrugBank.d81.s7,in,169,170,O
DDI-DrugBank.d81.s7,isradipine,172,181,B-drug
DDI-DrugBank.d81.s7,mean,183,186,O
DDI-DrugBank.d81.s7,peak,188,191,O
DDI-DrugBank.d81.s7,plasma,193,198,O
DDI-DrugBank.d81.s7,concentrations,200,213,O
DDI-DrugBank.d81.s7,(,215,215,O
DDI-DrugBank.d81.s7,36,216,217,O
DDI-DrugBank.d81.s7,%,218,218,O
DDI-DrugBank.d81.s7,),219,219,O
DDI-DrugBank.d81.s7,and,221,223,O
DDI-DrugBank.d81.s7,significant,225,235,O
DDI-DrugBank.d81.s7,increase,237,244,O
DDI-DrugBank.d81.s7,in,246,247,O
DDI-DrugBank.d81.s7,area,249,252,O
DDI-DrugBank.d81.s7,under,254,258,O
DDI-DrugBank.d81.s7,the,260,262,O
DDI-DrugBank.d81.s7,curve,264,268,O
DDI-DrugBank.d81.s7,(,270,270,O
DDI-DrugBank.d81.s7,50,271,272,O
DDI-DrugBank.d81.s7,%,273,273,O
DDI-DrugBank.d81.s7,),274,274,O
DDI-DrugBank.d81.s7,.,275,275,O
DDI-DrugBank.d81.s8,If,0,1,O
DDI-DrugBank.d81.s8,isradipine,3,12,B-drug
DDI-DrugBank.d81.s8,therapy,14,20,O
DDI-DrugBank.d81.s8,is,22,23,O
DDI-DrugBank.d81.s8,initiated,25,33,O
DDI-DrugBank.d81.s8,in,35,36,O
DDI-DrugBank.d81.s8,a,38,38,O
DDI-DrugBank.d81.s8,patient,40,46,O
DDI-DrugBank.d81.s8,currently,48,56,O
DDI-DrugBank.d81.s8,receiving,58,66,O
DDI-DrugBank.d81.s8,cimetidine,68,77,B-drug
DDI-DrugBank.d81.s8,careful,79,85,O
DDI-DrugBank.d81.s8,monitoring,87,96,O
DDI-DrugBank.d81.s8,for,98,100,O
DDI-DrugBank.d81.s8,adverse,102,108,O
DDI-DrugBank.d81.s8,reactions,110,118,O
DDI-DrugBank.d81.s8,is,120,121,O
DDI-DrugBank.d81.s8,advised,123,129,O
DDI-DrugBank.d81.s8,and,131,133,O
DDI-DrugBank.d81.s8,downward,135,142,O
DDI-DrugBank.d81.s8,dose,144,147,O
DDI-DrugBank.d81.s8,adjustment,149,158,O
DDI-DrugBank.d81.s8,may,160,162,O
DDI-DrugBank.d81.s8,be,164,165,O
DDI-DrugBank.d81.s8,required,167,174,O
DDI-DrugBank.d81.s8,.,175,175,O
DDI-DrugBank.d81.s9,Rifampicin,0,9,B-drug
DDI-DrugBank.d81.s9,:,10,10,O
DDI-DrugBank.d81.s9,In,12,13,O
DDI-DrugBank.d81.s9,a,15,15,O
DDI-DrugBank.d81.s9,study,17,21,O
DDI-DrugBank.d81.s9,in,23,24,O
DDI-DrugBank.d81.s9,healthy,26,32,O
DDI-DrugBank.d81.s9,volunteers,34,43,O
DDI-DrugBank.d81.s9,",",44,44,O
DDI-DrugBank.d81.s9,a,46,46,O
DDI-DrugBank.d81.s9,six-day,48,54,O
DDI-DrugBank.d81.s9,course,56,61,O
DDI-DrugBank.d81.s9,of,63,64,O
DDI-DrugBank.d81.s9,rifampicin,66,75,B-drug
DDI-DrugBank.d81.s9,at,77,78,O
DDI-DrugBank.d81.s9,600,80,82,O
DDI-DrugBank.d81.s9,mg/day,84,89,O
DDI-DrugBank.d81.s9,followed,91,98,O
DDI-DrugBank.d81.s9,by,100,101,O
DDI-DrugBank.d81.s9,a,103,103,O
DDI-DrugBank.d81.s9,single,105,110,O
DDI-DrugBank.d81.s9,5,112,112,O
DDI-DrugBank.d81.s9,mg,114,115,O
DDI-DrugBank.d81.s9,dose,117,120,O
DDI-DrugBank.d81.s9,of,122,123,O
DDI-DrugBank.d81.s9,isradipine,125,134,B-drug
DDI-DrugBank.d81.s9,resulted,136,143,O
DDI-DrugBank.d81.s9,in,145,146,O
DDI-DrugBank.d81.s9,a,148,148,O
DDI-DrugBank.d81.s9,reduction,150,158,O
DDI-DrugBank.d81.s9,in,160,161,O
DDI-DrugBank.d81.s9,isradipine,163,172,B-drug
DDI-DrugBank.d81.s9,levels,174,179,O
DDI-DrugBank.d81.s9,to,181,182,O
DDI-DrugBank.d81.s9,below,184,188,O
DDI-DrugBank.d81.s9,detectable,190,199,O
DDI-DrugBank.d81.s9,limits,201,206,O
DDI-DrugBank.d81.s9,.,207,207,O
DDI-DrugBank.d81.s10,If,0,1,O
DDI-DrugBank.d81.s10,rifampicin,3,12,B-drug
DDI-DrugBank.d81.s10,therapy,14,20,O
DDI-DrugBank.d81.s10,is,22,23,O
DDI-DrugBank.d81.s10,required,25,32,O
DDI-DrugBank.d81.s10,",",33,33,O
DDI-DrugBank.d81.s10,isradipine,35,44,B-drug
DDI-DrugBank.d81.s10,concentrations,46,59,O
DDI-DrugBank.d81.s10,and,61,63,O
DDI-DrugBank.d81.s10,therapeutic,65,75,O
DDI-DrugBank.d81.s10,effects,77,83,O
DDI-DrugBank.d81.s10,are,85,87,O
DDI-DrugBank.d81.s10,likely,89,94,O
DDI-DrugBank.d81.s10,to,96,97,O
DDI-DrugBank.d81.s10,be,99,100,O
DDI-DrugBank.d81.s10,markedly,102,109,O
DDI-DrugBank.d81.s10,reduced,111,117,O
DDI-DrugBank.d81.s10,or,119,120,O
DDI-DrugBank.d81.s10,abolished,122,130,O
DDI-DrugBank.d81.s10,as,132,133,O
DDI-DrugBank.d81.s10,a,135,135,O
DDI-DrugBank.d81.s10,consequence,137,147,O
DDI-DrugBank.d81.s10,of,149,150,O
DDI-DrugBank.d81.s10,increased,152,160,O
DDI-DrugBank.d81.s10,metabolism,162,171,O
DDI-DrugBank.d81.s10,and,173,175,O
DDI-DrugBank.d81.s10,higher,177,182,O
DDI-DrugBank.d81.s10,clearance,184,192,O
DDI-DrugBank.d81.s10,of,194,195,O
DDI-DrugBank.d81.s10,isradipine,197,206,B-drug
DDI-DrugBank.d81.s10,.,207,207,O
DDI-DrugBank.d81.s11,Warfarin,0,7,B-drug
DDI-DrugBank.d81.s11,:,8,8,O
DDI-DrugBank.d81.s11,In,10,11,O
DDI-DrugBank.d81.s11,a,13,13,O
DDI-DrugBank.d81.s11,study,15,19,O
DDI-DrugBank.d81.s11,in,21,22,O
DDI-DrugBank.d81.s11,healthy,24,30,O
DDI-DrugBank.d81.s11,volunteers,32,41,O
DDI-DrugBank.d81.s11,",",42,42,O
DDI-DrugBank.d81.s11,no,44,45,O
DDI-DrugBank.d81.s11,clinically,47,56,O
DDI-DrugBank.d81.s11,relevant,58,65,O
DDI-DrugBank.d81.s11,pharmacokinetic,67,81,O
DDI-DrugBank.d81.s11,or,83,84,O
DDI-DrugBank.d81.s11,pharmacodynamic,86,100,O
DDI-DrugBank.d81.s11,interaction,102,112,O
DDI-DrugBank.d81.s11,between,114,120,O
DDI-DrugBank.d81.s11,isradipine,122,131,B-drug
DDI-DrugBank.d81.s11,and,133,135,O
DDI-DrugBank.d81.s11,racemic,137,143,O
DDI-DrugBank.d81.s11,warfarin,145,152,B-drug
DDI-DrugBank.d81.s11,was,154,156,O
DDI-DrugBank.d81.s11,seen,158,161,O
DDI-DrugBank.d81.s11,when,163,166,O
DDI-DrugBank.d81.s11,two,168,170,O
DDI-DrugBank.d81.s11,single,172,177,O
DDI-DrugBank.d81.s11,oral,179,182,O
DDI-DrugBank.d81.s11,doses,184,188,O
DDI-DrugBank.d81.s11,of,190,191,O
DDI-DrugBank.d81.s11,warfarin,193,200,B-drug
DDI-DrugBank.d81.s11,(,202,202,O
DDI-DrugBank.d81.s11,0.7,203,205,O
DDI-DrugBank.d81.s11,mg/kg,207,211,O
DDI-DrugBank.d81.s11,body,213,216,O
DDI-DrugBank.d81.s11,weight,218,223,O
DDI-DrugBank.d81.s11,),224,224,O
DDI-DrugBank.d81.s11,were,226,229,O
DDI-DrugBank.d81.s11,administered,231,242,O
DDI-DrugBank.d81.s11,during,244,249,O
DDI-DrugBank.d81.s11,11,251,252,O
DDI-DrugBank.d81.s11,days,254,257,O
DDI-DrugBank.d81.s11,of,259,260,O
DDI-DrugBank.d81.s11,multipledose,262,273,O
DDI-DrugBank.d81.s11,treatment,275,283,O
DDI-DrugBank.d81.s11,with,285,288,O
DDI-DrugBank.d81.s11,5,290,290,O
DDI-DrugBank.d81.s11,mg,292,293,O
DDI-DrugBank.d81.s11,b.i.d,295,299,O
DDI-DrugBank.d81.s11,.,300,300,O
DDI-DrugBank.d81.s11,isradipine,302,311,B-drug
DDI-DrugBank.d81.s11,.,312,312,O
DDI-DrugBank.d81.s12,Neither,0,6,O
DDI-DrugBank.d81.s12,racemic,8,14,O
DDI-DrugBank.d81.s12,warfarin,16,23,B-drug
DDI-DrugBank.d81.s12,nor,25,27,O
DDI-DrugBank.d81.s12,isradipine,29,38,B-drug
DDI-DrugBank.d81.s12,binding,40,46,O
DDI-DrugBank.d81.s12,to,48,49,O
DDI-DrugBank.d81.s12,plasma,51,56,O
DDI-DrugBank.d81.s12,proteins,58,65,O
DDI-DrugBank.d81.s12,in,67,68,O
DDI-DrugBank.d81.s12,vitro,70,74,O
DDI-DrugBank.d81.s12,was,76,78,O
DDI-DrugBank.d81.s12,altered,80,86,O
DDI-DrugBank.d81.s12,by,88,89,O
DDI-DrugBank.d81.s12,the,91,93,O
DDI-DrugBank.d81.s12,addition,95,102,O
DDI-DrugBank.d81.s12,of,104,105,O
DDI-DrugBank.d81.s12,the,107,109,O
DDI-DrugBank.d81.s12,other,111,115,O
DDI-DrugBank.d81.s12,drug,117,120,O
DDI-DrugBank.d81.s12,.,121,121,O
DDI-DrugBank.d81.s13,Digoxin,0,6,B-drug
DDI-DrugBank.d81.s13,:,7,7,O
DDI-DrugBank.d81.s13,The,9,11,O
DDI-DrugBank.d81.s13,concomitant,13,23,O
DDI-DrugBank.d81.s13,administration,25,38,O
DDI-DrugBank.d81.s13,of,40,41,O
DDI-DrugBank.d81.s13,DynaCirc,43,50,B-brand
DDI-DrugBank.d81.s13,(,53,53,O
DDI-DrugBank.d81.s13,isradipine,54,63,B-drug
DDI-DrugBank.d81.s13,),64,64,O
DDI-DrugBank.d81.s13,and,66,68,O
DDI-DrugBank.d81.s13,digoxin,70,76,B-drug
DDI-DrugBank.d81.s13,in,78,79,O
DDI-DrugBank.d81.s13,a,81,81,O
DDI-DrugBank.d81.s13,single-dose,83,93,O
DDI-DrugBank.d81.s13,pharmacokinetic,95,109,O
DDI-DrugBank.d81.s13,study,111,115,O
DDI-DrugBank.d81.s13,did,117,119,O
DDI-DrugBank.d81.s13,not,121,123,O
DDI-DrugBank.d81.s13,affect,125,130,O
DDI-DrugBank.d81.s13,renal,132,136,O
DDI-DrugBank.d81.s13,",",137,137,O
DDI-DrugBank.d81.s13,nonrenal,139,146,O
DDI-DrugBank.d81.s13,and,148,150,O
DDI-DrugBank.d81.s13,total,152,156,O
DDI-DrugBank.d81.s13,body,158,161,O
DDI-DrugBank.d81.s13,clearance,163,171,O
DDI-DrugBank.d81.s13,of,173,174,O
DDI-DrugBank.d81.s13,digoxin,176,182,B-drug
DDI-DrugBank.d81.s13,.,183,183,O
DDI-DrugBank.d81.s14,Fentanyl,0,7,B-drug
DDI-DrugBank.d81.s14,Anesthesia,9,18,O
DDI-DrugBank.d81.s14,:,19,19,O
DDI-DrugBank.d81.s14,Severe,21,26,O
DDI-DrugBank.d81.s14,hypotension,28,38,O
DDI-DrugBank.d81.s14,has,40,42,O
DDI-DrugBank.d81.s14,been,44,47,O
DDI-DrugBank.d81.s14,reported,49,56,O
DDI-DrugBank.d81.s14,during,58,63,O
DDI-DrugBank.d81.s14,fentanyl,65,72,B-drug
DDI-DrugBank.d81.s14,anesthesia,74,83,O
DDI-DrugBank.d81.s14,with,85,88,O
DDI-DrugBank.d81.s14,concomitant,90,100,O
DDI-DrugBank.d81.s14,use,102,104,O
DDI-DrugBank.d81.s14,of,106,107,O
DDI-DrugBank.d81.s14,a,109,109,O
DDI-DrugBank.d81.s14,beta,111,114,B-group
DDI-DrugBank.d81.s14,blocker,116,122,I-group
DDI-DrugBank.d81.s14,and,124,126,O
DDI-DrugBank.d81.s14,a,128,128,O
DDI-DrugBank.d81.s14,calcium,130,136,B-group
DDI-DrugBank.d81.s14,channel,138,144,I-group
DDI-DrugBank.d81.s14,blocker,146,152,I-group
DDI-DrugBank.d81.s14,.,153,153,O
DDI-DrugBank.d81.s15,Even,0,3,O
DDI-DrugBank.d81.s15,though,5,10,O
DDI-DrugBank.d81.s15,such,12,15,O
DDI-DrugBank.d81.s15,interactions,17,28,O
DDI-DrugBank.d81.s15,have,30,33,O
DDI-DrugBank.d81.s15,not,35,37,O
DDI-DrugBank.d81.s15,been,39,42,O
DDI-DrugBank.d81.s15,seen,44,47,O
DDI-DrugBank.d81.s15,in,49,50,O
DDI-DrugBank.d81.s15,clinical,52,59,O
DDI-DrugBank.d81.s15,studies,61,67,O
DDI-DrugBank.d81.s15,with,69,72,O
DDI-DrugBank.d81.s15,DynaCirc,74,81,B-brand
DDI-DrugBank.d81.s15,(,84,84,O
DDI-DrugBank.d81.s15,isradipine,85,94,B-drug
DDI-DrugBank.d81.s15,),95,95,O
DDI-DrugBank.d81.s15,",",96,96,O
DDI-DrugBank.d81.s15,an,98,99,O
DDI-DrugBank.d81.s15,increased,101,109,O
DDI-DrugBank.d81.s15,volume,111,116,O
DDI-DrugBank.d81.s15,of,118,119,O
DDI-DrugBank.d81.s15,circulating,121,131,O
DDI-DrugBank.d81.s15,fluids,133,138,O
DDI-DrugBank.d81.s15,might,140,144,O
DDI-DrugBank.d81.s15,be,146,147,O
DDI-DrugBank.d81.s15,required,149,156,O
DDI-DrugBank.d81.s15,if,158,159,O
DDI-DrugBank.d81.s15,such,161,164,O
DDI-DrugBank.d81.s15,an,166,167,O
DDI-DrugBank.d81.s15,interaction,169,179,O
DDI-DrugBank.d81.s15,were,181,184,O
DDI-DrugBank.d81.s15,to,186,187,O
DDI-DrugBank.d81.s15,occur,189,193,O
DDI-DrugBank.d81.s15,.,194,194,O
DDI-DrugBank.d95.s0,Cyclosporine,0,11,B-drug
DDI-DrugBank.d95.s0,-,13,13,O
DDI-DrugBank.d95.s0,L-arginine,15,24,B-drug
DDI-DrugBank.d95.s0,may,26,28,O
DDI-DrugBank.d95.s0,counteract,30,39,O
DDI-DrugBank.d95.s0,the,41,43,O
DDI-DrugBank.d95.s0,antinaturetic,45,57,O
DDI-DrugBank.d95.s0,effect,59,64,O
DDI-DrugBank.d95.s0,of,66,67,O
DDI-DrugBank.d95.s0,cyclosporin,69,79,B-drug
DDI-DrugBank.d95.s0,.,80,80,O
DDI-DrugBank.d95.s1,Ibuprofen,0,8,B-drug
DDI-DrugBank.d95.s1,-,10,10,O
DDI-DrugBank.d95.s1,L-arginine,12,21,B-drug
DDI-DrugBank.d95.s1,may,23,25,O
DDI-DrugBank.d95.s1,increase,27,34,O
DDI-DrugBank.d95.s1,the,36,38,O
DDI-DrugBank.d95.s1,absorption,40,49,O
DDI-DrugBank.d95.s1,of,51,52,O
DDI-DrugBank.d95.s1,ibuprofen,54,62,B-drug
DDI-DrugBank.d95.s1,if,64,65,O
DDI-DrugBank.d95.s1,taken,67,71,O
DDI-DrugBank.d95.s1,concomitantly,73,85,O
DDI-DrugBank.d95.s1,.,86,86,O
DDI-DrugBank.d95.s2,Organic,0,6,O
DDI-DrugBank.d95.s2,nitrates,8,15,B-group
DDI-DrugBank.d95.s2,-,17,17,O
DDI-DrugBank.d95.s2,L-arginine,19,28,B-drug
DDI-DrugBank.d95.s2,supplements,30,40,O
DDI-DrugBank.d95.s2,theoretically,42,54,O
DDI-DrugBank.d95.s2,may,56,58,O
DDI-DrugBank.d95.s2,potentiate,60,69,O
DDI-DrugBank.d95.s2,the,71,73,O
DDI-DrugBank.d95.s2,effects,75,81,O
DDI-DrugBank.d95.s2,of,83,84,O
DDI-DrugBank.d95.s2,organic,86,92,O
DDI-DrugBank.d95.s2,nitrates,94,101,B-drug
DDI-DrugBank.d95.s2,if,103,104,O
DDI-DrugBank.d95.s2,taken,106,110,O
DDI-DrugBank.d95.s2,concomitantly,112,124,O
DDI-DrugBank.d95.s2,.,125,125,O
DDI-DrugBank.d95.s3,Sildenafil,0,9,B-drug
DDI-DrugBank.d95.s3,citrate,11,17,I-drug
DDI-DrugBank.d95.s3,-,19,19,O
DDI-DrugBank.d95.s3,Theoretically,21,33,O
DDI-DrugBank.d95.s3,",",34,34,O
DDI-DrugBank.d95.s3,L-arginine,36,45,B-drug
DDI-DrugBank.d95.s3,supplements,47,57,O
DDI-DrugBank.d95.s3,taken,59,63,O
DDI-DrugBank.d95.s3,concomitantly,65,77,O
DDI-DrugBank.d95.s3,with,79,82,O
DDI-DrugBank.d95.s3,sildenafil,84,93,B-drug
DDI-DrugBank.d95.s3,citrate,95,101,I-drug
DDI-DrugBank.d95.s3,",",102,102,O
DDI-DrugBank.d95.s3,may,104,106,O
DDI-DrugBank.d95.s3,potentiate,108,117,O
DDI-DrugBank.d95.s3,the,119,121,O
DDI-DrugBank.d95.s3,effects,123,129,O
DDI-DrugBank.d95.s3,of,131,132,O
DDI-DrugBank.d95.s3,the,134,136,O
DDI-DrugBank.d95.s3,drug,138,141,O
DDI-DrugBank.d95.s3,.,142,142,O
DDI-DrugBank.d530.s0,Non-selective,0,12,B-group
DDI-DrugBank.d530.s0,monoamine,14,22,I-group
DDI-DrugBank.d530.s0,oxidase,24,30,I-group
DDI-DrugBank.d530.s0,(,32,32,I-group
DDI-DrugBank.d530.s0,MAO,33,35,I-group
DDI-DrugBank.d530.s0,),36,36,I-group
DDI-DrugBank.d530.s0,inhibitors,38,47,I-group
DDI-DrugBank.d530.s0,-,49,49,O
DDI-DrugBank.d530.s0,including,51,59,O
DDI-DrugBank.d530.s0,phenelzine,61,70,B-drug
DDI-DrugBank.d530.s0,sulfate,72,78,I-drug
DDI-DrugBank.d530.s0,",",79,79,O
DDI-DrugBank.d530.s0,tranylcypromine,81,95,B-drug
DDI-DrugBank.d530.s0,sulfate,97,103,I-drug
DDI-DrugBank.d530.s0,and,105,107,O
DDI-DrugBank.d530.s0,pargyline,109,117,B-drug
DDI-DrugBank.d530.s0,HC1,119,121,O
DDI-DrugBank.d530.s0,.,122,122,O
DDI-DrugBank.d530.s1,Concomitant,0,10,O
DDI-DrugBank.d530.s1,use,12,14,O
DDI-DrugBank.d530.s1,of,16,17,O
DDI-DrugBank.d530.s1,L-phenylalanine,19,33,B-drug
DDI-DrugBank.d530.s1,and,35,37,O
DDI-DrugBank.d530.s1,non-selective,39,51,B-group
DDI-DrugBank.d530.s1,MAO,53,55,I-group
DDI-DrugBank.d530.s1,inhibitors,57,66,I-group
DDI-DrugBank.d530.s1,may,68,70,O
DDI-DrugBank.d530.s1,cause,72,76,O
DDI-DrugBank.d530.s1,hypertension,78,89,O
DDI-DrugBank.d530.s1,.,90,90,O
DDI-DrugBank.d530.s2,Selegiline,0,9,B-drug
DDI-DrugBank.d530.s2,-,11,11,O
DDI-DrugBank.d530.s2,L-phenylalanine,13,27,B-drug
DDI-DrugBank.d530.s2,and,29,31,O
DDI-DrugBank.d530.s2,the,33,35,O
DDI-DrugBank.d530.s2,selective,37,45,B-group
DDI-DrugBank.d530.s2,MAO,47,49,I-group
DDI-DrugBank.d530.s2,inhibitor,51,59,I-group
DDI-DrugBank.d530.s2,selegiline,61,70,B-drug
DDI-DrugBank.d530.s2,may,72,74,O
DDI-DrugBank.d530.s2,have,76,79,O
DDI-DrugBank.d530.s2,synergistic,81,91,O
DDI-DrugBank.d530.s2,antidepressant,93,106,O
DDI-DrugBank.d530.s2,activity,108,115,O
DDI-DrugBank.d530.s2,if,117,118,O
DDI-DrugBank.d530.s2,used,120,123,O
DDI-DrugBank.d530.s2,concomitantly,125,137,O
DDI-DrugBank.d530.s2,.,138,138,O
DDI-DrugBank.d530.s3,Neuroleptic,0,10,B-group
DDI-DrugBank.d530.s3,Drugs,12,16,I-group
DDI-DrugBank.d530.s3,-,18,18,O
DDI-DrugBank.d530.s3,L-phenylalanine,20,34,B-drug
DDI-DrugBank.d530.s3,may,36,38,O
DDI-DrugBank.d530.s3,potentiate,40,49,O
DDI-DrugBank.d530.s3,the,51,53,O
DDI-DrugBank.d530.s3,tardive,55,61,O
DDI-DrugBank.d530.s3,dyskinesia,63,72,O
DDI-DrugBank.d530.s3,side,74,77,O
DDI-DrugBank.d530.s3,reactions,79,87,O
DDI-DrugBank.d530.s3,of,89,90,O
DDI-DrugBank.d530.s3,neuroleptic,92,102,B-group
DDI-DrugBank.d530.s3,drugs,104,108,I-group
DDI-DrugBank.d530.s3,if,110,111,O
DDI-DrugBank.d530.s3,used,113,116,O
DDI-DrugBank.d530.s3,concomitantly,118,130,O
DDI-DrugBank.d530.s3,with,132,135,O
DDI-DrugBank.d530.s3,them,137,140,O
DDI-DrugBank.d530.s3,.,141,141,O
DDI-DrugBank.d41.s0,Cholestyramine,0,13,B-drug
DDI-DrugBank.d41.s0,and,15,17,O
DDI-DrugBank.d41.s0,Charcoal,19,26,B-drug
DDI-DrugBank.d41.s0,Administration,28,41,O
DDI-DrugBank.d41.s0,of,43,44,O
DDI-DrugBank.d41.s0,cholestyramine,46,59,B-drug
DDI-DrugBank.d41.s0,or,61,62,O
DDI-DrugBank.d41.s0,activated,64,72,B-drug
DDI-DrugBank.d41.s0,charcoal,74,81,I-drug
DDI-DrugBank.d41.s0,in,83,84,O
DDI-DrugBank.d41.s0,patients,86,93,O
DDI-DrugBank.d41.s0,(,95,95,O
DDI-DrugBank.d41.s0,n=13,96,99,O
DDI-DrugBank.d41.s0,),100,100,O
DDI-DrugBank.d41.s0,and,102,104,O
DDI-DrugBank.d41.s0,volunteers,106,115,O
DDI-DrugBank.d41.s0,(,117,117,O
DDI-DrugBank.d41.s0,n=96,118,121,O
DDI-DrugBank.d41.s0,),122,122,O
DDI-DrugBank.d41.s0,resulted,124,131,O
DDI-DrugBank.d41.s0,in,133,134,O
DDI-DrugBank.d41.s0,a,136,136,O
DDI-DrugBank.d41.s0,rapid,138,142,O
DDI-DrugBank.d41.s0,and,144,146,O
DDI-DrugBank.d41.s0,significant,148,158,O
DDI-DrugBank.d41.s0,decrease,160,167,O
DDI-DrugBank.d41.s0,in,169,170,O
DDI-DrugBank.d41.s0,plasma,172,177,O
DDI-DrugBank.d41.s0,M1,179,180,O
DDI-DrugBank.d41.s0,(,182,182,O
DDI-DrugBank.d41.s0,the,183,185,O
DDI-DrugBank.d41.s0,active,187,192,O
DDI-DrugBank.d41.s0,metabolite,194,203,O
DDI-DrugBank.d41.s0,of,205,206,O
DDI-DrugBank.d41.s0,leflunomide,208,218,B-drug
DDI-DrugBank.d41.s0,),219,219,O
DDI-DrugBank.d41.s0,concentration,221,233,O
DDI-DrugBank.d41.s0,.,235,235,O
DDI-DrugBank.d41.s1,Hepatotoxic,0,10,O
DDI-DrugBank.d41.s1,Drugs,12,16,O
DDI-DrugBank.d41.s1,Increased,18,26,O
DDI-DrugBank.d41.s1,side,28,31,O
DDI-DrugBank.d41.s1,effects,33,39,O
DDI-DrugBank.d41.s1,may,41,43,O
DDI-DrugBank.d41.s1,occur,45,49,O
DDI-DrugBank.d41.s1,when,51,54,O
DDI-DrugBank.d41.s1,leflunomide,56,66,B-drug
DDI-DrugBank.d41.s1,is,68,69,O
DDI-DrugBank.d41.s1,given,71,75,O
DDI-DrugBank.d41.s1,concomitantly,77,89,O
DDI-DrugBank.d41.s1,with,91,94,O
DDI-DrugBank.d41.s1,hepatotoxic,96,106,O
DDI-DrugBank.d41.s1,substances,108,117,O
DDI-DrugBank.d41.s1,.,118,118,O
DDI-DrugBank.d41.s2,This,0,3,O
DDI-DrugBank.d41.s2,is,5,6,O
DDI-DrugBank.d41.s2,also,8,11,O
DDI-DrugBank.d41.s2,to,13,14,O
DDI-DrugBank.d41.s2,be,16,17,O
DDI-DrugBank.d41.s2,considered,19,28,O
DDI-DrugBank.d41.s2,when,30,33,O
DDI-DrugBank.d41.s2,leflunomide,35,45,B-drug
DDI-DrugBank.d41.s2,treatment,47,55,O
DDI-DrugBank.d41.s2,is,57,58,O
DDI-DrugBank.d41.s2,followed,60,67,O
DDI-DrugBank.d41.s2,by,69,70,O
DDI-DrugBank.d41.s2,such,72,75,O
DDI-DrugBank.d41.s2,drugs,77,81,O
DDI-DrugBank.d41.s2,without,83,89,O
DDI-DrugBank.d41.s2,a,91,91,O
DDI-DrugBank.d41.s2,drug,93,96,O
DDI-DrugBank.d41.s2,elimination,98,108,O
DDI-DrugBank.d41.s2,procedure,110,118,O
DDI-DrugBank.d41.s2,.,119,119,O
DDI-DrugBank.d41.s3,In,0,1,O
DDI-DrugBank.d41.s3,a,3,3,O
DDI-DrugBank.d41.s3,small,5,9,O
DDI-DrugBank.d41.s3,(,11,11,O
DDI-DrugBank.d41.s3,n=30,12,15,O
DDI-DrugBank.d41.s3,),16,16,O
DDI-DrugBank.d41.s3,combination,18,28,O
DDI-DrugBank.d41.s3,study,30,34,O
DDI-DrugBank.d41.s3,of,36,37,O
DDI-DrugBank.d41.s3,ARAVA,39,43,B-brand
DDI-DrugBank.d41.s3,with,45,48,O
DDI-DrugBank.d41.s3,methotrexate,50,61,B-drug
DDI-DrugBank.d41.s3,",",62,62,O
DDI-DrugBank.d41.s3,a,64,64,O
DDI-DrugBank.d41.s3,2-,66,67,O
DDI-DrugBank.d41.s3,to,69,70,O
DDI-DrugBank.d41.s3,3-fold,72,77,O
DDI-DrugBank.d41.s3,elevation,79,87,O
DDI-DrugBank.d41.s3,in,89,90,O
DDI-DrugBank.d41.s3,liver,92,96,O
DDI-DrugBank.d41.s3,enzymes,98,104,O
DDI-DrugBank.d41.s3,was,106,108,O
DDI-DrugBank.d41.s3,seen,110,113,O
DDI-DrugBank.d41.s3,in,115,116,O
DDI-DrugBank.d41.s3,5,118,118,O
DDI-DrugBank.d41.s3,of,120,121,O
DDI-DrugBank.d41.s3,30,123,124,O
DDI-DrugBank.d41.s3,patients,126,133,O
DDI-DrugBank.d41.s3,.,134,134,O
DDI-DrugBank.d41.s4,All,0,2,O
DDI-DrugBank.d41.s4,elevations,4,13,O
DDI-DrugBank.d41.s4,resolved,15,22,O
DDI-DrugBank.d41.s4,",",23,23,O
DDI-DrugBank.d41.s4,2,25,25,O
DDI-DrugBank.d41.s4,with,27,30,O
DDI-DrugBank.d41.s4,continuation,32,43,O
DDI-DrugBank.d41.s4,of,45,46,O
DDI-DrugBank.d41.s4,both,48,51,O
DDI-DrugBank.d41.s4,drugs,53,57,O
DDI-DrugBank.d41.s4,and,59,61,O
DDI-DrugBank.d41.s4,3,63,63,O
DDI-DrugBank.d41.s4,after,65,69,O
DDI-DrugBank.d41.s4,discontinuation,71,85,O
DDI-DrugBank.d41.s4,of,87,88,O
DDI-DrugBank.d41.s4,leflunomide,90,100,B-drug
DDI-DrugBank.d41.s4,.,101,101,O
DDI-DrugBank.d41.s5,A,0,0,O
DDI-DrugBank.d41.s5,3-fold,3,8,O
DDI-DrugBank.d41.s5,increase,10,17,O
DDI-DrugBank.d41.s5,was,19,21,O
DDI-DrugBank.d41.s5,seen,23,26,O
DDI-DrugBank.d41.s5,in,28,29,O
DDI-DrugBank.d41.s5,another,31,37,O
DDI-DrugBank.d41.s5,5,39,39,O
DDI-DrugBank.d41.s5,patients,41,48,O
DDI-DrugBank.d41.s5,.,49,49,O
DDI-DrugBank.d41.s6,All,0,2,O
DDI-DrugBank.d41.s6,of,4,5,O
DDI-DrugBank.d41.s6,these,7,11,O
DDI-DrugBank.d41.s6,also,13,16,O
DDI-DrugBank.d41.s6,resolved,18,25,O
DDI-DrugBank.d41.s6,",",26,26,O
DDI-DrugBank.d41.s6,2,28,28,O
DDI-DrugBank.d41.s6,with,30,33,O
DDI-DrugBank.d41.s6,continuation,35,46,O
DDI-DrugBank.d41.s6,of,48,49,O
DDI-DrugBank.d41.s6,both,51,54,O
DDI-DrugBank.d41.s6,drugs,56,60,O
DDI-DrugBank.d41.s6,and,62,64,O
DDI-DrugBank.d41.s6,3,66,66,O
DDI-DrugBank.d41.s6,after,68,72,O
DDI-DrugBank.d41.s6,discontinuation,74,88,O
DDI-DrugBank.d41.s6,of,90,91,O
DDI-DrugBank.d41.s6,leflunomide,93,103,B-drug
DDI-DrugBank.d41.s6,.,104,104,O
DDI-DrugBank.d41.s7,Three,0,4,O
DDI-DrugBank.d41.s7,patients,6,13,O
DDI-DrugBank.d41.s7,met,15,17,O
DDI-DrugBank.d41.s7,ACR,19,21,O
DDI-DrugBank.d41.s7,criteria,23,30,O
DDI-DrugBank.d41.s7,for,32,34,O
DDI-DrugBank.d41.s7,liver,36,40,O
DDI-DrugBank.d41.s7,biopsy,42,47,O
DDI-DrugBank.d41.s7,(,49,49,O
DDI-DrugBank.d41.s7,1,50,50,O
DDI-DrugBank.d41.s7,:,51,51,O
DDI-DrugBank.d41.s7,Roegnik,53,59,O
DDI-DrugBank.d41.s7,Grade,61,65,O
DDI-DrugBank.d41.s7,I,67,67,O
DDI-DrugBank.d41.s7,",",68,68,O
DDI-DrugBank.d41.s7,2,70,70,O
DDI-DrugBank.d41.s7,:,71,71,O
DDI-DrugBank.d41.s7,Roegnik,73,79,O
DDI-DrugBank.d41.s7,Grade,81,85,O
DDI-DrugBank.d41.s7,IIIa,87,90,O
DDI-DrugBank.d41.s7,),91,91,O
DDI-DrugBank.d41.s7,.,92,92,O
DDI-DrugBank.d41.s8,No,0,1,O
DDI-DrugBank.d41.s8,pharmacokinetic,3,17,O
DDI-DrugBank.d41.s8,interaction,19,29,O
DDI-DrugBank.d41.s8,was,31,33,O
DDI-DrugBank.d41.s8,identified,35,44,O
DDI-DrugBank.d41.s8,.,45,45,O
DDI-DrugBank.d41.s9,NSAIDs,0,5,B-group
DDI-DrugBank.d41.s9,:,6,6,O
DDI-DrugBank.d41.s9,In,8,9,O
DDI-DrugBank.d41.s9,in,11,12,O
DDI-DrugBank.d41.s9,vitro,14,18,O
DDI-DrugBank.d41.s9,studies,20,26,O
DDI-DrugBank.d41.s9,",",27,27,O
DDI-DrugBank.d41.s9,M1,29,30,O
DDI-DrugBank.d41.s9,was,32,34,O
DDI-DrugBank.d41.s9,shown,36,40,O
DDI-DrugBank.d41.s9,to,42,43,O
DDI-DrugBank.d41.s9,cause,45,49,O
DDI-DrugBank.d41.s9,increases,51,59,O
DDI-DrugBank.d41.s9,ranging,61,67,O
DDI-DrugBank.d41.s9,from,69,72,O
DDI-DrugBank.d41.s9,13,74,75,O
DDI-DrugBank.d41.s9,-,77,77,O
DDI-DrugBank.d41.s9,50,79,80,O
DDI-DrugBank.d41.s9,%,81,81,O
DDI-DrugBank.d41.s9,in,83,84,O
DDI-DrugBank.d41.s9,the,86,88,O
DDI-DrugBank.d41.s9,free,90,93,O
DDI-DrugBank.d41.s9,fraction,95,102,O
DDI-DrugBank.d41.s9,of,104,105,O
DDI-DrugBank.d41.s9,diclofenac,107,116,B-drug
DDI-DrugBank.d41.s9,and,118,120,O
DDI-DrugBank.d41.s9,ibuprofen,122,130,B-drug
DDI-DrugBank.d41.s9,at,132,133,O
DDI-DrugBank.d41.s9,concentrations,135,148,O
DDI-DrugBank.d41.s9,in,150,151,O
DDI-DrugBank.d41.s9,the,153,155,O
DDI-DrugBank.d41.s9,clinical,157,164,O
DDI-DrugBank.d41.s9,range,166,170,O
DDI-DrugBank.d41.s9,.,171,171,O
DDI-DrugBank.d41.s10,The,0,2,O
DDI-DrugBank.d41.s10,clinical,4,11,O
DDI-DrugBank.d41.s10,significance,13,24,O
DDI-DrugBank.d41.s10,of,26,27,O
DDI-DrugBank.d41.s10,this,29,32,O
DDI-DrugBank.d41.s10,finding,34,40,O
DDI-DrugBank.d41.s10,is,42,43,O
DDI-DrugBank.d41.s10,unknown,45,51,O
DDI-DrugBank.d41.s10,;,52,52,O
DDI-DrugBank.d41.s11,however,0,6,O
DDI-DrugBank.d41.s11,",",7,7,O
DDI-DrugBank.d41.s11,there,9,13,O
DDI-DrugBank.d41.s11,was,15,17,O
DDI-DrugBank.d41.s11,extensive,19,27,O
DDI-DrugBank.d41.s11,concomitant,29,39,O
DDI-DrugBank.d41.s11,use,41,43,O
DDI-DrugBank.d41.s11,of,45,46,O
DDI-DrugBank.d41.s11,NSAIDs,48,53,B-group
DDI-DrugBank.d41.s11,in,55,56,O
DDI-DrugBank.d41.s11,clinical,58,65,O
DDI-DrugBank.d41.s11,studies,67,73,O
DDI-DrugBank.d41.s11,and,75,77,O
DDI-DrugBank.d41.s11,no,79,80,O
DDI-DrugBank.d41.s11,differential,82,93,O
DDI-DrugBank.d41.s11,effect,95,100,O
DDI-DrugBank.d41.s11,was,102,104,O
DDI-DrugBank.d41.s11,observed,106,113,O
DDI-DrugBank.d41.s11,.,114,114,O
DDI-DrugBank.d41.s12,Tolbutamide,0,10,B-drug
DDI-DrugBank.d41.s12,:,11,11,O
DDI-DrugBank.d41.s12,In,13,14,O
DDI-DrugBank.d41.s12,in,16,17,O
DDI-DrugBank.d41.s12,vitro,19,23,O
DDI-DrugBank.d41.s12,studies,25,31,O
DDI-DrugBank.d41.s12,",",32,32,O
DDI-DrugBank.d41.s12,M1,34,35,O
DDI-DrugBank.d41.s12,was,37,39,O
DDI-DrugBank.d41.s12,shown,41,45,O
DDI-DrugBank.d41.s12,to,47,48,O
DDI-DrugBank.d41.s12,cause,50,54,O
DDI-DrugBank.d41.s12,increases,56,64,O
DDI-DrugBank.d41.s12,ranging,66,72,O
DDI-DrugBank.d41.s12,from,74,77,O
DDI-DrugBank.d41.s12,13,79,80,O
DDI-DrugBank.d41.s12,-,82,82,O
DDI-DrugBank.d41.s12,50,84,85,O
DDI-DrugBank.d41.s12,%,86,86,O
DDI-DrugBank.d41.s12,in,88,89,O
DDI-DrugBank.d41.s12,the,91,93,O
DDI-DrugBank.d41.s12,free,95,98,O
DDI-DrugBank.d41.s12,fraction,100,107,O
DDI-DrugBank.d41.s12,of,109,110,O
DDI-DrugBank.d41.s12,tolbutamide,112,122,B-drug
DDI-DrugBank.d41.s12,at,124,125,O
DDI-DrugBank.d41.s12,concentrations,127,140,O
DDI-DrugBank.d41.s12,in,142,143,O
DDI-DrugBank.d41.s12,the,145,147,O
DDI-DrugBank.d41.s12,clinical,149,156,O
DDI-DrugBank.d41.s12,range,158,162,O
DDI-DrugBank.d41.s12,.,163,163,O
DDI-DrugBank.d41.s13,The,0,2,O
DDI-DrugBank.d41.s13,clinical,4,11,O
DDI-DrugBank.d41.s13,significance,13,24,O
DDI-DrugBank.d41.s13,of,26,27,O
DDI-DrugBank.d41.s13,this,29,32,O
DDI-DrugBank.d41.s13,finding,34,40,O
DDI-DrugBank.d41.s13,is,42,43,O
DDI-DrugBank.d41.s13,unknown,45,51,O
DDI-DrugBank.d41.s13,.,52,52,O
DDI-DrugBank.d41.s14,Rifampin,0,7,B-drug
DDI-DrugBank.d41.s14,:,8,8,O
DDI-DrugBank.d41.s14,Following,10,18,O
DDI-DrugBank.d41.s14,concomitant,20,30,O
DDI-DrugBank.d41.s14,administration,32,45,O
DDI-DrugBank.d41.s14,of,47,48,O
DDI-DrugBank.d41.s14,a,50,50,O
DDI-DrugBank.d41.s14,single,52,57,O
DDI-DrugBank.d41.s14,dose,59,62,O
DDI-DrugBank.d41.s14,of,64,65,O
DDI-DrugBank.d41.s14,ARAVA,67,71,B-brand
DDI-DrugBank.d41.s14,to,73,74,O
DDI-DrugBank.d41.s14,subjects,76,83,O
DDI-DrugBank.d41.s14,receiving,85,93,O
DDI-DrugBank.d41.s14,multiple,95,102,O
DDI-DrugBank.d41.s14,doses,104,108,O
DDI-DrugBank.d41.s14,of,110,111,O
DDI-DrugBank.d41.s14,rifampin,113,120,B-drug
DDI-DrugBank.d41.s14,",",121,121,O
DDI-DrugBank.d41.s14,M1,123,124,O
DDI-DrugBank.d41.s14,peak,126,129,O
DDI-DrugBank.d41.s14,levels,131,136,O
DDI-DrugBank.d41.s14,were,138,141,O
DDI-DrugBank.d41.s14,increased,143,151,O
DDI-DrugBank.d41.s14,(,153,153,O
DDI-DrugBank.d41.s14,~40,154,156,O
DDI-DrugBank.d41.s14,%,157,157,O
DDI-DrugBank.d41.s14,),158,158,O
DDI-DrugBank.d41.s14,over,160,163,O
DDI-DrugBank.d41.s14,those,165,169,O
DDI-DrugBank.d41.s14,seen,171,174,O
DDI-DrugBank.d41.s14,when,176,179,O
DDI-DrugBank.d41.s14,ARAVA,181,185,B-brand
DDI-DrugBank.d41.s14,was,187,189,O
DDI-DrugBank.d41.s14,given,191,195,O
DDI-DrugBank.d41.s14,alone,197,201,O
DDI-DrugBank.d41.s14,.,202,202,O
DDI-DrugBank.d41.s15,Because,0,6,O
DDI-DrugBank.d41.s15,of,8,9,O
DDI-DrugBank.d41.s15,the,11,13,O
DDI-DrugBank.d41.s15,potential,15,23,O
DDI-DrugBank.d41.s15,for,25,27,O
DDI-DrugBank.d41.s15,ARAVA,29,33,B-brand
DDI-DrugBank.d41.s15,levels,35,40,O
DDI-DrugBank.d41.s15,to,42,43,O
DDI-DrugBank.d41.s15,continue,45,52,O
DDI-DrugBank.d41.s15,to,54,55,O
DDI-DrugBank.d41.s15,increase,57,64,O
DDI-DrugBank.d41.s15,with,66,69,O
DDI-DrugBank.d41.s15,multiple,71,78,O
DDI-DrugBank.d41.s15,dosing,80,85,O
DDI-DrugBank.d41.s15,",",86,86,O
DDI-DrugBank.d41.s15,caution,88,94,O
DDI-DrugBank.d41.s15,should,96,101,O
DDI-DrugBank.d41.s15,be,103,104,O
DDI-DrugBank.d41.s15,used,106,109,O
DDI-DrugBank.d41.s15,if,111,112,O
DDI-DrugBank.d41.s15,patients,114,121,O
DDI-DrugBank.d41.s15,are,123,125,O
DDI-DrugBank.d41.s15,to,127,128,O
DDI-DrugBank.d41.s15,be,130,131,O
DDI-DrugBank.d41.s15,receiving,133,141,O
DDI-DrugBank.d41.s15,both,143,146,O
DDI-DrugBank.d41.s15,ARAVA,148,152,B-brand
DDI-DrugBank.d41.s15,and,154,156,O
DDI-DrugBank.d41.s15,rifampin,158,165,B-drug
DDI-DrugBank.d41.s15,.,166,166,O
DDI-DrugBank.d41.s16,Warfarin,0,7,B-drug
DDI-DrugBank.d41.s16,:,8,8,O
DDI-DrugBank.d41.s16,Increased,10,18,O
DDI-DrugBank.d41.s16,INR,20,22,O
DDI-DrugBank.d41.s16,(,24,24,O
DDI-DrugBank.d41.s16,International,25,37,O
DDI-DrugBank.d41.s16,Normalized,39,48,O
DDI-DrugBank.d41.s16,Ratio,50,54,O
DDI-DrugBank.d41.s16,),55,55,O
DDI-DrugBank.d41.s16,when,57,60,O
DDI-DrugBank.d41.s16,ARAVA,62,66,B-brand
DDI-DrugBank.d41.s16,and,68,70,O
DDI-DrugBank.d41.s16,warfarin,72,79,B-drug
DDI-DrugBank.d41.s16,were,81,84,O
DDI-DrugBank.d41.s16,co-administered,86,100,O
DDI-DrugBank.d41.s16,has,102,104,O
DDI-DrugBank.d41.s16,been,106,109,O
DDI-DrugBank.d41.s16,rarely,111,116,O
DDI-DrugBank.d41.s16,reported,118,125,O
DDI-DrugBank.d41.s16,.,126,126,O
DDI-DrugBank.d252.s0,Although,0,7,O
DDI-DrugBank.d252.s0,BETAGAN,9,15,B-brand
DDI-DrugBank.d252.s0,used,17,20,O
DDI-DrugBank.d252.s0,alone,22,26,O
DDI-DrugBank.d252.s0,has,28,30,O
DDI-DrugBank.d252.s0,little,32,37,O
DDI-DrugBank.d252.s0,or,39,40,O
DDI-DrugBank.d252.s0,no,42,43,O
DDI-DrugBank.d252.s0,effect,45,50,O
DDI-DrugBank.d252.s0,on,52,53,O
DDI-DrugBank.d252.s0,pupil,55,59,O
DDI-DrugBank.d252.s0,size,61,64,O
DDI-DrugBank.d252.s0,",",65,65,O
DDI-DrugBank.d252.s0,mydriasis,67,75,O
DDI-DrugBank.d252.s0,resulting,77,85,O
DDI-DrugBank.d252.s0,from,87,90,O
DDI-DrugBank.d252.s0,concomitant,92,102,O
DDI-DrugBank.d252.s0,therapy,104,110,O
DDI-DrugBank.d252.s0,with,112,115,O
DDI-DrugBank.d252.s0,BETAGAN,117,123,B-brand
DDI-DrugBank.d252.s0,and,125,127,O
DDI-DrugBank.d252.s0,epinephrine,129,139,B-drug
DDI-DrugBank.d252.s0,may,141,143,O
DDI-DrugBank.d252.s0,occur,145,149,O
DDI-DrugBank.d252.s0,.,150,150,O
DDI-DrugBank.d252.s1,Close,0,4,O
DDI-DrugBank.d252.s1,observation,6,16,O
DDI-DrugBank.d252.s1,of,18,19,O
DDI-DrugBank.d252.s1,the,21,23,O
DDI-DrugBank.d252.s1,patient,25,31,O
DDI-DrugBank.d252.s1,is,33,34,O
DDI-DrugBank.d252.s1,recommended,36,46,O
DDI-DrugBank.d252.s1,when,48,51,O
DDI-DrugBank.d252.s1,a,53,53,O
DDI-DrugBank.d252.s1,beta-blocker,55,66,B-group
DDI-DrugBank.d252.s1,is,68,69,O
DDI-DrugBank.d252.s1,administered,71,82,O
DDI-DrugBank.d252.s1,to,84,85,O
DDI-DrugBank.d252.s1,patients,87,94,O
DDI-DrugBank.d252.s1,receiving,96,104,O
DDI-DrugBank.d252.s1,catecholamine-depleting,106,128,O
DDI-DrugBank.d252.s1,drugs,130,134,O
DDI-DrugBank.d252.s1,such,136,139,O
DDI-DrugBank.d252.s1,as,141,142,O
DDI-DrugBank.d252.s1,reserpine,144,152,B-drug
DDI-DrugBank.d252.s1,",",153,153,O
DDI-DrugBank.d252.s1,because,155,161,O
DDI-DrugBank.d252.s1,of,163,164,O
DDI-DrugBank.d252.s1,possible,166,173,O
DDI-DrugBank.d252.s1,additive,175,182,O
DDI-DrugBank.d252.s1,effects,184,190,O
DDI-DrugBank.d252.s1,and,192,194,O
DDI-DrugBank.d252.s1,the,196,198,O
DDI-DrugBank.d252.s1,production,200,209,O
DDI-DrugBank.d252.s1,of,211,212,O
DDI-DrugBank.d252.s1,hypotension,214,224,O
DDI-DrugBank.d252.s1,and/or,226,231,O
DDI-DrugBank.d252.s1,marked,233,238,O
DDI-DrugBank.d252.s1,bradycardia,240,250,O
DDI-DrugBank.d252.s1,",",251,251,O
DDI-DrugBank.d252.s1,which,253,257,O
DDI-DrugBank.d252.s1,may,259,261,O
DDI-DrugBank.d252.s1,produce,263,269,O
DDI-DrugBank.d252.s1,vertigo,271,277,O
DDI-DrugBank.d252.s1,",",278,278,O
DDI-DrugBank.d252.s1,syncope,280,286,O
DDI-DrugBank.d252.s1,or,288,289,O
DDI-DrugBank.d252.s1,postural,291,298,O
DDI-DrugBank.d252.s1,hypotension,300,310,O
DDI-DrugBank.d252.s1,.,311,311,O
DDI-DrugBank.d252.s2,Patients,0,7,O
DDI-DrugBank.d252.s2,receiving,9,17,O
DDI-DrugBank.d252.s2,beta-adrenergic,19,33,B-group
DDI-DrugBank.d252.s2,blocking,35,42,I-group
DDI-DrugBank.d252.s2,agents,44,49,I-group
DDI-DrugBank.d252.s2,along,51,55,O
DDI-DrugBank.d252.s2,with,57,60,O
DDI-DrugBank.d252.s2,either,62,67,O
DDI-DrugBank.d252.s2,oral,69,72,O
DDI-DrugBank.d252.s2,or,74,75,O
DDI-DrugBank.d252.s2,intravenous,77,87,O
DDI-DrugBank.d252.s2,calcium,89,95,B-group
DDI-DrugBank.d252.s2,antagonists,97,107,I-group
DDI-DrugBank.d252.s2,should,109,114,O
DDI-DrugBank.d252.s2,be,116,117,O
DDI-DrugBank.d252.s2,monitored,119,127,O
DDI-DrugBank.d252.s2,for,129,131,O
DDI-DrugBank.d252.s2,possible,133,140,O
DDI-DrugBank.d252.s2,atrioventricular,142,157,O
DDI-DrugBank.d252.s2,conduction,159,168,O
DDI-DrugBank.d252.s2,disturbances,170,181,O
DDI-DrugBank.d252.s2,",",182,182,O
DDI-DrugBank.d252.s2,left,184,187,O
DDI-DrugBank.d252.s2,ventricular,189,199,O
DDI-DrugBank.d252.s2,failure,201,207,O
DDI-DrugBank.d252.s2,and,209,211,O
DDI-DrugBank.d252.s2,hypotension,213,223,O
DDI-DrugBank.d252.s2,.,224,224,O
DDI-DrugBank.d252.s3,In,0,1,O
DDI-DrugBank.d252.s3,patients,3,10,O
DDI-DrugBank.d252.s3,with,12,15,O
DDI-DrugBank.d252.s3,impaired,17,24,O
DDI-DrugBank.d252.s3,cardiac,26,32,O
DDI-DrugBank.d252.s3,function,34,41,O
DDI-DrugBank.d252.s3,",",42,42,O
DDI-DrugBank.d252.s3,simultaneous,44,55,O
DDI-DrugBank.d252.s3,use,57,59,O
DDI-DrugBank.d252.s3,should,61,66,O
DDI-DrugBank.d252.s3,be,68,69,O
DDI-DrugBank.d252.s3,avoided,71,77,O
DDI-DrugBank.d252.s3,altogether,79,88,O
DDI-DrugBank.d252.s3,.,89,89,O
DDI-DrugBank.d252.s4,The,0,2,O
DDI-DrugBank.d252.s4,concomitant,4,14,O
DDI-DrugBank.d252.s4,use,16,18,O
DDI-DrugBank.d252.s4,of,20,21,O
DDI-DrugBank.d252.s4,beta-adrenergic,23,37,B-group
DDI-DrugBank.d252.s4,blocking,39,46,I-group
DDI-DrugBank.d252.s4,agents,48,53,I-group
DDI-DrugBank.d252.s4,with,55,58,O
DDI-DrugBank.d252.s4,digitalis,60,68,B-group
DDI-DrugBank.d252.s4,and,70,72,O
DDI-DrugBank.d252.s4,calcium,74,80,B-group
DDI-DrugBank.d252.s4,antagonists,82,92,I-group
DDI-DrugBank.d252.s4,may,94,96,O
DDI-DrugBank.d252.s4,have,98,101,O
DDI-DrugBank.d252.s4,additive,103,110,O
DDI-DrugBank.d252.s4,effects,112,118,O
DDI-DrugBank.d252.s4,on,120,121,O
DDI-DrugBank.d252.s4,prolonging,123,132,O
DDI-DrugBank.d252.s4,atrioventricular,134,149,O
DDI-DrugBank.d252.s4,conduction,151,160,O
DDI-DrugBank.d252.s4,time,162,165,O
DDI-DrugBank.d252.s4,.,166,166,O
DDI-DrugBank.d252.s5,Phenothiazine-related,0,20,B-group
DDI-DrugBank.d252.s5,compounds,22,30,I-group
DDI-DrugBank.d252.s5,and,32,34,O
DDI-DrugBank.d252.s5,beta-adrenergic,36,50,B-group
DDI-DrugBank.d252.s5,blocking,52,59,I-group
DDI-DrugBank.d252.s5,agents,61,66,I-group
DDI-DrugBank.d252.s5,may,68,70,O
DDI-DrugBank.d252.s5,have,72,75,O
DDI-DrugBank.d252.s5,additive,77,84,O
DDI-DrugBank.d252.s5,hypotensite,86,96,O
DDI-DrugBank.d252.s5,effects,98,104,O
DDI-DrugBank.d252.s5,due,106,108,O
DDI-DrugBank.d252.s5,to,110,111,O
DDI-DrugBank.d252.s5,the,113,115,O
DDI-DrugBank.d252.s5,inhibition,117,126,O
DDI-DrugBank.d252.s5,of,128,129,O
DDI-DrugBank.d252.s5,each,131,134,O
DDI-DrugBank.d252.s5,other,136,140,O
DDI-DrugBank.d252.s5,s,142,142,O
DDI-DrugBank.d252.s5,metabolism,144,153,O
DDI-DrugBank.d252.s5,.,154,154,O
DDI-DrugBank.d320.s0,Chirocaine,0,9,B-brand
DDI-DrugBank.d320.s0,should,13,18,O
DDI-DrugBank.d320.s0,be,20,21,O
DDI-DrugBank.d320.s0,used,23,26,O
DDI-DrugBank.d320.s0,with,28,31,O
DDI-DrugBank.d320.s0,caution,33,39,O
DDI-DrugBank.d320.s0,in,41,42,O
DDI-DrugBank.d320.s0,patients,44,51,O
DDI-DrugBank.d320.s0,receiving,53,61,O
DDI-DrugBank.d320.s0,other,63,67,O
DDI-DrugBank.d320.s0,local,69,73,O
DDI-DrugBank.d320.s0,anesthetics,75,85,B-group
DDI-DrugBank.d320.s0,or,87,88,O
DDI-DrugBank.d320.s0,agents,90,95,O
DDI-DrugBank.d320.s0,structurally,97,108,O
DDI-DrugBank.d320.s0,related,110,116,O
DDI-DrugBank.d320.s0,to,118,119,O
DDI-DrugBank.d320.s0,amide-type,121,130,O
DDI-DrugBank.d320.s0,local,132,136,O
DDI-DrugBank.d320.s0,anesthetics,138,148,O
DDI-DrugBank.d320.s0,since,150,154,O
DDI-DrugBank.d320.s0,the,156,158,O
DDI-DrugBank.d320.s0,toxic,160,164,O
DDI-DrugBank.d320.s0,effects,166,172,O
DDI-DrugBank.d320.s0,of,174,175,O
DDI-DrugBank.d320.s0,these,177,181,O
DDI-DrugBank.d320.s0,drugs,183,187,O
DDI-DrugBank.d320.s0,could,189,193,O
DDI-DrugBank.d320.s0,be,195,196,O
DDI-DrugBank.d320.s0,additive,198,205,O
DDI-DrugBank.d320.s0,.,206,206,O
DDI-DrugBank.d320.s1,In,0,1,O
DDI-DrugBank.d320.s1,vitro,3,7,O
DDI-DrugBank.d320.s1,studies,9,15,O
DDI-DrugBank.d320.s1,indicate,17,24,O
DDI-DrugBank.d320.s1,CYP3A4,26,31,O
DDI-DrugBank.d320.s1,isoform,33,39,O
DDI-DrugBank.d320.s1,and,41,43,O
DDI-DrugBank.d320.s1,CYP1A2,45,50,O
DDI-DrugBank.d320.s1,isoform,52,58,O
DDI-DrugBank.d320.s1,mediate,60,66,O
DDI-DrugBank.d320.s1,the,68,70,O
DDI-DrugBank.d320.s1,metabolism,72,81,O
DDI-DrugBank.d320.s1,of,83,84,O
DDI-DrugBank.d320.s1,levobupivacaine,86,100,B-drug
DDI-DrugBank.d320.s1,to,102,103,O
DDI-DrugBank.d320.s1,desbutyl,105,112,B-drug_n
DDI-DrugBank.d320.s1,levobupivacaine,114,128,I-drug_n
DDI-DrugBank.d320.s1,and,130,132,O
DDI-DrugBank.d320.s1,3-hydroxy,134,142,B-drug_n
DDI-DrugBank.d320.s1,levobupivacaine,144,158,I-drug_n
DDI-DrugBank.d320.s1,",",159,159,O
DDI-DrugBank.d320.s1,respectively,161,172,O
DDI-DrugBank.d320.s1,.,173,173,O
DDI-DrugBank.d320.s2,Thus,0,3,O
DDI-DrugBank.d320.s2,agents,5,10,O
DDI-DrugBank.d320.s2,likely,12,17,O
DDI-DrugBank.d320.s2,to,19,20,O
DDI-DrugBank.d320.s2,be,22,23,O
DDI-DrugBank.d320.s2,concomitantly,25,37,O
DDI-DrugBank.d320.s2,administered,39,50,O
DDI-DrugBank.d320.s2,with,52,55,O
DDI-DrugBank.d320.s2,Chirocaine,57,66,B-brand
DDI-DrugBank.d320.s2,that,68,71,O
DDI-DrugBank.d320.s2,are,73,75,O
DDI-DrugBank.d320.s2,metabolized,77,87,O
DDI-DrugBank.d320.s2,by,89,90,O
DDI-DrugBank.d320.s2,this,92,95,O
DDI-DrugBank.d320.s2,isoenzyme,97,105,O
DDI-DrugBank.d320.s2,family,107,112,O
DDI-DrugBank.d320.s2,may,114,116,O
DDI-DrugBank.d320.s2,potentially,118,128,O
DDI-DrugBank.d320.s2,interact,130,137,O
DDI-DrugBank.d320.s2,with,139,142,O
DDI-DrugBank.d320.s2,Chirocaine,144,153,B-brand
DDI-DrugBank.d320.s2,.,154,154,O
DDI-DrugBank.d320.s3,Although,0,7,O
DDI-DrugBank.d320.s3,no,9,10,O
DDI-DrugBank.d320.s3,clinical,12,19,O
DDI-DrugBank.d320.s3,studies,21,27,O
DDI-DrugBank.d320.s3,have,29,32,O
DDI-DrugBank.d320.s3,been,34,37,O
DDI-DrugBank.d320.s3,conducted,39,47,O
DDI-DrugBank.d320.s3,",",48,48,O
DDI-DrugBank.d320.s3,it,50,51,O
DDI-DrugBank.d320.s3,is,53,54,O
DDI-DrugBank.d320.s3,likely,56,61,O
DDI-DrugBank.d320.s3,that,63,66,O
DDI-DrugBank.d320.s3,the,68,70,O
DDI-DrugBank.d320.s3,metabolism,72,81,O
DDI-DrugBank.d320.s3,of,83,84,O
DDI-DrugBank.d320.s3,levobupivacaine,86,100,B-drug
DDI-DrugBank.d320.s3,may,102,104,O
DDI-DrugBank.d320.s3,be,106,107,O
DDI-DrugBank.d320.s3,affected,109,116,O
DDI-DrugBank.d320.s3,by,118,119,O
DDI-DrugBank.d320.s3,the,121,123,O
DDI-DrugBank.d320.s3,known,125,129,O
DDI-DrugBank.d320.s3,CYP3A4,131,136,O
DDI-DrugBank.d320.s3,inducers,138,145,O
DDI-DrugBank.d320.s3,(,147,147,O
DDI-DrugBank.d320.s3,such,148,151,O
DDI-DrugBank.d320.s3,as,153,154,O
DDI-DrugBank.d320.s3,phenytoin,156,164,B-drug
DDI-DrugBank.d320.s3,",",165,165,O
DDI-DrugBank.d320.s3,phenobarbital,167,179,B-drug
DDI-DrugBank.d320.s3,",",180,180,O
DDI-DrugBank.d320.s3,rifampin,182,189,B-drug
DDI-DrugBank.d320.s3,),190,190,O
DDI-DrugBank.d320.s3,",",191,191,O
DDI-DrugBank.d320.s3,CYP3A4,193,198,O
DDI-DrugBank.d320.s3,inhibitors,200,209,O
DDI-DrugBank.d320.s3,(,211,211,O
DDI-DrugBank.d320.s3,azole,212,216,O
DDI-DrugBank.d320.s3,antimycotics,218,229,O
DDI-DrugBank.d320.s3,e.g.,231,234,O
DDI-DrugBank.d320.s3,",",235,235,O
DDI-DrugBank.d320.s3,ketoconazole,237,248,B-drug
DDI-DrugBank.d320.s3,;,249,249,O
DDI-DrugBank.d320.s4,certain,0,6,O
DDI-DrugBank.d320.s4,protease,8,15,B-group
DDI-DrugBank.d320.s4,inhibitors,17,26,I-group
DDI-DrugBank.d320.s4,e.g.,28,31,O
DDI-DrugBank.d320.s4,",",32,32,O
DDI-DrugBank.d320.s4,ritanovir,34,42,O
DDI-DrugBank.d320.s4,;,43,43,O
DDI-DrugBank.d320.s5,macrolide,0,8,B-group
DDI-DrugBank.d320.s5,antibiotics,10,20,I-group
DDI-DrugBank.d320.s5,e.g.,22,25,O
DDI-DrugBank.d320.s5,",",26,26,O
DDI-DrugBank.d320.s5,erythromycin,28,39,B-drug
DDI-DrugBank.d320.s5,;,40,40,O
DDI-DrugBank.d320.s6,and,0,2,O
DDI-DrugBank.d320.s6,calcium,4,10,B-group
DDI-DrugBank.d320.s6,channel,12,18,I-group
DDI-DrugBank.d320.s6,antagonists,20,30,I-group
DDI-DrugBank.d320.s6,e.g.,32,35,O
DDI-DrugBank.d320.s6,",",36,36,O
DDI-DrugBank.d320.s6,verapamil,38,46,B-drug
DDI-DrugBank.d320.s6,),47,47,O
DDI-DrugBank.d320.s6,",",48,48,O
DDI-DrugBank.d320.s6,CYP1A2,50,55,O
DDI-DrugBank.d320.s6,inducers,57,64,O
DDI-DrugBank.d320.s6,(,66,66,O
DDI-DrugBank.d320.s6,omeprazole,67,76,B-drug
DDI-DrugBank.d320.s6,),77,77,O
DDI-DrugBank.d320.s6,and,79,81,O
DDI-DrugBank.d320.s6,CYP1A2,83,88,O
DDI-DrugBank.d320.s6,inhibitors,90,99,O
DDI-DrugBank.d320.s6,(,101,101,O
DDI-DrugBank.d320.s6,furafylline,102,112,B-drug
DDI-DrugBank.d320.s6,and,114,116,O
DDI-DrugBank.d320.s6,clarithromycin,118,131,B-drug
DDI-DrugBank.d320.s6,),132,132,O
DDI-DrugBank.d320.s6,.,133,133,O
DDI-DrugBank.d320.s7,Dosage,0,5,O
DDI-DrugBank.d320.s7,adjustment,7,16,O
DDI-DrugBank.d320.s7,may,18,20,O
DDI-DrugBank.d320.s7,be,22,23,O
DDI-DrugBank.d320.s7,warranted,25,33,O
DDI-DrugBank.d320.s7,when,35,38,O
DDI-DrugBank.d320.s7,levobupivacaine,40,54,B-drug
DDI-DrugBank.d320.s7,is,56,57,O
DDI-DrugBank.d320.s7,concurrently,59,70,O
DDI-DrugBank.d320.s7,administered,72,83,O
DDI-DrugBank.d320.s7,with,85,88,O
DDI-DrugBank.d320.s7,CYP3A4,90,95,O
DDI-DrugBank.d320.s7,inhibitors,97,106,O
DDI-DrugBank.d320.s7,and,108,110,O
DDI-DrugBank.d320.s7,CYP1A2,112,117,O
DDI-DrugBank.d320.s7,inhibitors,119,128,O
DDI-DrugBank.d320.s7,as,130,131,O
DDI-DrugBank.d320.s7,systemic,133,140,O
DDI-DrugBank.d320.s7,levobupivacaine,142,156,B-drug
DDI-DrugBank.d320.s7,levels,158,163,O
DDI-DrugBank.d320.s7,may,165,167,O
DDI-DrugBank.d320.s7,rise,169,172,O
DDI-DrugBank.d320.s7,resulting,174,182,O
DDI-DrugBank.d320.s7,in,184,185,O
DDI-DrugBank.d320.s7,toxicity,187,194,O
DDI-DrugBank.d320.s7,.,195,195,O
DDI-DrugBank.d454.s0,-,0,0,O
DDI-DrugBank.d454.s0,Lofexidine,2,11,B-drug
DDI-DrugBank.d454.s0,may,13,15,O
DDI-DrugBank.d454.s0,enhance,17,23,O
DDI-DrugBank.d454.s0,the,25,27,O
DDI-DrugBank.d454.s0,CNS,29,31,O
DDI-DrugBank.d454.s0,depressive,33,42,O
DDI-DrugBank.d454.s0,effects,44,50,O
DDI-DrugBank.d454.s0,of,52,53,O
DDI-DrugBank.d454.s0,alcohol,55,61,B-drug
DDI-DrugBank.d454.s0,",",62,62,O
DDI-DrugBank.d454.s0,barbiturates,64,75,B-group
DDI-DrugBank.d454.s0,and,77,79,O
DDI-DrugBank.d454.s0,other,81,85,O
DDI-DrugBank.d454.s0,sedatives,87,95,B-group
DDI-DrugBank.d454.s1,.,0,0,O
DDI-DrugBank.d454.s2,-,0,0,O
DDI-DrugBank.d454.s2,Lofexidine,2,11,B-drug
DDI-DrugBank.d454.s2,may,13,15,O
DDI-DrugBank.d454.s2,enhance,17,23,O
DDI-DrugBank.d454.s2,the,25,27,O
DDI-DrugBank.d454.s2,effects,29,35,O
DDI-DrugBank.d454.s2,of,37,38,O
DDI-DrugBank.d454.s2,anti-hypertensive,40,56,B-group
DDI-DrugBank.d454.s2,drug,58,61,I-group
DDI-DrugBank.d454.s2,therapy,63,69,O
DDI-DrugBank.d454.s3,.,0,0,O
DDI-DrugBank.d454.s4,-,0,0,O
DDI-DrugBank.d454.s4,Concomitant,2,12,O
DDI-DrugBank.d454.s4,use,14,16,O
DDI-DrugBank.d454.s4,of,18,19,O
DDI-DrugBank.d454.s4,tricyclic,21,29,B-group
DDI-DrugBank.d454.s4,antidepressants,31,45,I-group
DDI-DrugBank.d454.s4,may,47,49,O
DDI-DrugBank.d454.s4,reduce,51,56,O
DDI-DrugBank.d454.s4,the,58,60,O
DDI-DrugBank.d454.s4,efficacy,62,69,O
DDI-DrugBank.d454.s4,of,71,72,O
DDI-DrugBank.d454.s4,lofexidine,74,83,B-drug
DDI-DrugBank.d454.s4,.,84,84,O
DDI-DrugBank.d30.s0,No,0,1,O
DDI-DrugBank.d30.s0,significant,3,13,O
DDI-DrugBank.d30.s0,drug-drug,15,23,O
DDI-DrugBank.d30.s0,pharmacokinetic,25,39,O
DDI-DrugBank.d30.s0,interactions,41,52,O
DDI-DrugBank.d30.s0,have,54,57,O
DDI-DrugBank.d30.s0,been,59,62,O
DDI-DrugBank.d30.s0,found,64,68,O
DDI-DrugBank.d30.s0,in,70,71,O
DDI-DrugBank.d30.s0,interaction,73,83,O
DDI-DrugBank.d30.s0,studies,85,91,O
DDI-DrugBank.d30.s0,with,93,96,O
DDI-DrugBank.d30.s0,hydrochlorothiazide,98,116,B-drug
DDI-DrugBank.d30.s0,",",117,117,O
DDI-DrugBank.d30.s0,digoxin,119,125,B-drug
DDI-DrugBank.d30.s0,",",126,126,O
DDI-DrugBank.d30.s0,warfarin,128,135,B-drug
DDI-DrugBank.d30.s0,",",136,136,O
DDI-DrugBank.d30.s0,cimetidine,138,147,B-drug
DDI-DrugBank.d30.s0,and,149,151,O
DDI-DrugBank.d30.s0,phenobarbital,153,165,B-drug
DDI-DrugBank.d30.s0,.,166,166,O
DDI-DrugBank.d30.s1,Rifampin,0,7,B-drug
DDI-DrugBank.d30.s1,",",8,8,O
DDI-DrugBank.d30.s1,an,10,11,O
DDI-DrugBank.d30.s1,inducer,13,19,O
DDI-DrugBank.d30.s1,of,21,22,O
DDI-DrugBank.d30.s1,drug,24,27,O
DDI-DrugBank.d30.s1,metabolism,29,38,O
DDI-DrugBank.d30.s1,",",39,39,O
DDI-DrugBank.d30.s1,decreased,41,49,O
DDI-DrugBank.d30.s1,the,51,53,O
DDI-DrugBank.d30.s1,concentrations,55,68,O
DDI-DrugBank.d30.s1,of,70,71,O
DDI-DrugBank.d30.s1,losartan,73,80,B-drug
DDI-DrugBank.d30.s1,and,82,84,O
DDI-DrugBank.d30.s1,its,86,88,O
DDI-DrugBank.d30.s1,active,90,95,O
DDI-DrugBank.d30.s1,metabolite,97,106,O
DDI-DrugBank.d30.s1,.,107,107,O
DDI-DrugBank.d30.s2,In,0,1,O
DDI-DrugBank.d30.s2,humans,3,8,O
DDI-DrugBank.d30.s2,",",9,9,O
DDI-DrugBank.d30.s2,two,11,13,O
DDI-DrugBank.d30.s2,inhibitors,15,24,O
DDI-DrugBank.d30.s2,of,26,27,O
DDI-DrugBank.d30.s2,P450,29,32,O
DDI-DrugBank.d30.s2,3A4,34,36,O
DDI-DrugBank.d30.s2,have,38,41,O
DDI-DrugBank.d30.s2,been,43,46,O
DDI-DrugBank.d30.s2,studied,48,54,O
DDI-DrugBank.d30.s2,.,55,55,O
DDI-DrugBank.d30.s3,Ketoconazole,0,11,B-drug
DDI-DrugBank.d30.s3,did,13,15,O
DDI-DrugBank.d30.s3,not,17,19,O
DDI-DrugBank.d30.s3,affect,21,26,O
DDI-DrugBank.d30.s3,the,28,30,O
DDI-DrugBank.d30.s3,conversion,32,41,O
DDI-DrugBank.d30.s3,of,43,44,O
DDI-DrugBank.d30.s3,losartan,46,53,B-drug
DDI-DrugBank.d30.s3,to,55,56,O
DDI-DrugBank.d30.s3,the,58,60,O
DDI-DrugBank.d30.s3,active,62,67,O
DDI-DrugBank.d30.s3,metabolite,69,78,O
DDI-DrugBank.d30.s3,after,80,84,O
DDI-DrugBank.d30.s3,intravenous,86,96,O
DDI-DrugBank.d30.s3,administration,98,111,O
DDI-DrugBank.d30.s3,of,113,114,O
DDI-DrugBank.d30.s3,losartan,116,123,B-drug
DDI-DrugBank.d30.s3,",",124,124,O
DDI-DrugBank.d30.s3,and,126,128,O
DDI-DrugBank.d30.s3,erythromycin,130,141,B-drug
DDI-DrugBank.d30.s3,had,143,145,O
DDI-DrugBank.d30.s3,no,147,148,O
DDI-DrugBank.d30.s3,clinically,150,159,O
DDI-DrugBank.d30.s3,significant,161,171,O
DDI-DrugBank.d30.s3,effect,173,178,O
DDI-DrugBank.d30.s3,after,180,184,O
DDI-DrugBank.d30.s3,oral,186,189,O
DDI-DrugBank.d30.s3,administration,191,204,O
DDI-DrugBank.d30.s3,.,205,205,O
DDI-DrugBank.d30.s4,Fluconazole,0,10,B-drug
DDI-DrugBank.d30.s4,",",11,11,O
DDI-DrugBank.d30.s4,an,13,14,O
DDI-DrugBank.d30.s4,inhibitor,16,24,O
DDI-DrugBank.d30.s4,of,26,27,O
DDI-DrugBank.d30.s4,P450,29,32,O
DDI-DrugBank.d30.s4,2C9,34,36,O
DDI-DrugBank.d30.s4,",",37,37,O
DDI-DrugBank.d30.s4,decreased,39,47,O
DDI-DrugBank.d30.s4,active,49,54,O
DDI-DrugBank.d30.s4,metabolite,56,65,O
DDI-DrugBank.d30.s4,concentration,67,79,O
DDI-DrugBank.d30.s4,and,81,83,O
DDI-DrugBank.d30.s4,increased,85,93,O
DDI-DrugBank.d30.s4,losartan,95,102,B-drug
DDI-DrugBank.d30.s4,concentration,104,116,O
DDI-DrugBank.d30.s4,.,117,117,O
DDI-DrugBank.d30.s5,The,0,2,O
DDI-DrugBank.d30.s5,pharmacodynamic,4,18,O
DDI-DrugBank.d30.s5,consequences,20,31,O
DDI-DrugBank.d30.s5,of,33,34,O
DDI-DrugBank.d30.s5,concomitant,36,46,O
DDI-DrugBank.d30.s5,use,48,50,O
DDI-DrugBank.d30.s5,of,52,53,O
DDI-DrugBank.d30.s5,losartan,55,62,B-drug
DDI-DrugBank.d30.s5,and,64,66,O
DDI-DrugBank.d30.s5,inhibitors,68,77,O
DDI-DrugBank.d30.s5,of,79,80,O
DDI-DrugBank.d30.s5,P450,82,85,O
DDI-DrugBank.d30.s5,2C9,87,89,O
DDI-DrugBank.d30.s5,have,91,94,O
DDI-DrugBank.d30.s5,not,96,98,O
DDI-DrugBank.d30.s5,been,100,103,O
DDI-DrugBank.d30.s5,examined,105,112,O
DDI-DrugBank.d30.s5,.,113,113,O
DDI-DrugBank.d30.s6,Subjects,0,7,O
DDI-DrugBank.d30.s6,who,9,11,O
DDI-DrugBank.d30.s6,do,13,14,O
DDI-DrugBank.d30.s6,not,16,18,O
DDI-DrugBank.d30.s6,metabolize,20,29,O
DDI-DrugBank.d30.s6,losartan,31,38,B-drug
DDI-DrugBank.d30.s6,to,40,41,O
DDI-DrugBank.d30.s6,active,43,48,O
DDI-DrugBank.d30.s6,metabolite,50,59,O
DDI-DrugBank.d30.s6,have,61,64,O
DDI-DrugBank.d30.s6,been,66,69,O
DDI-DrugBank.d30.s6,shown,71,75,O
DDI-DrugBank.d30.s6,to,77,78,O
DDI-DrugBank.d30.s6,have,80,83,O
DDI-DrugBank.d30.s6,a,85,85,O
DDI-DrugBank.d30.s6,specific,87,94,O
DDI-DrugBank.d30.s6,",",95,95,O
DDI-DrugBank.d30.s6,rare,97,100,O
DDI-DrugBank.d30.s6,defect,102,107,O
DDI-DrugBank.d30.s6,in,109,110,O
DDI-DrugBank.d30.s6,cytochrome,112,121,O
DDI-DrugBank.d30.s6,P450,123,126,O
DDI-DrugBank.d30.s6,2C9,128,130,O
DDI-DrugBank.d30.s6,.,131,131,O
DDI-DrugBank.d30.s7,These,0,4,O
DDI-DrugBank.d30.s7,data,6,9,O
DDI-DrugBank.d30.s7,suggest,11,17,O
DDI-DrugBank.d30.s7,that,19,22,O
DDI-DrugBank.d30.s7,the,24,26,O
DDI-DrugBank.d30.s7,conversion,28,37,O
DDI-DrugBank.d30.s7,of,39,40,O
DDI-DrugBank.d30.s7,losartan,42,49,B-drug
DDI-DrugBank.d30.s7,to,51,52,O
DDI-DrugBank.d30.s7,its,54,56,O
DDI-DrugBank.d30.s7,active,58,63,O
DDI-DrugBank.d30.s7,metabolite,65,74,O
DDI-DrugBank.d30.s7,is,76,77,O
DDI-DrugBank.d30.s7,mediated,79,86,O
DDI-DrugBank.d30.s7,primarily,88,96,O
DDI-DrugBank.d30.s7,by,98,99,O
DDI-DrugBank.d30.s7,P450,101,104,O
DDI-DrugBank.d30.s7,2C9,106,108,O
DDI-DrugBank.d30.s7,and,110,112,O
DDI-DrugBank.d30.s7,not,114,116,O
DDI-DrugBank.d30.s7,P450,118,121,O
DDI-DrugBank.d30.s7,3A4,123,125,O
DDI-DrugBank.d30.s7,.,126,126,O
DDI-DrugBank.d30.s8,As,0,1,O
DDI-DrugBank.d30.s8,with,3,6,O
DDI-DrugBank.d30.s8,other,8,12,O
DDI-DrugBank.d30.s8,drugs,14,18,O
DDI-DrugBank.d30.s8,that,20,23,O
DDI-DrugBank.d30.s8,block,25,29,O
DDI-DrugBank.d30.s8,angiotensin,31,41,O
DDI-DrugBank.d30.s8,II,43,44,O
DDI-DrugBank.d30.s8,or,46,47,O
DDI-DrugBank.d30.s8,its,49,51,O
DDI-DrugBank.d30.s8,effects,53,59,O
DDI-DrugBank.d30.s8,",",60,60,O
DDI-DrugBank.d30.s8,concomitant,62,72,O
DDI-DrugBank.d30.s8,use,74,76,O
DDI-DrugBank.d30.s8,of,78,79,O
DDI-DrugBank.d30.s8,potassium-sparing,81,97,B-group
DDI-DrugBank.d30.s8,diuretics,99,107,I-group
DDI-DrugBank.d30.s8,(,109,109,O
DDI-DrugBank.d30.s8,e.g.,110,113,O
DDI-DrugBank.d30.s8,",",114,114,O
DDI-DrugBank.d30.s8,spironolactone,116,129,B-drug
DDI-DrugBank.d30.s8,",",130,130,O
DDI-DrugBank.d30.s8,triamterene,132,142,B-drug
DDI-DrugBank.d30.s8,",",143,143,O
DDI-DrugBank.d30.s8,amiloride,145,153,B-drug
DDI-DrugBank.d30.s8,),154,154,O
DDI-DrugBank.d30.s8,",",155,155,O
DDI-DrugBank.d30.s8,potassium,157,165,B-drug
DDI-DrugBank.d30.s8,supplements,167,177,O
DDI-DrugBank.d30.s8,",",178,178,O
DDI-DrugBank.d30.s8,or,180,181,O
DDI-DrugBank.d30.s8,salt,183,186,O
DDI-DrugBank.d30.s8,substitutes,188,198,O
DDI-DrugBank.d30.s8,containing,200,209,O
DDI-DrugBank.d30.s8,potassium,211,219,O
DDI-DrugBank.d30.s8,may,221,223,O
DDI-DrugBank.d30.s8,lead,225,228,O
DDI-DrugBank.d30.s8,to,230,231,O
DDI-DrugBank.d30.s8,increases,233,241,O
DDI-DrugBank.d30.s8,in,243,244,O
DDI-DrugBank.d30.s8,serum,246,250,O
DDI-DrugBank.d30.s8,potassium,252,260,O
DDI-DrugBank.d30.s8,.,261,261,O
DDI-DrugBank.d30.s9,As,0,1,O
DDI-DrugBank.d30.s9,with,3,6,O
DDI-DrugBank.d30.s9,other,8,12,O
DDI-DrugBank.d30.s9,antihypertensive,14,29,B-group
DDI-DrugBank.d30.s9,agents,31,36,I-group
DDI-DrugBank.d30.s9,",",37,37,O
DDI-DrugBank.d30.s9,the,39,41,O
DDI-DrugBank.d30.s9,antihypertensive,43,58,O
DDI-DrugBank.d30.s9,effect,60,65,O
DDI-DrugBank.d30.s9,of,67,68,O
DDI-DrugBank.d30.s9,losartan,70,77,B-drug
DDI-DrugBank.d30.s9,may,79,81,O
DDI-DrugBank.d30.s9,be,83,84,O
DDI-DrugBank.d30.s9,blunted,86,92,O
DDI-DrugBank.d30.s9,by,94,95,O
DDI-DrugBank.d30.s9,the,97,99,O
DDI-DrugBank.d30.s9,non-steroidal,101,113,B-group
DDI-DrugBank.d30.s9,anti-inflammatory,115,131,I-group
DDI-DrugBank.d30.s9,drug,133,136,I-group
DDI-DrugBank.d30.s9,indomethacin,138,149,B-drug
DDI-DrugBank.d30.s10,.,0,0,O
DDI-DrugBank.d746.s0,ARAMINE,0,6,B-brand
DDI-DrugBank.d746.s0,should,8,13,O
DDI-DrugBank.d746.s0,be,15,16,O
DDI-DrugBank.d746.s0,used,18,21,O
DDI-DrugBank.d746.s0,with,23,26,O
DDI-DrugBank.d746.s0,caution,28,34,O
DDI-DrugBank.d746.s0,in,36,37,O
DDI-DrugBank.d746.s0,digitalized,39,49,O
DDI-DrugBank.d746.s0,patients,51,58,O
DDI-DrugBank.d746.s0,",",59,59,O
DDI-DrugBank.d746.s0,since,61,65,O
DDI-DrugBank.d746.s0,the,67,69,O
DDI-DrugBank.d746.s0,combination,71,81,O
DDI-DrugBank.d746.s0,of,83,84,O
DDI-DrugBank.d746.s0,digitalis,86,94,B-group
DDI-DrugBank.d746.s0,and,96,98,O
DDI-DrugBank.d746.s0,sympathomimetic,100,114,B-group
DDI-DrugBank.d746.s0,amines,116,121,I-group
DDI-DrugBank.d746.s0,may,123,125,O
DDI-DrugBank.d746.s0,cause,127,131,O
DDI-DrugBank.d746.s0,ectopic,133,139,O
DDI-DrugBank.d746.s0,arrhythmias,141,151,O
DDI-DrugBank.d746.s0,.,152,152,O
DDI-DrugBank.d746.s1,Monoamine,0,8,B-group
DDI-DrugBank.d746.s1,oxidase,10,16,I-group
DDI-DrugBank.d746.s1,inhibitors,18,27,I-group
DDI-DrugBank.d746.s1,or,29,30,O
DDI-DrugBank.d746.s1,tricyclic,32,40,B-group
DDI-DrugBank.d746.s1,antidepressants,42,56,I-group
DDI-DrugBank.d746.s1,may,58,60,O
DDI-DrugBank.d746.s1,potentiate,62,71,O
DDI-DrugBank.d746.s1,the,73,75,O
DDI-DrugBank.d746.s1,action,77,82,O
DDI-DrugBank.d746.s1,of,84,85,O
DDI-DrugBank.d746.s1,sympathomimetic,87,101,B-group
DDI-DrugBank.d746.s1,amines,103,108,I-group
DDI-DrugBank.d746.s1,.,109,109,O
DDI-DrugBank.d746.s2,Therefore,0,8,O
DDI-DrugBank.d746.s2,",",9,9,O
DDI-DrugBank.d746.s2,when,11,14,O
DDI-DrugBank.d746.s2,initiating,16,25,O
DDI-DrugBank.d746.s2,pressor,27,33,O
DDI-DrugBank.d746.s2,therapy,35,41,O
DDI-DrugBank.d746.s2,in,43,44,O
DDI-DrugBank.d746.s2,patients,46,53,O
DDI-DrugBank.d746.s2,receiving,55,63,O
DDI-DrugBank.d746.s2,these,65,69,O
DDI-DrugBank.d746.s2,drugs,71,75,O
DDI-DrugBank.d746.s2,",",76,76,O
DDI-DrugBank.d746.s2,the,78,80,O
DDI-DrugBank.d746.s2,initial,82,88,O
DDI-DrugBank.d746.s2,dose,90,93,O
DDI-DrugBank.d746.s2,should,95,100,O
DDI-DrugBank.d746.s2,be,102,103,O
DDI-DrugBank.d746.s2,small,105,109,O
DDI-DrugBank.d746.s2,and,111,113,O
DDI-DrugBank.d746.s2,given,115,119,O
DDI-DrugBank.d746.s2,with,121,124,O
DDI-DrugBank.d746.s2,caution,126,132,O
DDI-DrugBank.d746.s2,.,133,133,O
DDI-DrugBank.d630.s0,Methazolamide,0,12,B-drug
DDI-DrugBank.d630.s0,should,14,19,O
DDI-DrugBank.d630.s0,be,21,22,O
DDI-DrugBank.d630.s0,used,24,27,O
DDI-DrugBank.d630.s0,with,29,32,O
DDI-DrugBank.d630.s0,caution,34,40,O
DDI-DrugBank.d630.s0,in,42,43,O
DDI-DrugBank.d630.s0,patients,45,52,O
DDI-DrugBank.d630.s0,on,54,55,O
DDI-DrugBank.d630.s0,steroid,57,63,O
DDI-DrugBank.d630.s0,therapy,65,71,O
DDI-DrugBank.d630.s0,because,73,79,O
DDI-DrugBank.d630.s0,of,81,82,O
DDI-DrugBank.d630.s0,the,84,86,O
DDI-DrugBank.d630.s0,potential,88,96,O
DDI-DrugBank.d630.s0,for,98,100,O
DDI-DrugBank.d630.s0,developing,102,111,O
DDI-DrugBank.d630.s0,hypokalemia,113,123,O
DDI-DrugBank.d630.s0,.,124,124,O
DDI-DrugBank.d630.s1,Caution,0,6,O
DDI-DrugBank.d630.s1,is,8,9,O
DDI-DrugBank.d630.s1,advised,11,17,O
DDI-DrugBank.d630.s1,for,19,21,O
DDI-DrugBank.d630.s1,patients,23,30,O
DDI-DrugBank.d630.s1,receiving,32,40,O
DDI-DrugBank.d630.s1,high-dose,42,50,O
DDI-DrugBank.d630.s1,aspirin,52,58,B-brand
DDI-DrugBank.d630.s1,and,60,62,O
DDI-DrugBank.d630.s1,methazolamide,64,76,B-drug
DDI-DrugBank.d630.s1,concomitantly,78,90,O
DDI-DrugBank.d630.s1,",",91,91,O
DDI-DrugBank.d630.s1,as,93,94,O
DDI-DrugBank.d630.s1,anorexia,96,103,O
DDI-DrugBank.d630.s1,",",104,104,O
DDI-DrugBank.d630.s1,tachypnea,106,114,O
DDI-DrugBank.d630.s1,",",115,115,O
DDI-DrugBank.d630.s1,lethargy,117,124,O
DDI-DrugBank.d630.s1,",",125,125,O
DDI-DrugBank.d630.s1,coma,127,130,O
DDI-DrugBank.d630.s1,and,132,134,O
DDI-DrugBank.d630.s1,death,136,140,O
DDI-DrugBank.d630.s1,have,142,145,O
DDI-DrugBank.d630.s1,been,147,150,O
DDI-DrugBank.d630.s1,reported,152,159,O
DDI-DrugBank.d630.s1,with,161,164,O
DDI-DrugBank.d630.s1,concomitant,166,176,O
DDI-DrugBank.d630.s1,use,178,180,O
DDI-DrugBank.d630.s1,of,182,183,O
DDI-DrugBank.d630.s1,high-dose,185,193,O
DDI-DrugBank.d630.s1,aspirin,195,201,B-brand
DDI-DrugBank.d630.s1,and,203,205,O
DDI-DrugBank.d630.s1,carbonic,207,214,B-group
DDI-DrugBank.d630.s1,anhydrase,216,224,I-group
DDI-DrugBank.d630.s1,inhibitors,226,235,I-group
DDI-DrugBank.d630.s1,.,236,236,O
DDI-DrugBank.d756.s0,Dosages,0,6,O
DDI-DrugBank.d756.s0,of,8,9,O
DDI-DrugBank.d756.s0,concomitantly,11,23,O
DDI-DrugBank.d756.s0,administered,25,36,O
DDI-DrugBank.d756.s0,opioids,38,44,B-group
DDI-DrugBank.d756.s0,should,46,51,O
DDI-DrugBank.d756.s0,be,53,54,O
DDI-DrugBank.d756.s0,reduced,56,62,O
DDI-DrugBank.d756.s0,by,64,65,O
DDI-DrugBank.d756.s0,approximately,67,79,O
DDI-DrugBank.d756.s0,half,81,84,O
DDI-DrugBank.d756.s0,",",85,85,O
DDI-DrugBank.d756.s0,because,87,93,O
DDI-DrugBank.d756.s0,levomepromazine,95,109,B-drug
DDI-DrugBank.d756.s0,amplifies,111,119,O
DDI-DrugBank.d756.s0,the,121,123,O
DDI-DrugBank.d756.s0,therapeutic,125,135,O
DDI-DrugBank.d756.s0,actions,137,143,O
DDI-DrugBank.d756.s0,and,145,147,O
DDI-DrugBank.d756.s0,side-effects,149,160,O
DDI-DrugBank.d756.s0,of,162,163,O
DDI-DrugBank.d756.s0,opioids,165,171,B-group
DDI-DrugBank.d756.s0,.,172,172,O
DDI-DrugBank.d756.s1,Combination,0,10,O
DDI-DrugBank.d756.s1,with,12,15,O
DDI-DrugBank.d756.s1,tramadol,17,24,B-drug
DDI-DrugBank.d756.s1,(,26,26,O
DDI-DrugBank.d756.s1,Ultram,27,32,B-brand
DDI-DrugBank.d756.s1,),33,33,O
DDI-DrugBank.d756.s1,is,35,36,O
DDI-DrugBank.d756.s1,associated,38,47,O
DDI-DrugBank.d756.s1,with,49,52,O
DDI-DrugBank.d756.s1,increased,54,62,O
DDI-DrugBank.d756.s1,risk,64,67,O
DDI-DrugBank.d756.s1,of,69,70,O
DDI-DrugBank.d756.s1,seizures,72,79,O
DDI-DrugBank.d756.s1,.,80,80,O
DDI-DrugBank.d756.s2,Additive,0,7,O
DDI-DrugBank.d756.s2,sedative,9,16,O
DDI-DrugBank.d756.s2,effects,18,24,O
DDI-DrugBank.d756.s2,and,26,28,O
DDI-DrugBank.d756.s2,confusional,30,40,O
DDI-DrugBank.d756.s2,states,42,47,O
DDI-DrugBank.d756.s2,may,49,51,O
DDI-DrugBank.d756.s2,emerge,53,58,O
DDI-DrugBank.d756.s2,if,60,61,O
DDI-DrugBank.d756.s2,levomepromazine,63,77,B-drug
DDI-DrugBank.d756.s2,is,79,80,O
DDI-DrugBank.d756.s2,given,82,86,O
DDI-DrugBank.d756.s2,with,88,91,O
DDI-DrugBank.d756.s2,benzodiazepines,93,107,B-group
DDI-DrugBank.d756.s2,or,109,110,O
DDI-DrugBank.d756.s2,barbiturates,112,123,B-group
DDI-DrugBank.d756.s2,.,124,124,O
DDI-DrugBank.d756.s3,This,0,3,O
DDI-DrugBank.d756.s3,may,5,7,O
DDI-DrugBank.d756.s3,be,9,10,O
DDI-DrugBank.d756.s3,avoided,12,18,O
DDI-DrugBank.d756.s3,by,20,21,O
DDI-DrugBank.d756.s3,using,23,27,O
DDI-DrugBank.d756.s3,the,29,31,O
DDI-DrugBank.d756.s3,lowest,33,38,O
DDI-DrugBank.d756.s3,dose,40,43,O
DDI-DrugBank.d756.s3,possible,45,52,O
DDI-DrugBank.d756.s3,with,54,57,O
DDI-DrugBank.d756.s3,the,59,61,O
DDI-DrugBank.d756.s3,substances,63,72,O
DDI-DrugBank.d756.s3,in,74,75,O
DDI-DrugBank.d756.s3,question,77,84,O
DDI-DrugBank.d756.s3,.,85,85,O
DDI-DrugBank.d756.s4,Exert,0,4,O
DDI-DrugBank.d756.s4,particular,6,15,O
DDI-DrugBank.d756.s4,caution,17,23,O
DDI-DrugBank.d756.s4,in,25,26,O
DDI-DrugBank.d756.s4,combining,28,36,O
DDI-DrugBank.d756.s4,levomepromazine,38,52,B-drug
DDI-DrugBank.d756.s4,with,54,57,O
DDI-DrugBank.d756.s4,other,59,63,O
DDI-DrugBank.d756.s4,anticholinergic,65,79,B-group
DDI-DrugBank.d756.s4,drugs,81,85,I-group
DDI-DrugBank.d756.s4,(,87,87,O
DDI-DrugBank.d756.s4,tricyclic,88,96,B-group
DDI-DrugBank.d756.s4,antidepressants,98,112,I-group
DDI-DrugBank.d756.s4,and,114,116,O
DDI-DrugBank.d756.s4,antiparkinsonian-agents,118,140,B-group
DDI-DrugBank.d756.s4,),141,141,O
DDI-DrugBank.d756.s4,:,142,142,O
DDI-DrugBank.d756.s4,Particularly,144,155,O
DDI-DrugBank.d756.s4,the,157,159,O
DDI-DrugBank.d756.s4,elderly,161,167,O
DDI-DrugBank.d756.s4,may,169,171,O
DDI-DrugBank.d756.s4,develop,173,179,O
DDI-DrugBank.d756.s4,delirium,181,188,O
DDI-DrugBank.d756.s4,",",189,189,O
DDI-DrugBank.d756.s4,high,191,194,O
DDI-DrugBank.d756.s4,fever,196,200,O
DDI-DrugBank.d756.s4,",",201,201,O
DDI-DrugBank.d756.s4,severe,203,208,O
DDI-DrugBank.d756.s4,obstipation,210,220,O
DDI-DrugBank.d756.s4,",",221,221,O
DDI-DrugBank.d756.s4,even,223,226,O
DDI-DrugBank.d756.s4,ileus,228,232,O
DDI-DrugBank.d756.s4,and,234,236,O
DDI-DrugBank.d756.s4,glaucoma,238,245,O
DDI-DrugBank.d756.s4,.,246,246,O
DDI-DrugBank.d756.s5,Reduce,0,5,O
DDI-DrugBank.d756.s5,both,7,10,O
DDI-DrugBank.d756.s5,the,12,14,O
DDI-DrugBank.d756.s5,dose,16,19,O
DDI-DrugBank.d756.s5,of,21,22,O
DDI-DrugBank.d756.s5,levomepromazine,24,38,B-drug
DDI-DrugBank.d756.s5,and,40,42,O
DDI-DrugBank.d756.s5,the,44,46,O
DDI-DrugBank.d756.s5,dose,48,51,O
DDI-DrugBank.d756.s5,of,53,54,O
DDI-DrugBank.d756.s5,the,56,58,O
DDI-DrugBank.d756.s5,other,60,64,O
DDI-DrugBank.d756.s5,drug,66,69,O
DDI-DrugBank.d756.s5,.,70,70,O
DDI-DrugBank.d756.s6,If,0,1,O
DDI-DrugBank.d756.s6,possible,3,10,O
DDI-DrugBank.d756.s6,",",11,11,O
DDI-DrugBank.d756.s6,avoid,13,17,O
DDI-DrugBank.d756.s6,such,19,22,O
DDI-DrugBank.d756.s6,combinations,24,35,O
DDI-DrugBank.d756.s6,.,36,36,O
DDI-DrugBank.d756.s7,Caffeine,0,7,B-drug
DDI-DrugBank.d756.s7,and/or,9,14,O
DDI-DrugBank.d756.s7,stimulantes,16,26,O
DDI-DrugBank.d756.s7,of,28,29,O
DDI-DrugBank.d756.s7,the,31,33,O
DDI-DrugBank.d756.s7,ephedrine/amphetamine,35,55,O
DDI-DrugBank.d756.s7,type,57,60,O
DDI-DrugBank.d756.s7,may,62,64,O
DDI-DrugBank.d756.s7,counteract,66,75,O
DDI-DrugBank.d756.s7,the,77,79,O
DDI-DrugBank.d756.s7,specific,81,88,O
DDI-DrugBank.d756.s7,actions,90,96,O
DDI-DrugBank.d756.s7,of,98,99,O
DDI-DrugBank.d756.s7,levomepromazine,101,115,B-drug
DDI-DrugBank.d756.s7,.,116,116,O
DDI-DrugBank.d756.s8,Concomitant,0,10,O
DDI-DrugBank.d756.s8,use,12,14,O
DDI-DrugBank.d756.s8,of,16,17,O
DDI-DrugBank.d756.s8,these,19,23,O
DDI-DrugBank.d756.s8,substances,25,34,O
DDI-DrugBank.d756.s8,should,36,41,O
DDI-DrugBank.d756.s8,be,43,44,O
DDI-DrugBank.d756.s8,avoided,46,52,O
DDI-DrugBank.d756.s8,.,53,53,O
DDI-DrugBank.d756.s9,Coffee,0,5,O
DDI-DrugBank.d756.s9,and,7,9,O
DDI-DrugBank.d756.s9,black,11,15,O
DDI-DrugBank.d756.s9,tea,17,19,O
DDI-DrugBank.d756.s9,should,21,26,O
DDI-DrugBank.d756.s9,be,28,29,O
DDI-DrugBank.d756.s9,avoided,31,37,O
DDI-DrugBank.d756.s9,because,39,45,O
DDI-DrugBank.d756.s9,they,47,50,O
DDI-DrugBank.d756.s9,decrease,52,59,O
DDI-DrugBank.d756.s9,the,61,63,O
DDI-DrugBank.d756.s9,absorption,65,74,O
DDI-DrugBank.d756.s9,of,76,77,O
DDI-DrugBank.d756.s9,levomepromazine,79,93,B-drug
DDI-DrugBank.d756.s9,considerably,95,106,O
DDI-DrugBank.d756.s9,.,107,107,O
DDI-DrugBank.d756.s10,The,0,2,O
DDI-DrugBank.d756.s10,same,4,7,O
DDI-DrugBank.d756.s10,is,9,10,O
DDI-DrugBank.d756.s10,true,12,15,O
DDI-DrugBank.d756.s10,for,17,19,O
DDI-DrugBank.d756.s10,antacids,21,28,B-group
DDI-DrugBank.d756.s10,;,29,29,O
DDI-DrugBank.d756.s11,these,0,4,O
DDI-DrugBank.d756.s11,should,6,11,O
DDI-DrugBank.d756.s11,be,13,14,O
DDI-DrugBank.d756.s11,given,16,20,O
DDI-DrugBank.d756.s11,1,22,22,O
DDI-DrugBank.d756.s11,to,24,25,O
DDI-DrugBank.d756.s11,2,27,27,O
DDI-DrugBank.d756.s11,hours,29,33,O
DDI-DrugBank.d756.s11,before,35,40,O
DDI-DrugBank.d756.s11,or,42,43,O
DDI-DrugBank.d756.s11,after,45,49,O
DDI-DrugBank.d756.s11,oral,51,54,O
DDI-DrugBank.d756.s11,administration,56,69,O
DDI-DrugBank.d756.s11,of,71,72,O
DDI-DrugBank.d756.s11,leveomepromazine,74,89,B-drug
DDI-DrugBank.d756.s11,.,90,90,O
DDI-DrugBank.d736.s0,Hypokalemia,0,10,O
DDI-DrugBank.d736.s0,can,12,14,O
DDI-DrugBank.d736.s0,sensitize,16,24,O
DDI-DrugBank.d736.s0,or,26,27,O
DDI-DrugBank.d736.s0,exaggerate,29,38,O
DDI-DrugBank.d736.s0,the,40,42,O
DDI-DrugBank.d736.s0,response,44,51,O
DDI-DrugBank.d736.s0,of,53,54,O
DDI-DrugBank.d736.s0,the,56,58,O
DDI-DrugBank.d736.s0,heart,60,64,O
DDI-DrugBank.d736.s0,to,66,67,O
DDI-DrugBank.d736.s0,the,69,71,O
DDI-DrugBank.d736.s0,toxic,73,77,O
DDI-DrugBank.d736.s0,effects,79,85,O
DDI-DrugBank.d736.s0,of,87,88,O
DDI-DrugBank.d736.s0,digitalis,90,98,B-group
DDI-DrugBank.d736.s0,(,100,100,O
DDI-DrugBank.d736.s0,e.g.,101,104,O
DDI-DrugBank.d736.s0,",",105,105,O
DDI-DrugBank.d736.s0,increased,107,115,O
DDI-DrugBank.d736.s0,ventricular,117,127,O
DDI-DrugBank.d736.s0,irritability,129,140,O
DDI-DrugBank.d736.s0,),141,141,O
DDI-DrugBank.d736.s0,.,142,142,O
DDI-DrugBank.d736.s1,Hypokalemia,0,10,O
DDI-DrugBank.d736.s1,may,12,14,O
DDI-DrugBank.d736.s1,develop,16,22,O
DDI-DrugBank.d736.s1,during,24,29,O
DDI-DrugBank.d736.s1,concomitant,31,41,O
DDI-DrugBank.d736.s1,use,43,45,O
DDI-DrugBank.d736.s1,of,47,48,O
DDI-DrugBank.d736.s1,steroids,50,57,B-group
DDI-DrugBank.d736.s1,or,59,60,O
DDI-DrugBank.d736.s1,ACTH,62,65,B-drug
DDI-DrugBank.d736.s1,.,66,66,O
DDI-DrugBank.d736.s2,Insulin,0,6,B-drug
DDI-DrugBank.d736.s2,requirements,8,19,O
DDI-DrugBank.d736.s2,in,21,22,O
DDI-DrugBank.d736.s2,diabetic,24,31,O
DDI-DrugBank.d736.s2,patients,33,40,O
DDI-DrugBank.d736.s2,may,42,44,O
DDI-DrugBank.d736.s2,be,46,47,O
DDI-DrugBank.d736.s2,increased,49,57,O
DDI-DrugBank.d736.s2,",",58,58,O
DDI-DrugBank.d736.s2,decreased,60,68,O
DDI-DrugBank.d736.s2,",",69,69,O
DDI-DrugBank.d736.s2,or,71,72,O
DDI-DrugBank.d736.s2,unchanged,74,82,O
DDI-DrugBank.d736.s2,.,83,83,O
DDI-DrugBank.d736.s3,Thiazides,0,8,B-group
DDI-DrugBank.d736.s3,may,10,12,O
DDI-DrugBank.d736.s3,decrease,14,21,O
DDI-DrugBank.d736.s3,arterial,23,30,O
DDI-DrugBank.d736.s3,responsiveness,32,45,O
DDI-DrugBank.d736.s3,to,47,48,O
DDI-DrugBank.d736.s3,norepinephrine,50,63,B-drug
DDI-DrugBank.d736.s3,.,64,64,O
DDI-DrugBank.d736.s4,This,0,3,O
DDI-DrugBank.d736.s4,diminution,5,14,O
DDI-DrugBank.d736.s4,is,16,17,O
DDI-DrugBank.d736.s4,not,19,21,O
DDI-DrugBank.d736.s4,sufficient,23,32,O
DDI-DrugBank.d736.s4,to,34,35,O
DDI-DrugBank.d736.s4,preclude,37,44,O
DDI-DrugBank.d736.s4,effectiveness,46,58,O
DDI-DrugBank.d736.s4,of,60,61,O
DDI-DrugBank.d736.s4,the,63,65,O
DDI-DrugBank.d736.s4,pressor,67,73,O
DDI-DrugBank.d736.s4,agent,75,79,O
DDI-DrugBank.d736.s4,for,81,83,O
DDI-DrugBank.d736.s4,therapeutic,85,95,O
DDI-DrugBank.d736.s4,use,97,99,O
DDI-DrugBank.d736.s4,.,100,100,O
DDI-DrugBank.d736.s5,Thiazide,0,7,B-group
DDI-DrugBank.d736.s5,drugs,9,13,I-group
DDI-DrugBank.d736.s5,may,15,17,O
DDI-DrugBank.d736.s5,increase,19,26,O
DDI-DrugBank.d736.s5,the,28,30,O
DDI-DrugBank.d736.s5,responsiveness,32,45,O
DDI-DrugBank.d736.s5,of,47,48,O
DDI-DrugBank.d736.s5,tubocurarine,50,61,B-drug
DDI-DrugBank.d736.s5,.,62,62,O
DDI-DrugBank.d736.s6,Lithium,0,6,B-drug
DDI-DrugBank.d736.s6,renal,8,12,O
DDI-DrugBank.d736.s6,clearance,14,22,O
DDI-DrugBank.d736.s6,is,24,25,O
DDI-DrugBank.d736.s6,reduced,27,33,O
DDI-DrugBank.d736.s6,by,35,36,O
DDI-DrugBank.d736.s6,thiazides,38,46,B-group
DDI-DrugBank.d736.s6,",",47,47,O
DDI-DrugBank.d736.s6,increasing,49,58,O
DDI-DrugBank.d736.s6,the,60,62,O
DDI-DrugBank.d736.s6,risk,64,67,O
DDI-DrugBank.d736.s6,of,69,70,O
DDI-DrugBank.d736.s6,lithium,72,78,B-drug
DDI-DrugBank.d736.s6,toxicity,80,87,O
DDI-DrugBank.d736.s6,.,88,88,O
DDI-DrugBank.d736.s7,Thiazides,0,8,B-group
DDI-DrugBank.d736.s7,may,10,12,O
DDI-DrugBank.d736.s7,add,14,16,O
DDI-DrugBank.d736.s7,to,18,19,O
DDI-DrugBank.d736.s7,or,21,22,O
DDI-DrugBank.d736.s7,potentiate,24,33,O
DDI-DrugBank.d736.s7,the,35,37,O
DDI-DrugBank.d736.s7,action,39,44,O
DDI-DrugBank.d736.s7,of,46,47,O
DDI-DrugBank.d736.s7,other,49,53,O
DDI-DrugBank.d736.s7,antihypertensive,55,70,B-group
DDI-DrugBank.d736.s7,drugs,72,76,I-group
DDI-DrugBank.d736.s7,.,77,77,O
DDI-DrugBank.d736.s8,Potentiation,0,11,O
DDI-DrugBank.d736.s8,occurs,13,18,O
DDI-DrugBank.d736.s8,with,20,23,O
DDI-DrugBank.d736.s8,ganglionic,25,34,B-group
DDI-DrugBank.d736.s8,or,36,37,O
DDI-DrugBank.d736.s8,peripheral,39,48,B-group
DDI-DrugBank.d736.s8,adrenergic,50,59,I-group
DDI-DrugBank.d736.s8,blocking,61,68,I-group
DDI-DrugBank.d736.s8,drugs,70,74,I-group
DDI-DrugBank.d736.s8,.,75,75,O
DDI-DrugBank.d706.s0,Catecholamine-depleting,0,22,O
DDI-DrugBank.d706.s0,drugs,24,28,O
DDI-DrugBank.d706.s0,(,30,30,O
DDI-DrugBank.d706.s0,e.g.,31,34,O
DDI-DrugBank.d706.s0,",",35,35,O
DDI-DrugBank.d706.s0,reserpine,37,45,B-drug
DDI-DrugBank.d706.s0,),46,46,O
DDI-DrugBank.d706.s0,may,48,50,O
DDI-DrugBank.d706.s0,have,52,55,O
DDI-DrugBank.d706.s0,an,57,58,O
DDI-DrugBank.d706.s0,additive,60,67,O
DDI-DrugBank.d706.s0,effect,69,74,O
DDI-DrugBank.d706.s0,when,76,79,O
DDI-DrugBank.d706.s0,given,81,85,O
DDI-DrugBank.d706.s0,with,87,90,O
DDI-DrugBank.d706.s0,beta-blocking,92,104,B-group
DDI-DrugBank.d706.s0,agents,106,111,I-group
DDI-DrugBank.d706.s0,.,112,112,O
DDI-DrugBank.d706.s1,Patients,0,7,O
DDI-DrugBank.d706.s1,treated,9,15,O
DDI-DrugBank.d706.s1,with,17,20,O
DDI-DrugBank.d706.s1,extended,22,29,O
DDI-DrugBank.d706.s1,release,31,37,O
DDI-DrugBank.d706.s1,metoprolol,39,48,B-drug
DDI-DrugBank.d706.s1,succinate,50,58,I-drug
DDI-DrugBank.d706.s1,plus,60,63,O
DDI-DrugBank.d706.s1,a,65,65,O
DDI-DrugBank.d706.s1,catecholamine,67,79,O
DDI-DrugBank.d706.s1,depletor,81,88,O
DDI-DrugBank.d706.s1,should,90,95,O
DDI-DrugBank.d706.s1,therefore,97,105,O
DDI-DrugBank.d706.s1,be,107,108,O
DDI-DrugBank.d706.s1,closely,110,116,O
DDI-DrugBank.d706.s1,observed,118,125,O
DDI-DrugBank.d706.s1,for,127,129,O
DDI-DrugBank.d706.s1,evidence,131,138,O
DDI-DrugBank.d706.s1,of,140,141,O
DDI-DrugBank.d706.s1,hypotension,143,153,O
DDI-DrugBank.d706.s1,or,155,156,O
DDI-DrugBank.d706.s1,marked,158,163,O
DDI-DrugBank.d706.s1,bradycardia,165,175,O
DDI-DrugBank.d706.s1,",",176,176,O
DDI-DrugBank.d706.s1,which,178,182,O
DDI-DrugBank.d706.s1,may,184,186,O
DDI-DrugBank.d706.s1,produce,188,194,O
DDI-DrugBank.d706.s1,vertigo,196,202,O
DDI-DrugBank.d706.s1,",",203,203,O
DDI-DrugBank.d706.s1,syncope,205,211,O
DDI-DrugBank.d706.s1,",",212,212,O
DDI-DrugBank.d706.s1,or,214,215,O
DDI-DrugBank.d706.s1,postural,217,224,O
DDI-DrugBank.d706.s1,hypotension,226,236,O
DDI-DrugBank.d706.s1,.,237,237,O
DDI-DrugBank.d715.s0,Caution,0,6,O
DDI-DrugBank.d715.s0,should,8,13,O
DDI-DrugBank.d715.s0,be,15,16,O
DDI-DrugBank.d715.s0,observed,18,25,O
DDI-DrugBank.d715.s0,in,27,28,O
DDI-DrugBank.d715.s0,administering,30,42,O
DDI-DrugBank.d715.s0,DEMSER,44,49,B-brand
DDI-DrugBank.d715.s0,to,51,52,O
DDI-DrugBank.d715.s0,patients,54,61,O
DDI-DrugBank.d715.s0,receiving,63,71,O
DDI-DrugBank.d715.s0,phenothiazines,73,86,B-group
DDI-DrugBank.d715.s0,or,88,89,O
DDI-DrugBank.d715.s0,haloperidol,91,101,B-drug
DDI-DrugBank.d715.s0,because,103,109,O
DDI-DrugBank.d715.s0,the,111,113,O
DDI-DrugBank.d715.s0,extrapyramidal,115,128,O
DDI-DrugBank.d715.s0,effects,130,136,O
DDI-DrugBank.d715.s0,of,138,139,O
DDI-DrugBank.d715.s0,these,141,145,O
DDI-DrugBank.d715.s0,drugs,147,151,O
DDI-DrugBank.d715.s0,can,153,155,O
DDI-DrugBank.d715.s0,be,157,158,O
DDI-DrugBank.d715.s0,expected,160,167,O
DDI-DrugBank.d715.s0,to,169,170,O
DDI-DrugBank.d715.s0,be,172,173,O
DDI-DrugBank.d715.s0,potentiated,175,185,O
DDI-DrugBank.d715.s0,by,187,188,O
DDI-DrugBank.d715.s0,inhibition,190,199,O
DDI-DrugBank.d715.s0,of,201,202,O
DDI-DrugBank.d715.s0,catecholamine,204,216,O
DDI-DrugBank.d715.s0,synthesis,218,226,O
DDI-DrugBank.d715.s0,.,227,227,O
DDI-DrugBank.d715.s1,Concurrent,0,9,O
DDI-DrugBank.d715.s1,use,11,13,O
DDI-DrugBank.d715.s1,of,15,16,O
DDI-DrugBank.d715.s1,DEMSER,18,23,B-brand
DDI-DrugBank.d715.s1,with,25,28,O
DDI-DrugBank.d715.s1,alcohol,30,36,B-drug
DDI-DrugBank.d715.s1,or,38,39,O
DDI-DrugBank.d715.s1,other,41,45,O
DDI-DrugBank.d715.s1,CNS,47,49,B-drug
DDI-DrugBank.d715.s1,depressants,51,61,I-drug
DDI-DrugBank.d715.s1,can,63,65,O
DDI-DrugBank.d715.s1,increase,67,74,O
DDI-DrugBank.d715.s1,their,76,80,O
DDI-DrugBank.d715.s1,sedative,82,89,O
DDI-DrugBank.d715.s1,effects,91,97,O
DDI-DrugBank.d715.s1,.,98,98,O
DDI-DrugBank.d640.s0,Diuretics,0,8,B-group
DDI-DrugBank.d640.s0,:,9,9,O
DDI-DrugBank.d640.s0,Excessive,11,19,O
DDI-DrugBank.d640.s0,reductions,21,30,O
DDI-DrugBank.d640.s0,in,32,33,O
DDI-DrugBank.d640.s0,blood,35,39,O
DDI-DrugBank.d640.s0,pressure,41,48,O
DDI-DrugBank.d640.s0,may,50,52,O
DDI-DrugBank.d640.s0,occur,54,58,O
DDI-DrugBank.d640.s0,in,60,61,O
DDI-DrugBank.d640.s0,patients,63,70,O
DDI-DrugBank.d640.s0,on,72,73,O
DDI-DrugBank.d640.s0,diuretic,75,82,O
DDI-DrugBank.d640.s0,therapy,84,90,O
DDI-DrugBank.d640.s0,when,92,95,O
DDI-DrugBank.d640.s0,ACE,97,99,B-group
DDI-DrugBank.d640.s0,inhibitors,101,110,I-group
DDI-DrugBank.d640.s0,are,112,114,O
DDI-DrugBank.d640.s0,started,116,122,O
DDI-DrugBank.d640.s0,.,123,123,O
DDI-DrugBank.d640.s1,The,0,2,O
DDI-DrugBank.d640.s1,possibility,4,14,O
DDI-DrugBank.d640.s1,of,16,17,O
DDI-DrugBank.d640.s1,hypotensive,19,29,O
DDI-DrugBank.d640.s1,effects,31,37,O
DDI-DrugBank.d640.s1,with,39,42,O
DDI-DrugBank.d640.s1,UNIVASC,44,50,B-brand
DDI-DrugBank.d640.s1,can,55,57,O
DDI-DrugBank.d640.s1,be,59,60,O
DDI-DrugBank.d640.s1,minimized,62,70,O
DDI-DrugBank.d640.s1,by,72,73,O
DDI-DrugBank.d640.s1,discontinuing,75,87,O
DDI-DrugBank.d640.s1,diuretic,89,96,O
DDI-DrugBank.d640.s1,therapy,98,104,O
DDI-DrugBank.d640.s1,for,106,108,O
DDI-DrugBank.d640.s1,several,110,116,O
DDI-DrugBank.d640.s1,days,118,121,O
DDI-DrugBank.d640.s1,or,123,124,O
DDI-DrugBank.d640.s1,cautiously,126,135,O
DDI-DrugBank.d640.s1,increasing,137,146,O
DDI-DrugBank.d640.s1,salt,148,151,O
DDI-DrugBank.d640.s1,intake,153,158,O
DDI-DrugBank.d640.s1,before,160,165,O
DDI-DrugBank.d640.s1,initiation,167,176,O
DDI-DrugBank.d640.s1,of,178,179,O
DDI-DrugBank.d640.s1,treatment,181,189,O
DDI-DrugBank.d640.s1,with,191,194,O
DDI-DrugBank.d640.s1,UNIVASC,196,202,B-brand
DDI-DrugBank.d640.s1,.,206,206,O
DDI-DrugBank.d640.s1,If,208,209,O
DDI-DrugBank.d640.s1,this,211,214,O
DDI-DrugBank.d640.s1,is,216,217,O
DDI-DrugBank.d640.s1,not,219,221,O
DDI-DrugBank.d640.s1,possible,223,230,O
DDI-DrugBank.d640.s1,",",231,231,O
DDI-DrugBank.d640.s1,the,233,235,O
DDI-DrugBank.d640.s1,starting,237,244,O
DDI-DrugBank.d640.s1,dose,246,249,O
DDI-DrugBank.d640.s1,of,251,252,O
DDI-DrugBank.d640.s1,moexpril,254,261,B-drug
DDI-DrugBank.d640.s1,should,263,268,O
DDI-DrugBank.d640.s1,be,270,271,O
DDI-DrugBank.d640.s1,reduced,273,279,O
DDI-DrugBank.d640.s1,..,280,281,O
DDI-DrugBank.d640.s2,Potassium,0,8,B-drug
DDI-DrugBank.d640.s2,Supplements,10,20,O
DDI-DrugBank.d640.s2,and,22,24,O
DDI-DrugBank.d640.s2,Potassium-Sparing,26,42,B-group
DDI-DrugBank.d640.s2,Diuretics,44,52,I-group
DDI-DrugBank.d640.s2,:,53,53,O
DDI-DrugBank.d640.s2,UNIVASC,55,61,B-brand
DDI-DrugBank.d640.s2,can,66,68,O
DDI-DrugBank.d640.s2,increase,70,77,O
DDI-DrugBank.d640.s2,serum,79,83,O
DDI-DrugBank.d640.s2,potassium,85,93,O
DDI-DrugBank.d640.s2,because,95,101,O
DDI-DrugBank.d640.s2,it,103,104,O
DDI-DrugBank.d640.s2,decreases,106,114,O
DDI-DrugBank.d640.s2,aldosterone,116,126,O
DDI-DrugBank.d640.s2,secretion,128,136,O
DDI-DrugBank.d640.s2,.,137,137,O
DDI-DrugBank.d640.s3,Use,0,2,O
DDI-DrugBank.d640.s3,of,4,5,O
DDI-DrugBank.d640.s3,potassium-sparing,7,23,B-group
DDI-DrugBank.d640.s3,diuretics,25,33,I-group
DDI-DrugBank.d640.s3,(,35,35,O
DDI-DrugBank.d640.s3,spironolactone,36,49,B-drug
DDI-DrugBank.d640.s3,",",50,50,O
DDI-DrugBank.d640.s3,triamterene,52,62,B-drug
DDI-DrugBank.d640.s3,",",63,63,O
DDI-DrugBank.d640.s3,amiloride,65,73,B-drug
DDI-DrugBank.d640.s3,),74,74,O
DDI-DrugBank.d640.s3,or,76,77,O
DDI-DrugBank.d640.s3,potassium,79,87,B-drug
DDI-DrugBank.d640.s3,supplements,89,99,O
DDI-DrugBank.d640.s3,concomitantly,101,113,O
DDI-DrugBank.d640.s3,with,115,118,O
DDI-DrugBank.d640.s3,ACE,120,122,B-group
DDI-DrugBank.d640.s3,inhibitors,124,133,I-group
DDI-DrugBank.d640.s3,can,135,137,O
DDI-DrugBank.d640.s3,increase,139,146,O
DDI-DrugBank.d640.s3,the,148,150,O
DDI-DrugBank.d640.s3,risk,152,155,O
DDI-DrugBank.d640.s3,of,157,158,O
DDI-DrugBank.d640.s3,hyperkalemia,160,171,O
DDI-DrugBank.d640.s3,.,172,172,O
DDI-DrugBank.d640.s4,Therefore,0,8,O
DDI-DrugBank.d640.s4,",",9,9,O
DDI-DrugBank.d640.s4,if,11,12,O
DDI-DrugBank.d640.s4,concomitant,14,24,O
DDI-DrugBank.d640.s4,use,26,28,O
DDI-DrugBank.d640.s4,of,30,31,O
DDI-DrugBank.d640.s4,such,33,36,O
DDI-DrugBank.d640.s4,agents,38,43,O
DDI-DrugBank.d640.s4,is,45,46,O
DDI-DrugBank.d640.s4,indicated,48,56,O
DDI-DrugBank.d640.s4,",",57,57,O
DDI-DrugBank.d640.s4,they,59,62,O
DDI-DrugBank.d640.s4,should,64,69,O
DDI-DrugBank.d640.s4,be,71,72,O
DDI-DrugBank.d640.s4,given,74,78,O
DDI-DrugBank.d640.s4,with,80,83,O
DDI-DrugBank.d640.s4,caution,85,91,O
DDI-DrugBank.d640.s4,and,93,95,O
DDI-DrugBank.d640.s4,the,97,99,O
DDI-DrugBank.d640.s4,patient,101,107,O
DDI-DrugBank.d640.s4,'s,108,109,O
DDI-DrugBank.d640.s4,serum,111,115,O
DDI-DrugBank.d640.s4,potassium,117,125,O
DDI-DrugBank.d640.s4,should,127,132,O
DDI-DrugBank.d640.s4,be,134,135,O
DDI-DrugBank.d640.s4,monitored,137,145,O
DDI-DrugBank.d640.s4,.,146,146,O
DDI-DrugBank.d640.s5,Oral,0,3,O
DDI-DrugBank.d640.s5,Anticoagulants,5,18,B-group
DDI-DrugBank.d640.s5,:,19,19,O
DDI-DrugBank.d640.s5,Interaction,21,31,O
DDI-DrugBank.d640.s5,studies,33,39,O
DDI-DrugBank.d640.s5,with,41,44,O
DDI-DrugBank.d640.s5,warfarin,46,53,B-drug
DDI-DrugBank.d640.s5,failed,55,60,O
DDI-DrugBank.d640.s5,to,62,63,O
DDI-DrugBank.d640.s5,identify,65,72,O
DDI-DrugBank.d640.s5,any,74,76,O
DDI-DrugBank.d640.s5,clinically,78,87,O
DDI-DrugBank.d640.s5,important,89,97,O
DDI-DrugBank.d640.s5,effect,99,104,O
DDI-DrugBank.d640.s5,on,106,107,O
DDI-DrugBank.d640.s5,the,109,111,O
DDI-DrugBank.d640.s5,serum,113,117,O
DDI-DrugBank.d640.s5,concentrations,119,132,O
DDI-DrugBank.d640.s5,of,134,135,O
DDI-DrugBank.d640.s5,the,137,139,O
DDI-DrugBank.d640.s5,anticoagulant,141,153,B-group
DDI-DrugBank.d640.s5,or,155,156,O
DDI-DrugBank.d640.s5,on,158,159,O
DDI-DrugBank.d640.s5,its,161,163,O
DDI-DrugBank.d640.s5,anticoagulant,165,177,O
DDI-DrugBank.d640.s5,effect,179,184,O
DDI-DrugBank.d640.s5,.,185,185,O
DDI-DrugBank.d640.s6,Lithium,0,6,B-drug
DDI-DrugBank.d640.s6,:,7,7,O
DDI-DrugBank.d640.s6,Increased,9,17,O
DDI-DrugBank.d640.s6,serum,19,23,O
DDI-DrugBank.d640.s6,lithium,25,31,B-drug
DDI-DrugBank.d640.s6,levels,33,38,O
DDI-DrugBank.d640.s6,and,40,42,O
DDI-DrugBank.d640.s6,symptoms,44,51,O
DDI-DrugBank.d640.s6,of,53,54,O
DDI-DrugBank.d640.s6,lithium,56,62,B-drug
DDI-DrugBank.d640.s6,toxicity,64,71,O
DDI-DrugBank.d640.s6,have,73,76,O
DDI-DrugBank.d640.s6,been,78,81,O
DDI-DrugBank.d640.s6,reported,83,90,O
DDI-DrugBank.d640.s6,in,92,93,O
DDI-DrugBank.d640.s6,patients,95,102,O
DDI-DrugBank.d640.s6,receiving,104,112,O
DDI-DrugBank.d640.s6,ACE,114,116,B-group
DDI-DrugBank.d640.s6,inhibitors,118,127,I-group
DDI-DrugBank.d640.s6,during,129,134,O
DDI-DrugBank.d640.s6,therapy,136,142,O
DDI-DrugBank.d640.s6,with,144,147,O
DDI-DrugBank.d640.s6,lithium,149,155,B-drug
DDI-DrugBank.d640.s6,.,156,156,O
DDI-DrugBank.d640.s7,These,0,4,O
DDI-DrugBank.d640.s7,drugs,6,10,O
DDI-DrugBank.d640.s7,should,12,17,O
DDI-DrugBank.d640.s7,be,19,20,O
DDI-DrugBank.d640.s7,coadministered,22,35,O
DDI-DrugBank.d640.s7,with,37,40,O
DDI-DrugBank.d640.s7,caution,42,48,O
DDI-DrugBank.d640.s7,",",49,49,O
DDI-DrugBank.d640.s7,and,51,53,O
DDI-DrugBank.d640.s7,frequent,55,62,O
DDI-DrugBank.d640.s7,monitoring,64,73,O
DDI-DrugBank.d640.s7,of,75,76,O
DDI-DrugBank.d640.s7,serum,78,82,O
DDI-DrugBank.d640.s7,lithium,84,90,B-drug
DDI-DrugBank.d640.s7,levels,92,97,O
DDI-DrugBank.d640.s7,is,99,100,O
DDI-DrugBank.d640.s7,recommended,102,112,O
DDI-DrugBank.d640.s7,.,113,113,O
DDI-DrugBank.d640.s8,If,0,1,O
DDI-DrugBank.d640.s8,a,3,3,O
DDI-DrugBank.d640.s8,diuretic,5,12,B-group
DDI-DrugBank.d640.s8,is,14,15,O
DDI-DrugBank.d640.s8,also,17,20,O
DDI-DrugBank.d640.s8,used,22,25,O
DDI-DrugBank.d640.s8,",",26,26,O
DDI-DrugBank.d640.s8,the,28,30,O
DDI-DrugBank.d640.s8,risk,32,35,O
DDI-DrugBank.d640.s8,of,37,38,O
DDI-DrugBank.d640.s8,lithium,40,46,B-drug
DDI-DrugBank.d640.s8,toxicity,48,55,O
DDI-DrugBank.d640.s8,may,57,59,O
DDI-DrugBank.d640.s8,be,61,62,O
DDI-DrugBank.d640.s8,increased,64,72,O
DDI-DrugBank.d640.s8,.,73,73,O
DDI-DrugBank.d640.s9,Other,0,4,O
DDI-DrugBank.d640.s9,Agents,6,11,O
DDI-DrugBank.d640.s9,:,12,12,O
DDI-DrugBank.d640.s9,No,14,15,O
DDI-DrugBank.d640.s9,clinically,17,26,O
DDI-DrugBank.d640.s9,important,28,36,O
DDI-DrugBank.d640.s9,pharmacokinetic,38,52,O
DDI-DrugBank.d640.s9,interactions,54,65,O
DDI-DrugBank.d640.s9,occurred,67,74,O
DDI-DrugBank.d640.s9,when,76,79,O
DDI-DrugBank.d640.s9,UNIVASC,81,87,B-brand
DDI-DrugBank.d640.s9,was,92,94,O
DDI-DrugBank.d640.s9,administered,96,107,O
DDI-DrugBank.d640.s9,concomitantly,109,121,O
DDI-DrugBank.d640.s9,with,123,126,O
DDI-DrugBank.d640.s9,hydrochlorothiazide,128,146,B-drug
DDI-DrugBank.d640.s9,",",147,147,O
DDI-DrugBank.d640.s9,digoxin,149,155,B-drug
DDI-DrugBank.d640.s9,",",156,156,O
DDI-DrugBank.d640.s9,or,158,159,O
DDI-DrugBank.d640.s9,cimetidine,161,170,B-drug
DDI-DrugBank.d640.s9,.,171,171,O
DDI-DrugBank.d640.s10,UNIVASC,0,6,B-brand
DDI-DrugBank.d640.s10,has,11,13,O
DDI-DrugBank.d640.s10,been,15,18,O
DDI-DrugBank.d640.s10,used,20,23,O
DDI-DrugBank.d640.s10,in,25,26,O
DDI-DrugBank.d640.s10,clinical,28,35,O
DDI-DrugBank.d640.s10,trials,37,42,O
DDI-DrugBank.d640.s10,concomitantly,44,56,O
DDI-DrugBank.d640.s10,with,58,61,O
DDI-DrugBank.d640.s10,calcium-channel-blocking,63,86,B-group
DDI-DrugBank.d640.s10,agents,88,93,I-group
DDI-DrugBank.d640.s10,",",94,94,O
DDI-DrugBank.d640.s10,diuretics,96,104,B-group
DDI-DrugBank.d640.s10,",",105,105,O
DDI-DrugBank.d640.s10,H2,107,108,B-group
DDI-DrugBank.d640.s10,blockers,110,117,I-group
DDI-DrugBank.d640.s10,",",118,118,O
DDI-DrugBank.d640.s10,digoxin,120,126,B-drug
DDI-DrugBank.d640.s10,",",127,127,O
DDI-DrugBank.d640.s10,oral,129,132,O
DDI-DrugBank.d640.s10,hypoglycemic,134,145,B-group
DDI-DrugBank.d640.s10,agents,147,152,I-group
DDI-DrugBank.d640.s10,",",153,153,O
DDI-DrugBank.d640.s10,and,155,157,O
DDI-DrugBank.d640.s10,cholesterol-lowering,159,178,O
DDI-DrugBank.d640.s10,agents,180,185,O
DDI-DrugBank.d640.s10,.,186,186,O
DDI-DrugBank.d640.s11,There,0,4,O
DDI-DrugBank.d640.s11,was,6,8,O
DDI-DrugBank.d640.s11,no,10,11,O
DDI-DrugBank.d640.s11,evidence,13,20,O
DDI-DrugBank.d640.s11,of,22,23,O
DDI-DrugBank.d640.s11,clinically,25,34,O
DDI-DrugBank.d640.s11,important,36,44,O
DDI-DrugBank.d640.s11,adverse,46,52,O
DDI-DrugBank.d640.s11,interactions,54,65,O
DDI-DrugBank.d640.s11,.,66,66,O
DDI-DrugBank.d580.s0,In,0,1,O
DDI-DrugBank.d580.s0,clinical,3,10,O
DDI-DrugBank.d580.s0,studies,12,18,O
DDI-DrugBank.d580.s0,",",19,19,O
DDI-DrugBank.d580.s0,the,21,23,O
DDI-DrugBank.d580.s0,concurrent,25,34,O
DDI-DrugBank.d580.s0,administration,36,49,O
DDI-DrugBank.d580.s0,of,51,52,O
DDI-DrugBank.d580.s0,the,54,56,O
DDI-DrugBank.d580.s0,ASMANEX,58,64,B-brand
DDI-DrugBank.d580.s0,TWISTHALER,66,75,I-brand
DDI-DrugBank.d580.s0,inhaler,80,86,O
DDI-DrugBank.d580.s0,and,88,90,O
DDI-DrugBank.d580.s0,other,92,96,O
DDI-DrugBank.d580.s0,drugs,98,102,O
DDI-DrugBank.d580.s0,commonly,104,111,O
DDI-DrugBank.d580.s0,used,113,116,O
DDI-DrugBank.d580.s0,in,118,119,O
DDI-DrugBank.d580.s0,the,121,123,O
DDI-DrugBank.d580.s0,treatment,125,133,O
DDI-DrugBank.d580.s0,of,135,136,O
DDI-DrugBank.d580.s0,asthma,138,143,O
DDI-DrugBank.d580.s0,was,145,147,O
DDI-DrugBank.d580.s0,not,149,151,O
DDI-DrugBank.d580.s0,associated,153,162,O
DDI-DrugBank.d580.s0,with,164,167,O
DDI-DrugBank.d580.s0,any,169,171,O
DDI-DrugBank.d580.s0,unusual,173,179,O
DDI-DrugBank.d580.s0,adverse,181,187,O
DDI-DrugBank.d580.s0,events,189,194,O
DDI-DrugBank.d580.s0,.,195,195,O
DDI-DrugBank.d580.s1,However,0,6,O
DDI-DrugBank.d580.s1,",",7,7,O
DDI-DrugBank.d580.s1,ketoconazole,9,20,B-drug
DDI-DrugBank.d580.s1,",",21,21,O
DDI-DrugBank.d580.s1,a,23,23,O
DDI-DrugBank.d580.s1,potent,25,30,O
DDI-DrugBank.d580.s1,inhibitor,32,40,O
DDI-DrugBank.d580.s1,of,42,43,O
DDI-DrugBank.d580.s1,cytochrome,45,54,O
DDI-DrugBank.d580.s1,P450,56,59,O
DDI-DrugBank.d580.s1,3A4,61,63,O
DDI-DrugBank.d580.s1,",",64,64,O
DDI-DrugBank.d580.s1,may,66,68,O
DDI-DrugBank.d580.s1,increase,70,77,O
DDI-DrugBank.d580.s1,plasma,79,84,O
DDI-DrugBank.d580.s1,levels,86,91,O
DDI-DrugBank.d580.s1,of,93,94,O
DDI-DrugBank.d580.s1,mometasone,96,105,B-drug
DDI-DrugBank.d580.s1,furoate,107,113,I-drug
DDI-DrugBank.d580.s1,during,115,120,O
DDI-DrugBank.d580.s1,concomitant,122,132,O
DDI-DrugBank.d580.s1,dosing,134,139,O
DDI-DrugBank.d580.s1,.,140,140,O
DDI-DrugBank.d739.s0,Montelukast,0,10,B-drug
DDI-DrugBank.d739.s0,at,12,13,O
DDI-DrugBank.d739.s0,a,15,15,O
DDI-DrugBank.d739.s0,Dose,17,20,O
DDI-DrugBank.d739.s0,of,22,23,O
DDI-DrugBank.d739.s0,10,25,26,O
DDI-DrugBank.d739.s0,mg,28,29,O
DDI-DrugBank.d739.s0,Once,31,34,O
DDI-DrugBank.d739.s0,Daily,36,40,O
DDI-DrugBank.d739.s0,Dosed,42,46,O
DDI-DrugBank.d739.s0,to,48,49,O
DDI-DrugBank.d739.s0,Pharmacokinetic,51,65,O
DDI-DrugBank.d739.s0,Steady,67,72,O
DDI-DrugBank.d739.s0,State,74,78,O
DDI-DrugBank.d739.s0,-,81,81,O
DDI-DrugBank.d739.s0,did,83,85,O
DDI-DrugBank.d739.s0,not,87,89,O
DDI-DrugBank.d739.s0,cause,91,95,O
DDI-DrugBank.d739.s0,clinically,97,106,O
DDI-DrugBank.d739.s0,significant,108,118,O
DDI-DrugBank.d739.s0,changes,120,126,O
DDI-DrugBank.d739.s0,in,128,129,O
DDI-DrugBank.d739.s0,the,131,133,O
DDI-DrugBank.d739.s0,kinetics,135,142,O
DDI-DrugBank.d739.s0,of,144,145,O
DDI-DrugBank.d739.s0,a,147,147,O
DDI-DrugBank.d739.s0,single,149,154,O
DDI-DrugBank.d739.s0,intravenous,156,166,O
DDI-DrugBank.d739.s0,dose,168,171,O
DDI-DrugBank.d739.s0,of,173,174,O
DDI-DrugBank.d739.s0,theophylline,176,187,B-drug
DDI-DrugBank.d739.s0,(,189,189,O
DDI-DrugBank.d739.s0,predominantly,190,202,O
DDI-DrugBank.d739.s0,a,204,204,O
DDI-DrugBank.d739.s0,cytochrome,206,215,O
DDI-DrugBank.d739.s0,P450,217,220,O
DDI-DrugBank.d739.s0,1A2,222,224,O
DDI-DrugBank.d739.s0,substrate,226,234,O
DDI-DrugBank.d739.s0,),235,235,O
DDI-DrugBank.d739.s0,.,236,236,O
DDI-DrugBank.d739.s1,-,0,0,O
DDI-DrugBank.d739.s1,did,2,4,O
DDI-DrugBank.d739.s1,not,6,8,O
DDI-DrugBank.d739.s1,change,10,15,O
DDI-DrugBank.d739.s1,the,17,19,O
DDI-DrugBank.d739.s1,pharmacokinetic,21,35,O
DDI-DrugBank.d739.s1,profile,37,43,O
DDI-DrugBank.d739.s1,of,45,46,O
DDI-DrugBank.d739.s1,warfarin,48,55,B-drug
DDI-DrugBank.d739.s1,(,57,57,O
DDI-DrugBank.d739.s1,a,58,58,O
DDI-DrugBank.d739.s1,substrate,60,68,O
DDI-DrugBank.d739.s1,of,70,71,O
DDI-DrugBank.d739.s1,cytochromes,73,83,O
DDI-DrugBank.d739.s1,P450,85,88,O
DDI-DrugBank.d739.s1,2A6,90,92,O
DDI-DrugBank.d739.s1,and,94,96,O
DDI-DrugBank.d739.s1,2C9,98,100,O
DDI-DrugBank.d739.s1,),101,101,O
DDI-DrugBank.d739.s1,or,103,104,O
DDI-DrugBank.d739.s1,influence,106,114,O
DDI-DrugBank.d739.s1,the,116,118,O
DDI-DrugBank.d739.s1,effect,120,125,O
DDI-DrugBank.d739.s1,of,127,128,O
DDI-DrugBank.d739.s1,a,130,130,O
DDI-DrugBank.d739.s1,single,132,137,O
DDI-DrugBank.d739.s1,30-mg,139,143,O
DDI-DrugBank.d739.s1,oral,145,148,O
DDI-DrugBank.d739.s1,dose,150,153,O
DDI-DrugBank.d739.s1,of,155,156,O
DDI-DrugBank.d739.s1,warfarin,158,165,B-drug
DDI-DrugBank.d739.s1,on,167,168,O
DDI-DrugBank.d739.s1,prothrombin,170,180,O
DDI-DrugBank.d739.s1,time,182,185,O
DDI-DrugBank.d739.s1,or,187,188,O
DDI-DrugBank.d739.s1,the,190,192,O
DDI-DrugBank.d739.s1,INR,194,196,O
DDI-DrugBank.d739.s1,(,198,198,O
DDI-DrugBank.d739.s1,International,199,211,O
DDI-DrugBank.d739.s1,Normalized,213,222,O
DDI-DrugBank.d739.s1,Ratio,224,228,O
DDI-DrugBank.d739.s1,),229,229,O
DDI-DrugBank.d739.s1,.,230,230,O
DDI-DrugBank.d739.s2,-,0,0,O
DDI-DrugBank.d739.s2,did,2,4,O
DDI-DrugBank.d739.s2,not,6,8,O
DDI-DrugBank.d739.s2,change,10,15,O
DDI-DrugBank.d739.s2,the,17,19,O
DDI-DrugBank.d739.s2,pharmacokinetic,21,35,O
DDI-DrugBank.d739.s2,profile,37,43,O
DDI-DrugBank.d739.s2,or,45,46,O
DDI-DrugBank.d739.s2,urinary,48,54,O
DDI-DrugBank.d739.s2,excretion,56,64,O
DDI-DrugBank.d739.s2,of,66,67,O
DDI-DrugBank.d739.s2,immunoreactive,69,82,O
DDI-DrugBank.d739.s2,digoxin,84,90,B-drug
DDI-DrugBank.d739.s2,.,91,91,O
DDI-DrugBank.d739.s3,-,0,0,O
DDI-DrugBank.d739.s3,did,2,4,O
DDI-DrugBank.d739.s3,not,6,8,O
DDI-DrugBank.d739.s3,change,10,15,O
DDI-DrugBank.d739.s3,the,17,19,O
DDI-DrugBank.d739.s3,plasma,21,26,O
DDI-DrugBank.d739.s3,concentration,28,40,O
DDI-DrugBank.d739.s3,profile,42,48,O
DDI-DrugBank.d739.s3,of,50,51,O
DDI-DrugBank.d739.s3,terfenadine,53,63,B-drug
DDI-DrugBank.d739.s3,(,65,65,O
DDI-DrugBank.d739.s3,a,66,66,O
DDI-DrugBank.d739.s3,substrate,68,76,O
DDI-DrugBank.d739.s3,of,78,79,O
DDI-DrugBank.d739.s3,cytochrome,81,90,O
DDI-DrugBank.d739.s3,P450,92,95,O
DDI-DrugBank.d739.s3,3A4,97,99,O
DDI-DrugBank.d739.s3,),100,100,O
DDI-DrugBank.d739.s3,or,102,103,O
DDI-DrugBank.d739.s3,fexofenadine,105,116,B-drug
DDI-DrugBank.d739.s3,",",117,117,O
DDI-DrugBank.d739.s3,its,119,121,O
DDI-DrugBank.d739.s3,carboxylated,123,134,O
DDI-DrugBank.d739.s3,metabolite,136,145,O
DDI-DrugBank.d739.s3,",",146,146,O
DDI-DrugBank.d739.s3,and,148,150,O
DDI-DrugBank.d739.s3,did,152,154,O
DDI-DrugBank.d739.s3,not,156,158,O
DDI-DrugBank.d739.s3,prolong,160,166,O
DDI-DrugBank.d739.s3,the,168,170,O
DDI-DrugBank.d739.s3,QTc,172,174,O
DDI-DrugBank.d739.s3,interval,176,183,O
DDI-DrugBank.d739.s3,following,185,193,O
DDI-DrugBank.d739.s3,co-administration,195,211,O
DDI-DrugBank.d739.s3,with,213,216,O
DDI-DrugBank.d739.s3,terfenadine,218,228,B-drug
DDI-DrugBank.d739.s3,60,230,231,O
DDI-DrugBank.d739.s3,mg,233,234,O
DDI-DrugBank.d739.s3,twice,236,240,O
DDI-DrugBank.d739.s3,daily,242,246,O
DDI-DrugBank.d739.s3,.,247,247,O
DDI-DrugBank.d739.s4,Montelukast,0,10,B-drug
DDI-DrugBank.d739.s4,at,12,13,O
DDI-DrugBank.d739.s4,Doses,15,19,O
DDI-DrugBank.d739.s4,of,21,22,O
DDI-DrugBank.d739.s4,100,27,29,O
DDI-DrugBank.d739.s4,mg,31,32,O
DDI-DrugBank.d739.s4,Daily,34,38,O
DDI-DrugBank.d739.s4,Dosed,40,44,O
DDI-DrugBank.d739.s4,to,46,47,O
DDI-DrugBank.d739.s4,Pharmacokinetic,49,63,O
DDI-DrugBank.d739.s4,Steady,65,70,O
DDI-DrugBank.d739.s4,State,72,76,O
DDI-DrugBank.d739.s4,:,77,77,O
DDI-DrugBank.d739.s4,-,80,80,O
DDI-DrugBank.d739.s4,did,82,84,O
DDI-DrugBank.d739.s4,not,86,88,O
DDI-DrugBank.d739.s4,significantly,90,102,O
DDI-DrugBank.d739.s4,alter,104,108,O
DDI-DrugBank.d739.s4,the,110,112,O
DDI-DrugBank.d739.s4,plasma,114,119,O
DDI-DrugBank.d739.s4,concentrations,121,134,O
DDI-DrugBank.d739.s4,of,136,137,O
DDI-DrugBank.d739.s4,either,139,144,O
DDI-DrugBank.d739.s4,component,146,154,O
DDI-DrugBank.d739.s4,of,156,157,O
DDI-DrugBank.d739.s4,an,159,160,O
DDI-DrugBank.d739.s4,oral,162,165,O
DDI-DrugBank.d739.s4,contraceptive,167,179,B-group
DDI-DrugBank.d739.s4,containing,181,190,O
DDI-DrugBank.d739.s4,norethindrone,192,204,B-drug
DDI-DrugBank.d739.s4,1,206,206,O
DDI-DrugBank.d739.s4,mg/ethinyl,208,217,O
DDI-DrugBank.d739.s4,estradiol,219,227,B-drug
DDI-DrugBank.d739.s4,35,229,230,O
DDI-DrugBank.d739.s4,mcg,232,234,O
DDI-DrugBank.d739.s4,.,235,235,O
DDI-DrugBank.d739.s5,-,0,0,O
DDI-DrugBank.d739.s5,did,2,4,O
DDI-DrugBank.d739.s5,not,6,8,O
DDI-DrugBank.d739.s5,cause,10,14,O
DDI-DrugBank.d739.s5,any,16,18,O
DDI-DrugBank.d739.s5,clinically,20,29,O
DDI-DrugBank.d739.s5,significant,31,41,O
DDI-DrugBank.d739.s5,change,43,48,O
DDI-DrugBank.d739.s5,in,50,51,O
DDI-DrugBank.d739.s5,plasma,53,58,O
DDI-DrugBank.d739.s5,profiles,60,67,O
DDI-DrugBank.d739.s5,of,69,70,O
DDI-DrugBank.d739.s5,prednisone,72,81,B-drug
DDI-DrugBank.d739.s5,or,83,84,O
DDI-DrugBank.d739.s5,prednisolone,86,97,B-drug
DDI-DrugBank.d739.s5,following,99,107,O
DDI-DrugBank.d739.s5,administration,109,122,O
DDI-DrugBank.d739.s5,of,124,125,O
DDI-DrugBank.d739.s5,either,127,132,O
DDI-DrugBank.d739.s5,oral,134,137,O
DDI-DrugBank.d739.s5,prednisone,139,148,B-drug
DDI-DrugBank.d739.s5,or,150,151,O
DDI-DrugBank.d739.s5,intravenous,153,163,O
DDI-DrugBank.d739.s5,prednisolone,165,176,B-drug
DDI-DrugBank.d739.s5,.,177,177,O
DDI-DrugBank.d739.s6,Phenobarbital,0,12,B-drug
DDI-DrugBank.d739.s6,",",13,13,O
DDI-DrugBank.d739.s6,which,15,19,O
DDI-DrugBank.d739.s6,induces,21,27,O
DDI-DrugBank.d739.s6,hepatic,29,35,O
DDI-DrugBank.d739.s6,metabolism,37,46,O
DDI-DrugBank.d739.s6,",",47,47,O
DDI-DrugBank.d739.s6,decreased,49,57,O
DDI-DrugBank.d739.s6,the,59,61,O
DDI-DrugBank.d739.s6,AUC,63,65,O
DDI-DrugBank.d739.s6,of,67,68,O
DDI-DrugBank.d739.s6,montelukast,70,80,B-drug
DDI-DrugBank.d739.s6,approximately,82,94,O
DDI-DrugBank.d739.s6,40,96,97,O
DDI-DrugBank.d739.s6,%,98,98,O
DDI-DrugBank.d739.s6,following,100,108,O
DDI-DrugBank.d739.s6,a,110,110,O
DDI-DrugBank.d739.s6,single,112,117,O
DDI-DrugBank.d739.s6,10-mg,119,123,O
DDI-DrugBank.d739.s6,dose,125,128,O
DDI-DrugBank.d739.s6,of,130,131,O
DDI-DrugBank.d739.s6,montelukast,133,143,B-drug
DDI-DrugBank.d739.s6,.,144,144,O
DDI-DrugBank.d739.s7,No,0,1,O
DDI-DrugBank.d739.s7,dosage,3,8,O
DDI-DrugBank.d739.s7,adjustment,10,19,O
DDI-DrugBank.d739.s7,for,21,23,O
DDI-DrugBank.d739.s7,montelukast,25,35,B-drug
DDI-DrugBank.d739.s7,is,37,38,O
DDI-DrugBank.d739.s7,recommended,40,50,O
DDI-DrugBank.d739.s7,.,51,51,O
DDI-DrugBank.d739.s8,It,0,1,O
DDI-DrugBank.d739.s8,is,3,4,O
DDI-DrugBank.d739.s8,reasonable,6,15,O
DDI-DrugBank.d739.s8,to,17,18,O
DDI-DrugBank.d739.s8,employ,20,25,O
DDI-DrugBank.d739.s8,appropriate,27,37,O
DDI-DrugBank.d739.s8,clinical,39,46,O
DDI-DrugBank.d739.s8,monitoring,48,57,O
DDI-DrugBank.d739.s8,when,59,62,O
DDI-DrugBank.d739.s8,potent,64,69,O
DDI-DrugBank.d739.s8,cytochrome,71,80,O
DDI-DrugBank.d739.s8,P450,82,85,O
DDI-DrugBank.d739.s8,enzyme,87,92,O
DDI-DrugBank.d739.s8,inducers,94,101,O
DDI-DrugBank.d739.s8,",",102,102,O
DDI-DrugBank.d739.s8,such,104,107,O
DDI-DrugBank.d739.s8,as,109,110,O
DDI-DrugBank.d739.s8,phenobarbital,112,124,B-drug
DDI-DrugBank.d739.s8,or,126,127,O
DDI-DrugBank.d739.s8,rifampin,129,136,B-drug
DDI-DrugBank.d739.s8,",",137,137,O
DDI-DrugBank.d739.s8,are,139,141,O
DDI-DrugBank.d739.s8,co-administered,143,157,O
DDI-DrugBank.d739.s8,with,159,162,O
DDI-DrugBank.d739.s8,montelukast,164,174,B-drug
DDI-DrugBank.d739.s8,.,175,175,O
DDI-DrugBank.d739.s9,Montelukast,0,10,B-drug
DDI-DrugBank.d739.s9,has,12,14,O
DDI-DrugBank.d739.s9,been,16,19,O
DDI-DrugBank.d739.s9,administered,21,32,O
DDI-DrugBank.d739.s9,with,34,37,O
DDI-DrugBank.d739.s9,other,39,43,O
DDI-DrugBank.d739.s9,therapies,45,53,O
DDI-DrugBank.d739.s9,routinely,55,63,O
DDI-DrugBank.d739.s9,used,65,68,O
DDI-DrugBank.d739.s9,in,70,71,O
DDI-DrugBank.d739.s9,the,73,75,O
DDI-DrugBank.d739.s9,prophylaxis,77,87,O
DDI-DrugBank.d739.s9,and,89,91,O
DDI-DrugBank.d739.s9,chronic,93,99,O
DDI-DrugBank.d739.s9,treatment,101,109,O
DDI-DrugBank.d739.s9,of,111,112,O
DDI-DrugBank.d739.s9,asthma,114,119,O
DDI-DrugBank.d739.s9,with,121,124,O
DDI-DrugBank.d739.s9,no,126,127,O
DDI-DrugBank.d739.s9,apparent,129,136,O
DDI-DrugBank.d739.s9,increase,138,145,O
DDI-DrugBank.d739.s9,in,147,148,O
DDI-DrugBank.d739.s9,adverse,150,156,O
DDI-DrugBank.d739.s9,reactions,158,166,O
DDI-DrugBank.d739.s9,.,167,167,O
DDI-DrugBank.d739.s10,In,0,1,O
DDI-DrugBank.d739.s10,drug-interaction,3,18,O
DDI-DrugBank.d739.s10,studies,20,26,O
DDI-DrugBank.d739.s10,",",27,27,O
DDI-DrugBank.d739.s10,the,29,31,O
DDI-DrugBank.d739.s10,recommended,33,43,O
DDI-DrugBank.d739.s10,clinical,45,52,O
DDI-DrugBank.d739.s10,dose,54,57,O
DDI-DrugBank.d739.s10,of,59,60,O
DDI-DrugBank.d739.s10,montelukast,62,72,B-drug
DDI-DrugBank.d739.s10,did,74,76,O
DDI-DrugBank.d739.s10,not,78,80,O
DDI-DrugBank.d739.s10,have,82,85,O
DDI-DrugBank.d739.s10,clinically,87,96,O
DDI-DrugBank.d739.s10,important,98,106,O
DDI-DrugBank.d739.s10,effects,108,114,O
DDI-DrugBank.d739.s10,on,116,117,O
DDI-DrugBank.d739.s10,the,119,121,O
DDI-DrugBank.d739.s10,pharmacokinetics,123,138,O
DDI-DrugBank.d739.s10,of,140,141,O
DDI-DrugBank.d739.s10,the,143,145,O
DDI-DrugBank.d739.s10,following,147,155,O
DDI-DrugBank.d739.s10,drugs,157,161,O
DDI-DrugBank.d739.s10,:,162,162,O
DDI-DrugBank.d739.s10,theophylline,164,175,B-drug
DDI-DrugBank.d739.s10,",",176,176,O
DDI-DrugBank.d739.s10,prednisone,178,187,B-drug
DDI-DrugBank.d739.s10,",",188,188,O
DDI-DrugBank.d739.s10,prednisolone,190,201,B-drug
DDI-DrugBank.d739.s10,",",202,202,O
DDI-DrugBank.d739.s10,oral,204,207,O
DDI-DrugBank.d739.s10,contraceptives,209,222,B-group
DDI-DrugBank.d739.s10,(,224,224,O
DDI-DrugBank.d739.s10,norethindrone,225,237,B-drug
DDI-DrugBank.d739.s10,1,239,239,O
DDI-DrugBank.d739.s10,mg/ethinyl,241,250,O
DDI-DrugBank.d739.s10,estradiol,252,260,I-drug
DDI-DrugBank.d739.s10,35,262,263,O
DDI-DrugBank.d739.s10,mcg,265,267,O
DDI-DrugBank.d739.s10,),268,268,O
DDI-DrugBank.d739.s10,",",269,269,O
DDI-DrugBank.d739.s10,terfenadine,271,281,B-drug
DDI-DrugBank.d739.s10,",",282,282,O
DDI-DrugBank.d739.s10,digoxin,284,290,B-drug
DDI-DrugBank.d739.s10,",",291,291,O
DDI-DrugBank.d739.s10,and,293,295,O
DDI-DrugBank.d739.s10,warfarin,297,304,B-drug
DDI-DrugBank.d739.s10,.,305,305,O
DDI-DrugBank.d739.s11,Although,0,7,O
DDI-DrugBank.d739.s11,additional,9,18,O
DDI-DrugBank.d739.s11,specific,20,27,O
DDI-DrugBank.d739.s11,interaction,29,39,O
DDI-DrugBank.d739.s11,studies,41,47,O
DDI-DrugBank.d739.s11,were,49,52,O
DDI-DrugBank.d739.s11,not,54,56,O
DDI-DrugBank.d739.s11,performed,58,66,O
DDI-DrugBank.d739.s11,",",67,67,O
DDI-DrugBank.d739.s11,montelukast,69,79,B-drug
DDI-DrugBank.d739.s11,was,81,83,O
DDI-DrugBank.d739.s11,used,85,88,O
DDI-DrugBank.d739.s11,concomitantly,90,102,O
DDI-DrugBank.d739.s11,with,104,107,O
DDI-DrugBank.d739.s11,a,109,109,O
DDI-DrugBank.d739.s11,wide,111,114,O
DDI-DrugBank.d739.s11,range,116,120,O
DDI-DrugBank.d739.s11,of,122,123,O
DDI-DrugBank.d739.s11,commonly,125,132,O
DDI-DrugBank.d739.s11,prescribed,134,143,O
DDI-DrugBank.d739.s11,drugs,145,149,O
DDI-DrugBank.d739.s11,in,151,152,O
DDI-DrugBank.d739.s11,clinical,154,161,O
DDI-DrugBank.d739.s11,studies,163,169,O
DDI-DrugBank.d739.s11,without,171,177,O
DDI-DrugBank.d739.s11,evidence,179,186,O
DDI-DrugBank.d739.s11,of,188,189,O
DDI-DrugBank.d739.s11,clinical,191,198,O
DDI-DrugBank.d739.s11,adverse,200,206,O
DDI-DrugBank.d739.s11,interactions,208,219,O
DDI-DrugBank.d739.s11,.,220,220,O
DDI-DrugBank.d739.s12,These,0,4,O
DDI-DrugBank.d739.s12,medications,6,16,O
DDI-DrugBank.d739.s12,included,18,25,O
DDI-DrugBank.d739.s12,thyroid,27,33,B-group
DDI-DrugBank.d739.s12,hormones,35,42,I-group
DDI-DrugBank.d739.s12,",",43,43,O
DDI-DrugBank.d739.s12,sedative,45,52,B-group
DDI-DrugBank.d739.s12,hypnotics,54,62,I-group
DDI-DrugBank.d739.s12,",",63,63,O
DDI-DrugBank.d739.s12,non-steroidal,65,77,B-group
DDI-DrugBank.d739.s12,anti-inflammatory,79,95,I-group
DDI-DrugBank.d739.s12,agents,97,102,I-group
DDI-DrugBank.d739.s12,",",103,103,O
DDI-DrugBank.d739.s12,benzodiazepines,105,119,B-group
DDI-DrugBank.d739.s12,",",120,120,O
DDI-DrugBank.d739.s12,and,122,124,O
DDI-DrugBank.d739.s12,decongestants,126,138,B-group
DDI-DrugBank.d739.s12,.,139,139,O
DDI-DrugBank.d739.s13,Phenobarbital,0,12,B-drug
DDI-DrugBank.d739.s13,",",13,13,O
DDI-DrugBank.d739.s13,which,15,19,O
DDI-DrugBank.d739.s13,induces,21,27,O
DDI-DrugBank.d739.s13,hepatic,29,35,O
DDI-DrugBank.d739.s13,metabolism,37,46,O
DDI-DrugBank.d739.s13,",",47,47,O
DDI-DrugBank.d739.s13,decreased,49,57,O
DDI-DrugBank.d739.s13,the,59,61,O
DDI-DrugBank.d739.s13,AUC,63,65,O
DDI-DrugBank.d739.s13,of,67,68,O
DDI-DrugBank.d739.s13,montelukast,70,80,B-drug
DDI-DrugBank.d739.s13,approximately,82,94,O
DDI-DrugBank.d739.s13,40,96,97,O
DDI-DrugBank.d739.s13,%,98,98,O
DDI-DrugBank.d739.s13,following,100,108,O
DDI-DrugBank.d739.s13,a,110,110,O
DDI-DrugBank.d739.s13,single,112,117,O
DDI-DrugBank.d739.s13,10-mg,119,123,O
DDI-DrugBank.d739.s13,dose,125,128,O
DDI-DrugBank.d739.s13,of,130,131,O
DDI-DrugBank.d739.s13,montelukast,133,143,B-drug
DDI-DrugBank.d739.s13,.,144,144,O
DDI-DrugBank.d739.s14,No,0,1,O
DDI-DrugBank.d739.s14,dosage,3,8,O
DDI-DrugBank.d739.s14,adjustment,10,19,O
DDI-DrugBank.d739.s14,for,21,23,O
DDI-DrugBank.d739.s14,montelukast,25,35,B-drug
DDI-DrugBank.d739.s14,is,37,38,O
DDI-DrugBank.d739.s14,recommended,40,50,O
DDI-DrugBank.d739.s14,.,51,51,O
DDI-DrugBank.d739.s15,It,0,1,O
DDI-DrugBank.d739.s15,is,3,4,O
DDI-DrugBank.d739.s15,reasonable,6,15,O
DDI-DrugBank.d739.s15,to,17,18,O
DDI-DrugBank.d739.s15,employ,20,25,O
DDI-DrugBank.d739.s15,appropriate,27,37,O
DDI-DrugBank.d739.s15,clinical,39,46,O
DDI-DrugBank.d739.s15,monitoring,48,57,O
DDI-DrugBank.d739.s15,when,59,62,O
DDI-DrugBank.d739.s15,potent,64,69,O
DDI-DrugBank.d739.s15,cytochrome,71,80,O
DDI-DrugBank.d739.s15,P450,82,85,O
DDI-DrugBank.d739.s15,enzyme,87,92,O
DDI-DrugBank.d739.s15,inducers,94,101,O
DDI-DrugBank.d739.s15,",",102,102,O
DDI-DrugBank.d739.s15,such,104,107,O
DDI-DrugBank.d739.s15,as,109,110,O
DDI-DrugBank.d739.s15,phenobarbital,112,124,B-drug
DDI-DrugBank.d739.s15,or,126,127,O
DDI-DrugBank.d739.s15,rifampin,129,136,B-drug
DDI-DrugBank.d739.s15,",",137,137,O
DDI-DrugBank.d739.s15,are,139,141,O
DDI-DrugBank.d739.s15,co-administered,143,157,O
DDI-DrugBank.d739.s15,with,159,162,O
DDI-DrugBank.d739.s15,montelukast,164,174,B-drug
DDI-DrugBank.d739.s15,.,175,175,O
DDI-DrugBank.d346.s0,Studies,0,6,O
DDI-DrugBank.d346.s0,to,8,9,O
DDI-DrugBank.d346.s0,evaluate,11,18,O
DDI-DrugBank.d346.s0,possible,20,27,O
DDI-DrugBank.d346.s0,interactions,29,40,O
DDI-DrugBank.d346.s0,between,42,48,O
DDI-DrugBank.d346.s0,REVIA,50,54,B-brand
DDI-DrugBank.d346.s0,and,56,58,O
DDI-DrugBank.d346.s0,drugs,60,64,O
DDI-DrugBank.d346.s0,other,66,70,O
DDI-DrugBank.d346.s0,than,72,75,O
DDI-DrugBank.d346.s0,opiates,77,83,B-group
DDI-DrugBank.d346.s0,have,85,88,O
DDI-DrugBank.d346.s0,not,90,92,O
DDI-DrugBank.d346.s0,been,94,97,O
DDI-DrugBank.d346.s0,performed,99,107,O
DDI-DrugBank.d346.s0,.,108,108,O
DDI-DrugBank.d346.s1,Consequently,0,11,O
DDI-DrugBank.d346.s1,",",12,12,O
DDI-DrugBank.d346.s1,caution,14,20,O
DDI-DrugBank.d346.s1,is,22,23,O
DDI-DrugBank.d346.s1,advised,25,31,O
DDI-DrugBank.d346.s1,if,33,34,O
DDI-DrugBank.d346.s1,the,36,38,O
DDI-DrugBank.d346.s1,concomitant,40,50,O
DDI-DrugBank.d346.s1,administration,52,65,O
DDI-DrugBank.d346.s1,of,67,68,O
DDI-DrugBank.d346.s1,REVIA,70,74,B-brand
DDI-DrugBank.d346.s1,and,76,78,O
DDI-DrugBank.d346.s1,other,80,84,O
DDI-DrugBank.d346.s1,drugs,86,90,O
DDI-DrugBank.d346.s1,is,92,93,O
DDI-DrugBank.d346.s1,required,95,102,O
DDI-DrugBank.d346.s1,.,103,103,O
DDI-DrugBank.d346.s2,The,0,2,O
DDI-DrugBank.d346.s2,safety,4,9,O
DDI-DrugBank.d346.s2,and,11,13,O
DDI-DrugBank.d346.s2,efficacy,15,22,O
DDI-DrugBank.d346.s2,of,24,25,O
DDI-DrugBank.d346.s2,concomitant,27,37,O
DDI-DrugBank.d346.s2,use,39,41,O
DDI-DrugBank.d346.s2,of,43,44,O
DDI-DrugBank.d346.s2,REVIA,46,50,B-brand
DDI-DrugBank.d346.s2,and,52,54,O
DDI-DrugBank.d346.s2,disulfiram,56,65,B-drug
DDI-DrugBank.d346.s2,is,67,68,O
DDI-DrugBank.d346.s2,unknown,70,76,O
DDI-DrugBank.d346.s2,",",77,77,O
DDI-DrugBank.d346.s2,and,79,81,O
DDI-DrugBank.d346.s2,the,83,85,O
DDI-DrugBank.d346.s2,concomitant,87,97,O
DDI-DrugBank.d346.s2,use,99,101,O
DDI-DrugBank.d346.s2,of,103,104,O
DDI-DrugBank.d346.s2,two,106,108,O
DDI-DrugBank.d346.s2,potentially,110,120,O
DDI-DrugBank.d346.s2,hepatotoxic,122,132,O
DDI-DrugBank.d346.s2,medications,134,144,O
DDI-DrugBank.d346.s2,is,146,147,O
DDI-DrugBank.d346.s2,not,149,151,O
DDI-DrugBank.d346.s2,ordinarily,153,162,O
DDI-DrugBank.d346.s2,recommended,164,174,O
DDI-DrugBank.d346.s2,unless,176,181,O
DDI-DrugBank.d346.s2,the,183,185,O
DDI-DrugBank.d346.s2,probable,187,194,O
DDI-DrugBank.d346.s2,benefits,196,203,O
DDI-DrugBank.d346.s2,outweigh,205,212,O
DDI-DrugBank.d346.s2,the,214,216,O
DDI-DrugBank.d346.s2,known,218,222,O
DDI-DrugBank.d346.s2,risks,224,228,O
DDI-DrugBank.d346.s2,.,229,229,O
DDI-DrugBank.d346.s3,Lethargy,0,7,O
DDI-DrugBank.d346.s3,and,9,11,O
DDI-DrugBank.d346.s3,somnolence,13,22,O
DDI-DrugBank.d346.s3,have,24,27,O
DDI-DrugBank.d346.s3,been,29,32,O
DDI-DrugBank.d346.s3,reported,34,41,O
DDI-DrugBank.d346.s3,following,43,51,O
DDI-DrugBank.d346.s3,doses,53,57,O
DDI-DrugBank.d346.s3,of,59,60,O
DDI-DrugBank.d346.s3,REVIA,62,66,B-brand
DDI-DrugBank.d346.s3,and,68,70,O
DDI-DrugBank.d346.s3,thioridazine,72,83,B-drug
DDI-DrugBank.d346.s3,.,84,84,O
DDI-DrugBank.d346.s4,Patients,0,7,O
DDI-DrugBank.d346.s4,taking,9,14,O
DDI-DrugBank.d346.s4,REVIA,16,20,B-brand
DDI-DrugBank.d346.s4,may,22,24,O
DDI-DrugBank.d346.s4,not,26,28,O
DDI-DrugBank.d346.s4,benefit,30,36,O
DDI-DrugBank.d346.s4,from,38,41,O
DDI-DrugBank.d346.s4,opioid,43,48,B-group
DDI-DrugBank.d346.s4,containing,50,59,O
DDI-DrugBank.d346.s4,medicines,61,69,O
DDI-DrugBank.d346.s4,",",70,70,O
DDI-DrugBank.d346.s4,such,72,75,O
DDI-DrugBank.d346.s4,as,77,78,O
DDI-DrugBank.d346.s4,cough,80,84,O
DDI-DrugBank.d346.s4,and,86,88,O
DDI-DrugBank.d346.s4,cold,90,93,O
DDI-DrugBank.d346.s4,preparations,95,106,O
DDI-DrugBank.d346.s4,",",107,107,O
DDI-DrugBank.d346.s4,antidiarrheal,109,121,O
DDI-DrugBank.d346.s4,preparations,123,134,O
DDI-DrugBank.d346.s4,",",135,135,O
DDI-DrugBank.d346.s4,and,137,139,O
DDI-DrugBank.d346.s4,opioid,141,146,B-group
DDI-DrugBank.d346.s4,analgesics,148,157,I-group
DDI-DrugBank.d346.s4,.,158,158,O
DDI-DrugBank.d346.s5,In,0,1,O
DDI-DrugBank.d346.s5,an,3,4,O
DDI-DrugBank.d346.s5,emergency,6,14,O
DDI-DrugBank.d346.s5,situation,16,24,O
DDI-DrugBank.d346.s5,when,26,29,O
DDI-DrugBank.d346.s5,opioid,31,36,O
DDI-DrugBank.d346.s5,analgesia,38,46,O
DDI-DrugBank.d346.s5,must,48,51,O
DDI-DrugBank.d346.s5,be,53,54,O
DDI-DrugBank.d346.s5,administered,56,67,O
DDI-DrugBank.d346.s5,to,69,70,O
DDI-DrugBank.d346.s5,a,72,72,O
DDI-DrugBank.d346.s5,patient,74,80,O
DDI-DrugBank.d346.s5,receiving,82,90,O
DDI-DrugBank.d346.s5,REVIA,92,96,B-brand
DDI-DrugBank.d346.s5,",",97,97,O
DDI-DrugBank.d346.s5,the,99,101,O
DDI-DrugBank.d346.s5,amount,103,108,O
DDI-DrugBank.d346.s5,of,110,111,O
DDI-DrugBank.d346.s5,opioid,113,118,B-group
DDI-DrugBank.d346.s5,required,120,127,O
DDI-DrugBank.d346.s5,may,129,131,O
DDI-DrugBank.d346.s5,be,133,134,O
DDI-DrugBank.d346.s5,greater,136,142,O
DDI-DrugBank.d346.s5,than,144,147,O
DDI-DrugBank.d346.s5,usual,149,153,O
DDI-DrugBank.d346.s5,",",154,154,O
DDI-DrugBank.d346.s5,and,156,158,O
DDI-DrugBank.d346.s5,the,160,162,O
DDI-DrugBank.d346.s5,resulting,164,172,O
DDI-DrugBank.d346.s5,respiratory,174,184,O
DDI-DrugBank.d346.s5,depression,186,195,O
DDI-DrugBank.d346.s5,may,197,199,O
DDI-DrugBank.d346.s5,be,201,202,O
DDI-DrugBank.d346.s5,deeper,204,209,O
DDI-DrugBank.d346.s5,and,211,213,O
DDI-DrugBank.d346.s5,more,215,218,O
DDI-DrugBank.d346.s5,prolonged,220,228,O
DDI-DrugBank.d346.s5,.,229,229,O
DDI-DrugBank.d14.s0,The,0,2,O
DDI-DrugBank.d14.s0,vasodilating,4,15,O
DDI-DrugBank.d14.s0,effects,17,23,O
DDI-DrugBank.d14.s0,of,25,26,O
DDI-DrugBank.d14.s0,nitroglycerin,28,40,B-drug
DDI-DrugBank.d14.s0,may,42,44,O
DDI-DrugBank.d14.s0,be,46,47,O
DDI-DrugBank.d14.s0,additive,49,56,O
DDI-DrugBank.d14.s0,with,58,61,O
DDI-DrugBank.d14.s0,those,63,67,O
DDI-DrugBank.d14.s0,of,69,70,O
DDI-DrugBank.d14.s0,other,72,76,O
DDI-DrugBank.d14.s0,vasodilators,78,89,B-group
DDI-DrugBank.d14.s0,.,90,90,O
DDI-DrugBank.d14.s1,Alcohol,0,6,B-drug
DDI-DrugBank.d14.s1,",",7,7,O
DDI-DrugBank.d14.s1,in,9,10,O
DDI-DrugBank.d14.s1,particular,12,21,O
DDI-DrugBank.d14.s1,",",22,22,O
DDI-DrugBank.d14.s1,has,24,26,O
DDI-DrugBank.d14.s1,been,28,31,O
DDI-DrugBank.d14.s1,found,33,37,O
DDI-DrugBank.d14.s1,to,39,40,O
DDI-DrugBank.d14.s1,exhibit,42,48,O
DDI-DrugBank.d14.s1,additive,50,57,O
DDI-DrugBank.d14.s1,effects,59,65,O
DDI-DrugBank.d14.s1,of,67,68,O
DDI-DrugBank.d14.s1,this,70,73,O
DDI-DrugBank.d14.s1,variety,75,81,O
DDI-DrugBank.d14.s1,.,82,82,O
DDI-DrugBank.d14.s2,Marked,0,5,O
DDI-DrugBank.d14.s2,symptomatic,7,17,O
DDI-DrugBank.d14.s2,orthostatic,19,29,O
DDI-DrugBank.d14.s2,hypotension,31,41,O
DDI-DrugBank.d14.s2,has,43,45,O
DDI-DrugBank.d14.s2,been,47,50,O
DDI-DrugBank.d14.s2,reported,52,59,O
DDI-DrugBank.d14.s2,when,61,64,O
DDI-DrugBank.d14.s2,calcium,66,72,B-group
DDI-DrugBank.d14.s2,channel,74,80,I-group
DDI-DrugBank.d14.s2,blockers,82,89,I-group
DDI-DrugBank.d14.s2,and,91,93,O
DDI-DrugBank.d14.s2,organic,95,101,O
DDI-DrugBank.d14.s2,nitrates,103,110,B-group
DDI-DrugBank.d14.s2,were,112,115,O
DDI-DrugBank.d14.s2,used,117,120,O
DDI-DrugBank.d14.s2,in,122,123,O
DDI-DrugBank.d14.s2,combination,125,135,O
DDI-DrugBank.d14.s2,.,136,136,O
DDI-DrugBank.d14.s3,Dose,0,3,O
DDI-DrugBank.d14.s3,adjustments,5,15,O
DDI-DrugBank.d14.s3,of,17,18,O
DDI-DrugBank.d14.s3,either,20,25,O
DDI-DrugBank.d14.s3,class,27,31,O
DDI-DrugBank.d14.s3,of,33,34,O
DDI-DrugBank.d14.s3,agents,36,41,O
DDI-DrugBank.d14.s3,may,43,45,O
DDI-DrugBank.d14.s3,be,47,48,O
DDI-DrugBank.d14.s3,necessary,50,58,O
DDI-DrugBank.d14.s3,.,59,59,O
DDI-DrugBank.d475.s0,No,0,1,O
DDI-DrugBank.d475.s0,interactions,3,14,O
DDI-DrugBank.d475.s0,have,16,19,O
DDI-DrugBank.d475.s0,been,21,24,O
DDI-DrugBank.d475.s0,observed,26,33,O
DDI-DrugBank.d475.s0,between,35,41,O
DDI-DrugBank.d475.s0,nizatidine,43,52,B-drug
DDI-DrugBank.d475.s0,and,54,56,O
DDI-DrugBank.d475.s0,theophylline,58,69,B-drug
DDI-DrugBank.d475.s0,",",70,70,O
DDI-DrugBank.d475.s0,chlordiazepoxide,72,87,B-drug
DDI-DrugBank.d475.s0,",",88,88,O
DDI-DrugBank.d475.s0,lorazepam,90,98,B-drug
DDI-DrugBank.d475.s0,",",99,99,O
DDI-DrugBank.d475.s0,lidocaine,101,109,B-drug
DDI-DrugBank.d475.s0,",",110,110,O
DDI-DrugBank.d475.s0,phenytoin,112,120,B-drug
DDI-DrugBank.d475.s0,",",121,121,O
DDI-DrugBank.d475.s0,and,123,125,O
DDI-DrugBank.d475.s0,warfarin,127,134,B-drug
DDI-DrugBank.d475.s0,.,135,135,O
DDI-DrugBank.d475.s1,Nizatidine,0,9,B-drug
DDI-DrugBank.d475.s1,does,11,14,O
DDI-DrugBank.d475.s1,not,16,18,O
DDI-DrugBank.d475.s1,inhibit,20,26,O
DDI-DrugBank.d475.s1,the,28,30,O
DDI-DrugBank.d475.s1,cytochrome,32,41,O
DDI-DrugBank.d475.s1,P-450-linked,43,54,O
DDI-DrugBank.d475.s1,drug-metabolizing,56,72,O
DDI-DrugBank.d475.s1,enzyme,74,79,O
DDI-DrugBank.d475.s1,system,81,86,O
DDI-DrugBank.d475.s1,;,87,87,O
DDI-DrugBank.d475.s2,therefore,0,8,O
DDI-DrugBank.d475.s2,",",9,9,O
DDI-DrugBank.d475.s2,drug,11,14,O
DDI-DrugBank.d475.s2,interactions,16,27,O
DDI-DrugBank.d475.s2,mediated,29,36,O
DDI-DrugBank.d475.s2,by,38,39,O
DDI-DrugBank.d475.s2,inhibition,41,50,O
DDI-DrugBank.d475.s2,of,52,53,O
DDI-DrugBank.d475.s2,hepatic,55,61,O
DDI-DrugBank.d475.s2,metabolism,63,72,O
DDI-DrugBank.d475.s2,are,74,76,O
DDI-DrugBank.d475.s2,not,78,80,O
DDI-DrugBank.d475.s2,expected,82,89,O
DDI-DrugBank.d475.s2,to,91,92,O
DDI-DrugBank.d475.s2,occur,94,98,O
DDI-DrugBank.d475.s2,.,99,99,O
DDI-DrugBank.d475.s3,In,0,1,O
DDI-DrugBank.d475.s3,patients,3,10,O
DDI-DrugBank.d475.s3,given,12,16,O
DDI-DrugBank.d475.s3,very,18,21,O
DDI-DrugBank.d475.s3,high,23,26,O
DDI-DrugBank.d475.s3,doses,28,32,O
DDI-DrugBank.d475.s3,(,34,34,O
DDI-DrugBank.d475.s3,3900,35,38,O
DDI-DrugBank.d475.s3,mg,40,41,O
DDI-DrugBank.d475.s3,),42,42,O
DDI-DrugBank.d475.s3,of,44,45,O
DDI-DrugBank.d475.s3,aspirin,47,53,B-brand
DDI-DrugBank.d475.s3,daily,55,59,O
DDI-DrugBank.d475.s3,",",60,60,O
DDI-DrugBank.d475.s3,increases,62,70,O
DDI-DrugBank.d475.s3,in,72,73,O
DDI-DrugBank.d475.s3,serum,75,79,O
DDI-DrugBank.d475.s3,salicylate,81,90,B-group
DDI-DrugBank.d475.s3,levels,92,97,O
DDI-DrugBank.d475.s3,were,99,102,O
DDI-DrugBank.d475.s3,seen,104,107,O
DDI-DrugBank.d475.s3,when,109,112,O
DDI-DrugBank.d475.s3,nizatidine,114,123,B-drug
DDI-DrugBank.d475.s3,",",124,124,O
DDI-DrugBank.d475.s3,150,126,128,O
DDI-DrugBank.d475.s3,mg,130,131,O
DDI-DrugBank.d475.s3,b.i.d.,133,138,O
DDI-DrugBank.d475.s3,",",139,139,O
DDI-DrugBank.d475.s3,was,141,143,O
DDI-DrugBank.d475.s3,administered,145,156,O
DDI-DrugBank.d475.s3,concurrently,158,169,O
DDI-DrugBank.d475.s3,.,170,170,O
DDI-DrugBank.d761.s0,Alcohol,0,6,B-drug
DDI-DrugBank.d761.s0,:,7,7,O
DDI-DrugBank.d761.s0,In,9,10,O
DDI-DrugBank.d761.s0,a,12,12,O
DDI-DrugBank.d761.s0,multiple-dose,14,26,O
DDI-DrugBank.d761.s0,study,28,32,O
DDI-DrugBank.d761.s0,in,34,35,O
DDI-DrugBank.d761.s0,30,37,38,O
DDI-DrugBank.d761.s0,normal,40,45,O
DDI-DrugBank.d761.s0,weight,47,52,O
DDI-DrugBank.d761.s0,subjects,54,61,O
DDI-DrugBank.d761.s0,",",62,62,O
DDI-DrugBank.d761.s0,coadministration,64,79,O
DDI-DrugBank.d761.s0,of,81,82,O
DDI-DrugBank.d761.s0,XENICAL,84,90,B-brand
DDI-DrugBank.d761.s0,and,92,94,O
DDI-DrugBank.d761.s0,40,96,97,O
DDI-DrugBank.d761.s0,grams,99,103,O
DDI-DrugBank.d761.s0,of,105,106,O
DDI-DrugBank.d761.s0,alcohol,108,114,B-drug
DDI-DrugBank.d761.s0,(,116,116,O
DDI-DrugBank.d761.s0,e.g.,117,120,O
DDI-DrugBank.d761.s0,",",121,121,O
DDI-DrugBank.d761.s0,approximately,123,135,O
DDI-DrugBank.d761.s0,3,137,137,O
DDI-DrugBank.d761.s0,glasses,139,145,O
DDI-DrugBank.d761.s0,of,147,148,O
DDI-DrugBank.d761.s0,wine,150,153,O
DDI-DrugBank.d761.s0,),154,154,O
DDI-DrugBank.d761.s0,did,156,158,O
DDI-DrugBank.d761.s0,not,160,162,O
DDI-DrugBank.d761.s0,result,164,169,O
DDI-DrugBank.d761.s0,in,171,172,O
DDI-DrugBank.d761.s0,alteration,174,183,O
DDI-DrugBank.d761.s0,of,185,186,O
DDI-DrugBank.d761.s0,alcohol,188,194,B-drug
DDI-DrugBank.d761.s0,pharmacokinetics,196,211,O
DDI-DrugBank.d761.s0,",",212,212,O
DDI-DrugBank.d761.s0,orlistat,214,221,B-drug
DDI-DrugBank.d761.s0,pharmacodynamics,223,238,O
DDI-DrugBank.d761.s0,(,240,240,O
DDI-DrugBank.d761.s0,fecal,241,245,O
DDI-DrugBank.d761.s0,fat,247,249,O
DDI-DrugBank.d761.s0,excretion,251,259,O
DDI-DrugBank.d761.s0,),260,260,O
DDI-DrugBank.d761.s0,",",261,261,O
DDI-DrugBank.d761.s0,or,263,264,O
DDI-DrugBank.d761.s0,systemic,266,273,O
DDI-DrugBank.d761.s0,exposure,275,282,O
DDI-DrugBank.d761.s0,to,284,285,O
DDI-DrugBank.d761.s0,orlistat,287,294,B-drug
DDI-DrugBank.d761.s0,.,295,295,O
DDI-DrugBank.d761.s1,Cyclosporine,0,11,B-drug
DDI-DrugBank.d761.s1,:,12,12,O
DDI-DrugBank.d761.s1,Preliminary,14,24,O
DDI-DrugBank.d761.s1,data,26,29,O
DDI-DrugBank.d761.s1,from,31,34,O
DDI-DrugBank.d761.s1,a,36,36,O
DDI-DrugBank.d761.s1,XENICAL,38,44,B-brand
DDI-DrugBank.d761.s1,and,46,48,O
DDI-DrugBank.d761.s1,cyclosporine,50,61,B-drug
DDI-DrugBank.d761.s1,drug,63,66,O
DDI-DrugBank.d761.s1,interaction,68,78,O
DDI-DrugBank.d761.s1,study,80,84,O
DDI-DrugBank.d761.s1,indicate,86,93,O
DDI-DrugBank.d761.s1,a,95,95,O
DDI-DrugBank.d761.s1,reduction,97,105,O
DDI-DrugBank.d761.s1,in,107,108,O
DDI-DrugBank.d761.s1,cyclosporine,110,121,B-drug
DDI-DrugBank.d761.s1,plasma,123,128,O
DDI-DrugBank.d761.s1,levels,130,135,O
DDI-DrugBank.d761.s1,when,137,140,O
DDI-DrugBank.d761.s1,XENICAL,142,148,B-brand
DDI-DrugBank.d761.s1,was,150,152,O
DDI-DrugBank.d761.s1,coadministered,154,167,O
DDI-DrugBank.d761.s1,with,169,172,O
DDI-DrugBank.d761.s1,cyclosporine,174,185,B-drug
DDI-DrugBank.d761.s1,.,186,186,O
DDI-DrugBank.d761.s2,Digoxin,0,6,B-drug
DDI-DrugBank.d761.s2,:,7,7,O
DDI-DrugBank.d761.s2,In,9,10,O
DDI-DrugBank.d761.s2,12,12,13,O
DDI-DrugBank.d761.s2,normal-weight,15,27,O
DDI-DrugBank.d761.s2,subjects,29,36,O
DDI-DrugBank.d761.s2,receiving,38,46,O
DDI-DrugBank.d761.s2,XENICAL,48,54,B-brand
DDI-DrugBank.d761.s2,120,56,58,O
DDI-DrugBank.d761.s2,mg,60,61,O
DDI-DrugBank.d761.s2,three,63,67,O
DDI-DrugBank.d761.s2,times,69,73,O
DDI-DrugBank.d761.s2,a,75,75,O
DDI-DrugBank.d761.s2,day,77,79,O
DDI-DrugBank.d761.s2,for,81,83,O
DDI-DrugBank.d761.s2,6,85,85,O
DDI-DrugBank.d761.s2,days,87,90,O
DDI-DrugBank.d761.s2,",",91,91,O
DDI-DrugBank.d761.s2,XENICAL,93,99,B-brand
DDI-DrugBank.d761.s2,did,101,103,O
DDI-DrugBank.d761.s2,not,105,107,O
DDI-DrugBank.d761.s2,alter,109,113,O
DDI-DrugBank.d761.s2,the,115,117,O
DDI-DrugBank.d761.s2,pharmacokinetics,119,134,O
DDI-DrugBank.d761.s2,of,136,137,O
DDI-DrugBank.d761.s2,a,139,139,O
DDI-DrugBank.d761.s2,single,141,146,O
DDI-DrugBank.d761.s2,dose,148,151,O
DDI-DrugBank.d761.s2,of,153,154,O
DDI-DrugBank.d761.s2,digoxin,156,162,B-drug
DDI-DrugBank.d761.s2,.,163,163,O
DDI-DrugBank.d761.s3,Fat-soluble,0,10,B-group
DDI-DrugBank.d761.s3,Vitamin,12,18,I-group
DDI-DrugBank.d761.s3,Supplements,20,30,I-group
DDI-DrugBank.d761.s3,and,32,34,O
DDI-DrugBank.d761.s3,Analogues,36,44,O
DDI-DrugBank.d761.s3,:,45,45,O
DDI-DrugBank.d761.s3,A,47,47,O
DDI-DrugBank.d761.s3,pharmacokinetic,49,63,O
DDI-DrugBank.d761.s3,interaction,65,75,O
DDI-DrugBank.d761.s3,study,77,81,O
DDI-DrugBank.d761.s3,showed,83,88,O
DDI-DrugBank.d761.s3,a,90,90,O
DDI-DrugBank.d761.s3,30,92,93,O
DDI-DrugBank.d761.s3,%,94,94,O
DDI-DrugBank.d761.s3,reduction,96,104,O
DDI-DrugBank.d761.s3,in,106,107,O
DDI-DrugBank.d761.s3,beta-carotene,109,121,B-drug
DDI-DrugBank.d761.s3,supplement,123,132,O
DDI-DrugBank.d761.s3,absorption,134,143,O
DDI-DrugBank.d761.s3,when,145,148,O
DDI-DrugBank.d761.s3,concomitantly,150,162,O
DDI-DrugBank.d761.s3,administered,164,175,O
DDI-DrugBank.d761.s3,with,177,180,O
DDI-DrugBank.d761.s3,XENICAL,182,188,B-brand
DDI-DrugBank.d761.s3,.,189,189,O
DDI-DrugBank.d761.s4,XENICAL,0,6,B-brand
DDI-DrugBank.d761.s4,inhibited,8,16,O
DDI-DrugBank.d761.s4,absorption,18,27,O
DDI-DrugBank.d761.s4,of,29,30,O
DDI-DrugBank.d761.s4,a,32,32,O
DDI-DrugBank.d761.s4,vitamin,34,40,B-drug
DDI-DrugBank.d761.s4,E,42,42,I-drug
DDI-DrugBank.d761.s4,acetate,44,50,I-drug
DDI-DrugBank.d761.s4,supplement,52,61,O
DDI-DrugBank.d761.s4,by,63,64,O
DDI-DrugBank.d761.s4,approximately,66,78,O
DDI-DrugBank.d761.s4,60,80,81,O
DDI-DrugBank.d761.s4,%,82,82,O
DDI-DrugBank.d761.s4,.,83,83,O
DDI-DrugBank.d761.s5,The,0,2,O
DDI-DrugBank.d761.s5,effect,4,9,O
DDI-DrugBank.d761.s5,of,11,12,O
DDI-DrugBank.d761.s5,orlistat,14,21,B-drug
DDI-DrugBank.d761.s5,on,23,24,O
DDI-DrugBank.d761.s5,the,26,28,O
DDI-DrugBank.d761.s5,absorption,30,39,O
DDI-DrugBank.d761.s5,of,41,42,O
DDI-DrugBank.d761.s5,supplemental,44,55,O
DDI-DrugBank.d761.s5,vitamin,57,63,B-group
DDI-DrugBank.d761.s5,D,65,65,I-group
DDI-DrugBank.d761.s5,",",66,66,O
DDI-DrugBank.d761.s5,vitamin,68,74,B-group
DDI-DrugBank.d761.s5,A,76,76,I-group
DDI-DrugBank.d761.s5,",",77,77,O
DDI-DrugBank.d761.s5,and,79,81,O
DDI-DrugBank.d761.s5,nutritionally-derived,83,103,O
DDI-DrugBank.d761.s5,vitamin,105,111,B-group
DDI-DrugBank.d761.s5,K,113,113,I-group
DDI-DrugBank.d761.s5,is,115,116,O
DDI-DrugBank.d761.s5,not,118,120,O
DDI-DrugBank.d761.s5,known,122,126,O
DDI-DrugBank.d761.s5,at,128,129,O
DDI-DrugBank.d761.s5,this,131,134,O
DDI-DrugBank.d761.s5,time,136,139,O
DDI-DrugBank.d761.s5,.,140,140,O
DDI-DrugBank.d761.s6,Glyburide,0,8,B-drug
DDI-DrugBank.d761.s6,:,9,9,O
DDI-DrugBank.d761.s6,In,11,12,O
DDI-DrugBank.d761.s6,12,14,15,O
DDI-DrugBank.d761.s6,normal-weight,17,29,O
DDI-DrugBank.d761.s6,subjects,31,38,O
DDI-DrugBank.d761.s6,receiving,40,48,O
DDI-DrugBank.d761.s6,orlistat,50,57,B-drug
DDI-DrugBank.d761.s6,80,59,60,O
DDI-DrugBank.d761.s6,mg,62,63,O
DDI-DrugBank.d761.s6,three,65,69,O
DDI-DrugBank.d761.s6,times,71,75,O
DDI-DrugBank.d761.s6,a,77,77,O
DDI-DrugBank.d761.s6,day,79,81,O
DDI-DrugBank.d761.s6,for,83,85,O
DDI-DrugBank.d761.s6,5,87,87,O
DDI-DrugBank.d761.s6,days,89,92,O
DDI-DrugBank.d761.s6,",",93,93,O
DDI-DrugBank.d761.s6,orlistat,95,102,B-drug
DDI-DrugBank.d761.s6,did,104,106,O
DDI-DrugBank.d761.s6,not,108,110,O
DDI-DrugBank.d761.s6,alter,112,116,O
DDI-DrugBank.d761.s6,the,118,120,O
DDI-DrugBank.d761.s6,pharmacokinetics,122,137,O
DDI-DrugBank.d761.s6,or,139,140,O
DDI-DrugBank.d761.s6,pharmacodynamics,142,157,O
DDI-DrugBank.d761.s6,(,159,159,O
DDI-DrugBank.d761.s6,blood,160,164,O
DDI-DrugBank.d761.s6,glucose-lowering,166,181,O
DDI-DrugBank.d761.s6,),182,182,O
DDI-DrugBank.d761.s6,of,184,185,O
DDI-DrugBank.d761.s6,glyburide,187,195,B-drug
DDI-DrugBank.d761.s6,.,196,196,O
DDI-DrugBank.d761.s7,Nifedipine,0,9,B-drug
DDI-DrugBank.d761.s7,(,11,11,O
DDI-DrugBank.d761.s7,extended-release,12,27,O
DDI-DrugBank.d761.s7,tablets,29,35,O
DDI-DrugBank.d761.s7,),36,36,O
DDI-DrugBank.d761.s7,:,37,37,O
DDI-DrugBank.d761.s7,In,39,40,O
DDI-DrugBank.d761.s7,17,42,43,O
DDI-DrugBank.d761.s7,normal-weight,45,57,O
DDI-DrugBank.d761.s7,subjects,59,66,O
DDI-DrugBank.d761.s7,receiving,68,76,O
DDI-DrugBank.d761.s7,XENICAL,78,84,B-brand
DDI-DrugBank.d761.s7,120,86,88,O
DDI-DrugBank.d761.s7,mg,90,91,O
DDI-DrugBank.d761.s7,three,93,97,O
DDI-DrugBank.d761.s7,times,99,103,O
DDI-DrugBank.d761.s7,a,105,105,O
DDI-DrugBank.d761.s7,day,107,109,O
DDI-DrugBank.d761.s7,for,111,113,O
DDI-DrugBank.d761.s7,6,115,115,O
DDI-DrugBank.d761.s7,days,117,120,O
DDI-DrugBank.d761.s7,",",121,121,O
DDI-DrugBank.d761.s7,XENICAL,123,129,B-brand
DDI-DrugBank.d761.s7,did,131,133,O
DDI-DrugBank.d761.s7,not,135,137,O
DDI-DrugBank.d761.s7,alter,139,143,O
DDI-DrugBank.d761.s7,the,145,147,O
DDI-DrugBank.d761.s7,bioavailability,149,163,O
DDI-DrugBank.d761.s7,of,165,166,O
DDI-DrugBank.d761.s7,nifedipine,168,177,B-drug
DDI-DrugBank.d761.s7,(,179,179,O
DDI-DrugBank.d761.s7,extended-release,180,195,O
DDI-DrugBank.d761.s7,tablets,197,203,O
DDI-DrugBank.d761.s7,),204,204,O
DDI-DrugBank.d761.s7,.,205,205,O
DDI-DrugBank.d761.s8,Oral,0,3,O
DDI-DrugBank.d761.s8,Contraceptives,5,18,B-group
DDI-DrugBank.d761.s8,:,19,19,O
DDI-DrugBank.d761.s8,In,21,22,O
DDI-DrugBank.d761.s8,20,24,25,O
DDI-DrugBank.d761.s8,normal-weight,27,39,O
DDI-DrugBank.d761.s8,female,41,46,O
DDI-DrugBank.d761.s8,subjects,48,55,O
DDI-DrugBank.d761.s8,",",56,56,O
DDI-DrugBank.d761.s8,the,58,60,O
DDI-DrugBank.d761.s8,treatment,62,70,O
DDI-DrugBank.d761.s8,of,72,73,O
DDI-DrugBank.d761.s8,XENICAL,75,81,B-brand
DDI-DrugBank.d761.s8,120,83,85,O
DDI-DrugBank.d761.s8,mg,87,88,O
DDI-DrugBank.d761.s8,three,90,94,O
DDI-DrugBank.d761.s8,times,96,100,O
DDI-DrugBank.d761.s8,a,102,102,O
DDI-DrugBank.d761.s8,day,104,106,O
DDI-DrugBank.d761.s8,for,108,110,O
DDI-DrugBank.d761.s8,23,112,113,O
DDI-DrugBank.d761.s8,days,115,118,O
DDI-DrugBank.d761.s8,resulted,120,127,O
DDI-DrugBank.d761.s8,in,129,130,O
DDI-DrugBank.d761.s8,no,132,133,O
DDI-DrugBank.d761.s8,changes,135,141,O
DDI-DrugBank.d761.s8,in,143,144,O
DDI-DrugBank.d761.s8,the,146,148,O
DDI-DrugBank.d761.s8,ovulation-suppressing,150,170,O
DDI-DrugBank.d761.s8,action,172,177,O
DDI-DrugBank.d761.s8,of,179,180,O
DDI-DrugBank.d761.s8,oral,182,185,O
DDI-DrugBank.d761.s8,contraceptives,187,200,B-group
DDI-DrugBank.d761.s8,.,201,201,O
DDI-DrugBank.d761.s9,Phenytoin,0,8,B-drug
DDI-DrugBank.d761.s9,:,9,9,O
DDI-DrugBank.d761.s9,In,11,12,O
DDI-DrugBank.d761.s9,12,14,15,O
DDI-DrugBank.d761.s9,normal-weight,17,29,O
DDI-DrugBank.d761.s9,subjects,31,38,O
DDI-DrugBank.d761.s9,receiving,40,48,O
DDI-DrugBank.d761.s9,XENICAL,50,56,B-brand
DDI-DrugBank.d761.s9,120,58,60,O
DDI-DrugBank.d761.s9,mg,62,63,O
DDI-DrugBank.d761.s9,three,65,69,O
DDI-DrugBank.d761.s9,times,71,75,O
DDI-DrugBank.d761.s9,a,77,77,O
DDI-DrugBank.d761.s9,day,79,81,O
DDI-DrugBank.d761.s9,for,83,85,O
DDI-DrugBank.d761.s9,7,87,87,O
DDI-DrugBank.d761.s9,days,89,92,O
DDI-DrugBank.d761.s9,",",93,93,O
DDI-DrugBank.d761.s9,XENICAL,95,101,B-brand
DDI-DrugBank.d761.s9,did,103,105,O
DDI-DrugBank.d761.s9,not,107,109,O
DDI-DrugBank.d761.s9,alter,111,115,O
DDI-DrugBank.d761.s9,the,117,119,O
DDI-DrugBank.d761.s9,pharmacokinetics,121,136,O
DDI-DrugBank.d761.s9,of,138,139,O
DDI-DrugBank.d761.s9,a,141,141,O
DDI-DrugBank.d761.s9,single,143,148,O
DDI-DrugBank.d761.s9,300-mg,150,155,O
DDI-DrugBank.d761.s9,dose,157,160,O
DDI-DrugBank.d761.s9,of,162,163,O
DDI-DrugBank.d761.s9,phenytoin,165,173,B-drug
DDI-DrugBank.d761.s9,.,174,174,O
DDI-DrugBank.d761.s10,Pravastatin,0,10,B-drug
DDI-DrugBank.d761.s10,:,11,11,O
DDI-DrugBank.d761.s10,In,13,14,O
DDI-DrugBank.d761.s10,a,16,16,O
DDI-DrugBank.d761.s10,2-way,18,22,O
DDI-DrugBank.d761.s10,crossover,24,32,O
DDI-DrugBank.d761.s10,study,34,38,O
DDI-DrugBank.d761.s10,of,40,41,O
DDI-DrugBank.d761.s10,24,43,44,O
DDI-DrugBank.d761.s10,normal-weight,46,58,O
DDI-DrugBank.d761.s10,",",59,59,O
DDI-DrugBank.d761.s10,mildly,61,66,O
DDI-DrugBank.d761.s10,hypercholesterolemic,68,87,O
DDI-DrugBank.d761.s10,patients,89,96,O
DDI-DrugBank.d761.s10,receiving,98,106,O
DDI-DrugBank.d761.s10,XENICAL,108,114,B-brand
DDI-DrugBank.d761.s10,120,116,118,O
DDI-DrugBank.d761.s10,mg,120,121,O
DDI-DrugBank.d761.s10,three,123,127,O
DDI-DrugBank.d761.s10,times,129,133,O
DDI-DrugBank.d761.s10,a,135,135,O
DDI-DrugBank.d761.s10,day,137,139,O
DDI-DrugBank.d761.s10,for,141,143,O
DDI-DrugBank.d761.s10,6,145,145,O
DDI-DrugBank.d761.s10,days,147,150,O
DDI-DrugBank.d761.s10,",",151,151,O
DDI-DrugBank.d761.s10,XENICAL,153,159,B-brand
DDI-DrugBank.d761.s10,did,161,163,O
DDI-DrugBank.d761.s10,not,165,167,O
DDI-DrugBank.d761.s10,affect,169,174,O
DDI-DrugBank.d761.s10,the,176,178,O
DDI-DrugBank.d761.s10,pharmacokinetics,180,195,O
DDI-DrugBank.d761.s10,of,197,198,O
DDI-DrugBank.d761.s10,pravastatin,200,210,B-drug
DDI-DrugBank.d761.s10,.,211,211,O
DDI-DrugBank.d761.s11,Warfarin,0,7,B-drug
DDI-DrugBank.d761.s11,:,8,8,O
DDI-DrugBank.d761.s11,In,10,11,O
DDI-DrugBank.d761.s11,12,13,14,O
DDI-DrugBank.d761.s11,normal-weight,16,28,O
DDI-DrugBank.d761.s11,subjects,30,37,O
DDI-DrugBank.d761.s11,",",38,38,O
DDI-DrugBank.d761.s11,administration,40,53,O
DDI-DrugBank.d761.s11,of,55,56,O
DDI-DrugBank.d761.s11,XENICAL,58,64,B-brand
DDI-DrugBank.d761.s11,120,66,68,O
DDI-DrugBank.d761.s11,mg,70,71,O
DDI-DrugBank.d761.s11,three,73,77,O
DDI-DrugBank.d761.s11,times,79,83,O
DDI-DrugBank.d761.s11,a,85,85,O
DDI-DrugBank.d761.s11,day,87,89,O
DDI-DrugBank.d761.s11,for,91,93,O
DDI-DrugBank.d761.s11,16,95,96,O
DDI-DrugBank.d761.s11,days,98,101,O
DDI-DrugBank.d761.s11,did,103,105,O
DDI-DrugBank.d761.s11,not,107,109,O
DDI-DrugBank.d761.s11,result,111,116,O
DDI-DrugBank.d761.s11,in,118,119,O
DDI-DrugBank.d761.s11,any,121,123,O
DDI-DrugBank.d761.s11,change,125,130,O
DDI-DrugBank.d761.s11,in,132,133,O
DDI-DrugBank.d761.s11,either,135,140,O
DDI-DrugBank.d761.s11,warfarin,142,149,B-drug
DDI-DrugBank.d761.s11,pharmacokinetics,151,166,O
DDI-DrugBank.d761.s11,(,168,168,O
DDI-DrugBank.d761.s11,both,169,172,O
DDI-DrugBank.d761.s11,R-,174,175,O
DDI-DrugBank.d761.s11,and,177,179,O
DDI-DrugBank.d761.s11,S-enantiomers,181,193,O
DDI-DrugBank.d761.s11,),194,194,O
DDI-DrugBank.d761.s11,or,196,197,O
DDI-DrugBank.d761.s11,pharmacodynamics,199,214,O
DDI-DrugBank.d761.s11,(,216,216,O
DDI-DrugBank.d761.s11,prothrombin,217,227,O
DDI-DrugBank.d761.s11,time,229,232,O
DDI-DrugBank.d761.s11,and,234,236,O
DDI-DrugBank.d761.s11,serum,238,242,O
DDI-DrugBank.d761.s11,Factor,244,249,O
DDI-DrugBank.d761.s11,VII,251,253,O
DDI-DrugBank.d761.s11,),254,254,O
DDI-DrugBank.d761.s11,.,255,255,O
DDI-DrugBank.d761.s12,Although,0,7,O
DDI-DrugBank.d761.s12,undercarboxylated,9,25,O
DDI-DrugBank.d761.s12,osteocalcin,27,37,O
DDI-DrugBank.d761.s12,",",38,38,O
DDI-DrugBank.d761.s12,a,40,40,O
DDI-DrugBank.d761.s12,marker,42,47,O
DDI-DrugBank.d761.s12,of,49,50,O
DDI-DrugBank.d761.s12,vitamin,52,58,O
DDI-DrugBank.d761.s12,K,60,60,O
DDI-DrugBank.d761.s12,nutritional,62,72,O
DDI-DrugBank.d761.s12,status,74,79,O
DDI-DrugBank.d761.s12,",",80,80,O
DDI-DrugBank.d761.s12,was,82,84,O
DDI-DrugBank.d761.s12,unaltered,86,94,O
DDI-DrugBank.d761.s12,with,96,99,O
DDI-DrugBank.d761.s12,XENICAL,101,107,B-brand
DDI-DrugBank.d761.s12,administration,109,122,O
DDI-DrugBank.d761.s12,",",123,123,O
DDI-DrugBank.d761.s12,vitamin,125,131,O
DDI-DrugBank.d761.s12,K,133,133,O
DDI-DrugBank.d761.s12,levels,135,140,O
DDI-DrugBank.d761.s12,tended,142,147,O
DDI-DrugBank.d761.s12,to,149,150,O
DDI-DrugBank.d761.s12,decline,152,158,O
DDI-DrugBank.d761.s12,in,160,161,O
DDI-DrugBank.d761.s12,subjects,163,170,O
DDI-DrugBank.d761.s12,taking,172,177,O
DDI-DrugBank.d761.s12,XENICAL,179,185,B-brand
DDI-DrugBank.d761.s12,.,186,186,O
DDI-DrugBank.d761.s13,Therefore,0,8,O
DDI-DrugBank.d761.s13,",",9,9,O
DDI-DrugBank.d761.s13,as,11,12,O
DDI-DrugBank.d761.s13,vitamin,14,20,B-group
DDI-DrugBank.d761.s13,K,22,22,I-group
DDI-DrugBank.d761.s13,absorption,24,33,O
DDI-DrugBank.d761.s13,may,35,37,O
DDI-DrugBank.d761.s13,be,39,40,O
DDI-DrugBank.d761.s13,decreased,42,50,O
DDI-DrugBank.d761.s13,with,52,55,O
DDI-DrugBank.d761.s13,XENICAL,57,63,B-brand
DDI-DrugBank.d761.s13,",",64,64,O
DDI-DrugBank.d761.s13,patients,66,73,O
DDI-DrugBank.d761.s13,on,75,76,O
DDI-DrugBank.d761.s13,chronic,78,84,O
DDI-DrugBank.d761.s13,stable,86,91,O
DDI-DrugBank.d761.s13,doses,93,97,O
DDI-DrugBank.d761.s13,of,99,100,O
DDI-DrugBank.d761.s13,warfarin,102,109,B-drug
DDI-DrugBank.d761.s13,who,111,113,O
DDI-DrugBank.d761.s13,are,115,117,O
DDI-DrugBank.d761.s13,prescribed,119,128,O
DDI-DrugBank.d761.s13,XENICAL,130,136,B-brand
DDI-DrugBank.d761.s13,should,138,143,O
DDI-DrugBank.d761.s13,be,145,146,O
DDI-DrugBank.d761.s13,monitored,148,156,O
DDI-DrugBank.d761.s13,closely,158,164,O
DDI-DrugBank.d761.s13,for,166,168,O
DDI-DrugBank.d761.s13,changes,170,176,O
DDI-DrugBank.d761.s13,in,178,179,O
DDI-DrugBank.d761.s13,coagulation,181,191,O
DDI-DrugBank.d761.s13,parameters,193,202,O
DDI-DrugBank.d761.s13,.,203,203,O
DDI-DrugBank.d744.s0,Acromegalic,0,10,O
DDI-DrugBank.d744.s0,patients,12,19,O
DDI-DrugBank.d744.s0,with,21,24,O
DDI-DrugBank.d744.s0,diabetes,26,33,O
DDI-DrugBank.d744.s0,mellitus,35,42,O
DDI-DrugBank.d744.s0,being,44,48,O
DDI-DrugBank.d744.s0,treated,50,56,O
DDI-DrugBank.d744.s0,with,58,61,O
DDI-DrugBank.d744.s0,insulin,63,69,B-drug
DDI-DrugBank.d744.s0,and/or,71,76,O
DDI-DrugBank.d744.s0,oral,78,81,O
DDI-DrugBank.d744.s0,hypoglycemic,83,94,B-group
DDI-DrugBank.d744.s0,agents,96,101,O
DDI-DrugBank.d744.s0,may,103,105,O
DDI-DrugBank.d744.s0,require,107,113,O
DDI-DrugBank.d744.s0,dose,115,118,O
DDI-DrugBank.d744.s0,reductions,120,129,O
DDI-DrugBank.d744.s0,of,131,132,O
DDI-DrugBank.d744.s0,these,134,138,O
DDI-DrugBank.d744.s0,therapeutic,140,150,O
DDI-DrugBank.d744.s0,agents,152,157,O
DDI-DrugBank.d744.s0,after,159,163,O
DDI-DrugBank.d744.s0,the,165,167,O
DDI-DrugBank.d744.s0,initiation,169,178,O
DDI-DrugBank.d744.s0,of,180,181,O
DDI-DrugBank.d744.s0,therapy,183,189,O
DDI-DrugBank.d744.s0,with,191,194,O
DDI-DrugBank.d744.s0,SOMAVERT,196,203,B-brand
DDI-DrugBank.d744.s0,.,204,204,O
DDI-DrugBank.d744.s1,In,0,1,O
DDI-DrugBank.d744.s1,clinical,3,10,O
DDI-DrugBank.d744.s1,studies,12,18,O
DDI-DrugBank.d744.s1,",",19,19,O
DDI-DrugBank.d744.s1,patients,21,28,O
DDI-DrugBank.d744.s1,on,30,31,O
DDI-DrugBank.d744.s1,opioids,33,39,B-group
DDI-DrugBank.d744.s1,often,41,45,O
DDI-DrugBank.d744.s1,needed,47,52,O
DDI-DrugBank.d744.s1,higher,54,59,O
DDI-DrugBank.d744.s1,serum,61,65,O
DDI-DrugBank.d744.s1,pegvisomant,67,77,B-drug
DDI-DrugBank.d744.s1,concentrations,79,92,O
DDI-DrugBank.d744.s1,to,94,95,O
DDI-DrugBank.d744.s1,achieve,97,103,O
DDI-DrugBank.d744.s1,appropriate,105,115,O
DDI-DrugBank.d744.s1,IGF-I,117,121,O
DDI-DrugBank.d744.s1,suppression,123,133,O
DDI-DrugBank.d744.s1,compared,135,142,O
DDI-DrugBank.d744.s1,with,144,147,O
DDI-DrugBank.d744.s1,patients,149,156,O
DDI-DrugBank.d744.s1,not,158,160,O
DDI-DrugBank.d744.s1,receiving,162,170,O
DDI-DrugBank.d744.s1,opioids,172,178,B-group
DDI-DrugBank.d744.s1,.,179,179,O
DDI-DrugBank.d744.s2,The,0,2,O
DDI-DrugBank.d744.s2,mechanism,4,12,O
DDI-DrugBank.d744.s2,of,14,15,O
DDI-DrugBank.d744.s2,this,17,20,O
DDI-DrugBank.d744.s2,interaction,22,32,O
DDI-DrugBank.d744.s2,is,34,35,O
DDI-DrugBank.d744.s2,not,37,39,O
DDI-DrugBank.d744.s2,known,41,45,O
DDI-DrugBank.d744.s2,.,46,46,O
DDI-DrugBank.d671.s0,The,0,2,O
DDI-DrugBank.d671.s0,interaction,4,14,O
DDI-DrugBank.d671.s0,of,16,17,O
DDI-DrugBank.d671.s0,CYLERT,19,24,B-brand
DDI-DrugBank.d671.s0,(,26,26,O
DDI-DrugBank.d671.s0,pemoline,27,34,B-drug
DDI-DrugBank.d671.s0,),35,35,O
DDI-DrugBank.d671.s0,with,37,40,O
DDI-DrugBank.d671.s0,other,42,46,O
DDI-DrugBank.d671.s0,drugs,48,52,O
DDI-DrugBank.d671.s0,has,54,56,O
DDI-DrugBank.d671.s0,not,58,60,O
DDI-DrugBank.d671.s0,been,62,65,O
DDI-DrugBank.d671.s0,studied,67,73,O
DDI-DrugBank.d671.s0,in,75,76,O
DDI-DrugBank.d671.s0,humans,78,83,O
DDI-DrugBank.d671.s0,.,84,84,O
DDI-DrugBank.d671.s1,Patients,0,7,O
DDI-DrugBank.d671.s1,who,9,11,O
DDI-DrugBank.d671.s1,are,13,15,O
DDI-DrugBank.d671.s1,receiving,17,25,O
DDI-DrugBank.d671.s1,CYLERT,27,32,B-brand
DDI-DrugBank.d671.s1,concurrently,34,45,O
DDI-DrugBank.d671.s1,with,47,50,O
DDI-DrugBank.d671.s1,other,52,56,O
DDI-DrugBank.d671.s1,drugs,58,62,O
DDI-DrugBank.d671.s1,",",63,63,O
DDI-DrugBank.d671.s1,especially,65,74,O
DDI-DrugBank.d671.s1,drugs,76,80,O
DDI-DrugBank.d671.s1,with,82,85,O
DDI-DrugBank.d671.s1,CNS,87,89,O
DDI-DrugBank.d671.s1,activity,91,98,O
DDI-DrugBank.d671.s1,",",99,99,O
DDI-DrugBank.d671.s1,should,101,106,O
DDI-DrugBank.d671.s1,be,108,109,O
DDI-DrugBank.d671.s1,monitored,111,119,O
DDI-DrugBank.d671.s1,carefully,121,129,O
DDI-DrugBank.d671.s1,.,130,130,O
DDI-DrugBank.d671.s2,Decreased,0,8,O
DDI-DrugBank.d671.s2,seizure,10,16,O
DDI-DrugBank.d671.s2,threshold,18,26,O
DDI-DrugBank.d671.s2,has,28,30,O
DDI-DrugBank.d671.s2,been,32,35,O
DDI-DrugBank.d671.s2,reported,37,44,O
DDI-DrugBank.d671.s2,in,46,47,O
DDI-DrugBank.d671.s2,patients,49,56,O
DDI-DrugBank.d671.s2,receiving,58,66,O
DDI-DrugBank.d671.s2,CYLERT,68,73,B-brand
DDI-DrugBank.d671.s2,concomitantly,75,87,O
DDI-DrugBank.d671.s2,with,89,92,O
DDI-DrugBank.d671.s2,antiepileptic,94,106,B-group
DDI-DrugBank.d671.s2,medications,108,118,I-group
DDI-DrugBank.d671.s2,.,119,119,O
DDI-DrugBank.d635.s0,Other,0,4,O
DDI-DrugBank.d635.s0,short-acting,6,17,B-group
DDI-DrugBank.d635.s0,beta,19,22,I-group
DDI-DrugBank.d635.s0,adrenergic,24,33,I-group
DDI-DrugBank.d635.s0,aerosol,35,41,I-group
DDI-DrugBank.d635.s0,bronchodilators,43,57,I-group
DDI-DrugBank.d635.s0,should,59,64,O
DDI-DrugBank.d635.s0,not,66,68,O
DDI-DrugBank.d635.s0,be,70,71,O
DDI-DrugBank.d635.s0,used,73,76,O
DDI-DrugBank.d635.s0,concomitantly,78,90,O
DDI-DrugBank.d635.s0,with,92,95,O
DDI-DrugBank.d635.s0,MAXAIR,97,102,B-brand
DDI-DrugBank.d635.s0,AUTOHALER,104,112,I-brand
DDI-DrugBank.d635.s0,because,114,120,O
DDI-DrugBank.d635.s0,they,122,125,O
DDI-DrugBank.d635.s0,may,127,129,O
DDI-DrugBank.d635.s0,have,131,134,O
DDI-DrugBank.d635.s0,additive,136,143,O
DDI-DrugBank.d635.s0,effects,145,151,O
DDI-DrugBank.d635.s0,.,152,152,O
DDI-DrugBank.d622.s0,When,0,3,O
DDI-DrugBank.d622.s0,atropine,5,12,B-drug
DDI-DrugBank.d622.s0,and,14,16,O
DDI-DrugBank.d622.s0,pralidoxime,18,28,B-drug
DDI-DrugBank.d622.s0,are,30,32,O
DDI-DrugBank.d622.s0,used,34,37,O
DDI-DrugBank.d622.s0,together,39,46,O
DDI-DrugBank.d622.s0,",",47,47,O
DDI-DrugBank.d622.s0,the,49,51,O
DDI-DrugBank.d622.s0,signs,53,57,O
DDI-DrugBank.d622.s0,of,59,60,O
DDI-DrugBank.d622.s0,atropinization,62,75,O
DDI-DrugBank.d622.s0,(,77,77,O
DDI-DrugBank.d622.s0,flushing,78,85,O
DDI-DrugBank.d622.s0,",",86,86,O
DDI-DrugBank.d622.s0,mydriasis,88,96,O
DDI-DrugBank.d622.s0,",",97,97,O
DDI-DrugBank.d622.s0,tachycardia,99,109,O
DDI-DrugBank.d622.s0,",",110,110,O
DDI-DrugBank.d622.s0,dryness,112,118,O
DDI-DrugBank.d622.s0,of,120,121,O
DDI-DrugBank.d622.s0,the,123,125,O
DDI-DrugBank.d622.s0,mouth,127,131,O
DDI-DrugBank.d622.s0,and,133,135,O
DDI-DrugBank.d622.s0,nose,137,140,O
DDI-DrugBank.d622.s0,),141,141,O
DDI-DrugBank.d622.s0,may,143,145,O
DDI-DrugBank.d622.s0,occur,147,151,O
DDI-DrugBank.d622.s0,earlier,153,159,O
DDI-DrugBank.d622.s0,than,161,164,O
DDI-DrugBank.d622.s0,might,166,170,O
DDI-DrugBank.d622.s0,be,172,173,O
DDI-DrugBank.d622.s0,expected,175,182,O
DDI-DrugBank.d622.s0,when,184,187,O
DDI-DrugBank.d622.s0,atropine,189,196,B-drug
DDI-DrugBank.d622.s0,is,198,199,O
DDI-DrugBank.d622.s0,used,201,204,O
DDI-DrugBank.d622.s0,alone,206,210,O
DDI-DrugBank.d622.s0,.,211,211,O
DDI-DrugBank.d622.s1,This,0,3,O
DDI-DrugBank.d622.s1,is,5,6,O
DDI-DrugBank.d622.s1,especially,8,17,O
DDI-DrugBank.d622.s1,true,19,22,O
DDI-DrugBank.d622.s1,if,24,25,O
DDI-DrugBank.d622.s1,the,27,29,O
DDI-DrugBank.d622.s1,total,31,35,O
DDI-DrugBank.d622.s1,dose,37,40,O
DDI-DrugBank.d622.s1,of,42,43,O
DDI-DrugBank.d622.s1,atropine,45,52,B-drug
DDI-DrugBank.d622.s1,has,54,56,O
DDI-DrugBank.d622.s1,been,58,61,O
DDI-DrugBank.d622.s1,large,63,67,O
DDI-DrugBank.d622.s1,and,69,71,O
DDI-DrugBank.d622.s1,the,73,75,O
DDI-DrugBank.d622.s1,administration,77,90,O
DDI-DrugBank.d622.s1,of,92,93,O
DDI-DrugBank.d622.s1,pralidoxime,95,105,B-drug
DDI-DrugBank.d622.s1,has,107,109,O
DDI-DrugBank.d622.s1,been,111,114,O
DDI-DrugBank.d622.s1,delayed,116,122,O
DDI-DrugBank.d622.s1,.,123,123,O
DDI-DrugBank.d622.s2,2,0,0,O
DDI-DrugBank.d622.s2,-,2,2,O
DDI-DrugBank.d622.s2,4,4,4,O
DDI-DrugBank.d622.s2,The,6,8,O
DDI-DrugBank.d622.s2,following,10,18,O
DDI-DrugBank.d622.s2,precautions,20,30,O
DDI-DrugBank.d622.s2,should,32,37,O
DDI-DrugBank.d622.s2,be,39,40,O
DDI-DrugBank.d622.s2,kept,42,45,O
DDI-DrugBank.d622.s2,in,47,48,O
DDI-DrugBank.d622.s2,mind,50,53,O
DDI-DrugBank.d622.s2,in,55,56,O
DDI-DrugBank.d622.s2,the,58,60,O
DDI-DrugBank.d622.s2,treatment,62,70,O
DDI-DrugBank.d622.s2,of,72,73,O
DDI-DrugBank.d622.s2,anticholinesterase,75,92,O
DDI-DrugBank.d622.s2,poisoning,94,102,O
DDI-DrugBank.d622.s2,",",103,103,O
DDI-DrugBank.d622.s2,although,105,112,O
DDI-DrugBank.d622.s2,they,114,117,O
DDI-DrugBank.d622.s2,do,119,120,O
DDI-DrugBank.d622.s2,not,122,124,O
DDI-DrugBank.d622.s2,bear,126,129,O
DDI-DrugBank.d622.s2,directly,131,138,O
DDI-DrugBank.d622.s2,on,140,141,O
DDI-DrugBank.d622.s2,the,143,145,O
DDI-DrugBank.d622.s2,use,147,149,O
DDI-DrugBank.d622.s2,of,151,152,O
DDI-DrugBank.d622.s2,pralidoxime,154,164,B-drug
DDI-DrugBank.d622.s2,:,165,165,O
DDI-DrugBank.d622.s2,since,167,171,O
DDI-DrugBank.d622.s2,barbiturates,173,184,B-group
DDI-DrugBank.d622.s2,are,186,188,O
DDI-DrugBank.d622.s2,potentiated,190,200,O
DDI-DrugBank.d622.s2,by,202,203,O
DDI-DrugBank.d622.s2,the,205,207,O
DDI-DrugBank.d622.s2,anticholinesterases,209,227,B-group
DDI-DrugBank.d622.s2,",",228,228,O
DDI-DrugBank.d622.s2,they,230,233,O
DDI-DrugBank.d622.s2,should,235,240,O
DDI-DrugBank.d622.s2,be,242,243,O
DDI-DrugBank.d622.s2,used,245,248,O
DDI-DrugBank.d622.s2,cautiously,250,259,O
DDI-DrugBank.d622.s2,in,261,262,O
DDI-DrugBank.d622.s2,the,264,266,O
DDI-DrugBank.d622.s2,treatment,268,276,O
DDI-DrugBank.d622.s2,of,278,279,O
DDI-DrugBank.d622.s2,convulsions,281,291,O
DDI-DrugBank.d622.s2,;,292,292,O
DDI-DrugBank.d622.s3,morphine,0,7,B-drug
DDI-DrugBank.d622.s3,",",8,8,O
DDI-DrugBank.d622.s3,theophylline,10,21,B-drug
DDI-DrugBank.d622.s3,",",22,22,O
DDI-DrugBank.d622.s3,aminophylline,24,36,B-drug
DDI-DrugBank.d622.s3,",",37,37,O
DDI-DrugBank.d622.s3,succinylcholine,39,53,B-drug
DDI-DrugBank.d622.s3,",",54,54,O
DDI-DrugBank.d622.s3,reserpine,56,64,B-drug
DDI-DrugBank.d622.s3,",",65,65,O
DDI-DrugBank.d622.s3,and,67,69,O
DDI-DrugBank.d622.s3,phenothiazine-type,71,88,B-group
DDI-DrugBank.d622.s3,tranquilizers,90,102,I-group
DDI-DrugBank.d622.s3,should,104,109,O
DDI-DrugBank.d622.s3,be,111,112,O
DDI-DrugBank.d622.s3,avoided,114,120,O
DDI-DrugBank.d622.s3,in,122,123,O
DDI-DrugBank.d622.s3,patients,125,132,O
DDI-DrugBank.d622.s3,with,134,137,O
DDI-DrugBank.d622.s3,organophosphate,139,153,O
DDI-DrugBank.d622.s3,poisoning,155,163,O
DDI-DrugBank.d622.s3,.,164,164,O
DDI-DrugBank.d737.s0,Carbidopa/Levodopa,0,17,O
DDI-DrugBank.d737.s0,:,18,18,O
DDI-DrugBank.d737.s0,Carbidopa/Levodopa,20,37,O
DDI-DrugBank.d737.s0,does,39,42,O
DDI-DrugBank.d737.s0,not,44,46,O
DDI-DrugBank.d737.s0,influence,48,56,O
DDI-DrugBank.d737.s0,the,58,60,O
DDI-DrugBank.d737.s0,pharmacokinetics,62,77,O
DDI-DrugBank.d737.s0,of,79,80,O
DDI-DrugBank.d737.s0,pramipexole,82,92,B-drug
DDI-DrugBank.d737.s0,in,94,95,O
DDI-DrugBank.d737.s0,healthy,97,103,O
DDI-DrugBank.d737.s0,volunteers,105,114,O
DDI-DrugBank.d737.s0,(,116,116,O
DDI-DrugBank.d737.s0,N=,117,118,O
DDI-DrugBank.d737.s0,10,120,121,O
DDI-DrugBank.d737.s0,),122,122,O
DDI-DrugBank.d737.s0,.,123,123,O
DDI-DrugBank.d737.s1,5,0,0,O
DDI-DrugBank.d737.s1,hours,2,6,O
DDI-DrugBank.d737.s1,.,7,7,O
DDI-DrugBank.d737.s2,Selegiline,0,9,B-drug
DDI-DrugBank.d737.s2,:,10,10,O
DDI-DrugBank.d737.s2,In,12,13,O
DDI-DrugBank.d737.s2,healthy,15,21,O
DDI-DrugBank.d737.s2,volunteers,23,32,O
DDI-DrugBank.d737.s2,(,34,34,O
DDI-DrugBank.d737.s2,N=,35,36,O
DDI-DrugBank.d737.s2,11,38,39,O
DDI-DrugBank.d737.s2,),40,40,O
DDI-DrugBank.d737.s2,",",41,41,O
DDI-DrugBank.d737.s2,selegiline,43,52,B-drug
DDI-DrugBank.d737.s2,did,54,56,O
DDI-DrugBank.d737.s2,not,58,60,O
DDI-DrugBank.d737.s2,influence,62,70,O
DDI-DrugBank.d737.s2,the,72,74,O
DDI-DrugBank.d737.s2,pharmacokinetics,76,91,O
DDI-DrugBank.d737.s2,of,93,94,O
DDI-DrugBank.d737.s2,pramipexole,96,106,B-drug
DDI-DrugBank.d737.s2,.,107,107,O
DDI-DrugBank.d737.s3,Amantadine,0,9,B-drug
DDI-DrugBank.d737.s3,:,10,10,O
DDI-DrugBank.d737.s3,Population,12,21,O
DDI-DrugBank.d737.s3,pharmacokinetic,23,37,O
DDI-DrugBank.d737.s3,analysis,39,46,O
DDI-DrugBank.d737.s3,suggests,48,55,O
DDI-DrugBank.d737.s3,that,57,60,O
DDI-DrugBank.d737.s3,amantadine,62,71,B-drug
DDI-DrugBank.d737.s3,is,73,74,O
DDI-DrugBank.d737.s3,unlikely,76,83,O
DDI-DrugBank.d737.s3,to,85,86,O
DDI-DrugBank.d737.s3,alter,88,92,O
DDI-DrugBank.d737.s3,the,94,96,O
DDI-DrugBank.d737.s3,oral,98,101,O
DDI-DrugBank.d737.s3,clearance,103,111,O
DDI-DrugBank.d737.s3,of,113,114,O
DDI-DrugBank.d737.s3,pramipexole,116,126,B-drug
DDI-DrugBank.d737.s3,(,128,128,O
DDI-DrugBank.d737.s3,N=,129,130,O
DDI-DrugBank.d737.s3,54,132,133,O
DDI-DrugBank.d737.s3,),134,134,O
DDI-DrugBank.d737.s3,.,135,135,O
DDI-DrugBank.d737.s4,Cimetidine,0,9,B-drug
DDI-DrugBank.d737.s4,:,10,10,O
DDI-DrugBank.d737.s4,Cimetidine,12,21,B-drug
DDI-DrugBank.d737.s4,",",22,22,O
DDI-DrugBank.d737.s4,a,24,24,O
DDI-DrugBank.d737.s4,known,26,30,O
DDI-DrugBank.d737.s4,inhibitor,32,40,O
DDI-DrugBank.d737.s4,of,42,43,O
DDI-DrugBank.d737.s4,renal,45,49,O
DDI-DrugBank.d737.s4,tubular,51,57,O
DDI-DrugBank.d737.s4,secretion,59,67,O
DDI-DrugBank.d737.s4,of,69,70,O
DDI-DrugBank.d737.s4,organic,72,78,O
DDI-DrugBank.d737.s4,bases,80,84,O
DDI-DrugBank.d737.s4,via,86,88,O
DDI-DrugBank.d737.s4,the,90,92,O
DDI-DrugBank.d737.s4,cationic,94,101,O
DDI-DrugBank.d737.s4,transport,103,111,O
DDI-DrugBank.d737.s4,system,113,118,O
DDI-DrugBank.d737.s4,",",119,119,O
DDI-DrugBank.d737.s4,caused,121,126,O
DDI-DrugBank.d737.s4,a,128,128,O
DDI-DrugBank.d737.s4,50,130,131,O
DDI-DrugBank.d737.s4,%,132,132,O
DDI-DrugBank.d737.s4,increase,134,141,O
DDI-DrugBank.d737.s4,in,143,144,O
DDI-DrugBank.d737.s4,pramipexole,146,156,B-drug
DDI-DrugBank.d737.s4,AUC,158,160,O
DDI-DrugBank.d737.s4,and,162,164,O
DDI-DrugBank.d737.s4,a,166,166,O
DDI-DrugBank.d737.s4,40,168,169,O
DDI-DrugBank.d737.s4,%,170,170,O
DDI-DrugBank.d737.s4,increase,172,179,O
DDI-DrugBank.d737.s4,in,181,182,O
DDI-DrugBank.d737.s4,half-life,184,192,O
DDI-DrugBank.d737.s4,(,194,194,O
DDI-DrugBank.d737.s4,N=,195,196,O
DDI-DrugBank.d737.s4,12,198,199,O
DDI-DrugBank.d737.s4,),200,200,O
DDI-DrugBank.d737.s4,.,201,201,O
DDI-DrugBank.d737.s5,Probenecid,0,9,B-drug
DDI-DrugBank.d737.s5,:,10,10,O
DDI-DrugBank.d737.s5,Probenecid,12,21,B-drug
DDI-DrugBank.d737.s5,",",22,22,O
DDI-DrugBank.d737.s5,a,24,24,O
DDI-DrugBank.d737.s5,known,26,30,O
DDI-DrugBank.d737.s5,inhibitor,32,40,O
DDI-DrugBank.d737.s5,of,42,43,O
DDI-DrugBank.d737.s5,renal,45,49,O
DDI-DrugBank.d737.s5,tubular,51,57,O
DDI-DrugBank.d737.s5,secretion,59,67,O
DDI-DrugBank.d737.s5,of,69,70,O
DDI-DrugBank.d737.s5,organic,72,78,O
DDI-DrugBank.d737.s5,acids,80,84,O
DDI-DrugBank.d737.s5,via,86,88,O
DDI-DrugBank.d737.s5,the,90,92,O
DDI-DrugBank.d737.s5,aruonic,94,100,O
DDI-DrugBank.d737.s5,transporter,102,112,O
DDI-DrugBank.d737.s5,",",113,113,O
DDI-DrugBank.d737.s5,did,115,117,O
DDI-DrugBank.d737.s5,not,119,121,O
DDI-DrugBank.d737.s5,noticeably,123,132,O
DDI-DrugBank.d737.s5,influence,134,142,O
DDI-DrugBank.d737.s5,pramipexole,144,154,B-drug
DDI-DrugBank.d737.s5,pharmacokinetics,156,171,O
DDI-DrugBank.d737.s5,(,173,173,O
DDI-DrugBank.d737.s5,N=,174,175,O
DDI-DrugBank.d737.s5,12,177,178,O
DDI-DrugBank.d737.s5,),179,179,O
DDI-DrugBank.d737.s5,.,180,180,O
DDI-DrugBank.d737.s6,Other,0,4,O
DDI-DrugBank.d737.s6,drugs,6,10,O
DDI-DrugBank.d737.s6,eliminated,12,21,O
DDI-DrugBank.d737.s6,via,23,25,O
DDI-DrugBank.d737.s6,renal,27,31,O
DDI-DrugBank.d737.s6,secretion,33,41,O
DDI-DrugBank.d737.s6,:,42,42,O
DDI-DrugBank.d737.s6,Population,44,53,O
DDI-DrugBank.d737.s6,pharmacokinetic,55,69,O
DDI-DrugBank.d737.s6,analysis,71,78,O
DDI-DrugBank.d737.s6,suggests,80,87,O
DDI-DrugBank.d737.s6,that,89,92,O
DDI-DrugBank.d737.s6,coadministration,94,109,O
DDI-DrugBank.d737.s6,of,111,112,O
DDI-DrugBank.d737.s6,drugs,114,118,O
DDI-DrugBank.d737.s6,that,120,123,O
DDI-DrugBank.d737.s6,are,125,127,O
DDI-DrugBank.d737.s6,secreted,129,136,O
DDI-DrugBank.d737.s6,by,138,139,O
DDI-DrugBank.d737.s6,the,141,143,O
DDI-DrugBank.d737.s6,cationic,145,152,O
DDI-DrugBank.d737.s6,transport,154,162,O
DDI-DrugBank.d737.s6,system,164,169,O
DDI-DrugBank.d737.s6,(,171,171,O
DDI-DrugBank.d737.s6,e.g.,172,175,O
DDI-DrugBank.d737.s6,",",176,176,O
DDI-DrugBank.d737.s6,cimetidine,178,187,B-drug
DDI-DrugBank.d737.s6,",",188,188,O
DDI-DrugBank.d737.s6,ranitidine,190,199,B-drug
DDI-DrugBank.d737.s6,",",200,200,O
DDI-DrugBank.d737.s6,diltiazem,202,210,B-drug
DDI-DrugBank.d737.s6,",",211,211,O
DDI-DrugBank.d737.s6,triamterene,213,223,B-drug
DDI-DrugBank.d737.s6,",",224,224,O
DDI-DrugBank.d737.s6,verapamil,226,234,B-drug
DDI-DrugBank.d737.s6,",",235,235,O
DDI-DrugBank.d737.s6,quinidine,237,245,B-drug
DDI-DrugBank.d737.s6,",",246,246,O
DDI-DrugBank.d737.s6,and,248,250,O
DDI-DrugBank.d737.s6,quinine,252,258,B-drug
DDI-DrugBank.d737.s6,),259,259,O
DDI-DrugBank.d737.s6,decreases,261,269,O
DDI-DrugBank.d737.s6,the,271,273,O
DDI-DrugBank.d737.s6,oral,275,278,O
DDI-DrugBank.d737.s6,clearance,280,288,O
DDI-DrugBank.d737.s6,of,290,291,O
DDI-DrugBank.d737.s6,pramipexole,293,303,B-drug
DDI-DrugBank.d737.s6,by,305,306,O
DDI-DrugBank.d737.s6,about,308,312,O
DDI-DrugBank.d737.s6,20,314,315,O
DDI-DrugBank.d737.s6,%,316,316,O
DDI-DrugBank.d737.s6,",",317,317,O
DDI-DrugBank.d737.s6,while,319,323,O
DDI-DrugBank.d737.s6,those,325,329,O
DDI-DrugBank.d737.s6,secreted,331,338,O
DDI-DrugBank.d737.s6,by,340,341,O
DDI-DrugBank.d737.s6,the,343,345,O
DDI-DrugBank.d737.s6,anionic,347,353,O
DDI-DrugBank.d737.s6,transport,355,363,O
DDI-DrugBank.d737.s6,system,365,370,O
DDI-DrugBank.d737.s6,(,372,372,O
DDI-DrugBank.d737.s6,e.g.,373,376,O
DDI-DrugBank.d737.s6,",",377,377,O
DDI-DrugBank.d737.s6,cephalosporins,379,392,B-group
DDI-DrugBank.d737.s6,",",393,393,O
DDI-DrugBank.d737.s6,penicillins,395,405,B-group
DDI-DrugBank.d737.s6,",",406,406,O
DDI-DrugBank.d737.s6,indomethacin,408,419,B-drug
DDI-DrugBank.d737.s6,",",420,420,O
DDI-DrugBank.d737.s6,hydrochlorothiazide,422,440,B-drug
DDI-DrugBank.d737.s6,",",441,441,O
DDI-DrugBank.d737.s6,and,443,445,O
DDI-DrugBank.d737.s6,chlorpropamide,447,460,B-drug
DDI-DrugBank.d737.s6,),461,461,O
DDI-DrugBank.d737.s6,are,463,465,O
DDI-DrugBank.d737.s6,likely,467,472,O
DDI-DrugBank.d737.s6,to,474,475,O
DDI-DrugBank.d737.s6,have,477,480,O
DDI-DrugBank.d737.s6,little,482,487,O
DDI-DrugBank.d737.s6,effect,489,494,O
DDI-DrugBank.d737.s6,on,496,497,O
DDI-DrugBank.d737.s6,the,499,501,O
DDI-DrugBank.d737.s6,oral,503,506,O
DDI-DrugBank.d737.s6,clearance,508,516,O
DDI-DrugBank.d737.s6,of,518,519,O
DDI-DrugBank.d737.s6,pramipexole,521,531,B-drug
DDI-DrugBank.d737.s6,.,532,532,O
DDI-DrugBank.d737.s7,CYP,0,2,O
DDI-DrugBank.d737.s7,interactions,4,15,O
DDI-DrugBank.d737.s7,:,16,16,O
DDI-DrugBank.d737.s7,Inhibitors,18,27,O
DDI-DrugBank.d737.s7,of,29,30,O
DDI-DrugBank.d737.s7,cytochrome,32,41,O
DDI-DrugBank.d737.s7,P450,43,46,O
DDI-DrugBank.d737.s7,enzymes,48,54,O
DDI-DrugBank.d737.s7,would,56,60,O
DDI-DrugBank.d737.s7,not,62,64,O
DDI-DrugBank.d737.s7,be,66,67,O
DDI-DrugBank.d737.s7,expected,69,76,O
DDI-DrugBank.d737.s7,to,78,79,O
DDI-DrugBank.d737.s7,affect,81,86,O
DDI-DrugBank.d737.s7,pramipexole,88,98,B-drug
DDI-DrugBank.d737.s7,elimination,100,110,O
DDI-DrugBank.d737.s7,because,112,118,O
DDI-DrugBank.d737.s7,pramipexole,120,130,B-drug
DDI-DrugBank.d737.s7,is,132,133,O
DDI-DrugBank.d737.s7,not,135,137,O
DDI-DrugBank.d737.s7,appreciably,139,149,O
DDI-DrugBank.d737.s7,metabolized,151,161,O
DDI-DrugBank.d737.s7,by,163,164,O
DDI-DrugBank.d737.s7,these,166,170,O
DDI-DrugBank.d737.s7,enzymes,172,178,O
DDI-DrugBank.d737.s7,in,180,181,O
DDI-DrugBank.d737.s7,vivo,183,186,O
DDI-DrugBank.d737.s7,or,188,189,O
DDI-DrugBank.d737.s7,in,191,192,O
DDI-DrugBank.d737.s7,vitro,194,198,O
DDI-DrugBank.d737.s7,.,199,199,O
DDI-DrugBank.d737.s8,Pramipexole,0,10,B-drug
DDI-DrugBank.d737.s8,does,12,15,O
DDI-DrugBank.d737.s8,not,17,19,O
DDI-DrugBank.d737.s8,inhibit,21,27,O
DDI-DrugBank.d737.s8,CYP,29,31,O
DDI-DrugBank.d737.s8,enzymes,33,39,O
DDI-DrugBank.d737.s8,CYPIA2,41,46,O
DDI-DrugBank.d737.s8,",",47,47,O
DDI-DrugBank.d737.s8,CYP2C9,49,54,O
DDI-DrugBank.d737.s8,",",55,55,O
DDI-DrugBank.d737.s8,CYP2CI9,57,63,O
DDI-DrugBank.d737.s8,",",64,64,O
DDI-DrugBank.d737.s8,CYP2EI,66,71,O
DDI-DrugBank.d737.s8,",",72,72,O
DDI-DrugBank.d737.s8,and,74,76,O
DDI-DrugBank.d737.s8,CYP3A4,78,83,O
DDI-DrugBank.d737.s8,.,84,84,O
DDI-DrugBank.d737.s9,Inhibition,0,9,O
DDI-DrugBank.d737.s9,of,11,12,O
DDI-DrugBank.d737.s9,CYP2D6,14,19,O
DDI-DrugBank.d737.s9,was,21,23,O
DDI-DrugBank.d737.s9,observed,25,32,O
DDI-DrugBank.d737.s9,with,34,37,O
DDI-DrugBank.d737.s9,an,39,40,O
DDI-DrugBank.d737.s9,apparent,42,49,O
DDI-DrugBank.d737.s9,Ki,51,52,O
DDI-DrugBank.d737.s9,of,54,55,O
DDI-DrugBank.d737.s9,30,57,58,O
DDI-DrugBank.d737.s9,uM,60,61,O
DDI-DrugBank.d737.s9,",",62,62,O
DDI-DrugBank.d737.s9,indicating,64,73,O
DDI-DrugBank.d737.s9,that,75,78,O
DDI-DrugBank.d737.s9,pramipexole,80,90,B-drug
DDI-DrugBank.d737.s9,will,92,95,O
DDI-DrugBank.d737.s9,not,97,99,O
DDI-DrugBank.d737.s9,inhibit,101,107,O
DDI-DrugBank.d737.s9,CYP,109,111,O
DDI-DrugBank.d737.s9,enzymes,113,119,O
DDI-DrugBank.d737.s9,at,121,122,O
DDI-DrugBank.d737.s9,plasma,124,129,O
DDI-DrugBank.d737.s9,concentrations,131,144,O
DDI-DrugBank.d737.s9,observed,146,153,O
DDI-DrugBank.d737.s9,following,155,163,O
DDI-DrugBank.d737.s9,the,165,167,O
DDI-DrugBank.d737.s9,highest,169,175,O
DDI-DrugBank.d737.s9,recommended,177,187,O
DDI-DrugBank.d737.s9,clinical,189,196,O
DDI-DrugBank.d737.s9,dose,198,201,O
DDI-DrugBank.d737.s9,(,203,203,O
DDI-DrugBank.d737.s9,1.5,204,206,O
DDI-DrugBank.d737.s9,mg,208,209,O
DDI-DrugBank.d737.s9,tid,211,213,O
DDI-DrugBank.d737.s9,),214,214,O
DDI-DrugBank.d737.s9,.,215,215,O
DDI-DrugBank.d737.s10,Dopamine,0,7,B-group
DDI-DrugBank.d737.s10,antagonists,9,19,I-group
DDI-DrugBank.d737.s10,:,20,20,O
DDI-DrugBank.d737.s10,Since,22,26,O
DDI-DrugBank.d737.s10,pramipexole,28,38,B-drug
DDI-DrugBank.d737.s10,is,40,41,O
DDI-DrugBank.d737.s10,a,43,43,O
DDI-DrugBank.d737.s10,dopamine,45,52,B-group
DDI-DrugBank.d737.s10,agonist,54,60,I-group
DDI-DrugBank.d737.s10,",",61,61,O
DDI-DrugBank.d737.s10,it,63,64,O
DDI-DrugBank.d737.s10,is,66,67,O
DDI-DrugBank.d737.s10,possible,69,76,O
DDI-DrugBank.d737.s10,that,78,81,O
DDI-DrugBank.d737.s10,dopamine,83,90,B-group
DDI-DrugBank.d737.s10,antagonists,92,102,I-group
DDI-DrugBank.d737.s10,",",103,103,O
DDI-DrugBank.d737.s10,such,105,108,O
DDI-DrugBank.d737.s10,as,110,111,O
DDI-DrugBank.d737.s10,the,113,115,O
DDI-DrugBank.d737.s10,neuroleptics,117,128,B-group
DDI-DrugBank.d737.s10,(,130,130,O
DDI-DrugBank.d737.s10,phenothiazines,131,144,B-group
DDI-DrugBank.d737.s10,",",145,145,O
DDI-DrugBank.d737.s10,butyrophenones,147,160,B-group
DDI-DrugBank.d737.s10,",",161,161,O
DDI-DrugBank.d737.s10,thioxanthenes,163,175,B-group
DDI-DrugBank.d737.s10,),176,176,O
DDI-DrugBank.d737.s10,or,178,179,O
DDI-DrugBank.d737.s10,metoclopramide,181,194,B-group
DDI-DrugBank.d737.s10,",",195,195,O
DDI-DrugBank.d737.s10,may,197,199,O
DDI-DrugBank.d737.s10,diminish,201,208,O
DDI-DrugBank.d737.s10,the,210,212,O
DDI-DrugBank.d737.s10,effectiveness,214,226,O
DDI-DrugBank.d737.s10,of,228,229,O
DDI-DrugBank.d737.s10,MIRAPEX,231,237,B-brand
DDI-DrugBank.d737.s10,.,238,238,O
DDI-DrugBank.d737.s11,Drug/,0,4,O
DDI-DrugBank.d737.s11,Laboratory,6,15,O
DDI-DrugBank.d737.s11,Test,17,20,O
DDI-DrugBank.d737.s11,Interactions,22,33,O
DDI-DrugBank.d737.s11,There,35,39,O
DDI-DrugBank.d737.s11,are,41,43,O
DDI-DrugBank.d737.s11,no,45,46,O
DDI-DrugBank.d737.s11,known,48,52,O
DDI-DrugBank.d737.s11,interactions,54,65,O
DDI-DrugBank.d737.s11,between,67,73,O
DDI-DrugBank.d737.s11,MIRAPEX,75,81,B-brand
DDI-DrugBank.d737.s11,and,83,85,O
DDI-DrugBank.d737.s11,laboratory,87,96,O
DDI-DrugBank.d737.s11,tests,98,102,O
DDI-DrugBank.d737.s11,.,103,103,O
DDI-DrugBank.d632.s0,Due,0,2,O
DDI-DrugBank.d632.s0,to,4,5,O
DDI-DrugBank.d632.s0,its,7,9,O
DDI-DrugBank.d632.s0,effects,11,17,O
DDI-DrugBank.d632.s0,on,19,20,O
DDI-DrugBank.d632.s0,gastric,22,28,O
DDI-DrugBank.d632.s0,emptying,30,37,O
DDI-DrugBank.d632.s0,",",38,38,O
DDI-DrugBank.d632.s0,SYMLIN,40,45,B-brand
DDI-DrugBank.d632.s0,therapy,47,53,O
DDI-DrugBank.d632.s0,should,55,60,O
DDI-DrugBank.d632.s0,not,62,64,O
DDI-DrugBank.d632.s0,be,66,67,O
DDI-DrugBank.d632.s0,considered,69,78,O
DDI-DrugBank.d632.s0,for,80,82,O
DDI-DrugBank.d632.s0,patients,84,91,O
DDI-DrugBank.d632.s0,taking,93,98,O
DDI-DrugBank.d632.s0,drugs,100,104,O
DDI-DrugBank.d632.s0,that,106,109,O
DDI-DrugBank.d632.s0,alter,111,115,O
DDI-DrugBank.d632.s0,gastrointestinal,117,132,O
DDI-DrugBank.d632.s0,motility,134,141,O
DDI-DrugBank.d632.s0,(,143,143,O
DDI-DrugBank.d632.s0,e.g.,144,147,O
DDI-DrugBank.d632.s0,",",148,148,O
DDI-DrugBank.d632.s0,anticholinergic,150,164,B-group
DDI-DrugBank.d632.s0,agents,166,171,I-group
DDI-DrugBank.d632.s0,such,173,176,O
DDI-DrugBank.d632.s0,as,178,179,O
DDI-DrugBank.d632.s0,atropine,181,188,B-drug
DDI-DrugBank.d632.s0,),189,189,O
DDI-DrugBank.d632.s0,and,191,193,O
DDI-DrugBank.d632.s0,agents,195,200,O
DDI-DrugBank.d632.s0,that,202,205,O
DDI-DrugBank.d632.s0,slow,207,210,O
DDI-DrugBank.d632.s0,the,212,214,O
DDI-DrugBank.d632.s0,intestinal,216,225,O
DDI-DrugBank.d632.s0,absorption,227,236,O
DDI-DrugBank.d632.s0,of,238,239,O
DDI-DrugBank.d632.s0,nutrients,241,249,O
DDI-DrugBank.d632.s0,(,251,251,O
DDI-DrugBank.d632.s0,e.g.,252,255,O
DDI-DrugBank.d632.s0,",",256,256,O
DDI-DrugBank.d632.s0,alpha,258,262,B-group
DDI-DrugBank.d632.s0,glucosidase,264,274,I-group
DDI-DrugBank.d632.s0,inhibitors,276,285,I-group
DDI-DrugBank.d632.s0,),286,286,O
DDI-DrugBank.d632.s0,.,287,287,O
DDI-DrugBank.d632.s1,Patients,0,7,O
DDI-DrugBank.d632.s1,using,9,13,O
DDI-DrugBank.d632.s1,these,15,19,O
DDI-DrugBank.d632.s1,drugs,21,25,O
DDI-DrugBank.d632.s1,have,27,30,O
DDI-DrugBank.d632.s1,not,32,34,O
DDI-DrugBank.d632.s1,been,36,39,O
DDI-DrugBank.d632.s1,studied,41,47,O
DDI-DrugBank.d632.s1,in,49,50,O
DDI-DrugBank.d632.s1,clinical,52,59,O
DDI-DrugBank.d632.s1,trials,61,66,O
DDI-DrugBank.d632.s1,.,67,67,O
DDI-DrugBank.d632.s2,SYMLIN,0,5,B-brand
DDI-DrugBank.d632.s2,has,7,9,O
DDI-DrugBank.d632.s2,the,11,13,O
DDI-DrugBank.d632.s2,potential,15,23,O
DDI-DrugBank.d632.s2,to,25,26,O
DDI-DrugBank.d632.s2,delay,28,32,O
DDI-DrugBank.d632.s2,the,34,36,O
DDI-DrugBank.d632.s2,absorption,38,47,O
DDI-DrugBank.d632.s2,of,49,50,O
DDI-DrugBank.d632.s2,concomitantly,52,64,O
DDI-DrugBank.d632.s2,administered,66,77,O
DDI-DrugBank.d632.s2,oral,79,82,O
DDI-DrugBank.d632.s2,medications,84,94,O
DDI-DrugBank.d632.s2,.,95,95,O
DDI-DrugBank.d632.s3,When,0,3,O
DDI-DrugBank.d632.s3,the,5,7,O
DDI-DrugBank.d632.s3,rapid,9,13,O
DDI-DrugBank.d632.s3,onset,15,19,O
DDI-DrugBank.d632.s3,of,21,22,O
DDI-DrugBank.d632.s3,a,24,24,O
DDI-DrugBank.d632.s3,concomitant,26,36,O
DDI-DrugBank.d632.s3,orally,38,43,O
DDI-DrugBank.d632.s3,administered,45,56,O
DDI-DrugBank.d632.s3,agent,58,62,O
DDI-DrugBank.d632.s3,is,64,65,O
DDI-DrugBank.d632.s3,a,67,67,O
DDI-DrugBank.d632.s3,critical,69,76,O
DDI-DrugBank.d632.s3,determinant,78,88,O
DDI-DrugBank.d632.s3,of,90,91,O
DDI-DrugBank.d632.s3,effectiveness,93,105,O
DDI-DrugBank.d632.s3,(,107,107,O
DDI-DrugBank.d632.s3,such,108,111,O
DDI-DrugBank.d632.s3,as,113,114,O
DDI-DrugBank.d632.s3,analgesics,116,125,B-group
DDI-DrugBank.d632.s3,),126,126,O
DDI-DrugBank.d632.s3,",",127,127,O
DDI-DrugBank.d632.s3,the,129,131,O
DDI-DrugBank.d632.s3,agent,133,137,O
DDI-DrugBank.d632.s3,should,139,144,O
DDI-DrugBank.d632.s3,be,146,147,O
DDI-DrugBank.d632.s3,administered,149,160,O
DDI-DrugBank.d632.s3,at,162,163,O
DDI-DrugBank.d632.s3,least,165,169,O
DDI-DrugBank.d632.s3,1,171,171,O
DDI-DrugBank.d632.s3,hour,173,176,O
DDI-DrugBank.d632.s3,prior,178,182,O
DDI-DrugBank.d632.s3,to,184,185,O
DDI-DrugBank.d632.s3,or,187,188,O
DDI-DrugBank.d632.s3,2,190,190,O
DDI-DrugBank.d632.s3,hours,192,196,O
DDI-DrugBank.d632.s3,after,198,202,O
DDI-DrugBank.d632.s3,SYMLIN,204,209,B-brand
DDI-DrugBank.d632.s3,injection,211,219,O
DDI-DrugBank.d632.s3,.,220,220,O
DDI-DrugBank.d632.s4,In,0,1,O
DDI-DrugBank.d632.s4,clinical,3,10,O
DDI-DrugBank.d632.s4,trials,12,17,O
DDI-DrugBank.d632.s4,",",18,18,O
DDI-DrugBank.d632.s4,the,20,22,O
DDI-DrugBank.d632.s4,concomitant,24,34,O
DDI-DrugBank.d632.s4,use,36,38,O
DDI-DrugBank.d632.s4,of,40,41,O
DDI-DrugBank.d632.s4,sulfonylureas,43,55,B-group
DDI-DrugBank.d632.s4,or,57,58,O
DDI-DrugBank.d632.s4,biguanides,60,69,B-group
DDI-DrugBank.d632.s4,did,71,73,O
DDI-DrugBank.d632.s4,not,75,77,O
DDI-DrugBank.d632.s4,alter,79,83,O
DDI-DrugBank.d632.s4,the,85,87,O
DDI-DrugBank.d632.s4,adverse,89,95,O
DDI-DrugBank.d632.s4,event,97,101,O
DDI-DrugBank.d632.s4,profile,103,109,O
DDI-DrugBank.d632.s4,of,111,112,O
DDI-DrugBank.d632.s4,SYMLIN,114,119,B-brand
DDI-DrugBank.d632.s4,.,120,120,O
DDI-DrugBank.d632.s5,No,0,1,O
DDI-DrugBank.d632.s5,formal,3,8,O
DDI-DrugBank.d632.s5,interaction,10,20,O
DDI-DrugBank.d632.s5,studies,22,28,O
DDI-DrugBank.d632.s5,have,30,33,O
DDI-DrugBank.d632.s5,been,35,38,O
DDI-DrugBank.d632.s5,performed,40,48,O
DDI-DrugBank.d632.s5,to,50,51,O
DDI-DrugBank.d632.s5,assess,53,58,O
DDI-DrugBank.d632.s5,the,60,62,O
DDI-DrugBank.d632.s5,effect,64,69,O
DDI-DrugBank.d632.s5,of,71,72,O
DDI-DrugBank.d632.s5,SYMLIN,74,79,B-brand
DDI-DrugBank.d632.s5,on,81,82,O
DDI-DrugBank.d632.s5,the,84,86,O
DDI-DrugBank.d632.s5,kinetics,88,95,O
DDI-DrugBank.d632.s5,of,97,98,O
DDI-DrugBank.d632.s5,oral,100,103,O
DDI-DrugBank.d632.s5,antidiabetic,105,116,B-group
DDI-DrugBank.d632.s5,agents,118,123,I-group
DDI-DrugBank.d632.s5,.,124,124,O
DDI-DrugBank.d632.s6,Mixing,0,5,O
DDI-DrugBank.d632.s6,SYMLIN,7,12,B-brand
DDI-DrugBank.d632.s6,and,14,16,O
DDI-DrugBank.d632.s6,Insulin,18,24,B-drug
DDI-DrugBank.d632.s6,The,26,28,O
DDI-DrugBank.d632.s6,pharmacokinetic,30,44,O
DDI-DrugBank.d632.s6,parameters,46,55,O
DDI-DrugBank.d632.s6,of,57,58,O
DDI-DrugBank.d632.s6,SYMLIN,60,65,B-brand
DDI-DrugBank.d632.s6,were,67,70,O
DDI-DrugBank.d632.s6,altered,72,78,O
DDI-DrugBank.d632.s6,when,80,83,O
DDI-DrugBank.d632.s6,mixed,85,89,O
DDI-DrugBank.d632.s6,with,91,94,O
DDI-DrugBank.d632.s6,regular,96,102,O
DDI-DrugBank.d632.s6,",",103,103,O
DDI-DrugBank.d632.s6,NPH,105,107,O
DDI-DrugBank.d632.s6,",",108,108,O
DDI-DrugBank.d632.s6,and,110,112,O
DDI-DrugBank.d632.s6,70/30,114,118,O
DDI-DrugBank.d632.s6,premixed,120,127,O
DDI-DrugBank.d632.s6,formulations,129,140,O
DDI-DrugBank.d632.s6,of,142,143,O
DDI-DrugBank.d632.s6,recombinant,145,155,O
DDI-DrugBank.d632.s6,human,157,161,B-drug
DDI-DrugBank.d632.s6,insulin,163,169,I-drug
DDI-DrugBank.d632.s6,immediately,171,181,O
DDI-DrugBank.d632.s6,prior,183,187,O
DDI-DrugBank.d632.s6,to,189,190,O
DDI-DrugBank.d632.s6,injection,192,200,O
DDI-DrugBank.d632.s6,.,201,201,O
DDI-DrugBank.d632.s7,Thus,0,3,O
DDI-DrugBank.d632.s7,",",4,4,O
DDI-DrugBank.d632.s7,SYMLIN,6,11,B-brand
DDI-DrugBank.d632.s7,and,13,15,O
DDI-DrugBank.d632.s7,insulin,17,23,B-drug
DDI-DrugBank.d632.s7,should,25,30,O
DDI-DrugBank.d632.s7,not,32,34,O
DDI-DrugBank.d632.s7,be,36,37,O
DDI-DrugBank.d632.s7,mixed,39,43,O
DDI-DrugBank.d632.s7,and,45,47,O
DDI-DrugBank.d632.s7,must,49,52,O
DDI-DrugBank.d632.s7,be,54,55,O
DDI-DrugBank.d632.s7,administered,57,68,O
DDI-DrugBank.d632.s7,separately,70,79,O
DDI-DrugBank.d632.s7,.,80,80,O
DDI-DrugBank.d734.s0,Thiazide,0,7,B-group
DDI-DrugBank.d734.s0,diuretics,9,17,I-group
DDI-DrugBank.d734.s0,may,19,21,O
DDI-DrugBank.d734.s0,accentuate,23,32,O
DDI-DrugBank.d734.s0,the,34,36,O
DDI-DrugBank.d734.s0,orthostatic,38,48,O
DDI-DrugBank.d734.s0,hypotension,50,60,O
DDI-DrugBank.d734.s0,that,62,65,O
DDI-DrugBank.d734.s0,may,67,69,O
DDI-DrugBank.d734.s0,occur,71,75,O
DDI-DrugBank.d734.s0,with,77,80,O
DDI-DrugBank.d734.s0,phenothiazines,82,95,B-group
DDI-DrugBank.d734.s0,.,96,96,O
DDI-DrugBank.d734.s1,Antihypertensive,0,15,O
DDI-DrugBank.d734.s1,effects,17,23,O
DDI-DrugBank.d734.s1,of,25,26,O
DDI-DrugBank.d734.s1,guanethidine,28,39,B-drug
DDI-DrugBank.d734.s1,and,41,43,O
DDI-DrugBank.d734.s1,related,45,51,O
DDI-DrugBank.d734.s1,compounds,53,61,O
DDI-DrugBank.d734.s1,may,63,65,O
DDI-DrugBank.d734.s1,be,67,68,O
DDI-DrugBank.d734.s1,counteracted,70,81,O
DDI-DrugBank.d734.s1,when,83,86,O
DDI-DrugBank.d734.s1,phenothiazines,88,101,B-group
DDI-DrugBank.d734.s1,are,103,105,O
DDI-DrugBank.d734.s1,used,107,110,O
DDI-DrugBank.d734.s1,concomitantly,112,124,O
DDI-DrugBank.d734.s1,.,125,125,O
DDI-DrugBank.d734.s2,Concomitant,0,10,O
DDI-DrugBank.d734.s2,administration,12,25,O
DDI-DrugBank.d734.s2,of,27,28,O
DDI-DrugBank.d734.s2,propranolol,30,40,B-drug
DDI-DrugBank.d734.s2,with,42,45,O
DDI-DrugBank.d734.s2,phenothiazines,47,60,B-group
DDI-DrugBank.d734.s2,results,62,68,O
DDI-DrugBank.d734.s2,in,70,71,O
DDI-DrugBank.d734.s2,increased,73,81,O
DDI-DrugBank.d734.s2,plasma,83,88,O
DDI-DrugBank.d734.s2,levels,90,95,O
DDI-DrugBank.d734.s2,of,97,98,O
DDI-DrugBank.d734.s2,both,100,103,O
DDI-DrugBank.d734.s2,drugs,105,109,O
DDI-DrugBank.d734.s2,.,110,110,O
DDI-DrugBank.d590.s0,Coadministration,0,15,O
DDI-DrugBank.d590.s0,of,17,18,O
DDI-DrugBank.d590.s0,TRITEC,20,25,B-brand
DDI-DrugBank.d590.s0,with,27,30,O
DDI-DrugBank.d590.s0,clarithromycin,32,45,B-drug
DDI-DrugBank.d590.s0,resulted,47,54,O
DDI-DrugBank.d590.s0,in,56,57,O
DDI-DrugBank.d590.s0,increased,59,67,O
DDI-DrugBank.d590.s0,plasma,69,74,O
DDI-DrugBank.d590.s0,ranitidine,76,85,B-drug
DDI-DrugBank.d590.s0,concentrations,87,100,O
DDI-DrugBank.d590.s0,(,102,102,O
DDI-DrugBank.d590.s0,57,103,104,O
DDI-DrugBank.d590.s0,%,105,105,O
DDI-DrugBank.d590.s0,),106,106,O
DDI-DrugBank.d590.s0,",",107,107,O
DDI-DrugBank.d590.s0,increased,109,117,O
DDI-DrugBank.d590.s0,plasma,119,124,O
DDI-DrugBank.d590.s0,bismuth,126,132,O
DDI-DrugBank.d590.s0,trough,134,139,O
DDI-DrugBank.d590.s0,concentrations,141,154,O
DDI-DrugBank.d590.s0,(,156,156,O
DDI-DrugBank.d590.s0,48,157,158,O
DDI-DrugBank.d590.s0,%,159,159,O
DDI-DrugBank.d590.s0,),160,160,O
DDI-DrugBank.d590.s0,",",161,161,O
DDI-DrugBank.d590.s0,and,163,165,O
DDI-DrugBank.d590.s0,increased,167,175,O
DDI-DrugBank.d590.s0,14-,177,179,B-drug_n
DDI-DrugBank.d590.s0,hydroxy-,181,188,I-drug_n
DDI-DrugBank.d590.s0,clarithromycin,190,203,I-drug_n
DDI-DrugBank.d590.s0,plasma,205,210,O
DDI-DrugBank.d590.s0,concentrations,212,225,O
DDI-DrugBank.d590.s0,(,227,227,O
DDI-DrugBank.d590.s0,31,228,229,O
DDI-DrugBank.d590.s0,%,230,230,O
DDI-DrugBank.d590.s0,),231,231,O
DDI-DrugBank.d590.s0,.,232,232,O
DDI-DrugBank.d590.s1,Coadministration,0,15,O
DDI-DrugBank.d590.s1,with,17,20,O
DDI-DrugBank.d590.s1,aspirin,22,28,B-brand
DDI-DrugBank.d590.s1,results,30,36,O
DDI-DrugBank.d590.s1,in,38,39,O
DDI-DrugBank.d590.s1,a,41,41,O
DDI-DrugBank.d590.s1,slight,43,48,O
DDI-DrugBank.d590.s1,decrease,50,57,O
DDI-DrugBank.d590.s1,in,59,60,O
DDI-DrugBank.d590.s1,the,62,64,O
DDI-DrugBank.d590.s1,rate,66,69,O
DDI-DrugBank.d590.s1,of,71,72,O
DDI-DrugBank.d590.s1,salicylate,74,83,B-group
DDI-DrugBank.d590.s1,absorption,85,94,O
DDI-DrugBank.d590.s1,that,96,99,O
DDI-DrugBank.d590.s1,is,101,102,O
DDI-DrugBank.d590.s1,clinically,104,113,O
DDI-DrugBank.d590.s1,unimportant,115,125,O
DDI-DrugBank.d590.s1,.,126,126,O
DDI-DrugBank.d590.s2,Coadministration,0,15,O
DDI-DrugBank.d590.s2,with,17,20,O
DDI-DrugBank.d590.s2,a,22,22,O
DDI-DrugBank.d590.s2,high,24,27,O
DDI-DrugBank.d590.s2,dose,29,32,O
DDI-DrugBank.d590.s2,of,34,35,O
DDI-DrugBank.d590.s2,antacid,37,43,B-group
DDI-DrugBank.d590.s2,(,45,45,O
DDI-DrugBank.d590.s2,170,46,48,O
DDI-DrugBank.d590.s2,mEq,50,52,O
DDI-DrugBank.d590.s2,),53,53,O
DDI-DrugBank.d590.s2,results,55,61,O
DDI-DrugBank.d590.s2,in,63,64,O
DDI-DrugBank.d590.s2,a,66,66,O
DDI-DrugBank.d590.s2,28,68,69,O
DDI-DrugBank.d590.s2,%,70,70,O
DDI-DrugBank.d590.s2,decrease,72,79,O
DDI-DrugBank.d590.s2,in,81,82,O
DDI-DrugBank.d590.s2,plasma,84,89,O
DDI-DrugBank.d590.s2,concentrations,91,104,O
DDI-DrugBank.d590.s2,of,106,107,O
DDI-DrugBank.d590.s2,ranitidine,109,118,B-drug
DDI-DrugBank.d590.s2,and,120,122,O
DDI-DrugBank.d590.s2,may,124,126,O
DDI-DrugBank.d590.s2,decrease,128,135,O
DDI-DrugBank.d590.s2,plasma,137,142,O
DDI-DrugBank.d590.s2,concentrations,144,157,O
DDI-DrugBank.d590.s2,of,159,160,O
DDI-DrugBank.d590.s2,bismuth,162,168,O
DDI-DrugBank.d590.s2,from,170,173,O
DDI-DrugBank.d590.s2,TRITEC,175,180,B-brand
DDI-DrugBank.d590.s2,.,181,181,O
DDI-DrugBank.d590.s3,These,0,4,O
DDI-DrugBank.d590.s3,effects,6,12,O
DDI-DrugBank.d590.s3,are,14,16,O
DDI-DrugBank.d590.s3,clinically,18,27,O
DDI-DrugBank.d590.s3,insignificant,29,41,O
DDI-DrugBank.d590.s3,.,42,42,O
DDI-DrugBank.d590.s4,For,0,2,O
DDI-DrugBank.d590.s4,information,4,14,O
DDI-DrugBank.d590.s4,on,16,17,O
DDI-DrugBank.d590.s4,drug,19,22,O
DDI-DrugBank.d590.s4,interactions,24,35,O
DDI-DrugBank.d590.s4,associated,37,46,O
DDI-DrugBank.d590.s4,with,48,51,O
DDI-DrugBank.d590.s4,ranitidine,53,62,B-drug
DDI-DrugBank.d590.s4,",",63,63,O
DDI-DrugBank.d590.s4,refer,65,69,O
DDI-DrugBank.d590.s4,to,71,72,O
DDI-DrugBank.d590.s4,the,74,76,O
DDI-DrugBank.d590.s4,ZANTAC,78,83,B-brand
DDI-DrugBank.d590.s4,package,89,95,O
DDI-DrugBank.d590.s4,insert,97,102,O
DDI-DrugBank.d590.s4,.,103,103,O
DDI-DrugBank.d654.s0,Co-administration,0,16,O
DDI-DrugBank.d654.s0,of,18,19,O
DDI-DrugBank.d654.s0,oral,21,24,O
DDI-DrugBank.d654.s0,ketoconazole,26,37,B-drug
DDI-DrugBank.d654.s0,200,39,41,O
DDI-DrugBank.d654.s0,mg,43,44,O
DDI-DrugBank.d654.s0,twice,46,50,O
DDI-DrugBank.d654.s0,daily,52,56,O
DDI-DrugBank.d654.s0,increased,58,66,O
DDI-DrugBank.d654.s0,retapamulin,68,78,B-drug
DDI-DrugBank.d654.s0,geometric,80,88,O
DDI-DrugBank.d654.s0,mean,90,93,O
DDI-DrugBank.d654.s0,AUC,95,97,O
DDI-DrugBank.d654.s0,(,98,98,O
DDI-DrugBank.d654.s0,0-24,99,102,O
DDI-DrugBank.d654.s0,),103,103,O
DDI-DrugBank.d654.s0,and,105,107,O
DDI-DrugBank.d654.s0,Cmax,109,112,O
DDI-DrugBank.d654.s0,by,114,115,O
DDI-DrugBank.d654.s0,81,117,118,O
DDI-DrugBank.d654.s0,%,119,119,O
DDI-DrugBank.d654.s0,after,121,125,O
DDI-DrugBank.d654.s0,topical,127,133,O
DDI-DrugBank.d654.s0,application,135,145,O
DDI-DrugBank.d654.s0,of,147,148,O
DDI-DrugBank.d654.s0,retapamulin,150,160,B-drug
DDI-DrugBank.d654.s0,ointment,162,169,O
DDI-DrugBank.d654.s0,",",170,170,O
DDI-DrugBank.d654.s0,1,172,172,O
DDI-DrugBank.d654.s0,%,173,173,O
DDI-DrugBank.d654.s0,on,175,176,O
DDI-DrugBank.d654.s0,the,178,180,O
DDI-DrugBank.d654.s0,abraded,182,188,O
DDI-DrugBank.d654.s0,skin,190,193,O
DDI-DrugBank.d654.s0,of,195,196,O
DDI-DrugBank.d654.s0,healthy,198,204,O
DDI-DrugBank.d654.s0,adult,206,210,O
DDI-DrugBank.d654.s0,males,212,216,O
DDI-DrugBank.d654.s0,.,217,217,O
DDI-DrugBank.d654.s1,Due,0,2,O
DDI-DrugBank.d654.s1,to,4,5,O
DDI-DrugBank.d654.s1,low,7,9,O
DDI-DrugBank.d654.s1,systemic,11,18,O
DDI-DrugBank.d654.s1,exposure,20,27,O
DDI-DrugBank.d654.s1,to,29,30,O
DDI-DrugBank.d654.s1,retapamulin,32,42,B-drug
DDI-DrugBank.d654.s1,following,44,52,O
DDI-DrugBank.d654.s1,topical,54,60,O
DDI-DrugBank.d654.s1,application,62,72,O
DDI-DrugBank.d654.s1,in,74,75,O
DDI-DrugBank.d654.s1,patients,77,84,O
DDI-DrugBank.d654.s1,",",85,85,O
DDI-DrugBank.d654.s1,dosage,87,92,O
DDI-DrugBank.d654.s1,adjustments,94,104,O
DDI-DrugBank.d654.s1,for,106,108,O
DDI-DrugBank.d654.s1,retapamulin,110,120,B-drug
DDI-DrugBank.d654.s1,are,122,124,O
DDI-DrugBank.d654.s1,unnecessary,126,136,O
DDI-DrugBank.d654.s1,when,138,141,O
DDI-DrugBank.d654.s1,co-administered,143,157,O
DDI-DrugBank.d654.s1,with,159,162,O
DDI-DrugBank.d654.s1,CYP3A4,164,169,O
DDI-DrugBank.d654.s1,inhibitors,171,180,O
DDI-DrugBank.d654.s1,",",181,181,O
DDI-DrugBank.d654.s1,such,183,186,O
DDI-DrugBank.d654.s1,as,188,189,O
DDI-DrugBank.d654.s1,ketoconazole,191,202,B-drug
DDI-DrugBank.d654.s1,.,203,203,O
DDI-DrugBank.d654.s2,Based,0,4,O
DDI-DrugBank.d654.s2,on,6,7,O
DDI-DrugBank.d654.s2,in,9,10,O
DDI-DrugBank.d654.s2,vitro,12,16,O
DDI-DrugBank.d654.s2,P450,18,21,O
DDI-DrugBank.d654.s2,inhibition,23,32,O
DDI-DrugBank.d654.s2,studies,34,40,O
DDI-DrugBank.d654.s2,and,42,44,O
DDI-DrugBank.d654.s2,the,46,48,O
DDI-DrugBank.d654.s2,low,50,52,O
DDI-DrugBank.d654.s2,systemic,54,61,O
DDI-DrugBank.d654.s2,exposure,63,70,O
DDI-DrugBank.d654.s2,observed,72,79,O
DDI-DrugBank.d654.s2,following,81,89,O
DDI-DrugBank.d654.s2,topical,91,97,O
DDI-DrugBank.d654.s2,application,99,109,O
DDI-DrugBank.d654.s2,of,111,112,O
DDI-DrugBank.d654.s2,ALTABAX,114,120,B-brand
DDI-DrugBank.d654.s2,",",121,121,O
DDI-DrugBank.d654.s2,retapamulin,123,133,B-drug
DDI-DrugBank.d654.s2,is,135,136,O
DDI-DrugBank.d654.s2,unlikely,138,145,O
DDI-DrugBank.d654.s2,to,147,148,O
DDI-DrugBank.d654.s2,affect,150,155,O
DDI-DrugBank.d654.s2,the,157,159,O
DDI-DrugBank.d654.s2,metabolism,161,170,O
DDI-DrugBank.d654.s2,of,172,173,O
DDI-DrugBank.d654.s2,other,175,179,O
DDI-DrugBank.d654.s2,P450,181,184,O
DDI-DrugBank.d654.s2,substrates,186,195,O
DDI-DrugBank.d654.s2,.,196,196,O
DDI-DrugBank.d654.s3,The,0,2,O
DDI-DrugBank.d654.s3,effect,4,9,O
DDI-DrugBank.d654.s3,of,11,12,O
DDI-DrugBank.d654.s3,concurrent,14,23,O
DDI-DrugBank.d654.s3,application,25,35,O
DDI-DrugBank.d654.s3,of,37,38,O
DDI-DrugBank.d654.s3,ALTABAX,40,46,B-brand
DDI-DrugBank.d654.s3,and,48,50,O
DDI-DrugBank.d654.s3,other,52,56,O
DDI-DrugBank.d654.s3,topical,58,64,O
DDI-DrugBank.d654.s3,products,66,73,O
DDI-DrugBank.d654.s3,to,75,76,O
DDI-DrugBank.d654.s3,the,78,80,O
DDI-DrugBank.d654.s3,same,82,85,O
DDI-DrugBank.d654.s3,area,87,90,O
DDI-DrugBank.d654.s3,of,92,93,O
DDI-DrugBank.d654.s3,skin,95,98,O
DDI-DrugBank.d654.s3,has,100,102,O
DDI-DrugBank.d654.s3,not,104,106,O
DDI-DrugBank.d654.s3,been,108,111,O
DDI-DrugBank.d654.s3,studied,113,119,O
DDI-DrugBank.d654.s3,.,120,120,O
DDI-DrugBank.d124.s0,DRUG,0,3,O
DDI-DrugBank.d124.s0,INTERACTIONS,5,16,O
DDI-DrugBank.d124.s1,Several,0,6,O
DDI-DrugBank.d124.s1,drug,8,11,O
DDI-DrugBank.d124.s1,interaction,13,23,O
DDI-DrugBank.d124.s1,studies,25,31,O
DDI-DrugBank.d124.s1,have,33,36,O
DDI-DrugBank.d124.s1,been,38,41,O
DDI-DrugBank.d124.s1,completed,43,51,O
DDI-DrugBank.d124.s1,with,53,56,O
DDI-DrugBank.d124.s1,both,58,61,O
DDI-DrugBank.d124.s1,INVIRASE,63,70,B-brand
DDI-DrugBank.d124.s1,and,72,74,O
DDI-DrugBank.d124.s1,FORTOVASE,76,84,B-brand
DDI-DrugBank.d124.s1,.,85,85,O
DDI-DrugBank.d124.s2,Observations,0,11,O
DDI-DrugBank.d124.s2,from,13,16,O
DDI-DrugBank.d124.s2,drug,18,21,O
DDI-DrugBank.d124.s2,interaction,23,33,O
DDI-DrugBank.d124.s2,studies,35,41,O
DDI-DrugBank.d124.s2,with,43,46,O
DDI-DrugBank.d124.s2,FORTOVASE,48,56,B-brand
DDI-DrugBank.d124.s2,may,58,60,O
DDI-DrugBank.d124.s2,not,62,64,O
DDI-DrugBank.d124.s2,be,66,67,O
DDI-DrugBank.d124.s2,predictive,69,78,O
DDI-DrugBank.d124.s2,for,80,82,O
DDI-DrugBank.d124.s2,INVIRASE,84,91,B-brand
DDI-DrugBank.d124.s2,.,92,92,O
DDI-DrugBank.d124.s3,Because,0,6,O
DDI-DrugBank.d124.s3,ritonavir,8,16,B-drug
DDI-DrugBank.d124.s3,is,18,19,O
DDI-DrugBank.d124.s3,coadministered,21,34,O
DDI-DrugBank.d124.s3,",",35,35,O
DDI-DrugBank.d124.s3,prescribers,37,47,O
DDI-DrugBank.d124.s3,should,49,54,O
DDI-DrugBank.d124.s3,also,56,59,O
DDI-DrugBank.d124.s3,refer,61,65,O
DDI-DrugBank.d124.s3,to,67,68,O
DDI-DrugBank.d124.s3,the,70,72,O
DDI-DrugBank.d124.s3,prescribing,74,84,O
DDI-DrugBank.d124.s3,information,86,96,O
DDI-DrugBank.d124.s3,for,98,100,O
DDI-DrugBank.d124.s3,ritonavir,102,110,B-drug
DDI-DrugBank.d124.s3,regarding,112,120,O
DDI-DrugBank.d124.s3,drug,122,125,O
DDI-DrugBank.d124.s3,interactions,127,138,O
DDI-DrugBank.d124.s3,associated,140,149,O
DDI-DrugBank.d124.s3,with,151,154,O
DDI-DrugBank.d124.s3,this,156,159,O
DDI-DrugBank.d124.s3,agent,161,165,O
DDI-DrugBank.d124.s3,.,166,166,O
DDI-DrugBank.d124.s4,The,0,2,O
DDI-DrugBank.d124.s4,metabolism,4,13,O
DDI-DrugBank.d124.s4,of,15,16,O
DDI-DrugBank.d124.s4,saquinavir,18,27,B-drug
DDI-DrugBank.d124.s4,is,29,30,O
DDI-DrugBank.d124.s4,mediated,32,39,O
DDI-DrugBank.d124.s4,by,41,42,O
DDI-DrugBank.d124.s4,cytochrome,44,53,O
DDI-DrugBank.d124.s4,P450,55,58,O
DDI-DrugBank.d124.s4,",",59,59,O
DDI-DrugBank.d124.s4,with,61,64,O
DDI-DrugBank.d124.s4,the,66,68,O
DDI-DrugBank.d124.s4,specific,70,77,O
DDI-DrugBank.d124.s4,isoenzyme,79,87,O
DDI-DrugBank.d124.s4,CYP3A4,89,94,O
DDI-DrugBank.d124.s4,responsible,96,106,O
DDI-DrugBank.d124.s4,for,108,110,O
DDI-DrugBank.d124.s4,90,112,113,O
DDI-DrugBank.d124.s4,%,114,114,O
DDI-DrugBank.d124.s4,of,116,117,O
DDI-DrugBank.d124.s4,the,119,121,O
DDI-DrugBank.d124.s4,hepatic,123,129,O
DDI-DrugBank.d124.s4,metabolism,131,140,O
DDI-DrugBank.d124.s4,.,141,141,O
DDI-DrugBank.d124.s5,Additionally,0,11,O
DDI-DrugBank.d124.s5,",",12,12,O
DDI-DrugBank.d124.s5,saquinavir,14,23,B-drug
DDI-DrugBank.d124.s5,is,25,26,O
DDI-DrugBank.d124.s5,a,28,28,O
DDI-DrugBank.d124.s5,substrate,30,38,O
DDI-DrugBank.d124.s5,for,40,42,O
DDI-DrugBank.d124.s5,P-Glycoprotein,44,57,O
DDI-DrugBank.d124.s5,(,59,59,O
DDI-DrugBank.d124.s5,Pgp,60,62,O
DDI-DrugBank.d124.s5,),63,63,O
DDI-DrugBank.d124.s5,.,64,64,O
DDI-DrugBank.d124.s6,Therefore,0,8,O
DDI-DrugBank.d124.s6,",",9,9,O
DDI-DrugBank.d124.s6,drugs,11,15,O
DDI-DrugBank.d124.s6,that,17,20,O
DDI-DrugBank.d124.s6,affect,22,27,O
DDI-DrugBank.d124.s6,CYP3A4,29,34,O
DDI-DrugBank.d124.s6,and/or,36,41,O
DDI-DrugBank.d124.s6,Pgp,43,45,O
DDI-DrugBank.d124.s6,",",46,46,O
DDI-DrugBank.d124.s6,may,48,50,O
DDI-DrugBank.d124.s6,modify,52,57,O
DDI-DrugBank.d124.s6,the,59,61,O
DDI-DrugBank.d124.s6,pharmacokinetics,63,78,O
DDI-DrugBank.d124.s6,of,80,81,O
DDI-DrugBank.d124.s6,saquinavir,83,92,B-drug
DDI-DrugBank.d124.s6,.,93,93,O
DDI-DrugBank.d124.s7,Similarly,0,8,O
DDI-DrugBank.d124.s7,",",9,9,O
DDI-DrugBank.d124.s7,saquinavir,11,20,B-drug
DDI-DrugBank.d124.s7,might,22,26,O
DDI-DrugBank.d124.s7,also,28,31,O
DDI-DrugBank.d124.s7,modify,33,38,O
DDI-DrugBank.d124.s7,the,40,42,O
DDI-DrugBank.d124.s7,pharmacokinetics,44,59,O
DDI-DrugBank.d124.s7,of,61,62,O
DDI-DrugBank.d124.s7,other,64,68,O
DDI-DrugBank.d124.s7,drugs,70,74,O
DDI-DrugBank.d124.s7,that,76,79,O
DDI-DrugBank.d124.s7,are,81,83,O
DDI-DrugBank.d124.s7,substrates,85,94,O
DDI-DrugBank.d124.s7,for,96,98,O
DDI-DrugBank.d124.s7,CYP3A4,100,105,O
DDI-DrugBank.d124.s7,or,107,108,O
DDI-DrugBank.d124.s7,Pgp,110,112,O
DDI-DrugBank.d124.s7,.,113,113,O
DDI-DrugBank.d124.s8,Drugs,0,4,O
DDI-DrugBank.d124.s8,that,6,9,O
DDI-DrugBank.d124.s8,are,11,13,O
DDI-DrugBank.d124.s8,contraindicated,15,29,O
DDI-DrugBank.d124.s8,specifically,31,42,O
DDI-DrugBank.d124.s8,due,44,46,O
DDI-DrugBank.d124.s8,to,48,49,O
DDI-DrugBank.d124.s8,the,51,53,O
DDI-DrugBank.d124.s8,expected,55,62,O
DDI-DrugBank.d124.s8,magnitude,64,72,O
DDI-DrugBank.d124.s8,of,74,75,O
DDI-DrugBank.d124.s8,interaction,77,87,O
DDI-DrugBank.d124.s8,and,89,91,O
DDI-DrugBank.d124.s8,potential,93,101,O
DDI-DrugBank.d124.s8,for,103,105,O
DDI-DrugBank.d124.s8,serious,107,113,O
DDI-DrugBank.d124.s8,adverse,115,121,O
DDI-DrugBank.d124.s8,events,123,128,O
DDI-DrugBank.d124.s8,are,130,132,O
DDI-DrugBank.d124.s8,listed,134,139,O
DDI-DrugBank.d124.s8,CONTRAINDICATIONS,141,157,O
DDI-DrugBank.d124.s8,.,158,158,O
DDI-DrugBank.d124.s9,Additional,0,9,O
DDI-DrugBank.d124.s9,drugs,11,15,O
DDI-DrugBank.d124.s9,that,17,20,O
DDI-DrugBank.d124.s9,are,22,24,O
DDI-DrugBank.d124.s9,not,26,28,O
DDI-DrugBank.d124.s9,recommended,30,40,O
DDI-DrugBank.d124.s9,for,42,44,O
DDI-DrugBank.d124.s9,coadministration,46,61,O
DDI-DrugBank.d124.s9,with,63,66,O
DDI-DrugBank.d124.s9,INVIRASE,68,75,B-brand
DDI-DrugBank.d124.s9,and,77,79,O
DDI-DrugBank.d124.s9,ritonavir,81,89,B-drug
DDI-DrugBank.d124.s9,are,91,93,O
DDI-DrugBank.d124.s9,included,95,102,O
DDI-DrugBank.d124.s9,below,104,108,O
DDI-DrugBank.d124.s9,.,109,109,O
DDI-DrugBank.d124.s10,These,0,4,O
DDI-DrugBank.d124.s10,recommendations,6,20,O
DDI-DrugBank.d124.s10,are,22,24,O
DDI-DrugBank.d124.s10,based,26,30,O
DDI-DrugBank.d124.s10,on,32,33,O
DDI-DrugBank.d124.s10,either,35,40,O
DDI-DrugBank.d124.s10,drug,42,45,O
DDI-DrugBank.d124.s10,interaction,47,57,O
DDI-DrugBank.d124.s10,studies,59,65,O
DDI-DrugBank.d124.s10,or,67,68,O
DDI-DrugBank.d124.s10,predicted,70,78,O
DDI-DrugBank.d124.s10,interactions,80,91,O
DDI-DrugBank.d124.s10,due,93,95,O
DDI-DrugBank.d124.s10,to,97,98,O
DDI-DrugBank.d124.s10,the,100,102,O
DDI-DrugBank.d124.s10,expected,104,111,O
DDI-DrugBank.d124.s10,magnitude,113,121,O
DDI-DrugBank.d124.s10,of,123,124,O
DDI-DrugBank.d124.s10,interaction,126,136,O
DDI-DrugBank.d124.s10,and,138,140,O
DDI-DrugBank.d124.s10,potential,142,150,O
DDI-DrugBank.d124.s10,for,152,154,O
DDI-DrugBank.d124.s10,serious,156,162,O
DDI-DrugBank.d124.s10,events,164,169,O
DDI-DrugBank.d124.s10,or,171,172,O
DDI-DrugBank.d124.s10,loss,174,177,O
DDI-DrugBank.d124.s10,of,179,180,O
DDI-DrugBank.d124.s10,efficacy,182,189,O
DDI-DrugBank.d124.s10,.,190,190,O
DDI-DrugBank.d124.s11,With,0,3,O
DDI-DrugBank.d124.s11,some,5,8,O
DDI-DrugBank.d124.s11,agents,10,15,O
DDI-DrugBank.d124.s11,",",16,16,O
DDI-DrugBank.d124.s11,the,18,20,O
DDI-DrugBank.d124.s11,metabolism,22,31,O
DDI-DrugBank.d124.s11,may,33,35,O
DDI-DrugBank.d124.s11,be,37,38,O
DDI-DrugBank.d124.s11,induced,40,46,O
DDI-DrugBank.d124.s11,",",47,47,O
DDI-DrugBank.d124.s11,resulting,49,57,O
DDI-DrugBank.d124.s11,in,59,60,O
DDI-DrugBank.d124.s11,decreased,62,70,O
DDI-DrugBank.d124.s11,concentrations,72,85,O
DDI-DrugBank.d124.s11,.,86,86,O
DDI-DrugBank.d124.s12,Drugs,0,4,O
DDI-DrugBank.d124.s12,That,6,9,O
DDI-DrugBank.d124.s12,Should,11,16,O
DDI-DrugBank.d124.s12,Not,18,20,O
DDI-DrugBank.d124.s12,Be,22,23,O
DDI-DrugBank.d124.s12,Coadministered,25,38,O
DDI-DrugBank.d124.s12,With,40,43,O
DDI-DrugBank.d124.s12,INVIRASE/Ritonavir,45,62,O
DDI-DrugBank.d124.s13,Drug,0,3,O
DDI-DrugBank.d124.s13,Class,5,9,O
DDI-DrugBank.d124.s13,:,10,10,O
DDI-DrugBank.d124.s13,Drug,12,15,O
DDI-DrugBank.d124.s13,Name,17,20,O
DDI-DrugBank.d124.s13,Clinical,22,29,O
DDI-DrugBank.d124.s13,Comment,31,37,O
DDI-DrugBank.d124.s14,Antiarrhythmics,0,14,B-group
DDI-DrugBank.d124.s14,:,15,15,O
DDI-DrugBank.d124.s14,Amiodarone,17,26,B-drug
DDI-DrugBank.d124.s14,",",27,27,O
DDI-DrugBank.d124.s14,bepridil,29,36,B-drug
DDI-DrugBank.d124.s14,",",37,37,O
DDI-DrugBank.d124.s14,flecainide,39,48,B-drug
DDI-DrugBank.d124.s14,",",49,49,O
DDI-DrugBank.d124.s14,propafenone,51,61,B-drug
DDI-DrugBank.d124.s14,",",62,62,O
DDI-DrugBank.d124.s14,quinidine,64,72,B-drug
DDI-DrugBank.d124.s14,CONTRAINDICATED,74,88,O
DDI-DrugBank.d124.s14,due,90,92,O
DDI-DrugBank.d124.s14,to,94,95,O
DDI-DrugBank.d124.s14,potential,97,105,O
DDI-DrugBank.d124.s14,for,107,109,O
DDI-DrugBank.d124.s14,serious,111,117,O
DDI-DrugBank.d124.s14,and/or,119,124,O
DDI-DrugBank.d124.s14,life-threatening,126,141,O
DDI-DrugBank.d124.s14,reactions,143,151,O
DDI-DrugBank.d124.s14,.,152,152,O
DDI-DrugBank.d124.s15,Antihistamines,0,13,B-drug
DDI-DrugBank.d124.s15,:,14,14,O
DDI-DrugBank.d124.s15,astemizole,16,25,B-drug
DDI-DrugBank.d124.s15,*,26,26,O
DDI-DrugBank.d124.s15,",",27,27,O
DDI-DrugBank.d124.s15,terfenadine,29,39,B-drug
DDI-DrugBank.d124.s15,*,40,40,O
DDI-DrugBank.d124.s15,CONTRAINDICATED,42,56,O
DDI-DrugBank.d124.s15,due,58,60,O
DDI-DrugBank.d124.s15,to,62,63,O
DDI-DrugBank.d124.s15,potential,65,73,O
DDI-DrugBank.d124.s15,for,75,77,O
DDI-DrugBank.d124.s15,serious,79,85,O
DDI-DrugBank.d124.s15,and/or,87,92,O
DDI-DrugBank.d124.s15,life-threatening,94,109,O
DDI-DrugBank.d124.s15,cardiac,111,117,O
DDI-DrugBank.d124.s15,arrhythmias,119,129,O
DDI-DrugBank.d124.s15,.,130,130,O
DDI-DrugBank.d124.s16,Ergot,0,4,B-group
DDI-DrugBank.d124.s16,Derivatives,6,16,I-group
DDI-DrugBank.d124.s16,:,17,17,O
DDI-DrugBank.d124.s16,Dihydroergotamine,19,35,B-drug
DDI-DrugBank.d124.s16,",",36,36,O
DDI-DrugBank.d124.s16,ergonovine,38,47,B-drug
DDI-DrugBank.d124.s16,",",48,48,O
DDI-DrugBank.d124.s16,ergotamine,50,59,B-drug
DDI-DrugBank.d124.s16,",",60,60,O
DDI-DrugBank.d124.s16,methylergonovine,62,77,B-drug
DDI-DrugBank.d124.s16,CONTRAINDICATED,79,93,O
DDI-DrugBank.d124.s16,due,95,97,O
DDI-DrugBank.d124.s16,to,99,100,O
DDI-DrugBank.d124.s16,potential,102,110,O
DDI-DrugBank.d124.s16,for,112,114,O
DDI-DrugBank.d124.s16,serious,116,122,O
DDI-DrugBank.d124.s16,and,124,126,O
DDI-DrugBank.d124.s16,life-threatening,128,143,O
DDI-DrugBank.d124.s16,reactions,145,153,O
DDI-DrugBank.d124.s16,such,155,158,O
DDI-DrugBank.d124.s16,as,160,161,O
DDI-DrugBank.d124.s16,acute,163,167,O
DDI-DrugBank.d124.s16,ergot,169,173,B-group
DDI-DrugBank.d124.s16,toxicity,175,182,O
DDI-DrugBank.d124.s16,characterized,184,196,O
DDI-DrugBank.d124.s16,by,198,199,O
DDI-DrugBank.d124.s16,peripheral,201,210,O
DDI-DrugBank.d124.s16,vasospasm,212,220,O
DDI-DrugBank.d124.s16,and,222,224,O
DDI-DrugBank.d124.s16,ischemia,226,233,O
DDI-DrugBank.d124.s16,of,235,236,O
DDI-DrugBank.d124.s16,the,238,240,O
DDI-DrugBank.d124.s16,extremities,242,252,O
DDI-DrugBank.d124.s16,and,254,256,O
DDI-DrugBank.d124.s16,other,258,262,O
DDI-DrugBank.d124.s16,tissues,264,270,O
DDI-DrugBank.d124.s16,.,271,271,O
DDI-DrugBank.d124.s17,Antimycobacterial,0,16,B-group
DDI-DrugBank.d124.s17,Agents,18,23,I-group
DDI-DrugBank.d124.s17,:,24,24,O
DDI-DrugBank.d124.s17,rifampin,26,33,B-drug
DDI-DrugBank.d124.s17,CONTRAINDICATED,35,49,O
DDI-DrugBank.d124.s17,since,51,55,O
DDI-DrugBank.d124.s17,the,57,59,O
DDI-DrugBank.d124.s17,coadministration,61,76,O
DDI-DrugBank.d124.s17,of,78,79,O
DDI-DrugBank.d124.s17,this,81,84,O
DDI-DrugBank.d124.s17,product,86,92,O
DDI-DrugBank.d124.s17,with,94,97,O
DDI-DrugBank.d124.s17,saquinavir,99,108,B-drug
DDI-DrugBank.d124.s17,in,110,111,O
DDI-DrugBank.d124.s17,an,113,114,O
DDI-DrugBank.d124.s17,antiretroviral,116,129,B-group
DDI-DrugBank.d124.s17,regimen,131,137,O
DDI-DrugBank.d124.s17,reduces,139,145,O
DDI-DrugBank.d124.s17,the,147,149,O
DDI-DrugBank.d124.s17,plasma,151,156,O
DDI-DrugBank.d124.s17,concentrations,158,171,O
DDI-DrugBank.d124.s17,of,173,174,O
DDI-DrugBank.d124.s17,saquinavir,176,185,B-drug
DDI-DrugBank.d124.s17,.,186,186,O
DDI-DrugBank.d124.s18,Garlic,0,5,O
DDI-DrugBank.d124.s18,Capsules,7,14,O
DDI-DrugBank.d124.s18,Garlic,16,21,O
DDI-DrugBank.d124.s18,capsules,23,30,O
DDI-DrugBank.d124.s18,should,32,37,O
DDI-DrugBank.d124.s18,not,39,41,O
DDI-DrugBank.d124.s18,be,43,44,O
DDI-DrugBank.d124.s18,used,46,49,O
DDI-DrugBank.d124.s18,while,51,55,O
DDI-DrugBank.d124.s18,taking,57,62,O
DDI-DrugBank.d124.s18,saquinavir,64,73,B-drug
DDI-DrugBank.d124.s18,(,75,75,O
DDI-DrugBank.d124.s18,FORTOVASE,76,84,B-brand
DDI-DrugBank.d124.s18,),85,85,O
DDI-DrugBank.d124.s18,as,87,88,O
DDI-DrugBank.d124.s18,the,90,92,O
DDI-DrugBank.d124.s18,sole,94,97,O
DDI-DrugBank.d124.s18,protease,99,106,B-group
DDI-DrugBank.d124.s18,inhibitor,108,116,I-group
DDI-DrugBank.d124.s18,due,118,120,O
DDI-DrugBank.d124.s18,to,122,123,O
DDI-DrugBank.d124.s18,the,125,127,O
DDI-DrugBank.d124.s18,risk,129,132,O
DDI-DrugBank.d124.s18,of,134,135,O
DDI-DrugBank.d124.s18,decreased,137,145,O
DDI-DrugBank.d124.s18,saquinavir,147,156,B-drug
DDI-DrugBank.d124.s18,plasma,158,163,O
DDI-DrugBank.d124.s18,concentrations,165,178,O
DDI-DrugBank.d124.s18,.,179,179,O
DDI-DrugBank.d124.s19,No,0,1,O
DDI-DrugBank.d124.s19,data,3,6,O
DDI-DrugBank.d124.s19,are,8,10,O
DDI-DrugBank.d124.s19,available,12,20,O
DDI-DrugBank.d124.s19,for,22,24,O
DDI-DrugBank.d124.s19,the,26,28,O
DDI-DrugBank.d124.s19,coadministration,30,45,O
DDI-DrugBank.d124.s19,of,47,48,O
DDI-DrugBank.d124.s19,INVIRASE/ritonavir,50,67,O
DDI-DrugBank.d124.s19,or,69,70,O
DDI-DrugBank.d124.s19,FORTOVASE/ritonavir,72,90,O
DDI-DrugBank.d124.s19,and,92,94,O
DDI-DrugBank.d124.s19,garlic,96,101,O
DDI-DrugBank.d124.s19,capsules,103,110,O
DDI-DrugBank.d124.s19,.,111,111,O
DDI-DrugBank.d124.s20,GI,0,1,O
DDI-DrugBank.d124.s20,Motility,3,10,O
DDI-DrugBank.d124.s20,Agent,12,16,O
DDI-DrugBank.d124.s20,:,17,17,O
DDI-DrugBank.d124.s20,cisapride,19,27,B-drug
DDI-DrugBank.d124.s20,*,28,28,O
DDI-DrugBank.d124.s20,CONTRAINDICATED,30,44,O
DDI-DrugBank.d124.s20,due,46,48,O
DDI-DrugBank.d124.s20,to,50,51,O
DDI-DrugBank.d124.s20,potential,53,61,O
DDI-DrugBank.d124.s20,for,63,65,O
DDI-DrugBank.d124.s20,serious,67,73,O
DDI-DrugBank.d124.s20,and/or,75,80,O
DDI-DrugBank.d124.s20,life-threatening,82,97,O
DDI-DrugBank.d124.s20,reactions,99,107,O
DDI-DrugBank.d124.s20,such,109,112,O
DDI-DrugBank.d124.s20,as,114,115,O
DDI-DrugBank.d124.s20,cardiac,117,123,O
DDI-DrugBank.d124.s20,arrhythmias,125,135,O
DDI-DrugBank.d124.s20,.,136,136,O
DDI-DrugBank.d124.s21,Herbal,0,5,O
DDI-DrugBank.d124.s21,Products,7,14,O
DDI-DrugBank.d124.s21,:,15,15,O
DDI-DrugBank.d124.s21,St.,17,19,O
DDI-DrugBank.d124.s21,John,21,24,O
DDI-DrugBank.d124.s21,s,26,26,O
DDI-DrugBank.d124.s21,wort,28,31,O
DDI-DrugBank.d124.s21,(,33,33,O
DDI-DrugBank.d124.s21,hypericum,34,42,O
DDI-DrugBank.d124.s21,perforatum,44,53,O
DDI-DrugBank.d124.s21,),54,54,O
DDI-DrugBank.d124.s21,WARNING,56,62,O
DDI-DrugBank.d124.s21,coadministration,64,79,O
DDI-DrugBank.d124.s21,may,81,83,O
DDI-DrugBank.d124.s21,lead,85,88,O
DDI-DrugBank.d124.s21,to,90,91,O
DDI-DrugBank.d124.s21,loss,93,96,O
DDI-DrugBank.d124.s21,of,98,99,O
DDI-DrugBank.d124.s21,virologic,101,109,O
DDI-DrugBank.d124.s21,response,111,118,O
DDI-DrugBank.d124.s21,and,120,122,O
DDI-DrugBank.d124.s21,possible,124,131,O
DDI-DrugBank.d124.s21,resistance,133,142,O
DDI-DrugBank.d124.s21,to,144,145,O
DDI-DrugBank.d124.s21,INVIRASE,147,154,B-brand
DDI-DrugBank.d124.s21,or,156,157,O
DDI-DrugBank.d124.s21,to,159,160,O
DDI-DrugBank.d124.s21,the,162,164,O
DDI-DrugBank.d124.s21,class,166,170,O
DDI-DrugBank.d124.s21,of,172,173,O
DDI-DrugBank.d124.s21,protease,175,182,O
DDI-DrugBank.d124.s21,inhibitors,184,193,O
DDI-DrugBank.d124.s21,.,194,194,O
DDI-DrugBank.d124.s22,HMG-CoA,0,6,B-group
DDI-DrugBank.d124.s22,Reductase,8,16,I-group
DDI-DrugBank.d124.s22,Inhibitors,18,27,I-group
DDI-DrugBank.d124.s22,:,28,28,O
DDI-DrugBank.d124.s22,lovastatin,30,39,B-drug
DDI-DrugBank.d124.s22,",",40,40,O
DDI-DrugBank.d124.s22,simvastatin,42,52,B-drug
DDI-DrugBank.d124.s22,WARNING,54,60,O
DDI-DrugBank.d124.s22,potential,62,70,O
DDI-DrugBank.d124.s22,for,72,74,O
DDI-DrugBank.d124.s22,serious,76,82,O
DDI-DrugBank.d124.s22,reactions,84,92,O
DDI-DrugBank.d124.s22,such,94,97,O
DDI-DrugBank.d124.s22,as,99,100,O
DDI-DrugBank.d124.s22,risk,102,105,O
DDI-DrugBank.d124.s22,of,107,108,O
DDI-DrugBank.d124.s22,myopathy,110,117,O
DDI-DrugBank.d124.s22,including,119,127,O
DDI-DrugBank.d124.s22,rhabdomyolysis,129,142,O
DDI-DrugBank.d124.s22,.,143,143,O
DDI-DrugBank.d124.s23,Sedatives/Hypnotics,0,18,O
DDI-DrugBank.d124.s23,:,19,19,O
DDI-DrugBank.d124.s23,triazolam,21,29,B-drug
DDI-DrugBank.d124.s23,",",30,30,O
DDI-DrugBank.d124.s23,midazolam,32,40,B-drug
DDI-DrugBank.d124.s23,CONTRAINDICATED,42,56,O
DDI-DrugBank.d124.s23,due,58,60,O
DDI-DrugBank.d124.s23,to,62,63,O
DDI-DrugBank.d124.s23,potential,65,73,O
DDI-DrugBank.d124.s23,for,75,77,O
DDI-DrugBank.d124.s23,serious,79,85,O
DDI-DrugBank.d124.s23,and/or,87,92,O
DDI-DrugBank.d124.s23,life-threatening,94,109,O
DDI-DrugBank.d124.s23,reactions,111,119,O
DDI-DrugBank.d124.s23,such,121,124,O
DDI-DrugBank.d124.s23,as,126,127,O
DDI-DrugBank.d124.s23,prolonged,129,137,O
DDI-DrugBank.d124.s23,or,139,140,O
DDI-DrugBank.d124.s23,increased,142,150,O
DDI-DrugBank.d124.s23,sedation,152,159,O
DDI-DrugBank.d124.s23,or,161,162,O
DDI-DrugBank.d124.s23,respiratory,164,174,O
DDI-DrugBank.d124.s23,depression,176,185,O
DDI-DrugBank.d124.s23,.,186,186,O
DDI-DrugBank.d124.s24,*,0,0,O
DDI-DrugBank.d124.s24,No,2,3,O
DDI-DrugBank.d124.s24,longer,5,10,O
DDI-DrugBank.d124.s24,marketed,12,19,O
DDI-DrugBank.d124.s24,in,21,22,O
DDI-DrugBank.d124.s24,the,24,26,O
DDI-DrugBank.d124.s24,US,28,29,O
DDI-DrugBank.d124.s24,.,30,30,O
DDI-DrugBank.d124.s25,Drugs,0,4,O
DDI-DrugBank.d124.s25,That,6,9,O
DDI-DrugBank.d124.s25,Are,11,13,O
DDI-DrugBank.d124.s25,Mainly,15,20,O
DDI-DrugBank.d124.s25,Metabolized,22,32,O
DDI-DrugBank.d124.s25,by,34,35,O
DDI-DrugBank.d124.s25,CYP3A4,37,42,O
DDI-DrugBank.d124.s26,Although,0,7,O
DDI-DrugBank.d124.s26,specific,9,16,O
DDI-DrugBank.d124.s26,studies,18,24,O
DDI-DrugBank.d124.s26,have,26,29,O
DDI-DrugBank.d124.s26,not,31,33,O
DDI-DrugBank.d124.s26,been,35,38,O
DDI-DrugBank.d124.s26,performed,40,48,O
DDI-DrugBank.d124.s26,",",49,49,O
DDI-DrugBank.d124.s26,coadministration,51,66,O
DDI-DrugBank.d124.s26,with,68,71,O
DDI-DrugBank.d124.s26,drugs,73,77,O
DDI-DrugBank.d124.s26,that,79,82,O
DDI-DrugBank.d124.s26,are,84,86,O
DDI-DrugBank.d124.s26,mainly,88,93,O
DDI-DrugBank.d124.s26,metabolized,95,105,O
DDI-DrugBank.d124.s26,by,107,108,O
DDI-DrugBank.d124.s26,CYP3A4,110,115,O
DDI-DrugBank.d124.s26,(,117,117,O
DDI-DrugBank.d124.s26,eg,118,119,O
DDI-DrugBank.d124.s26,",",120,120,O
DDI-DrugBank.d124.s26,calcium,122,128,B-group
DDI-DrugBank.d124.s26,channel,130,136,I-group
DDI-DrugBank.d124.s26,blockers,138,145,I-group
DDI-DrugBank.d124.s26,",",146,146,O
DDI-DrugBank.d124.s26,dapsone,148,154,B-drug
DDI-DrugBank.d124.s26,",",155,155,O
DDI-DrugBank.d124.s26,disopyramide,157,168,B-drug
DDI-DrugBank.d124.s26,",",169,169,O
DDI-DrugBank.d124.s26,quinine,171,177,B-drug
DDI-DrugBank.d124.s26,",",178,178,O
DDI-DrugBank.d124.s26,amiodarone,180,189,B-drug
DDI-DrugBank.d124.s26,",",190,190,O
DDI-DrugBank.d124.s26,quinidine,192,200,B-drug
DDI-DrugBank.d124.s26,",",201,201,O
DDI-DrugBank.d124.s26,warfarin,203,210,B-drug
DDI-DrugBank.d124.s26,",",211,211,O
DDI-DrugBank.d124.s26,tacrolimus,213,222,B-drug
DDI-DrugBank.d124.s26,",",223,223,O
DDI-DrugBank.d124.s26,cyclosporine,225,236,B-drug
DDI-DrugBank.d124.s26,",",237,237,O
DDI-DrugBank.d124.s26,ergot,239,243,B-group
DDI-DrugBank.d124.s26,derivatives,245,255,I-group
DDI-DrugBank.d124.s26,",",256,256,O
DDI-DrugBank.d124.s26,pimozide,258,265,B-drug
DDI-DrugBank.d124.s26,",",266,266,O
DDI-DrugBank.d124.s26,carbamazepine,268,280,B-drug
DDI-DrugBank.d124.s26,",",281,281,O
DDI-DrugBank.d124.s26,fentanyl,283,290,B-drug
DDI-DrugBank.d124.s26,",",291,291,O
DDI-DrugBank.d124.s26,alfentanyl,293,302,B-drug
DDI-DrugBank.d124.s26,",",303,303,O
DDI-DrugBank.d124.s26,alprazolam,305,314,B-drug
DDI-DrugBank.d124.s26,",",315,315,O
DDI-DrugBank.d124.s26,and,317,319,O
DDI-DrugBank.d124.s26,triazolam,321,329,B-drug
DDI-DrugBank.d124.s26,),330,330,O
DDI-DrugBank.d124.s26,may,332,334,O
DDI-DrugBank.d124.s26,have,336,339,O
DDI-DrugBank.d124.s26,elevated,341,348,O
DDI-DrugBank.d124.s26,plasma,350,355,O
DDI-DrugBank.d124.s26,concentrations,357,370,O
DDI-DrugBank.d124.s26,when,372,375,O
DDI-DrugBank.d124.s26,coadministered,377,390,O
DDI-DrugBank.d124.s26,with,392,395,O
DDI-DrugBank.d124.s26,saquinavir,397,406,B-drug
DDI-DrugBank.d124.s26,;,407,407,O
DDI-DrugBank.d124.s27,therefore,0,8,O
DDI-DrugBank.d124.s27,",",9,9,O
DDI-DrugBank.d124.s27,these,11,15,O
DDI-DrugBank.d124.s27,combinations,17,28,O
DDI-DrugBank.d124.s27,should,30,35,O
DDI-DrugBank.d124.s27,be,37,38,O
DDI-DrugBank.d124.s27,used,40,43,O
DDI-DrugBank.d124.s27,with,45,48,O
DDI-DrugBank.d124.s27,caution,50,56,O
DDI-DrugBank.d124.s27,.,57,57,O
DDI-DrugBank.d124.s28,Since,0,4,O
DDI-DrugBank.d124.s28,INVIRASE,6,13,B-brand
DDI-DrugBank.d124.s28,is,15,16,O
DDI-DrugBank.d124.s28,coadministered,18,31,O
DDI-DrugBank.d124.s28,with,33,36,O
DDI-DrugBank.d124.s28,ritonavir,38,46,B-drug
DDI-DrugBank.d124.s28,",",47,47,O
DDI-DrugBank.d124.s28,the,49,51,O
DDI-DrugBank.d124.s28,ritonavir,53,61,B-drug
DDI-DrugBank.d124.s28,label,63,67,O
DDI-DrugBank.d124.s28,should,69,74,O
DDI-DrugBank.d124.s28,be,76,77,O
DDI-DrugBank.d124.s28,reviewed,79,86,O
DDI-DrugBank.d124.s28,for,88,90,O
DDI-DrugBank.d124.s28,additional,92,101,O
DDI-DrugBank.d124.s28,drugs,103,107,O
DDI-DrugBank.d124.s28,that,109,112,O
DDI-DrugBank.d124.s28,should,114,119,O
DDI-DrugBank.d124.s28,not,121,123,O
DDI-DrugBank.d124.s28,be,125,126,O
DDI-DrugBank.d124.s28,coadministered,128,141,O
DDI-DrugBank.d124.s28,.,142,142,O
DDI-DrugBank.d124.s29,Inducers,0,7,O
DDI-DrugBank.d124.s29,of,9,10,O
DDI-DrugBank.d124.s29,CYP3A4,12,17,O
DDI-DrugBank.d124.s30,Coadministration,0,15,O
DDI-DrugBank.d124.s30,with,17,20,O
DDI-DrugBank.d124.s30,compounds,22,30,O
DDI-DrugBank.d124.s30,that,32,35,O
DDI-DrugBank.d124.s30,are,37,39,O
DDI-DrugBank.d124.s30,potent,41,46,O
DDI-DrugBank.d124.s30,inducers,48,55,O
DDI-DrugBank.d124.s30,of,57,58,O
DDI-DrugBank.d124.s30,CYP3A4,60,65,O
DDI-DrugBank.d124.s30,(,67,67,O
DDI-DrugBank.d124.s30,eg,68,69,O
DDI-DrugBank.d124.s30,",",70,70,O
DDI-DrugBank.d124.s30,phenobarbital,72,84,B-drug
DDI-DrugBank.d124.s30,",",85,85,O
DDI-DrugBank.d124.s30,phenytoin,87,95,B-drug
DDI-DrugBank.d124.s30,",",96,96,O
DDI-DrugBank.d124.s30,dexamethasone,98,110,B-drug
DDI-DrugBank.d124.s30,",",111,111,O
DDI-DrugBank.d124.s30,carbamazepine,113,125,B-drug
DDI-DrugBank.d124.s30,),126,126,O
DDI-DrugBank.d124.s30,may,128,130,O
DDI-DrugBank.d124.s30,result,132,137,O
DDI-DrugBank.d124.s30,in,139,140,O
DDI-DrugBank.d124.s30,decreased,142,150,O
DDI-DrugBank.d124.s30,plasma,152,157,O
DDI-DrugBank.d124.s30,levels,159,164,O
DDI-DrugBank.d124.s30,of,166,167,O
DDI-DrugBank.d124.s30,saquinavir,169,178,B-drug
DDI-DrugBank.d124.s30,.,179,179,O
DDI-DrugBank.d694.s0,Digoxin,0,6,B-drug
DDI-DrugBank.d694.s0,:,7,7,O
DDI-DrugBank.d694.s0,There,9,13,O
DDI-DrugBank.d694.s0,was,15,17,O
DDI-DrugBank.d694.s0,a,19,19,O
DDI-DrugBank.d694.s0,slight,21,26,O
DDI-DrugBank.d694.s0,increase,28,35,O
DDI-DrugBank.d694.s0,in,37,38,O
DDI-DrugBank.d694.s0,the,40,42,O
DDI-DrugBank.d694.s0,area,44,47,O
DDI-DrugBank.d694.s0,under,49,53,O
DDI-DrugBank.d694.s0,the,55,57,O
DDI-DrugBank.d694.s0,curve,59,63,O
DDI-DrugBank.d694.s0,(,65,65,O
DDI-DrugBank.d694.s0,AUC,66,68,O
DDI-DrugBank.d694.s0,",",69,69,O
DDI-DrugBank.d694.s0,11,71,72,O
DDI-DrugBank.d694.s0,%,73,73,O
DDI-DrugBank.d694.s0,),74,74,O
DDI-DrugBank.d694.s0,and,76,78,O
DDI-DrugBank.d694.s0,mean,80,83,O
DDI-DrugBank.d694.s0,peak,85,88,O
DDI-DrugBank.d694.s0,drug,90,93,O
DDI-DrugBank.d694.s0,concentration,95,107,O
DDI-DrugBank.d694.s0,(,109,109,O
DDI-DrugBank.d694.s0,Cmax,110,113,O
DDI-DrugBank.d694.s0,",",114,114,O
DDI-DrugBank.d694.s0,18,116,117,O
DDI-DrugBank.d694.s0,%,118,118,O
DDI-DrugBank.d694.s0,),119,119,O
DDI-DrugBank.d694.s0,of,121,122,O
DDI-DrugBank.d694.s0,digoxin,124,130,B-drug
DDI-DrugBank.d694.s0,with,132,135,O
DDI-DrugBank.d694.s0,the,137,139,O
DDI-DrugBank.d694.s0,co-administration,141,157,O
DDI-DrugBank.d694.s0,of,159,160,O
DDI-DrugBank.d694.s0,100,162,164,O
DDI-DrugBank.d694.s0,mg,166,167,O
DDI-DrugBank.d694.s0,sitagliptin,169,179,B-drug
DDI-DrugBank.d694.s0,for,181,183,O
DDI-DrugBank.d694.s0,10,185,186,O
DDI-DrugBank.d694.s0,days,188,191,O
DDI-DrugBank.d694.s0,.,192,192,O
DDI-DrugBank.d694.s1,Patients,0,7,O
DDI-DrugBank.d694.s1,receiving,9,17,O
DDI-DrugBank.d694.s1,digoxin,19,25,B-drug
DDI-DrugBank.d694.s1,should,27,32,O
DDI-DrugBank.d694.s1,be,34,35,O
DDI-DrugBank.d694.s1,monitored,37,45,O
DDI-DrugBank.d694.s1,appropriately,47,59,O
DDI-DrugBank.d694.s1,.,60,60,O
DDI-DrugBank.d694.s2,No,0,1,O
DDI-DrugBank.d694.s2,dosage,3,8,O
DDI-DrugBank.d694.s2,adjustment,10,19,O
DDI-DrugBank.d694.s2,of,21,22,O
DDI-DrugBank.d694.s2,digoxin,24,30,B-drug
DDI-DrugBank.d694.s2,or,32,33,O
DDI-DrugBank.d694.s2,JANUVIA,35,41,B-brand
DDI-DrugBank.d694.s2,is,43,44,O
DDI-DrugBank.d694.s2,recommended,46,56,O
DDI-DrugBank.d694.s2,.,57,57,O
DDI-DrugBank.d65.s0,Sulfacetamide,0,12,B-drug
DDI-DrugBank.d65.s0,preparations,14,25,O
DDI-DrugBank.d65.s0,are,27,29,O
DDI-DrugBank.d65.s0,incompatible,31,42,O
DDI-DrugBank.d65.s0,with,44,47,O
DDI-DrugBank.d65.s0,silver,49,54,B-drug
DDI-DrugBank.d65.s0,preparations,56,67,O
DDI-DrugBank.d65.s0,.,68,68,O
DDI-DrugBank.d179.s0,Interations,0,10,O
DDI-DrugBank.d179.s1,Sulfapyridine,0,12,B-drug
DDI-DrugBank.d179.s1,may,14,16,O
DDI-DrugBank.d179.s1,interact,18,25,O
DDI-DrugBank.d179.s1,with,27,30,O
DDI-DrugBank.d179.s1,any,32,34,O
DDI-DrugBank.d179.s1,of,36,37,O
DDI-DrugBank.d179.s1,the,39,41,O
DDI-DrugBank.d179.s1,following,43,51,O
DDI-DrugBank.d179.s1,:,52,52,O
DDI-DrugBank.d179.s1,-,54,54,O
DDI-DrugBank.d179.s1,Acetaminophen,56,68,B-drug
DDI-DrugBank.d179.s1,(,70,70,O
DDI-DrugBank.d179.s1,e.g.,71,74,O
DDI-DrugBank.d179.s1,",",75,75,O
DDI-DrugBank.d179.s1,Tylenol,77,83,B-brand
DDI-DrugBank.d179.s1,),84,84,O
DDI-DrugBank.d179.s1,(,86,86,O
DDI-DrugBank.d179.s1,with,87,90,O
DDI-DrugBank.d179.s1,long-term,92,100,O
DDI-DrugBank.d179.s1,",",101,101,O
DDI-DrugBank.d179.s1,high-dose,103,111,O
DDI-DrugBank.d179.s1,use,113,115,O
DDI-DrugBank.d179.s1,),116,116,O
DDI-DrugBank.d179.s1,or,118,119,O
DDI-DrugBank.d179.s2,-,0,0,O
DDI-DrugBank.d179.s2,Amiodarone,2,11,B-drug
DDI-DrugBank.d179.s2,(,13,13,O
DDI-DrugBank.d179.s2,e.g.,14,17,O
DDI-DrugBank.d179.s2,",",18,18,O
DDI-DrugBank.d179.s2,Cordarone,20,28,B-brand
DDI-DrugBank.d179.s2,),29,29,O
DDI-DrugBank.d179.s2,or,31,32,O
DDI-DrugBank.d179.s3,-,0,0,O
DDI-DrugBank.d179.s3,Anabolic,2,9,B-group
DDI-DrugBank.d179.s3,steroids,11,18,I-group
DDI-DrugBank.d179.s3,(,20,20,O
DDI-DrugBank.d179.s3,nandrolone,21,30,B-drug
DDI-DrugBank.d179.s3,[,32,32,O
DDI-DrugBank.d179.s3,e.g.,33,36,O
DDI-DrugBank.d179.s3,",",37,37,O
DDI-DrugBank.d179.s3,Anabolin,39,46,B-brand
DDI-DrugBank.d179.s3,],47,47,O
DDI-DrugBank.d179.s3,",",48,48,O
DDI-DrugBank.d179.s3,oxandrolone,50,60,B-drug
DDI-DrugBank.d179.s3,[,62,62,O
DDI-DrugBank.d179.s3,e.g.,63,66,O
DDI-DrugBank.d179.s3,",",67,67,O
DDI-DrugBank.d179.s3,Anavar,69,74,B-brand
DDI-DrugBank.d179.s3,],75,75,O
DDI-DrugBank.d179.s3,",",76,76,O
DDI-DrugBank.d179.s3,oxymetholone,78,89,B-drug
DDI-DrugBank.d179.s3,[,91,91,O
DDI-DrugBank.d179.s3,e.g.,92,95,O
DDI-DrugBank.d179.s3,",",96,96,O
DDI-DrugBank.d179.s3,Anadrol,98,104,B-brand
DDI-DrugBank.d179.s3,],105,105,O
DDI-DrugBank.d179.s3,",",106,106,O
DDI-DrugBank.d179.s3,stanozolol,108,117,B-drug
DDI-DrugBank.d179.s3,[,119,119,O
DDI-DrugBank.d179.s3,e.g.,120,123,O
DDI-DrugBank.d179.s3,",",124,124,O
DDI-DrugBank.d179.s3,Winstrol,126,133,B-brand
DDI-DrugBank.d179.s3,],134,134,O
DDI-DrugBank.d179.s3,),135,135,O
DDI-DrugBank.d179.s3,or,137,138,O
DDI-DrugBank.d179.s4,-,0,0,O
DDI-DrugBank.d179.s4,Androgens,2,10,B-group
DDI-DrugBank.d179.s4,(,12,12,O
DDI-DrugBank.d179.s4,male,13,16,O
DDI-DrugBank.d179.s4,hormones,18,25,O
DDI-DrugBank.d179.s4,),26,26,O
DDI-DrugBank.d179.s4,or,28,29,O
DDI-DrugBank.d179.s5,-,0,0,O
DDI-DrugBank.d179.s5,Antithyroid,2,12,B-group
DDI-DrugBank.d179.s5,agents,14,19,I-group
DDI-DrugBank.d179.s5,(,21,21,O
DDI-DrugBank.d179.s5,medicine,22,29,O
DDI-DrugBank.d179.s5,for,31,33,O
DDI-DrugBank.d179.s5,overactive,35,44,O
DDI-DrugBank.d179.s5,thyroid,46,52,O
DDI-DrugBank.d179.s5,),53,53,O
DDI-DrugBank.d179.s5,or,55,56,O
DDI-DrugBank.d179.s6,-,0,0,O
DDI-DrugBank.d179.s6,Carbamazepine,2,14,B-drug
DDI-DrugBank.d179.s6,(,16,16,O
DDI-DrugBank.d179.s6,e.g.,17,20,O
DDI-DrugBank.d179.s6,",",21,21,O
DDI-DrugBank.d179.s6,Tegretol,23,30,B-brand
DDI-DrugBank.d179.s6,),31,31,O
DDI-DrugBank.d179.s6,or,33,34,O
DDI-DrugBank.d179.s7,-,0,0,O
DDI-DrugBank.d179.s7,Carmustine,2,11,B-drug
DDI-DrugBank.d179.s7,(,13,13,O
DDI-DrugBank.d179.s7,e.g.,14,17,O
DDI-DrugBank.d179.s7,",",18,18,O
DDI-DrugBank.d179.s7,BiCNU,20,24,B-brand
DDI-DrugBank.d179.s7,),25,25,O
DDI-DrugBank.d179.s7,or,27,28,O
DDI-DrugBank.d179.s8,-,0,0,O
DDI-DrugBank.d179.s8,Chloroquine,2,12,B-drug
DDI-DrugBank.d179.s8,(,14,14,O
DDI-DrugBank.d179.s8,e.g.,15,18,O
DDI-DrugBank.d179.s8,",",19,19,O
DDI-DrugBank.d179.s8,Aralen,21,26,B-brand
DDI-DrugBank.d179.s8,),27,27,O
DDI-DrugBank.d179.s8,or,29,30,O
DDI-DrugBank.d179.s9,-,0,0,O
DDI-DrugBank.d179.s9,Dantrolene,2,11,B-drug
DDI-DrugBank.d179.s9,(,13,13,O
DDI-DrugBank.d179.s9,e.g.,14,17,O
DDI-DrugBank.d179.s9,",",18,18,O
DDI-DrugBank.d179.s9,Dantrium,20,27,B-brand
DDI-DrugBank.d179.s9,),28,28,O
DDI-DrugBank.d179.s9,or,30,31,O
DDI-DrugBank.d179.s10,-,0,0,O
DDI-DrugBank.d179.s10,Daunorubicin,2,13,B-drug
DDI-DrugBank.d179.s10,(,15,15,O
DDI-DrugBank.d179.s10,e.g.,16,19,O
DDI-DrugBank.d179.s10,",",20,20,O
DDI-DrugBank.d179.s10,Cerubidine,22,31,B-brand
DDI-DrugBank.d179.s10,),32,32,O
DDI-DrugBank.d179.s10,or,34,35,O
DDI-DrugBank.d179.s11,-,0,0,O
DDI-DrugBank.d179.s11,Disulfiram,2,11,B-drug
DDI-DrugBank.d179.s11,(,13,13,O
DDI-DrugBank.d179.s11,e.g.,14,17,O
DDI-DrugBank.d179.s11,",",18,18,O
DDI-DrugBank.d179.s11,Antabuse,20,27,B-brand
DDI-DrugBank.d179.s11,),28,28,O
DDI-DrugBank.d179.s11,or,30,31,O
DDI-DrugBank.d179.s12,-,0,0,O
DDI-DrugBank.d179.s12,Divalproex,2,11,B-drug
DDI-DrugBank.d179.s12,(,13,13,O
DDI-DrugBank.d179.s12,e.g.,14,17,O
DDI-DrugBank.d179.s12,",",18,18,O
DDI-DrugBank.d179.s12,Depakote,20,27,B-brand
DDI-DrugBank.d179.s12,),28,28,O
DDI-DrugBank.d179.s12,or,30,31,O
DDI-DrugBank.d179.s13,-,0,0,O
DDI-DrugBank.d179.s13,Estrogens,2,10,B-group
DDI-DrugBank.d179.s13,(,12,12,O
DDI-DrugBank.d179.s13,female,13,18,O
DDI-DrugBank.d179.s13,hormones,20,27,O
DDI-DrugBank.d179.s13,),28,28,O
DDI-DrugBank.d179.s13,or,30,31,O
DDI-DrugBank.d179.s14,-,0,0,O
DDI-DrugBank.d179.s14,Etretinate,2,11,B-drug
DDI-DrugBank.d179.s14,(,13,13,O
DDI-DrugBank.d179.s14,e.g.,14,17,O
DDI-DrugBank.d179.s14,",",18,18,O
DDI-DrugBank.d179.s14,Tegison,20,26,B-brand
DDI-DrugBank.d179.s14,),27,27,O
DDI-DrugBank.d179.s14,or,29,30,O
DDI-DrugBank.d179.s15,-,0,0,O
DDI-DrugBank.d179.s15,Gold,2,5,B-drug
DDI-DrugBank.d179.s15,salts,7,11,O
DDI-DrugBank.d179.s15,(,13,13,O
DDI-DrugBank.d179.s15,medicine,14,21,O
DDI-DrugBank.d179.s15,for,23,25,O
DDI-DrugBank.d179.s15,arthritis,27,35,O
DDI-DrugBank.d179.s15,),36,36,O
DDI-DrugBank.d179.s15,or,38,39,O
DDI-DrugBank.d179.s16,-,0,0,O
DDI-DrugBank.d179.s16,Hydroxychloroquine,2,19,B-drug
DDI-DrugBank.d179.s16,(,21,21,O
DDI-DrugBank.d179.s16,e.g.,22,25,O
DDI-DrugBank.d179.s16,",",26,26,O
DDI-DrugBank.d179.s16,Plaquenil,28,36,B-brand
DDI-DrugBank.d179.s16,),37,37,O
DDI-DrugBank.d179.s16,or,39,40,O
DDI-DrugBank.d179.s17,-,0,0,O
DDI-DrugBank.d179.s17,Mercaptopurine,2,15,B-drug
DDI-DrugBank.d179.s17,(,17,17,O
DDI-DrugBank.d179.s17,e.g.,18,21,O
DDI-DrugBank.d179.s17,",",22,22,O
DDI-DrugBank.d179.s17,Purinethol,24,33,B-brand
DDI-DrugBank.d179.s17,),34,34,O
DDI-DrugBank.d179.s17,or,36,37,O
DDI-DrugBank.d179.s18,-,0,0,O
DDI-DrugBank.d179.s18,Naltrexone,2,11,B-drug
DDI-DrugBank.d179.s18,(,13,13,O
DDI-DrugBank.d179.s18,e.g.,14,17,O
DDI-DrugBank.d179.s18,",",18,18,O
DDI-DrugBank.d179.s18,Trexan,20,25,B-brand
DDI-DrugBank.d179.s18,),26,26,O
DDI-DrugBank.d179.s18,(,28,28,O
DDI-DrugBank.d179.s18,with,29,32,O
DDI-DrugBank.d179.s18,long-term,34,42,O
DDI-DrugBank.d179.s18,",",43,43,O
DDI-DrugBank.d179.s18,high-dose,45,53,O
DDI-DrugBank.d179.s18,use,55,57,O
DDI-DrugBank.d179.s18,),58,58,O
DDI-DrugBank.d179.s18,or,60,61,O
DDI-DrugBank.d179.s19,-,0,0,O
DDI-DrugBank.d179.s19,Oral,2,5,O
DDI-DrugBank.d179.s19,contraceptives,7,20,B-group
DDI-DrugBank.d179.s19,(,22,22,O
DDI-DrugBank.d179.s19,birth,23,27,O
DDI-DrugBank.d179.s19,control,29,35,O
DDI-DrugBank.d179.s19,pills,37,41,O
DDI-DrugBank.d179.s19,),42,42,O
DDI-DrugBank.d179.s19,containing,44,53,O
DDI-DrugBank.d179.s19,estrogen,55,62,B-group
DDI-DrugBank.d179.s19,or,64,65,O
DDI-DrugBank.d179.s20,-,0,0,O
DDI-DrugBank.d179.s20,Other,2,6,O
DDI-DrugBank.d179.s20,anti-infectives,8,22,B-group
DDI-DrugBank.d179.s20,by,24,25,O
DDI-DrugBank.d179.s20,mouth,27,31,O
DDI-DrugBank.d179.s20,or,33,34,O
DDI-DrugBank.d179.s20,by,36,37,O
DDI-DrugBank.d179.s20,injection,39,47,O
DDI-DrugBank.d179.s20,(,49,49,O
DDI-DrugBank.d179.s20,medicine,50,57,O
DDI-DrugBank.d179.s20,for,59,61,O
DDI-DrugBank.d179.s20,infection,63,71,O
DDI-DrugBank.d179.s20,),72,72,O
DDI-DrugBank.d179.s20,or,74,75,O
DDI-DrugBank.d179.s21,-,0,0,O
DDI-DrugBank.d179.s21,Phenothiazines,2,15,B-group
DDI-DrugBank.d179.s21,(,17,17,O
DDI-DrugBank.d179.s21,acetophenazine,18,31,B-drug
DDI-DrugBank.d179.s21,[,33,33,O
DDI-DrugBank.d179.s21,e.g.,34,37,O
DDI-DrugBank.d179.s21,",",38,38,O
DDI-DrugBank.d179.s21,Tindal,40,45,B-brand
DDI-DrugBank.d179.s21,],46,46,O
DDI-DrugBank.d179.s21,",",47,47,O
DDI-DrugBank.d179.s21,chlorpromazine,49,62,B-drug
DDI-DrugBank.d179.s21,[,64,64,O
DDI-DrugBank.d179.s21,e.g.,65,68,O
DDI-DrugBank.d179.s21,",",69,69,O
DDI-DrugBank.d179.s21,Thorazine,71,79,B-brand
DDI-DrugBank.d179.s21,],80,80,O
DDI-DrugBank.d179.s21,",",81,81,O
DDI-DrugBank.d179.s21,fluphenazine,83,94,B-drug
DDI-DrugBank.d179.s21,[,96,96,O
DDI-DrugBank.d179.s21,e.g.,97,100,O
DDI-DrugBank.d179.s21,",",101,101,O
DDI-DrugBank.d179.s21,Prolixin,103,110,B-brand
DDI-DrugBank.d179.s21,],111,111,O
DDI-DrugBank.d179.s21,",",112,112,O
DDI-DrugBank.d179.s21,mesoridazine,114,125,B-brand
DDI-DrugBank.d179.s21,[,127,127,O
DDI-DrugBank.d179.s21,e.g.,128,131,O
DDI-DrugBank.d179.s21,",",132,132,O
DDI-DrugBank.d179.s21,Serentil,134,141,B-brand
DDI-DrugBank.d179.s21,],142,142,O
DDI-DrugBank.d179.s21,",",143,143,O
DDI-DrugBank.d179.s21,perphenazine,145,156,B-drug
DDI-DrugBank.d179.s21,[,158,158,O
DDI-DrugBank.d179.s21,e.g.,159,162,O
DDI-DrugBank.d179.s21,",",163,163,O
DDI-DrugBank.d179.s21,Trilafon,165,172,B-brand
DDI-DrugBank.d179.s21,],173,173,O
DDI-DrugBank.d179.s21,",",174,174,O
DDI-DrugBank.d179.s21,prochlorperazine,176,191,B-drug
DDI-DrugBank.d179.s21,[,193,193,O
DDI-DrugBank.d179.s21,e.g.,194,197,O
DDI-DrugBank.d179.s21,",",198,198,O
DDI-DrugBank.d179.s21,Compazine,200,208,B-brand
DDI-DrugBank.d179.s21,],209,209,O
DDI-DrugBank.d179.s21,",",210,210,O
DDI-DrugBank.d179.s21,promazine,212,220,B-drug
DDI-DrugBank.d179.s21,[,222,222,O
DDI-DrugBank.d179.s21,e.g.,223,226,O
DDI-DrugBank.d179.s21,",",227,227,O
DDI-DrugBank.d179.s21,Sparine,229,235,B-brand
DDI-DrugBank.d179.s21,],236,236,O
DDI-DrugBank.d179.s21,",",237,237,O
DDI-DrugBank.d179.s21,promethazine,239,250,B-drug
DDI-DrugBank.d179.s21,[,252,252,O
DDI-DrugBank.d179.s21,e.g.,253,256,O
DDI-DrugBank.d179.s21,",",257,257,O
DDI-DrugBank.d179.s21,Phenergan,259,267,B-brand
DDI-DrugBank.d179.s21,],268,268,O
DDI-DrugBank.d179.s21,",",269,269,O
DDI-DrugBank.d179.s21,thioridazine,271,282,B-drug
DDI-DrugBank.d179.s21,[,284,284,O
DDI-DrugBank.d179.s21,e.g.,285,288,O
DDI-DrugBank.d179.s21,",",289,289,O
DDI-DrugBank.d179.s21,Mellaril,291,298,B-brand
DDI-DrugBank.d179.s21,],299,299,O
DDI-DrugBank.d179.s21,",",300,300,O
DDI-DrugBank.d179.s21,trifluoperazine,302,316,B-drug
DDI-DrugBank.d179.s21,[,318,318,O
DDI-DrugBank.d179.s21,e.g.,319,322,O
DDI-DrugBank.d179.s21,",",323,323,O
DDI-DrugBank.d179.s21,Stelazine,325,333,B-brand
DDI-DrugBank.d179.s21,],334,334,O
DDI-DrugBank.d179.s21,",",335,335,O
DDI-DrugBank.d179.s21,triflupromazine,337,351,B-drug
DDI-DrugBank.d179.s21,[,353,353,O
DDI-DrugBank.d179.s21,e.g.,354,357,O
DDI-DrugBank.d179.s21,",",358,358,O
DDI-DrugBank.d179.s21,Vesprin,360,366,B-brand
DDI-DrugBank.d179.s21,],367,367,O
DDI-DrugBank.d179.s21,",",368,368,O
DDI-DrugBank.d179.s21,trimeprazine,370,381,B-drug
DDI-DrugBank.d179.s21,[,383,383,O
DDI-DrugBank.d179.s21,e.g.,384,387,O
DDI-DrugBank.d179.s21,",",388,388,O
DDI-DrugBank.d179.s21,Temaril,390,396,B-brand
DDI-DrugBank.d179.s21,],397,397,O
DDI-DrugBank.d179.s21,),398,398,O
DDI-DrugBank.d179.s21,or,400,401,O
DDI-DrugBank.d179.s22,-,0,0,O
DDI-DrugBank.d179.s22,Plicamycin,2,11,B-drug
DDI-DrugBank.d179.s22,(,13,13,O
DDI-DrugBank.d179.s22,e.g.,14,17,O
DDI-DrugBank.d179.s22,",",18,18,O
DDI-DrugBank.d179.s22,Mithracin,20,28,B-brand
DDI-DrugBank.d179.s22,),29,29,O
DDI-DrugBank.d179.s22,or,31,32,O
DDI-DrugBank.d179.s23,-,0,0,O
DDI-DrugBank.d179.s23,Valproic,2,9,B-drug
DDI-DrugBank.d179.s23,acid,11,14,I-drug
DDI-DrugBank.d179.s23,(,16,16,O
DDI-DrugBank.d179.s23,e.g.,17,20,O
DDI-DrugBank.d179.s23,",",21,21,O
DDI-DrugBank.d179.s23,Depakene,23,30,B-brand
DDI-DrugBank.d179.s23,),31,31,O
DDI-DrugBank.d179.s23,Use,33,35,O
DDI-DrugBank.d179.s23,of,37,38,O
DDI-DrugBank.d179.s23,sulfapyridine,40,52,B-drug
DDI-DrugBank.d179.s23,with,54,57,O
DDI-DrugBank.d179.s23,these,59,63,O
DDI-DrugBank.d179.s23,medicines,65,73,O
DDI-DrugBank.d179.s23,may,75,77,O
DDI-DrugBank.d179.s23,increase,79,86,O
DDI-DrugBank.d179.s23,the,88,90,O
DDI-DrugBank.d179.s23,chance,92,97,O
DDI-DrugBank.d179.s23,of,99,100,O
DDI-DrugBank.d179.s23,side,102,105,O
DDI-DrugBank.d179.s23,effects,107,113,O
DDI-DrugBank.d179.s23,affecting,115,123,O
DDI-DrugBank.d179.s23,the,125,127,O
DDI-DrugBank.d179.s23,liver,129,133,O
DDI-DrugBank.d179.s24,-,0,0,O
DDI-DrugBank.d179.s24,Acetohydroxamic,2,16,B-drug
DDI-DrugBank.d179.s24,acid,18,21,I-drug
DDI-DrugBank.d179.s24,(,23,23,O
DDI-DrugBank.d179.s24,e.g.,24,27,O
DDI-DrugBank.d179.s24,",",28,28,O
DDI-DrugBank.d179.s24,Lithostat,30,38,B-brand
DDI-DrugBank.d179.s24,),39,39,O
DDI-DrugBank.d179.s24,or,41,42,O
DDI-DrugBank.d179.s25,-,0,0,O
DDI-DrugBank.d179.s25,Dapsone,2,8,B-drug
DDI-DrugBank.d179.s25,or,10,11,O
DDI-DrugBank.d179.s26,-,0,0,O
DDI-DrugBank.d179.s26,Furazolidone,2,13,B-drug
DDI-DrugBank.d179.s26,(,15,15,O
DDI-DrugBank.d179.s26,e.g.,16,19,O
DDI-DrugBank.d179.s26,",",20,20,O
DDI-DrugBank.d179.s26,Furoxone,22,29,B-brand
DDI-DrugBank.d179.s26,),30,30,O
DDI-DrugBank.d179.s26,or,32,33,O
DDI-DrugBank.d179.s27,-,0,0,O
DDI-DrugBank.d179.s27,Nitrofurantoin,2,15,B-drug
DDI-DrugBank.d179.s27,(,17,17,O
DDI-DrugBank.d179.s27,e.g.,18,21,O
DDI-DrugBank.d179.s27,",",22,22,O
DDI-DrugBank.d179.s27,Furadantin,24,33,B-brand
DDI-DrugBank.d179.s27,),34,34,O
DDI-DrugBank.d179.s27,or,36,37,O
DDI-DrugBank.d179.s28,-,0,0,O
DDI-DrugBank.d179.s28,Primaquine,2,11,B-drug
DDI-DrugBank.d179.s28,or,13,14,O
DDI-DrugBank.d179.s29,-,0,0,O
DDI-DrugBank.d179.s29,Procainamide,2,13,B-drug
DDI-DrugBank.d179.s29,(,15,15,O
DDI-DrugBank.d179.s29,e.g.,16,19,O
DDI-DrugBank.d179.s29,",",20,20,O
DDI-DrugBank.d179.s29,Pronestyl,22,30,B-brand
DDI-DrugBank.d179.s29,),31,31,O
DDI-DrugBank.d179.s29,or,33,34,O
DDI-DrugBank.d179.s30,-,0,0,O
DDI-DrugBank.d179.s30,Quinidine,2,10,B-drug
DDI-DrugBank.d179.s30,(,12,12,O
DDI-DrugBank.d179.s30,e.g.,13,16,O
DDI-DrugBank.d179.s30,",",17,17,O
DDI-DrugBank.d179.s30,Quinidex,19,26,B-brand
DDI-DrugBank.d179.s30,),27,27,O
DDI-DrugBank.d179.s30,or,29,30,O
DDI-DrugBank.d179.s31,-,0,0,O
DDI-DrugBank.d179.s31,Quinine,2,8,B-drug
DDI-DrugBank.d179.s31,(,10,10,O
DDI-DrugBank.d179.s31,e.g.,11,14,O
DDI-DrugBank.d179.s31,",",15,15,O
DDI-DrugBank.d179.s31,Quinamm,17,23,B-brand
DDI-DrugBank.d179.s31,),24,24,O
DDI-DrugBank.d179.s31,or,26,27,O
DDI-DrugBank.d179.s32,-,0,0,O
DDI-DrugBank.d179.s32,Sulfoxone,2,10,B-drug
DDI-DrugBank.d179.s32,(,12,12,O
DDI-DrugBank.d179.s32,e.g.,13,16,O
DDI-DrugBank.d179.s32,",",17,17,O
DDI-DrugBank.d179.s32,Diasone,19,25,B-brand
DDI-DrugBank.d179.s32,),26,26,O
DDI-DrugBank.d179.s32,or,28,29,O
DDI-DrugBank.d179.s33,-,0,0,O
DDI-DrugBank.d179.s33,Vitamin,2,8,B-group
DDI-DrugBank.d179.s33,K,10,10,I-group
DDI-DrugBank.d179.s33,(,12,12,O
DDI-DrugBank.d179.s33,e.g.,13,16,O
DDI-DrugBank.d179.s33,",",17,17,O
DDI-DrugBank.d179.s33,AquaMEPHYTON,19,30,B-brand
DDI-DrugBank.d179.s33,",",31,31,O
DDI-DrugBank.d179.s33,Synkayvite,33,42,B-brand
DDI-DrugBank.d179.s33,),43,43,O
DDI-DrugBank.d179.s33,Use,45,47,O
DDI-DrugBank.d179.s33,of,49,50,O
DDI-DrugBank.d179.s33,sulfapyridine,52,64,B-drug
DDI-DrugBank.d179.s33,with,66,69,O
DDI-DrugBank.d179.s33,these,71,75,O
DDI-DrugBank.d179.s33,medicines,77,85,O
DDI-DrugBank.d179.s33,may,87,89,O
DDI-DrugBank.d179.s33,increase,91,98,O
DDI-DrugBank.d179.s33,the,100,102,O
DDI-DrugBank.d179.s33,chance,104,109,O
DDI-DrugBank.d179.s33,of,111,112,O
DDI-DrugBank.d179.s33,side,114,117,O
DDI-DrugBank.d179.s33,effects,119,125,O
DDI-DrugBank.d179.s33,affecting,127,135,O
DDI-DrugBank.d179.s33,the,137,139,O
DDI-DrugBank.d179.s33,blood,141,145,O
DDI-DrugBank.d179.s34,-,0,0,O
DDI-DrugBank.d179.s34,Anticoagulants,2,15,B-group
DDI-DrugBank.d179.s34,(,17,17,O
DDI-DrugBank.d179.s34,blood,18,22,B-group
DDI-DrugBank.d179.s34,thinners,24,31,I-group
DDI-DrugBank.d179.s34,),32,32,I-group
DDI-DrugBank.d179.s34,or,34,35,O
DDI-DrugBank.d179.s35,-,0,0,O
DDI-DrugBank.d179.s35,Ethotoin,2,9,B-drug
DDI-DrugBank.d179.s35,(,11,11,O
DDI-DrugBank.d179.s35,e.g.,12,15,O
DDI-DrugBank.d179.s35,",",16,16,O
DDI-DrugBank.d179.s35,Peganone,18,25,B-brand
DDI-DrugBank.d179.s35,),26,26,O
DDI-DrugBank.d179.s35,or,28,29,O
DDI-DrugBank.d179.s36,-,0,0,O
DDI-DrugBank.d179.s36,Mephenytoin,2,12,B-drug
DDI-DrugBank.d179.s36,(,14,14,O
DDI-DrugBank.d179.s36,e.g.,15,18,O
DDI-DrugBank.d179.s36,",",19,19,O
DDI-DrugBank.d179.s36,Mesantoin,21,29,B-brand
DDI-DrugBank.d179.s36,),30,30,O
DDI-DrugBank.d179.s36,Use,32,34,O
DDI-DrugBank.d179.s36,of,36,37,O
DDI-DrugBank.d179.s36,sulfapyridine,39,51,B-drug
DDI-DrugBank.d179.s36,with,53,56,O
DDI-DrugBank.d179.s36,these,58,62,O
DDI-DrugBank.d179.s36,medicines,64,72,O
DDI-DrugBank.d179.s36,may,74,76,O
DDI-DrugBank.d179.s36,increase,78,85,O
DDI-DrugBank.d179.s36,the,87,89,O
DDI-DrugBank.d179.s36,chance,91,96,O
DDI-DrugBank.d179.s36,of,98,99,O
DDI-DrugBank.d179.s36,side,101,104,O
DDI-DrugBank.d179.s36,effects,106,112,O
DDI-DrugBank.d179.s36,of,114,115,O
DDI-DrugBank.d179.s36,these,117,121,O
DDI-DrugBank.d179.s36,medicines,123,131,O
DDI-DrugBank.d179.s37,-,0,0,O
DDI-DrugBank.d179.s37,Antidiabetics,2,14,B-group
DDI-DrugBank.d179.s37,",",15,15,O
DDI-DrugBank.d179.s37,oral,17,20,O
DDI-DrugBank.d179.s37,(,22,22,O
DDI-DrugBank.d179.s37,diabetes,23,30,O
DDI-DrugBank.d179.s37,medicine,32,39,O
DDI-DrugBank.d179.s37,you,41,43,O
DDI-DrugBank.d179.s37,take,45,48,O
DDI-DrugBank.d179.s37,by,50,51,O
DDI-DrugBank.d179.s37,mouth,53,57,O
DDI-DrugBank.d179.s37,),58,58,O
DDI-DrugBank.d179.s37,Use,60,62,O
DDI-DrugBank.d179.s37,of,64,65,O
DDI-DrugBank.d179.s37,oral,67,70,O
DDI-DrugBank.d179.s37,antidiabetics,72,84,B-group
DDI-DrugBank.d179.s37,with,86,89,O
DDI-DrugBank.d179.s37,sulfapyridine,91,103,B-drug
DDI-DrugBank.d179.s37,may,105,107,O
DDI-DrugBank.d179.s37,increase,109,116,O
DDI-DrugBank.d179.s37,the,118,120,O
DDI-DrugBank.d179.s37,chance,122,127,O
DDI-DrugBank.d179.s37,of,129,130,O
DDI-DrugBank.d179.s37,side,132,135,O
DDI-DrugBank.d179.s37,effects,137,143,O
DDI-DrugBank.d179.s37,affecting,145,153,O
DDI-DrugBank.d179.s37,the,155,157,O
DDI-DrugBank.d179.s37,blood,159,163,O
DDI-DrugBank.d179.s37,and/or,165,170,O
DDI-DrugBank.d179.s37,the,172,174,O
DDI-DrugBank.d179.s37,side,176,179,O
DDI-DrugBank.d179.s37,effects,181,187,O
DDI-DrugBank.d179.s37,or,189,190,O
DDI-DrugBank.d179.s37,oral,192,195,O
DDI-DrugBank.d179.s37,antidiabetics,197,209,B-group
DDI-DrugBank.d179.s38,-,0,0,O
DDI-DrugBank.d179.s38,Methotrexate,2,13,B-drug
DDI-DrugBank.d179.s38,(,15,15,O
DDI-DrugBank.d179.s38,e.g.,16,19,O
DDI-DrugBank.d179.s38,",",20,20,O
DDI-DrugBank.d179.s38,Mexate,22,27,B-brand
DDI-DrugBank.d179.s38,),28,28,O
DDI-DrugBank.d179.s38,Use,30,32,O
DDI-DrugBank.d179.s38,of,34,35,O
DDI-DrugBank.d179.s38,methotrexate,37,48,B-drug
DDI-DrugBank.d179.s38,with,50,53,O
DDI-DrugBank.d179.s38,sulfapyridine,55,67,B-drug
DDI-DrugBank.d179.s38,may,69,71,O
DDI-DrugBank.d179.s38,increase,73,80,O
DDI-DrugBank.d179.s38,the,82,84,O
DDI-DrugBank.d179.s38,chance,86,91,O
DDI-DrugBank.d179.s38,of,93,94,O
DDI-DrugBank.d179.s38,side,96,99,O
DDI-DrugBank.d179.s38,effects,101,107,O
DDI-DrugBank.d179.s38,affecting,109,117,O
DDI-DrugBank.d179.s38,the,119,121,O
DDI-DrugBank.d179.s38,liver,123,127,O
DDI-DrugBank.d179.s38,and/or,129,134,O
DDI-DrugBank.d179.s38,the,136,138,O
DDI-DrugBank.d179.s38,side,140,143,O
DDI-DrugBank.d179.s38,effects,145,151,O
DDI-DrugBank.d179.s38,of,153,154,O
DDI-DrugBank.d179.s38,methotrexate,156,167,B-drug
DDI-DrugBank.d179.s39,-,0,0,O
DDI-DrugBank.d179.s39,Methyldopa,2,11,B-drug
DDI-DrugBank.d179.s39,(,13,13,O
DDI-DrugBank.d179.s39,e.g.,14,17,O
DDI-DrugBank.d179.s39,",",18,18,O
DDI-DrugBank.d179.s39,Aldomet,20,26,B-brand
DDI-DrugBank.d179.s39,),27,27,O
DDI-DrugBank.d179.s39,Use,29,31,O
DDI-DrugBank.d179.s39,of,33,34,O
DDI-DrugBank.d179.s39,methyldopa,36,45,B-drug
DDI-DrugBank.d179.s39,with,47,50,O
DDI-DrugBank.d179.s39,sulfapyridine,52,64,B-drug
DDI-DrugBank.d179.s39,may,66,68,O
DDI-DrugBank.d179.s39,increase,70,77,O
DDI-DrugBank.d179.s39,the,79,81,O
DDI-DrugBank.d179.s39,chance,83,88,O
DDI-DrugBank.d179.s39,of,90,91,O
DDI-DrugBank.d179.s39,side,93,96,O
DDI-DrugBank.d179.s39,effects,98,104,O
DDI-DrugBank.d179.s39,affecting,106,114,O
DDI-DrugBank.d179.s39,the,116,118,O
DDI-DrugBank.d179.s39,liver,120,124,O
DDI-DrugBank.d179.s39,and/or,126,131,O
DDI-DrugBank.d179.s39,the,133,135,O
DDI-DrugBank.d179.s39,blood,137,141,O
DDI-DrugBank.d179.s40,-,0,0,O
DDI-DrugBank.d179.s40,Phenytoin,2,10,B-drug
DDI-DrugBank.d179.s40,(,12,12,O
DDI-DrugBank.d179.s40,e.g.,13,16,O
DDI-DrugBank.d179.s40,",",17,17,O
DDI-DrugBank.d179.s40,Dilantin,19,26,B-brand
DDI-DrugBank.d179.s40,),27,27,O
DDI-DrugBank.d179.s40,Use,29,31,O
DDI-DrugBank.d179.s40,of,33,34,O
DDI-DrugBank.d179.s40,phenytoin,36,44,B-drug
DDI-DrugBank.d179.s40,with,46,49,O
DDI-DrugBank.d179.s40,sulfapyridine,51,63,B-drug
DDI-DrugBank.d179.s40,may,65,67,O
DDI-DrugBank.d179.s40,increase,69,76,O
DDI-DrugBank.d179.s40,the,78,80,O
DDI-DrugBank.d179.s40,chance,82,87,O
DDI-DrugBank.d179.s40,of,89,90,O
DDI-DrugBank.d179.s40,side,92,95,O
DDI-DrugBank.d179.s40,effects,97,103,O
DDI-DrugBank.d179.s40,affecting,105,113,O
DDI-DrugBank.d179.s40,the,115,117,O
DDI-DrugBank.d179.s40,liver,119,123,O
DDI-DrugBank.d179.s40,and/or,125,130,O
DDI-DrugBank.d179.s40,the,132,134,O
DDI-DrugBank.d179.s40,side,136,139,O
DDI-DrugBank.d179.s40,effects,141,147,O
DDI-DrugBank.d179.s40,of,149,150,O
DDI-DrugBank.d179.s40,phenytoin,152,160,B-drug
DDI-DrugBank.d639.s0,Co-administration,0,16,O
DDI-DrugBank.d639.s0,of,18,19,O
DDI-DrugBank.d639.s0,SUTENT,21,26,B-brand
DDI-DrugBank.d639.s0,with,28,31,O
DDI-DrugBank.d639.s0,strong,33,38,O
DDI-DrugBank.d639.s0,inhibitors,40,49,O
DDI-DrugBank.d639.s0,of,51,52,O
DDI-DrugBank.d639.s0,the,54,56,O
DDI-DrugBank.d639.s0,CYP3A4,58,63,O
DDI-DrugBank.d639.s0,family,65,70,O
DDI-DrugBank.d639.s0,(,72,72,O
DDI-DrugBank.d639.s0,e.g.,73,76,O
DDI-DrugBank.d639.s0,",",77,77,O
DDI-DrugBank.d639.s0,ketoconazole,79,90,B-drug
DDI-DrugBank.d639.s0,",",91,91,O
DDI-DrugBank.d639.s0,itraconazole,93,104,B-drug
DDI-DrugBank.d639.s0,",",105,105,O
DDI-DrugBank.d639.s0,clarithromycin,107,120,B-drug
DDI-DrugBank.d639.s0,",",121,121,O
DDI-DrugBank.d639.s0,atazanavir,123,132,B-drug
DDI-DrugBank.d639.s0,",",133,133,O
DDI-DrugBank.d639.s0,indinavir,135,143,B-drug
DDI-DrugBank.d639.s0,",",144,144,O
DDI-DrugBank.d639.s0,nefazodone,146,155,B-drug
DDI-DrugBank.d639.s0,",",156,156,O
DDI-DrugBank.d639.s0,nelfinavir,158,167,B-drug
DDI-DrugBank.d639.s0,",",168,168,O
DDI-DrugBank.d639.s0,ritonavir,170,178,B-drug
DDI-DrugBank.d639.s0,",",179,179,O
DDI-DrugBank.d639.s0,saquinavir,181,190,B-drug
DDI-DrugBank.d639.s0,",",191,191,O
DDI-DrugBank.d639.s0,telithromycin,193,205,B-drug
DDI-DrugBank.d639.s0,",",206,206,O
DDI-DrugBank.d639.s0,voriconizole,208,219,B-drug
DDI-DrugBank.d639.s0,),220,220,O
DDI-DrugBank.d639.s0,may,222,224,O
DDI-DrugBank.d639.s0,increases,226,234,O
DDI-DrugBank.d639.s0,sunitinib,236,244,B-drug
DDI-DrugBank.d639.s0,concentrations,246,259,O
DDI-DrugBank.d639.s0,.,260,260,O
DDI-DrugBank.d639.s1,Grapefruit,0,9,O
DDI-DrugBank.d639.s1,may,11,13,O
DDI-DrugBank.d639.s1,also,15,18,O
DDI-DrugBank.d639.s1,increase,20,27,O
DDI-DrugBank.d639.s1,plasma,29,34,O
DDI-DrugBank.d639.s1,concentrations,36,49,O
DDI-DrugBank.d639.s1,of,51,52,O
DDI-DrugBank.d639.s1,SUTENT,54,59,B-brand
DDI-DrugBank.d639.s1,.,60,60,O
DDI-DrugBank.d639.s2,Co-administration,0,16,O
DDI-DrugBank.d639.s2,of,18,19,O
DDI-DrugBank.d639.s2,SUTENT,21,26,B-brand
DDI-DrugBank.d639.s2,with,28,31,O
DDI-DrugBank.d639.s2,inducers,33,40,O
DDI-DrugBank.d639.s2,of,42,43,O
DDI-DrugBank.d639.s2,the,45,47,O
DDI-DrugBank.d639.s2,CYP3A4,49,54,O
DDI-DrugBank.d639.s2,family,56,61,O
DDI-DrugBank.d639.s2,(,63,63,O
DDI-DrugBank.d639.s2,e.g.,64,67,O
DDI-DrugBank.d639.s2,",",68,68,O
DDI-DrugBank.d639.s2,dexamethasone,70,82,B-drug
DDI-DrugBank.d639.s2,",",83,83,O
DDI-DrugBank.d639.s2,phenytoin,85,93,B-drug
DDI-DrugBank.d639.s2,",",94,94,O
DDI-DrugBank.d639.s2,carbamazepine,96,108,B-drug
DDI-DrugBank.d639.s2,",",109,109,O
DDI-DrugBank.d639.s2,rifampin,111,118,B-drug
DDI-DrugBank.d639.s2,",",119,119,O
DDI-DrugBank.d639.s2,rifabutin,121,129,B-drug
DDI-DrugBank.d639.s2,",",130,130,O
DDI-DrugBank.d639.s2,rifapentin,132,141,B-drug
DDI-DrugBank.d639.s2,",",142,142,O
DDI-DrugBank.d639.s2,phenobarbital,144,156,B-drug
DDI-DrugBank.d639.s2,",",157,157,O
DDI-DrugBank.d639.s2,St.,159,161,O
DDI-DrugBank.d639.s2,Johns,163,167,O
DDI-DrugBank.d639.s2,Wort,169,172,O
DDI-DrugBank.d639.s2,),173,173,O
DDI-DrugBank.d639.s2,may,175,177,O
DDI-DrugBank.d639.s2,decrease,179,186,O
DDI-DrugBank.d639.s2,sunitinib,188,196,B-drug
DDI-DrugBank.d639.s2,concentrations,198,211,O
DDI-DrugBank.d639.s2,.,212,212,O
DDI-DrugBank.d639.s3,St,0,1,O
DDI-DrugBank.d639.s3,.,2,2,O
DDI-DrugBank.d639.s4,Johns,0,4,O
DDI-DrugBank.d639.s4,Wort,6,9,O
DDI-DrugBank.d639.s4,may,11,13,O
DDI-DrugBank.d639.s4,decrease,15,22,O
DDI-DrugBank.d639.s4,SUTENT,24,29,B-brand
DDI-DrugBank.d639.s4,plasma,31,36,O
DDI-DrugBank.d639.s4,concentrations,38,51,O
DDI-DrugBank.d639.s4,unpredictably,53,65,O
DDI-DrugBank.d639.s4,.,66,66,O
DDI-DrugBank.d639.s5,Patients,0,7,O
DDI-DrugBank.d639.s5,receiving,9,17,O
DDI-DrugBank.d639.s5,SUTENT,19,24,B-brand
DDI-DrugBank.d639.s5,should,26,31,O
DDI-DrugBank.d639.s5,not,33,35,O
DDI-DrugBank.d639.s5,take,37,40,O
DDI-DrugBank.d639.s5,St,42,43,O
DDI-DrugBank.d639.s5,.,44,44,O
DDI-DrugBank.d639.s6,Johns,0,4,O
DDI-DrugBank.d639.s6,Wort,6,9,O
DDI-DrugBank.d639.s6,concomitantly,11,23,O
DDI-DrugBank.d639.s6,.,24,24,O
DDI-DrugBank.d639.s7,SUTENT,0,5,B-brand
DDI-DrugBank.d639.s7,dose,7,10,O
DDI-DrugBank.d639.s7,modification,12,23,O
DDI-DrugBank.d639.s7,is,25,26,O
DDI-DrugBank.d639.s7,recommended,28,38,O
DDI-DrugBank.d639.s7,in,40,41,O
DDI-DrugBank.d639.s7,patients,43,50,O
DDI-DrugBank.d639.s7,using,52,56,O
DDI-DrugBank.d639.s7,concomitant,58,68,O
DDI-DrugBank.d639.s7,CYP3A4,70,75,O
DDI-DrugBank.d639.s7,inhibitors,77,86,O
DDI-DrugBank.d639.s7,or,88,89,O
DDI-DrugBank.d639.s7,inducers,91,98,O
DDI-DrugBank.d639.s7,.,99,99,O
DDI-DrugBank.d723.s0,Other,0,4,O
DDI-DrugBank.d723.s0,eye,6,8,O
DDI-DrugBank.d723.s0,drops,10,14,O
DDI-DrugBank.d723.s0,or,16,17,O
DDI-DrugBank.d723.s0,medications,19,29,O
DDI-DrugBank.d723.s0,such,31,34,O
DDI-DrugBank.d723.s0,as,36,37,O
DDI-DrugBank.d723.s0,acetylcholine,39,51,B-drug
DDI-DrugBank.d723.s0,chloride,53,60,I-drug
DDI-DrugBank.d723.s0,(,62,62,O
DDI-DrugBank.d723.s0,Miochol,63,69,B-brand
DDI-DrugBank.d723.s0,),70,70,O
DDI-DrugBank.d723.s0,and,72,74,O
DDI-DrugBank.d723.s0,carbachol,76,84,B-drug
DDI-DrugBank.d723.s0,(,86,86,O
DDI-DrugBank.d723.s0,Carboptic,87,95,B-brand
DDI-DrugBank.d723.s0,",",96,96,O
DDI-DrugBank.d723.s0,Isopto,98,103,B-brand
DDI-DrugBank.d723.s0,Carbachol,105,113,I-brand
DDI-DrugBank.d723.s0,),114,114,O
DDI-DrugBank.d723.s0,may,116,118,O
DDI-DrugBank.d723.s0,decrease,120,127,O
DDI-DrugBank.d723.s0,the,129,131,O
DDI-DrugBank.d723.s0,effects,133,139,O
DDI-DrugBank.d723.s0,of,141,142,O
DDI-DrugBank.d723.s0,suprofen,144,151,B-drug
DDI-DrugBank.d723.s0,ophthalmic,153,162,O
DDI-DrugBank.d723.s0,.,163,163,O
DDI-DrugBank.d704.s0,Drug-Drug,0,8,O
DDI-DrugBank.d704.s0,Interactions,10,21,O
DDI-DrugBank.d704.s0,:,22,22,O
DDI-DrugBank.d704.s0,The,24,26,O
DDI-DrugBank.d704.s0,pharmacokinetic,28,42,O
DDI-DrugBank.d704.s0,and,44,46,O
DDI-DrugBank.d704.s0,pharmacodynamic,48,62,O
DDI-DrugBank.d704.s0,interactions,64,75,O
DDI-DrugBank.d704.s0,between,77,83,O
DDI-DrugBank.d704.s0,FLOMAX,85,90,B-brand
DDI-DrugBank.d704.s0,capsules,92,99,O
DDI-DrugBank.d704.s0,and,101,103,O
DDI-DrugBank.d704.s0,other,105,109,O
DDI-DrugBank.d704.s0,alpha-adrenergic,111,126,B-group
DDI-DrugBank.d704.s0,blocking,128,135,I-group
DDI-DrugBank.d704.s0,agents,137,142,I-group
DDI-DrugBank.d704.s0,have,144,147,O
DDI-DrugBank.d704.s0,not,149,151,O
DDI-DrugBank.d704.s0,been,153,156,O
DDI-DrugBank.d704.s0,determined,158,167,O
DDI-DrugBank.d704.s0,.,168,168,O
DDI-DrugBank.d704.s1,However,0,6,O
DDI-DrugBank.d704.s1,",",7,7,O
DDI-DrugBank.d704.s1,interactions,9,20,O
DDI-DrugBank.d704.s1,may,22,24,O
DDI-DrugBank.d704.s1,be,26,27,O
DDI-DrugBank.d704.s1,expected,29,36,O
DDI-DrugBank.d704.s1,and,38,40,O
DDI-DrugBank.d704.s1,FLOMAX,42,47,B-brand
DDI-DrugBank.d704.s1,capsules,49,56,O
DDI-DrugBank.d704.s1,should,58,63,O
DDI-DrugBank.d704.s1,NOT,65,67,O
DDI-DrugBank.d704.s1,be,69,70,O
DDI-DrugBank.d704.s1,used,72,75,O
DDI-DrugBank.d704.s1,in,77,78,O
DDI-DrugBank.d704.s1,combination,80,90,O
DDI-DrugBank.d704.s1,with,92,95,O
DDI-DrugBank.d704.s1,other,97,101,O
DDI-DrugBank.d704.s1,alpha-adrenergic,103,118,B-group
DDI-DrugBank.d704.s1,blocking,120,127,I-group
DDI-DrugBank.d704.s1,agents,129,134,I-group
DDI-DrugBank.d704.s1,.,135,135,O
DDI-DrugBank.d704.s2,The,0,2,O
DDI-DrugBank.d704.s2,pharmacokinetic,4,18,O
DDI-DrugBank.d704.s2,interaction,20,30,O
DDI-DrugBank.d704.s2,between,32,38,O
DDI-DrugBank.d704.s2,cimetidine,40,49,B-drug
DDI-DrugBank.d704.s2,and,51,53,O
DDI-DrugBank.d704.s2,FLOMAX,55,60,B-brand
DDI-DrugBank.d704.s2,capsules,62,69,O
DDI-DrugBank.d704.s2,was,71,73,O
DDI-DrugBank.d704.s2,investigated,75,86,O
DDI-DrugBank.d704.s2,.,87,87,O
DDI-DrugBank.d704.s3,The,0,2,O
DDI-DrugBank.d704.s3,results,4,10,O
DDI-DrugBank.d704.s3,indicate,12,19,O
DDI-DrugBank.d704.s3,significant,21,31,O
DDI-DrugBank.d704.s3,changes,33,39,O
DDI-DrugBank.d704.s3,in,41,42,O
DDI-DrugBank.d704.s3,tamsulosin,44,53,B-drug
DDI-DrugBank.d704.s3,HCI,55,57,I-drug
DDI-DrugBank.d704.s3,clearance,59,67,O
DDI-DrugBank.d704.s3,(,69,69,O
DDI-DrugBank.d704.s3,26,70,71,O
DDI-DrugBank.d704.s3,%,72,72,O
DDI-DrugBank.d704.s3,decrease,74,81,O
DDI-DrugBank.d704.s3,),82,82,O
DDI-DrugBank.d704.s3,and,84,86,O
DDI-DrugBank.d704.s3,AUC,88,90,O
DDI-DrugBank.d704.s3,(,92,92,O
DDI-DrugBank.d704.s3,44,93,94,O
DDI-DrugBank.d704.s3,%,95,95,O
DDI-DrugBank.d704.s3,increase,97,104,O
DDI-DrugBank.d704.s3,),105,105,O
DDI-DrugBank.d704.s3,.,106,106,O
DDI-DrugBank.d704.s4,Therefore,0,8,O
DDI-DrugBank.d704.s4,",",9,9,O
DDI-DrugBank.d704.s4,FLOMAX,11,16,B-brand
DDI-DrugBank.d704.s4,capsules,18,25,O
DDI-DrugBank.d704.s4,should,27,32,O
DDI-DrugBank.d704.s4,be,34,35,O
DDI-DrugBank.d704.s4,used,37,40,O
DDI-DrugBank.d704.s4,with,42,45,O
DDI-DrugBank.d704.s4,caution,47,53,O
DDI-DrugBank.d704.s4,in,55,56,O
DDI-DrugBank.d704.s4,combination,58,68,O
DDI-DrugBank.d704.s4,with,70,73,O
DDI-DrugBank.d704.s4,cimetidine,75,84,B-drug
DDI-DrugBank.d704.s4,",",85,85,O
DDI-DrugBank.d704.s4,particularly,87,98,O
DDI-DrugBank.d704.s4,at,100,101,O
DDI-DrugBank.d704.s4,doses,103,107,O
DDI-DrugBank.d704.s4,higher,109,114,O
DDI-DrugBank.d704.s4,than,116,119,O
DDI-DrugBank.d704.s4,0.4,121,123,O
DDI-DrugBank.d704.s4,mg,125,126,O
DDI-DrugBank.d704.s4,.,127,127,O
DDI-DrugBank.d704.s5,Results,0,6,O
DDI-DrugBank.d704.s5,from,8,11,O
DDI-DrugBank.d704.s5,limited,13,19,O
DDI-DrugBank.d704.s5,in,21,22,O
DDI-DrugBank.d704.s5,vitro,24,28,O
DDI-DrugBank.d704.s5,and,30,32,O
DDI-DrugBank.d704.s5,in,34,35,O
DDI-DrugBank.d704.s5,vivo,37,40,O
DDI-DrugBank.d704.s5,drug-drug,42,50,O
DDI-DrugBank.d704.s5,interaction,52,62,O
DDI-DrugBank.d704.s5,studies,64,70,O
DDI-DrugBank.d704.s5,between,72,78,O
DDI-DrugBank.d704.s5,tamsulosin,80,89,B-drug
DDI-DrugBank.d704.s5,HCI,91,93,I-drug
DDI-DrugBank.d704.s5,and,95,97,O
DDI-DrugBank.d704.s5,warfarin,99,106,B-drug
DDI-DrugBank.d704.s5,are,108,110,O
DDI-DrugBank.d704.s5,inconclusive,112,123,O
DDI-DrugBank.d704.s5,.,124,124,O
DDI-DrugBank.d704.s6,Therefore,0,8,O
DDI-DrugBank.d704.s6,",",9,9,O
DDI-DrugBank.d704.s6,caution,11,17,O
DDI-DrugBank.d704.s6,should,19,24,O
DDI-DrugBank.d704.s6,be,26,27,O
DDI-DrugBank.d704.s6,exercised,29,37,O
DDI-DrugBank.d704.s6,with,39,42,O
DDI-DrugBank.d704.s6,concomitant,44,54,O
DDI-DrugBank.d704.s6,administration,56,69,O
DDI-DrugBank.d704.s6,of,71,72,O
DDI-DrugBank.d704.s6,warfarin,74,81,B-drug
DDI-DrugBank.d704.s6,and,83,85,O
DDI-DrugBank.d704.s6,FLOMAX,87,92,B-brand
DDI-DrugBank.d704.s6,capsules,94,101,O
DDI-DrugBank.d704.s6,.,102,102,O
DDI-DrugBank.d658.s0,When,0,3,O
DDI-DrugBank.d658.s0,administered,5,16,O
DDI-DrugBank.d658.s0,concurrently,18,29,O
DDI-DrugBank.d658.s0,",",30,30,O
DDI-DrugBank.d658.s0,testolactone,32,43,B-drug
DDI-DrugBank.d658.s0,may,45,47,O
DDI-DrugBank.d658.s0,increase,49,56,O
DDI-DrugBank.d658.s0,the,58,60,O
DDI-DrugBank.d658.s0,effects,62,68,O
DDI-DrugBank.d658.s0,of,70,71,O
DDI-DrugBank.d658.s0,oral,73,76,O
DDI-DrugBank.d658.s0,anticoagulants,78,91,B-group
DDI-DrugBank.d658.s0,;,92,92,O
DDI-DrugBank.d658.s1,monitor,0,6,O
DDI-DrugBank.d658.s1,and,8,10,O
DDI-DrugBank.d658.s1,adjust,12,17,O
DDI-DrugBank.d658.s1,anticoagulant,19,31,B-group
DDI-DrugBank.d658.s1,dosage,33,38,O
DDI-DrugBank.d658.s1,accordingly,40,50,O
DDI-DrugBank.d658.s1,.,51,51,O
DDI-DrugBank.d658.s2,Drug/Laboratory,0,14,O
DDI-DrugBank.d658.s2,Test,16,19,O
DDI-DrugBank.d658.s2,Interactions,21,32,O
DDI-DrugBank.d658.s2,:,33,33,O
DDI-DrugBank.d658.s2,Physiologic,35,45,O
DDI-DrugBank.d658.s2,effects,47,53,O
DDI-DrugBank.d658.s2,of,55,56,O
DDI-DrugBank.d658.s2,testolactone,58,69,B-drug
DDI-DrugBank.d658.s2,may,71,73,O
DDI-DrugBank.d658.s2,result,75,80,O
DDI-DrugBank.d658.s2,in,82,83,O
DDI-DrugBank.d658.s2,decreased,85,93,O
DDI-DrugBank.d658.s2,estradiol,95,103,O
DDI-DrugBank.d658.s2,concentrations,105,118,O
DDI-DrugBank.d658.s2,with,120,123,O
DDI-DrugBank.d658.s2,radioimmunoassays,125,141,O
DDI-DrugBank.d658.s2,for,143,145,O
DDI-DrugBank.d658.s2,estradiol,147,155,O
DDI-DrugBank.d658.s2,",",156,156,O
DDI-DrugBank.d658.s2,increased,158,166,O
DDI-DrugBank.d658.s2,plasma,168,173,O
DDI-DrugBank.d658.s2,calcium,175,181,O
DDI-DrugBank.d658.s2,concentrations,183,196,O
DDI-DrugBank.d658.s2,",",197,197,O
DDI-DrugBank.d658.s2,and,199,201,O
DDI-DrugBank.d658.s2,increased,203,211,O
DDI-DrugBank.d658.s2,24-hour,213,219,O
DDI-DrugBank.d658.s2,urinary,221,227,O
DDI-DrugBank.d658.s2,excretion,229,237,O
DDI-DrugBank.d658.s2,of,239,240,O
DDI-DrugBank.d658.s2,creatine,242,249,O
DDI-DrugBank.d658.s2,and,251,253,O
DDI-DrugBank.d658.s2,17-ketosteroids,255,269,O
DDI-DrugBank.d658.s2,.,270,270,O
DDI-DrugBank.d766.s0,Since,0,4,O
DDI-DrugBank.d766.s0,trimetrexate,6,17,B-drug
DDI-DrugBank.d766.s0,is,19,20,O
DDI-DrugBank.d766.s0,metabolized,22,32,O
DDI-DrugBank.d766.s0,by,34,35,O
DDI-DrugBank.d766.s0,a,37,37,O
DDI-DrugBank.d766.s0,P450,39,42,O
DDI-DrugBank.d766.s0,enzyme,44,49,O
DDI-DrugBank.d766.s0,system,51,56,O
DDI-DrugBank.d766.s0,",",57,57,O
DDI-DrugBank.d766.s0,drugs,59,63,O
DDI-DrugBank.d766.s0,that,65,68,O
DDI-DrugBank.d766.s0,induce,70,75,O
DDI-DrugBank.d766.s0,or,77,78,O
DDI-DrugBank.d766.s0,inhibit,80,86,O
DDI-DrugBank.d766.s0,this,88,91,O
DDI-DrugBank.d766.s0,drug,93,96,O
DDI-DrugBank.d766.s0,metabolizing,98,109,O
DDI-DrugBank.d766.s0,enzyme,111,116,O
DDI-DrugBank.d766.s0,system,118,123,O
DDI-DrugBank.d766.s0,may,125,127,O
DDI-DrugBank.d766.s0,elicit,129,134,O
DDI-DrugBank.d766.s0,important,136,144,O
DDI-DrugBank.d766.s0,drug-drug,146,154,O
DDI-DrugBank.d766.s0,interactions,156,167,O
DDI-DrugBank.d766.s0,that,169,172,O
DDI-DrugBank.d766.s0,may,174,176,O
DDI-DrugBank.d766.s0,alter,178,182,O
DDI-DrugBank.d766.s0,trimetrexate,184,195,B-drug
DDI-DrugBank.d766.s0,plasma,197,202,O
DDI-DrugBank.d766.s0,concentrations,204,217,O
DDI-DrugBank.d766.s0,.,218,218,O
DDI-DrugBank.d766.s1,Agents,0,5,O
DDI-DrugBank.d766.s1,that,7,10,O
DDI-DrugBank.d766.s1,might,12,16,O
DDI-DrugBank.d766.s1,be,18,19,O
DDI-DrugBank.d766.s1,coadministered,21,34,O
DDI-DrugBank.d766.s1,with,36,39,O
DDI-DrugBank.d766.s1,trimetrexate,41,52,B-drug
DDI-DrugBank.d766.s1,in,54,55,O
DDI-DrugBank.d766.s1,AIDS,57,60,O
DDI-DrugBank.d766.s1,patients,62,69,O
DDI-DrugBank.d766.s1,for,71,73,O
DDI-DrugBank.d766.s1,other,75,79,O
DDI-DrugBank.d766.s1,indications,81,91,O
DDI-DrugBank.d766.s1,that,93,96,O
DDI-DrugBank.d766.s1,could,98,102,O
DDI-DrugBank.d766.s1,elicit,104,109,O
DDI-DrugBank.d766.s1,this,111,114,O
DDI-DrugBank.d766.s1,activity,116,123,O
DDI-DrugBank.d766.s1,include,125,131,O
DDI-DrugBank.d766.s1,erythromycin,133,144,B-drug
DDI-DrugBank.d766.s1,",",145,145,O
DDI-DrugBank.d766.s1,rifampin,147,154,B-drug
DDI-DrugBank.d766.s1,",",155,155,O
DDI-DrugBank.d766.s1,rifabutin,157,165,B-drug
DDI-DrugBank.d766.s1,",",166,166,O
DDI-DrugBank.d766.s1,ketoconazole,168,179,B-drug
DDI-DrugBank.d766.s1,",",180,180,O
DDI-DrugBank.d766.s1,and,182,184,O
DDI-DrugBank.d766.s1,fluconazole,186,196,B-drug
DDI-DrugBank.d766.s1,.,197,197,O
DDI-DrugBank.d766.s2,In,0,1,O
DDI-DrugBank.d766.s2,vitro,3,7,O
DDI-DrugBank.d766.s2,perfusion,9,17,O
DDI-DrugBank.d766.s2,of,19,20,O
DDI-DrugBank.d766.s2,isolated,22,29,O
DDI-DrugBank.d766.s2,rat,31,33,O
DDI-DrugBank.d766.s2,liver,35,39,O
DDI-DrugBank.d766.s2,has,41,43,O
DDI-DrugBank.d766.s2,shown,45,49,O
DDI-DrugBank.d766.s2,that,51,54,O
DDI-DrugBank.d766.s2,cimetidine,56,65,B-drug
DDI-DrugBank.d766.s2,caused,67,72,O
DDI-DrugBank.d766.s2,a,74,74,O
DDI-DrugBank.d766.s2,significant,76,86,O
DDI-DrugBank.d766.s2,reduction,88,96,O
DDI-DrugBank.d766.s2,in,98,99,O
DDI-DrugBank.d766.s2,trimetrexate,101,112,B-drug
DDI-DrugBank.d766.s2,metabolism,114,123,O
DDI-DrugBank.d766.s2,and,125,127,O
DDI-DrugBank.d766.s2,that,129,132,O
DDI-DrugBank.d766.s2,acetaminophen,134,146,B-drug
DDI-DrugBank.d766.s2,altered,148,154,O
DDI-DrugBank.d766.s2,the,156,158,O
DDI-DrugBank.d766.s2,relative,160,167,O
DDI-DrugBank.d766.s2,concentration,169,181,O
DDI-DrugBank.d766.s2,of,183,184,O
DDI-DrugBank.d766.s2,trimetrexate,186,197,O
DDI-DrugBank.d766.s2,metabolites,199,209,O
DDI-DrugBank.d766.s2,possibly,211,218,O
DDI-DrugBank.d766.s2,by,220,221,O
DDI-DrugBank.d766.s2,competing,223,231,O
DDI-DrugBank.d766.s2,for,233,235,O
DDI-DrugBank.d766.s2,sulfate,237,243,O
DDI-DrugBank.d766.s2,metabolites,245,255,O
DDI-DrugBank.d766.s2,.,256,256,O
DDI-DrugBank.d766.s3,Based,0,4,O
DDI-DrugBank.d766.s3,on,6,7,O
DDI-DrugBank.d766.s3,an,9,10,O
DDI-DrugBank.d766.s3,in,12,13,O
DDI-DrugBank.d766.s3,vitro,15,19,O
DDI-DrugBank.d766.s3,rat,21,23,O
DDI-DrugBank.d766.s3,liver,25,29,O
DDI-DrugBank.d766.s3,model,31,35,O
DDI-DrugBank.d766.s3,",",36,36,O
DDI-DrugBank.d766.s3,nitrogen,38,45,O
DDI-DrugBank.d766.s3,substituted,47,57,O
DDI-DrugBank.d766.s3,imidazole,59,67,B-group
DDI-DrugBank.d766.s3,drugs,69,73,I-group
DDI-DrugBank.d766.s3,(,75,75,O
DDI-DrugBank.d766.s3,clotrimazole,76,87,B-drug
DDI-DrugBank.d766.s3,",",88,88,O
DDI-DrugBank.d766.s3,ketoconazole,90,101,B-drug
DDI-DrugBank.d766.s3,",",102,102,O
DDI-DrugBank.d766.s3,miconazole,104,113,B-drug
DDI-DrugBank.d766.s3,),114,114,O
DDI-DrugBank.d766.s3,were,116,119,O
DDI-DrugBank.d766.s3,potent,121,126,O
DDI-DrugBank.d766.s3,",",127,127,O
DDI-DrugBank.d766.s3,non-competitive,129,143,O
DDI-DrugBank.d766.s3,inhibitors,145,154,O
DDI-DrugBank.d766.s3,of,156,157,O
DDI-DrugBank.d766.s3,trimetrexate,159,170,B-drug
DDI-DrugBank.d766.s3,metabolism,172,181,O
DDI-DrugBank.d766.s3,.,182,182,O
DDI-DrugBank.d766.s4,Patients,0,7,O
DDI-DrugBank.d766.s4,medicated,9,17,O
DDI-DrugBank.d766.s4,with,19,22,O
DDI-DrugBank.d766.s4,these,24,28,O
DDI-DrugBank.d766.s4,drugs,30,34,O
DDI-DrugBank.d766.s4,and,36,38,O
DDI-DrugBank.d766.s4,trimetrexate,40,51,B-drug
DDI-DrugBank.d766.s4,should,53,58,O
DDI-DrugBank.d766.s4,be,60,61,O
DDI-DrugBank.d766.s4,carefully,63,71,O
DDI-DrugBank.d766.s4,monitored,73,81,O
DDI-DrugBank.d766.s4,.,82,82,O
DDI-DrugBank.d328.s0,The,0,2,O
DDI-DrugBank.d328.s0,drug,4,7,O
DDI-DrugBank.d328.s0,interaction,9,19,O
DDI-DrugBank.d328.s0,studies,21,27,O
DDI-DrugBank.d328.s0,with,29,32,O
DDI-DrugBank.d328.s0,valdecoxib,34,43,B-drug
DDI-DrugBank.d328.s0,were,45,48,O
DDI-DrugBank.d328.s0,performed,50,58,O
DDI-DrugBank.d328.s0,both,60,63,O
DDI-DrugBank.d328.s0,with,65,68,O
DDI-DrugBank.d328.s0,valdecoxib,70,79,B-drug
DDI-DrugBank.d328.s0,and,81,83,O
DDI-DrugBank.d328.s0,a,85,85,O
DDI-DrugBank.d328.s0,rapidly,87,93,O
DDI-DrugBank.d328.s0,hydrolyzed,95,104,O
DDI-DrugBank.d328.s0,intravenous,106,116,O
DDI-DrugBank.d328.s0,prodrug,118,124,O
DDI-DrugBank.d328.s0,form,126,129,O
DDI-DrugBank.d328.s0,.,130,130,O
DDI-DrugBank.d328.s1,The,0,2,O
DDI-DrugBank.d328.s1,results,4,10,O
DDI-DrugBank.d328.s1,from,12,15,O
DDI-DrugBank.d328.s1,trials,17,22,O
DDI-DrugBank.d328.s1,using,24,28,O
DDI-DrugBank.d328.s1,the,30,32,O
DDI-DrugBank.d328.s1,intravenous,34,44,O
DDI-DrugBank.d328.s1,prodrug,46,52,O
DDI-DrugBank.d328.s1,are,54,56,O
DDI-DrugBank.d328.s1,reported,58,65,O
DDI-DrugBank.d328.s1,in,67,68,O
DDI-DrugBank.d328.s1,this,70,73,O
DDI-DrugBank.d328.s1,section,75,81,O
DDI-DrugBank.d328.s1,as,83,84,O
DDI-DrugBank.d328.s1,they,86,89,O
DDI-DrugBank.d328.s1,relate,91,96,O
DDI-DrugBank.d328.s1,to,98,99,O
DDI-DrugBank.d328.s1,the,101,103,O
DDI-DrugBank.d328.s1,role,105,108,O
DDI-DrugBank.d328.s1,of,110,111,O
DDI-DrugBank.d328.s1,valdecoxib,113,122,B-drug
DDI-DrugBank.d328.s1,in,124,125,O
DDI-DrugBank.d328.s1,drug,127,130,O
DDI-DrugBank.d328.s1,interactions,132,143,O
DDI-DrugBank.d328.s1,.,144,144,O
DDI-DrugBank.d328.s2,General,0,6,O
DDI-DrugBank.d328.s2,:,7,7,O
DDI-DrugBank.d328.s2,In,9,10,O
DDI-DrugBank.d328.s2,humans,12,17,O
DDI-DrugBank.d328.s2,",",18,18,O
DDI-DrugBank.d328.s2,valdecoxib,20,29,B-drug
DDI-DrugBank.d328.s2,metabolism,31,40,O
DDI-DrugBank.d328.s2,is,42,43,O
DDI-DrugBank.d328.s2,predominantly,45,57,O
DDI-DrugBank.d328.s2,mediated,59,66,O
DDI-DrugBank.d328.s2,via,68,70,O
DDI-DrugBank.d328.s2,CYP,72,74,O
DDI-DrugBank.d328.s2,3A4,76,78,O
DDI-DrugBank.d328.s2,and,80,82,O
DDI-DrugBank.d328.s2,2C9,84,86,O
DDI-DrugBank.d328.s2,with,88,91,O
DDI-DrugBank.d328.s2,glucuronidation,93,107,O
DDI-DrugBank.d328.s2,being,109,113,O
DDI-DrugBank.d328.s2,a,115,115,O
DDI-DrugBank.d328.s2,further,117,123,O
DDI-DrugBank.d328.s2,(,125,125,O
DDI-DrugBank.d328.s2,20,126,127,O
DDI-DrugBank.d328.s2,%,128,128,O
DDI-DrugBank.d328.s2,),129,129,O
DDI-DrugBank.d328.s2,route,131,135,O
DDI-DrugBank.d328.s2,of,137,138,O
DDI-DrugBank.d328.s2,metabolism,140,149,O
DDI-DrugBank.d328.s2,.,150,150,O
DDI-DrugBank.d328.s3,In,0,1,O
DDI-DrugBank.d328.s3,vitro,3,7,O
DDI-DrugBank.d328.s3,studies,9,15,O
DDI-DrugBank.d328.s3,indicate,17,24,O
DDI-DrugBank.d328.s3,that,26,29,O
DDI-DrugBank.d328.s3,valdecoxib,31,40,B-drug
DDI-DrugBank.d328.s3,is,42,43,O
DDI-DrugBank.d328.s3,a,45,45,O
DDI-DrugBank.d328.s3,moderate,47,54,O
DDI-DrugBank.d328.s3,inhibitor,56,64,O
DDI-DrugBank.d328.s3,of,66,67,O
DDI-DrugBank.d328.s3,CYP,69,71,O
DDI-DrugBank.d328.s3,2C19,73,76,O
DDI-DrugBank.d328.s3,(,78,78,O
DDI-DrugBank.d328.s3,IC50,79,82,O
DDI-DrugBank.d328.s3,=,84,84,O
DDI-DrugBank.d328.s3,6,86,86,O
DDI-DrugBank.d328.s3,g/mL,89,92,O
DDI-DrugBank.d328.s3,or,94,95,O
DDI-DrugBank.d328.s3,19,97,98,O
DDI-DrugBank.d328.s3,M,101,101,O
DDI-DrugBank.d328.s3,),102,102,O
DDI-DrugBank.d328.s3,and,104,106,O
DDI-DrugBank.d328.s3,2C9,108,110,O
DDI-DrugBank.d328.s3,(,112,112,O
DDI-DrugBank.d328.s3,IC50,113,116,O
DDI-DrugBank.d328.s3,=,118,118,O
DDI-DrugBank.d328.s3,13,120,121,O
DDI-DrugBank.d328.s3,g/mL,124,127,O
DDI-DrugBank.d328.s3,or,129,130,O
DDI-DrugBank.d328.s3,41,132,133,O
DDI-DrugBank.d328.s3,M,136,136,O
DDI-DrugBank.d328.s3,),137,137,O
DDI-DrugBank.d328.s3,",",138,138,O
DDI-DrugBank.d328.s3,and,140,142,O
DDI-DrugBank.d328.s3,a,144,144,O
DDI-DrugBank.d328.s3,weak,146,149,O
DDI-DrugBank.d328.s3,inhibitor,151,159,O
DDI-DrugBank.d328.s3,of,161,162,O
DDI-DrugBank.d328.s3,CYP,164,166,O
DDI-DrugBank.d328.s3,2D6,168,170,O
DDI-DrugBank.d328.s3,(,172,172,O
DDI-DrugBank.d328.s3,IC50,173,176,O
DDI-DrugBank.d328.s3,=,178,178,O
DDI-DrugBank.d328.s3,31,180,181,O
DDI-DrugBank.d328.s3,g/mL,184,187,O
DDI-DrugBank.d328.s3,or,189,190,O
DDI-DrugBank.d328.s3,100,192,194,O
DDI-DrugBank.d328.s3,M,197,197,O
DDI-DrugBank.d328.s3,),198,198,O
DDI-DrugBank.d328.s3,and,200,202,O
DDI-DrugBank.d328.s3,3A4,204,206,O
DDI-DrugBank.d328.s3,(,208,208,O
DDI-DrugBank.d328.s3,IC50,209,212,O
DDI-DrugBank.d328.s3,=,214,214,O
DDI-DrugBank.d328.s3,44,216,217,O
DDI-DrugBank.d328.s3,g/mL,220,223,O
DDI-DrugBank.d328.s3,or,225,226,O
DDI-DrugBank.d328.s3,141,228,230,O
DDI-DrugBank.d328.s3,M,233,233,O
DDI-DrugBank.d328.s3,),235,235,O
DDI-DrugBank.d328.s3,..,236,237,O
DDI-DrugBank.d328.s4,Aspirin,0,6,B-brand
DDI-DrugBank.d328.s4,:,7,7,O
DDI-DrugBank.d328.s4,Concomitant,9,19,O
DDI-DrugBank.d328.s4,administration,21,34,O
DDI-DrugBank.d328.s4,of,36,37,O
DDI-DrugBank.d328.s4,aspirin,39,45,B-brand
DDI-DrugBank.d328.s4,with,47,50,O
DDI-DrugBank.d328.s4,valdecoxib,52,61,B-drug
DDI-DrugBank.d328.s4,may,63,65,O
DDI-DrugBank.d328.s4,result,67,72,O
DDI-DrugBank.d328.s4,in,74,75,O
DDI-DrugBank.d328.s4,an,77,78,O
DDI-DrugBank.d328.s4,increased,80,88,O
DDI-DrugBank.d328.s4,risk,90,93,O
DDI-DrugBank.d328.s4,of,95,96,O
DDI-DrugBank.d328.s4,GI,98,99,O
DDI-DrugBank.d328.s4,ulceration,101,110,O
DDI-DrugBank.d328.s4,and,112,114,O
DDI-DrugBank.d328.s4,complications,116,128,O
DDI-DrugBank.d328.s4,compared,130,137,O
DDI-DrugBank.d328.s4,to,139,140,O
DDI-DrugBank.d328.s4,valdecoxib,142,151,B-drug
DDI-DrugBank.d328.s4,alone,153,157,O
DDI-DrugBank.d328.s4,.,158,158,O
DDI-DrugBank.d328.s5,Because,0,6,O
DDI-DrugBank.d328.s5,of,8,9,O
DDI-DrugBank.d328.s5,its,11,13,O
DDI-DrugBank.d328.s5,lack,15,18,O
DDI-DrugBank.d328.s5,of,20,21,O
DDI-DrugBank.d328.s5,anti-platelet,23,35,O
DDI-DrugBank.d328.s5,effect,37,42,O
DDI-DrugBank.d328.s5,valdecoxib,44,53,B-drug
DDI-DrugBank.d328.s5,is,55,56,O
DDI-DrugBank.d328.s5,not,58,60,O
DDI-DrugBank.d328.s5,a,62,62,O
DDI-DrugBank.d328.s5,substitute,64,73,O
DDI-DrugBank.d328.s5,for,75,77,O
DDI-DrugBank.d328.s5,aspirin,79,85,B-brand
DDI-DrugBank.d328.s5,for,87,89,O
DDI-DrugBank.d328.s5,cardiovascular,91,104,O
DDI-DrugBank.d328.s5,prophylaxis,106,116,O
DDI-DrugBank.d328.s5,.,117,117,O
DDI-DrugBank.d328.s6,In,0,1,O
DDI-DrugBank.d328.s6,a,3,3,O
DDI-DrugBank.d328.s6,parallel,5,12,O
DDI-DrugBank.d328.s6,group,14,18,O
DDI-DrugBank.d328.s6,drug,20,23,O
DDI-DrugBank.d328.s6,interaction,25,35,O
DDI-DrugBank.d328.s6,study,37,41,O
DDI-DrugBank.d328.s6,comparing,43,51,O
DDI-DrugBank.d328.s6,the,53,55,O
DDI-DrugBank.d328.s6,intravenous,57,67,O
DDI-DrugBank.d328.s6,prodrug,69,75,O
DDI-DrugBank.d328.s6,form,77,80,O
DDI-DrugBank.d328.s6,of,82,83,O
DDI-DrugBank.d328.s6,valdecoxib,85,94,B-drug
DDI-DrugBank.d328.s6,at,96,97,O
DDI-DrugBank.d328.s6,40,99,100,O
DDI-DrugBank.d328.s6,mg,102,103,O
DDI-DrugBank.d328.s6,BID,105,107,O
DDI-DrugBank.d328.s6,(,109,109,O
DDI-DrugBank.d328.s6,n=10,110,113,O
DDI-DrugBank.d328.s6,),114,114,O
DDI-DrugBank.d328.s6,vs,116,117,O
DDI-DrugBank.d328.s6,placebo,119,125,O
DDI-DrugBank.d328.s6,(,127,127,O
DDI-DrugBank.d328.s6,n=9,128,130,O
DDI-DrugBank.d328.s6,),131,131,O
DDI-DrugBank.d328.s6,",",132,132,O
DDI-DrugBank.d328.s6,valdecoxib,134,143,B-drug
DDI-DrugBank.d328.s6,had,145,147,O
DDI-DrugBank.d328.s6,no,149,150,O
DDI-DrugBank.d328.s6,effect,152,157,O
DDI-DrugBank.d328.s6,on,159,160,O
DDI-DrugBank.d328.s6,in,162,163,O
DDI-DrugBank.d328.s6,vitro,165,169,O
DDI-DrugBank.d328.s6,aspirin-mediated,171,186,O
DDI-DrugBank.d328.s6,inhibition,188,197,O
DDI-DrugBank.d328.s6,of,199,200,O
DDI-DrugBank.d328.s6,arachidonate-,202,214,O
DDI-DrugBank.d328.s6,or,216,217,O
DDI-DrugBank.d328.s6,collagen-stimulated,219,237,O
DDI-DrugBank.d328.s6,platelet,239,246,O
DDI-DrugBank.d328.s6,aggregation,248,258,O
DDI-DrugBank.d328.s6,.,259,259,O
DDI-DrugBank.d328.s7,Methotrexate,0,11,B-drug
DDI-DrugBank.d328.s7,:,12,12,O
DDI-DrugBank.d328.s7,Valdecoxib,14,23,B-drug
DDI-DrugBank.d328.s7,10,25,26,I-drug
DDI-DrugBank.d328.s7,mg,28,29,I-drug
DDI-DrugBank.d328.s7,BID,31,33,O
DDI-DrugBank.d328.s7,did,35,37,O
DDI-DrugBank.d328.s7,not,39,41,O
DDI-DrugBank.d328.s7,show,43,46,O
DDI-DrugBank.d328.s7,a,48,48,O
DDI-DrugBank.d328.s7,significant,50,60,O
DDI-DrugBank.d328.s7,effect,62,67,O
DDI-DrugBank.d328.s7,on,69,70,O
DDI-DrugBank.d328.s7,the,72,74,O
DDI-DrugBank.d328.s7,plasma,76,81,O
DDI-DrugBank.d328.s7,exposure,83,90,O
DDI-DrugBank.d328.s7,or,92,93,O
DDI-DrugBank.d328.s7,renal,95,99,O
DDI-DrugBank.d328.s7,clearance,101,109,O
DDI-DrugBank.d328.s7,of,111,112,O
DDI-DrugBank.d328.s7,methotrexate,114,125,B-drug
DDI-DrugBank.d328.s7,.,126,126,O
DDI-DrugBank.d328.s8,ACE-inhibitors,0,13,B-group
DDI-DrugBank.d328.s8,:,14,14,O
DDI-DrugBank.d328.s8,Reports,15,21,O
DDI-DrugBank.d328.s8,suggest,23,29,O
DDI-DrugBank.d328.s8,that,31,34,O
DDI-DrugBank.d328.s8,NSAIDs,36,41,B-group
DDI-DrugBank.d328.s8,may,43,45,O
DDI-DrugBank.d328.s8,diminish,47,54,O
DDI-DrugBank.d328.s8,the,56,58,O
DDI-DrugBank.d328.s8,antihypertensive,60,75,O
DDI-DrugBank.d328.s8,effect,77,82,O
DDI-DrugBank.d328.s8,of,84,85,O
DDI-DrugBank.d328.s8,ACE-inhibitors,87,100,B-group
DDI-DrugBank.d328.s8,.,101,101,O
DDI-DrugBank.d328.s9,This,0,3,O
DDI-DrugBank.d328.s9,interaction,5,15,O
DDI-DrugBank.d328.s9,should,17,22,O
DDI-DrugBank.d328.s9,be,24,25,O
DDI-DrugBank.d328.s9,given,27,31,O
DDI-DrugBank.d328.s9,consideration,33,45,O
DDI-DrugBank.d328.s9,in,47,48,O
DDI-DrugBank.d328.s9,patients,50,57,O
DDI-DrugBank.d328.s9,taking,59,64,O
DDI-DrugBank.d328.s9,BEXTRA,66,71,B-brand
DDI-DrugBank.d328.s9,concomitantly,73,85,O
DDI-DrugBank.d328.s9,with,87,90,O
DDI-DrugBank.d328.s9,ACE-inhibitors,92,105,B-group
DDI-DrugBank.d328.s9,.,106,106,O
DDI-DrugBank.d328.s10,Furosemide,0,9,B-drug
DDI-DrugBank.d328.s10,:,10,10,O
DDI-DrugBank.d328.s10,Clinical,12,19,O
DDI-DrugBank.d328.s10,studies,21,27,O
DDI-DrugBank.d328.s10,",",28,28,O
DDI-DrugBank.d328.s10,as,30,31,O
DDI-DrugBank.d328.s10,well,33,36,O
DDI-DrugBank.d328.s10,as,38,39,O
DDI-DrugBank.d328.s10,post-marketing,41,54,O
DDI-DrugBank.d328.s10,observations,56,67,O
DDI-DrugBank.d328.s10,",",68,68,O
DDI-DrugBank.d328.s10,have,70,73,O
DDI-DrugBank.d328.s10,shown,75,79,O
DDI-DrugBank.d328.s10,that,81,84,O
DDI-DrugBank.d328.s10,NSAIDs,86,91,B-group
DDI-DrugBank.d328.s10,can,93,95,O
DDI-DrugBank.d328.s10,reduce,97,102,O
DDI-DrugBank.d328.s10,the,104,106,O
DDI-DrugBank.d328.s10,natriuretic,108,118,O
DDI-DrugBank.d328.s10,effect,120,125,O
DDI-DrugBank.d328.s10,of,127,128,O
DDI-DrugBank.d328.s10,furosemide,130,139,B-drug
DDI-DrugBank.d328.s10,and,141,143,O
DDI-DrugBank.d328.s10,thiazides,145,153,B-group
DDI-DrugBank.d328.s10,in,155,156,O
DDI-DrugBank.d328.s10,some,158,161,O
DDI-DrugBank.d328.s10,patients,163,170,O
DDI-DrugBank.d328.s10,.,171,171,O
DDI-DrugBank.d328.s11,This,0,3,O
DDI-DrugBank.d328.s11,response,5,12,O
DDI-DrugBank.d328.s11,has,14,16,O
DDI-DrugBank.d328.s11,been,18,21,O
DDI-DrugBank.d328.s11,attributed,23,32,O
DDI-DrugBank.d328.s11,to,34,35,O
DDI-DrugBank.d328.s11,inhibition,37,46,O
DDI-DrugBank.d328.s11,of,48,49,O
DDI-DrugBank.d328.s11,renal,51,55,O
DDI-DrugBank.d328.s11,prostaglandin,57,69,O
DDI-DrugBank.d328.s11,synthesis,71,79,O
DDI-DrugBank.d328.s11,.,80,80,O
DDI-DrugBank.d328.s12,Anticonvulsants,0,14,B-group
DDI-DrugBank.d328.s12,(,16,16,O
DDI-DrugBank.d328.s12,Phenytoin,17,25,B-drug
DDI-DrugBank.d328.s12,),26,26,O
DDI-DrugBank.d328.s12,:,27,27,O
DDI-DrugBank.d328.s12,Steady,29,34,O
DDI-DrugBank.d328.s12,state,36,40,O
DDI-DrugBank.d328.s12,plasma,42,47,O
DDI-DrugBank.d328.s12,exposure,49,56,O
DDI-DrugBank.d328.s12,(,58,58,O
DDI-DrugBank.d328.s12,AUC,59,61,O
DDI-DrugBank.d328.s12,),62,62,O
DDI-DrugBank.d328.s12,of,64,65,O
DDI-DrugBank.d328.s12,valdecoxib,67,76,B-drug
DDI-DrugBank.d328.s12,(,78,78,O
DDI-DrugBank.d328.s12,40,79,80,O
DDI-DrugBank.d328.s12,mg,82,83,O
DDI-DrugBank.d328.s12,BID,85,87,O
DDI-DrugBank.d328.s12,for,89,91,O
DDI-DrugBank.d328.s12,12,93,94,O
DDI-DrugBank.d328.s12,days,96,99,O
DDI-DrugBank.d328.s12,),100,100,O
DDI-DrugBank.d328.s12,was,102,104,O
DDI-DrugBank.d328.s12,decreased,106,114,O
DDI-DrugBank.d328.s12,by,116,117,O
DDI-DrugBank.d328.s12,27,119,120,O
DDI-DrugBank.d328.s12,%,121,121,O
DDI-DrugBank.d328.s12,when,123,126,O
DDI-DrugBank.d328.s12,co-administered,128,142,O
DDI-DrugBank.d328.s12,with,144,147,O
DDI-DrugBank.d328.s12,multiple,149,156,O
DDI-DrugBank.d328.s12,doses,158,162,O
DDI-DrugBank.d328.s12,(,164,164,O
DDI-DrugBank.d328.s12,300,165,167,O
DDI-DrugBank.d328.s12,mg,169,170,O
DDI-DrugBank.d328.s12,QD,172,173,O
DDI-DrugBank.d328.s12,for,175,177,O
DDI-DrugBank.d328.s12,12,179,180,O
DDI-DrugBank.d328.s12,days,182,185,O
DDI-DrugBank.d328.s12,),186,186,O
DDI-DrugBank.d328.s12,of,188,189,O
DDI-DrugBank.d328.s12,phenytoin,191,199,B-drug
DDI-DrugBank.d328.s12,(,201,201,O
DDI-DrugBank.d328.s12,a,202,202,O
DDI-DrugBank.d328.s12,CYP,204,206,O
DDI-DrugBank.d328.s12,3A4,208,210,O
DDI-DrugBank.d328.s12,inducer,212,218,O
DDI-DrugBank.d328.s12,),219,219,O
DDI-DrugBank.d328.s12,.,220,220,O
DDI-DrugBank.d328.s13,Patients,0,7,O
DDI-DrugBank.d328.s13,already,9,15,O
DDI-DrugBank.d328.s13,stabilized,17,26,O
DDI-DrugBank.d328.s13,on,28,29,O
DDI-DrugBank.d328.s13,valdecoxib,31,40,B-drug
DDI-DrugBank.d328.s13,should,42,47,O
DDI-DrugBank.d328.s13,be,49,50,O
DDI-DrugBank.d328.s13,closely,52,58,O
DDI-DrugBank.d328.s13,monitored,60,68,O
DDI-DrugBank.d328.s13,for,70,72,O
DDI-DrugBank.d328.s13,loss,74,77,O
DDI-DrugBank.d328.s13,of,79,80,O
DDI-DrugBank.d328.s13,symptom,82,88,O
DDI-DrugBank.d328.s13,control,90,96,O
DDI-DrugBank.d328.s13,with,98,101,O
DDI-DrugBank.d328.s13,phenytoin,103,111,B-drug
DDI-DrugBank.d328.s13,coadministration,113,128,O
DDI-DrugBank.d328.s13,.,129,129,O
DDI-DrugBank.d328.s14,Valdecoxib,0,9,B-drug
DDI-DrugBank.d328.s14,did,11,13,O
DDI-DrugBank.d328.s14,not,15,17,O
DDI-DrugBank.d328.s14,have,19,22,O
DDI-DrugBank.d328.s14,a,24,24,O
DDI-DrugBank.d328.s14,statistically,26,38,O
DDI-DrugBank.d328.s14,significant,40,50,O
DDI-DrugBank.d328.s14,effect,52,57,O
DDI-DrugBank.d328.s14,on,59,60,O
DDI-DrugBank.d328.s14,the,62,64,O
DDI-DrugBank.d328.s14,pharmacokinetics,66,81,O
DDI-DrugBank.d328.s14,of,83,84,O
DDI-DrugBank.d328.s14,phenytoin,86,94,B-drug
DDI-DrugBank.d328.s14,(,96,96,O
DDI-DrugBank.d328.s14,a,97,97,O
DDI-DrugBank.d328.s14,CYP,99,101,O
DDI-DrugBank.d328.s14,2C9,103,105,O
DDI-DrugBank.d328.s14,and,107,109,O
DDI-DrugBank.d328.s14,CYP,111,113,O
DDI-DrugBank.d328.s14,2C19,115,118,O
DDI-DrugBank.d328.s14,substrate,120,128,O
DDI-DrugBank.d328.s14,),129,129,O
DDI-DrugBank.d328.s14,.,130,130,O
DDI-DrugBank.d328.s15,Drug,0,3,O
DDI-DrugBank.d328.s15,interaction,5,15,O
DDI-DrugBank.d328.s15,studies,17,23,O
DDI-DrugBank.d328.s15,with,25,28,O
DDI-DrugBank.d328.s15,other,30,34,O
DDI-DrugBank.d328.s15,anticonvulsants,36,50,B-group
DDI-DrugBank.d328.s15,have,52,55,O
DDI-DrugBank.d328.s15,not,57,59,O
DDI-DrugBank.d328.s15,been,61,64,O
DDI-DrugBank.d328.s15,conducted,66,74,O
DDI-DrugBank.d328.s15,.,75,75,O
DDI-DrugBank.d328.s16,Routine,0,6,O
DDI-DrugBank.d328.s16,monitoring,8,17,O
DDI-DrugBank.d328.s16,should,19,24,O
DDI-DrugBank.d328.s16,be,26,27,O
DDI-DrugBank.d328.s16,performed,29,37,O
DDI-DrugBank.d328.s16,when,39,42,O
DDI-DrugBank.d328.s16,therapy,44,50,O
DDI-DrugBank.d328.s16,with,52,55,O
DDI-DrugBank.d328.s16,BEXTRA,57,62,B-brand
DDI-DrugBank.d328.s16,is,64,65,O
DDI-DrugBank.d328.s16,either,67,72,O
DDI-DrugBank.d328.s16,initiated,74,82,O
DDI-DrugBank.d328.s16,or,84,85,O
DDI-DrugBank.d328.s16,discontinued,87,98,O
DDI-DrugBank.d328.s16,in,100,101,O
DDI-DrugBank.d328.s16,patients,103,110,O
DDI-DrugBank.d328.s16,on,112,113,O
DDI-DrugBank.d328.s16,anticonvulsant,115,128,O
DDI-DrugBank.d328.s16,therapy,130,136,O
DDI-DrugBank.d328.s16,.,137,137,O
DDI-DrugBank.d328.s17,Dextromethorphan,0,15,B-drug
DDI-DrugBank.d328.s17,:,16,16,O
DDI-DrugBank.d328.s17,Dextromethorphan,18,33,B-drug
DDI-DrugBank.d328.s17,is,35,36,O
DDI-DrugBank.d328.s17,primarily,38,46,O
DDI-DrugBank.d328.s17,metabolized,48,58,O
DDI-DrugBank.d328.s17,by,60,61,O
DDI-DrugBank.d328.s17,CYP,63,65,O
DDI-DrugBank.d328.s17,2D6,67,69,O
DDI-DrugBank.d328.s17,and,71,73,O
DDI-DrugBank.d328.s17,to,75,76,O
DDI-DrugBank.d328.s17,a,78,78,O
DDI-DrugBank.d328.s17,lesser,80,85,O
DDI-DrugBank.d328.s17,extent,87,92,O
DDI-DrugBank.d328.s17,by,94,95,O
DDI-DrugBank.d328.s17,3A4,97,99,O
DDI-DrugBank.d328.s17,.,100,100,O
DDI-DrugBank.d328.s18,Coadministration,0,15,O
DDI-DrugBank.d328.s18,with,17,20,O
DDI-DrugBank.d328.s18,valdecoxib,22,31,B-drug
DDI-DrugBank.d328.s18,(,33,33,O
DDI-DrugBank.d328.s18,40,34,35,O
DDI-DrugBank.d328.s18,mg,37,38,O
DDI-DrugBank.d328.s18,BID,40,42,O
DDI-DrugBank.d328.s18,for,44,46,O
DDI-DrugBank.d328.s18,7,48,48,O
DDI-DrugBank.d328.s18,days,50,53,O
DDI-DrugBank.d328.s18,),54,54,O
DDI-DrugBank.d328.s18,resulted,56,63,O
DDI-DrugBank.d328.s18,in,65,66,O
DDI-DrugBank.d328.s18,a,68,68,O
DDI-DrugBank.d328.s18,significant,70,80,O
DDI-DrugBank.d328.s18,increase,82,89,O
DDI-DrugBank.d328.s18,in,91,92,O
DDI-DrugBank.d328.s18,dextromethorphan,94,109,B-drug
DDI-DrugBank.d328.s18,plasma,111,116,O
DDI-DrugBank.d328.s18,levels,118,123,O
DDI-DrugBank.d328.s18,suggesting,125,134,O
DDI-DrugBank.d328.s18,that,136,139,O
DDI-DrugBank.d328.s18,",",140,140,O
DDI-DrugBank.d328.s18,at,142,143,O
DDI-DrugBank.d328.s18,these,145,149,O
DDI-DrugBank.d328.s18,doses,151,155,O
DDI-DrugBank.d328.s18,",",156,156,O
DDI-DrugBank.d328.s18,valdecoxib,158,167,B-drug
DDI-DrugBank.d328.s18,is,169,170,O
DDI-DrugBank.d328.s18,a,172,172,O
DDI-DrugBank.d328.s18,weak,174,177,O
DDI-DrugBank.d328.s18,inhibitor,179,187,O
DDI-DrugBank.d328.s18,of,189,190,O
DDI-DrugBank.d328.s18,2D6,192,194,O
DDI-DrugBank.d328.s18,.,195,195,O
DDI-DrugBank.d328.s19,Even,0,3,O
DDI-DrugBank.d328.s19,so,5,6,O
DDI-DrugBank.d328.s19,dextromethorphan,8,23,B-drug
DDI-DrugBank.d328.s19,plasma,25,30,O
DDI-DrugBank.d328.s19,concentrations,32,45,O
DDI-DrugBank.d328.s19,in,47,48,O
DDI-DrugBank.d328.s19,the,50,52,O
DDI-DrugBank.d328.s19,presence,54,61,O
DDI-DrugBank.d328.s19,of,63,64,O
DDI-DrugBank.d328.s19,high,66,69,O
DDI-DrugBank.d328.s19,doses,71,75,O
DDI-DrugBank.d328.s19,of,77,78,O
DDI-DrugBank.d328.s19,valdecoxib,80,89,B-drug
DDI-DrugBank.d328.s19,were,91,94,O
DDI-DrugBank.d328.s19,almost,96,101,O
DDI-DrugBank.d328.s19,5-fold,103,108,O
DDI-DrugBank.d328.s19,lower,110,114,O
DDI-DrugBank.d328.s19,than,116,119,O
DDI-DrugBank.d328.s19,those,121,125,O
DDI-DrugBank.d328.s19,seen,127,130,O
DDI-DrugBank.d328.s19,in,132,133,O
DDI-DrugBank.d328.s19,CYP,135,137,O
DDI-DrugBank.d328.s19,2D6,139,141,O
DDI-DrugBank.d328.s19,poor,143,146,O
DDI-DrugBank.d328.s19,metabolizers,148,159,O
DDI-DrugBank.d328.s19,suggesting,161,170,O
DDI-DrugBank.d328.s19,that,172,175,O
DDI-DrugBank.d328.s19,dose,177,180,O
DDI-DrugBank.d328.s19,adjustment,182,191,O
DDI-DrugBank.d328.s19,is,193,194,O
DDI-DrugBank.d328.s19,not,196,198,O
DDI-DrugBank.d328.s19,necessary,200,208,O
DDI-DrugBank.d328.s19,.,209,209,O
DDI-DrugBank.d328.s20,Lithium,0,6,B-drug
DDI-DrugBank.d328.s20,:,7,7,O
DDI-DrugBank.d328.s20,Valdecoxib,9,18,B-drug
DDI-DrugBank.d328.s20,40,20,21,O
DDI-DrugBank.d328.s20,mg,23,24,O
DDI-DrugBank.d328.s20,BID,26,28,O
DDI-DrugBank.d328.s20,for,30,32,O
DDI-DrugBank.d328.s20,7,34,34,O
DDI-DrugBank.d328.s20,days,36,39,O
DDI-DrugBank.d328.s20,produced,41,48,O
DDI-DrugBank.d328.s20,significant,50,60,O
DDI-DrugBank.d328.s20,decreases,62,70,O
DDI-DrugBank.d328.s20,in,72,73,O
DDI-DrugBank.d328.s20,lithium,75,81,B-drug
DDI-DrugBank.d328.s20,serum,83,87,O
DDI-DrugBank.d328.s20,clearance,89,97,O
DDI-DrugBank.d328.s20,(,99,99,O
DDI-DrugBank.d328.s20,25,100,101,O
DDI-DrugBank.d328.s20,%,102,102,O
DDI-DrugBank.d328.s20,),103,103,O
DDI-DrugBank.d328.s20,and,105,107,O
DDI-DrugBank.d328.s20,renal,109,113,O
DDI-DrugBank.d328.s20,clearance,115,123,O
DDI-DrugBank.d328.s20,(,125,125,O
DDI-DrugBank.d328.s20,30,126,127,O
DDI-DrugBank.d328.s20,%,128,128,O
DDI-DrugBank.d328.s20,),129,129,O
DDI-DrugBank.d328.s20,with,131,134,O
DDI-DrugBank.d328.s20,a,136,136,O
DDI-DrugBank.d328.s20,34,138,139,O
DDI-DrugBank.d328.s20,%,140,140,O
DDI-DrugBank.d328.s20,higher,142,147,O
DDI-DrugBank.d328.s20,serum,149,153,O
DDI-DrugBank.d328.s20,exposure,155,162,O
DDI-DrugBank.d328.s20,compared,164,171,O
DDI-DrugBank.d328.s20,to,173,174,O
DDI-DrugBank.d328.s20,lithium,176,182,B-drug
DDI-DrugBank.d328.s20,alone,184,188,O
DDI-DrugBank.d328.s20,.,189,189,O
DDI-DrugBank.d328.s21,Lithium,0,6,B-drug
DDI-DrugBank.d328.s21,serum,8,12,O
DDI-DrugBank.d328.s21,concentrations,14,27,O
DDI-DrugBank.d328.s21,should,29,34,O
DDI-DrugBank.d328.s21,be,36,37,O
DDI-DrugBank.d328.s21,monitored,39,47,O
DDI-DrugBank.d328.s21,closely,49,55,O
DDI-DrugBank.d328.s21,when,57,60,O
DDI-DrugBank.d328.s21,initiating,62,71,O
DDI-DrugBank.d328.s21,or,73,74,O
DDI-DrugBank.d328.s21,changing,76,83,O
DDI-DrugBank.d328.s21,therapy,85,91,O
DDI-DrugBank.d328.s21,with,93,96,O
DDI-DrugBank.d328.s21,BEXTRA,98,103,B-brand
DDI-DrugBank.d328.s21,in,105,106,O
DDI-DrugBank.d328.s21,patients,108,115,O
DDI-DrugBank.d328.s21,receiving,117,125,O
DDI-DrugBank.d328.s21,lithium,127,133,B-drug
DDI-DrugBank.d328.s21,.,134,134,O
DDI-DrugBank.d328.s22,Lithium,0,6,B-drug
DDI-DrugBank.d328.s22,carbonate,8,16,I-drug
DDI-DrugBank.d328.s22,(,18,18,O
DDI-DrugBank.d328.s22,450,19,21,O
DDI-DrugBank.d328.s22,mg,23,24,O
DDI-DrugBank.d328.s22,BID,26,28,O
DDI-DrugBank.d328.s22,for,30,32,O
DDI-DrugBank.d328.s22,7,34,34,O
DDI-DrugBank.d328.s22,days,36,39,O
DDI-DrugBank.d328.s22,),40,40,O
DDI-DrugBank.d328.s22,had,42,44,O
DDI-DrugBank.d328.s22,no,46,47,O
DDI-DrugBank.d328.s22,effect,49,54,O
DDI-DrugBank.d328.s22,on,56,57,O
DDI-DrugBank.d328.s22,valdecoxib,59,68,B-drug
DDI-DrugBank.d328.s22,pharmacokinetics,70,85,O
DDI-DrugBank.d328.s22,.,86,86,O
DDI-DrugBank.d328.s23,Warfarin,0,7,B-drug
DDI-DrugBank.d328.s23,:,8,8,O
DDI-DrugBank.d328.s23,The,10,12,O
DDI-DrugBank.d328.s23,effect,14,19,O
DDI-DrugBank.d328.s23,of,21,22,O
DDI-DrugBank.d328.s23,valdecoxib,24,33,B-drug
DDI-DrugBank.d328.s23,on,35,36,O
DDI-DrugBank.d328.s23,the,38,40,O
DDI-DrugBank.d328.s23,anticoagulant,42,54,O
DDI-DrugBank.d328.s23,effect,56,61,O
DDI-DrugBank.d328.s23,of,63,64,O
DDI-DrugBank.d328.s23,warfarin,66,73,B-drug
DDI-DrugBank.d328.s23,(,75,75,O
DDI-DrugBank.d328.s23,1,76,76,O
DDI-DrugBank.d328.s23,-,78,78,O
DDI-DrugBank.d328.s23,8,80,80,O
DDI-DrugBank.d328.s23,mg/day,82,87,O
DDI-DrugBank.d328.s23,),88,88,O
DDI-DrugBank.d328.s23,was,90,92,O
DDI-DrugBank.d328.s23,studied,94,100,O
DDI-DrugBank.d328.s23,in,102,103,O
DDI-DrugBank.d328.s23,healthy,105,111,O
DDI-DrugBank.d328.s23,subjects,113,120,O
DDI-DrugBank.d328.s23,by,122,123,O
DDI-DrugBank.d328.s23,coadministration,125,140,O
DDI-DrugBank.d328.s23,of,142,143,O
DDI-DrugBank.d328.s23,BEXTRA,145,150,B-brand
DDI-DrugBank.d328.s23,40,152,153,O
DDI-DrugBank.d328.s23,mg,155,156,O
DDI-DrugBank.d328.s23,BID,158,160,O
DDI-DrugBank.d328.s23,for,162,164,O
DDI-DrugBank.d328.s23,7,166,166,O
DDI-DrugBank.d328.s23,days,168,171,O
DDI-DrugBank.d328.s23,.,172,172,O
DDI-DrugBank.d328.s24,Valdecoxib,0,9,B-drug
DDI-DrugBank.d328.s24,caused,11,16,O
DDI-DrugBank.d328.s24,a,18,18,O
DDI-DrugBank.d328.s24,statistically,20,32,O
DDI-DrugBank.d328.s24,significant,34,44,O
DDI-DrugBank.d328.s24,increase,46,53,O
DDI-DrugBank.d328.s24,in,55,56,O
DDI-DrugBank.d328.s24,plasma,58,63,O
DDI-DrugBank.d328.s24,exposures,65,73,O
DDI-DrugBank.d328.s24,of,75,76,O
DDI-DrugBank.d328.s24,R-warfarin,78,87,B-drug
DDI-DrugBank.d328.s24,and,89,91,O
DDI-DrugBank.d328.s24,S-warfarin,93,102,B-drug
DDI-DrugBank.d328.s24,(,104,104,O
DDI-DrugBank.d328.s24,12,105,106,O
DDI-DrugBank.d328.s24,%,107,107,O
DDI-DrugBank.d328.s24,and,109,111,O
DDI-DrugBank.d328.s24,15,113,114,O
DDI-DrugBank.d328.s24,%,115,115,O
DDI-DrugBank.d328.s24,",",116,116,O
DDI-DrugBank.d328.s24,respectively,118,129,O
DDI-DrugBank.d328.s24,),130,130,O
DDI-DrugBank.d328.s24,",",131,131,O
DDI-DrugBank.d328.s24,and,133,135,O
DDI-DrugBank.d328.s24,in,137,138,O
DDI-DrugBank.d328.s24,the,140,142,O
DDI-DrugBank.d328.s24,pharmacodynamic,144,158,O
DDI-DrugBank.d328.s24,effects,160,166,O
DDI-DrugBank.d328.s24,(,168,168,O
DDI-DrugBank.d328.s24,prothrombin,169,179,O
DDI-DrugBank.d328.s24,time,181,184,O
DDI-DrugBank.d328.s24,",",185,185,O
DDI-DrugBank.d328.s24,measured,187,194,O
DDI-DrugBank.d328.s24,as,196,197,O
DDI-DrugBank.d328.s24,INR,199,201,O
DDI-DrugBank.d328.s24,),202,202,O
DDI-DrugBank.d328.s24,of,204,205,O
DDI-DrugBank.d328.s24,warfarin,207,214,B-drug
DDI-DrugBank.d328.s24,.,215,215,O
DDI-DrugBank.d328.s25,While,0,4,O
DDI-DrugBank.d328.s25,mean,6,9,O
DDI-DrugBank.d328.s25,INR,11,13,O
DDI-DrugBank.d328.s25,values,15,20,O
DDI-DrugBank.d328.s25,were,22,25,O
DDI-DrugBank.d328.s25,only,27,30,O
DDI-DrugBank.d328.s25,slightly,32,39,O
DDI-DrugBank.d328.s25,increased,41,49,O
DDI-DrugBank.d328.s25,with,51,54,O
DDI-DrugBank.d328.s25,coadministration,56,71,O
DDI-DrugBank.d328.s25,of,73,74,O
DDI-DrugBank.d328.s25,valdecoxib,76,85,B-drug
DDI-DrugBank.d328.s25,",",86,86,O
DDI-DrugBank.d328.s25,the,88,90,O
DDI-DrugBank.d328.s25,day-to-day,92,101,O
DDI-DrugBank.d328.s25,variability,103,113,O
DDI-DrugBank.d328.s25,in,115,116,O
DDI-DrugBank.d328.s25,individual,118,127,O
DDI-DrugBank.d328.s25,INR,129,131,O
DDI-DrugBank.d328.s25,values,133,138,O
DDI-DrugBank.d328.s25,was,140,142,O
DDI-DrugBank.d328.s25,increased,144,152,O
DDI-DrugBank.d328.s25,.,153,153,O
DDI-DrugBank.d328.s26,Anticoagulant,0,12,B-brand
DDI-DrugBank.d328.s26,therapy,14,20,O
DDI-DrugBank.d328.s26,should,22,27,O
DDI-DrugBank.d328.s26,be,29,30,O
DDI-DrugBank.d328.s26,monitored,32,40,O
DDI-DrugBank.d328.s26,",",41,41,O
DDI-DrugBank.d328.s26,particularly,43,54,O
DDI-DrugBank.d328.s26,during,56,61,O
DDI-DrugBank.d328.s26,the,63,65,O
DDI-DrugBank.d328.s26,first,67,71,O
DDI-DrugBank.d328.s26,few,73,75,O
DDI-DrugBank.d328.s26,weeks,77,81,O
DDI-DrugBank.d328.s26,",",82,82,O
DDI-DrugBank.d328.s26,after,84,88,O
DDI-DrugBank.d328.s26,initiating,90,99,O
DDI-DrugBank.d328.s26,therapy,101,107,O
DDI-DrugBank.d328.s26,with,109,112,O
DDI-DrugBank.d328.s26,BEXTRA,114,119,B-brand
DDI-DrugBank.d328.s26,in,121,122,O
DDI-DrugBank.d328.s26,patients,124,131,O
DDI-DrugBank.d328.s26,receiving,133,141,O
DDI-DrugBank.d328.s26,warfarin,143,150,B-drug
DDI-DrugBank.d328.s26,or,152,153,O
DDI-DrugBank.d328.s26,similar,155,161,O
DDI-DrugBank.d328.s26,agents,163,168,O
DDI-DrugBank.d328.s26,.,169,169,O
DDI-DrugBank.d328.s27,Fluconazole,0,10,B-drug
DDI-DrugBank.d328.s27,and,12,14,O
DDI-DrugBank.d328.s27,Ketoconazole,16,27,B-drug
DDI-DrugBank.d328.s27,:,28,28,O
DDI-DrugBank.d328.s27,Ketoconazole,30,41,B-drug
DDI-DrugBank.d328.s27,and,43,45,O
DDI-DrugBank.d328.s27,fluconazole,47,57,B-drug
DDI-DrugBank.d328.s27,are,59,61,O
DDI-DrugBank.d328.s27,predominantly,63,75,O
DDI-DrugBank.d328.s27,CYP,77,79,O
DDI-DrugBank.d328.s27,3A4,81,83,O
DDI-DrugBank.d328.s27,and,85,87,O
DDI-DrugBank.d328.s27,2C9,89,91,O
DDI-DrugBank.d328.s27,inhibitors,93,102,O
DDI-DrugBank.d328.s27,",",103,103,O
DDI-DrugBank.d328.s27,respectively,105,116,O
DDI-DrugBank.d328.s27,.,117,117,O
DDI-DrugBank.d328.s28,Concomitant,0,10,O
DDI-DrugBank.d328.s28,single,12,17,O
DDI-DrugBank.d328.s28,dose,19,22,O
DDI-DrugBank.d328.s28,administration,24,37,O
DDI-DrugBank.d328.s28,of,39,40,O
DDI-DrugBank.d328.s28,valdecoxib,42,51,B-drug
DDI-DrugBank.d328.s28,20,53,54,O
DDI-DrugBank.d328.s28,mg,56,57,O
DDI-DrugBank.d328.s28,with,59,62,O
DDI-DrugBank.d328.s28,multiple,64,71,O
DDI-DrugBank.d328.s28,doses,73,77,O
DDI-DrugBank.d328.s28,of,79,80,O
DDI-DrugBank.d328.s28,ketoconazole,82,93,B-drug
DDI-DrugBank.d328.s28,and,95,97,O
DDI-DrugBank.d328.s28,fluconazole,99,109,B-drug
DDI-DrugBank.d328.s28,produced,111,118,O
DDI-DrugBank.d328.s28,a,120,120,O
DDI-DrugBank.d328.s28,significant,122,132,O
DDI-DrugBank.d328.s28,increase,134,141,O
DDI-DrugBank.d328.s28,in,143,144,O
DDI-DrugBank.d328.s28,exposure,146,153,O
DDI-DrugBank.d328.s28,of,155,156,O
DDI-DrugBank.d328.s28,valdecoxib,158,167,B-drug
DDI-DrugBank.d328.s28,.,168,168,O
DDI-DrugBank.d328.s29,Plasma,0,5,O
DDI-DrugBank.d328.s29,exposure,7,14,O
DDI-DrugBank.d328.s29,(,16,16,O
DDI-DrugBank.d328.s29,AUC,17,19,O
DDI-DrugBank.d328.s29,),20,20,O
DDI-DrugBank.d328.s29,to,22,23,O
DDI-DrugBank.d328.s29,valdecoxib,25,34,B-drug
DDI-DrugBank.d328.s29,was,36,38,O
DDI-DrugBank.d328.s29,increased,40,48,O
DDI-DrugBank.d328.s29,62,50,51,O
DDI-DrugBank.d328.s29,%,52,52,O
DDI-DrugBank.d328.s29,when,54,57,O
DDI-DrugBank.d328.s29,coadministered,59,72,O
DDI-DrugBank.d328.s29,with,74,77,O
DDI-DrugBank.d328.s29,fluconazole,79,89,B-drug
DDI-DrugBank.d328.s29,and,91,93,O
DDI-DrugBank.d328.s29,38,95,96,O
DDI-DrugBank.d328.s29,%,97,97,O
DDI-DrugBank.d328.s29,when,99,102,O
DDI-DrugBank.d328.s29,coadministered,104,117,O
DDI-DrugBank.d328.s29,with,119,122,O
DDI-DrugBank.d328.s29,ketoconazole,124,135,B-drug
DDI-DrugBank.d328.s29,.,136,136,O
DDI-DrugBank.d328.s30,Glyburide,0,8,B-drug
DDI-DrugBank.d328.s30,:,9,9,O
DDI-DrugBank.d328.s30,Glyburide,11,19,B-drug
DDI-DrugBank.d328.s30,is,21,22,O
DDI-DrugBank.d328.s30,a,24,24,O
DDI-DrugBank.d328.s30,CYP,26,28,O
DDI-DrugBank.d328.s30,2C9,30,32,O
DDI-DrugBank.d328.s30,substrate,34,42,O
DDI-DrugBank.d328.s30,.,43,43,O
DDI-DrugBank.d328.s31,Coadministration,0,15,O
DDI-DrugBank.d328.s31,of,17,18,O
DDI-DrugBank.d328.s31,valdecoxib,20,29,B-drug
DDI-DrugBank.d328.s31,(,31,31,O
DDI-DrugBank.d328.s31,10,32,33,O
DDI-DrugBank.d328.s31,mg,35,36,O
DDI-DrugBank.d328.s31,BID,38,40,O
DDI-DrugBank.d328.s31,for,42,44,O
DDI-DrugBank.d328.s31,7,46,46,O
DDI-DrugBank.d328.s31,days,48,51,O
DDI-DrugBank.d328.s31,),52,52,O
DDI-DrugBank.d328.s31,with,54,57,O
DDI-DrugBank.d328.s31,glyburide,59,67,B-drug
DDI-DrugBank.d328.s31,(,69,69,O
DDI-DrugBank.d328.s31,5,70,70,O
DDI-DrugBank.d328.s31,mg,72,73,O
DDI-DrugBank.d328.s31,QD,75,76,O
DDI-DrugBank.d328.s31,or,78,79,O
DDI-DrugBank.d328.s31,10,81,82,O
DDI-DrugBank.d328.s31,mg,84,85,O
DDI-DrugBank.d328.s31,BID,87,89,O
DDI-DrugBank.d328.s31,),90,90,O
DDI-DrugBank.d328.s31,did,92,94,O
DDI-DrugBank.d328.s31,not,96,98,O
DDI-DrugBank.d328.s31,affect,100,105,O
DDI-DrugBank.d328.s31,the,107,109,O
DDI-DrugBank.d328.s31,pharmacokinetics,111,126,O
DDI-DrugBank.d328.s31,(,128,128,O
DDI-DrugBank.d328.s31,exposure,129,136,O
DDI-DrugBank.d328.s31,),137,137,O
DDI-DrugBank.d328.s31,of,139,140,O
DDI-DrugBank.d328.s31,glyburide,142,150,B-drug
DDI-DrugBank.d328.s31,.,151,151,O
DDI-DrugBank.d328.s32,Coadministration,0,15,O
DDI-DrugBank.d328.s32,of,17,18,O
DDI-DrugBank.d328.s32,valdecoxib,20,29,B-drug
DDI-DrugBank.d328.s32,(,31,31,O
DDI-DrugBank.d328.s32,40,32,33,O
DDI-DrugBank.d328.s32,mg,35,36,O
DDI-DrugBank.d328.s32,BID,38,40,O
DDI-DrugBank.d328.s32,(,42,42,O
DDI-DrugBank.d328.s32,day,43,45,O
DDI-DrugBank.d328.s32,1,47,47,O
DDI-DrugBank.d328.s32,),48,48,O
DDI-DrugBank.d328.s32,and,50,52,O
DDI-DrugBank.d328.s32,40,54,55,O
DDI-DrugBank.d328.s32,mg,57,58,O
DDI-DrugBank.d328.s32,QD,60,61,O
DDI-DrugBank.d328.s32,(,63,63,O
DDI-DrugBank.d328.s32,days,64,67,O
DDI-DrugBank.d328.s32,2-7,69,71,O
DDI-DrugBank.d328.s32,),72,72,O
DDI-DrugBank.d328.s32,),73,73,O
DDI-DrugBank.d328.s32,with,75,78,O
DDI-DrugBank.d328.s32,glyburide,80,88,B-drug
DDI-DrugBank.d328.s32,(,90,90,O
DDI-DrugBank.d328.s32,5,91,91,O
DDI-DrugBank.d328.s32,mg,93,94,O
DDI-DrugBank.d328.s32,QD,96,97,O
DDI-DrugBank.d328.s32,),98,98,O
DDI-DrugBank.d328.s32,did,100,102,O
DDI-DrugBank.d328.s32,not,104,106,O
DDI-DrugBank.d328.s32,affect,108,113,O
DDI-DrugBank.d328.s32,either,115,120,O
DDI-DrugBank.d328.s32,the,122,124,O
DDI-DrugBank.d328.s32,pharmacokinetics,126,141,O
DDI-DrugBank.d328.s32,(,143,143,O
DDI-DrugBank.d328.s32,exposure,144,151,O
DDI-DrugBank.d328.s32,),152,152,O
DDI-DrugBank.d328.s32,or,154,155,O
DDI-DrugBank.d328.s32,the,157,159,O
DDI-DrugBank.d328.s32,pharmacodynamics,161,176,O
DDI-DrugBank.d328.s32,(,178,178,O
DDI-DrugBank.d328.s32,blood,179,183,O
DDI-DrugBank.d328.s32,glucose,185,191,O
DDI-DrugBank.d328.s32,and,193,195,O
DDI-DrugBank.d328.s32,insulin,197,203,O
DDI-DrugBank.d328.s32,levels,205,210,O
DDI-DrugBank.d328.s32,),211,211,O
DDI-DrugBank.d328.s32,of,213,214,O
DDI-DrugBank.d328.s32,glyburide,216,224,B-drug
DDI-DrugBank.d328.s32,.,225,225,O
DDI-DrugBank.d328.s33,Coadministration,0,15,O
DDI-DrugBank.d328.s33,of,17,18,O
DDI-DrugBank.d328.s33,valdecoxib,20,29,B-drug
DDI-DrugBank.d328.s33,(,31,31,O
DDI-DrugBank.d328.s33,40,32,33,O
DDI-DrugBank.d328.s33,mg,35,36,O
DDI-DrugBank.d328.s33,BID,38,40,O
DDI-DrugBank.d328.s33,(,42,42,O
DDI-DrugBank.d328.s33,day,43,45,O
DDI-DrugBank.d328.s33,1,47,47,O
DDI-DrugBank.d328.s33,),48,48,O
DDI-DrugBank.d328.s33,and,50,52,O
DDI-DrugBank.d328.s33,40,54,55,O
DDI-DrugBank.d328.s33,mg,57,58,O
DDI-DrugBank.d328.s33,QD,60,61,O
DDI-DrugBank.d328.s33,(,63,63,O
DDI-DrugBank.d328.s33,days,64,67,O
DDI-DrugBank.d328.s33,2-7,69,71,O
DDI-DrugBank.d328.s33,),72,72,O
DDI-DrugBank.d328.s33,),73,73,O
DDI-DrugBank.d328.s33,with,75,78,O
DDI-DrugBank.d328.s33,glyburide,80,88,B-drug
DDI-DrugBank.d328.s33,(,90,90,O
DDI-DrugBank.d328.s33,10,91,92,O
DDI-DrugBank.d328.s33,mg,94,95,O
DDI-DrugBank.d328.s33,glyburide,97,105,B-drug
DDI-DrugBank.d328.s33,BID,107,109,O
DDI-DrugBank.d328.s33,),110,110,O
DDI-DrugBank.d328.s33,resulted,112,119,O
DDI-DrugBank.d328.s33,in,121,122,O
DDI-DrugBank.d328.s33,21,124,125,O
DDI-DrugBank.d328.s33,%,126,126,O
DDI-DrugBank.d328.s33,increase,128,135,O
DDI-DrugBank.d328.s33,in,137,138,O
DDI-DrugBank.d328.s33,glyburide,140,148,B-drug
DDI-DrugBank.d328.s33,AUC0-12,150,156,O
DDI-DrugBank.d328.s33,and,158,160,O
DDI-DrugBank.d328.s33,a,162,162,O
DDI-DrugBank.d328.s33,16,164,165,O
DDI-DrugBank.d328.s33,%,166,166,O
DDI-DrugBank.d328.s33,increase,168,175,O
DDI-DrugBank.d328.s33,in,177,178,O
DDI-DrugBank.d328.s33,glyburide,180,188,B-drug
DDI-DrugBank.d328.s33,Cmax,190,193,O
DDI-DrugBank.d328.s33,leading,195,201,O
DDI-DrugBank.d328.s33,to,203,204,O
DDI-DrugBank.d328.s33,a,206,206,O
DDI-DrugBank.d328.s33,16,208,209,O
DDI-DrugBank.d328.s33,%,210,210,O
DDI-DrugBank.d328.s33,decrease,212,219,O
DDI-DrugBank.d328.s33,in,221,222,O
DDI-DrugBank.d328.s33,glucose,224,230,O
DDI-DrugBank.d328.s33,AUC0-24,232,238,O
DDI-DrugBank.d328.s33,.,239,239,O
DDI-DrugBank.d328.s34,Insulin,0,6,O
DDI-DrugBank.d328.s34,parameters,8,17,O
DDI-DrugBank.d328.s34,were,19,22,O
DDI-DrugBank.d328.s34,not,24,26,O
DDI-DrugBank.d328.s34,affected,28,35,O
DDI-DrugBank.d328.s34,.,36,36,O
DDI-DrugBank.d328.s35,Because,0,6,O
DDI-DrugBank.d328.s35,changes,8,14,O
DDI-DrugBank.d328.s35,in,16,17,O
DDI-DrugBank.d328.s35,glucose,19,25,O
DDI-DrugBank.d328.s35,concentrations,27,40,O
DDI-DrugBank.d328.s35,with,42,45,O
DDI-DrugBank.d328.s35,valdecoxib,47,56,B-drug
DDI-DrugBank.d328.s35,coadministration,58,73,O
DDI-DrugBank.d328.s35,were,75,78,O
DDI-DrugBank.d328.s35,within,80,85,O
DDI-DrugBank.d328.s35,the,87,89,O
DDI-DrugBank.d328.s35,normal,91,96,O
DDI-DrugBank.d328.s35,variability,98,108,O
DDI-DrugBank.d328.s35,and,110,112,O
DDI-DrugBank.d328.s35,individual,114,123,O
DDI-DrugBank.d328.s35,glucose,125,131,O
DDI-DrugBank.d328.s35,concentrations,133,146,O
DDI-DrugBank.d328.s35,were,148,151,O
DDI-DrugBank.d328.s35,above,153,157,O
DDI-DrugBank.d328.s35,or,159,160,O
DDI-DrugBank.d328.s35,near,162,165,O
DDI-DrugBank.d328.s35,70,167,168,O
DDI-DrugBank.d328.s35,mg/dL,170,174,O
DDI-DrugBank.d328.s35,",",175,175,O
DDI-DrugBank.d328.s35,dose,177,180,O
DDI-DrugBank.d328.s35,adjustment,182,191,O
DDI-DrugBank.d328.s35,for,193,195,O
DDI-DrugBank.d328.s35,glyburide,197,205,B-drug
DDI-DrugBank.d328.s35,(,207,207,O
DDI-DrugBank.d328.s35,5,208,208,O
DDI-DrugBank.d328.s35,mg,210,211,O
DDI-DrugBank.d328.s35,QD,213,214,O
DDI-DrugBank.d328.s35,and,216,218,O
DDI-DrugBank.d328.s35,10,220,221,O
DDI-DrugBank.d328.s35,mg,223,224,O
DDI-DrugBank.d328.s35,BID,226,228,O
DDI-DrugBank.d328.s35,),229,229,O
DDI-DrugBank.d328.s35,with,231,234,O
DDI-DrugBank.d328.s35,valdecoxib,236,245,B-drug
DDI-DrugBank.d328.s35,coadministration,247,262,O
DDI-DrugBank.d328.s35,(,264,264,O
DDI-DrugBank.d328.s35,up,265,266,O
DDI-DrugBank.d328.s35,to,268,269,O
DDI-DrugBank.d328.s35,40,271,272,O
DDI-DrugBank.d328.s35,mg,274,275,O
DDI-DrugBank.d328.s35,QD,277,278,O
DDI-DrugBank.d328.s35,),279,279,O
DDI-DrugBank.d328.s35,is,281,282,O
DDI-DrugBank.d328.s35,not,284,286,O
DDI-DrugBank.d328.s35,indicated,288,296,O
DDI-DrugBank.d328.s35,.,297,297,O
DDI-DrugBank.d328.s36,Coadministration,0,15,O
DDI-DrugBank.d328.s36,of,17,18,O
DDI-DrugBank.d328.s36,glyburide,20,28,B-drug
DDI-DrugBank.d328.s36,with,30,33,O
DDI-DrugBank.d328.s36,doses,35,39,O
DDI-DrugBank.d328.s36,higher,41,46,O
DDI-DrugBank.d328.s36,than,48,51,O
DDI-DrugBank.d328.s36,40,53,54,O
DDI-DrugBank.d328.s36,mg,56,57,O
DDI-DrugBank.d328.s36,valdecoxib,59,68,B-drug
DDI-DrugBank.d328.s36,(,70,70,O
DDI-DrugBank.d328.s36,e.g.,71,74,O
DDI-DrugBank.d328.s36,",",75,75,O
DDI-DrugBank.d328.s36,40,77,78,O
DDI-DrugBank.d328.s36,mg,80,81,O
DDI-DrugBank.d328.s36,BID,83,85,O
DDI-DrugBank.d328.s36,),86,86,O
DDI-DrugBank.d328.s36,have,88,91,O
DDI-DrugBank.d328.s36,not,93,95,O
DDI-DrugBank.d328.s36,been,97,100,O
DDI-DrugBank.d328.s36,studied,102,108,O
DDI-DrugBank.d328.s36,.,109,109,O
DDI-DrugBank.d328.s37,Omeprazole,0,9,B-drug
DDI-DrugBank.d328.s37,:,10,10,O
DDI-DrugBank.d328.s37,Omeprazole,12,21,B-drug
DDI-DrugBank.d328.s37,is,23,24,O
DDI-DrugBank.d328.s37,a,26,26,O
DDI-DrugBank.d328.s37,CYP,28,30,O
DDI-DrugBank.d328.s37,3A4,32,34,O
DDI-DrugBank.d328.s37,substrate,36,44,O
DDI-DrugBank.d328.s37,and,46,48,O
DDI-DrugBank.d328.s37,CYP,50,52,O
DDI-DrugBank.d328.s37,2C19,54,57,O
DDI-DrugBank.d328.s37,substrate,59,67,O
DDI-DrugBank.d328.s37,and,69,71,O
DDI-DrugBank.d328.s37,inhibitor,73,81,O
DDI-DrugBank.d328.s37,.,82,82,O
DDI-DrugBank.d328.s38,Valdecoxib,0,9,B-drug
DDI-DrugBank.d328.s38,steady,11,16,O
DDI-DrugBank.d328.s38,state,18,22,O
DDI-DrugBank.d328.s38,plasma,24,29,O
DDI-DrugBank.d328.s38,concentrations,31,44,O
DDI-DrugBank.d328.s38,(,46,46,O
DDI-DrugBank.d328.s38,40,47,48,O
DDI-DrugBank.d328.s38,mg,50,51,O
DDI-DrugBank.d328.s38,BID,53,55,O
DDI-DrugBank.d328.s38,),56,56,O
DDI-DrugBank.d328.s38,were,58,61,O
DDI-DrugBank.d328.s38,not,63,65,O
DDI-DrugBank.d328.s38,affected,67,74,O
DDI-DrugBank.d328.s38,significantly,76,88,O
DDI-DrugBank.d328.s38,with,90,93,O
DDI-DrugBank.d328.s38,multiple,95,102,O
DDI-DrugBank.d328.s38,doses,104,108,O
DDI-DrugBank.d328.s38,of,110,111,O
DDI-DrugBank.d328.s38,omeprazole,113,122,B-drug
DDI-DrugBank.d328.s38,(,124,124,O
DDI-DrugBank.d328.s38,40,125,126,O
DDI-DrugBank.d328.s38,mg,128,129,O
DDI-DrugBank.d328.s38,QD,131,132,O
DDI-DrugBank.d328.s38,),133,133,O
DDI-DrugBank.d328.s38,.,134,134,O
DDI-DrugBank.d328.s39,Coadministration,0,15,O
DDI-DrugBank.d328.s39,with,17,20,O
DDI-DrugBank.d328.s39,valdecoxib,22,31,B-drug
DDI-DrugBank.d328.s39,increased,33,41,O
DDI-DrugBank.d328.s39,exposure,43,50,O
DDI-DrugBank.d328.s39,of,52,53,O
DDI-DrugBank.d328.s39,omeprazole,55,64,B-drug
DDI-DrugBank.d328.s39,(,66,66,O
DDI-DrugBank.d328.s39,AUC,67,69,O
DDI-DrugBank.d328.s39,),70,70,O
DDI-DrugBank.d328.s39,by,72,73,O
DDI-DrugBank.d328.s39,46,75,76,O
DDI-DrugBank.d328.s39,%,77,77,O
DDI-DrugBank.d328.s39,.,78,78,O
DDI-DrugBank.d328.s40,Drugs,0,4,O
DDI-DrugBank.d328.s40,whose,6,10,O
DDI-DrugBank.d328.s40,absorption,12,21,O
DDI-DrugBank.d328.s40,is,23,24,O
DDI-DrugBank.d328.s40,sensitive,26,34,O
DDI-DrugBank.d328.s40,to,36,37,O
DDI-DrugBank.d328.s40,pH,39,40,O
DDI-DrugBank.d328.s40,may,42,44,O
DDI-DrugBank.d328.s40,be,46,47,O
DDI-DrugBank.d328.s40,negatively,49,58,O
DDI-DrugBank.d328.s40,impacted,60,67,O
DDI-DrugBank.d328.s40,by,69,70,O
DDI-DrugBank.d328.s40,concomitant,72,82,O
DDI-DrugBank.d328.s40,administration,84,97,O
DDI-DrugBank.d328.s40,of,99,100,O
DDI-DrugBank.d328.s40,omeprazole,102,111,B-drug
DDI-DrugBank.d328.s40,and,113,115,O
DDI-DrugBank.d328.s40,valdecoxib,117,126,B-drug
DDI-DrugBank.d328.s40,.,127,127,O
DDI-DrugBank.d328.s41,However,0,6,O
DDI-DrugBank.d328.s41,",",7,7,O
DDI-DrugBank.d328.s41,because,9,15,O
DDI-DrugBank.d328.s41,higher,17,22,O
DDI-DrugBank.d328.s41,doses,24,28,O
DDI-DrugBank.d328.s41,(,30,30,O
DDI-DrugBank.d328.s41,up,31,32,O
DDI-DrugBank.d328.s41,to,34,35,O
DDI-DrugBank.d328.s41,360,37,39,O
DDI-DrugBank.d328.s41,mg,41,42,O
DDI-DrugBank.d328.s41,QD,44,45,O
DDI-DrugBank.d328.s41,),46,46,O
DDI-DrugBank.d328.s41,of,48,49,O
DDI-DrugBank.d328.s41,omeprazole,51,60,B-drug
DDI-DrugBank.d328.s41,are,62,64,O
DDI-DrugBank.d328.s41,tolerated,66,74,O
DDI-DrugBank.d328.s41,in,76,77,O
DDI-DrugBank.d328.s41,Zollinger-Ellison,79,95,O
DDI-DrugBank.d328.s41,(,97,97,O
DDI-DrugBank.d328.s41,ZE,98,99,O
DDI-DrugBank.d328.s41,),100,100,O
DDI-DrugBank.d328.s41,patients,102,109,O
DDI-DrugBank.d328.s41,",",110,110,O
DDI-DrugBank.d328.s41,no,112,113,O
DDI-DrugBank.d328.s41,dose,115,118,O
DDI-DrugBank.d328.s41,adjustment,120,129,O
DDI-DrugBank.d328.s41,for,131,133,O
DDI-DrugBank.d328.s41,omeprazole,135,144,B-drug
DDI-DrugBank.d328.s41,is,146,147,O
DDI-DrugBank.d328.s41,recommended,149,159,O
DDI-DrugBank.d328.s41,at,161,162,O
DDI-DrugBank.d328.s41,current,164,170,O
DDI-DrugBank.d328.s41,doses,172,176,O
DDI-DrugBank.d328.s41,.,177,177,O
DDI-DrugBank.d328.s42,Coadministration,0,15,O
DDI-DrugBank.d328.s42,of,17,18,O
DDI-DrugBank.d328.s42,valdecoxib,20,29,B-drug
DDI-DrugBank.d328.s42,with,31,34,O
DDI-DrugBank.d328.s42,doses,36,40,O
DDI-DrugBank.d328.s42,higher,42,47,O
DDI-DrugBank.d328.s42,than,49,52,O
DDI-DrugBank.d328.s42,40,54,55,O
DDI-DrugBank.d328.s42,mg,57,58,O
DDI-DrugBank.d328.s42,QD,60,61,O
DDI-DrugBank.d328.s42,omeprazole,63,72,B-drug
DDI-DrugBank.d328.s42,has,74,76,O
DDI-DrugBank.d328.s42,not,78,80,O
DDI-DrugBank.d328.s42,been,82,85,O
DDI-DrugBank.d328.s42,studied,87,93,O
DDI-DrugBank.d328.s42,.,94,94,O
DDI-DrugBank.d328.s43,Oral,0,3,O
DDI-DrugBank.d328.s43,Contraceptives,5,18,B-group
DDI-DrugBank.d328.s43,:,19,19,O
DDI-DrugBank.d328.s43,Valdecoxib,21,30,B-drug
DDI-DrugBank.d328.s43,(,32,32,O
DDI-DrugBank.d328.s43,40,33,34,O
DDI-DrugBank.d328.s43,mg,36,37,O
DDI-DrugBank.d328.s43,BID,39,41,O
DDI-DrugBank.d328.s43,),42,42,O
DDI-DrugBank.d328.s43,did,44,46,O
DDI-DrugBank.d328.s43,not,48,50,O
DDI-DrugBank.d328.s43,induce,52,57,O
DDI-DrugBank.d328.s43,the,59,61,O
DDI-DrugBank.d328.s43,metabolism,63,72,O
DDI-DrugBank.d328.s43,of,74,75,O
DDI-DrugBank.d328.s43,the,77,79,O
DDI-DrugBank.d328.s43,combination,81,91,O
DDI-DrugBank.d328.s43,oral,93,96,O
DDI-DrugBank.d328.s43,contraceptive,98,110,B-group
DDI-DrugBank.d328.s43,norethindrone/ethinyl,112,132,O
DDI-DrugBank.d328.s43,estradiol,134,142,I-drug
DDI-DrugBank.d328.s43,(,144,144,O
DDI-DrugBank.d328.s43,1,145,145,O
DDI-DrugBank.d328.s43,mg,147,148,O
DDI-DrugBank.d328.s43,/35,150,152,O
DDI-DrugBank.d328.s43,mcg,154,156,O
DDI-DrugBank.d328.s43,combination,158,168,O
DDI-DrugBank.d328.s43,",",169,169,O
DDI-DrugBank.d328.s43,Ortho-Novum,171,181,B-brand
DDI-DrugBank.d328.s43,1/35,183,186,O
DDI-DrugBank.d328.s43,),188,188,O
DDI-DrugBank.d328.s43,.,189,189,O
DDI-DrugBank.d328.s44,Coadministration,0,15,O
DDI-DrugBank.d328.s44,of,17,18,O
DDI-DrugBank.d328.s44,valdecoxib,20,29,B-drug
DDI-DrugBank.d328.s44,and,31,33,O
DDI-DrugBank.d328.s44,Ortho-Novum,35,45,B-brand
DDI-DrugBank.d328.s44,1/35,47,50,O
DDI-DrugBank.d328.s44,increased,53,61,O
DDI-DrugBank.d328.s44,the,63,65,O
DDI-DrugBank.d328.s44,exposure,67,74,O
DDI-DrugBank.d328.s44,of,76,77,O
DDI-DrugBank.d328.s44,norethindrone,79,91,B-drug
DDI-DrugBank.d328.s44,and,93,95,O
DDI-DrugBank.d328.s44,ethinyl,97,103,B-drug
DDI-DrugBank.d328.s44,estradiol,105,113,I-drug
DDI-DrugBank.d328.s44,by,115,116,O
DDI-DrugBank.d328.s44,20,118,119,O
DDI-DrugBank.d328.s44,%,120,120,O
DDI-DrugBank.d328.s44,and,122,124,O
DDI-DrugBank.d328.s44,34,126,127,O
DDI-DrugBank.d328.s44,%,128,128,O
DDI-DrugBank.d328.s44,",",129,129,O
DDI-DrugBank.d328.s44,respectively,131,142,O
DDI-DrugBank.d328.s44,.,143,143,O
DDI-DrugBank.d328.s45,Although,0,7,O
DDI-DrugBank.d328.s45,there,9,13,O
DDI-DrugBank.d328.s45,is,15,16,O
DDI-DrugBank.d328.s45,little,18,23,O
DDI-DrugBank.d328.s45,risk,25,28,O
DDI-DrugBank.d328.s45,for,30,32,O
DDI-DrugBank.d328.s45,loss,34,37,O
DDI-DrugBank.d328.s45,of,39,40,O
DDI-DrugBank.d328.s45,contraceptive,42,54,O
DDI-DrugBank.d328.s45,efficacy,56,63,O
DDI-DrugBank.d328.s45,",",64,64,O
DDI-DrugBank.d328.s45,the,66,68,O
DDI-DrugBank.d328.s45,clinical,70,77,O
DDI-DrugBank.d328.s45,significance,79,90,O
DDI-DrugBank.d328.s45,of,92,93,O
DDI-DrugBank.d328.s45,these,95,99,O
DDI-DrugBank.d328.s45,increased,101,109,O
DDI-DrugBank.d328.s45,exposures,111,119,O
DDI-DrugBank.d328.s45,in,121,122,O
DDI-DrugBank.d328.s45,terms,124,128,O
DDI-DrugBank.d328.s45,of,130,131,O
DDI-DrugBank.d328.s45,safety,133,138,O
DDI-DrugBank.d328.s45,is,140,141,O
DDI-DrugBank.d328.s45,not,143,145,O
DDI-DrugBank.d328.s45,known,147,151,O
DDI-DrugBank.d328.s45,.,152,152,O
DDI-DrugBank.d328.s46,These,0,4,O
DDI-DrugBank.d328.s46,increased,6,14,O
DDI-DrugBank.d328.s46,exposures,16,24,O
DDI-DrugBank.d328.s46,of,26,27,O
DDI-DrugBank.d328.s46,norethindrone,29,41,B-drug
DDI-DrugBank.d328.s46,and,43,45,O
DDI-DrugBank.d328.s46,ethinyl,47,53,B-drug
DDI-DrugBank.d328.s46,estradiol,55,63,I-drug
DDI-DrugBank.d328.s46,should,65,70,O
DDI-DrugBank.d328.s46,be,72,73,O
DDI-DrugBank.d328.s46,taken,75,79,O
DDI-DrugBank.d328.s46,into,81,84,O
DDI-DrugBank.d328.s46,consideration,86,98,O
DDI-DrugBank.d328.s46,when,100,103,O
DDI-DrugBank.d328.s46,selecting,105,113,O
DDI-DrugBank.d328.s46,an,115,116,O
DDI-DrugBank.d328.s46,oral,118,121,O
DDI-DrugBank.d328.s46,contraceptive,123,135,B-group
DDI-DrugBank.d328.s46,for,137,139,O
DDI-DrugBank.d328.s46,women,141,145,O
DDI-DrugBank.d328.s46,taking,147,152,O
DDI-DrugBank.d328.s46,valdecoxib,154,163,B-drug
DDI-DrugBank.d328.s46,.,164,164,O
DDI-DrugBank.d328.s47,Diazepam,0,7,B-drug
DDI-DrugBank.d328.s47,:,8,8,O
DDI-DrugBank.d328.s47,Diazepam,10,17,B-drug
DDI-DrugBank.d328.s47,(,19,19,O
DDI-DrugBank.d328.s47,Valium,20,25,B-brand
DDI-DrugBank.d328.s47,),26,26,O
DDI-DrugBank.d328.s47,is,28,29,O
DDI-DrugBank.d328.s47,a,31,31,O
DDI-DrugBank.d328.s47,CYP,33,35,O
DDI-DrugBank.d328.s47,3A4,37,39,O
DDI-DrugBank.d328.s47,and,41,43,O
DDI-DrugBank.d328.s47,CYP,45,47,O
DDI-DrugBank.d328.s47,2C19,49,52,O
DDI-DrugBank.d328.s47,substrate,54,62,O
DDI-DrugBank.d328.s47,.,63,63,O
DDI-DrugBank.d328.s48,Plasma,0,5,O
DDI-DrugBank.d328.s48,exposure,7,14,O
DDI-DrugBank.d328.s48,of,16,17,O
DDI-DrugBank.d328.s48,diazepam,19,26,B-drug
DDI-DrugBank.d328.s48,(,28,28,O
DDI-DrugBank.d328.s48,10,29,30,O
DDI-DrugBank.d328.s48,mg,32,33,O
DDI-DrugBank.d328.s48,BID,35,37,O
DDI-DrugBank.d328.s48,),38,38,O
DDI-DrugBank.d328.s48,was,40,42,O
DDI-DrugBank.d328.s48,increased,44,52,O
DDI-DrugBank.d328.s48,by,54,55,O
DDI-DrugBank.d328.s48,28,57,58,O
DDI-DrugBank.d328.s48,%,59,59,O
DDI-DrugBank.d328.s48,following,61,69,O
DDI-DrugBank.d328.s48,administration,71,84,O
DDI-DrugBank.d328.s48,of,86,87,O
DDI-DrugBank.d328.s48,valdecoxib,89,98,B-drug
DDI-DrugBank.d328.s48,(,100,100,O
DDI-DrugBank.d328.s48,40,101,102,O
DDI-DrugBank.d328.s48,mg,104,105,O
DDI-DrugBank.d328.s48,BID,107,109,O
DDI-DrugBank.d328.s48,),110,110,O
DDI-DrugBank.d328.s48,for,112,114,O
DDI-DrugBank.d328.s48,12,116,117,O
DDI-DrugBank.d328.s48,days,119,122,O
DDI-DrugBank.d328.s48,",",123,123,O
DDI-DrugBank.d328.s48,while,125,129,O
DDI-DrugBank.d328.s48,plasma,131,136,O
DDI-DrugBank.d328.s48,exposure,138,145,O
DDI-DrugBank.d328.s48,of,147,148,O
DDI-DrugBank.d328.s48,valdecoxib,150,159,B-drug
DDI-DrugBank.d328.s48,(,161,161,O
DDI-DrugBank.d328.s48,40,162,163,O
DDI-DrugBank.d328.s48,mg,165,166,O
DDI-DrugBank.d328.s48,BID,168,170,O
DDI-DrugBank.d328.s48,),171,171,O
DDI-DrugBank.d328.s48,was,173,175,O
DDI-DrugBank.d328.s48,not,177,179,O
DDI-DrugBank.d328.s48,substantially,181,193,O
DDI-DrugBank.d328.s48,increased,195,203,O
DDI-DrugBank.d328.s48,following,205,213,O
DDI-DrugBank.d328.s48,administration,215,228,O
DDI-DrugBank.d328.s48,of,230,231,O
DDI-DrugBank.d328.s48,diazepam,233,240,B-drug
DDI-DrugBank.d328.s48,(,242,242,O
DDI-DrugBank.d328.s48,10,243,244,O
DDI-DrugBank.d328.s48,mg,246,247,O
DDI-DrugBank.d328.s48,BID,249,251,O
DDI-DrugBank.d328.s48,),252,252,O
DDI-DrugBank.d328.s48,for,254,256,O
DDI-DrugBank.d328.s48,12,258,259,O
DDI-DrugBank.d328.s48,days,261,264,O
DDI-DrugBank.d328.s48,.,265,265,O
DDI-DrugBank.d328.s49,Although,0,7,O
DDI-DrugBank.d328.s49,the,9,11,O
DDI-DrugBank.d328.s49,magnitude,13,21,O
DDI-DrugBank.d328.s49,of,23,24,O
DDI-DrugBank.d328.s49,changes,26,32,O
DDI-DrugBank.d328.s49,in,34,35,O
DDI-DrugBank.d328.s49,diazepam,37,44,B-drug
DDI-DrugBank.d328.s49,plasma,46,51,O
DDI-DrugBank.d328.s49,exposure,53,60,O
DDI-DrugBank.d328.s49,when,62,65,O
DDI-DrugBank.d328.s49,coadministered,67,80,O
DDI-DrugBank.d328.s49,with,82,85,O
DDI-DrugBank.d328.s49,valdecoxib,87,96,B-drug
DDI-DrugBank.d328.s49,were,98,101,O
DDI-DrugBank.d328.s49,not,103,105,O
DDI-DrugBank.d328.s49,sufficient,107,116,O
DDI-DrugBank.d328.s49,to,118,119,O
DDI-DrugBank.d328.s49,warrant,121,127,O
DDI-DrugBank.d328.s49,dosage,129,134,O
DDI-DrugBank.d328.s49,adjustments,136,146,O
DDI-DrugBank.d328.s49,",",147,147,O
DDI-DrugBank.d328.s49,patients,149,156,O
DDI-DrugBank.d328.s49,may,158,160,O
DDI-DrugBank.d328.s49,experience,162,171,O
DDI-DrugBank.d328.s49,enhanced,173,180,O
DDI-DrugBank.d328.s49,sedative,182,189,O
DDI-DrugBank.d328.s49,side,191,194,O
DDI-DrugBank.d328.s49,effects,196,202,O
DDI-DrugBank.d328.s49,caused,204,209,O
DDI-DrugBank.d328.s49,by,211,212,O
DDI-DrugBank.d328.s49,increased,214,222,O
DDI-DrugBank.d328.s49,exposure,224,231,O
DDI-DrugBank.d328.s49,of,233,234,O
DDI-DrugBank.d328.s49,diazepam,236,243,B-drug
DDI-DrugBank.d328.s49,under,245,249,O
DDI-DrugBank.d328.s49,this,251,254,O
DDI-DrugBank.d328.s49,circumstance,256,267,O
DDI-DrugBank.d328.s49,.,268,268,O
DDI-DrugBank.d328.s50,Patients,0,7,O
DDI-DrugBank.d328.s50,should,9,14,O
DDI-DrugBank.d328.s50,be,16,17,O
DDI-DrugBank.d328.s50,cautioned,19,27,O
DDI-DrugBank.d328.s50,against,29,35,O
DDI-DrugBank.d328.s50,engaging,37,44,O
DDI-DrugBank.d328.s50,in,46,47,O
DDI-DrugBank.d328.s50,hazardous,49,57,O
DDI-DrugBank.d328.s50,activities,59,68,O
DDI-DrugBank.d328.s50,requiring,70,78,O
DDI-DrugBank.d328.s50,complete,80,87,O
DDI-DrugBank.d328.s50,mental,89,94,O
DDI-DrugBank.d328.s50,alertness,96,104,O
DDI-DrugBank.d328.s50,such,106,109,O
DDI-DrugBank.d328.s50,as,111,112,O
DDI-DrugBank.d328.s50,operating,114,122,O
DDI-DrugBank.d328.s50,machinery,124,132,O
DDI-DrugBank.d328.s50,or,134,135,O
DDI-DrugBank.d328.s50,driving,137,143,O
DDI-DrugBank.d328.s50,a,145,145,O
DDI-DrugBank.d328.s50,motor,147,151,O
DDI-DrugBank.d328.s50,vehicle,153,159,O
DDI-DrugBank.d328.s50,.,160,160,O
DDI-DrugBank.d759.s0,Limited,0,6,O
DDI-DrugBank.d759.s0,evidence,8,15,O
DDI-DrugBank.d759.s0,suggests,17,24,O
DDI-DrugBank.d759.s0,that,26,29,O
DDI-DrugBank.d759.s0,ascorbic,31,38,B-drug
DDI-DrugBank.d759.s0,acid,40,43,I-drug
DDI-DrugBank.d759.s0,may,45,47,O
DDI-DrugBank.d759.s0,influence,49,57,O
DDI-DrugBank.d759.s0,the,59,61,O
DDI-DrugBank.d759.s0,intensity,63,71,O
DDI-DrugBank.d759.s0,and,73,75,O
DDI-DrugBank.d759.s0,duration,77,84,O
DDI-DrugBank.d759.s0,of,86,87,O
DDI-DrugBank.d759.s0,action,89,94,O
DDI-DrugBank.d759.s0,of,96,97,O
DDI-DrugBank.d759.s0,bishydroxycoumarin,99,116,B-drug
DDI-DrugBank.d759.s0,.,117,117,O
